data_2ld4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ld4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.832 0.349 . . . . 2.35 110.83 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -122.24 22.55 10.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 3.48 110.842 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.31 40.14 52.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.29 112.529 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.51 159.26 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 1.61 111.15 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.43 163.48 39.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 1.73 110.859 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.47 126.1 35.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 1.65 111.096 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.69 -0.0 20.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.72 -0.752 . . . . 0.3 112.477 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -117.55 170.64 8.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.827 0.346 . . . . 1.35 110.902 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.81 113.79 27.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 2.34 110.856 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.5 125.89 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 3.06 111.177 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.16 128.44 50.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 1.53 111.124 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.32 120.84 51.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 1.55 111.166 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.5 t -104.31 120.87 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 1.6 111.128 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.4 p-90 -120.48 168.99 10.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.23 110.898 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.76 -169.93 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 1.75 110.813 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -57.41 -35.56 70.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 4.65 110.886 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.54 -9.9 59.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 1.49 110.837 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.04 94.44 10.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.686 0.755 . . . . 0.79 110.912 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 142.03 46.72 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.683 2.255 . . . . 0.22 112.34 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.0 t -48.99 -32.57 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 1.49 111.12 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.38 -52.93 41.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 2.67 110.851 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.55 -44.96 10.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 1.5 111.048 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.45 -61.25 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 1.64 110.917 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -35.95 24.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 4.48 110.87 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.41 -47.25 44.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.786 -0.721 . . . . 0.21 112.439 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 mt -61.94 -38.61 89.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 1.61 110.928 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.5 m -78.09 -31.35 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 1.67 111.155 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.33 -58.0 9.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 1.59 110.84 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -40.05 74.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 2.72 110.909 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.4 mt -73.12 -25.07 60.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 1.55 110.891 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -78.37 -25.26 46.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.44 110.877 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.49 -30.25 17.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 1.49 111.153 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -90.75 -35.18 15.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 1.61 110.904 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.4 -46.9 4.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 1.4 111.135 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.31 -13.74 50.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.73 . . . . 0.26 112.477 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -62.58 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 2.32 110.882 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -96.01 -38.11 10.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 2.03 110.903 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.56 -132.98 6.52 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.759 -0.734 . . . . 0.27 112.461 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -149.22 152.67 36.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 2.89 110.906 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.8 t -137.68 122.81 24.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 1.4 111.1 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -112.14 157.63 20.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 1.13 110.844 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.58 135.19 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 1.66 111.132 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -142.51 151.1 41.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 2.02 110.847 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -103.26 134.59 46.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.63 110.861 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 mt -51.89 -36.48 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 1.56 111.15 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -32.84 69.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 2.99 110.869 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.52 20.92 16.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 3.52 110.93 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -27.8 3.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 2.02 110.928 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -55.1 -32.7 62.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 2.1 110.888 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -84.86 -15.33 45.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 1.11 110.929 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.0 m -63.77 -12.61 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 1.78 110.892 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.83 63.1 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 1.47 111.083 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -64.46 -70.17 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.48 110.873 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.12 -168.2 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 2.05 110.914 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -106.35 128.12 53.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 2.01 110.846 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 48.93 77.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 1.35 110.843 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.7 p -130.12 -34.2 1.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.99 110.845 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -98.99 120.25 39.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 2.52 110.886 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.13 -20.72 62.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 1.5 110.842 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.2 mt -146.62 144.5 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 1.56 111.153 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.2 mm -134.69 131.71 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 1.58 111.118 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.94 137.06 52.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 1.44 110.976 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.47 101.64 6.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 1.4 110.873 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.63 74.66 0.27 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.804 -0.713 . . . . 0.16 112.428 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.63 56.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 1.49 110.893 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.0 159.79 60.1 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.621 0.724 . . . . 1.59 111.2 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 124.14 10.77 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.25 112.32 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.5 7.11 88.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.27 112.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.0 p -55.58 151.49 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.972 0.415 . . . . 1.15 110.829 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.7 p -140.33 108.96 5.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 1.55 111.132 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.79 153.81 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 1.58 111.126 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mt -132.25 105.78 7.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 1.45 110.916 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -82.35 152.5 26.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.25 110.845 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.0 m -131.94 176.98 7.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 1.51 110.843 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -37.27 45.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 1.25 111.079 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.25 -44.41 96.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 2.07 110.883 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -75.11 -54.85 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 1.5 111.133 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 mt -51.08 -38.92 54.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 1.49 110.906 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.84 -55.2 24.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 1.5 111.101 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -44.96 79.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 2.82 110.887 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.9 mm -55.08 -67.76 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 1.58 111.132 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.07 -40.1 57.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 1.38 111.067 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -52.95 -49.06 66.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 3.84 110.883 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.7 pt -87.02 -5.3 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 1.49 111.162 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.92 117.3 21.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 1.57 110.887 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -56.81 158.69 8.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.598 0.714 . . . . 3.08 110.917 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 114.03 3.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 0.21 112.365 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.03 3.27 54.75 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.15 112.504 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.38 -162.8 17.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.784 -0.722 . . . . 0.14 112.502 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.3 m -137.01 155.5 49.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.347 . . . . 1.55 110.872 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -139.56 115.55 10.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 1.52 110.893 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -110.15 132.1 54.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 3.34 110.873 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.78 158.76 44.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 1.42 110.883 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.38 128.29 44.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 2.68 110.905 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.69 146.19 19.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 2.26 110.914 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.07 37.04 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.656 2.238 . . . . 0.18 112.365 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.9 m -120.71 146.55 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 1.57 111.098 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -110.59 132.58 54.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 1.93 110.851 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.2 p -105.15 25.9 10.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 1.84 111.145 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.63 25.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 1.91 111.106 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.66 159.79 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 1.86 111.123 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.66 -178.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 1.79 110.889 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -66.81 -68.27 0.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 2.6 110.873 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -60.0 -75.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 3.04 110.859 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.81 -167.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 2.61 110.863 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -7.48 58.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 2.73 110.886 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.44 141.02 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 1.68 111.106 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -63.17 115.09 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 3.6 110.895 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.1 p -83.19 -179.8 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 1.61 111.113 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.63 55.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 1.59 111.091 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.19 -48.9 77.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 1.45 110.887 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -37.92 75.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 3.59 110.888 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.17 -55.05 20.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 1.59 110.912 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.8 m -57.37 -45.59 84.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 1.51 110.897 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -42.42 91.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 1.54 110.852 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.89 97.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 1.64 111.075 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.52 -51.44 62.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 1.49 110.916 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.5 m -62.28 -31.55 72.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 1.42 111.113 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.04 -10.27 53.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 1.8 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.5 6.51 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 2.39 110.864 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.82 6.0 32.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.49 112.465 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.69 171.63 7.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 1.63 110.942 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.4 m -150.14 171.15 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 1.57 111.144 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 51.76 44.29 29.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 1.85 110.903 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.6 t -81.09 143.03 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 1.53 111.109 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 160.22 8.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 2.58 110.902 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -77.75 146.18 36.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 2.5 110.906 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.6 -36.96 6.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 1.52 110.964 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.85 176.21 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 1.16 110.932 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -132.87 137.98 46.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 4.87 110.845 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -125.74 138.07 31.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.615 0.722 . . . . 1.82 110.888 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 165.04 32.27 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.729 2.286 . . . . 0.26 112.35 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.03 126.48 43.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 1.57 110.944 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.52 161.27 23.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.619 0.723 . . . . 2.75 111.107 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -24.57 29.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.241 . . . . 0.34 112.353 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -85.49 -22.54 28.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 2.54 110.886 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -87.51 -52.86 5.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 2.5 110.901 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -49.62 -40.34 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 1.5 111.169 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -33.49 74.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 1.38 110.921 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -46.19 67.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 1.15 110.888 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.37 -30.71 48.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 1.56 111.101 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -76.21 -31.45 58.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 2.34 110.862 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -89.7 -20.44 23.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 1.63 110.841 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.66 -32.87 13.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.29 110.849 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.19 -54.17 1.38 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 1.64 110.934 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.51 13.75 2.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.32 112.483 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -70.63 122.01 18.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 1.06 110.826 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -151.53 105.32 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 2.4 110.837 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.1 t -160.53 173.82 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 1.07 110.86 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.71 -17.59 14.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 1.56 110.858 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.76 12.52 29.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 1.53 110.911 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.61 165.18 21.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 1.56 110.952 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -173.44 130.24 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 1.53 110.973 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -74.34 133.44 42.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 3.2 110.877 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.04 145.19 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 1.49 111.156 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -98.97 129.26 45.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.93 110.957 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.54 151.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 1.44 111.102 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.1 t -134.91 161.56 34.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 1.44 111.141 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.43 139.5 7.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.21 112.476 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -97.56 140.62 31.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.368 . . . . 2.55 110.889 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -80.71 134.79 53.28 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.599 0.714 . . . . 3.46 110.877 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 119.19 6.18 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.39 112.301 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.37 110.883 179.985 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.77 0.319 . . . . 1.97 110.802 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -122.14 21.4 10.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 2.68 110.898 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 54.46 41.82 73.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.768 -0.73 . . . . 0.35 112.451 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.14 160.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 1.48 111.137 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.62 168.99 25.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 2.91 110.831 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.8 132.28 35.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 1.64 111.034 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.05 1.31 30.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.34 112.482 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -118.18 166.95 11.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.781 0.324 . . . . 1.29 110.933 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.67 113.05 26.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 3.8 110.899 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -117.35 132.52 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 2.85 111.136 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.03 125.29 51.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 1.3 111.057 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.35 120.37 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 1.55 111.144 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.31 118.45 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 1.47 111.134 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -118.6 168.85 10.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 0.22 110.912 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -151.48 -169.91 3.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.267 -0.424 . . . . 1.85 110.857 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -57.63 -35.49 70.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 3.65 110.882 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.61 -9.51 58.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 1.48 110.848 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.92 94.62 10.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.748 0.785 . . . . 0.76 110.923 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 142.11 47.33 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.657 2.238 . . . . 0.25 112.34 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.13 -32.57 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 1.65 111.108 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.28 -52.92 40.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 2.59 110.907 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.9 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 1.47 111.155 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.6 -61.41 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 1.46 110.918 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -49.6 -36.01 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 3.33 110.901 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.21 -47.22 45.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 0.22 112.47 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.96 -38.57 89.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.755 0.312 . . . . 1.61 110.87 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.0 m -78.21 -31.09 16.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 1.67 111.079 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -62.54 -57.86 9.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 1.69 110.852 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -40.01 75.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 2.71 110.94 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.1 mt -73.17 -24.77 60.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 1.76 110.89 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.5 -25.03 45.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.45 110.825 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.74 -30.36 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 1.3 111.026 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.81 -34.93 15.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 1.7 110.905 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 -46.06 4.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 1.53 111.139 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.83 -12.62 54.42 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.828 -0.701 . . . . 0.25 112.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.61 -62.6 1.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.754 0.311 . . . . 2.37 110.938 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -96.33 -37.85 10.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 2.56 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.13 -129.87 5.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 0.26 112.497 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -152.59 152.03 31.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.88 0.371 . . . . 2.89 110.885 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.0 t -136.33 124.83 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 1.61 111.036 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -114.07 155.83 25.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 1.47 110.9 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.52 134.8 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 1.58 111.141 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -142.76 151.3 41.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 1.26 110.864 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -103.3 134.99 45.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.63 110.906 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.4 mt -52.17 -36.12 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 1.4 111.128 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -71.54 -32.25 67.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 2.66 110.877 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -103.18 20.11 18.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 3.61 110.856 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.32 -28.08 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 2.08 110.899 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.53 -33.46 63.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 2.13 110.9 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -84.06 -15.15 48.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 1.06 110.969 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.5 m -66.55 -10.13 41.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 1.72 110.859 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.5 63.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 1.55 111.059 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -64.02 -67.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.46 110.873 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.85 -178.22 6.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 3.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -92.63 130.52 38.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 1.83 110.885 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 t 51.79 83.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 2.21 110.879 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.4 p -136.06 -39.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 1.04 110.773 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -100.51 122.25 42.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 3.58 110.975 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.73 -21.9 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 1.73 110.853 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.4 mt -145.34 144.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 1.54 111.087 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.2 mm -133.75 132.7 56.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 1.58 111.104 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -114.58 136.88 52.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 1.54 110.916 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.44 100.33 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 1.24 110.854 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.54 74.97 0.24 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.16 112.446 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.45 58.19 0.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.866 0.365 . . . . 1.58 110.928 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.0 159.65 63.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.611 0.719 . . . . 1.63 111.146 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 116.73 4.7 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.601 2.201 . . . . 0.26 112.355 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.46 7.13 69.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.841 -0.695 . . . . 0.19 112.465 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.55 150.24 12.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.939 0.4 . . . . 1.22 110.87 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.5 p -138.98 108.45 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 1.51 111.127 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.14 153.44 18.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 1.49 111.239 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 mt -132.77 104.57 6.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 1.53 110.856 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -81.16 153.74 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.26 110.885 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.1 m -131.56 -176.29 3.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 1.36 110.925 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.8 -36.93 70.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 1.49 111.106 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.59 -46.48 88.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 2.32 110.874 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.04 -54.96 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 1.61 111.079 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.2 mt -50.72 -40.18 53.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 1.49 110.96 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.02 -53.94 35.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.053 -0.521 . . . . 1.48 111.15 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.23 -44.8 88.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 3.01 110.868 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.7 mm -55.67 -68.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 1.54 111.099 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.33 -37.82 49.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 1.54 111.187 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -55.11 -49.83 70.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 4.46 110.898 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.21 -7.02 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 1.68 111.108 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.95 111.78 14.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.142 -0.481 . . . . 1.58 110.9 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -51.46 159.53 1.17 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.59 0.71 . . . . 2.96 110.852 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 114.44 3.7 Favored 'Trans proline' 0 N--CA 1.466 -0.113 0 C-N-CA 122.786 2.324 . . . . 0.17 112.342 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.77 2.41 56.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.662 -0.78 . . . . 0.15 112.416 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.28 -162.57 13.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.647 -0.787 . . . . 0.13 112.551 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.2 m -138.32 156.03 48.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.832 0.349 . . . . 1.43 110.9 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -140.01 114.31 9.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 1.44 110.974 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -108.46 132.34 53.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 2.91 110.897 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.51 162.31 39.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 1.52 110.845 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.05 129.35 35.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 2.67 110.842 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.72 148.65 20.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.655 0.74 . . . . 3.71 110.854 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 140.88 43.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.61 2.206 . . . . 0.18 112.309 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.9 m -125.86 146.67 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 1.58 111.099 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -108.89 132.75 53.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 2.06 110.953 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p -90.94 -42.68 10.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 2.1 111.091 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.5 40.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 1.68 111.111 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.4 t -148.03 150.05 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 1.63 111.069 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.86 171.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.69 110.854 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -66.37 -54.17 27.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 3.07 110.96 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -70.66 -75.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 2.61 110.837 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t 52.31 -169.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.034 0.445 . . . . 3.15 110.841 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -81.71 -4.69 56.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 2.63 110.877 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.12 150.4 21.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 1.61 111.043 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.18 119.2 13.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 4.09 110.844 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 62.8 p -91.81 178.86 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.52 111.201 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.4 -53.61 55.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 1.6 111.127 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -61.06 -47.16 87.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 1.4 110.819 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -42.25 91.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 3.84 110.889 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.82 -57.43 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 1.92 110.886 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 66.6 m -52.05 -44.97 64.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 1.62 110.888 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -42.06 87.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 1.47 110.824 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.11 97.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 1.47 111.095 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.2 -50.93 62.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 1.52 110.987 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.0 m -61.99 -33.31 74.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 1.35 111.138 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.87 -10.45 53.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 1.77 110.897 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.72 5.25 29.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 2.39 110.872 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.81 11.23 25.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.647 -0.787 . . . . 0.68 112.38 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.13 171.0 7.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 1.57 110.883 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.2 m -150.9 170.19 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 1.51 111.168 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 53.01 44.41 30.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 2.32 110.92 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.4 t -81.04 142.94 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 1.61 111.174 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.93 158.58 7.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 2.6 110.866 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -77.23 145.68 37.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 2.28 110.784 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.15 -35.55 7.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 1.62 110.975 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.1 176.42 12.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 1.15 110.879 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.86 137.4 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 4.74 110.907 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -124.02 137.65 29.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 1.83 110.874 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 165.02 32.34 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.693 2.262 . . . . 0.23 112.353 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.15 127.47 44.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 1.51 110.914 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.21 161.1 24.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 2.22 111.145 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -28.79 24.83 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.625 2.217 . . . . 0.38 112.307 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -85.24 -17.86 35.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 2.77 110.924 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.23 -53.25 4.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 2.33 110.909 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.22 -40.65 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 1.61 111.123 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -34.86 76.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 1.21 110.926 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.86 -46.18 72.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 1.35 110.904 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.38 -30.19 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.077 -0.51 . . . . 1.53 111.2 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -75.64 -32.59 60.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 2.31 110.834 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -89.54 -20.18 24.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 1.72 110.877 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -94.11 -32.81 13.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.32 110.887 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -127.98 -54.25 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 1.6 110.85 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.65 8.02 2.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.37 112.459 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -70.2 121.26 17.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 0.95 110.822 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -152.32 104.72 2.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 3.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 t -161.03 172.13 17.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.06 110.879 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.28 -11.57 15.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 1.57 110.864 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -99.92 14.29 30.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 1.94 110.923 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.39 165.86 15.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 1.63 110.866 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -171.46 130.06 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 1.57 111.023 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -72.7 132.31 43.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 3.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.17 143.89 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 1.57 111.148 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -98.69 133.08 43.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 1.97 110.848 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.73 148.14 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 1.81 111.205 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.1 t -132.62 156.06 47.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 1.76 111.122 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -145.58 139.11 8.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.19 112.465 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -96.74 132.7 42.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.36 . . . . 4.66 110.926 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 135.3 77.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.597 0.713 . . . . 2.17 110.887 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 128.22 15.6 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.631 2.221 . . . . 0.31 112.32 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.3 110.887 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.804 0.335 . . . . 3.23 110.926 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -93.72 -14.98 25.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 3.59 110.869 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.5 48.59 10.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.725 -0.75 . . . . 0.74 112.45 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mp -88.32 162.01 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.37 . . . . 1.83 111.136 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.34 170.01 20.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 1.83 110.811 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.67 133.36 34.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 1.63 111.109 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.21 -6.07 30.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.781 -0.723 . . . . 0.34 112.536 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -111.88 168.96 9.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 1.4 110.899 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.04 114.32 28.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 2.25 110.872 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.2 t -119.3 126.97 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 3.05 111.149 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.0 128.22 51.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 1.67 111.153 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.38 119.23 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 1.56 111.159 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.84 118.14 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 1.59 111.171 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -118.19 169.03 10.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.35 110.952 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -151.67 -170.47 3.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 1.83 110.875 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -35.56 69.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 7.25 110.901 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.61 -9.36 58.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.62 110.87 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.93 94.43 10.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.613 0.72 . . . . 0.8 110.823 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 142.37 47.55 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.678 2.252 . . . . 0.32 112.45 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -49.07 -32.68 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 1.71 111.042 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -51.09 -52.93 38.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 2.51 110.878 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.62 -44.93 10.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 1.53 111.067 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.76 -61.3 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 1.52 110.929 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.55 -37.07 25.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 3.51 110.878 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -47.29 50.35 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.736 -0.745 . . . . 0.29 112.437 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.5 mt -61.75 -38.84 89.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 1.62 110.934 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.13 -30.77 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 1.77 111.11 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.52 -58.27 8.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 1.58 110.875 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -39.57 74.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 2.69 110.884 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.36 -25.37 60.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 1.38 110.872 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -77.63 -24.81 49.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 0.48 110.964 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.66 -29.7 16.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 1.78 111.179 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.49 -31.05 16.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 1.58 110.912 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.84 -45.47 4.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 1.46 111.15 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.44 -12.42 51.47 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.722 -0.751 . . . . 0.31 112.529 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.79 -62.71 1.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.329 . . . . 2.47 110.822 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -99.57 -36.5 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 2.65 110.861 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.22 -129.46 4.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.741 . . . . 0.26 112.448 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -154.9 152.01 29.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.357 . . . . 2.96 110.882 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.9 t -136.0 122.97 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 1.42 111.165 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.6 t -113.09 154.03 27.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 1.06 110.829 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -117.14 134.28 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 1.43 111.208 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -142.04 151.24 42.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 1.26 110.882 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -103.25 134.95 45.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.67 110.862 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.5 mt -52.29 -36.54 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 1.67 111.092 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -70.79 -32.44 69.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 2.67 110.924 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.75 20.71 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 3.64 110.855 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.09 -27.84 3.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 2.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -55.01 -33.09 62.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 1.81 110.937 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -84.81 -15.53 44.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 1.16 110.937 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.0 m -63.69 -12.73 36.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 1.79 110.899 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.13 61.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.51 111.082 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -63.03 -69.54 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.48 110.869 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.02 -168.75 2.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 2.16 110.957 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -107.37 131.02 54.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 1.73 110.923 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.25 73.5 0.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 1.4 110.829 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.2 p -127.76 -34.46 2.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.95 110.836 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -99.29 118.34 35.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 2.52 110.849 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.78 -20.89 63.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.04 -0.527 . . . . 1.75 110.939 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.3 mt -146.98 144.88 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 1.6 111.116 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mm -135.09 131.58 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 1.55 111.104 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.68 137.34 51.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 1.53 110.883 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.61 100.55 5.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 1.17 110.844 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.61 74.28 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 0.18 112.514 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.03 59.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.348 . . . . 1.65 110.879 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.84 159.77 66.7 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.542 0.687 . . . . 1.42 111.124 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 116.31 4.49 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.657 2.238 . . . . 0.26 112.426 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.58 6.42 68.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.22 112.493 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -56.03 150.55 13.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 1.04 110.896 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.2 p -140.24 108.59 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 1.42 111.148 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.15 147.67 12.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 1.64 111.049 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 mt -126.23 99.9 6.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 1.65 110.874 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -76.71 149.01 36.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.24 110.948 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.9 m -128.25 177.33 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.99 110.885 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.17 -37.77 48.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 1.67 111.101 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.82 -44.53 96.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.448 . . . . 2.08 110.882 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -74.94 -55.25 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 1.61 111.175 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.0 mt -50.71 -38.64 48.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 1.6 110.876 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.19 -56.54 15.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 1.68 111.122 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.03 -42.39 72.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 2.76 110.862 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mm -57.66 -68.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 1.55 111.097 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.71 -36.21 35.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 1.47 111.051 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -56.84 -52.3 65.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 3.76 110.881 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.6 pt -82.29 -6.5 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 1.77 111.081 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.8 127.97 32.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 1.57 110.93 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -66.82 159.76 73.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.582 0.705 . . . . 3.03 110.835 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 114.33 3.67 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.21 112.328 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.8 2.75 56.2 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.772 -0.728 . . . . 0.24 112.531 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.76 -161.36 10.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.805 -0.712 . . . . 0.16 112.484 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 15.7 m -139.08 153.7 48.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 2.03 110.954 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -138.06 114.47 10.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 1.59 110.883 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -108.79 133.47 52.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 2.89 110.956 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.51 159.12 44.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.445 . . . . 1.59 110.919 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 125.15 38.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 2.76 110.886 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.97 147.44 24.02 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.649 0.738 . . . . 2.48 110.897 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 145.23 56.25 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.654 2.236 . . . . 0.21 112.332 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.8 m -131.41 146.67 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 1.62 111.154 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -104.88 132.97 50.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 2.09 110.899 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 p -105.71 26.01 10.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 1.79 111.083 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.29 26.51 0.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 1.78 111.098 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.19 159.48 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 1.87 111.152 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.24 -179.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 1.97 110.837 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -66.09 -67.93 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 2.92 110.897 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -60.99 -75.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 3.59 110.913 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 54.63 -166.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 2.33 110.855 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -79.9 -7.97 59.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 2.94 110.872 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.0 m -145.16 150.13 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 1.85 111.079 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -68.29 113.29 5.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.135 -0.484 . . . . 3.48 110.874 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.2 p -84.42 179.69 7.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 1.77 111.108 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.49 -53.34 59.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 1.62 111.136 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.74 -49.18 78.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 1.16 110.922 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -58.37 -40.91 83.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 3.59 110.909 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.97 -54.83 36.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 1.66 110.84 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 70.8 m -55.45 -47.79 75.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 2.11 110.89 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 1.24 110.809 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.99 98.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 1.54 111.076 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.9 tp -65.8 -50.23 65.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 1.63 110.922 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.1 m -65.52 -30.73 71.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.108 -0.496 . . . . 1.26 111.204 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.5 mt -86.99 -10.47 53.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 1.78 110.942 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.19 5.52 29.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 2.46 110.847 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.04 5.19 35.47 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.747 -0.74 . . . . 0.56 112.468 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.45 172.48 6.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 1.57 110.88 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.2 m -151.14 171.38 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 1.62 111.078 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 55.16 43.53 29.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 2.04 110.924 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.9 t -77.7 140.91 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 1.59 111.124 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.16 159.79 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 2.6 110.899 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.08 147.44 30.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 2.18 110.939 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mp -107.45 -36.43 6.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 1.52 110.957 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 176.24 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 1.15 110.9 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -132.35 137.27 47.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 4.98 110.942 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -124.38 138.72 31.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.635 0.731 . . . . 1.39 110.902 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 163.43 38.39 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.653 2.235 . . . . 0.3 112.299 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.65 127.09 41.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 1.48 110.95 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.53 160.53 27.2 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.554 0.693 . . . . 2.23 111.105 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -29.2 24.53 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.68 2.253 . . . . 0.51 112.316 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -84.97 -19.06 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 2.98 110.876 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -53.58 5.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 2.17 110.905 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.5 -41.93 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 1.54 111.158 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -33.86 72.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 1.37 110.872 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.94 -44.93 68.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 1.34 110.796 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.97 -31.59 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 1.53 111.188 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -76.65 -30.9 57.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.076 -0.511 . . . . 2.94 110.929 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -89.73 -20.62 23.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.221 -0.445 . . . . 1.78 110.919 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -95.01 -32.51 13.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.51 110.857 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mp -127.18 -54.06 1.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 1.68 110.891 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.37 10.51 2.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.71 -0.757 . . . . 0.48 112.472 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -70.08 120.42 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.711 0.291 . . . . 1.63 110.869 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.44 112.3 4.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 3.02 110.897 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.66 172.17 17.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 1.63 110.865 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.56 -9.35 16.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 2.18 110.86 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -110.63 13.35 22.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 1.85 110.925 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.57 164.86 25.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 1.63 110.912 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -173.92 130.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 1.46 110.901 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -74.29 131.77 41.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 3.19 110.879 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.94 140.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.54 111.114 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -93.65 128.5 39.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 2.6 110.895 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.01 151.73 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.58 111.239 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.6 t -131.4 159.32 38.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.252 -0.431 . . . . 1.48 111.168 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.33 129.9 3.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.774 -0.727 . . . . 0.3 112.527 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -89.52 139.28 30.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 2.4 110.925 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.24 135.27 50.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.587 0.708 . . . . 2.75 110.906 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 129.65 18.03 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.731 2.287 . . . . 0.43 112.361 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.298 -0.41 . . . . 0.49 110.922 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.864 0.364 . . . . 2.2 110.953 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -122.33 21.64 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 2.67 110.89 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.82 39.98 56.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.78 -0.724 . . . . 0.26 112.507 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.97 159.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.857 0.36 . . . . 1.42 111.164 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.55 162.21 41.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.57 110.934 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.4 126.34 35.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 1.61 111.135 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.06 -2.59 19.24 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.735 -0.745 . . . . 0.27 112.433 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -115.49 170.49 8.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.842 0.353 . . . . 1.37 110.9 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.87 114.14 28.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 3.86 110.929 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.4 t -119.28 125.38 74.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.117 -0.492 . . . . 2.9 111.154 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.79 129.96 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 1.37 111.125 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.3 t -101.3 119.92 50.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 1.55 111.146 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.24 118.35 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 1.51 111.074 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -118.5 169.24 9.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.498 . . . . 0.22 110.898 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -151.49 -170.72 3.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.483 . . . . 1.78 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -57.06 -35.67 69.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 3.95 110.9 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -73.28 -9.59 58.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 1.54 110.848 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.02 94.44 10.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.647 0.737 . . . . 0.88 110.855 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 142.23 47.11 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.662 2.242 . . . . 0.23 112.359 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -48.83 -32.75 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 1.63 111.122 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.13 -53.04 37.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 2.69 110.893 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -44.89 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 1.58 111.055 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.6 -61.46 2.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 1.44 110.976 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -36.96 24.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 3.67 110.867 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.72 -47.14 50.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 0.21 112.523 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.83 -39.29 91.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.768 0.318 . . . . 1.56 110.872 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.5 m -77.69 -31.19 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 1.73 111.075 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.29 -58.56 7.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 1.55 110.845 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -39.94 74.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 2.65 110.945 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.07 -24.67 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 1.34 110.996 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -78.55 -25.18 45.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.947 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 -29.9 17.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 1.5 111.163 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.42 -35.21 14.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 1.49 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.9 -45.86 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 1.44 111.091 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.47 -12.87 53.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.27 112.456 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.17 -62.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 3.37 110.897 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -90.08 -40.85 12.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.96 110.921 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.43 -130.04 6.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.741 -0.742 . . . . 0.25 112.553 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -150.23 152.87 35.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.887 0.375 . . . . 2.92 110.928 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.4 125.44 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 1.5 111.146 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -114.53 156.89 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 1.15 110.814 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -118.53 135.04 60.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 1.53 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -143.14 151.31 40.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 2.01 110.868 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -103.22 134.9 45.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.193 -0.458 . . . . 0.62 110.854 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mt -52.4 -36.51 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 1.41 111.108 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -70.87 -32.13 69.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 2.73 110.868 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.87 20.62 17.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 3.54 110.92 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.09 -27.94 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 2.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.26 -33.37 63.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 1.95 110.938 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -84.62 -15.14 46.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 1.18 110.935 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.5 m -64.64 -11.61 37.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 1.75 110.796 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.33 61.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 1.5 111.023 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -62.8 -69.74 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.51 110.865 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.97 -168.64 2.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 2.09 111.045 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.13 130.55 54.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.335 -0.393 . . . . 1.81 110.944 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.38 73.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 1.35 110.853 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.8 p -127.93 -34.59 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.93 110.832 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -98.85 117.9 34.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 2.53 110.921 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.41 -20.36 63.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 1.48 110.887 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mt -148.05 144.91 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 1.65 111.142 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.6 mm -135.28 130.1 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 1.55 111.113 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.46 137.29 48.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 1.52 110.897 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.56 100.63 5.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 1.17 110.84 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.74 76.0 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.15 112.458 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.35 58.21 0.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 1.57 110.902 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.54 160.11 62.25 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 121.618 0.723 . . . . 1.5 111.18 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 116.64 4.66 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.672 2.248 . . . . 0.26 112.361 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.1 7.39 70.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.18 112.537 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.49 149.75 13.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.408 . . . . 1.41 110.839 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.1 p -138.73 108.58 6.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 1.52 111.117 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.96 146.52 10.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 1.5 111.102 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mt -125.36 103.37 7.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 1.48 110.843 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -79.75 151.49 30.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.24 110.809 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -130.59 177.14 7.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 1.36 110.885 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.99 51.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 1.58 111.166 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -61.48 -45.68 93.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 1.75 110.885 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -73.63 -55.41 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 1.66 111.07 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.0 mt -50.63 -38.68 47.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 1.66 110.875 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.8 -55.13 29.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 1.46 111.056 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -42.34 77.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 2.76 110.935 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.9 mm -58.62 -68.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 1.63 111.054 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.74 -36.06 24.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 1.32 111.028 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -54.58 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 3.44 110.861 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 pt -79.39 -5.89 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 1.48 111.192 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.73 127.99 33.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 1.84 110.847 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -65.7 158.77 72.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.669 0.747 . . . . 3.07 110.867 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 114.1 3.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.246 . . . . 0.22 112.34 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.28 2.72 54.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.737 . . . . 0.17 112.476 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.63 -163.48 16.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.15 112.505 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 67.6 m -135.75 153.48 51.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 1.57 110.833 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -137.56 114.36 10.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 1.54 110.88 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -108.82 133.34 53.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 3.34 110.949 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.86 164.11 35.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 1.41 110.959 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.74 130.46 36.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 2.78 110.915 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.95 147.75 18.68 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.588 0.709 . . . . 2.34 110.896 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 141.58 45.39 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.594 2.196 . . . . 0.18 112.361 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.78 146.66 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 1.57 111.135 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -109.7 132.64 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 2.07 110.827 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.4 p -91.62 -42.23 10.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 2.05 111.061 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.77 39.94 1.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.259 -0.428 . . . . 1.71 111.096 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.7 t -147.59 150.4 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.187 -0.461 . . . . 1.65 111.099 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.94 170.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 1.77 110.836 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -64.35 -57.39 9.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 3.21 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.99 -75.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 2.51 110.87 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t 52.38 -168.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 2.83 110.906 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.37 -6.8 58.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 3.12 110.865 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.09 142.63 31.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 1.69 111.248 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -65.35 111.05 2.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.21 -0.45 . . . . 3.36 110.907 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.5 p -82.13 -177.72 6.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 1.63 111.161 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.13 -52.32 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 1.37 111.132 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.32 -49.77 75.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.91 110.877 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -56.87 -38.86 73.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 2.35 110.838 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.89 -54.56 28.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 1.53 110.927 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.2 m -58.13 -46.24 85.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 2.01 110.925 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -43.0 94.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.498 . . . . 1.22 110.919 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.51 98.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 1.48 111.107 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.5 tp -65.13 -51.65 59.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.216 -0.447 . . . . 1.58 110.909 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.1 m -63.92 -31.16 72.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 1.45 111.084 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.3 mt -86.79 -10.48 53.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 2.05 110.893 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.12 5.69 28.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 2.35 110.88 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.13 5.12 35.33 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.806 -0.712 . . . . 0.48 112.523 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tp -105.57 173.11 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 1.64 110.956 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.7 m -151.51 173.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 1.57 111.205 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 51.6 45.15 28.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 1.99 110.874 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.3 t -80.75 143.06 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 1.65 111.142 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.92 160.49 8.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 3.64 110.915 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -80.26 146.43 31.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 2.25 110.916 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mp -104.23 -37.1 7.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 1.67 110.936 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.0 pm0 -159.07 176.25 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 2.95 110.888 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -130.44 137.21 49.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 5.03 110.82 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -123.77 135.02 25.74 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.726 0.774 . . . . 1.8 110.9 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 159.14 54.45 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.721 2.281 . . . . 0.31 112.351 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.97 151.65 20.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 1.47 110.948 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.65 162.91 54.78 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.498 0.666 . . . . 2.7 111.186 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -23.72 30.17 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.669 2.246 . . . . 0.67 112.293 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -86.26 -23.82 26.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 2.47 110.809 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -87.82 -52.72 5.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 3.95 110.927 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.4 -39.52 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 1.66 111.128 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -32.64 73.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 1.31 110.97 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.49 -46.74 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 1.41 110.856 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.19 -29.75 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 1.42 111.091 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -76.45 -33.3 58.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 4.09 110.885 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -88.88 -19.98 25.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 1.84 110.822 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -94.69 -32.26 13.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.37 110.924 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.31 -54.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 1.53 110.869 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.77 8.1 2.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.658 -0.782 . . . . 0.35 112.518 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -69.94 121.62 17.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.709 0.29 . . . . 0.85 110.87 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -151.93 104.99 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 3.37 110.906 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.6 t -160.8 171.02 19.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 1.14 110.868 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.22 -11.85 15.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 1.94 110.877 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -99.57 14.39 30.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 1.86 110.894 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.51 168.92 12.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 1.69 110.824 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -172.16 130.36 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 1.56 110.894 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -74.31 132.81 42.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 3.21 110.897 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.26 147.96 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 1.62 111.077 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -101.67 135.6 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 2.8 110.938 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.41 149.18 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 1.48 111.148 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.2 t -129.55 159.47 36.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 1.47 111.196 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.93 134.3 4.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.731 -0.747 . . . . 0.18 112.483 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -94.44 140.77 29.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 2.39 110.942 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -81.49 134.79 50.68 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.606 0.717 . . . . 3.03 110.886 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 119.76 6.65 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.714 2.276 . . . . 0.35 112.319 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.32 110.866 179.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.823 0.344 . . . . 2.55 110.804 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -109.48 23.26 14.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 2.81 110.94 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.04 41.96 53.72 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 0.49 112.485 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.31 158.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 1.58 111.129 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.2 m -146.18 156.35 43.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 1.76 110.863 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.32 127.41 34.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 1.68 111.143 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.81 -7.48 21.94 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.74 -0.743 . . . . 0.29 112.513 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.17 170.39 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 1.72 110.942 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.92 110.7 22.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 2.33 110.836 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.2 129.6 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 3.01 111.168 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.59 130.35 52.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 1.73 111.101 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.79 117.78 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 1.54 111.158 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -101.54 113.63 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 1.48 111.21 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -114.51 167.64 10.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 0.21 110.919 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -151.53 -169.59 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 1.79 110.812 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -35.87 69.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 7.65 110.876 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -11.26 60.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 1.43 110.889 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.67 92.87 9.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.609 0.718 . . . . 0.81 110.871 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.72 143.53 51.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.3 112.336 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -48.76 -32.55 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 1.47 111.125 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.02 -53.57 32.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 2.48 110.895 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.79 -44.75 10.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 1.52 111.116 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.2 -61.32 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 1.48 110.916 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -49.79 -38.35 34.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 3.62 110.813 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.61 -47.58 55.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.8 -0.714 . . . . 0.25 112.428 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.46 -40.26 93.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.366 . . . . 1.77 110.897 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.1 m -76.72 -31.04 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 1.74 111.209 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.03 -60.07 4.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.183 -0.462 . . . . 1.57 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -40.79 71.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 2.99 110.958 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.27 -25.2 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 2.04 110.887 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.09 -24.18 47.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.45 110.885 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.72 -30.03 17.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 1.37 111.115 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.59 -35.34 14.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 1.47 110.882 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.88 -45.28 5.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 1.44 111.178 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.78 -12.72 49.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.679 -0.772 . . . . 0.3 112.537 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -67.04 -62.74 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.786 0.327 . . . . 2.6 110.883 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -94.66 -39.32 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 2.07 110.958 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.51 -135.2 7.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.801 . . . . 0.38 112.504 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -147.74 151.44 36.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 2.95 110.794 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.9 t -135.94 117.82 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 1.66 111.114 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 t -106.93 157.19 17.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 1.28 110.85 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.22 133.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 1.75 111.142 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -143.69 151.79 40.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 1.27 110.892 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.6 135.21 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.63 110.825 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.3 mt -52.37 -35.87 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 1.71 111.103 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -31.81 66.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 3.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -105.22 20.32 19.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 3.6 110.896 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.78 -26.14 9.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 4.01 110.94 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 mp -53.68 -32.91 53.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 2.12 110.945 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -84.97 -15.76 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 1.12 110.906 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.4 m -64.46 -12.21 41.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 1.86 110.888 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.93 61.34 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.494 . . . . 1.71 111.184 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -59.48 -71.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.63 110.796 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.27 -168.23 2.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 2.68 110.956 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -102.27 116.58 32.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 2.22 110.869 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 t 60.16 84.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 1.97 110.839 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.0 p -134.84 -37.24 0.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.96 110.836 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -96.84 121.98 39.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.059 -0.519 . . . . 3.57 110.78 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.21 -19.7 60.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 1.51 110.845 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.26 143.95 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 1.64 111.112 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.1 mm -136.51 127.69 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 1.53 111.036 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -109.77 137.87 46.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 1.55 110.95 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.8 100.04 5.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 1.21 110.866 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.87 74.63 0.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.18 112.518 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.29 58.18 0.68 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 1.57 110.902 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.92 160.01 61.44 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.659 0.742 . . . . 1.43 111.108 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.74 123.88 10.54 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.726 2.284 . . . . 0.31 112.33 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.46 7.11 88.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.667 -0.778 . . . . 0.23 112.535 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.2 p -55.9 151.58 11.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.958 0.409 . . . . 1.01 110.843 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.3 p -140.58 109.04 5.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 1.49 111.101 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.12 143.19 12.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 1.48 111.183 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.8 mt -119.98 102.37 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 1.53 110.93 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -79.1 144.22 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.29 110.844 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 m -124.38 174.92 7.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 1.01 110.908 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.94 -40.34 57.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 1.7 111.128 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.99 -45.78 91.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 1.96 110.898 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -72.07 -55.38 13.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 1.64 111.132 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.9 mt -50.67 -38.54 47.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.52 . . . . 1.61 110.946 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.9 -56.13 13.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 1.55 111.021 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.56 -44.94 73.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.39 . . . . 2.84 110.855 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.9 mm -56.08 -68.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 1.54 111.098 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.54 -39.65 49.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 1.4 111.134 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -52.56 -49.63 64.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 4.13 110.829 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.0 pt -88.18 -4.05 9.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 1.76 111.102 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.04 112.44 19.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 1.6 110.941 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -52.45 157.68 2.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.645 0.736 . . . . 4.1 110.816 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 113.98 3.55 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.725 2.283 . . . . 0.44 112.326 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.41 2.72 50.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.811 -0.709 . . . . 0.23 112.563 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.78 -165.13 21.61 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.664 -0.779 . . . . 0.18 112.418 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 90.9 m -133.22 151.91 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 1.41 110.893 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.58 115.22 12.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 1.61 110.934 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -110.33 132.05 54.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 3.35 110.877 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.66 163.17 38.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 1.45 110.891 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.91 126.89 29.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 2.73 110.784 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.65 149.27 30.57 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.65 0.738 . . . . 2.55 110.892 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 139.38 40.28 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.66 2.24 . . . . 0.29 112.329 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.8 m -121.62 146.7 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 1.72 111.143 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -117.82 132.0 56.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 1.86 110.887 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.0 p -91.93 -37.43 12.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 1.83 111.099 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.59 37.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 1.76 111.191 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.8 t -147.79 149.55 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 1.93 111.141 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.86 178.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.85 110.929 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -66.55 -70.44 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 2.83 110.896 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -75.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 3.07 110.922 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.47 -169.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 2.31 110.78 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.0 -2.97 50.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 3.12 110.893 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 m -145.26 144.49 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 1.64 111.102 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.32 113.15 4.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 3.11 110.877 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -84.33 177.45 8.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 1.61 111.204 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.33 -54.7 36.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 1.53 111.102 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -59.97 -50.24 74.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.93 110.85 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -38.8 71.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.148 -0.478 . . . . 2.89 110.893 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.51 -54.27 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 1.68 110.963 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.7 m -59.24 -46.78 87.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 1.55 110.851 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -44.03 95.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 1.3 110.874 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.27 98.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 1.58 111.195 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.9 tp -65.38 -50.76 64.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 1.7 110.913 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.2 m -63.51 -31.5 72.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 1.46 111.16 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.6 mt -87.0 -10.48 53.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 1.75 110.913 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.58 4.66 31.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.306 -0.406 . . . . 2.38 110.835 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.1 6.7 33.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.49 112.496 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.92 172.21 6.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.79 0.328 . . . . 1.55 110.985 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.5 m -151.71 174.27 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 1.75 111.103 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 52.68 43.9 30.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 2.15 110.88 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.0 143.29 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 1.58 111.097 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.06 160.19 8.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 2.59 110.85 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -82.34 139.55 34.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 2.98 110.87 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.5 mp -96.6 -37.92 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 1.53 110.899 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.05 176.3 12.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 1.11 110.941 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 141.27 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 4.74 110.89 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -129.18 136.82 29.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.599 0.714 . . . . 1.41 110.828 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 165.16 31.82 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.667 2.245 . . . . 0.26 112.357 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.7 126.13 42.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 1.8 110.936 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.62 160.88 24.72 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.615 0.721 . . . . 2.83 111.08 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -24.63 29.31 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.38 112.36 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -85.52 -22.09 28.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 2.49 110.893 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -87.53 -53.58 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 2.43 110.916 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -49.8 -40.36 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 1.69 111.142 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.05 -33.42 74.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 1.37 110.904 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.42 -46.44 66.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.93 110.845 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.51 -30.02 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 1.62 111.207 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -76.77 -31.57 57.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 3.23 110.9 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -89.57 -20.83 23.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.73 110.799 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.97 -32.0 13.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.44 110.927 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 mp -127.29 -54.68 1.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 1.72 110.845 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.53 13.55 2.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.749 -0.739 . . . . 0.48 112.527 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -70.65 121.51 18.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 1.16 110.807 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -151.74 105.87 3.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 2.85 110.872 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.9 t -160.51 170.47 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 1.23 110.852 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.61 -11.34 16.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 1.86 110.87 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -103.59 20.6 17.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 1.93 110.908 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.45 162.98 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 1.68 110.841 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -169.88 130.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 1.69 110.965 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -75.85 135.57 40.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 3.09 110.956 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.0 144.27 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 1.64 111.128 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -97.67 128.81 44.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 1.98 110.949 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.39 148.95 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.67 111.144 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.1 t -127.35 159.62 33.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 1.49 111.097 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.43 132.13 3.83 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.701 -0.761 . . . . 0.21 112.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -94.65 140.35 29.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.814 0.34 . . . . 2.27 110.938 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -80.32 135.41 53.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.638 0.732 . . . . 2.93 110.929 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 120.01 6.87 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.724 2.283 . . . . 0.4 112.361 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.47 110.869 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.841 0.353 . . . . 2.0 110.78 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -122.27 18.44 10.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 2.67 110.884 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.38 39.5 73.07 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.751 -0.738 . . . . 0.39 112.519 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.85 157.53 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 1.54 111.126 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.8 m -149.34 155.75 40.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 1.64 110.83 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.93 123.3 29.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 1.55 111.096 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.18 -12.06 14.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.41 112.52 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -103.61 168.66 9.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 1.68 110.914 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -101.21 133.39 45.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 2.28 110.924 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.38 134.59 43.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 3.19 111.16 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.35 127.4 55.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 1.62 111.114 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.2 t -97.63 117.95 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 1.56 111.131 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 t -102.35 110.25 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 1.74 111.116 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -111.56 167.24 10.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.19 110.97 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -151.0 -169.71 3.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.423 . . . . 1.84 110.874 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -56.68 -35.81 68.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.459 . . . . 3.77 110.903 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.62 -11.4 60.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 1.45 110.894 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.34 93.79 10.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.624 0.726 . . . . 1.05 110.845 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 142.81 49.15 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.677 2.252 . . . . 0.21 112.341 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.1 t -48.82 -32.59 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 1.56 111.134 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -51.24 -53.35 36.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 2.56 110.8 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.55 -44.79 11.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 1.55 111.131 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.36 -61.04 2.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 1.58 111.017 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.76 -37.91 31.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 3.14 110.871 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.8 -47.67 54.0 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.838 -0.696 . . . . 0.22 112.45 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.51 -40.05 93.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 1.63 110.873 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -76.88 -31.45 19.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 1.66 111.132 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -61.72 -59.95 4.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 1.72 110.947 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -40.41 71.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 2.63 110.882 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.68 -24.56 61.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 1.63 110.895 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.7 -24.78 44.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.44 110.911 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 -29.82 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 1.31 111.163 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.75 -35.02 14.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 1.44 110.872 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.87 -44.81 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 1.63 111.12 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.66 -11.2 52.97 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 0.25 112.433 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.99 -62.58 1.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 2.38 110.931 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -90.96 -40.68 11.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 1.97 110.857 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.49 -126.44 4.93 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.759 -0.734 . . . . 0.26 112.438 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -155.58 152.49 28.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 2.93 110.902 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.7 t -137.0 127.72 40.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 1.5 111.12 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 t -116.53 154.12 30.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 1.17 110.83 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.73 134.65 58.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 1.65 111.054 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -146.33 152.32 38.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.077 -0.511 . . . . 2.1 110.913 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -102.43 137.78 40.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.64 110.809 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.5 mt -52.26 -37.04 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 1.44 111.139 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -26.18 58.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 3.41 110.902 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -104.97 18.12 22.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 3.44 110.899 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -26.07 22.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.201 -0.454 . . . . 4.04 110.872 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.96 -34.9 57.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 2.01 110.871 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -85.97 -16.0 39.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.1 111.008 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.5 m -63.64 -12.72 36.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 1.7 110.798 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.55 59.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 1.54 111.134 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -59.17 -70.55 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.61 110.915 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.39 -169.59 2.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 2.37 111.0 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -105.47 122.11 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 2.19 110.827 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t 59.52 78.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 2.08 110.888 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.5 p -132.7 -37.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.95 110.834 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -98.13 122.37 41.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 3.61 110.85 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.28 -20.46 60.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 1.51 110.901 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mt -143.06 144.81 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 1.54 111.115 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.3 mm -137.56 124.45 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 1.65 111.072 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.61 137.16 46.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 1.58 111.034 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.48 100.91 5.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 1.17 110.908 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.67 76.04 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.826 -0.702 . . . . 0.17 112.417 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.52 57.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.855 0.359 . . . . 1.53 110.908 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.32 159.64 61.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.708 0.766 . . . . 1.53 111.11 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 124.42 11.05 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.666 2.244 . . . . 0.26 112.359 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.33 7.33 88.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.797 -0.716 . . . . 0.26 112.533 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.2 p -55.54 150.88 11.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.429 . . . . 1.33 110.772 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.8 p -138.84 108.86 6.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 1.46 111.107 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.36 152.43 16.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 1.5 111.199 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mt -130.6 101.11 5.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 1.5 110.894 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -78.06 141.35 38.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.36 110.863 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.82 178.46 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 1.3 110.909 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.15 62.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 1.25 111.103 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -56.61 -48.21 77.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 1.96 110.885 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.1 -56.59 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 1.65 111.129 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt -50.15 -39.09 42.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 1.67 110.964 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.97 -56.74 10.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 1.76 111.1 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -43.25 70.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 3.03 110.918 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.9 mm -57.94 -69.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 1.56 111.189 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.12 -36.21 28.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 1.56 111.075 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -51.5 67.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 3.5 110.983 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.6 pt -86.81 -2.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 1.79 111.171 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.0 115.28 21.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 1.63 110.952 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -55.52 157.95 6.49 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.532 0.682 . . . . 4.3 110.889 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 114.02 3.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.735 2.29 . . . . 0.39 112.33 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.16 2.33 51.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 0.22 112.512 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.07 -165.51 19.4 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.781 -0.723 . . . . 0.18 112.456 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 69.1 m -134.55 148.79 50.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.33 . . . . 1.72 110.901 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -132.72 114.98 14.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 1.6 110.911 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -110.19 132.13 54.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 3.29 110.952 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.74 164.03 35.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 1.61 110.939 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.91 129.33 36.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 2.9 110.9 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.63 148.44 19.68 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.677 0.751 . . . . 2.52 110.865 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 145.53 57.75 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.656 2.237 . . . . 0.25 112.367 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.4 m -129.0 146.49 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 1.55 111.088 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -107.32 132.75 52.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 2.19 110.803 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.8 p -90.69 -42.73 10.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 2.28 111.125 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.83 42.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 1.91 111.053 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.7 t -148.98 150.0 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.26 -0.427 . . . . 1.72 111.12 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.45 169.75 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 2.17 110.844 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -62.37 -54.72 36.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 2.77 110.845 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -66.8 -78.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 3.2 110.869 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p 53.65 -173.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 2.53 110.791 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.52 -3.37 49.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 3.68 110.848 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.86 153.82 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 1.66 111.148 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.01 110.48 6.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 3.97 110.933 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.7 p -84.97 179.52 7.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 1.61 111.191 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.43 -53.74 53.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 1.38 111.001 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.84 -50.09 74.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.99 0.424 . . . . 0.87 110.884 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -56.69 -39.91 74.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 2.58 110.985 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.52 -54.55 34.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 1.57 110.905 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.1 m -58.6 -46.94 85.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.228 -0.442 . . . . 1.82 110.827 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -43.58 97.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 1.25 110.834 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.16 -43.52 98.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 1.57 111.117 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.1 tp -64.81 -50.46 66.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 1.66 110.94 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.4 m -63.89 -31.2 72.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 1.59 111.129 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.5 mt -87.07 -10.5 52.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 1.79 110.917 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.53 6.21 28.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 2.34 110.845 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.61 7.68 31.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.67 -0.776 . . . . 0.55 112.452 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.57 171.03 7.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 1.57 110.847 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.05 170.42 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 1.61 111.131 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 52.89 44.21 30.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 2.27 110.857 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.71 142.77 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 1.47 111.158 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.97 157.92 6.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 2.68 110.901 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.29 145.7 39.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 2.23 110.858 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mp -105.5 -36.19 7.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 1.61 110.944 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.16 176.0 13.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 1.19 110.981 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -130.93 145.17 51.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 4.94 110.885 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -135.1 136.15 24.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.67 0.748 . . . . 1.87 110.852 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 165.22 31.66 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.693 2.262 . . . . 0.36 112.384 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.96 128.21 44.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 1.49 110.949 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.44 160.88 25.3 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.53 0.681 . . . . 2.44 111.163 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -28.69 24.61 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.701 2.267 . . . . 0.43 112.294 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -85.37 -17.74 35.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 3.63 110.936 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.59 -53.06 4.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 2.83 110.963 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.32 -40.37 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 1.58 111.147 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -35.22 77.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.25 110.908 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.85 -46.61 71.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 1.27 110.831 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.99 -29.97 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 1.53 111.118 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -75.0 -33.67 61.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 2.99 110.95 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -89.0 -19.97 25.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.056 -0.52 . . . . 1.93 110.842 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -94.01 -32.73 13.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.88 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.58 -54.24 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 1.61 110.901 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.97 6.11 2.6 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.806 -0.712 . . . . 0.43 112.479 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -69.9 120.1 15.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.723 0.297 . . . . 0.96 110.903 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.25 104.82 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 2.38 110.913 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.45 174.95 12.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 1.6 110.864 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.76 -10.54 16.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.55 110.869 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.15 6.6 46.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 2.23 110.935 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.81 166.67 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 1.64 111.004 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -172.94 130.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 1.62 110.925 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -75.62 134.87 40.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 3.23 110.879 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.83 141.53 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 1.65 111.183 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -93.66 131.26 39.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.97 110.937 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.92 151.73 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 1.46 111.106 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.3 t -135.9 161.85 34.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 1.48 111.048 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.26 137.92 6.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.715 -0.755 . . . . 0.17 112.487 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.65 137.5 35.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.308 . . . . 4.7 110.935 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -77.33 135.45 65.7 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.609 0.719 . . . . 2.97 110.905 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 120.09 6.94 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.652 2.235 . . . . 0.39 112.39 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.45 110.94 179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.826 0.346 . . . . 2.4 110.831 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.26 21.18 10.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 2.71 110.848 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.93 37.96 54.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.656 -0.783 . . . . 0.28 112.552 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.27 156.93 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.343 . . . . 1.59 111.146 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.2 m -146.13 158.5 43.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 1.52 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.56 129.75 35.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 1.56 111.131 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.11 -8.52 33.33 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.687 -0.768 . . . . 0.55 112.522 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -103.61 169.37 8.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 1.75 110.919 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.87 113.21 26.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 2.26 110.824 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.57 129.56 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 3.15 111.105 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.65 128.06 52.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 1.55 111.048 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.9 t -99.93 120.34 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 1.52 111.13 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.25 123.05 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 1.61 111.086 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -122.6 169.68 10.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.2 110.908 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.75 -171.0 3.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 1.76 110.862 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -56.97 -35.66 69.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 4.29 110.904 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.32 -9.1 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 2.04 110.917 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.05 94.29 10.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.665 0.745 . . . . 0.85 110.799 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.35 47.7 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.659 2.239 . . . . 0.23 112.416 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.01 -32.59 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 1.54 111.182 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.16 -53.09 37.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.148 -0.478 . . . . 3.2 110.827 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.87 10.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 1.5 111.151 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -51.66 -61.49 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 1.49 110.995 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -36.96 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 3.36 110.934 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.36 -48.31 52.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.729 -0.748 . . . . 0.24 112.495 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.1 mt -60.84 -41.39 95.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 1.71 110.927 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -75.45 -31.11 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 1.7 111.11 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.74 -61.89 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 1.77 110.887 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -40.73 67.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 2.7 110.87 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.5 mt -71.83 -25.5 62.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 1.58 110.96 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.05 -24.33 47.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.47 110.984 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.52 -30.52 17.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 1.31 111.113 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.7 pp -90.91 -35.41 14.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 1.69 110.896 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.65 -46.83 4.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 1.57 111.083 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.57 -14.33 49.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.742 . . . . 0.28 112.467 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 3.21 110.817 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.34 -35.48 8.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 2.38 110.867 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.17 -133.48 5.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.32 112.499 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -151.39 152.24 32.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 4.61 110.745 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.6 t -136.7 116.51 16.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 1.69 111.095 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.4 t -106.43 155.98 19.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.98 110.892 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.84 135.69 59.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 1.43 111.174 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -142.69 151.05 40.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 1.3 110.926 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.54 134.65 46.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.62 110.872 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.7 mt -52.3 -36.82 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 1.58 111.155 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -70.23 -32.6 70.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 2.72 110.899 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.54 20.72 17.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 3.52 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.96 -28.54 3.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 2.13 110.902 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -55.82 -32.93 64.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.269 -0.423 . . . . 2.27 110.882 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -84.35 -14.5 49.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 1.09 110.878 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.7 m -64.94 -10.87 32.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 1.74 110.817 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.17 63.99 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 1.49 111.122 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -66.07 -70.51 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.55 110.813 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.57 -167.82 2.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 2.06 110.923 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -111.12 124.07 51.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 1.58 110.906 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t 58.96 75.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 2.04 110.779 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 p -134.07 -35.15 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.911 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.06 117.47 33.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.107 -0.497 . . . . 2.59 110.846 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.02 -19.82 62.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 1.51 110.874 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.2 mt -146.27 144.12 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 1.52 111.101 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.0 mm -136.3 129.2 46.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 1.49 111.126 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.29 137.75 51.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 1.64 110.938 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.24 101.7 6.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 1.21 110.861 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.3 78.09 0.11 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.778 -0.725 . . . . 0.17 112.434 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.8 58.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 1.61 110.894 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.1 158.83 67.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.573 0.702 . . . . 1.65 111.175 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.63 115.88 4.28 Favored 'Trans proline' 0 C--O 1.231 0.125 0 C-N-CA 122.702 2.268 . . . . 0.26 112.394 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.15 6.61 66.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.19 112.456 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.3 152.08 8.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.39 . . . . 1.07 110.924 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.0 p -140.14 108.55 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 1.64 111.159 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.3 150.08 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 1.48 111.153 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 mt -129.63 99.61 5.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 1.55 110.876 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -75.44 153.72 37.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.31 110.82 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 m -130.02 174.99 9.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 1.49 110.889 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -35.92 37.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 1.42 111.142 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.0 -42.87 99.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 1.94 110.864 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -77.21 -54.27 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 1.59 111.148 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.5 mt -49.73 -48.37 50.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 1.6 110.939 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.63 -50.11 55.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 2.19 111.17 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -43.84 83.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 4.79 110.824 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.6 mm -57.13 -65.18 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 1.52 111.142 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.99 -38.09 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 1.6 111.111 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -54.39 -58.03 9.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 3.21 110.875 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.1 pt -75.5 -8.33 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 1.63 111.128 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.48 132.67 36.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 1.82 110.883 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -70.0 159.56 83.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.568 0.699 . . . . 3.16 110.876 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 113.79 3.49 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.638 2.225 . . . . 0.19 112.345 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.22 3.46 54.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.688 -0.768 . . . . 0.19 112.52 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.41 -160.12 12.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.18 112.473 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.3 m -140.11 154.96 47.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.928 0.394 . . . . 1.47 110.912 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -139.44 115.38 10.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 1.56 111.008 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -110.96 133.1 53.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 2.87 110.868 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.77 156.9 42.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 1.59 110.936 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.36 128.32 46.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 2.66 110.816 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.43 144.6 17.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.64 0.734 . . . . 2.29 110.868 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 140.19 41.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.653 2.235 . . . . 0.29 112.329 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 m -122.86 146.59 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 1.42 111.156 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -110.4 132.86 53.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 1.98 110.887 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.0 p -104.38 25.7 9.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 1.84 111.203 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.07 24.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 1.76 111.182 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.46 159.97 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 1.74 111.13 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.68 178.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 1.84 110.846 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -66.13 -62.65 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 2.66 110.9 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -65.98 -75.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 2.79 110.894 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.11 -168.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 2.41 110.868 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 -4.22 52.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 2.99 110.897 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.8 m -145.38 141.11 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 1.63 111.132 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.57 117.8 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 3.35 110.914 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -89.68 177.72 6.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 1.48 111.07 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.02 -54.26 48.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 1.54 111.054 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.28 -49.75 76.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.042 0.448 . . . . 1.26 110.859 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -57.9 -40.69 80.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 3.07 110.928 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.77 -54.79 37.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 1.56 110.925 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 54.6 m -58.34 -48.85 79.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 2.01 110.893 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -45.62 92.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.472 . . . . 1.46 110.812 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.64 -48.15 83.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 1.54 111.154 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.39 -52.98 62.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 1.59 110.921 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.0 m -63.12 -27.1 69.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 1.6 111.129 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.4 mt -86.97 -12.41 47.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 1.75 110.968 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.8 p -82.87 3.96 27.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 3.05 110.85 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.67 -4.88 34.68 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.781 -0.723 . . . . 0.71 112.528 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -88.95 170.33 10.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.946 0.403 . . . . 1.72 110.923 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.9 m -148.13 172.75 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 1.64 111.169 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 51.47 45.03 28.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 2.18 110.924 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.0 t -81.57 142.02 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 1.63 111.093 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.65 8.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 2.63 110.895 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -79.57 145.92 32.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 2.27 110.862 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.77 -37.31 6.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 1.53 110.922 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -162.1 176.67 10.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 1.28 110.983 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -126.72 165.31 19.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 6.49 110.808 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -148.39 136.43 11.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.669 0.747 . . . . 1.38 110.926 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 158.05 58.37 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.746 2.298 . . . . 0.38 112.375 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.35 127.01 38.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 1.51 110.999 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.12 161.45 22.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.492 0.663 . . . . 2.87 111.254 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -24.67 29.72 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.707 2.271 . . . . 0.53 112.386 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -85.46 -22.93 28.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 2.59 110.799 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -87.72 -53.03 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 2.44 110.911 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.73 -40.01 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 1.65 111.162 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -33.93 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 1.51 110.932 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -46.57 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 1.35 110.871 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.94 -30.96 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 1.39 111.128 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -76.72 -30.31 56.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 2.72 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -89.7 -21.08 22.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 1.67 110.891 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -94.8 -32.64 13.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 0.42 110.851 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.9 mp -127.35 -54.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 1.62 110.865 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.65 20.5 1.52 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.39 112.517 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -75.37 121.56 22.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.725 0.298 . . . . 1.12 110.864 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -151.83 106.44 3.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 2.64 110.911 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.71 173.21 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 1.54 110.872 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.47 -19.59 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 1.82 110.835 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -96.19 19.9 11.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 1.59 110.925 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.54 163.57 15.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 1.64 110.823 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -173.48 130.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 1.68 110.948 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.22 135.16 48.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 3.24 110.824 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.73 147.23 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 1.64 111.146 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -104.69 125.56 50.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 2.47 110.829 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.24 153.21 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 1.6 111.152 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.6 t -136.92 162.92 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 1.82 111.136 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.23 136.31 5.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.772 -0.727 . . . . 0.2 112.464 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.64 139.48 30.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.362 . . . . 2.5 110.817 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 135.6 51.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.693 0.759 . . . . 2.34 110.821 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 135.77 31.2 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.622 2.215 . . . . 0.53 112.387 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.46 110.756 -179.863 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.4 t0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.871 0.367 . . . . 2.88 110.898 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.33 15.27 10.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 3.54 110.842 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.96 41.06 99.24 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.843 -0.694 . . . . 0.32 112.469 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.36 158.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 1.63 111.081 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.58 164.83 33.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.6 110.864 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.49 129.13 36.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 1.5 111.023 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.84 -6.51 23.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.773 . . . . 0.25 112.519 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -113.14 167.91 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 1.49 110.846 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.67 137.3 37.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.178 -0.465 . . . . 2.33 110.908 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.0 t -140.75 133.21 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 2.9 111.111 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.3 121.98 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 1.34 111.085 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.9 t -94.59 118.06 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 1.55 111.068 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.66 113.59 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 1.73 111.12 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -113.39 167.19 10.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.23 111.013 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -148.57 -169.71 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.279 -0.419 . . . . 1.78 110.926 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -58.3 -35.58 72.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 4.57 110.953 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.1 m -73.98 -8.03 54.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 1.89 110.931 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.35 93.33 9.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.716 . . . . 1.07 110.833 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 143.09 50.16 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.729 2.286 . . . . 0.25 112.326 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.81 -32.9 4.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 1.49 111.101 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -50.99 -53.09 36.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 2.42 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.46 -44.85 11.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 1.63 111.048 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -52.16 -62.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 1.46 110.9 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.61 -37.42 27.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 4.32 110.848 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.44 -47.08 53.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.23 112.53 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.5 mt -61.94 -39.35 91.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 1.69 110.943 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -77.68 -31.75 17.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.231 -0.44 . . . . 1.68 111.134 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.01 -58.82 6.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 1.82 110.812 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -41.1 75.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 4.19 110.88 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.2 mt -72.35 -24.4 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 1.43 110.952 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -78.16 -24.67 47.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.45 110.897 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.35 -30.29 16.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 1.35 111.068 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.55 -35.65 14.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 1.53 110.96 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.62 -44.2 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 1.49 111.17 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.33 -11.0 55.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.42 112.424 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.29 -61.97 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.782 0.325 . . . . 3.5 110.918 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -86.49 -43.0 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 2.06 110.866 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.25 -122.03 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.852 -0.69 . . . . 0.34 112.523 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -157.49 153.35 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 2.98 110.877 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.0 t -138.27 128.72 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 1.56 111.182 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t -118.11 154.48 32.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 1.11 110.84 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -115.52 133.31 62.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 1.67 111.089 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -144.53 152.98 41.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 1.97 110.92 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -101.91 139.62 37.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.7 110.982 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 mt -51.87 -44.24 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 1.65 111.169 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -20.11 60.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 4.91 110.833 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -107.12 18.5 21.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 3.52 110.86 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.51 -24.56 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 3.99 110.911 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -52.19 -34.7 46.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 1.86 110.95 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -86.25 -16.34 37.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 1.2 110.907 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 m -63.47 -12.84 34.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 1.73 110.897 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.71 59.46 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.498 . . . . 1.58 111.068 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -61.81 -70.29 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.51 110.829 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.28 -168.78 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 2.24 110.844 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -105.82 131.05 53.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 1.96 110.825 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 49.01 71.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 1.82 110.82 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.8 p -125.61 -34.42 2.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.9 110.884 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -99.85 119.18 37.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.495 . . . . 2.58 110.88 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.42 -19.4 62.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 1.54 110.904 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.3 mt -146.03 145.44 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 1.59 111.117 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.3 mm -136.83 127.85 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 1.63 111.147 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -109.55 137.59 47.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.224 -0.444 . . . . 1.58 110.926 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.13 96.42 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 1.13 110.933 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.03 75.0 0.25 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 0.16 112.436 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.49 62.5 0.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.847 0.356 . . . . 1.53 110.9 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.99 160.12 66.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.533 0.682 . . . . 1.65 111.172 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 116.62 4.65 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.231 . . . . 0.29 112.35 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.14 7.27 70.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.647 -0.787 . . . . 0.23 112.5 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.33 150.23 11.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.075 0.464 . . . . 1.0 110.789 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.7 p -140.05 108.57 5.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.046 -0.525 . . . . 1.54 111.094 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.8 152.72 15.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.53 111.132 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 mt -130.36 101.76 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 1.7 110.891 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -77.56 149.05 34.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.28 110.84 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.1 m -125.57 178.43 5.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.9 110.857 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.14 -45.21 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 1.2 111.079 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.92 -48.53 75.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 2.32 110.906 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -68.23 -56.55 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 1.56 111.07 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -50.67 -39.56 51.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 1.65 110.966 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.85 -57.1 12.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.6 111.062 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.0 -41.97 65.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 2.93 110.833 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mm -58.94 -68.58 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.437 . . . . 1.58 111.056 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.79 29.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 1.43 111.125 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -57.55 -56.0 27.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 4.0 110.934 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.2 pt -80.01 -5.69 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 1.52 111.17 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.72 129.4 36.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 1.64 110.904 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -70.4 160.41 81.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.623 0.725 . . . . 3.04 110.908 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 114.17 3.59 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.726 2.284 . . . . 0.29 112.393 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.43 4.79 57.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.24 112.501 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.4 -164.61 14.38 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.73 . . . . 0.2 112.435 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 67.6 m -137.71 146.28 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 1.72 110.815 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -129.49 125.39 36.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 1.55 110.867 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -121.34 131.4 54.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 3.35 110.935 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.76 157.18 43.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 1.62 110.86 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.85 127.28 44.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 3.21 110.907 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.3 146.93 19.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.635 0.731 . . . . 2.33 110.832 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.92 142.44 47.25 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.68 2.253 . . . . 0.23 112.336 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.18 146.69 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 1.41 111.112 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -105.22 132.63 51.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 2.04 110.946 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.0 p -103.64 26.04 9.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 1.77 111.108 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.99 24.82 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 1.67 111.105 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -143.73 158.85 16.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 1.92 111.134 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -177.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 2.07 110.808 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -68.69 -68.81 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 2.71 110.904 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -56.94 -75.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.082 -0.508 . . . . 2.86 110.939 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.7 -169.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 2.71 110.9 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -4.45 54.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 3.08 110.915 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.5 153.36 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 1.74 111.126 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -71.25 108.87 4.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 2.9 110.912 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.2 p -85.88 177.7 7.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 1.48 111.13 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.49 -54.31 42.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 1.45 111.119 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -49.97 75.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 1.11 110.814 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.46 -41.58 76.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 2.58 110.924 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.64 -54.63 40.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 1.66 110.932 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.7 m -58.47 -48.84 79.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 1.62 110.886 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -46.53 89.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 1.54 110.879 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.36 -43.47 98.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 1.68 111.051 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.1 tp -63.37 -52.37 61.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 1.53 110.91 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -65.64 -24.65 67.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 1.44 111.114 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.34 -15.71 42.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 2.1 110.853 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 40.2 p -83.42 4.69 26.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 3.01 110.873 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.8 -4.77 34.4 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.632 -0.794 . . . . 0.59 112.469 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.45 169.37 12.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.904 0.383 . . . . 1.65 110.894 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.56 170.15 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 1.58 111.118 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 51.99 44.9 29.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 2.43 110.897 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.1 t -80.33 141.75 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 1.41 111.049 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 158.87 7.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 2.66 110.92 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -77.31 145.92 37.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 2.35 110.86 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 mp -105.26 -36.51 7.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 1.56 110.949 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.83 176.2 13.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 1.18 110.944 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.2 137.04 47.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 4.75 110.83 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.78 138.26 30.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.699 0.762 . . . . 1.84 110.853 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 164.05 35.98 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.664 2.242 . . . . 0.22 112.357 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.74 128.47 42.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 1.52 110.941 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.46 160.91 25.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.576 0.703 . . . . 2.22 111.117 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -29.83 23.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.261 . . . . 0.49 112.288 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.08 -17.96 35.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 2.79 110.856 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -53.47 4.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 2.48 110.92 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -49.14 -41.09 13.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 1.54 111.142 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -34.67 73.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 1.27 110.976 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.18 -44.89 71.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 1.06 110.802 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.0 -32.54 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 1.63 111.153 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -76.06 -29.9 58.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 2.72 110.858 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -90.14 -20.68 22.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 1.77 110.911 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -94.58 -32.63 13.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.38 110.858 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.6 mp -127.88 -53.87 1.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 1.63 110.99 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.96 12.3 2.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 0.39 112.501 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -70.24 120.38 15.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 1.58 110.818 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -151.9 111.22 3.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 3.27 110.928 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.62 175.09 13.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 1.71 110.869 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.34 -14.19 14.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 2.24 110.876 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -104.82 11.4 33.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 1.83 110.868 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.01 163.18 28.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 1.7 110.939 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -173.88 129.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 1.66 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -73.54 132.89 43.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 3.28 110.869 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.01 140.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 1.59 111.116 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -94.42 126.38 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 2.41 110.922 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.8 mp -123.15 153.65 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 1.63 111.174 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.5 t -139.2 164.46 29.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 1.49 111.141 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -154.7 135.84 4.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.2 112.488 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -91.36 140.02 30.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.866 0.365 . . . . 2.38 110.899 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 135.47 49.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.604 0.716 . . . . 2.26 110.969 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.85 127.87 15.14 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.695 2.263 . . . . 0.36 112.348 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.31 110.869 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.875 0.369 . . . . 2.67 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -122.12 11.71 10.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 3.56 110.933 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.37 40.65 99.14 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.726 -0.75 . . . . 0.33 112.502 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.53 160.42 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 1.61 111.019 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.3 168.63 26.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.08 -0.509 . . . . 2.01 110.773 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.73 132.81 35.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 1.68 111.092 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.88 -8.12 29.55 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.757 -0.735 . . . . 0.3 112.546 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -111.96 165.33 12.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 1.51 110.924 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.56 140.09 33.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 3.8 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -142.68 140.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 3.06 111.178 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.02 122.1 42.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 1.56 111.085 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.64 118.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 1.53 111.086 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.4 t -102.95 110.07 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 1.52 111.188 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -111.54 167.55 10.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.15 -0.477 . . . . 0.17 110.939 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -151.34 -169.63 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 1.69 110.876 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -56.97 -35.72 69.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 3.48 110.846 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.4 m -73.11 -10.61 59.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 1.73 110.832 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.63 94.9 10.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.729 . . . . 0.81 110.881 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 141.46 45.2 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.717 2.278 . . . . 0.23 112.285 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -48.89 -32.7 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 1.5 111.154 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.55 -52.66 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 2.54 110.963 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.34 -45.06 10.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 1.44 111.097 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.48 -61.34 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 1.42 110.877 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -49.87 -36.1 25.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 4.14 110.857 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.52 -47.2 43.54 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.21 112.486 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.4 mt -62.13 -38.62 89.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 1.8 110.922 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -77.96 -31.55 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 1.72 111.099 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -62.2 -58.01 9.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 1.6 110.872 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -40.24 75.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 3.57 110.929 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.03 -24.49 60.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 1.45 110.986 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -78.64 -25.25 44.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.44 110.942 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.83 -29.6 17.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 1.68 111.095 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.66 -35.0 14.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 1.42 110.981 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.73 -44.98 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 1.65 111.06 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.07 -10.94 53.75 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.674 -0.774 . . . . 0.26 112.478 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.5 -62.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.728 0.299 . . . . 3.97 110.852 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -90.22 -40.97 11.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 2.18 110.872 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.38 -123.03 4.01 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.661 -0.78 . . . . 0.32 112.572 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -158.28 153.54 25.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.863 0.363 . . . . 3.02 110.827 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.6 t -138.5 130.86 38.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.187 -0.46 . . . . 1.63 111.137 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 t -119.67 156.02 31.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 1.19 110.916 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -117.07 135.3 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 1.58 111.125 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -145.74 151.95 38.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 2.17 110.965 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.73 135.43 44.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.64 110.936 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.8 mt -51.68 -35.15 17.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 1.63 111.058 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -75.09 -31.22 61.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 2.96 110.838 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -95.82 18.44 13.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 3.32 110.948 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.83 -31.13 4.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 2.08 110.937 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -53.39 -38.84 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 1.92 110.899 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -85.09 -15.85 42.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 1.27 110.899 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -65.94 -11.64 48.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 2.03 110.787 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 63.36 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 1.66 111.144 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -60.93 -71.66 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.47 110.826 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.12 -168.99 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 3.07 110.951 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -102.36 137.47 40.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.74 110.926 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 p 46.57 85.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 1.35 110.833 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.6 p -141.05 -40.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 1.21 110.87 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -99.85 119.52 38.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.51 . . . . 3.62 110.931 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.2 -21.23 62.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 1.51 110.814 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.8 mt -142.63 144.25 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 1.63 111.091 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.7 mm -134.9 126.58 47.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 1.35 111.13 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.04 136.82 47.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 1.56 110.925 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.3 98.39 4.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 1.25 110.857 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.61 75.52 0.21 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.735 -0.745 . . . . 0.15 112.577 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.24 56.17 0.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.801 0.334 . . . . 1.54 110.938 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.44 160.32 53.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.707 0.765 . . . . 1.73 111.12 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 120.35 7.15 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 0.27 112.283 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.22 6.91 83.83 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.828 -0.701 . . . . 0.2 112.54 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 p -55.97 151.56 11.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.951 0.405 . . . . 1.01 110.825 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.5 p -141.5 109.12 5.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 1.53 111.187 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.4 145.48 11.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 1.56 111.194 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mt -124.18 105.17 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 1.61 110.894 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -80.1 153.8 28.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.28 110.822 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m -131.34 -176.62 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 1.32 110.902 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.33 69.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.526 . . . . 1.4 111.139 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -62.56 -45.04 94.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 1.64 110.841 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 mp -74.97 -55.31 12.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.171 -0.468 . . . . 1.65 111.092 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 mt -50.28 -43.88 53.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 1.47 110.831 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.45 -52.06 49.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 1.6 111.111 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -44.43 92.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 2.96 110.877 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.3 mm -54.94 -68.18 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 1.57 111.085 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.65 57.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 1.51 111.126 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -53.14 -52.61 58.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 2.93 110.874 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.5 pt -81.63 -8.63 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 1.58 111.21 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.24 124.2 27.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 1.56 110.876 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -63.1 160.25 40.85 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.703 . . . . 2.99 110.887 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 114.22 3.65 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.265 . . . . 0.31 112.3 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.56 5.52 56.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.587 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.71 -160.95 14.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.16 112.462 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.9 m -139.19 154.26 48.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 1.97 110.936 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -138.56 115.67 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 1.53 110.796 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -110.19 132.4 54.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 3.27 110.903 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.87 158.71 44.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 1.44 110.928 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.08 131.38 44.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 3.11 110.899 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.7 150.25 22.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.62 0.724 . . . . 3.59 110.844 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 144.71 55.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 0.27 112.412 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.7 146.59 32.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 1.53 111.125 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.19 133.28 52.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 2.02 110.876 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.8 p -92.42 -42.76 9.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 1.98 111.209 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.67 40.45 1.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 1.95 111.037 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.7 t -147.65 151.9 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 1.95 111.113 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.34 178.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 2.31 110.825 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.15 -63.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 2.68 110.895 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -63.65 -75.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 2.64 110.895 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.86 -167.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.479 . . . . 2.27 110.849 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -8.29 59.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 3.25 110.919 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.58 150.96 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 2.08 111.119 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -65.99 126.21 27.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 6.05 110.885 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 71.7 p -97.83 177.7 5.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 1.8 111.147 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.87 -54.53 45.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 1.41 111.056 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -55.16 -48.04 74.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.93 110.908 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -36.41 75.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 3.26 110.838 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.94 -56.57 14.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 1.78 110.904 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 48.6 m -57.44 -47.62 81.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 1.5 110.861 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -45.57 92.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.24 110.854 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.31 99.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.479 . . . . 1.54 111.082 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.0 tp -65.39 -52.57 52.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 1.56 110.906 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.2 m -61.28 -31.75 71.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 1.7 111.114 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.9 mt -87.09 -10.67 52.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 1.78 110.912 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.63 4.95 29.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 2.44 110.869 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.27 7.66 32.29 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.54 112.485 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.3 168.44 9.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.849 0.357 . . . . 1.59 110.898 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.0 m -148.41 172.53 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 1.56 111.133 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 51.63 44.67 29.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.471 . . . . 2.12 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.5 t -79.3 144.66 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 1.64 111.163 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.3 158.48 5.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 4.05 110.976 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -78.83 147.09 33.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.39 . . . . 2.44 110.837 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mp -106.09 -36.51 6.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 1.65 110.967 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 176.39 11.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.11 110.916 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.9 137.31 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 4.88 110.848 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -123.53 136.2 26.95 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.592 0.71 . . . . 1.81 110.875 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 162.46 41.98 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.642 2.228 . . . . 0.31 112.427 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.63 136.13 37.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 1.46 110.909 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.67 162.46 28.74 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.519 0.676 . . . . 2.75 111.11 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -22.65 31.53 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.574 2.183 . . . . 0.54 112.323 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -85.15 -26.37 26.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 2.43 110.826 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -88.53 -51.01 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 2.47 110.829 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.82 -38.92 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 1.57 111.188 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.85 -32.95 73.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.45 110.924 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -45.65 68.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 1.03 110.862 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.75 -30.96 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 1.57 111.081 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -76.44 -31.1 57.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 2.85 110.876 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -90.26 -20.41 23.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.164 -0.471 . . . . 1.67 110.903 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -94.75 -33.0 13.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.34 110.914 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -126.2 -54.18 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 1.56 110.938 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.45 10.67 2.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 0.33 112.45 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -70.18 121.98 18.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.86 110.89 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.48 105.07 3.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 3.22 110.928 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.25 170.7 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 1.63 110.907 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.49 -6.33 18.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 1.56 110.893 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -105.14 10.56 33.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 3.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.62 166.93 19.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.43 110.934 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -172.49 130.71 0.57 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 1.66 110.906 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -75.67 132.13 40.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 3.03 110.88 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.04 146.91 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 1.53 111.142 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -102.07 131.52 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 2.78 110.899 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.48 149.96 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 1.53 111.116 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.3 t -132.05 159.87 37.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 1.52 111.149 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.19 135.2 5.13 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.821 -0.704 . . . . 0.17 112.506 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -91.54 139.47 30.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.348 . . . . 2.48 110.973 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.23 134.77 51.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 2.23 110.933 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.67 121.66 8.37 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.743 2.296 . . . . 0.37 112.353 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 120.921 0.391 . . . . 0.62 110.89 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.858 0.361 . . . . 2.11 110.835 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -122.3 20.72 10.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 2.69 110.935 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.33 41.68 80.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.29 112.531 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.44 160.52 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 1.54 111.145 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.5 168.61 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 2.12 110.929 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.62 131.81 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 1.57 111.1 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.88 2.62 30.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.757 -0.735 . . . . 0.4 112.472 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -122.38 165.51 16.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 1.48 110.92 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.73 139.65 34.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 2.27 110.869 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.6 t -142.42 142.48 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 2.84 111.197 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.2 118.28 30.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 1.35 111.194 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.91 118.5 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 1.48 111.091 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.58 116.33 46.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 1.55 111.168 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -116.79 168.08 10.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.22 110.939 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.63 -169.86 3.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.26 -0.427 . . . . 1.86 110.882 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -57.11 -35.61 69.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 4.34 110.88 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 t -73.49 -10.21 59.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 1.71 110.862 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.96 94.24 10.36 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.698 0.761 . . . . 0.77 110.85 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.89 142.48 47.46 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.667 2.245 . . . . 0.25 112.339 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.07 -32.52 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 1.54 111.136 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -51.26 -52.97 40.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 2.48 110.957 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -44.68 11.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 1.61 111.128 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.74 -61.59 2.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 1.61 110.92 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -36.41 22.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 3.37 110.918 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.37 -46.76 47.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.682 -0.77 . . . . 0.22 112.426 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.9 mt -62.23 -38.64 90.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 1.66 110.929 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.2 m -77.97 -31.55 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.432 . . . . 1.73 111.119 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.31 -58.16 8.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.191 -0.459 . . . . 1.65 110.883 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -40.11 74.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 2.73 110.967 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.06 -25.17 60.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 1.6 110.862 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -78.51 -25.38 45.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.44 110.845 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 -29.58 17.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 1.31 111.092 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 pp -91.46 -34.72 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 1.48 110.935 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.28 -45.84 4.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 1.64 111.164 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.03 -12.04 53.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.27 112.513 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -62.56 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 3.84 110.912 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -94.45 -38.97 10.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.15 -0.477 . . . . 2.62 110.865 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.55 -126.8 4.43 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.24 112.453 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -155.28 153.46 30.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 2.94 110.836 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.4 t -138.38 128.41 34.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.138 -0.483 . . . . 1.65 111.143 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.0 t -116.87 157.87 24.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 1.11 110.959 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.07 135.52 60.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 1.41 111.082 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -144.08 151.41 39.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 1.26 110.82 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.4 134.89 46.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.66 110.905 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.6 mt -52.23 -36.13 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 1.55 111.188 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -71.55 -32.27 67.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 2.67 110.968 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -102.54 20.25 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 3.61 110.845 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.03 -28.89 4.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 2.26 110.909 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.81 -34.04 64.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 3.7 110.993 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -83.68 -13.89 53.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 1.15 110.926 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.8 m -68.49 -6.97 28.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 1.68 110.867 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.26 64.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.118 -0.492 . . . . 1.78 111.089 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -65.24 -69.46 0.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.46 110.902 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.66 -175.21 5.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 3.29 110.84 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -94.42 135.15 36.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 2.01 110.845 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 p 46.29 82.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 1.48 110.852 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -133.33 -38.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 1.17 110.813 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.46 122.7 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 2.56 110.886 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.33 -20.56 61.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 1.72 110.769 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.5 mt -144.21 144.47 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 1.7 111.165 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mm -135.29 130.23 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 1.6 111.158 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -113.88 136.92 52.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 1.52 110.915 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.57 100.88 5.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 1.14 110.793 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.79 74.06 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.771 -0.728 . . . . 0.19 112.478 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.97 58.68 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 1.53 110.91 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.53 159.89 63.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.587 0.708 . . . . 1.68 111.129 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 116.43 4.56 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.642 2.228 . . . . 0.26 112.377 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.15 7.01 68.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.822 -0.704 . . . . 0.18 112.471 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -54.92 150.49 10.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.967 0.413 . . . . 1.02 110.881 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.2 p -140.15 109.0 5.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 1.41 111.121 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.68 152.86 16.38 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 1.6 111.051 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.1 mt -130.94 99.76 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 1.73 110.913 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -77.57 138.36 39.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.34 110.901 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 m -115.31 175.61 5.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 1.16 110.803 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.98 -35.41 33.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 1.84 111.246 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -62.7 -39.69 94.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.126 -0.488 . . . . 2.3 110.909 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -81.86 -55.17 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 1.64 111.146 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.3 mt -49.27 -46.1 45.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 1.77 110.826 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.03 -50.54 58.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 1.98 111.077 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -47.13 84.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 4.91 110.901 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.12 -64.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 1.63 111.115 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.7 -41.36 61.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 1.52 111.053 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 tpp85 -51.99 -52.99 46.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 3.12 110.854 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.4 pt -80.85 -8.41 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 1.57 111.163 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.17 114.11 15.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 1.58 110.884 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -53.7 160.43 2.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.702 . . . . 4.7 110.864 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 114.76 3.81 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.677 2.252 . . . . 0.31 112.291 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.67 5.77 57.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 0.24 112.486 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.5 -162.25 20.69 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.694 -0.765 . . . . 0.17 112.482 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.6 m -139.0 153.52 48.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 1.52 110.94 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -138.28 117.07 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 1.52 110.898 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -112.74 133.51 54.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 2.87 110.867 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.64 159.21 44.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 1.62 110.946 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.96 126.4 41.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 2.8 110.89 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.33 146.77 20.41 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.673 0.749 . . . . 2.34 110.905 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 143.3 50.34 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.761 2.307 . . . . 0.2 112.316 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.2 m -126.97 146.43 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 1.44 111.121 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -109.25 132.57 54.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 2.13 110.873 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.9 p -91.27 -38.92 12.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 2.13 111.125 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.77 40.75 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 1.67 111.101 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.2 t -148.07 150.19 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 1.82 111.068 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.38 172.01 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.488 . . . . 1.71 110.872 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -63.95 -62.83 1.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 2.91 110.856 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -65.66 -75.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 3.34 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 t 53.49 -168.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 2.83 110.928 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.45 -5.73 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 2.4 110.921 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.93 146.63 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 1.62 111.085 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -67.29 115.06 6.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 3.36 110.891 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.1 p -88.94 -179.85 6.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.482 . . . . 1.48 111.165 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.18 -53.09 62.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 1.59 111.08 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -60.19 -49.73 76.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.043 0.449 . . . . 1.14 110.86 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -58.12 -43.11 87.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 3.03 110.902 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.58 -55.2 37.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 1.66 110.876 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 61.2 m -57.79 -49.26 77.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 1.54 110.912 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -45.5 88.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 1.15 110.868 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.65 -46.93 87.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 1.6 111.111 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.6 tp -60.49 -50.96 71.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 1.52 110.88 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.5 m -66.31 -26.24 67.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 1.4 111.214 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.7 mt -86.17 -14.04 45.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 1.73 110.888 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 p -81.94 2.92 28.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 3.11 110.854 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.8 -4.93 34.43 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.729 . . . . 0.79 112.551 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -87.61 170.82 10.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 1.74 110.896 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.78 170.97 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 1.7 111.126 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 53.11 44.29 30.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 2.1 110.892 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.9 t -81.69 139.42 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 1.77 111.009 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.29 162.4 8.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 2.59 110.96 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.57 145.69 32.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 2.54 110.904 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.8 mp -103.89 -36.79 7.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.472 . . . . 1.56 110.955 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.08 176.29 12.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 1.12 110.926 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -131.26 137.24 48.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 5.16 110.881 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -124.53 137.84 30.04 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.607 0.718 . . . . 1.38 110.958 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.72 165.13 31.96 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.755 2.304 . . . . 0.24 112.329 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.86 127.21 44.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 1.49 110.963 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.74 161.25 23.36 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.555 0.693 . . . . 2.86 111.179 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -24.64 29.31 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.281 . . . . 0.35 112.319 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -85.71 -22.25 27.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 2.58 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -87.71 -52.23 5.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 2.41 110.995 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.84 -40.31 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 1.58 111.136 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -33.03 73.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 1.27 111.011 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -46.34 66.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 1.08 110.879 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.3 -30.12 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 1.55 111.113 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -76.34 -32.68 58.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.108 -0.496 . . . . 3.33 110.806 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -89.35 -20.13 24.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.74 110.877 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -94.6 -32.61 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.31 110.894 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -127.79 -54.37 1.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 1.58 110.921 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.18 9.26 2.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.735 -0.745 . . . . 0.31 112.454 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -70.21 120.93 16.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.87 110.858 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -152.63 104.9 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 2.24 110.894 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -161.11 171.26 18.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 1.08 110.789 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.78 -8.11 17.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 1.87 110.885 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -102.74 12.01 36.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 2.95 110.872 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 167.51 14.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 1.68 110.831 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -172.61 130.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 1.7 110.916 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -73.61 132.69 43.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.473 . . . . 3.18 110.939 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.39 142.9 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.5 111.09 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -96.86 127.81 43.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 2.41 110.85 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.95 151.39 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 1.73 111.156 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.9 t -134.96 162.96 30.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 1.47 111.217 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.84 134.09 4.21 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 0.16 112.511 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.77 140.37 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 2.41 110.891 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.11 135.48 47.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.54 0.685 . . . . 2.98 110.863 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 125.1 11.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.623 2.215 . . . . 0.38 112.372 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.933 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.919 0.39 . . . . 1.98 110.93 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -122.33 22.68 10.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 2.65 110.817 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.15 41.08 53.01 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.772 -0.728 . . . . 0.27 112.454 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.02 159.68 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 1.5 111.139 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.5 164.7 37.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.82 110.952 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.46 126.19 35.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 1.63 111.051 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.96 0.96 21.05 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.807 -0.711 . . . . 0.29 112.512 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.89 167.15 11.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 1.32 110.974 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.15 112.79 25.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 2.26 110.947 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.1 t -117.37 130.16 72.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 2.86 111.013 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.11 124.66 49.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 1.33 111.105 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.1 t -97.3 117.03 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 1.59 111.079 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 t -102.56 117.49 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 1.57 111.085 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -114.88 172.46 7.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 0.44 110.908 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -151.73 -172.98 4.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 2.13 110.879 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -35.49 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 4.37 110.929 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -73.91 -8.03 54.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 1.51 110.831 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -107.05 93.78 9.73 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.604 0.716 . . . . 1.1 110.833 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 143.79 52.06 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.634 2.223 . . . . 0.23 112.424 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.0 t -48.88 -32.9 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 1.56 111.153 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.94 -53.01 36.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 3.25 110.888 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -44.85 10.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 1.42 111.13 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -52.13 -62.42 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 1.66 110.938 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.16 -36.25 18.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 3.63 110.911 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.14 -47.16 46.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.714 -0.755 . . . . 0.21 112.5 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.7 mt -61.9 -38.89 90.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 1.69 110.96 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.6 m -77.6 -31.48 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 1.7 111.095 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -62.1 -58.52 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 1.58 110.815 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -39.97 75.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 2.68 110.923 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.06 -24.32 60.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 1.53 110.972 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.67 -24.98 44.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.45 110.947 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.98 -29.92 17.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 1.68 111.087 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.46 -35.24 14.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 1.49 110.87 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.14 -45.39 4.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 1.48 111.059 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.15 -12.24 54.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.25 112.5 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -70.91 -62.55 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.323 . . . . 3.41 110.88 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -89.42 -41.11 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 2.38 110.807 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.75 -128.36 5.81 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.788 -0.72 . . . . 0.25 112.541 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -151.82 152.53 32.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 2.92 110.903 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.2 t -135.46 130.0 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 1.56 111.121 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 t -120.74 153.14 37.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 1.18 110.793 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -115.86 138.61 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 1.61 111.155 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -146.9 151.23 36.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 1.21 110.984 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.09 138.68 39.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.39 110.846 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.3 mt -55.04 -42.65 65.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 1.77 111.147 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -25.56 67.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 5.28 110.904 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -111.24 19.32 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 3.55 110.83 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.27 -27.65 6.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 2.09 110.904 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -55.6 -32.53 63.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.29 110.875 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -83.45 -14.31 52.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 1.04 110.951 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 m -67.56 -8.52 34.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 1.73 110.884 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.41 64.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 1.58 111.129 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -65.13 -67.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.48 110.807 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.37 -177.9 6.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 3.03 110.931 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -93.07 130.46 38.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 1.83 110.861 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t 51.63 83.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.16 110.8 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 91.2 p -136.15 -39.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.792 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -100.59 122.01 42.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 2.54 110.8 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.23 -22.04 62.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 1.49 110.854 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 mt -145.5 143.68 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 1.59 111.076 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 18.2 mm -133.03 132.72 58.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 1.62 111.148 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.14 137.21 52.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 1.55 110.957 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.35 101.33 5.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 1.24 110.863 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.23 75.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.852 -0.689 . . . . 0.17 112.427 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.48 59.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 1.52 110.85 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.78 159.71 64.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 1.56 111.125 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 116.84 4.76 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.59 2.193 . . . . 0.24 112.406 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.79 7.49 71.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.798 -0.715 . . . . 0.17 112.523 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.47 148.84 14.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.946 0.403 . . . . 1.13 110.882 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.2 p -137.88 108.57 6.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 1.53 111.127 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.09 153.47 18.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 1.51 111.145 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mt -132.12 104.23 6.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 1.49 110.852 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -79.87 153.84 28.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.34 110.829 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.8 m -130.94 175.82 8.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 1.08 110.824 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.28 -38.22 51.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 1.65 111.07 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.44 -46.03 91.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.193 -0.458 . . . . 2.41 110.819 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -72.6 -54.6 15.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 1.67 111.073 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.8 mt -51.08 -38.26 50.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 1.68 110.857 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.88 -56.55 15.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 1.47 111.049 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -44.12 76.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 2.98 110.949 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.1 mm -55.53 -68.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 1.59 111.172 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.71 -37.4 50.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 1.38 111.096 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -55.2 -50.07 70.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 4.16 110.873 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.3 pt -84.99 -7.31 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 1.52 111.165 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.97 112.04 14.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.17 -0.468 . . . . 1.59 110.834 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -51.35 159.31 1.16 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 3.04 110.878 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 114.61 3.76 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.663 2.242 . . . . 0.18 112.306 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.47 3.32 56.44 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.733 -0.746 . . . . 0.17 112.455 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.98 -159.72 10.31 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.14 112.525 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.7 m -140.91 157.91 44.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.825 0.345 . . . . 1.71 110.942 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -141.76 115.05 8.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 1.49 110.896 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -109.23 133.9 52.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 2.89 110.914 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.34 162.41 39.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 1.63 110.874 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.1 123.45 27.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 4.37 110.855 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.53 147.84 31.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.613 0.72 . . . . 2.58 110.847 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 145.61 57.58 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.671 2.247 . . . . 0.2 112.311 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.3 146.45 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 1.61 111.11 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.73 132.68 53.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 3.6 110.866 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.4 p -100.47 26.07 7.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 1.88 111.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.94 27.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 1.83 111.129 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.78 157.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 1.66 111.162 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.31 -172.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 1.9 110.841 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.41 -74.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 3.45 110.87 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -52.57 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 3.03 110.893 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.69 -169.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 2.56 110.872 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -5.02 56.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 3.16 110.981 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -146.77 145.8 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 1.83 111.227 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -66.07 110.46 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 3.37 110.983 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.4 p -82.11 177.25 8.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 1.44 111.103 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.88 -54.67 41.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.61 111.076 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.88 -48.02 83.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 1.02 110.822 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -57.99 -39.02 77.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 2.82 110.888 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.84 -55.17 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 1.57 110.873 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -56.76 -45.87 81.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 1.95 110.804 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -43.13 89.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 1.5 110.85 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 1.52 111.124 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.6 tp -65.97 -51.43 58.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 1.54 110.858 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.0 m -62.76 -32.3 73.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 1.47 111.125 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.1 mt -86.82 -10.33 53.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.394 . . . . 1.89 110.974 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.02 5.8 27.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 2.45 110.902 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.75 8.36 30.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.755 -0.736 . . . . 0.56 112.445 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.92 171.37 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.346 . . . . 1.45 110.953 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.9 m -149.98 170.71 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 1.55 111.054 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 52.34 44.94 29.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.02 -0.536 . . . . 2.35 110.88 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.1 t -81.78 142.64 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 1.71 111.121 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 159.75 7.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 2.57 110.894 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.01 139.83 38.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 2.82 110.818 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.63 -37.58 9.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 1.57 110.831 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.7 176.35 12.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 1.15 110.889 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 138.83 50.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 4.9 110.85 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -125.37 136.91 28.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.64 0.733 . . . . 1.42 110.938 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 161.49 45.7 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.694 2.263 . . . . 0.23 112.443 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.96 125.4 39.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 1.72 110.963 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.24 160.75 27.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.539 0.685 . . . . 2.19 111.128 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 -28.92 24.15 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.62 2.214 . . . . 0.46 112.369 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -85.32 -17.82 35.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 3.9 110.88 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.86 -53.52 4.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 2.35 110.899 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.7 p -50.15 -42.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 1.54 111.14 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -32.35 73.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 1.83 110.854 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -50.61 28.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 1.19 110.856 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.21 -28.59 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 1.43 111.123 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -76.13 -47.34 24.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 2.48 110.842 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -74.45 -19.56 60.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 1.88 110.831 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.48 -33.11 13.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.48 110.786 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.82 -54.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 1.72 110.828 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.15 8.2 2.38 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.712 -0.756 . . . . 0.45 112.513 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -70.64 119.94 15.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.76 0.314 . . . . 0.86 110.814 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.53 105.08 2.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 2.19 110.868 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.14 177.52 10.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 1.18 110.902 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.46 -13.45 15.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 1.84 110.857 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.87 3.5 53.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 3.33 110.881 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.05 163.11 28.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 1.71 110.974 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -173.55 129.58 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.256 -0.429 . . . . 1.56 110.902 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -75.73 135.92 40.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 3.22 110.86 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.79 141.99 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 1.58 111.194 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -94.57 127.66 40.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 2.38 110.938 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.39 149.14 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 1.49 111.177 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.2 t -132.5 162.35 31.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 1.59 111.13 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.56 135.86 5.01 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.666 -0.778 . . . . 0.16 112.436 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -92.91 140.0 29.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 2.53 110.918 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.3 135.02 50.9 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.518 0.675 . . . . 2.18 110.917 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.9 125.2 11.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.612 2.208 . . . . 0.31 112.297 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.855 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.767 0.318 . . . . 2.4 110.876 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -122.21 11.92 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 2.75 110.854 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.34 39.5 97.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.812 -0.709 . . . . 0.46 112.445 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -81.52 159.82 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.765 0.316 . . . . 1.62 111.181 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.65 168.62 26.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.78 110.865 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.77 130.1 36.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 1.67 111.106 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.19 2.04 26.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.782 -0.723 . . . . 0.4 112.53 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -118.85 168.0 11.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.816 0.341 . . . . 1.3 110.864 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.02 115.03 29.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.98 0.419 . . . . 3.92 110.851 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.42 131.82 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 2.85 111.172 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.18 125.29 51.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 1.56 111.133 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.6 t -97.47 119.22 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 1.68 111.11 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 t -103.82 112.21 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 1.54 111.031 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -113.73 170.53 8.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.24 110.928 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -151.96 -169.85 3.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.428 . . . . 1.79 110.909 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -35.69 71.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 7.11 110.865 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.1 m -72.96 -9.55 58.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 2.8 110.835 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.01 94.24 10.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.664 0.745 . . . . 1.08 110.84 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 142.57 48.14 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.726 2.284 . . . . 0.31 112.331 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.9 t -48.47 -33.14 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 1.63 111.158 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.09 -52.66 41.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 3.1 110.961 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -45.26 10.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 1.51 111.119 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.69 -61.54 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 1.49 110.977 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.46 -35.58 20.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 3.11 110.874 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.47 -47.56 41.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.766 -0.73 . . . . 0.25 112.486 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.7 mt -61.88 -38.1 87.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 1.63 110.94 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.5 m -78.59 -31.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 1.73 111.079 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.48 -57.37 11.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 1.67 110.834 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -39.88 76.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.271 -0.422 . . . . 3.5 110.932 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -73.26 -24.92 60.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 1.51 110.932 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.17 -25.14 47.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.45 110.969 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.7 -30.74 16.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 1.56 111.099 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.23 -34.86 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 1.66 110.97 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.83 -47.02 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 1.59 111.149 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.5 -13.55 50.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.26 112.451 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.8 -62.62 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 3.67 110.917 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -98.44 -36.87 9.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 2.2 110.935 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.92 -130.91 5.18 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.665 -0.779 . . . . 0.32 112.51 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -152.11 152.24 32.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.323 . . . . 2.93 110.944 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.3 t -137.0 121.09 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 1.42 111.174 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -110.13 155.83 21.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 1.11 110.859 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 p -118.02 133.89 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 1.62 111.12 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -144.01 151.6 39.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 1.94 110.955 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -103.17 133.28 48.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.74 110.91 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.9 mt -49.57 -32.98 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 1.46 111.091 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -71.32 -39.67 71.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 2.95 110.967 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.3 19.43 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 3.99 110.842 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.24 -27.87 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.431 . . . . 2.11 110.948 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mp -55.65 -32.85 63.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 2.24 110.942 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -83.88 -14.13 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.433 . . . . 1.06 110.906 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 m -66.47 -9.21 32.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 1.75 110.875 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.29 63.48 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 1.67 111.12 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -63.31 -67.75 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.5 110.818 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.28 179.87 8.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 3.25 110.876 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -87.78 133.94 33.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 1.93 110.944 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.7 p 46.3 83.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 1.51 110.807 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.1 p -134.19 -38.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 1.02 110.858 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -100.87 121.74 42.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 2.56 110.839 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.95 -21.44 61.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 1.73 110.844 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.0 mt -145.22 144.4 21.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 1.48 111.104 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 mm -134.5 129.17 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 1.59 111.128 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.03 136.31 50.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 1.56 110.912 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.51 100.65 5.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 1.48 110.775 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.02 74.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.451 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.31 52.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 1.58 110.83 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.99 159.83 54.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 1.65 111.141 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.88 10.53 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.633 2.222 . . . . 0.29 112.308 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.67 6.33 88.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.28 112.457 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 p -56.5 151.58 13.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.909 0.385 . . . . 1.23 110.848 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -141.62 109.17 5.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 1.57 111.205 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.63 143.64 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 1.53 111.104 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mt -122.52 106.01 10.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 1.61 110.898 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -81.14 153.79 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.31 110.842 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 m -131.97 175.66 9.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 1.03 110.856 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.71 -38.51 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 1.39 111.043 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.09 -47.32 86.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.99 110.856 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -71.53 -54.87 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 1.66 111.077 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.9 mt -50.3 -39.24 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 1.54 110.868 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.58 -54.43 27.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 1.5 111.033 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.9 -43.38 81.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 2.7 110.913 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.0 mm -60.02 -68.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 1.69 111.047 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.25 -31.26 13.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 1.85 111.167 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -63.83 -49.97 70.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 3.3 110.903 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.0 pt -84.67 -2.95 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 1.71 111.077 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.6 111.99 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 1.52 110.934 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -51.9 159.53 1.36 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 2.95 110.827 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 114.75 3.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.723 2.282 . . . . 0.21 112.289 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.14 3.69 56.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.677 -0.773 . . . . 0.18 112.413 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.42 -163.32 15.66 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.747 -0.739 . . . . 0.15 112.494 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 32.5 m -137.02 154.44 50.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.828 0.347 . . . . 1.71 110.855 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -139.16 115.59 10.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 1.56 110.902 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -110.29 132.16 54.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 2.9 110.886 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.68 164.17 35.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 1.53 110.896 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.87 131.48 31.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 2.5 110.922 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.81 149.41 22.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 3.61 110.882 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 131.92 22.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.266 . . . . 0.41 112.326 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.73 146.8 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 1.56 111.174 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -108.48 132.48 53.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 2.09 110.931 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.9 p -91.15 -26.23 19.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 2.28 111.195 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.73 39.33 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 1.54 111.129 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.5 t -148.24 150.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 1.85 111.087 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.67 175.58 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 1.88 110.902 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -65.92 -66.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 2.86 110.813 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -62.15 -75.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 3.24 110.944 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t 51.25 -168.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 3.0 110.883 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -80.84 -3.1 50.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 2.44 110.942 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.53 144.14 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 1.74 111.12 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.44 117.33 9.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 3.27 110.896 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 45.0 p -92.78 -176.02 4.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 1.58 111.237 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.43 -50.87 69.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 1.65 111.102 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -52.21 65.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.8 110.832 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -54.88 -41.15 70.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 3.35 110.92 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.43 -54.82 34.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 1.73 110.888 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 70.3 m -56.0 -48.07 76.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 1.78 110.843 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -44.97 93.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 1.26 110.79 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.08 99.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 1.65 111.063 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.4 tp -66.29 -53.33 37.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 1.46 110.875 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.1 m -59.84 -33.01 71.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 1.47 111.112 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.7 mt -87.15 -10.53 52.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 1.92 110.936 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.72 4.38 32.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 2.44 110.884 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.87 11.51 26.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 0.7 112.499 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.9 170.41 8.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.356 . . . . 1.62 110.956 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.7 m -151.5 174.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 1.55 111.063 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 52.07 43.93 30.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 2.17 110.863 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.4 t -75.7 143.04 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 1.56 111.099 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 159.1 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 2.54 110.849 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.37 146.8 30.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 2.34 110.881 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.4 mp -106.76 -35.67 6.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 1.54 110.948 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.22 176.24 11.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.23 110.886 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.97 140.4 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.495 . . . . 5.04 110.895 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -126.13 137.46 30.24 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.681 0.753 . . . . 1.53 110.947 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 162.51 41.76 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.65 2.233 . . . . 0.3 112.35 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.8 123.13 42.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 1.53 110.941 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.72 161.04 25.13 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.653 0.74 . . . . 2.81 111.054 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 -25.78 28.76 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.683 2.255 . . . . 0.73 112.388 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -85.42 -22.06 28.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 2.8 110.916 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -87.85 -52.32 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 2.39 110.995 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.89 -39.98 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 1.68 111.109 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -33.42 74.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 1.44 110.87 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -46.02 67.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 1.26 110.949 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.51 -30.25 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 1.58 111.189 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -31.44 56.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.159 -0.473 . . . . 3.91 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -90.31 -19.83 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 2.04 110.888 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -94.25 -33.62 13.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.68 110.874 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 mp -125.19 -54.19 1.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 1.62 110.936 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.96 10.1 2.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 0.39 112.44 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -69.54 120.86 15.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 1.46 110.846 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -149.75 106.38 3.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 3.05 110.936 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.6 174.59 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 1.55 110.906 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -19.14 13.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 2.72 110.818 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -96.6 12.77 30.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 2.3 110.903 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 163.7 25.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 1.69 110.951 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -173.49 130.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 1.6 110.855 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -74.76 132.95 42.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 2.97 110.894 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.82 144.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 1.59 111.229 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -101.04 128.27 47.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 1.99 110.949 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.0 148.16 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 1.63 111.103 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.0 t -125.84 158.99 33.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 1.51 111.228 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.03 130.77 3.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.79 -0.719 . . . . 0.2 112.521 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.16 139.14 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.924 0.393 . . . . 2.49 110.834 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 135.09 53.29 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.515 0.674 . . . . 2.19 110.964 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 127.15 14.24 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.676 2.251 . . . . 0.32 112.38 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.3 110.885 -179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.808 0.337 . . . . 1.94 110.883 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.29 22.38 10.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 2.65 110.84 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.12 40.74 52.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 0.25 112.529 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.25 159.48 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.725 0.298 . . . . 1.49 111.206 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.93 162.69 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 2.03 110.822 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.42 126.53 35.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 1.49 111.124 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.11 -6.67 17.17 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.73 -0.748 . . . . 0.28 112.487 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -113.69 167.66 10.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 1.57 110.965 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -97.96 140.87 31.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 3.76 110.837 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.3 t -142.59 142.69 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 2.8 111.16 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.95 121.74 39.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 1.34 111.024 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.41 118.57 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 1.64 111.102 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -102.52 110.71 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 1.56 111.121 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -112.45 167.19 10.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.18 110.925 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -149.99 -169.65 3.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 1.98 110.846 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -57.53 -35.62 70.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 3.64 110.894 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.37 -9.54 58.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 2.08 110.866 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.84 94.7 10.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.617 0.722 . . . . 1.66 110.851 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 141.78 46.0 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.7 2.267 . . . . 0.22 112.338 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -48.79 -32.97 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 1.48 111.114 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.08 -52.92 38.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 3.14 110.834 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.46 -44.96 10.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 1.51 111.145 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.74 -61.62 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 1.6 110.894 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -49.7 -37.41 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 4.03 110.947 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.31 -47.33 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.22 112.475 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.89 -39.84 93.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 1.69 110.915 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.2 m -76.79 -31.57 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 1.71 111.231 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.09 -59.56 4.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.115 -0.493 . . . . 1.64 110.786 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -39.82 72.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 2.67 110.874 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.0 mt -73.1 -24.7 60.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 1.34 110.994 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.67 -25.21 44.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.47 110.907 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.84 -29.81 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 1.36 111.141 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.48 -35.19 14.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 1.68 110.93 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -45.34 4.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 1.61 111.166 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.44 -11.75 53.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.672 -0.775 . . . . 0.36 112.453 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.43 -62.39 1.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 3.5 110.944 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -85.91 -43.18 13.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 2.13 110.841 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.23 -121.03 4.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.727 -0.749 . . . . 0.33 112.533 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -158.33 154.13 26.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 3.04 110.81 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.2 t -139.54 131.61 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 1.6 111.161 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -120.76 157.99 28.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 1.33 110.831 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.2 134.99 59.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 1.52 111.138 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -144.76 151.9 39.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.432 . . . . 1.23 110.89 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -101.4 137.39 39.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 2.82 110.9 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.5 mt -51.03 -49.86 26.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 1.74 111.107 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -22.55 63.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 4.29 110.927 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -98.52 18.44 16.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 3.46 110.885 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.98 -28.03 6.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 2.09 110.835 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.81 -37.79 60.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 2.27 110.87 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -85.23 -17.21 37.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 1.19 110.972 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -65.37 -12.51 52.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 1.84 110.908 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.76 64.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 1.64 111.074 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -65.71 -67.98 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.45 110.86 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.32 -175.48 5.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 2.94 110.856 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -94.06 134.85 36.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 1.83 110.864 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p 46.3 82.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 1.42 110.84 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.8 p -133.53 -38.44 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 1.05 110.885 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -101.97 122.0 43.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 3.6 110.84 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.99 -21.48 61.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 1.49 110.827 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.3 mt -142.6 143.88 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 1.74 111.034 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.0 mm -134.27 128.79 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 1.58 111.142 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -111.95 136.31 51.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 1.56 110.913 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.44 101.81 6.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 1.16 110.826 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.84 75.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.783 -0.722 . . . . 0.17 112.47 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.66 58.26 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 1.53 110.883 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.02 159.74 65.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.697 0.761 . . . . 1.67 111.196 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 116.73 4.69 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.738 2.292 . . . . 0.28 112.362 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.18 7.14 70.41 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.805 -0.712 . . . . 0.19 112.416 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -55.27 149.7 12.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.859 0.361 . . . . 1.4 110.853 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.5 p -140.23 108.86 5.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 1.41 111.212 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.1 150.27 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 1.48 111.147 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mt -127.79 102.98 7.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 1.56 110.918 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -77.63 148.66 34.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.25 110.794 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.0 m -127.17 -178.02 4.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.98 110.789 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.75 -41.33 67.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.048 -0.523 . . . . 1.55 111.159 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -57.85 -47.24 83.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 1.85 110.9 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -71.81 -56.75 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 1.68 111.132 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 mt -50.73 -40.83 55.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 1.43 110.968 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.56 -56.7 11.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 1.54 111.114 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -44.49 86.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 2.44 110.855 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.2 mm -53.0 -68.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 1.63 111.166 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.1 -39.85 60.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 1.39 111.121 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.6 tpp85 -53.32 -50.25 65.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 2.89 110.893 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.2 pt -84.11 -8.13 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 1.48 111.067 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.37 113.42 15.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 1.52 110.947 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -52.84 159.88 1.65 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.669 0.747 . . . . 3.08 110.867 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.86 114.5 3.74 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.24 112.332 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.26 5.47 57.1 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.17 112.45 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.44 -163.11 18.72 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.844 -0.694 . . . . 0.14 112.407 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 22.8 m -136.55 154.99 50.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 1.52 110.854 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -139.69 116.38 10.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 1.58 110.919 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -112.21 131.29 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 2.88 110.927 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.41 160.7 42.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 1.59 110.97 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.53 127.94 36.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 2.54 110.909 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.78 148.95 29.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.651 0.739 . . . . 2.2 110.842 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 140.01 41.3 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.598 2.199 . . . . 0.22 112.376 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.81 146.97 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 1.61 111.091 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -109.55 132.46 54.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 2.22 110.869 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.4 p -105.61 26.45 9.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 1.8 111.093 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.58 24.41 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 1.6 111.133 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.4 t -144.81 159.24 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 2.13 111.043 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.02 167.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 1.74 110.819 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -62.78 -50.67 70.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 2.85 110.847 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -74.13 -75.73 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 2.65 110.928 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t 53.56 -166.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 3.16 110.799 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -8.93 59.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 4.92 110.855 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.62 142.78 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 1.59 111.117 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -63.13 116.15 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 3.28 110.932 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 55.7 p -85.03 178.49 7.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.439 . . . . 1.68 111.033 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.97 -54.02 49.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 1.53 111.144 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -59.9 -48.7 80.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 1.06 110.851 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -56.8 -39.55 74.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 2.5 110.898 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.53 -54.98 23.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 1.5 110.857 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.2 m -56.09 -45.34 79.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 2.02 110.954 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -42.56 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 1.41 110.82 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.44 98.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 1.48 111.111 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.66 -52.98 38.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.421 . . . . 1.45 110.874 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.5 m -59.8 -34.72 73.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 1.61 111.083 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.7 mt -84.96 -10.21 57.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 1.71 110.905 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.12 5.45 29.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 2.36 110.8 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.26 7.77 32.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.64 112.495 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.31 170.18 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 1.63 110.992 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -150.86 170.63 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 1.53 111.162 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 54.77 43.27 30.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 2.1 110.858 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.0 t -75.65 143.51 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 1.49 111.106 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.1 159.66 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 2.6 110.867 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -81.86 146.05 30.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 2.37 110.924 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.92 -35.64 7.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 1.52 110.885 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.3 176.27 11.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 1.09 110.888 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.35 137.84 47.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 5.2 110.823 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.91 137.53 29.01 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.593 0.711 . . . . 1.84 111.002 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 165.08 32.09 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.706 2.271 . . . . 0.23 112.389 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.19 126.56 43.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 1.47 110.868 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.34 161.4 23.0 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.606 0.717 . . . . 2.83 111.157 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -24.57 29.81 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.692 2.261 . . . . 0.36 112.366 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.59 -22.52 28.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 2.56 110.898 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -87.79 -52.22 5.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 2.57 110.867 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -49.69 -40.08 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 1.56 111.171 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -33.44 74.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 1.37 110.954 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.35 -45.93 68.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 1.13 110.832 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.36 -30.44 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 1.54 111.103 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -75.98 -32.48 59.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 3.22 110.87 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -89.32 -20.29 24.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 1.65 110.912 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -94.47 -32.78 13.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.32 110.866 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -127.55 -54.37 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 1.56 110.929 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.98 9.11 2.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.768 -0.729 . . . . 0.34 112.537 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -70.3 121.5 17.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.749 0.309 . . . . 0.84 110.879 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -152.08 104.75 3.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 2.15 110.882 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.3 t -161.2 173.12 15.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 1.03 110.858 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.82 -12.71 15.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 1.7 110.797 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -97.67 10.41 40.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 1.94 110.832 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.59 166.61 18.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.189 -0.46 . . . . 1.64 110.83 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -172.97 130.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 1.56 110.978 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.79 131.3 40.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 3.04 110.908 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.0 144.18 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 1.64 111.081 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -99.56 128.41 45.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 1.97 110.919 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.3 149.61 30.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 1.47 111.118 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.5 t -127.84 160.88 30.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 1.45 111.109 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.44 132.1 3.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.2 112.503 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -92.94 140.1 29.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 2.44 110.896 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.46 135.13 50.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.603 0.716 . . . . 2.24 110.939 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 123.6 10.26 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.634 2.223 . . . . 0.3 112.346 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.34 110.84 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.871 0.367 . . . . 3.05 110.917 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -122.32 21.79 10.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 3.52 110.917 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.21 39.77 51.19 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.741 -0.742 . . . . 0.39 112.451 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.03 159.19 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 1.56 111.145 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.1 m -147.33 157.03 43.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 1.73 110.85 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.11 123.71 33.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.513 . . . . 1.74 111.112 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.68 -3.51 21.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.758 -0.734 . . . . 0.35 112.5 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -108.89 169.63 8.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.376 . . . . 1.75 110.898 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -104.62 109.68 21.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 2.36 110.873 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.7 135.49 55.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 3.13 111.092 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.7 125.85 53.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 1.68 111.083 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.5 t -97.72 120.53 47.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 1.53 111.129 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.0 t -104.31 121.86 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 1.6 111.13 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -121.38 170.24 9.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.29 110.905 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.25 -171.02 3.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 1.84 110.919 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -57.05 -36.11 70.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 4.7 110.881 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -72.08 -10.21 59.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 1.91 110.807 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -107.68 92.86 9.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.618 0.723 . . . . 0.73 110.884 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.79 143.07 49.52 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.678 2.252 . . . . 0.48 112.306 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.6 t -48.29 -32.61 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 1.56 111.144 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.54 -53.44 37.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 2.59 110.9 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.9 -45.01 10.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 1.59 111.064 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -50.19 -60.26 3.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 1.5 110.91 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -49.44 -35.76 20.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 3.7 110.952 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.89 -48.31 49.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.698 -0.763 . . . . 0.3 112.478 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.43 -40.55 91.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.865 0.364 . . . . 2.76 110.937 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -76.79 -30.81 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 1.69 111.081 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.94 -60.87 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 1.91 110.929 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -40.58 68.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 3.59 110.821 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.36 -25.57 61.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 1.69 110.991 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.36 -24.94 46.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.53 110.844 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.23 -30.1 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 1.77 111.112 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.34 -34.88 14.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 1.81 110.887 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -103.2 -47.0 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 1.41 111.186 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.24 -14.64 48.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.763 -0.732 . . . . 0.44 112.478 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -60.78 -62.55 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 2.6 110.858 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.23 -36.35 9.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 2.03 110.873 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.72 -137.48 7.61 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.67 -0.776 . . . . 0.47 112.467 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -146.4 150.33 35.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 4.94 110.925 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.8 t -133.66 119.31 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 1.68 111.102 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -108.12 158.04 17.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 1.16 110.796 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.48 138.14 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 1.45 111.109 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -145.82 151.31 37.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 1.23 110.891 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.4 134.62 46.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.66 110.958 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.2 mt -52.77 -35.86 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 1.57 111.119 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -71.51 -31.64 67.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 2.89 110.896 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.91 20.18 18.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 3.61 110.896 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.19 -28.37 4.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 2.09 110.893 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mp -55.27 -34.01 63.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 2.11 110.892 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -84.04 -14.94 49.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 1.07 110.898 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.8 m -67.14 -9.38 39.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 1.64 110.863 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.87 63.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 1.57 111.02 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -63.22 -68.13 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.53 110.849 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.85 -176.95 6.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 3.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -92.72 128.95 38.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 1.82 110.91 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 t 51.67 84.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 1.98 110.806 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.1 p -136.23 -38.87 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 1.01 110.863 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -100.21 123.76 44.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 3.57 110.804 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.38 -21.48 60.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 1.72 110.785 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 mt -144.05 143.3 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 1.57 111.06 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.6 mm -135.62 128.75 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 1.51 111.187 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -112.61 136.31 52.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 1.56 110.845 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.97 105.0 8.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 1.27 110.834 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.26 71.44 0.63 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.768 -0.73 . . . . 0.27 112.488 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.52 57.09 0.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.818 0.342 . . . . 1.53 110.948 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.57 153.01 69.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.637 0.732 . . . . 1.65 111.149 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 116.87 4.75 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.674 2.249 . . . . 0.47 112.336 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.99 6.94 71.15 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.708 -0.758 . . . . 0.47 112.453 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 t -66.2 152.97 43.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 3.69 110.832 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 p -136.68 112.42 9.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.521 . . . . 1.54 111.142 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -162.81 144.82 10.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 1.48 111.1 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.3 mt -125.28 116.28 21.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 1.92 110.833 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -89.97 154.06 20.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.28 110.806 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 m -129.51 -177.7 4.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 1.66 110.923 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.5 -37.06 69.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.472 . . . . 1.33 111.025 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -61.77 -46.28 90.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 2.05 110.85 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.31 -54.64 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.468 . . . . 1.63 111.119 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 mt -50.31 -40.8 49.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 1.63 110.924 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.49 -55.48 18.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 1.48 111.12 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -45.26 82.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 3.12 110.869 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.4 mm -54.65 -68.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 1.59 111.088 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.84 -39.3 53.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 1.49 111.181 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -53.18 -51.47 61.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 3.8 110.912 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.8 pt -83.96 -6.98 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 1.49 111.134 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.02 111.25 15.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 1.59 110.854 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -51.79 158.93 1.46 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 4.92 110.923 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 114.15 3.62 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.738 2.292 . . . . 0.3 112.243 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.84 2.8 55.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.18 112.453 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.83 -165.78 23.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.544 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 65.5 m -133.51 152.81 51.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.86 0.362 . . . . 1.69 110.924 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -137.29 114.79 11.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 1.63 110.922 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -110.54 132.54 54.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 3.31 110.897 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.25 157.91 43.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 1.55 110.81 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.1 126.51 43.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.012 -0.54 . . . . 3.7 110.817 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.53 145.96 19.13 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.689 0.757 . . . . 2.27 110.83 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 139.76 41.06 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.721 2.281 . . . . 0.21 112.434 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.52 146.73 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 1.63 111.144 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.29 132.59 54.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 1.88 110.892 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.9 p -104.18 26.1 9.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 1.83 111.145 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.99 23.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 1.85 111.131 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.6 t -144.49 159.01 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 1.84 111.145 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -178.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 2.16 110.848 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -68.54 -63.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 2.71 110.84 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.4 -76.03 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 3.11 110.938 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.5 p 51.44 -169.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 2.8 110.809 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.54 -3.84 51.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 2.69 110.846 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.41 153.61 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.426 . . . . 1.55 111.112 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.0 mmtm -72.28 109.7 6.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 2.73 110.833 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.2 p -82.4 177.99 8.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 1.56 111.156 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.85 -54.88 39.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 1.42 111.101 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.16 -49.28 77.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 1.01 110.836 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -56.75 -38.63 72.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.191 -0.459 . . . . 2.39 110.96 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.15 -54.89 22.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 1.51 110.929 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.7 m -57.74 -45.8 85.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 1.6 110.834 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -42.95 91.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 1.41 110.87 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.59 93.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 1.56 111.043 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.9 tp -65.63 -50.35 65.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 1.6 110.925 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 96.8 m -61.97 -34.6 76.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 1.33 111.082 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.13 -10.22 57.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 1.8 110.87 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.6 6.52 27.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 2.51 110.884 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.41 4.77 34.86 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.51 112.406 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.63 170.61 7.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 1.65 110.895 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.2 m -151.7 173.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 1.62 111.068 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 51.55 44.1 29.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 2.04 110.878 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 95.3 t -77.73 143.1 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 1.53 111.186 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.15 159.25 7.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.244 -0.435 . . . . 2.61 110.95 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.99 143.33 32.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 3.29 110.923 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.19 -37.0 7.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 1.58 110.931 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.81 176.08 13.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 1.21 110.948 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -132.35 137.49 47.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 5.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -123.87 136.81 27.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.632 0.73 . . . . 1.83 110.941 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 163.03 39.81 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.759 2.306 . . . . 0.31 112.293 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.45 124.15 40.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 1.57 110.915 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.77 161.38 25.19 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 121.567 0.699 . . . . 2.35 111.088 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -28.41 25.0 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.678 2.252 . . . . 0.44 112.4 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -85.41 -17.71 35.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 3.66 110.824 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.13 -53.66 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 2.33 110.974 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.9 p -49.43 -40.56 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 1.6 111.127 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -34.61 75.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 1.23 110.831 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.19 -46.38 70.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 1.48 110.791 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.37 -30.37 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 1.4 111.14 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -75.49 -32.29 60.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 2.39 110.953 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -89.62 -20.22 23.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 1.95 110.875 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.42 -32.55 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.33 110.809 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mp -128.04 -53.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 1.72 110.946 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.22 12.4 2.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.814 -0.707 . . . . 0.33 112.491 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -70.6 122.07 19.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.324 . . . . 1.06 110.894 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -151.6 105.44 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 2.73 110.893 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.57 175.21 12.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 1.21 110.836 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.09 -20.31 13.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 1.75 110.881 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -93.57 13.27 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 1.72 110.984 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.91 163.23 23.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 1.66 110.938 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -173.53 129.99 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 1.48 110.948 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -73.81 133.49 43.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 3.21 110.842 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.0 139.74 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 1.69 111.101 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -93.74 129.62 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 2.58 110.938 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.86 150.93 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.424 . . . . 1.56 111.174 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 t -130.04 160.5 33.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 1.46 111.061 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.76 131.38 3.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.719 -0.753 . . . . 0.21 112.441 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -93.83 140.42 29.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 2.29 110.905 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -81.78 134.75 49.8 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.609 0.719 . . . . 3.39 110.818 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 119.39 6.34 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.753 2.302 . . . . 0.42 112.291 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.37 110.904 179.945 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.91 0.386 . . . . 2.1 110.877 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -122.3 18.26 10.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 2.71 110.867 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.17 40.04 73.22 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.788 -0.72 . . . . 0.32 112.417 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.0 157.5 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 1.7 111.184 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.2 m -148.3 156.61 42.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 1.59 110.846 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.77 125.31 33.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 1.69 111.093 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.09 -6.23 23.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 0.32 112.51 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.72 167.57 10.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 1.65 110.975 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.51 137.03 38.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 3.84 110.929 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 p -141.86 140.71 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 3.24 111.147 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.64 124.16 50.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 1.54 111.17 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.3 t -95.88 118.52 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 1.54 111.086 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 t -102.7 115.28 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 1.49 111.153 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -115.91 167.2 11.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 0.21 110.967 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -151.3 -169.54 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 1.75 110.892 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -56.8 -35.74 69.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 4.35 110.937 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -73.06 -10.9 60.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 2.72 110.863 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.25 93.57 9.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.604 0.716 . . . . 0.78 110.891 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 142.76 48.76 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.719 2.279 . . . . 0.23 112.336 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -48.92 -32.52 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 1.62 111.144 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.28 -53.2 38.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 2.4 110.913 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -44.95 10.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 1.43 111.091 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.27 -61.51 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 1.44 110.922 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -36.8 31.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 3.19 110.843 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.68 49.91 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.801 -0.714 . . . . 0.24 112.47 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.6 mt -61.7 -40.36 94.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 1.74 110.918 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -76.16 -31.46 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 1.71 111.177 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.02 -60.29 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 1.55 110.821 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -40.15 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 2.71 110.938 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.69 -24.68 61.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 1.65 110.841 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.4 -24.86 46.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.44 110.926 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.82 -30.02 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 1.54 111.132 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.43 -35.3 14.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 1.71 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.33 -44.77 5.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 1.48 111.057 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.49 -10.94 55.46 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.729 -0.748 . . . . 0.25 112.498 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.32 -62.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 2.4 110.966 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -91.47 -39.94 11.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 2.24 110.875 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.21 -125.73 4.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.34 112.538 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -156.25 152.68 28.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 4.61 110.965 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -135.84 130.21 48.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 1.62 111.203 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -118.61 156.9 28.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 1.46 110.869 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 p -119.39 136.71 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 1.42 111.118 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -147.26 152.17 37.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 1.3 110.894 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.66 135.72 43.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.66 110.944 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.6 mt -51.61 -35.43 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 1.63 111.19 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -29.99 59.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 3.56 110.905 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -97.89 18.44 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 3.34 110.942 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.74 -30.23 5.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 2.15 110.999 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -54.51 -37.36 65.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 1.82 110.923 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -84.6 -15.66 44.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 1.15 110.946 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 m -66.95 -10.17 46.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 1.67 110.872 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.07 63.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 1.59 111.116 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -61.75 -69.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.46 110.889 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.76 -175.5 5.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 3.33 110.865 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.47 134.84 35.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.59 110.929 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p 46.24 82.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 1.48 110.848 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.3 p -133.4 -38.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 1.3 110.87 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -101.65 122.44 43.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 3.55 110.906 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.55 -21.09 61.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.155 -0.475 . . . . 1.49 110.861 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 mt -143.38 143.52 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 1.65 111.089 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.3 mm -134.99 129.04 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 1.61 111.062 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.19 136.77 52.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 1.53 110.888 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.15 101.92 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 1.13 110.859 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.4 77.43 0.13 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.81 -0.709 . . . . 0.18 112.423 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.45 58.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 1.63 110.894 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.18 160.12 61.44 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.654 0.74 . . . . 1.62 111.163 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 115.95 4.32 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.709 2.273 . . . . 0.3 112.365 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.84 6.43 67.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.711 -0.756 . . . . 0.21 112.496 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.49 150.37 12.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.991 0.424 . . . . 0.99 110.877 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 p -140.8 108.96 5.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 1.65 111.16 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.2 148.35 11.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 1.55 111.142 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.23 101.2 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 1.64 110.935 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.16 138.17 38.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.41 110.848 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -115.83 -175.67 2.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.98 110.843 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.68 70.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 1.5 111.167 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -62.31 -42.95 99.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 1.81 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -77.79 -55.2 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 1.64 111.165 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.4 mt -50.36 -41.57 51.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 1.61 110.895 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.61 -56.51 13.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 1.56 111.105 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -41.44 74.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.433 . . . . 2.47 110.815 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.9 mm -58.55 -68.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 1.51 111.107 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.82 -35.0 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 1.4 111.168 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -59.31 -51.42 70.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 3.67 110.891 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.2 pt -83.46 -4.04 8.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 1.56 111.083 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.1 112.06 18.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 1.55 110.917 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -51.65 159.58 1.24 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.61 0.719 . . . . 2.82 110.873 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 114.26 3.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.685 2.257 . . . . 0.2 112.306 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.63 3.73 56.13 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 0.17 112.466 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.05 -166.94 26.63 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.782 -0.723 . . . . 0.21 112.491 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.5 m -133.1 153.36 51.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.873 0.368 . . . . 1.87 110.95 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -137.93 116.37 12.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 1.43 110.914 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -112.33 131.89 55.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 3.27 110.836 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.2 156.92 43.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 1.58 110.866 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.03 126.76 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 3.05 110.917 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.88 146.9 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.65 0.738 . . . . 2.31 110.852 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 143.72 52.11 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.586 2.19 . . . . 0.25 112.368 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.38 146.75 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 1.54 111.135 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -106.8 132.85 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 2.18 110.832 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -93.01 -42.11 9.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 1.86 111.129 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.72 39.91 1.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 1.9 111.182 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.25 150.6 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 1.93 111.128 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.66 167.92 0.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 1.96 110.912 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -60.54 -55.0 38.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 2.68 110.822 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.59 -77.3 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 3.37 110.853 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p 54.0 -173.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 2.4 110.814 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.63 -2.1 45.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 3.54 110.927 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.1 m -143.39 154.52 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.177 -0.465 . . . . 2.07 111.09 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -69.88 121.03 16.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 3.24 110.958 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.7 p -97.05 -177.96 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 1.42 111.109 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -52.9 63.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 1.4 111.103 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.92 -50.5 73.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 1.04 110.853 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -58.93 -40.59 85.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 3.21 110.956 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.52 -54.64 43.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 1.81 110.926 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 67.2 m -55.54 -50.99 68.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 1.52 110.863 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -48.22 82.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.32 110.826 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.27 -51.52 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.064 -0.516 . . . . 1.48 111.092 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.38 -47.12 82.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 1.65 110.839 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.2 m -67.34 -22.24 65.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 1.74 111.162 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.48 -15.37 40.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 2.51 110.884 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.9 5.0 30.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 2.7 110.892 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.45 -4.86 35.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 0.48 112.573 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.06 168.96 12.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.844 0.354 . . . . 1.68 110.899 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.5 m -151.39 171.86 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 1.71 111.135 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 53.58 43.72 30.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 2.11 110.836 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.22 142.51 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 1.79 111.14 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.07 160.65 8.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 2.67 110.844 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -82.36 146.69 29.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 2.39 110.932 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 mp -107.39 -35.76 6.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 1.54 110.919 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.47 176.24 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 1.18 110.883 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -133.19 137.82 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 5.08 110.877 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -125.49 138.8 32.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.636 0.731 . . . . 1.44 110.91 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.84 164.49 34.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.615 2.21 . . . . 0.27 112.329 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.07 135.76 38.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 1.46 110.886 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.24 160.98 25.59 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 2.24 111.194 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -29.3 24.02 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.684 2.256 . . . . 0.44 112.27 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -85.31 -19.26 31.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 2.76 110.864 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -53.24 5.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 2.21 110.968 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.7 p -49.21 -41.94 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.66 111.033 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -33.69 72.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 1.35 110.866 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.28 -45.05 70.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 1.07 110.898 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.89 -32.39 54.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.492 . . . . 1.8 111.172 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -76.3 -30.0 57.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 3.58 110.85 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -90.43 -20.49 22.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 1.63 110.836 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -94.72 -32.96 13.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.59 110.8 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.0 mp -126.75 -53.98 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 2.11 110.925 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.78 12.07 2.01 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.635 -0.793 . . . . 0.9 112.435 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -70.12 121.25 17.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.687 0.279 . . . . 1.86 110.896 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -149.41 111.65 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 3.21 110.847 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.55 165.18 31.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 2.3 110.86 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.76 -7.48 19.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 2.47 110.814 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -115.56 22.8 12.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 1.9 110.862 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.16 169.48 13.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 1.81 110.92 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -173.51 130.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 1.6 110.961 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -72.94 131.84 42.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 3.21 110.943 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.95 140.38 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 1.53 111.16 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -93.95 126.84 39.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 2.44 110.864 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -122.35 151.4 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 1.59 111.147 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.2 t -129.72 161.45 30.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 1.65 111.145 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.5 130.48 3.07 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.3 112.485 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -94.86 140.56 29.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 2.32 110.838 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -82.31 134.54 48.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.535 0.684 . . . . 3.45 110.955 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 118.88 5.94 Favored 'Trans proline' 0 C--O 1.23 0.1 0 C-N-CA 122.723 2.282 . . . . 0.36 112.29 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.32 110.851 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t0 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.863 0.363 . . . . 2.32 110.874 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -122.22 20.81 10.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 2.71 110.966 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 56.24 40.79 85.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.752 -0.737 . . . . 0.44 112.472 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 mp -83.46 160.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.826 0.346 . . . . 1.77 111.067 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.36 168.01 28.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 1.84 110.899 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.51 134.41 34.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 1.73 111.135 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.51 2.5 37.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.41 112.458 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -121.04 171.88 8.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.793 0.33 . . . . 1.35 110.96 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.54 137.39 40.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 2.34 110.833 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.3 t -141.92 123.96 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 2.83 111.098 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.41 125.9 49.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 1.36 111.216 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.3 t -98.12 112.41 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 1.67 111.113 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.8 t -98.09 129.87 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 1.58 111.132 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -128.68 170.68 12.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.33 110.915 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -151.65 -172.76 4.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 1.77 110.924 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -23.41 62.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 4.04 110.857 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.83 -16.31 48.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.83 110.924 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 m -101.67 102.79 24.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.66 0.743 . . . . 0.99 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 136.85 34.08 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.66 2.24 . . . . 0.54 112.428 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.19 -31.66 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 1.75 111.121 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.02 -52.46 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 2.48 110.922 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.94 -43.81 12.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 1.53 111.099 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -51.48 -60.28 3.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 1.59 110.915 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.45 -46.83 27.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 3.02 110.963 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.68 -37.02 93.1 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.771 -0.728 . . . . 0.66 112.462 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.8 mt -60.25 -50.75 72.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 2.07 110.928 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.66 -25.28 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 4.61 111.099 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -60.91 -62.43 1.86 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 1.94 110.873 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -40.34 62.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 2.55 110.891 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.7 mt -72.22 -24.48 61.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 1.56 110.934 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -77.49 -25.58 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 2.25 110.938 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.15 -31.34 17.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 1.38 111.056 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.06 -34.76 15.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 1.58 110.874 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -103.08 -47.54 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 1.6 111.174 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.03 -15.6 50.27 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.764 . . . . 0.51 112.467 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.23 -61.06 2.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 2.62 110.793 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -102.88 -34.27 9.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 2.2 110.957 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.34 -120.55 1.9 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 0.61 112.464 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -166.44 156.45 11.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 3.03 110.846 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.4 137.55 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 1.95 111.128 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -129.43 158.37 39.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 1.26 110.804 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -117.25 141.0 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.488 . . . . 1.52 111.135 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -145.92 151.53 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 2.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -103.58 134.79 46.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.64 110.894 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.8 mt -52.94 -36.14 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 1.68 111.061 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -31.41 67.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 3.46 110.816 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -104.0 20.1 18.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 3.54 110.969 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.32 -27.93 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 2.12 110.914 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -54.96 -34.34 63.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 2.07 110.853 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -84.47 -15.55 45.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 1.07 110.877 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.9 m -65.83 -11.05 43.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 1.94 110.838 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.97 63.0 0.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 1.66 111.172 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -62.95 -70.82 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.5 110.832 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.7 -169.02 3.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 2.96 110.909 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -102.46 136.37 42.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 1.78 110.87 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.8 p 47.21 85.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 1.6 110.84 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.1 p -140.52 -40.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 1.16 110.798 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -99.42 119.18 37.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 3.69 110.889 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.87 -20.09 62.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 1.69 110.864 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.4 mt -146.46 143.7 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 1.63 111.13 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.0 mm -134.09 130.67 55.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 1.45 111.145 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.78 134.14 54.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.213 -0.448 . . . . 1.61 110.931 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.46 95.68 4.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.188 -0.46 . . . . 1.24 110.87 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 53.68 72.17 0.58 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 0.32 112.515 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.97 56.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.792 0.33 . . . . 1.51 110.898 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.42 159.9 52.95 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.613 0.72 . . . . 1.53 111.12 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 123.18 9.86 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.669 2.246 . . . . 0.27 112.381 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.27 6.97 87.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.757 -0.735 . . . . 0.23 112.507 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.8 p -55.48 148.57 15.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 1.1 110.874 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.5 p -137.83 109.1 6.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 1.59 111.14 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.37 152.28 16.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 1.55 111.195 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.15 103.45 6.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 1.53 110.959 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -79.52 152.94 29.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.28 110.874 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 m -129.23 176.28 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.87 110.823 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.27 53.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 1.68 111.11 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.37 -46.1 91.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 1.73 110.853 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -72.9 -54.54 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 1.65 111.129 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.0 mt -50.68 -38.68 48.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 1.39 110.997 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.83 -52.96 61.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 1.64 111.108 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 -43.18 79.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 2.84 110.922 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.31 -68.44 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 1.72 111.194 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.52 -33.8 15.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 1.43 111.106 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -61.06 -52.51 64.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 3.43 110.94 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.9 pt -81.43 -4.41 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 1.58 111.134 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.03 122.4 27.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 1.65 110.887 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -61.08 159.67 26.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.525 0.679 . . . . 4.67 110.885 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 114.24 3.64 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.598 2.199 . . . . 0.3 112.39 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.47 5.1 55.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 0.25 112.496 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.11 -159.61 13.19 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 0.25 112.428 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.4 m -140.9 155.04 46.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.332 . . . . 1.62 110.835 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -139.31 115.57 10.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.184 -0.462 . . . . 1.61 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -109.98 133.71 52.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 3.31 110.846 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.69 158.0 43.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 1.65 110.954 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.3 123.68 36.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 2.85 110.945 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.55 147.92 29.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.576 0.703 . . . . 2.27 110.947 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 144.77 54.97 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.665 2.244 . . . . 0.22 112.293 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 m -125.41 147.1 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 1.53 111.227 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -115.1 132.36 56.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 1.96 110.893 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.5 p -105.99 25.92 10.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 2.02 111.171 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.19 25.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 1.76 111.079 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.4 159.96 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 1.85 111.114 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.91 179.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.071 -0.513 . . . . 2.08 110.865 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -65.32 -66.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 2.74 110.901 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -63.32 -75.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 2.86 110.898 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.23 -168.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 2.34 110.802 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -5.72 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.046 -0.525 . . . . 3.38 110.955 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 m -146.19 145.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.165 -0.47 . . . . 1.73 111.066 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -67.68 116.31 8.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 3.5 110.884 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.7 p -85.35 -179.87 7.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 1.46 111.077 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.94 -54.56 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 1.64 111.052 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -48.81 78.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 1.08 110.829 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -58.95 -38.24 78.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 2.85 110.871 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.59 -54.6 33.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.427 . . . . 2.04 110.933 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.4 m -58.7 -49.56 77.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 1.68 110.965 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -47.47 86.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 1.65 110.852 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.01 -54.64 42.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 1.74 111.058 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 tp -53.8 -48.14 70.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 1.63 110.926 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.8 m -67.63 -22.43 65.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 1.4 111.125 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.4 mt -86.98 -15.08 39.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 1.91 110.881 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.46 5.37 27.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 2.88 110.847 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.87 -5.03 34.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.664 -0.779 . . . . 0.68 112.48 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.5 166.71 15.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 1.68 110.912 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.0 m -147.02 170.43 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 1.65 111.103 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 52.24 44.72 29.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 2.28 110.895 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.6 t -82.77 141.38 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 1.63 111.133 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.93 158.84 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 2.69 110.846 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -75.87 146.01 40.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 2.23 110.925 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.0 mp -104.47 -37.36 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 1.56 110.975 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.43 176.18 12.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 1.17 110.906 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.85 145.3 51.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 5.1 110.786 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -134.32 136.16 25.36 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.624 0.726 . . . . 1.44 110.889 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 164.91 32.75 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.665 2.243 . . . . 0.35 112.344 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.03 126.05 43.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 1.53 110.948 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.01 161.48 22.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.574 0.702 . . . . 2.77 111.153 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -24.64 29.74 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.711 2.274 . . . . 0.4 112.31 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -85.46 -22.03 28.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.437 . . . . 2.76 110.882 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -87.81 -53.59 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 2.51 110.945 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -49.58 -40.08 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 1.57 111.093 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -34.53 76.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 1.48 110.921 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.5 -47.15 67.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 1.11 110.853 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.59 -30.92 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 1.42 111.033 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -76.57 -29.58 56.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 2.15 110.936 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -89.91 -21.39 22.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 1.89 110.9 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.63 -32.41 13.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.33 110.923 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.6 -54.37 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 1.63 110.874 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.11 18.4 1.69 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.767 -0.73 . . . . 0.33 112.512 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -72.69 122.08 20.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 1.23 110.845 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -151.64 107.62 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 2.74 110.863 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.5 t -160.47 173.8 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 1.62 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.32 -19.75 13.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.64 110.865 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -96.83 17.05 17.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 1.58 110.959 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.78 165.38 19.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 1.7 110.918 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -173.73 130.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 1.69 110.876 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -75.84 138.46 41.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 3.03 110.871 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.93 148.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 1.76 111.14 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -100.2 130.29 46.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 2.3 110.902 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.91 150.77 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 1.66 111.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.1 t -135.25 161.43 35.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 1.67 111.125 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.59 135.61 5.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.707 -0.758 . . . . 0.25 112.442 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -91.86 140.31 29.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 2.47 110.898 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 135.26 49.28 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.612 0.72 . . . . 2.32 110.853 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 127.68 14.9 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.688 2.258 . . . . 0.45 112.306 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.34 110.904 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.848 0.356 . . . . 1.83 110.893 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.22 19.97 10.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 2.69 110.854 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.26 41.51 54.46 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.722 -0.752 . . . . 0.25 112.461 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.0 158.61 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 1.72 111.089 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.8 m -148.38 157.13 43.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 1.75 110.916 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.33 128.32 34.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 1.52 111.095 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.36 28.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.738 -0.744 . . . . 0.26 112.487 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.99 167.41 10.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 1.64 110.873 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.21 136.68 38.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 2.27 110.843 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.43 138.72 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.481 . . . . 3.18 111.183 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.59 129.5 56.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 1.57 111.154 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.1 123.79 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 1.67 111.12 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.15 116.45 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 1.65 111.11 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -119.33 164.63 15.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.23 110.846 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -148.73 -169.52 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 4.66 110.792 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -35.68 67.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 4.06 110.913 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.5 -11.55 60.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 1.51 110.896 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.47 95.52 11.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.673 0.749 . . . . 0.87 110.89 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 141.19 44.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.627 2.218 . . . . 0.22 112.36 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.19 -32.7 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 1.6 111.106 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.36 -52.5 45.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 2.48 110.922 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.4 -45.07 10.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 1.41 111.085 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.9 -61.12 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 1.56 110.902 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.81 -35.66 23.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 3.45 110.904 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.44 -48.21 45.95 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.731 . . . . 0.23 112.485 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 mt -61.63 -41.22 97.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.746 0.308 . . . . 1.74 110.846 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.2 m -74.91 -31.6 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 1.71 111.197 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.08 -62.18 1.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 1.8 110.871 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -40.16 65.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 2.79 110.888 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 76.7 mt -72.77 -25.05 61.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.195 -0.457 . . . . 1.62 110.853 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.43 -24.75 46.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.48 110.912 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.9 -29.85 17.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 1.41 111.088 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.63 -35.05 14.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 1.61 110.946 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.45 -44.72 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 1.56 111.126 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.23 -10.98 54.56 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.661 -0.781 . . . . 0.32 112.446 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -71.38 -62.38 1.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.754 0.311 . . . . 2.26 110.961 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -91.58 -40.18 11.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 1.94 110.881 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.95 -126.49 5.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.68 -0.772 . . . . 0.27 112.488 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -155.27 152.83 29.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 2.93 110.992 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.7 t -136.72 130.36 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 1.47 111.132 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 t -118.56 156.14 29.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 1.59 110.799 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -117.62 132.02 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 1.43 111.099 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -142.07 152.24 43.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 1.21 110.896 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -101.77 135.61 43.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.62 110.851 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mt -50.07 -44.09 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 1.65 111.15 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -72.24 -27.6 62.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 4.27 110.874 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -95.22 19.24 10.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 3.49 110.942 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.93 -29.65 3.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 2.11 110.91 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mp -51.91 -36.99 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 2.21 110.959 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -86.01 -19.45 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 1.22 110.926 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.2 m -60.21 -16.85 36.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 1.82 110.889 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.44 63.27 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 1.62 111.053 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -65.27 -70.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.51 110.89 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 -167.92 2.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 2.04 110.829 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -108.79 131.81 54.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 1.86 110.845 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 p 47.16 72.44 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 1.25 110.851 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -127.22 -33.69 2.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 1.07 110.842 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -99.81 118.34 36.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 2.56 110.893 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.1 -19.21 62.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 1.72 110.803 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 mt -145.46 144.61 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 1.65 111.076 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.3 mm -136.7 129.13 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 1.71 111.144 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.7 136.57 52.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 1.49 110.945 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.13 102.16 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 1.18 110.914 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.31 77.37 0.13 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.762 -0.732 . . . . 0.24 112.481 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.49 53.75 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 1.51 110.921 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.56 160.34 53.74 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.611 0.72 . . . . 1.4 111.071 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 116.35 4.51 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.671 2.248 . . . . 0.28 112.433 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.83 6.73 69.46 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.681 -0.771 . . . . 0.21 112.486 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.92 132.08 48.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 1.04 110.907 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -122.54 108.5 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 1.58 111.171 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 m -162.73 154.8 18.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 1.59 111.147 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.7 mt -133.17 104.58 6.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 1.75 110.853 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -76.18 153.72 35.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.074 -0.512 . . . . 0.38 110.886 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.1 m -131.56 177.42 7.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.98 110.836 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.7 -42.03 56.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 1.35 111.002 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.14 -46.07 86.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 1.91 110.954 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -71.9 -56.68 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 1.6 111.104 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.1 mt -50.84 -43.45 59.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 1.52 110.909 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.34 -54.24 34.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 1.58 111.057 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -43.32 84.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 2.71 110.836 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.6 mm -54.98 -67.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 1.58 111.088 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.13 -39.77 56.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 1.54 111.106 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -52.87 -53.9 42.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 3.07 110.889 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.3 pt -80.15 -8.5 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 1.57 111.129 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.3 127.56 32.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 1.49 110.916 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -67.41 160.28 72.84 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.657 0.742 . . . . 2.91 110.763 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 113.91 3.53 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.736 2.291 . . . . 0.17 112.336 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.74 56.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.747 -0.739 . . . . 0.14 112.496 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.51 -164.58 19.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.661 -0.78 . . . . 0.13 112.48 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 45.0 m -134.72 154.21 51.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.876 0.369 . . . . 1.77 110.887 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -139.61 113.99 9.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 1.61 110.944 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -109.39 131.73 54.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 3.38 110.927 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.79 158.09 43.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 1.46 110.815 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.74 130.59 45.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 2.59 110.918 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.4 145.67 17.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.637 0.732 . . . . 2.23 110.886 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.92 137.54 35.23 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.678 2.252 . . . . 0.36 112.282 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 m -120.33 146.41 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 1.67 111.091 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -111.4 132.79 54.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 1.98 110.856 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.2 p -106.39 26.09 10.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 2.13 111.169 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.85 24.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 2.02 111.145 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 t -144.22 161.0 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 1.86 111.137 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.77 177.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.91 110.895 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -67.87 -53.48 26.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 3.86 110.912 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -70.77 -75.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 3.02 110.825 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.03 -168.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 2.03 110.799 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -4.02 53.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 2.35 110.921 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.42 140.25 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.111 -0.495 . . . . 1.86 111.114 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.9 mmpp? -63.66 112.94 3.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 3.87 111.016 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.3 p -80.28 176.66 9.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 1.75 111.13 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.98 -54.9 32.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 1.43 111.075 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.33 -48.85 80.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 1.37 110.752 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -39.11 72.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 3.12 110.9 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.39 -55.15 19.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 1.56 110.994 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.4 m -56.7 -44.92 82.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.243 -0.435 . . . . 1.67 110.963 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.83 -42.34 85.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 1.33 110.867 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.2 97.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 1.46 111.161 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 tp -65.17 -53.98 36.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 1.72 110.894 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 96.1 m -58.28 -36.88 73.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 1.46 111.173 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.6 mt -83.42 -10.39 58.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 1.76 110.969 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m -84.65 4.89 30.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 2.39 110.886 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.01 8.68 31.3 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.662 -0.78 . . . . 0.62 112.446 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.46 168.66 9.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.789 0.328 . . . . 1.57 110.892 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.2 m -150.57 169.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 1.53 111.144 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 56.2 42.64 27.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 2.02 110.927 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.81 144.33 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 1.7 111.136 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.82 157.13 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 2.51 110.923 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -81.48 147.3 29.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 2.1 110.902 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.21 -36.01 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 1.54 110.927 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -164.86 176.57 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 1.34 110.981 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -126.56 166.25 17.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 9.43 110.84 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -147.96 135.71 10.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.572 0.701 . . . . 1.44 110.897 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 155.83 65.04 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.618 2.212 . . . . 0.35 112.434 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.34 122.83 35.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.26 -0.427 . . . . 1.48 110.973 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.46 162.0 22.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.539 0.685 . . . . 2.42 111.2 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -26.12 27.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.651 2.234 . . . . 0.36 112.334 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -85.33 -19.79 30.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 2.91 110.888 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.22 -54.41 4.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 2.65 110.934 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.95 -38.85 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 1.5 111.125 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -39.04 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 3.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -45.59 79.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 1.47 110.864 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.71 -31.25 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 1.57 111.158 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -75.74 -30.65 59.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.122 -0.49 . . . . 2.62 110.875 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -90.02 -20.48 23.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 1.76 110.876 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.43 -32.8 13.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.31 110.941 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.65 -54.15 1.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 1.58 110.92 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.8 18.4 1.57 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.36 112.473 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -73.72 122.03 21.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.778 0.323 . . . . 1.47 110.923 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -151.58 105.57 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 2.79 110.966 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.9 t -160.55 170.72 20.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 1.32 110.873 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.34 -18.34 14.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 1.6 110.902 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -98.5 20.25 13.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 1.55 110.83 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.67 164.26 15.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 1.44 111.025 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -173.26 130.35 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.214 -0.448 . . . . 1.46 110.936 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -69.79 134.76 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 3.3 110.848 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.6 144.94 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 1.7 111.176 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -103.29 130.65 50.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 2.65 110.921 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.05 152.58 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 1.59 111.118 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.2 t -131.98 159.19 39.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 1.52 111.128 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -148.3 133.61 4.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 0.19 112.514 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -94.26 131.82 39.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.925 0.393 . . . . 4.68 110.862 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 135.45 81.19 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.549 0.69 . . . . 2.17 110.898 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 128.79 16.53 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.695 2.263 . . . . 0.36 112.35 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.31 110.903 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.88 0.372 . . . . 2.46 110.901 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -122.26 22.45 10.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 2.77 110.883 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.14 41.65 53.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.718 -0.753 . . . . 0.27 112.488 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mp -81.02 160.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.904 0.383 . . . . 1.54 111.101 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.0 167.84 29.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 2.5 110.858 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.6 128.81 36.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 1.62 111.098 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.07 2.92 26.52 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.754 -0.736 . . . . 0.36 112.505 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -116.63 166.95 11.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.86 0.362 . . . . 1.19 110.864 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -106.13 112.89 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 2.36 110.906 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -115.23 141.47 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 3.29 111.165 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.59 112.19 20.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 1.33 111.066 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.2 t -86.53 121.13 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 1.52 111.074 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.53 115.76 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 1.56 111.067 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -115.49 168.73 9.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 0.23 110.977 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -151.42 -170.22 3.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.83 110.896 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -57.1 -35.73 69.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 4.37 110.863 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.8 m -73.34 -9.66 58.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 1.87 110.786 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.29 93.75 10.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.621 0.724 . . . . 0.92 110.848 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 142.8 48.92 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.723 2.282 . . . . 0.24 112.333 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.05 -32.43 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 1.55 111.08 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -51.29 -53.24 37.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 2.43 110.903 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.73 -44.86 10.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 1.5 111.054 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.2 -61.22 2.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 1.64 110.914 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -49.83 -35.63 23.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 3.6 110.888 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.02 -47.72 44.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 0.31 112.53 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.67 -39.44 91.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.38 . . . . 1.55 110.911 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 m -77.14 -31.32 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 1.77 111.026 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.31 -59.25 5.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 1.75 110.826 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -40.43 73.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 2.55 110.885 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.59 -25.07 61.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 1.36 110.953 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.02 -25.02 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 0.54 110.848 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.47 -30.84 17.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 1.45 111.114 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.47 -34.89 15.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 1.57 110.907 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.32 -47.13 4.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 1.45 111.132 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.1 -14.5 53.48 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.699 -0.762 . . . . 0.36 112.481 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.43 -62.68 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.756 0.313 . . . . 2.71 110.816 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.95 -33.7 8.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 1.97 110.982 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.61 -131.04 4.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.3 112.54 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -153.28 152.74 31.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.791 0.329 . . . . 4.84 110.872 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.3 t -139.27 113.69 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.67 111.125 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -103.93 153.18 21.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 1.14 110.895 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.92 133.46 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.11 -0.495 . . . . 1.56 111.148 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -142.16 151.97 42.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 1.32 110.921 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -102.66 135.11 44.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.63 110.921 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.9 mt -51.76 -35.15 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 1.64 111.181 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -29.75 60.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 2.97 110.925 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -98.21 18.59 15.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 3.36 110.926 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.31 -30.77 5.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 2.12 110.912 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -53.93 -37.91 64.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 1.83 111.062 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -84.9 -15.64 43.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 1.22 110.948 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.6 m -66.31 -10.82 46.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 2.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.68 63.43 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.473 . . . . 1.65 111.11 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -61.55 -69.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.46 110.801 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.16 -175.88 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 2.9 110.837 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -93.73 135.22 35.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 1.8 110.896 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p 46.64 81.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 1.41 110.819 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.9 p -132.07 -39.17 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 1.09 110.795 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -102.16 123.89 46.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 3.62 110.89 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.28 -21.64 62.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 1.71 110.805 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.0 mt -146.6 142.7 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 1.71 111.166 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.6 mm -129.2 136.76 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 1.62 111.147 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.12 135.77 53.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 1.73 110.966 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.72 98.02 4.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 1.45 110.851 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.11 79.58 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.752 . . . . 0.18 112.502 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.85 55.42 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.935 0.398 . . . . 1.51 110.959 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.77 158.72 58.78 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.636 0.731 . . . . 1.62 111.141 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 115.91 4.31 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.635 2.223 . . . . 0.28 112.393 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.3 6.6 66.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 0.24 112.474 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.32 151.86 9.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.952 0.406 . . . . 1.02 110.841 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.1 p -140.11 108.77 5.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 1.46 111.135 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.92 148.57 12.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 1.54 111.08 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mt -126.75 99.79 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 1.67 110.904 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -76.78 143.77 39.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.28 110.848 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.83 -175.52 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 1.42 110.746 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.54 -36.17 71.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 1.37 111.016 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.58 -44.31 96.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 1.78 110.804 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -76.03 -55.18 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 1.38 111.187 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 mt -50.14 -41.86 49.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 1.58 110.933 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.56 -55.77 17.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 1.45 111.12 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -43.25 77.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 2.78 110.903 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.9 mm -56.74 -68.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 1.53 111.116 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.14 -35.89 38.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 1.52 111.018 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -57.25 -51.05 70.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 4.39 110.867 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.79 -6.37 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 1.46 111.072 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.29 112.66 16.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.254 -0.43 . . . . 1.6 110.851 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -51.77 159.53 1.31 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.651 0.738 . . . . 2.79 110.87 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 115.82 4.27 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.77 2.313 . . . . 0.24 112.307 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.5 3.06 57.53 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.25 112.43 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.87 -157.51 9.59 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.691 -0.766 . . . . 0.21 112.483 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.5 m -145.29 158.87 43.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.35 . . . . 2.43 110.911 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.25 116.28 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 1.64 110.921 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -108.07 132.57 53.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 2.88 110.896 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.34 158.01 43.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 1.56 110.902 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.84 129.08 46.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 2.94 110.871 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.78 146.56 18.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.659 0.743 . . . . 2.23 110.849 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.8 142.74 48.59 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.707 2.272 . . . . 0.26 112.321 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.99 146.76 31.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 1.61 111.195 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -109.2 132.88 53.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 1.98 110.892 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.2 p -92.47 -41.83 10.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.95 111.185 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.54 39.18 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 1.89 111.124 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 t -147.11 149.08 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 1.89 111.174 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.76 163.1 0.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.167 -0.469 . . . . 1.98 110.767 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -59.86 -47.56 85.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 3.51 110.849 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -75.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 2.9 110.901 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p 52.26 -170.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 2.8 110.89 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -80.51 -3.7 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 2.53 110.87 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.57 145.03 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.407 . . . . 1.63 111.183 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.7 mmtm -65.3 114.52 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 2.99 110.87 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 45.5 p -85.91 179.33 7.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 1.41 111.107 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.4 -53.42 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 1.63 111.14 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -49.29 78.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 1.04 110.873 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -58.36 -37.95 76.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.028 -0.533 . . . . 2.97 110.918 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.74 -54.68 27.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 1.59 110.94 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.2 m -58.3 -46.6 85.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 1.86 110.88 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -43.71 93.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 1.35 110.918 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.78 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 1.56 111.081 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.45 -57.87 8.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 1.65 110.914 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.3 m -55.57 -36.38 66.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 1.83 111.134 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.9 mt -83.11 -10.71 58.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 2.2 110.909 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.43 6.42 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 2.45 110.852 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.51 8.04 31.24 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.778 -0.725 . . . . 0.58 112.482 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tp -107.5 171.29 7.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.82 0.343 . . . . 1.76 111.005 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.61 169.56 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 1.6 111.091 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 51.47 43.89 29.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 2.41 110.917 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.27 143.19 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 1.58 111.136 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 160.06 8.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 2.72 110.883 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.47 140.83 37.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 3.15 110.893 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 mp -98.94 -39.2 8.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 1.63 110.902 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -160.18 177.09 11.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 1.41 110.811 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 -123.99 168.71 12.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 9.56 110.785 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -151.56 136.67 10.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.743 0.782 . . . . 1.38 110.826 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.91 154.76 66.79 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.711 2.274 . . . . 0.43 112.303 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.55 128.44 37.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 1.51 110.851 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.02 161.45 22.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.618 0.723 . . . . 2.91 111.104 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -24.33 29.59 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.68 2.253 . . . . 0.57 112.351 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -85.3 -22.49 28.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 3.87 110.877 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -87.58 -53.77 4.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.117 -0.492 . . . . 2.73 110.903 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.44 -39.25 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 1.66 111.061 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -36.12 77.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 2.9 110.965 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -45.76 73.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 1.02 110.831 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.26 -30.81 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 1.58 111.161 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -75.82 -31.94 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 2.72 110.905 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -89.88 -20.16 23.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 1.74 110.84 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.45 -32.92 13.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.46 110.848 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.64 -54.2 1.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 1.68 110.864 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.1 11.39 2.28 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.787 -0.721 . . . . 0.32 112.51 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -70.34 121.81 18.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.75 0.309 . . . . 0.82 110.798 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -151.76 105.55 3.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 2.24 110.922 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.2 t -160.5 168.38 25.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 1.04 110.828 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.66 -13.49 15.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.66 110.817 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -100.28 19.97 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.63 110.814 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.8 169.55 10.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 1.72 110.919 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -173.57 130.24 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 1.76 110.931 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -69.98 139.9 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 3.01 110.891 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.13 151.86 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.72 111.216 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -107.8 129.29 55.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 2.53 110.925 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.18 151.17 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.63 111.137 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.9 t -140.54 151.15 44.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 2.0 111.083 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -143.35 144.62 13.97 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 0.32 112.496 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -97.66 137.37 36.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 2.6 110.851 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 134.76 65.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.662 0.744 . . . . 2.18 110.856 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 122.05 8.75 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.702 2.268 . . . . 0.37 112.384 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.66 110.894 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.737 0.303 . . . . 2.37 110.808 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.23 22.08 10.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.44 . . . . 2.66 110.89 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.34 40.39 60.8 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.731 -0.747 . . . . 0.28 112.479 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.75 159.4 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 1.43 111.069 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.52 164.56 38.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 2.43 110.883 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.33 129.87 35.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.474 . . . . 1.55 111.073 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.18 -5.27 25.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.71 -0.757 . . . . 0.26 112.488 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -114.7 167.96 10.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 1.49 110.835 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.37 140.16 33.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 2.31 110.866 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -142.3 140.13 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 2.99 111.102 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.16 121.89 42.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.37 111.107 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.1 t -95.1 119.6 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 1.58 111.154 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.35 112.88 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 1.54 111.228 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -114.38 167.66 10.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.19 111.012 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.4 -169.79 3.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.354 -0.384 . . . . 1.91 110.82 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -35.52 69.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 4.15 110.861 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -10.25 59.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 2.05 110.863 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.93 94.26 10.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.668 0.747 . . . . 0.98 110.861 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 142.36 47.25 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.713 2.275 . . . . 0.23 112.381 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -49.07 -32.48 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 1.6 111.105 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -51.32 -53.15 38.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 2.7 110.81 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.48 -44.65 11.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 1.59 111.163 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.85 -61.4 2.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 1.44 110.923 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -49.88 -36.8 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 5.82 110.854 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -47.38 49.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.815 -0.707 . . . . 0.21 112.471 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.6 mt -61.82 -39.7 92.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 1.63 110.959 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.6 m -76.98 -31.71 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 1.66 111.047 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -61.96 -59.76 4.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 1.77 110.893 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -40.15 70.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 2.79 110.935 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.1 mt -72.76 -25.25 61.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 1.6 110.966 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -78.59 -25.19 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.46 110.924 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 -29.15 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 1.54 111.093 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 pp -91.72 -34.88 14.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 1.63 110.933 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.52 -45.11 5.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.168 -0.469 . . . . 1.61 111.149 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.87 -12.09 52.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.28 112.51 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -65.74 -62.6 1.42 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 2.48 110.858 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -97.16 -37.4 10.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 2.35 110.959 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.27 -128.91 5.04 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.27 112.499 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -154.93 153.57 31.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.947 0.403 . . . . 3.01 110.847 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.0 t -138.56 128.44 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 1.45 111.189 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -117.42 157.65 25.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 1.16 110.821 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -118.51 135.72 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 1.72 111.137 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -145.34 151.96 39.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 1.94 110.892 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.56 135.97 43.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.63 110.905 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.4 mt -51.25 -35.33 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 1.65 111.156 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -31.57 61.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 3.39 110.871 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -96.76 19.27 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 3.4 110.911 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.86 -30.81 4.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 2.09 111.005 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -53.13 -35.84 60.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 2.02 110.924 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -85.75 -18.76 32.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 1.17 110.913 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.3 m -60.47 -16.6 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 1.82 110.822 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.8 63.59 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 1.75 111.118 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -61.65 -71.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.48 110.832 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.4 -167.59 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 2.87 110.85 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -104.29 125.78 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 2.03 110.868 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.6 80.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 2.15 110.816 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.2 p -130.61 -36.47 1.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 1.32 110.812 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -97.23 121.04 38.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 2.59 110.92 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.28 -20.88 61.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 1.7 110.85 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.5 mt -143.32 144.51 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 1.63 111.19 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.7 mm -135.17 128.86 49.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 1.41 111.207 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.46 136.35 52.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.257 -0.429 . . . . 1.55 110.907 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.33 101.74 6.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 1.57 110.895 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.59 75.95 0.19 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.704 -0.76 . . . . 0.18 112.557 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.23 57.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 1.66 110.93 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.08 159.62 63.92 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.62 0.724 . . . . 1.5 111.152 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 116.56 4.61 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.27 112.404 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.56 7.14 69.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.671 -0.776 . . . . 0.19 112.539 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.41 150.02 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.88 0.371 . . . . 0.99 110.857 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.7 p -138.48 108.71 6.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 1.53 111.167 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.86 149.98 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 1.49 111.122 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 mt -128.04 99.84 5.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 1.6 110.892 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -76.9 143.05 39.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.37 110.836 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.6 m -121.81 -175.3 3.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.91 110.829 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.82 -35.91 71.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 1.34 111.1 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.16 -43.54 97.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 2.12 110.851 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -76.18 -54.9 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 1.6 111.141 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.5 mt -51.11 -42.51 60.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 1.75 110.945 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.5 -56.83 11.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 1.66 111.082 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.36 -43.25 71.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.443 . . . . 3.07 110.922 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.4 mm -55.8 -67.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 1.65 111.087 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.15 -39.55 56.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 1.44 111.086 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -52.86 -50.83 63.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 3.3 110.861 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.5 pt -85.37 -5.97 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 1.5 111.09 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.53 115.24 19.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 1.55 110.882 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -55.05 158.79 4.48 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.69 0.757 . . . . 4.1 110.828 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 114.25 3.64 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.717 2.278 . . . . 0.18 112.306 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.39 55.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.787 -0.72 . . . . 0.17 112.52 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.92 -164.67 24.34 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.754 -0.736 . . . . 0.13 112.467 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.6 m -135.55 152.18 51.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 1.5 110.857 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -136.18 115.97 13.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 1.57 110.917 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -112.02 131.37 55.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 2.9 110.925 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.54 159.86 43.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 1.62 110.855 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.4 128.66 41.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 2.58 110.933 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.33 148.31 22.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.591 0.71 . . . . 2.28 110.902 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 142.86 48.77 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.67 2.247 . . . . 0.18 112.307 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.0 m -128.88 146.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 1.64 111.067 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -106.99 132.48 52.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 1.89 110.885 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.6 p -103.78 26.11 9.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 1.71 111.192 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.56 26.14 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 1.52 111.097 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.13 157.77 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 1.73 111.067 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.56 174.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.501 . . . . 1.9 110.887 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -65.67 -64.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 2.87 110.855 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -61.54 -75.84 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.231 -0.441 . . . . 3.17 110.888 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t 51.64 -168.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 2.94 110.857 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -3.55 50.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 4.71 110.817 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -144.38 148.66 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.457 . . . . 1.65 111.113 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.64 112.72 6.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 3.02 110.947 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.7 p -87.31 178.6 6.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 1.45 111.093 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.68 -54.09 50.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 1.41 111.037 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.74 -49.07 79.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 1.22 110.909 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -57.72 -41.96 82.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 2.59 110.946 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.05 -54.76 40.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 1.54 110.881 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -57.81 -48.9 78.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 1.53 111.006 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -45.68 92.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.475 . . . . 1.53 110.931 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.25 -45.79 93.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 1.62 111.093 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.87 -54.07 47.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.314 -0.403 . . . . 1.48 110.83 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.9 m -62.38 -27.53 69.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 1.51 111.118 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.05 -14.38 50.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 1.74 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.0 p -84.43 5.58 26.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 2.92 110.863 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.53 -4.7 34.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.663 -0.779 . . . . 0.6 112.5 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.16 168.92 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 1.57 111.04 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.9 m -151.0 171.32 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.089 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 52.39 45.02 29.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 2.22 110.853 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.4 t -79.68 143.56 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 1.64 111.132 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.9 160.23 8.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 3.69 110.889 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.88 147.16 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 2.4 110.862 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mp -106.68 -36.0 6.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 1.59 110.905 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.7 176.29 12.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 1.1 110.89 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.96 137.18 47.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 5.29 110.847 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -123.58 137.65 28.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.735 0.779 . . . . 1.4 110.815 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 163.92 36.54 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.593 2.195 . . . . 0.24 112.308 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.99 127.03 42.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 1.53 110.805 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.15 160.91 25.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.584 0.707 . . . . 2.25 111.166 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -28.88 24.89 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.636 2.224 . . . . 0.36 112.378 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.33 -17.9 35.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 2.67 110.822 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.22 -52.83 5.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 2.33 110.892 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 p -49.27 -41.05 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 1.61 111.125 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -34.82 76.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 1.22 110.986 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -46.19 71.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.167 -0.47 . . . . 1.11 110.89 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.23 -30.15 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 1.41 111.055 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -75.29 -33.34 61.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 2.3 110.878 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -89.09 -19.93 24.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 1.86 110.838 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -94.1 -32.82 13.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.34 110.881 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -128.44 -54.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 1.74 110.936 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.59 7.05 2.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.701 -0.761 . . . . 0.43 112.465 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -70.21 120.44 15.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.78 0.324 . . . . 1.04 110.866 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -152.78 105.03 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 3.3 110.851 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.3 t -161.03 175.98 11.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 1.07 110.793 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.58 -14.43 14.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 1.55 110.872 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -96.44 6.86 47.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 1.69 110.867 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.98 165.59 23.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 1.48 110.919 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -173.51 130.14 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 1.57 110.898 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -74.23 133.11 42.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 2.98 110.84 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.71 144.47 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 1.56 111.139 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -98.75 130.69 45.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 2.68 110.89 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.83 150.46 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 1.55 111.084 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.1 t -130.22 160.16 34.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 1.48 111.089 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.56 132.12 3.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.18 112.474 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -94.15 142.79 27.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 2.57 110.963 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -84.23 135.33 41.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.583 0.706 . . . . 3.4 110.859 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 118.73 5.85 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.703 2.269 . . . . 0.38 112.281 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.47 110.853 -179.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.798 0.332 . . . . 2.07 110.798 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -122.28 13.72 10.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 2.71 110.82 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.76 40.67 96.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.659 -0.781 . . . . 0.32 112.482 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.99 159.96 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 1.47 111.179 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.89 168.48 27.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 2.83 110.934 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.75 130.39 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 1.64 111.042 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.35 2.63 29.45 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.764 -0.732 . . . . 0.31 112.53 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -116.73 166.7 11.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 1.21 110.896 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -105.39 114.94 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 3.79 110.794 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.85 139.27 45.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.473 . . . . 3.33 111.151 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.01 115.69 28.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 1.7 111.077 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.8 t -88.95 120.5 37.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 1.56 111.175 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -106.17 113.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.48 . . . . 1.54 111.173 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -112.67 167.39 10.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.27 110.871 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -148.34 -169.25 3.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 1.72 110.974 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -58.67 -35.58 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 3.73 110.935 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -7.82 53.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 2.0 110.809 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.58 92.71 8.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.636 0.732 . . . . 0.87 110.907 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 143.27 50.56 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.707 2.271 . . . . 0.32 112.314 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.5 t -48.35 -33.06 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 1.67 111.145 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.33 -52.92 41.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 2.64 110.846 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.45 -45.3 10.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 1.64 111.219 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.2 -61.68 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 1.52 111.039 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.59 -35.83 22.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 3.52 110.928 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.16 -47.49 44.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.737 . . . . 0.27 112.573 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 mt -61.59 -38.84 89.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 1.77 110.973 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.66 -31.43 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 1.68 111.13 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.25 -58.24 8.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 1.59 110.835 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -40.43 76.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 3.71 110.818 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -72.73 -24.78 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 1.66 110.948 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.92 -24.87 48.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.436 . . . . 0.47 110.839 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.8 -31.47 16.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 1.46 111.08 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -89.74 -35.21 15.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.55 110.931 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 -46.9 4.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 1.56 111.194 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.24 -13.37 53.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.668 -0.777 . . . . 0.26 112.53 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -62.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 3.77 110.897 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -99.85 -35.82 9.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 2.12 110.834 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.32 -129.64 4.53 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.24 112.471 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -153.67 152.28 30.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.854 0.359 . . . . 2.92 110.853 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -137.8 117.19 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 1.47 111.069 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.2 t -106.93 153.75 22.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 1.24 110.875 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.53 134.36 58.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 1.51 111.073 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -144.46 152.52 40.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 1.25 110.921 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -102.49 137.41 40.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.75 110.824 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.8 mt -51.38 -44.49 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 1.65 111.105 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -24.54 61.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 4.84 110.883 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -99.3 18.76 16.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 3.45 110.961 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -29.31 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 1.98 110.9 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.82 -36.5 48.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 1.99 110.929 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.1 mm-40 -85.77 -20.4 29.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 1.25 110.897 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 m -59.53 -17.73 34.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 1.72 110.836 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.76 63.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 1.53 111.07 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -63.82 -71.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.47 110.79 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.73 -167.65 2.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 2.82 110.921 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -104.76 125.99 51.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 1.88 110.87 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.27 79.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 1.35 110.887 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.6 p -129.61 -35.42 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.89 110.89 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -98.15 121.5 40.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 2.53 110.926 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.29 -21.5 62.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 1.69 110.888 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.1 mt -146.49 143.45 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 1.63 111.085 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.1 mm -131.22 132.44 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 1.73 111.045 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.15 134.96 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.55 110.959 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.34 101.18 5.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 1.11 110.846 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.68 78.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.711 -0.756 . . . . 0.2 112.505 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.95 53.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 1.54 110.91 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.78 160.34 49.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.683 0.754 . . . . 1.57 111.028 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 123.34 9.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.765 2.31 . . . . 0.3 112.27 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.78 7.2 88.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.777 -0.725 . . . . 0.26 112.445 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 p -55.56 151.67 10.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 1.05 110.819 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.1 p -141.36 111.92 7.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 1.42 111.136 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.55 152.35 14.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 1.54 111.112 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mt -129.68 100.1 5.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 1.56 110.907 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -75.67 144.79 41.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.25 110.76 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.9 m -122.67 178.96 4.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.98 110.856 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.6 -42.77 62.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 1.27 111.115 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.96 -46.78 81.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 2.04 110.954 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mp -71.55 -56.81 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 1.7 111.157 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.2 mt -50.2 -43.01 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 1.58 110.874 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.78 -56.68 12.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 1.6 111.083 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -43.43 73.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 2.91 110.849 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.3 mm -55.35 -67.72 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 1.59 111.14 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.49 -39.54 57.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 1.77 111.069 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.9 tpp85 -52.82 -50.15 64.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 3.67 110.856 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.8 pt -86.13 -5.8 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.62 111.119 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.15 113.98 18.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 1.52 110.866 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -52.95 159.03 2.0 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.599 0.714 . . . . 3.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.77 114.1 3.59 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.698 2.265 . . . . 0.19 112.401 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.29 2.9 55.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.81 -0.71 . . . . 0.18 112.521 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.53 -163.66 16.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.657 -0.783 . . . . 0.16 112.483 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.3 m -137.55 154.52 49.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 1.83 110.856 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -137.49 116.31 12.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 1.54 110.943 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -109.74 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 2.88 110.868 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.73 163.15 38.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 1.56 110.926 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.03 129.71 34.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 2.55 110.913 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.26 149.5 23.2 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.673 0.749 . . . . 2.49 110.875 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 143.22 50.27 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.246 . . . . 0.2 112.39 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.0 m -129.74 146.36 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 1.58 111.111 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.92 132.79 53.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 2.04 110.824 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.7 p -91.63 -42.72 10.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 1.94 111.154 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.56 40.28 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 1.79 111.093 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -147.96 151.85 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 1.77 111.146 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.55 173.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 1.89 110.874 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -66.95 -53.96 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 3.04 110.914 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -72.94 -76.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 3.63 110.871 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t 54.01 -167.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 2.94 110.933 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -6.16 57.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 3.22 110.884 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.48 146.42 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 1.68 111.16 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 123.26 19.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 3.32 110.902 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 70.0 p -96.1 -179.54 4.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 1.67 111.166 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.78 -53.89 49.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 1.61 111.099 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.13 -48.41 81.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 1.22 110.889 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.28 -49.61 76.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 3.79 110.9 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.45 -55.52 21.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 2.09 110.96 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 74.8 m -51.2 -49.1 61.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 1.87 110.909 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -43.85 92.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 1.79 110.815 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.44 -48.79 80.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.488 . . . . 1.58 111.057 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.1 tp -57.78 -52.4 65.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 1.51 110.917 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.2 m -63.13 -29.46 70.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 1.73 111.154 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.0 mt -79.5 -17.17 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 2.4 110.932 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.3 p -82.64 3.57 28.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 2.91 110.953 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.48 -4.85 35.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.6 112.472 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.5 168.4 14.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 1.77 110.88 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.16 171.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 1.62 111.084 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 54.29 43.64 30.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.16 -0.473 . . . . 2.19 110.907 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.8 t -75.36 142.87 13.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 1.68 111.176 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.09 159.18 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 2.75 110.922 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -81.87 146.69 29.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 2.25 110.854 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.0 mp -106.44 -35.83 6.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 1.56 110.948 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.55 176.22 12.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 1.15 110.886 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -133.79 138.11 45.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 4.94 110.809 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -125.07 137.87 30.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.633 0.73 . . . . 1.43 110.868 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 163.93 36.47 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.69 2.26 . . . . 0.3 112.346 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.7 125.53 44.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 1.48 110.999 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.1 161.58 22.48 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.603 0.716 . . . . 2.6 111.129 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -23.77 30.35 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.75 2.3 . . . . 0.44 112.344 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -85.08 -24.21 28.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 2.34 110.826 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -88.46 -51.03 5.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 2.62 110.948 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.32 -39.33 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 1.62 111.157 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -34.68 76.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 2.77 110.857 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -46.2 71.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 1.29 110.869 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.91 -30.47 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 1.63 111.169 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -75.51 -32.74 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 2.93 110.958 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -89.47 -20.0 24.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 1.74 110.882 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -94.17 -33.13 13.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.38 110.846 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.77 -54.15 1.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 1.65 110.863 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.2 6.71 2.69 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.717 -0.754 . . . . 0.35 112.451 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -70.1 119.99 15.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 1.17 110.827 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -153.45 104.8 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 2.29 110.961 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -161.29 174.38 13.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 1.11 110.897 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.88 -8.17 17.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 1.88 110.848 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -101.92 8.04 41.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 2.2 110.872 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.16 165.28 20.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 1.66 110.997 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -171.33 130.59 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 1.79 110.921 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -75.24 131.38 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 3.02 110.916 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.13 144.84 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 1.54 111.173 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -100.09 128.38 46.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 2.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.14 150.98 28.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 1.62 111.11 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.9 t -129.29 158.74 38.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 1.52 111.127 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.51 130.74 3.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 0.26 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -94.27 140.86 29.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 2.38 110.97 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -82.25 134.41 48.92 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.568 0.699 . . . . 2.44 110.884 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 118.79 5.89 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 0.41 112.354 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.35 110.871 -179.961 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.83 0.348 . . . . 2.07 110.826 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -122.29 20.6 10.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 2.67 110.891 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.08 39.49 49.69 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.718 -0.753 . . . . 0.25 112.39 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.92 157.68 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 1.68 111.136 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.9 m -146.21 157.53 43.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 1.63 110.836 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.2 129.22 35.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 1.68 111.159 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.09 -9.02 31.42 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.742 . . . . 0.54 112.495 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -103.41 168.0 9.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.869 0.366 . . . . 1.81 110.832 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.79 112.05 24.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 2.28 110.907 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.36 133.67 65.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 3.18 111.08 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.89 133.44 52.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 1.34 111.08 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -104.43 120.51 54.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 1.52 111.087 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.88 115.41 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 1.48 111.16 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -114.68 168.0 10.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.26 110.913 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.95 -169.45 3.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 1.94 110.92 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -57.8 -35.56 70.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 4.26 110.9 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.69 -9.29 58.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 2.36 110.82 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.95 92.16 8.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.606 0.717 . . . . 0.98 110.902 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 143.98 52.59 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.703 2.269 . . . . 0.26 112.227 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.3 t -48.39 -32.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 1.66 111.161 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.23 -53.0 39.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 3.27 110.924 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.8 -45.02 10.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 1.55 111.067 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.5 -61.89 1.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 1.65 110.881 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -49.69 -37.86 30.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 5.88 110.894 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.39 -48.15 53.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.765 -0.731 . . . . 0.23 112.427 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.15 -41.04 96.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 1.62 110.991 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.84 -31.13 21.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 1.7 111.166 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -61.75 -61.38 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 1.6 110.92 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -40.78 68.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 2.71 110.854 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.7 mt -72.01 -25.31 61.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.465 . . . . 1.36 110.9 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.17 -24.62 47.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.45 110.922 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.62 -30.11 17.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 1.34 111.114 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.54 -35.05 14.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 1.52 110.872 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.87 -45.4 4.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 1.62 111.058 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.74 -12.13 52.13 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.791 -0.719 . . . . 0.3 112.447 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -67.96 -62.72 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.33 . . . . 3.43 110.879 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -95.09 -38.9 10.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 2.79 110.896 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.58 -130.6 5.68 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.717 -0.754 . . . . 0.25 112.473 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -152.59 151.28 30.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.841 0.353 . . . . 2.93 110.853 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.0 t -134.54 121.42 35.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 1.73 111.123 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 t -110.66 152.94 25.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 1.55 110.881 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -115.65 136.67 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 1.53 111.17 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -146.47 152.69 39.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.38 110.911 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -102.35 138.61 39.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.81 110.878 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mt -53.87 -43.26 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 1.69 111.179 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.58 -21.69 61.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 4.83 110.914 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -100.73 16.39 25.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 3.42 110.903 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.59 -29.79 4.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 2.19 110.905 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.89 -41.07 61.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 1.95 110.884 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -84.98 -15.96 42.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 1.1 110.908 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m -66.67 -11.46 54.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 2.02 110.911 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.14 61.0 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 1.63 111.092 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -58.52 -71.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.57 110.839 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 -168.51 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 3.27 110.813 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.58 136.05 43.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 1.99 110.903 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.2 p 47.45 86.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 1.31 110.885 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 p -142.3 -39.02 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 1.51 110.91 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.66 120.08 39.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.051 -0.522 . . . . 2.57 110.85 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.44 -21.76 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 1.72 110.93 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mt -144.53 144.11 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 1.59 111.157 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 18.9 mm -136.54 130.15 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 1.54 111.195 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -113.57 137.54 51.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 1.51 110.956 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.58 100.81 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 1.42 110.902 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.7 77.97 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.18 112.493 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.77 56.71 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 1.54 110.853 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.65 159.91 55.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.661 0.743 . . . . 1.63 111.09 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 116.82 4.74 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.672 2.248 . . . . 0.24 112.369 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.96 7.21 70.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.21 112.431 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -54.93 150.56 9.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 1.51 110.821 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.3 p -140.68 109.45 6.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 1.58 111.195 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.09 151.29 15.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 1.45 111.161 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.2 mt -127.01 99.82 5.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 1.85 110.905 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -76.9 130.21 37.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.52 110.876 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.7 m -107.11 177.0 4.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 1.16 110.924 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.19 -40.07 57.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 1.59 111.142 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.63 -43.41 89.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 1.73 110.879 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mp -76.04 -56.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 1.45 111.16 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 mt -49.59 -47.29 49.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 1.63 110.917 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.75 -52.76 37.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 1.89 111.068 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -43.9 80.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 2.84 110.893 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.6 mm -55.86 -67.15 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 1.61 111.102 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.22 -36.65 42.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 1.65 111.09 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 tpp85 -56.33 -54.98 39.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 3.4 110.926 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.2 pt -78.44 -8.42 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 1.76 111.093 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.54 124.7 28.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 1.53 110.942 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -64.25 160.67 47.63 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.578 0.704 . . . . 2.9 110.857 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 114.02 3.56 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.656 2.237 . . . . 0.25 112.408 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.43 3.38 56.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.688 -0.768 . . . . 0.22 112.426 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.01 -161.6 13.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.758 . . . . 0.18 112.479 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.7 m -139.59 154.16 47.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.83 0.347 . . . . 1.59 110.883 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -138.87 113.5 9.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 1.51 110.945 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -108.45 133.44 52.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 2.89 110.85 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.98 164.15 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 1.43 110.901 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -135.25 126.99 29.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 2.79 110.998 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.97 148.4 27.12 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.675 0.75 . . . . 2.35 110.863 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 139.89 40.99 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.605 2.203 . . . . 0.24 112.355 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 m -120.96 147.4 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 1.61 111.143 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -116.1 132.63 56.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 1.97 110.904 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.4 p -106.45 26.04 10.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 2.09 111.077 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.17 25.93 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 2.1 111.046 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -143.75 159.92 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 2.13 111.084 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.02 179.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 2.09 110.772 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -64.61 -68.84 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 2.43 110.897 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -62.47 -75.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 2.62 110.87 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.37 -167.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 2.19 110.811 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -6.83 58.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 3.05 110.954 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.29 140.24 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 2.03 111.114 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.23 115.49 5.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 3.23 110.869 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.4 p -83.3 177.77 8.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 1.73 111.126 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.52 -55.05 28.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 1.69 111.137 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.8 -51.73 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.98 110.805 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 -38.13 67.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 3.35 110.886 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.74 -54.61 28.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 1.71 110.874 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 36.4 m -60.07 -46.41 89.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.463 . . . . 1.69 110.922 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -43.98 96.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 1.26 110.801 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.73 -53.33 59.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 1.8 111.105 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.66 -53.16 61.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 1.82 110.876 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.8 m -61.57 -26.25 67.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 1.52 111.177 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.8 mt -87.01 -13.6 44.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 1.88 110.939 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.0 p -82.0 3.5 26.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 3.5 110.877 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.06 -4.35 33.77 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.802 -0.713 . . . . 0.85 112.564 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 tp -87.9 171.2 10.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 1.97 110.797 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.44 169.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 1.69 111.105 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 54.6 44.2 29.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 2.28 110.886 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 86.1 t -81.85 142.68 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 1.72 111.105 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 160.62 8.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 2.67 110.959 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -78.91 142.91 36.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 3.12 110.913 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 mp -100.2 -39.08 8.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 1.63 110.907 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.35 176.34 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 1.12 110.932 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -130.19 138.18 50.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 4.76 110.919 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -125.06 135.8 27.28 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.605 0.717 . . . . 1.89 110.946 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 162.52 41.75 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.764 2.309 . . . . 0.34 112.405 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.93 118.54 34.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 1.57 110.92 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.71 161.07 27.83 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.595 0.712 . . . . 2.71 111.077 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -25.53 28.91 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.6 2.2 . . . . 0.68 112.344 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -85.46 -20.75 29.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 4.23 110.821 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -88.25 -53.29 4.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 2.38 110.85 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -49.64 -39.46 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 1.72 111.111 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.01 75.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 1.37 110.874 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.67 -46.69 68.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 1.03 110.817 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.29 -30.24 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.157 -0.474 . . . . 1.56 111.21 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -76.13 -31.5 58.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.481 . . . . 2.26 110.886 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -89.73 -20.41 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.432 . . . . 2.02 110.905 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -94.54 -32.91 13.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.49 110.805 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -127.26 -54.28 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 1.74 110.896 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.1 17.21 1.66 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.696 -0.764 . . . . 0.41 112.496 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -72.37 122.36 21.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 1.39 110.869 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.38 107.95 3.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 2.87 110.95 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.9 t -160.55 172.23 17.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 1.14 110.872 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.01 -18.06 14.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 1.69 110.818 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -100.01 18.73 17.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 1.57 110.844 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.21 165.35 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 1.52 110.977 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -173.94 130.3 0.4 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 1.57 110.917 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -75.87 138.63 41.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 3.25 110.924 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.88 148.41 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 1.55 111.079 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -102.36 132.55 48.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 2.7 110.866 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.59 148.85 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 1.51 111.129 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 9.6 t -134.49 157.3 46.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 1.64 111.109 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -146.53 141.77 9.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.759 -0.734 . . . . 0.37 112.483 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -98.54 131.97 44.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 4.57 110.91 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.53 135.58 78.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.541 0.686 . . . . 2.95 110.882 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 129.32 17.4 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.667 2.245 . . . . 0.41 112.394 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.39 110.906 -179.99 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.872 0.368 . . . . 1.95 110.85 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.37 22.41 10.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 3.55 110.909 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.28 40.95 53.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 0.27 112.531 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.01 159.91 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.793 0.33 . . . . 1.52 111.118 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.44 165.37 36.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 1.65 110.873 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.58 123.71 33.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 1.52 111.09 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.44 2.87 21.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.646 -0.788 . . . . 0.33 112.467 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -115.15 168.7 9.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.36 . . . . 1.18 110.898 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -106.93 112.87 26.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 2.36 110.857 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -116.05 140.2 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 3.28 111.135 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.92 113.02 22.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 1.58 111.059 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.4 t -86.97 120.28 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 1.56 111.082 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.29 116.64 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 1.56 111.09 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -116.2 169.22 9.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.152 -0.476 . . . . 0.22 110.934 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -151.4 -169.74 3.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 1.78 110.832 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.86 -35.59 71.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 4.04 110.876 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.6 m -73.5 -9.18 58.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 1.74 110.896 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.08 94.47 10.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.655 0.74 . . . . 0.88 110.847 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 142.03 46.69 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.664 2.242 . . . . 0.22 112.345 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.2 t -48.69 -32.94 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 1.66 111.141 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.34 -52.62 43.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 3.17 110.878 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -45.03 10.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 1.58 111.097 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.8 -61.61 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 1.52 110.846 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -35.42 24.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 3.45 110.784 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.25 -47.54 43.71 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.722 -0.752 . . . . 0.24 112.487 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.05 -39.19 91.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.967 0.413 . . . . 1.72 110.968 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -77.07 -31.46 18.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 1.74 111.116 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.5 -58.83 6.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 1.66 110.874 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -40.4 74.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 4.06 110.883 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.65 -25.19 61.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.228 -0.442 . . . . 1.6 110.929 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -77.89 -24.74 48.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.5 110.904 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.66 -31.09 16.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 1.35 111.083 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -90.08 -35.14 15.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 1.64 110.964 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.25 -47.2 4.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.486 . . . . 1.58 111.218 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.83 -14.68 52.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.749 . . . . 0.29 112.53 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.11 -62.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 2.59 110.869 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -103.86 -33.86 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 2.22 110.854 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.42 -133.34 4.9 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.672 -0.775 . . . . 0.3 112.526 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -150.8 151.53 32.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 2.92 110.869 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -139.11 113.35 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 1.67 111.172 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 t -103.91 154.56 19.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 1.42 110.811 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.73 130.03 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 1.6 111.134 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -137.73 150.92 47.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 1.45 110.92 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -103.64 135.32 45.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.67 110.888 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.0 mt -54.22 -34.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 1.58 111.185 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -73.27 -30.77 63.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 2.76 110.862 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -102.28 19.4 18.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 3.75 110.924 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.59 -27.37 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 2.09 110.929 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -52.73 -38.65 61.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 2.08 110.907 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -84.48 -14.35 49.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 1.26 110.896 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.4 t -63.96 -11.51 29.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 3.3 110.838 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 53.97 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 1.67 111.153 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -52.1 -71.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.51 110.81 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.83 -168.6 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 3.28 110.878 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -103.73 129.75 51.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 1.68 110.957 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t 51.55 88.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 2.26 110.803 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.4 p -140.59 -39.54 0.42 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.057 -0.519 . . . . 1.25 110.818 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -99.9 123.61 44.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 2.56 110.868 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.23 -22.04 62.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 1.52 110.958 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.4 mt -146.14 143.25 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 1.67 111.164 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.7 mm -130.21 133.68 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 1.39 111.093 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -112.48 135.64 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 1.54 110.938 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.32 98.97 5.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 1.57 110.921 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.7 80.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.695 -0.764 . . . . 0.22 112.591 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.94 55.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 1.64 110.985 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.11 159.52 56.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.696 0.76 . . . . 1.72 111.173 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 116.56 4.6 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.644 2.23 . . . . 0.26 112.437 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.32 7.29 69.88 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.722 -0.751 . . . . 0.18 112.461 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.8 148.41 16.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.384 . . . . 1.11 110.797 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.9 p -136.84 108.66 7.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.494 . . . . 1.41 111.089 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.95 152.54 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 1.52 111.174 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 mt -132.05 103.68 6.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 1.77 110.915 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -80.03 146.85 31.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.27 110.817 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.3 m -124.56 -176.2 3.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 1.25 110.867 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.71 70.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 1.75 111.129 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.72 -45.14 94.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 1.83 110.974 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -74.28 -55.37 12.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 1.38 111.091 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 mt -49.68 -43.77 47.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 1.59 110.911 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.41 -50.82 58.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 1.43 111.136 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -44.53 90.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 3.08 110.86 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.9 mm -58.08 -68.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 1.65 111.127 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.37 -37.3 24.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 1.35 111.135 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -56.9 -52.84 63.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 3.51 110.813 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.9 pt -81.69 -4.91 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 1.52 111.135 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.34 115.76 20.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 1.49 110.904 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -53.42 158.77 2.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.63 0.729 . . . . 4.07 110.846 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 113.59 3.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.624 2.216 . . . . 0.25 112.426 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.71 3.0 55.27 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.731 -0.747 . . . . 0.26 112.42 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.24 -162.1 15.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.22 112.485 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 98.9 m -138.4 157.17 46.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 1.51 110.831 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -139.86 115.94 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 1.53 110.88 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -109.18 131.86 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 3.32 110.847 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.28 164.34 34.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 1.62 110.91 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.76 129.3 32.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 2.81 110.907 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.52 149.61 23.02 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.674 0.749 . . . . 2.53 110.864 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 144.19 52.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.667 2.245 . . . . 0.21 112.308 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.82 146.61 33.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 1.5 111.167 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -106.79 132.91 52.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 2.09 110.94 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p -93.27 -42.5 9.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 1.96 111.161 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.36 39.89 1.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 1.99 111.162 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.1 t -147.29 150.97 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.246 -0.434 . . . . 1.83 111.147 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.05 164.32 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 2.27 110.866 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -59.99 -48.32 82.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 2.91 110.941 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.12 -75.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 2.58 110.846 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p 53.02 -171.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 2.48 110.862 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -4.42 53.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 3.28 110.961 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.81 151.26 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.286 -0.415 . . . . 1.71 111.228 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -68.26 111.66 4.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 3.34 110.9 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.9 p -83.14 179.65 7.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 1.69 111.198 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.65 -53.59 55.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 1.52 111.102 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.88 -47.95 84.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.92 110.843 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -39.11 80.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 3.98 110.91 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.7 -55.25 21.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.449 . . . . 1.66 110.904 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 60.6 m -55.93 -44.83 78.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 1.8 110.842 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.4 -40.78 96.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 1.18 110.852 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.82 92.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 1.49 111.125 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.82 -50.77 65.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 1.52 110.978 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.3 m -63.63 -35.22 79.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 1.49 111.145 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -83.48 -10.28 58.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 1.73 110.884 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 m -84.87 5.78 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 2.43 110.881 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.22 3.98 35.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 0.5 112.507 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.81 172.42 6.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.932 0.396 . . . . 1.63 110.865 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 m -151.58 174.08 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 1.63 111.23 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 51.22 45.09 28.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 2.02 110.938 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.4 t -79.7 143.81 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 1.46 111.107 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.49 8.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 3.69 110.92 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -81.15 145.77 30.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 2.27 110.969 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.23 -35.65 7.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 1.57 110.949 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.57 176.33 12.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.172 -0.467 . . . . 1.16 111.02 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -132.4 138.16 47.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 4.93 110.785 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -125.18 137.97 30.76 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.625 0.726 . . . . 1.86 110.967 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.6 164.05 35.86 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.76 2.307 . . . . 0.26 112.403 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.61 128.58 44.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 1.6 110.913 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.48 160.95 25.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.608 0.718 . . . . 2.27 111.108 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.86 -28.81 24.31 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.649 2.233 . . . . 0.37 112.333 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -85.35 -17.78 35.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 3.74 110.844 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 -52.9 5.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 2.27 110.936 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.8 p -49.19 -40.66 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 1.63 111.134 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -34.78 76.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 1.22 110.884 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.98 -46.31 71.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 1.28 110.882 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.12 -30.08 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 1.64 111.167 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -75.27 -33.33 61.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 2.33 110.855 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -89.12 -19.91 24.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 1.7 110.818 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -94.16 -32.77 13.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.83 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.4 -54.26 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 1.53 110.871 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.31 4.95 2.76 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.705 -0.76 . . . . 0.47 112.484 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -70.08 120.17 15.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 1.15 110.805 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -153.26 104.76 2.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 2.21 110.967 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.34 173.42 15.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 1.67 110.911 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.98 -10.06 16.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 1.95 110.895 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -99.9 9.08 43.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 3.13 110.904 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.2 167.14 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 1.57 110.938 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -172.33 130.13 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 1.63 110.898 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.76 132.23 42.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 3.02 110.853 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.07 142.26 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 1.49 111.171 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -96.46 129.44 43.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 2.16 110.874 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.97 151.63 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 1.47 111.198 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.0 t -131.91 160.85 34.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 1.51 111.156 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.39 134.51 4.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.757 -0.735 . . . . 0.2 112.509 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -95.19 141.1 29.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 2.55 110.914 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -81.95 134.09 50.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.559 0.695 . . . . 2.48 110.871 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 119.26 6.23 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.645 2.23 . . . . 0.44 112.376 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.38 110.929 -179.961 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.749 0.309 . . . . 2.83 110.874 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.31 22.0 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 2.68 110.876 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.15 40.63 52.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.788 -0.72 . . . . 0.28 112.469 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.05 159.8 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.821 0.343 . . . . 1.66 111.121 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -154.32 166.52 32.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 2.24 110.842 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.6 125.41 35.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 1.51 111.159 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.91 2.9 23.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.814 -0.707 . . . . 0.32 112.514 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -115.54 166.99 11.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 1.19 110.882 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -105.61 114.96 29.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 2.34 110.796 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -118.06 139.13 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 3.27 111.08 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.64 114.44 25.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 1.33 111.146 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.66 121.84 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 1.48 111.182 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 t -107.36 116.72 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 1.5 111.139 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -115.76 167.18 11.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.26 110.881 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -146.29 -169.52 3.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 1.74 110.89 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -59.42 -35.21 73.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 3.78 110.972 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.76 -6.83 51.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.492 . . . . 1.98 110.891 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.17 93.87 10.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.706 0.765 . . . . 0.88 110.881 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.63 142.47 48.58 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.727 2.284 . . . . 0.23 112.456 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -49.2 -32.42 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 1.58 111.125 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.49 -52.82 43.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 3.21 110.946 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.53 -44.88 10.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 1.54 111.178 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.66 -61.72 2.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 1.49 110.935 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -34.61 22.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 3.16 110.9 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.11 -48.24 40.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.23 112.437 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.6 mt -61.33 -39.98 92.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.368 . . . . 1.55 110.92 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.23 -31.69 21.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 1.73 111.186 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.89 -60.03 4.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 1.66 110.851 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -40.22 72.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 2.61 110.926 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.52 -24.65 61.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 1.56 110.927 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.41 -24.95 45.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.45 110.914 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.78 -30.07 17.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.195 -0.457 . . . . 1.49 111.104 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.42 -35.05 14.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 1.44 110.877 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.11 -45.47 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 1.62 111.137 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.26 -12.61 56.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.822 -0.704 . . . . 0.27 112.449 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -65.78 -62.72 1.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 3.48 110.858 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -96.52 -37.43 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 2.23 110.88 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.55 -129.43 4.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.784 -0.722 . . . . 0.24 112.489 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -153.4 153.04 31.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 5.04 110.835 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -138.98 119.81 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 1.69 111.188 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -109.76 154.69 22.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 1.39 110.899 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -115.83 134.53 58.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 1.37 111.097 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -144.3 152.38 40.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 1.27 110.986 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -102.56 137.64 40.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.75 110.852 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mt -50.91 -46.77 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 1.68 111.208 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -24.73 63.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 4.99 110.905 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -98.22 18.52 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 3.42 110.812 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.75 -29.13 4.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 2.16 110.943 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.52 -36.31 55.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 3.47 110.975 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -85.86 -19.47 30.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 1.25 110.905 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 63.6 m -60.69 -16.69 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 1.77 110.877 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.94 63.49 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 1.52 111.174 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -64.9 -70.24 0.24 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 0.48 110.846 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -168.08 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 2.07 110.924 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -105.88 126.68 52.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 2.22 110.905 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.14 79.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 2.26 110.846 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.7 p -130.11 -35.33 1.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 1.38 110.856 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -98.52 122.02 41.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.094 -0.503 . . . . 3.6 110.873 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.61 -21.69 61.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 1.52 110.949 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.67 143.46 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 1.68 111.155 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 18.8 mm -130.52 132.85 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.444 . . . . 1.38 111.155 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -111.7 135.2 52.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 1.61 110.836 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.52 98.52 4.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 1.24 110.766 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.64 78.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.22 112.475 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.71 54.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.358 . . . . 1.64 110.939 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.4 159.77 53.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.569 0.699 . . . . 1.64 111.128 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 116.34 4.52 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.702 2.268 . . . . 0.24 112.373 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.61 7.02 69.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.739 -0.743 . . . . 0.22 112.495 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.26 136.59 48.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 1.05 110.906 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.2 p -126.03 108.41 11.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 1.55 111.122 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 m -163.3 155.8 18.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 1.52 111.202 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mt -133.55 105.8 7.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.251 -0.431 . . . . 1.46 110.983 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -79.44 150.98 31.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.24 110.903 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m -130.64 -177.46 4.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 1.46 110.884 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.98 68.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 1.38 111.078 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -47.12 86.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 2.14 110.929 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -71.9 -56.48 10.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 1.59 111.185 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 mt -50.78 -39.54 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 1.59 110.949 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.14 -56.88 12.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 1.67 111.099 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.97 -43.53 77.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 2.93 110.968 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.4 mm -55.15 -68.33 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 1.6 111.047 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.17 -39.75 57.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 1.39 111.194 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -52.84 -49.54 65.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 3.32 110.946 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 pt -86.66 -5.62 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 1.77 111.23 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.13 113.36 18.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 1.55 110.851 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -52.8 158.49 2.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 3.28 110.863 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 114.22 3.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.669 2.246 . . . . 0.27 112.299 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.99 3.09 54.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.829 -0.701 . . . . 0.26 112.522 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.77 -159.7 12.46 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 0.22 112.453 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.3 m -141.98 157.28 45.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 2.32 110.918 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -139.37 114.61 9.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 1.6 110.927 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -106.33 132.55 52.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 3.28 110.848 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.81 163.84 36.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 1.54 110.895 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.46 130.8 35.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 2.76 110.837 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.8 147.28 18.3 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.64 0.733 . . . . 2.16 110.915 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 141.38 45.13 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.776 2.317 . . . . 0.26 112.329 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.39 146.95 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 1.59 111.11 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -108.97 133.04 53.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 1.97 110.844 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.0 p -92.0 -41.91 10.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 1.95 111.179 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.74 40.34 1.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 1.65 111.094 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 t -147.93 149.82 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 1.79 111.02 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.11 175.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 2.11 110.945 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.7 -63.51 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 2.72 110.89 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.41 -75.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 2.47 110.894 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.77 -168.23 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 2.24 110.826 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -7.9 59.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 2.66 110.928 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.14 145.73 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 1.72 111.15 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -64.93 115.35 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 3.38 110.947 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.8 p -86.82 178.88 6.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 1.69 111.145 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.76 -51.75 66.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 1.39 111.153 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.66 -49.41 77.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 1.16 110.838 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -37.56 76.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 2.64 110.931 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.61 -55.39 20.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 1.49 110.844 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.9 m -57.64 -46.2 84.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 1.63 110.894 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -42.85 95.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 1.39 110.828 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.46 -44.31 96.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.496 . . . . 1.47 111.175 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.9 tp -64.45 -52.11 59.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 1.56 110.893 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.7 m -61.55 -31.62 71.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 1.46 111.085 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.91 -10.32 53.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 1.71 110.897 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.01 5.6 28.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 2.33 110.866 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.74 5.92 33.22 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.755 . . . . 0.48 112.436 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.87 170.38 7.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 1.56 110.985 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -150.19 170.59 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.432 . . . . 1.61 111.162 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 53.77 44.15 30.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 2.47 110.858 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.14 144.43 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 1.52 111.216 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 156.99 6.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 2.63 110.915 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.45 141.34 38.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 3.04 110.907 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 mp -99.74 -36.4 9.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 1.53 110.869 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -163.15 176.9 9.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 1.33 110.886 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -125.53 166.05 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 8.1 110.927 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -149.21 136.17 10.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.695 0.76 . . . . 1.38 110.895 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 154.78 67.43 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.726 2.284 . . . . 0.34 112.372 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.14 125.96 36.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.43 . . . . 1.76 110.932 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.36 161.37 24.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.598 0.713 . . . . 2.2 111.107 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -28.49 25.09 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.661 2.241 . . . . 0.44 112.388 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.36 -17.97 35.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 2.81 110.839 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 -53.01 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 2.59 110.899 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 p -49.66 -40.61 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 1.58 111.095 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -34.67 76.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 1.23 110.905 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -46.12 71.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.86 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.45 -30.34 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 1.53 111.059 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -75.56 -32.52 60.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 3.42 110.935 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -89.56 -20.01 24.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 1.79 110.903 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -94.3 -32.74 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.3 110.884 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.03 -54.29 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 1.57 110.878 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.36 9.1 2.43 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.818 -0.706 . . . . 0.35 112.478 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -70.31 121.68 18.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.88 110.901 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -151.8 105.42 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 2.62 110.864 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.6 t -160.44 169.55 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.51 110.888 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.65 -14.87 15.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 1.62 110.858 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -99.33 19.94 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 1.6 110.896 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.2 167.96 11.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 1.66 110.969 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -172.49 129.81 0.56 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 1.53 110.926 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -70.16 135.98 49.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 3.26 110.861 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.32 148.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 1.6 111.183 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -105.03 132.03 51.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 2.61 110.839 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.23 153.04 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 1.49 111.139 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.8 t -139.25 152.46 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 1.53 111.123 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.84 140.74 10.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.31 112.49 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -97.28 139.54 33.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.732 0.301 . . . . 2.46 110.962 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -78.99 134.37 60.07 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.508 0.67 . . . . 3.51 110.899 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 118.61 5.78 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.694 2.263 . . . . 0.44 112.304 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.33 110.923 179.954 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.8 0.333 . . . . 2.41 110.839 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -122.3 24.35 9.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 3.6 110.908 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.94 38.33 46.38 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.861 -0.685 . . . . 0.47 112.471 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.82 158.73 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.869 0.366 . . . . 1.62 111.129 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.7 m -147.14 158.55 43.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.506 . . . . 1.95 110.839 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.18 130.6 35.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 2.06 111.153 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.86 -6.12 32.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.751 -0.737 . . . . 0.54 112.479 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -106.56 168.91 8.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.778 0.323 . . . . 1.77 110.904 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.66 110.98 23.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 2.4 110.886 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.99 130.52 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.129 -0.487 . . . . 3.09 111.043 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.97 132.72 51.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.51 . . . . 1.74 111.081 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -101.6 120.13 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 1.62 111.088 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 t -103.24 116.66 47.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 1.51 111.154 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -117.04 166.36 12.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.4 110.863 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.24 -169.79 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 1.91 110.885 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.58 -35.52 74.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 3.98 110.939 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 t -73.41 -7.84 53.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 2.13 110.926 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.2 93.21 9.03 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.682 0.753 . . . . 0.8 110.886 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 143.12 50.11 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.671 2.247 . . . . 0.51 112.372 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.09 -32.47 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 1.55 111.096 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.19 -53.36 35.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 2.55 110.89 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.81 -44.92 10.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 1.59 111.046 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.12 -61.01 2.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.24 -0.436 . . . . 1.5 110.897 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -33.59 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 4.43 110.881 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.77 -49.05 38.33 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.748 -0.739 . . . . 0.42 112.473 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.8 mt -60.68 -40.61 92.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.867 0.365 . . . . 2.07 110.939 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 m -75.7 -31.36 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 1.73 111.132 179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -61.91 -61.75 2.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 1.73 110.863 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -40.48 66.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 2.53 110.87 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.7 mt -72.23 -25.86 61.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 1.66 110.899 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.33 -23.85 46.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.47 110.898 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.97 -29.64 17.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.208 -0.451 . . . . 1.43 111.124 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pp -91.38 -36.09 14.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 1.45 110.84 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.06 -45.92 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 1.57 111.176 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.74 -15.8 42.9 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.58 112.532 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.36 -62.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 2.96 110.945 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -107.02 -33.8 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 2.33 110.99 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.08 -134.54 5.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.689 -0.767 . . . . 0.38 112.481 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -154.15 152.3 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 4.78 110.937 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.9 t -136.32 123.71 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 1.5 111.12 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.4 t -113.22 153.85 27.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 1.18 110.834 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.97 132.41 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 1.55 111.22 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -142.25 152.46 43.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 1.31 110.925 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -102.7 137.49 40.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.77 110.887 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.5 mt -52.46 -43.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 1.76 111.214 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -24.16 61.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 4.64 110.867 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -98.02 16.54 20.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 3.37 110.963 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.42 -28.15 4.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.465 . . . . 2.07 110.899 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -49.89 -44.11 49.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 2.0 110.995 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -85.82 -14.77 44.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 1.34 110.865 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 t -60.44 -15.39 26.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 3.06 110.844 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.17 52.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 1.6 111.126 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -50.85 -71.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.59 110.893 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.38 -168.32 2.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 3.1 110.813 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -108.46 130.17 55.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.123 -0.489 . . . . 1.73 110.967 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.8 72.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 1.46 110.895 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.5 p -126.76 -33.72 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 1.03 110.784 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.3 118.4 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 2.55 110.868 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.37 -20.2 62.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.497 . . . . 1.52 110.879 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 mt -145.88 144.41 20.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 1.52 111.126 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.3 mm -137.29 130.22 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 1.44 111.134 179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -111.47 137.63 49.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 1.56 110.894 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.52 97.56 4.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 1.33 110.889 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.65 73.68 0.35 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.745 -0.74 . . . . 0.4 112.465 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.54 -19.35 19.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 2.12 110.884 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.34 152.59 1.52 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 1.78 111.125 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.9 123.52 10.13 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.638 2.225 . . . . 0.75 112.33 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.72 0.21 75.78 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.6 112.454 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.61 146.66 16.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.984 0.421 . . . . 2.07 110.866 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 p -137.02 109.07 7.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 1.58 111.114 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 m -162.28 140.06 8.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 1.76 111.164 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.8 mt -113.65 105.96 13.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 1.84 110.912 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -79.63 151.06 30.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.34 110.806 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.8 m -130.94 -177.15 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 1.06 110.831 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.01 69.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 1.62 111.096 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -47.78 84.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 2.46 110.933 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -70.82 -56.59 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 1.54 111.15 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.0 mt -50.95 -39.18 54.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 1.53 110.907 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.95 -56.87 13.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 1.69 111.089 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.02 -41.87 79.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 2.48 110.897 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.2 mm -56.6 -68.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 1.55 111.134 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.45 -38.23 42.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 1.71 111.117 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.59 -56.07 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 3.57 110.893 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.2 pt -77.42 -8.22 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 1.58 111.062 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.24 127.27 31.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 1.69 110.971 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -66.54 159.99 69.99 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 3.13 110.916 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 114.15 3.62 Favored 'Trans proline' 0 C--N 1.34 0.082 0 C-N-CA 122.632 2.221 . . . . 0.18 112.356 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.05 1.98 55.98 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.17 112.51 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.78 -164.03 11.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.636 -0.792 . . . . 0.14 112.519 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 60.0 m -135.47 152.3 51.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 1.46 110.863 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -137.0 112.24 9.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 1.48 110.903 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -106.44 133.62 50.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 2.92 110.828 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.58 158.78 44.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 1.51 110.955 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.79 125.62 34.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 3.48 110.97 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.43 146.05 21.79 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 2.24 110.864 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.61 140.04 42.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.718 2.279 . . . . 0.25 112.392 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.1 m -126.71 146.76 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.69 111.103 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.79 132.38 55.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 3.62 110.875 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.0 p -104.29 26.15 9.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 1.91 111.134 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -146.68 23.11 1.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 1.71 111.119 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.8 t -145.02 159.45 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 1.81 111.127 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.04 169.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 1.91 110.809 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -64.25 -49.73 70.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 2.79 110.987 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -72.62 -75.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 3.4 110.93 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t 52.0 -169.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 3.18 110.8 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.41 -3.23 48.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 2.39 110.948 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.2 141.14 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 1.71 111.116 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 114.17 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 3.12 110.846 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 44.0 p -83.55 177.61 8.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 1.58 111.125 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.95 -53.93 49.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 1.42 111.041 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -49.68 76.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.441 . . . . 0.91 110.903 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -56.29 -40.22 73.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 2.39 110.806 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.75 -55.04 26.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 1.67 110.954 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -57.58 -46.27 84.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 1.82 110.865 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.42 -42.96 95.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 1.26 110.883 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.74 92.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 1.58 111.137 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.7 -52.83 61.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 1.63 110.901 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.8 m -61.8 -35.52 78.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 1.43 111.147 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.3 mt -81.59 -10.4 59.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 1.71 110.919 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.83 5.19 29.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 2.49 110.842 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.21 -2.47 35.07 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.772 -0.728 . . . . 0.51 112.465 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.13 169.87 9.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.815 0.341 . . . . 1.58 110.98 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.0 m -151.05 171.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 1.62 111.128 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 56.93 43.61 24.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 2.03 110.905 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.4 t -75.19 142.83 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 1.8 111.128 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.63 156.38 6.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 2.57 110.938 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -82.17 145.36 30.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 2.13 110.874 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.76 -35.22 7.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 1.63 110.95 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.56 ' NE2' HE21 ' A' ' 158' ' ' GLN . 0.7 OUTLIER -166.17 176.64 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 1.31 110.906 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -125.41 166.12 17.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 9.4 110.875 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -146.91 134.22 10.22 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.684 0.754 . . . . 1.52 110.876 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 157.56 60.07 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.629 2.219 . . . . 0.5 112.369 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.46 129.59 41.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 1.61 110.95 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.68 162.74 20.21 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.52 0.676 . . . . 2.46 111.151 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 -22.66 32.24 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.642 2.228 . . . . 0.63 112.397 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -85.03 -25.76 27.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 2.64 110.964 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -88.58 -52.73 5.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.111 -0.495 . . . . 2.63 110.794 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.77 -39.05 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 1.81 111.101 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.08 -33.86 75.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 1.7 110.941 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -46.6 67.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 1.08 110.951 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.11 -30.86 49.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 1.69 111.11 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -76.87 -29.99 56.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 2.52 110.92 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -89.64 -21.6 22.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 1.97 110.884 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -95.03 -32.17 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.46 110.804 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mp -127.04 -54.49 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 1.74 110.857 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.58 14.17 2.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.57 112.543 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -70.76 121.29 17.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.793 0.33 . . . . 1.14 110.812 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -152.17 105.36 3.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 2.54 110.863 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.74 172.16 17.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 1.3 110.816 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.71 -17.27 14.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 1.88 110.917 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -96.89 20.32 11.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 1.61 110.859 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.53 162.67 13.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 1.61 110.923 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -171.2 130.65 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 1.64 110.933 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -70.33 135.28 48.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 3.0 110.885 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.19 142.47 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 1.65 111.155 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.56 HE21 ' NE2' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -101.09 127.37 47.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 2.09 110.894 -179.981 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.33 151.48 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.426 . . . . 1.75 111.188 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.1 t -130.43 154.59 47.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.222 -0.445 . . . . 1.43 111.107 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.89 131.39 4.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.755 -0.736 . . . . 0.24 112.467 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -91.63 131.63 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 4.73 110.918 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.81 135.44 77.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 2.76 110.963 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 131.47 21.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.731 2.288 . . . . 0.47 112.365 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.44 110.824 -179.946 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.845 0.355 . . . . 1.96 110.901 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -122.34 16.95 10.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 2.7 110.767 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.74 39.14 96.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.43 112.439 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.89 156.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.884 0.373 . . . . 1.74 111.128 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.73 161.38 38.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 1.92 110.879 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.54 134.9 33.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 1.52 111.088 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.64 -1.66 30.61 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.719 -0.753 . . . . 0.26 112.501 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -117.14 173.26 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 1.45 110.868 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.4 116.3 31.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 2.31 110.919 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.3 t -119.58 129.38 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 2.87 111.124 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.33 126.41 52.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 1.33 111.122 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.1 t -98.9 119.41 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 1.6 111.094 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -102.31 117.58 47.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 1.54 111.108 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -118.02 169.91 9.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.438 . . . . 0.26 110.9 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.65 -169.87 3.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 1.74 110.837 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -58.21 -35.55 71.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 3.9 110.883 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.9 -8.15 55.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 1.57 110.873 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.71 95.25 11.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.651 0.739 . . . . 0.94 110.873 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 141.57 45.27 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.628 2.219 . . . . 0.36 112.326 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.02 -32.84 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 1.73 111.154 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -50.98 -52.8 38.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 2.4 110.903 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.6 11.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 1.53 111.085 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -52.6 -61.69 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 1.7 110.99 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -36.57 27.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 3.15 110.962 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.75 49.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.24 112.534 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.6 mt -61.55 -39.97 93.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 1.91 110.918 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -76.9 -30.71 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 1.77 111.18 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.82 -59.84 4.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 1.63 110.909 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -40.08 70.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 3.17 110.881 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.8 mt -73.27 -25.7 60.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 1.57 110.825 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -77.1 -24.06 51.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.309 -0.405 . . . . 0.49 110.935 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.13 -32.22 15.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 1.3 111.133 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.31 -36.51 16.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 1.61 110.87 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -96.64 -47.09 6.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 1.79 111.11 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.34 -15.58 45.91 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.753 -0.737 . . . . 0.48 112.523 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -56.07 -62.59 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 2.56 110.898 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -107.19 -33.26 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 2.71 110.88 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.22 -131.52 4.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.31 112.522 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -156.35 153.08 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 5.21 110.798 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.7 t -134.93 126.51 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 1.79 111.169 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.8 t -116.5 152.62 33.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.95 110.827 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.03 131.77 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 1.62 111.069 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -139.23 150.97 46.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 1.38 110.87 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -103.44 135.18 45.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.61 110.876 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.4 mt -53.69 -34.18 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 1.4 111.09 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -31.7 63.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 2.99 110.937 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -100.84 19.7 16.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 3.7 110.893 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.26 -26.94 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 2.08 110.885 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.26 -38.49 58.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.226 -0.443 . . . . 1.98 110.911 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -84.5 -14.36 49.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.169 -0.469 . . . . 1.23 110.906 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.6 t -60.08 -15.19 21.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 3.04 110.805 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.17 53.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 1.58 111.111 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -53.56 -70.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.74 110.922 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -168.26 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 2.1 110.888 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -107.74 129.87 55.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 1.73 110.901 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.19 75.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 1.94 110.88 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.0 p -129.65 -34.15 1.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 1.49 110.843 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.73 118.06 35.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 2.54 110.842 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.07 -20.08 64.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 1.48 110.857 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mt -147.8 143.6 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 1.51 111.134 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 18.5 mm -133.92 132.69 56.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 1.61 111.162 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.8 137.64 51.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 1.61 110.847 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.23 98.35 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 1.19 110.814 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.59 74.41 0.29 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.818 -0.706 . . . . 0.18 112.469 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.45 61.41 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.352 . . . . 1.62 110.883 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.34 159.93 66.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 1.52 111.204 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 115.82 4.26 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.66 2.24 . . . . 0.32 112.409 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.71 7.65 68.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 0.22 112.51 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.4 150.93 10.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 1.11 110.858 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.1 p -139.72 108.18 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 1.52 111.196 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.51 156.18 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 1.53 111.126 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mt -133.85 109.6 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 1.6 110.844 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -86.51 153.92 21.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.28 110.869 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 m -131.78 -175.75 3.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.93 110.766 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.16 -36.54 70.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 1.5 111.031 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.39 -45.94 88.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 2.08 110.899 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -73.02 -55.27 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 1.7 111.146 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.7 mt -50.33 -44.8 54.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 1.57 110.874 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.59 -53.8 34.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 1.69 111.012 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.32 -43.37 74.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 2.88 110.904 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.9 mm -57.12 -67.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 1.6 111.168 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.05 -36.58 40.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 1.77 111.132 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.2 tpp85 -56.74 -50.67 71.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 3.32 110.846 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.2 pt -84.29 -6.02 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 1.55 111.12 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.14 123.34 28.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 1.61 110.926 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -61.85 159.08 38.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 4.25 110.869 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 114.2 3.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.688 2.259 . . . . 0.21 112.326 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.74 4.28 54.64 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.71 -0.757 . . . . 0.23 112.496 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.72 -164.31 22.79 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.787 -0.72 . . . . 0.18 112.485 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 53.8 m -136.25 151.06 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.808 0.337 . . . . 1.67 110.86 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -134.02 127.45 32.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.175 -0.466 . . . . 1.64 110.94 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -122.72 133.54 54.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 3.28 110.872 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.65 163.69 36.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.47 . . . . 1.53 110.913 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.02 129.87 30.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 3.95 110.972 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.88 148.59 19.63 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.742 0.782 . . . . 3.63 110.873 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 136.51 33.23 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.645 2.23 . . . . 0.31 112.382 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.9 m -120.66 146.83 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 1.62 111.202 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -110.48 132.97 53.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.92 110.901 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.0 p -91.41 -40.7 11.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 1.96 111.135 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.52 38.28 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 1.59 111.166 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.53 149.92 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 1.71 111.121 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.31 173.05 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 1.82 110.793 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -67.15 -53.37 31.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.167 -0.47 . . . . 3.13 110.94 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -75.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 2.88 110.862 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.67 -169.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 2.3 110.894 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 pttt -80.51 -4.86 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 4.26 110.922 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.92 148.21 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 1.44 111.16 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -69.14 115.06 7.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 3.04 110.875 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.7 p -87.83 -178.33 6.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 1.57 111.153 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.78 64.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 1.42 111.151 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.27 -49.46 77.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.85 110.854 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.56 -43.21 71.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 2.53 110.883 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.8 -55.74 26.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.93 110.975 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.9 m -55.3 -46.81 76.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 1.56 110.894 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -44.23 94.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 1.09 110.892 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.21 -49.81 74.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 1.77 111.106 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.55 -52.46 65.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 1.66 110.923 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 92.0 m -64.21 -29.04 70.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 1.87 111.198 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.1 mt -81.11 -16.27 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 2.08 110.835 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 p -82.32 3.2 28.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 3.2 110.859 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.46 -4.94 35.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.804 -0.712 . . . . 0.86 112.502 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.97 169.02 15.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 1.62 110.927 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.52 170.25 2.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 1.7 111.126 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 53.4 44.48 29.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 2.23 110.956 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.8 142.54 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 1.61 111.109 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.15 160.04 7.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 3.06 110.868 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.86 140.73 36.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 2.87 110.956 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 mp -98.6 -37.28 9.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 1.54 110.926 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -163.16 176.78 9.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 1.38 110.917 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.1 mtt-85 -125.63 167.01 15.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 9.5 110.875 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -149.7 134.22 9.23 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.662 0.744 . . . . 1.81 110.898 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 156.54 63.08 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.269 . . . . 0.35 112.38 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.6 154.1 20.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 1.55 110.92 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.07 163.28 48.87 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.56 0.695 . . . . 2.64 111.111 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -23.75 30.37 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.706 2.271 . . . . 0.59 112.32 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -85.66 -24.66 26.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 3.99 110.954 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -88.13 -53.85 4.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 4.08 110.931 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.59 -39.15 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 1.6 111.112 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.02 -34.03 75.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 1.69 110.916 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -46.48 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 1.4 110.854 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.73 -30.95 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 1.6 111.131 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -77.22 -29.97 54.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 2.74 110.866 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -89.37 -21.85 22.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 1.82 110.813 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -95.04 -31.97 13.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.35 110.814 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mp -127.25 -54.67 1.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 1.64 110.87 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.93 13.09 2.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.771 . . . . 0.43 112.437 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -70.55 122.23 19.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.83 110.803 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -151.38 105.57 3.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 2.92 110.924 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t -158.35 171.28 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 1.64 110.86 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.09 -17.12 14.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 2.01 110.786 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -99.28 21.29 12.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.299 -0.41 . . . . 1.65 110.866 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.4 166.14 13.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.45 . . . . 1.58 111.016 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -172.03 130.31 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 1.48 110.841 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -72.6 133.74 44.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 3.04 110.87 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.07 157.19 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 1.59 111.068 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -113.57 133.56 55.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 2.72 110.905 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.94 152.32 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 1.45 111.132 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.7 t -136.29 163.62 29.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 1.65 111.172 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.98 136.76 5.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.753 -0.737 . . . . 0.26 112.491 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -94.92 142.67 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 2.7 110.925 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -82.8 135.55 45.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.574 0.702 . . . . 2.99 110.935 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 118.89 5.95 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.727 2.285 . . . . 0.46 112.41 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.62 110.878 -179.923 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.761 0.315 . . . . 2.37 110.857 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -122.14 24.31 9.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 3.6 110.899 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.45 44.54 53.25 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.81 -0.709 . . . . 0.51 112.426 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.53 163.55 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.784 0.326 . . . . 1.77 111.17 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.22 163.6 38.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 2.07 110.811 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.33 134.31 34.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 1.53 111.086 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.52 2.41 32.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.28 112.439 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.43 172.42 7.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.806 0.336 . . . . 1.23 110.955 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.18 114.29 28.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 3.76 110.891 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.06 133.9 62.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.81 111.101 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.45 125.91 54.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 1.31 111.092 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -98.04 122.22 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 1.55 111.223 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t -105.93 114.83 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 1.5 111.169 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -115.58 168.93 9.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.19 110.956 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -151.08 -170.34 3.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 1.9 110.82 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -57.0 -35.89 69.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 4.7 110.912 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -73.14 -10.38 59.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 1.93 110.839 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.61 93.41 10.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.683 0.754 . . . . 0.93 110.851 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.7 143.11 50.06 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.615 2.21 . . . . 0.41 112.38 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.0 t -48.96 -32.08 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 1.58 111.061 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.62 -53.69 35.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 2.33 110.888 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.69 -44.7 10.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 1.67 111.114 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -50.18 -59.58 3.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 1.71 110.904 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -48.26 -32.84 7.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 5.79 110.868 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.37 -46.41 33.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 0.54 112.48 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.0 mt -61.96 -35.63 79.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 2.52 110.903 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 m -80.93 -32.94 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 1.73 111.109 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -61.6 -54.61 40.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 1.68 110.904 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -36.89 71.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 3.51 110.836 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.1 mt -76.9 -25.01 52.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 1.97 110.96 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -78.18 -26.13 47.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.58 110.927 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.52 -31.67 15.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 1.86 111.105 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 pp -89.36 -35.86 15.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 1.92 110.985 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.7 -47.16 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 1.6 111.101 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.91 -15.36 42.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.769 -0.729 . . . . 0.36 112.495 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.06 -62.85 1.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.331 . . . . 2.49 110.846 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -105.82 -34.77 7.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 2.76 110.817 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.5 -127.3 2.14 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.822 -0.704 . . . . 0.29 112.493 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -157.52 151.27 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 5.11 110.782 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.3 t -136.24 120.13 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 1.51 111.167 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.7 t -110.34 155.44 22.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 1.11 110.879 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.47 134.7 61.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 1.52 111.139 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -143.46 151.83 40.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 1.3 110.932 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -103.01 135.98 43.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.61 110.812 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mt -52.17 -35.31 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 1.56 111.102 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -74.96 -29.24 60.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 2.64 110.905 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -99.5 18.49 17.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 3.4 110.908 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.56 -30.47 5.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 2.1 110.901 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mp -54.32 -37.35 64.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 1.95 110.882 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -84.82 -15.52 44.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 1.08 110.864 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.9 m -66.63 -10.37 45.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 1.65 110.894 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.02 63.47 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 1.49 111.091 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -62.03 -69.34 0.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.45 110.795 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.38 -175.76 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 3.13 110.903 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -93.84 135.12 35.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 1.94 110.917 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p 46.42 82.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.423 . . . . 1.35 110.87 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.3 p -133.57 -38.35 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 1.29 110.893 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -102.0 122.72 44.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 2.54 110.821 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.87 -23.19 62.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 1.5 110.841 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.4 mt -145.04 143.02 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 1.63 111.108 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.3 mm -132.75 133.74 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 1.51 111.097 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -114.21 135.94 53.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 1.57 110.943 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.32 97.47 4.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 1.24 110.894 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.15 73.28 0.38 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.719 -0.753 . . . . 0.39 112.554 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.97 -19.14 21.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 2.16 110.971 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -47.54 151.12 1.51 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.659 0.742 . . . . 1.9 111.113 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 135.38 30.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.657 2.238 . . . . 0.82 112.298 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.92 1.4 78.78 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.702 -0.761 . . . . 0.38 112.437 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.62 154.63 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.991 0.424 . . . . 1.82 110.815 -179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 p -140.86 109.4 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 1.58 111.106 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.72 154.19 22.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 1.54 111.241 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.3 mt -130.93 107.35 9.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 1.45 110.896 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -84.2 153.88 23.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.893 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.3 m -131.8 -176.15 3.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 1.21 110.845 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.68 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 1.37 111.171 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -62.52 -45.99 90.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 2.08 110.884 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.7 -54.96 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 1.45 111.109 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.9 mt -50.66 -41.12 55.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 1.6 110.898 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.0 -54.86 24.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 1.67 111.139 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.45 -43.33 83.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 2.38 110.936 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.2 mm -56.24 -68.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 1.5 111.202 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.91 -36.66 39.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 1.32 111.152 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -56.24 -51.76 66.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 2.98 110.871 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.8 pt -83.13 -6.62 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 1.67 111.093 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.13 112.88 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 1.52 110.932 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -51.82 159.51 1.33 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.662 0.744 . . . . 2.99 110.791 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.61 114.59 3.73 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.666 2.244 . . . . 0.22 112.413 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.35 3.65 56.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.68 -0.772 . . . . 0.14 112.479 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.16 -157.97 8.9 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.767 -0.73 . . . . 0.13 112.545 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.5 m -144.2 156.07 44.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.365 . . . . 1.42 110.874 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -138.5 112.74 8.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 1.53 110.949 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.42 133.01 50.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 2.96 110.842 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.5 164.15 35.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 1.54 110.904 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.23 123.94 19.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 3.69 110.82 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.61 150.93 45.26 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 3.64 110.946 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 138.21 37.06 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.641 2.227 . . . . 0.25 112.365 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.31 147.28 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 1.63 111.061 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -114.76 132.59 56.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 1.98 110.859 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.7 p -104.4 25.98 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 1.99 111.093 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.68 23.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 1.77 111.053 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.4 160.47 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 1.72 111.19 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.94 179.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 1.93 110.854 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.07 -60.42 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 2.53 110.808 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -64.61 -75.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 3.16 110.886 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.93 -168.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 2.15 110.878 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -5.0 55.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 2.73 110.972 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.06 140.43 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 1.8 111.17 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.54 119.15 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 3.03 110.944 179.841 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 49.0 p -89.07 175.31 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 1.55 111.195 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.55 -55.13 38.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 1.65 111.123 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -61.05 -47.96 83.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.87 110.865 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -58.1 -40.96 82.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 2.54 110.864 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.96 -57.37 10.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 1.68 110.863 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 61.9 m -51.72 -44.71 63.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 1.64 110.945 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -42.12 85.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 1.16 110.914 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.74 97.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 1.46 111.073 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.7 tp -66.36 -51.74 54.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 1.73 110.92 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -62.39 -32.23 73.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 1.41 111.146 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.09 -10.73 52.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 1.95 110.889 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.34 4.62 30.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 2.41 110.855 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.47 10.0 28.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.784 -0.722 . . . . 0.53 112.45 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.3 171.63 7.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 1.6 110.946 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 m -150.01 173.04 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 1.54 111.088 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 51.73 44.92 28.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 2.06 110.927 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.5 t -81.6 141.73 14.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 1.4 111.131 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 159.07 7.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.116 -0.493 . . . . 2.79 110.983 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.22 139.72 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 3.38 110.959 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 mp -95.84 -38.17 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 1.68 110.945 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.7 pm0 -157.68 176.37 12.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.452 . . . . 2.99 110.926 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -128.1 138.08 52.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 4.93 110.829 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -124.3 136.38 27.61 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.683 0.754 . . . . 1.38 110.853 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 164.75 33.4 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.743 2.295 . . . . 0.27 112.291 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.61 125.71 42.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 1.6 110.9 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.0 161.34 23.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.528 0.68 . . . . 2.81 111.108 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -24.08 29.94 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.628 2.219 . . . . 0.46 112.382 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -85.08 -22.26 29.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 2.6 110.944 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -87.76 -54.6 4.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 2.38 110.832 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -49.03 -39.12 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 1.65 111.116 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -37.86 80.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 2.8 110.865 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -46.91 75.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 1.05 110.888 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.37 -30.67 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 1.64 111.131 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -75.95 -30.63 58.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 4.77 110.864 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -90.06 -20.51 23.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 1.89 110.887 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.5 -32.69 13.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.34 110.871 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -127.9 -53.86 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 1.72 110.982 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.79 15.21 1.97 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.776 -0.726 . . . . 0.54 112.541 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -70.92 121.69 18.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.768 0.318 . . . . 1.33 110.891 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -152.11 105.53 3.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 2.34 110.833 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -160.66 175.79 12.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 1.42 110.777 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.24 -21.89 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 1.72 110.842 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -91.4 13.29 17.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 1.54 110.965 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.54 164.63 21.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 1.58 110.89 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -173.72 130.09 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 1.67 110.902 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -76.08 137.99 40.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 3.03 110.925 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.45 150.06 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 1.66 111.128 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -103.49 133.91 47.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 2.82 110.896 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.43 147.35 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 1.8 111.126 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.4 t -132.63 148.97 52.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 1.8 111.024 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.99 135.4 7.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.71 -0.757 . . . . 0.26 112.519 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -90.89 140.09 30.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 2.74 110.836 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 135.04 51.38 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 2.18 110.872 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 124.03 10.67 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.644 2.229 . . . . 0.29 112.38 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.33 110.942 179.995 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.915 0.388 . . . . 2.15 110.865 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.27 21.55 10.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 3.54 110.912 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.67 38.91 59.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.721 . . . . 0.34 112.502 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.97 158.12 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 1.53 111.126 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.5 m -149.62 157.02 42.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.177 -0.465 . . . . 1.64 110.8 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.53 125.59 33.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 1.78 111.063 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.95 -6.2 23.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 0.31 112.53 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.05 167.57 10.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.758 0.313 . . . . 1.69 110.917 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.66 136.33 39.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 2.28 110.841 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 p -141.03 136.89 34.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 3.25 111.087 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.3 124.14 51.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 1.34 111.159 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.7 t -94.69 116.97 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 1.65 111.121 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.31 112.05 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 1.77 111.15 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -114.52 165.85 12.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.25 110.967 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -147.36 -170.54 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.305 -0.407 . . . . 1.87 110.916 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -56.95 -35.94 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 4.89 110.815 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -72.61 -9.31 58.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.55 110.804 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.16 94.04 10.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.703 0.763 . . . . 0.94 110.838 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.3 47.64 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.691 2.261 . . . . 0.23 112.335 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.9 t -48.74 -32.94 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 1.51 111.149 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.84 -53.06 35.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 2.52 110.874 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.57 -44.88 10.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 1.51 111.095 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -51.96 -61.7 2.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.298 -0.41 . . . . 1.41 110.81 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.72 -36.76 26.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 3.57 110.89 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.38 -47.75 49.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.74 . . . . 0.24 112.478 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 mt -61.72 -40.44 95.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 1.63 110.921 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 m -75.92 -31.68 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 1.79 111.087 179.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.92 -60.46 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 1.7 110.916 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -40.16 71.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 2.63 110.802 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.7 -24.69 61.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 1.85 110.935 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.47 -24.96 45.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.46 110.927 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.72 -29.93 17.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 1.69 111.093 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.61 -35.23 14.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 1.45 110.873 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.46 -44.9 5.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 1.46 111.053 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.97 -11.18 54.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.793 -0.718 . . . . 0.25 112.512 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.3 -62.44 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.685 0.278 . . . . 3.89 110.775 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -91.41 -40.08 11.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 2.25 110.915 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.92 -125.86 4.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.756 -0.735 . . . . 0.27 112.49 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -156.37 152.88 28.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.885 0.374 . . . . 2.89 110.846 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.3 t -136.91 127.96 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 1.4 111.104 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.4 t -116.93 152.91 33.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 1.43 110.823 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.69 132.28 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 1.75 111.197 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -143.54 152.0 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 1.28 110.905 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -102.38 137.78 40.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.64 110.886 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 mt -52.65 -36.74 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 1.7 111.095 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -75.7 -25.18 56.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 2.7 110.862 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -103.89 16.15 27.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 3.37 110.981 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.49 -24.72 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 3.9 110.91 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -51.16 -38.96 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 2.09 110.902 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -84.91 -14.2 48.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 1.37 110.907 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.4 t -58.97 -15.46 13.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 3.54 110.795 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.63 53.18 0.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 1.77 111.168 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -51.14 -72.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.48 110.865 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.83 -168.24 2.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 2.82 110.926 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -100.5 121.09 41.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 2.14 110.944 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.05 84.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.69 110.842 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 p -132.59 -36.84 1.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 1.52 110.854 -179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.03 120.4 36.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 2.56 110.878 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.39 -20.48 61.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 1.77 110.9 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.1 mt -143.51 144.28 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 1.65 111.071 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.9 mm -136.13 126.11 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 1.54 111.189 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.85 137.41 46.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 1.58 111.001 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.62 99.75 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 1.5 110.869 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.48 78.93 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.655 -0.783 . . . . 0.18 112.478 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.04 58.07 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.51 110.867 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.09 159.75 65.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.676 0.751 . . . . 1.61 111.124 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.74 115.63 4.18 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.738 2.292 . . . . 0.3 112.294 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.69 6.32 65.83 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.679 -0.772 . . . . 0.23 112.515 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.43 150.21 12.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 1.05 110.804 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 p -140.3 108.86 5.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 1.55 111.062 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.16 144.18 9.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 1.63 111.162 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt -120.68 99.63 6.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 1.68 111.032 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -75.69 137.55 40.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.4 110.785 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.0 m -116.99 178.45 4.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.94 110.884 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.57 -44.12 62.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 1.18 111.059 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.28 -47.75 77.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 1.87 110.912 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.79 -56.53 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 1.4 111.17 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.4 mt -50.23 -40.45 47.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 1.71 110.953 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.93 -57.04 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 1.6 111.177 179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.69 -43.09 68.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 2.83 110.903 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.7 mm -57.47 -68.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.118 -0.492 . . . . 1.59 111.051 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.3 -37.69 37.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 1.41 111.117 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -53.95 -55.23 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 3.8 110.756 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -81.29 -5.6 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 1.49 111.066 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.64 117.86 20.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 1.64 110.874 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.7 mtt-85 -57.56 158.87 10.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.598 0.713 . . . . 4.04 110.891 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 114.14 3.59 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.26 . . . . 0.2 112.32 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.33 3.58 55.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.2 112.46 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.02 -165.62 23.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.83 -0.7 . . . . 0.17 112.542 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.3 m -134.84 150.48 50.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.866 0.365 . . . . 2.02 110.896 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -134.7 115.0 13.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 1.44 110.963 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -110.37 132.47 54.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 2.89 110.792 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.53 159.02 44.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 1.56 110.871 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 130.12 44.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 3.68 110.958 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.66 146.89 18.0 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.653 0.74 . . . . 2.33 110.885 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 142.23 47.68 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.674 2.25 . . . . 0.27 112.361 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.4 m -127.05 146.83 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 1.52 111.114 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -107.84 132.92 52.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 1.95 110.926 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.4 p -92.85 -41.4 10.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 1.85 111.15 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.51 38.53 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 1.74 110.973 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.89 150.63 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 1.82 111.13 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.51 173.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.82 110.834 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -66.97 -53.7 29.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 3.03 110.91 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -75.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 2.58 110.916 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 52.37 -169.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 2.4 110.836 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -80.3 -5.34 56.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 2.99 110.966 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.81 147.91 22.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 1.61 111.05 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.2 116.08 8.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 2.86 110.908 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.4 p -88.21 -178.98 6.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 1.43 111.102 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.6 64.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 1.61 111.111 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.66 -49.63 76.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 1.19 110.939 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -57.1 -44.62 83.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 3.15 110.888 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.03 -55.45 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 1.61 110.954 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 71.5 m -53.71 -49.12 68.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 1.56 110.949 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -45.64 93.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 1.04 110.862 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.82 -44.84 93.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 1.56 111.116 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.5 tp -61.54 -54.12 47.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 1.55 110.912 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 100.0 m -61.85 -27.7 68.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 2.07 111.149 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.01 -17.45 50.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 2.14 110.854 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 p -82.37 3.03 29.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 2.97 110.823 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.38 -4.87 35.28 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.789 -0.72 . . . . 0.56 112.523 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.56 168.13 15.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 1.82 110.916 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.2 m -150.79 172.97 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.7 111.142 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 53.14 43.05 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 2.21 110.912 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.89 142.27 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 1.72 111.132 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.78 158.33 7.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 2.56 110.891 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -82.26 147.22 29.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 2.39 110.829 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 mp -107.78 -36.03 6.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 1.51 111.017 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -164.6 176.49 8.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.471 . . . . 1.29 110.853 179.872 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -126.12 165.76 18.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 9.43 110.867 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -148.62 136.34 11.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.671 0.748 . . . . 1.39 110.83 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 157.13 61.51 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.588 2.192 . . . . 0.4 112.448 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.98 127.58 39.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.31 -0.405 . . . . 1.64 110.933 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.56 161.37 23.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.544 0.687 . . . . 2.86 111.121 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -24.85 29.22 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.688 2.259 . . . . 0.5 112.325 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -85.75 -21.99 27.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 3.64 110.922 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -87.5 -53.07 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 2.5 110.93 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.13 -41.36 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 1.76 111.069 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -32.39 74.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.4 110.772 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -51.32 24.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.98 110.841 -179.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.54 -28.39 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 1.43 111.125 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -75.99 -48.58 20.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 2.49 110.915 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -73.26 -19.73 61.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 1.84 110.929 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.19 -33.36 13.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.56 110.835 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 mp -129.44 -54.09 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 1.68 110.916 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.57 14.59 1.9 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.688 -0.768 . . . . 0.36 112.513 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -74.62 120.34 20.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.853 0.359 . . . . 0.87 110.84 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -152.09 105.08 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 4.31 110.865 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.04 167.89 25.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.468 . . . . 1.43 110.816 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.77 -6.72 20.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 1.97 110.945 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.08 14.02 31.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 3.02 110.844 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.26 168.95 11.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 1.75 110.919 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -173.51 130.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 1.54 111.013 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -69.38 134.66 49.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 3.28 110.825 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.73 143.28 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.085 -0.507 . . . . 1.67 111.139 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -100.79 127.88 47.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 2.64 110.967 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.84 152.18 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 1.58 111.069 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.1 t -131.54 159.13 39.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 1.48 111.154 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.4 130.19 3.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.21 112.433 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -93.0 140.27 29.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 2.36 110.919 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -81.24 134.27 52.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.507 0.67 . . . . 2.49 110.92 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 119.78 6.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.625 2.217 . . . . 0.32 112.413 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.36 110.868 -179.973 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.789 0.328 . . . . 2.28 110.858 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.16 22.27 10.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.235 -0.439 . . . . 3.54 110.894 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.16 37.82 47.24 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.29 112.527 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -73.95 156.42 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.791 0.329 . . . . 1.7 111.175 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.7 m -147.7 154.73 40.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 1.51 110.897 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.17 125.31 33.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 1.6 111.177 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.27 -6.56 19.05 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.744 -0.741 . . . . 0.28 112.498 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.8 170.62 7.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 1.77 110.972 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.13 112.44 25.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 2.32 110.926 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.31 131.75 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 3.09 111.153 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.26 125.63 51.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 1.35 111.097 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.4 t -96.18 117.4 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 1.55 111.24 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -100.86 119.9 49.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 1.71 111.102 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -120.0 168.95 10.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 0.2 110.946 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -151.83 -170.28 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 1.91 110.842 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -57.03 -35.6 69.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 3.65 110.975 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 m -73.62 -9.24 58.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.497 . . . . 2.02 110.842 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.97 94.2 10.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.634 0.731 . . . . 1.56 110.888 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 142.29 47.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.681 2.254 . . . . 0.24 112.386 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.2 t -48.99 -32.61 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 1.6 111.096 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.13 -53.06 37.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 2.42 110.903 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.66 -44.56 11.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 1.52 111.078 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -52.07 -61.42 2.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 1.61 110.908 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.14 -37.6 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 3.6 110.914 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.8 -47.54 54.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 0.25 112.409 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 mt -61.49 -40.98 96.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.915 0.388 . . . . 1.61 110.937 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.81 -31.42 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 1.69 111.065 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.75 -61.15 2.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 1.57 110.843 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.8 -40.59 69.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 2.7 110.85 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.6 mt -71.99 -25.07 61.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 1.53 110.944 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.33 -24.54 46.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.45 111.0 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.76 -29.79 17.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 1.59 111.156 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.58 -35.46 14.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 1.62 110.945 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.16 -44.89 5.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 1.43 111.13 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.22 -12.16 49.12 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.704 -0.76 . . . . 0.27 112.555 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -67.67 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 2.53 110.871 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -95.56 -38.99 10.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.093 -0.503 . . . . 2.61 110.94 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.1 -131.32 5.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 0.24 112.492 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -152.88 151.73 30.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.932 0.396 . . . . 4.67 110.832 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.01 125.06 44.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 1.59 111.107 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -115.87 152.49 33.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 1.02 110.833 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.32 133.66 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.5 . . . . 1.57 111.089 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -140.93 150.83 43.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 1.59 110.874 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -103.44 134.64 46.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.67 110.833 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 mt -51.56 -34.56 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 1.65 111.151 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -71.46 -34.76 70.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.507 . . . . 2.73 110.896 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -101.1 16.15 26.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.262 -0.427 . . . . 3.67 110.874 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.87 -42.8 37.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 2.15 110.89 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.5 -39.48 70.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 4.7 110.908 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.16 -13.14 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 5.15 110.924 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.7 m -77.19 -0.47 25.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 2.7 110.874 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.1 70.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 1.9 111.135 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -51.06 -73.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.439 . . . . 2.19 110.78 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.58 -165.18 1.98 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 2.29 110.915 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -106.36 128.71 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 2.15 110.866 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.44 71.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.33 110.826 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.7 p -126.39 -32.13 2.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 1.1 110.802 -179.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -100.24 119.31 38.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 2.53 110.897 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.39 -20.04 62.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 1.52 110.88 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 mt -143.99 144.46 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 1.59 111.161 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.3 mm -137.66 127.85 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 1.62 111.185 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.3 137.98 48.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 1.57 110.885 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.63 100.96 5.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 1.25 110.879 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.37 72.2 0.56 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.687 -0.768 . . . . 0.18 112.512 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.86 58.85 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.339 . . . . 1.6 110.939 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.2 159.73 65.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.546 0.688 . . . . 1.49 111.172 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.89 117.42 5.08 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.233 . . . . 0.24 112.302 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.51 7.24 72.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.818 -0.706 . . . . 0.21 112.53 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.72 146.83 20.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.997 0.427 . . . . 1.16 110.845 -179.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.8 p -136.11 108.58 7.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 1.65 111.127 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.87 147.51 15.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 1.58 111.143 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.4 mt -123.63 103.54 8.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 1.59 110.911 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -81.26 141.95 33.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.34 110.893 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.3 m -123.57 174.73 7.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 1.32 110.804 -179.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.08 55.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 1.46 111.144 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.38 -46.05 91.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.144 -0.48 . . . . 2.14 110.889 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -73.15 -55.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 1.47 111.062 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.1 mt -49.75 -37.68 30.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 1.74 110.933 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.75 -57.0 9.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 1.58 111.096 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.05 -40.58 77.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.189 -0.459 . . . . 2.7 110.905 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.9 mm -59.33 -67.58 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 1.67 111.095 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.43 -33.69 31.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 1.4 111.106 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -57.23 13.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 3.23 110.824 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.7 pt -75.15 -8.88 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 1.62 111.172 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.07 125.84 29.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.143 -0.481 . . . . 1.56 110.924 179.875 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -67.05 160.52 69.95 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.651 0.738 . . . . 4.83 110.966 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 114.06 3.57 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.631 2.221 . . . . 0.2 112.366 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.83 3.99 56.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.18 112.468 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.12 -164.48 17.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 0.13 112.435 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 61.2 m -135.32 150.6 50.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 1.52 110.892 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -135.44 114.4 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 1.51 110.867 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -109.59 132.35 54.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 2.95 110.88 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.48 164.16 35.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 1.6 110.905 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -136.26 124.56 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 2.83 110.959 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.31 150.52 41.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 2.3 110.945 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 139.87 41.49 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.697 2.265 . . . . 0.27 112.382 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.37 147.27 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 1.79 111.119 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -119.31 131.92 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 1.96 110.925 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 p -92.73 -36.24 13.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 1.88 111.123 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.51 37.33 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 1.65 111.137 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.7 t -147.68 149.35 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 2.05 111.123 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.59 179.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 1.71 110.81 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.41 -74.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 2.71 110.857 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -54.74 -77.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 2.86 110.945 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.25 -169.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 2.36 110.955 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -4.08 52.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 3.39 110.945 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -145.85 141.18 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 1.7 111.143 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -65.66 111.54 3.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 3.67 110.878 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 44.8 p -81.0 177.39 9.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 1.46 111.165 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.56 -55.29 26.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 1.39 111.191 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 m -60.49 -49.68 76.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.88 110.877 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -38.51 70.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 4.1 110.943 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.4 -54.89 22.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 1.53 110.874 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 48.2 m -57.67 -45.33 85.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 2.05 110.856 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -42.95 88.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 1.39 110.858 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.84 97.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 1.54 111.088 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.5 tp -65.52 -50.46 65.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 1.65 110.878 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 95.5 m -64.13 -31.72 73.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 1.33 111.131 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.2 mt -86.75 -10.39 53.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.402 . . . . 1.81 110.894 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.07 5.17 30.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.416 . . . . 2.43 110.859 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.27 6.42 33.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.672 -0.775 . . . . 0.54 112.405 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.67 172.44 6.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.777 0.322 . . . . 1.45 110.985 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 m -151.18 173.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 1.64 111.101 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 53.37 43.93 30.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 2.22 110.862 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 95.5 t -77.5 141.35 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 1.66 111.03 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 161.43 8.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 2.78 110.841 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -82.26 145.9 29.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 2.09 110.855 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.0 mp -105.59 -35.97 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 1.57 110.927 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.41 175.82 13.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.19 110.981 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -128.62 147.95 50.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 4.78 110.834 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -137.32 134.4 18.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.695 0.759 . . . . 1.4 110.955 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 165.21 31.73 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.737 2.292 . . . . 0.27 112.352 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.77 125.53 42.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 1.78 110.894 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.97 161.95 21.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.603 0.716 . . . . 2.37 111.089 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -27.85 26.01 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.822 2.348 . . . . 0.37 112.253 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.54 -18.13 34.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 2.66 110.888 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.59 -54.27 4.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 2.78 110.931 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -49.89 -39.96 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.59 111.086 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -34.11 76.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 1.22 110.912 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -47.16 67.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 1.05 110.811 -179.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.08 -30.02 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 1.41 111.197 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -75.76 -32.25 59.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 2.44 110.908 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -89.4 -20.16 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 1.74 110.916 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -94.34 -32.84 13.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.34 110.848 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.11 -54.1 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 1.51 110.88 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.6 16.25 1.68 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.709 -0.758 . . . . 0.31 112.433 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -72.84 122.0 20.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.733 0.302 . . . . 1.23 110.887 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -151.51 105.45 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 2.1 110.848 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -160.54 170.03 21.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 1.16 110.882 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.14 -14.07 15.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 1.97 110.891 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -101.74 23.39 11.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 1.72 110.855 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 163.49 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.23 -0.441 . . . . 1.67 110.891 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -169.72 130.69 1.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 1.65 110.939 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -76.42 136.86 39.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 3.11 110.874 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.54 145.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 1.72 111.128 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -97.83 129.62 44.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 1.95 110.898 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.44 149.18 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 1.48 111.071 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.5 t -126.8 160.73 30.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 1.47 111.087 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.7 128.88 2.67 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.68 -0.772 . . . . 0.25 112.495 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -90.02 139.67 30.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 2.25 110.84 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.81 135.22 49.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.567 0.699 . . . . 2.15 110.873 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 128.41 16.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.647 2.231 . . . . 0.38 112.298 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.854 -179.989 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.798 0.332 . . . . 1.86 110.839 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -122.31 13.82 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 3.49 110.797 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.76 38.98 96.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.27 112.504 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.9 158.78 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 1.49 111.071 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.65 162.07 41.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 1.6 110.915 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.23 126.32 35.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 1.5 111.058 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.08 -5.85 17.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.674 -0.774 . . . . 0.25 112.46 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -114.13 168.96 9.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.319 . . . . 1.52 110.857 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.58 140.64 32.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 2.3 110.808 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -142.63 138.46 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 2.86 111.135 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.4 123.94 49.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 1.63 111.136 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.1 t -97.43 118.19 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 1.7 111.1 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.47 110.98 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.55 111.092 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -112.4 167.38 10.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.21 110.928 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -151.18 -169.46 3.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.69 110.858 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.98 -35.95 69.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 6.63 110.857 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.8 m -72.95 -10.34 59.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 2.69 110.869 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.91 94.48 10.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 0.77 110.879 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 141.42 45.29 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.718 2.279 . . . . 0.24 112.396 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.0 t -48.64 -32.9 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 1.61 111.128 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.28 -52.64 43.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 3.15 110.891 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.53 -44.94 10.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 1.44 111.036 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.87 -61.55 2.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.275 -0.421 . . . . 1.72 110.939 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -37.41 28.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 3.72 110.874 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.21 -47.37 53.04 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.3 112.457 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.93 -39.97 93.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 1.74 110.92 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.1 m -76.82 -31.56 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 1.72 111.12 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -61.98 -59.8 4.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 1.85 110.868 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -40.2 71.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.425 . . . . 3.58 110.876 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.6 mt -72.94 -24.57 60.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 1.46 110.957 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.59 -25.36 45.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.49 110.917 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.88 -30.0 17.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.474 . . . . 1.81 111.076 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.48 -35.08 14.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 1.56 110.894 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.59 -45.49 4.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 1.59 111.128 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.07 -12.29 54.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.747 -0.74 . . . . 0.45 112.445 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.39 -62.54 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 3.53 110.951 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.81 -43.6 14.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 2.04 110.923 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.52 -121.86 4.31 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.33 112.471 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -157.03 153.84 28.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 4.46 110.853 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -139.24 129.91 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 1.62 111.084 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -118.2 157.95 26.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 1.14 110.816 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.87 135.07 60.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 1.57 111.19 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -145.45 151.76 38.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 1.29 110.811 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.85 135.94 43.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.63 110.913 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.1 mt -51.34 -35.03 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 1.39 111.087 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -32.05 62.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 3.79 110.863 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.7 19.48 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 3.36 110.882 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.67 -31.05 4.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.424 . . . . 2.17 110.91 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -54.31 -36.3 63.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 2.16 110.947 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -85.46 -15.91 41.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 1.07 110.991 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 m -64.01 -13.32 45.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 1.91 110.874 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.64 65.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 1.58 111.118 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -63.84 -72.46 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.51 110.888 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.77 -166.28 2.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 2.83 110.967 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -106.69 127.13 53.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.957 0.408 . . . . 1.69 110.885 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 49.15 75.88 0.14 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.5 . . . . 1.34 110.886 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.2 p -127.48 -34.4 2.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 1.01 110.808 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.54 120.82 39.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 2.59 110.885 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.5 -20.61 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 1.69 110.862 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.6 mt -143.87 144.23 23.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.226 -0.443 . . . . 1.73 111.101 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.1 mm -134.65 126.52 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 1.58 111.137 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -111.16 131.96 54.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 1.56 110.841 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.7 100.01 6.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 1.11 110.852 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.59 75.37 0.22 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.792 -0.718 . . . . 0.17 112.479 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -106.27 55.71 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.891 0.377 . . . . 1.58 110.88 -179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.96 160.07 53.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.579 0.705 . . . . 1.47 111.081 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 123.29 9.93 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.653 2.236 . . . . 0.28 112.427 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.93 7.52 87.82 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.712 -0.756 . . . . 0.22 112.54 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.7 p -55.58 149.1 14.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.052 0.453 . . . . 1.47 110.828 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.5 p -138.79 109.12 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.044 -0.526 . . . . 1.6 111.2 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.43 156.77 26.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 1.51 111.106 -179.856 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.7 mt -135.04 106.55 6.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 1.76 110.915 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -82.11 153.83 25.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.37 110.901 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.7 m -131.0 176.32 8.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.95 110.884 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.47 -36.28 43.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.486 . . . . 1.37 111.094 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -62.5 -42.79 99.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 1.62 110.868 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -77.53 -55.58 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 1.69 111.138 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.0 mt -48.87 -49.69 38.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 1.43 110.998 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.89 -48.28 51.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 1.96 111.062 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -46.76 88.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 4.92 110.903 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.9 mm -53.63 -64.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 1.58 111.122 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.78 -41.38 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 1.36 111.134 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -51.63 -51.31 56.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 3.39 110.867 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.4 pt -84.3 -6.29 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 1.46 111.175 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.45 116.64 20.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 1.62 110.883 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -55.91 159.19 5.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.665 0.745 . . . . 3.07 110.811 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 113.93 3.53 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.721 2.281 . . . . 0.24 112.395 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.23 4.46 55.18 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.788 -0.72 . . . . 0.22 112.436 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.53 -163.46 19.97 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.776 -0.726 . . . . 0.16 112.407 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.9 m -136.18 154.61 50.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 1.57 110.9 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -138.94 116.36 11.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 1.51 110.904 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -111.68 131.26 55.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 2.97 110.831 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.67 163.44 37.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 1.66 110.851 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -137.11 134.43 36.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 4.54 110.894 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.72 148.94 20.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.699 0.761 . . . . 3.48 110.876 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 131.91 22.31 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.706 2.271 . . . . 0.46 112.383 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.2 m -120.15 146.59 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 1.76 111.197 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.28 132.87 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 3.43 110.875 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.1 p -102.56 26.61 7.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 1.83 111.152 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.77 24.72 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 1.86 111.114 179.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.22 160.39 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.21 -0.45 . . . . 1.76 111.11 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.02 177.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 1.95 110.925 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -67.9 -53.03 29.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 3.68 110.875 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -70.88 -76.43 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 2.96 110.877 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.65 -168.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 2.41 110.851 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -5.28 56.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 2.67 110.872 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -146.02 140.92 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 1.68 111.149 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -60.6 121.51 12.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 3.54 110.856 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.3 p -90.02 177.2 6.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 1.53 111.13 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.07 -54.73 43.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 1.6 111.097 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -59.51 -48.51 81.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 1.09 110.872 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -56.73 -40.83 76.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 3.77 110.874 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.91 -54.11 43.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.429 . . . . 1.75 110.894 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.3 m -55.83 -47.93 76.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 1.6 110.923 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -45.57 88.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 1.43 110.868 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.32 97.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 1.59 111.083 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.94 -53.77 34.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.416 . . . . 1.5 110.957 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.2 m -59.12 -33.48 70.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.38 111.155 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.4 mt -86.99 -10.27 53.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 1.9 110.953 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.2 m -85.06 4.85 32.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 2.35 110.814 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.14 11.25 26.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.71 112.492 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.32 170.77 7.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 1.62 110.839 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.6 m -151.38 173.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 1.53 111.112 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 51.72 43.88 29.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 2.2 110.81 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.8 t -75.54 143.63 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 1.72 111.15 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.16 158.42 6.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 2.63 110.949 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.5 145.35 31.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 2.14 110.915 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.3 mp -104.34 -36.71 7.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 1.54 110.867 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.59 176.16 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.16 110.937 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -133.17 138.0 46.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 5.07 110.92 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -123.84 136.11 27.02 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.672 0.749 . . . . 1.5 110.868 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.89 158.82 55.51 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.597 2.198 . . . . 0.36 112.342 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.44 124.53 38.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 1.46 110.91 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 137' ' ' PRO . 0.0 OUTLIER -105.07 162.7 18.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 2.58 111.135 179.918 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 136' ' ' THR . 53.4 Cg_endo -69.79 -23.15 30.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.661 2.241 . . . . 0.74 112.31 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.79 -22.53 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 2.34 110.965 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -87.65 -53.91 4.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 3.98 110.911 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.66 -40.21 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 1.75 111.149 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -31.98 73.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 1.31 110.987 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -51.38 19.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.95 110.89 -179.849 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.72 -28.29 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 1.57 111.098 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -76.28 -48.24 20.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 3.09 110.86 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -73.63 -19.32 60.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 2.17 110.959 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.5 -33.56 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.65 110.82 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 mp -128.32 -54.43 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 1.83 110.925 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.81 12.66 1.91 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.736 -0.745 . . . . 0.68 112.556 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -70.77 121.37 17.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 1.22 110.834 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -152.04 105.48 3.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 2.73 110.946 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.48 175.02 13.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 1.28 110.826 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.82 -17.82 13.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.072 -0.513 . . . . 1.71 110.793 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -94.66 12.17 28.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 1.53 110.839 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.31 164.02 22.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 1.85 110.92 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -173.35 132.08 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 1.45 110.876 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -77.09 131.86 38.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 3.04 110.845 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.69 144.37 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 1.62 111.139 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -102.01 130.6 48.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 2.06 110.898 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.03 149.72 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 1.54 111.183 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.5 t -127.88 160.48 31.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 1.46 111.062 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.52 132.22 3.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.83 -0.7 . . . . 0.19 112.606 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -94.71 140.84 29.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 2.71 110.925 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -81.46 134.52 51.23 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.621 0.724 . . . . 2.48 110.851 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 118.75 5.87 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.775 2.316 . . . . 0.44 112.328 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.5 110.895 179.961 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.898 0.38 . . . . 2.72 110.851 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -122.4 22.13 10.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 2.69 110.758 -179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.51 41.92 56.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.814 -0.708 . . . . 0.33 112.445 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mp -81.51 160.22 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.817 0.342 . . . . 1.68 111.099 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.48 168.21 28.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 2.66 110.818 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.64 130.62 35.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 1.65 111.099 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.15 2.79 29.79 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.719 -0.753 . . . . 0.3 112.448 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -116.96 166.88 11.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 1.19 110.958 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.02 115.19 29.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 2.29 110.848 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.95 139.78 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 3.31 111.151 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.04 112.12 22.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 1.73 111.089 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -87.65 121.87 38.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 1.66 111.163 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 t -108.29 119.84 58.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 1.53 111.219 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -117.8 166.15 12.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.22 110.972 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -145.65 -169.06 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.309 -0.405 . . . . 1.69 110.872 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -59.59 -35.28 73.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 4.35 110.937 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.4 m -74.68 -6.92 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 1.78 110.86 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.62 92.7 8.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.682 0.753 . . . . 0.84 110.906 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 143.08 49.94 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 0.23 112.413 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t -48.8 -32.77 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 1.58 111.193 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -51.0 -53.26 34.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 3.13 110.872 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.57 -44.95 10.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 1.42 111.12 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.45 -61.95 1.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 1.43 110.968 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.52 -35.77 21.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 3.65 110.921 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.87 -47.67 45.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.677 -0.773 . . . . 0.21 112.548 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.4 mt -61.73 -39.86 93.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.92 0.391 . . . . 1.78 110.987 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.65 -31.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 1.66 111.199 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.38 -59.68 4.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 1.66 110.807 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -40.29 72.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 2.62 110.945 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.4 mt -72.78 -24.93 61.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 1.59 110.883 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.49 -25.01 45.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.45 110.82 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.59 -29.95 17.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 1.32 111.094 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.6 -34.82 14.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 1.44 110.892 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.17 -45.6 4.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 1.6 111.134 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.47 -12.27 55.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.3 112.505 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -65.33 -62.66 1.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 3.51 110.989 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.09 -36.49 10.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 1.88 110.925 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.32 -128.74 4.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.25 112.452 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -154.32 153.19 31.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 2.95 110.799 -179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.8 t -138.88 117.05 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 1.59 111.116 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.3 t -107.01 151.35 25.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.794 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -114.24 136.29 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 1.56 111.02 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -144.99 152.2 39.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.142 -0.481 . . . . 1.27 110.842 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -102.8 134.34 46.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.67 110.952 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.2 mt -50.29 -33.56 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.81 111.101 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -76.48 -34.3 58.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 3.72 110.878 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -93.37 18.57 9.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 3.16 110.821 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.49 -30.25 4.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 2.15 110.961 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mp -53.45 -37.95 63.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 2.1 110.844 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -85.23 -16.18 41.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 1.18 110.834 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.8 m -65.41 -12.38 51.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 1.96 110.873 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.84 61.2 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 1.57 111.099 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -58.62 -71.82 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.117 -0.492 . . . . 0.48 110.806 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.2 -168.68 3.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 3.07 110.866 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -102.18 137.71 40.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 1.94 110.899 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 p 46.55 85.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 1.38 110.873 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 p -139.97 -40.49 0.44 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 1.28 110.865 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.64 120.42 39.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 2.58 110.889 -179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.62 -21.6 63.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 1.5 110.819 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.5 mt -147.16 142.64 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 1.69 111.165 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.5 mm -129.43 134.42 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 1.53 111.109 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -114.54 135.24 54.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 1.63 110.924 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.76 97.73 4.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 1.47 110.801 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.48 79.54 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.22 112.47 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.88 56.69 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.963 0.411 . . . . 1.63 110.959 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.31 159.35 57.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.617 0.723 . . . . 1.63 111.16 179.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 116.46 4.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.683 2.255 . . . . 0.25 112.375 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.31 7.37 69.82 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.22 112.533 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -54.79 144.25 23.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.974 0.416 . . . . 1.08 110.87 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.5 p -133.49 108.5 8.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 1.43 111.166 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -162.7 149.53 13.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 1.53 111.095 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 mt -127.52 99.99 5.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.13 -0.486 . . . . 1.54 110.967 179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -73.23 145.95 45.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.32 110.881 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 m -120.28 172.8 7.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 1.41 110.742 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.34 -39.7 47.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 1.61 111.125 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.6 -38.31 84.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 2.38 110.909 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -79.81 -54.84 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 1.6 111.201 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.0 mt -49.84 -45.87 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 1.77 110.906 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.75 -51.65 54.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.174 -0.467 . . . . 1.56 111.014 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -42.48 77.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 2.61 110.886 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.9 mm -59.93 -68.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 1.51 111.093 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.57 -32.68 19.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 1.89 111.127 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -61.02 -56.15 24.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 3.13 110.906 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.8 pt -76.95 -6.72 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 1.48 111.165 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.36 124.31 27.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 1.61 110.891 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -62.67 160.23 37.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.572 0.701 . . . . 2.85 110.869 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 114.04 3.56 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.73 2.286 . . . . 0.24 112.318 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.71 3.5 56.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.819 -0.705 . . . . 0.22 112.44 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.11 -156.9 9.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.716 -0.754 . . . . 0.22 112.423 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.3 m -146.0 158.18 43.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.888 0.375 . . . . 1.75 110.833 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.38 116.14 10.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 1.6 110.954 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -108.76 132.73 53.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 2.89 110.84 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.56 160.59 42.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 1.5 110.878 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 126.37 36.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 2.79 110.862 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.9 148.13 24.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.659 0.742 . . . . 2.3 110.875 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 143.95 53.05 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.718 2.279 . . . . 0.23 112.386 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 m -127.12 147.0 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 1.7 111.1 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.01 132.42 56.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 3.15 110.811 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.7 p -104.75 25.99 9.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 2.09 111.247 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.65 26.31 0.83 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 1.98 111.104 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.8 t -144.09 158.64 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 1.79 111.114 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.11 -177.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.86 110.886 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -66.5 -73.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 3.08 110.874 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.34 -75.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 3.17 110.834 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.75 -168.56 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 2.15 110.747 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -6.28 57.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 2.67 110.886 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.3 m -146.61 143.44 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 1.86 111.079 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -65.61 113.18 4.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 3.55 110.963 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.3 p -83.19 179.83 7.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 1.7 111.187 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.65 -54.27 47.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 1.48 111.042 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -49.54 76.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 1.2 110.865 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -39.74 76.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 3.18 110.865 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.97 -55.1 28.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 1.56 110.965 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.7 m -57.84 -47.43 82.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 1.75 110.853 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -44.33 96.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 1.3 110.912 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.11 -50.96 71.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 1.72 111.182 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tp -59.68 -57.31 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 1.8 110.865 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -57.52 -26.56 61.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 1.49 111.14 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.9 mt -84.3 -16.0 44.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 1.85 110.93 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.0 p -82.2 3.09 28.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 3.07 110.809 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.81 -4.85 34.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.92 112.49 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tp -83.32 171.3 13.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 1.78 110.92 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.07 169.66 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 1.74 111.146 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 51.64 44.93 28.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 2.24 110.881 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.16 139.44 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 1.69 111.149 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.18 159.98 7.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 2.79 110.879 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -77.54 145.29 37.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 2.61 110.913 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 mp -102.16 -37.53 8.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 1.53 110.917 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -156.04 176.27 12.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 3.0 110.957 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -129.39 136.87 50.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.328 -0.397 . . . . 4.84 110.929 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -123.55 136.56 27.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.62 0.724 . . . . 1.39 110.999 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 163.2 39.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.649 2.233 . . . . 0.27 112.388 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.79 124.35 40.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.174 -0.466 . . . . 1.46 110.909 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.09 161.21 25.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.64 0.734 . . . . 2.32 111.145 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -28.57 25.06 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.704 2.27 . . . . 0.51 112.32 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -85.1 -17.76 36.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.217 -0.447 . . . . 2.49 110.936 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.32 -54.0 4.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 2.82 110.998 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.58 -40.03 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 1.55 111.095 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -34.72 76.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 1.28 110.86 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -46.77 69.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 1.02 110.793 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.3 p -68.0 -30.03 46.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 1.57 111.183 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -75.66 -32.25 60.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 2.53 110.923 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -89.43 -20.29 24.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 1.61 110.901 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -94.36 -32.55 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.31 110.828 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -128.31 -54.05 1.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 1.49 110.843 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.38 12.12 2.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.807 -0.711 . . . . 0.34 112.49 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -70.9 121.53 18.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.682 0.277 . . . . 0.89 110.853 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -152.18 105.27 3.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.296 -0.411 . . . . 2.27 110.923 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.7 t -160.73 176.52 11.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 1.08 110.91 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.12 -20.8 13.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.7 110.952 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -92.02 13.13 19.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 1.57 110.938 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.54 163.89 22.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 1.51 110.921 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -173.35 129.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 1.6 110.851 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -75.39 137.62 41.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 3.01 110.882 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.3 146.41 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 1.58 111.154 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -98.9 132.05 44.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 2.54 110.926 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -126.99 149.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 1.62 111.144 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.0 t -137.06 152.64 50.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 1.72 111.094 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -144.1 137.48 7.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.73 . . . . 0.24 112.483 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -92.83 140.18 29.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 2.6 110.832 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.57 135.29 49.77 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.622 0.725 . . . . 2.28 110.855 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 127.47 14.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.724 2.283 . . . . 0.32 112.292 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.34 110.908 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.774 0.321 . . . . 4.11 110.875 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.02 -21.94 62.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 1.45 111.092 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -51.49 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 2.35 110.83 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -122.24 22.55 10.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 3.48 110.842 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.31 40.14 52.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.29 112.529 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.51 159.26 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 1.61 111.15 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.43 163.48 39.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 1.73 110.859 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.47 126.1 35.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 1.65 111.096 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.69 -0.0 20.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.72 -0.752 . . . . 0.3 112.477 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -117.55 170.64 8.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.827 0.346 . . . . 1.35 110.902 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.81 113.79 27.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 2.34 110.856 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.5 125.89 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 3.06 111.177 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.16 128.44 50.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 1.53 111.124 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.32 120.84 51.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 1.55 111.166 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.5 t -104.31 120.87 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 1.6 111.128 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.4 p-90 -120.48 168.99 10.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.23 110.898 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.76 -169.93 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 1.75 110.813 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -57.41 -35.56 70.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 4.65 110.886 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.54 -9.9 59.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 1.49 110.837 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.04 94.44 10.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.686 0.755 . . . . 0.79 110.912 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 142.03 46.72 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.683 2.255 . . . . 0.22 112.34 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.0 t -48.99 -32.57 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 1.49 111.12 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.38 -52.93 41.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 2.67 110.851 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.55 -44.96 10.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 1.5 111.048 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.45 -61.25 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 1.64 110.917 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -35.95 24.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 4.48 110.87 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.41 -47.25 44.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.786 -0.721 . . . . 0.21 112.439 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 mt -61.94 -38.61 89.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 1.61 110.928 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.5 m -78.09 -31.35 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 1.67 111.155 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.33 -58.0 9.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 1.59 110.84 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -40.05 74.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 2.72 110.909 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.4 mt -73.12 -25.07 60.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 1.55 110.891 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -78.37 -25.26 46.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.44 110.877 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.49 -30.25 17.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 1.49 111.153 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -90.75 -35.18 15.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 1.61 110.904 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.4 -46.9 4.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 1.4 111.135 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.31 -13.74 50.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.73 . . . . 0.26 112.477 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -62.58 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 2.32 110.882 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -96.01 -38.11 10.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 2.03 110.903 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.56 -132.98 6.52 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.759 -0.734 . . . . 0.27 112.461 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -149.22 152.67 36.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 2.89 110.906 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.8 t -137.68 122.81 24.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 1.4 111.1 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -112.14 157.63 20.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 1.13 110.844 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.58 135.19 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 1.66 111.132 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -142.51 151.1 41.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 2.02 110.847 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -103.26 134.59 46.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.63 110.861 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.7 mt -51.89 -36.48 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 1.56 111.15 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -32.84 69.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 2.99 110.869 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.52 20.92 16.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 3.52 110.93 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.15 -27.8 3.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 2.02 110.928 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -55.1 -32.7 62.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 2.1 110.888 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -84.86 -15.33 45.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 1.11 110.929 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.0 m -63.77 -12.61 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 1.78 110.892 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.83 63.1 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 1.47 111.083 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -64.46 -70.17 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.48 110.873 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.12 -168.2 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 2.05 110.914 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -106.35 128.12 53.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 2.01 110.846 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 48.93 77.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 1.35 110.843 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.7 p -130.12 -34.2 1.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.99 110.845 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -98.99 120.25 39.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 2.52 110.886 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.13 -20.72 62.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 1.5 110.842 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.2 mt -146.62 144.5 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 1.56 111.153 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.2 mm -134.69 131.71 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 1.58 111.118 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.94 137.06 52.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 1.44 110.976 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.47 101.64 6.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 1.4 110.873 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.63 74.66 0.27 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.804 -0.713 . . . . 0.16 112.428 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.63 56.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 1.49 110.893 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.0 159.79 60.1 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.621 0.724 . . . . 1.59 111.2 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 124.14 10.77 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.25 112.32 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.5 7.11 88.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.27 112.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.0 p -55.58 151.49 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.972 0.415 . . . . 1.15 110.829 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.7 p -140.33 108.96 5.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 1.55 111.132 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.79 153.81 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 1.58 111.126 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mt -132.25 105.78 7.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 1.45 110.916 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -82.35 152.5 26.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.25 110.845 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.0 m -131.94 176.98 7.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 1.51 110.843 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -37.27 45.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 1.25 111.079 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.25 -44.41 96.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 2.07 110.883 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -75.11 -54.85 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 1.5 111.133 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 mt -51.08 -38.92 54.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 1.49 110.906 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.84 -55.2 24.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 1.5 111.101 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.09 -44.96 79.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 2.82 110.887 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.9 mm -55.08 -67.76 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 1.58 111.132 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.07 -40.1 57.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 1.38 111.067 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -52.95 -49.06 66.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 3.84 110.883 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.7 pt -87.02 -5.3 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 1.49 111.162 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.92 117.3 21.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 1.57 110.887 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -56.81 158.69 8.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.598 0.714 . . . . 3.08 110.917 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 114.03 3.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 0.21 112.365 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.03 3.27 54.75 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.15 112.504 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.38 -162.8 17.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.784 -0.722 . . . . 0.14 112.502 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.3 m -137.01 155.5 49.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.347 . . . . 1.55 110.872 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -139.56 115.55 10.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 1.52 110.893 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -110.15 132.1 54.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 3.34 110.873 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.78 158.76 44.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 1.42 110.883 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.38 128.29 44.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 2.68 110.905 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.69 146.19 19.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 2.26 110.914 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 138.07 37.04 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.656 2.238 . . . . 0.18 112.365 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.9 m -120.71 146.55 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 1.57 111.098 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -110.59 132.58 54.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 1.93 110.851 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.2 p -105.15 25.9 10.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 1.84 111.145 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.63 25.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 1.91 111.106 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.66 159.79 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 1.86 111.123 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.66 -178.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 1.79 110.889 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -66.81 -68.27 0.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 2.6 110.873 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -60.0 -75.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 3.04 110.859 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.81 -167.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 2.61 110.863 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -7.48 58.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 2.73 110.886 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.44 141.02 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 1.68 111.106 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -63.17 115.09 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 3.6 110.895 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 33.1 p -83.19 -179.8 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 1.61 111.113 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.63 55.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 1.59 111.091 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.19 -48.9 77.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 1.45 110.887 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -37.92 75.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 3.59 110.888 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.17 -55.05 20.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 1.59 110.912 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.8 m -57.37 -45.59 84.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 1.51 110.897 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -42.42 91.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 1.54 110.852 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.89 97.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 1.64 111.075 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.8 tp -64.52 -51.44 62.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 1.49 110.916 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.5 m -62.28 -31.55 72.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 1.42 111.113 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.04 -10.27 53.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 1.8 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.5 6.51 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 2.39 110.864 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.82 6.0 32.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.49 112.465 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.69 171.63 7.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 1.63 110.942 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.4 m -150.14 171.15 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 1.57 111.144 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 51.76 44.29 29.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 1.85 110.903 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.6 t -81.09 143.03 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 1.53 111.109 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 160.22 8.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 2.58 110.902 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -77.75 146.18 36.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 2.5 110.906 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.6 -36.96 6.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 1.52 110.964 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.85 176.21 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 1.16 110.932 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -132.87 137.98 46.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 4.87 110.845 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -125.74 138.07 31.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.615 0.722 . . . . 1.82 110.888 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 165.04 32.27 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.729 2.286 . . . . 0.26 112.35 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.03 126.48 43.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 1.57 110.944 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.52 161.27 23.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.619 0.723 . . . . 2.75 111.107 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -24.57 29.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.241 . . . . 0.34 112.353 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -85.49 -22.54 28.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 2.54 110.886 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -87.51 -52.86 5.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 2.5 110.901 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -49.62 -40.34 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 1.5 111.169 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -33.49 74.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 1.38 110.921 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -46.19 67.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 1.15 110.888 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.37 -30.71 48.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 1.56 111.101 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -76.21 -31.45 58.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 2.34 110.862 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -89.7 -20.44 23.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 1.63 110.841 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.66 -32.87 13.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.29 110.849 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.19 -54.17 1.38 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 1.64 110.934 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.51 13.75 2.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.32 112.483 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -70.63 122.01 18.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 1.06 110.826 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -151.53 105.32 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 2.4 110.837 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.1 t -160.53 173.82 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 1.07 110.86 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.71 -17.59 14.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 1.56 110.858 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.76 12.52 29.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 1.53 110.911 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.61 165.18 21.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 1.56 110.952 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -173.44 130.24 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 1.53 110.973 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -74.34 133.44 42.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 3.2 110.877 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.04 145.19 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 1.49 111.156 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -98.97 129.26 45.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.93 110.957 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.54 151.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 1.44 111.102 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.1 t -134.91 161.56 34.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 1.44 111.141 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.43 139.5 7.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.21 112.476 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -97.56 140.62 31.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.368 . . . . 2.55 110.889 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -80.71 134.79 53.28 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.599 0.714 . . . . 3.46 110.877 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 119.19 6.18 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.39 112.301 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -102.3 152.0 21.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.37 110.883 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -71.51 81.44 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 8.28 110.92 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -179.26 34.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 10.14 110.865 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.0 t -149.92 -72.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 7.75 111.105 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 97.41 28.11 8.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 6.09 112.487 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.5 m -55.03 -60.78 2.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.384 . . . . 8.21 110.879 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.4 -74.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 7.0 110.896 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 12.46 110.893 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 ptp . . . . . 0 N--CA 1.458 -0.036 0 CA-C-O 120.784 0.326 . . . . 4.79 110.893 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.6 -21.07 65.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 1.45 111.098 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.1 -51.42 64.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 1.97 110.802 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -122.14 21.4 10.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 2.68 110.898 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 54.46 41.82 73.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.768 -0.73 . . . . 0.35 112.451 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.14 160.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 1.48 111.137 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.62 168.99 25.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 2.91 110.831 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.8 132.28 35.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 1.64 111.034 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.05 1.31 30.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.34 112.482 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -118.18 166.95 11.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.781 0.324 . . . . 1.29 110.933 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.67 113.05 26.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 3.8 110.899 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.3 t -117.35 132.52 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 2.85 111.136 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.03 125.29 51.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 1.3 111.057 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.6 t -98.35 120.37 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 1.55 111.144 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.31 118.45 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 1.47 111.134 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -118.6 168.85 10.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 0.22 110.912 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -151.48 -169.91 3.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.267 -0.424 . . . . 1.85 110.857 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -57.63 -35.49 70.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 3.65 110.882 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.61 -9.51 58.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 1.48 110.848 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.92 94.62 10.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.748 0.785 . . . . 0.76 110.923 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 142.11 47.33 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.657 2.238 . . . . 0.25 112.34 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.13 -32.57 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 1.65 111.108 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.28 -52.92 40.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 2.59 110.907 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.9 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 1.47 111.155 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.6 -61.41 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 1.46 110.918 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -49.6 -36.01 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 3.33 110.901 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.21 -47.22 45.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 0.22 112.47 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.96 -38.57 89.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.755 0.312 . . . . 1.61 110.87 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.0 m -78.21 -31.09 16.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 1.67 111.079 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -62.54 -57.86 9.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 1.69 110.852 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -40.01 75.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 2.71 110.94 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.1 mt -73.17 -24.77 60.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 1.76 110.89 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.5 -25.03 45.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.45 110.825 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.74 -30.36 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 1.3 111.026 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.81 -34.93 15.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 1.7 110.905 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 -46.06 4.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 1.53 111.139 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.83 -12.62 54.42 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.828 -0.701 . . . . 0.25 112.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.61 -62.6 1.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.754 0.311 . . . . 2.37 110.938 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -96.33 -37.85 10.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 2.56 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.13 -129.87 5.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 0.26 112.497 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -152.59 152.03 31.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.88 0.371 . . . . 2.89 110.885 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.0 t -136.33 124.83 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 1.61 111.036 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -114.07 155.83 25.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 1.47 110.9 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.52 134.8 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 1.58 111.141 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -142.76 151.3 41.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 1.26 110.864 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -103.3 134.99 45.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.63 110.906 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.4 mt -52.17 -36.12 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 1.4 111.128 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -71.54 -32.25 67.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 2.66 110.877 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -103.18 20.11 18.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 3.61 110.856 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.32 -28.08 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 2.08 110.899 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.53 -33.46 63.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 2.13 110.9 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -84.06 -15.15 48.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 1.06 110.969 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.5 m -66.55 -10.13 41.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 1.72 110.859 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.5 63.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 1.55 111.059 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -64.02 -67.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.46 110.873 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.85 -178.22 6.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 3.0 110.849 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -92.63 130.52 38.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 1.83 110.885 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 t 51.79 83.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 2.21 110.879 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.4 p -136.06 -39.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 1.04 110.773 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -100.51 122.25 42.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 3.58 110.975 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.73 -21.9 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 1.73 110.853 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 21.4 mt -145.34 144.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 1.54 111.087 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.2 mm -133.75 132.7 56.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 1.58 111.104 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -114.58 136.88 52.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 1.54 110.916 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.44 100.33 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 1.24 110.854 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.54 74.97 0.24 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.16 112.446 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.45 58.19 0.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.866 0.365 . . . . 1.58 110.928 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.0 159.65 63.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.611 0.719 . . . . 1.63 111.146 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 116.73 4.7 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.601 2.201 . . . . 0.26 112.355 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.46 7.13 69.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.841 -0.695 . . . . 0.19 112.465 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.55 150.24 12.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.939 0.4 . . . . 1.22 110.87 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.5 p -138.98 108.45 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 1.51 111.127 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.14 153.44 18.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 1.49 111.239 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 mt -132.77 104.57 6.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 1.53 110.856 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -81.16 153.74 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.26 110.885 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.1 m -131.56 -176.29 3.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 1.36 110.925 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.8 -36.93 70.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 1.49 111.106 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.59 -46.48 88.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 2.32 110.874 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.04 -54.96 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 1.61 111.079 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.2 mt -50.72 -40.18 53.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 1.49 110.96 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.02 -53.94 35.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.053 -0.521 . . . . 1.48 111.15 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.23 -44.8 88.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 3.01 110.868 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.7 mm -55.67 -68.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 1.54 111.099 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.33 -37.82 49.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 1.54 111.187 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -55.11 -49.83 70.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 4.46 110.898 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.3 pt -85.21 -7.02 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 1.68 111.108 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.95 111.78 14.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.142 -0.481 . . . . 1.58 110.9 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.8 mtt180 -51.46 159.53 1.17 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.59 0.71 . . . . 2.96 110.852 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 114.44 3.7 Favored 'Trans proline' 0 N--CA 1.466 -0.113 0 C-N-CA 122.786 2.324 . . . . 0.17 112.342 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.77 2.41 56.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.662 -0.78 . . . . 0.15 112.416 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.28 -162.57 13.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.647 -0.787 . . . . 0.13 112.551 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.2 m -138.32 156.03 48.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.832 0.349 . . . . 1.43 110.9 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -140.01 114.31 9.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 1.44 110.974 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -108.46 132.34 53.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 2.91 110.897 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.51 162.31 39.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 1.52 110.845 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.05 129.35 35.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 2.67 110.842 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.72 148.65 20.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.655 0.74 . . . . 3.71 110.854 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 140.88 43.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.61 2.206 . . . . 0.18 112.309 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.9 m -125.86 146.67 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 1.58 111.099 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -108.89 132.75 53.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 2.06 110.953 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p -90.94 -42.68 10.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 2.1 111.091 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.5 40.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 1.68 111.111 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.4 t -148.03 150.05 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 1.63 111.069 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.86 171.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.69 110.854 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -66.37 -54.17 27.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 3.07 110.96 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -70.66 -75.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 2.61 110.837 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t 52.31 -169.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.034 0.445 . . . . 3.15 110.841 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -81.71 -4.69 56.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 2.63 110.877 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.12 150.4 21.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 1.61 111.043 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.18 119.2 13.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 4.09 110.844 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 62.8 p -91.81 178.86 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.52 111.201 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.4 -53.61 55.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 1.6 111.127 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -61.06 -47.16 87.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 1.4 110.819 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -42.25 91.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 3.84 110.889 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.82 -57.43 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 1.92 110.886 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 66.6 m -52.05 -44.97 64.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 1.62 110.888 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -42.06 87.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 1.47 110.824 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.11 97.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 1.47 111.095 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.2 -50.93 62.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 1.52 110.987 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.0 m -61.99 -33.31 74.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 1.35 111.138 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.87 -10.45 53.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 1.77 110.897 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.72 5.25 29.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 2.39 110.872 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.81 11.23 25.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.647 -0.787 . . . . 0.68 112.38 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.13 171.0 7.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 1.57 110.883 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.2 m -150.9 170.19 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 1.51 111.168 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 53.01 44.41 30.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 2.32 110.92 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.4 t -81.04 142.94 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 1.61 111.174 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.93 158.58 7.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 2.6 110.866 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -77.23 145.68 37.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 2.28 110.784 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.15 -35.55 7.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 1.62 110.975 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.1 176.42 12.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 1.15 110.879 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.86 137.4 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 4.74 110.907 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -124.02 137.65 29.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 1.83 110.874 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 165.02 32.34 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.693 2.262 . . . . 0.23 112.353 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.15 127.47 44.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 1.51 110.914 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.21 161.1 24.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 2.22 111.145 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -28.79 24.83 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.625 2.217 . . . . 0.38 112.307 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -85.24 -17.86 35.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 2.77 110.924 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.23 -53.25 4.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 2.33 110.909 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.22 -40.65 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 1.61 111.123 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -34.86 76.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 1.21 110.926 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.86 -46.18 72.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 1.35 110.904 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.38 -30.19 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.077 -0.51 . . . . 1.53 111.2 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -75.64 -32.59 60.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 2.31 110.834 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -89.54 -20.18 24.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 1.72 110.877 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -94.11 -32.81 13.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.32 110.887 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -127.98 -54.25 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 1.6 110.85 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.65 8.02 2.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.37 112.459 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -70.2 121.26 17.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 0.95 110.822 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -152.32 104.72 2.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 3.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 t -161.03 172.13 17.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.06 110.879 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.28 -11.57 15.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 1.57 110.864 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -99.92 14.29 30.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 1.94 110.923 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.39 165.86 15.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 1.63 110.866 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -171.46 130.06 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 1.57 111.023 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -72.7 132.31 43.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 3.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.17 143.89 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 1.57 111.148 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -98.69 133.08 43.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 1.97 110.848 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.73 148.14 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 1.81 111.205 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.1 t -132.62 156.06 47.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 1.76 111.122 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -145.58 139.11 8.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.19 112.465 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -96.74 132.7 42.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.36 . . . . 4.66 110.926 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 135.3 77.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.597 0.713 . . . . 2.17 110.887 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 128.22 15.6 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.631 2.221 . . . . 0.31 112.32 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -108.83 150.56 27.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.3 110.887 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.3 t80 65.01 151.8 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 7.26 110.869 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -73.61 109.62 7.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 9.8 110.868 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.1 m -116.81 -27.03 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 5.37 111.123 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.82 38.11 63.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 5.88 112.464 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.3 p -130.4 175.94 8.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 6.19 110.883 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.5 m 72.15 -69.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 7.12 110.803 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 7.31 110.863 -179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttm . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.765 0.317 . . . . 9.57 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.94 -13.69 60.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 1.79 111.158 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -51.38 65.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 3.23 110.926 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -93.72 -14.98 25.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 3.59 110.869 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.5 48.59 10.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.725 -0.75 . . . . 0.74 112.45 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.2 mp -88.32 162.01 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.37 . . . . 1.83 111.136 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.34 170.01 20.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 1.83 110.811 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.67 133.36 34.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 1.63 111.109 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.21 -6.07 30.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.781 -0.723 . . . . 0.34 112.536 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -111.88 168.96 9.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 1.4 110.899 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.04 114.32 28.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 2.25 110.872 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.2 t -119.3 126.97 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 3.05 111.149 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.0 128.22 51.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 1.67 111.153 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.7 t -100.38 119.23 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 1.56 111.159 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.84 118.14 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 1.59 111.171 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -118.19 169.03 10.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.35 110.952 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -151.67 -170.47 3.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 1.83 110.875 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -35.56 69.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 7.25 110.901 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.61 -9.36 58.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.62 110.87 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.93 94.43 10.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.613 0.72 . . . . 0.8 110.823 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 142.37 47.55 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.678 2.252 . . . . 0.32 112.45 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -49.07 -32.68 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 1.71 111.042 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -51.09 -52.93 38.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 2.51 110.878 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.62 -44.93 10.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 1.53 111.067 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.76 -61.3 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 1.52 110.929 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.55 -37.07 25.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 3.51 110.878 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -47.29 50.35 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.736 -0.745 . . . . 0.29 112.437 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.5 mt -61.75 -38.84 89.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 1.62 110.934 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.8 m -78.13 -30.77 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 1.77 111.11 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.52 -58.27 8.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 1.58 110.875 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -39.57 74.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 2.69 110.884 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.36 -25.37 60.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 1.38 110.872 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -77.63 -24.81 49.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 0.48 110.964 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.66 -29.7 16.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 1.78 111.179 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.49 -31.05 16.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 1.58 110.912 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.84 -45.47 4.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 1.46 111.15 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.44 -12.42 51.47 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.722 -0.751 . . . . 0.31 112.529 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.79 -62.71 1.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.329 . . . . 2.47 110.822 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -99.57 -36.5 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 2.65 110.861 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.22 -129.46 4.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.741 . . . . 0.26 112.448 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -154.9 152.01 29.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.357 . . . . 2.96 110.882 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.9 t -136.0 122.97 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 1.42 111.165 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.6 t -113.09 154.03 27.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 1.06 110.829 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -117.14 134.28 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 1.43 111.208 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -142.04 151.24 42.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 1.26 110.882 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -103.25 134.95 45.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.67 110.862 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.5 mt -52.29 -36.54 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 1.67 111.092 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -70.79 -32.44 69.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 2.67 110.924 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.75 20.71 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 3.64 110.855 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.09 -27.84 3.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 2.0 110.899 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -55.01 -33.09 62.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 1.81 110.937 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -84.81 -15.53 44.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 1.16 110.937 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.0 m -63.69 -12.73 36.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 1.79 110.899 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.13 61.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.51 111.082 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -63.03 -69.54 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.48 110.869 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.02 -168.75 2.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 2.16 110.957 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -107.37 131.02 54.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 1.73 110.923 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.25 73.5 0.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 1.4 110.829 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.2 p -127.76 -34.46 2.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.95 110.836 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -99.29 118.34 35.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 2.52 110.849 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.78 -20.89 63.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.04 -0.527 . . . . 1.75 110.939 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 25.3 mt -146.98 144.88 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 1.6 111.116 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mm -135.09 131.58 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 1.55 111.104 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.68 137.34 51.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 1.53 110.883 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.61 100.55 5.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 1.17 110.844 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.61 74.28 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 0.18 112.514 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.03 59.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.348 . . . . 1.65 110.879 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.84 159.77 66.7 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.542 0.687 . . . . 1.42 111.124 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 116.31 4.49 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.657 2.238 . . . . 0.26 112.426 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.58 6.42 68.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.22 112.493 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -56.03 150.55 13.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 1.04 110.896 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.2 p -140.24 108.59 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 1.42 111.148 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.15 147.67 12.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 1.64 111.049 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 mt -126.23 99.9 6.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 1.65 110.874 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -76.71 149.01 36.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.24 110.948 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.9 m -128.25 177.33 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.99 110.885 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.17 -37.77 48.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 1.67 111.101 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.82 -44.53 96.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.448 . . . . 2.08 110.882 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -74.94 -55.25 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 1.61 111.175 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.0 mt -50.71 -38.64 48.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 1.6 110.876 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.19 -56.54 15.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 1.68 111.122 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.03 -42.39 72.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 2.76 110.862 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mm -57.66 -68.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 1.55 111.097 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.71 -36.21 35.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 1.47 111.051 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -56.84 -52.3 65.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 3.76 110.881 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.6 pt -82.29 -6.5 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 1.77 111.081 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.8 127.97 32.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 1.57 110.93 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -66.82 159.76 73.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.582 0.705 . . . . 3.03 110.835 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 114.33 3.67 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.21 112.328 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.8 2.75 56.2 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.772 -0.728 . . . . 0.24 112.531 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.76 -161.36 10.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.805 -0.712 . . . . 0.16 112.484 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 15.7 m -139.08 153.7 48.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 2.03 110.954 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -138.06 114.47 10.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 1.59 110.883 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -108.79 133.47 52.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 2.89 110.956 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.51 159.12 44.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.445 . . . . 1.59 110.919 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 125.15 38.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 2.76 110.886 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.97 147.44 24.02 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.649 0.738 . . . . 2.48 110.897 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 145.23 56.25 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.654 2.236 . . . . 0.21 112.332 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.8 m -131.41 146.67 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 1.62 111.154 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -104.88 132.97 50.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 2.09 110.899 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 p -105.71 26.01 10.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 1.79 111.083 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.29 26.51 0.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 1.78 111.098 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.19 159.48 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 1.87 111.152 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.24 -179.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 1.97 110.837 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -66.09 -67.93 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 2.92 110.897 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -60.99 -75.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 3.59 110.913 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 54.63 -166.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 2.33 110.855 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -79.9 -7.97 59.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 2.94 110.872 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.0 m -145.16 150.13 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 1.85 111.079 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -68.29 113.29 5.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.135 -0.484 . . . . 3.48 110.874 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.2 p -84.42 179.69 7.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 1.77 111.108 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.49 -53.34 59.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 1.62 111.136 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.74 -49.18 78.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 1.16 110.922 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -58.37 -40.91 83.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 3.59 110.909 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.97 -54.83 36.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 1.66 110.84 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 70.8 m -55.45 -47.79 75.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 2.11 110.89 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 1.24 110.809 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.99 98.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 1.54 111.076 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.9 tp -65.8 -50.23 65.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 1.63 110.922 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.1 m -65.52 -30.73 71.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.108 -0.496 . . . . 1.26 111.204 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.5 mt -86.99 -10.47 53.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 1.78 110.942 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.19 5.52 29.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 2.46 110.847 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.04 5.19 35.47 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.747 -0.74 . . . . 0.56 112.468 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.45 172.48 6.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 1.57 110.88 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.2 m -151.14 171.38 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 1.62 111.078 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 55.16 43.53 29.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 2.04 110.924 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.9 t -77.7 140.91 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 1.59 111.124 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.16 159.79 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 2.6 110.899 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.08 147.44 30.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 2.18 110.939 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mp -107.45 -36.43 6.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 1.52 110.957 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 176.24 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 1.15 110.9 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -132.35 137.27 47.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 4.98 110.942 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -124.38 138.72 31.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.635 0.731 . . . . 1.39 110.902 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 163.43 38.39 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.653 2.235 . . . . 0.3 112.299 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.65 127.09 41.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 1.48 110.95 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.53 160.53 27.2 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.554 0.693 . . . . 2.23 111.105 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -29.2 24.53 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.68 2.253 . . . . 0.51 112.316 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -84.97 -19.06 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 2.98 110.876 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -53.58 5.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 2.17 110.905 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.5 -41.93 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 1.54 111.158 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -33.86 72.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 1.37 110.872 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.94 -44.93 68.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 1.34 110.796 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.97 -31.59 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 1.53 111.188 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -76.65 -30.9 57.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.076 -0.511 . . . . 2.94 110.929 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -89.73 -20.62 23.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.221 -0.445 . . . . 1.78 110.919 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -95.01 -32.51 13.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.51 110.857 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mp -127.18 -54.06 1.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 1.68 110.891 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.37 10.51 2.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.71 -0.757 . . . . 0.48 112.472 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -70.08 120.42 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.711 0.291 . . . . 1.63 110.869 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.44 112.3 4.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 3.02 110.897 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.66 172.17 17.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 1.63 110.865 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.56 -9.35 16.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 2.18 110.86 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -110.63 13.35 22.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 1.85 110.925 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.57 164.86 25.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 1.63 110.912 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -173.92 130.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 1.46 110.901 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -74.29 131.77 41.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 3.19 110.879 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.94 140.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 1.54 111.114 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -93.65 128.5 39.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 2.6 110.895 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.01 151.73 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.58 111.239 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.6 t -131.4 159.32 38.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.252 -0.431 . . . . 1.48 111.168 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.33 129.9 3.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.774 -0.727 . . . . 0.3 112.527 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -89.52 139.28 30.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 2.4 110.925 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.24 135.27 50.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.587 0.708 . . . . 2.75 110.906 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 129.65 18.03 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.731 2.287 . . . . 0.43 112.361 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -109.8 149.32 29.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.298 -0.41 . . . . 0.49 110.922 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 30.1 t80 64.97 151.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 6.83 110.876 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.86 173.83 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 10.21 110.856 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.6 m -151.98 -41.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.525 . . . . 6.43 111.121 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 129.04 -45.98 1.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.803 -0.713 . . . . 7.46 112.518 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.15 -73.81 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.376 . . . . 8.91 110.81 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.7 m 56.54 -176.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 6.34 110.843 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.9 tmm_? . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 7.53 110.889 -179.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.759 0.314 . . . . 4.28 110.87 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.97 -20.79 65.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 1.65 111.095 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -54.04 -51.2 64.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 2.2 110.953 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -122.33 21.64 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 2.67 110.89 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.82 39.98 56.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.78 -0.724 . . . . 0.26 112.507 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.97 159.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.857 0.36 . . . . 1.42 111.164 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.55 162.21 41.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 2.57 110.934 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.4 126.34 35.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 1.61 111.135 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.06 -2.59 19.24 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.735 -0.745 . . . . 0.27 112.433 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -115.49 170.49 8.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.842 0.353 . . . . 1.37 110.9 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.87 114.14 28.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 3.86 110.929 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.4 t -119.28 125.38 74.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.117 -0.492 . . . . 2.9 111.154 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.79 129.96 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 1.37 111.125 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.3 t -101.3 119.92 50.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 1.55 111.146 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.24 118.35 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 1.51 111.074 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -118.5 169.24 9.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.498 . . . . 0.22 110.898 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -151.49 -170.72 3.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.483 . . . . 1.78 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -57.06 -35.67 69.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 3.95 110.9 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -73.28 -9.59 58.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 1.54 110.848 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.02 94.44 10.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.647 0.737 . . . . 0.88 110.855 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 142.23 47.11 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.662 2.242 . . . . 0.23 112.359 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -48.83 -32.75 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 1.63 111.122 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.13 -53.04 37.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 2.69 110.893 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -44.89 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 1.58 111.055 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.6 -61.46 2.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 1.44 110.976 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -36.96 24.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 3.67 110.867 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.72 -47.14 50.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 0.21 112.523 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.83 -39.29 91.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.768 0.318 . . . . 1.56 110.872 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.5 m -77.69 -31.19 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 1.73 111.075 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.29 -58.56 7.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 1.55 110.845 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -39.94 74.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 2.65 110.945 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.07 -24.67 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 1.34 110.996 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -78.55 -25.18 45.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.947 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 -29.9 17.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 1.5 111.163 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.42 -35.21 14.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 1.49 110.853 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.9 -45.86 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 1.44 111.091 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.47 -12.87 53.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.27 112.456 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.17 -62.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 3.37 110.897 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -90.08 -40.85 12.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.96 110.921 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.43 -130.04 6.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.741 -0.742 . . . . 0.25 112.553 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -150.23 152.87 35.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.887 0.375 . . . . 2.92 110.928 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.4 125.44 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 1.5 111.146 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -114.53 156.89 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 1.15 110.814 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -118.53 135.04 60.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 1.53 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -143.14 151.31 40.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 2.01 110.868 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -103.22 134.9 45.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.193 -0.458 . . . . 0.62 110.854 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 29.1 mt -52.4 -36.51 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 1.41 111.108 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -70.87 -32.13 69.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 2.73 110.868 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.87 20.62 17.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 3.54 110.92 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.09 -27.94 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 2.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.26 -33.37 63.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 1.95 110.938 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -84.62 -15.14 46.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 1.18 110.935 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.5 m -64.64 -11.61 37.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 1.75 110.796 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.33 61.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 1.5 111.023 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -62.8 -69.74 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.51 110.865 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.97 -168.64 2.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 2.09 111.045 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.13 130.55 54.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.335 -0.393 . . . . 1.81 110.944 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.38 73.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 1.35 110.853 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.8 p -127.93 -34.59 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.93 110.832 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -98.85 117.9 34.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 2.53 110.921 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.41 -20.36 63.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 1.48 110.887 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.1 mt -148.05 144.91 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 1.65 111.142 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.6 mm -135.28 130.1 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 1.55 111.113 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.46 137.29 48.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 1.52 110.897 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.56 100.63 5.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 1.17 110.84 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.74 76.0 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.15 112.458 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.35 58.21 0.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 1.57 110.902 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.54 160.11 62.25 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 121.618 0.723 . . . . 1.5 111.18 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 116.64 4.66 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.672 2.248 . . . . 0.26 112.361 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.1 7.39 70.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.18 112.537 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.49 149.75 13.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.408 . . . . 1.41 110.839 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.1 p -138.73 108.58 6.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 1.52 111.117 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.96 146.52 10.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 1.5 111.102 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mt -125.36 103.37 7.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 1.48 110.843 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -79.75 151.49 30.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.24 110.809 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -130.59 177.14 7.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 1.36 110.885 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.99 51.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 1.58 111.166 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -61.48 -45.68 93.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 1.75 110.885 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -73.63 -55.41 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 1.66 111.07 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.0 mt -50.63 -38.68 47.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 1.66 110.875 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.8 -55.13 29.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 1.46 111.056 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -42.34 77.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 2.76 110.935 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.9 mm -58.62 -68.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 1.63 111.054 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.74 -36.06 24.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 1.32 111.028 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -54.58 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 3.44 110.861 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 pt -79.39 -5.89 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 1.48 111.192 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -81.73 127.99 33.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 1.84 110.847 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -65.7 158.77 72.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.669 0.747 . . . . 3.07 110.867 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 114.1 3.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.246 . . . . 0.22 112.34 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.28 2.72 54.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.737 . . . . 0.17 112.476 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.63 -163.48 16.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.15 112.505 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 67.6 m -135.75 153.48 51.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 1.57 110.833 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -137.56 114.36 10.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 1.54 110.88 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -108.82 133.34 53.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 3.34 110.949 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.86 164.11 35.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 1.41 110.959 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.74 130.46 36.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 2.78 110.915 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.95 147.75 18.68 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.588 0.709 . . . . 2.34 110.896 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 141.58 45.39 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.594 2.196 . . . . 0.18 112.361 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.78 146.66 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 1.57 111.135 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -109.7 132.64 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 2.07 110.827 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.4 p -91.62 -42.23 10.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 2.05 111.061 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.77 39.94 1.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.259 -0.428 . . . . 1.71 111.096 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.7 t -147.59 150.4 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.187 -0.461 . . . . 1.65 111.099 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.94 170.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 1.77 110.836 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -64.35 -57.39 9.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 3.21 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.99 -75.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 2.51 110.87 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t 52.38 -168.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 2.83 110.906 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.37 -6.8 58.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 3.12 110.865 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 m -140.09 142.63 31.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 1.69 111.248 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -65.35 111.05 2.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.21 -0.45 . . . . 3.36 110.907 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.5 p -82.13 -177.72 6.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 1.63 111.161 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.13 -52.32 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 1.37 111.132 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.32 -49.77 75.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.91 110.877 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -56.87 -38.86 73.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 2.35 110.838 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.89 -54.56 28.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 1.53 110.927 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.2 m -58.13 -46.24 85.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 2.01 110.925 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -43.0 94.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.498 . . . . 1.22 110.919 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.51 98.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 1.48 111.107 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.5 tp -65.13 -51.65 59.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.216 -0.447 . . . . 1.58 110.909 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.1 m -63.92 -31.16 72.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 1.45 111.084 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.3 mt -86.79 -10.48 53.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 2.05 110.893 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.12 5.69 28.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 2.35 110.88 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.13 5.12 35.33 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.806 -0.712 . . . . 0.48 112.523 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tp -105.57 173.11 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 1.64 110.956 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.7 m -151.51 173.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 1.57 111.205 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 51.6 45.15 28.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 1.99 110.874 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.3 t -80.75 143.06 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 1.65 111.142 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.92 160.49 8.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 3.64 110.915 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -80.26 146.43 31.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 2.25 110.916 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mp -104.23 -37.1 7.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 1.67 110.936 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.0 pm0 -159.07 176.25 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 2.95 110.888 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -130.44 137.21 49.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 5.03 110.82 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -123.77 135.02 25.74 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.726 0.774 . . . . 1.8 110.9 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 159.14 54.45 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.721 2.281 . . . . 0.31 112.351 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.97 151.65 20.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 1.47 110.948 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.65 162.91 54.78 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.498 0.666 . . . . 2.7 111.186 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -23.72 30.17 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.669 2.246 . . . . 0.67 112.293 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -86.26 -23.82 26.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 2.47 110.809 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -87.82 -52.72 5.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 3.95 110.927 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.4 -39.52 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 1.66 111.128 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -32.64 73.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 1.31 110.97 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.49 -46.74 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 1.41 110.856 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.19 -29.75 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 1.42 111.091 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -76.45 -33.3 58.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 4.09 110.885 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -88.88 -19.98 25.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 1.84 110.822 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -94.69 -32.26 13.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.37 110.924 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.31 -54.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 1.53 110.869 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.77 8.1 2.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.658 -0.782 . . . . 0.35 112.518 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -69.94 121.62 17.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.709 0.29 . . . . 0.85 110.87 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -151.93 104.99 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 3.37 110.906 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.6 t -160.8 171.02 19.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 1.14 110.868 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.22 -11.85 15.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 1.94 110.877 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -99.57 14.39 30.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 1.86 110.894 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.51 168.92 12.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 1.69 110.824 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -172.16 130.36 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 1.56 110.894 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -74.31 132.81 42.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 3.21 110.897 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.26 147.96 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 1.62 111.077 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -101.67 135.6 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 2.8 110.938 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.41 149.18 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 1.48 111.148 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.2 t -129.55 159.47 36.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 1.47 111.196 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.93 134.3 4.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.731 -0.747 . . . . 0.18 112.483 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -94.44 140.77 29.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 2.39 110.942 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -81.49 134.79 50.68 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.606 0.717 . . . . 3.03 110.886 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 119.76 6.65 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.714 2.276 . . . . 0.35 112.319 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -103.34 151.91 22.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.32 110.866 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.4 t80 64.63 112.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 7.45 110.887 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 62.08 89.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 9.17 110.926 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 25.0 m -59.9 140.85 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 10.6 111.116 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -141.78 38.22 1.52 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.789 -0.719 . . . . 8.0 112.554 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.8 p -85.74 82.81 8.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 12.92 110.862 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.8 m -56.71 -68.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 8.87 110.833 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 12.56 110.905 -179.895 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mmm . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.747 0.308 . . . . 9.02 110.933 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.37 -16.09 55.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 1.84 111.044 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -55.05 -51.92 64.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 2.55 110.804 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -109.48 23.26 14.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 2.81 110.94 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.04 41.96 53.72 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 0.49 112.485 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -81.31 158.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 1.58 111.129 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.2 m -146.18 156.35 43.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 1.76 110.863 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.32 127.41 34.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 1.68 111.143 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.81 -7.48 21.94 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.74 -0.743 . . . . 0.29 112.513 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.17 170.39 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 1.72 110.942 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.92 110.7 22.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 2.33 110.836 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.2 129.6 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 3.01 111.168 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.59 130.35 52.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 1.73 111.101 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.79 117.78 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 1.54 111.158 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 t -101.54 113.63 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 1.48 111.21 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -114.51 167.64 10.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 0.21 110.919 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -151.53 -169.59 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 1.79 110.812 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -35.87 69.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 7.65 110.876 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -11.26 60.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 1.43 110.889 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.67 92.87 9.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.609 0.718 . . . . 0.81 110.871 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.72 143.53 51.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.3 112.336 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -48.76 -32.55 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 1.47 111.125 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.02 -53.57 32.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 2.48 110.895 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.79 -44.75 10.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 1.52 111.116 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.2 -61.32 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 1.48 110.916 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -49.79 -38.35 34.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 3.62 110.813 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.61 -47.58 55.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.8 -0.714 . . . . 0.25 112.428 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.46 -40.26 93.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.366 . . . . 1.77 110.897 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.1 m -76.72 -31.04 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 1.74 111.209 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.03 -60.07 4.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.183 -0.462 . . . . 1.57 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -40.79 71.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 2.99 110.958 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.8 mt -72.27 -25.2 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 2.04 110.887 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.09 -24.18 47.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.45 110.885 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.72 -30.03 17.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 1.37 111.115 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.59 -35.34 14.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 1.47 110.882 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.88 -45.28 5.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 1.44 111.178 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.78 -12.72 49.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.679 -0.772 . . . . 0.3 112.537 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -67.04 -62.74 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.786 0.327 . . . . 2.6 110.883 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -94.66 -39.32 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 2.07 110.958 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.51 -135.2 7.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.801 . . . . 0.38 112.504 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -147.74 151.44 36.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 2.95 110.794 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.9 t -135.94 117.82 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 1.66 111.114 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 t -106.93 157.19 17.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 1.28 110.85 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.22 133.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 1.75 111.142 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -143.69 151.79 40.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 1.27 110.892 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.6 135.21 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.63 110.825 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 45.3 mt -52.37 -35.87 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 1.71 111.103 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -31.81 66.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 3.0 110.853 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -105.22 20.32 19.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 3.6 110.896 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.78 -26.14 9.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 4.01 110.94 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 mp -53.68 -32.91 53.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 2.12 110.945 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -84.97 -15.76 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 1.12 110.906 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.4 m -64.46 -12.21 41.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 1.86 110.888 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.93 61.34 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.494 . . . . 1.71 111.184 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -59.48 -71.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.63 110.796 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.27 -168.23 2.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 2.68 110.956 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -102.27 116.58 32.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 2.22 110.869 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 t 60.16 84.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 1.97 110.839 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.0 p -134.84 -37.24 0.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.96 110.836 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -96.84 121.98 39.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.059 -0.519 . . . . 3.57 110.78 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.21 -19.7 60.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 1.51 110.845 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.26 143.95 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 1.64 111.112 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.1 mm -136.51 127.69 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 1.53 111.036 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -109.77 137.87 46.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 1.55 110.95 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.8 100.04 5.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 1.21 110.866 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.87 74.63 0.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.18 112.518 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.29 58.18 0.68 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 1.57 110.902 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.92 160.01 61.44 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.659 0.742 . . . . 1.43 111.108 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.74 123.88 10.54 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.726 2.284 . . . . 0.31 112.33 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.46 7.11 88.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.667 -0.778 . . . . 0.23 112.535 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.2 p -55.9 151.58 11.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.958 0.409 . . . . 1.01 110.843 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.3 p -140.58 109.04 5.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 1.49 111.101 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.12 143.19 12.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 1.48 111.183 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.8 mt -119.98 102.37 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 1.53 110.93 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -79.1 144.22 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.29 110.844 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 m -124.38 174.92 7.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 1.01 110.908 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.94 -40.34 57.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 1.7 111.128 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.99 -45.78 91.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 1.96 110.898 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -72.07 -55.38 13.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 1.64 111.132 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.9 mt -50.67 -38.54 47.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.52 . . . . 1.61 110.946 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.9 -56.13 13.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 1.55 111.021 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -54.56 -44.94 73.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.39 . . . . 2.84 110.855 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.9 mm -56.08 -68.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 1.54 111.098 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.54 -39.65 49.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 1.4 111.134 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -52.56 -49.63 64.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 4.13 110.829 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.0 pt -88.18 -4.05 9.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 1.76 111.102 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.04 112.44 19.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 1.6 110.941 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -52.45 157.68 2.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.645 0.736 . . . . 4.1 110.816 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 113.98 3.55 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.725 2.283 . . . . 0.44 112.326 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.41 2.72 50.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.811 -0.709 . . . . 0.23 112.563 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.78 -165.13 21.61 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.664 -0.779 . . . . 0.18 112.418 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 90.9 m -133.22 151.91 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 1.41 110.893 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -136.58 115.22 12.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 1.61 110.934 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -110.33 132.05 54.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 3.35 110.877 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.66 163.17 38.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 1.45 110.891 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.91 126.89 29.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 2.73 110.784 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.65 149.27 30.57 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.65 0.738 . . . . 2.55 110.892 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 139.38 40.28 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.66 2.24 . . . . 0.29 112.329 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.8 m -121.62 146.7 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 1.72 111.143 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -117.82 132.0 56.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 1.86 110.887 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.0 p -91.93 -37.43 12.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 1.83 111.099 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.59 37.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 1.76 111.191 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 31.8 t -147.79 149.55 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 1.93 111.141 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.86 178.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.85 110.929 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -66.55 -70.44 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 2.83 110.896 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -75.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 3.07 110.922 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.47 -169.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 2.31 110.78 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.0 -2.97 50.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 3.12 110.893 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 m -145.26 144.49 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 1.64 111.102 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.32 113.15 4.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 3.11 110.877 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 60.3 p -84.33 177.45 8.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 1.61 111.204 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.33 -54.7 36.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 1.53 111.102 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -59.97 -50.24 74.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.93 110.85 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -38.8 71.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.148 -0.478 . . . . 2.89 110.893 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.51 -54.27 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 1.68 110.963 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.7 m -59.24 -46.78 87.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 1.55 110.851 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -44.03 95.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 1.3 110.874 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.27 98.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 1.58 111.195 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.9 tp -65.38 -50.76 64.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 1.7 110.913 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.2 m -63.51 -31.5 72.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 1.46 111.16 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.6 mt -87.0 -10.48 53.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 1.75 110.913 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.58 4.66 31.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.306 -0.406 . . . . 2.38 110.835 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.1 6.7 33.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.49 112.496 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.92 172.21 6.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.79 0.328 . . . . 1.55 110.985 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.5 m -151.71 174.27 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 1.75 111.103 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 52.68 43.9 30.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 2.15 110.88 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.0 143.29 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 1.58 111.097 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.06 160.19 8.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 2.59 110.85 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -82.34 139.55 34.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 2.98 110.87 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.5 mp -96.6 -37.92 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 1.53 110.899 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.05 176.3 12.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 1.11 110.941 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 141.27 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 4.74 110.89 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -129.18 136.82 29.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.599 0.714 . . . . 1.41 110.828 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 165.16 31.82 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.667 2.245 . . . . 0.26 112.357 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.7 126.13 42.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 1.8 110.936 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.62 160.88 24.72 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.615 0.721 . . . . 2.83 111.08 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -24.63 29.31 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.38 112.36 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -85.52 -22.09 28.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 2.49 110.893 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -87.53 -53.58 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 2.43 110.916 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -49.8 -40.36 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 1.69 111.142 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.05 -33.42 74.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 1.37 110.904 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.42 -46.44 66.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.93 110.845 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.51 -30.02 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 1.62 111.207 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -76.77 -31.57 57.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 3.23 110.9 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -89.57 -20.83 23.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.73 110.799 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.97 -32.0 13.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.44 110.927 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 mp -127.29 -54.68 1.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 1.72 110.845 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.53 13.55 2.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.749 -0.739 . . . . 0.48 112.527 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -70.65 121.51 18.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 1.16 110.807 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -151.74 105.87 3.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 2.85 110.872 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.9 t -160.51 170.47 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 1.23 110.852 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.61 -11.34 16.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 1.86 110.87 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -103.59 20.6 17.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 1.93 110.908 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.45 162.98 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 1.68 110.841 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -169.88 130.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 1.69 110.965 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -75.85 135.57 40.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 3.09 110.956 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.0 144.27 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 1.64 111.128 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -97.67 128.81 44.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 1.98 110.949 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.39 148.95 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 1.67 111.144 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.1 t -127.35 159.62 33.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 1.49 111.097 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.43 132.13 3.83 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.701 -0.761 . . . . 0.21 112.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -94.65 140.35 29.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.814 0.34 . . . . 2.27 110.938 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -80.32 135.41 53.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.638 0.732 . . . . 2.93 110.929 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 120.01 6.87 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.724 2.283 . . . . 0.4 112.361 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -106.15 151.6 24.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.47 110.869 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 17.9 t80 59.92 20.28 9.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 7.65 110.97 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.87 -177.19 0.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 9.89 110.83 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.77 -26.48 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 10.05 111.111 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.7 -49.5 0.84 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.698 -0.763 . . . . 8.32 112.439 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.98 -49.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 8.46 110.909 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.72 -63.9 0.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 10.53 110.864 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 9.66 110.885 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.822 0.344 . . . . 4.2 110.902 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.37 -19.61 56.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 1.8 111.177 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.41 -50.1 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 2.0 110.78 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -122.27 18.44 10.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 2.67 110.884 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.38 39.5 73.07 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.751 -0.738 . . . . 0.39 112.519 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.85 157.53 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 1.54 111.126 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.8 m -149.34 155.75 40.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 1.64 110.83 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.93 123.3 29.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 1.55 111.096 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.18 -12.06 14.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.41 112.52 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -103.61 168.66 9.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 1.68 110.914 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -101.21 133.39 45.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 2.28 110.924 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 p -138.38 134.59 43.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 3.19 111.16 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.35 127.4 55.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 1.62 111.114 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.2 t -97.63 117.95 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 1.56 111.131 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.6 t -102.35 110.25 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 1.74 111.116 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -111.56 167.24 10.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.19 110.97 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -151.0 -169.71 3.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.423 . . . . 1.84 110.874 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -56.68 -35.81 68.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.459 . . . . 3.77 110.903 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.62 -11.4 60.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 1.45 110.894 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.34 93.79 10.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.624 0.726 . . . . 1.05 110.845 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 142.81 49.15 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.677 2.252 . . . . 0.21 112.341 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.1 t -48.82 -32.59 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 1.56 111.134 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -51.24 -53.35 36.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 2.56 110.8 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.55 -44.79 11.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 1.55 111.131 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.36 -61.04 2.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 1.58 111.017 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.76 -37.91 31.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 3.14 110.871 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.8 -47.67 54.0 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.838 -0.696 . . . . 0.22 112.45 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.51 -40.05 93.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 1.63 110.873 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -76.88 -31.45 19.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 1.66 111.132 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -61.72 -59.95 4.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 1.72 110.947 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -40.41 71.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 2.63 110.882 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.68 -24.56 61.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 1.63 110.895 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.7 -24.78 44.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.44 110.911 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 -29.82 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 1.31 111.163 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.75 -35.02 14.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 1.44 110.872 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.87 -44.81 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 1.63 111.12 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.66 -11.2 52.97 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 0.25 112.433 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.99 -62.58 1.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 2.38 110.931 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -90.96 -40.68 11.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 1.97 110.857 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.49 -126.44 4.93 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.759 -0.734 . . . . 0.26 112.438 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -155.58 152.49 28.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 2.93 110.902 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.7 t -137.0 127.72 40.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 1.5 111.12 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 t -116.53 154.12 30.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 1.17 110.83 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.73 134.65 58.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 1.65 111.054 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -146.33 152.32 38.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.077 -0.511 . . . . 2.1 110.913 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -102.43 137.78 40.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.64 110.809 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.5 mt -52.26 -37.04 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 1.44 111.139 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -26.18 58.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 3.41 110.902 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -104.97 18.12 22.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 3.44 110.899 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -26.07 22.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.201 -0.454 . . . . 4.04 110.872 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.96 -34.9 57.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 2.01 110.871 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -85.97 -16.0 39.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.1 111.008 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.5 m -63.64 -12.72 36.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 1.7 110.798 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.55 59.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 1.54 111.134 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -59.17 -70.55 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.61 110.915 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.39 -169.59 2.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 2.37 111.0 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -105.47 122.11 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 2.19 110.827 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t 59.52 78.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 2.08 110.888 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.5 p -132.7 -37.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.95 110.834 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -98.13 122.37 41.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 3.61 110.85 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.28 -20.46 60.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 1.51 110.901 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.4 mt -143.06 144.81 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 1.54 111.115 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.3 mm -137.56 124.45 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 1.65 111.072 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.61 137.16 46.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 1.58 111.034 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.48 100.91 5.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 1.17 110.908 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.67 76.04 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.826 -0.702 . . . . 0.17 112.417 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.52 57.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.855 0.359 . . . . 1.53 110.908 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.32 159.64 61.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.708 0.766 . . . . 1.53 111.11 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 124.42 11.05 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.666 2.244 . . . . 0.26 112.359 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.33 7.33 88.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.797 -0.716 . . . . 0.26 112.533 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.2 p -55.54 150.88 11.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.429 . . . . 1.33 110.772 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.8 p -138.84 108.86 6.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 1.46 111.107 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.36 152.43 16.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 1.5 111.199 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mt -130.6 101.11 5.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 1.5 110.894 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -78.06 141.35 38.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.36 110.863 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.82 178.46 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 1.3 110.909 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.15 62.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 1.25 111.103 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -56.61 -48.21 77.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 1.96 110.885 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.1 -56.59 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 1.65 111.129 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt -50.15 -39.09 42.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 1.67 110.964 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.97 -56.74 10.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 1.76 111.1 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.16 -43.25 70.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 3.03 110.918 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.9 mm -57.94 -69.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 1.56 111.189 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.12 -36.21 28.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 1.56 111.075 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -51.5 67.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 3.5 110.983 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 43.6 pt -86.81 -2.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 1.79 111.171 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.0 115.28 21.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 1.63 110.952 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -55.52 157.95 6.49 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.532 0.682 . . . . 4.3 110.889 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 114.02 3.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.735 2.29 . . . . 0.39 112.33 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.16 2.33 51.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 0.22 112.512 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.07 -165.51 19.4 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.781 -0.723 . . . . 0.18 112.456 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 69.1 m -134.55 148.79 50.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.33 . . . . 1.72 110.901 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -132.72 114.98 14.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 1.6 110.911 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -110.19 132.13 54.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 3.29 110.952 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.74 164.03 35.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 1.61 110.939 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.91 129.33 36.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 2.9 110.9 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.63 148.44 19.68 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.677 0.751 . . . . 2.52 110.865 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 145.53 57.75 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.656 2.237 . . . . 0.25 112.367 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.4 m -129.0 146.49 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 1.55 111.088 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -107.32 132.75 52.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 2.19 110.803 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.8 p -90.69 -42.73 10.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 2.28 111.125 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -94.83 42.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 1.91 111.053 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 24.7 t -148.98 150.0 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.26 -0.427 . . . . 1.72 111.12 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.45 169.75 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 2.17 110.844 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -62.37 -54.72 36.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 2.77 110.845 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -66.8 -78.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 3.2 110.869 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p 53.65 -173.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 2.53 110.791 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.52 -3.37 49.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 3.68 110.848 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.86 153.82 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 1.66 111.148 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.01 110.48 6.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 3.97 110.933 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.7 p -84.97 179.52 7.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 1.61 111.191 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.43 -53.74 53.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 1.38 111.001 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.84 -50.09 74.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.99 0.424 . . . . 0.87 110.884 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -56.69 -39.91 74.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 2.58 110.985 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.52 -54.55 34.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 1.57 110.905 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.1 m -58.6 -46.94 85.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.228 -0.442 . . . . 1.82 110.827 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -43.58 97.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 1.25 110.834 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.16 -43.52 98.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 1.57 111.117 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.1 tp -64.81 -50.46 66.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 1.66 110.94 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.4 m -63.89 -31.2 72.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 1.59 111.129 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.5 mt -87.07 -10.5 52.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 1.79 110.917 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.53 6.21 28.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 2.34 110.845 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.61 7.68 31.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.67 -0.776 . . . . 0.55 112.452 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.57 171.03 7.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 1.57 110.847 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.05 170.42 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 1.61 111.131 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 52.89 44.21 30.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 2.27 110.857 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.71 142.77 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 1.47 111.158 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.97 157.92 6.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 2.68 110.901 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.29 145.7 39.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 2.23 110.858 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mp -105.5 -36.19 7.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 1.61 110.944 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.16 176.0 13.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 1.19 110.981 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -130.93 145.17 51.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 4.94 110.885 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -135.1 136.15 24.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.67 0.748 . . . . 1.87 110.852 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 165.22 31.66 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.693 2.262 . . . . 0.36 112.384 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.96 128.21 44.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 1.49 110.949 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.44 160.88 25.3 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.53 0.681 . . . . 2.44 111.163 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -28.69 24.61 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.701 2.267 . . . . 0.43 112.294 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -85.37 -17.74 35.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 3.63 110.936 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.59 -53.06 4.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 2.83 110.963 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.32 -40.37 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 1.58 111.147 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -35.22 77.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.25 110.908 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.85 -46.61 71.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 1.27 110.831 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.99 -29.97 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 1.53 111.118 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -75.0 -33.67 61.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 2.99 110.95 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -89.0 -19.97 25.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.056 -0.52 . . . . 1.93 110.842 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -94.01 -32.73 13.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.88 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.58 -54.24 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 1.61 110.901 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.97 6.11 2.6 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.806 -0.712 . . . . 0.43 112.479 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -69.9 120.1 15.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.723 0.297 . . . . 0.96 110.903 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.25 104.82 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 2.38 110.913 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.45 174.95 12.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 1.6 110.864 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.76 -10.54 16.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.55 110.869 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.15 6.6 46.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 2.23 110.935 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.81 166.67 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 1.64 111.004 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -172.94 130.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 1.62 110.925 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -75.62 134.87 40.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 3.23 110.879 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.83 141.53 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 1.65 111.183 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -93.66 131.26 39.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.97 110.937 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.92 151.73 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 1.46 111.106 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.3 t -135.9 161.85 34.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 1.48 111.048 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.26 137.92 6.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.715 -0.755 . . . . 0.17 112.487 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.65 137.5 35.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.308 . . . . 4.7 110.935 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -77.33 135.45 65.7 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.609 0.719 . . . . 2.97 110.905 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 120.09 6.94 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.652 2.235 . . . . 0.39 112.39 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -105.57 151.57 24.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.45 110.94 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 22.4 t80 60.43 19.98 9.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 7.57 110.816 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 62.3 166.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 9.57 110.906 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 33.7 m -150.08 -179.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 6.07 111.194 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -149.85 46.75 0.64 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.717 -0.754 . . . . 6.21 112.517 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.47 -66.76 1.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.36 . . . . 7.99 110.861 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.13 -170.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 7.68 110.865 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . 0.277 4.0 tmm_? . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 6.97 110.855 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.853 0.358 . . . . 4.99 110.908 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.28 -22.19 63.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 1.48 111.132 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.11 -51.47 64.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.225 -0.443 . . . . 2.4 110.831 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.26 21.18 10.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 2.71 110.848 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.93 37.96 54.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.656 -0.783 . . . . 0.28 112.552 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -74.27 156.93 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.343 . . . . 1.59 111.146 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.2 m -146.13 158.5 43.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 1.52 110.891 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.56 129.75 35.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 1.56 111.131 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.11 -8.52 33.33 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.687 -0.768 . . . . 0.55 112.522 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -103.61 169.37 8.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 1.75 110.919 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.87 113.21 26.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 2.26 110.824 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -120.57 129.56 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 3.15 111.105 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.65 128.06 52.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 1.55 111.048 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.9 t -99.93 120.34 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 1.52 111.13 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.25 123.05 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 1.61 111.086 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -122.6 169.68 10.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.2 110.908 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.75 -171.0 3.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 1.76 110.862 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -56.97 -35.66 69.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 4.29 110.904 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.32 -9.1 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 2.04 110.917 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.05 94.29 10.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.665 0.745 . . . . 0.85 110.799 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.35 47.7 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.659 2.239 . . . . 0.23 112.416 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.01 -32.59 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 1.54 111.182 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.16 -53.09 37.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.148 -0.478 . . . . 3.2 110.827 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.87 10.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 1.5 111.151 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -51.66 -61.49 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 1.49 110.995 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -36.96 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 3.36 110.934 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.36 -48.31 52.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.729 -0.748 . . . . 0.24 112.495 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.1 mt -60.84 -41.39 95.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 1.71 110.927 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -75.45 -31.11 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 1.7 111.11 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.74 -61.89 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 1.77 110.887 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -40.73 67.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 2.7 110.87 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.5 mt -71.83 -25.5 62.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 1.58 110.96 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.05 -24.33 47.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.47 110.984 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.52 -30.52 17.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 1.31 111.113 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.7 pp -90.91 -35.41 14.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 1.69 110.896 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.65 -46.83 4.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 1.57 111.083 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.57 -14.33 49.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.742 . . . . 0.28 112.467 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 3.21 110.817 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.34 -35.48 8.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 2.38 110.867 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.17 -133.48 5.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.32 112.499 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -151.39 152.24 32.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 4.61 110.745 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.6 t -136.7 116.51 16.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 1.69 111.095 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.4 t -106.43 155.98 19.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.98 110.892 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.84 135.69 59.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 1.43 111.174 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -142.69 151.05 40.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 1.3 110.926 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.54 134.65 46.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.62 110.872 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.7 mt -52.3 -36.82 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 1.58 111.155 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -70.23 -32.6 70.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 2.72 110.899 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.54 20.72 17.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 3.52 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.96 -28.54 3.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 2.13 110.902 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -55.82 -32.93 64.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.269 -0.423 . . . . 2.27 110.882 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -84.35 -14.5 49.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 1.09 110.878 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.7 m -64.94 -10.87 32.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 1.74 110.817 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.17 63.99 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 1.49 111.122 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -66.07 -70.51 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.55 110.813 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.57 -167.82 2.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 2.06 110.923 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -111.12 124.07 51.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 1.58 110.906 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t 58.96 75.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 2.04 110.779 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 p -134.07 -35.15 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.911 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.06 117.47 33.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.107 -0.497 . . . . 2.59 110.846 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.02 -19.82 62.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 1.51 110.874 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.2 mt -146.27 144.12 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 1.52 111.101 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.0 mm -136.3 129.2 46.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 1.49 111.126 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.29 137.75 51.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 1.64 110.938 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.24 101.7 6.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 1.21 110.861 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.3 78.09 0.11 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.778 -0.725 . . . . 0.17 112.434 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.8 58.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 1.61 110.894 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.1 158.83 67.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.573 0.702 . . . . 1.65 111.175 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.63 115.88 4.28 Favored 'Trans proline' 0 C--O 1.231 0.125 0 C-N-CA 122.702 2.268 . . . . 0.26 112.394 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.15 6.61 66.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.19 112.456 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.3 152.08 8.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.39 . . . . 1.07 110.924 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.0 p -140.14 108.55 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 1.64 111.159 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.3 150.08 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 1.48 111.153 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.2 mt -129.63 99.61 5.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 1.55 110.876 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -75.44 153.72 37.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.31 110.82 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 m -130.02 174.99 9.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 1.49 110.889 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -35.92 37.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 1.42 111.142 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.0 -42.87 99.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 1.94 110.864 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -77.21 -54.27 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 1.59 111.148 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.5 mt -49.73 -48.37 50.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 1.6 110.939 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.63 -50.11 55.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 2.19 111.17 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -43.84 83.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 4.79 110.824 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.6 mm -57.13 -65.18 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 1.52 111.142 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.99 -38.09 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 1.6 111.111 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -54.39 -58.03 9.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 3.21 110.875 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.1 pt -75.5 -8.33 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 1.63 111.128 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.48 132.67 36.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 1.82 110.883 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -70.0 159.56 83.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.568 0.699 . . . . 3.16 110.876 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 113.79 3.49 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.638 2.225 . . . . 0.19 112.345 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.22 3.46 54.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.688 -0.768 . . . . 0.19 112.52 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.41 -160.12 12.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.18 112.473 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.3 m -140.11 154.96 47.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.928 0.394 . . . . 1.47 110.912 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -139.44 115.38 10.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 1.56 111.008 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -110.96 133.1 53.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 2.87 110.868 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.77 156.9 42.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 1.59 110.936 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.36 128.32 46.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 2.66 110.816 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.43 144.6 17.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.64 0.734 . . . . 2.29 110.868 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 140.19 41.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.653 2.235 . . . . 0.29 112.329 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.2 m -122.86 146.59 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 1.42 111.156 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -110.4 132.86 53.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 1.98 110.887 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.0 p -104.38 25.7 9.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 1.84 111.203 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.07 24.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 1.76 111.182 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.46 159.97 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 1.74 111.13 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.68 178.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 1.84 110.846 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -66.13 -62.65 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 2.66 110.9 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -65.98 -75.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 2.79 110.894 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.11 -168.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 2.41 110.868 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 -4.22 52.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 2.99 110.897 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.8 m -145.38 141.11 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 1.63 111.132 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.57 117.8 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 3.35 110.914 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.2 p -89.68 177.72 6.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 1.48 111.07 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.02 -54.26 48.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 1.54 111.054 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.28 -49.75 76.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.042 0.448 . . . . 1.26 110.859 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -57.9 -40.69 80.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 3.07 110.928 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.77 -54.79 37.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 1.56 110.925 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 54.6 m -58.34 -48.85 79.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 2.01 110.893 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -45.62 92.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.472 . . . . 1.46 110.812 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.64 -48.15 83.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 1.54 111.154 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.39 -52.98 62.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 1.59 110.921 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.0 m -63.12 -27.1 69.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 1.6 111.129 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.4 mt -86.97 -12.41 47.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 1.75 110.968 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.8 p -82.87 3.96 27.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 3.05 110.85 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.67 -4.88 34.68 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.781 -0.723 . . . . 0.71 112.528 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -88.95 170.33 10.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.946 0.403 . . . . 1.72 110.923 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.9 m -148.13 172.75 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 1.64 111.169 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 51.47 45.03 28.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 2.18 110.924 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.0 t -81.57 142.02 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 1.63 111.093 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.65 8.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 2.63 110.895 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -79.57 145.92 32.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 2.27 110.862 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.77 -37.31 6.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 1.53 110.922 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -162.1 176.67 10.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 1.28 110.983 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -126.72 165.31 19.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 6.49 110.808 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -148.39 136.43 11.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.669 0.747 . . . . 1.38 110.926 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 158.05 58.37 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.746 2.298 . . . . 0.38 112.375 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.35 127.01 38.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 1.51 110.999 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.12 161.45 22.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.492 0.663 . . . . 2.87 111.254 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -24.67 29.72 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.707 2.271 . . . . 0.53 112.386 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -85.46 -22.93 28.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 2.59 110.799 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -87.72 -53.03 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 2.44 110.911 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.73 -40.01 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 1.65 111.162 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -33.93 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 1.51 110.932 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -46.57 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 1.35 110.871 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.94 -30.96 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 1.39 111.128 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -76.72 -30.31 56.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 2.72 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -89.7 -21.08 22.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 1.67 110.891 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -94.8 -32.64 13.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 0.42 110.851 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.9 mp -127.35 -54.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 1.62 110.865 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.65 20.5 1.52 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.39 112.517 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -75.37 121.56 22.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.725 0.298 . . . . 1.12 110.864 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -151.83 106.44 3.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 2.64 110.911 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.71 173.21 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 1.54 110.872 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.47 -19.59 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 1.82 110.835 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -96.19 19.9 11.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 1.59 110.925 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.54 163.57 15.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 1.64 110.823 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -173.48 130.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 1.68 110.948 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -70.22 135.16 48.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 3.24 110.824 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.73 147.23 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 1.64 111.146 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -104.69 125.56 50.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 2.47 110.829 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.24 153.21 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 1.6 111.152 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.6 t -136.92 162.92 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 1.82 111.136 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.23 136.31 5.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.772 -0.727 . . . . 0.2 112.464 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.64 139.48 30.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.362 . . . . 2.5 110.817 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 135.6 51.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.693 0.759 . . . . 2.34 110.821 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 135.77 31.2 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.622 2.215 . . . . 0.53 112.387 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -116.46 150.17 38.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.46 110.756 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 37.5 t80 64.39 112.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 6.98 110.893 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -53.87 111.88 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 10.08 110.886 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.28 -26.56 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 5.71 111.125 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.05 -47.93 2.7 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.78 -0.724 . . . . 6.24 112.475 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 35.2 m -84.71 83.86 7.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.924 0.392 . . . . 7.46 110.95 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.3 m -161.23 -176.0 5.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 6.89 110.856 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.456 . . . . 7.81 110.867 -179.945 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.795 0.331 . . . . 9.34 110.896 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.96 -13.5 59.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 1.92 111.078 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.07 -39.31 74.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 2.88 110.898 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -122.33 15.27 10.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 3.54 110.842 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.96 41.06 99.24 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.843 -0.694 . . . . 0.32 112.469 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mp -83.36 158.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 1.63 111.081 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.58 164.83 33.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.6 110.864 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.49 129.13 36.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 1.5 111.023 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.84 -6.51 23.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.773 . . . . 0.25 112.519 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -113.14 167.91 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 1.49 110.846 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.67 137.3 37.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.178 -0.465 . . . . 2.33 110.908 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.0 t -140.75 133.21 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 2.9 111.111 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.3 121.98 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 1.34 111.085 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.9 t -94.59 118.06 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 1.55 111.068 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.66 113.59 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 1.73 111.12 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -113.39 167.19 10.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.23 111.013 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -148.57 -169.71 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.279 -0.419 . . . . 1.78 110.926 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -58.3 -35.58 72.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 4.57 110.953 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.1 m -73.98 -8.03 54.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 1.89 110.931 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.35 93.33 9.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.716 . . . . 1.07 110.833 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 143.09 50.16 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.729 2.286 . . . . 0.25 112.326 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.81 -32.9 4.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 1.49 111.101 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -50.99 -53.09 36.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 2.42 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.46 -44.85 11.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 1.63 111.048 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -52.16 -62.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 1.46 110.9 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.61 -37.42 27.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 4.32 110.848 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.44 -47.08 53.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.23 112.53 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.5 mt -61.94 -39.35 91.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 1.69 110.943 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -77.68 -31.75 17.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.231 -0.44 . . . . 1.68 111.134 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.01 -58.82 6.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 1.82 110.812 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -41.1 75.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 4.19 110.88 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.2 mt -72.35 -24.4 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 1.43 110.952 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -78.16 -24.67 47.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.45 110.897 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.35 -30.29 16.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 1.35 111.068 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.55 -35.65 14.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 1.53 110.96 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.62 -44.2 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 1.49 111.17 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.33 -11.0 55.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.42 112.424 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.29 -61.97 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.782 0.325 . . . . 3.5 110.918 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -86.49 -43.0 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 2.06 110.866 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.25 -122.03 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.852 -0.69 . . . . 0.34 112.523 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -157.49 153.35 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 2.98 110.877 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.0 t -138.27 128.72 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 1.56 111.182 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t -118.11 154.48 32.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 1.11 110.84 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -115.52 133.31 62.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 1.67 111.089 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -144.53 152.98 41.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 1.97 110.92 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -101.91 139.62 37.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.7 110.982 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 mt -51.87 -44.24 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 1.65 111.169 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -20.11 60.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 4.91 110.833 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -107.12 18.5 21.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 3.52 110.86 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.51 -24.56 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 3.99 110.911 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -52.19 -34.7 46.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 1.86 110.95 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -86.25 -16.34 37.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 1.2 110.907 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 m -63.47 -12.84 34.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 1.73 110.897 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.71 59.46 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.498 . . . . 1.58 111.068 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -61.81 -70.29 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.51 110.829 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.28 -168.78 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 2.24 110.844 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -105.82 131.05 53.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 1.96 110.825 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 49.01 71.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 1.82 110.82 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.8 p -125.61 -34.42 2.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.9 110.884 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -99.85 119.18 37.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.495 . . . . 2.58 110.88 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.42 -19.4 62.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 1.54 110.904 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 27.3 mt -146.03 145.44 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 1.59 111.117 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.3 mm -136.83 127.85 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 1.63 111.147 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -109.55 137.59 47.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.224 -0.444 . . . . 1.58 110.926 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.13 96.42 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 1.13 110.933 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.03 75.0 0.25 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 0.16 112.436 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.49 62.5 0.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.847 0.356 . . . . 1.53 110.9 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.99 160.12 66.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.533 0.682 . . . . 1.65 111.172 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 116.62 4.65 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.231 . . . . 0.29 112.35 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.14 7.27 70.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.647 -0.787 . . . . 0.23 112.5 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.33 150.23 11.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.075 0.464 . . . . 1.0 110.789 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.7 p -140.05 108.57 5.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.046 -0.525 . . . . 1.54 111.094 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.8 152.72 15.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.53 111.132 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 mt -130.36 101.76 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 1.7 110.891 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -77.56 149.05 34.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.28 110.84 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.1 m -125.57 178.43 5.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.9 110.857 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.14 -45.21 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 1.2 111.079 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.92 -48.53 75.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 2.32 110.906 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -68.23 -56.55 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 1.56 111.07 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.0 mt -50.67 -39.56 51.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 1.65 110.966 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.85 -57.1 12.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.6 111.062 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.0 -41.97 65.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 2.93 110.833 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mm -58.94 -68.58 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.437 . . . . 1.58 111.056 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.79 29.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 1.43 111.125 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -57.55 -56.0 27.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 4.0 110.934 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.2 pt -80.01 -5.69 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 1.52 111.17 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.72 129.4 36.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 1.64 110.904 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -70.4 160.41 81.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.623 0.725 . . . . 3.04 110.908 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 114.17 3.59 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.726 2.284 . . . . 0.29 112.393 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.43 4.79 57.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.24 112.501 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.4 -164.61 14.38 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.73 . . . . 0.2 112.435 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 67.6 m -137.71 146.28 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 1.72 110.815 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -129.49 125.39 36.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 1.55 110.867 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -121.34 131.4 54.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 3.35 110.935 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.76 157.18 43.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 1.62 110.86 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.85 127.28 44.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 3.21 110.907 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.3 146.93 19.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.635 0.731 . . . . 2.33 110.832 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.92 142.44 47.25 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.68 2.253 . . . . 0.23 112.336 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.18 146.69 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 1.41 111.112 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -105.22 132.63 51.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 2.04 110.946 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.0 p -103.64 26.04 9.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 1.77 111.108 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.99 24.82 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 1.67 111.105 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -143.73 158.85 16.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 1.92 111.134 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -177.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 2.07 110.808 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -68.69 -68.81 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 2.71 110.904 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -56.94 -75.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.082 -0.508 . . . . 2.86 110.939 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.7 -169.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 2.71 110.9 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -4.45 54.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 3.08 110.915 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 m -144.5 153.36 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 1.74 111.126 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -71.25 108.87 4.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 2.9 110.912 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 32.2 p -85.88 177.7 7.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 1.48 111.13 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.49 -54.31 42.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 1.45 111.119 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -49.97 75.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 1.11 110.814 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.46 -41.58 76.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 2.58 110.924 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.64 -54.63 40.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 1.66 110.932 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.7 m -58.47 -48.84 79.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 1.62 110.886 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -46.53 89.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 1.54 110.879 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.36 -43.47 98.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 1.68 111.051 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.1 tp -63.37 -52.37 61.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 1.53 110.91 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -65.64 -24.65 67.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 1.44 111.114 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.34 -15.71 42.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 2.1 110.853 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 40.2 p -83.42 4.69 26.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 3.01 110.873 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.8 -4.77 34.4 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.632 -0.794 . . . . 0.59 112.469 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.45 169.37 12.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.904 0.383 . . . . 1.65 110.894 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.56 170.15 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 1.58 111.118 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 51.99 44.9 29.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 2.43 110.897 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 91.1 t -80.33 141.75 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 1.41 111.049 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 158.87 7.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 2.66 110.92 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -77.31 145.92 37.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 2.35 110.86 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 mp -105.26 -36.51 7.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 1.56 110.949 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.83 176.2 13.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 1.18 110.944 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.2 137.04 47.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 4.75 110.83 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.78 138.26 30.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.699 0.762 . . . . 1.84 110.853 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 164.05 35.98 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.664 2.242 . . . . 0.22 112.357 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.74 128.47 42.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 1.52 110.941 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.46 160.91 25.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.576 0.703 . . . . 2.22 111.117 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -29.83 23.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.261 . . . . 0.49 112.288 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.08 -17.96 35.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 2.79 110.856 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -53.47 4.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 2.48 110.92 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -49.14 -41.09 13.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 1.54 111.142 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -34.67 73.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 1.27 110.976 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.18 -44.89 71.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 1.06 110.802 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.0 -32.54 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 1.63 111.153 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -76.06 -29.9 58.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 2.72 110.858 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -90.14 -20.68 22.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 1.77 110.911 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -94.58 -32.63 13.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.38 110.858 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.6 mp -127.88 -53.87 1.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 1.63 110.99 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.96 12.3 2.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 0.39 112.501 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -70.24 120.38 15.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 1.58 110.818 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -151.9 111.22 3.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 3.27 110.928 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.62 175.09 13.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 1.71 110.869 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.34 -14.19 14.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 2.24 110.876 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -104.82 11.4 33.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 1.83 110.868 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.01 163.18 28.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 1.7 110.939 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -173.88 129.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 1.66 110.88 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -73.54 132.89 43.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 3.28 110.869 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.01 140.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 1.59 111.116 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -94.42 126.38 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 2.41 110.922 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.8 mp -123.15 153.65 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 1.63 111.174 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.5 t -139.2 164.46 29.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 1.49 111.141 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -154.7 135.84 4.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.2 112.488 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -91.36 140.02 30.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.866 0.365 . . . . 2.38 110.899 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 135.47 49.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.604 0.716 . . . . 2.26 110.969 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.85 127.87 15.14 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.695 2.263 . . . . 0.36 112.348 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -108.56 149.56 28.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.31 110.869 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.5 t80 65.04 151.81 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 6.99 110.829 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.42 99.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 9.58 110.841 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.8 m -112.03 -30.19 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 5.28 111.129 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 108.91 -28.17 11.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 6.32 112.5 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.5 t -77.98 82.11 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 7.77 110.855 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.77 -170.35 3.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 8.88 110.945 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 10.52 110.845 -179.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.752 0.31 . . . . 4.94 110.881 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.49 60.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.299 -0.409 . . . . 2.09 111.094 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.96 -50.31 66.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 2.67 110.897 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -122.12 11.71 10.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 3.56 110.933 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.37 40.65 99.14 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.726 -0.75 . . . . 0.33 112.502 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.53 160.42 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 1.61 111.019 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.3 168.63 26.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.08 -0.509 . . . . 2.01 110.773 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.73 132.81 35.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 1.68 111.092 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.88 -8.12 29.55 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.757 -0.735 . . . . 0.3 112.546 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -111.96 165.33 12.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 1.51 110.924 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.56 140.09 33.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 3.8 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -142.68 140.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 3.06 111.178 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.02 122.1 42.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 1.56 111.085 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.6 t -94.64 118.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 1.53 111.086 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.4 t -102.95 110.07 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 1.52 111.188 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -111.54 167.55 10.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.15 -0.477 . . . . 0.17 110.939 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -151.34 -169.63 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 1.69 110.876 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -56.97 -35.72 69.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 3.48 110.846 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.4 m -73.11 -10.61 59.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 1.73 110.832 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.63 94.9 10.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.729 . . . . 0.81 110.881 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 141.46 45.2 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.717 2.278 . . . . 0.23 112.285 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -48.89 -32.7 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 1.5 111.154 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.55 -52.66 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 2.54 110.963 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.34 -45.06 10.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 1.44 111.097 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.48 -61.34 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 1.42 110.877 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -49.87 -36.1 25.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 4.14 110.857 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.52 -47.2 43.54 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.21 112.486 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.4 mt -62.13 -38.62 89.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 1.8 110.922 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -77.96 -31.55 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 1.72 111.099 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -62.2 -58.01 9.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 1.6 110.872 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -40.24 75.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 3.57 110.929 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.3 mt -73.03 -24.49 60.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 1.45 110.986 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -78.64 -25.25 44.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.44 110.942 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.83 -29.6 17.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 1.68 111.095 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.66 -35.0 14.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 1.42 110.981 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.73 -44.98 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 1.65 111.06 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.07 -10.94 53.75 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.674 -0.774 . . . . 0.26 112.478 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.5 -62.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.728 0.299 . . . . 3.97 110.852 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -90.22 -40.97 11.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 2.18 110.872 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.38 -123.03 4.01 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.661 -0.78 . . . . 0.32 112.572 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -158.28 153.54 25.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.863 0.363 . . . . 3.02 110.827 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 96.6 t -138.5 130.86 38.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.187 -0.46 . . . . 1.63 111.137 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 t -119.67 156.02 31.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 1.19 110.916 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -117.07 135.3 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 1.58 111.125 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -145.74 151.95 38.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 2.17 110.965 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.73 135.43 44.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.64 110.936 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.8 mt -51.68 -35.15 17.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 1.63 111.058 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -75.09 -31.22 61.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 2.96 110.838 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -95.82 18.44 13.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 3.32 110.948 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.83 -31.13 4.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 2.08 110.937 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -53.39 -38.84 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 1.92 110.899 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -85.09 -15.85 42.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 1.27 110.899 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -65.94 -11.64 48.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 2.03 110.787 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 63.36 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 1.66 111.144 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -60.93 -71.66 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.47 110.826 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.12 -168.99 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 3.07 110.951 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -102.36 137.47 40.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.74 110.926 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 p 46.57 85.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 1.35 110.833 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.6 p -141.05 -40.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 1.21 110.87 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -99.85 119.52 38.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.51 . . . . 3.62 110.931 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.2 -21.23 62.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 1.51 110.814 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.8 mt -142.63 144.25 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 1.63 111.091 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.7 mm -134.9 126.58 47.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 1.35 111.13 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.04 136.82 47.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 1.56 110.925 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.3 98.39 4.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 1.25 110.857 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.61 75.52 0.21 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.735 -0.745 . . . . 0.15 112.577 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.24 56.17 0.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.801 0.334 . . . . 1.54 110.938 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.44 160.32 53.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.707 0.765 . . . . 1.73 111.12 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 120.35 7.15 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 0.27 112.283 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.22 6.91 83.83 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.828 -0.701 . . . . 0.2 112.54 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 p -55.97 151.56 11.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.951 0.405 . . . . 1.01 110.825 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.5 p -141.5 109.12 5.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 1.53 111.187 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.4 145.48 11.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 1.56 111.194 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mt -124.18 105.17 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 1.61 110.894 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -80.1 153.8 28.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.28 110.822 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m -131.34 -176.62 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 1.32 110.902 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.33 69.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.526 . . . . 1.4 111.139 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -62.56 -45.04 94.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 1.64 110.841 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 mp -74.97 -55.31 12.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.171 -0.468 . . . . 1.65 111.092 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 mt -50.28 -43.88 53.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 1.47 110.831 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.45 -52.06 49.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 1.6 111.111 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -44.43 92.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 2.96 110.877 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.3 mm -54.94 -68.18 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 1.57 111.085 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.65 57.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 1.51 111.126 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -53.14 -52.61 58.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 2.93 110.874 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.5 pt -81.63 -8.63 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 1.58 111.21 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.24 124.2 27.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 1.56 110.876 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -63.1 160.25 40.85 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.703 . . . . 2.99 110.887 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 114.22 3.65 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.265 . . . . 0.31 112.3 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.56 5.52 56.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.587 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.71 -160.95 14.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.16 112.462 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.9 m -139.19 154.26 48.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 1.97 110.936 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -138.56 115.67 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 1.53 110.796 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -110.19 132.4 54.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 3.27 110.903 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.87 158.71 44.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 1.44 110.928 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.08 131.38 44.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 3.11 110.899 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.7 150.25 22.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.62 0.724 . . . . 3.59 110.844 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 144.71 55.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 0.27 112.412 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.7 146.59 32.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 1.53 111.125 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.19 133.28 52.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 2.02 110.876 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.8 p -92.42 -42.76 9.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 1.98 111.209 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.67 40.45 1.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 1.95 111.037 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.7 t -147.65 151.9 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 1.95 111.113 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.34 178.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 2.31 110.825 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.15 -63.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 2.68 110.895 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -63.65 -75.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 2.64 110.895 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.86 -167.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.479 . . . . 2.27 110.849 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -8.29 59.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 3.25 110.919 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.58 150.96 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 2.08 111.119 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -65.99 126.21 27.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 6.05 110.885 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 71.7 p -97.83 177.7 5.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 1.8 111.147 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.87 -54.53 45.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 1.41 111.056 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -55.16 -48.04 74.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.93 110.908 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -36.41 75.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 3.26 110.838 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.94 -56.57 14.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 1.78 110.904 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 48.6 m -57.44 -47.62 81.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 1.5 110.861 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -45.57 92.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.24 110.854 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.31 99.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.479 . . . . 1.54 111.082 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.0 tp -65.39 -52.57 52.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 1.56 110.906 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.2 m -61.28 -31.75 71.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 1.7 111.114 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.9 mt -87.09 -10.67 52.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 1.78 110.912 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.63 4.95 29.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 2.44 110.869 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.27 7.66 32.29 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.54 112.485 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.3 168.44 9.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.849 0.357 . . . . 1.59 110.898 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.0 m -148.41 172.53 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 1.56 111.133 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 51.63 44.67 29.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.471 . . . . 2.12 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 45.5 t -79.3 144.66 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 1.64 111.163 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.3 158.48 5.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 4.05 110.976 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -78.83 147.09 33.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.39 . . . . 2.44 110.837 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mp -106.09 -36.51 6.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 1.65 110.967 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 176.39 11.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.11 110.916 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.9 137.31 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 4.88 110.848 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -123.53 136.2 26.95 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.592 0.71 . . . . 1.81 110.875 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 162.46 41.98 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.642 2.228 . . . . 0.31 112.427 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.63 136.13 37.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 1.46 110.909 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.67 162.46 28.74 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.519 0.676 . . . . 2.75 111.11 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -22.65 31.53 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.574 2.183 . . . . 0.54 112.323 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -85.15 -26.37 26.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 2.43 110.826 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -88.53 -51.01 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 2.47 110.829 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.82 -38.92 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 1.57 111.188 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.85 -32.95 73.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.45 110.924 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -45.65 68.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 1.03 110.862 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.75 -30.96 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 1.57 111.081 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -76.44 -31.1 57.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 2.85 110.876 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -90.26 -20.41 23.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.164 -0.471 . . . . 1.67 110.903 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -94.75 -33.0 13.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.34 110.914 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -126.2 -54.18 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 1.56 110.938 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.45 10.67 2.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 0.33 112.45 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -70.18 121.98 18.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.86 110.89 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.48 105.07 3.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 3.22 110.928 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.25 170.7 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 1.63 110.907 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.49 -6.33 18.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 1.56 110.893 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -105.14 10.56 33.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 3.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.62 166.93 19.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.43 110.934 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -172.49 130.71 0.57 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 1.66 110.906 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -75.67 132.13 40.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 3.03 110.88 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.04 146.91 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 1.53 111.142 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -102.07 131.52 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 2.78 110.899 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.48 149.96 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 1.53 111.116 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.3 t -132.05 159.87 37.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 1.52 111.149 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.19 135.2 5.13 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.821 -0.704 . . . . 0.17 112.506 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -91.54 139.47 30.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.348 . . . . 2.48 110.973 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.23 134.77 51.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 2.23 110.933 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.67 121.66 8.37 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.743 2.296 . . . . 0.37 112.353 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -96.16 153.03 18.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.921 0.391 . . . . 0.62 110.89 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -49.2 113.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 8.88 110.883 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 65.51 96.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 7.95 110.977 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.8 m -122.65 -34.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 8.58 111.131 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 127.2 -47.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 8.92 112.57 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.91 116.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.982 0.42 . . . . 8.74 110.89 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 16.3 m -165.49 -75.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 9.57 110.877 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 7.42 110.926 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.766 0.317 . . . . 4.86 110.903 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.88 -21.41 66.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 1.29 111.119 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -51.51 63.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 2.11 110.835 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -122.3 20.72 10.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 2.69 110.935 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.33 41.68 80.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.29 112.531 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.44 160.52 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 1.54 111.145 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.5 168.61 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 2.12 110.929 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.62 131.81 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 1.57 111.1 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.88 2.62 30.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.757 -0.735 . . . . 0.4 112.472 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -122.38 165.51 16.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 1.48 110.92 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.73 139.65 34.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 2.27 110.869 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.6 t -142.42 142.48 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 2.84 111.197 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.2 118.28 30.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 1.35 111.194 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 63.9 t -92.91 118.5 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 1.48 111.091 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.58 116.33 46.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 1.55 111.168 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -116.79 168.08 10.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.22 110.939 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.63 -169.86 3.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.26 -0.427 . . . . 1.86 110.882 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -57.11 -35.61 69.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 4.34 110.88 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 t -73.49 -10.21 59.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 1.71 110.862 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.96 94.24 10.36 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.698 0.761 . . . . 0.77 110.85 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.89 142.48 47.46 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.667 2.245 . . . . 0.25 112.339 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.07 -32.52 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 1.54 111.136 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -51.26 -52.97 40.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 2.48 110.957 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -44.68 11.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 1.61 111.128 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.74 -61.59 2.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 1.61 110.92 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -36.41 22.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 3.37 110.918 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.37 -46.76 47.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.682 -0.77 . . . . 0.22 112.426 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.9 mt -62.23 -38.64 90.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 1.66 110.929 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.2 m -77.97 -31.55 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.432 . . . . 1.73 111.119 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.31 -58.16 8.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.191 -0.459 . . . . 1.65 110.883 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -40.11 74.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 2.73 110.967 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.06 -25.17 60.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 1.6 110.862 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -78.51 -25.38 45.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.44 110.845 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 -29.58 17.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 1.31 111.092 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 pp -91.46 -34.72 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 1.48 110.935 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.28 -45.84 4.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 1.64 111.164 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.03 -12.04 53.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.27 112.513 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -62.56 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 3.84 110.912 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -94.45 -38.97 10.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.15 -0.477 . . . . 2.62 110.865 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.55 -126.8 4.43 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.24 112.453 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -155.28 153.46 30.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 2.94 110.836 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.4 t -138.38 128.41 34.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.138 -0.483 . . . . 1.65 111.143 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.0 t -116.87 157.87 24.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 1.11 110.959 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.07 135.52 60.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 1.41 111.082 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -144.08 151.41 39.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 1.26 110.82 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.4 134.89 46.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.66 110.905 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 24.6 mt -52.23 -36.13 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 1.55 111.188 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -71.55 -32.27 67.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 2.67 110.968 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -102.54 20.25 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 3.61 110.845 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.03 -28.89 4.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 2.26 110.909 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.81 -34.04 64.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 3.7 110.993 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -83.68 -13.89 53.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 1.15 110.926 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.8 m -68.49 -6.97 28.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 1.68 110.867 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.26 64.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.118 -0.492 . . . . 1.78 111.089 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -65.24 -69.46 0.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.46 110.902 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.66 -175.21 5.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 3.29 110.84 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -94.42 135.15 36.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 2.01 110.845 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 p 46.29 82.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 1.48 110.852 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -133.33 -38.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 1.17 110.813 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -102.46 122.7 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 2.56 110.886 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.33 -20.56 61.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 1.72 110.769 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.5 mt -144.21 144.47 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 1.7 111.165 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.9 mm -135.29 130.23 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 1.6 111.158 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -113.88 136.92 52.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 1.52 110.915 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.57 100.88 5.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 1.14 110.793 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.79 74.06 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.771 -0.728 . . . . 0.19 112.478 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.97 58.68 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 1.53 110.91 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.53 159.89 63.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.587 0.708 . . . . 1.68 111.129 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 116.43 4.56 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.642 2.228 . . . . 0.26 112.377 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.15 7.01 68.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.822 -0.704 . . . . 0.18 112.471 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -54.92 150.49 10.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.967 0.413 . . . . 1.02 110.881 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.2 p -140.15 109.0 5.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 1.41 111.121 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.68 152.86 16.38 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 1.6 111.051 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.1 mt -130.94 99.76 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 1.73 110.913 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -77.57 138.36 39.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.34 110.901 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 16.4 m -115.31 175.61 5.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 1.16 110.803 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.98 -35.41 33.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 1.84 111.246 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -62.7 -39.69 94.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.126 -0.488 . . . . 2.3 110.909 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -81.86 -55.17 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 1.64 111.146 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.3 mt -49.27 -46.1 45.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 1.77 110.826 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.03 -50.54 58.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 1.98 111.077 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -47.13 84.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 4.91 110.901 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 48.8 mm -53.12 -64.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 1.63 111.115 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.7 -41.36 61.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 1.52 111.053 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 tpp85 -51.99 -52.99 46.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 3.12 110.854 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.4 pt -80.85 -8.41 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 1.57 111.163 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.17 114.11 15.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 1.58 110.884 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -53.7 160.43 2.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.702 . . . . 4.7 110.864 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 114.76 3.81 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.677 2.252 . . . . 0.31 112.291 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.67 5.77 57.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 0.24 112.486 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.5 -162.25 20.69 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.694 -0.765 . . . . 0.17 112.482 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.6 m -139.0 153.52 48.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 1.52 110.94 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -138.28 117.07 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 1.52 110.898 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -112.74 133.51 54.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 2.87 110.867 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.64 159.21 44.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 1.62 110.946 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.96 126.4 41.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 2.8 110.89 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.33 146.77 20.41 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.673 0.749 . . . . 2.34 110.905 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 143.3 50.34 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.761 2.307 . . . . 0.2 112.316 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.2 m -126.97 146.43 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 1.44 111.121 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -109.25 132.57 54.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 2.13 110.873 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.9 p -91.27 -38.92 12.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 2.13 111.125 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.77 40.75 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 1.67 111.101 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 26.2 t -148.07 150.19 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 1.82 111.068 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.38 172.01 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.488 . . . . 1.71 110.872 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -63.95 -62.83 1.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 2.91 110.856 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -65.66 -75.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 3.34 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 t 53.49 -168.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 2.83 110.928 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.45 -5.73 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 2.4 110.921 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.93 146.63 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 1.62 111.085 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -67.29 115.06 6.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 3.36 110.891 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 72.1 p -88.94 -179.85 6.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.482 . . . . 1.48 111.165 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.18 -53.09 62.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 1.59 111.08 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -60.19 -49.73 76.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.043 0.449 . . . . 1.14 110.86 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -58.12 -43.11 87.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 3.03 110.902 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.58 -55.2 37.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 1.66 110.876 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 61.2 m -57.79 -49.26 77.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 1.54 110.912 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -45.5 88.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 1.15 110.868 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.65 -46.93 87.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 1.6 111.111 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.6 tp -60.49 -50.96 71.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 1.52 110.88 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.5 m -66.31 -26.24 67.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 1.4 111.214 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.7 mt -86.17 -14.04 45.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 1.73 110.888 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 p -81.94 2.92 28.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 3.11 110.854 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.8 -4.93 34.43 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.729 . . . . 0.79 112.551 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 tp -87.61 170.82 10.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 1.74 110.896 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.78 170.97 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 1.7 111.126 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 53.11 44.29 30.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 2.1 110.892 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.9 t -81.69 139.42 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 1.77 111.009 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.29 162.4 8.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 2.59 110.96 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.57 145.69 32.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 2.54 110.904 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.8 mp -103.89 -36.79 7.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.472 . . . . 1.56 110.955 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.08 176.29 12.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 1.12 110.926 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -131.26 137.24 48.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 5.16 110.881 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -124.53 137.84 30.04 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.607 0.718 . . . . 1.38 110.958 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.72 165.13 31.96 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.755 2.304 . . . . 0.24 112.329 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.86 127.21 44.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 1.49 110.963 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.74 161.25 23.36 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.555 0.693 . . . . 2.86 111.179 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -24.64 29.31 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.281 . . . . 0.35 112.319 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -85.71 -22.25 27.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 2.58 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -87.71 -52.23 5.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 2.41 110.995 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.84 -40.31 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 1.58 111.136 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -33.03 73.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 1.27 111.011 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -46.34 66.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 1.08 110.879 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.3 -30.12 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 1.55 111.113 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -76.34 -32.68 58.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.108 -0.496 . . . . 3.33 110.806 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -89.35 -20.13 24.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.74 110.877 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -94.6 -32.61 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.31 110.894 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -127.79 -54.37 1.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 1.58 110.921 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.18 9.26 2.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.735 -0.745 . . . . 0.31 112.454 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -70.21 120.93 16.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.87 110.858 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -152.63 104.9 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 2.24 110.894 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -161.11 171.26 18.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 1.08 110.789 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.78 -8.11 17.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 1.87 110.885 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -102.74 12.01 36.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 2.95 110.872 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.07 167.51 14.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 1.68 110.831 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -172.61 130.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 1.7 110.916 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -73.61 132.69 43.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.473 . . . . 3.18 110.939 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.39 142.9 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 1.5 111.09 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -96.86 127.81 43.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 2.41 110.85 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.95 151.39 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 1.73 111.156 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.9 t -134.96 162.96 30.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 1.47 111.217 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.84 134.09 4.21 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 0.16 112.511 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.77 140.37 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 2.41 110.891 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.11 135.48 47.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.54 0.685 . . . . 2.98 110.863 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 125.1 11.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.623 2.215 . . . . 0.38 112.372 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -106.23 150.47 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.933 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.9 t80 65.02 151.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 7.13 111.002 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -66.35 119.69 12.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 9.69 110.849 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.9 m -120.7 178.92 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 5.53 111.105 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -146.78 27.39 1.62 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.797 -0.716 . . . . 5.57 112.521 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.6 m -116.45 75.23 0.95 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.347 . . . . 7.34 110.9 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.25 -170.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 7.49 110.804 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 8.53 110.927 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptm . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.827 0.346 . . . . 4.83 110.853 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.64 -21.42 63.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 1.76 111.155 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.15 -51.48 64.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 1.98 110.93 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -122.33 22.68 10.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 2.65 110.817 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.15 41.08 53.01 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.772 -0.728 . . . . 0.27 112.454 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.02 159.68 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 1.5 111.139 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.5 164.7 37.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.82 110.952 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.46 126.19 35.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 1.63 111.051 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.96 0.96 21.05 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.807 -0.711 . . . . 0.29 112.512 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.89 167.15 11.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 1.32 110.974 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.15 112.79 25.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 2.26 110.947 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.1 t -117.37 130.16 72.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 2.86 111.013 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.11 124.66 49.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 1.33 111.105 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.1 t -97.3 117.03 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 1.59 111.079 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 t -102.56 117.49 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 1.57 111.085 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -114.88 172.46 7.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 0.44 110.908 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -151.73 -172.98 4.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 2.13 110.879 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -35.49 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 4.37 110.929 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -73.91 -8.03 54.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 1.51 110.831 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 m -107.05 93.78 9.73 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.604 0.716 . . . . 1.1 110.833 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 143.79 52.06 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.634 2.223 . . . . 0.23 112.424 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.0 t -48.88 -32.9 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 1.56 111.153 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.94 -53.01 36.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 3.25 110.888 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -44.85 10.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 1.42 111.13 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -52.13 -62.42 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 1.66 110.938 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.16 -36.25 18.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 3.63 110.911 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.14 -47.16 46.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.714 -0.755 . . . . 0.21 112.5 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.7 mt -61.9 -38.89 90.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 1.69 110.96 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.6 m -77.6 -31.48 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 1.7 111.095 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -62.1 -58.52 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 1.58 110.815 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -39.97 75.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 2.68 110.923 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.06 -24.32 60.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 1.53 110.972 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.67 -24.98 44.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.45 110.947 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.98 -29.92 17.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 1.68 111.087 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.46 -35.24 14.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 1.49 110.87 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.14 -45.39 4.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 1.48 111.059 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.15 -12.24 54.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.25 112.5 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -70.91 -62.55 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.323 . . . . 3.41 110.88 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -89.42 -41.11 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 2.38 110.807 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.75 -128.36 5.81 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.788 -0.72 . . . . 0.25 112.541 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -151.82 152.53 32.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 2.92 110.903 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.2 t -135.46 130.0 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 1.56 111.121 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 t -120.74 153.14 37.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 1.18 110.793 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -115.86 138.61 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 1.61 111.155 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -146.9 151.23 36.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 1.21 110.984 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.09 138.68 39.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.39 110.846 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.3 mt -55.04 -42.65 65.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 1.77 111.147 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -25.56 67.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 5.28 110.904 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -111.24 19.32 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 3.55 110.83 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.27 -27.65 6.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 2.09 110.904 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -55.6 -32.53 63.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.29 110.875 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -83.45 -14.31 52.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 1.04 110.951 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 20.7 m -67.56 -8.52 34.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 1.73 110.884 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.41 64.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 1.58 111.129 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -65.13 -67.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.48 110.807 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.37 -177.9 6.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 3.03 110.931 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -93.07 130.46 38.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 1.83 110.861 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t 51.63 83.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.16 110.8 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 91.2 p -136.15 -39.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.792 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -100.59 122.01 42.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 2.54 110.8 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.23 -22.04 62.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 1.49 110.854 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.4 mt -145.5 143.68 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 1.59 111.076 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 18.2 mm -133.03 132.72 58.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 1.62 111.148 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.14 137.21 52.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 1.55 110.957 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.35 101.33 5.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 1.24 110.863 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.23 75.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.852 -0.689 . . . . 0.17 112.427 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.48 59.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 1.52 110.85 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.78 159.71 64.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 1.56 111.125 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 116.84 4.76 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.59 2.193 . . . . 0.24 112.406 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.79 7.49 71.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.798 -0.715 . . . . 0.17 112.523 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.47 148.84 14.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.946 0.403 . . . . 1.13 110.882 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.2 p -137.88 108.57 6.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 1.53 111.127 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.09 153.47 18.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 1.51 111.145 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mt -132.12 104.23 6.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 1.49 110.852 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -79.87 153.84 28.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.34 110.829 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.8 m -130.94 175.82 8.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 1.08 110.824 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.28 -38.22 51.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 1.65 111.07 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.44 -46.03 91.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.193 -0.458 . . . . 2.41 110.819 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -72.6 -54.6 15.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 1.67 111.073 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.8 mt -51.08 -38.26 50.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 1.68 110.857 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.88 -56.55 15.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 1.47 111.049 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -44.12 76.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 2.98 110.949 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.1 mm -55.53 -68.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 1.59 111.172 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.71 -37.4 50.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 1.38 111.096 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -55.2 -50.07 70.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 4.16 110.873 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 32.3 pt -84.99 -7.31 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 1.52 111.165 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.97 112.04 14.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.17 -0.468 . . . . 1.59 110.834 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -51.35 159.31 1.16 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 3.04 110.878 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 114.61 3.76 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.663 2.242 . . . . 0.18 112.306 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.47 3.32 56.44 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.733 -0.746 . . . . 0.17 112.455 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.98 -159.72 10.31 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.14 112.525 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.7 m -140.91 157.91 44.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.825 0.345 . . . . 1.71 110.942 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -141.76 115.05 8.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 1.49 110.896 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -109.23 133.9 52.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 2.89 110.914 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.34 162.41 39.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 1.63 110.874 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.1 123.45 27.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 4.37 110.855 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -146.53 147.84 31.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.613 0.72 . . . . 2.58 110.847 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 145.61 57.58 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.671 2.247 . . . . 0.2 112.311 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 m -131.3 146.45 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 1.61 111.11 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.73 132.68 53.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 3.6 110.866 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.4 p -100.47 26.07 7.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 1.88 111.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.94 27.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 1.83 111.129 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.3 t -143.78 157.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 1.66 111.162 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -59.31 -172.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 1.9 110.841 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.41 -74.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 3.45 110.87 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -52.57 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 3.03 110.893 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.69 -169.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 2.56 110.872 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -5.02 56.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 3.16 110.981 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -146.77 145.8 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 1.83 111.227 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -66.07 110.46 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 3.37 110.983 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.4 p -82.11 177.25 8.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 1.44 111.103 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.88 -54.67 41.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 1.61 111.076 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.88 -48.02 83.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 1.02 110.822 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -57.99 -39.02 77.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 2.82 110.888 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.84 -55.17 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 1.57 110.873 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -56.76 -45.87 81.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 1.95 110.804 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -43.13 89.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 1.5 110.85 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 1.52 111.124 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.6 tp -65.97 -51.43 58.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 1.54 110.858 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.0 m -62.76 -32.3 73.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 1.47 111.125 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.1 mt -86.82 -10.33 53.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.394 . . . . 1.89 110.974 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.02 5.8 27.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 2.45 110.902 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.75 8.36 30.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.755 -0.736 . . . . 0.56 112.445 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.92 171.37 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.346 . . . . 1.45 110.953 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.9 m -149.98 170.71 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 1.55 111.054 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 52.34 44.94 29.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.02 -0.536 . . . . 2.35 110.88 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.1 t -81.78 142.64 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 1.71 111.121 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 159.75 7.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 2.57 110.894 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.01 139.83 38.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 2.82 110.818 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mp -97.63 -37.58 9.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 1.57 110.831 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.7 176.35 12.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 1.15 110.889 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 138.83 50.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 4.9 110.85 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -125.37 136.91 28.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.64 0.733 . . . . 1.42 110.938 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 161.49 45.7 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.694 2.263 . . . . 0.23 112.443 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.96 125.4 39.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 1.72 110.963 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.24 160.75 27.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.539 0.685 . . . . 2.19 111.128 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 -28.92 24.15 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.62 2.214 . . . . 0.46 112.369 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -85.32 -17.82 35.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 3.9 110.88 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.86 -53.52 4.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 2.35 110.899 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.7 p -50.15 -42.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 1.54 111.14 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -32.35 73.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 1.83 110.854 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -50.61 28.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 1.19 110.856 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.21 -28.59 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 1.43 111.123 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -76.13 -47.34 24.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 2.48 110.842 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -74.45 -19.56 60.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 1.88 110.831 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.48 -33.11 13.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.48 110.786 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.82 -54.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 1.72 110.828 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.15 8.2 2.38 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.712 -0.756 . . . . 0.45 112.513 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -70.64 119.94 15.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.76 0.314 . . . . 0.86 110.814 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.53 105.08 2.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 2.19 110.868 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.14 177.52 10.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 1.18 110.902 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.46 -13.45 15.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 1.84 110.857 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.87 3.5 53.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 3.33 110.881 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.05 163.11 28.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 1.71 110.974 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -173.55 129.58 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.256 -0.429 . . . . 1.56 110.902 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -75.73 135.92 40.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 3.22 110.86 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.79 141.99 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 1.58 111.194 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -94.57 127.66 40.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 2.38 110.938 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.39 149.14 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 1.49 111.177 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.2 t -132.5 162.35 31.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 1.59 111.13 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.56 135.86 5.01 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.666 -0.778 . . . . 0.16 112.436 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -92.91 140.0 29.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 2.53 110.918 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.3 135.02 50.9 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.518 0.675 . . . . 2.18 110.917 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.9 125.2 11.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.612 2.208 . . . . 0.31 112.297 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -105.18 149.26 26.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.855 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -72.85 78.35 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 8.77 110.854 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -178.25 34.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 9.74 110.864 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.7 t -147.09 -63.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 7.51 111.194 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 167.05 -26.83 0.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 5.69 112.489 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.22 172.67 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.889 0.376 . . . . 8.01 110.85 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.18 -42.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 6.58 110.931 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.513 . . . . 7.1 110.885 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.844 0.354 . . . . 4.51 110.917 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.06 -18.69 59.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 1.91 111.149 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -50.01 67.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 2.4 110.876 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -122.21 11.92 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 2.75 110.854 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.34 39.5 97.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.812 -0.709 . . . . 0.46 112.445 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -81.52 159.82 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.765 0.316 . . . . 1.62 111.181 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.65 168.62 26.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.78 110.865 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.77 130.1 36.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 1.67 111.106 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.19 2.04 26.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.782 -0.723 . . . . 0.4 112.53 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -118.85 168.0 11.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.816 0.341 . . . . 1.3 110.864 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.02 115.03 29.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.98 0.419 . . . . 3.92 110.851 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.3 t -118.42 131.82 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 2.85 111.172 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.18 125.29 51.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 1.56 111.133 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.6 t -97.47 119.22 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 1.68 111.11 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 t -103.82 112.21 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 1.54 111.031 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -113.73 170.53 8.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.24 110.928 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -151.96 -169.85 3.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.428 . . . . 1.79 110.909 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -35.69 71.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 7.11 110.865 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.1 m -72.96 -9.55 58.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 2.8 110.835 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.01 94.24 10.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.664 0.745 . . . . 1.08 110.84 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 142.57 48.14 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.726 2.284 . . . . 0.31 112.331 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.9 t -48.47 -33.14 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 1.63 111.158 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.09 -52.66 41.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 3.1 110.961 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -45.26 10.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 1.51 111.119 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.69 -61.54 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 1.49 110.977 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.46 -35.58 20.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 3.11 110.874 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.47 -47.56 41.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.766 -0.73 . . . . 0.25 112.486 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.7 mt -61.88 -38.1 87.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 1.63 110.94 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.5 m -78.59 -31.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 1.73 111.079 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.48 -57.37 11.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 1.67 110.834 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -39.88 76.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.271 -0.422 . . . . 3.5 110.932 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -73.26 -24.92 60.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 1.51 110.932 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.17 -25.14 47.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.45 110.969 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.7 -30.74 16.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 1.56 111.099 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.23 -34.86 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 1.66 110.97 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.83 -47.02 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 1.59 111.149 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.5 -13.55 50.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.26 112.451 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.8 -62.62 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 3.67 110.917 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -98.44 -36.87 9.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 2.2 110.935 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.92 -130.91 5.18 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.665 -0.779 . . . . 0.32 112.51 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -152.11 152.24 32.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.323 . . . . 2.93 110.944 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.3 t -137.0 121.09 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 1.42 111.174 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -110.13 155.83 21.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 1.11 110.859 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 p -118.02 133.89 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 1.62 111.12 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -144.01 151.6 39.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 1.94 110.955 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -103.17 133.28 48.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.74 110.91 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.9 mt -49.57 -32.98 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 1.46 111.091 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -71.32 -39.67 71.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 2.95 110.967 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.3 19.43 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 3.99 110.842 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.24 -27.87 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.431 . . . . 2.11 110.948 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mp -55.65 -32.85 63.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 2.24 110.942 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -83.88 -14.13 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.433 . . . . 1.06 110.906 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.4 m -66.47 -9.21 32.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 1.75 110.875 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.29 63.48 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 1.67 111.12 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -63.31 -67.75 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.5 110.818 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.28 179.87 8.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 3.25 110.876 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -87.78 133.94 33.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 1.93 110.944 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.7 p 46.3 83.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 1.51 110.807 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.1 p -134.19 -38.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 1.02 110.858 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -100.87 121.74 42.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 2.56 110.839 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.95 -21.44 61.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 1.73 110.844 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.0 mt -145.22 144.4 21.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 1.48 111.104 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.5 mm -134.5 129.17 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 1.59 111.128 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -111.03 136.31 50.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 1.56 110.912 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.51 100.65 5.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 1.48 110.775 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.02 74.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.451 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -106.31 52.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 1.58 110.83 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.99 159.83 54.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 1.65 111.141 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.88 10.53 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.633 2.222 . . . . 0.29 112.308 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.67 6.33 88.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.28 112.457 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 p -56.5 151.58 13.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.909 0.385 . . . . 1.23 110.848 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -141.62 109.17 5.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 1.57 111.205 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.63 143.64 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 1.53 111.104 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mt -122.52 106.01 10.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 1.61 110.898 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -81.14 153.79 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.31 110.842 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 m -131.97 175.66 9.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 1.03 110.856 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.71 -38.51 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 1.39 111.043 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.09 -47.32 86.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.99 110.856 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.7 mp -71.53 -54.87 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 1.66 111.077 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 66.9 mt -50.3 -39.24 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 1.54 110.868 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.58 -54.43 27.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 1.5 111.033 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.9 -43.38 81.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 2.7 110.913 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.0 mm -60.02 -68.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 1.69 111.047 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.25 -31.26 13.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 1.85 111.167 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -63.83 -49.97 70.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 3.3 110.903 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.0 pt -84.67 -2.95 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 1.71 111.077 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.6 111.99 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 1.52 110.934 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -51.9 159.53 1.36 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 2.95 110.827 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 114.75 3.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.723 2.282 . . . . 0.21 112.289 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.14 3.69 56.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.677 -0.773 . . . . 0.18 112.413 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.42 -163.32 15.66 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.747 -0.739 . . . . 0.15 112.494 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 32.5 m -137.02 154.44 50.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.828 0.347 . . . . 1.71 110.855 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -139.16 115.59 10.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 1.56 110.902 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -110.29 132.16 54.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 2.9 110.886 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.68 164.17 35.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 1.53 110.896 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.87 131.48 31.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 2.5 110.922 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.81 149.41 22.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 3.61 110.882 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 131.92 22.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.266 . . . . 0.41 112.326 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.73 146.8 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 1.56 111.174 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -108.48 132.48 53.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 2.09 110.931 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.9 p -91.15 -26.23 19.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 2.28 111.195 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.73 39.33 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 1.54 111.129 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.5 t -148.24 150.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 1.85 111.087 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.67 175.58 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 1.88 110.902 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -65.92 -66.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 2.86 110.813 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -62.15 -75.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 3.24 110.944 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t 51.25 -168.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 3.0 110.883 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -80.84 -3.1 50.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 2.44 110.942 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.53 144.14 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 1.74 111.12 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.44 117.33 9.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 3.27 110.896 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 45.0 p -92.78 -176.02 4.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 1.58 111.237 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.43 -50.87 69.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 1.65 111.102 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -52.21 65.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.8 110.832 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -54.88 -41.15 70.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 3.35 110.92 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.43 -54.82 34.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 1.73 110.888 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 70.3 m -56.0 -48.07 76.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 1.78 110.843 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -44.97 93.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 1.26 110.79 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.08 99.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 1.65 111.063 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.4 tp -66.29 -53.33 37.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 1.46 110.875 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.1 m -59.84 -33.01 71.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 1.47 111.112 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.7 mt -87.15 -10.53 52.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 1.92 110.936 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.72 4.38 32.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 2.44 110.884 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.87 11.51 26.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 0.7 112.499 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.9 170.41 8.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.356 . . . . 1.62 110.956 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.7 m -151.5 174.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 1.55 111.063 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 52.07 43.93 30.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 2.17 110.863 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.4 t -75.7 143.04 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 1.56 111.099 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 159.1 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 2.54 110.849 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.37 146.8 30.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 2.34 110.881 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.4 mp -106.76 -35.67 6.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 1.54 110.948 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.22 176.24 11.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.23 110.886 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.97 140.4 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.495 . . . . 5.04 110.895 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -126.13 137.46 30.24 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.681 0.753 . . . . 1.53 110.947 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 162.51 41.76 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.65 2.233 . . . . 0.3 112.35 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.8 123.13 42.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 1.53 110.941 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.72 161.04 25.13 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.653 0.74 . . . . 2.81 111.054 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 -25.78 28.76 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.683 2.255 . . . . 0.73 112.388 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -85.42 -22.06 28.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 2.8 110.916 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -87.85 -52.32 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 2.39 110.995 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.89 -39.98 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 1.68 111.109 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -33.42 74.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 1.44 110.87 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -46.02 67.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 1.26 110.949 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.51 -30.25 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 1.58 111.189 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -31.44 56.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.159 -0.473 . . . . 3.91 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -90.31 -19.83 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 2.04 110.888 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -94.25 -33.62 13.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.68 110.874 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 mp -125.19 -54.19 1.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 1.62 110.936 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.96 10.1 2.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 0.39 112.44 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -69.54 120.86 15.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 1.46 110.846 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -149.75 106.38 3.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 3.05 110.936 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.6 174.59 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 1.55 110.906 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -19.14 13.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 2.72 110.818 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -96.6 12.77 30.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 2.3 110.903 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.74 163.7 25.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 1.69 110.951 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -173.49 130.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 1.6 110.855 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -74.76 132.95 42.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 2.97 110.894 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.82 144.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 1.59 111.229 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -101.04 128.27 47.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 1.99 110.949 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.0 148.16 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 1.63 111.103 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.0 t -125.84 158.99 33.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 1.51 111.228 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.03 130.77 3.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.79 -0.719 . . . . 0.2 112.521 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.16 139.14 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.924 0.393 . . . . 2.49 110.834 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 135.09 53.29 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.515 0.674 . . . . 2.19 110.964 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 127.15 14.24 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.676 2.251 . . . . 0.32 112.38 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -107.7 150.56 26.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.3 110.885 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -66.32 90.04 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 8.48 110.934 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -179.32 34.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 9.65 110.897 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.7 m -152.07 -41.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 6.56 111.084 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 52.51 33.0 39.68 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 5.77 112.483 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.81 -67.39 0.82 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.837 0.351 . . . . 7.15 110.91 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.67 -74.29 0.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 6.37 110.809 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 7.96 110.885 -179.976 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptm . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.836 0.35 . . . . 4.76 110.876 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.96 -20.57 66.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 1.44 111.108 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -51.28 65.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 1.94 110.883 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.29 22.38 10.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 2.65 110.84 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.12 40.74 52.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 0.25 112.529 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.25 159.48 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.725 0.298 . . . . 1.49 111.206 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.93 162.69 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 2.03 110.822 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.42 126.53 35.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 1.49 111.124 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.11 -6.67 17.17 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.73 -0.748 . . . . 0.28 112.487 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -113.69 167.66 10.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 1.57 110.965 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -97.96 140.87 31.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 3.76 110.837 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.3 t -142.59 142.69 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 2.8 111.16 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -119.95 121.74 39.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 1.34 111.024 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.7 t -94.41 118.57 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 1.64 111.102 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 t -102.52 110.71 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 1.56 111.121 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -112.45 167.19 10.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.18 110.925 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -149.99 -169.65 3.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 1.98 110.846 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -57.53 -35.62 70.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 3.64 110.894 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.37 -9.54 58.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 2.08 110.866 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.84 94.7 10.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.617 0.722 . . . . 1.66 110.851 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 141.78 46.0 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.7 2.267 . . . . 0.22 112.338 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -48.79 -32.97 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 1.48 111.114 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.08 -52.92 38.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 3.14 110.834 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.46 -44.96 10.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 1.51 111.145 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.74 -61.62 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 1.6 110.894 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -49.7 -37.41 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 4.03 110.947 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.31 -47.33 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.22 112.475 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.89 -39.84 93.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 1.69 110.915 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.2 m -76.79 -31.57 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 1.71 111.231 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.09 -59.56 4.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.115 -0.493 . . . . 1.64 110.786 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -39.82 72.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 2.67 110.874 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.0 mt -73.1 -24.7 60.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 1.34 110.994 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.67 -25.21 44.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.47 110.907 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.84 -29.81 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 1.36 111.141 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.48 -35.19 14.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 1.68 110.93 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -45.34 4.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 1.61 111.166 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.44 -11.75 53.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.672 -0.775 . . . . 0.36 112.453 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.43 -62.39 1.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 3.5 110.944 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -85.91 -43.18 13.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 2.13 110.841 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.23 -121.03 4.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.727 -0.749 . . . . 0.33 112.533 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -158.33 154.13 26.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 3.04 110.81 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.2 t -139.54 131.61 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 1.6 111.161 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -120.76 157.99 28.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 1.33 110.831 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.2 134.99 59.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 1.52 111.138 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -144.76 151.9 39.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.432 . . . . 1.23 110.89 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -101.4 137.39 39.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 2.82 110.9 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.5 mt -51.03 -49.86 26.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 1.74 111.107 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -22.55 63.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 4.29 110.927 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -98.52 18.44 16.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 3.46 110.885 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.98 -28.03 6.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 2.09 110.835 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.81 -37.79 60.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 2.27 110.87 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -85.23 -17.21 37.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 1.19 110.972 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -65.37 -12.51 52.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 1.84 110.908 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.76 64.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 1.64 111.074 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -65.71 -67.98 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.45 110.86 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.32 -175.48 5.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 2.94 110.856 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -94.06 134.85 36.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 1.83 110.864 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p 46.3 82.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 1.42 110.84 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.8 p -133.53 -38.44 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 1.05 110.885 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -101.97 122.0 43.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 3.6 110.84 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.99 -21.48 61.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 1.49 110.827 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.3 mt -142.6 143.88 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 1.74 111.034 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.0 mm -134.27 128.79 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 1.58 111.142 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -111.95 136.31 51.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 1.56 110.913 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.44 101.81 6.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 1.16 110.826 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.84 75.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.783 -0.722 . . . . 0.17 112.47 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.66 58.26 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 1.53 110.883 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.02 159.74 65.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.697 0.761 . . . . 1.67 111.196 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 116.73 4.69 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.738 2.292 . . . . 0.28 112.362 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.18 7.14 70.41 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.805 -0.712 . . . . 0.19 112.416 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -55.27 149.7 12.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.859 0.361 . . . . 1.4 110.853 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.5 p -140.23 108.86 5.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 1.41 111.212 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.1 150.27 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 1.48 111.147 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mt -127.79 102.98 7.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 1.56 110.918 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -77.63 148.66 34.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.25 110.794 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.0 m -127.17 -178.02 4.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.98 110.789 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.75 -41.33 67.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.048 -0.523 . . . . 1.55 111.159 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -57.85 -47.24 83.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 1.85 110.9 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -71.81 -56.75 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 1.68 111.132 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 mt -50.73 -40.83 55.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 1.43 110.968 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.56 -56.7 11.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 1.54 111.114 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -44.49 86.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 2.44 110.855 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.2 mm -53.0 -68.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 1.63 111.166 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.1 -39.85 60.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 1.39 111.121 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.6 tpp85 -53.32 -50.25 65.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 2.89 110.893 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.2 pt -84.11 -8.13 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 1.48 111.067 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.37 113.42 15.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 1.52 110.947 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -52.84 159.88 1.65 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.669 0.747 . . . . 3.08 110.867 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.86 114.5 3.74 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.24 112.332 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.26 5.47 57.1 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.17 112.45 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.44 -163.11 18.72 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.844 -0.694 . . . . 0.14 112.407 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 22.8 m -136.55 154.99 50.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 1.52 110.854 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -139.69 116.38 10.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 1.58 110.919 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -112.21 131.29 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 2.88 110.927 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.41 160.7 42.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 1.59 110.97 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.53 127.94 36.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 2.54 110.909 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.78 148.95 29.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.651 0.739 . . . . 2.2 110.842 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 140.01 41.3 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.598 2.199 . . . . 0.22 112.376 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.81 146.97 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 1.61 111.091 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -109.55 132.46 54.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 2.22 110.869 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.4 p -105.61 26.45 9.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 1.8 111.093 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.58 24.41 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 1.6 111.133 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.4 t -144.81 159.24 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 2.13 111.043 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.02 167.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 1.74 110.819 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -62.78 -50.67 70.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 2.85 110.847 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -74.13 -75.73 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 2.65 110.928 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t 53.56 -166.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 3.16 110.799 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -8.93 59.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 4.92 110.855 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.62 142.78 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 1.59 111.117 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -63.13 116.15 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 3.28 110.932 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 55.7 p -85.03 178.49 7.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.439 . . . . 1.68 111.033 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.97 -54.02 49.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 1.53 111.144 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -59.9 -48.7 80.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 1.06 110.851 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -56.8 -39.55 74.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 2.5 110.898 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.53 -54.98 23.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 1.5 110.857 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.2 m -56.09 -45.34 79.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 2.02 110.954 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -42.56 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 1.41 110.82 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.44 98.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 1.48 111.111 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.66 -52.98 38.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.421 . . . . 1.45 110.874 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.5 m -59.8 -34.72 73.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 1.61 111.083 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.7 mt -84.96 -10.21 57.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 1.71 110.905 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.12 5.45 29.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 2.36 110.8 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.26 7.77 32.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.64 112.495 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.31 170.18 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 1.63 110.992 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -150.86 170.63 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 1.53 111.162 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 54.77 43.27 30.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 2.1 110.858 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.0 t -75.65 143.51 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 1.49 111.106 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.1 159.66 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 2.6 110.867 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -81.86 146.05 30.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 2.37 110.924 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.92 -35.64 7.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 1.52 110.885 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.3 176.27 11.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 1.09 110.888 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.35 137.84 47.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 5.2 110.823 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.91 137.53 29.01 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.593 0.711 . . . . 1.84 111.002 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 165.08 32.09 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.706 2.271 . . . . 0.23 112.389 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.19 126.56 43.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 1.47 110.868 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.34 161.4 23.0 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.606 0.717 . . . . 2.83 111.157 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -24.57 29.81 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.692 2.261 . . . . 0.36 112.366 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.59 -22.52 28.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 2.56 110.898 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -87.79 -52.22 5.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 2.57 110.867 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -49.69 -40.08 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 1.56 111.171 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -33.44 74.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 1.37 110.954 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.35 -45.93 68.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 1.13 110.832 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.4 p -68.36 -30.44 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 1.54 111.103 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -75.98 -32.48 59.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 3.22 110.87 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -89.32 -20.29 24.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 1.65 110.912 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -94.47 -32.78 13.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.32 110.866 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -127.55 -54.37 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 1.56 110.929 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.98 9.11 2.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.768 -0.729 . . . . 0.34 112.537 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -70.3 121.5 17.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.749 0.309 . . . . 0.84 110.879 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -152.08 104.75 3.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 2.15 110.882 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.3 t -161.2 173.12 15.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 1.03 110.858 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.82 -12.71 15.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 1.7 110.797 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -97.67 10.41 40.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 1.94 110.832 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.59 166.61 18.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.189 -0.46 . . . . 1.64 110.83 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -172.97 130.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 1.56 110.978 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -74.79 131.3 40.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 3.04 110.908 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.0 144.18 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 1.64 111.081 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -99.56 128.41 45.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 1.97 110.919 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.3 149.61 30.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 1.47 111.118 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.5 t -127.84 160.88 30.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 1.45 111.109 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.44 132.1 3.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.2 112.503 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -92.94 140.1 29.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 2.44 110.896 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.46 135.13 50.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.603 0.716 . . . . 2.24 110.939 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 123.6 10.26 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.634 2.223 . . . . 0.3 112.346 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -103.55 147.6 26.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.34 110.84 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.2 t80 60.66 19.75 9.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 6.81 110.895 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.54 163.18 24.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.079 -0.509 . . . . 9.33 110.808 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.65 -30.49 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 10.63 111.05 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.47 39.79 60.59 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.743 -0.742 . . . . 9.17 112.451 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.27 -32.75 38.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 12.79 110.881 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.6 m -58.51 -41.93 86.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.5 . . . . 8.3 110.925 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 8.49 110.819 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.812 0.339 . . . . 5.03 110.934 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.17 -21.15 63.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 1.9 111.142 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.57 -51.53 64.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 3.05 110.917 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -122.32 21.79 10.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 3.52 110.917 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.21 39.77 51.19 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.741 -0.742 . . . . 0.39 112.451 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.03 159.19 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 1.56 111.145 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.1 m -147.33 157.03 43.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 1.73 110.85 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.11 123.71 33.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.513 . . . . 1.74 111.112 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.68 -3.51 21.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.758 -0.734 . . . . 0.35 112.5 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -108.89 169.63 8.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.376 . . . . 1.75 110.898 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -104.62 109.68 21.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 2.36 110.873 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.7 135.49 55.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 3.13 111.092 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.7 125.85 53.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 1.68 111.083 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.5 t -97.72 120.53 47.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 1.53 111.129 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.0 t -104.31 121.86 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 1.6 111.13 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -121.38 170.24 9.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.29 110.905 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.25 -171.02 3.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 1.84 110.919 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -57.05 -36.11 70.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 4.7 110.881 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -72.08 -10.21 59.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 1.91 110.807 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -107.68 92.86 9.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.618 0.723 . . . . 0.73 110.884 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.79 143.07 49.52 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.678 2.252 . . . . 0.48 112.306 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.6 t -48.29 -32.61 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 1.56 111.144 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.54 -53.44 37.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 2.59 110.9 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.9 -45.01 10.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 1.59 111.064 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -50.19 -60.26 3.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 1.5 110.91 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -49.44 -35.76 20.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 3.7 110.952 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.89 -48.31 49.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.698 -0.763 . . . . 0.3 112.478 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.1 mt -60.43 -40.55 91.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.865 0.364 . . . . 2.76 110.937 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -76.79 -30.81 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 1.69 111.081 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.94 -60.87 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 1.91 110.929 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -40.58 68.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 3.59 110.821 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.36 -25.57 61.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 1.69 110.991 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.36 -24.94 46.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.53 110.844 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.23 -30.1 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 1.77 111.112 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.34 -34.88 14.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 1.81 110.887 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -103.2 -47.0 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 1.41 111.186 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.24 -14.64 48.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.763 -0.732 . . . . 0.44 112.478 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -60.78 -62.55 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 2.6 110.858 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.23 -36.35 9.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 2.03 110.873 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.72 -137.48 7.61 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.67 -0.776 . . . . 0.47 112.467 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -146.4 150.33 35.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 4.94 110.925 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.8 t -133.66 119.31 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 1.68 111.102 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -108.12 158.04 17.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 1.16 110.796 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.48 138.14 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 1.45 111.109 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -145.82 151.31 37.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 1.23 110.891 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.4 134.62 46.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.66 110.958 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.2 mt -52.77 -35.86 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 1.57 111.119 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -71.51 -31.64 67.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 2.89 110.896 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.91 20.18 18.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 3.61 110.896 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.19 -28.37 4.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 2.09 110.893 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mp -55.27 -34.01 63.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 2.11 110.892 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -84.04 -14.94 49.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 1.07 110.898 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.8 m -67.14 -9.38 39.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 1.64 110.863 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.87 63.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 1.57 111.02 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -63.22 -68.13 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.53 110.849 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.85 -176.95 6.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 3.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -92.72 128.95 38.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 1.82 110.91 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 t 51.67 84.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 1.98 110.806 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.1 p -136.23 -38.87 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 1.01 110.863 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -100.21 123.76 44.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 3.57 110.804 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.38 -21.48 60.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 1.72 110.785 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 mt -144.05 143.3 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 1.57 111.06 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.6 mm -135.62 128.75 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 1.51 111.187 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -112.61 136.31 52.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 1.56 110.845 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.97 105.0 8.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 1.27 110.834 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.26 71.44 0.63 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.768 -0.73 . . . . 0.27 112.488 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.52 57.09 0.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.818 0.342 . . . . 1.53 110.948 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.57 153.01 69.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.637 0.732 . . . . 1.65 111.149 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 116.87 4.75 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.674 2.249 . . . . 0.47 112.336 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.99 6.94 71.15 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.708 -0.758 . . . . 0.47 112.453 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.7 t -66.2 152.97 43.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 3.69 110.832 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 p -136.68 112.42 9.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.521 . . . . 1.54 111.142 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -162.81 144.82 10.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 1.48 111.1 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.3 mt -125.28 116.28 21.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 1.92 110.833 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -89.97 154.06 20.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.28 110.806 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 m -129.51 -177.7 4.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 1.66 110.923 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.5 -37.06 69.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.472 . . . . 1.33 111.025 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -61.77 -46.28 90.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 2.05 110.85 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.31 -54.64 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.468 . . . . 1.63 111.119 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 mt -50.31 -40.8 49.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 1.63 110.924 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.49 -55.48 18.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 1.48 111.12 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -45.26 82.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 3.12 110.869 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.4 mm -54.65 -68.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 1.59 111.088 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.84 -39.3 53.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 1.49 111.181 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -53.18 -51.47 61.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 3.8 110.912 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.8 pt -83.96 -6.98 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 1.49 111.134 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.02 111.25 15.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 1.59 110.854 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -51.79 158.93 1.46 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 4.92 110.923 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 114.15 3.62 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.738 2.292 . . . . 0.3 112.243 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.84 2.8 55.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.18 112.453 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.83 -165.78 23.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.544 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 65.5 m -133.51 152.81 51.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.86 0.362 . . . . 1.69 110.924 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -137.29 114.79 11.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 1.63 110.922 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -110.54 132.54 54.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 3.31 110.897 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.25 157.91 43.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 1.55 110.81 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.1 126.51 43.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.012 -0.54 . . . . 3.7 110.817 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.53 145.96 19.13 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.689 0.757 . . . . 2.27 110.83 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 139.76 41.06 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.721 2.281 . . . . 0.21 112.434 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.52 146.73 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 1.63 111.144 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -110.29 132.59 54.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 1.88 110.892 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.9 p -104.18 26.1 9.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 1.83 111.145 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.99 23.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 1.85 111.131 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.6 t -144.49 159.01 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 1.84 111.145 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -178.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 2.16 110.848 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -68.54 -63.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 2.71 110.84 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.4 -76.03 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 3.11 110.938 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.5 p 51.44 -169.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 2.8 110.809 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.54 -3.84 51.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 2.69 110.846 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.41 153.61 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.426 . . . . 1.55 111.112 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 10.0 mmtm -72.28 109.7 6.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 2.73 110.833 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.2 p -82.4 177.99 8.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 1.56 111.156 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.85 -54.88 39.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 1.42 111.101 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.16 -49.28 77.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 1.01 110.836 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -56.75 -38.63 72.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.191 -0.459 . . . . 2.39 110.96 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.15 -54.89 22.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 1.51 110.929 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.7 m -57.74 -45.8 85.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 1.6 110.834 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -42.95 91.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 1.41 110.87 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.59 93.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 1.56 111.043 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.9 tp -65.63 -50.35 65.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 1.6 110.925 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 96.8 m -61.97 -34.6 76.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 1.33 111.082 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.13 -10.22 57.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 1.8 110.87 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.6 6.52 27.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 2.51 110.884 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.41 4.77 34.86 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.51 112.406 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.63 170.61 7.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 1.65 110.895 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.2 m -151.7 173.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 1.62 111.068 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 51.55 44.1 29.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 2.04 110.878 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 95.3 t -77.73 143.1 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 1.53 111.186 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.15 159.25 7.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.244 -0.435 . . . . 2.61 110.95 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.99 143.33 32.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 3.29 110.923 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 mp -103.19 -37.0 7.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 1.58 110.931 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.81 176.08 13.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 1.21 110.948 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -132.35 137.49 47.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 5.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -123.87 136.81 27.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.632 0.73 . . . . 1.83 110.941 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.77 163.03 39.81 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.759 2.306 . . . . 0.31 112.293 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.45 124.15 40.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 1.57 110.915 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.77 161.38 25.19 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 121.567 0.699 . . . . 2.35 111.088 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 -28.41 25.0 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.678 2.252 . . . . 0.44 112.4 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -85.41 -17.71 35.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 3.66 110.824 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.13 -53.66 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 2.33 110.974 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.9 p -49.43 -40.56 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 1.6 111.127 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -34.61 75.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 1.23 110.831 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.19 -46.38 70.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 1.48 110.791 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.7 p -68.37 -30.37 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 1.4 111.14 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -75.49 -32.29 60.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 2.39 110.953 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -89.62 -20.22 23.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 1.95 110.875 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.42 -32.55 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.33 110.809 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mp -128.04 -53.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 1.72 110.946 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.22 12.4 2.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.814 -0.707 . . . . 0.33 112.491 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -70.6 122.07 19.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.324 . . . . 1.06 110.894 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -151.6 105.44 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 2.73 110.893 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.57 175.21 12.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 1.21 110.836 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.09 -20.31 13.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 1.75 110.881 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -93.57 13.27 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 1.72 110.984 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.91 163.23 23.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 1.66 110.938 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -173.53 129.99 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 1.48 110.948 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -73.81 133.49 43.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 3.21 110.842 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.0 139.74 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 1.69 111.101 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -93.74 129.62 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 2.58 110.938 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.86 150.93 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.424 . . . . 1.56 111.174 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 t -130.04 160.5 33.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 1.46 111.061 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.76 131.38 3.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.719 -0.753 . . . . 0.21 112.441 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -93.83 140.42 29.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 2.29 110.905 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.4 tptt -81.78 134.75 49.8 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.609 0.719 . . . . 3.39 110.818 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 119.39 6.34 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.753 2.302 . . . . 0.42 112.291 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -102.48 151.9 21.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.37 110.904 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -64.44 96.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 8.16 110.934 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -178.41 37.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 10.27 110.91 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 41.0 t -146.27 -69.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 6.73 111.154 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.0 -46.8 1.05 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.788 -0.72 . . . . 5.91 112.502 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 86.3 p -153.77 90.45 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 7.76 110.815 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.5 m -137.21 -64.37 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 8.4 110.819 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 9.36 110.932 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.837 0.351 . . . . 4.68 110.942 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.9 -19.04 59.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 1.57 111.166 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.96 -49.27 69.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 2.1 110.877 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -122.3 18.26 10.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 2.71 110.867 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.17 40.04 73.22 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.788 -0.72 . . . . 0.32 112.417 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -77.0 157.5 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 1.7 111.184 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.2 m -148.3 156.61 42.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 1.59 110.846 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.77 125.31 33.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 1.69 111.093 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.09 -6.23 23.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 0.32 112.51 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.72 167.57 10.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 1.65 110.975 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.51 137.03 38.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 3.84 110.929 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 p -141.86 140.71 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 3.24 111.147 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.64 124.16 50.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 1.54 111.17 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.3 t -95.88 118.52 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 1.54 111.086 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 t -102.7 115.28 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 1.49 111.153 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -115.91 167.2 11.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 0.21 110.967 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -151.3 -169.54 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 1.75 110.892 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -56.8 -35.74 69.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 4.35 110.937 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -73.06 -10.9 60.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 2.72 110.863 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.25 93.57 9.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.604 0.716 . . . . 0.78 110.891 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 142.76 48.76 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.719 2.279 . . . . 0.23 112.336 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -48.92 -32.52 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 1.62 111.144 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.28 -53.2 38.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 2.4 110.913 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -44.95 10.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 1.43 111.091 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.27 -61.51 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 1.44 110.922 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -36.8 31.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 3.19 110.843 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.68 49.91 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.801 -0.714 . . . . 0.24 112.47 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.6 mt -61.7 -40.36 94.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 1.74 110.918 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -76.16 -31.46 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 1.71 111.177 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.02 -60.29 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 1.55 110.821 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -40.15 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 2.71 110.938 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.4 mt -72.69 -24.68 61.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 1.65 110.841 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.4 -24.86 46.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.44 110.926 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.82 -30.02 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 1.54 111.132 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.43 -35.3 14.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 1.71 110.879 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.33 -44.77 5.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 1.48 111.057 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.49 -10.94 55.46 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.729 -0.748 . . . . 0.25 112.498 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.32 -62.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 2.4 110.966 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -91.47 -39.94 11.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 2.24 110.875 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.21 -125.73 4.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.34 112.538 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -156.25 152.68 28.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 4.61 110.965 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -135.84 130.21 48.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 1.62 111.203 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -118.61 156.9 28.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 1.46 110.869 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 p -119.39 136.71 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 1.42 111.118 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -147.26 152.17 37.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 1.3 110.894 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.66 135.72 43.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.66 110.944 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.6 mt -51.61 -35.43 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 1.63 111.19 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -29.99 59.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 3.56 110.905 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -97.89 18.44 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 3.34 110.942 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.74 -30.23 5.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 2.15 110.999 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -54.51 -37.36 65.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 1.82 110.923 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -84.6 -15.66 44.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 1.15 110.946 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 m -66.95 -10.17 46.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 1.67 110.872 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.07 63.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 1.59 111.116 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -61.75 -69.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.46 110.889 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.76 -175.5 5.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 3.33 110.865 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.47 134.84 35.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.59 110.929 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p 46.24 82.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 1.48 110.848 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.3 p -133.4 -38.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 1.3 110.87 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -101.65 122.44 43.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 3.55 110.906 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.55 -21.09 61.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.155 -0.475 . . . . 1.49 110.861 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 mt -143.38 143.52 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 1.65 111.089 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.3 mm -134.99 129.04 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 1.61 111.062 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -113.19 136.77 52.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 1.53 110.888 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.15 101.92 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 1.13 110.859 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.4 77.43 0.13 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.81 -0.709 . . . . 0.18 112.423 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.45 58.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 1.63 110.894 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.18 160.12 61.44 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.654 0.74 . . . . 1.62 111.163 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 115.95 4.32 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.709 2.273 . . . . 0.3 112.365 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.84 6.43 67.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.711 -0.756 . . . . 0.21 112.496 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.49 150.37 12.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.991 0.424 . . . . 0.99 110.877 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.6 p -140.8 108.96 5.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 1.65 111.16 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.2 148.35 11.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 1.55 111.142 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.23 101.2 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 1.64 110.935 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.16 138.17 38.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.41 110.848 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -115.83 -175.67 2.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.98 110.843 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.68 70.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 1.5 111.167 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -62.31 -42.95 99.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 1.81 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -77.79 -55.2 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 1.64 111.165 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.4 mt -50.36 -41.57 51.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 1.61 110.895 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.61 -56.51 13.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 1.56 111.105 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -41.44 74.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.433 . . . . 2.47 110.815 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.9 mm -58.55 -68.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 1.51 111.107 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.82 -35.0 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 1.4 111.168 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -59.31 -51.42 70.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 3.67 110.891 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.2 pt -83.46 -4.04 8.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 1.56 111.083 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.1 112.06 18.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 1.55 110.917 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -51.65 159.58 1.24 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.61 0.719 . . . . 2.82 110.873 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 114.26 3.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.685 2.257 . . . . 0.2 112.306 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.63 3.73 56.13 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 0.17 112.466 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.05 -166.94 26.63 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.782 -0.723 . . . . 0.21 112.491 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.5 m -133.1 153.36 51.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.873 0.368 . . . . 1.87 110.95 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -137.93 116.37 12.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 1.43 110.914 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -112.33 131.89 55.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 3.27 110.836 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.2 156.92 43.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 1.58 110.866 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.03 126.76 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 3.05 110.917 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.88 146.9 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.65 0.738 . . . . 2.31 110.852 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 143.72 52.11 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.586 2.19 . . . . 0.25 112.368 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.38 146.75 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 1.54 111.135 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -106.8 132.85 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 2.18 110.832 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -93.01 -42.11 9.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 1.86 111.129 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.72 39.91 1.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 1.9 111.182 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.25 150.6 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 1.93 111.128 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.66 167.92 0.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 1.96 110.912 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -60.54 -55.0 38.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 2.68 110.822 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.59 -77.3 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 3.37 110.853 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p 54.0 -173.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 2.4 110.814 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.63 -2.1 45.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 3.54 110.927 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.1 m -143.39 154.52 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.177 -0.465 . . . . 2.07 111.09 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -69.88 121.03 16.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 3.24 110.958 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.7 p -97.05 -177.96 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 1.42 111.109 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -52.9 63.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 1.4 111.103 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.92 -50.5 73.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 1.04 110.853 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -58.93 -40.59 85.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 3.21 110.956 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.52 -54.64 43.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 1.81 110.926 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 67.2 m -55.54 -50.99 68.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 1.52 110.863 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -48.22 82.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 1.32 110.826 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.27 -51.52 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.064 -0.516 . . . . 1.48 111.092 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.0 tp -57.38 -47.12 82.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 1.65 110.839 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.2 m -67.34 -22.24 65.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 1.74 111.162 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.48 -15.37 40.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 2.51 110.884 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.9 5.0 30.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 2.7 110.892 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.45 -4.86 35.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 0.48 112.573 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.06 168.96 12.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.844 0.354 . . . . 1.68 110.899 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.5 m -151.39 171.86 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 1.71 111.135 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 53.58 43.72 30.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 2.11 110.836 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.22 142.51 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 1.79 111.14 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.07 160.65 8.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 2.67 110.844 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -82.36 146.69 29.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 2.39 110.932 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 mp -107.39 -35.76 6.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 1.54 110.919 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.47 176.24 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 1.18 110.883 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -133.19 137.82 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 5.08 110.877 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -125.49 138.8 32.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.636 0.731 . . . . 1.44 110.91 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.84 164.49 34.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.615 2.21 . . . . 0.27 112.329 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.07 135.76 38.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 1.46 110.886 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.24 160.98 25.59 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 2.24 111.194 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -29.3 24.02 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.684 2.256 . . . . 0.44 112.27 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -85.31 -19.26 31.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 2.76 110.864 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -53.24 5.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 2.21 110.968 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.7 p -49.21 -41.94 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 1.66 111.033 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -33.69 72.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 1.35 110.866 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.28 -45.05 70.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 1.07 110.898 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.89 -32.39 54.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.492 . . . . 1.8 111.172 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -76.3 -30.0 57.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 3.58 110.85 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -90.43 -20.49 22.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 1.63 110.836 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -94.72 -32.96 13.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.59 110.8 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.0 mp -126.75 -53.98 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 2.11 110.925 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.78 12.07 2.01 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.635 -0.793 . . . . 0.9 112.435 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -70.12 121.25 17.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.687 0.279 . . . . 1.86 110.896 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -149.41 111.65 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 3.21 110.847 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.55 165.18 31.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 2.3 110.86 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.76 -7.48 19.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 2.47 110.814 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -115.56 22.8 12.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 1.9 110.862 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.16 169.48 13.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 1.81 110.92 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -173.51 130.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 1.6 110.961 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -72.94 131.84 42.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 3.21 110.943 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.95 140.38 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 1.53 111.16 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -93.95 126.84 39.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 2.44 110.864 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -122.35 151.4 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 1.59 111.147 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.2 t -129.72 161.45 30.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 1.65 111.145 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.5 130.48 3.07 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.3 112.485 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -94.86 140.56 29.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 2.32 110.838 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -82.31 134.54 48.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.535 0.684 . . . . 3.45 110.955 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 118.88 5.94 Favored 'Trans proline' 0 C--O 1.23 0.1 0 C-N-CA 122.723 2.282 . . . . 0.36 112.29 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -100.29 151.97 20.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.32 110.851 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -171.27 -174.62 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 8.89 110.819 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -107.77 30.22 6.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 8.9 110.908 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.0 t -145.21 149.77 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 11.38 111.083 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -52.3 -41.17 54.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 13.02 112.57 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.33 -75.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.396 . . . . 10.99 110.849 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.7 -174.07 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 14.74 110.955 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 10.82 110.882 -179.886 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.5 mtt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.831 0.348 . . . . 5.26 110.874 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.5 -21.32 66.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 1.79 111.094 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -54.1 -51.61 63.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 2.32 110.874 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -122.22 20.81 10.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 2.71 110.966 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 56.24 40.79 85.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.752 -0.737 . . . . 0.44 112.472 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 mp -83.46 160.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.826 0.346 . . . . 1.77 111.067 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.36 168.01 28.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 1.84 110.899 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.51 134.41 34.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 1.73 111.135 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.51 2.5 37.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.41 112.458 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -121.04 171.88 8.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.793 0.33 . . . . 1.35 110.96 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.54 137.39 40.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 2.34 110.833 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.3 t -141.92 123.96 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 2.83 111.098 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.41 125.9 49.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 1.36 111.216 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.3 t -98.12 112.41 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 1.67 111.113 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.8 t -98.09 129.87 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 1.58 111.132 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -128.68 170.68 12.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.33 110.915 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -151.65 -172.76 4.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 1.77 110.924 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -23.41 62.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 4.04 110.857 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.83 -16.31 48.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.83 110.924 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 m -101.67 102.79 24.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.66 0.743 . . . . 0.99 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 136.85 34.08 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.66 2.24 . . . . 0.54 112.428 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.19 -31.66 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 1.75 111.121 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.02 -52.46 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 2.48 110.922 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.94 -43.81 12.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 1.53 111.099 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -51.48 -60.28 3.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 1.59 110.915 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.45 -46.83 27.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 3.02 110.963 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.68 -37.02 93.1 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.771 -0.728 . . . . 0.66 112.462 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 33.8 mt -60.25 -50.75 72.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 2.07 110.928 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -77.66 -25.28 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 4.61 111.099 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -60.91 -62.43 1.86 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 1.94 110.873 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -40.34 62.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 2.55 110.891 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.7 mt -72.22 -24.48 61.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 1.56 110.934 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -77.49 -25.58 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 2.25 110.938 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.15 -31.34 17.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 1.38 111.056 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.06 -34.76 15.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 1.58 110.874 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -103.08 -47.54 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 1.6 111.174 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.03 -15.6 50.27 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.764 . . . . 0.51 112.467 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.23 -61.06 2.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 2.62 110.793 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -102.88 -34.27 9.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 2.2 110.957 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.34 -120.55 1.9 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 0.61 112.464 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -166.44 156.45 11.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 3.03 110.846 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.4 137.55 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 1.95 111.128 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -129.43 158.37 39.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 1.26 110.804 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -117.25 141.0 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.488 . . . . 1.52 111.135 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -145.92 151.53 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 2.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -103.58 134.79 46.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.64 110.894 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.8 mt -52.94 -36.14 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 1.68 111.061 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -31.41 67.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 3.46 110.816 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -104.0 20.1 18.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 3.54 110.969 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.32 -27.93 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 2.12 110.914 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -54.96 -34.34 63.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 2.07 110.853 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -84.47 -15.55 45.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 1.07 110.877 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.9 m -65.83 -11.05 43.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 1.94 110.838 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.97 63.0 0.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 1.66 111.172 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -62.95 -70.82 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.5 110.832 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.7 -169.02 3.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 2.96 110.909 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -102.46 136.37 42.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 1.78 110.87 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.8 p 47.21 85.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 1.6 110.84 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.1 p -140.52 -40.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 1.16 110.798 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -99.42 119.18 37.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 3.69 110.889 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.87 -20.09 62.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 1.69 110.864 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.4 mt -146.46 143.7 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 1.63 111.13 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.0 mm -134.09 130.67 55.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 1.45 111.145 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.78 134.14 54.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.213 -0.448 . . . . 1.61 110.931 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.46 95.68 4.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.188 -0.46 . . . . 1.24 110.87 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 53.68 72.17 0.58 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 0.32 112.515 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.97 56.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.792 0.33 . . . . 1.51 110.898 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.42 159.9 52.95 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.613 0.72 . . . . 1.53 111.12 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 123.18 9.86 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.669 2.246 . . . . 0.27 112.381 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.27 6.97 87.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.757 -0.735 . . . . 0.23 112.507 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.8 p -55.48 148.57 15.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 1.1 110.874 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.5 p -137.83 109.1 6.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 1.59 111.14 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.37 152.28 16.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 1.55 111.195 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mt -131.15 103.45 6.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 1.53 110.959 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -79.52 152.94 29.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.28 110.874 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 m -129.23 176.28 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.87 110.823 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.27 53.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 1.68 111.11 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.37 -46.1 91.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 1.73 110.853 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -72.9 -54.54 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 1.65 111.129 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.0 mt -50.68 -38.68 48.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 1.39 110.997 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.83 -52.96 61.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 1.64 111.108 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 -43.18 79.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 2.84 110.922 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.31 -68.44 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 1.72 111.194 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.52 -33.8 15.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 1.43 111.106 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -61.06 -52.51 64.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 3.43 110.94 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.9 pt -81.43 -4.41 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 1.58 111.134 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.03 122.4 27.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 1.65 110.887 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -61.08 159.67 26.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.525 0.679 . . . . 4.67 110.885 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 114.24 3.64 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.598 2.199 . . . . 0.3 112.39 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.47 5.1 55.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 0.25 112.496 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.11 -159.61 13.19 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 0.25 112.428 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.4 m -140.9 155.04 46.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.332 . . . . 1.62 110.835 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -139.31 115.57 10.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.184 -0.462 . . . . 1.61 110.917 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -109.98 133.71 52.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 3.31 110.846 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.69 158.0 43.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 1.65 110.954 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.3 123.68 36.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 2.85 110.945 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.55 147.92 29.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.576 0.703 . . . . 2.27 110.947 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 144.77 54.97 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.665 2.244 . . . . 0.22 112.293 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 m -125.41 147.1 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 1.53 111.227 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -115.1 132.36 56.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 1.96 110.893 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.5 p -105.99 25.92 10.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 2.02 111.171 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.19 25.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 1.76 111.079 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.4 159.96 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 1.85 111.114 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.91 179.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.071 -0.513 . . . . 2.08 110.865 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -65.32 -66.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 2.74 110.901 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -63.32 -75.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 2.86 110.898 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.23 -168.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 2.34 110.802 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -5.72 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.046 -0.525 . . . . 3.38 110.955 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 m -146.19 145.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.165 -0.47 . . . . 1.73 111.066 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -67.68 116.31 8.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 3.5 110.884 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.7 p -85.35 -179.87 7.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 1.46 111.077 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.94 -54.56 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 1.64 111.052 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -48.81 78.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 1.08 110.829 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -58.95 -38.24 78.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 2.85 110.871 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.59 -54.6 33.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.427 . . . . 2.04 110.933 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.4 m -58.7 -49.56 77.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 1.68 110.965 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -47.47 86.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 1.65 110.852 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.01 -54.64 42.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 1.74 111.058 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 tp -53.8 -48.14 70.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 1.63 110.926 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.8 m -67.63 -22.43 65.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 1.4 111.125 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.4 mt -86.98 -15.08 39.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 1.91 110.881 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.46 5.37 27.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 2.88 110.847 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.87 -5.03 34.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.664 -0.779 . . . . 0.68 112.48 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.5 166.71 15.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 1.68 110.912 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.0 m -147.02 170.43 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 1.65 111.103 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 52.24 44.72 29.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 2.28 110.895 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.6 t -82.77 141.38 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 1.63 111.133 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.93 158.84 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 2.69 110.846 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -75.87 146.01 40.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 2.23 110.925 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.0 mp -104.47 -37.36 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 1.56 110.975 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.43 176.18 12.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 1.17 110.906 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.85 145.3 51.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 5.1 110.786 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -134.32 136.16 25.36 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.624 0.726 . . . . 1.44 110.889 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 164.91 32.75 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.665 2.243 . . . . 0.35 112.344 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.03 126.05 43.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 1.53 110.948 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.01 161.48 22.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.574 0.702 . . . . 2.77 111.153 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -24.64 29.74 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.711 2.274 . . . . 0.4 112.31 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -85.46 -22.03 28.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.437 . . . . 2.76 110.882 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -87.81 -53.59 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 2.51 110.945 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.5 p -49.58 -40.08 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 1.57 111.093 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -34.53 76.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 1.48 110.921 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.5 -47.15 67.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 1.11 110.853 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.59 -30.92 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 1.42 111.033 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -76.57 -29.58 56.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 2.15 110.936 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -89.91 -21.39 22.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 1.89 110.9 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.63 -32.41 13.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.33 110.923 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.6 -54.37 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 1.63 110.874 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.11 18.4 1.69 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.767 -0.73 . . . . 0.33 112.512 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -72.69 122.08 20.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 1.23 110.845 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -151.64 107.62 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 2.74 110.863 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.5 t -160.47 173.8 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 1.62 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.32 -19.75 13.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.64 110.865 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -96.83 17.05 17.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 1.58 110.959 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.78 165.38 19.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 1.7 110.918 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -173.73 130.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 1.69 110.876 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -75.84 138.46 41.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 3.03 110.871 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.93 148.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 1.76 111.14 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -100.2 130.29 46.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 2.3 110.902 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.91 150.77 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 1.66 111.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.1 t -135.25 161.43 35.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 1.67 111.125 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.59 135.61 5.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.707 -0.758 . . . . 0.25 112.442 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -91.86 140.31 29.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 2.47 110.898 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 135.26 49.28 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.612 0.72 . . . . 2.32 110.853 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 127.68 14.9 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.688 2.258 . . . . 0.45 112.306 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -108.33 150.03 27.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.34 110.904 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 36.0 t80 64.97 151.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 6.91 110.836 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -80.03 132.91 36.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 8.7 110.908 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.3 m -122.83 -35.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 5.66 111.14 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.15 -36.35 4.27 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.761 -0.733 . . . . 6.08 112.478 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.24 149.28 24.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 6.35 110.786 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.69 144.85 27.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.514 . . . . 9.3 110.898 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 11.9 110.886 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.813 0.339 . . . . 5.47 110.872 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.54 -19.43 57.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 1.33 111.127 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -49.73 68.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 1.83 110.893 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.22 19.97 10.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 2.69 110.854 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.26 41.51 54.46 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.722 -0.752 . . . . 0.25 112.461 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.0 158.61 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 1.72 111.089 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.8 m -148.38 157.13 43.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 1.75 110.916 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.33 128.32 34.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 1.52 111.095 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.36 28.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.738 -0.744 . . . . 0.26 112.487 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.99 167.41 10.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 1.64 110.873 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.21 136.68 38.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 2.27 110.843 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.43 138.72 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.481 . . . . 3.18 111.183 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.59 129.5 56.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 1.57 111.154 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -101.1 123.79 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 1.67 111.12 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.6 t -105.15 116.45 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 1.65 111.11 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -119.33 164.63 15.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.23 110.846 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -148.73 -169.52 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 4.66 110.792 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -35.68 67.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 4.06 110.913 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.5 -11.55 60.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 1.51 110.896 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.47 95.52 11.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.673 0.749 . . . . 0.87 110.89 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 141.19 44.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.627 2.218 . . . . 0.22 112.36 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.19 -32.7 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 1.6 111.106 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.36 -52.5 45.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 2.48 110.922 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.4 -45.07 10.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 1.41 111.085 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.9 -61.12 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 1.56 110.902 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.81 -35.66 23.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 3.45 110.904 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.44 -48.21 45.95 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.731 . . . . 0.23 112.485 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 mt -61.63 -41.22 97.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.746 0.308 . . . . 1.74 110.846 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.2 m -74.91 -31.6 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 1.71 111.197 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.08 -62.18 1.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 1.8 110.871 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -40.16 65.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 2.79 110.888 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 76.7 mt -72.77 -25.05 61.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.195 -0.457 . . . . 1.62 110.853 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.43 -24.75 46.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.48 110.912 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.9 -29.85 17.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 1.41 111.088 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.63 -35.05 14.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 1.61 110.946 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.45 -44.72 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 1.56 111.126 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.23 -10.98 54.56 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.661 -0.781 . . . . 0.32 112.446 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -71.38 -62.38 1.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.754 0.311 . . . . 2.26 110.961 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -91.58 -40.18 11.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 1.94 110.881 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.95 -126.49 5.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.68 -0.772 . . . . 0.27 112.488 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -155.27 152.83 29.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 2.93 110.992 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.7 t -136.72 130.36 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 1.47 111.132 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 t -118.56 156.14 29.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 1.59 110.799 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -117.62 132.02 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 1.43 111.099 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -142.07 152.24 43.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 1.21 110.896 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -101.77 135.61 43.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.62 110.851 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mt -50.07 -44.09 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 1.65 111.15 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -72.24 -27.6 62.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 4.27 110.874 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -95.22 19.24 10.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 3.49 110.942 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.93 -29.65 3.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 2.11 110.91 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mp -51.91 -36.99 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 2.21 110.959 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -86.01 -19.45 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 1.22 110.926 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.2 m -60.21 -16.85 36.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 1.82 110.889 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.44 63.27 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 1.62 111.053 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -65.27 -70.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.51 110.89 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 -167.92 2.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 2.04 110.829 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -108.79 131.81 54.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 1.86 110.845 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 p 47.16 72.44 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 1.25 110.851 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -127.22 -33.69 2.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 1.07 110.842 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -99.81 118.34 36.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 2.56 110.893 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.1 -19.21 62.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 1.72 110.803 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.9 mt -145.46 144.61 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 1.65 111.076 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.3 mm -136.7 129.13 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 1.71 111.144 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.7 136.57 52.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 1.49 110.945 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.13 102.16 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 1.18 110.914 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.31 77.37 0.13 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.762 -0.732 . . . . 0.24 112.481 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.49 53.75 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 1.51 110.921 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.56 160.34 53.74 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.611 0.72 . . . . 1.4 111.071 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 116.35 4.51 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.671 2.248 . . . . 0.28 112.433 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.83 6.73 69.46 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.681 -0.771 . . . . 0.21 112.486 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.92 132.08 48.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 1.04 110.907 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.9 p -122.54 108.5 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 1.58 111.171 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 m -162.73 154.8 18.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 1.59 111.147 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.7 mt -133.17 104.58 6.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 1.75 110.853 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -76.18 153.72 35.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.074 -0.512 . . . . 0.38 110.886 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.1 m -131.56 177.42 7.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.98 110.836 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.7 -42.03 56.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 1.35 111.002 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.14 -46.07 86.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 1.91 110.954 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -71.9 -56.68 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 1.6 111.104 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.1 mt -50.84 -43.45 59.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 1.52 110.909 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.34 -54.24 34.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 1.58 111.057 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -43.32 84.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 2.71 110.836 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.6 mm -54.98 -67.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 1.58 111.088 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.13 -39.77 56.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 1.54 111.106 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -52.87 -53.9 42.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 3.07 110.889 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 36.3 pt -80.15 -8.5 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 1.57 111.129 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.3 127.56 32.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 1.49 110.916 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -67.41 160.28 72.84 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.657 0.742 . . . . 2.91 110.763 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 113.91 3.53 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.736 2.291 . . . . 0.17 112.336 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.74 56.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.747 -0.739 . . . . 0.14 112.496 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.51 -164.58 19.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.661 -0.78 . . . . 0.13 112.48 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 45.0 m -134.72 154.21 51.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.876 0.369 . . . . 1.77 110.887 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -139.61 113.99 9.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 1.61 110.944 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -109.39 131.73 54.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 3.38 110.927 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.79 158.09 43.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 1.46 110.815 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.74 130.59 45.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 2.59 110.918 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.4 145.67 17.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.637 0.732 . . . . 2.23 110.886 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.92 137.54 35.23 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.678 2.252 . . . . 0.36 112.282 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 m -120.33 146.41 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 1.67 111.091 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -111.4 132.79 54.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 1.98 110.856 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.2 p -106.39 26.09 10.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 2.13 111.169 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.85 24.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 2.02 111.145 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.1 t -144.22 161.0 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 1.86 111.137 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.77 177.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.91 110.895 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -67.87 -53.48 26.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 3.86 110.912 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -70.77 -75.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 3.02 110.825 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.03 -168.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 2.03 110.799 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -4.02 53.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 2.35 110.921 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.42 140.25 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.111 -0.495 . . . . 1.86 111.114 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.9 mmpp? -63.66 112.94 3.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 3.87 111.016 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.3 p -80.28 176.66 9.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 1.75 111.13 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.98 -54.9 32.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 1.43 111.075 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.33 -48.85 80.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 1.37 110.752 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -39.11 72.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 3.12 110.9 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.39 -55.15 19.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 1.56 110.994 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.4 m -56.7 -44.92 82.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.243 -0.435 . . . . 1.67 110.963 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.83 -42.34 85.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 1.33 110.867 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.2 97.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 1.46 111.161 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 tp -65.17 -53.98 36.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 1.72 110.894 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 96.1 m -58.28 -36.88 73.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 1.46 111.173 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.6 mt -83.42 -10.39 58.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 1.76 110.969 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m -84.65 4.89 30.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 2.39 110.886 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.01 8.68 31.3 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.662 -0.78 . . . . 0.62 112.446 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.46 168.66 9.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.789 0.328 . . . . 1.57 110.892 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.2 m -150.57 169.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 1.53 111.144 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 56.2 42.64 27.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 2.02 110.927 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.81 144.33 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 1.7 111.136 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.82 157.13 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 2.51 110.923 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -81.48 147.3 29.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 2.1 110.902 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 mp -108.21 -36.01 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 1.54 110.927 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -164.86 176.57 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 1.34 110.981 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -126.56 166.25 17.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 9.43 110.84 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -147.96 135.71 10.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.572 0.701 . . . . 1.44 110.897 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 155.83 65.04 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.618 2.212 . . . . 0.35 112.434 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.34 122.83 35.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.26 -0.427 . . . . 1.48 110.973 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.46 162.0 22.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.539 0.685 . . . . 2.42 111.2 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -26.12 27.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.651 2.234 . . . . 0.36 112.334 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -85.33 -19.79 30.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 2.91 110.888 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.22 -54.41 4.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 2.65 110.934 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.95 -38.85 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 1.5 111.125 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -39.04 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 3.0 110.916 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -45.59 79.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 1.47 110.864 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.71 -31.25 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 1.57 111.158 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -75.74 -30.65 59.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.122 -0.49 . . . . 2.62 110.875 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -90.02 -20.48 23.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 1.76 110.876 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.43 -32.8 13.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.31 110.941 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.65 -54.15 1.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 1.58 110.92 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.8 18.4 1.57 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.36 112.473 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -73.72 122.03 21.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.778 0.323 . . . . 1.47 110.923 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -151.58 105.57 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 2.79 110.966 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.9 t -160.55 170.72 20.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 1.32 110.873 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.34 -18.34 14.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 1.6 110.902 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -98.5 20.25 13.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 1.55 110.83 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.67 164.26 15.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 1.44 111.025 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -173.26 130.35 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.214 -0.448 . . . . 1.46 110.936 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -69.79 134.76 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 3.3 110.848 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.6 144.94 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 1.7 111.176 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -103.29 130.65 50.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 2.65 110.921 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.05 152.58 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 1.59 111.118 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.2 t -131.98 159.19 39.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 1.52 111.128 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -148.3 133.61 4.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 0.19 112.514 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -94.26 131.82 39.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.925 0.393 . . . . 4.68 110.862 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 135.45 81.19 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.549 0.69 . . . . 2.17 110.898 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 128.79 16.53 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.695 2.263 . . . . 0.36 112.35 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -109.67 150.44 28.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.31 110.903 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.8 t80 64.59 112.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 7.15 110.867 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.46 107.77 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 10.17 110.864 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.0 m -115.46 -30.3 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 5.53 111.114 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.1 24.6 65.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.745 -0.741 . . . . 6.06 112.5 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 19.4 m -90.67 137.91 31.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.377 . . . . 6.29 110.817 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.26 -75.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 7.09 110.892 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 7.56 110.923 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.747 0.308 . . . . 4.36 110.868 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.55 63.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 1.41 111.08 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.35 -51.58 64.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 2.46 110.901 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -122.26 22.45 10.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 2.77 110.883 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.14 41.65 53.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.718 -0.753 . . . . 0.27 112.488 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mp -81.02 160.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.904 0.383 . . . . 1.54 111.101 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.0 167.84 29.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 2.5 110.858 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.6 128.81 36.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 1.62 111.098 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.07 2.92 26.52 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.754 -0.736 . . . . 0.36 112.505 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -116.63 166.95 11.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.86 0.362 . . . . 1.19 110.864 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -106.13 112.89 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 2.36 110.906 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -115.23 141.47 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 3.29 111.165 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -116.59 112.19 20.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 1.33 111.066 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.2 t -86.53 121.13 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 1.52 111.074 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.53 115.76 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 1.56 111.067 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -115.49 168.73 9.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 0.23 110.977 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -151.42 -170.22 3.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.83 110.896 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -57.1 -35.73 69.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 4.37 110.863 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.8 m -73.34 -9.66 58.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 1.87 110.786 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.29 93.75 10.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.621 0.724 . . . . 0.92 110.848 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 142.8 48.92 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.723 2.282 . . . . 0.24 112.333 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.05 -32.43 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 1.55 111.08 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -51.29 -53.24 37.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 2.43 110.903 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.73 -44.86 10.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 1.5 111.054 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.2 -61.22 2.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 1.64 110.914 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -49.83 -35.63 23.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 3.6 110.888 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.02 -47.72 44.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 0.31 112.53 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.67 -39.44 91.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.38 . . . . 1.55 110.911 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 m -77.14 -31.32 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 1.77 111.026 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.31 -59.25 5.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 1.75 110.826 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -40.43 73.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 2.55 110.885 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.4 mt -72.59 -25.07 61.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 1.36 110.953 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.02 -25.02 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 0.54 110.848 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.47 -30.84 17.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 1.45 111.114 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.47 -34.89 15.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 1.57 110.907 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.32 -47.13 4.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 1.45 111.132 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.1 -14.5 53.48 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.699 -0.762 . . . . 0.36 112.481 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.43 -62.68 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.756 0.313 . . . . 2.71 110.816 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.95 -33.7 8.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 1.97 110.982 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.61 -131.04 4.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.3 112.54 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -153.28 152.74 31.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.791 0.329 . . . . 4.84 110.872 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.3 t -139.27 113.69 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.67 111.125 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -103.93 153.18 21.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 1.14 110.895 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.92 133.46 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.11 -0.495 . . . . 1.56 111.148 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -142.16 151.97 42.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 1.32 110.921 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -102.66 135.11 44.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.63 110.921 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.9 mt -51.76 -35.15 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 1.64 111.181 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -29.75 60.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 2.97 110.925 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -98.21 18.59 15.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 3.36 110.926 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.31 -30.77 5.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 2.12 110.912 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -53.93 -37.91 64.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 1.83 111.062 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -84.9 -15.64 43.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 1.22 110.948 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.6 m -66.31 -10.82 46.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 2.0 110.9 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.68 63.43 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.473 . . . . 1.65 111.11 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -61.55 -69.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.46 110.801 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.16 -175.88 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 2.9 110.837 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -93.73 135.22 35.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 1.8 110.896 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p 46.64 81.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 1.41 110.819 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.9 p -132.07 -39.17 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 1.09 110.795 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -102.16 123.89 46.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 3.62 110.89 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.28 -21.64 62.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 1.71 110.805 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.0 mt -146.6 142.7 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 1.71 111.166 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.6 mm -129.2 136.76 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 1.62 111.147 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.12 135.77 53.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 1.73 110.966 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.72 98.02 4.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 1.45 110.851 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.11 79.58 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.752 . . . . 0.18 112.502 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.85 55.42 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.935 0.398 . . . . 1.51 110.959 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.77 158.72 58.78 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.636 0.731 . . . . 1.62 111.141 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 115.91 4.31 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.635 2.223 . . . . 0.28 112.393 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.3 6.6 66.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 0.24 112.474 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.32 151.86 9.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.952 0.406 . . . . 1.02 110.841 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.1 p -140.11 108.77 5.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 1.46 111.135 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.92 148.57 12.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 1.54 111.08 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mt -126.75 99.79 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 1.67 110.904 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -76.78 143.77 39.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.28 110.848 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.83 -175.52 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 1.42 110.746 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.54 -36.17 71.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 1.37 111.016 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.58 -44.31 96.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 1.78 110.804 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -76.03 -55.18 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 1.38 111.187 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 mt -50.14 -41.86 49.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 1.58 110.933 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.56 -55.77 17.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 1.45 111.12 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -43.25 77.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 2.78 110.903 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.9 mm -56.74 -68.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 1.53 111.116 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.14 -35.89 38.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 1.52 111.018 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -57.25 -51.05 70.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 4.39 110.867 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.3 pt -83.79 -6.37 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 1.46 111.072 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.29 112.66 16.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.254 -0.43 . . . . 1.6 110.851 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -51.77 159.53 1.31 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.651 0.738 . . . . 2.79 110.87 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 115.82 4.27 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.77 2.313 . . . . 0.24 112.307 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.5 3.06 57.53 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.25 112.43 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.87 -157.51 9.59 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.691 -0.766 . . . . 0.21 112.483 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.5 m -145.29 158.87 43.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.35 . . . . 2.43 110.911 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.25 116.28 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 1.64 110.921 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -108.07 132.57 53.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 2.88 110.896 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.34 158.01 43.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 1.56 110.902 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.84 129.08 46.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 2.94 110.871 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.78 146.56 18.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.659 0.743 . . . . 2.23 110.849 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.8 142.74 48.59 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.707 2.272 . . . . 0.26 112.321 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.99 146.76 31.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 1.61 111.195 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -109.2 132.88 53.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 1.98 110.892 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.2 p -92.47 -41.83 10.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.95 111.185 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.54 39.18 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 1.89 111.124 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.6 t -147.11 149.08 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 1.89 111.174 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.76 163.1 0.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.167 -0.469 . . . . 1.98 110.767 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -59.86 -47.56 85.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 3.51 110.849 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -75.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 2.9 110.901 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p 52.26 -170.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 2.8 110.89 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -80.51 -3.7 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 2.53 110.87 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 m -140.57 145.03 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.407 . . . . 1.63 111.183 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.7 mmtm -65.3 114.52 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 2.99 110.87 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 45.5 p -85.91 179.33 7.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 1.41 111.107 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.4 -53.42 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 1.63 111.14 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -49.29 78.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 1.04 110.873 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -58.36 -37.95 76.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.028 -0.533 . . . . 2.97 110.918 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.74 -54.68 27.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 1.59 110.94 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.2 m -58.3 -46.6 85.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 1.86 110.88 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -43.71 93.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 1.35 110.918 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.78 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 1.56 111.081 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.45 -57.87 8.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 1.65 110.914 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.3 m -55.57 -36.38 66.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 1.83 111.134 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.9 mt -83.11 -10.71 58.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 2.2 110.909 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.43 6.42 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 2.45 110.852 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.51 8.04 31.24 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.778 -0.725 . . . . 0.58 112.482 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tp -107.5 171.29 7.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.82 0.343 . . . . 1.76 111.005 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.61 169.56 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 1.6 111.091 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 51.47 43.89 29.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 2.41 110.917 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.27 143.19 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 1.58 111.136 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 160.06 8.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 2.72 110.883 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.47 140.83 37.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 3.15 110.893 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 mp -98.94 -39.2 8.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 1.63 110.902 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -160.18 177.09 11.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 1.41 110.811 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 -123.99 168.71 12.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 9.56 110.785 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -151.56 136.67 10.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.743 0.782 . . . . 1.38 110.826 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.91 154.76 66.79 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.711 2.274 . . . . 0.43 112.303 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.55 128.44 37.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 1.51 110.851 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.02 161.45 22.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.618 0.723 . . . . 2.91 111.104 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -24.33 29.59 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.68 2.253 . . . . 0.57 112.351 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -85.3 -22.49 28.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 3.87 110.877 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -87.58 -53.77 4.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.117 -0.492 . . . . 2.73 110.903 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.44 -39.25 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 1.66 111.061 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -36.12 77.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 2.9 110.965 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -45.76 73.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 1.02 110.831 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.26 -30.81 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 1.58 111.161 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -75.82 -31.94 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 2.72 110.905 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -89.88 -20.16 23.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 1.74 110.84 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.45 -32.92 13.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.46 110.848 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.64 -54.2 1.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 1.68 110.864 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.1 11.39 2.28 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.787 -0.721 . . . . 0.32 112.51 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 14.8 t-160 -70.34 121.81 18.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.75 0.309 . . . . 0.82 110.798 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -151.76 105.55 3.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 2.24 110.922 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.2 t -160.5 168.38 25.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 1.04 110.828 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.66 -13.49 15.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.66 110.817 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -100.28 19.97 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.63 110.814 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.8 169.55 10.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 1.72 110.919 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -173.57 130.24 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 1.76 110.931 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -69.98 139.9 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 3.01 110.891 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.13 151.86 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.72 111.216 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -107.8 129.29 55.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 2.53 110.925 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.18 151.17 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.63 111.137 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.9 t -140.54 151.15 44.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 2.0 111.083 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -143.35 144.62 13.97 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 0.32 112.496 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -97.66 137.37 36.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 2.6 110.851 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 134.76 65.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.662 0.744 . . . . 2.18 110.856 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 122.05 8.75 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.702 2.268 . . . . 0.37 112.384 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -96.94 153.62 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.66 110.894 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -48.99 113.32 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 6.4 110.865 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 65.63 109.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 8.6 110.853 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.2 m -154.19 -41.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 8.33 111.112 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 137.19 -33.2 2.33 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.733 -0.746 . . . . 8.47 112.437 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.98 97.91 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.936 0.398 . . . . 8.13 110.844 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.9 m -108.08 -175.64 2.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 8.65 110.899 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 8.27 110.898 -179.986 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.749 0.309 . . . . 4.29 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.98 -22.2 64.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 1.45 111.046 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.11 -51.61 63.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 2.37 110.808 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.23 22.08 10.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.44 . . . . 2.66 110.89 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.34 40.39 60.8 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.731 -0.747 . . . . 0.28 112.479 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.75 159.4 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 1.43 111.069 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.52 164.56 38.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 2.43 110.883 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.33 129.87 35.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.474 . . . . 1.55 111.073 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.18 -5.27 25.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.71 -0.757 . . . . 0.26 112.488 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -114.7 167.96 10.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 1.49 110.835 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.37 140.16 33.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 2.31 110.866 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.2 t -142.3 140.13 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 2.99 111.102 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.16 121.89 42.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.37 111.107 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.1 t -95.1 119.6 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 1.58 111.154 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.1 t -103.35 112.88 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 1.54 111.228 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -114.38 167.66 10.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.19 111.012 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.4 -169.79 3.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.354 -0.384 . . . . 1.91 110.82 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -35.52 69.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 4.15 110.861 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -10.25 59.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 2.05 110.863 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.93 94.26 10.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.668 0.747 . . . . 0.98 110.861 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 142.36 47.25 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.713 2.275 . . . . 0.23 112.381 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -49.07 -32.48 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 1.6 111.105 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -51.32 -53.15 38.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 2.7 110.81 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.48 -44.65 11.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 1.59 111.163 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.85 -61.4 2.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 1.44 110.923 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -49.88 -36.8 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 5.82 110.854 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -47.38 49.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.815 -0.707 . . . . 0.21 112.471 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.6 mt -61.82 -39.7 92.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 1.63 110.959 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.6 m -76.98 -31.71 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 1.66 111.047 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -61.96 -59.76 4.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 1.77 110.893 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -40.15 70.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 2.79 110.935 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.1 mt -72.76 -25.25 61.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 1.6 110.966 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -78.59 -25.19 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.46 110.924 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 -29.15 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 1.54 111.093 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 pp -91.72 -34.88 14.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 1.63 110.933 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.52 -45.11 5.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.168 -0.469 . . . . 1.61 111.149 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.87 -12.09 52.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.28 112.51 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -65.74 -62.6 1.42 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 2.48 110.858 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -97.16 -37.4 10.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 2.35 110.959 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.27 -128.91 5.04 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.27 112.499 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -154.93 153.57 31.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.947 0.403 . . . . 3.01 110.847 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 86.0 t -138.56 128.44 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 1.45 111.189 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -117.42 157.65 25.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 1.16 110.821 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -118.51 135.72 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 1.72 111.137 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -145.34 151.96 39.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 1.94 110.892 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.56 135.97 43.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.63 110.905 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.4 mt -51.25 -35.33 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 1.65 111.156 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -31.57 61.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 3.39 110.871 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -96.76 19.27 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 3.4 110.911 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.86 -30.81 4.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 2.09 111.005 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -53.13 -35.84 60.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 2.02 110.924 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -85.75 -18.76 32.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 1.17 110.913 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.3 m -60.47 -16.6 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 1.82 110.822 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.8 63.59 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 1.75 111.118 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -61.65 -71.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.48 110.832 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.4 -167.59 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 2.87 110.85 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -104.29 125.78 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 2.03 110.868 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.6 80.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 2.15 110.816 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.2 p -130.61 -36.47 1.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 1.32 110.812 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -97.23 121.04 38.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 2.59 110.92 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.28 -20.88 61.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 1.7 110.85 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.5 mt -143.32 144.51 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 1.63 111.19 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.7 mm -135.17 128.86 49.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 1.41 111.207 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.46 136.35 52.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.257 -0.429 . . . . 1.55 110.907 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.33 101.74 6.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 1.57 110.895 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.59 75.95 0.19 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.704 -0.76 . . . . 0.18 112.557 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.23 57.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 1.66 110.93 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.08 159.62 63.92 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.62 0.724 . . . . 1.5 111.152 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 116.56 4.61 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.27 112.404 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.56 7.14 69.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.671 -0.776 . . . . 0.19 112.539 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.41 150.02 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.88 0.371 . . . . 0.99 110.857 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.7 p -138.48 108.71 6.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 1.53 111.167 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.86 149.98 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 1.49 111.122 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 mt -128.04 99.84 5.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 1.6 110.892 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -76.9 143.05 39.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.37 110.836 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.6 m -121.81 -175.3 3.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.91 110.829 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.82 -35.91 71.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 1.34 111.1 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.16 -43.54 97.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 2.12 110.851 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -76.18 -54.9 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 1.6 111.141 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.5 mt -51.11 -42.51 60.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 1.75 110.945 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.5 -56.83 11.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 1.66 111.082 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.36 -43.25 71.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.443 . . . . 3.07 110.922 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.4 mm -55.8 -67.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 1.65 111.087 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.15 -39.55 56.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 1.44 111.086 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -52.86 -50.83 63.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 3.3 110.861 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.5 pt -85.37 -5.97 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 1.5 111.09 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.53 115.24 19.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 1.55 110.882 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -55.05 158.79 4.48 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.69 0.757 . . . . 4.1 110.828 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 114.25 3.64 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.717 2.278 . . . . 0.18 112.306 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.39 55.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.787 -0.72 . . . . 0.17 112.52 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.92 -164.67 24.34 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.754 -0.736 . . . . 0.13 112.467 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.6 m -135.55 152.18 51.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 1.5 110.857 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -136.18 115.97 13.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 1.57 110.917 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -112.02 131.37 55.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 2.9 110.925 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.54 159.86 43.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 1.62 110.855 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.4 128.66 41.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 2.58 110.933 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.33 148.31 22.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.591 0.71 . . . . 2.28 110.902 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 142.86 48.77 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.67 2.247 . . . . 0.18 112.307 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.0 m -128.88 146.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 1.64 111.067 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -106.99 132.48 52.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 1.89 110.885 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.6 p -103.78 26.11 9.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 1.71 111.192 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.56 26.14 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 1.52 111.097 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 5.9 t -144.13 157.77 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 1.73 111.067 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.56 174.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.501 . . . . 1.9 110.887 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -65.67 -64.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 2.87 110.855 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -61.54 -75.84 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.231 -0.441 . . . . 3.17 110.888 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t 51.64 -168.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 2.94 110.857 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -3.55 50.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 4.71 110.817 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -144.38 148.66 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.457 . . . . 1.65 111.113 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.64 112.72 6.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 3.02 110.947 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 43.7 p -87.31 178.6 6.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 1.45 111.093 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.68 -54.09 50.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 1.41 111.037 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.74 -49.07 79.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 1.22 110.909 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -57.72 -41.96 82.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 2.59 110.946 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.05 -54.76 40.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 1.54 110.881 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -57.81 -48.9 78.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 1.53 111.006 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -45.68 92.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.475 . . . . 1.53 110.931 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.25 -45.79 93.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 1.62 111.093 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.87 -54.07 47.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.314 -0.403 . . . . 1.48 110.83 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.9 m -62.38 -27.53 69.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 1.51 111.118 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.05 -14.38 50.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 1.74 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.0 p -84.43 5.58 26.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 2.92 110.863 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.53 -4.7 34.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.663 -0.779 . . . . 0.6 112.5 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.16 168.92 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 1.57 111.04 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.9 m -151.0 171.32 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 1.53 111.089 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 52.39 45.02 29.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 2.22 110.853 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.4 t -79.68 143.56 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 1.64 111.132 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.9 160.23 8.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 3.69 110.889 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.88 147.16 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 2.4 110.862 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mp -106.68 -36.0 6.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 1.59 110.905 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.7 176.29 12.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 1.1 110.89 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.96 137.18 47.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 5.29 110.847 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -123.58 137.65 28.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.735 0.779 . . . . 1.4 110.815 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 163.92 36.54 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.593 2.195 . . . . 0.24 112.308 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.99 127.03 42.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 1.53 110.805 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.15 160.91 25.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.584 0.707 . . . . 2.25 111.166 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -28.88 24.89 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.636 2.224 . . . . 0.36 112.378 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.33 -17.9 35.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 2.67 110.822 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.22 -52.83 5.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 2.33 110.892 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 p -49.27 -41.05 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 1.61 111.125 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -34.82 76.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 1.22 110.986 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -46.19 71.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.167 -0.47 . . . . 1.11 110.89 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.23 -30.15 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 1.41 111.055 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -75.29 -33.34 61.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 2.3 110.878 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -89.09 -19.93 24.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 1.86 110.838 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -94.1 -32.82 13.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.34 110.881 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -128.44 -54.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 1.74 110.936 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.59 7.05 2.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.701 -0.761 . . . . 0.43 112.465 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -70.21 120.44 15.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.78 0.324 . . . . 1.04 110.866 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -152.78 105.03 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 3.3 110.851 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.3 t -161.03 175.98 11.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 1.07 110.793 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.58 -14.43 14.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 1.55 110.872 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -96.44 6.86 47.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 1.69 110.867 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.98 165.59 23.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 1.48 110.919 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -173.51 130.14 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 1.57 110.898 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -74.23 133.11 42.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 2.98 110.84 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.71 144.47 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 1.56 111.139 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -98.75 130.69 45.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 2.68 110.89 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.83 150.46 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 1.55 111.084 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.1 t -130.22 160.16 34.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 1.48 111.089 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.56 132.12 3.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.18 112.474 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -94.15 142.79 27.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 2.57 110.963 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -84.23 135.33 41.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.583 0.706 . . . . 3.4 110.859 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 118.73 5.85 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.703 2.269 . . . . 0.38 112.281 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -102.4 152.16 21.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.47 110.853 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -61.23 99.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 8.05 110.882 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.413 ' O ' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -176.38 -173.76 0.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 10.36 110.869 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 167' ' ' GLU . 12.2 m 43.46 -164.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 8.12 111.106 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -93.68 -42.1 4.26 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.738 -0.744 . . . . 7.7 112.466 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.94 157.31 3.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.91 0.386 . . . . 8.04 110.872 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.48 -60.32 0.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 9.8 110.848 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 9.79 110.867 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.743 0.306 . . . . 4.19 110.852 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.99 -19.18 65.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 1.35 111.088 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.03 -50.93 65.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 2.07 110.798 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -122.28 13.72 10.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 2.71 110.82 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.76 40.67 96.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.659 -0.781 . . . . 0.32 112.482 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.99 159.96 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 1.47 111.179 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.89 168.48 27.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 2.83 110.934 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.75 130.39 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 1.64 111.042 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.35 2.63 29.45 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.764 -0.732 . . . . 0.31 112.53 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -116.73 166.7 11.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 1.21 110.896 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -105.39 114.94 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 3.79 110.794 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.85 139.27 45.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.473 . . . . 3.33 111.151 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.01 115.69 28.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 1.7 111.077 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 64.8 t -88.95 120.5 37.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 1.56 111.175 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 t -106.17 113.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.48 . . . . 1.54 111.173 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -112.67 167.39 10.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.27 110.871 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -148.34 -169.25 3.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 1.72 110.974 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -58.67 -35.58 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 3.73 110.935 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -7.82 53.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 2.0 110.809 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.58 92.71 8.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.636 0.732 . . . . 0.87 110.907 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 143.27 50.56 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.707 2.271 . . . . 0.32 112.314 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.5 t -48.35 -33.06 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 1.67 111.145 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.33 -52.92 41.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 2.64 110.846 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.45 -45.3 10.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 1.64 111.219 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.2 -61.68 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 1.52 111.039 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.59 -35.83 22.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 3.52 110.928 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.16 -47.49 44.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.737 . . . . 0.27 112.573 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 mt -61.59 -38.84 89.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 1.77 110.973 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.66 -31.43 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 1.68 111.13 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.25 -58.24 8.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 1.59 110.835 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -40.43 76.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 3.71 110.818 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.6 mt -72.73 -24.78 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 1.66 110.948 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.92 -24.87 48.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.436 . . . . 0.47 110.839 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.8 -31.47 16.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 1.46 111.08 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -89.74 -35.21 15.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.55 110.931 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.64 -46.9 4.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 1.56 111.194 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.24 -13.37 53.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.668 -0.777 . . . . 0.26 112.53 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -62.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 3.77 110.897 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -99.85 -35.82 9.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 2.12 110.834 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.32 -129.64 4.53 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.24 112.471 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -153.67 152.28 30.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.854 0.359 . . . . 2.92 110.853 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -137.8 117.19 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 1.47 111.069 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.2 t -106.93 153.75 22.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 1.24 110.875 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.53 134.36 58.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 1.51 111.073 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -144.46 152.52 40.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 1.25 110.921 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -102.49 137.41 40.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.75 110.824 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.8 mt -51.38 -44.49 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 1.65 111.105 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -24.54 61.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 4.84 110.883 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -99.3 18.76 16.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 3.45 110.961 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.36 -29.31 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 1.98 110.9 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.82 -36.5 48.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 1.99 110.929 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.1 mm-40 -85.77 -20.4 29.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 1.25 110.897 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.5 m -59.53 -17.73 34.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 1.72 110.836 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.76 63.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 1.53 111.07 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -63.82 -71.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.47 110.79 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.73 -167.65 2.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 2.82 110.921 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -104.76 125.99 51.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 1.88 110.87 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.27 79.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 1.35 110.887 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.6 p -129.61 -35.42 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.89 110.89 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -98.15 121.5 40.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 2.53 110.926 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.29 -21.5 62.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 1.69 110.888 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.1 mt -146.49 143.45 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 1.63 111.085 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.1 mm -131.22 132.44 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 1.73 111.045 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.15 134.96 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 1.55 110.959 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.34 101.18 5.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 1.11 110.846 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.68 78.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.711 -0.756 . . . . 0.2 112.505 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.95 53.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 1.54 110.91 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.78 160.34 49.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.683 0.754 . . . . 1.57 111.028 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 123.34 9.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.765 2.31 . . . . 0.3 112.27 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.78 7.2 88.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.777 -0.725 . . . . 0.26 112.445 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.5 p -55.56 151.67 10.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 1.05 110.819 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.1 p -141.36 111.92 7.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 1.42 111.136 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.55 152.35 14.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 1.54 111.112 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mt -129.68 100.1 5.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 1.56 110.907 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -75.67 144.79 41.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.25 110.76 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.9 m -122.67 178.96 4.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.98 110.856 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.6 -42.77 62.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 1.27 111.115 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.96 -46.78 81.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 2.04 110.954 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mp -71.55 -56.81 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 1.7 111.157 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.2 mt -50.2 -43.01 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 1.58 110.874 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.78 -56.68 12.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 1.6 111.083 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.85 -43.43 73.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 2.91 110.849 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.3 mm -55.35 -67.72 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 1.59 111.14 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.49 -39.54 57.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 1.77 111.069 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.9 tpp85 -52.82 -50.15 64.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 3.67 110.856 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.8 pt -86.13 -5.8 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.62 111.119 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.15 113.98 18.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 1.52 110.866 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -52.95 159.03 2.0 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.599 0.714 . . . . 3.0 110.899 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.77 114.1 3.59 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.698 2.265 . . . . 0.19 112.401 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.29 2.9 55.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.81 -0.71 . . . . 0.18 112.521 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.53 -163.66 16.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.657 -0.783 . . . . 0.16 112.483 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.3 m -137.55 154.52 49.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 1.83 110.856 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -137.49 116.31 12.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 1.54 110.943 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -109.74 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 2.88 110.868 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.73 163.15 38.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 1.56 110.926 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.03 129.71 34.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 2.55 110.913 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.26 149.5 23.2 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.673 0.749 . . . . 2.49 110.875 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 143.22 50.27 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.246 . . . . 0.2 112.39 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.0 m -129.74 146.36 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 1.58 111.111 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -107.92 132.79 53.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 2.04 110.824 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.7 p -91.63 -42.72 10.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 1.94 111.154 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.56 40.28 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 1.79 111.093 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.4 t -147.96 151.85 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 1.77 111.146 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.55 173.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 1.89 110.874 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -66.95 -53.96 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 3.04 110.914 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -72.94 -76.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 3.63 110.871 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t 54.01 -167.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 2.94 110.933 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -6.16 57.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 3.22 110.884 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.48 146.42 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 1.68 111.16 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 123.26 19.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 3.32 110.902 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 70.0 p -96.1 -179.54 4.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 1.67 111.166 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.78 -53.89 49.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 1.61 111.099 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.13 -48.41 81.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 1.22 110.889 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.28 -49.61 76.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 3.79 110.9 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -52.45 -55.52 21.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 2.09 110.96 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 74.8 m -51.2 -49.1 61.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 1.87 110.909 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -43.85 92.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 1.79 110.815 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.44 -48.79 80.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.488 . . . . 1.58 111.057 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.1 tp -57.78 -52.4 65.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 1.51 110.917 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.2 m -63.13 -29.46 70.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 1.73 111.154 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.0 mt -79.5 -17.17 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 2.4 110.932 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.3 p -82.64 3.57 28.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 2.91 110.953 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.48 -4.85 35.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.6 112.472 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.5 168.4 14.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 1.77 110.88 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.16 171.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 1.62 111.084 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 54.29 43.64 30.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.16 -0.473 . . . . 2.19 110.907 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.8 t -75.36 142.87 13.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 1.68 111.176 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.09 159.18 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 2.75 110.922 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -81.87 146.69 29.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 2.25 110.854 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.0 mp -106.44 -35.83 6.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 1.56 110.948 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.55 176.22 12.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 1.15 110.886 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -133.79 138.11 45.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 4.94 110.809 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -125.07 137.87 30.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.633 0.73 . . . . 1.43 110.868 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 163.93 36.47 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.69 2.26 . . . . 0.3 112.346 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.7 125.53 44.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 1.48 110.999 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.1 161.58 22.48 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.603 0.716 . . . . 2.6 111.129 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -23.77 30.35 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.75 2.3 . . . . 0.44 112.344 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -85.08 -24.21 28.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 2.34 110.826 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -88.46 -51.03 5.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 2.62 110.948 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.32 -39.33 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 1.62 111.157 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -34.68 76.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 2.77 110.857 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -46.2 71.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 1.29 110.869 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.91 -30.47 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 1.63 111.169 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -75.51 -32.74 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 2.93 110.958 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -89.47 -20.0 24.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 1.74 110.882 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -94.17 -33.13 13.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.38 110.846 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -127.77 -54.15 1.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 1.65 110.863 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.2 6.71 2.69 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.717 -0.754 . . . . 0.35 112.451 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -70.1 119.99 15.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 1.17 110.827 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -153.45 104.8 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 2.29 110.961 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -161.29 174.38 13.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 1.11 110.897 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.88 -8.17 17.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 1.88 110.848 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -101.92 8.04 41.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 2.2 110.872 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.16 165.28 20.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 1.66 110.997 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -171.33 130.59 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 1.79 110.921 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -75.24 131.38 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 3.02 110.916 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.13 144.84 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 1.54 111.173 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -100.09 128.38 46.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 2.0 110.924 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.14 150.98 28.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 1.62 111.11 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.9 t -129.29 158.74 38.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 1.52 111.127 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.51 130.74 3.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 0.26 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -94.27 140.86 29.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 2.38 110.97 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -82.25 134.41 48.92 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.568 0.699 . . . . 2.44 110.884 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 118.79 5.89 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 0.41 112.354 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -100.45 152.16 20.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.35 110.871 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 29.0 t80 60.83 19.4 9.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 7.35 110.926 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 62.79 164.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.499 . . . . 9.74 110.878 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.7 m -145.55 -178.36 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 5.93 111.166 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -156.72 33.21 0.57 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.69 -0.767 . . . . 5.92 112.463 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.43 -71.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 7.11 110.817 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.7 m -95.5 -67.15 0.87 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.084 -0.507 . . . . 7.83 110.809 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 6.76 110.902 -179.917 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptm . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.765 0.317 . . . . 5.13 110.901 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.36 -19.67 56.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 1.63 111.094 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.03 -49.55 68.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 2.07 110.826 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -122.29 20.6 10.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 2.67 110.891 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.08 39.49 49.69 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.718 -0.753 . . . . 0.25 112.39 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.92 157.68 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 1.68 111.136 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 37.9 m -146.21 157.53 43.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 1.63 110.836 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.2 129.22 35.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 1.68 111.159 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.09 -9.02 31.42 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.742 . . . . 0.54 112.495 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -103.41 168.0 9.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.869 0.366 . . . . 1.81 110.832 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.79 112.05 24.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 2.28 110.907 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 p -119.36 133.67 65.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 3.18 111.08 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.89 133.44 52.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 1.34 111.08 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -104.43 120.51 54.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 1.52 111.087 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 t -103.88 115.41 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 1.48 111.16 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -114.68 168.0 10.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.26 110.913 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.95 -169.45 3.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 1.94 110.92 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -57.8 -35.56 70.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 4.26 110.9 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.69 -9.29 58.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 2.36 110.82 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.95 92.16 8.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.606 0.717 . . . . 0.98 110.902 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 143.98 52.59 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.703 2.269 . . . . 0.26 112.227 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.3 t -48.39 -32.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 1.66 111.161 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.23 -53.0 39.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 3.27 110.924 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.8 -45.02 10.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 1.55 111.067 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.5 -61.89 1.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 1.65 110.881 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -49.69 -37.86 30.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 5.88 110.894 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.39 -48.15 53.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.765 -0.731 . . . . 0.23 112.427 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.15 -41.04 96.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 1.62 110.991 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.84 -31.13 21.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 1.7 111.166 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -61.75 -61.38 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 1.6 110.92 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -40.78 68.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 2.71 110.854 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.7 mt -72.01 -25.31 61.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.465 . . . . 1.36 110.9 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.17 -24.62 47.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.45 110.922 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.62 -30.11 17.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 1.34 111.114 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.54 -35.05 14.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 1.52 110.872 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.87 -45.4 4.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 1.62 111.058 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.74 -12.13 52.13 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.791 -0.719 . . . . 0.3 112.447 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -67.96 -62.72 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.33 . . . . 3.43 110.879 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -95.09 -38.9 10.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 2.79 110.896 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.58 -130.6 5.68 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.717 -0.754 . . . . 0.25 112.473 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -152.59 151.28 30.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.841 0.353 . . . . 2.93 110.853 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.0 t -134.54 121.42 35.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 1.73 111.123 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 t -110.66 152.94 25.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 1.55 110.881 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -115.65 136.67 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 1.53 111.17 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -146.47 152.69 39.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.38 110.911 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -102.35 138.61 39.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.81 110.878 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.0 mt -53.87 -43.26 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 1.69 111.179 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.58 -21.69 61.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 4.83 110.914 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -100.73 16.39 25.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 3.42 110.903 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.59 -29.79 4.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 2.19 110.905 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.89 -41.07 61.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 1.95 110.884 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -84.98 -15.96 42.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 1.1 110.908 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m -66.67 -11.46 54.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 2.02 110.911 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.14 61.0 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 1.63 111.092 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -58.52 -71.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.57 110.839 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 -168.51 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 3.27 110.813 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.58 136.05 43.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 1.99 110.903 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.2 p 47.45 86.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 1.31 110.885 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 p -142.3 -39.02 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 1.51 110.91 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -99.66 120.08 39.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.051 -0.522 . . . . 2.57 110.85 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.44 -21.76 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 1.72 110.93 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mt -144.53 144.11 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 1.59 111.157 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 18.9 mm -136.54 130.15 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 1.54 111.195 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -113.57 137.54 51.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 1.51 110.956 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.58 100.81 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 1.42 110.902 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.7 77.97 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.18 112.493 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.77 56.71 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 1.54 110.853 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.65 159.91 55.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.661 0.743 . . . . 1.63 111.09 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 116.82 4.74 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.672 2.248 . . . . 0.24 112.369 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.96 7.21 70.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.21 112.431 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -54.93 150.56 9.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 1.51 110.821 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.3 p -140.68 109.45 6.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 1.58 111.195 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.09 151.29 15.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 1.45 111.161 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.2 mt -127.01 99.82 5.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 1.85 110.905 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -76.9 130.21 37.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.52 110.876 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 29.7 m -107.11 177.0 4.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 1.16 110.924 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.19 -40.07 57.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 1.59 111.142 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.63 -43.41 89.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 1.73 110.879 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.1 mp -76.04 -56.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 1.45 111.16 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 mt -49.59 -47.29 49.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 1.63 110.917 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.75 -52.76 37.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 1.89 111.068 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -43.9 80.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 2.84 110.893 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.6 mm -55.86 -67.15 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 1.61 111.102 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.22 -36.65 42.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 1.65 111.09 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 tpp85 -56.33 -54.98 39.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 3.4 110.926 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.2 pt -78.44 -8.42 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 1.76 111.093 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.54 124.7 28.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 1.53 110.942 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -64.25 160.67 47.63 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.578 0.704 . . . . 2.9 110.857 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 114.02 3.56 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.656 2.237 . . . . 0.25 112.408 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.43 3.38 56.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.688 -0.768 . . . . 0.22 112.426 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.01 -161.6 13.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.758 . . . . 0.18 112.479 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.7 m -139.59 154.16 47.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.83 0.347 . . . . 1.59 110.883 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -138.87 113.5 9.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 1.51 110.945 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -108.45 133.44 52.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 2.89 110.85 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.98 164.15 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 1.43 110.901 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -135.25 126.99 29.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 2.79 110.998 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.97 148.4 27.12 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.675 0.75 . . . . 2.35 110.863 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 139.89 40.99 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.605 2.203 . . . . 0.24 112.355 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 m -120.96 147.4 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 1.61 111.143 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -116.1 132.63 56.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 1.97 110.904 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.4 p -106.45 26.04 10.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 2.09 111.077 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.17 25.93 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 2.1 111.046 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -143.75 159.92 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 2.13 111.084 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.02 179.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 2.09 110.772 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -64.61 -68.84 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 2.43 110.897 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -62.47 -75.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 2.62 110.87 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.37 -167.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 2.19 110.811 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -6.83 58.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 3.05 110.954 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.29 140.24 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 2.03 111.114 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.23 115.49 5.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 3.23 110.869 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.4 p -83.3 177.77 8.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 1.73 111.126 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.52 -55.05 28.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 1.69 111.137 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.8 -51.73 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.98 110.805 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 -38.13 67.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 3.35 110.886 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.74 -54.61 28.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 1.71 110.874 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 36.4 m -60.07 -46.41 89.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.463 . . . . 1.69 110.922 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -43.98 96.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 1.26 110.801 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.73 -53.33 59.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 1.8 111.105 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.66 -53.16 61.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 1.82 110.876 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.8 m -61.57 -26.25 67.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 1.52 111.177 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.8 mt -87.01 -13.6 44.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 1.88 110.939 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.0 p -82.0 3.5 26.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 3.5 110.877 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.06 -4.35 33.77 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.802 -0.713 . . . . 0.85 112.564 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.6 tp -87.9 171.2 10.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 1.97 110.797 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.44 169.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 1.69 111.105 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 54.6 44.2 29.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 2.28 110.886 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 86.1 t -81.85 142.68 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 1.72 111.105 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 160.62 8.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 2.67 110.959 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -78.91 142.91 36.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 3.12 110.913 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 mp -100.2 -39.08 8.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 1.63 110.907 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.35 176.34 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 1.12 110.932 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -130.19 138.18 50.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 4.76 110.919 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -125.06 135.8 27.28 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.605 0.717 . . . . 1.89 110.946 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 162.52 41.75 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.764 2.309 . . . . 0.34 112.405 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.93 118.54 34.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 1.57 110.92 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.71 161.07 27.83 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.595 0.712 . . . . 2.71 111.077 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -25.53 28.91 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.6 2.2 . . . . 0.68 112.344 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -85.46 -20.75 29.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 4.23 110.821 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -88.25 -53.29 4.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 2.38 110.85 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -49.64 -39.46 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 1.72 111.111 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.01 75.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 1.37 110.874 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.67 -46.69 68.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 1.03 110.817 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.29 -30.24 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.157 -0.474 . . . . 1.56 111.21 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -76.13 -31.5 58.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.481 . . . . 2.26 110.886 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -89.73 -20.41 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.432 . . . . 2.02 110.905 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -94.54 -32.91 13.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.49 110.805 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -127.26 -54.28 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 1.74 110.896 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.1 17.21 1.66 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.696 -0.764 . . . . 0.41 112.496 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -72.37 122.36 21.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 1.39 110.869 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.38 107.95 3.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 2.87 110.95 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.9 t -160.55 172.23 17.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 1.14 110.872 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.01 -18.06 14.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 1.69 110.818 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -100.01 18.73 17.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 1.57 110.844 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.21 165.35 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 1.52 110.977 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -173.94 130.3 0.4 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 1.57 110.917 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -75.87 138.63 41.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 3.25 110.924 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.88 148.41 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 1.55 111.079 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -102.36 132.55 48.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 2.7 110.866 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.59 148.85 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 1.51 111.129 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 9.6 t -134.49 157.3 46.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 1.64 111.109 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -146.53 141.77 9.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.759 -0.734 . . . . 0.37 112.483 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -98.54 131.97 44.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 4.57 110.91 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.53 135.58 78.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.541 0.686 . . . . 2.95 110.882 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 129.32 17.4 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.667 2.245 . . . . 0.41 112.394 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -110.67 149.92 29.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.39 110.906 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 19.6 t80 64.82 151.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 7.43 110.941 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.67 112.82 3.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 8.13 110.963 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 33.7 m -134.81 169.25 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 5.53 111.132 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -154.61 56.74 0.41 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 5.62 112.505 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.7 t -107.26 -53.67 2.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 7.86 110.943 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.62 -170.06 1.63 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 7.38 110.862 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 6.79 110.878 -179.935 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptm . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.802 0.334 . . . . 5.03 110.849 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.69 -21.74 63.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 1.5 111.189 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.15 -51.52 64.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 1.95 110.85 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.37 22.41 10.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 3.55 110.909 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.28 40.95 53.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 0.27 112.531 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -80.01 159.91 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.793 0.33 . . . . 1.52 111.118 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.44 165.37 36.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 1.65 110.873 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.58 123.71 33.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 1.52 111.09 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.44 2.87 21.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.646 -0.788 . . . . 0.33 112.467 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -115.15 168.7 9.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.36 . . . . 1.18 110.898 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -106.93 112.87 26.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 2.36 110.857 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 m -116.05 140.2 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 3.28 111.135 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.92 113.02 22.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 1.58 111.059 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 62.4 t -86.97 120.28 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 1.56 111.082 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.29 116.64 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 1.56 111.09 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -116.2 169.22 9.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.152 -0.476 . . . . 0.22 110.934 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -151.4 -169.74 3.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 1.78 110.832 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.86 -35.59 71.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 4.04 110.876 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.6 m -73.5 -9.18 58.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 1.74 110.896 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.08 94.47 10.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.655 0.74 . . . . 0.88 110.847 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 142.03 46.69 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.664 2.242 . . . . 0.22 112.345 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.2 t -48.69 -32.94 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 1.66 111.141 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.34 -52.62 43.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 3.17 110.878 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -45.03 10.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 1.58 111.097 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.8 -61.61 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 1.52 110.846 -179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -35.42 24.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 3.45 110.784 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.25 -47.54 43.71 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.722 -0.752 . . . . 0.24 112.487 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.05 -39.19 91.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.967 0.413 . . . . 1.72 110.968 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.8 m -77.07 -31.46 18.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 1.74 111.116 179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.5 -58.83 6.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 1.66 110.874 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -40.4 74.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 4.06 110.883 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.5 mt -72.65 -25.19 61.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.228 -0.442 . . . . 1.6 110.929 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -77.89 -24.74 48.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.5 110.904 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.66 -31.09 16.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 1.35 111.083 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -90.08 -35.14 15.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 1.64 110.964 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.25 -47.2 4.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.486 . . . . 1.58 111.218 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.83 -14.68 52.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.749 . . . . 0.29 112.53 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.11 -62.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 2.59 110.869 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -103.86 -33.86 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 2.22 110.854 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.42 -133.34 4.9 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.672 -0.775 . . . . 0.3 112.526 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -150.8 151.53 32.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 2.92 110.869 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.0 t -139.11 113.35 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 1.67 111.172 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 t -103.91 154.56 19.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 1.42 110.811 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.73 130.03 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 1.6 111.134 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -137.73 150.92 47.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 1.45 110.92 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -103.64 135.32 45.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.67 110.888 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 32.0 mt -54.22 -34.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 1.58 111.185 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -73.27 -30.77 63.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 2.76 110.862 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -102.28 19.4 18.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 3.75 110.924 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.59 -27.37 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 2.09 110.929 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -52.73 -38.65 61.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 2.08 110.907 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -84.48 -14.35 49.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 1.26 110.896 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.4 t -63.96 -11.51 29.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 3.3 110.838 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 53.97 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 1.67 111.153 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -52.1 -71.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.51 110.81 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.83 -168.6 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 3.28 110.878 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -103.73 129.75 51.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 1.68 110.957 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t 51.55 88.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 2.26 110.803 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.4 p -140.59 -39.54 0.42 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.057 -0.519 . . . . 1.25 110.818 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -99.9 123.61 44.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 2.56 110.868 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.23 -22.04 62.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 1.52 110.958 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.4 mt -146.14 143.25 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 1.67 111.164 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.7 mm -130.21 133.68 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 1.39 111.093 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -112.48 135.64 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 1.54 110.938 179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.32 98.97 5.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 1.57 110.921 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.7 80.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.695 -0.764 . . . . 0.22 112.591 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.94 55.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 1.64 110.985 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.11 159.52 56.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.696 0.76 . . . . 1.72 111.173 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 116.56 4.6 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.644 2.23 . . . . 0.26 112.437 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.32 7.29 69.88 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.722 -0.751 . . . . 0.18 112.461 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.8 148.41 16.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.384 . . . . 1.11 110.797 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.9 p -136.84 108.66 7.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.494 . . . . 1.41 111.089 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.95 152.54 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 1.52 111.174 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 mt -132.05 103.68 6.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 1.77 110.915 179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -80.03 146.85 31.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.27 110.817 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.3 m -124.56 -176.2 3.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 1.25 110.867 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.71 70.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 1.75 111.129 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.72 -45.14 94.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 1.83 110.974 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -74.28 -55.37 12.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 1.38 111.091 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 mt -49.68 -43.77 47.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 1.59 110.911 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.41 -50.82 58.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 1.43 111.136 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -44.53 90.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 3.08 110.86 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.9 mm -58.08 -68.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 1.65 111.127 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.37 -37.3 24.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 1.35 111.135 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -56.9 -52.84 63.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 3.51 110.813 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.9 pt -81.69 -4.91 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 1.52 111.135 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.34 115.76 20.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 1.49 110.904 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -53.42 158.77 2.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.63 0.729 . . . . 4.07 110.846 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 113.59 3.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.624 2.216 . . . . 0.25 112.426 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.71 3.0 55.27 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.731 -0.747 . . . . 0.26 112.42 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.24 -162.1 15.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.22 112.485 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 98.9 m -138.4 157.17 46.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 1.51 110.831 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -139.86 115.94 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 1.53 110.88 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -109.18 131.86 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 3.32 110.847 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.28 164.34 34.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 1.62 110.91 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.76 129.3 32.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 2.81 110.907 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.52 149.61 23.02 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.674 0.749 . . . . 2.53 110.864 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 144.19 52.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.667 2.245 . . . . 0.21 112.308 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.82 146.61 33.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 1.5 111.167 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -106.79 132.91 52.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 2.09 110.94 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p -93.27 -42.5 9.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 1.96 111.161 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.36 39.89 1.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 1.99 111.162 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.1 t -147.29 150.97 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.246 -0.434 . . . . 1.83 111.147 179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.05 164.32 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 2.27 110.866 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -59.99 -48.32 82.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 2.91 110.941 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.12 -75.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 2.58 110.846 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p 53.02 -171.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 2.48 110.862 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -4.42 53.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 3.28 110.961 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.81 151.26 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.286 -0.415 . . . . 1.71 111.228 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -68.26 111.66 4.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 3.34 110.9 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.9 p -83.14 179.65 7.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 1.69 111.198 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.65 -53.59 55.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 1.52 111.102 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.88 -47.95 84.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.92 110.843 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -39.11 80.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 3.98 110.91 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.7 -55.25 21.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.449 . . . . 1.66 110.904 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 60.6 m -55.93 -44.83 78.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 1.8 110.842 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.4 -40.78 96.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 1.18 110.852 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.82 92.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 1.49 111.125 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.82 -50.77 65.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 1.52 110.978 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.3 m -63.63 -35.22 79.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 1.49 111.145 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -83.48 -10.28 58.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 1.73 110.884 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 m -84.87 5.78 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 2.43 110.881 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.22 3.98 35.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 0.5 112.507 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.81 172.42 6.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.932 0.396 . . . . 1.63 110.865 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 m -151.58 174.08 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 1.63 111.23 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 51.22 45.09 28.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 2.02 110.938 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.4 t -79.7 143.81 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 1.46 111.107 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.49 8.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 3.69 110.92 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -81.15 145.77 30.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 2.27 110.969 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.8 mp -105.23 -35.65 7.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 1.57 110.949 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.57 176.33 12.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.172 -0.467 . . . . 1.16 111.02 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -132.4 138.16 47.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 4.93 110.785 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -125.18 137.97 30.76 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.625 0.726 . . . . 1.86 110.967 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.6 164.05 35.86 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.76 2.307 . . . . 0.26 112.403 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.61 128.58 44.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 1.6 110.913 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.48 160.95 25.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.608 0.718 . . . . 2.27 111.108 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.86 -28.81 24.31 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.649 2.233 . . . . 0.37 112.333 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -85.35 -17.78 35.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 3.74 110.844 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 -52.9 5.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 2.27 110.936 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.8 p -49.19 -40.66 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 1.63 111.134 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -34.78 76.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 1.22 110.884 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.98 -46.31 71.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 1.28 110.882 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.12 -30.08 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 1.64 111.167 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -75.27 -33.33 61.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 2.33 110.855 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -89.12 -19.91 24.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 1.7 110.818 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -94.16 -32.77 13.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.83 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.4 -54.26 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 1.53 110.871 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.31 4.95 2.76 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.705 -0.76 . . . . 0.47 112.484 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -70.08 120.17 15.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 1.15 110.805 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -153.26 104.76 2.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 2.21 110.967 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.34 173.42 15.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 1.67 110.911 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.98 -10.06 16.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 1.95 110.895 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -99.9 9.08 43.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 3.13 110.904 -179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.2 167.14 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 1.57 110.938 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -172.33 130.13 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 1.63 110.898 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.76 132.23 42.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 3.02 110.853 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.07 142.26 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 1.49 111.171 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -96.46 129.44 43.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 2.16 110.874 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.97 151.63 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 1.47 111.198 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.0 t -131.91 160.85 34.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 1.51 111.156 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.39 134.51 4.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.757 -0.735 . . . . 0.2 112.509 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -95.19 141.1 29.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 2.55 110.914 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -81.95 134.09 50.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.559 0.695 . . . . 2.48 110.871 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 119.26 6.23 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.645 2.23 . . . . 0.44 112.376 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -99.39 151.62 20.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.38 110.929 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 42.5 t80 65.1 151.95 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 6.99 110.823 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.8 111.56 2.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 8.4 110.947 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.18 171.33 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 5.89 111.08 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -141.73 47.9 0.82 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.741 -0.742 . . . . 5.65 112.469 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.4 t -139.1 161.87 36.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 7.35 110.85 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.47 -75.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 8.16 110.743 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 7.85 110.887 -179.864 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.817 0.341 . . . . 4.89 110.952 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.93 -21.37 63.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 1.43 111.063 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -54.33 -51.21 65.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 2.83 110.874 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.31 22.0 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 2.68 110.876 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.15 40.63 52.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.788 -0.72 . . . . 0.28 112.469 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -79.05 159.8 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.821 0.343 . . . . 1.66 111.121 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -154.32 166.52 32.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 2.24 110.842 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.6 125.41 35.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 1.51 111.159 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.91 2.9 23.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.814 -0.707 . . . . 0.32 112.514 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -115.54 166.99 11.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 1.19 110.882 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -105.61 114.96 29.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 2.34 110.796 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -118.06 139.13 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 3.27 111.08 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.64 114.44 25.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 1.33 111.146 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.66 121.84 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 1.48 111.182 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 t -107.36 116.72 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 1.5 111.139 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -115.76 167.18 11.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.26 110.881 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -146.29 -169.52 3.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 1.74 110.89 179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -59.42 -35.21 73.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 3.78 110.972 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.76 -6.83 51.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.492 . . . . 1.98 110.891 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.17 93.87 10.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.706 0.765 . . . . 0.88 110.881 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.63 142.47 48.58 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.727 2.284 . . . . 0.23 112.456 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -49.2 -32.42 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 1.58 111.125 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.49 -52.82 43.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 3.21 110.946 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.53 -44.88 10.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 1.54 111.178 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.66 -61.72 2.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 1.49 110.935 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -34.61 22.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 3.16 110.9 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.11 -48.24 40.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.23 112.437 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.6 mt -61.33 -39.98 92.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.368 . . . . 1.55 110.92 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 m -76.23 -31.69 21.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 1.73 111.186 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.89 -60.03 4.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 1.66 110.851 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -40.22 72.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 2.61 110.926 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.52 -24.65 61.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 1.56 110.927 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.41 -24.95 45.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.45 110.914 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.78 -30.07 17.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.195 -0.457 . . . . 1.49 111.104 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.42 -35.05 14.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 1.44 110.877 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.11 -45.47 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 1.62 111.137 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.26 -12.61 56.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.822 -0.704 . . . . 0.27 112.449 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -65.78 -62.72 1.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 3.48 110.858 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -96.52 -37.43 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 2.23 110.88 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.55 -129.43 4.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.784 -0.722 . . . . 0.24 112.489 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -153.4 153.04 31.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 5.04 110.835 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -138.98 119.81 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 1.69 111.188 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -109.76 154.69 22.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 1.39 110.899 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -115.83 134.53 58.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 1.37 111.097 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -144.3 152.38 40.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 1.27 110.986 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -102.56 137.64 40.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.75 110.852 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.2 mt -50.91 -46.77 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 1.68 111.208 179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -24.73 63.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 4.99 110.905 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -98.22 18.52 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 3.42 110.812 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.75 -29.13 4.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 2.16 110.943 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.52 -36.31 55.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 3.47 110.975 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -85.86 -19.47 30.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 1.25 110.905 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 63.6 m -60.69 -16.69 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 1.77 110.877 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.94 63.49 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 1.52 111.174 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -64.9 -70.24 0.24 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 0.48 110.846 -179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.13 -168.08 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 2.07 110.924 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -105.88 126.68 52.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 2.22 110.905 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.14 79.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 2.26 110.846 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.7 p -130.11 -35.33 1.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 1.38 110.856 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -98.52 122.02 41.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.094 -0.503 . . . . 3.6 110.873 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.61 -21.69 61.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 1.52 110.949 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.67 143.46 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 1.68 111.155 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 18.8 mm -130.52 132.85 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.444 . . . . 1.38 111.155 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -111.7 135.2 52.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 1.61 110.836 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.52 98.52 4.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 1.24 110.766 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.64 78.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.22 112.475 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.71 54.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.358 . . . . 1.64 110.939 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.4 159.77 53.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.569 0.699 . . . . 1.64 111.128 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 116.34 4.52 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.702 2.268 . . . . 0.24 112.373 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.61 7.02 69.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.739 -0.743 . . . . 0.22 112.495 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.26 136.59 48.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 1.05 110.906 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.2 p -126.03 108.41 11.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 1.55 111.122 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 m -163.3 155.8 18.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 1.52 111.202 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mt -133.55 105.8 7.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.251 -0.431 . . . . 1.46 110.983 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -79.44 150.98 31.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.24 110.903 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m -130.64 -177.46 4.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 1.46 110.884 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.98 68.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 1.38 111.078 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -47.12 86.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 2.14 110.929 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -71.9 -56.48 10.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 1.59 111.185 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.6 mt -50.78 -39.54 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 1.59 110.949 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.14 -56.88 12.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 1.67 111.099 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.97 -43.53 77.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 2.93 110.968 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.4 mm -55.15 -68.33 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 1.6 111.047 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.17 -39.75 57.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 1.39 111.194 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -52.84 -49.54 65.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 3.32 110.946 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 pt -86.66 -5.62 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 1.77 111.23 179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.13 113.36 18.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 1.55 110.851 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -52.8 158.49 2.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 3.28 110.863 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 114.22 3.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.669 2.246 . . . . 0.27 112.299 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.99 3.09 54.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.829 -0.701 . . . . 0.26 112.522 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.77 -159.7 12.46 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 0.22 112.453 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.3 m -141.98 157.28 45.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 2.32 110.918 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -139.37 114.61 9.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 1.6 110.927 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -106.33 132.55 52.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 3.28 110.848 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.81 163.84 36.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 1.54 110.895 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.46 130.8 35.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 2.76 110.837 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.8 147.28 18.3 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.64 0.733 . . . . 2.16 110.915 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 141.38 45.13 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.776 2.317 . . . . 0.26 112.329 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.39 146.95 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 1.59 111.11 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -108.97 133.04 53.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 1.97 110.844 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.0 p -92.0 -41.91 10.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 1.95 111.179 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.74 40.34 1.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 1.65 111.094 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.8 t -147.93 149.82 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 1.79 111.02 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.11 175.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 2.11 110.945 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.7 -63.51 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 2.72 110.89 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.41 -75.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 2.47 110.894 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.77 -168.23 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 2.24 110.826 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -7.9 59.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 2.66 110.928 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 m -141.14 145.73 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 1.72 111.15 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -64.93 115.35 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 3.38 110.947 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 80.8 p -86.82 178.88 6.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 1.69 111.145 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.76 -51.75 66.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 1.39 111.153 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.66 -49.41 77.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 1.16 110.838 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -37.56 76.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 2.64 110.931 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.61 -55.39 20.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 1.49 110.844 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.9 m -57.64 -46.2 84.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 1.63 110.894 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -42.85 95.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 1.39 110.828 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.46 -44.31 96.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.496 . . . . 1.47 111.175 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.9 tp -64.45 -52.11 59.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 1.56 110.893 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.7 m -61.55 -31.62 71.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 1.46 111.085 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.91 -10.32 53.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 1.71 110.897 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.01 5.6 28.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 2.33 110.866 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.74 5.92 33.22 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.755 . . . . 0.48 112.436 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.87 170.38 7.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 1.56 110.985 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -150.19 170.59 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.432 . . . . 1.61 111.162 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 53.77 44.15 30.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 2.47 110.858 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.14 144.43 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 1.52 111.216 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 156.99 6.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 2.63 110.915 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.45 141.34 38.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 3.04 110.907 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 mp -99.74 -36.4 9.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 1.53 110.869 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -163.15 176.9 9.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 1.33 110.886 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -125.53 166.05 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 8.1 110.927 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -149.21 136.17 10.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.695 0.76 . . . . 1.38 110.895 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 154.78 67.43 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.726 2.284 . . . . 0.34 112.372 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.14 125.96 36.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.43 . . . . 1.76 110.932 179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.36 161.37 24.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.598 0.713 . . . . 2.2 111.107 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -28.49 25.09 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.661 2.241 . . . . 0.44 112.388 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.36 -17.97 35.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 2.81 110.839 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 -53.01 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 2.59 110.899 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 p -49.66 -40.61 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 1.58 111.095 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -34.67 76.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 1.23 110.905 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -46.12 71.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.86 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.0 p -68.45 -30.34 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 1.53 111.059 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -75.56 -32.52 60.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 3.42 110.935 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -89.56 -20.01 24.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 1.79 110.903 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -94.3 -32.74 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.3 110.884 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.03 -54.29 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 1.57 110.878 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.36 9.1 2.43 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.818 -0.706 . . . . 0.35 112.478 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -70.31 121.68 18.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.88 110.901 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -151.8 105.42 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 2.62 110.864 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.6 t -160.44 169.55 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.51 110.888 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.65 -14.87 15.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 1.62 110.858 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -99.33 19.94 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 1.6 110.896 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.2 167.96 11.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 1.66 110.969 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -172.49 129.81 0.56 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 1.53 110.926 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -70.16 135.98 49.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 3.26 110.861 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.32 148.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 1.6 111.183 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -105.03 132.03 51.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 2.61 110.839 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.23 153.04 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 1.49 111.139 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.8 t -139.25 152.46 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 1.53 111.123 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.84 140.74 10.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.31 112.49 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -97.28 139.54 33.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.732 0.301 . . . . 2.46 110.962 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -78.99 134.37 60.07 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.508 0.67 . . . . 3.51 110.899 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 118.61 5.78 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.694 2.263 . . . . 0.44 112.304 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -100.4 152.23 20.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.33 110.923 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.0 t80 61.06 19.31 9.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.421 . . . . 7.08 110.959 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 63.53 160.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.506 . . . . 10.07 110.86 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.32 178.29 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 6.54 111.167 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.49 28.82 1.33 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 5.86 112.479 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.3 p -147.09 59.16 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 7.08 110.876 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.1 -176.14 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 8.19 110.85 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 6.73 110.843 -179.936 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.721 0.296 . . . . 4.09 110.878 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.45 -22.62 66.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 1.44 111.163 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -54.13 -51.57 63.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 2.41 110.839 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -122.3 24.35 9.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 3.6 110.908 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.94 38.33 46.38 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.861 -0.685 . . . . 0.47 112.471 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.82 158.73 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.869 0.366 . . . . 1.62 111.129 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.7 m -147.14 158.55 43.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.506 . . . . 1.95 110.839 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.18 130.6 35.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 2.06 111.153 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.86 -6.12 32.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.751 -0.737 . . . . 0.54 112.479 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -106.56 168.91 8.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.778 0.323 . . . . 1.77 110.904 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.66 110.98 23.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 2.4 110.886 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.99 130.52 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.129 -0.487 . . . . 3.09 111.043 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -105.97 132.72 51.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.51 . . . . 1.74 111.081 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -101.6 120.13 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 1.62 111.088 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.8 t -103.24 116.66 47.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 1.51 111.154 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -117.04 166.36 12.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.4 110.863 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.24 -169.79 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 1.91 110.885 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.58 -35.52 74.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 3.98 110.939 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 t -73.41 -7.84 53.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 2.13 110.926 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.2 93.21 9.03 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.682 0.753 . . . . 0.8 110.886 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 143.12 50.11 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.671 2.247 . . . . 0.51 112.372 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.09 -32.47 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 1.55 111.096 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.19 -53.36 35.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 2.55 110.89 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.81 -44.92 10.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 1.59 111.046 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.12 -61.01 2.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.24 -0.436 . . . . 1.5 110.897 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -33.59 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 4.43 110.881 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.77 -49.05 38.33 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.748 -0.739 . . . . 0.42 112.473 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.8 mt -60.68 -40.61 92.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.867 0.365 . . . . 2.07 110.939 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 m -75.7 -31.36 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 1.73 111.132 179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -61.91 -61.75 2.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 1.73 110.863 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -40.48 66.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 2.53 110.87 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.7 mt -72.23 -25.86 61.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 1.66 110.899 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.33 -23.85 46.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.47 110.898 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.97 -29.64 17.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.208 -0.451 . . . . 1.43 111.124 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pp -91.38 -36.09 14.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 1.45 110.84 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.06 -45.92 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 1.57 111.176 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.74 -15.8 42.9 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.58 112.532 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.36 -62.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 2.96 110.945 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -107.02 -33.8 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 2.33 110.99 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.08 -134.54 5.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.689 -0.767 . . . . 0.38 112.481 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -154.15 152.3 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 4.78 110.937 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.9 t -136.32 123.71 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 1.5 111.12 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.4 t -113.22 153.85 27.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 1.18 110.834 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.97 132.41 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 1.55 111.22 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -142.25 152.46 43.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 1.31 110.925 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -102.7 137.49 40.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.77 110.887 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 12.5 mt -52.46 -43.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 1.76 111.214 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -24.16 61.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 4.64 110.867 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -98.02 16.54 20.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 3.37 110.963 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.42 -28.15 4.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.465 . . . . 2.07 110.899 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -49.89 -44.11 49.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 2.0 110.995 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -85.82 -14.77 44.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 1.34 110.865 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.8 t -60.44 -15.39 26.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 3.06 110.844 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.17 52.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 1.6 111.126 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -50.85 -71.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.59 110.893 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.38 -168.32 2.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 3.1 110.813 179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -108.46 130.17 55.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.123 -0.489 . . . . 1.73 110.967 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.8 72.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 1.46 110.895 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.5 p -126.76 -33.72 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 1.03 110.784 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.3 118.4 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 2.55 110.868 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.37 -20.2 62.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.497 . . . . 1.52 110.879 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 mt -145.88 144.41 20.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 1.52 111.126 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.3 mm -137.29 130.22 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 1.44 111.134 179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -111.47 137.63 49.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 1.56 110.894 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.52 97.56 4.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 1.33 110.889 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.65 73.68 0.35 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.745 -0.74 . . . . 0.4 112.465 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.54 -19.35 19.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 2.12 110.884 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -48.34 152.59 1.52 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 1.78 111.125 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.9 123.52 10.13 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.638 2.225 . . . . 0.75 112.33 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.72 0.21 75.78 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.6 112.454 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.61 146.66 16.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.984 0.421 . . . . 2.07 110.866 -179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 p -137.02 109.07 7.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 1.58 111.114 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 m -162.28 140.06 8.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 1.76 111.164 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 15.8 mt -113.65 105.96 13.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 1.84 110.912 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -79.63 151.06 30.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.34 110.806 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.8 m -130.94 -177.15 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 1.06 110.831 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.01 69.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 1.62 111.096 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -47.78 84.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 2.46 110.933 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -70.82 -56.59 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 1.54 111.15 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.0 mt -50.95 -39.18 54.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 1.53 110.907 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.95 -56.87 13.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 1.69 111.089 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.02 -41.87 79.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 2.48 110.897 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 37.2 mm -56.6 -68.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 1.55 111.134 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.45 -38.23 42.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 1.71 111.117 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.59 -56.07 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 3.57 110.893 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.2 pt -77.42 -8.22 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 1.58 111.062 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.24 127.27 31.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 1.69 110.971 179.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -66.54 159.99 69.99 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 3.13 110.916 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 114.15 3.62 Favored 'Trans proline' 0 C--N 1.34 0.082 0 C-N-CA 122.632 2.221 . . . . 0.18 112.356 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.05 1.98 55.98 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.17 112.51 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.78 -164.03 11.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.636 -0.792 . . . . 0.14 112.519 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 60.0 m -135.47 152.3 51.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 1.46 110.863 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -137.0 112.24 9.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 1.48 110.903 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -106.44 133.62 50.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 2.92 110.828 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.58 158.78 44.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 1.51 110.955 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.79 125.62 34.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 3.48 110.97 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.43 146.05 21.79 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 2.24 110.864 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.61 140.04 42.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.718 2.279 . . . . 0.25 112.392 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.1 m -126.71 146.76 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.69 111.103 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.79 132.38 55.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 3.62 110.875 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.0 p -104.29 26.15 9.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 1.91 111.134 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -146.68 23.11 1.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 1.71 111.119 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.8 t -145.02 159.45 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 1.81 111.127 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.04 169.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 1.91 110.809 179.926 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -64.25 -49.73 70.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 2.79 110.987 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -72.62 -75.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 3.4 110.93 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t 52.0 -169.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 3.18 110.8 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.41 -3.23 48.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 2.39 110.948 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.2 141.14 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 1.71 111.116 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 114.17 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 3.12 110.846 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 44.0 p -83.55 177.61 8.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 1.58 111.125 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.95 -53.93 49.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 1.42 111.041 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -49.68 76.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.441 . . . . 0.91 110.903 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -56.29 -40.22 73.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 2.39 110.806 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.75 -55.04 26.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 1.67 110.954 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -57.58 -46.27 84.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 1.82 110.865 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.42 -42.96 95.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 1.26 110.883 -179.764 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.74 92.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 1.58 111.137 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.7 -52.83 61.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 1.63 110.901 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.8 m -61.8 -35.52 78.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 1.43 111.147 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.3 mt -81.59 -10.4 59.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 1.71 110.919 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.83 5.19 29.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 2.49 110.842 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.21 -2.47 35.07 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.772 -0.728 . . . . 0.51 112.465 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.13 169.87 9.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.815 0.341 . . . . 1.58 110.98 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.0 m -151.05 171.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 1.62 111.128 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 56.93 43.61 24.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 2.03 110.905 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.4 t -75.19 142.83 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 1.8 111.128 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.63 156.38 6.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 2.57 110.938 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -82.17 145.36 30.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 2.13 110.874 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.5 mp -105.76 -35.22 7.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 1.63 110.95 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.56 ' NE2' HE21 ' A' ' 158' ' ' GLN . 0.7 OUTLIER -166.17 176.64 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 1.31 110.906 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -125.41 166.12 17.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 9.4 110.875 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -146.91 134.22 10.22 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.684 0.754 . . . . 1.52 110.876 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 157.56 60.07 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.629 2.219 . . . . 0.5 112.369 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.46 129.59 41.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 1.61 110.95 179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.68 162.74 20.21 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.52 0.676 . . . . 2.46 111.151 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 -22.66 32.24 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.642 2.228 . . . . 0.63 112.397 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -85.03 -25.76 27.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 2.64 110.964 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -88.58 -52.73 5.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.111 -0.495 . . . . 2.63 110.794 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.77 -39.05 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 1.81 111.101 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.08 -33.86 75.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 1.7 110.941 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -46.6 67.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 1.08 110.951 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.8 p -68.11 -30.86 49.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 1.69 111.11 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -76.87 -29.99 56.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 2.52 110.92 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -89.64 -21.6 22.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 1.97 110.884 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -95.03 -32.17 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.46 110.804 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mp -127.04 -54.49 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 1.74 110.857 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.58 14.17 2.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.57 112.543 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -70.76 121.29 17.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.793 0.33 . . . . 1.14 110.812 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -152.17 105.36 3.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 2.54 110.863 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.74 172.16 17.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 1.3 110.816 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.71 -17.27 14.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 1.88 110.917 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -96.89 20.32 11.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 1.61 110.859 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.53 162.67 13.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 1.61 110.923 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -171.2 130.65 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 1.64 110.933 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -70.33 135.28 48.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 3.0 110.885 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.19 142.47 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 1.65 111.155 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.56 HE21 ' NE2' ' A' ' 131' ' ' GLN . 0.2 OUTLIER -101.09 127.37 47.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 2.09 110.894 -179.981 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.33 151.48 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.426 . . . . 1.75 111.188 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.1 t -130.43 154.59 47.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.222 -0.445 . . . . 1.43 111.107 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.89 131.39 4.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.755 -0.736 . . . . 0.24 112.467 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -91.63 131.63 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 4.73 110.918 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.81 135.44 77.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 2.76 110.963 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 131.47 21.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.731 2.288 . . . . 0.47 112.365 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -111.85 150.2 30.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.44 110.824 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.01 72.35 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.463 . . . . 8.78 110.888 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.39 32.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 10.07 110.903 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.3 m -151.3 -178.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 7.22 111.13 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -132.07 25.12 3.94 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.666 -0.778 . . . . 7.15 112.5 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.17 -74.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.891 0.377 . . . . 8.93 110.848 -179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.98 -73.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 6.75 110.942 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 8.18 110.821 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.821 0.343 . . . . 6.51 110.849 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.94 60.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 1.89 111.129 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.93 -40.91 70.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 1.96 110.901 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -122.34 16.95 10.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 2.7 110.767 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.74 39.14 96.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.43 112.439 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.89 156.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.884 0.373 . . . . 1.74 111.128 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.73 161.38 38.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 1.92 110.879 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.54 134.9 33.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 1.52 111.088 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.64 -1.66 30.61 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.719 -0.753 . . . . 0.26 112.501 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -117.14 173.26 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 1.45 110.868 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.4 116.3 31.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 2.31 110.919 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 97.3 t -119.58 129.38 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 2.87 111.124 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.33 126.41 52.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 1.33 111.122 179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.1 t -98.9 119.41 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 1.6 111.094 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -102.31 117.58 47.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 1.54 111.108 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -118.02 169.91 9.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.438 . . . . 0.26 110.9 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.65 -169.87 3.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 1.74 110.837 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -58.21 -35.55 71.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 3.9 110.883 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.9 -8.15 55.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 1.57 110.873 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.71 95.25 11.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.651 0.739 . . . . 0.94 110.873 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 141.57 45.27 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.628 2.219 . . . . 0.36 112.326 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.02 -32.84 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 1.73 111.154 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -50.98 -52.8 38.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 2.4 110.903 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.6 11.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 1.53 111.085 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -52.6 -61.69 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 1.7 110.99 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -36.57 27.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 3.15 110.962 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.75 49.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.24 112.534 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.6 mt -61.55 -39.97 93.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 1.91 110.918 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 m -76.9 -30.71 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 1.77 111.18 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.82 -59.84 4.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 1.63 110.909 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -40.08 70.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 3.17 110.881 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.8 mt -73.27 -25.7 60.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 1.57 110.825 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -77.1 -24.06 51.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.309 -0.405 . . . . 0.49 110.935 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.13 -32.22 15.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 1.3 111.133 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.31 -36.51 16.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 1.61 110.87 -179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -96.64 -47.09 6.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 1.79 111.11 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.34 -15.58 45.91 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.753 -0.737 . . . . 0.48 112.523 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -56.07 -62.59 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 2.56 110.898 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -107.19 -33.26 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 2.71 110.88 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.22 -131.52 4.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.31 112.522 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -156.35 153.08 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 5.21 110.798 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.7 t -134.93 126.51 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 1.79 111.169 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.8 t -116.5 152.62 33.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.95 110.827 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.03 131.77 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 1.62 111.069 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -139.23 150.97 46.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 1.38 110.87 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -103.44 135.18 45.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.61 110.876 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.4 mt -53.69 -34.18 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 1.4 111.09 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -31.7 63.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 2.99 110.937 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -100.84 19.7 16.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 3.7 110.893 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.26 -26.94 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 2.08 110.885 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.26 -38.49 58.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.226 -0.443 . . . . 1.98 110.911 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -84.5 -14.36 49.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.169 -0.469 . . . . 1.23 110.906 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.6 t -60.08 -15.19 21.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 3.04 110.805 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.17 53.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 1.58 111.111 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -53.56 -70.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.74 110.922 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -168.26 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 2.1 110.888 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -107.74 129.87 55.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 1.73 110.901 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.19 75.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 1.94 110.88 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.0 p -129.65 -34.15 1.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 1.49 110.843 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.73 118.06 35.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 2.54 110.842 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.07 -20.08 64.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 1.48 110.857 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mt -147.8 143.6 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 1.51 111.134 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 18.5 mm -133.92 132.69 56.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 1.61 111.162 179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -113.8 137.64 51.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 1.61 110.847 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.23 98.35 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 1.19 110.814 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.59 74.41 0.29 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.818 -0.706 . . . . 0.18 112.469 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.45 61.41 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.352 . . . . 1.62 110.883 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.34 159.93 66.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 1.52 111.204 179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 115.82 4.26 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.66 2.24 . . . . 0.32 112.409 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.71 7.65 68.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 0.22 112.51 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.4 150.93 10.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 1.11 110.858 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.1 p -139.72 108.18 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 1.52 111.196 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -162.51 156.18 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 1.53 111.126 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.7 mt -133.85 109.6 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 1.6 110.844 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -86.51 153.92 21.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.28 110.869 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 m -131.78 -175.75 3.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.93 110.766 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.16 -36.54 70.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 1.5 111.031 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.39 -45.94 88.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 2.08 110.899 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -73.02 -55.27 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 1.7 111.146 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.7 mt -50.33 -44.8 54.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 1.57 110.874 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.59 -53.8 34.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 1.69 111.012 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.32 -43.37 74.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 2.88 110.904 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.9 mm -57.12 -67.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 1.6 111.168 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.05 -36.58 40.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 1.77 111.132 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.2 tpp85 -56.74 -50.67 71.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 3.32 110.846 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.2 pt -84.29 -6.02 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 1.55 111.12 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.14 123.34 28.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 1.61 110.926 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -61.85 159.08 38.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 4.25 110.869 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 114.2 3.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.688 2.259 . . . . 0.21 112.326 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.74 4.28 54.64 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.71 -0.757 . . . . 0.23 112.496 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.72 -164.31 22.79 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.787 -0.72 . . . . 0.18 112.485 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 53.8 m -136.25 151.06 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.808 0.337 . . . . 1.67 110.86 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -134.02 127.45 32.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.175 -0.466 . . . . 1.64 110.94 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -122.72 133.54 54.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 3.28 110.872 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.65 163.69 36.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.47 . . . . 1.53 110.913 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.02 129.87 30.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 3.95 110.972 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.88 148.59 19.63 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.742 0.782 . . . . 3.63 110.873 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 136.51 33.23 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.645 2.23 . . . . 0.31 112.382 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.9 m -120.66 146.83 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 1.62 111.202 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -110.48 132.97 53.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.92 110.901 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.0 p -91.41 -40.7 11.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 1.96 111.135 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.52 38.28 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 1.59 111.166 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.53 149.92 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 1.71 111.121 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.31 173.05 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 1.82 110.793 179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -67.15 -53.37 31.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.167 -0.47 . . . . 3.13 110.94 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -75.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 2.88 110.862 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.67 -169.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 2.3 110.894 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 pttt -80.51 -4.86 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 4.26 110.922 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.92 148.21 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 1.44 111.16 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -69.14 115.06 7.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 3.04 110.875 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 48.7 p -87.83 -178.33 6.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 1.57 111.153 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.78 64.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 1.42 111.151 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.27 -49.46 77.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.85 110.854 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.56 -43.21 71.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 2.53 110.883 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.8 -55.74 26.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 1.93 110.975 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.9 m -55.3 -46.81 76.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 1.56 110.894 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -44.23 94.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 1.09 110.892 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.21 -49.81 74.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 1.77 111.106 179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.55 -52.46 65.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 1.66 110.923 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 92.0 m -64.21 -29.04 70.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 1.87 111.198 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.1 mt -81.11 -16.27 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 2.08 110.835 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 p -82.32 3.2 28.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 3.2 110.859 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.46 -4.94 35.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.804 -0.712 . . . . 0.86 112.502 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.97 169.02 15.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 1.62 110.927 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.52 170.25 2.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 1.7 111.126 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 53.4 44.48 29.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 2.23 110.956 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.8 142.54 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 1.61 111.109 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.15 160.04 7.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 3.06 110.868 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.86 140.73 36.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 2.87 110.956 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.4 mp -98.6 -37.28 9.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 1.54 110.926 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -163.16 176.78 9.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 1.38 110.917 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.1 mtt-85 -125.63 167.01 15.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 9.5 110.875 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -149.7 134.22 9.23 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.662 0.744 . . . . 1.81 110.898 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 156.54 63.08 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.269 . . . . 0.35 112.38 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.6 154.1 20.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 1.55 110.92 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.07 163.28 48.87 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.56 0.695 . . . . 2.64 111.111 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 -23.75 30.37 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.706 2.271 . . . . 0.59 112.32 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -85.66 -24.66 26.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 3.99 110.954 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -88.13 -53.85 4.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 4.08 110.931 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.1 p -50.59 -39.15 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 1.6 111.112 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.02 -34.03 75.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 1.69 110.916 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -46.48 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 1.4 110.854 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -67.73 -30.95 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 1.6 111.131 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -77.22 -29.97 54.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 2.74 110.866 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -89.37 -21.85 22.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 1.82 110.813 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -95.04 -31.97 13.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.35 110.814 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mp -127.25 -54.67 1.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 1.64 110.87 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.93 13.09 2.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.771 . . . . 0.43 112.437 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 15.5 t-160 -70.55 122.23 19.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.83 110.803 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -151.38 105.57 3.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 2.92 110.924 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t -158.35 171.28 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 1.64 110.86 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.09 -17.12 14.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 2.01 110.786 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -99.28 21.29 12.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.299 -0.41 . . . . 1.65 110.866 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.4 166.14 13.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.45 . . . . 1.58 111.016 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -172.03 130.31 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 1.48 110.841 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -72.6 133.74 44.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 3.04 110.87 179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.07 157.19 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 1.59 111.068 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -113.57 133.56 55.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 2.72 110.905 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.94 152.32 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 1.45 111.132 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.7 t -136.29 163.62 29.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 1.65 111.172 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.98 136.76 5.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.753 -0.737 . . . . 0.26 112.491 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -94.92 142.67 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 2.7 110.925 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -82.8 135.55 45.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.574 0.702 . . . . 2.99 110.935 179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 118.89 5.95 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.727 2.285 . . . . 0.46 112.41 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -104.05 152.81 21.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.62 110.878 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -69.35 85.01 0.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 7.93 110.9 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -179.39 34.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 10.69 110.968 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 89.6 t -131.73 -74.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 7.33 111.157 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 178.9 31.19 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.788 -0.72 . . . . 6.9 112.488 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.41 -169.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.371 . . . . 8.82 110.816 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.66 -178.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.493 . . . . 7.96 110.87 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 6.77 110.88 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ptt? . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.836 0.35 . . . . 4.46 110.956 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.09 -18.3 62.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 1.78 111.055 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.99 -51.22 70.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 2.37 110.857 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -122.14 24.31 9.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 3.6 110.899 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.45 44.54 53.25 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.81 -0.709 . . . . 0.51 112.426 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -88.53 163.55 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.784 0.326 . . . . 1.77 111.17 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.22 163.6 38.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 2.07 110.811 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.33 134.31 34.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 1.53 111.086 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.52 2.41 32.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.28 112.439 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.43 172.42 7.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.806 0.336 . . . . 1.23 110.955 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.18 114.29 28.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 3.76 110.891 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 92.6 t -117.06 133.9 62.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 2.81 111.101 179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.45 125.91 54.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 1.31 111.092 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.2 t -98.04 122.22 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 1.55 111.223 179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t -105.93 114.83 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 1.5 111.169 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -115.58 168.93 9.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.19 110.956 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -151.08 -170.34 3.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 1.9 110.82 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -57.0 -35.89 69.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 4.7 110.912 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -73.14 -10.38 59.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 1.93 110.839 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.61 93.41 10.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.683 0.754 . . . . 0.93 110.851 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.7 143.11 50.06 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.615 2.21 . . . . 0.41 112.38 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.0 t -48.96 -32.08 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 1.58 111.061 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.62 -53.69 35.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 2.33 110.888 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.69 -44.7 10.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 1.67 111.114 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -50.18 -59.58 3.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 1.71 110.904 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -48.26 -32.84 7.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 5.79 110.868 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.37 -46.41 33.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 0.54 112.48 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.0 mt -61.96 -35.63 79.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 2.52 110.903 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 22.0 m -80.93 -32.94 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 1.73 111.109 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -61.6 -54.61 40.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 1.68 110.904 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -36.89 71.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 3.51 110.836 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 60.1 mt -76.9 -25.01 52.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 1.97 110.96 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -78.18 -26.13 47.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.58 110.927 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.52 -31.67 15.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 1.86 111.105 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 pp -89.36 -35.86 15.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 1.92 110.985 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.7 -47.16 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 1.6 111.101 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.91 -15.36 42.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.769 -0.729 . . . . 0.36 112.495 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.06 -62.85 1.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.331 . . . . 2.49 110.846 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -105.82 -34.77 7.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 2.76 110.817 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.5 -127.3 2.14 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.822 -0.704 . . . . 0.29 112.493 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -157.52 151.27 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 5.11 110.782 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.3 t -136.24 120.13 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 1.51 111.167 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.7 t -110.34 155.44 22.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 1.11 110.879 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.47 134.7 61.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 1.52 111.139 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -143.46 151.83 40.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 1.3 110.932 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -103.01 135.98 43.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.61 110.812 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 25.3 mt -52.17 -35.31 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 1.56 111.102 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -74.96 -29.24 60.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 2.64 110.905 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -99.5 18.49 17.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 3.4 110.908 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.56 -30.47 5.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 2.1 110.901 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mp -54.32 -37.35 64.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 1.95 110.882 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -84.82 -15.52 44.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 1.08 110.864 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.9 m -66.63 -10.37 45.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 1.65 110.894 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.02 63.47 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 1.49 111.091 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -62.03 -69.34 0.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.45 110.795 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -153.38 -175.76 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 3.13 110.903 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -93.84 135.12 35.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 1.94 110.917 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p 46.42 82.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.423 . . . . 1.35 110.87 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.3 p -133.57 -38.35 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 1.29 110.893 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -102.0 122.72 44.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 2.54 110.821 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.87 -23.19 62.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 1.5 110.841 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.4 mt -145.04 143.02 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 1.63 111.108 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.3 mm -132.75 133.74 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 1.51 111.097 179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -114.21 135.94 53.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 1.57 110.943 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.32 97.47 4.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 1.24 110.894 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.15 73.28 0.38 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.719 -0.753 . . . . 0.39 112.554 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.97 -19.14 21.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 2.16 110.971 -179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -47.54 151.12 1.51 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.659 0.742 . . . . 1.9 111.113 179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 135.38 30.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.657 2.238 . . . . 0.82 112.298 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.92 1.4 78.78 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.702 -0.761 . . . . 0.38 112.437 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.62 154.63 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.991 0.424 . . . . 1.82 110.815 -179.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 p -140.86 109.4 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 1.58 111.106 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.72 154.19 22.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 1.54 111.241 179.967 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.3 mt -130.93 107.35 9.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 1.45 110.896 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -84.2 153.88 23.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.893 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.3 m -131.8 -176.15 3.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 1.21 110.845 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.68 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 1.37 111.171 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -62.52 -45.99 90.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 2.08 110.884 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.5 mp -73.7 -54.96 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 1.45 111.109 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.9 mt -50.66 -41.12 55.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 1.6 110.898 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.0 -54.86 24.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 1.67 111.139 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.45 -43.33 83.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 2.38 110.936 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.2 mm -56.24 -68.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 1.5 111.202 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.91 -36.66 39.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 1.32 111.152 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -56.24 -51.76 66.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 2.98 110.871 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.8 pt -83.13 -6.62 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 1.67 111.093 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.13 112.88 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 1.52 110.932 179.879 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -51.82 159.51 1.33 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.662 0.744 . . . . 2.99 110.791 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.61 114.59 3.73 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.666 2.244 . . . . 0.22 112.413 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.35 3.65 56.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.68 -0.772 . . . . 0.14 112.479 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.16 -157.97 8.9 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.767 -0.73 . . . . 0.13 112.545 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.5 m -144.2 156.07 44.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.365 . . . . 1.42 110.874 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -138.5 112.74 8.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 1.53 110.949 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.42 133.01 50.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 2.96 110.842 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.5 164.15 35.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 1.54 110.904 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.23 123.94 19.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 3.69 110.82 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.61 150.93 45.26 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 3.64 110.946 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 138.21 37.06 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.641 2.227 . . . . 0.25 112.365 179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.31 147.28 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 1.63 111.061 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -114.76 132.59 56.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 1.98 110.859 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.7 p -104.4 25.98 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 1.99 111.093 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.68 23.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 1.77 111.053 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.4 t -144.4 160.47 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 1.72 111.19 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.94 179.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 1.93 110.854 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.07 -60.42 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 2.53 110.808 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -64.61 -75.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 3.16 110.886 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.93 -168.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 2.15 110.878 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -5.0 55.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 2.73 110.972 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.06 140.43 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 1.8 111.17 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.54 119.15 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 3.03 110.944 179.841 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 49.0 p -89.07 175.31 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 1.55 111.195 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.55 -55.13 38.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 1.65 111.123 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -61.05 -47.96 83.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.87 110.865 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -58.1 -40.96 82.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 2.54 110.864 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.96 -57.37 10.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 1.68 110.863 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 61.9 m -51.72 -44.71 63.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 1.64 110.945 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -42.12 85.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 1.16 110.914 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.74 97.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 1.46 111.073 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.7 tp -66.36 -51.74 54.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 1.73 110.92 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -62.39 -32.23 73.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 1.41 111.146 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.09 -10.73 52.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 1.95 110.889 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.34 4.62 30.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 2.41 110.855 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.47 10.0 28.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.784 -0.722 . . . . 0.53 112.45 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.3 171.63 7.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 1.6 110.946 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 m -150.01 173.04 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 1.54 111.088 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 51.73 44.92 28.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 2.06 110.927 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.5 t -81.6 141.73 14.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 1.4 111.131 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 159.07 7.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.116 -0.493 . . . . 2.79 110.983 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.22 139.72 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 3.38 110.959 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 mp -95.84 -38.17 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 1.68 110.945 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.7 pm0 -157.68 176.37 12.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.452 . . . . 2.99 110.926 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -128.1 138.08 52.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 4.93 110.829 -179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -124.3 136.38 27.61 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.683 0.754 . . . . 1.38 110.853 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 164.75 33.4 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.743 2.295 . . . . 0.27 112.291 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.61 125.71 42.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 1.6 110.9 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.0 161.34 23.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.528 0.68 . . . . 2.81 111.108 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -24.08 29.94 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.628 2.219 . . . . 0.46 112.382 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -85.08 -22.26 29.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 2.6 110.944 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -87.76 -54.6 4.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 2.38 110.832 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -49.03 -39.12 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 1.65 111.116 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -37.86 80.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 2.8 110.865 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -46.91 75.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 1.05 110.888 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.37 -30.67 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 1.64 111.131 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -75.95 -30.63 58.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 4.77 110.864 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -90.06 -20.51 23.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 1.89 110.887 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.5 -32.69 13.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.34 110.871 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.4 mp -127.9 -53.86 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 1.72 110.982 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.79 15.21 1.97 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.776 -0.726 . . . . 0.54 112.541 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -70.92 121.69 18.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.768 0.318 . . . . 1.33 110.891 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -152.11 105.53 3.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 2.34 110.833 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -160.66 175.79 12.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 1.42 110.777 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.24 -21.89 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 1.72 110.842 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -91.4 13.29 17.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 1.54 110.965 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.54 164.63 21.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 1.58 110.89 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -173.72 130.09 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 1.67 110.902 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -76.08 137.99 40.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 3.03 110.925 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.45 150.06 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 1.66 111.128 179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -103.49 133.91 47.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 2.82 110.896 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.43 147.35 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 1.8 111.126 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 5.4 t -132.63 148.97 52.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 1.8 111.024 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.99 135.4 7.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.71 -0.757 . . . . 0.26 112.519 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -90.89 140.09 30.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 2.74 110.836 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 135.04 51.38 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 2.18 110.872 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 124.03 10.67 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.644 2.229 . . . . 0.29 112.38 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -104.1 150.78 24.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.33 110.942 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -76.45 66.76 2.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 8.73 110.894 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -109.74 30.27 6.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 10.12 110.843 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.5 t -149.66 -72.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.202 -0.454 . . . . 7.67 111.117 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 167.7 -26.85 0.15 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.731 . . . . 8.31 112.483 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.28 126.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.957 0.408 . . . . 10.13 110.758 -179.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.81 -74.34 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 7.81 110.776 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 8.7 tpm_? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 9.19 110.867 -179.895 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.741 0.305 . . . . 4.21 110.899 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.94 -21.95 65.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 2.08 111.127 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.06 -51.58 63.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 2.15 110.865 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.27 21.55 10.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 3.54 110.912 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.67 38.91 59.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.721 . . . . 0.34 112.502 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.97 158.12 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 1.53 111.126 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.5 m -149.62 157.02 42.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.177 -0.465 . . . . 1.64 110.8 -179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.53 125.59 33.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 1.78 111.063 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.95 -6.2 23.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 0.31 112.53 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.05 167.57 10.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.758 0.313 . . . . 1.69 110.917 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.66 136.33 39.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 2.28 110.841 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.8 p -141.03 136.89 34.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 3.25 111.087 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -112.3 124.14 51.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 1.34 111.159 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.7 t -94.69 116.97 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 1.65 111.121 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.31 112.05 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 1.77 111.15 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -114.52 165.85 12.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.25 110.967 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -147.36 -170.54 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.305 -0.407 . . . . 1.87 110.916 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -56.95 -35.94 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 4.89 110.815 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -72.61 -9.31 58.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.55 110.804 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.16 94.04 10.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.703 0.763 . . . . 0.94 110.838 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.3 47.64 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.691 2.261 . . . . 0.23 112.335 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.9 t -48.74 -32.94 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 1.51 111.149 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.84 -53.06 35.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 2.52 110.874 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.57 -44.88 10.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 1.51 111.095 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -51.96 -61.7 2.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.298 -0.41 . . . . 1.41 110.81 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.72 -36.76 26.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 3.57 110.89 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.38 -47.75 49.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.74 . . . . 0.24 112.478 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 mt -61.72 -40.44 95.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 1.63 110.921 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.9 m -75.92 -31.68 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 1.79 111.087 179.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.92 -60.46 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 1.7 110.916 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -40.16 71.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 2.63 110.802 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.2 mt -72.7 -24.69 61.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 1.85 110.935 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.47 -24.96 45.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.46 110.927 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.72 -29.93 17.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 1.69 111.093 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.61 -35.23 14.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 1.45 110.873 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.46 -44.9 5.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 1.46 111.053 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.97 -11.18 54.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.793 -0.718 . . . . 0.25 112.512 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.3 -62.44 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.685 0.278 . . . . 3.89 110.775 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -91.41 -40.08 11.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 2.25 110.915 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.92 -125.86 4.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.756 -0.735 . . . . 0.27 112.49 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -156.37 152.88 28.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.885 0.374 . . . . 2.89 110.846 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.3 t -136.91 127.96 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 1.4 111.104 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.4 t -116.93 152.91 33.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 1.43 110.823 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.69 132.28 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 1.75 111.197 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -143.54 152.0 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 1.28 110.905 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -102.38 137.78 40.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.64 110.886 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 mt -52.65 -36.74 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 1.7 111.095 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -75.7 -25.18 56.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 2.7 110.862 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -103.89 16.15 27.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 3.37 110.981 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.49 -24.72 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 3.9 110.91 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -51.16 -38.96 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 2.09 110.902 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -84.91 -14.2 48.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 1.37 110.907 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.4 t -58.97 -15.46 13.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 3.54 110.795 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.63 53.18 0.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 1.77 111.168 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -51.14 -72.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.48 110.865 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.83 -168.24 2.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 2.82 110.926 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -100.5 121.09 41.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 2.14 110.944 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.05 84.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.69 110.842 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 p -132.59 -36.84 1.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 1.52 110.854 -179.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.03 120.4 36.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 2.56 110.878 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.39 -20.48 61.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 1.77 110.9 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.1 mt -143.51 144.28 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 1.65 111.071 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.9 mm -136.13 126.11 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 1.54 111.189 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.85 137.41 46.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 1.58 111.001 179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.62 99.75 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 1.5 110.869 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.48 78.93 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.655 -0.783 . . . . 0.18 112.478 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.04 58.07 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 1.51 110.867 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.09 159.75 65.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.676 0.751 . . . . 1.61 111.124 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.74 115.63 4.18 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.738 2.292 . . . . 0.3 112.294 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.69 6.32 65.83 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.679 -0.772 . . . . 0.23 112.515 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.43 150.21 12.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 1.05 110.804 -179.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 p -140.3 108.86 5.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 1.55 111.062 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.16 144.18 9.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 1.63 111.162 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.4 mt -120.68 99.63 6.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 1.68 111.032 179.915 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -75.69 137.55 40.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.4 110.785 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.0 m -116.99 178.45 4.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.94 110.884 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.57 -44.12 62.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 1.18 111.059 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.28 -47.75 77.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 1.87 110.912 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.79 -56.53 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 1.4 111.17 179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.4 mt -50.23 -40.45 47.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 1.71 110.953 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.93 -57.04 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 1.6 111.177 179.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.69 -43.09 68.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 2.83 110.903 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.7 mm -57.47 -68.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.118 -0.492 . . . . 1.59 111.051 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.3 -37.69 37.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 1.41 111.117 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -53.95 -55.23 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 3.8 110.756 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.5 pt -81.29 -5.6 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 1.49 111.066 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.64 117.86 20.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 1.64 110.874 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.7 mtt-85 -57.56 158.87 10.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.598 0.713 . . . . 4.04 110.891 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 114.14 3.59 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.26 . . . . 0.2 112.32 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.33 3.58 55.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.2 112.46 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.02 -165.62 23.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.83 -0.7 . . . . 0.17 112.542 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.3 m -134.84 150.48 50.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.866 0.365 . . . . 2.02 110.896 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -134.7 115.0 13.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 1.44 110.963 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -110.37 132.47 54.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 2.89 110.792 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.53 159.02 44.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 1.56 110.871 -179.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 130.12 44.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 3.68 110.958 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.66 146.89 18.0 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.653 0.74 . . . . 2.33 110.885 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 142.23 47.68 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.674 2.25 . . . . 0.27 112.361 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.4 m -127.05 146.83 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 1.52 111.114 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -107.84 132.92 52.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 1.95 110.926 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.4 p -92.85 -41.4 10.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 1.85 111.15 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.51 38.53 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 1.74 110.973 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.89 150.63 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 1.82 111.13 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.51 173.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.82 110.834 179.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -66.97 -53.7 29.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 3.03 110.91 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -75.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 2.58 110.916 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 52.37 -169.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 2.4 110.836 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -80.3 -5.34 56.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 2.99 110.966 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.81 147.91 22.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 1.61 111.05 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.2 116.08 8.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 2.86 110.908 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.4 p -88.21 -178.98 6.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 1.43 111.102 179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.6 64.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 1.61 111.111 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.66 -49.63 76.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 1.19 110.939 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -57.1 -44.62 83.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 3.15 110.888 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.03 -55.45 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 1.61 110.954 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 71.5 m -53.71 -49.12 68.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 1.56 110.949 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -45.64 93.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 1.04 110.862 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.82 -44.84 93.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 1.56 111.116 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 12.5 tp -61.54 -54.12 47.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 1.55 110.912 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 100.0 m -61.85 -27.7 68.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 2.07 111.149 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.01 -17.45 50.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 2.14 110.854 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 p -82.37 3.03 29.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 2.97 110.823 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.38 -4.87 35.28 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.789 -0.72 . . . . 0.56 112.523 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.56 168.13 15.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 1.82 110.916 -179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.2 m -150.79 172.97 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 1.7 111.142 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 53.14 43.05 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 2.21 110.912 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.89 142.27 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 1.72 111.132 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.78 158.33 7.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 2.56 110.891 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -82.26 147.22 29.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 2.39 110.829 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.2 mp -107.78 -36.03 6.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 1.51 111.017 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -164.6 176.49 8.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.471 . . . . 1.29 110.853 179.872 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -126.12 165.76 18.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 9.43 110.867 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -148.62 136.34 11.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.671 0.748 . . . . 1.39 110.83 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 157.13 61.51 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.588 2.192 . . . . 0.4 112.448 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.98 127.58 39.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.31 -0.405 . . . . 1.64 110.933 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.56 161.37 23.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.544 0.687 . . . . 2.86 111.121 179.983 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -24.85 29.22 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.688 2.259 . . . . 0.5 112.325 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -85.75 -21.99 27.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 3.64 110.922 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -87.5 -53.07 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 2.5 110.93 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -50.13 -41.36 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 1.76 111.069 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -32.39 74.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.4 110.772 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -51.32 24.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.98 110.841 -179.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.4 p -61.54 -28.39 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 1.43 111.125 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -75.99 -48.58 20.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 2.49 110.915 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -73.26 -19.73 61.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 1.84 110.929 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.19 -33.36 13.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.56 110.835 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 mp -129.44 -54.09 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 1.68 110.916 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.57 14.59 1.9 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.688 -0.768 . . . . 0.36 112.513 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -74.62 120.34 20.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.853 0.359 . . . . 0.87 110.84 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -152.09 105.08 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 4.31 110.865 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.04 167.89 25.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.468 . . . . 1.43 110.816 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.77 -6.72 20.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 1.97 110.945 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.08 14.02 31.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 3.02 110.844 -179.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.26 168.95 11.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 1.75 110.919 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -173.51 130.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 1.54 111.013 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -69.38 134.66 49.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 3.28 110.825 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.73 143.28 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.085 -0.507 . . . . 1.67 111.139 179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -100.79 127.88 47.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 2.64 110.967 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.84 152.18 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 1.58 111.069 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.1 t -131.54 159.13 39.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 1.48 111.154 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.4 130.19 3.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.21 112.433 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -93.0 140.27 29.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 2.36 110.919 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -81.24 134.27 52.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.507 0.67 . . . . 2.49 110.92 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 119.78 6.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.625 2.217 . . . . 0.32 112.413 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -101.54 151.82 21.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.36 110.868 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -63.94 96.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 8.26 110.876 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -174.89 32.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 9.73 110.965 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.04 -65.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 6.58 111.103 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 174.52 -50.59 0.14 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.624 -0.798 . . . . 6.81 112.42 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.75 -46.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 8.56 110.842 -179.767 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.18 -169.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 7.88 110.897 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.9 tpt85 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 7.02 110.902 -179.844 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.702 0.287 . . . . 4.52 110.782 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.78 63.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 1.32 111.148 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.35 -51.51 64.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.28 110.858 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.16 22.27 10.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.235 -0.439 . . . . 3.54 110.894 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.16 37.82 47.24 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.29 112.527 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.9 mp -73.95 156.42 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.791 0.329 . . . . 1.7 111.175 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.7 m -147.7 154.73 40.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 1.51 110.897 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.17 125.31 33.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 1.6 111.177 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.27 -6.56 19.05 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.744 -0.741 . . . . 0.28 112.498 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.8 170.62 7.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 1.77 110.972 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.13 112.44 25.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 2.32 110.926 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -118.31 131.75 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 3.09 111.153 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.26 125.63 51.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 1.35 111.097 179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.4 t -96.18 117.4 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 1.55 111.24 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -100.86 119.9 49.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 1.71 111.102 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -120.0 168.95 10.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 0.2 110.946 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -151.83 -170.28 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 1.91 110.842 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -57.03 -35.6 69.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 3.65 110.975 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 m -73.62 -9.24 58.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.497 . . . . 2.02 110.842 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.97 94.2 10.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.634 0.731 . . . . 1.56 110.888 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 142.29 47.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.681 2.254 . . . . 0.24 112.386 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.2 t -48.99 -32.61 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 1.6 111.096 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.13 -53.06 37.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 2.42 110.903 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.66 -44.56 11.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 1.52 111.078 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -52.07 -61.42 2.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 1.61 110.908 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.14 -37.6 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 3.6 110.914 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.8 -47.54 54.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 0.25 112.409 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 mt -61.49 -40.98 96.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.915 0.388 . . . . 1.61 110.937 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.2 m -75.81 -31.42 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 1.69 111.065 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.75 -61.15 2.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 1.57 110.843 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.8 -40.59 69.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 2.7 110.85 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.6 mt -71.99 -25.07 61.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 1.53 110.944 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.33 -24.54 46.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.45 111.0 179.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.76 -29.79 17.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 1.59 111.156 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.58 -35.46 14.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 1.62 110.945 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.16 -44.89 5.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 1.43 111.13 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.22 -12.16 49.12 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.704 -0.76 . . . . 0.27 112.555 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -67.67 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 2.53 110.871 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -95.56 -38.99 10.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.093 -0.503 . . . . 2.61 110.94 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.1 -131.32 5.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 0.24 112.492 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -152.88 151.73 30.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.932 0.396 . . . . 4.67 110.832 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.01 125.06 44.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 1.59 111.107 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -115.87 152.49 33.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 1.02 110.833 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.32 133.66 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.5 . . . . 1.57 111.089 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -140.93 150.83 43.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 1.59 110.874 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -103.44 134.64 46.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.67 110.833 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.2 mt -51.56 -34.56 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 1.65 111.151 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -71.46 -34.76 70.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.507 . . . . 2.73 110.896 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -101.1 16.15 26.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.262 -0.427 . . . . 3.67 110.874 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.87 -42.8 37.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 2.15 110.89 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.5 -39.48 70.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 4.7 110.908 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.16 -13.14 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 5.15 110.924 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.7 m -77.19 -0.47 25.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 2.7 110.874 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.1 70.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 1.9 111.135 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -51.06 -73.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.439 . . . . 2.19 110.78 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.58 -165.18 1.98 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 2.29 110.915 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -106.36 128.71 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 2.15 110.866 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.44 71.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.33 110.826 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.7 p -126.39 -32.13 2.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 1.1 110.802 -179.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -100.24 119.31 38.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 2.53 110.897 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.39 -20.04 62.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 1.52 110.88 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 mt -143.99 144.46 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 1.59 111.161 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.3 mm -137.66 127.85 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 1.62 111.185 179.876 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -111.3 137.98 48.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 1.57 110.885 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.63 100.96 5.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 1.25 110.879 -179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.37 72.2 0.56 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.687 -0.768 . . . . 0.18 112.512 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.86 58.85 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.339 . . . . 1.6 110.939 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.2 159.73 65.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.546 0.688 . . . . 1.49 111.172 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.89 117.42 5.08 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.233 . . . . 0.24 112.302 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.51 7.24 72.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.818 -0.706 . . . . 0.21 112.53 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.72 146.83 20.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.997 0.427 . . . . 1.16 110.845 -179.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.8 p -136.11 108.58 7.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 1.65 111.127 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.87 147.51 15.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 1.58 111.143 179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.4 mt -123.63 103.54 8.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 1.59 110.911 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -81.26 141.95 33.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.34 110.893 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.3 m -123.57 174.73 7.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 1.32 110.804 -179.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.08 55.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 1.46 111.144 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.38 -46.05 91.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.144 -0.48 . . . . 2.14 110.889 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -73.15 -55.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 1.47 111.062 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.1 mt -49.75 -37.68 30.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 1.74 110.933 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.75 -57.0 9.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 1.58 111.096 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.05 -40.58 77.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.189 -0.459 . . . . 2.7 110.905 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.9 mm -59.33 -67.58 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 1.67 111.095 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.43 -33.69 31.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 1.4 111.106 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -57.23 13.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 3.23 110.824 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.7 pt -75.15 -8.88 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 1.62 111.172 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.07 125.84 29.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.143 -0.481 . . . . 1.56 110.924 179.875 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -67.05 160.52 69.95 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.651 0.738 . . . . 4.83 110.966 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 114.06 3.57 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.631 2.221 . . . . 0.2 112.366 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.83 3.99 56.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.18 112.468 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.12 -164.48 17.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 0.13 112.435 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 61.2 m -135.32 150.6 50.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 1.52 110.892 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -135.44 114.4 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 1.51 110.867 -179.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -109.59 132.35 54.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 2.95 110.88 179.889 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.48 164.16 35.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 1.6 110.905 -179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -136.26 124.56 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 2.83 110.959 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.31 150.52 41.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 2.3 110.945 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 139.87 41.49 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.697 2.265 . . . . 0.27 112.382 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.37 147.27 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 1.79 111.119 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -119.31 131.92 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 1.96 110.925 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 p -92.73 -36.24 13.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 1.88 111.123 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.51 37.33 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 1.65 111.137 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 30.7 t -147.68 149.35 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 2.05 111.123 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.59 179.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 1.71 110.81 179.98 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.41 -74.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 2.71 110.857 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -54.74 -77.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 2.86 110.945 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.25 -169.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 2.36 110.955 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -4.08 52.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 3.39 110.945 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -145.85 141.18 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 1.7 111.143 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -65.66 111.54 3.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 3.67 110.878 179.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 44.8 p -81.0 177.39 9.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 1.46 111.165 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.56 -55.29 26.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 1.39 111.191 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 m -60.49 -49.68 76.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.88 110.877 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -38.51 70.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 4.1 110.943 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.4 -54.89 22.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 1.53 110.874 179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 48.2 m -57.67 -45.33 85.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 2.05 110.856 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -42.95 88.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 1.39 110.858 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.84 97.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 1.54 111.088 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.5 tp -65.52 -50.46 65.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 1.65 110.878 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 95.5 m -64.13 -31.72 73.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 1.33 111.131 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.2 mt -86.75 -10.39 53.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.402 . . . . 1.81 110.894 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.07 5.17 30.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.416 . . . . 2.43 110.859 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.27 6.42 33.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.672 -0.775 . . . . 0.54 112.405 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.67 172.44 6.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.777 0.322 . . . . 1.45 110.985 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 m -151.18 173.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 1.64 111.101 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 53.37 43.93 30.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 2.22 110.862 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 95.5 t -77.5 141.35 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 1.66 111.03 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 161.43 8.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 2.78 110.841 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -82.26 145.9 29.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 2.09 110.855 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.0 mp -105.59 -35.97 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 1.57 110.927 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.41 175.82 13.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.19 110.981 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -128.62 147.95 50.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 4.78 110.834 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -137.32 134.4 18.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.695 0.759 . . . . 1.4 110.955 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 165.21 31.73 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.737 2.292 . . . . 0.27 112.352 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.77 125.53 42.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 1.78 110.894 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.97 161.95 21.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.603 0.716 . . . . 2.37 111.089 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -27.85 26.01 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.822 2.348 . . . . 0.37 112.253 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.54 -18.13 34.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 2.66 110.888 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.59 -54.27 4.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 2.78 110.931 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -49.89 -39.96 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.59 111.086 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -34.11 76.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 1.22 110.912 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -47.16 67.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 1.05 110.811 -179.772 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.08 -30.02 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 1.41 111.197 179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -75.76 -32.25 59.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 2.44 110.908 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -89.4 -20.16 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 1.74 110.916 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -94.34 -32.84 13.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.34 110.848 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 mp -128.11 -54.1 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 1.51 110.88 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.6 16.25 1.68 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.709 -0.758 . . . . 0.31 112.433 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -72.84 122.0 20.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.733 0.302 . . . . 1.23 110.887 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -151.51 105.45 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 2.1 110.848 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -160.54 170.03 21.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 1.16 110.882 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.14 -14.07 15.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 1.97 110.891 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -101.74 23.39 11.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 1.72 110.855 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 163.49 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.23 -0.441 . . . . 1.67 110.891 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -169.72 130.69 1.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 1.65 110.939 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -76.42 136.86 39.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 3.11 110.874 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.54 145.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 1.72 111.128 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -97.83 129.62 44.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 1.95 110.898 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.44 149.18 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 1.48 111.071 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.5 t -126.8 160.73 30.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 1.47 111.087 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.7 128.88 2.67 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.68 -0.772 . . . . 0.25 112.495 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -90.02 139.67 30.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 2.25 110.84 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.81 135.22 49.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.567 0.699 . . . . 2.15 110.873 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 128.41 16.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.647 2.231 . . . . 0.38 112.298 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -108.43 149.48 28.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.854 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -65.05 92.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 8.72 110.897 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.33 34.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 9.0 110.857 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.87 -69.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 6.27 111.054 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.77 -19.82 4.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.835 -0.698 . . . . 5.72 112.525 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.8 m -59.42 -175.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 6.57 110.851 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -68.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 7.67 110.798 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 8.81 110.974 180.0 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.817 0.342 . . . . 4.56 110.886 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.16 -18.78 64.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 2.01 111.1 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.99 -50.91 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 1.86 110.839 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -122.31 13.82 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 3.49 110.797 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.76 38.98 96.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.27 112.504 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 mp -78.9 158.78 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 1.49 111.071 -179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -152.65 162.07 41.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 1.6 110.915 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.23 126.32 35.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 1.5 111.058 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.08 -5.85 17.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.674 -0.774 . . . . 0.25 112.46 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -114.13 168.96 9.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.319 . . . . 1.52 110.857 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.58 140.64 32.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 2.3 110.808 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.9 t -142.63 138.46 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 2.86 111.135 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.4 123.94 49.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 1.63 111.136 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.1 t -97.43 118.19 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 1.7 111.1 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.4 t -102.47 110.98 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.55 111.092 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -112.4 167.38 10.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.21 110.928 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -151.18 -169.46 3.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.69 110.858 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.98 -35.95 69.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 6.63 110.857 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.8 m -72.95 -10.34 59.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 2.69 110.869 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.91 94.48 10.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 0.77 110.879 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 141.42 45.29 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.718 2.279 . . . . 0.24 112.396 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.0 t -48.64 -32.9 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 1.61 111.128 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.28 -52.64 43.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 3.15 110.891 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.53 -44.94 10.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 1.44 111.036 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -51.87 -61.55 2.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.275 -0.421 . . . . 1.72 110.939 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -37.41 28.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 3.72 110.874 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.21 -47.37 53.04 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.3 112.457 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.93 -39.97 93.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 1.74 110.92 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.1 m -76.82 -31.56 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 1.72 111.12 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -61.98 -59.8 4.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 1.85 110.868 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -40.2 71.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.425 . . . . 3.58 110.876 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.6 mt -72.94 -24.57 60.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 1.46 110.957 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -78.59 -25.36 45.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.49 110.917 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.88 -30.0 17.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.474 . . . . 1.81 111.076 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.48 -35.08 14.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 1.56 110.894 -179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.59 -45.49 4.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 1.59 111.128 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.07 -12.29 54.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.747 -0.74 . . . . 0.45 112.445 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.39 -62.54 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 3.53 110.951 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -84.81 -43.6 14.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 2.04 110.923 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.52 -121.86 4.31 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.33 112.471 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -157.03 153.84 28.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 4.46 110.853 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -139.24 129.91 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 1.62 111.084 -179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -118.2 157.95 26.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 1.14 110.816 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.87 135.07 60.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 1.57 111.19 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -145.45 151.76 38.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 1.29 110.811 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.85 135.94 43.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.63 110.913 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.1 mt -51.34 -35.03 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 1.39 111.087 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -32.05 62.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 3.79 110.863 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.7 19.48 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 3.36 110.882 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.67 -31.05 4.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.424 . . . . 2.17 110.91 -179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -54.31 -36.3 63.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 2.16 110.947 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -85.46 -15.91 41.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 1.07 110.991 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 m -64.01 -13.32 45.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 1.91 110.874 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.64 65.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 1.58 111.118 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -63.84 -72.46 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.51 110.888 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.77 -166.28 2.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 2.83 110.967 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -106.69 127.13 53.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.957 0.408 . . . . 1.69 110.885 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 49.15 75.88 0.14 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.5 . . . . 1.34 110.886 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.2 p -127.48 -34.4 2.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 1.01 110.808 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.54 120.82 39.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 2.59 110.885 -179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.5 -20.61 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 1.69 110.862 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.6 mt -143.87 144.23 23.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.226 -0.443 . . . . 1.73 111.101 -179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 23.1 mm -134.65 126.52 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 1.58 111.137 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -111.16 131.96 54.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 1.56 110.841 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.7 100.01 6.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 1.11 110.852 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.59 75.37 0.22 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.792 -0.718 . . . . 0.17 112.479 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -106.27 55.71 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.891 0.377 . . . . 1.58 110.88 -179.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.96 160.07 53.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.579 0.705 . . . . 1.47 111.081 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 123.29 9.93 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.653 2.236 . . . . 0.28 112.427 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.93 7.52 87.82 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.712 -0.756 . . . . 0.22 112.54 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.7 p -55.58 149.1 14.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.052 0.453 . . . . 1.47 110.828 -179.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.5 p -138.79 109.12 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.044 -0.526 . . . . 1.6 111.2 -179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.43 156.77 26.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 1.51 111.106 -179.856 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.7 mt -135.04 106.55 6.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 1.76 110.915 179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -82.11 153.83 25.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.37 110.901 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.7 m -131.0 176.32 8.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.95 110.884 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.47 -36.28 43.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.486 . . . . 1.37 111.094 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -62.5 -42.79 99.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 1.62 110.868 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.4 mp -77.53 -55.58 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 1.69 111.138 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.0 mt -48.87 -49.69 38.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 1.43 110.998 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.89 -48.28 51.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 1.96 111.062 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -46.76 88.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 4.92 110.903 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.9 mm -53.63 -64.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 1.58 111.122 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.78 -41.38 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 1.36 111.134 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -51.63 -51.31 56.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 3.39 110.867 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.4 pt -84.3 -6.29 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 1.46 111.175 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.45 116.64 20.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 1.62 110.883 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -55.91 159.19 5.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.665 0.745 . . . . 3.07 110.811 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 113.93 3.53 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.721 2.281 . . . . 0.24 112.395 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.23 4.46 55.18 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.788 -0.72 . . . . 0.22 112.436 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.53 -163.46 19.97 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.776 -0.726 . . . . 0.16 112.407 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.9 m -136.18 154.61 50.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 1.57 110.9 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -138.94 116.36 11.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 1.51 110.904 -179.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -111.68 131.26 55.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 2.97 110.831 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.67 163.44 37.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 1.66 110.851 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -137.11 134.43 36.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 4.54 110.894 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.72 148.94 20.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.699 0.761 . . . . 3.48 110.876 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 131.91 22.31 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.706 2.271 . . . . 0.46 112.383 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.2 m -120.15 146.59 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 1.76 111.197 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.28 132.87 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 3.43 110.875 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.1 p -102.56 26.61 7.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 1.83 111.152 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.77 24.72 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 1.86 111.114 179.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.22 160.39 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.21 -0.45 . . . . 1.76 111.11 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.02 177.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 1.95 110.925 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -67.9 -53.03 29.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 3.68 110.875 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -70.88 -76.43 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 2.96 110.877 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.65 -168.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 2.41 110.851 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -5.28 56.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 2.67 110.872 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -146.02 140.92 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 1.68 111.149 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -60.6 121.51 12.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 3.54 110.856 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 47.3 p -90.02 177.2 6.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 1.53 111.13 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.07 -54.73 43.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 1.6 111.097 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -59.51 -48.51 81.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 1.09 110.872 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -56.73 -40.83 76.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 3.77 110.874 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.91 -54.11 43.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.429 . . . . 1.75 110.894 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.3 m -55.83 -47.93 76.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 1.6 110.923 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -45.57 88.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 1.43 110.868 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.32 97.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 1.59 111.083 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.94 -53.77 34.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.416 . . . . 1.5 110.957 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.2 m -59.12 -33.48 70.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 1.38 111.155 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.4 mt -86.99 -10.27 53.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 1.9 110.953 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.2 m -85.06 4.85 32.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 2.35 110.814 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.14 11.25 26.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.71 112.492 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -111.32 170.77 7.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 1.62 110.839 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 25.6 m -151.38 173.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 1.53 111.112 179.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 51.72 43.88 29.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 2.2 110.81 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.8 t -75.54 143.63 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 1.72 111.15 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.16 158.42 6.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 2.63 110.949 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.5 145.35 31.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 2.14 110.915 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.3 mp -104.34 -36.71 7.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 1.54 110.867 -179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.59 176.16 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.16 110.937 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -133.17 138.0 46.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 5.07 110.92 -179.85 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -123.84 136.11 27.02 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.672 0.749 . . . . 1.5 110.868 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.89 158.82 55.51 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.597 2.198 . . . . 0.36 112.342 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.44 124.53 38.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 1.46 110.91 -179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.404 ' HB ' ' HD2' ' A' ' 137' ' ' PRO . 0.0 OUTLIER -105.07 162.7 18.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 2.58 111.135 179.918 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 136' ' ' THR . 53.4 Cg_endo -69.79 -23.15 30.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.661 2.241 . . . . 0.74 112.31 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.79 -22.53 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 2.34 110.965 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -87.65 -53.91 4.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 3.98 110.911 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.7 p -50.66 -40.21 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 1.75 111.149 179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -31.98 73.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 1.31 110.987 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -51.38 19.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.95 110.89 -179.849 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -61.72 -28.29 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 1.57 111.098 179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -76.28 -48.24 20.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 3.09 110.86 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -73.63 -19.32 60.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 2.17 110.959 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.5 -33.56 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.65 110.82 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 mp -128.32 -54.43 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 1.83 110.925 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.81 12.66 1.91 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.736 -0.745 . . . . 0.68 112.556 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.9 t-160 -70.77 121.37 17.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 1.22 110.834 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -152.04 105.48 3.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 2.73 110.946 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.48 175.02 13.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 1.28 110.826 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.82 -17.82 13.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.072 -0.513 . . . . 1.71 110.793 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -94.66 12.17 28.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 1.53 110.839 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.31 164.02 22.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 1.85 110.92 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -173.35 132.08 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 1.45 110.876 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -77.09 131.86 38.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 3.04 110.845 179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.69 144.37 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 1.62 111.139 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -102.01 130.6 48.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 2.06 110.898 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.03 149.72 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 1.54 111.183 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.5 t -127.88 160.48 31.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 1.46 111.062 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.52 132.22 3.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.83 -0.7 . . . . 0.19 112.606 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -94.71 140.84 29.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 2.71 110.925 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -81.46 134.52 51.23 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.621 0.724 . . . . 2.48 110.851 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 118.75 5.87 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.775 2.316 . . . . 0.44 112.328 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -100.48 152.02 20.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.5 110.895 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.4 t80 61.13 19.53 10.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 7.28 110.902 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -179.2 -172.65 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 9.73 110.908 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -75.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 10.32 111.16 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 52.27 70.29 0.94 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.772 -0.728 . . . . 8.11 112.525 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 46.6 p -175.38 32.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.851 0.358 . . . . 10.47 110.854 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.26 -75.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 11.78 110.814 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 30.2 ttp85 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 10.01 110.951 -179.885 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptp . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.75 0.31 . . . . 4.58 110.866 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.42 -21.73 63.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 1.55 111.04 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -54.14 -51.59 63.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.328 -0.396 . . . . 2.72 110.851 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -122.4 22.13 10.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 2.69 110.758 -179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.51 41.92 56.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.814 -0.708 . . . . 0.33 112.445 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 mp -81.51 160.22 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.817 0.342 . . . . 1.68 111.099 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.48 168.21 28.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 2.66 110.818 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.64 130.62 35.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 1.65 111.099 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.15 2.79 29.79 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.719 -0.753 . . . . 0.3 112.448 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -116.96 166.88 11.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 1.19 110.958 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.02 115.19 29.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 2.29 110.848 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 m -117.95 139.78 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 3.31 111.151 179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.04 112.12 22.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 1.73 111.089 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -87.65 121.87 38.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 1.66 111.163 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 t -108.29 119.84 58.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 1.53 111.219 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -117.8 166.15 12.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.22 110.972 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -145.65 -169.06 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.309 -0.405 . . . . 1.69 110.872 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -59.59 -35.28 73.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 4.35 110.937 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.4 m -74.68 -6.92 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 1.78 110.86 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.62 92.7 8.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.682 0.753 . . . . 0.84 110.906 -179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 143.08 49.94 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 0.23 112.413 179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t -48.8 -32.77 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 1.58 111.193 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -51.0 -53.26 34.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 3.13 110.872 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.57 -44.95 10.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 1.42 111.12 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -51.45 -61.95 1.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 1.43 110.968 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.52 -35.77 21.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 3.65 110.921 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.87 -47.67 45.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.677 -0.773 . . . . 0.21 112.548 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.4 mt -61.73 -39.86 93.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.92 0.391 . . . . 1.78 110.987 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.0 m -76.65 -31.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 1.66 111.199 179.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.38 -59.68 4.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 1.66 110.807 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -40.29 72.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 2.62 110.945 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.4 mt -72.78 -24.93 61.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 1.59 110.883 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.49 -25.01 45.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.45 110.82 -180.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.59 -29.95 17.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 1.32 111.094 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 pp -91.6 -34.82 14.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 1.44 110.892 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.17 -45.6 4.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 1.6 111.134 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.47 -12.27 55.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.3 112.505 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -65.33 -62.66 1.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 3.51 110.989 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.09 -36.49 10.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 1.88 110.925 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.32 -128.74 4.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.25 112.452 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -154.32 153.19 31.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 2.95 110.799 -179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.8 t -138.88 117.05 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 1.59 111.116 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.3 t -107.01 151.35 25.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.794 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -114.24 136.29 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 1.56 111.02 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -144.99 152.2 39.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.142 -0.481 . . . . 1.27 110.842 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -102.8 134.34 46.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.67 110.952 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.2 mt -50.29 -33.56 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.81 111.101 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -76.48 -34.3 58.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 3.72 110.878 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -93.37 18.57 9.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 3.16 110.821 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.49 -30.25 4.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 2.15 110.961 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mp -53.45 -37.95 63.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 2.1 110.844 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -85.23 -16.18 41.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 1.18 110.834 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.8 m -65.41 -12.38 51.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 1.96 110.873 -179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.84 61.2 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 1.57 111.099 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -58.62 -71.82 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.117 -0.492 . . . . 0.48 110.806 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.2 -168.68 3.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 3.07 110.866 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -102.18 137.71 40.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 1.94 110.899 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 p 46.55 85.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 1.38 110.873 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 p -139.97 -40.49 0.44 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 1.28 110.865 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.64 120.42 39.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 2.58 110.889 -179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.62 -21.6 63.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 1.5 110.819 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.5 mt -147.16 142.64 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 1.69 111.165 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 22.5 mm -129.43 134.42 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 1.53 111.109 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -114.54 135.24 54.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 1.63 110.924 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.76 97.73 4.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 1.47 110.801 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.48 79.54 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.22 112.47 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.88 56.69 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.963 0.411 . . . . 1.63 110.959 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.31 159.35 57.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.617 0.723 . . . . 1.63 111.16 179.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 116.46 4.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.683 2.255 . . . . 0.25 112.375 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.31 7.37 69.82 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.22 112.533 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -54.79 144.25 23.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.974 0.416 . . . . 1.08 110.87 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.5 p -133.49 108.5 8.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 1.43 111.166 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -162.7 149.53 13.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 1.53 111.095 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 mt -127.52 99.99 5.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.13 -0.486 . . . . 1.54 110.967 179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -73.23 145.95 45.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.32 110.881 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 m -120.28 172.8 7.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 1.41 110.742 -179.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.34 -39.7 47.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 1.61 111.125 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.6 -38.31 84.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 2.38 110.909 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 mp -79.81 -54.84 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 1.6 111.201 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.0 mt -49.84 -45.87 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 1.77 110.906 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.75 -51.65 54.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.174 -0.467 . . . . 1.56 111.014 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -42.48 77.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 2.61 110.886 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.9 mm -59.93 -68.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 1.51 111.093 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.57 -32.68 19.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 1.89 111.127 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -61.02 -56.15 24.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 3.13 110.906 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.8 pt -76.95 -6.72 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 1.48 111.165 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.36 124.31 27.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 1.61 110.891 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -62.67 160.23 37.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.572 0.701 . . . . 2.85 110.869 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 114.04 3.56 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.73 2.286 . . . . 0.24 112.318 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.71 3.5 56.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.819 -0.705 . . . . 0.22 112.44 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.11 -156.9 9.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.716 -0.754 . . . . 0.22 112.423 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.3 m -146.0 158.18 43.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.888 0.375 . . . . 1.75 110.833 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.38 116.14 10.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 1.6 110.954 -179.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -108.76 132.73 53.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 2.89 110.84 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.56 160.59 42.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 1.5 110.878 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 126.37 36.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 2.79 110.862 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.9 148.13 24.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.659 0.742 . . . . 2.3 110.875 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.65 143.95 53.05 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.718 2.279 . . . . 0.23 112.386 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.6 m -127.12 147.0 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 1.7 111.1 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.01 132.42 56.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 3.15 110.811 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.7 p -104.75 25.99 9.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 2.09 111.247 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.65 26.31 0.83 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 1.98 111.104 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.8 t -144.09 158.64 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 1.79 111.114 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.11 -177.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.86 110.886 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -66.5 -73.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 3.08 110.874 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.34 -75.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 3.17 110.834 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.75 -168.56 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 2.15 110.747 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -6.28 57.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 2.67 110.886 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.3 m -146.61 143.44 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 1.86 111.079 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -65.61 113.18 4.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 3.55 110.963 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.3 p -83.19 179.83 7.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 1.7 111.187 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.65 -54.27 47.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 1.48 111.042 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -49.54 76.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 1.2 110.865 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -39.74 76.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 3.18 110.865 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.97 -55.1 28.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 1.56 110.965 179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.7 m -57.84 -47.43 82.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 1.75 110.853 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -44.33 96.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 1.3 110.912 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.11 -50.96 71.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 1.72 111.182 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.1 tp -59.68 -57.31 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 1.8 110.865 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -57.52 -26.56 61.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 1.49 111.14 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.9 mt -84.3 -16.0 44.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 1.85 110.93 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.0 p -82.2 3.09 28.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 3.07 110.809 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.81 -4.85 34.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.92 112.49 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tp -83.32 171.3 13.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 1.78 110.92 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.07 169.66 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 1.74 111.146 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 51.64 44.93 28.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 2.24 110.881 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.16 139.44 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 1.69 111.149 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.18 159.98 7.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 2.79 110.879 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -77.54 145.29 37.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 2.61 110.913 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.1 mp -102.16 -37.53 8.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 1.53 110.917 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -156.04 176.27 12.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 3.0 110.957 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -129.39 136.87 50.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.328 -0.397 . . . . 4.84 110.929 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -123.55 136.56 27.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.62 0.724 . . . . 1.39 110.999 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.71 163.2 39.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.649 2.233 . . . . 0.27 112.388 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.79 124.35 40.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.174 -0.466 . . . . 1.46 110.909 179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.09 161.21 25.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.64 0.734 . . . . 2.32 111.145 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -28.57 25.06 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.704 2.27 . . . . 0.51 112.32 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -85.1 -17.76 36.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.217 -0.447 . . . . 2.49 110.936 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.32 -54.0 4.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 2.82 110.998 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.58 -40.03 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 1.55 111.095 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -34.72 76.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 1.28 110.86 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -46.77 69.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 1.02 110.793 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.3 p -68.0 -30.03 46.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 1.57 111.183 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -75.66 -32.25 60.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 2.53 110.923 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -89.43 -20.29 24.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 1.61 110.901 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -94.36 -32.55 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.31 110.828 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 mp -128.31 -54.05 1.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 1.49 110.843 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.38 12.12 2.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.807 -0.711 . . . . 0.34 112.49 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -70.9 121.53 18.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.682 0.277 . . . . 0.89 110.853 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -152.18 105.27 3.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.296 -0.411 . . . . 2.27 110.923 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.7 t -160.73 176.52 11.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 1.08 110.91 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.12 -20.8 13.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.7 110.952 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -92.02 13.13 19.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 1.57 110.938 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.54 163.89 22.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 1.51 110.921 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -173.35 129.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 1.6 110.851 179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -75.39 137.62 41.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 3.01 110.882 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.3 146.41 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 1.58 111.154 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -98.9 132.05 44.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 2.54 110.926 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -126.99 149.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 1.62 111.144 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.0 t -137.06 152.64 50.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 1.72 111.094 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -144.1 137.48 7.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.73 . . . . 0.24 112.483 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -92.83 140.18 29.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 2.6 110.832 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.57 135.29 49.77 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.622 0.725 . . . . 2.28 110.855 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 127.47 14.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.724 2.283 . . . . 0.32 112.292 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -107.67 149.24 28.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.34 110.908 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -69.31 85.31 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 8.46 110.953 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.46 34.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 9.25 110.851 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 26.6 m -150.06 166.35 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 6.79 111.121 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -112.41 -19.61 6.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.685 -0.769 . . . . 6.93 112.531 179.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 87.1 p -53.51 170.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.341 . . . . 7.95 110.869 -179.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 -170.97 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 7.84 110.89 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 12.18 110.864 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.832 0.349 . . . . 2.35 110.83 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -122.24 22.55 10.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 1.97 110.842 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.31 40.14 52.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.26 112.529 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.543 HG23 HG21 ' A' ' 12' ' ' VAL . 1.7 mp -78.51 159.26 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.23 111.15 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.725 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -152.43 163.48 39.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 1.36 110.859 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.47 126.1 35.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.32 111.096 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.69 -0.0 20.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.72 -0.752 . . . . 0.3 112.477 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -117.55 170.64 8.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.827 0.346 . . . . 1.12 110.902 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.81 113.79 27.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 1.36 110.856 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 ' HB ' ' A' ' 62' ' ' ILE . 99.1 t -118.5 125.89 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 1.96 111.177 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.781 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -103.16 128.44 50.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.28 111.124 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.843 HG11 HG12 ' A' ' 29' ' ' VAL . 60.7 t -101.32 120.84 51.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.17 111.166 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.5 t -104.31 120.87 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.23 111.128 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.4 p-90 -120.48 168.99 10.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.19 110.898 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.76 -169.93 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 1.75 110.813 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -57.41 -35.56 70.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 3.53 110.886 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.54 -9.9 59.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 1.24 110.837 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.04 94.44 10.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.686 0.755 . . . . 0.13 110.912 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 142.03 46.72 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.683 2.255 . . . . 0.19 112.34 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.0 t -48.99 -32.57 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.17 111.12 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.38 -52.93 41.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 2.67 110.851 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.55 -44.96 10.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.17 111.048 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.467 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.45 -61.25 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.13 110.917 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -35.95 24.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 3.42 110.87 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.41 -47.25 44.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.786 -0.721 . . . . 0.18 112.439 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 mt -61.94 -38.61 89.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.48 110.928 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.843 HG12 HG11 ' A' ' 14' ' ' VAL . 17.5 m -78.09 -31.35 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.62 111.155 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.33 -58.0 9.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 1.59 110.84 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -40.05 74.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 1.73 110.909 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.879 HD23 HD21 ' A' ' 35' ' ' LEU . 88.4 mt -73.12 -25.07 60.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.24 110.891 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.472 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.37 -25.26 46.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.37 110.877 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.49 -30.25 17.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.22 111.153 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.879 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -90.75 -35.18 15.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.2 110.904 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.725 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.4 -46.9 4.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.2 111.135 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.31 -13.74 50.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.73 . . . . 0.26 112.477 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -62.58 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 2.0 110.882 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -96.01 -38.11 10.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 2.03 110.903 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.56 -132.98 6.52 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.759 -0.734 . . . . 0.27 112.461 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -149.22 152.67 36.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 2.18 110.906 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.8 t -137.68 122.81 24.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.23 111.1 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -112.14 157.63 20.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.18 110.844 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.58 135.19 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.17 111.132 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -142.51 151.1 41.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 2.02 110.847 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -103.26 134.59 46.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.4 110.861 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.722 ' CD1' HG21 ' A' ' 73' ' ' THR . 26.7 mt -51.89 -36.48 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.33 111.15 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -32.84 69.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 2.19 110.869 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -103.52 20.92 16.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 3.52 110.93 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.845 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.15 -27.8 3.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 1.06 110.928 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -55.1 -32.7 62.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 1.04 110.888 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -84.86 -15.33 45.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 1.06 110.929 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB2' HD13 ' A' ' 50' ' ' LEU . 47.0 m -63.77 -12.61 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.88 110.892 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -73.83 63.1 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.28 111.083 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.406 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 4.8 m80 -64.46 -70.17 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.38 110.873 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.686 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.12 -168.2 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 1.13 110.914 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -106.35 128.12 53.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 2.01 110.846 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 48.93 77.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 1.34 110.843 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.7 p -130.12 -34.2 1.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.26 110.845 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.2 m-85 -98.99 120.25 39.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 1.42 110.886 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.13 -20.72 62.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 1.5 110.842 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.699 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.2 mt -146.62 144.5 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.23 111.153 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.92 HG21 HG23 ' A' ' 83' ' ' ILE . 17.2 mm -134.69 131.71 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.12 111.118 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -113.94 137.06 52.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.17 110.976 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.47 101.64 6.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.15 110.873 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.63 74.66 0.27 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.804 -0.713 . . . . 0.16 112.428 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.576 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.2 mm? -106.63 56.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 0.58 110.893 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.0 159.79 60.1 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.621 0.724 . . . . 0.23 111.2 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 124.14 10.77 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.24 112.32 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.5 7.11 88.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.21 112.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 68' ' ' VAL . 10.0 p -55.58 151.49 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.972 0.415 . . . . 0.78 110.829 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 29.7 p -140.33 108.96 5.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.18 111.132 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.722 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.79 153.81 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 0.26 111.126 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.96 HD12 HD22 ' A' ' 147' ' ' LEU . 5.3 mt -132.25 105.78 7.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.22 110.916 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -82.35 152.5 26.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.25 110.845 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.0 m -131.94 176.98 7.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.48 110.843 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -37.27 45.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.24 111.079 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.25 -44.41 96.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 2.07 110.883 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.845 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -75.11 -54.85 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.19 111.133 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 119' ' ' LEU . 61.7 mt -51.08 -38.92 54.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.22 110.906 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.84 -55.2 24.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.32 111.101 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -56.09 -44.96 79.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 2.82 110.887 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.92 HG23 HG21 ' A' ' 63' ' ' ILE . 49.9 mm -55.08 -67.76 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.22 111.132 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.07 -40.1 57.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.25 111.067 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -52.95 -49.06 66.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 2.85 110.883 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.686 HG22 ' O ' ' A' ' 56' ' ' LYS . 38.7 pt -87.02 -5.3 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.19 111.162 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -80.92 117.3 21.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.25 110.887 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -56.81 158.69 8.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.598 0.714 . . . . 2.29 110.917 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 54.0 Cg_endo -69.73 114.03 3.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 0.19 112.365 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.03 3.27 54.75 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.15 112.504 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.38 -162.8 17.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.784 -0.722 . . . . 0.14 112.502 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.3 m -137.01 155.5 49.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.347 . . . . 0.27 110.872 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -139.56 115.55 10.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.15 110.893 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.551 ' N ' HD22 ' A' ' 93' ' ' LEU . 58.6 m-85 -110.15 132.1 54.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 1.9 110.873 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.549 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.78 158.76 44.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.15 110.883 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.38 128.29 44.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 1.86 110.905 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.596 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -150.69 146.19 19.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 2.26 110.914 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.608 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.73 138.07 37.04 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.656 2.238 . . . . 0.18 112.365 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 155' ' ' LEU . 14.9 m -120.71 146.55 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.19 111.098 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -110.59 132.58 54.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 1.93 110.851 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.2 p -105.15 25.9 10.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 1.11 111.145 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.63 25.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.7 111.106 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.5 t -143.66 159.79 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.74 111.123 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.53 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -56.66 -178.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 1.79 110.889 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -66.81 -68.27 0.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 2.05 110.873 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -60.0 -75.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 2.19 110.859 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.81 -167.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 1.72 110.863 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -7.48 58.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 1.91 110.886 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.44 141.02 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.53 111.106 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -63.17 115.09 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 2.43 110.895 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.53 HG21 ' O ' ' A' ' 104' ' ' ASP . 33.1 p -83.19 -179.8 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.27 111.113 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.63 55.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.28 111.091 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.19 -48.9 77.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.31 110.887 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -37.92 75.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 2.3 110.888 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.596 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.3 tm? -65.17 -55.05 20.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.34 110.912 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.8 m -57.37 -45.59 84.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.35 110.897 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -42.42 91.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.48 110.852 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.89 97.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.32 111.075 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.56 HD11 HD12 ' A' ' 93' ' ' LEU . 14.8 tp -64.52 -51.44 62.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.25 110.916 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.5 m -62.28 -31.55 72.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.34 111.113 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.04 -10.27 53.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.67 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.5 6.51 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 1.7 110.864 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.82 6.0 32.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.49 112.465 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -106.69 171.63 7.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 0.28 110.942 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 126' ' ' GLU . 27.4 m -150.14 171.15 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.27 111.144 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.516 ' HG3' HG23 ' A' ' 125' ' ' VAL . 22.5 mt-10 51.76 44.29 29.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 1.85 110.903 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.419 HG13 HD23 ' A' ' 119' ' ' LEU . 89.6 t -81.09 143.03 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.25 111.109 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 160.22 8.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 1.57 110.902 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -77.75 146.18 36.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 2.5 110.906 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.475 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.1 mp -105.6 -36.96 6.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.2 110.964 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.85 176.21 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 1.16 110.932 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.698 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.7 tmt_? -132.87 137.98 46.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 4.28 110.845 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -125.74 138.07 31.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.615 0.722 . . . . 1.82 110.888 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.413 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.7 Cg_endo -69.71 165.04 32.27 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.729 2.286 . . . . 0.23 112.35 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.676 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.03 126.48 43.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.28 110.944 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.52 161.27 23.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.619 0.723 . . . . 1.49 111.107 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -24.57 29.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.241 . . . . 0.31 112.353 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -85.49 -22.54 28.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 2.54 110.886 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -87.51 -52.86 5.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 2.5 110.901 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 136' ' ' THR . 7.4 p -49.62 -40.34 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.23 111.169 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -33.49 74.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 1.16 110.921 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -46.19 67.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.23 110.888 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.708 HG23 HD13 ' A' ' 147' ' ' LEU . 9.2 p -68.37 -30.71 48.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.16 111.101 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -76.21 -31.45 58.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 1.87 110.862 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -89.7 -20.44 23.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 1.63 110.841 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -94.66 -32.87 13.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.27 110.849 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.96 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.19 -54.17 1.38 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.3 110.934 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.51 13.75 2.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.28 112.483 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -70.63 122.01 18.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 0.75 110.826 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -151.53 105.32 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 2.4 110.837 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.1 t -160.53 173.82 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.7 110.86 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.71 -17.59 14.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 1.56 110.858 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.76 12.52 29.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 1.53 110.911 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.676 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -81.61 165.18 21.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.25 110.952 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.44 130.24 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.18 110.973 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.2 m-85 -74.34 133.44 42.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 1.8 110.877 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.04 145.19 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.22 111.156 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.576 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.6 tt0 -98.97 129.26 45.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.91 110.957 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.54 151.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.21 111.102 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.456 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.1 t -134.91 161.56 34.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.25 111.141 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.43 139.5 7.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.19 112.476 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -97.56 140.62 31.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.368 . . . . 1.62 110.889 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 5.2 tptt -80.71 134.79 53.28 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.599 0.714 . . . . 2.32 110.877 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 119.19 6.18 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.39 112.301 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.37 110.883 179.985 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.77 0.319 . . . . 1.97 110.802 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' A' ' 6' ' ' ILE . 4.5 m-85 -122.14 21.4 10.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 1.53 110.898 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 54.46 41.82 73.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.768 -0.73 . . . . 0.31 112.451 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.538 HG23 HG21 ' A' ' 12' ' ' VAL . 1.5 mp -83.14 160.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.32 111.137 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.733 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -156.62 168.99 25.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.82 110.831 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.8 132.28 35.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.46 111.034 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.05 1.31 30.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.28 112.482 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -118.18 166.95 11.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.781 0.324 . . . . 1.2 110.933 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.67 113.05 26.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 2.17 110.899 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 62' ' ' ILE . 95.3 t -117.35 132.52 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 1.92 111.136 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.793 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -109.03 125.29 51.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.23 111.057 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.828 HG11 HG12 ' A' ' 29' ' ' VAL . 99.6 t -98.35 120.37 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.16 111.144 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.31 118.45 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.2 111.134 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -118.6 168.85 10.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 0.19 110.912 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -151.48 -169.91 3.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.267 -0.424 . . . . 1.85 110.857 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -57.63 -35.49 70.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 3.02 110.882 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.61 -9.51 58.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 1.21 110.848 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.92 94.62 10.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.748 0.785 . . . . 0.15 110.923 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 142.11 47.33 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.657 2.238 . . . . 0.23 112.34 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.13 -32.57 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.21 111.108 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.28 -52.92 40.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 2.59 110.907 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.9 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.19 111.155 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.6 -61.41 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.15 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -49.6 -36.01 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 2.49 110.901 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.21 -47.22 45.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 0.2 112.47 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.96 -38.57 89.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.755 0.312 . . . . 0.52 110.87 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.828 HG12 HG11 ' A' ' 14' ' ' VAL . 17.0 m -78.21 -31.09 16.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.63 111.079 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -62.54 -57.86 9.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 1.69 110.852 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -40.01 75.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 1.75 110.94 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.886 HD23 HD21 ' A' ' 35' ' ' LEU . 88.1 mt -73.17 -24.77 60.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.24 110.89 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.547 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.5 -25.03 45.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.38 110.825 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.74 -30.36 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.22 111.026 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.886 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.81 -34.93 15.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.21 110.905 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.79 -46.06 4.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.21 111.139 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.83 -12.62 54.42 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.828 -0.701 . . . . 0.25 112.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.61 -62.6 1.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.754 0.311 . . . . 2.18 110.938 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -96.33 -37.85 10.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 2.56 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.13 -129.87 5.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 0.26 112.497 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -152.59 152.03 31.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.88 0.371 . . . . 2.18 110.885 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.547 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.0 t -136.33 124.83 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.22 111.036 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -114.07 155.83 25.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.15 110.9 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.52 134.8 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.14 111.141 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -142.76 151.3 41.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 1.26 110.864 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -103.3 134.99 45.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.4 110.906 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.673 ' CD1' HG21 ' A' ' 73' ' ' THR . 26.4 mt -52.17 -36.12 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.28 111.128 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -71.54 -32.25 67.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 2.01 110.877 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -103.18 20.11 18.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 3.61 110.856 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.833 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.32 -28.08 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 1.07 110.899 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.53 -33.46 63.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 1.05 110.9 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -84.06 -15.15 48.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 1.06 110.969 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.454 ' HB2' HD13 ' A' ' 50' ' ' LEU . 34.5 m -66.55 -10.13 41.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.87 110.859 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.5 63.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.27 111.059 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -64.02 -67.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.36 110.873 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -153.85 -178.22 6.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 1.38 110.849 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -92.63 130.52 38.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 1.83 110.885 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 t 51.79 83.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 2.11 110.879 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.4 p -136.06 -39.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.28 110.773 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.7 m-85 -100.51 122.25 42.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 2.03 110.975 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.5 m-20 -71.73 -21.9 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 1.73 110.853 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.693 ' HB ' HG22 ' A' ' 12' ' ' VAL . 21.4 mt -145.34 144.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.22 111.087 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.93 HG21 HG23 ' A' ' 83' ' ' ILE . 17.2 mm -133.75 132.7 56.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.13 111.104 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -114.58 136.88 52.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.15 110.916 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.44 100.33 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.13 110.854 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.54 74.97 0.24 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.16 112.446 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.556 HD13 ' OE1' ' A' ' 158' ' ' GLN . 3.9 mm? -107.45 58.19 0.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.866 0.365 . . . . 0.57 110.928 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.0 159.65 63.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.611 0.719 . . . . 0.23 111.146 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 116.73 4.7 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.601 2.201 . . . . 0.26 112.355 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.46 7.13 69.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.841 -0.695 . . . . 0.17 112.465 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.55 150.24 12.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.939 0.4 . . . . 0.68 110.87 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.773 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 39.5 p -138.98 108.45 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.21 111.127 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.673 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.14 153.44 18.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.25 111.239 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.879 HD12 HD22 ' A' ' 147' ' ' LEU . 3.3 mt -132.77 104.57 6.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.28 110.856 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -81.16 153.74 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.26 110.885 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.1 m -131.56 -176.29 3.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.43 110.925 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.8 -36.93 70.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.23 111.106 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.59 -46.48 88.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 2.32 110.874 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.833 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -73.04 -54.96 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 0.2 111.079 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 119' ' ' LEU . 65.2 mt -50.72 -40.18 53.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.19 110.96 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.02 -53.94 35.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.053 -0.521 . . . . 0.3 111.15 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.23 -44.8 88.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 3.01 110.868 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.93 HG23 HG21 ' A' ' 63' ' ' ILE . 38.7 mm -55.67 -68.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.2 111.099 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.33 -37.82 49.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.21 111.187 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -55.11 -49.83 70.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 3.35 110.898 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 56' ' ' LYS . 34.3 pt -85.21 -7.02 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.2 111.108 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.95 111.78 14.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.142 -0.481 . . . . 0.38 110.9 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 61' ' ' ASP . 48.8 mtt180 -51.46 159.53 1.17 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.59 0.71 . . . . 2.24 110.852 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 114.44 3.7 Favored 'Trans proline' 0 N--CA 1.466 -0.113 0 C-N-CA 122.786 2.324 . . . . 0.16 112.342 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.77 2.41 56.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.662 -0.78 . . . . 0.15 112.416 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.28 -162.57 13.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.647 -0.787 . . . . 0.13 112.551 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.2 m -138.32 156.03 48.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.832 0.349 . . . . 0.35 110.9 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.704 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -140.01 114.31 9.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.16 110.974 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.554 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.0 m-85 -108.46 132.34 53.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 1.65 110.897 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.576 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.51 162.31 39.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.13 110.845 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.05 129.35 35.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 1.88 110.842 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.72 148.65 20.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.655 0.74 . . . . 3.71 110.854 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.617 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.1 Cg_endo -69.82 140.88 43.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.61 2.206 . . . . 0.18 112.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.9 m -125.86 146.67 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.22 111.099 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' CD ' HG21 ' A' ' 103' ' ' VAL . 46.8 mt-10 -108.89 132.75 53.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 2.06 110.953 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p -90.94 -42.68 10.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 1.29 111.091 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.559 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.5 40.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.59 111.111 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' CD ' ' A' ' 100' ' ' GLU . 26.4 t -148.03 150.05 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.63 111.069 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -52.86 171.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.69 110.854 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -66.37 -54.17 27.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 2.83 110.96 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -70.66 -75.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 1.69 110.837 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t 52.31 -169.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.034 0.445 . . . . 2.2 110.841 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -81.71 -4.69 56.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 1.77 110.877 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.12 150.4 21.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.4 111.043 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.18 119.2 13.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 2.97 110.844 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.647 HG21 ' O ' ' A' ' 104' ' ' ASP . 62.8 p -91.81 178.86 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.29 111.201 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.4 -53.61 55.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.2 111.127 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -61.06 -47.16 87.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.26 110.819 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -42.25 91.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 2.47 110.889 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -61.82 -57.43 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.48 110.886 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 66.6 m -52.05 -44.97 64.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.23 110.888 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -42.06 87.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.29 110.824 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.11 97.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.22 111.095 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.556 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.0 tp -66.2 -50.93 62.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.23 110.987 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.0 m -61.99 -33.31 74.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.31 111.138 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.87 -10.45 53.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.66 110.897 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.72 5.25 29.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 1.7 110.872 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.81 11.23 25.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.647 -0.787 . . . . 0.68 112.38 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.704 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -112.13 171.0 7.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 0.26 110.883 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.2 m -150.9 170.19 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.21 111.168 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 53.01 44.41 30.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 2.32 110.92 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.4 t -81.04 142.94 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.25 111.174 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.93 158.58 7.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 1.59 110.866 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -77.23 145.68 37.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 2.28 110.784 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.502 HD11 ' N ' ' A' ' 160' ' ' THR . 2.1 mp -105.15 -35.55 7.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.23 110.975 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.1 176.42 12.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 1.09 110.879 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.72 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -131.86 137.4 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 4.12 110.907 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -124.02 137.65 29.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 1.83 110.874 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.426 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.9 Cg_endo -69.74 165.02 32.34 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.693 2.262 . . . . 0.22 112.353 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.671 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.15 127.47 44.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.27 110.914 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.434 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.21 161.1 24.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 1.21 111.145 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.434 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.6 Cg_endo -69.76 -28.79 24.83 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.625 2.217 . . . . 0.32 112.307 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -85.24 -17.86 35.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 2.77 110.924 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.23 -53.25 4.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 2.33 110.909 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.22 -40.65 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.25 111.123 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -34.86 76.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 1.18 110.926 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.86 -46.18 72.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.22 110.904 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 8.5 p -68.38 -30.19 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.077 -0.51 . . . . 0.18 111.2 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -75.64 -32.59 60.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.81 110.834 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -89.54 -20.18 24.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 1.72 110.877 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -94.11 -32.81 13.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.32 110.887 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.879 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.98 -54.25 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.36 110.85 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.65 8.02 2.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.32 112.459 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -70.2 121.26 17.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 0.7 110.822 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -152.32 104.72 2.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 3.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 t -161.03 172.13 17.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.61 110.879 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.28 -11.57 15.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 1.57 110.864 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.559 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 4.9 m-80 -99.92 14.29 30.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 1.55 110.923 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.671 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -87.39 165.86 15.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.34 110.866 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.72 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -171.46 130.06 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.19 111.023 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.773 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.4 m-85 -72.7 132.31 43.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 1.7 110.883 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.17 143.89 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.22 111.148 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.556 ' OE1' HD13 ' A' ' 67' ' ' LEU . 3.0 tt0 -98.69 133.08 43.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 1.86 110.848 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.73 148.14 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.48 111.205 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.502 ' N ' HD11 ' A' ' 130' ' ' LEU . 6.1 t -132.62 156.06 47.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.29 111.122 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -145.58 139.11 8.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.19 112.465 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -96.74 132.7 42.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.36 . . . . 3.5 110.926 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 135.3 77.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.597 0.713 . . . . 1.2 110.887 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 128.22 15.6 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.631 2.221 . . . . 0.31 112.32 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.3 110.887 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.804 0.335 . . . . 3.23 110.926 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.514 ' HE1' HD12 ' A' ' 67' ' ' LEU . 2.9 m-85 -93.72 -14.98 25.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 2.07 110.869 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.5 48.59 10.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.725 -0.75 . . . . 0.39 112.45 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.824 HG23 HG21 ' A' ' 12' ' ' VAL . 1.2 mp -88.32 162.01 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.37 . . . . 0.6 111.136 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.64 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -150.34 170.01 20.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.811 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.67 133.36 34.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.4 111.109 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.21 -6.07 30.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.781 -0.723 . . . . 0.31 112.536 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -111.88 168.96 9.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 1.16 110.899 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.04 114.32 28.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 1.28 110.872 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.824 HG21 HG23 ' A' ' 6' ' ' ILE . 88.2 t -119.3 126.97 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 2.01 111.149 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.804 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -104.0 128.22 51.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.33 111.153 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.805 HG11 HG12 ' A' ' 29' ' ' VAL . 97.7 t -100.38 119.23 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.23 111.159 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.84 118.14 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.25 111.171 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -118.19 169.03 10.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.31 110.952 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.414 ' HB3' HD12 ' A' ' 47' ' ' ILE . 9.4 p-10 -151.67 -170.47 3.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 1.83 110.875 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -35.56 69.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 6.31 110.901 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.61 -9.36 58.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.34 110.87 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.93 94.43 10.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.613 0.72 . . . . 0.23 110.823 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 142.37 47.55 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.678 2.252 . . . . 0.3 112.45 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -49.07 -32.68 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.32 111.042 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -51.09 -52.93 38.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 2.51 110.878 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.62 -44.93 10.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.27 111.067 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.468 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.76 -61.3 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.23 110.929 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.55 -37.07 25.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 2.55 110.878 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -47.29 50.35 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.736 -0.745 . . . . 0.27 112.437 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.5 mt -61.75 -38.84 89.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.52 110.934 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.805 HG12 HG11 ' A' ' 14' ' ' VAL . 17.8 m -78.13 -30.77 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.64 111.11 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.52 -58.27 8.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 1.58 110.875 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -39.57 74.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 1.8 110.884 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.813 HD23 HD21 ' A' ' 35' ' ' LEU . 97.0 mt -73.36 -25.37 60.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 0.24 110.872 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.561 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -77.63 -24.81 49.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 0.41 110.964 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.66 -29.7 16.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.29 111.179 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.813 HD21 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -91.49 -31.05 16.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.29 110.912 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -106.84 -45.47 4.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.26 111.15 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.44 -12.42 51.47 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.722 -0.751 . . . . 0.31 112.529 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.79 -62.71 1.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.329 . . . . 1.85 110.822 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -99.57 -36.5 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 2.65 110.861 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.22 -129.46 4.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.741 . . . . 0.26 112.448 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -154.9 152.01 29.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.357 . . . . 2.23 110.882 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.561 HG21 ' HA ' ' A' ' 33' ' ' GLN . 92.9 t -136.0 122.97 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.22 111.165 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.6 t -113.09 154.03 27.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.17 110.829 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -117.14 134.28 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.17 111.208 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -142.04 151.24 42.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 1.26 110.882 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -103.25 134.95 45.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.862 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.725 ' CD1' HG21 ' A' ' 73' ' ' THR . 29.5 mt -52.29 -36.54 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.32 111.092 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -70.79 -32.44 69.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 2.03 110.924 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -103.75 20.71 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 3.64 110.855 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.838 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.09 -27.84 3.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 1.07 110.899 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -55.01 -33.09 62.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 1.02 110.937 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -84.81 -15.53 44.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 1.16 110.937 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.508 ' HB2' HD13 ' A' ' 50' ' ' LEU . 48.0 m -63.69 -12.73 36.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.87 110.899 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -74.13 61.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.3 111.082 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.403 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 3.4 m80 -63.03 -69.54 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.37 110.869 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.664 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.02 -168.75 2.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 1.16 110.957 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -107.37 131.02 54.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 1.73 110.923 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.25 73.5 0.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 1.2 110.829 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.2 p -127.76 -34.46 2.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.28 110.836 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.4 m-85 -99.29 118.34 35.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 1.42 110.849 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.78 -20.89 63.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.04 -0.527 . . . . 1.75 110.939 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.701 ' HB ' HG22 ' A' ' 12' ' ' VAL . 25.3 mt -146.98 144.88 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.26 111.116 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.864 HG21 HG23 ' A' ' 83' ' ' ILE . 15.9 mm -135.09 131.58 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.14 111.104 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -112.68 137.34 51.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.16 110.883 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.61 100.55 5.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.14 110.844 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.61 74.28 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 0.18 112.514 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.514 HD12 ' HE1' ' A' ' 4' ' ' PHE . 4.0 mm? -107.03 59.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.348 . . . . 0.6 110.879 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.84 159.77 66.7 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.542 0.687 . . . . 0.25 111.124 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 116.31 4.49 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.657 2.238 . . . . 0.26 112.426 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.58 6.42 68.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.2 112.493 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -56.03 150.55 13.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.66 110.896 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.765 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 37.2 p -140.24 108.59 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.22 111.148 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.725 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.15 147.67 12.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.25 111.049 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.941 HD12 HD22 ' A' ' 147' ' ' LEU . 2.4 mt -126.23 99.9 6.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.34 110.874 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -76.71 149.01 36.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.24 110.948 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.9 m -128.25 177.33 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.55 110.885 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.17 -37.77 48.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.23 111.101 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.82 -44.53 96.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.448 . . . . 2.08 110.882 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.838 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.2 mp -74.94 -55.25 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.21 111.175 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 119' ' ' LEU . 61.0 mt -50.71 -38.64 48.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.24 110.876 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.19 -56.54 15.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.36 111.122 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.443 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -55.03 -42.39 72.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 2.76 110.862 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.864 HG23 HG21 ' A' ' 63' ' ' ILE . 50.2 mm -57.66 -68.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.22 111.097 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.71 -36.21 35.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.23 111.051 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -56.84 -52.3 65.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 2.79 110.881 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 56' ' ' LYS . 46.6 pt -82.29 -6.5 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.26 111.081 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -79.8 127.97 32.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.4 110.93 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -66.82 159.76 73.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.582 0.705 . . . . 2.25 110.835 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 114.33 3.67 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.2 112.328 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.8 2.75 56.2 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.772 -0.728 . . . . 0.24 112.531 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.76 -161.36 10.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.805 -0.712 . . . . 0.16 112.484 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 15.7 m -139.08 153.7 48.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.36 110.954 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.707 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.06 114.47 10.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.2 110.883 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.555 ' N ' HD22 ' A' ' 93' ' ' LEU . 45.7 m-85 -108.79 133.47 52.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 1.64 110.956 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.51 159.12 44.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.15 110.919 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 125.15 38.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 1.81 110.886 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.617 ' OE1' HD23 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -148.97 147.44 24.02 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.649 0.738 . . . . 2.48 110.897 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.619 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.1 Cg_endo -69.81 145.23 56.25 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.654 2.236 . . . . 0.21 112.332 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.8 m -131.41 146.67 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.19 111.154 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -104.88 132.97 50.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 2.09 110.899 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 p -105.71 26.01 10.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 1.56 111.083 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.29 26.51 0.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.67 111.098 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.19 159.48 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.78 111.152 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.57 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -57.24 -179.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 1.97 110.837 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -66.09 -67.93 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 2.67 110.897 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -60.99 -75.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 2.55 110.913 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 54.63 -166.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 1.93 110.855 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -79.9 -7.97 59.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 2.07 110.872 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.645 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.0 m -145.16 150.13 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.6 111.079 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -68.29 113.29 5.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.135 -0.484 . . . . 2.33 110.874 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.57 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.2 p -84.42 179.69 7.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.34 111.108 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.49 -53.34 59.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.2 111.136 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.74 -49.18 78.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.922 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -58.37 -40.91 83.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 2.61 110.909 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -61.97 -54.83 36.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.41 110.84 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 70.8 m -55.45 -47.79 75.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.24 110.89 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.26 110.809 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.99 98.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.23 111.076 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.587 HD11 HD12 ' A' ' 93' ' ' LEU . 14.9 tp -65.8 -50.23 65.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.24 110.922 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.1 m -65.52 -30.73 71.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.108 -0.496 . . . . 0.25 111.204 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.5 mt -86.99 -10.47 53.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.58 110.942 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.19 5.52 29.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 1.8 110.847 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.04 5.19 35.47 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.747 -0.74 . . . . 0.56 112.468 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -105.45 172.48 6.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.26 110.88 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.486 HG23 ' HG3' ' A' ' 126' ' ' GLU . 28.2 m -151.14 171.38 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.29 111.078 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HG3' HG23 ' A' ' 125' ' ' VAL . 28.8 mt-10 55.16 43.53 29.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 2.04 110.924 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.506 HG13 HD23 ' A' ' 119' ' ' LEU . 97.9 t -77.7 140.91 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.32 111.124 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.16 159.79 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 1.61 110.899 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.08 147.44 30.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 2.18 110.939 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.754 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.5 mp -107.45 -36.43 6.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.18 110.957 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -157.1 176.24 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 1.15 110.9 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.731 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.9 tmt_? -132.35 137.27 47.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 4.33 110.942 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -124.38 138.72 31.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.635 0.731 . . . . 1.39 110.902 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.418 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.4 Cg_endo -69.86 163.43 38.39 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.653 2.235 . . . . 0.27 112.299 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.661 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -95.65 127.09 41.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 0.35 110.95 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.53 160.53 27.2 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.554 0.693 . . . . 1.28 111.105 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.7 Cg_endo -69.7 -29.2 24.53 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.68 2.253 . . . . 0.45 112.316 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -84.97 -19.06 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 2.98 110.876 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -53.58 5.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 2.17 110.905 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.5 -41.93 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.29 111.158 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -33.86 72.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 1.37 110.872 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.94 -44.93 68.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.34 110.796 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.68 HG23 HD13 ' A' ' 147' ' ' LEU . 7.4 p -68.97 -31.59 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.21 111.188 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -76.65 -30.9 57.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.076 -0.511 . . . . 2.52 110.929 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -89.73 -20.62 23.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.221 -0.445 . . . . 1.78 110.919 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -95.01 -32.51 13.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.857 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.941 HD22 HD12 ' A' ' 74' ' ' LEU . 2.7 mp -127.18 -54.06 1.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.42 110.891 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.37 10.51 2.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.71 -0.757 . . . . 0.48 112.472 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.645 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.8 t-160 -70.08 120.42 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.711 0.291 . . . . 1.2 110.869 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.44 112.3 4.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 3.02 110.897 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.66 172.17 17.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 1.06 110.865 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.56 -9.35 16.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 2.18 110.86 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.63 13.35 22.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 1.85 110.925 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.661 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -75.57 164.86 25.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.27 110.912 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -173.92 130.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.21 110.901 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.765 ' CZ ' HG22 ' A' ' 72' ' ' THR . 32.3 m-85 -74.29 131.77 41.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 1.79 110.879 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.94 140.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.2 111.114 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.754 ' HG2' HD13 ' A' ' 130' ' ' LEU . 39.1 tt0 -93.65 128.5 39.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 2.3 110.895 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.01 151.73 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.24 111.239 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.46 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.6 t -131.4 159.32 38.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.252 -0.431 . . . . 0.28 111.168 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.478 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -149.33 129.9 3.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.774 -0.727 . . . . 0.25 112.527 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -89.52 139.28 30.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 1.55 110.925 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.24 135.27 50.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.587 0.708 . . . . 1.62 110.906 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 129.65 18.03 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.731 2.287 . . . . 0.41 112.361 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.298 -0.41 . . . . 0.49 110.922 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.864 0.364 . . . . 2.2 110.953 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -122.33 21.64 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 1.52 110.89 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.82 39.98 56.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.78 -0.724 . . . . 0.23 112.507 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.52 HG23 HG21 ' A' ' 12' ' ' VAL . 1.7 mp -77.97 159.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.857 0.36 . . . . 0.22 111.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -151.55 162.21 41.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 1.44 110.934 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.4 126.34 35.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.28 111.135 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.06 -2.59 19.24 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.735 -0.745 . . . . 0.27 112.433 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -115.49 170.49 8.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.842 0.353 . . . . 1.1 110.9 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.87 114.14 28.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 2.23 110.929 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 62' ' ' ILE . 92.4 t -119.28 125.38 74.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.117 -0.492 . . . . 1.98 111.154 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.766 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -102.79 129.96 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.32 111.125 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.831 HG11 HG12 ' A' ' 29' ' ' VAL . 60.3 t -101.3 119.92 50.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.18 111.146 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.24 118.35 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.21 111.074 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -118.5 169.24 9.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.498 . . . . 0.19 110.898 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -151.49 -170.72 3.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.483 . . . . 1.78 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -57.06 -35.67 69.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 3.09 110.9 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -73.28 -9.59 58.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 1.27 110.848 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.02 94.44 10.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.647 0.737 . . . . 0.15 110.855 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 142.23 47.11 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.662 2.242 . . . . 0.21 112.359 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -48.83 -32.75 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.2 111.122 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.13 -53.04 37.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 2.69 110.893 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -44.89 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.17 111.055 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.476 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.6 -61.46 2.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.14 110.976 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -36.96 24.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 2.8 110.867 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.72 -47.14 50.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 0.19 112.523 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.83 -39.29 91.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.768 0.318 . . . . 0.46 110.872 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.831 HG12 HG11 ' A' ' 14' ' ' VAL . 17.5 m -77.69 -31.19 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.63 111.075 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.29 -58.56 7.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 1.55 110.845 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -39.94 74.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 1.73 110.945 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.892 HD23 HD21 ' A' ' 35' ' ' LEU . 85.1 mt -73.07 -24.67 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.23 110.996 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.486 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.55 -25.18 45.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.37 110.947 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 -29.9 17.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.22 111.163 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.892 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.42 -35.21 14.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.18 110.853 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.738 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.9 -45.86 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.21 111.091 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.47 -12.87 53.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.27 112.456 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.17 -62.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 2.5 110.897 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -90.08 -40.85 12.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.96 110.921 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.43 -130.04 6.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.741 -0.742 . . . . 0.25 112.553 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -150.23 152.87 35.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.887 0.375 . . . . 2.2 110.928 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 33' ' ' GLN . 96.6 t -136.4 125.44 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.22 111.146 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -114.53 156.89 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 0.16 110.814 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -118.53 135.04 60.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.15 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -143.14 151.31 40.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 2.01 110.868 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -103.22 134.9 45.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.193 -0.458 . . . . 0.4 110.854 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.729 ' CD1' HG21 ' A' ' 73' ' ' THR . 29.1 mt -52.4 -36.51 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.27 111.108 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -70.87 -32.13 69.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 2.0 110.868 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -103.87 20.62 17.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 3.54 110.92 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.83 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.09 -27.94 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 1.07 110.918 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.26 -33.37 63.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 1.07 110.938 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -84.62 -15.14 46.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 1.18 110.935 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.459 ' HB2' HD13 ' A' ' 50' ' ' LEU . 45.5 m -64.64 -11.61 37.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.87 110.796 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.33 61.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.28 111.023 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.401 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 3.2 m80 -62.8 -69.74 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.4 110.865 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.661 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.97 -168.64 2.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 1.12 111.045 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.13 130.55 54.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.335 -0.393 . . . . 1.81 110.944 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.38 73.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 1.21 110.853 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.8 p -127.93 -34.59 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.26 110.832 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.2 m-85 -98.85 117.9 34.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 1.43 110.921 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.41 -20.36 63.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 1.48 110.887 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.693 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.1 mt -148.05 144.91 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.25 111.142 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.915 HG21 HG23 ' A' ' 83' ' ' ILE . 20.6 mm -135.28 130.1 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.18 111.113 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -110.46 137.29 48.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.16 110.897 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.56 100.63 5.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.13 110.84 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.74 76.0 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.15 112.458 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.35 58.21 0.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.59 110.902 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.54 160.11 62.25 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 121.618 0.723 . . . . 0.22 111.18 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 116.64 4.66 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.672 2.248 . . . . 0.24 112.361 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.1 7.39 70.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.16 112.537 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.49 149.75 13.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.408 . . . . 0.68 110.839 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.768 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 31.1 p -138.73 108.58 6.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.17 111.117 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.729 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.96 146.52 10.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.24 111.102 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.92 HD12 HD22 ' A' ' 147' ' ' LEU . 4.1 mt -125.36 103.37 7.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.21 110.843 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -79.75 151.49 30.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.24 110.809 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -130.59 177.14 7.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.48 110.885 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.99 51.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.32 111.166 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -61.48 -45.68 93.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 1.75 110.885 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.83 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -73.63 -55.41 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.23 111.07 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.0 mt -50.63 -38.68 47.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.26 110.875 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.8 -55.13 29.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.29 111.056 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -42.34 77.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 2.76 110.935 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.915 HG23 HG21 ' A' ' 63' ' ' ILE . 44.9 mm -58.62 -68.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.26 111.054 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.74 -36.06 24.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.21 111.028 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -54.58 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 2.19 110.861 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 56' ' ' LYS . 47.5 pt -79.39 -5.89 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.28 111.192 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -81.73 127.99 33.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.45 110.847 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -65.7 158.77 72.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.669 0.747 . . . . 2.28 110.867 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 114.1 3.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.246 . . . . 0.2 112.34 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.28 2.72 54.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.737 . . . . 0.16 112.476 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.63 -163.48 16.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.15 112.505 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 67.6 m -135.75 153.48 51.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 0.3 110.833 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.662 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.56 114.36 10.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.16 110.88 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.541 ' N ' HD22 ' A' ' 93' ' ' LEU . 50.2 m-85 -108.82 133.34 53.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 1.9 110.949 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.563 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.86 164.11 35.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.14 110.959 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.74 130.46 36.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 1.85 110.915 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.598 ' OE1' HD23 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -153.95 147.75 18.68 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.588 0.709 . . . . 2.34 110.896 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.639 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.0 Cg_endo -69.81 141.58 45.39 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.594 2.196 . . . . 0.17 112.361 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.78 146.66 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.18 111.135 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' CD ' HG21 ' A' ' 103' ' ' VAL . 51.9 mt-10 -109.7 132.64 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 2.07 110.827 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.4 p -91.62 -42.23 10.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 1.18 111.061 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.77 39.94 1.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.259 -0.428 . . . . 0.59 111.096 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' CD ' ' A' ' 100' ' ' GLU . 22.7 t -147.59 150.4 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.187 -0.461 . . . . 0.63 111.099 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.573 ' O ' HG21 ' A' ' 111' ' ' THR . 0.4 OUTLIER -52.94 170.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 1.77 110.836 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -64.35 -57.39 9.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 2.57 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.99 -75.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 1.63 110.87 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t 52.38 -168.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 2.14 110.906 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.37 -6.8 58.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 1.98 110.865 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.437 HG11 ' CG ' ' A' ' 149' ' ' HIS . 2.9 m -140.09 142.63 31.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.4 111.248 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -65.35 111.05 2.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.21 -0.45 . . . . 2.46 110.907 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 104' ' ' ASP . 47.5 p -82.13 -177.72 6.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.23 111.161 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.13 -52.32 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.17 111.132 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.32 -49.77 75.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.21 110.877 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -56.87 -38.86 73.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 1.66 110.838 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -64.89 -54.56 28.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.31 110.927 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.2 m -58.13 -46.24 85.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.24 110.925 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -43.0 94.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.498 . . . . 0.29 110.919 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.51 98.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.21 111.107 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 93' ' ' LEU . 15.5 tp -65.13 -51.65 59.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.216 -0.447 . . . . 0.32 110.909 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.1 m -63.92 -31.16 72.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.25 111.084 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.3 mt -86.79 -10.48 53.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.74 110.893 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.12 5.69 28.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 1.71 110.88 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.13 5.12 35.33 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.806 -0.712 . . . . 0.48 112.523 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.662 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.1 tp -105.57 173.11 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.32 110.956 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.7 m -151.51 173.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.28 111.205 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 51.6 45.15 28.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 1.99 110.874 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.523 HG13 HD23 ' A' ' 119' ' ' LEU . 94.3 t -80.75 143.06 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.2 111.142 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.92 160.49 8.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 2.52 110.915 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -80.26 146.43 31.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 2.25 110.916 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.784 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -104.23 -37.1 7.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.23 110.936 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.0 pm0 -159.07 176.25 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 2.95 110.888 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.732 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.4 tmt_? -130.44 137.21 49.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 4.37 110.82 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -123.77 135.02 25.74 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.726 0.774 . . . . 1.8 110.9 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.425 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.2 Cg_endo -69.82 159.14 54.45 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.721 2.281 . . . . 0.26 112.351 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.668 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -91.97 151.65 20.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.57 110.948 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.531 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -133.65 162.91 54.78 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.498 0.666 . . . . 1.63 111.186 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -23.72 30.17 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.669 2.246 . . . . 0.57 112.293 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -86.26 -23.82 26.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 2.47 110.809 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -87.82 -52.72 5.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 3.95 110.927 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 136' ' ' THR . 7.3 p -50.4 -39.52 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.29 111.128 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -32.64 73.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 1.11 110.97 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.49 -46.74 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.29 110.856 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.706 HG23 HD13 ' A' ' 147' ' ' LEU . 9.7 p -68.19 -29.75 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 0.21 111.091 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -76.45 -33.3 58.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 3.12 110.885 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -88.88 -19.98 25.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 1.84 110.822 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -94.69 -32.26 13.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.34 110.924 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.92 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.31 -54.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.35 110.869 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.77 8.1 2.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.658 -0.782 . . . . 0.32 112.518 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.437 ' CG ' HG11 ' A' ' 109' ' ' VAL . 15.0 t-160 -69.94 121.62 17.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.709 0.29 . . . . 0.64 110.87 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -151.93 104.99 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 3.37 110.906 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.6 t -160.8 171.02 19.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.61 110.868 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.22 -11.85 15.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 1.94 110.877 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.527 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 5.7 m-80 -99.57 14.39 30.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 1.6 110.894 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -87.51 168.92 12.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.34 110.824 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.732 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -172.16 130.36 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.18 110.894 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.768 ' CZ ' HG22 ' A' ' 72' ' ' THR . 19.4 m-85 -74.31 132.81 42.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 1.82 110.897 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.26 147.96 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.22 111.077 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.784 ' HG2' HD13 ' A' ' 130' ' ' LEU . 33.3 tt0 -101.67 135.6 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 2.06 110.938 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.41 149.18 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.22 111.148 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.477 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.2 t -129.55 159.47 36.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.25 111.196 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.49 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -149.93 134.3 4.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.731 -0.747 . . . . 0.15 112.483 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -94.44 140.77 29.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 1.55 110.942 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -81.49 134.79 50.68 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.606 0.717 . . . . 1.94 110.886 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 119.76 6.65 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.714 2.276 . . . . 0.35 112.319 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.32 110.866 179.99 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.823 0.344 . . . . 2.55 110.804 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.461 ' CE1' HD12 ' A' ' 67' ' ' LEU . 5.5 m-85 -109.48 23.26 14.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 1.66 110.94 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.04 41.96 53.72 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 0.45 112.485 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.488 HD13 HD21 ' A' ' 32' ' ' LEU . 1.7 mp -81.31 158.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.31 111.129 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 36' ' ' THR . 37.2 m -146.18 156.35 43.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 1.12 110.863 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.32 127.41 34.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.42 111.143 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.81 -7.48 21.94 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.74 -0.743 . . . . 0.27 112.513 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.17 170.39 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 1.57 110.942 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.92 110.7 22.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 1.34 110.836 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.697 HG12 HG21 ' A' ' 36' ' ' THR . 2.3 p -117.2 129.6 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 2.01 111.168 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.757 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -104.59 130.35 52.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.3 111.101 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.847 HG11 HG12 ' A' ' 29' ' ' VAL . 97.6 t -99.79 117.78 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.16 111.158 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.482 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.3 t -101.54 113.63 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.21 111.21 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -114.51 167.64 10.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 0.19 110.919 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.452 ' HB3' HD12 ' A' ' 47' ' ' ILE . 9.9 p-10 -151.53 -169.59 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 1.79 110.812 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -35.87 69.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 6.79 110.876 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -11.26 60.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 1.13 110.889 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.67 92.87 9.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.609 0.718 . . . . 0.22 110.871 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.72 143.53 51.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.26 112.336 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -48.76 -32.55 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.2 111.125 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.02 -53.57 32.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 2.48 110.895 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.79 -44.75 10.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.17 111.116 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.482 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.2 -61.32 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.14 110.916 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -49.79 -38.35 34.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 2.69 110.813 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.61 -47.58 55.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.8 -0.714 . . . . 0.23 112.428 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.46 -40.26 93.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.366 . . . . 0.59 110.897 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.847 HG12 HG11 ' A' ' 14' ' ' VAL . 18.1 m -76.72 -31.04 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.63 111.209 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.03 -60.07 4.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.183 -0.462 . . . . 1.57 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -40.79 71.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 1.87 110.958 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 HD21 ' A' ' 35' ' ' LEU . 92.8 mt -72.27 -25.2 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.38 110.887 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.426 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.09 -24.18 47.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.39 110.885 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.72 -30.03 17.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.28 111.115 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.821 HD21 HD23 ' A' ' 32' ' ' LEU . 1.6 pp -91.59 -35.34 14.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.27 110.882 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.697 HG21 HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -101.88 -45.28 5.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.25 111.178 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.78 -12.72 49.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.679 -0.772 . . . . 0.29 112.537 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -67.04 -62.74 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.786 0.327 . . . . 1.98 110.883 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -94.66 -39.32 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 2.07 110.958 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.51 -135.2 7.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.801 . . . . 0.38 112.504 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -147.74 151.44 36.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 2.22 110.794 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 33' ' ' GLN . 91.9 t -135.94 117.82 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.33 111.114 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 t -106.93 157.19 17.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.26 110.85 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.22 133.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 0.21 111.142 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -143.69 151.79 40.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 1.27 110.892 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.6 135.21 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.41 110.825 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 50' ' ' LEU . 45.3 mt -52.37 -35.87 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 0.36 111.103 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -31.81 66.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 2.22 110.853 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -105.22 20.32 19.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 3.6 110.896 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.983 HD13 HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -51.78 -26.14 9.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 2.72 110.94 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 mp -53.68 -32.91 53.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 1.14 110.945 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -84.97 -15.76 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 1.09 110.906 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.4 m -64.46 -12.21 41.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 0.88 110.888 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.47 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -73.93 61.34 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.494 . . . . 0.4 111.184 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -59.48 -71.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.58 110.796 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.495 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.27 -168.23 2.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 1.35 110.956 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -102.27 116.58 32.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 2.22 110.869 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 t 60.16 84.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 1.97 110.839 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.0 p -134.84 -37.24 0.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.28 110.836 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.1 m-85 -96.84 121.98 39.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.059 -0.519 . . . . 2.01 110.78 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.21 -19.7 60.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 1.51 110.845 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.26 143.95 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.22 111.112 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.941 HG21 HG23 ' A' ' 83' ' ' ILE . 22.1 mm -136.51 127.69 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.17 111.036 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.3 mm? -109.77 137.87 46.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.18 110.95 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.8 100.04 5.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.16 110.866 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.87 74.63 0.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.18 112.518 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.619 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.1 mm? -105.29 58.18 0.68 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 0.61 110.902 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.92 160.01 61.44 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.659 0.742 . . . . 0.23 111.108 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.74 123.88 10.54 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.726 2.284 . . . . 0.31 112.33 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.46 7.11 88.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.667 -0.778 . . . . 0.2 112.535 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 68' ' ' VAL . 8.2 p -55.9 151.58 11.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.958 0.409 . . . . 0.74 110.843 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.74 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.3 p -140.58 109.04 5.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.23 111.101 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.574 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.12 143.19 12.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.32 111.183 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.972 HD12 HD22 ' A' ' 147' ' ' LEU . 4.8 mt -119.98 102.37 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.25 110.93 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -79.1 144.22 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.29 110.844 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 m -124.38 174.92 7.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.42 110.908 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.94 -40.34 57.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.3 111.128 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.99 -45.78 91.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 1.96 110.898 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.983 HG23 HD13 ' A' ' 50' ' ' LEU . 4.3 mp -72.07 -55.38 13.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.31 111.132 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.541 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.9 mt -50.67 -38.54 47.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.52 . . . . 0.28 110.946 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.9 -56.13 13.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.39 111.021 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -54.56 -44.94 73.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.39 . . . . 2.84 110.855 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.941 HG23 HG21 ' A' ' 63' ' ' ILE . 37.9 mm -56.08 -68.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.24 111.098 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.54 -39.65 49.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.28 111.134 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -52.56 -49.63 64.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 3.2 110.829 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 56' ' ' LYS . 41.0 pt -88.18 -4.05 9.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.27 111.102 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -82.04 112.44 19.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.32 110.941 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -52.45 157.68 2.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.645 0.736 . . . . 3.05 110.816 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 113.98 3.55 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.725 2.283 . . . . 0.38 112.326 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.41 2.72 50.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.811 -0.709 . . . . 0.23 112.563 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.78 -165.13 21.61 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.664 -0.779 . . . . 0.18 112.418 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 90.9 m -133.22 151.91 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.46 110.893 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.703 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -136.58 115.22 12.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.15 110.934 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.549 ' N ' HD22 ' A' ' 93' ' ' LEU . 54.7 m-85 -110.33 132.05 54.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 1.91 110.877 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.551 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.66 163.17 38.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.12 110.891 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.91 126.89 29.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 1.85 110.784 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -148.65 149.27 30.57 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.65 0.738 . . . . 2.55 110.892 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.614 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.8 Cg_endo -69.71 139.38 40.28 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.66 2.24 . . . . 0.24 112.329 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.8 m -121.62 146.7 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.31 111.143 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.476 ' CD ' HG21 ' A' ' 103' ' ' VAL . 51.4 mt-10 -117.82 132.0 56.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 1.86 110.887 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.0 p -91.93 -37.43 12.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 1.41 111.099 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.59 37.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.6 111.191 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.476 HG21 ' CD ' ' A' ' 100' ' ' GLU . 31.8 t -147.79 149.55 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.7 111.141 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.575 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -55.86 178.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.85 110.929 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -66.55 -70.44 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 2.64 110.896 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -75.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 2.14 110.922 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.47 -169.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 1.6 110.78 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.0 -2.97 50.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 2.03 110.893 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 m -145.26 144.49 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.44 111.102 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.684 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -67.32 113.15 4.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 2.21 110.877 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 104' ' ' ASP . 60.3 p -84.33 177.45 8.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.21 111.204 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.33 -54.7 36.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.17 111.102 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -59.97 -50.24 74.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.21 110.85 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -38.8 71.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.148 -0.478 . . . . 2.12 110.893 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.533 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -64.51 -54.27 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.37 110.963 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.7 m -59.24 -46.78 87.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.21 110.851 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -44.03 95.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.29 110.874 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.27 98.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.21 111.195 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.541 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.9 tp -65.38 -50.76 64.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.26 110.913 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.2 m -63.51 -31.5 72.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.26 111.16 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.6 mt -87.0 -10.48 53.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.56 110.913 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.58 4.66 31.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.306 -0.406 . . . . 1.73 110.835 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.1 6.7 33.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.49 112.496 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -106.92 172.21 6.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.79 0.328 . . . . 0.27 110.985 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.5 m -151.71 174.27 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.35 111.103 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 52.68 43.9 30.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 2.15 110.88 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.0 143.29 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.26 111.097 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.06 160.19 8.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 1.62 110.85 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -82.34 139.55 34.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 2.98 110.87 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.548 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.5 mp -96.6 -37.92 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.24 110.899 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.05 176.3 12.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 1.11 110.941 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.694 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -129.44 141.27 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 4.01 110.89 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -129.18 136.82 29.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.599 0.714 . . . . 1.41 110.828 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.423 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.9 Cg_endo -69.69 165.16 31.82 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.667 2.245 . . . . 0.25 112.357 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.712 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -97.7 126.13 42.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.29 110.936 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -103.62 160.88 24.72 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.615 0.721 . . . . 1.54 111.08 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -24.63 29.31 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.34 112.36 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -85.52 -22.09 28.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 2.49 110.893 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -87.53 -53.58 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 2.43 110.916 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 136' ' ' THR . 7.4 p -49.8 -40.36 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.29 111.142 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -33.42 74.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 1.19 110.904 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.42 -46.44 66.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.26 110.845 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.0 p -68.51 -30.02 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.3 111.207 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -76.77 -31.57 57.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 2.36 110.9 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -89.57 -20.83 23.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.73 110.799 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.97 -32.0 13.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.44 110.927 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.972 HD22 HD12 ' A' ' 74' ' ' LEU . 2.1 mp -127.29 -54.68 1.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.48 110.845 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.53 13.55 2.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.749 -0.739 . . . . 0.43 112.527 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -70.65 121.51 18.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.85 110.807 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -151.74 105.87 3.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 2.85 110.872 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.9 t -160.51 170.47 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.82 110.852 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.61 -11.34 16.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 1.86 110.87 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -103.59 20.6 17.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 1.93 110.908 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.712 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -90.45 162.98 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.31 110.841 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.6 tm? -169.88 130.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.22 110.965 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.74 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.0 m-85 -75.85 135.57 40.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 1.78 110.956 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.0 144.27 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.29 111.128 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.619 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.7 tt0 -97.67 128.81 44.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 1.98 110.949 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.39 148.95 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.22 111.144 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.471 ' HB ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -127.35 159.62 33.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.3 111.097 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.447 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -150.43 132.13 3.83 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.701 -0.761 . . . . 0.16 112.454 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -94.65 140.35 29.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.814 0.34 . . . . 1.55 110.938 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -80.32 135.41 53.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.638 0.732 . . . . 1.65 110.929 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 120.01 6.87 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.724 2.283 . . . . 0.4 112.361 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.47 110.869 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.841 0.353 . . . . 2.0 110.78 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -122.27 18.44 10.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 1.52 110.884 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.38 39.5 73.07 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.751 -0.738 . . . . 0.34 112.519 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.473 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -76.85 157.53 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 0.33 111.126 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 36' ' ' THR . 26.8 m -149.34 155.75 40.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 1.06 110.83 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.93 123.3 29.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.31 111.096 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.18 -12.06 14.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.41 112.52 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.61 168.66 9.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 1.54 110.914 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -101.21 133.39 45.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.3 110.924 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.566 HG12 HG21 ' A' ' 36' ' ' THR . 1.8 p -138.38 134.59 43.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 2.13 111.16 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.755 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -110.35 127.4 55.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.21 111.114 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.824 HG11 HG12 ' A' ' 29' ' ' VAL . 59.2 t -97.63 117.95 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.22 111.131 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.481 HG12 ' CG1' ' A' ' 47' ' ' ILE . 13.6 t -102.35 110.25 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.26 111.116 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -111.56 167.24 10.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.17 110.97 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.454 ' HB3' HD12 ' A' ' 47' ' ' ILE . 11.3 p-10 -151.0 -169.71 3.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.423 . . . . 1.84 110.874 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -56.68 -35.81 68.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.459 . . . . 2.92 110.903 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.62 -11.4 60.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 1.16 110.894 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.34 93.79 10.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.624 0.726 . . . . 0.14 110.845 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.4 Cg_endo -69.71 142.81 49.15 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.677 2.252 . . . . 0.19 112.341 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.1 t -48.82 -32.59 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 0.17 111.134 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -51.24 -53.35 36.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 2.56 110.8 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.55 -44.79 11.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.16 111.131 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.482 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.36 -61.04 2.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.13 111.017 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.76 -37.91 31.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 2.31 110.871 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.8 -47.67 54.0 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.838 -0.696 . . . . 0.19 112.45 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.51 -40.05 93.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.55 110.873 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.824 HG12 HG11 ' A' ' 14' ' ' VAL . 18.2 m -76.88 -31.45 19.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.63 111.132 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -61.72 -59.95 4.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 1.72 110.947 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -40.41 71.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 1.71 110.882 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.874 HD23 HD21 ' A' ' 35' ' ' LEU . 80.4 mt -72.68 -24.56 61.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.23 110.895 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.7 -24.78 44.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.38 110.911 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 -29.82 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.22 111.163 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.874 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.75 -35.02 14.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.2 110.872 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.566 HG21 HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -102.87 -44.81 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.22 111.12 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.66 -11.2 52.97 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 0.25 112.433 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.99 -62.58 1.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 2.25 110.931 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -90.96 -40.68 11.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 1.97 110.857 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.49 -126.44 4.93 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.759 -0.734 . . . . 0.26 112.438 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -155.58 152.49 28.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 2.2 110.902 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.48 HG21 ' HA ' ' A' ' 33' ' ' GLN . 87.7 t -137.0 127.72 40.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.24 111.12 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 t -116.53 154.12 30.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.16 110.83 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.73 134.65 58.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 0.24 111.054 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -146.33 152.32 38.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.077 -0.511 . . . . 2.1 110.913 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -102.43 137.78 40.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.39 110.809 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.688 ' HA ' HD12 ' A' ' 50' ' ' LEU . 35.5 mt -52.26 -37.04 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.29 111.139 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -26.18 58.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 2.47 110.902 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -104.97 18.12 22.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 3.44 110.899 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.027 HD13 HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -53.84 -26.07 22.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.201 -0.454 . . . . 2.73 110.872 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.96 -34.9 57.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -85.97 -16.0 39.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.1 111.008 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.5 m -63.64 -12.72 36.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.92 110.798 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -74.55 59.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.32 111.134 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -59.17 -70.55 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.47 110.915 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.682 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.39 -169.59 2.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 1.3 111.0 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -105.47 122.11 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 2.19 110.827 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t 59.52 78.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 1.99 110.888 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.5 p -132.7 -37.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.25 110.834 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CD2' HD12 ' A' ' 86' ' ' ILE . 92.8 m-85 -98.13 122.37 41.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 2.06 110.85 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.28 -20.46 60.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 1.51 110.901 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 6' ' ' ILE . 12.4 mt -143.06 144.81 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.28 111.115 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.967 HG21 HG23 ' A' ' 83' ' ' ILE . 20.3 mm -137.56 124.45 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.21 111.072 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.6 mm? -107.61 137.16 46.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 0.24 111.034 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.48 100.91 5.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.17 110.908 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.67 76.04 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.826 -0.702 . . . . 0.17 112.417 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.521 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.4 mm? -107.52 57.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.855 0.359 . . . . 0.59 110.908 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.32 159.64 61.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.708 0.766 . . . . 0.24 111.11 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 124.42 11.05 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.666 2.244 . . . . 0.26 112.359 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.33 7.33 88.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.797 -0.716 . . . . 0.21 112.533 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB3' HG23 ' A' ' 68' ' ' VAL . 10.2 p -55.54 150.88 11.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.429 . . . . 0.78 110.772 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.766 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 30.8 p -138.84 108.86 6.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.16 111.107 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.624 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.36 152.43 16.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.25 111.199 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.993 HD12 HD22 ' A' ' 147' ' ' LEU . 4.4 mt -130.6 101.11 5.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.21 110.894 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -78.06 141.35 38.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.36 110.863 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.82 178.46 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.84 110.909 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.15 62.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.29 111.103 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -56.61 -48.21 77.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 1.96 110.885 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.027 HG23 HD13 ' A' ' 50' ' ' LEU . 4.2 mp -69.1 -56.59 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.29 111.129 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.586 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.8 mt -50.15 -39.09 42.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.29 110.964 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.97 -56.74 10.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.46 111.1 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.426 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -54.16 -43.25 70.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 3.03 110.918 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.967 HG23 HG21 ' A' ' 63' ' ' ILE . 41.9 mm -57.94 -69.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.26 111.189 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.12 -36.21 28.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.28 111.075 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -51.5 67.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 2.31 110.983 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 56' ' ' LYS . 43.6 pt -86.81 -2.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.33 111.171 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -83.0 115.28 21.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.27 110.952 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -55.52 157.95 6.49 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.532 0.682 . . . . 3.2 110.889 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 114.02 3.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.735 2.29 . . . . 0.34 112.33 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.16 2.33 51.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 0.22 112.512 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.07 -165.51 19.4 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.781 -0.723 . . . . 0.18 112.456 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 69.1 m -134.55 148.79 50.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.33 . . . . 0.36 110.901 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.725 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.6 tm? -132.72 114.98 14.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.15 110.911 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.501 ' N ' HD22 ' A' ' 93' ' ' LEU . 70.4 m-85 -110.19 132.13 54.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 1.85 110.952 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.561 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.74 164.03 35.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.21 110.939 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.91 129.33 36.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 1.94 110.9 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.461 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -153.63 148.44 19.68 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.677 0.751 . . . . 2.52 110.865 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.651 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.7 145.53 57.75 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.656 2.237 . . . . 0.25 112.367 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 155' ' ' LEU . 14.4 m -129.0 146.49 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.18 111.088 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CD ' HG21 ' A' ' 103' ' ' VAL . 47.7 mt-10 -107.32 132.75 52.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 2.19 110.803 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.8 p -90.69 -42.73 10.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 1.15 111.125 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.633 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -94.83 42.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.64 111.053 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.403 HG21 ' CD ' ' A' ' 100' ' ' GLU . 24.7 t -148.98 150.0 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.26 -0.427 . . . . 0.72 111.12 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.628 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -56.45 169.75 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 2.17 110.844 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.4 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 1.9 p30 -62.37 -54.72 36.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 2.56 110.845 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -66.8 -78.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 2.11 110.869 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p 53.65 -173.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 1.91 110.791 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.52 -3.37 49.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 2.5 110.848 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.86 153.82 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.148 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.01 110.48 6.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 2.85 110.933 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.628 HG21 ' O ' ' A' ' 104' ' ' ASP . 32.7 p -84.97 179.52 7.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.21 111.191 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.43 -53.74 53.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.18 111.001 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.84 -50.09 74.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.99 0.424 . . . . 0.22 110.884 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -56.69 -39.91 74.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 1.7 110.985 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.49 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -63.52 -54.55 34.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.32 110.905 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.1 m -58.6 -46.94 85.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.228 -0.442 . . . . 0.21 110.827 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -43.58 97.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.27 110.834 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.16 -43.52 98.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.21 111.117 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.586 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.1 tp -64.81 -50.46 66.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.23 110.94 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.4 m -63.89 -31.2 72.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.26 111.129 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.5 mt -87.07 -10.5 52.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.56 110.917 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.53 6.21 28.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 1.74 110.845 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.61 7.68 31.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.67 -0.776 . . . . 0.55 112.452 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.725 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -107.57 171.03 7.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.26 110.847 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.05 170.42 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.25 111.131 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 52.89 44.21 30.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 2.27 110.857 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.71 142.77 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.27 111.158 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.97 157.92 6.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 1.61 110.901 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.29 145.7 39.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 2.23 110.858 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.486 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -105.5 -36.19 7.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.2 110.944 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.16 176.0 13.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 1.19 110.981 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -130.93 145.17 51.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 4.25 110.885 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -135.1 136.15 24.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.67 0.748 . . . . 1.87 110.852 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 165.22 31.66 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.693 2.262 . . . . 0.32 112.384 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.683 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -97.96 128.21 44.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.32 110.949 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.425 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.44 160.88 25.3 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.53 0.681 . . . . 1.21 111.163 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.5 Cg_endo -69.83 -28.69 24.61 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.701 2.267 . . . . 0.43 112.294 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -85.37 -17.74 35.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 3.63 110.936 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.59 -53.06 4.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 2.83 110.963 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.32 -40.37 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.33 111.147 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -35.22 77.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.19 110.908 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.85 -46.61 71.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.26 110.831 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.706 HG23 HD13 ' A' ' 147' ' ' LEU . 9.6 p -67.99 -29.97 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.18 111.118 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -75.0 -33.67 61.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 2.32 110.95 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -89.0 -19.97 25.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.056 -0.52 . . . . 1.93 110.842 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -94.01 -32.73 13.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.88 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.993 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.58 -54.24 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.4 110.901 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.97 6.11 2.6 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.806 -0.712 . . . . 0.37 112.479 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -69.9 120.1 15.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.723 0.297 . . . . 0.71 110.903 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.25 104.82 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 2.38 110.913 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.45 174.95 12.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.79 110.864 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.76 -10.54 16.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.55 110.869 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.633 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -99.15 6.6 46.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 1.79 110.935 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.683 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -78.81 166.67 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.3 111.004 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.592 ' HA ' HD23 ' A' ' 135' ' ' LEU . 2.7 tm? -172.94 130.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.25 110.925 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.766 ' CZ ' HG22 ' A' ' 72' ' ' THR . 27.3 m-85 -75.62 134.87 40.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 1.83 110.879 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.83 141.53 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.24 111.183 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.521 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.3 tt0 -93.66 131.26 39.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.88 110.937 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.92 151.73 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.25 111.106 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.472 HG21 HD21 ' A' ' 130' ' ' LEU . 5.3 t -135.9 161.85 34.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.27 111.048 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.26 137.92 6.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.715 -0.755 . . . . 0.15 112.487 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.65 137.5 35.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.308 . . . . 3.5 110.935 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -77.33 135.45 65.7 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.609 0.719 . . . . 1.74 110.905 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 120.09 6.94 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.652 2.235 . . . . 0.39 112.39 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.45 110.94 179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.826 0.346 . . . . 2.4 110.831 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.26 21.18 10.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 1.56 110.848 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.93 37.96 54.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.656 -0.783 . . . . 0.23 112.552 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.455 HG21 HD22 ' A' ' 32' ' ' LEU . 1.9 mp -74.27 156.93 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.343 . . . . 0.27 111.146 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 36' ' ' THR . 28.2 m -146.13 158.5 43.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 1.08 110.891 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.56 129.75 35.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.33 111.131 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.11 -8.52 33.33 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.687 -0.768 . . . . 0.55 112.522 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.61 169.37 8.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 1.49 110.919 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.87 113.21 26.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 1.28 110.824 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.712 HG12 HG21 ' A' ' 36' ' ' THR . 2.4 p -120.57 129.56 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 2.04 111.105 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.753 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -104.65 128.06 52.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.23 111.048 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.778 HG11 HG12 ' A' ' 29' ' ' VAL . 94.9 t -99.93 120.34 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.19 111.13 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 65' ' ' SER . 61.1 t -103.25 123.05 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.086 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -122.6 169.68 10.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.17 110.908 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.75 -171.0 3.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 1.76 110.862 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -56.97 -35.66 69.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 3.36 110.904 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.32 -9.1 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 1.19 110.917 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.05 94.29 10.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.665 0.745 . . . . 0.14 110.799 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.35 47.7 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.659 2.239 . . . . 0.21 112.416 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.01 -32.59 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.22 111.182 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.16 -53.09 37.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.148 -0.478 . . . . 3.2 110.827 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.87 10.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.19 111.151 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.405 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -51.66 -61.49 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.15 110.995 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -36.96 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 2.4 110.934 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.36 -48.31 52.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.729 -0.748 . . . . 0.21 112.495 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.1 mt -60.84 -41.39 95.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.45 110.927 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.778 HG12 HG11 ' A' ' 14' ' ' VAL . 17.1 m -75.45 -31.11 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.64 111.11 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.74 -61.89 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 1.77 110.887 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -40.73 67.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 1.79 110.87 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.843 HD23 HD21 ' A' ' 35' ' ' LEU . 83.5 mt -71.83 -25.5 62.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.3 110.96 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.543 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.05 -24.33 47.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.41 110.984 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.52 -30.52 17.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.26 111.113 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.843 HD21 HD23 ' A' ' 32' ' ' LEU . 1.7 pp -90.91 -35.41 14.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.23 110.896 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.712 HG21 HG12 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -101.65 -46.83 4.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.26 111.083 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.57 -14.33 49.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.742 . . . . 0.28 112.467 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 2.16 110.817 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.34 -35.48 8.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 2.38 110.867 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.17 -133.48 5.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.32 112.499 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -151.39 152.24 32.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 3.45 110.745 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' A' ' 33' ' ' GLN . 84.6 t -136.7 116.51 16.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.38 111.095 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.4 t -106.43 155.98 19.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.27 110.892 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.84 135.69 59.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 0.23 111.174 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -142.69 151.05 40.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 1.3 110.926 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.54 134.65 46.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.4 110.872 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 73' ' ' THR . 19.7 mt -52.3 -36.82 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.35 111.155 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -70.23 -32.6 70.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 2.01 110.899 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -103.54 20.72 17.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 3.52 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.788 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -48.96 -28.54 3.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 1.11 110.902 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -55.82 -32.93 64.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.269 -0.423 . . . . 1.13 110.882 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -84.35 -14.5 49.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 1.09 110.878 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.7 m -64.94 -10.87 32.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.9 110.817 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.17 63.99 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.31 111.122 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.404 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 3.1 m80 -66.07 -70.51 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.43 110.813 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.641 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -142.57 -167.82 2.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.11 110.923 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -111.12 124.07 51.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 1.58 110.906 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t 58.96 75.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 2.04 110.779 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 p -134.07 -35.15 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.28 110.911 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 97.6 m-85 -99.06 117.47 33.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.107 -0.497 . . . . 1.49 110.846 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.02 -19.82 62.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 1.51 110.874 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.2 mt -146.27 144.12 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.22 111.101 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.966 HG21 HG23 ' A' ' 83' ' ' ILE . 20.0 mm -136.3 129.2 46.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.14 111.126 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.1 mm? -113.29 137.75 51.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.26 110.938 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.405 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -129.24 101.7 6.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.16 110.861 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.3 78.09 0.11 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.778 -0.725 . . . . 0.17 112.434 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.8 58.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.57 110.894 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -127.1 158.83 67.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.573 0.702 . . . . 0.22 111.175 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.63 115.88 4.28 Favored 'Trans proline' 0 C--O 1.231 0.125 0 C-N-CA 122.702 2.268 . . . . 0.26 112.394 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.15 6.61 66.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.17 112.456 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.3 152.08 8.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.39 . . . . 0.79 110.924 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.696 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 24.0 p -140.14 108.55 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.21 111.159 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.753 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.3 150.08 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.24 111.153 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.018 HD12 HD22 ' A' ' 147' ' ' LEU . 4.2 mt -129.63 99.61 5.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.31 110.876 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -75.44 153.72 37.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.31 110.82 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 m -130.02 174.99 9.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.47 110.889 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -35.92 37.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.54 111.142 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.0 -42.87 99.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 1.94 110.864 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.788 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -77.21 -54.27 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.38 111.148 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 119' ' ' LEU . 86.5 mt -49.73 -48.37 50.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.4 110.939 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.63 -50.11 55.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.8 111.17 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -43.84 83.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 4.79 110.824 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.966 HG23 HG21 ' A' ' 63' ' ' ILE . 36.6 mm -57.13 -65.18 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.31 111.142 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.99 -38.09 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.31 111.111 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -54.39 -58.03 9.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 2.18 110.875 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 56' ' ' LYS . 50.1 pt -75.5 -8.33 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 0.3 111.128 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -79.48 132.67 36.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.52 110.883 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -70.0 159.56 83.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.568 0.699 . . . . 2.37 110.876 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 113.79 3.49 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.638 2.225 . . . . 0.17 112.345 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.22 3.46 54.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.688 -0.768 . . . . 0.18 112.52 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.41 -160.12 12.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.18 112.473 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.3 m -140.11 154.96 47.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.928 0.394 . . . . 0.26 110.912 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.698 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.5 tm? -139.44 115.38 10.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.17 111.008 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.531 ' N ' HD22 ' A' ' 93' ' ' LEU . 53.9 m-85 -110.96 133.1 53.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 1.61 110.868 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.77 156.9 42.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.19 110.936 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.36 128.32 46.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 1.61 110.816 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.633 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -151.43 144.6 17.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.64 0.734 . . . . 2.29 110.868 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.633 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.87 140.19 41.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.653 2.235 . . . . 0.24 112.329 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.408 HG13 HG23 ' A' ' 157' ' ' VAL . 15.2 m -122.86 146.59 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.19 111.156 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -110.4 132.86 53.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 1.98 110.887 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.0 p -104.38 25.7 9.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 1.15 111.203 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.07 24.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.71 111.182 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.4 t -143.46 159.97 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.72 111.13 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.572 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -55.68 178.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 1.84 110.846 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -66.13 -62.65 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 2.66 110.9 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -65.98 -75.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 1.82 110.894 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.11 -168.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 1.54 110.868 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 -4.22 52.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 2.12 110.897 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.8 m -145.38 141.11 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.48 111.132 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.476 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -63.57 117.8 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 2.45 110.914 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.572 HG21 ' O ' ' A' ' 104' ' ' ASP . 39.2 p -89.68 177.72 6.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.24 111.07 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.02 -54.26 48.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.17 111.054 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.28 -49.75 76.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.042 0.448 . . . . 0.29 110.859 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -57.9 -40.69 80.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 2.21 110.928 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.633 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -61.77 -54.79 37.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.36 110.925 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 54.6 m -58.34 -48.85 79.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.21 110.893 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -45.62 92.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.472 . . . . 0.29 110.812 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.64 -48.15 83.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.23 111.154 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.616 HD11 HD12 ' A' ' 93' ' ' LEU . 15.0 tp -60.39 -52.98 62.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.37 110.921 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.0 m -63.12 -27.1 69.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.34 111.129 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.4 mt -86.97 -12.41 47.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.56 110.968 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.8 p -82.87 3.96 27.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 2.45 110.85 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.67 -4.88 34.68 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.781 -0.723 . . . . 0.71 112.528 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.2 tp -88.95 170.33 10.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.946 0.403 . . . . 0.39 110.923 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.9 m -148.13 172.75 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.31 111.169 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 51.47 45.03 28.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 2.18 110.924 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.465 HG13 HD23 ' A' ' 119' ' ' LEU . 91.0 t -81.57 142.02 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.3 111.093 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.65 8.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 1.66 110.895 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -79.57 145.92 32.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 2.27 110.862 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.678 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.5 mp -105.77 -37.31 6.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.21 110.922 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -162.1 176.67 10.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 1.28 110.983 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -126.72 165.31 19.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 5.53 110.808 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -148.39 136.43 11.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.669 0.747 . . . . 1.38 110.926 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 158.05 58.37 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.746 2.298 . . . . 0.34 112.375 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -93.35 127.01 38.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.36 110.999 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.498 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.12 161.45 22.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.492 0.663 . . . . 1.58 111.254 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -24.67 29.72 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.707 2.271 . . . . 0.5 112.386 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -85.46 -22.93 28.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 2.59 110.799 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -87.72 -53.03 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 2.44 110.911 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.73 -40.01 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.36 111.162 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -33.93 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 1.19 110.932 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -46.57 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.3 110.871 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.741 HG23 HD13 ' A' ' 147' ' ' LEU . 9.0 p -67.94 -30.96 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.17 111.128 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -76.72 -30.31 56.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 2.17 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -89.7 -21.08 22.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 1.67 110.891 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -94.8 -32.64 13.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 0.37 110.851 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.018 HD22 HD12 ' A' ' 74' ' ' LEU . 2.9 mp -127.35 -54.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.38 110.865 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.65 20.5 1.52 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.33 112.517 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -75.37 121.56 22.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.84 110.864 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -151.83 106.44 3.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 2.64 110.911 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.71 173.21 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.61 110.872 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.47 -19.59 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 1.82 110.835 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -96.19 19.9 11.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 1.59 110.925 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.516 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -89.54 163.57 15.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.31 110.823 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -173.48 130.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.28 110.948 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.696 ' CZ ' HG22 ' A' ' 72' ' ' THR . 20.6 m-85 -70.22 135.16 48.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 1.85 110.824 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.408 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.73 147.23 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.29 111.146 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.678 ' HG2' HD13 ' A' ' 130' ' ' LEU . 25.8 tt0 -104.69 125.56 50.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 1.65 110.829 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.24 153.21 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.21 111.152 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.427 ' HB ' HD11 ' A' ' 130' ' ' LEU . 6.6 t -136.92 162.92 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.28 111.136 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.449 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -153.23 136.31 5.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.772 -0.727 . . . . 0.16 112.464 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.64 139.48 30.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.362 . . . . 1.66 110.817 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 135.6 51.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.693 0.759 . . . . 1.34 110.821 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 135.77 31.2 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.622 2.215 . . . . 0.53 112.387 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.43 110.756 -179.863 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.4 t0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.871 0.367 . . . . 2.88 110.898 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.453 ' HB2' HD11 ' A' ' 6' ' ' ILE . 9.4 m-85 -122.33 15.27 10.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 2.01 110.842 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.96 41.06 99.24 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.843 -0.694 . . . . 0.24 112.469 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.653 HD13 HD21 ' A' ' 32' ' ' LEU . 1.6 mp -83.36 158.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.33 111.081 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 36' ' ' THR . 0.8 OUTLIER -148.58 164.83 33.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.35 110.864 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.49 129.13 36.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.27 111.023 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.84 -6.51 23.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.773 . . . . 0.25 112.519 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -113.14 167.91 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 1.16 110.846 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.67 137.3 37.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.178 -0.465 . . . . 1.35 110.908 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.614 HG22 ' HB ' ' A' ' 62' ' ' ILE . 47.0 t -140.75 133.21 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 1.86 111.111 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.787 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -110.3 121.98 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.26 111.085 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.817 HG11 HG12 ' A' ' 29' ' ' VAL . 94.9 t -94.59 118.06 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.17 111.068 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.599 HG12 HG13 ' A' ' 47' ' ' ILE . 21.3 t -102.66 113.59 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.2 111.12 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -113.39 167.19 10.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.2 111.013 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.578 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.9 p-10 -148.57 -169.71 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.279 -0.419 . . . . 1.78 110.926 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -58.3 -35.58 72.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 3.64 110.953 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.1 m -73.98 -8.03 54.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 1.45 110.931 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.35 93.33 9.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.716 . . . . 0.17 110.833 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 143.09 50.16 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.729 2.286 . . . . 0.22 112.326 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.81 -32.9 4.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.22 111.101 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -50.99 -53.09 36.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 2.42 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.46 -44.85 11.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.21 111.048 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -52.16 -62.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.15 110.9 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.61 -37.42 27.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 3.34 110.848 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.44 -47.08 53.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.2 112.53 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.47 HD23 ' HZ3' ' A' ' 31' ' ' LYS . 44.5 mt -61.94 -39.35 91.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.47 110.943 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.817 HG12 HG11 ' A' ' 14' ' ' VAL . 18.2 m -77.68 -31.75 17.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.231 -0.44 . . . . 0.62 111.134 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.01 -58.82 6.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 1.82 110.812 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HZ3' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -56.22 -41.1 75.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 3.13 110.88 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.867 HD23 HD21 ' A' ' 35' ' ' LEU . 91.2 mt -72.35 -24.4 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.23 110.952 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.429 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.0 mt-30 -78.16 -24.67 47.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.38 110.897 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.35 -30.29 16.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.31 111.068 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.867 HD21 HD23 ' A' ' 32' ' ' LEU . 1.6 pp -91.55 -35.65 14.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.27 110.96 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.62 -44.2 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.36 111.17 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.33 -11.0 55.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.42 112.424 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.29 -61.97 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.782 0.325 . . . . 2.92 110.918 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 3.7 mm-40 -86.49 -43.0 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 2.06 110.866 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.25 -122.03 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.852 -0.69 . . . . 0.34 112.523 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -157.49 153.35 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 2.25 110.877 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.0 t -138.27 128.72 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.28 111.182 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t -118.11 154.48 32.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.16 110.84 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -115.52 133.31 62.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.17 111.089 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -144.53 152.98 41.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 1.97 110.92 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -101.91 139.62 37.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.46 110.982 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.87 HD13 HG21 ' A' ' 73' ' ' THR . 14.5 mt -51.87 -44.24 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.34 111.169 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -20.11 60.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 3.68 110.833 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -107.12 18.5 21.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 3.52 110.86 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.005 HD13 HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -55.51 -24.56 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 2.7 110.911 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -52.19 -34.7 46.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 1.03 110.95 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -86.25 -16.34 37.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 1.2 110.907 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 m -63.47 -12.84 34.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.88 110.897 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.71 59.46 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.498 . . . . 0.35 111.068 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -61.81 -70.29 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.4 110.829 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.28 -168.78 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 1.23 110.844 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -105.82 131.05 53.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 1.96 110.825 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 49.01 71.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 1.16 110.82 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.8 p -125.61 -34.42 2.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.25 110.884 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 86' ' ' ILE . 99.1 m-85 -99.85 119.18 37.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.495 . . . . 1.48 110.88 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.42 -19.4 62.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 1.54 110.904 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.614 ' HB ' HG22 ' A' ' 12' ' ' VAL . 27.3 mt -146.03 145.44 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.25 111.117 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.976 HG21 HG23 ' A' ' 83' ' ' ILE . 13.3 mm -136.83 127.85 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.16 111.147 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -109.55 137.59 47.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.224 -0.444 . . . . 0.18 110.926 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -130.13 96.42 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.17 110.933 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.03 75.0 0.25 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 0.16 112.436 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.49 62.5 0.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.847 0.356 . . . . 0.59 110.9 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.99 160.12 66.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.533 0.682 . . . . 0.26 111.172 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 116.62 4.65 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.231 . . . . 0.29 112.35 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.14 7.27 70.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.647 -0.787 . . . . 0.22 112.5 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.33 150.23 11.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.075 0.464 . . . . 0.71 110.789 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.757 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 31.7 p -140.05 108.57 5.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.046 -0.525 . . . . 0.26 111.094 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.87 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.8 152.72 15.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.29 111.132 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.973 HD12 HD22 ' A' ' 147' ' ' LEU . 2.3 mt -130.36 101.76 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.36 110.891 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -77.56 149.05 34.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.28 110.84 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.1 m -125.57 178.43 5.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.55 110.857 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.14 -45.21 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.35 111.079 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.92 -48.53 75.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 2.32 110.906 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.005 HG23 HD13 ' A' ' 50' ' ' LEU . 4.3 mp -68.23 -56.55 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.24 111.07 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.602 HD13 ' HA ' ' A' ' 119' ' ' LEU . 62.0 mt -50.67 -39.56 51.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.26 110.966 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.85 -57.1 12.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.31 111.062 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB3' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -53.0 -41.97 65.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 2.93 110.833 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 63' ' ' ILE . 33.7 mm -58.94 -68.58 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.437 . . . . 0.21 111.056 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.79 29.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.23 111.125 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -57.55 -56.0 27.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 3.06 110.934 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.665 HG22 ' O ' ' A' ' 56' ' ' LYS . 50.2 pt -80.01 -5.69 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.22 111.17 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -76.72 129.4 36.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.4 110.904 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -70.4 160.41 81.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.623 0.725 . . . . 2.26 110.908 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 114.17 3.59 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.726 2.284 . . . . 0.27 112.393 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.43 4.79 57.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.22 112.501 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.4 -164.61 14.38 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.73 . . . . 0.2 112.435 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 67.6 m -137.71 146.28 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.4 110.815 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 124' ' ' LEU . 2.0 tm? -129.49 125.39 36.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.4 110.867 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.584 ' N ' HD22 ' A' ' 93' ' ' LEU . 69.9 m-85 -121.34 131.4 54.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 1.91 110.935 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.76 157.18 43.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.18 110.86 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.85 127.28 44.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 2.04 110.907 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -151.3 146.93 19.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.635 0.731 . . . . 2.33 110.832 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.602 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.92 142.44 47.25 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.68 2.253 . . . . 0.2 112.336 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.18 146.69 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.17 111.112 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -105.22 132.63 51.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 2.04 110.946 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.0 p -103.64 26.04 9.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 1.37 111.108 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.99 24.82 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.67 111.105 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -143.73 158.85 16.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.7 111.134 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.598 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -58.39 -177.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 2.07 110.808 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -68.69 -68.81 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 2.09 110.904 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -56.94 -75.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.082 -0.508 . . . . 1.99 110.939 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.7 -169.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 1.81 110.9 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -4.45 54.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 2.16 110.915 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.61 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.4 m -144.5 153.36 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.51 111.126 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.492 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.4 tptt -71.25 108.87 4.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 2.08 110.912 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.598 HG21 ' O ' ' A' ' 104' ' ' ASP . 32.2 p -85.88 177.7 7.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.27 111.13 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.49 -54.31 42.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.27 111.119 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -49.97 75.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.48 110.814 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.46 -41.58 76.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 1.81 110.924 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -61.64 -54.63 40.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 0.38 110.932 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.7 m -58.47 -48.84 79.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.34 110.886 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -46.53 89.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.55 110.879 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.36 -43.47 98.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.36 111.051 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.602 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.1 tp -63.37 -52.37 61.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.29 110.91 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -65.64 -24.65 67.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.33 111.114 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.34 -15.71 42.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.87 110.853 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 40.2 p -83.42 4.69 26.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 2.34 110.873 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.8 -4.77 34.4 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.632 -0.794 . . . . 0.59 112.469 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -86.45 169.37 12.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.904 0.383 . . . . 0.3 110.894 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.56 170.15 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.23 111.118 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 51.99 44.9 29.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 2.43 110.897 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.488 HG13 HD23 ' A' ' 119' ' ' LEU . 91.1 t -80.33 141.75 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.32 111.049 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 158.87 7.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 1.62 110.92 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -77.31 145.92 37.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 2.35 110.86 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.674 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.6 mp -105.26 -36.51 7.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.25 110.949 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.83 176.2 13.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 1.11 110.944 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.697 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -132.2 137.04 47.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 4.12 110.83 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.78 138.26 30.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.699 0.762 . . . . 1.84 110.853 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.413 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.5 Cg_endo -69.77 164.05 35.98 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.664 2.242 . . . . 0.2 112.357 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -95.74 128.47 42.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.29 110.941 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.455 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.46 160.91 25.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.576 0.703 . . . . 1.26 111.117 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.455 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.0 Cg_endo -69.69 -29.83 23.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.261 . . . . 0.4 112.288 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.08 -17.96 35.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 2.79 110.856 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -53.47 4.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 2.48 110.92 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -49.14 -41.09 13.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.26 111.142 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -34.67 73.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 1.27 110.976 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.18 -44.89 71.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.33 110.802 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.675 HG23 HD13 ' A' ' 147' ' ' LEU . 7.2 p -69.0 -32.54 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.19 111.153 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -76.06 -29.9 58.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 2.33 110.858 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -90.14 -20.68 22.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 1.77 110.911 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -94.58 -32.63 13.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.33 110.858 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.973 HD22 HD12 ' A' ' 74' ' ' LEU . 2.6 mp -127.88 -53.87 1.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.45 110.99 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.96 12.3 2.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 0.39 112.501 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.61 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.5 t-160 -70.24 120.38 15.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 1.12 110.818 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -151.9 111.22 3.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 3.27 110.928 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.62 175.09 13.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 1.05 110.869 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.34 -14.19 14.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 2.24 110.876 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -104.82 11.4 33.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 1.83 110.868 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.603 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -74.01 163.18 28.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.32 110.939 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.697 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.88 129.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.18 110.88 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.757 ' CZ ' HG22 ' A' ' 72' ' ' THR . 33.2 m-85 -73.54 132.89 43.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 1.88 110.869 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.01 140.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.22 111.116 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.674 ' HG2' HD13 ' A' ' 130' ' ' LEU . 22.3 tt0 -94.42 126.38 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 1.65 110.922 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.446 HD13 ' HG ' ' A' ' 115' ' ' LEU . 2.8 mp -123.15 153.65 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.34 111.174 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.443 ' HB ' HD11 ' A' ' 130' ' ' LEU . 7.5 t -139.2 164.46 29.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.35 111.141 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -154.7 135.84 4.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.17 112.488 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -91.36 140.02 30.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.866 0.365 . . . . 1.64 110.899 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 135.47 49.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.604 0.716 . . . . 1.26 110.969 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.85 127.87 15.14 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.695 2.263 . . . . 0.36 112.348 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.3 110.869 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.875 0.369 . . . . 2.67 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 6' ' ' ILE . 7.2 m-85 -122.12 11.71 10.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 2.06 110.933 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.37 40.65 99.14 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.726 -0.75 . . . . 0.29 112.502 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.485 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.5 mp -83.53 160.42 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 0.26 111.019 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -158.3 168.63 26.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.08 -0.509 . . . . 1.84 110.773 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.73 132.81 35.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 0.36 111.092 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.88 -8.12 29.55 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.757 -0.735 . . . . 0.25 112.546 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -111.96 165.33 12.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 1.26 110.924 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.56 140.09 33.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 2.16 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 62' ' ' ILE . 47.2 t -142.68 140.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 1.85 111.178 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.767 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -118.02 122.1 42.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.23 111.085 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.799 HG11 HG12 ' A' ' 29' ' ' VAL . 59.6 t -94.64 118.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.18 111.086 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.516 HG12 ' CG1' ' A' ' 47' ' ' ILE . 9.4 t -102.95 110.07 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.26 111.188 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -111.54 167.55 10.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.15 -0.477 . . . . 0.15 110.939 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 7.7 p-10 -151.34 -169.63 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 1.69 110.876 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -56.97 -35.72 69.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 2.91 110.846 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.4 m -73.11 -10.61 59.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 1.57 110.832 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.63 94.9 10.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.729 . . . . 0.13 110.881 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 141.46 45.2 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.717 2.278 . . . . 0.21 112.285 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -48.89 -32.7 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.18 111.154 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.55 -52.66 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 2.54 110.963 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.34 -45.06 10.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.17 111.097 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.488 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.48 -61.34 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.14 110.877 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -49.87 -36.1 25.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 3.31 110.857 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.52 -47.2 43.54 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.486 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.4 mt -62.13 -38.62 89.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.48 110.922 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.799 HG12 HG11 ' A' ' 14' ' ' VAL . 18.2 m -77.96 -31.55 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.62 111.099 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -62.2 -58.01 9.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 1.6 110.872 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -40.24 75.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 2.43 110.929 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.887 HD23 HD21 ' A' ' 35' ' ' LEU . 87.3 mt -73.03 -24.49 60.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.23 110.986 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.465 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.64 -25.25 44.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.37 110.942 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.83 -29.6 17.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.24 111.095 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.887 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.66 -35.0 14.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.19 110.981 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.73 -44.98 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.23 111.06 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.07 -10.94 53.75 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.674 -0.774 . . . . 0.26 112.478 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.5 -62.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.728 0.299 . . . . 3.06 110.852 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.637 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 2.9 mm-40 -90.22 -40.97 11.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 2.18 110.872 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.38 -123.03 4.01 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.661 -0.78 . . . . 0.32 112.572 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -158.28 153.54 25.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.863 0.363 . . . . 2.28 110.827 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 33' ' ' GLN . 96.6 t -138.5 130.86 38.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.187 -0.46 . . . . 0.33 111.137 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 t -119.67 156.02 31.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.17 110.916 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -117.07 135.3 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.18 111.125 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -145.74 151.95 38.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 2.17 110.965 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.73 135.43 44.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.4 110.936 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.66 ' CD1' HG21 ' A' ' 73' ' ' THR . 32.8 mt -51.68 -35.15 17.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.26 111.058 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -75.09 -31.22 61.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 2.1 110.838 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -95.82 18.44 13.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 3.32 110.948 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.791 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.83 -31.13 4.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.11 110.937 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -53.39 -38.84 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 1.11 110.899 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -85.09 -15.85 42.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 1.27 110.899 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -65.94 -11.64 48.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 1.01 110.787 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 63.36 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.32 111.144 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -60.93 -71.66 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.36 110.826 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -150.12 -168.99 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 1.82 110.951 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -102.36 137.47 40.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.74 110.926 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 p 46.57 85.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 1.23 110.833 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.6 p -141.05 -40.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.25 110.87 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.492 ' O ' HD23 ' A' ' 87' ' ' LEU . 94.5 m-85 -99.85 119.52 38.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.51 . . . . 2.06 110.931 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.2 -21.23 62.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 1.51 110.814 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 12' ' ' VAL . 35.8 mt -142.63 144.25 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.34 111.091 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.958 HG21 HG23 ' A' ' 83' ' ' ILE . 19.7 mm -134.9 126.58 47.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.12 111.13 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.1 mm? -109.04 136.82 47.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.19 110.925 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.3 98.39 4.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.12 110.857 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.61 75.52 0.21 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.735 -0.745 . . . . 0.15 112.577 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.24 56.17 0.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.801 0.334 . . . . 0.57 110.938 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -124.44 160.32 53.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.707 0.765 . . . . 0.22 111.12 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 120.35 7.15 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 0.24 112.283 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.22 6.91 83.83 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.828 -0.701 . . . . 0.18 112.54 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.413 ' HB3' HG23 ' A' ' 68' ' ' VAL . 4.7 p -55.97 151.56 11.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.951 0.405 . . . . 0.71 110.825 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.704 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 19.5 p -141.5 109.12 5.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.2 111.187 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.66 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.4 145.48 11.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.3 111.194 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.959 HD12 HD22 ' A' ' 147' ' ' LEU . 4.1 mt -124.18 105.17 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.22 110.894 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -80.1 153.8 28.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.28 110.822 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m -131.34 -176.62 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.39 110.902 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.33 69.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.526 . . . . 0.33 111.139 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -62.56 -45.04 94.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 1.64 110.841 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.791 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -74.97 -55.31 12.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.171 -0.468 . . . . 0.24 111.092 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.544 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.5 mt -50.28 -43.88 53.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.22 110.831 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.45 -52.06 49.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.111 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -44.43 92.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 2.96 110.877 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.958 HG23 HG21 ' A' ' 63' ' ' ILE . 42.3 mm -54.94 -68.18 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.2 111.085 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.65 57.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.27 111.126 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -53.14 -52.61 58.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 2.19 110.874 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 56' ' ' LYS . 36.5 pt -81.63 -8.63 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.18 111.21 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -77.24 124.2 27.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.34 110.876 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -63.1 160.25 40.85 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.703 . . . . 2.24 110.887 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 114.22 3.65 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.265 . . . . 0.28 112.3 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.56 5.52 56.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.587 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.71 -160.95 14.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.16 112.462 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.9 m -139.19 154.26 48.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.28 110.936 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.729 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.56 115.67 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.15 110.796 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.566 ' N ' HD22 ' A' ' 93' ' ' LEU . 47.9 m-85 -110.19 132.4 54.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 1.84 110.903 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.558 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.87 158.71 44.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.21 110.928 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.08 131.38 44.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 2.12 110.899 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.7 150.25 22.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.62 0.724 . . . . 3.59 110.844 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.638 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.72 144.71 55.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 0.24 112.412 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.7 146.59 32.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.28 111.125 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.478 ' HB2' HG22 ' A' ' 111' ' ' THR . 41.9 mt-10 -107.19 133.28 52.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 2.02 110.876 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.8 p -92.42 -42.76 9.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 1.07 111.209 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.677 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.67 40.45 1.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.91 111.037 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.421 HG21 ' CD ' ' A' ' 100' ' ' GLU . 20.7 t -147.65 151.9 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.85 111.113 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.64 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -56.34 178.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 2.31 110.825 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.15 -63.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 2.29 110.895 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -63.65 -75.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 1.82 110.895 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.86 -167.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.479 . . . . 1.73 110.849 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -8.29 59.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 2.31 110.919 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 149' ' ' HIS . 1.5 m -142.58 150.96 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.77 111.119 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HZ3' HD23 ' A' ' 74' ' ' LEU . 2.5 ttpm? -65.99 126.21 27.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 5.11 110.885 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.64 HG21 ' O ' ' A' ' 104' ' ' ASP . 71.7 p -97.83 177.7 5.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.38 111.147 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.87 -54.53 45.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.26 111.056 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -55.16 -48.04 74.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.23 110.908 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -36.41 75.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 2.41 110.838 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.537 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -63.94 -56.57 14.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.51 110.904 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 48.6 m -57.44 -47.62 81.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.28 110.861 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -45.57 92.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.27 110.854 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.31 99.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.479 . . . . 0.23 111.082 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.544 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.0 tp -65.39 -52.57 52.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.22 110.906 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.2 m -61.28 -31.75 71.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.27 111.114 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.9 mt -87.09 -10.67 52.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.6 110.912 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.63 4.95 29.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 1.71 110.869 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.27 7.66 32.29 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.54 112.485 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -106.3 168.44 9.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.849 0.357 . . . . 0.27 110.898 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.0 m -148.41 172.53 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.23 111.133 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 51.63 44.67 29.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.471 . . . . 2.12 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.408 HG13 HD23 ' A' ' 119' ' ' LEU . 45.5 t -79.3 144.66 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.26 111.163 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.3 158.48 5.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 2.85 110.976 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -78.83 147.09 33.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.39 . . . . 2.44 110.837 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.724 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -106.09 -36.51 6.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.21 110.967 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -160.13 176.39 11.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.11 110.916 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.72 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -131.9 137.31 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 4.12 110.848 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -123.53 136.2 26.95 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.592 0.71 . . . . 1.81 110.875 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.416 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.3 Cg_endo -69.75 162.46 41.98 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.642 2.228 . . . . 0.27 112.427 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.681 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -96.63 136.13 37.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.28 110.909 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.577 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -117.67 162.46 28.74 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.519 0.676 . . . . 1.44 111.11 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -22.65 31.53 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.574 2.183 . . . . 0.45 112.323 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -85.15 -26.37 26.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 2.43 110.826 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -88.53 -51.01 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 2.47 110.829 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -49.82 -38.92 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.24 111.188 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.85 -32.95 73.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.16 110.924 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -45.65 68.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.29 110.862 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.712 HG23 HD13 ' A' ' 147' ' ' LEU . 7.4 p -68.75 -30.96 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.18 111.081 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -76.44 -31.1 57.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 2.47 110.876 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -90.26 -20.41 23.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.164 -0.471 . . . . 1.67 110.903 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -94.75 -33.0 13.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.31 110.914 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.959 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -126.2 -54.18 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.32 110.938 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.45 10.67 2.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 0.32 112.45 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.483 ' CD2' HG11 ' A' ' 109' ' ' VAL . 13.0 t-160 -70.18 121.98 18.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.64 110.89 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.48 105.07 3.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 3.22 110.928 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.25 170.7 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.79 110.907 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.49 -6.33 18.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 1.56 110.893 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.677 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 1.8 m120 -105.14 10.56 33.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 3.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.681 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.62 166.93 19.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.31 110.934 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.72 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -172.49 130.71 0.57 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.27 110.906 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.704 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.1 m-85 -75.67 132.13 40.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 1.73 110.88 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.04 146.91 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.22 111.142 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.724 ' HG2' HD13 ' A' ' 130' ' ' LEU . 9.4 tt0 -102.07 131.52 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 2.11 110.899 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.48 149.96 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.25 111.116 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.507 ' N ' HD11 ' A' ' 130' ' ' LEU . 3.3 t -132.05 159.87 37.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.22 111.149 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.19 135.2 5.13 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.821 -0.704 . . . . 0.13 112.506 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -91.54 139.47 30.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.348 . . . . 1.66 110.973 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.23 134.77 51.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 1.29 110.933 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.67 121.66 8.37 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.743 2.296 . . . . 0.37 112.353 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 120.921 0.391 . . . . 0.62 110.89 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.858 0.361 . . . . 2.11 110.835 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.419 ' HB2' HD11 ' A' ' 6' ' ' ILE . 4.7 m-85 -122.3 20.72 10.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 1.53 110.935 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.33 41.68 80.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.26 112.531 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.515 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.5 mp -83.44 160.52 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.27 111.145 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -157.5 168.61 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 1.81 110.929 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.62 131.81 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.35 111.1 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.88 2.62 30.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.757 -0.735 . . . . 0.4 112.472 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -122.38 165.51 16.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 1.29 110.92 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.73 139.65 34.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 1.29 110.869 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.636 HG22 ' HB ' ' A' ' 62' ' ' ILE . 48.6 t -142.42 142.48 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 1.85 111.197 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.79 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -119.2 118.28 30.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.29 111.194 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.835 HG11 HG12 ' A' ' 29' ' ' VAL . 63.9 t -92.91 118.5 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.16 111.091 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.422 HG12 ' CG1' ' A' ' 47' ' ' ILE . 21.3 t -102.58 116.33 46.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.19 111.168 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -116.79 168.08 10.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.2 110.939 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.63 -169.86 3.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.26 -0.427 . . . . 1.86 110.882 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -57.11 -35.61 69.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 3.38 110.88 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 t -73.49 -10.21 59.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 1.3 110.862 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.96 94.24 10.36 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.698 0.761 . . . . 0.16 110.85 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.89 142.48 47.46 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.667 2.245 . . . . 0.23 112.339 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.07 -32.52 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.22 111.136 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -51.26 -52.97 40.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 2.48 110.957 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -44.68 11.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.2 111.128 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.479 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.74 -61.59 2.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.15 110.92 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -36.41 22.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 2.53 110.918 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.37 -46.76 47.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.682 -0.77 . . . . 0.2 112.426 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.9 mt -62.23 -38.64 90.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.45 110.929 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.835 HG12 HG11 ' A' ' 14' ' ' VAL . 17.2 m -77.97 -31.55 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.62 111.119 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.31 -58.16 8.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.191 -0.459 . . . . 1.65 110.883 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -40.11 74.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.71 110.967 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.861 HD23 HD21 ' A' ' 35' ' ' LEU . 90.2 mt -73.06 -25.17 60.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.24 110.862 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.51 -25.38 45.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.37 110.845 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 -29.58 17.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.24 111.092 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.861 HD21 HD23 ' A' ' 32' ' ' LEU . 1.3 pp -91.46 -34.72 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.23 110.935 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.28 -45.84 4.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.23 111.164 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.03 -12.04 53.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.26 112.513 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -62.56 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 2.88 110.912 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -94.45 -38.97 10.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.15 -0.477 . . . . 2.62 110.865 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.55 -126.8 4.43 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.24 112.453 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -155.28 153.46 30.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 2.21 110.836 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 33' ' ' GLN . 97.4 t -138.38 128.41 34.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.25 111.143 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.0 t -116.87 157.87 24.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.15 110.959 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.07 135.52 60.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.14 111.082 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -144.08 151.41 39.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 1.26 110.82 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.4 134.89 46.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.43 110.905 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.693 ' CD1' HG21 ' A' ' 73' ' ' THR . 24.6 mt -52.23 -36.13 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.37 111.188 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -71.55 -32.27 67.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 2.06 110.968 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -102.54 20.25 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 3.61 110.845 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.79 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -49.03 -28.89 4.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 1.12 110.909 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.581 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -55.81 -34.04 64.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 2.67 110.993 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -83.68 -13.89 53.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 1.12 110.926 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.8 m -68.49 -6.97 28.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.93 110.867 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.26 64.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.118 -0.492 . . . . 0.46 111.089 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -65.24 -69.46 0.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.34 110.902 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.667 ' O ' HG22 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -155.66 -175.21 5.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 2.16 110.84 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -94.42 135.15 36.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 2.01 110.845 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 p 46.29 82.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 1.12 110.852 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -133.33 -38.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.32 110.813 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.467 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.1 m-85 -102.46 122.7 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 1.45 110.886 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.33 -20.56 61.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 1.72 110.769 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.636 ' HB ' HG22 ' A' ' 12' ' ' VAL . 33.5 mt -144.21 144.47 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.35 111.165 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.004 HG21 HG23 ' A' ' 83' ' ' ILE . 15.9 mm -135.29 130.23 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.15 111.158 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.7 mm? -113.88 136.92 52.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.18 110.915 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.57 100.88 5.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.14 110.793 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.79 74.06 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.771 -0.728 . . . . 0.19 112.478 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.97 58.68 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.57 110.91 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.53 159.89 63.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.587 0.708 . . . . 0.22 111.129 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 116.43 4.56 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.642 2.228 . . . . 0.25 112.377 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.15 7.01 68.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.822 -0.704 . . . . 0.17 112.471 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -54.92 150.49 10.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.967 0.413 . . . . 0.7 110.881 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.746 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.2 p -140.15 109.0 5.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.15 111.121 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.693 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.68 152.86 16.38 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.25 111.051 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.974 HD12 HD22 ' A' ' 147' ' ' LEU . 6.1 mt -130.94 99.76 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.23 110.913 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -77.57 138.36 39.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.34 110.901 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.531 ' H ' HD13 ' A' ' 79' ' ' ILE . 16.4 m -115.31 175.61 5.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.63 110.803 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.98 -35.41 33.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.27 111.246 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -62.7 -39.69 94.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.126 -0.488 . . . . 2.3 110.909 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.79 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.8 mp -81.86 -55.17 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.24 111.146 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.3 mt -49.27 -46.1 45.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.32 110.826 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.03 -50.54 58.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.57 111.077 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.515 ' OE2' HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -58.09 -47.13 84.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 4.91 110.901 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.004 HG23 HG21 ' A' ' 63' ' ' ILE . 48.8 mm -53.12 -64.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.26 111.115 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.7 -41.36 61.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.26 111.053 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 tpp85 -51.99 -52.99 46.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 2.1 110.854 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 56' ' ' LYS . 32.4 pt -80.85 -8.41 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.27 111.163 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.17 114.11 15.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.33 110.884 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -53.7 160.43 2.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.702 . . . . 3.52 110.864 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 114.76 3.81 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.677 2.252 . . . . 0.28 112.291 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.67 5.77 57.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 0.24 112.486 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.5 -162.25 20.69 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.694 -0.765 . . . . 0.17 112.482 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.6 m -139.0 153.52 48.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.28 110.94 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.2 tm? -138.28 117.07 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.15 110.898 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.604 ' N ' HD22 ' A' ' 93' ' ' LEU . 47.1 m-85 -112.74 133.51 54.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 1.61 110.867 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.64 159.21 44.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.17 110.946 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.96 126.4 41.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 1.97 110.89 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.627 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -150.33 146.77 20.41 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.673 0.749 . . . . 2.34 110.905 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.628 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.8 Cg_endo -69.77 143.3 50.34 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.761 2.307 . . . . 0.2 112.316 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 155' ' ' LEU . 14.2 m -126.97 146.43 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.2 111.121 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.491 ' HB2' HG22 ' A' ' 111' ' ' THR . 54.1 mt-10 -109.25 132.57 54.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 2.13 110.873 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.9 p -91.27 -38.92 12.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 1.22 111.125 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.556 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -97.77 40.75 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.54 111.101 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.438 HG21 ' CD ' ' A' ' 100' ' ' GLU . 26.2 t -148.07 150.19 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.64 111.068 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.601 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -53.38 172.01 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.488 . . . . 1.71 110.872 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -63.95 -62.83 1.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 2.3 110.856 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -65.66 -75.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 2.36 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 t 53.49 -168.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 2.14 110.928 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.45 -5.73 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 1.71 110.921 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.93 146.63 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.39 111.085 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -67.29 115.06 6.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 2.39 110.891 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.601 HG21 ' O ' ' A' ' 104' ' ' ASP . 72.1 p -88.94 -179.85 6.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.482 . . . . 0.23 111.165 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.18 -53.09 62.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.18 111.08 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -60.19 -49.73 76.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.043 0.449 . . . . 0.27 110.86 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -58.12 -43.11 87.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 2.31 110.902 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.627 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -59.58 -55.2 37.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.3 110.876 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 61.2 m -57.79 -49.26 77.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.24 110.912 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -45.5 88.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.32 110.868 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.65 -46.93 87.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.28 111.111 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.648 HD23 HG13 ' A' ' 127' ' ' VAL . 14.6 tp -60.49 -50.96 71.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.38 110.88 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.5 m -66.31 -26.24 67.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.35 111.214 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.7 mt -86.17 -14.04 45.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.55 110.888 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 p -81.94 2.92 28.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 2.53 110.854 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.8 -4.93 34.43 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.729 . . . . 0.79 112.551 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.2 tp -87.61 170.82 10.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.38 110.896 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.78 170.97 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.4 111.126 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 53.11 44.29 30.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 2.1 110.892 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.648 HG13 HD23 ' A' ' 119' ' ' LEU . 89.9 t -81.69 139.42 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.3 111.009 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.29 162.4 8.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 1.85 110.96 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.57 145.69 32.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 2.54 110.904 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.674 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.8 mp -103.89 -36.79 7.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.472 . . . . 0.22 110.955 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -157.08 176.29 12.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 1.12 110.926 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.742 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.1 tmt_? -131.26 137.24 48.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 4.45 110.881 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -124.53 137.84 30.04 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.607 0.718 . . . . 1.38 110.958 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.414 ' HA ' HD21 ' A' ' 155' ' ' LEU . 52.8 Cg_endo -69.72 165.13 31.96 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.755 2.304 . . . . 0.24 112.329 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.672 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.86 127.21 44.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.27 110.963 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.459 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.74 161.25 23.36 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.555 0.693 . . . . 1.56 111.179 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -24.64 29.31 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.281 . . . . 0.32 112.319 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -85.71 -22.25 27.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 2.58 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -87.71 -52.23 5.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 2.41 110.995 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -49.84 -40.31 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.25 111.136 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -33.03 73.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 1.13 111.011 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -46.34 66.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.26 110.879 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.2 p -68.3 -30.12 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.17 111.113 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -76.34 -32.68 58.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.108 -0.496 . . . . 2.5 110.806 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -89.35 -20.13 24.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.74 110.877 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -94.6 -32.61 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.28 110.894 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.974 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.79 -54.37 1.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.31 110.921 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.18 9.26 2.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.735 -0.745 . . . . 0.29 112.454 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -70.21 120.93 16.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.64 110.858 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -152.63 104.9 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 2.24 110.894 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -161.11 171.26 18.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.67 110.789 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.78 -8.11 17.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 1.87 110.885 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.556 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 2.3 m120 -102.74 12.01 36.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 2.95 110.872 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.672 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -86.07 167.51 14.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.33 110.831 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.742 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -172.61 130.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.2 110.916 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.746 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.3 m-85 -73.61 132.69 43.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.473 . . . . 1.8 110.939 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.39 142.9 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.2 111.09 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.674 ' HG2' HD13 ' A' ' 130' ' ' LEU . 24.0 tt0 -96.86 127.81 43.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 1.62 110.85 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.95 151.39 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.32 111.156 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.452 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.9 t -134.96 162.96 30.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.28 111.217 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.466 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -153.84 134.09 4.21 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 0.13 112.511 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.77 140.37 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 1.67 110.891 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.11 135.48 47.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.54 0.685 . . . . 1.83 110.863 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 125.1 11.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.623 2.215 . . . . 0.38 112.372 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.933 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.919 0.39 . . . . 1.98 110.93 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -122.33 22.68 10.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 1.5 110.817 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.15 41.08 53.01 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.772 -0.728 . . . . 0.25 112.454 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.504 HG23 HG21 ' A' ' 12' ' ' VAL . 1.6 mp -80.02 159.68 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 0.23 111.139 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.731 ' O ' HG23 ' A' ' 36' ' ' THR . 0.8 OUTLIER -153.5 164.7 37.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.26 110.952 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.46 126.19 35.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.29 111.051 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.96 0.96 21.05 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.807 -0.711 . . . . 0.29 112.512 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.89 167.15 11.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 1.14 110.974 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.15 112.79 25.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 1.28 110.947 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 62' ' ' ILE . 88.1 t -117.37 130.16 72.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.96 111.013 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.788 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -106.11 124.66 49.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.24 111.105 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.849 HG11 HG12 ' A' ' 29' ' ' VAL . 59.1 t -97.3 117.03 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.2 111.079 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 t -102.56 117.49 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.23 111.085 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -114.88 172.46 7.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 0.37 110.908 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.59 ' HB3' HD12 ' A' ' 47' ' ' ILE . 7.6 p-10 -151.73 -172.98 4.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 2.13 110.879 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -35.49 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 3.61 110.929 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -73.91 -8.03 54.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 1.28 110.831 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.8 m -107.05 93.78 9.73 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.604 0.716 . . . . 0.14 110.833 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.5 Cg_endo -69.74 143.79 52.06 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.634 2.223 . . . . 0.2 112.424 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.0 t -48.88 -32.9 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.2 111.153 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.94 -53.01 36.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 3.25 110.888 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -44.85 10.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.16 111.13 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.466 HD22 HG13 ' A' ' 29' ' ' VAL . 1.8 tm? -52.13 -62.42 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.14 110.938 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.16 -36.25 18.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 2.81 110.911 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.14 -47.16 46.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.714 -0.755 . . . . 0.19 112.5 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.7 mt -61.9 -38.89 90.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.47 110.96 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.849 HG12 HG11 ' A' ' 14' ' ' VAL . 17.6 m -77.6 -31.48 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.63 111.095 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -62.1 -58.52 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 1.58 110.815 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -39.97 75.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 1.68 110.923 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.9 HD23 HD21 ' A' ' 35' ' ' LEU . 84.1 mt -73.06 -24.32 60.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.23 110.972 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.492 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.67 -24.98 44.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.38 110.947 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.98 -29.92 17.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.21 111.087 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.9 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.46 -35.24 14.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.18 110.87 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.14 -45.39 4.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.23 111.059 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.15 -12.24 54.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.25 112.5 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -70.91 -62.55 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.323 . . . . 2.54 110.88 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.505 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 1.1 mm-40 -89.42 -41.11 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 2.38 110.807 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.75 -128.36 5.81 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.788 -0.72 . . . . 0.25 112.541 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -151.82 152.53 32.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 2.2 110.903 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 33' ' ' GLN . 88.2 t -135.46 130.0 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.27 111.121 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 t -120.74 153.14 37.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.18 110.793 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -115.86 138.61 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.23 111.155 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -146.9 151.23 36.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 1.21 110.984 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.09 138.68 39.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.27 110.846 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.814 HD13 HG21 ' A' ' 73' ' ' THR . 27.3 mt -55.04 -42.65 65.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.33 111.147 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -25.56 67.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 4.18 110.904 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -111.24 19.32 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 3.55 110.83 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.789 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -50.27 -27.65 6.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 1.1 110.904 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -55.6 -32.53 63.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 1.14 110.875 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -83.45 -14.31 52.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 1.04 110.951 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.427 ' HB2' HD13 ' A' ' 50' ' ' LEU . 20.7 m -67.56 -8.52 34.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.85 110.884 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.41 64.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.28 111.129 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -65.13 -67.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.38 110.807 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.639 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -154.37 -177.9 6.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 1.39 110.931 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -93.07 130.46 38.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 1.83 110.861 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t 51.63 83.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.14 110.8 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 91.2 p -136.15 -39.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.25 110.792 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 13' ' ' ALA . 99.6 m-85 -100.59 122.01 42.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 1.44 110.8 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.23 -22.04 62.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 1.49 110.854 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.7 ' HB ' HG22 ' A' ' 12' ' ' VAL . 20.4 mt -145.5 143.68 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.26 111.076 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.89 HG21 HG23 ' A' ' 83' ' ' ILE . 18.2 mm -133.03 132.72 58.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.12 111.148 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -115.14 137.21 52.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.19 110.957 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.35 101.33 5.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.16 110.863 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.23 75.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.852 -0.689 . . . . 0.17 112.427 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.48 59.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 0.6 110.85 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.78 159.71 64.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 0.21 111.125 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 116.84 4.76 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.59 2.193 . . . . 0.23 112.406 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.79 7.49 71.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.798 -0.715 . . . . 0.16 112.523 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.47 148.84 14.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.946 0.403 . . . . 0.67 110.882 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.765 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 32.2 p -137.88 108.57 6.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.19 111.127 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.814 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.09 153.47 18.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.26 111.145 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.938 HD12 HD22 ' A' ' 147' ' ' LEU . 4.5 mt -132.12 104.23 6.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 0.23 110.852 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -79.87 153.84 28.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.34 110.829 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.8 m -130.94 175.82 8.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.57 110.824 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.28 -38.22 51.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 0.23 111.07 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.44 -46.03 91.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.193 -0.458 . . . . 2.41 110.819 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.789 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -72.6 -54.6 15.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.22 111.073 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.518 HD13 ' HA ' ' A' ' 119' ' ' LEU . 58.8 mt -51.08 -38.26 50.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 0.19 110.857 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.88 -56.55 15.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.32 111.049 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -44.12 76.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 2.98 110.949 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.89 HG23 HG21 ' A' ' 63' ' ' ILE . 51.1 mm -55.53 -68.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.23 111.172 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.71 -37.4 50.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.18 111.096 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -55.2 -50.07 70.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 3.13 110.873 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 56' ' ' LYS . 32.3 pt -84.99 -7.31 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.2 111.165 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.97 112.04 14.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.17 -0.468 . . . . 0.35 110.834 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -51.35 159.31 1.16 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 2.3 110.878 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 114.61 3.76 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.663 2.242 . . . . 0.16 112.306 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.47 3.32 56.44 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.733 -0.746 . . . . 0.17 112.455 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.98 -159.72 10.31 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.14 112.525 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.7 m -140.91 157.91 44.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.825 0.345 . . . . 0.34 110.942 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.709 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -141.76 115.05 8.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.2 110.896 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.561 ' N ' HD22 ' A' ' 93' ' ' LEU . 44.8 m-85 -109.23 133.9 52.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 1.63 110.914 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.34 162.41 39.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.16 110.874 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.1 123.45 27.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 3.41 110.855 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.627 ' OE1' HD23 ' A' ' 115' ' ' LEU . 1.0 OUTLIER -146.53 147.84 31.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.613 0.72 . . . . 2.58 110.847 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.624 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -69.78 145.61 57.58 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.671 2.247 . . . . 0.2 112.311 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.0 m -131.3 146.45 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.24 111.11 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.73 132.68 53.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 3.6 110.866 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.4 p -100.47 26.07 7.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 1.24 111.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.414 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -151.94 27.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.61 111.129 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 104' ' ' ASP . 5.3 t -143.78 157.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.65 111.162 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.591 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -59.31 -172.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 1.9 110.841 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.41 -74.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 3.45 110.87 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -52.57 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 2.14 110.893 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.69 -169.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 1.8 110.872 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -5.02 56.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 2.09 110.981 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -146.77 145.8 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.46 111.227 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.432 ' H ' HD22 ' A' ' 74' ' ' LEU . 7.0 mmtm -66.07 110.46 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 2.49 110.983 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.591 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.4 p -82.11 177.25 8.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.21 111.103 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.88 -54.67 41.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.18 111.076 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.88 -48.02 83.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.27 110.822 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -57.99 -39.02 77.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 2.04 110.888 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.627 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -64.84 -55.17 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.3 110.873 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -56.76 -45.87 81.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.26 110.804 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -43.13 89.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.35 110.85 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.23 111.124 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.584 HD11 HD12 ' A' ' 93' ' ' LEU . 14.6 tp -65.97 -51.43 58.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.22 110.858 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.0 m -62.76 -32.3 73.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.28 111.125 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.1 mt -86.82 -10.33 53.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.394 . . . . 0.68 110.974 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.02 5.8 27.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 1.75 110.902 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.75 8.36 30.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.755 -0.736 . . . . 0.56 112.445 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -108.92 171.37 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.346 . . . . 0.26 110.953 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.9 m -149.98 170.71 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.21 111.054 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 52.34 44.94 29.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.02 -0.536 . . . . 2.35 110.88 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.422 HG13 HD23 ' A' ' 119' ' ' LEU . 93.1 t -81.78 142.64 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.25 111.121 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 159.75 7.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 1.78 110.894 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.01 139.83 38.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 2.82 110.818 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.665 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -97.63 -37.58 9.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.21 110.831 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.7 176.35 12.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 1.1 110.889 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.706 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -130.14 138.83 50.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 4.2 110.85 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -125.37 136.91 28.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.64 0.733 . . . . 1.42 110.938 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.401 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.1 Cg_endo -69.72 161.49 45.7 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.694 2.263 . . . . 0.21 112.443 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.665 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -94.96 125.4 39.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 0.27 110.963 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.454 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -98.24 160.75 27.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.539 0.685 . . . . 1.26 111.128 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.7 Cg_endo -69.87 -28.92 24.15 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.62 2.214 . . . . 0.39 112.369 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -85.32 -17.82 35.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 3.9 110.88 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.86 -53.52 4.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 2.35 110.899 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 141' ' ' GLN . 5.7 p -50.15 -42.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.25 111.14 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.404 ' N ' HG13 ' A' ' 140' ' ' VAL . 1.0 OUTLIER -65.58 -32.35 73.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 1.31 110.854 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -50.61 28.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.4 110.856 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.658 HG23 HD13 ' A' ' 147' ' ' LEU . 7.2 p -62.21 -28.59 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.2 111.123 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -76.13 -47.34 24.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 1.96 110.842 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -74.45 -19.56 60.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 1.88 110.831 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.48 -33.11 13.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.46 110.786 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.938 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.82 -54.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.45 110.828 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.15 8.2 2.38 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.712 -0.756 . . . . 0.44 112.513 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -70.64 119.94 15.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.76 0.314 . . . . 0.63 110.814 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.53 105.08 2.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 2.19 110.868 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.14 177.52 10.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.76 110.902 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.46 -13.45 15.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 1.84 110.857 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.414 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -95.87 3.5 53.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 3.33 110.881 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.665 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -74.05 163.11 28.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.4 110.974 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.706 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.7 tm? -173.55 129.58 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.256 -0.429 . . . . 0.2 110.902 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.765 ' CZ ' HG22 ' A' ' 72' ' ' THR . 31.6 m-85 -75.73 135.92 40.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 1.83 110.86 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.79 141.99 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.21 111.194 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.665 ' HG2' HD13 ' A' ' 130' ' ' LEU . 17.6 tt0 -94.57 127.66 40.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 1.62 110.938 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.39 149.14 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.22 111.177 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.473 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.2 t -132.5 162.35 31.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.24 111.13 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.56 135.86 5.01 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.666 -0.778 . . . . 0.13 112.436 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -92.91 140.0 29.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 1.61 110.918 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.3 135.02 50.9 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.518 0.675 . . . . 1.21 110.917 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.9 125.2 11.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.612 2.208 . . . . 0.31 112.297 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.855 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.767 0.318 . . . . 2.4 110.876 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 6' ' ' ILE . 6.8 m-85 -122.21 11.92 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 1.61 110.854 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.34 39.5 97.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.812 -0.709 . . . . 0.41 112.445 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.5 mp -81.52 159.82 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.765 0.316 . . . . 0.32 111.181 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.73 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -156.65 168.62 26.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.78 110.865 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.77 130.1 36.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.51 111.106 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.19 2.04 26.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.782 -0.723 . . . . 0.35 112.53 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -118.85 168.0 11.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.816 0.341 . . . . 1.16 110.864 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.02 115.03 29.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.98 0.419 . . . . 2.29 110.851 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.691 HG22 ' HB ' ' A' ' 62' ' ' ILE . 98.3 t -118.42 131.82 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 1.89 111.172 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.792 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -108.18 125.29 51.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.22 111.133 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.826 HG11 HG12 ' A' ' 29' ' ' VAL . 77.6 t -97.47 119.22 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.15 111.11 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.746 HG12 HG13 ' A' ' 47' ' ' ILE . 20.1 t -103.82 112.21 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.19 111.031 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -113.73 170.53 8.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.22 110.928 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 9.0 p-10 -151.96 -169.85 3.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.428 . . . . 1.79 110.909 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -35.69 71.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 6.23 110.865 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.1 m -72.96 -9.55 58.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 1.58 110.835 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.01 94.24 10.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.664 0.745 . . . . 0.23 110.84 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 142.57 48.14 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.726 2.284 . . . . 0.29 112.331 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.9 t -48.47 -33.14 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.27 111.158 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.09 -52.66 41.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 3.1 110.961 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -45.26 10.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.23 111.119 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.457 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.69 -61.54 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.19 110.977 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.46 -35.58 20.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 2.31 110.874 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.47 -47.56 41.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.766 -0.73 . . . . 0.22 112.486 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.7 mt -61.88 -38.1 87.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.5 110.94 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.826 HG12 HG11 ' A' ' 14' ' ' VAL . 17.5 m -78.59 -31.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.63 111.079 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.48 -57.37 11.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 1.67 110.834 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -39.88 76.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.271 -0.422 . . . . 2.35 110.932 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.885 HD23 HD21 ' A' ' 35' ' ' LEU . 89.9 mt -73.26 -24.92 60.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.28 110.932 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.519 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.17 -25.14 47.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.39 110.969 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.7 -30.74 16.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.26 111.099 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.885 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.23 -34.86 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.25 110.97 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.83 -47.02 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.23 111.149 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.5 -13.55 50.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.26 112.451 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.8 -62.62 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 2.66 110.917 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -98.44 -36.87 9.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 2.2 110.935 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.92 -130.91 5.18 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.665 -0.779 . . . . 0.32 112.51 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -152.11 152.24 32.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.323 . . . . 2.22 110.944 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 33' ' ' GLN . 99.3 t -137.0 121.09 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.25 111.174 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -110.13 155.83 21.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.18 110.859 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 p -118.02 133.89 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.15 111.12 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -144.01 151.6 39.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 1.94 110.955 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -103.17 133.28 48.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.49 110.91 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.84 HD13 HG21 ' A' ' 73' ' ' THR . 20.9 mt -49.57 -32.98 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.36 111.091 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -71.32 -39.67 71.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 2.14 110.967 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.3 19.43 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 3.99 110.842 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.736 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -49.24 -27.87 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.431 . . . . 1.08 110.948 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mp -55.65 -32.85 63.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 1.29 110.942 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -83.88 -14.13 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.433 . . . . 1.04 110.906 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB2' HD13 ' A' ' 50' ' ' LEU . 33.4 m -66.47 -9.21 32.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.85 110.875 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.29 63.48 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.31 111.12 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -63.31 -67.75 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.44 110.818 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.562 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -153.28 179.87 8.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 2.19 110.876 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -87.78 133.94 33.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 1.93 110.944 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.7 p 46.3 83.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 1.11 110.807 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.1 p -134.19 -38.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.3 110.858 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 13' ' ' ALA . 99.4 m-85 -100.87 121.74 42.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 1.46 110.839 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.95 -21.44 61.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 1.73 110.844 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.691 ' HB ' HG22 ' A' ' 12' ' ' VAL . 23.0 mt -145.22 144.4 21.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.22 111.104 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.974 HG21 HG23 ' A' ' 83' ' ' ILE . 16.5 mm -134.5 129.17 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.15 111.128 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.1 mm? -111.03 136.31 50.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.17 110.912 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.402 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -129.51 100.65 5.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.16 110.775 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.02 74.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.451 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.551 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.0 mm? -106.31 52.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.57 110.83 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -123.99 159.83 54.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.24 111.141 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.88 10.53 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.633 2.222 . . . . 0.29 112.308 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.67 6.33 88.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.23 112.457 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 68' ' ' VAL . 9.0 p -56.5 151.58 13.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.909 0.385 . . . . 0.76 110.848 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.718 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 26.4 p -141.62 109.17 5.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.15 111.205 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.84 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.63 143.64 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.29 111.104 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.946 HD12 HD22 ' A' ' 147' ' ' LEU . 7.6 mt -122.52 106.01 10.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.27 110.898 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -81.14 153.79 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.31 110.842 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 m -131.97 175.66 9.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.56 110.856 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.71 -38.51 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.28 111.043 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.09 -47.32 86.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.99 110.856 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.736 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.7 mp -71.53 -54.87 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.28 111.077 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 119' ' ' LEU . 66.9 mt -50.3 -39.24 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.2 110.868 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.58 -54.43 27.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.33 111.033 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -56.9 -43.38 81.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 2.7 110.913 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.974 HG23 HG21 ' A' ' 63' ' ' ILE . 44.0 mm -60.02 -68.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.36 111.047 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.25 -31.26 13.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.43 111.167 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -63.83 -49.97 70.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 2.15 110.903 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 56' ' ' LYS . 41.0 pt -84.67 -2.95 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.23 111.077 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -81.6 111.99 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.4 110.934 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -51.9 159.53 1.36 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 2.2 110.827 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 114.75 3.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.723 2.282 . . . . 0.19 112.289 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.14 3.69 56.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.677 -0.773 . . . . 0.17 112.413 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.42 -163.32 15.66 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.747 -0.739 . . . . 0.15 112.494 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 32.5 m -137.02 154.44 50.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.828 0.347 . . . . 0.29 110.855 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.71 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -139.16 115.59 10.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.17 110.902 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.566 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.8 m-85 -110.29 132.16 54.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.64 110.886 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.551 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.68 164.17 35.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.15 110.896 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.87 131.48 31.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.69 110.922 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.81 149.41 22.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 3.61 110.882 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.566 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.4 Cg_endo -69.74 131.92 22.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.266 . . . . 0.41 112.326 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.73 146.8 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.2 111.174 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.467 ' CD ' HG21 ' A' ' 103' ' ' VAL . 45.9 mt-10 -108.48 132.48 53.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 2.09 110.931 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.9 p -91.15 -26.23 19.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.99 111.195 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.73 39.33 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.5 111.129 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.467 HG21 ' CD ' ' A' ' 100' ' ' GLU . 40.5 t -148.24 150.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.69 111.087 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.575 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -54.67 175.58 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 1.88 110.902 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -65.92 -66.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 2.21 110.813 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -62.15 -75.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 2.26 110.944 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t 51.25 -168.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 2.12 110.883 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -80.84 -3.1 50.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 1.66 110.942 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.616 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.0 m -143.53 144.14 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.52 111.12 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.44 117.33 9.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 2.38 110.896 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 104' ' ' ASP . 45.0 p -92.78 -176.02 4.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.36 111.237 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.43 -50.87 69.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.27 111.102 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -52.21 65.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.38 110.832 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -54.88 -41.15 70.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 2.2 110.92 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.505 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -62.43 -54.82 34.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.38 110.888 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 70.3 m -56.0 -48.07 76.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.27 110.843 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -44.97 93.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.36 110.79 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.08 99.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.28 111.063 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.553 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.4 tp -66.29 -53.33 37.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.24 110.875 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.1 m -59.84 -33.01 71.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.28 111.112 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.7 mt -87.15 -10.53 52.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.69 110.936 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.72 4.38 32.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 1.7 110.884 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.87 11.51 26.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 0.7 112.499 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.71 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -110.9 170.41 8.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.356 . . . . 0.3 110.956 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.7 m -151.5 174.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.27 111.063 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 52.07 43.93 30.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 2.17 110.863 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.4 t -75.7 143.04 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.31 111.099 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 159.1 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 1.57 110.849 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.37 146.8 30.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 2.34 110.881 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.508 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.4 mp -106.76 -35.67 6.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.35 110.948 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -160.22 176.24 11.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.23 110.886 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.679 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -132.97 140.4 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.495 . . . . 4.02 110.895 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -126.13 137.46 30.24 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.681 0.753 . . . . 1.53 110.947 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.406 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.6 Cg_endo -69.74 162.51 41.76 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.65 2.233 . . . . 0.28 112.35 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.68 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -98.8 123.13 42.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.51 110.941 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.473 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -100.72 161.04 25.13 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.653 0.74 . . . . 1.51 111.054 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.5 Cg_endo -69.65 -25.78 28.76 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.683 2.255 . . . . 0.67 112.388 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -85.42 -22.06 28.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 2.8 110.916 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -87.85 -52.32 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 2.39 110.995 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.89 -39.98 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.35 111.109 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -33.42 74.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 1.44 110.87 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -46.02 67.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.4 110.949 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.768 HG23 HD13 ' A' ' 147' ' ' LEU . 7.6 p -68.51 -30.25 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.24 111.189 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -31.44 56.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.159 -0.473 . . . . 3.44 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -90.31 -19.83 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 2.04 110.888 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -94.25 -33.62 13.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.59 110.874 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.946 HD22 HD12 ' A' ' 74' ' ' LEU . 3.3 mp -125.19 -54.19 1.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.45 110.936 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.96 10.1 2.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 0.37 112.44 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.616 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.6 t-160 -69.54 120.86 15.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 1.03 110.846 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -149.75 106.38 3.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 3.05 110.936 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.6 174.59 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 1.06 110.906 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -19.14 13.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 2.72 110.818 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -96.6 12.77 30.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 2.3 110.903 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.68 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -77.74 163.7 25.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.29 110.951 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.679 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.49 130.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.22 110.855 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.718 ' CZ ' HG22 ' A' ' 72' ' ' THR . 29.9 m-85 -74.76 132.95 42.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 1.67 110.894 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.82 144.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.19 111.229 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.551 ' OE1' HD13 ' A' ' 67' ' ' LEU . 3.1 tt0 -101.04 128.27 47.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 1.99 110.949 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.0 148.16 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.23 111.103 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.487 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.0 t -125.84 158.99 33.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.31 111.228 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.03 130.77 3.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.79 -0.719 . . . . 0.16 112.521 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.16 139.14 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.924 0.393 . . . . 1.6 110.834 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 135.09 53.29 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.515 0.674 . . . . 1.18 110.964 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 127.15 14.24 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.676 2.251 . . . . 0.32 112.38 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.3 110.885 -179.981 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.808 0.337 . . . . 1.94 110.883 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.29 22.38 10.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 1.5 110.84 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.12 40.74 52.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 0.23 112.529 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.471 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -79.25 159.48 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.725 0.298 . . . . 0.22 111.206 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -152.93 162.69 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 1.33 110.822 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.42 126.53 35.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.28 111.124 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.11 -6.67 17.17 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.73 -0.748 . . . . 0.27 112.487 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -113.69 167.66 10.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 1.22 110.965 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -97.96 140.87 31.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 2.12 110.837 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.647 HG22 ' HB ' ' A' ' 62' ' ' ILE . 54.3 t -142.59 142.69 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 1.84 111.16 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.771 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -119.95 121.74 39.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.24 111.024 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.812 HG11 HG12 ' A' ' 29' ' ' VAL . 57.7 t -94.41 118.57 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.21 111.102 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 47' ' ' ILE . 11.4 t -102.52 110.71 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.28 111.121 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -112.45 167.19 10.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.16 110.925 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 47' ' ' ILE . 6.2 p-10 -149.99 -169.65 3.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 1.98 110.846 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -57.53 -35.62 70.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 2.91 110.894 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.37 -9.54 58.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 1.19 110.866 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.84 94.7 10.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.617 0.722 . . . . 0.13 110.851 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 141.78 46.0 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.7 2.267 . . . . 0.19 112.338 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -48.79 -32.97 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.18 111.114 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.08 -52.92 38.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 3.14 110.834 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.46 -44.96 10.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.16 111.145 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.485 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.74 -61.62 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.13 110.894 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -49.7 -37.41 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 3.08 110.947 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.31 -47.33 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.19 112.475 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.89 -39.84 93.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.45 110.915 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.812 HG12 HG11 ' A' ' 14' ' ' VAL . 17.2 m -76.79 -31.57 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.62 111.231 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.09 -59.56 4.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.115 -0.493 . . . . 1.64 110.786 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -39.82 72.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 1.73 110.874 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.888 HD23 HD21 ' A' ' 35' ' ' LEU . 84.0 mt -73.1 -24.7 60.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.23 110.994 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.417 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.67 -25.21 44.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.4 110.907 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.84 -29.81 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.27 111.141 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.888 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.48 -35.19 14.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.2 110.93 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.08 -45.34 4.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 0.27 111.166 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.44 -11.75 53.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.672 -0.775 . . . . 0.36 112.453 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.43 -62.39 1.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 2.62 110.944 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.536 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 3.2 mm-40 -85.91 -43.18 13.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 2.13 110.841 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.23 -121.03 4.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.727 -0.749 . . . . 0.33 112.533 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -158.33 154.13 26.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 2.3 110.81 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.417 HG21 ' HA ' ' A' ' 33' ' ' GLN . 99.2 t -139.54 131.61 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.33 111.161 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -120.76 157.99 28.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.22 110.831 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.2 134.99 59.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.16 111.138 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -144.76 151.9 39.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.432 . . . . 1.23 110.89 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -101.4 137.39 39.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 1.69 110.9 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.716 ' CD1' HG21 ' A' ' 73' ' ' THR . 17.5 mt -51.03 -49.86 26.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.45 111.107 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -22.55 63.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 3.04 110.927 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -98.52 18.44 16.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 3.46 110.885 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.806 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -49.98 -28.03 6.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 1.11 110.835 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.81 -37.79 60.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 1.19 110.87 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -85.23 -17.21 37.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 1.1 110.972 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.455 ' HB2' HD13 ' A' ' 50' ' ' LEU . 50.1 m -65.37 -12.51 52.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.89 110.908 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.76 64.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.4 111.074 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -65.71 -67.98 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.34 110.86 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.664 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -155.32 -175.48 5.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 1.33 110.856 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -94.06 134.85 36.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 1.83 110.864 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p 46.3 82.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 1.13 110.84 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.8 p -133.53 -38.44 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.31 110.885 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.456 ' O ' HD23 ' A' ' 87' ' ' LEU . 96.3 m-85 -101.97 122.0 43.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 2.04 110.84 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.99 -21.48 61.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 1.49 110.827 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.647 ' HB ' HG22 ' A' ' 12' ' ' VAL . 32.3 mt -142.6 143.88 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.34 111.034 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.875 HG21 HG23 ' A' ' 83' ' ' ILE . 23.0 mm -134.27 128.79 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.17 111.142 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -111.95 136.31 51.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.15 110.913 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.44 101.81 6.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.21 110.826 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.84 75.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.783 -0.722 . . . . 0.17 112.47 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.459 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.4 mm? -108.66 58.26 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.59 110.883 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.02 159.74 65.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.697 0.761 . . . . 0.23 111.196 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 116.73 4.69 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.738 2.292 . . . . 0.25 112.362 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.18 7.14 70.41 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.805 -0.712 . . . . 0.18 112.416 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -55.27 149.7 12.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.859 0.361 . . . . 0.69 110.853 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 27.5 p -140.23 108.86 5.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 0.15 111.212 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.716 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.1 150.27 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.23 111.147 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.971 HD12 HD22 ' A' ' 147' ' ' LEU . 4.5 mt -127.79 102.98 7.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.21 110.918 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -77.63 148.66 34.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.25 110.794 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.0 m -127.17 -178.02 4.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.789 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.75 -41.33 67.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.048 -0.523 . . . . 0.4 111.159 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -57.85 -47.24 83.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 1.85 110.9 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.806 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.2 mp -71.81 -56.75 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.31 111.132 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.513 HD13 ' HA ' ' A' ' 119' ' ' LEU . 56.8 mt -50.73 -40.83 55.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.2 110.968 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.56 -56.7 11.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.36 111.114 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -44.49 86.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 2.44 110.855 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.875 HG23 HG21 ' A' ' 63' ' ' ILE . 40.2 mm -53.0 -68.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.24 111.166 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.1 -39.85 60.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.2 111.121 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.6 tpp85 -53.32 -50.25 65.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 2.15 110.893 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 56' ' ' LYS . 34.2 pt -84.11 -8.13 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.18 111.067 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.37 113.42 15.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.31 110.947 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -52.84 159.88 1.65 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.669 0.747 . . . . 2.31 110.867 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.86 114.5 3.74 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.22 112.332 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.26 5.47 57.1 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.17 112.45 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.44 -163.11 18.72 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.844 -0.694 . . . . 0.14 112.407 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 22.8 m -136.55 154.99 50.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.28 110.854 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.703 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -139.69 116.38 10.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.18 110.919 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.578 ' N ' HD22 ' A' ' 93' ' ' LEU . 54.6 m-85 -112.21 131.29 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 1.62 110.927 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.41 160.7 42.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.16 110.97 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.53 127.94 36.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 1.8 110.909 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.78 148.95 29.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.651 0.739 . . . . 2.2 110.842 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.617 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.1 Cg_endo -69.85 140.01 41.3 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.598 2.199 . . . . 0.19 112.376 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.81 146.97 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 0.25 111.091 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.468 ' CD ' HG21 ' A' ' 103' ' ' VAL . 12.8 mt-10 -109.55 132.46 54.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 2.22 110.869 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.4 p -105.61 26.45 9.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 1.29 111.093 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.58 24.41 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.6 111.133 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.468 HG21 ' CD ' ' A' ' 100' ' ' GLU . 4.4 t -144.81 159.24 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.78 111.043 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.564 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -51.02 167.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 1.74 110.819 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -62.78 -50.67 70.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 2.27 110.847 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -74.13 -75.73 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 1.74 110.928 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.443 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.2 t 53.56 -166.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 2.24 110.799 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -8.93 59.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 3.86 110.855 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.436 HG11 ' CG ' ' A' ' 149' ' ' HIS . 2.7 m -140.62 142.78 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.38 111.117 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -63.13 116.15 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 2.24 110.932 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.564 HG21 ' O ' ' A' ' 104' ' ' ASP . 55.7 p -85.03 178.49 7.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.439 . . . . 0.26 111.033 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.97 -54.02 49.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.18 111.144 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -59.9 -48.7 80.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.25 110.851 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -56.8 -39.55 74.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 1.68 110.898 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.499 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -64.53 -54.98 23.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.33 110.857 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.2 m -56.09 -45.34 79.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.21 110.954 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -42.56 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.28 110.82 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.44 98.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.21 111.111 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.0 tp -66.66 -52.98 38.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.421 . . . . 0.23 110.874 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.5 m -59.8 -34.72 73.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.32 111.083 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.7 mt -84.96 -10.21 57.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.63 110.905 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.12 5.45 29.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 1.73 110.8 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.26 7.77 32.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.64 112.495 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -107.31 170.18 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.3 110.992 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -150.86 170.63 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.26 111.162 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 54.77 43.27 30.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 2.1 110.858 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.0 t -75.65 143.51 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.27 111.106 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.1 159.66 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 1.66 110.867 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -81.86 146.05 30.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 2.37 110.924 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.515 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.2 mp -105.92 -35.64 7.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.21 110.885 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -161.3 176.27 11.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 1.09 110.888 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.733 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.4 OUTLIER -132.35 137.84 47.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 4.46 110.823 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.91 137.53 29.01 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.593 0.711 . . . . 1.84 111.002 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.412 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.2 Cg_endo -69.69 165.08 32.09 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.706 2.271 . . . . 0.22 112.389 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.68 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.19 126.56 43.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.27 110.868 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.462 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.34 161.4 23.0 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.606 0.717 . . . . 1.54 111.157 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -24.57 29.81 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.692 2.261 . . . . 0.34 112.366 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.59 -22.52 28.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 2.56 110.898 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -87.79 -52.22 5.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 2.57 110.867 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 136' ' ' THR . 7.3 p -49.69 -40.08 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.27 111.171 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -33.44 74.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 1.13 110.954 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.35 -45.93 68.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.25 110.832 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 8.4 p -68.36 -30.44 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.16 111.103 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -75.98 -32.48 59.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 2.4 110.87 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -89.32 -20.29 24.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 1.65 110.912 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -94.47 -32.78 13.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.29 110.866 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.971 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.55 -54.37 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.31 110.929 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.98 9.11 2.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.768 -0.729 . . . . 0.34 112.537 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.436 ' CG ' HG11 ' A' ' 109' ' ' VAL . 15.3 t-160 -70.3 121.5 17.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.749 0.309 . . . . 0.62 110.879 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -152.08 104.75 3.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 2.15 110.882 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.3 t -161.2 173.12 15.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.72 110.858 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.82 -12.71 15.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 1.7 110.797 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -97.67 10.41 40.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 1.58 110.832 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.68 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -83.59 166.61 18.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.189 -0.46 . . . . 0.27 110.83 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.733 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -172.97 130.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.2 110.978 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 25.9 m-85 -74.79 131.3 40.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 1.74 110.908 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.0 144.18 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.21 111.081 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.515 ' HG2' HD13 ' A' ' 130' ' ' LEU . 3.8 tt0 -99.56 128.41 45.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 1.88 110.919 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.3 149.61 30.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.2 111.118 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.473 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.5 t -127.84 160.88 30.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.109 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.44 132.1 3.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.13 112.503 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -92.94 140.1 29.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 1.65 110.896 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.46 135.13 50.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.603 0.716 . . . . 1.23 110.939 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 123.6 10.26 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.634 2.223 . . . . 0.3 112.346 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.34 110.84 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.871 0.367 . . . . 3.05 110.917 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.427 ' CE1' HD12 ' A' ' 67' ' ' LEU . 5.6 m-85 -122.32 21.79 10.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 2.01 110.917 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.21 39.77 51.19 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.741 -0.742 . . . . 0.34 112.451 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.458 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.8 mp -77.03 159.19 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.38 111.145 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 36' ' ' THR . 38.1 m -147.33 157.03 43.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 1.15 110.85 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.11 123.71 33.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.513 . . . . 0.47 111.112 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.68 -3.51 21.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.758 -0.734 . . . . 0.29 112.5 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.89 169.63 8.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.376 . . . . 1.52 110.898 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -104.62 109.68 21.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 1.38 110.873 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.668 HG12 HG21 ' A' ' 36' ' ' THR . 2.3 p -115.7 135.49 55.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 2.05 111.092 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.754 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -109.7 125.85 53.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.22 111.083 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.842 HG11 HG12 ' A' ' 29' ' ' VAL . 58.5 t -97.72 120.53 47.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.19 111.129 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.408 HG12 HG13 ' A' ' 47' ' ' ILE . 41.0 t -104.31 121.86 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.25 111.13 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -121.38 170.24 9.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.25 110.905 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.408 ' HB3' HD12 ' A' ' 47' ' ' ILE . 9.8 p-10 -151.25 -171.02 3.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 1.84 110.919 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -57.05 -36.11 70.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 3.62 110.881 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -72.08 -10.21 59.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 1.77 110.807 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -107.68 92.86 9.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.618 0.723 . . . . 0.25 110.884 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.79 143.07 49.52 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.678 2.252 . . . . 0.42 112.306 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.6 t -48.29 -32.61 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.3 111.144 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.54 -53.44 37.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 2.59 110.9 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.9 -45.01 10.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.33 111.064 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.684 ' HA ' HD12 ' A' ' 28' ' ' LEU . 2.1 tm? -50.19 -60.26 3.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.22 110.91 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -49.44 -35.76 20.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 2.83 110.952 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.89 -48.31 49.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.698 -0.763 . . . . 0.27 112.478 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 1.045 HD11 HG13 ' A' ' 68' ' ' VAL . 2.1 mt -60.43 -40.55 91.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.865 0.364 . . . . 1.5 110.937 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.842 HG12 HG11 ' A' ' 14' ' ' VAL . 17.3 m -76.79 -30.81 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.63 111.081 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.94 -60.87 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 1.91 110.929 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -40.58 68.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 2.59 110.821 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.806 HD23 HD21 ' A' ' 35' ' ' LEU . 91.8 mt -72.36 -25.57 61.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.33 110.991 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.558 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.36 -24.94 46.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.46 110.844 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.23 -30.1 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.5 111.112 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.806 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.34 -34.88 14.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.4 110.887 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.668 HG21 HG12 ' A' ' 12' ' ' VAL . 1.2 m -103.2 -47.0 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.36 111.186 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.24 -14.64 48.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.763 -0.732 . . . . 0.44 112.478 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -60.78 -62.55 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 2.01 110.858 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.23 -36.35 9.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 2.03 110.873 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.72 -137.48 7.61 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.67 -0.776 . . . . 0.47 112.467 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -146.4 150.33 35.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 3.71 110.925 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 33' ' ' GLN . 85.8 t -133.66 119.31 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.3 111.102 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -108.12 158.04 17.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.22 110.796 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.48 138.14 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.22 111.109 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -145.82 151.31 37.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 1.23 110.891 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.4 134.62 46.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.43 110.958 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.73 ' CD1' HG21 ' A' ' 73' ' ' THR . 37.2 mt -52.77 -35.86 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.32 111.119 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -71.51 -31.64 67.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 2.1 110.896 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -103.91 20.18 18.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 3.61 110.896 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.825 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.19 -28.37 4.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 1.11 110.893 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mp -55.27 -34.01 63.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 1.06 110.892 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -84.04 -14.94 49.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 1.06 110.898 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB2' HD13 ' A' ' 50' ' ' LEU . 32.8 m -67.14 -9.38 39.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.89 110.863 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.87 63.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.31 111.02 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -63.22 -68.13 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.43 110.849 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.602 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -153.85 -176.95 6.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 1.38 110.896 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -92.72 128.95 38.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 1.82 110.91 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 t 51.67 84.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 1.98 110.806 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.1 p -136.23 -38.87 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.31 110.863 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.44 ' O ' HD23 ' A' ' 87' ' ' LEU . 98.6 m-85 -100.21 123.76 44.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 2.01 110.804 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.38 -21.48 60.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 1.72 110.785 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 6' ' ' ILE . 13.4 mt -144.05 143.3 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.22 111.06 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.916 HG21 HG23 ' A' ' 83' ' ' ILE . 22.6 mm -135.62 128.75 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.16 111.187 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.2 mm? -112.61 136.31 52.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.22 110.845 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.97 105.0 8.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.22 110.834 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.26 71.44 0.63 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.768 -0.73 . . . . 0.23 112.488 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.427 HD12 ' CE1' ' A' ' 4' ' ' PHE . 4.2 mm? -104.52 57.09 0.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.818 0.342 . . . . 0.68 110.948 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.045 HG13 HD11 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -124.57 153.01 69.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.637 0.732 . . . . 0.46 111.149 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.688 ' HD2' HG12 ' A' ' 68' ' ' VAL . 54.3 Cg_endo -69.71 116.87 4.75 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.674 2.249 . . . . 0.38 112.336 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.99 6.94 71.15 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.708 -0.758 . . . . 0.47 112.453 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.505 ' HB2' HG23 ' A' ' 68' ' ' VAL . 4.7 t -66.2 152.97 43.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 2.73 110.832 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.706 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 20.0 p -136.68 112.42 9.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.521 . . . . 0.28 111.142 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.73 HG21 ' CD1' ' A' ' 47' ' ' ILE . 1.2 m -162.81 144.82 10.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.42 111.1 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.867 HD12 HD22 ' A' ' 147' ' ' LEU . 9.3 mt -125.28 116.28 21.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.56 110.833 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -89.97 154.06 20.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.28 110.806 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 m -129.51 -177.7 4.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.57 110.923 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.5 -37.06 69.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.472 . . . . 0.25 111.025 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -61.77 -46.28 90.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 2.05 110.85 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.825 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -73.31 -54.64 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.22 111.119 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.8 mt -50.31 -40.8 49.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.22 110.924 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.49 -55.48 18.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.35 111.12 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -45.26 82.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 3.12 110.869 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.916 HG23 HG21 ' A' ' 63' ' ' ILE . 40.4 mm -54.65 -68.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.21 111.088 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.84 -39.3 53.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.21 111.181 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -53.18 -51.47 61.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 2.85 110.912 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 56' ' ' LYS . 29.8 pt -83.96 -6.98 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.19 111.134 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -79.02 111.25 15.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.37 110.854 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -51.79 158.93 1.46 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 3.67 110.923 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.419 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.3 Cg_endo -69.82 114.15 3.62 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.738 2.292 . . . . 0.27 112.243 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.84 2.8 55.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.18 112.453 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.83 -165.78 23.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.544 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 65.5 m -133.51 152.81 51.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.86 0.362 . . . . 0.35 110.924 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.694 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.29 114.79 11.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.15 110.922 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.539 ' N ' HD22 ' A' ' 93' ' ' LEU . 48.4 m-85 -110.54 132.54 54.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 1.88 110.897 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -148.25 157.91 43.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.15 110.81 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.1 126.51 43.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.012 -0.54 . . . . 2.58 110.817 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.607 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -150.53 145.96 19.13 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.689 0.757 . . . . 2.27 110.83 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.45 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.9 Cg_endo -69.75 139.76 41.06 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.721 2.281 . . . . 0.19 112.434 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.52 146.73 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.22 111.144 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.458 ' OE2' HG21 ' A' ' 103' ' ' VAL . 16.8 mt-10 -110.29 132.59 54.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 1.88 110.892 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.9 p -104.18 26.1 9.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 1.21 111.145 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.99 23.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.63 111.131 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.458 HG21 ' OE2' ' A' ' 100' ' ' GLU . 4.6 t -144.49 159.01 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.67 111.145 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.602 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -57.44 -178.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 2.16 110.848 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -68.54 -63.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 2.08 110.84 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.4 -76.03 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 2.27 110.938 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.435 ' HB2' HG11 ' A' ' 103' ' ' VAL . 1.5 p 51.44 -169.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 2.06 110.809 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.54 -3.84 51.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 1.86 110.846 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.41 153.61 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.426 . . . . 0.46 111.112 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.545 ' HB2' HD22 ' A' ' 74' ' ' LEU . 10.0 mmtm -72.28 109.7 6.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 1.89 110.833 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.602 HG21 ' O ' ' A' ' 104' ' ' ASP . 30.2 p -82.4 177.99 8.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.26 111.156 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.85 -54.88 39.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.2 111.101 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.16 -49.28 77.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.27 110.836 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -56.75 -38.63 72.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.191 -0.459 . . . . 1.69 110.96 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.607 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -65.15 -54.89 22.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.32 110.929 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.7 m -57.74 -45.8 85.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.21 110.834 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -42.95 91.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.27 110.87 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.59 93.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.23 111.043 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.654 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.9 tp -65.63 -50.35 65.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.32 110.925 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 96.8 m -61.97 -34.6 76.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.28 111.082 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.13 -10.22 57.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.57 110.87 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.6 6.52 27.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 1.77 110.884 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.41 4.77 34.86 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.51 112.406 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -104.63 170.61 7.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.37 110.895 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.2 m -151.7 173.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.31 111.068 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 51.55 44.1 29.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 2.04 110.878 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 95.3 t -77.73 143.1 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.25 111.186 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.15 159.25 7.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.244 -0.435 . . . . 1.56 110.95 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.99 143.33 32.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 3.29 110.923 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.755 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.3 mp -103.19 -37.0 7.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.28 110.931 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -155.81 176.08 13.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 1.21 110.948 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.689 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.4 tmt_? -132.35 137.49 47.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 4.32 110.893 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -123.87 136.81 27.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.632 0.73 . . . . 1.83 110.941 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HA ' HD21 ' A' ' 155' ' ' LEU . 52.9 Cg_endo -69.77 163.03 39.81 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.759 2.306 . . . . 0.28 112.293 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.679 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -96.45 124.15 40.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.27 110.915 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.445 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -98.77 161.38 25.19 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 121.567 0.699 . . . . 1.22 111.088 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.8 Cg_endo -69.82 -28.41 25.0 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.678 2.252 . . . . 0.37 112.4 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -85.41 -17.71 35.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 3.66 110.824 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.13 -53.66 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 2.33 110.974 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.9 p -49.43 -40.56 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.26 111.127 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -34.61 75.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 1.23 110.831 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.19 -46.38 70.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.28 110.791 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.847 HG23 HD13 ' A' ' 147' ' ' LEU . 9.7 p -68.37 -30.37 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.2 111.14 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -75.49 -32.29 60.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 1.89 110.953 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -89.62 -20.22 23.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 1.95 110.875 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.42 -32.55 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.3 110.809 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.867 HD22 HD12 ' A' ' 74' ' ' LEU . 3.5 mp -128.04 -53.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.41 110.946 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.22 12.4 2.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.814 -0.707 . . . . 0.31 112.491 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -70.6 122.07 19.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.324 . . . . 0.76 110.894 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -151.6 105.44 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 2.73 110.893 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.57 175.21 12.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.62 110.836 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.09 -20.31 13.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 1.75 110.881 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -93.57 13.27 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 1.72 110.984 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.679 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -80.91 163.23 23.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.31 110.938 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.689 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.53 129.99 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.23 110.948 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.706 ' CZ ' HG22 ' A' ' 72' ' ' THR . 33.6 m-85 -73.81 133.49 43.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 1.82 110.842 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.0 139.74 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.26 111.101 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.755 ' HG2' HD13 ' A' ' 130' ' ' LEU . 39.8 tt0 -93.74 129.62 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 2.29 110.938 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.86 150.93 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.424 . . . . 0.23 111.174 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.471 ' N ' HD11 ' A' ' 130' ' ' LEU . 3.1 t -130.04 160.5 33.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.23 111.061 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.76 131.38 3.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.719 -0.753 . . . . 0.16 112.441 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -93.83 140.42 29.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 1.55 110.905 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 9.4 tptt -81.78 134.75 49.8 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.609 0.719 . . . . 2.32 110.818 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 119.39 6.34 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.753 2.302 . . . . 0.42 112.291 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.37 110.904 179.945 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.91 0.386 . . . . 2.1 110.877 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -122.3 18.26 10.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 1.55 110.867 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.17 40.04 73.22 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.788 -0.72 . . . . 0.28 112.417 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.464 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.8 mp -77.0 157.5 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.3 111.184 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 36' ' ' THR . 46.2 m -148.3 156.61 42.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 1.11 110.846 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.77 125.31 33.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.44 111.093 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.09 -6.23 23.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 0.28 112.51 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.72 167.57 10.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 1.47 110.975 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.51 137.03 38.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 2.21 110.929 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG1' HG21 ' A' ' 36' ' ' THR . 2.1 p -141.86 140.71 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 2.11 111.147 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.745 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -115.64 124.16 50.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.21 111.17 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.851 HG11 HG12 ' A' ' 29' ' ' VAL . 95.3 t -95.88 118.52 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.16 111.086 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.441 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.1 t -102.7 115.28 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 0.18 111.153 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -115.91 167.2 11.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 0.19 110.967 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.421 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.7 p-10 -151.3 -169.54 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 1.75 110.892 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -56.8 -35.74 69.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 3.37 110.937 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -73.06 -10.9 60.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 1.51 110.863 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.25 93.57 9.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.604 0.716 . . . . 0.16 110.891 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.5 Cg_endo -69.77 142.76 48.76 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.719 2.279 . . . . 0.2 112.336 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -48.92 -32.52 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.19 111.144 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.28 -53.2 38.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 2.4 110.913 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -44.95 10.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.19 111.091 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.474 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.27 -61.51 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.16 110.922 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -36.8 31.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 2.38 110.843 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.68 49.91 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.801 -0.714 . . . . 0.23 112.47 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.6 mt -61.7 -40.36 94.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 0.52 110.918 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.851 HG12 HG11 ' A' ' 14' ' ' VAL . 17.3 m -76.16 -31.46 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.63 111.177 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.02 -60.29 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 1.55 110.821 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -40.15 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 1.73 110.938 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.913 HD23 HD21 ' A' ' 35' ' ' LEU . 77.4 mt -72.69 -24.68 61.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.26 110.841 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.4 -24.86 46.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.38 110.926 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.82 -30.02 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.23 111.132 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.913 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.43 -35.3 14.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.22 110.879 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.499 HG21 ' CG1' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -102.33 -44.77 5.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.24 111.057 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.49 -10.94 55.46 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.729 -0.748 . . . . 0.25 112.498 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.32 -62.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 2.26 110.966 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -91.47 -39.94 11.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 2.24 110.875 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.21 -125.73 4.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.34 112.538 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -156.25 152.68 28.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 3.47 110.965 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 33' ' ' GLN . 95.7 t -135.84 130.21 48.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.31 111.203 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -118.61 156.9 28.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.2 110.869 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 p -119.39 136.71 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.19 111.118 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -147.26 152.17 37.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 1.3 110.894 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.66 135.72 43.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.41 110.944 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.645 ' CD1' HG21 ' A' ' 73' ' ' THR . 28.6 mt -51.61 -35.43 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.35 111.19 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -29.99 59.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 2.63 110.905 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -97.89 18.44 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 3.34 110.942 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.827 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.74 -30.23 5.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 1.09 110.999 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -54.51 -37.36 65.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 1.04 110.923 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -84.6 -15.66 44.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 1.08 110.946 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 m -66.95 -10.17 46.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.99 110.872 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.07 63.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.34 111.116 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -61.75 -69.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.35 110.889 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.658 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -153.76 -175.5 5.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 2.12 110.865 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.47 134.84 35.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.59 110.929 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p 46.24 82.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 1.17 110.848 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.3 p -133.4 -38.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.32 110.87 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.442 ' O ' HD23 ' A' ' 87' ' ' LEU . 97.6 m-85 -101.65 122.44 43.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 1.99 110.906 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.55 -21.09 61.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.155 -0.475 . . . . 1.49 110.861 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 6' ' ' ILE . 11.3 mt -143.38 143.52 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.26 111.089 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.865 HG21 HG23 ' A' ' 83' ' ' ILE . 21.3 mm -134.99 129.04 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.13 111.062 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.4 mm? -113.19 136.77 52.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.2 110.888 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.15 101.92 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.18 110.859 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.4 77.43 0.13 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.81 -0.709 . . . . 0.18 112.423 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.45 58.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.61 110.894 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.18 160.12 61.44 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.654 0.74 . . . . 0.25 111.163 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 115.95 4.32 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.709 2.273 . . . . 0.29 112.365 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.84 6.43 67.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.711 -0.756 . . . . 0.2 112.496 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.49 150.37 12.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.991 0.424 . . . . 0.68 110.877 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 26.6 p -140.8 108.96 5.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.16 111.16 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.645 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.2 148.35 11.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 0.25 111.142 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.848 HD12 HD22 ' A' ' 147' ' ' LEU . 1.7 mt -126.23 101.2 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.34 110.935 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.16 138.17 38.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.41 110.848 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.414 ' H ' HD13 ' A' ' 79' ' ' ILE . 58.2 m -115.83 -175.67 2.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.843 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.68 70.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.3 111.167 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -62.31 -42.95 99.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 1.81 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.827 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -77.79 -55.2 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.27 111.165 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 119' ' ' LEU . 64.4 mt -50.36 -41.57 51.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.23 110.895 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.61 -56.51 13.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.34 111.105 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -41.44 74.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.433 . . . . 2.47 110.815 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.865 HG23 HG21 ' A' ' 63' ' ' ILE . 42.9 mm -58.55 -68.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.18 111.107 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.416 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -49.82 -35.0 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.28 111.168 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -59.31 -51.42 70.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 2.43 110.891 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 56' ' ' LYS . 33.2 pt -83.46 -4.04 8.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.22 111.083 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -82.1 112.06 18.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.35 110.917 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -51.65 159.58 1.24 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.61 0.719 . . . . 2.1 110.873 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.8 Cg_endo -69.88 114.26 3.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.685 2.257 . . . . 0.19 112.306 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.63 3.73 56.13 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 0.17 112.466 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.05 -166.94 26.63 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.782 -0.723 . . . . 0.21 112.491 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.5 m -133.1 153.36 51.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.873 0.368 . . . . 0.33 110.95 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.653 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.93 116.37 12.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.16 110.914 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.567 ' N ' HD22 ' A' ' 93' ' ' LEU . 52.6 m-85 -112.33 131.89 55.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 1.84 110.836 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -148.2 156.92 43.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.18 110.866 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.03 126.76 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 2.08 110.917 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.88 146.9 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.65 0.738 . . . . 2.31 110.852 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.59 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.5 Cg_endo -69.68 143.72 52.11 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.586 2.19 . . . . 0.25 112.368 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.38 146.75 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 0.2 111.135 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.459 ' HB2' HG22 ' A' ' 111' ' ' THR . 59.6 mt-10 -106.8 132.85 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 2.18 110.832 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -93.01 -42.11 9.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 1.11 111.129 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.72 39.91 1.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.83 111.182 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.25 150.6 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.85 111.128 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.641 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -56.66 167.92 0.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 1.96 110.912 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.425 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 1.7 p30 -60.54 -55.0 38.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 2.4 110.822 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.59 -77.3 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 2.28 110.853 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p 54.0 -173.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 1.71 110.814 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.63 -2.1 45.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 2.6 110.927 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.581 HG21 ' CE1' ' A' ' 149' ' ' HIS . 1.1 m -143.39 154.52 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.177 -0.465 . . . . 0.86 111.09 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -69.88 121.03 16.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 2.14 110.958 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.641 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.7 p -97.05 -177.96 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.23 111.109 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -52.9 63.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.22 111.103 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.92 -50.5 73.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.26 110.853 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -58.93 -40.59 85.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 2.23 110.956 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -60.52 -54.64 43.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.41 110.926 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 67.2 m -55.54 -50.99 68.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.34 110.863 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -48.22 82.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.32 110.826 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.27 -51.52 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.064 -0.516 . . . . 0.27 111.092 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.742 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.0 tp -57.38 -47.12 82.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.38 110.839 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.2 m -67.34 -22.24 65.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.54 111.162 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.48 -15.37 40.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 1.18 110.884 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.9 5.0 30.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 1.68 110.892 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.45 -4.86 35.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 0.48 112.573 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -87.06 168.96 12.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.49 110.899 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.5 m -151.39 171.86 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.42 111.135 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 53.58 43.72 30.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 2.11 110.836 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.22 142.51 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.34 111.14 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.07 160.65 8.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 1.74 110.844 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 21.2 tt0 -82.36 146.69 29.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 2.39 110.932 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.666 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.4 mp -107.39 -35.76 6.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.22 110.919 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.47 176.24 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 1.18 110.883 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.712 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.2 tmt_? -133.19 137.82 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 4.39 110.877 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -125.49 138.8 32.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.636 0.731 . . . . 1.44 110.91 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.438 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.3 Cg_endo -69.84 164.49 34.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.615 2.21 . . . . 0.25 112.329 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.654 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -97.07 135.76 38.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.4 110.886 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.24 160.98 25.59 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 1.18 111.194 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -29.3 24.02 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.684 2.256 . . . . 0.44 112.27 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -85.31 -19.26 31.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 2.76 110.864 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -53.24 5.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 2.21 110.968 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.7 p -49.21 -41.94 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.36 111.033 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -33.69 72.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 1.23 110.866 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.28 -45.05 70.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.31 110.898 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.716 HG23 HD13 ' A' ' 147' ' ' LEU . 7.2 p -68.89 -32.39 54.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.492 . . . . 0.47 111.172 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -76.3 -30.0 57.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 3.23 110.85 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -90.43 -20.49 22.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 1.63 110.836 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -94.72 -32.96 13.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.59 110.8 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.848 HD22 HD12 ' A' ' 74' ' ' LEU . 3.0 mp -126.75 -53.98 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.86 110.925 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.78 12.07 2.01 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.635 -0.793 . . . . 0.9 112.435 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.581 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.4 t-160 -70.12 121.25 17.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.687 0.279 . . . . 1.36 110.896 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -149.41 111.65 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 3.21 110.847 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.55 165.18 31.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 1.59 110.86 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.76 -7.48 19.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 2.47 110.814 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -115.56 22.8 12.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 1.9 110.862 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.654 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -85.16 169.48 13.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.42 110.92 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.712 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -173.51 130.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.21 110.961 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.2 m-85 -72.94 131.84 42.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 1.81 110.943 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.95 140.38 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.2 111.16 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.666 ' HG2' HD13 ' A' ' 130' ' ' LEU . 23.3 tt0 -93.95 126.84 39.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 1.62 110.864 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 3.3 mp -122.35 151.4 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.26 111.147 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.483 ' HB ' HD21 ' A' ' 130' ' ' LEU . 3.2 t -129.72 161.45 30.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.33 111.145 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.5 130.48 3.07 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.23 112.485 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -94.86 140.56 29.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 1.59 110.838 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 7.5 tptt -82.31 134.54 48.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.535 0.684 . . . . 2.25 110.955 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 118.88 5.94 Favored 'Trans proline' 0 C--O 1.23 0.1 0 C-N-CA 122.723 2.282 . . . . 0.36 112.29 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.32 110.851 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t0 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.863 0.363 . . . . 2.32 110.874 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 6' ' ' ILE . 3.9 m-85 -122.22 20.81 10.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 1.57 110.966 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 56.24 40.79 85.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.752 -0.737 . . . . 0.39 112.472 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.518 HG21 HD22 ' A' ' 32' ' ' LEU . 1.4 mp -83.46 160.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.826 0.346 . . . . 0.36 111.067 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.743 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -156.36 168.01 28.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 1.62 110.899 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.51 134.41 34.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.43 111.135 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.51 2.5 37.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.41 112.458 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -121.04 171.88 8.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.793 0.33 . . . . 1.13 110.96 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.54 137.39 40.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 1.36 110.833 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.69 HG22 ' HB ' ' A' ' 62' ' ' ILE . 66.3 t -141.92 123.96 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 1.88 111.098 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.764 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -102.41 125.9 49.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.33 111.216 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.551 HG21 ' CB ' ' A' ' 29' ' ' VAL . 61.3 t -98.12 112.41 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.43 111.113 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.8 t -98.09 129.87 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.46 111.132 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -128.68 170.68 12.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.22 110.915 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 47' ' ' ILE . 11.4 p-10 -151.65 -172.76 4.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 1.77 110.924 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -23.41 62.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 3.14 110.857 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.83 -16.31 48.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.09 110.924 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 m -101.67 102.79 24.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.66 0.743 . . . . 0.31 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 136.85 34.08 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.66 2.24 . . . . 0.45 112.428 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.19 -31.66 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.56 111.121 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.02 -52.46 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 2.48 110.922 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.94 -43.81 12.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.26 111.099 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.548 HD13 ' N ' ' A' ' 26' ' ' LYS . 1.3 tm? -51.48 -60.28 3.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.34 110.915 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.548 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -47.45 -46.83 27.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 2.2 110.963 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.68 -37.02 93.1 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.771 -0.728 . . . . 0.49 112.462 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.719 HD11 HG13 ' A' ' 68' ' ' VAL . 33.8 mt -60.25 -50.75 72.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.78 110.928 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.594 HG22 ' HG3' ' A' ' 33' ' ' GLN . 7.7 p -77.66 -25.28 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 3.33 111.099 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -60.91 -62.43 1.86 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 1.94 110.873 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -40.34 62.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 1.7 110.891 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.808 HD23 HD21 ' A' ' 35' ' ' LEU . 84.7 mt -72.22 -24.48 61.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.46 110.934 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.619 ' HA ' HG21 ' A' ' 42' ' ' VAL . 2.1 mm-40 -77.49 -25.58 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 1.89 110.938 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.15 -31.34 17.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 0.36 111.056 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.808 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.06 -34.76 15.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.37 110.874 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 7' ' ' SER . 1.2 m -103.08 -47.54 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.5 111.174 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.03 -15.6 50.27 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.764 . . . . 0.51 112.467 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.23 -61.06 2.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 1.83 110.793 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -102.88 -34.27 9.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 2.2 110.957 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.34 -120.55 1.9 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 0.61 112.464 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -166.44 156.45 11.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 2.29 110.846 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.619 HG21 ' HA ' ' A' ' 33' ' ' GLN . 21.5 t -145.4 137.55 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.54 111.128 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -129.43 158.37 39.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.45 110.804 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -117.25 141.0 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.488 . . . . 0.35 111.135 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -145.92 151.53 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 2.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -103.58 134.79 46.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.44 110.894 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.742 ' CD1' HG21 ' A' ' 73' ' ' THR . 37.8 mt -52.94 -36.14 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.41 111.061 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -31.41 67.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 2.54 110.816 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -104.0 20.1 18.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 3.54 110.969 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.831 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -49.32 -27.93 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 1.09 110.914 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -54.96 -34.34 63.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.05 110.853 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -84.47 -15.55 45.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 1.06 110.877 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.517 ' HB2' HD13 ' A' ' 50' ' ' LEU . 40.9 m -65.83 -11.05 43.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.95 110.838 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.97 63.0 0.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.32 111.172 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -62.95 -70.82 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.38 110.832 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.598 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -149.7 -169.02 3.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 1.88 110.909 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -102.46 136.37 42.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 1.78 110.87 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.8 p 47.21 85.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 1.37 110.84 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.1 p -140.52 -40.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.26 110.798 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.491 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.4 m-85 -99.42 119.18 37.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 2.13 110.889 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.87 -20.09 62.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 1.69 110.864 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.69 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.4 mt -146.46 143.7 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.27 111.13 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.958 HG21 HG23 ' A' ' 83' ' ' ILE . 16.0 mm -134.09 130.67 55.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.23 111.145 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -112.78 134.14 54.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.213 -0.448 . . . . 0.25 110.931 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.46 95.68 4.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.188 -0.46 . . . . 0.29 110.87 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 53.68 72.17 0.58 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 0.32 112.515 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.97 56.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.792 0.33 . . . . 0.57 110.898 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.719 HG13 HD11 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -123.42 159.9 52.95 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.613 0.72 . . . . 0.27 111.12 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.413 ' HD2' HG12 ' A' ' 68' ' ' VAL . 54.4 Cg_endo -69.72 123.18 9.86 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.669 2.246 . . . . 0.27 112.381 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.27 6.97 87.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.757 -0.735 . . . . 0.2 112.507 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.8 p -55.48 148.57 15.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.77 110.874 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.747 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 29.5 p -137.83 109.1 6.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.18 111.14 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.742 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.37 152.28 16.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.24 111.195 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.947 HD12 HD22 ' A' ' 147' ' ' LEU . 4.6 mt -131.15 103.45 6.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.21 110.959 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -79.52 152.94 29.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.28 110.874 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 m -129.23 176.28 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.57 110.823 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.27 53.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.25 111.11 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.37 -46.1 91.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 1.73 110.853 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.831 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -72.9 -54.54 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.23 111.129 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.63 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.0 mt -50.68 -38.68 48.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.19 110.997 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.83 -52.96 61.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 0.31 111.108 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 -43.18 79.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 2.84 110.922 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.958 HG23 HG21 ' A' ' 63' ' ' ILE . 43.4 mm -59.31 -68.44 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.33 111.194 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.52 -33.8 15.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.2 111.106 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -61.06 -52.51 64.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 2.18 110.94 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 56' ' ' LYS . 29.9 pt -81.43 -4.41 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.28 111.134 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -82.03 122.4 27.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.887 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -61.08 159.67 26.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.525 0.679 . . . . 3.49 110.885 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 114.24 3.64 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.598 2.199 . . . . 0.29 112.39 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.47 5.1 55.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 0.25 112.496 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.11 -159.61 13.19 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 0.25 112.428 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.4 m -140.9 155.04 46.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.332 . . . . 0.39 110.835 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.631 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -139.31 115.57 10.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.184 -0.462 . . . . 0.22 110.917 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.562 ' N ' HD22 ' A' ' 93' ' ' LEU . 49.9 m-85 -109.98 133.71 52.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.88 110.846 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -148.69 158.0 43.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.22 110.954 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.3 123.68 36.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 1.83 110.945 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.66 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -147.55 147.92 29.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.576 0.703 . . . . 2.27 110.947 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.607 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.0 Cg_endo -69.78 144.77 54.97 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.665 2.244 . . . . 0.22 112.293 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 155' ' ' LEU . 5.4 m -125.41 147.1 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.37 111.227 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -115.1 132.36 56.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 1.96 110.893 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.5 p -105.99 25.92 10.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 1.06 111.171 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.19 25.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.77 111.079 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.5 t -143.4 159.96 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.78 111.114 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.509 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -55.91 179.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.071 -0.513 . . . . 2.08 110.865 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -65.32 -66.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 2.48 110.901 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -63.32 -75.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 1.91 110.898 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.23 -168.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 1.67 110.802 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -5.72 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.046 -0.525 . . . . 2.35 110.955 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 m -146.19 145.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.165 -0.47 . . . . 0.51 111.066 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.639 ' H ' HD22 ' A' ' 74' ' ' LEU . 3.4 ttmt -67.68 116.31 8.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 2.32 110.884 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 104' ' ' ASP . 27.7 p -85.35 -179.87 7.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.36 111.077 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.94 -54.56 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.43 111.052 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -48.81 78.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.41 110.829 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -58.95 -38.24 78.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 2.14 110.871 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.66 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -63.59 -54.6 33.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.427 . . . . 0.62 110.933 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.4 m -58.7 -49.56 77.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 0.45 110.965 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -47.47 86.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.59 110.852 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.01 -54.64 42.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.49 111.058 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.63 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.2 tp -53.8 -48.14 70.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.3 110.926 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.8 m -67.63 -22.43 65.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.39 111.125 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.4 mt -86.98 -15.08 39.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.72 110.881 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.46 5.37 27.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 1.88 110.847 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.87 -5.03 34.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.664 -0.779 . . . . 0.68 112.48 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -86.5 166.71 15.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 0.33 110.912 -179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.0 m -147.02 170.43 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.29 111.103 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 52.24 44.72 29.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 2.28 110.895 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.6 t -82.77 141.38 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.34 111.133 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.93 158.84 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 1.69 110.846 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -75.87 146.01 40.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 2.23 110.925 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.684 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.0 mp -104.47 -37.36 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.23 110.975 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -155.43 176.18 12.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 1.17 110.906 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.668 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.9 OUTLIER -128.85 145.3 51.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 4.39 110.786 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -134.32 136.16 25.36 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.624 0.726 . . . . 1.44 110.889 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 164.91 32.75 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.665 2.243 . . . . 0.32 112.344 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.644 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -98.03 126.05 43.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.37 110.948 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.01 161.48 22.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.574 0.702 . . . . 1.49 111.153 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -24.64 29.74 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.711 2.274 . . . . 0.35 112.31 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -85.46 -22.03 28.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.437 . . . . 2.76 110.882 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -87.81 -53.59 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 2.51 110.945 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 136' ' ' THR . 7.5 p -49.58 -40.08 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.23 111.093 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -34.53 76.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 1.19 110.921 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.5 -47.15 67.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.24 110.853 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.697 HG23 HD13 ' A' ' 147' ' ' LEU . 10.3 p -67.59 -30.92 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.17 111.033 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -76.57 -29.58 56.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 1.69 110.936 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -89.91 -21.39 22.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 1.89 110.9 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -94.63 -32.41 13.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.29 110.923 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.947 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.6 -54.37 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.33 110.874 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.11 18.4 1.69 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.767 -0.73 . . . . 0.32 112.512 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -72.69 122.08 20.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.88 110.845 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -151.64 107.62 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 2.74 110.863 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.5 t -160.47 173.8 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.8 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.32 -19.75 13.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.64 110.865 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -96.83 17.05 17.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 1.58 110.959 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -82.78 165.38 19.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.39 110.918 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.668 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.5 tm? -173.73 130.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.25 110.876 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.747 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.8 m-85 -75.84 138.46 41.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 1.71 110.871 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -151.93 148.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.4 111.14 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.684 ' HG2' HD13 ' A' ' 130' ' ' LEU . 19.1 tt0 -100.2 130.29 46.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 1.68 110.902 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.91 150.77 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.36 111.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.466 ' N ' HD11 ' A' ' 130' ' ' LEU . 6.1 t -135.25 161.43 35.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.4 111.125 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.59 135.61 5.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.707 -0.758 . . . . 0.21 112.442 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -91.86 140.31 29.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 1.69 110.898 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 135.26 49.28 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.612 0.72 . . . . 1.29 110.853 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 127.68 14.9 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.688 2.258 . . . . 0.45 112.306 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.34 110.904 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.848 0.356 . . . . 1.83 110.893 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.22 19.97 10.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 1.53 110.854 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.26 41.51 54.46 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.722 -0.752 . . . . 0.21 112.461 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.488 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -78.0 158.61 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.25 111.089 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 36' ' ' THR . 25.8 m -148.38 157.13 43.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 1.05 110.916 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.33 128.32 34.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.29 111.095 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.36 28.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.738 -0.744 . . . . 0.26 112.487 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.99 167.41 10.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 1.46 110.873 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.21 136.68 38.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 1.29 110.843 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.548 ' CG1' HG21 ' A' ' 36' ' ' THR . 2.0 p -142.43 138.72 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.481 . . . . 2.09 111.183 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.775 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -115.59 129.5 56.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.22 111.154 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.663 HG11 HG12 ' A' ' 29' ' ' VAL . 48.6 t -101.1 123.79 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.3 111.12 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.729 HG12 HG13 ' A' ' 47' ' ' ILE . 4.6 t -105.15 116.45 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.34 111.11 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -119.33 164.63 15.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.21 110.846 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -148.73 -169.52 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 4.66 110.792 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -35.68 67.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 3.19 110.913 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.5 -11.55 60.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 1.13 110.896 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.47 95.52 11.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.673 0.749 . . . . 0.18 110.89 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 141.19 44.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.627 2.218 . . . . 0.2 112.36 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.19 -32.7 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.25 111.106 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.36 -52.5 45.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 2.48 110.922 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.4 -45.07 10.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.16 111.085 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.46 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.9 -61.12 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.17 110.902 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.81 -35.66 23.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 2.47 110.904 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.44 -48.21 45.95 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.731 . . . . 0.2 112.485 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 mt -61.63 -41.22 97.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.746 0.308 . . . . 0.46 110.846 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.663 HG12 HG11 ' A' ' 14' ' ' VAL . 16.2 m -74.91 -31.6 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.63 111.197 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.08 -62.18 1.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 1.8 110.871 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -40.16 65.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 1.78 110.888 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.892 HD23 HD21 ' A' ' 35' ' ' LEU . 76.7 mt -72.77 -25.05 61.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.195 -0.457 . . . . 0.23 110.853 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.51 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.43 -24.75 46.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.42 110.912 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.9 -29.85 17.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.32 111.088 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.892 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.63 -35.05 14.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.26 110.946 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.548 HG21 ' CG1' ' A' ' 12' ' ' VAL . 0.4 OUTLIER -102.45 -44.72 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.28 111.126 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.23 -10.98 54.56 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.661 -0.781 . . . . 0.32 112.446 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -71.38 -62.38 1.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.754 0.311 . . . . 2.21 110.961 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -91.58 -40.18 11.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 1.94 110.881 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.95 -126.49 5.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.68 -0.772 . . . . 0.27 112.488 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -155.27 152.83 29.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 2.21 110.992 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 33' ' ' GLN . 87.7 t -136.72 130.36 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.35 111.132 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 t -118.56 156.14 29.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.22 110.799 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -117.62 132.02 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.19 111.099 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -142.07 152.24 43.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 1.21 110.896 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -101.77 135.61 43.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.42 110.851 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.002 HD13 HG21 ' A' ' 73' ' ' THR . 3.0 mt -50.07 -44.09 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.47 111.15 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -72.24 -27.6 62.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 3.47 110.874 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -95.22 19.24 10.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 3.49 110.942 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.777 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.93 -29.65 3.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 1.09 110.91 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mp -51.91 -36.99 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 1.15 110.959 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -86.01 -19.45 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 1.14 110.926 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.513 ' HB2' HD13 ' A' ' 50' ' ' LEU . 69.2 m -60.21 -16.85 36.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.93 110.889 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -74.44 63.27 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.34 111.053 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.407 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 5.3 m80 -65.27 -70.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.44 110.89 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.666 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.65 -167.92 2.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 1.1 110.829 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -108.79 131.81 54.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 1.86 110.845 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 p 47.16 72.44 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 1.17 110.851 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -127.22 -33.69 2.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.23 110.842 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.2 m-85 -99.81 118.34 36.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 1.46 110.893 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.1 -19.21 62.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 1.72 110.803 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 6' ' ' ILE . 15.9 mt -145.46 144.61 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.25 111.076 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.857 HG21 HG23 ' A' ' 83' ' ' ILE . 19.3 mm -136.7 129.13 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.19 111.144 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -112.7 136.57 52.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.22 110.945 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.13 102.16 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.22 110.914 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.31 77.37 0.13 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.762 -0.732 . . . . 0.24 112.481 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.49 53.75 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.58 110.921 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.56 160.34 53.74 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.611 0.72 . . . . 0.22 111.071 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 116.35 4.51 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.671 2.248 . . . . 0.24 112.433 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.83 6.73 69.46 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.681 -0.771 . . . . 0.21 112.486 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.92 132.08 48.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 0.68 110.907 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.706 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 26.9 p -122.54 108.5 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.25 111.171 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 1.002 HG21 HD13 ' A' ' 47' ' ' ILE . 1.5 m -162.73 154.8 18.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.4 111.147 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.994 HD12 HD22 ' A' ' 147' ' ' LEU . 4.7 mt -133.17 104.58 6.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.31 110.853 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -76.18 153.72 35.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.074 -0.512 . . . . 0.38 110.886 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.1 m -131.56 177.42 7.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.41 110.836 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.7 -42.03 56.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.36 111.002 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.14 -46.07 86.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 1.91 110.954 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.777 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.2 mp -71.9 -56.68 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.3 111.104 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 119' ' ' LEU . 59.1 mt -50.84 -43.45 59.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.2 110.909 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.34 -54.24 34.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.29 111.057 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.417 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -57.63 -43.32 84.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 2.71 110.836 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.857 HG23 HG21 ' A' ' 63' ' ' ILE . 38.6 mm -54.98 -67.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.27 111.088 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.13 -39.77 56.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.23 111.106 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -52.87 -53.9 42.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 2.3 110.889 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 56' ' ' LYS . 36.3 pt -80.15 -8.5 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.21 111.129 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -78.3 127.56 32.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.39 110.916 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -67.41 160.28 72.84 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.657 0.742 . . . . 2.16 110.763 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 113.91 3.53 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.736 2.291 . . . . 0.16 112.336 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.74 56.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.747 -0.739 . . . . 0.14 112.496 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.51 -164.58 19.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.661 -0.78 . . . . 0.13 112.48 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 45.0 m -134.72 154.21 51.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.876 0.369 . . . . 0.34 110.887 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.645 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -139.61 113.99 9.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.18 110.944 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.536 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.3 m-85 -109.39 131.73 54.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 1.94 110.927 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.556 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.79 158.09 43.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.21 110.815 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.74 130.59 45.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 1.81 110.918 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.4 145.67 17.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.637 0.732 . . . . 2.23 110.886 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.615 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.0 Cg_endo -69.92 137.54 35.23 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.678 2.252 . . . . 0.3 112.282 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.491 HG13 HG23 ' A' ' 157' ' ' VAL . 12.2 m -120.33 146.41 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.21 111.091 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.467 ' OE1' HG21 ' A' ' 103' ' ' VAL . 52.1 mt-10 -111.4 132.79 54.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 1.98 110.856 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.2 p -106.39 26.09 10.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 1.11 111.169 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.85 24.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.74 111.145 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.467 HG21 ' OE1' ' A' ' 100' ' ' GLU . 3.1 t -144.22 161.0 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.8 111.137 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.574 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -54.77 177.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.91 110.895 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -67.87 -53.48 26.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 3.48 110.912 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -70.77 -75.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 2.13 110.825 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.03 -168.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 1.49 110.799 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -4.02 53.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 1.63 110.921 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.42 140.25 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.111 -0.495 . . . . 0.66 111.114 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.9 mmpp? -63.66 112.94 3.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 2.93 111.016 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.574 HG21 ' O ' ' A' ' 104' ' ' ASP . 29.3 p -80.28 176.66 9.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.26 111.13 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.98 -54.9 32.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.17 111.075 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.33 -48.85 80.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.23 110.752 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -39.11 72.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 2.3 110.9 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -65.39 -55.15 19.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.31 110.994 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.4 m -56.7 -44.92 82.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.243 -0.435 . . . . 0.24 110.963 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.83 -42.34 85.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 0.26 110.867 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.2 97.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.2 111.161 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.5 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.2 tp -65.17 -53.98 36.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.23 110.894 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 96.1 m -58.28 -36.88 73.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.31 111.173 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.6 mt -83.42 -10.39 58.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.65 110.969 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m -84.65 4.89 30.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 1.71 110.886 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.01 8.68 31.3 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.662 -0.78 . . . . 0.62 112.446 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.645 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -107.46 168.66 9.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.789 0.328 . . . . 0.31 110.892 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.4 HG23 ' HG3' ' A' ' 126' ' ' GLU . 34.2 m -150.57 169.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.25 111.144 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HG3' HG23 ' A' ' 125' ' ' VAL . 1.9 mt-10 56.2 42.64 27.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 2.02 110.927 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.81 144.33 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.46 111.136 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.82 157.13 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 1.48 110.923 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -81.48 147.3 29.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 2.1 110.902 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.764 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.2 mp -108.21 -36.01 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.27 110.927 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -164.86 176.57 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 1.34 110.981 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -126.56 166.25 17.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 8.3 110.84 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -147.96 135.71 10.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.572 0.701 . . . . 1.44 110.897 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 155.83 65.04 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.618 2.212 . . . . 0.31 112.434 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.646 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -92.34 122.83 35.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.26 -0.427 . . . . 0.31 110.973 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.442 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.46 162.0 22.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.539 0.685 . . . . 1.27 111.2 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.6 Cg_endo -69.82 -26.12 27.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.651 2.234 . . . . 0.32 112.334 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -85.33 -19.79 30.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 2.91 110.888 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.22 -54.41 4.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 2.65 110.934 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.95 -38.85 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.22 111.125 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -39.04 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 2.54 110.916 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -45.59 79.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.3 110.864 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.7 p -67.71 -31.25 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.18 111.158 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -75.74 -30.65 59.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.122 -0.49 . . . . 2.11 110.875 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -90.02 -20.48 23.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 1.76 110.876 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -94.43 -32.8 13.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.28 110.941 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.994 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.65 -54.15 1.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.32 110.92 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.8 18.4 1.57 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.36 112.473 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -73.72 122.03 21.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.778 0.323 . . . . 1.06 110.923 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -151.58 105.57 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 2.79 110.966 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.9 t -160.55 170.72 20.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.91 110.873 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.34 -18.34 14.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 1.6 110.902 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -98.5 20.25 13.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 1.55 110.83 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.646 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -88.67 164.26 15.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 0.29 111.025 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.6 tm? -173.26 130.35 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.214 -0.448 . . . . 0.31 110.936 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.706 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.5 m-85 -69.79 134.76 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 1.9 110.848 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.491 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.6 144.94 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 0.32 111.176 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.764 ' HG2' HD13 ' A' ' 130' ' ' LEU . 38.0 tt0 -103.29 130.65 50.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 2.29 110.921 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.05 152.58 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.35 111.118 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.443 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.2 t -131.98 159.19 39.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.31 111.128 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -148.3 133.61 4.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 0.18 112.514 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -94.26 131.82 39.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.925 0.393 . . . . 3.85 110.862 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 135.45 81.19 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.549 0.69 . . . . 1.25 110.898 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 128.79 16.53 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.695 2.263 . . . . 0.36 112.35 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.31 110.903 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.88 0.372 . . . . 2.46 110.901 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' A' ' 6' ' ' ILE . 5.2 m-85 -122.26 22.45 10.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 1.62 110.883 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.14 41.65 53.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.718 -0.753 . . . . 0.23 112.488 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.482 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.6 mp -81.02 160.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.904 0.383 . . . . 0.26 111.101 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.737 ' O ' HG23 ' A' ' 36' ' ' THR . 0.5 OUTLIER -156.0 167.84 29.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 1.61 110.858 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.6 128.81 36.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.29 111.098 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.07 2.92 26.52 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.754 -0.736 . . . . 0.36 112.505 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.446 ' NE2' ' HB2' ' A' ' 7' ' ' SER . 2.8 pt20 -116.63 166.95 11.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.86 0.362 . . . . 1.02 110.864 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -106.13 112.89 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 1.37 110.906 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.601 HG13 HG21 ' A' ' 36' ' ' THR . 3.1 m -115.23 141.47 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 2.31 111.165 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.797 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -116.59 112.19 20.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 0.38 111.066 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.843 HG11 HG12 ' A' ' 29' ' ' VAL . 92.2 t -86.53 121.13 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.18 111.074 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG12 ' CG1' ' A' ' 47' ' ' ILE . 18.3 t -106.53 115.76 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.17 111.067 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -115.49 168.73 9.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 0.2 110.977 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -151.42 -170.22 3.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.83 110.896 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -57.1 -35.73 69.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 3.59 110.863 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.8 m -73.34 -9.66 58.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 1.7 110.786 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.29 93.75 10.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.621 0.724 . . . . 0.13 110.848 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.7 Cg_endo -69.76 142.8 48.92 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.723 2.282 . . . . 0.21 112.333 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.05 -32.43 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.23 111.08 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -51.29 -53.24 37.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 2.43 110.903 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.73 -44.86 10.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.21 111.054 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.446 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.2 -61.22 2.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.17 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -49.83 -35.63 23.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 2.53 110.888 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.02 -47.72 44.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 0.28 112.53 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.67 -39.44 91.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.38 . . . . 0.48 110.911 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.843 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -77.14 -31.32 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.66 111.026 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.31 -59.25 5.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 1.75 110.826 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -40.43 73.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 1.66 110.885 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.871 HD23 HD21 ' A' ' 35' ' ' LEU . 87.4 mt -72.59 -25.07 61.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.28 110.953 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.496 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.02 -25.02 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 0.47 110.848 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.47 -30.84 17.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.38 111.114 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.871 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.47 -34.89 15.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.31 110.907 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.32 -47.13 4.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.29 111.132 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.1 -14.5 53.48 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.699 -0.762 . . . . 0.36 112.481 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.43 -62.68 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.756 0.313 . . . . 2.09 110.816 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.95 -33.7 8.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 1.97 110.982 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.61 -131.04 4.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.28 112.54 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -153.28 152.74 31.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.791 0.329 . . . . 3.65 110.872 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 12' ' ' VAL . 98.3 t -139.27 113.69 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.46 111.125 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -103.93 153.18 21.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.15 110.895 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.92 133.46 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.11 -0.495 . . . . 0.17 111.148 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -142.16 151.97 42.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 1.32 110.921 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -102.66 135.11 44.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.39 110.921 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.668 ' CD1' HG21 ' A' ' 73' ' ' THR . 23.9 mt -51.76 -35.15 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.29 111.181 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -29.75 60.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 2.15 110.925 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -98.21 18.59 15.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 3.36 110.926 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.816 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.31 -30.77 5.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 1.11 110.912 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -53.93 -37.91 64.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 1.06 111.062 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -84.9 -15.64 43.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 1.22 110.948 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.6 m -66.31 -10.82 46.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.98 110.9 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.68 63.43 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.473 . . . . 0.32 111.11 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -61.55 -69.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.35 110.801 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.664 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -153.16 -175.88 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 1.29 110.837 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -93.73 135.22 35.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 1.8 110.896 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p 46.64 81.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 1.18 110.819 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.9 p -132.07 -39.17 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.32 110.795 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.458 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.7 m-85 -102.16 123.89 46.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 2.06 110.89 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.28 -21.64 62.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 1.71 110.805 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.0 mt -146.6 142.7 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 0.45 111.166 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 83' ' ' ILE . 17.6 mm -129.2 136.76 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.18 111.147 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.5 mm? -116.12 135.77 53.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.37 110.966 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.72 98.02 4.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.13 110.851 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.11 79.58 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.752 . . . . 0.18 112.502 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.85 55.42 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.56 110.959 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -123.77 158.72 58.78 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.636 0.731 . . . . 0.23 111.141 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 115.91 4.31 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.635 2.223 . . . . 0.25 112.393 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.3 6.6 66.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 0.2 112.474 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.32 151.86 9.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.952 0.406 . . . . 0.83 110.841 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.708 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 21.1 p -140.11 108.77 5.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.27 111.135 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.668 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.92 148.57 12.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.26 111.08 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.042 HD12 HD22 ' A' ' 147' ' ' LEU . 10.1 mt -126.75 99.79 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.34 110.904 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -76.78 143.77 39.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.28 110.848 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.83 -175.52 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 1.08 110.746 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.54 -36.17 71.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.26 111.016 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.58 -44.31 96.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 1.78 110.804 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.816 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -76.03 -55.18 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.19 111.187 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.564 HD22 ' CD1' ' A' ' 119' ' ' LEU . 62.8 mt -50.14 -41.86 49.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.19 110.933 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.56 -55.77 17.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.29 111.12 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -43.25 77.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 2.78 110.903 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 63' ' ' ILE . 42.9 mm -56.74 -68.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.18 111.116 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.14 -35.89 38.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.21 111.018 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -57.25 -51.05 70.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 3.31 110.867 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 56' ' ' LYS . 26.3 pt -83.79 -6.37 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.19 111.072 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -79.29 112.66 16.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.254 -0.43 . . . . 0.3 110.851 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -51.77 159.53 1.31 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.651 0.738 . . . . 2.08 110.87 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 115.82 4.27 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.77 2.313 . . . . 0.23 112.307 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.5 3.06 57.53 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.23 112.43 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.87 -157.51 9.59 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.691 -0.766 . . . . 0.21 112.483 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.5 m -145.29 158.87 43.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.35 . . . . 0.6 110.911 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.628 HD22 ' N ' ' A' ' 94' ' ' PHE . 1.0 OUTLIER -141.25 116.28 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.24 110.921 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.628 ' N ' HD22 ' A' ' 93' ' ' LEU . 57.0 m-85 -108.07 132.57 53.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 1.62 110.896 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.34 158.01 43.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.16 110.902 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.84 129.08 46.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 1.75 110.871 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.78 146.56 18.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.659 0.743 . . . . 2.23 110.849 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.516 ' HG2' HD21 ' A' ' 74' ' ' LEU . 52.7 Cg_endo -69.8 142.74 48.59 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.707 2.272 . . . . 0.23 112.321 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.99 146.76 31.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.19 111.195 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.449 ' CD ' HG21 ' A' ' 103' ' ' VAL . 56.0 mt-10 -109.2 132.88 53.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 1.98 110.892 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.2 p -92.47 -41.83 10.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.12 111.185 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.54 39.18 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.67 111.124 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.449 HG21 ' CD ' ' A' ' 100' ' ' GLU . 22.6 t -147.11 149.08 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.74 111.174 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.594 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -51.76 163.1 0.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.167 -0.469 . . . . 1.98 110.767 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -59.86 -47.56 85.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 3.51 110.849 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -75.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 1.91 110.901 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p 52.26 -170.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 1.98 110.89 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -80.51 -3.7 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 1.71 110.87 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.417 HG11 ' CG ' ' A' ' 149' ' ' HIS . 2.7 m -140.57 145.03 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.407 . . . . 0.38 111.183 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.7 mmtm -65.3 114.52 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 2.1 110.87 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.594 HG21 ' O ' ' A' ' 104' ' ' ASP . 45.5 p -85.91 179.33 7.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.21 111.107 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.4 -53.42 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.19 111.14 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -49.29 78.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.24 110.873 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -58.36 -37.95 76.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.028 -0.533 . . . . 1.76 110.918 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -64.74 -54.68 27.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.32 110.94 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.2 m -58.3 -46.6 85.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.23 110.88 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -43.71 93.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.32 110.918 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.78 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.21 111.081 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.564 ' CD1' HD22 ' A' ' 80' ' ' LEU . 11.6 tp -64.45 -57.87 8.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.39 110.914 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.3 m -55.57 -36.38 66.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.33 111.134 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.9 mt -83.11 -10.71 58.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.88 110.909 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.43 6.42 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 1.75 110.852 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.51 8.04 31.24 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.778 -0.725 . . . . 0.58 112.482 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.643 HD23 ' HA3' ' A' ' 161' ' ' GLY . 1.5 tp -107.5 171.29 7.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.82 0.343 . . . . 0.54 111.005 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.61 169.56 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.28 111.091 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 51.47 43.89 29.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 2.41 110.917 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.27 143.19 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.34 111.136 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 160.06 8.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 1.67 110.883 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.47 140.83 37.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 3.15 110.893 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.705 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.6 mp -98.94 -39.2 8.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.41 110.902 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -160.18 177.09 11.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 1.41 110.811 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 -123.99 168.71 12.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 8.04 110.785 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -151.56 136.67 10.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.743 0.782 . . . . 1.38 110.826 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.91 154.76 66.79 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.711 2.274 . . . . 0.38 112.303 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.646 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -91.55 128.44 37.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.38 110.851 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -106.02 161.45 22.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.618 0.723 . . . . 1.65 111.104 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -24.33 29.59 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.68 2.253 . . . . 0.54 112.351 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -85.3 -22.49 28.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 3.87 110.877 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -87.58 -53.77 4.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.117 -0.492 . . . . 2.73 110.903 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.44 -39.25 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.34 111.061 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -36.12 77.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 2.9 110.965 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -45.76 73.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.4 110.831 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.708 HG23 HD13 ' A' ' 147' ' ' LEU . 9.2 p -68.26 -30.81 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 0.26 111.161 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -75.82 -31.94 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 2.13 110.905 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -89.88 -20.16 23.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 1.74 110.84 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -94.45 -32.92 13.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.848 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.042 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.64 -54.2 1.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.36 110.864 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.1 11.39 2.28 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.787 -0.721 . . . . 0.28 112.51 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.417 ' CG ' HG11 ' A' ' 109' ' ' VAL . 14.8 t-160 -70.34 121.81 18.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.75 0.309 . . . . 0.6 110.798 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -151.76 105.55 3.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 2.24 110.922 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.2 t -160.5 168.38 25.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.6 110.828 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.66 -13.49 15.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.66 110.817 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -100.28 19.97 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.63 110.814 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.646 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -92.8 169.55 10.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.34 110.919 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.662 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.1 tm? -173.57 130.24 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.35 110.931 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.708 ' CZ ' HG22 ' A' ' 72' ' ' THR . 20.1 m-85 -69.98 139.9 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 1.72 110.891 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.13 151.86 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.3 111.216 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.705 ' HG2' HD13 ' A' ' 130' ' ' LEU . 26.1 tt0 -107.8 129.29 55.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 1.56 110.925 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.18 151.17 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.24 111.137 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.512 HG21 HD21 ' A' ' 130' ' ' LEU . 8.9 t -140.54 151.15 44.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.44 111.083 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.643 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -143.35 144.62 13.97 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 0.21 112.496 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -97.66 137.37 36.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 1.81 110.851 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 134.76 65.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.662 0.744 . . . . 1.23 110.856 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 122.05 8.75 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.702 2.268 . . . . 0.37 112.384 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.66 110.894 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.737 0.303 . . . . 2.37 110.808 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.23 22.08 10.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.44 . . . . 1.5 110.89 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.34 40.39 60.8 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.731 -0.747 . . . . 0.25 112.479 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.512 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -79.75 159.4 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.22 111.069 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.629 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -154.52 164.56 38.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.29 110.883 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.33 129.87 35.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.31 111.073 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.18 -5.27 25.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.71 -0.757 . . . . 0.26 112.488 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -114.7 167.96 10.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 1.21 110.835 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.37 140.16 33.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 1.33 110.866 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' HB ' ' A' ' 62' ' ' ILE . 48.2 t -142.3 140.13 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 1.85 111.102 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.776 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -117.16 121.89 42.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.26 111.107 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.817 HG11 HG12 ' A' ' 29' ' ' VAL . 64.1 t -95.1 119.6 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.21 111.154 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.487 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.1 t -103.35 112.88 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.23 111.228 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -114.38 167.66 10.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.17 111.012 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.4 -169.79 3.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.354 -0.384 . . . . 1.91 110.82 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -35.52 69.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 3.44 110.861 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -10.25 59.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 1.24 110.863 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.93 94.26 10.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.668 0.747 . . . . 0.15 110.861 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 142.36 47.25 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.713 2.275 . . . . 0.21 112.381 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -49.07 -32.48 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.18 111.105 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -51.32 -53.15 38.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 2.7 110.81 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.48 -44.65 11.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.17 111.163 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.85 -61.4 2.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.13 110.923 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -49.88 -36.8 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 4.93 110.854 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -47.38 49.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.815 -0.707 . . . . 0.19 112.471 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.6 mt -61.82 -39.7 92.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.45 110.959 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.817 HG12 HG11 ' A' ' 14' ' ' VAL . 17.6 m -76.98 -31.71 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.62 111.047 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -61.96 -59.76 4.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 1.77 110.893 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -40.15 70.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 1.76 110.935 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.852 HD23 HD21 ' A' ' 35' ' ' LEU . 87.1 mt -72.76 -25.25 61.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.23 110.966 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.478 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.4 mt-30 -78.59 -25.19 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.39 110.924 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 -29.15 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.26 111.093 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.852 HD21 HD23 ' A' ' 32' ' ' LEU . 1.3 pp -91.72 -34.88 14.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.22 110.933 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -102.52 -45.11 5.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.168 -0.469 . . . . 0.24 111.149 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.87 -12.09 52.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.28 112.51 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -65.74 -62.6 1.42 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 1.86 110.858 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -97.16 -37.4 10.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 2.35 110.959 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.27 -128.91 5.04 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.27 112.499 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -154.93 153.57 31.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.947 0.403 . . . . 2.28 110.847 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 33' ' ' GLN . 86.0 t -138.56 128.44 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.28 111.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -117.42 157.65 25.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.17 110.821 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -118.51 135.72 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.17 111.137 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -145.34 151.96 39.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 1.94 110.892 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.56 135.97 43.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.905 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.747 HD13 HG21 ' A' ' 73' ' ' THR . 30.4 mt -51.25 -35.33 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.28 111.156 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -31.57 61.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 2.49 110.871 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -96.76 19.27 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 3.4 110.911 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.829 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.86 -30.81 4.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 1.06 111.005 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -53.13 -35.84 60.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 1.02 110.924 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -85.75 -18.76 32.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 1.08 110.913 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.475 ' HB2' HD13 ' A' ' 50' ' ' LEU . 65.3 m -60.47 -16.6 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.92 110.822 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.8 63.59 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.34 111.118 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -61.65 -71.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.37 110.832 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.683 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.4 -167.59 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 1.68 110.85 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -104.29 125.78 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 2.03 110.868 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.6 80.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 1.4 110.816 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.2 p -130.61 -36.47 1.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.22 110.812 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.468 ' CD2' HD12 ' A' ' 86' ' ' ILE . 95.7 m-85 -97.23 121.04 38.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 1.48 110.92 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.28 -20.88 61.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 1.7 110.85 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.646 ' HB ' HG22 ' A' ' 12' ' ' VAL . 30.5 mt -143.32 144.51 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.33 111.19 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.894 HG21 HG23 ' A' ' 83' ' ' ILE . 19.7 mm -135.17 128.86 49.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.17 111.207 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -112.46 136.35 52.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.257 -0.429 . . . . 0.17 110.907 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.33 101.74 6.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.18 110.895 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.59 75.95 0.19 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.704 -0.76 . . . . 0.18 112.557 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.23 57.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.58 110.93 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.08 159.62 63.92 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.62 0.724 . . . . 0.25 111.152 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 116.56 4.61 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.27 112.404 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.56 7.14 69.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.671 -0.776 . . . . 0.18 112.539 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.41 150.02 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.88 0.371 . . . . 0.69 110.857 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.763 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 33.7 p -138.48 108.71 6.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.18 111.167 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.747 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.86 149.98 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.26 111.122 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.897 HD12 HD22 ' A' ' 147' ' ' LEU . 2.4 mt -128.04 99.84 5.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.3 110.892 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -76.9 143.05 39.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.37 110.836 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.6 m -121.81 -175.3 3.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.52 110.829 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.82 -35.91 71.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.27 111.1 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.16 -43.54 97.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 2.12 110.851 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.829 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -76.18 -54.9 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.27 111.141 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.685 HD13 ' HA ' ' A' ' 119' ' ' LEU . 64.5 mt -51.11 -42.51 60.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.26 110.945 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.5 -56.83 11.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.35 111.082 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.426 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -54.36 -43.25 71.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.443 . . . . 3.07 110.922 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.894 HG23 HG21 ' A' ' 63' ' ' ILE . 41.4 mm -55.8 -67.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.27 111.087 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.15 -39.55 56.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.19 111.086 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -52.86 -50.83 63.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 2.45 110.861 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.683 HG22 ' O ' ' A' ' 56' ' ' LYS . 48.5 pt -85.37 -5.97 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.17 111.09 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -79.53 115.24 19.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.29 110.882 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -55.05 158.79 4.48 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.69 0.757 . . . . 3.06 110.828 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.9 Cg_endo -69.74 114.25 3.64 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.717 2.278 . . . . 0.17 112.306 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.39 55.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.787 -0.72 . . . . 0.17 112.52 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.92 -164.67 24.34 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.754 -0.736 . . . . 0.13 112.467 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.6 m -135.55 152.18 51.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.31 110.857 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.603 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -136.18 115.97 13.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.19 110.917 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.571 ' N ' HD22 ' A' ' 93' ' ' LEU . 55.3 m-85 -112.02 131.37 55.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 1.65 110.925 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.54 159.86 43.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.14 110.855 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.4 128.66 41.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 1.85 110.933 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.33 148.31 22.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.591 0.71 . . . . 2.28 110.902 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.595 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -69.82 142.86 48.77 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.67 2.247 . . . . 0.18 112.307 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.0 m -128.88 146.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.18 111.067 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.503 ' CD ' HG21 ' A' ' 103' ' ' VAL . 19.6 mt-10 -106.99 132.48 52.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 1.89 110.885 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.6 p -103.78 26.11 9.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 1.27 111.192 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.56 26.14 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.61 111.097 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.503 HG21 ' CD ' ' A' ' 100' ' ' GLU . 5.9 t -144.13 157.77 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.6 111.067 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.583 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -54.56 174.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.501 . . . . 1.9 110.887 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -65.67 -64.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 2.56 110.855 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -61.54 -75.84 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.231 -0.441 . . . . 2.18 110.888 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.401 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.7 t 51.64 -168.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 2.09 110.857 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -3.55 50.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 3.67 110.817 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -144.38 148.66 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.457 . . . . 0.44 111.113 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.521 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -69.64 112.72 6.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 2.17 110.947 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.583 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.7 p -87.31 178.6 6.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.22 111.093 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.68 -54.09 50.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.2 111.037 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.74 -49.07 79.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.28 110.909 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -57.72 -41.96 82.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 1.76 110.946 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -61.05 -54.76 40.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.3 110.881 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -57.81 -48.9 78.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.3 111.006 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -45.68 92.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.475 . . . . 0.36 110.931 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.25 -45.79 93.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.25 111.093 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.685 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.2 tp -61.87 -54.07 47.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.314 -0.403 . . . . 0.26 110.83 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.9 m -62.38 -27.53 69.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.25 111.118 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.05 -14.38 50.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.66 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.0 p -84.43 5.58 26.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 2.33 110.863 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.53 -4.7 34.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.663 -0.779 . . . . 0.6 112.5 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -87.16 168.92 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 0.35 111.04 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.9 m -151.0 171.32 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.22 111.089 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 52.39 45.02 29.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 2.22 110.853 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.4 t -79.68 143.56 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.21 111.132 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.9 160.23 8.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 2.49 110.889 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.88 147.16 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 2.4 110.862 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.783 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.5 mp -106.68 -36.0 6.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.21 110.905 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -159.7 176.29 12.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 1.1 110.89 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.707 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.0 OUTLIER -131.96 137.18 47.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 4.61 110.847 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -123.58 137.65 28.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.735 0.779 . . . . 1.4 110.815 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.411 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.8 Cg_endo -69.84 163.92 36.54 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.593 2.195 . . . . 0.22 112.308 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.671 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -96.99 127.03 42.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.28 110.805 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.44 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -100.15 160.91 25.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.584 0.707 . . . . 1.2 111.166 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.44 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.2 Cg_endo -69.72 -28.88 24.89 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.636 2.224 . . . . 0.34 112.378 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.33 -17.9 35.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 2.67 110.822 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.22 -52.83 5.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 2.33 110.892 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 p -49.27 -41.05 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.26 111.125 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -34.82 76.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 1.22 110.986 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -46.19 71.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.167 -0.47 . . . . 0.24 110.89 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.713 HG23 HD13 ' A' ' 147' ' ' LEU . 8.8 p -68.23 -30.15 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.18 111.055 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -75.29 -33.34 61.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 1.8 110.878 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -89.09 -19.93 24.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 1.86 110.838 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -94.1 -32.82 13.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.34 110.881 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.897 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -128.44 -54.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.41 110.936 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.59 7.05 2.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.701 -0.761 . . . . 0.36 112.465 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -70.21 120.44 15.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.78 0.324 . . . . 0.76 110.866 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -152.78 105.03 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 3.3 110.851 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.3 t -161.03 175.98 11.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.61 110.793 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.58 -14.43 14.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 1.55 110.872 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -96.44 6.86 47.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 1.41 110.867 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.671 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -77.98 165.59 23.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.29 110.919 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.707 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.51 130.14 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.21 110.898 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.763 ' CZ ' HG22 ' A' ' 72' ' ' THR . 29.8 m-85 -74.23 133.11 42.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.68 110.84 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.71 144.47 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.18 111.139 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.783 ' HG2' HD13 ' A' ' 130' ' ' LEU . 34.9 tt0 -98.75 130.69 45.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 2.23 110.89 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.83 150.46 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.21 111.084 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.486 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -130.22 160.16 34.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.32 111.089 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.56 132.12 3.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.13 112.474 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -94.15 142.79 27.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 1.71 110.963 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.408 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 2.0 tptt -84.23 135.33 41.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.583 0.706 . . . . 2.27 110.859 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 118.73 5.85 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.703 2.269 . . . . 0.38 112.281 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.47 110.853 -179.975 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.798 0.332 . . . . 2.07 110.798 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 6' ' ' ILE . 7.0 m-85 -122.28 13.72 10.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 1.55 110.82 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.76 40.67 96.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.659 -0.781 . . . . 0.32 112.482 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.485 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.6 mp -80.99 159.96 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.35 111.179 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.727 ' O ' HG23 ' A' ' 36' ' ' THR . 0.4 OUTLIER -155.89 168.48 27.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 1.73 110.934 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.75 130.39 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.37 111.042 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.35 2.63 29.45 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.764 -0.732 . . . . 0.31 112.53 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.443 ' NE2' ' HB2' ' A' ' 7' ' ' SER . 3.3 pt20 -116.73 166.7 11.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 1.06 110.896 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -105.39 114.94 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 2.15 110.794 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.608 HG13 HG21 ' A' ' 36' ' ' THR . 3.4 m -117.85 139.27 45.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.473 . . . . 2.33 111.151 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.763 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -114.01 115.69 28.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.31 111.077 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.808 HG11 HG12 ' A' ' 29' ' ' VAL . 64.8 t -88.95 120.5 37.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.19 111.175 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.628 HG12 HG13 ' A' ' 47' ' ' ILE . 18.5 t -106.17 113.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.48 . . . . 0.18 111.173 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -112.67 167.39 10.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.24 110.871 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.576 ' HB3' HD12 ' A' ' 47' ' ' ILE . 7.2 p-10 -148.34 -169.25 3.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 1.72 110.974 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -58.67 -35.58 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 3.04 110.935 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -7.82 53.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 1.17 110.809 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.58 92.71 8.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.636 0.732 . . . . 0.18 110.907 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 143.27 50.56 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.707 2.271 . . . . 0.29 112.314 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.5 t -48.35 -33.06 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.25 111.145 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.33 -52.92 41.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 2.64 110.846 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.45 -45.3 10.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.25 111.219 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.452 HD22 HG13 ' A' ' 29' ' ' VAL . 1.9 tm? -51.2 -61.68 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.21 111.039 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.59 -35.83 22.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 2.69 110.928 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.16 -47.49 44.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.737 . . . . 0.25 112.573 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.422 HD11 HG13 ' A' ' 68' ' ' VAL . 46.5 mt -61.59 -38.84 89.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.63 110.973 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.808 HG12 HG11 ' A' ' 14' ' ' VAL . 17.3 m -77.66 -31.43 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.65 111.13 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.25 -58.24 8.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 1.59 110.835 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -40.43 76.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 2.59 110.818 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.902 HD23 HD21 ' A' ' 35' ' ' LEU . 87.6 mt -72.73 -24.78 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 0.25 110.948 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.496 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -77.92 -24.87 48.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.436 . . . . 0.41 110.839 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.8 -31.47 16.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.22 111.08 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.902 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -89.74 -35.21 15.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.22 110.931 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.64 -46.9 4.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.21 111.194 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.24 -13.37 53.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.668 -0.777 . . . . 0.26 112.53 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -62.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 2.8 110.897 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -99.85 -35.82 9.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 2.12 110.834 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.32 -129.64 4.53 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.24 112.471 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -153.67 152.28 30.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.854 0.359 . . . . 2.19 110.853 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 12' ' ' VAL . 92.2 t -137.8 117.19 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 0.29 111.069 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.2 t -106.93 153.75 22.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 0.18 110.875 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.53 134.36 58.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.19 111.073 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -144.46 152.52 40.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 1.25 110.921 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -102.49 137.41 40.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.48 110.824 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.945 HD13 HG21 ' A' ' 73' ' ' THR . 9.8 mt -51.38 -44.49 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.39 111.105 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -24.54 61.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 3.6 110.883 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -99.3 18.76 16.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 3.45 110.961 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.803 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.36 -29.31 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 1.11 110.9 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.82 -36.5 48.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 1.13 110.929 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.1 mm-40 -85.77 -20.4 29.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 1.25 110.897 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB2' HD13 ' A' ' 50' ' ' LEU . 66.5 m -59.53 -17.73 34.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.88 110.836 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.76 63.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.29 111.07 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -63.82 -71.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.36 110.79 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.693 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.73 -167.65 2.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 1.62 110.921 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -104.76 125.99 51.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 1.88 110.87 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.27 79.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 1.32 110.887 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.6 p -129.61 -35.42 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.26 110.89 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.454 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.7 m-85 -98.15 121.5 40.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 1.43 110.926 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.29 -21.5 62.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 1.69 110.888 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.1 mt -146.49 143.45 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.38 111.085 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.792 HG21 HD12 ' A' ' 83' ' ' ILE . 22.1 mm -131.22 132.44 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.25 111.045 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -112.15 134.96 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.21 110.959 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.34 101.18 5.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.17 110.846 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.68 78.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.711 -0.756 . . . . 0.2 112.505 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.474 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.5 mm? -110.95 53.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.57 110.91 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -122.78 160.34 49.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.683 0.754 . . . . 0.25 111.028 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.4 ' HD2' HG12 ' A' ' 68' ' ' VAL . 53.2 Cg_endo -69.81 123.34 9.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.765 2.31 . . . . 0.27 112.27 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.78 7.2 88.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.777 -0.725 . . . . 0.2 112.445 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.433 ' HB3' HG23 ' A' ' 68' ' ' VAL . 9.5 p -55.56 151.67 10.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.78 110.819 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.688 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 13.1 p -141.36 111.92 7.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.25 111.136 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.945 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.55 152.35 14.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.23 111.112 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.017 HD12 HD22 ' A' ' 147' ' ' LEU . 5.1 mt -129.68 100.1 5.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.22 110.907 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -75.67 144.79 41.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.25 110.76 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.9 m -122.67 178.96 4.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.38 110.856 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.6 -42.77 62.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.29 111.115 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.96 -46.78 81.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 2.04 110.954 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.803 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.1 mp -71.55 -56.81 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.28 111.157 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.2 mt -50.2 -43.01 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.18 110.874 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.78 -56.68 12.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.29 111.083 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.433 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -54.85 -43.43 73.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 2.91 110.849 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.792 HD12 HG21 ' A' ' 63' ' ' ILE . 40.3 mm -55.35 -67.72 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.28 111.14 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -51.49 -39.54 57.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.22 111.069 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.9 tpp85 -52.82 -50.15 64.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 2.78 110.856 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 56' ' ' LYS . 46.8 pt -86.13 -5.8 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.24 111.119 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -80.15 113.98 18.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.33 110.866 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -52.95 159.03 2.0 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.599 0.714 . . . . 2.24 110.899 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 54.7 Cg_endo -69.77 114.1 3.59 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.698 2.265 . . . . 0.17 112.401 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.29 2.9 55.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.81 -0.71 . . . . 0.18 112.521 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.53 -163.66 16.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.657 -0.783 . . . . 0.16 112.483 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.3 m -137.55 154.52 49.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.35 110.856 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.6 HD22 ' N ' ' A' ' 94' ' ' PHE . 1.2 tm? -137.49 116.31 12.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.15 110.943 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.6 ' N ' HD22 ' A' ' 93' ' ' LEU . 61.1 m-85 -109.74 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 1.62 110.868 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.573 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.73 163.15 38.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.15 110.926 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.03 129.71 34.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 1.82 110.913 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -152.26 149.5 23.2 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.673 0.749 . . . . 2.49 110.875 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.618 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.4 Cg_endo -69.74 143.22 50.27 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.246 . . . . 0.19 112.39 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.0 m -129.74 146.36 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.24 111.111 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.421 ' CD ' HG21 ' A' ' 103' ' ' VAL . 46.6 mt-10 -107.92 132.79 53.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 2.04 110.824 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.7 p -91.63 -42.72 10.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 1.14 111.154 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.666 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.56 40.28 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.73 111.093 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.421 HG21 ' CD ' ' A' ' 100' ' ' GLU . 21.4 t -147.96 151.85 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.71 111.146 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.65 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -53.55 173.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 1.89 110.874 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -66.95 -53.96 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 2.73 110.914 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -72.94 -76.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 2.65 110.871 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t 54.01 -167.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 2.31 110.933 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -6.16 57.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 2.31 110.884 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.1 m -141.48 146.42 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.54 111.16 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 123.26 19.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 2.46 110.902 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.65 HG21 ' O ' ' A' ' 104' ' ' ASP . 70.0 p -96.1 -179.54 4.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.22 111.166 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.78 -53.89 49.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.24 111.099 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.13 -48.41 81.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.42 110.889 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.28 -49.61 76.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 2.96 110.9 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.539 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -52.45 -55.52 21.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.81 110.96 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 74.8 m -51.2 -49.1 61.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.45 110.909 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -43.85 92.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.52 110.815 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.44 -48.79 80.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.488 . . . . 0.35 111.057 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.703 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.1 tp -57.78 -52.4 65.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.35 110.917 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.2 m -63.13 -29.46 70.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.57 111.154 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.0 mt -79.5 -17.17 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 1.09 110.932 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.3 p -82.64 3.57 28.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 2.36 110.953 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.48 -4.85 35.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.6 112.472 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -85.5 168.4 14.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.45 110.88 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.16 171.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.31 111.084 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 54.29 43.64 30.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.16 -0.473 . . . . 2.19 110.907 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.8 t -75.36 142.87 13.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.34 111.176 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.09 159.18 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 1.76 110.922 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -81.87 146.69 29.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 2.25 110.854 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.547 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.0 mp -106.44 -35.83 6.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 0.19 110.948 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.55 176.22 12.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 1.15 110.886 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.724 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.8 tmt_? -133.79 138.11 45.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 4.29 110.809 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -125.07 137.87 30.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.633 0.73 . . . . 1.43 110.868 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.41 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.6 Cg_endo -69.78 163.93 36.47 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.69 2.26 . . . . 0.27 112.346 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.693 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -98.7 125.53 44.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.34 110.999 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.491 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.1 161.58 22.48 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.603 0.716 . . . . 1.39 111.129 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.481 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.8 Cg_endo -69.78 -23.77 30.35 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.75 2.3 . . . . 0.37 112.344 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -85.08 -24.21 28.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 2.34 110.826 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -88.46 -51.03 5.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 2.62 110.948 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.32 -39.33 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.26 111.157 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -34.68 76.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 2.74 110.857 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -46.2 71.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.27 110.869 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.706 HG23 HD13 ' A' ' 147' ' ' LEU . 8.6 p -67.91 -30.47 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.19 111.169 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -75.51 -32.74 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 2.3 110.958 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -89.47 -20.0 24.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 1.74 110.882 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -94.17 -33.13 13.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.35 110.846 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.017 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.77 -54.15 1.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.33 110.863 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.2 6.71 2.69 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.717 -0.754 . . . . 0.35 112.451 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.543 ' CE1' HG21 ' A' ' 109' ' ' VAL . 6.8 t-160 -70.1 119.99 15.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.83 110.827 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -153.45 104.8 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 2.29 110.961 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -161.29 174.38 13.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.74 110.897 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.88 -8.17 17.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 1.88 110.848 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.666 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 m-80 -101.92 8.04 41.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 1.76 110.872 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.693 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -82.16 165.28 20.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.33 110.997 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.724 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -171.33 130.59 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.28 110.921 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.688 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.4 m-85 -75.24 131.38 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 1.72 110.916 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.13 144.84 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.22 111.173 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.547 ' HG2' HD13 ' A' ' 130' ' ' LEU . 4.3 tt0 -100.09 128.38 46.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 1.84 110.924 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.14 150.98 28.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.26 111.11 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.448 ' N ' HD11 ' A' ' 130' ' ' LEU . 1.9 t -129.29 158.74 38.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.39 111.127 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.51 130.74 3.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 0.19 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -94.27 140.86 29.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 1.6 110.97 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 6.3 tptm -82.25 134.41 48.92 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.568 0.699 . . . . 1.41 110.884 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 118.79 5.89 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 0.41 112.354 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.35 110.871 -179.961 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.83 0.348 . . . . 2.07 110.826 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -122.29 20.6 10.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 1.52 110.891 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.08 39.49 49.69 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.718 -0.753 . . . . 0.22 112.39 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.418 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.8 mp -74.92 157.68 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.25 111.136 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.619 ' O ' HG23 ' A' ' 36' ' ' THR . 37.9 m -146.21 157.53 43.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 1.07 110.836 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.2 129.22 35.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.29 111.159 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.09 -9.02 31.42 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.742 . . . . 0.54 112.495 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -103.41 168.0 9.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.869 0.366 . . . . 1.52 110.832 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.79 112.05 24.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 1.3 110.907 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.721 HG12 HG21 ' A' ' 36' ' ' THR . 2.6 p -119.36 133.67 65.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 1.99 111.08 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -107.89 133.44 52.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.34 111.08 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.764 HG11 HG12 ' A' ' 29' ' ' VAL . 99.9 t -104.43 120.51 54.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.17 111.087 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 47' ' ' ILE . 12.1 t -103.88 115.41 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.18 111.16 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -114.68 168.0 10.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.913 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.595 ' HB3' HD12 ' A' ' 47' ' ' ILE . 5.2 p-10 -150.95 -169.45 3.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 1.94 110.92 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -57.8 -35.56 70.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 3.35 110.9 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.69 -9.29 58.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 1.35 110.82 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.95 92.16 8.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.606 0.717 . . . . 0.17 110.902 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 143.98 52.59 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.703 2.269 . . . . 0.23 112.227 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.3 t -48.39 -32.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.19 111.161 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.23 -53.0 39.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 3.27 110.924 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.8 -45.02 10.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.19 111.067 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.475 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.5 -61.89 1.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.16 110.881 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -49.69 -37.86 30.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 4.88 110.894 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.39 -48.15 53.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.765 -0.731 . . . . 0.21 112.427 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.15 -41.04 96.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.49 110.991 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.764 HG12 HG11 ' A' ' 14' ' ' VAL . 18.1 m -75.84 -31.13 21.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.63 111.166 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -61.75 -61.38 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 1.6 110.92 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -40.78 68.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 1.77 110.854 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.833 HD23 HD21 ' A' ' 35' ' ' LEU . 83.7 mt -72.01 -25.31 61.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.465 . . . . 0.3 110.9 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.538 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.17 -24.62 47.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.39 110.922 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.62 -30.11 17.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.27 111.114 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.833 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.54 -35.05 14.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.24 110.872 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.721 HG21 HG12 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -102.87 -45.4 4.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.27 111.058 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.74 -12.13 52.13 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.791 -0.719 . . . . 0.3 112.447 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -67.96 -62.72 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.33 . . . . 2.55 110.879 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -95.09 -38.9 10.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 2.79 110.896 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.58 -130.6 5.68 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.717 -0.754 . . . . 0.25 112.473 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -152.59 151.28 30.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.841 0.353 . . . . 2.21 110.853 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' A' ' 33' ' ' GLN . 84.0 t -134.54 121.42 35.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.22 111.123 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 t -110.66 152.94 25.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.23 110.881 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -115.65 136.67 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.2 111.17 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -146.47 152.69 39.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.38 110.911 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -102.35 138.61 39.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.5 110.878 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.978 HD13 HG21 ' A' ' 73' ' ' THR . 14.0 mt -53.87 -43.26 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.179 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.58 -21.69 61.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 3.61 110.914 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -100.73 16.39 25.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 3.42 110.903 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.785 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.59 -29.79 4.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 1.14 110.905 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.89 -41.07 61.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 1.12 110.884 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -84.98 -15.96 42.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 1.08 110.908 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.459 ' HB2' HD13 ' A' ' 50' ' ' LEU . 51.0 m -66.67 -11.46 54.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.911 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.14 61.0 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.48 111.092 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -58.52 -71.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.57 110.839 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -150.79 -168.51 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 1.91 110.813 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.58 136.05 43.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 1.99 110.903 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.2 p 47.45 86.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 1.21 110.885 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 p -142.3 -39.02 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.47 110.91 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.471 ' O ' HD23 ' A' ' 87' ' ' LEU . 97.9 m-85 -99.66 120.08 39.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.051 -0.522 . . . . 1.47 110.85 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.44 -21.76 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 1.72 110.93 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mt -144.53 144.11 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.28 111.157 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 83' ' ' ILE . 18.9 mm -136.54 130.15 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.15 111.195 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.7 mm? -113.57 137.54 51.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.21 110.956 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.58 100.81 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.14 110.902 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.7 77.97 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.18 112.493 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.77 56.71 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.57 110.853 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.65 159.91 55.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.661 0.743 . . . . 0.21 111.09 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 116.82 4.74 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.672 2.248 . . . . 0.24 112.369 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.96 7.21 70.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.2 112.431 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -54.93 150.56 9.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.69 110.821 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.718 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 19.3 p -140.68 109.45 6.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.22 111.195 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.978 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.09 151.29 15.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.24 111.161 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.037 HD12 HD22 ' A' ' 147' ' ' LEU . 5.2 mt -127.01 99.82 5.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.33 110.905 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -76.9 130.21 37.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.52 110.876 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.489 ' H ' HD13 ' A' ' 79' ' ' ILE . 29.7 m -107.11 177.0 4.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.47 110.924 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.19 -40.07 57.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.142 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.63 -43.41 89.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 1.73 110.879 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.785 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.1 mp -76.04 -56.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.26 111.16 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 mt -49.59 -47.29 49.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.917 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.75 -52.76 37.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.53 111.068 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -43.9 80.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 2.84 110.893 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 63' ' ' ILE . 38.6 mm -55.86 -67.15 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.29 111.102 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.22 -36.65 42.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.29 111.09 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 tpp85 -56.33 -54.98 39.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 2.4 110.926 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 56' ' ' LYS . 24.2 pt -78.44 -8.42 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.33 111.093 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -77.54 124.7 28.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 0.28 110.942 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -64.25 160.67 47.63 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.578 0.704 . . . . 2.15 110.857 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 114.02 3.56 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.656 2.237 . . . . 0.23 112.408 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.43 3.38 56.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.688 -0.768 . . . . 0.2 112.426 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.01 -161.6 13.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.758 . . . . 0.18 112.479 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.7 m -139.59 154.16 47.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.83 0.347 . . . . 0.27 110.883 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 119' ' ' LEU . 1.3 tm? -138.87 113.5 9.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.16 110.945 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.536 ' N ' HD22 ' A' ' 93' ' ' LEU . 46.2 m-85 -108.45 133.44 52.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 1.64 110.85 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.526 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.98 164.15 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.18 110.901 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -135.25 126.99 29.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 1.87 110.998 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.616 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -148.97 148.4 27.12 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.675 0.75 . . . . 2.35 110.863 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.507 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.4 Cg_endo -69.85 139.89 40.99 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.605 2.203 . . . . 0.21 112.355 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 155' ' ' LEU . 5.4 m -120.96 147.4 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.26 111.143 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' OE1' HG21 ' A' ' 103' ' ' VAL . 38.2 mt-10 -116.1 132.63 56.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 1.97 110.904 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.4 p -106.45 26.04 10.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 1.08 111.077 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.17 25.93 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.96 111.046 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.6 t -143.75 159.92 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.97 111.084 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.485 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -56.02 179.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 2.09 110.772 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -64.61 -68.84 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 2.09 110.897 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -62.47 -75.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 2.01 110.87 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.37 -167.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 1.58 110.811 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -6.83 58.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 2.07 110.954 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.29 140.24 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.67 111.114 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.667 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -64.23 115.49 5.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 2.11 110.869 179.973 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.485 HG21 ' O ' ' A' ' 104' ' ' ASP . 28.4 p -83.3 177.77 8.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.27 111.126 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.52 -55.05 28.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.32 111.137 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.8 -51.73 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.3 110.805 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 -38.13 67.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 2.5 110.886 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.616 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.1 tm? -64.74 -54.61 28.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.6 110.874 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 36.4 m -60.07 -46.41 89.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.463 . . . . 0.3 110.922 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -43.98 96.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.33 110.801 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.73 -53.33 59.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.37 111.105 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 93' ' ' LEU . 16.5 tp -57.66 -53.16 61.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.53 110.876 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.8 m -61.57 -26.25 67.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.44 111.177 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.8 mt -87.01 -13.6 44.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 0.67 110.939 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.0 p -82.0 3.5 26.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 2.57 110.877 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.06 -4.35 33.77 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.802 -0.713 . . . . 0.85 112.564 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.662 HD23 ' HA3' ' A' ' 161' ' ' GLY . 1.6 tp -87.9 171.2 10.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.67 110.797 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.44 169.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.38 111.105 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 54.6 44.2 29.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 2.28 110.886 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 86.1 t -81.85 142.68 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 0.33 111.105 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 160.62 8.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 1.63 110.959 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -78.91 142.91 36.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 3.12 110.913 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.725 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.2 mp -100.2 -39.08 8.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.19 110.907 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -154.35 176.34 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 1.12 110.932 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.703 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.0 tmt_? -130.19 138.18 50.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 4.16 110.919 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -125.06 135.8 27.28 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.605 0.717 . . . . 1.89 110.946 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.42 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.7 Cg_endo -69.72 162.52 41.75 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.764 2.309 . . . . 0.3 112.405 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.668 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -97.93 118.54 34.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.53 110.92 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.49 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.0 OUTLIER -96.71 161.07 27.83 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.595 0.712 . . . . 1.47 111.077 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.49 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.9 Cg_endo -69.67 -25.53 28.91 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.6 2.2 . . . . 0.62 112.344 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -85.46 -20.75 29.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 4.23 110.821 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -88.25 -53.29 4.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 2.38 110.85 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 136' ' ' THR . 7.0 p -49.64 -39.46 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.37 111.111 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.01 75.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 1.29 110.874 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.67 -46.69 68.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.4 110.817 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.8 p -68.29 -30.24 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.157 -0.474 . . . . 0.29 111.21 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -76.13 -31.5 58.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.481 . . . . 1.81 110.886 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -89.73 -20.41 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.432 . . . . 2.02 110.905 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -94.54 -32.91 13.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.47 110.805 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.037 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.26 -54.28 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.44 110.896 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.1 17.21 1.66 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.696 -0.764 . . . . 0.36 112.496 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -72.37 122.36 21.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 1.01 110.869 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.38 107.95 3.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 2.87 110.95 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.9 t -160.55 172.23 17.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.84 110.872 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.01 -18.06 14.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 1.69 110.818 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -100.01 18.73 17.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 1.57 110.844 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -83.21 165.35 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.36 110.977 179.952 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.703 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.4 tm? -173.94 130.3 0.4 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.26 110.917 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.718 ' CZ ' HG22 ' A' ' 72' ' ' THR . 23.1 m-85 -75.87 138.63 41.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 1.84 110.924 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -151.88 148.41 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.25 111.079 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.725 ' HG2' HD13 ' A' ' 130' ' ' LEU . 9.9 tt0 -102.36 132.55 48.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 2.16 110.866 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.59 148.85 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.22 111.129 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.512 ' N ' HD11 ' A' ' 130' ' ' LEU . 9.6 t -134.49 157.3 46.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.38 111.109 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.662 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -146.53 141.77 9.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.759 -0.734 . . . . 0.37 112.483 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -98.54 131.97 44.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 3.66 110.91 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.53 135.58 78.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.541 0.686 . . . . 1.79 110.882 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 129.32 17.4 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.667 2.245 . . . . 0.41 112.394 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.39 110.906 -179.99 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.872 0.368 . . . . 1.95 110.85 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.37 22.41 10.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 2.04 110.909 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.28 40.95 53.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 0.26 112.531 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.482 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -80.01 159.91 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.793 0.33 . . . . 0.3 111.118 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -154.44 165.37 36.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 1.17 110.873 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.58 123.71 33.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.32 111.09 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.44 2.87 21.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.646 -0.788 . . . . 0.33 112.467 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.401 HE22 HD12 ' A' ' 62' ' ' ILE . 2.8 pt20 -115.15 168.7 9.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.36 . . . . 1.05 110.898 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -106.93 112.87 26.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 1.37 110.857 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG13 HG21 ' A' ' 36' ' ' THR . 3.0 m -116.05 140.2 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 2.3 111.135 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.803 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -115.92 113.02 22.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.3 111.059 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.785 HG11 HG12 ' A' ' 29' ' ' VAL . 62.4 t -86.97 120.28 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.21 111.082 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.418 HG12 ' CG1' ' A' ' 47' ' ' ILE . 21.7 t -105.29 116.64 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.19 111.09 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -116.2 169.22 9.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.152 -0.476 . . . . 0.2 110.934 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.402 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 9.7 p-10 -151.4 -169.74 3.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 1.78 110.832 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.86 -35.59 71.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 3.13 110.876 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.6 m -73.5 -9.18 58.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 1.58 110.896 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.08 94.47 10.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.655 0.74 . . . . 0.16 110.847 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 142.03 46.69 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.664 2.242 . . . . 0.21 112.345 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.2 t -48.69 -32.94 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.2 111.141 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.34 -52.62 43.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 3.17 110.878 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -45.03 10.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.17 111.097 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.457 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.8 -61.61 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.18 110.846 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -35.42 24.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 2.61 110.784 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.25 -47.54 43.71 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.722 -0.752 . . . . 0.23 112.487 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.05 -39.19 91.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.55 110.968 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.785 HG12 HG11 ' A' ' 14' ' ' VAL . 16.8 m -77.07 -31.46 18.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.65 111.116 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.5 -58.83 6.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 1.66 110.874 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -40.4 74.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 3.01 110.883 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.853 HD23 HD21 ' A' ' 35' ' ' LEU . 89.5 mt -72.65 -25.19 61.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.228 -0.442 . . . . 0.32 110.929 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.468 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -77.89 -24.74 48.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.904 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.66 -31.09 16.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.28 111.083 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.853 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -90.08 -35.14 15.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.26 110.964 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.25 -47.2 4.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.486 . . . . 0.29 111.218 179.893 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.83 -14.68 52.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.749 . . . . 0.29 112.53 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.11 -62.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 1.98 110.869 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -103.86 -33.86 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 2.22 110.854 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.42 -133.34 4.9 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.672 -0.775 . . . . 0.29 112.526 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -150.8 151.53 32.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 2.19 110.869 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 12' ' ' VAL . 99.0 t -139.11 113.35 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.43 111.172 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 t -103.91 154.56 19.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.16 110.811 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.73 130.03 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.21 111.134 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -137.73 150.92 47.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 1.45 110.92 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -103.64 135.32 45.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.45 110.888 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.648 ' CD1' HG21 ' A' ' 73' ' ' THR . 32.0 mt -54.22 -34.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.31 111.185 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -73.27 -30.77 63.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 2.07 110.862 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -102.28 19.4 18.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 3.75 110.924 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.823 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.59 -27.37 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 1.08 110.929 -179.977 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -52.73 -38.65 61.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 1.06 110.907 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -84.48 -14.35 49.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 1.09 110.896 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.652 ' HB3' HD13 ' A' ' 50' ' ' LEU . 24.4 t -63.96 -11.51 29.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 2.05 110.838 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 53.97 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.39 111.153 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -52.1 -71.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.41 110.81 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.676 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -147.83 -168.6 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 1.94 110.878 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -103.73 129.75 51.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 1.68 110.957 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t 51.55 88.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 1.96 110.803 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.4 p -140.59 -39.54 0.42 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.057 -0.519 . . . . 0.26 110.818 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.472 ' O ' HD23 ' A' ' 87' ' ' LEU . 92.6 m-85 -99.9 123.61 44.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 1.47 110.868 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.23 -22.04 62.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 1.52 110.958 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.401 HD12 HE22 ' A' ' 10' ' ' GLN . 14.4 mt -146.14 143.25 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.45 111.164 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.976 HG21 HG23 ' A' ' 83' ' ' ILE . 16.7 mm -130.21 133.68 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.15 111.093 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.7 mm? -112.48 135.64 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.3 110.938 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.32 98.97 5.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.18 110.921 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.7 80.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.695 -0.764 . . . . 0.22 112.591 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.4 mm? -111.94 55.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.58 110.985 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.11 159.52 56.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.696 0.76 . . . . 0.22 111.173 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 116.56 4.6 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.644 2.23 . . . . 0.24 112.437 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.32 7.29 69.88 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.722 -0.751 . . . . 0.16 112.461 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.8 148.41 16.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.384 . . . . 0.67 110.797 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.761 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 32.9 p -136.84 108.66 7.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.494 . . . . 0.19 111.089 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.648 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.95 152.54 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.24 111.174 179.983 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.868 HD12 HD22 ' A' ' 147' ' ' LEU . 3.4 mt -132.05 103.68 6.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.28 110.915 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -80.03 146.85 31.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.27 110.817 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.3 m -124.56 -176.2 3.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.38 110.867 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.71 70.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.22 111.129 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.72 -45.14 94.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 1.83 110.974 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.823 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -74.28 -55.37 12.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.19 111.091 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 119' ' ' LEU . 61.4 mt -49.68 -43.77 47.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.2 110.911 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.41 -50.82 58.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.29 111.136 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -44.53 90.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 3.08 110.86 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 63' ' ' ILE . 41.9 mm -58.08 -68.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.21 111.127 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.37 -37.3 24.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.2 111.135 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -56.9 -52.84 63.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 2.26 110.813 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 56' ' ' LYS . 23.9 pt -81.69 -4.91 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.2 111.135 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -81.34 115.76 20.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.27 110.904 179.91 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -53.42 158.77 2.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.63 0.729 . . . . 3.03 110.846 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.8 Cg_endo -69.72 113.59 3.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.624 2.216 . . . . 0.23 112.426 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.71 3.0 55.27 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.731 -0.747 . . . . 0.26 112.42 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.24 -162.1 15.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.22 112.485 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 98.9 m -138.4 157.17 46.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.38 110.831 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.669 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.2 tm? -139.86 115.94 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.15 110.88 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.599 ' N ' HD22 ' A' ' 93' ' ' LEU . 67.5 m-85 -109.18 131.86 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 1.88 110.847 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.572 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.28 164.34 34.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.18 110.91 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.76 129.3 32.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 1.87 110.907 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.663 ' OE1' HD23 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -152.52 149.61 23.02 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.674 0.749 . . . . 2.53 110.864 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.629 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.2 Cg_endo -69.81 144.19 52.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.667 2.245 . . . . 0.21 112.308 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.82 146.61 33.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.25 111.167 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' CD ' HG21 ' A' ' 103' ' ' VAL . 42.8 mt-10 -106.79 132.91 52.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 2.09 110.94 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p -93.27 -42.5 9.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 1.1 111.161 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.677 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.36 39.89 1.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.8 111.162 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' CD ' ' A' ' 100' ' ' GLU . 20.1 t -147.29 150.97 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.76 111.147 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.616 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -54.05 164.32 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 2.27 110.866 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -59.99 -48.32 82.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 2.49 110.941 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.12 -75.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 1.99 110.846 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p 53.02 -171.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 1.82 110.862 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -4.42 53.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 2.29 110.961 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.505 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.5 m -140.81 151.26 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.286 -0.415 . . . . 0.52 111.228 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -68.26 111.66 4.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 2.41 110.9 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.616 HG21 ' O ' ' A' ' 104' ' ' ASP . 46.9 p -83.14 179.65 7.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.28 111.198 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.65 -53.59 55.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.19 111.102 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.88 -47.95 84.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.24 110.843 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -39.11 80.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 2.72 110.91 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -64.7 -55.25 21.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.449 . . . . 0.39 110.904 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 60.6 m -55.93 -44.83 78.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 0.21 110.842 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.4 -40.78 96.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.27 110.852 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.82 92.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.22 111.125 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.599 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.1 tp -64.82 -50.77 65.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.26 110.978 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.3 m -63.63 -35.22 79.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.29 111.145 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -83.48 -10.28 58.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.54 110.884 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 m -84.87 5.78 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 1.73 110.881 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.22 3.98 35.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 0.5 112.507 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -104.81 172.42 6.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.932 0.396 . . . . 0.3 110.865 -179.869 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 m -151.58 174.08 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.33 111.23 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 51.22 45.09 28.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 2.02 110.938 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.42 HG13 HD23 ' A' ' 119' ' ' LEU . 89.4 t -79.7 143.81 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.22 111.107 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.49 8.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 2.47 110.92 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -81.15 145.77 30.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 2.27 110.969 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.62 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.8 mp -105.23 -35.65 7.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.18 110.949 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -159.57 176.33 12.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.172 -0.467 . . . . 1.13 111.02 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.731 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.0 tmt_? -132.4 138.16 47.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 4.29 110.785 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -125.18 137.97 30.76 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.625 0.726 . . . . 1.86 110.967 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.422 ' HA ' HD21 ' A' ' 155' ' ' LEU . 55.2 Cg_endo -69.6 164.05 35.86 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.76 2.307 . . . . 0.26 112.403 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.678 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -97.61 128.58 44.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.31 110.913 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.48 160.95 25.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.608 0.718 . . . . 1.21 111.108 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.86 -28.81 24.31 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.649 2.233 . . . . 0.33 112.333 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -85.35 -17.78 35.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 3.74 110.844 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 -52.9 5.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 2.27 110.936 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.8 p -49.19 -40.66 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.29 111.134 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -34.78 76.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 1.18 110.884 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.98 -46.31 71.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.27 110.882 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.708 HG23 HD13 ' A' ' 147' ' ' LEU . 8.9 p -68.12 -30.08 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.24 111.167 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -75.27 -33.33 61.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 1.82 110.855 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -89.12 -19.91 24.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 1.7 110.818 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -94.16 -32.77 13.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.83 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.868 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -128.4 -54.26 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.45 110.871 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.31 4.95 2.76 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.705 -0.76 . . . . 0.41 112.484 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.505 ' CE1' HG21 ' A' ' 109' ' ' VAL . 8.1 t-160 -70.08 120.17 15.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.87 110.805 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -153.26 104.76 2.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 2.21 110.967 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.34 173.42 15.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.77 110.911 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.98 -10.06 16.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 1.95 110.895 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.677 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 1.6 m120 -99.9 9.08 43.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 3.13 110.904 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.678 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -83.2 167.14 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.44 110.938 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -172.33 130.13 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.24 110.898 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.761 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.9 m-85 -73.76 132.23 42.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 1.72 110.853 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.07 142.26 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.21 111.171 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.62 ' HG2' HD13 ' A' ' 130' ' ' LEU . 7.5 tt0 -96.46 129.44 43.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 1.69 110.874 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.97 151.63 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.22 111.198 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.448 ' N ' HD11 ' A' ' 130' ' ' LEU . 3.0 t -131.91 160.85 34.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.28 111.156 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.409 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -152.39 134.51 4.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.757 -0.735 . . . . 0.17 112.509 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -95.19 141.1 29.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 1.67 110.914 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 4.7 tptm -81.95 134.09 50.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.559 0.695 . . . . 1.38 110.871 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 119.26 6.23 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.645 2.23 . . . . 0.44 112.376 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.38 110.929 -179.961 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.749 0.309 . . . . 2.83 110.874 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.31 22.0 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 1.52 110.876 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.15 40.63 52.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.788 -0.72 . . . . 0.28 112.469 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.49 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -79.05 159.8 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.821 0.343 . . . . 0.25 111.121 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 36' ' ' THR . 1.3 m -154.32 166.52 32.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 1.13 110.842 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.6 125.41 35.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 0.3 111.159 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.91 2.9 23.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.814 -0.707 . . . . 0.32 112.514 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.422 HE22 HD12 ' A' ' 62' ' ' ILE . 2.3 pt20 -115.54 166.99 11.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 1.04 110.882 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -105.61 114.96 29.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 1.35 110.796 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 42' ' ' VAL . 3.3 m -118.06 139.13 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 2.29 111.08 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.788 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -114.64 114.44 25.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.34 111.146 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.828 HG11 HG12 ' A' ' 29' ' ' VAL . 97.2 t -87.66 121.84 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.2 111.182 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.548 HG12 HG13 ' A' ' 47' ' ' ILE . 18.1 t -107.36 116.72 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.17 111.139 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -115.76 167.18 11.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.881 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.63 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.2 p-10 -146.29 -169.52 3.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 1.74 110.89 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -59.42 -35.21 73.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 2.96 110.972 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.76 -6.83 51.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.492 . . . . 1.23 110.891 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.6 m -107.17 93.87 10.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.706 0.765 . . . . 0.16 110.881 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 54.8 Cg_endo -69.63 142.47 48.58 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.727 2.284 . . . . 0.21 112.456 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -49.2 -32.42 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.19 111.125 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.49 -52.82 43.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 3.21 110.946 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.53 -44.88 10.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.18 111.178 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.419 HD22 HG13 ' A' ' 29' ' ' VAL . 1.9 tm? -51.66 -61.72 2.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.14 110.935 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -34.61 22.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 2.31 110.9 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.11 -48.24 40.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.2 112.437 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.6 mt -61.33 -39.98 92.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.368 . . . . 0.47 110.92 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.828 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -76.23 -31.69 21.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.63 111.186 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.89 -60.03 4.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 1.66 110.851 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -40.22 72.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 1.71 110.926 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.904 HD23 HD21 ' A' ' 35' ' ' LEU . 81.2 mt -72.52 -24.65 61.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.25 110.927 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.41 -24.95 45.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.38 110.914 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.78 -30.07 17.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.23 111.104 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.904 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.42 -35.05 14.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.22 110.877 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.11 -45.47 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.25 111.137 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.26 -12.61 56.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.822 -0.704 . . . . 0.27 112.449 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -65.78 -62.72 1.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 2.6 110.858 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -96.52 -37.43 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 2.23 110.88 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.55 -129.43 4.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.784 -0.722 . . . . 0.24 112.489 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -153.4 153.04 31.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 3.79 110.835 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 12' ' ' VAL . 95.0 t -138.98 119.81 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.26 111.188 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -109.76 154.69 22.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.16 110.899 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -115.83 134.53 58.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.14 111.097 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -144.3 152.38 40.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 1.27 110.986 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -102.56 137.64 40.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.47 110.852 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.925 HD13 HG21 ' A' ' 73' ' ' THR . 11.2 mt -50.91 -46.77 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 0.4 111.208 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -24.73 63.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 3.71 110.905 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -98.22 18.52 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 3.42 110.812 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.809 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.75 -29.13 4.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 1.07 110.943 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.594 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -52.52 -36.31 55.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 2.55 110.975 179.844 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -85.86 -19.47 30.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 1.25 110.905 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.413 ' HB2' HD13 ' A' ' 50' ' ' LEU . 63.6 m -60.69 -16.69 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 0.88 110.877 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.94 63.49 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.4 111.174 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.403 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 12.5 m-70 -64.9 -70.24 0.24 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 0.39 110.846 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.706 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.13 -168.08 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 1.15 110.924 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -105.88 126.68 52.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 2.22 110.905 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.14 79.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 1.34 110.846 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.7 p -130.11 -35.33 1.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.33 110.856 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.446 ' O ' HD23 ' A' ' 87' ' ' LEU . 93.5 m-85 -98.52 122.02 41.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.094 -0.503 . . . . 2.05 110.873 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.61 -21.69 61.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 1.52 110.949 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.422 HD12 HE22 ' A' ' 10' ' ' GLN . 13.7 mt -145.67 143.46 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.42 111.155 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.832 HG21 HG23 ' A' ' 83' ' ' ILE . 18.8 mm -130.52 132.85 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.444 . . . . 0.16 111.155 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -111.7 135.2 52.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.836 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.52 98.52 4.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.766 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.64 78.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.22 112.475 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.71 54.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.358 . . . . 0.58 110.939 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.4 159.77 53.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.569 0.699 . . . . 0.21 111.128 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 116.34 4.52 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.702 2.268 . . . . 0.22 112.373 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.61 7.02 69.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.739 -0.743 . . . . 0.22 112.495 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.26 136.59 48.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.68 110.906 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.729 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.2 p -126.03 108.41 11.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.19 111.122 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.925 HG21 HD13 ' A' ' 47' ' ' ILE . 1.1 m -163.3 155.8 18.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.33 111.202 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.979 HD12 HD22 ' A' ' 147' ' ' LEU . 3.9 mt -133.55 105.8 7.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.251 -0.431 . . . . 0.22 110.983 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -79.44 150.98 31.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.24 110.903 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m -130.64 -177.46 4.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.49 110.884 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.98 68.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.38 111.078 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -47.12 86.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 2.14 110.929 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.809 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -71.9 -56.48 10.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.3 111.185 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.6 mt -50.78 -39.54 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.22 110.949 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.14 -56.88 12.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.41 111.099 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.422 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -55.97 -43.53 77.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 2.93 110.968 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.832 HG23 HG21 ' A' ' 63' ' ' ILE . 43.4 mm -55.15 -68.33 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.24 111.047 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.17 -39.75 57.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.28 111.194 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -52.84 -49.54 65.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 2.48 110.946 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 56' ' ' LYS . 40.0 pt -86.66 -5.62 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.26 111.23 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -80.13 113.36 18.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.27 110.851 179.966 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -52.8 158.49 2.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 2.45 110.863 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.404 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.3 Cg_endo -69.75 114.22 3.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.669 2.246 . . . . 0.24 112.299 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.99 3.09 54.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.829 -0.701 . . . . 0.26 112.522 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.77 -159.7 12.46 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 0.22 112.453 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.3 m -141.98 157.28 45.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.55 110.918 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.688 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.2 tm? -139.37 114.61 9.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.21 110.927 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.587 ' N ' HD22 ' A' ' 93' ' ' LEU . 73.5 m-85 -106.33 132.55 52.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.84 110.848 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.616 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.81 163.84 36.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.17 110.895 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.46 130.8 35.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 1.85 110.837 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.8 147.28 18.3 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.64 0.733 . . . . 2.16 110.915 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.464 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.4 Cg_endo -69.75 141.38 45.13 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.776 2.317 . . . . 0.22 112.329 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.39 146.95 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 0.2 111.11 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.438 ' CD ' HG21 ' A' ' 103' ' ' VAL . 52.2 mt-10 -108.97 133.04 53.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 1.97 110.844 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.0 p -92.0 -41.91 10.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 1.11 111.179 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.74 40.34 1.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.68 111.094 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.438 HG21 ' CD ' ' A' ' 100' ' ' GLU . 25.8 t -147.93 149.82 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.69 111.02 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -54.11 175.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 2.11 110.945 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.7 -63.51 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 2.32 110.89 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.41 -75.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 1.64 110.894 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.77 -168.23 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 1.67 110.826 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.467 ' HG3' HG13 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -79.9 -7.9 59.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 1.75 110.928 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.467 HG13 ' HG3' ' A' ' 108' ' ' LYS . 2.4 m -141.14 145.73 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.4 111.15 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -64.93 115.35 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 2.21 110.947 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 104' ' ' ASP . 80.8 p -86.82 178.88 6.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.29 111.145 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.76 -51.75 66.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.17 111.153 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.66 -49.41 77.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.23 110.838 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -37.56 76.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 1.88 110.931 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -64.61 -55.39 20.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.31 110.844 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.9 m -57.64 -46.2 84.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.21 110.894 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -42.85 95.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.26 110.828 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.46 -44.31 96.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.496 . . . . 0.21 111.175 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 93' ' ' LEU . 14.9 tp -64.45 -52.11 59.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.24 110.893 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.7 m -61.55 -31.62 71.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.24 111.085 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.91 -10.32 53.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 0.53 110.897 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.01 5.6 28.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 1.71 110.866 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.74 5.92 33.22 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.755 . . . . 0.48 112.436 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -105.87 170.38 7.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.28 110.985 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -150.19 170.59 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.432 . . . . 0.31 111.162 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 53.77 44.15 30.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 2.47 110.858 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.14 144.43 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.21 111.216 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 156.99 6.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 1.64 110.915 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.45 141.34 38.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 3.04 110.907 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.766 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.4 mp -99.74 -36.4 9.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.25 110.869 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -163.15 176.9 9.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 1.33 110.886 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -125.53 166.05 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 7.25 110.927 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -149.21 136.17 10.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.695 0.76 . . . . 1.38 110.895 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 154.78 67.43 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.726 2.284 . . . . 0.32 112.372 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.648 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -91.14 125.96 36.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.43 . . . . 0.31 110.932 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.417 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.36 161.37 24.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.598 0.713 . . . . 1.21 111.107 -179.991 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.417 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.2 Cg_endo -69.78 -28.49 25.09 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.661 2.241 . . . . 0.38 112.388 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.36 -17.97 35.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 2.81 110.839 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 -53.01 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 2.59 110.899 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 p -49.66 -40.61 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.24 111.095 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -34.67 76.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 1.15 110.905 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -46.12 71.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.22 110.86 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 9.0 p -68.45 -30.34 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.17 111.059 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -75.56 -32.52 60.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 2.57 110.935 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -89.56 -20.01 24.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 1.79 110.903 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -94.3 -32.74 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.3 110.884 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.979 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -128.03 -54.29 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.34 110.878 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.36 9.1 2.43 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.818 -0.706 . . . . 0.31 112.478 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.402 ' CG ' HG11 ' A' ' 109' ' ' VAL . 11.0 t-160 -70.31 121.68 18.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.64 110.901 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -151.8 105.42 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 2.62 110.864 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.6 t -160.44 169.55 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.72 110.888 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.65 -14.87 15.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 1.62 110.858 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -99.33 19.94 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 1.6 110.896 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.648 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -92.2 167.96 11.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.31 110.969 179.887 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -172.49 129.81 0.56 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.26 110.926 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.729 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.2 m-85 -70.16 135.98 49.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 1.86 110.861 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.32 148.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.25 111.183 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.766 ' HG2' HD13 ' A' ' 130' ' ' LEU . 37.7 tt0 -105.03 132.03 51.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 2.3 110.839 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.23 153.04 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.21 111.139 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.415 ' N ' HD11 ' A' ' 130' ' ' LEU . 7.8 t -139.25 152.46 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.34 111.123 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.84 140.74 10.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.19 112.49 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -97.28 139.54 33.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.732 0.301 . . . . 1.64 110.962 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 1.4 tptt -78.99 134.37 60.07 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.508 0.67 . . . . 2.37 110.899 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 118.61 5.78 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.694 2.263 . . . . 0.44 112.304 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.33 110.923 179.954 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.8 0.333 . . . . 2.41 110.839 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -122.3 24.35 9.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 2.09 110.908 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.94 38.33 46.38 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.861 -0.685 . . . . 0.44 112.471 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 7' ' ' SER . 1.7 mp -76.82 158.73 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.869 0.366 . . . . 0.45 111.129 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 36' ' ' THR . 33.7 m -147.14 158.55 43.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.506 . . . . 1.16 110.839 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.18 130.6 35.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.62 111.153 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.86 -6.12 32.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.751 -0.737 . . . . 0.49 112.479 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.56 168.91 8.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.778 0.323 . . . . 1.54 110.904 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.66 110.98 23.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 1.42 110.886 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.775 HG12 HG21 ' A' ' 36' ' ' THR . 2.5 p -118.99 130.52 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.129 -0.487 . . . . 2.06 111.043 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.758 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -105.97 132.72 51.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.51 . . . . 0.32 111.081 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.732 HG11 HG12 ' A' ' 29' ' ' VAL . 96.3 t -101.6 120.13 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.19 111.088 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.711 HG12 HG13 ' A' ' 47' ' ' ILE . 15.8 t -103.24 116.66 47.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.22 111.154 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -117.04 166.36 12.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.36 110.863 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.585 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.1 p-10 -144.24 -169.79 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 1.91 110.885 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.58 -35.52 74.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 3.37 110.939 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 t -73.41 -7.84 53.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 1.23 110.926 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.2 93.21 9.03 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.682 0.753 . . . . 0.31 110.886 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 143.12 50.11 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.671 2.247 . . . . 0.46 112.372 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.09 -32.47 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.35 111.096 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.19 -53.36 35.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 2.55 110.89 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.81 -44.92 10.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.4 111.046 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.12 -61.01 2.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.24 -0.436 . . . . 0.31 110.897 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -33.59 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 3.26 110.881 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.77 -49.05 38.33 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.748 -0.739 . . . . 0.37 112.473 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.701 HD12 HG13 ' A' ' 68' ' ' VAL . 21.8 mt -60.68 -40.61 92.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.867 0.365 . . . . 0.77 110.939 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.732 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -75.7 -31.36 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.64 111.132 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -61.91 -61.75 2.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 1.73 110.863 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -40.48 66.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 1.56 110.87 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.706 HD23 HD21 ' A' ' 35' ' ' LEU . 58.7 mt -72.23 -25.86 61.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.37 110.899 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.445 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.33 -23.85 46.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.41 110.898 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.97 -29.64 17.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.208 -0.451 . . . . 0.46 111.124 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.706 HD21 HD23 ' A' ' 32' ' ' LEU . 1.9 pp -91.38 -36.09 14.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.35 110.84 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.775 HG21 HG12 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -98.06 -45.92 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.42 111.176 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.74 -15.8 42.9 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.58 112.532 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.36 -62.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 2.27 110.945 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -107.02 -33.8 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 2.33 110.99 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.08 -134.54 5.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.689 -0.767 . . . . 0.34 112.481 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -154.15 152.3 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 3.63 110.937 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.9 t -136.32 123.71 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.25 111.12 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.4 t -113.22 153.85 27.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 0.16 110.834 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.97 132.41 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.16 111.22 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -142.25 152.46 43.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 1.31 110.925 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -102.7 137.49 40.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.53 110.887 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.04 HD13 HG21 ' A' ' 73' ' ' THR . 12.5 mt -52.46 -43.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.51 111.214 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -24.16 61.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 3.69 110.867 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -98.02 16.54 20.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 3.37 110.963 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.852 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -49.42 -28.15 4.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.465 . . . . 1.12 110.899 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -49.89 -44.11 49.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.18 110.995 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -85.82 -14.77 44.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 1.34 110.865 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.482 ' HB3' HD13 ' A' ' 50' ' ' LEU . 23.8 t -60.44 -15.39 26.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 2.04 110.844 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.628 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -75.17 52.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.46 111.126 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -50.85 -71.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.5 110.893 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.644 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.38 -168.32 2.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 1.89 110.813 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -108.46 130.17 55.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.123 -0.489 . . . . 1.73 110.967 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.8 72.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 1.17 110.895 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.5 p -126.76 -33.72 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 0.29 110.784 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 96.7 m-85 -99.3 118.4 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 1.45 110.868 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.37 -20.2 62.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.497 . . . . 1.52 110.879 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 mt -145.88 144.41 20.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.22 111.126 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.784 HG21 HG23 ' A' ' 83' ' ' ILE . 21.3 mm -137.29 130.22 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.2 111.134 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -111.47 137.63 49.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.2 110.894 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -129.52 97.56 4.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.3 110.889 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.65 73.68 0.35 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.745 -0.74 . . . . 0.4 112.465 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.694 HD13 ' OE1' ' A' ' 158' ' ' GLN . 3.9 mm? -95.54 -19.35 19.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 2.12 110.884 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.701 HG13 HD12 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -48.34 152.59 1.52 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 0.74 111.125 179.792 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.9 123.52 10.13 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.638 2.225 . . . . 0.66 112.33 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.72 0.21 75.78 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.58 112.454 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.565 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -54.61 146.66 16.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.984 0.421 . . . . 1.32 110.866 -179.749 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.711 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 18.3 p -137.02 109.07 7.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.39 111.114 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' THR . . . . . 1.04 HG21 HD13 ' A' ' 47' ' ' ILE . 2.3 m -162.28 140.06 8.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 0.66 111.164 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.092 HD12 HD22 ' A' ' 147' ' ' LEU . 15.8 mt -113.65 105.96 13.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.59 110.912 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -79.63 151.06 30.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.34 110.806 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.8 m -130.94 -177.15 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.41 110.831 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.01 69.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.44 111.096 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -47.78 84.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 2.46 110.933 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.852 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -70.82 -56.59 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.23 111.15 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.0 mt -50.95 -39.18 54.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.29 110.907 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.95 -56.87 13.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.4 111.089 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.628 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -57.02 -41.87 79.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 2.48 110.897 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.784 HG23 HG21 ' A' ' 63' ' ' ILE . 37.2 mm -56.6 -68.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.22 111.134 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.45 -38.23 42.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.26 111.117 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.59 -56.07 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 2.31 110.893 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 56' ' ' LYS . 34.2 pt -77.42 -8.22 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.25 111.062 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -79.24 127.27 31.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.45 110.971 179.886 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -66.54 159.99 69.99 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 2.34 110.916 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 114.15 3.62 Favored 'Trans proline' 0 C--N 1.34 0.082 0 C-N-CA 122.632 2.221 . . . . 0.16 112.356 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.05 1.98 55.98 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.17 112.51 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.78 -164.03 11.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.636 -0.792 . . . . 0.14 112.519 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 60.0 m -135.47 152.3 51.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.31 110.863 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.714 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.0 112.24 9.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.19 110.903 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.515 ' N ' HD22 ' A' ' 93' ' ' LEU . 48.0 m-85 -106.44 133.62 50.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 1.65 110.828 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -148.58 158.78 44.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.23 110.955 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.79 125.62 34.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 2.35 110.97 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.569 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -148.43 146.05 21.79 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 2.24 110.864 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.61 140.04 42.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.718 2.279 . . . . 0.22 112.392 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.417 HG13 HG23 ' A' ' 157' ' ' VAL . 9.1 m -126.71 146.76 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.28 111.103 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' OE2' HG21 ' A' ' 103' ' ' VAL . 0.9 OUTLIER -113.79 132.38 55.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 3.62 110.875 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.0 p -104.29 26.15 9.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 1.2 111.134 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -146.68 23.11 1.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.53 111.119 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.462 HG11 ' OG ' ' A' ' 107' ' ' SER . 3.8 t -145.02 159.45 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.74 111.127 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.571 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -52.04 169.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 1.91 110.809 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -64.25 -49.73 70.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 2.21 110.987 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -72.62 -75.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 2.41 110.93 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.462 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.5 t 52.0 -169.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 2.32 110.8 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.41 -3.23 48.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 1.65 110.948 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.2 141.14 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.47 111.116 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 114.17 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 2.22 110.846 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.571 HG21 ' O ' ' A' ' 104' ' ' ASP . 44.0 p -83.55 177.61 8.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.2 111.125 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.95 -53.93 49.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.17 111.041 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -49.68 76.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.441 . . . . 0.22 110.903 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -56.29 -40.22 73.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 1.69 110.806 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -63.75 -55.04 26.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.31 110.954 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -57.58 -46.27 84.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.26 110.865 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.425 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -64.42 -42.96 95.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.3 110.883 -179.764 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.74 92.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.26 111.137 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.617 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.7 tp -62.7 -52.83 61.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.26 110.901 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.8 m -61.8 -35.52 78.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.27 111.147 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 117' ' ' SER . 17.3 mt -81.59 -10.4 59.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.56 110.919 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.83 5.19 29.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 1.75 110.842 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.21 -2.47 35.07 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.772 -0.728 . . . . 0.51 112.465 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -96.13 169.87 9.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.815 0.341 . . . . 0.28 110.98 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.429 HG23 ' HG3' ' A' ' 126' ' ' GLU . 29.0 m -151.05 171.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.32 111.128 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 125' ' ' VAL . 2.9 mt-10 56.93 43.61 24.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 2.03 110.905 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.4 t -75.19 142.83 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.39 111.128 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.63 156.38 6.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 1.73 110.938 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -82.17 145.36 30.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 2.13 110.874 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.431 HD11 ' N ' ' A' ' 160' ' ' THR . 1.5 mp -105.76 -35.22 7.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.28 110.95 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -166.17 176.64 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 1.31 110.906 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -125.41 166.12 17.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 8.3 110.875 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -146.91 134.22 10.22 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.684 0.754 . . . . 1.52 110.876 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 157.56 60.07 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.629 2.219 . . . . 0.44 112.369 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.679 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -94.46 129.59 41.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.38 110.95 179.928 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.592 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -112.68 162.74 20.21 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.52 0.676 . . . . 1.39 111.151 179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 -22.66 32.24 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.642 2.228 . . . . 0.63 112.397 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -85.03 -25.76 27.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 2.64 110.964 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -88.58 -52.73 5.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.111 -0.495 . . . . 2.63 110.794 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -49.77 -39.05 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.48 111.101 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -33.86 75.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 1.2 110.941 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -46.6 67.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.951 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.683 HG23 HD13 ' A' ' 147' ' ' LEU . 8.8 p -68.11 -30.86 49.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.21 111.11 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -76.87 -29.99 56.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 2.06 110.92 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -89.64 -21.6 22.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 1.97 110.884 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -95.03 -32.17 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.39 110.804 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.092 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -127.04 -54.49 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.52 110.857 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.58 14.17 2.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.52 112.543 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -70.76 121.29 17.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.793 0.33 . . . . 0.85 110.812 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -152.17 105.36 3.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 2.54 110.863 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.74 172.16 17.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.63 110.816 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.71 -17.27 14.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 1.88 110.917 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -96.89 20.32 11.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 1.61 110.859 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.679 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -93.53 162.67 13.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.37 110.923 179.957 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.632 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -171.2 130.65 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.36 110.933 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.711 ' CZ ' HG22 ' A' ' 72' ' ' THR . 25.3 m-85 -70.33 135.28 48.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 1.7 110.885 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.417 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.19 142.47 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.36 111.155 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.694 ' OE1' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -101.09 127.37 47.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 2.09 110.894 -179.981 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.33 151.48 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.426 . . . . 0.27 111.188 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.431 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -130.43 154.59 47.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.222 -0.445 . . . . 0.3 111.107 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.431 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -142.89 131.39 4.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.755 -0.736 . . . . 0.19 112.467 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -91.63 131.63 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 3.59 110.918 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.81 135.44 77.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 1.65 110.963 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 131.47 21.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.731 2.288 . . . . 0.47 112.365 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.44 110.824 -179.946 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.845 0.355 . . . . 1.96 110.901 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 6' ' ' ILE . 9.8 m-85 -122.34 16.95 10.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 1.54 110.767 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.74 39.14 96.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.36 112.439 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.814 HD13 HD21 ' A' ' 32' ' ' LEU . 1.6 mp -80.89 156.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.884 0.373 . . . . 0.37 111.128 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.73 161.38 38.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 1.66 110.879 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.54 134.9 33.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.38 111.088 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.64 -1.66 30.61 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.719 -0.753 . . . . 0.26 112.501 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -117.14 173.26 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 1.13 110.868 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.4 116.3 31.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.34 110.919 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG22 ' HB ' ' A' ' 62' ' ' ILE . 97.3 t -119.58 129.38 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 1.94 111.124 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.778 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -107.33 126.41 52.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.24 111.122 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.74 HG11 HG12 ' A' ' 29' ' ' VAL . 98.1 t -98.9 119.41 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.2 111.094 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -102.31 117.58 47.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.18 111.108 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -118.02 169.91 9.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.438 . . . . 0.23 110.9 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.408 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 9.6 p-10 -151.65 -169.87 3.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 1.74 110.837 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -58.21 -35.55 71.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 3.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.9 -8.15 55.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 1.24 110.873 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.71 95.25 11.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.651 0.739 . . . . 0.19 110.873 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 141.57 45.27 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.628 2.219 . . . . 0.33 112.326 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.02 -32.84 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.31 111.154 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -50.98 -52.8 38.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 2.4 110.903 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.6 11.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.29 111.085 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.447 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -52.6 -61.69 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.21 110.99 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -36.57 27.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 2.25 110.962 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.75 49.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.21 112.534 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.6 mt -61.55 -39.97 93.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.64 110.918 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 HG11 ' A' ' 14' ' ' VAL . 17.1 m -76.9 -30.71 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.64 111.18 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.82 -59.84 4.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 1.63 110.909 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -40.08 70.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 1.91 110.881 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.919 HD23 HD21 ' A' ' 35' ' ' LEU . 85.8 mt -73.27 -25.7 60.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.27 110.825 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.624 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.0 mt-30 -77.1 -24.06 51.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.309 -0.405 . . . . 0.42 110.935 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.13 -32.22 15.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.27 111.133 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.919 HD21 HD23 ' A' ' 32' ' ' LEU . 1.7 pp -88.31 -36.51 16.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.3 110.87 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -96.64 -47.09 6.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.47 111.11 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.34 -15.58 45.91 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.753 -0.737 . . . . 0.48 112.523 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -56.07 -62.59 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 1.93 110.898 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -107.19 -33.26 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 2.71 110.88 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.22 -131.52 4.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.3 112.522 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -156.35 153.08 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 3.92 110.798 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 33' ' ' GLN . 97.7 t -134.93 126.51 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.25 111.169 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.8 t -116.5 152.62 33.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.28 110.827 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.03 131.77 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.19 111.069 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -139.23 150.97 46.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 1.38 110.87 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -103.44 135.18 45.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.4 110.876 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.681 ' CD1' HG21 ' A' ' 73' ' ' THR . 36.4 mt -53.69 -34.18 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.09 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -31.7 63.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 2.23 110.937 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -100.84 19.7 16.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 3.7 110.893 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.821 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.26 -26.94 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 1.08 110.885 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.26 -38.49 58.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.226 -0.443 . . . . 1.06 110.911 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -84.5 -14.36 49.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.169 -0.469 . . . . 1.08 110.906 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.654 ' HB3' HD13 ' A' ' 50' ' ' LEU . 19.6 t -60.08 -15.19 21.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 2.2 110.805 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.405 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -75.17 53.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.44 111.111 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -53.56 -70.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.65 110.922 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.673 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.68 -168.26 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 1.08 110.888 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -107.74 129.87 55.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 1.73 110.901 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.19 75.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 1.25 110.88 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.0 p -129.65 -34.15 1.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.22 110.843 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.6 m-85 -99.73 118.06 35.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 1.44 110.842 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.07 -20.08 64.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 1.48 110.857 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.685 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.8 mt -147.8 143.6 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.23 111.134 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.861 HG21 HG23 ' A' ' 83' ' ' ILE . 18.5 mm -133.92 132.69 56.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.14 111.162 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.6 mm? -113.8 137.64 51.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.19 110.847 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.23 98.35 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.16 110.814 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.59 74.41 0.29 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.818 -0.706 . . . . 0.18 112.469 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.45 61.41 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.352 . . . . 0.58 110.883 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.444 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -129.34 159.93 66.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 0.34 111.204 179.799 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 115.82 4.26 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.66 2.24 . . . . 0.32 112.409 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.71 7.65 68.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 0.22 112.51 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.4 150.93 10.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.73 110.858 -179.729 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.764 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 36.1 p -139.72 108.18 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.23 111.196 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.681 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.51 156.18 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.29 111.126 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.002 HD12 HD22 ' A' ' 147' ' ' LEU . 5.7 mt -133.85 109.6 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.24 110.844 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -86.51 153.92 21.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.28 110.869 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 m -131.78 -175.75 3.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.39 110.766 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.16 -36.54 70.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.27 111.031 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.39 -45.94 88.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 2.08 110.899 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.821 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -73.02 -55.27 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.23 111.146 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 119' ' ' LEU . 65.7 mt -50.33 -44.8 54.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.28 110.874 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.59 -53.8 34.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.39 111.012 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -55.32 -43.37 74.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 2.88 110.904 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.861 HG23 HG21 ' A' ' 63' ' ' ILE . 41.9 mm -57.12 -67.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.25 111.168 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.05 -36.58 40.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.24 111.132 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.2 tpp85 -56.74 -50.67 71.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 2.5 110.846 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 56' ' ' LYS . 37.2 pt -84.29 -6.02 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.19 111.12 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -81.14 123.34 28.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.29 110.926 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -61.85 159.08 38.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 3.19 110.869 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.407 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.7 Cg_endo -69.76 114.2 3.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.688 2.259 . . . . 0.2 112.326 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.74 4.28 54.64 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.71 -0.757 . . . . 0.23 112.496 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.72 -164.31 22.79 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.787 -0.72 . . . . 0.18 112.485 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 53.8 m -136.25 151.06 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.808 0.337 . . . . 0.37 110.86 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 94' ' ' PHE . 2.1 tm? -134.02 127.45 32.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.175 -0.466 . . . . 0.48 110.94 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.602 ' N ' HD22 ' A' ' 93' ' ' LEU . 59.2 m-85 -122.72 133.54 54.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 1.85 110.872 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -148.65 163.69 36.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.47 . . . . 0.23 110.913 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.02 129.87 30.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 2.79 110.972 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.88 148.59 19.63 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.742 0.782 . . . . 3.63 110.873 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 136.51 33.23 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.645 2.23 . . . . 0.31 112.382 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 157' ' ' VAL . 11.9 m -120.66 146.83 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.2 111.202 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.44 ' CD ' HG21 ' A' ' 103' ' ' VAL . 62.2 mt-10 -110.48 132.97 53.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.92 110.901 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.0 p -91.41 -40.7 11.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 1.25 111.135 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.52 38.28 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.56 111.166 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.44 HG21 ' CD ' ' A' ' 100' ' ' GLU . 22.0 t -147.53 149.92 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.64 111.121 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.634 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -53.31 173.05 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 1.82 110.793 179.888 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -67.15 -53.37 31.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.167 -0.47 . . . . 2.92 110.94 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -75.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 1.91 110.862 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.67 -169.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 1.52 110.894 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.691 ' HG3' HG13 ' A' ' 109' ' ' VAL . 17.0 pttt -80.51 -4.86 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 3.15 110.922 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.691 HG13 ' HG3' ' A' ' 108' ' ' LYS . 2.7 m -139.92 148.21 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.4 111.16 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.443 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.5 tppt? -69.14 115.06 7.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 2.2 110.875 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.634 HG21 ' O ' ' A' ' 104' ' ' ASP . 48.7 p -87.83 -178.33 6.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.33 111.153 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.78 64.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.32 111.151 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.27 -49.46 77.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.46 110.854 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.56 -43.21 71.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 1.87 110.883 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.499 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -61.8 -55.74 26.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.54 110.975 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.9 m -55.3 -46.81 76.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.27 110.894 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -44.23 94.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.46 110.892 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 80' ' ' LEU . . . -62.21 -49.81 74.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.42 111.106 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.603 ' HA ' HD13 ' A' ' 80' ' ' LEU . 12.8 tp -57.55 -52.46 65.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.3 110.923 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 92.0 m -64.21 -29.04 70.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.3 111.198 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.1 mt -81.11 -16.27 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.8 110.835 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 p -82.32 3.2 28.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 2.62 110.859 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.46 -4.94 35.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.804 -0.712 . . . . 0.86 112.502 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -83.97 169.02 15.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.31 110.927 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.52 170.25 2.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.37 111.126 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 53.4 44.48 29.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 2.23 110.956 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.8 142.54 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.29 111.109 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.15 160.04 7.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 1.79 110.868 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.86 140.73 36.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 2.87 110.956 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.746 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.4 mp -98.6 -37.28 9.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.31 110.926 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -163.16 176.78 9.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 1.38 110.917 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.1 mtt-85 -125.63 167.01 15.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 8.44 110.875 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -149.7 134.22 9.23 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.662 0.744 . . . . 1.81 110.898 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 156.54 63.08 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.269 . . . . 0.35 112.38 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.67 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -89.6 154.1 20.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.71 110.92 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.601 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -138.07 163.28 48.87 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.56 0.695 . . . . 1.6 111.111 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 136' ' ' THR . 53.2 Cg_endo -69.78 -23.75 30.37 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.706 2.271 . . . . 0.47 112.32 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -85.66 -24.66 26.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 3.99 110.954 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -88.13 -53.85 4.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 4.08 110.931 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 136' ' ' THR . 7.1 p -50.59 -39.15 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.23 111.112 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -34.03 75.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 1.24 110.916 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -46.48 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.29 110.854 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.696 HG23 HD13 ' A' ' 147' ' ' LEU . 8.6 p -67.73 -30.95 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.19 111.131 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -77.22 -29.97 54.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 2.16 110.866 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -89.37 -21.85 22.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 1.82 110.813 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -95.04 -31.97 13.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.814 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.002 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -127.25 -54.67 1.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.36 110.87 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.93 13.09 2.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.771 . . . . 0.37 112.437 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.404 ' CG ' HG11 ' A' ' 109' ' ' VAL . 15.5 t-160 -70.55 122.23 19.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.61 110.803 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -151.38 105.57 3.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 2.92 110.924 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t -158.35 171.28 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.58 110.86 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.09 -17.12 14.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 2.01 110.786 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -99.28 21.29 12.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.299 -0.41 . . . . 1.65 110.866 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -90.4 166.14 13.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.45 . . . . 0.27 111.016 179.928 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.67 ' HA ' HD23 ' A' ' 135' ' ' LEU . 2.7 tm? -172.03 130.31 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.2 110.841 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.764 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.1 m-85 -72.6 133.74 44.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 1.74 110.87 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.407 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.07 157.19 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.37 111.068 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.746 ' HG2' HD13 ' A' ' 130' ' ' LEU . 37.7 tt0 -113.57 133.56 55.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 2.2 110.905 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.94 152.32 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.24 111.132 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.431 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.7 t -136.29 163.62 29.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.26 111.172 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.98 136.76 5.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.753 -0.737 . . . . 0.21 112.491 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -94.92 142.67 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 1.78 110.925 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 13.4 tptm -82.8 135.55 45.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.574 0.702 . . . . 1.82 110.935 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 118.89 5.95 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.727 2.285 . . . . 0.46 112.41 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.62 110.878 -179.923 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.761 0.315 . . . . 2.37 110.857 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.472 ' HB2' HD11 ' A' ' 6' ' ' ILE . 12.4 m-85 -122.14 24.31 9.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 2.08 110.899 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.45 44.54 53.25 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.81 -0.709 . . . . 0.51 112.426 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -88.53 163.55 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.784 0.326 . . . . 0.5 111.17 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.628 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -151.22 163.6 38.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 1.47 110.811 -179.947 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.33 134.31 34.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.34 111.086 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.52 2.41 32.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.28 112.439 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.43 172.42 7.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.806 0.336 . . . . 1.04 110.955 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.18 114.29 28.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 2.14 110.891 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.632 HG22 ' HB ' ' A' ' 62' ' ' ILE . 92.6 t -117.06 133.9 62.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 1.87 111.101 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.758 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -111.45 125.91 54.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.21 111.092 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.691 HG11 HG12 ' A' ' 29' ' ' VAL . 95.2 t -98.04 122.22 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.2 111.223 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.422 HG12 ' CG1' ' A' ' 47' ' ' ILE . 18.7 t -105.93 114.83 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.21 111.169 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -115.58 168.93 9.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.17 110.956 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -151.08 -170.34 3.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 1.9 110.82 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -57.0 -35.89 69.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 3.63 110.912 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -73.14 -10.38 59.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 1.71 110.839 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.61 93.41 10.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.683 0.754 . . . . 0.24 110.851 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.7 143.11 50.06 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.615 2.21 . . . . 0.36 112.38 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.0 t -48.96 -32.08 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.25 111.061 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.62 -53.69 35.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 2.33 110.888 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB1' HG12 ' A' ' 68' ' ' VAL . . . -87.69 -44.7 10.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.33 111.114 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -50.18 -59.58 3.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.28 110.904 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -48.26 -32.84 7.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 4.79 110.868 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.37 -46.41 33.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 0.54 112.48 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.642 HD12 HG13 ' A' ' 68' ' ' VAL . 14.0 mt -61.96 -35.63 79.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 1.37 110.903 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.691 HG12 HG11 ' A' ' 14' ' ' VAL . 22.0 m -80.93 -32.94 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.64 111.109 179.837 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -61.6 -54.61 40.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 1.68 110.904 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.499 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -57.19 -36.89 71.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 2.52 110.836 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.706 HD23 HD21 ' A' ' 35' ' ' LEU . 60.1 mt -76.9 -25.01 52.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.91 110.96 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.579 ' HA ' HG21 ' A' ' 42' ' ' VAL . 4.8 mt-30 -78.18 -26.13 47.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.49 110.927 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.52 -31.67 15.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.52 111.105 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.706 HD21 HD23 ' A' ' 32' ' ' LEU . 1.3 pp -89.36 -35.86 15.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.59 110.985 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.7 -47.16 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.28 111.101 179.97 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.91 -15.36 42.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.769 -0.729 . . . . 0.36 112.495 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.06 -62.85 1.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.331 . . . . 1.84 110.846 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -105.82 -34.77 7.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 2.76 110.817 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.5 -127.3 2.14 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.822 -0.704 . . . . 0.29 112.493 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -157.52 151.27 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 3.84 110.782 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 33' ' ' GLN . 88.3 t -136.24 120.13 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.31 111.167 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.7 t -110.34 155.44 22.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.15 110.879 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.47 134.7 61.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.15 111.139 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -143.46 151.83 40.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 1.3 110.932 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -103.01 135.98 43.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.44 110.812 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.665 ' CD1' HG21 ' A' ' 73' ' ' THR . 25.3 mt -52.17 -35.31 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.25 111.102 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -74.96 -29.24 60.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 1.97 110.905 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -99.5 18.49 17.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 3.4 110.908 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.83 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.56 -30.47 5.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 1.13 110.901 -179.981 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mp -54.32 -37.35 64.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 1.07 110.882 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -84.82 -15.52 44.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 1.08 110.864 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.9 m -66.63 -10.37 45.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.95 110.894 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.02 63.47 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.28 111.091 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -62.03 -69.34 0.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.35 110.795 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.66 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -153.38 -175.76 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 2.17 110.903 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -93.84 135.12 35.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 1.94 110.917 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p 46.42 82.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.423 . . . . 1.12 110.87 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.3 p -133.57 -38.35 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.3 110.893 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.479 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.0 m-85 -102.0 122.72 44.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 1.44 110.821 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.87 -23.19 62.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 1.5 110.841 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 12' ' ' VAL . 19.4 mt -145.04 143.02 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.27 111.108 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.773 HG21 HG23 ' A' ' 83' ' ' ILE . 20.3 mm -132.75 133.74 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.16 111.097 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -114.21 135.94 53.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.21 110.943 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.32 97.47 4.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.29 110.894 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.15 73.28 0.38 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.719 -0.753 . . . . 0.39 112.554 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.417 HD11 ' HB3' ' A' ' 94' ' ' PHE . 4.1 mm? -93.97 -19.14 21.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 2.16 110.971 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.768 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.2 OUTLIER -47.54 151.12 1.51 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.659 0.742 . . . . 0.69 111.113 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 135.38 30.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.657 2.238 . . . . 0.71 112.298 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.92 1.4 78.78 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.702 -0.761 . . . . 0.38 112.437 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.768 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -54.62 154.63 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.991 0.424 . . . . 1.37 110.815 -179.739 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.733 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.4 p -140.86 109.4 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.16 111.106 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.665 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -160.72 154.19 22.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.23 111.241 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.996 HD12 HD22 ' A' ' 147' ' ' LEU . 6.3 mt -130.93 107.35 9.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 0.23 110.896 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -84.2 153.88 23.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.893 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.3 m -131.8 -176.15 3.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.39 110.845 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.68 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.28 111.171 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -62.52 -45.99 90.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 2.08 110.884 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.83 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -73.7 -54.96 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.23 111.109 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 119' ' ' LEU . 59.9 mt -50.66 -41.12 55.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.23 110.898 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.0 -54.86 24.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.3 111.139 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.45 -43.33 83.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 2.38 110.936 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.773 HG23 HG21 ' A' ' 63' ' ' ILE . 43.2 mm -56.24 -68.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.19 111.202 179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.91 -36.66 39.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 0.21 111.152 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -56.24 -51.76 66.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 2.06 110.871 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 56' ' ' LYS . 25.8 pt -83.13 -6.62 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.2 111.093 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -79.13 112.88 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.34 110.932 179.879 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -51.82 159.51 1.33 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.662 0.744 . . . . 2.24 110.791 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.61 114.59 3.73 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.666 2.244 . . . . 0.2 112.413 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.35 3.65 56.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.68 -0.772 . . . . 0.14 112.479 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.16 -157.97 8.9 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.767 -0.73 . . . . 0.13 112.545 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.5 m -144.2 156.07 44.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.365 . . . . 0.45 110.874 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.681 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.5 112.74 8.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.25 110.949 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.549 ' N ' HD22 ' A' ' 93' ' ' LEU . 45.5 m-85 -105.42 133.01 50.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 1.7 110.842 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.615 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.5 164.15 35.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.17 110.904 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.23 123.94 19.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 2.53 110.82 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.61 150.93 45.26 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 3.64 110.946 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.603 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.5 Cg_endo -69.83 138.21 37.06 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.641 2.227 . . . . 0.22 112.365 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.2 m -122.31 147.28 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.29 111.061 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.423 ' OE2' HG21 ' A' ' 103' ' ' VAL . 13.2 mt-10 -114.76 132.59 56.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 1.98 110.859 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.7 p -104.4 25.98 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 1.1 111.093 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.68 23.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.71 111.053 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.423 HG21 ' OE2' ' A' ' 100' ' ' GLU . 3.4 t -144.4 160.47 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.72 111.19 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.587 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -55.94 179.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 1.93 110.854 -179.989 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.07 -60.42 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 1.94 110.808 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -64.61 -75.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 2.28 110.886 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.93 -168.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 1.58 110.878 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -5.0 55.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 1.92 110.972 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.06 140.43 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.6 111.17 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.584 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -61.54 119.15 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 2.22 110.944 179.841 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.587 HG21 ' O ' ' A' ' 104' ' ' ASP . 49.0 p -89.07 175.31 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.26 111.195 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.55 -55.13 38.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.25 111.123 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -61.05 -47.96 83.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.43 110.865 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -58.1 -40.96 82.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 1.69 110.864 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.5 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -62.96 -57.37 10.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 0.42 110.863 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 61.9 m -51.72 -44.71 63.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.3 110.945 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -42.12 85.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.35 110.914 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.74 97.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.24 111.073 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 93' ' ' LEU . 14.7 tp -66.36 -51.74 54.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.27 110.92 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -62.39 -32.23 73.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.31 111.146 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.09 -10.73 52.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.72 110.889 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.34 4.62 30.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 1.7 110.855 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.47 10.0 28.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.784 -0.722 . . . . 0.53 112.45 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -110.3 171.63 7.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.3 110.946 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 m -150.01 173.04 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.27 111.088 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 51.73 44.92 28.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 2.06 110.927 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.417 HG13 HD23 ' A' ' 119' ' ' LEU . 96.5 t -81.6 141.73 14.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.22 111.131 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 159.07 7.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.116 -0.493 . . . . 1.87 110.983 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.22 139.72 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 3.38 110.959 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.752 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.2 mp -95.84 -38.17 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.23 110.945 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.7 pm0 -157.68 176.37 12.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.452 . . . . 2.99 110.926 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.726 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.7 tmt_? -128.1 138.08 52.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 4.33 110.829 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -124.3 136.38 27.61 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.683 0.754 . . . . 1.38 110.853 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 164.75 33.4 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.743 2.295 . . . . 0.25 112.291 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -97.61 125.71 42.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.3 110.9 179.993 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.0 161.34 23.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.528 0.68 . . . . 1.56 111.108 -179.976 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -24.08 29.94 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.628 2.219 . . . . 0.46 112.382 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -85.08 -22.26 29.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 2.6 110.944 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -87.76 -54.6 4.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 2.38 110.832 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 136' ' ' THR . 7.7 p -49.03 -39.12 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.34 111.116 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -37.86 80.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 2.78 110.865 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -46.91 75.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.32 110.888 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.682 HG23 HD13 ' A' ' 147' ' ' LEU . 10.8 p -67.37 -30.67 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 0.27 111.131 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -75.95 -30.63 58.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 3.55 110.864 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -90.06 -20.51 23.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 1.89 110.887 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -94.5 -32.69 13.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.34 110.871 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.996 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.9 -53.86 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.49 110.982 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.79 15.21 1.97 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.776 -0.726 . . . . 0.47 112.541 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -70.92 121.69 18.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.768 0.318 . . . . 0.98 110.891 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -152.11 105.53 3.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 2.34 110.833 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -160.66 175.79 12.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.76 110.777 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.24 -21.89 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 1.72 110.842 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -91.4 13.29 17.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 1.54 110.965 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.664 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.54 164.63 21.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.42 110.89 179.923 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.5 tm? -173.72 130.09 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.2 110.902 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.733 ' CZ ' HG22 ' A' ' 72' ' ' THR . 27.1 m-85 -76.08 137.99 40.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 1.72 110.925 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -150.45 150.06 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.26 111.128 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.752 ' HG2' HD13 ' A' ' 130' ' ' LEU . 11.3 tt0 -103.49 133.91 47.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 2.16 110.896 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.43 147.35 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.28 111.126 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.513 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.4 t -132.63 148.97 52.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.48 111.024 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.99 135.4 7.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.71 -0.757 . . . . 0.14 112.519 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -90.89 140.09 30.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 1.74 110.836 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 135.04 51.38 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 1.24 110.872 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 124.03 10.67 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.644 2.229 . . . . 0.29 112.38 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.33 110.942 179.995 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.915 0.388 . . . . 2.15 110.865 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.27 21.55 10.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 2.02 110.912 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.67 38.91 59.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.721 . . . . 0.29 112.502 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.467 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.8 mp -76.97 158.12 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.28 111.126 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 36' ' ' THR . 18.5 m -149.62 157.02 42.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.177 -0.465 . . . . 1.05 110.8 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.53 125.59 33.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.35 111.063 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.95 -6.2 23.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 0.31 112.53 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.05 167.57 10.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.758 0.313 . . . . 1.5 110.917 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.66 136.33 39.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 1.3 110.841 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.536 HG12 HG21 ' A' ' 36' ' ' THR . 1.8 p -141.03 136.89 34.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 2.14 111.087 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.745 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -112.3 124.14 51.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.23 111.159 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.85 HG11 HG12 ' A' ' 29' ' ' VAL . 65.7 t -94.69 116.97 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.2 111.121 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.531 HG12 ' CG1' ' A' ' 47' ' ' ILE . 14.5 t -101.31 112.05 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.22 111.15 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -114.52 165.85 12.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.23 110.967 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HB3' HD12 ' A' ' 47' ' ' ILE . 10.3 p-10 -147.36 -170.54 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.305 -0.407 . . . . 1.87 110.916 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -56.95 -35.94 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 4.09 110.815 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -72.61 -9.31 58.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.3 110.804 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.16 94.04 10.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.703 0.763 . . . . 0.15 110.838 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.3 47.64 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.691 2.261 . . . . 0.21 112.335 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.9 t -48.74 -32.94 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.21 111.149 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.84 -53.06 35.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 2.52 110.874 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.57 -44.88 10.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.18 111.095 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.464 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -51.96 -61.7 2.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.15 110.81 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.72 -36.76 26.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 2.59 110.89 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.38 -47.75 49.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.74 . . . . 0.21 112.478 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 mt -61.72 -40.44 95.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 0.49 110.921 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.85 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -75.92 -31.68 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.65 111.087 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.92 -60.46 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 1.7 110.916 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -40.16 71.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 1.73 110.802 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.909 HD23 HD21 ' A' ' 35' ' ' LEU . 77.2 mt -72.7 -24.69 61.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.25 110.935 179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.475 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.47 -24.96 45.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.39 110.927 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.72 -29.93 17.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.22 111.093 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.909 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.61 -35.23 14.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.22 110.873 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.536 HG21 HG12 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -102.46 -44.9 5.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 0.23 111.053 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.97 -11.18 54.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.793 -0.718 . . . . 0.25 112.512 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.3 -62.44 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.685 0.278 . . . . 2.96 110.775 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -91.41 -40.08 11.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 2.25 110.915 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.92 -125.86 4.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.756 -0.735 . . . . 0.27 112.49 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -156.37 152.88 28.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.885 0.374 . . . . 2.16 110.846 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 33' ' ' GLN . 92.3 t -136.91 127.96 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.23 111.104 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.4 t -116.93 152.91 33.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.19 110.823 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.69 132.28 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.23 111.197 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -143.54 152.0 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 1.28 110.905 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -102.38 137.78 40.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.44 110.886 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.784 HD13 HG21 ' A' ' 73' ' ' THR . 36.8 mt -52.65 -36.74 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.27 111.095 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -75.7 -25.18 56.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 2.03 110.862 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -103.89 16.15 27.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 3.37 110.981 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.885 HD13 HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -52.49 -24.72 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 2.74 110.91 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -51.16 -38.96 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.902 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -84.91 -14.2 48.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 1.37 110.907 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.463 ' O ' HG21 ' A' ' 86' ' ' ILE . 19.4 t -58.97 -15.46 13.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 2.4 110.795 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -74.63 53.18 0.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.56 111.168 179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -51.14 -72.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.35 110.865 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.505 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.83 -168.24 2.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 1.62 110.926 179.984 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -100.5 121.09 41.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 2.14 110.944 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.05 84.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.41 110.842 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 p -132.59 -36.84 1.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.28 110.854 -179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.465 ' CD2' HD12 ' A' ' 86' ' ' ILE . 98.1 m-85 -96.03 120.4 36.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 1.46 110.878 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.39 -20.48 61.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 1.77 110.9 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 6' ' ' ILE . 11.1 mt -143.51 144.28 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.3 111.071 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.014 HG21 HG23 ' A' ' 83' ' ' ILE . 20.9 mm -136.13 126.11 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.14 111.189 179.794 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.5 mm? -108.85 137.41 46.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.25 111.001 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.62 99.75 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.14 110.869 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.48 78.93 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.655 -0.783 . . . . 0.18 112.478 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.04 58.07 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 0.58 110.867 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -128.09 159.75 65.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.676 0.751 . . . . 0.24 111.124 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.74 115.63 4.18 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.738 2.292 . . . . 0.27 112.294 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.69 6.32 65.83 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.679 -0.772 . . . . 0.2 112.515 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.43 150.21 12.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.79 110.804 -179.69 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.727 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 22.0 p -140.3 108.86 5.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.22 111.062 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.784 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.16 144.18 9.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.29 111.162 179.989 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.009 HD12 HD22 ' A' ' 147' ' ' LEU . 10.4 mt -120.68 99.63 6.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 0.38 111.032 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -75.69 137.55 40.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.4 110.785 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.437 ' H ' HD13 ' A' ' 79' ' ' ILE . 68.0 m -116.99 178.45 4.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.42 110.884 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.57 -44.12 62.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.31 111.059 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.28 -47.75 77.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 1.87 110.912 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.885 HG23 HD13 ' A' ' 50' ' ' LEU . 4.2 mp -69.79 -56.53 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.23 111.17 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.716 HD13 ' HA ' ' A' ' 119' ' ' LEU . 69.4 mt -50.23 -40.45 47.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.21 110.953 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.93 -57.04 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.29 111.177 179.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -53.69 -43.09 68.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 2.83 110.903 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.014 HG23 HG21 ' A' ' 63' ' ' ILE . 41.7 mm -57.47 -68.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.118 -0.492 . . . . 0.19 111.051 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -50.3 -37.69 37.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.19 111.117 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -53.95 -55.23 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 2.85 110.756 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 56' ' ' LYS . 49.5 pt -81.29 -5.6 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.22 111.066 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -78.64 117.86 20.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.25 110.874 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.7 mtt-85 -57.56 158.87 10.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.598 0.713 . . . . 3.01 110.891 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 54.4 Cg_endo -69.65 114.14 3.59 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.26 . . . . 0.19 112.32 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.33 3.58 55.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.19 112.46 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.02 -165.62 23.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.83 -0.7 . . . . 0.17 112.542 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.3 m -134.84 150.48 50.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.866 0.365 . . . . 0.31 110.896 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.62 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -134.7 115.0 13.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.15 110.963 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.535 ' N ' HD22 ' A' ' 93' ' ' LEU . 54.4 m-85 -110.37 132.47 54.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 1.63 110.792 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.53 159.02 44.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.14 110.871 -179.964 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 130.12 44.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 2.5 110.958 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.66 146.89 18.0 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.653 0.74 . . . . 2.33 110.885 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.515 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.9 Cg_endo -69.69 142.23 47.68 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.674 2.25 . . . . 0.23 112.361 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 157' ' ' VAL . 12.4 m -127.05 146.83 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.19 111.114 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.453 ' CD ' HG21 ' A' ' 103' ' ' VAL . 50.2 mt-10 -107.84 132.92 52.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 1.95 110.926 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.4 p -92.85 -41.4 10.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 1.09 111.15 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.57 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.51 38.53 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.75 110.973 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.453 HG21 ' CD ' ' A' ' 100' ' ' GLU . 21.2 t -146.89 150.63 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.76 111.13 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.641 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -53.51 173.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.82 110.834 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -66.97 -53.7 29.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 2.74 110.91 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -75.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 1.7 110.916 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 52.37 -169.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 1.63 110.836 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -80.3 -5.34 56.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 2.05 110.966 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.81 147.91 22.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.48 111.05 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.2 116.08 8.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 2.11 110.908 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.641 HG21 ' O ' ' A' ' 104' ' ' ASP . 51.4 p -88.21 -178.98 6.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.24 111.102 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.6 64.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.23 111.111 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.66 -49.63 76.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.26 110.939 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -57.1 -44.62 83.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 1.88 110.888 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -59.03 -55.45 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.954 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 71.5 m -53.71 -49.12 68.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.37 110.949 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -45.64 93.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.48 110.862 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.82 -44.84 93.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.34 111.116 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.716 ' HA ' HD13 ' A' ' 80' ' ' LEU . 12.5 tp -61.54 -54.12 47.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.35 110.912 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 100.0 m -61.85 -27.7 68.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.53 111.149 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.01 -17.45 50.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 1.01 110.854 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 p -82.37 3.03 29.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 2.4 110.823 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.38 -4.87 35.28 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.789 -0.72 . . . . 0.56 112.523 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.62 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -84.56 168.13 15.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 0.44 110.916 -179.931 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.501 HG23 ' HG3' ' A' ' 126' ' ' GLU . 27.2 m -150.79 172.97 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.34 111.142 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.501 ' HG3' HG23 ' A' ' 125' ' ' VAL . 36.9 mt-10 53.14 43.05 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 2.21 110.912 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.89 142.27 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.29 111.132 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.78 158.33 7.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 1.65 110.891 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -82.26 147.22 29.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 2.39 110.829 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.775 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.2 mp -107.78 -36.03 6.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.18 111.017 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -164.6 176.49 8.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.471 . . . . 1.29 110.853 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -126.12 165.76 18.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 8.32 110.867 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -148.62 136.34 11.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.671 0.748 . . . . 1.39 110.83 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 157.13 61.51 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.588 2.192 . . . . 0.36 112.448 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.645 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -93.98 127.58 39.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.31 -0.405 . . . . 0.36 110.933 179.976 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.471 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.56 161.37 23.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.544 0.687 . . . . 1.58 111.121 179.983 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -24.85 29.22 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.688 2.259 . . . . 0.46 112.325 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -85.75 -21.99 27.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 3.64 110.922 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -87.5 -53.07 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 2.5 110.93 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -50.13 -41.36 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.34 111.069 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.4 ' N ' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -65.06 -32.39 74.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.13 110.772 -179.929 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -51.32 24.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.58 110.841 -179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.638 HG23 HD13 ' A' ' 147' ' ' LEU . 9.4 p -61.54 -28.39 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.34 111.125 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -75.99 -48.58 20.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 1.93 110.915 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -73.26 -19.73 61.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 1.84 110.929 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -94.19 -33.36 13.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.51 110.835 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.009 HD22 HD12 ' A' ' 74' ' ' LEU . 2.2 mp -129.44 -54.09 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.45 110.916 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.57 14.59 1.9 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.688 -0.768 . . . . 0.31 112.513 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -74.62 120.34 20.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.853 0.359 . . . . 0.62 110.84 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -152.09 105.08 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 4.31 110.865 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.04 167.89 25.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.468 . . . . 0.63 110.816 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.77 -6.72 20.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 1.97 110.945 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 153' ' ' ASN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 2.2 m120 -104.08 14.02 31.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 2.78 110.844 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.645 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -90.26 168.95 11.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.42 110.919 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.629 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -173.51 130.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.28 111.013 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.727 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.7 m-85 -69.38 134.66 49.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 1.88 110.825 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.409 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.73 143.28 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.085 -0.507 . . . . 0.31 111.139 179.976 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.775 ' HG2' HD13 ' A' ' 130' ' ' LEU . 37.5 tt0 -100.79 127.88 47.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 2.28 110.967 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.84 152.18 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.21 111.069 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.449 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -131.54 159.13 39.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.27 111.154 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.4 130.19 3.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.21 112.433 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -93.0 140.27 29.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 1.59 110.919 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 5.3 tptm -81.24 134.27 52.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.507 0.67 . . . . 1.38 110.92 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 119.78 6.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.625 2.217 . . . . 0.32 112.413 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.36 110.868 -179.973 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.789 0.328 . . . . 2.28 110.858 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.535 ' CE1' HD12 ' A' ' 67' ' ' LEU . 4.6 m-85 -122.16 22.27 10.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.235 -0.439 . . . . 2.03 110.894 -179.878 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.16 37.82 47.24 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.26 112.527 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.454 HG21 HD22 ' A' ' 32' ' ' LEU . 1.9 mp -73.95 156.42 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.791 0.329 . . . . 0.3 111.175 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.579 ' O ' HG23 ' A' ' 36' ' ' THR . 57.7 m -147.7 154.73 40.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 1.11 110.897 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.17 125.31 33.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.36 111.177 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.27 -6.56 19.05 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.744 -0.741 . . . . 0.26 112.498 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.8 170.62 7.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 1.54 110.972 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.13 112.44 25.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 1.33 110.926 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.695 HG12 HG21 ' A' ' 36' ' ' THR . 2.2 p -118.31 131.75 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 2.02 111.153 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.753 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -107.26 125.63 51.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.23 111.097 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.815 HG11 HG12 ' A' ' 29' ' ' VAL . 91.4 t -96.18 117.4 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.19 111.24 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 65' ' ' SER . 21.0 t -100.86 119.9 49.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.24 111.102 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -120.0 168.95 10.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 0.19 110.946 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.437 ' HB3' HD12 ' A' ' 47' ' ' ILE . 10.3 p-10 -151.83 -170.28 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 1.91 110.842 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -57.03 -35.6 69.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 2.93 110.975 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 m -73.62 -9.24 58.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.497 . . . . 1.61 110.842 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -106.97 94.2 10.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.634 0.731 . . . . 0.17 110.888 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 54.0 Cg_endo -69.75 142.29 47.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.681 2.254 . . . . 0.21 112.386 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.2 t -48.99 -32.61 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.18 111.096 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.13 -53.06 37.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 2.42 110.903 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.66 -44.56 11.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.17 111.078 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.454 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -52.07 -61.42 2.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.15 110.908 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.14 -37.6 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 2.81 110.914 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.8 -47.54 54.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 0.24 112.409 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 mt -61.49 -40.98 96.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.915 0.388 . . . . 0.46 110.937 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.815 HG12 HG11 ' A' ' 14' ' ' VAL . 17.2 m -75.81 -31.42 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.63 111.065 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.75 -61.15 2.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 1.57 110.843 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.8 -40.59 69.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 1.74 110.85 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.867 HD23 HD21 ' A' ' 35' ' ' LEU . 80.6 mt -71.99 -25.07 61.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.35 110.944 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.519 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.33 -24.54 46.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.38 111.0 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.76 -29.79 17.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.29 111.156 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.867 HD21 HD23 ' A' ' 32' ' ' LEU . 1.6 pp -91.58 -35.46 14.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.29 110.945 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.695 HG21 HG12 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -102.16 -44.89 5.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.23 111.13 -179.978 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.22 -12.16 49.12 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.704 -0.76 . . . . 0.27 112.555 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -67.67 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 1.93 110.871 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -95.56 -38.99 10.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.093 -0.503 . . . . 2.61 110.94 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.1 -131.32 5.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 0.24 112.492 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -152.88 151.73 30.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.932 0.396 . . . . 3.51 110.832 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 33' ' ' GLN . 89.6 t -135.01 125.06 44.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.22 111.107 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -115.87 152.49 33.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.22 110.833 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.32 133.66 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.5 . . . . 0.18 111.089 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -140.93 150.83 43.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 1.59 110.874 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -103.44 134.64 46.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.45 110.833 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.788 HD13 HG21 ' A' ' 73' ' ' THR . 35.2 mt -51.56 -34.56 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.31 111.151 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -71.46 -34.76 70.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.507 . . . . 2.0 110.896 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -101.1 16.15 26.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.262 -0.427 . . . . 3.67 110.874 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.686 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -48.87 -42.8 37.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.17 110.89 -179.971 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -55.5 -39.48 70.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 3.33 110.908 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.16 -13.14 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 5.15 110.924 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.7 m -77.19 -0.47 25.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 1.68 110.874 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.706 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -69.1 70.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.65 111.135 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -51.06 -73.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.439 . . . . 1.49 110.78 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.666 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -142.58 -165.18 1.98 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 1.21 110.915 -179.954 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -106.36 128.71 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 2.15 110.866 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.44 71.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.32 110.826 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.7 p -126.39 -32.13 2.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.28 110.802 -179.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.441 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.1 m-85 -100.24 119.31 38.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 1.43 110.897 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.39 -20.04 62.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 1.52 110.88 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 mt -143.99 144.46 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.25 111.161 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.934 HG21 HG23 ' A' ' 83' ' ' ILE . 22.3 mm -137.66 127.85 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.14 111.185 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.3 mm? -111.3 137.98 48.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.22 110.885 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.408 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -129.63 100.96 5.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.13 110.879 -179.981 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.37 72.2 0.56 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.687 -0.768 . . . . 0.18 112.512 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.578 HD13 ' OE1' ' A' ' 158' ' ' GLN . 3.9 mm? -103.86 58.85 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.339 . . . . 0.62 110.939 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.2 159.73 65.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.546 0.688 . . . . 0.22 111.172 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.89 117.42 5.08 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.233 . . . . 0.22 112.302 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.51 7.24 72.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.818 -0.706 . . . . 0.2 112.53 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.72 146.83 20.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.997 0.427 . . . . 0.69 110.845 -179.761 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.742 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 34.8 p -136.11 108.58 7.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.18 111.127 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.788 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -160.87 147.51 15.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.25 111.143 179.971 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.964 HD12 HD22 ' A' ' 147' ' ' LEU . 5.4 mt -123.63 103.54 8.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.25 110.911 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -81.26 141.95 33.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.34 110.893 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.3 m -123.57 174.73 7.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.46 110.804 -179.725 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.08 55.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.36 111.144 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.38 -46.05 91.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.144 -0.48 . . . . 2.14 110.889 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.686 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -73.15 -55.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.4 111.062 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 119' ' ' LEU . 57.1 mt -49.75 -37.68 30.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.26 110.933 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.75 -57.0 9.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.41 111.096 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.706 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -57.05 -40.58 77.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.189 -0.459 . . . . 2.7 110.905 -179.912 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.934 HG23 HG21 ' A' ' 63' ' ' ILE . 51.9 mm -59.33 -67.58 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.33 111.095 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.43 -33.69 31.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.27 111.106 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -57.23 13.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 2.21 110.824 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 56' ' ' LYS . 26.7 pt -75.15 -8.88 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.26 111.172 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -77.07 125.84 29.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.143 -0.481 . . . . 0.39 110.924 179.875 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -67.05 160.52 69.95 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.651 0.738 . . . . 3.67 110.966 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 114.06 3.57 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.631 2.221 . . . . 0.19 112.366 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.83 3.99 56.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.17 112.468 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.12 -164.48 17.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 0.13 112.435 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 61.2 m -135.32 150.6 50.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.35 110.892 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.694 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -135.44 114.4 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.15 110.867 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.538 ' N ' HD22 ' A' ' 93' ' ' LEU . 59.1 m-85 -109.59 132.35 54.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 1.68 110.88 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.545 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.48 164.16 35.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.19 110.905 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -136.26 124.56 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 1.92 110.959 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.451 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -146.31 150.52 41.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 2.3 110.945 179.935 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.599 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.9 Cg_endo -69.7 139.87 41.49 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.697 2.265 . . . . 0.22 112.382 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.7 m -121.37 147.27 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.37 111.119 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.47 ' CD ' HG21 ' A' ' 103' ' ' VAL . 50.7 mt-10 -119.31 131.92 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 1.96 110.925 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 p -92.73 -36.24 13.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 1.48 111.123 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.51 37.33 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.71 111.137 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.47 HG21 ' CD ' ' A' ' 100' ' ' GLU . 30.7 t -147.68 149.35 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.79 111.123 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.54 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -56.59 179.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 1.71 110.81 179.98 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.41 -74.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 2.71 110.857 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -54.74 -77.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 1.85 110.945 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.25 -169.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 1.64 110.955 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -4.08 52.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 2.35 110.945 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -145.85 141.18 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.55 111.143 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.599 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.1 mmtm -65.66 111.54 3.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 2.88 110.878 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.54 HG21 ' O ' ' A' ' 104' ' ' ASP . 44.8 p -81.0 177.39 9.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.2 111.165 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.56 -55.29 26.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 0.22 111.191 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 m -60.49 -49.68 76.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.27 110.877 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -38.51 70.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 2.83 110.943 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.492 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -65.4 -54.89 22.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.32 110.874 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 48.2 m -57.67 -45.33 85.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.26 110.856 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -42.95 88.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.34 110.858 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.84 97.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.24 111.088 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.574 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.5 tp -65.52 -50.46 65.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.22 110.878 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 95.5 m -64.13 -31.72 73.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.24 111.131 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.2 mt -86.75 -10.39 53.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.402 . . . . 0.63 110.894 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.07 5.17 30.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.416 . . . . 1.77 110.859 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.27 6.42 33.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.672 -0.775 . . . . 0.54 112.405 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -106.67 172.44 6.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.777 0.322 . . . . 0.27 110.985 -179.949 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' A' ' 126' ' ' GLU . 24.4 m -151.18 173.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.26 111.101 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HG3' HG23 ' A' ' 125' ' ' VAL . 36.6 mt-10 53.37 43.93 30.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 2.22 110.862 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 95.5 t -77.5 141.35 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.27 111.03 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 161.43 8.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 1.7 110.841 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 20.4 tt0 -82.26 145.9 29.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 2.09 110.855 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.0 mp -105.59 -35.97 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.33 110.927 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -157.41 175.82 13.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.19 110.981 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -128.62 147.95 50.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 4.12 110.834 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -137.32 134.4 18.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.695 0.759 . . . . 1.4 110.955 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.412 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.1 Cg_endo -69.77 165.21 31.73 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.737 2.292 . . . . 0.24 112.352 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.753 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -97.77 125.53 42.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.29 110.894 179.998 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.448 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.97 161.95 21.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.603 0.716 . . . . 1.27 111.089 -179.977 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.448 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.9 Cg_endo -69.75 -27.85 26.01 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.822 2.348 . . . . 0.33 112.253 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.54 -18.13 34.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 2.66 110.888 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.59 -54.27 4.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 2.78 110.931 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -49.89 -39.96 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.24 111.086 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -34.11 76.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 1.17 110.912 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -47.16 67.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.26 110.811 -179.772 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.69 HG23 HD13 ' A' ' 147' ' ' LEU . 11.1 p -68.08 -30.02 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.16 111.197 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -75.76 -32.25 59.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 1.94 110.908 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -89.4 -20.16 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 1.74 110.916 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -94.34 -32.84 13.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.3 110.848 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.964 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.11 -54.1 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.3 110.88 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.6 16.25 1.68 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.709 -0.758 . . . . 0.29 112.433 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -72.84 122.0 20.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.733 0.302 . . . . 0.88 110.887 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -151.51 105.45 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 2.1 110.848 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -160.54 170.03 21.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.69 110.882 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.14 -14.07 15.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 1.97 110.891 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -101.74 23.39 11.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 1.72 110.855 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.753 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -92.25 163.49 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.23 -0.441 . . . . 0.3 110.891 -179.962 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.587 ' HA ' HD23 ' A' ' 135' ' ' LEU . 2.6 tm? -169.72 130.69 1.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.22 110.939 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.742 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.3 m-85 -76.42 136.86 39.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 1.79 110.874 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.54 145.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.37 111.128 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.578 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.9 tt0 -97.83 129.62 44.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 1.9 110.898 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 3.8 mp -124.44 149.18 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.21 111.071 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.475 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.5 t -126.8 160.73 30.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.31 111.087 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -151.7 128.88 2.67 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.68 -0.772 . . . . 0.19 112.495 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -90.02 139.67 30.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 1.55 110.84 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.81 135.22 49.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.567 0.699 . . . . 1.24 110.873 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 128.41 16.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.647 2.231 . . . . 0.38 112.298 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.854 -179.989 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.798 0.332 . . . . 1.86 110.839 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 6' ' ' ILE . 8.3 m-85 -122.31 13.82 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 1.98 110.797 -179.839 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.76 38.98 96.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.23 112.504 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.7 mp -78.9 158.78 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.22 111.071 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -152.65 162.07 41.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 1.35 110.915 -179.921 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.23 126.32 35.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.26 111.058 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.08 -5.85 17.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.674 -0.774 . . . . 0.25 112.46 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -114.13 168.96 9.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.319 . . . . 1.19 110.857 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.58 140.64 32.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 1.32 110.808 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.654 HG22 ' HB ' ' A' ' 62' ' ' ILE . 61.9 t -142.63 138.46 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 1.84 111.135 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.764 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -115.4 123.94 49.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.23 111.136 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.805 HG11 HG12 ' A' ' 29' ' ' VAL . 59.1 t -97.43 118.19 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.24 111.1 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.503 HG12 ' CG1' ' A' ' 47' ' ' ILE . 13.4 t -102.47 110.98 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.29 111.092 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -112.4 167.38 10.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.19 110.928 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 10.1 p-10 -151.18 -169.46 3.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.69 110.858 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.98 -35.95 69.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 5.75 110.857 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.8 m -72.95 -10.34 59.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 1.52 110.869 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.91 94.48 10.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 0.16 110.879 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 141.42 45.29 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.718 2.279 . . . . 0.21 112.396 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.0 t -48.64 -32.9 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.24 111.128 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.28 -52.64 43.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 3.15 110.891 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.53 -44.94 10.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.22 111.036 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.486 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.87 -61.55 2.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.275 -0.421 . . . . 0.19 110.939 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -37.41 28.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 2.82 110.874 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.21 -47.37 53.04 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.27 112.457 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.93 -39.97 93.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.53 110.92 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.805 HG12 HG11 ' A' ' 14' ' ' VAL . 18.1 m -76.82 -31.56 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.63 111.12 179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -61.98 -59.8 4.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 1.85 110.868 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -40.2 71.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.425 . . . . 2.4 110.876 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.887 HD23 HD21 ' A' ' 35' ' ' LEU . 82.6 mt -72.94 -24.57 60.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.24 110.957 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.402 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.59 -25.36 45.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.43 110.917 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.88 -30.0 17.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.474 . . . . 0.37 111.076 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.887 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.48 -35.08 14.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.27 110.894 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.59 -45.49 4.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.31 111.128 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.07 -12.29 54.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.747 -0.74 . . . . 0.45 112.445 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.39 -62.54 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 2.86 110.951 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 3.6 mm-40 -84.81 -43.6 14.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 2.04 110.923 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.52 -121.86 4.31 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.33 112.471 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -157.03 153.84 28.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 3.32 110.853 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 33' ' ' GLN . 95.0 t -139.24 129.91 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 0.35 111.084 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -118.2 157.95 26.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.18 110.816 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.87 135.07 60.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.18 111.19 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -145.45 151.76 38.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 1.29 110.811 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.85 135.94 43.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.41 110.913 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.724 ' CD1' HG21 ' A' ' 73' ' ' THR . 23.1 mt -51.34 -35.03 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.24 111.087 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -32.05 62.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 2.67 110.863 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.7 19.48 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 3.36 110.882 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.736 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.67 -31.05 4.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.424 . . . . 1.13 110.91 -179.929 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -54.31 -36.3 63.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 1.09 110.947 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -85.46 -15.91 41.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 1.07 110.991 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 m -64.01 -13.32 45.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.93 110.874 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.64 65.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.37 111.118 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -63.84 -72.46 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.4 110.888 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.77 -166.28 2.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 1.61 110.967 179.954 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -106.69 127.13 53.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.957 0.408 . . . . 1.69 110.885 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 49.15 75.88 0.14 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.5 . . . . 1.25 110.886 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.2 p -127.48 -34.4 2.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.25 110.808 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.472 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.4 m-85 -98.54 120.82 39.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 1.48 110.885 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.5 -20.61 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 1.69 110.862 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.654 ' HB ' HG22 ' A' ' 12' ' ' VAL . 30.6 mt -143.87 144.23 23.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.226 -0.443 . . . . 0.32 111.101 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.933 HG21 HG23 ' A' ' 83' ' ' ILE . 23.1 mm -134.65 126.52 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.16 111.137 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.2 mm? -111.16 131.96 54.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.19 110.841 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.7 100.01 6.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.14 110.852 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.59 75.37 0.22 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.792 -0.718 . . . . 0.17 112.479 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.42 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.6 mm? -106.27 55.71 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.891 0.377 . . . . 0.59 110.88 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -123.96 160.07 53.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.579 0.705 . . . . 0.22 111.081 179.925 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 123.29 9.93 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.653 2.236 . . . . 0.27 112.427 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.93 7.52 87.82 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.712 -0.756 . . . . 0.17 112.54 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 68' ' ' VAL . 9.7 p -55.58 149.1 14.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.052 0.453 . . . . 0.75 110.828 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 30.5 p -138.79 109.12 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.044 -0.526 . . . . 0.18 111.2 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.724 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -160.43 156.77 26.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.31 111.106 -179.856 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.849 HD12 HD22 ' A' ' 147' ' ' LEU . 4.7 mt -135.04 106.55 6.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.29 110.915 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -82.11 153.83 25.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.37 110.901 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.7 m -131.0 176.32 8.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.63 110.884 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.47 -36.28 43.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.486 . . . . 0.23 111.094 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -62.5 -42.79 99.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 1.62 110.868 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.736 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -77.53 -55.58 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.3 111.138 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 119' ' ' LEU . 56.0 mt -48.87 -49.69 38.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.27 110.998 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.89 -48.28 51.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.59 111.062 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -46.76 88.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 4.92 110.903 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.933 HG23 HG21 ' A' ' 63' ' ' ILE . 49.9 mm -53.63 -64.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.25 111.122 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.78 -41.38 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.27 111.134 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -51.63 -51.31 56.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 2.55 110.867 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 56' ' ' LYS . 47.4 pt -84.3 -6.29 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.2 111.175 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -80.45 116.64 20.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.29 110.883 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -55.91 159.19 5.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.665 0.745 . . . . 2.3 110.811 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.6 Cg_endo -69.74 113.93 3.53 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.721 2.281 . . . . 0.23 112.395 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.23 4.46 55.18 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.788 -0.72 . . . . 0.21 112.436 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.53 -163.46 19.97 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.776 -0.726 . . . . 0.16 112.407 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.9 m -136.18 154.61 50.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.31 110.9 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.715 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.94 116.36 11.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.2 110.904 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.581 ' N ' HD22 ' A' ' 93' ' ' LEU . 47.6 m-85 -111.68 131.26 55.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 1.7 110.831 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.486 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.67 163.44 37.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.19 110.851 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -137.11 134.43 36.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 3.58 110.894 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.72 148.94 20.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.699 0.761 . . . . 3.48 110.876 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.607 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.6 Cg_endo -69.71 131.91 22.31 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.706 2.271 . . . . 0.46 112.383 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.2 m -120.15 146.59 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.29 111.197 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.28 132.87 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 3.43 110.875 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.1 p -102.56 26.61 7.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 1.06 111.152 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.77 24.72 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.64 111.114 179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.3 t -145.22 160.39 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.21 -0.45 . . . . 0.73 111.11 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.601 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -55.02 177.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 1.95 110.925 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -67.9 -53.03 29.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 3.43 110.875 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -70.88 -76.43 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.97 110.877 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.65 -168.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 1.54 110.851 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -5.28 56.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 1.74 110.872 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -146.02 140.92 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.52 111.149 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -60.6 121.51 12.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 2.37 110.856 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.601 HG21 ' O ' ' A' ' 104' ' ' ASP . 47.3 p -90.02 177.2 6.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.3 111.13 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.07 -54.73 43.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.22 111.097 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -59.51 -48.51 81.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.25 110.872 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -56.73 -40.83 76.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 2.9 110.874 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.514 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -62.91 -54.11 43.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.429 . . . . 0.41 110.894 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.3 m -55.83 -47.93 76.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.27 110.923 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -45.57 88.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.34 110.868 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.32 97.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.32 111.083 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.5 tp -65.94 -53.77 34.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.416 . . . . 0.26 110.957 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.2 m -59.12 -33.48 70.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.38 111.155 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.4 mt -86.99 -10.27 53.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.87 110.953 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.2 m -85.06 4.85 32.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 1.68 110.814 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.14 11.25 26.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.71 112.492 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -111.32 170.77 7.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 0.28 110.839 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.423 HG23 ' HG3' ' A' ' 126' ' ' GLU . 25.6 m -151.38 173.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.28 111.112 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 125' ' ' VAL . 29.8 mt-10 51.72 43.88 29.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 2.2 110.81 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.8 t -75.54 143.63 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.36 111.15 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.16 158.42 6.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 1.56 110.949 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 32.2 tt0 -80.5 145.35 31.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 2.14 110.915 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.3 mp -104.34 -36.71 7.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.29 110.867 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -159.59 176.16 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.16 110.937 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.719 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.3 tmt_? -133.17 138.0 46.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 4.41 110.92 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -123.84 136.11 27.02 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.672 0.749 . . . . 1.5 110.868 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.425 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.3 Cg_endo -69.89 158.82 55.51 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.597 2.198 . . . . 0.31 112.342 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -94.44 124.53 38.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.54 110.91 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.477 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.07 162.7 18.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 1.56 111.135 179.918 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 136' ' ' THR . 53.4 Cg_endo -69.79 -23.15 30.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.661 2.241 . . . . 0.66 112.31 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.79 -22.53 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 2.34 110.965 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -87.65 -53.91 4.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 3.98 110.911 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 136' ' ' THR . 7.7 p -50.66 -40.21 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.35 111.149 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -31.98 73.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 1.31 110.987 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -51.38 19.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.46 110.89 -179.849 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.641 HG23 HD13 ' A' ' 147' ' ' LEU . 7.3 p -61.72 -28.29 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.29 111.098 179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -76.28 -48.24 20.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 2.46 110.86 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -73.63 -19.32 60.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 2.17 110.959 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.5 -33.56 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.65 110.82 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.849 HD22 HD12 ' A' ' 74' ' ' LEU . 2.2 mp -128.32 -54.43 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.72 110.925 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.81 12.66 1.91 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.736 -0.745 . . . . 0.63 112.556 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.405 ' HB3' HG22 ' A' ' 143' ' ' VAL . 21.9 t-160 -70.77 121.37 17.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.93 110.834 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -152.04 105.48 3.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 2.73 110.946 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.48 175.02 13.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.66 110.826 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.82 -17.82 13.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.072 -0.513 . . . . 1.71 110.793 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -94.66 12.17 28.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 1.53 110.839 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.707 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.31 164.02 22.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.41 110.92 179.949 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.719 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.35 132.08 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.2 110.876 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 17.7 m-85 -77.09 131.86 38.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 1.73 110.845 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.69 144.37 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.21 111.139 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.527 ' HG2' HD13 ' A' ' 130' ' ' LEU . 3.4 tt0 -102.01 130.6 48.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 2.06 110.898 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 4.3 mp -126.03 149.72 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.31 111.183 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.45 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.5 t -127.88 160.48 31.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.29 111.062 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.52 132.22 3.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.83 -0.7 . . . . 0.15 112.606 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -94.71 140.84 29.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 1.77 110.925 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 6.2 tptm -81.46 134.52 51.23 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.621 0.724 . . . . 1.4 110.851 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 118.75 5.87 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.775 2.316 . . . . 0.42 112.328 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.5 110.895 179.961 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.898 0.38 . . . . 2.72 110.851 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.401 ' HB2' HD11 ' A' ' 6' ' ' ILE . 5.2 m-85 -122.4 22.13 10.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 1.53 110.758 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.51 41.92 56.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.814 -0.708 . . . . 0.31 112.445 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.483 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.6 mp -81.51 160.22 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.817 0.342 . . . . 0.34 111.099 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 36' ' ' THR . 0.4 OUTLIER -156.48 168.21 28.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 1.72 110.818 -179.927 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.64 130.62 35.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.4 111.099 179.881 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.15 2.79 29.79 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.719 -0.753 . . . . 0.3 112.448 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.446 ' NE2' ' HB2' ' A' ' 7' ' ' SER . 3.6 pt20 -116.96 166.88 11.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 1.05 110.958 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.02 115.19 29.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 1.3 110.848 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.591 HG13 HG21 ' A' ' 36' ' ' THR . 3.4 m -117.95 139.78 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 2.31 111.151 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.761 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -114.04 112.12 22.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.39 111.089 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.892 HG11 HG12 ' A' ' 29' ' ' VAL . 95.9 t -87.65 121.87 38.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.21 111.163 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.592 HG12 HG13 ' A' ' 47' ' ' ILE . 17.6 t -108.29 119.84 58.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.2 111.219 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -117.8 166.15 12.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.19 110.972 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.646 ' HB3' HD12 ' A' ' 47' ' ' ILE . 6.2 p-10 -145.65 -169.06 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.309 -0.405 . . . . 1.69 110.872 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -59.59 -35.28 73.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 3.44 110.937 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.4 m -74.68 -6.92 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 1.53 110.86 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.62 92.7 8.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.682 0.753 . . . . 0.13 110.906 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 54.9 Cg_endo -69.71 143.08 49.94 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 0.2 112.413 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t -48.8 -32.77 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.18 111.193 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -51.0 -53.26 34.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 3.13 110.872 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.57 -44.95 10.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 0.16 111.12 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.45 -61.95 1.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.13 110.968 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.52 -35.77 21.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 2.6 110.921 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.87 -47.67 45.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.677 -0.773 . . . . 0.19 112.548 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.4 mt -61.73 -39.86 93.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.92 0.391 . . . . 0.48 110.987 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.892 HG12 HG11 ' A' ' 14' ' ' VAL . 17.0 m -76.65 -31.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.63 111.199 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.38 -59.68 4.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 1.66 110.807 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -40.29 72.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 1.7 110.945 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.862 HD23 HD21 ' A' ' 35' ' ' LEU . 86.4 mt -72.78 -24.93 61.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.24 110.883 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.478 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.49 -25.01 45.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.38 110.82 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.59 -29.95 17.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.22 111.094 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.862 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.6 -34.82 14.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.19 110.892 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.17 -45.6 4.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.22 111.134 179.918 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.47 -12.27 55.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.3 112.505 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -65.33 -62.66 1.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 2.62 110.989 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.09 -36.49 10.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 1.88 110.925 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.32 -128.74 4.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.25 112.452 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -154.32 153.19 31.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 2.21 110.799 -179.899 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 12' ' ' VAL . 94.8 t -138.88 117.05 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.31 111.116 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.3 t -107.01 151.35 25.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.22 110.794 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -114.24 136.29 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.14 111.02 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -144.99 152.2 39.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.142 -0.481 . . . . 1.27 110.842 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -102.8 134.34 46.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.48 110.952 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.926 HD13 HG21 ' A' ' 73' ' ' THR . 10.2 mt -50.29 -33.56 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.34 111.101 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -76.48 -34.3 58.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 2.64 110.878 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -93.37 18.57 9.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 3.16 110.821 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.793 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.49 -30.25 4.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 1.12 110.961 179.891 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mp -53.45 -37.95 63.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 1.08 110.844 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -85.23 -16.18 41.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 1.18 110.834 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.467 ' HB2' HD13 ' A' ' 50' ' ' LEU . 48.8 m -65.41 -12.38 51.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 0.95 110.873 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.84 61.2 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.41 111.099 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -58.62 -71.82 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.117 -0.492 . . . . 0.47 110.806 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -150.2 -168.68 3.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 1.75 110.866 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -102.18 137.71 40.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 1.94 110.899 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 p 46.55 85.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 1.19 110.873 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 p -139.97 -40.49 0.44 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.46 110.865 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.494 ' O ' HD23 ' A' ' 87' ' ' LEU . 96.4 m-85 -99.64 120.42 39.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 1.48 110.889 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.62 -21.6 63.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 1.5 110.819 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.5 mt -147.16 142.64 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.38 111.165 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.921 HG21 HG23 ' A' ' 83' ' ' ILE . 22.5 mm -129.43 134.42 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.27 111.109 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -114.54 135.24 54.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.29 110.924 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.76 97.73 4.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.15 110.801 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.48 79.54 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.22 112.47 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.88 56.69 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.59 110.959 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.31 159.35 57.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.617 0.723 . . . . 0.21 111.16 179.809 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 116.46 4.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.683 2.255 . . . . 0.25 112.375 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.31 7.37 69.82 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.2 112.533 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -54.79 144.25 23.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.974 0.416 . . . . 0.68 110.87 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.76 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 31.5 p -133.49 108.5 8.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.19 111.166 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.926 HG21 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -162.7 149.53 13.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.25 111.095 -180.0 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.931 HD12 HD22 ' A' ' 147' ' ' LEU . 3.4 mt -127.52 99.99 5.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.13 -0.486 . . . . 0.26 110.967 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -73.23 145.95 45.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.32 110.881 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.513 ' H ' HD13 ' A' ' 79' ' ' ILE . 1.5 m -120.28 172.8 7.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.55 110.742 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.34 -39.7 47.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.33 111.125 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.6 -38.31 84.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 2.38 110.909 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.793 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -79.81 -54.84 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.23 111.201 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' A' ' 119' ' ' LEU . 50.0 mt -49.84 -45.87 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.33 110.906 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.75 -51.65 54.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.174 -0.467 . . . . 0.46 111.014 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -42.48 77.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 2.61 110.886 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.921 HG23 HG21 ' A' ' 63' ' ' ILE . 36.9 mm -59.93 -68.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.28 111.093 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.57 -32.68 19.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.45 111.127 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -61.02 -56.15 24.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 2.35 110.906 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 56' ' ' LYS . 29.8 pt -76.95 -6.72 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.3 111.165 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -78.36 124.31 27.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.27 110.891 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -62.67 160.23 37.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.572 0.701 . . . . 2.13 110.869 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 114.04 3.56 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.73 2.286 . . . . 0.23 112.318 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.71 3.5 56.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.819 -0.705 . . . . 0.21 112.44 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.11 -156.9 9.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.716 -0.754 . . . . 0.22 112.423 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.3 m -146.0 158.18 43.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.888 0.375 . . . . 0.5 110.833 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.631 HD22 ' N ' ' A' ' 94' ' ' PHE . 1.0 OUTLIER -140.38 116.14 10.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.18 110.954 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.631 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.0 m-85 -108.76 132.73 53.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.63 110.84 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.533 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.56 160.59 42.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.16 110.878 179.944 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 126.37 36.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 1.81 110.862 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.522 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -149.9 148.13 24.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.659 0.742 . . . . 2.3 110.875 179.982 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.6 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.5 Cg_endo -69.65 143.95 53.05 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.718 2.279 . . . . 0.23 112.386 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.6 m -127.12 147.0 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.25 111.1 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.01 132.42 56.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 3.15 110.811 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.7 p -104.75 25.99 9.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 1.04 111.247 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.65 26.31 0.83 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.74 111.104 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 104' ' ' ASP . 4.8 t -144.09 158.64 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.75 111.114 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.543 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -57.11 -177.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.86 110.886 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -66.5 -73.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 2.4 110.874 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.34 -75.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 2.34 110.834 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.75 -168.56 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 1.68 110.747 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -6.28 57.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 1.74 110.886 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.3 m -146.61 143.44 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.48 111.079 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.491 ' H ' HD22 ' A' ' 74' ' ' LEU . 7.6 ttmt -65.61 113.18 4.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.4 110.963 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.543 HG21 ' O ' ' A' ' 104' ' ' ASP . 30.3 p -83.19 179.83 7.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.25 111.187 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.65 -54.27 47.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.28 111.042 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -49.54 76.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.26 110.865 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -39.74 76.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 2.14 110.865 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.522 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.3 tm? -62.97 -55.1 28.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.4 110.965 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.7 m -57.84 -47.43 82.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.25 110.853 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -44.33 96.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.28 110.912 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.11 -50.96 71.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.3 111.182 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.634 ' CD1' HD22 ' A' ' 80' ' ' LEU . 7.1 tp -59.68 -57.31 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.54 110.865 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -57.52 -26.56 61.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.38 111.14 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.9 mt -84.3 -16.0 44.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.75 110.93 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.0 p -82.2 3.09 28.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 2.52 110.809 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.81 -4.85 34.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.92 112.49 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.637 HD23 ' HA3' ' A' ' 161' ' ' GLY . 1.4 tp -83.32 171.3 13.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.54 110.92 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.07 169.66 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.42 111.146 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 51.64 44.93 28.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 2.24 110.881 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.16 139.44 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.28 111.149 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.18 159.98 7.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 1.84 110.879 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -77.54 145.29 37.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 2.61 110.913 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.712 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.1 mp -102.16 -37.53 8.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.25 110.917 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -156.04 176.27 12.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 3.0 110.957 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ARG . . . . . 0.726 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.0 tmt_? -129.39 136.87 50.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.328 -0.397 . . . . 4.23 110.929 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -123.55 136.56 27.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.62 0.724 . . . . 1.39 110.999 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.403 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.7 Cg_endo -69.71 163.2 39.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.649 2.233 . . . . 0.26 112.388 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.669 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -96.79 124.35 40.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.174 -0.466 . . . . 0.29 110.909 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.456 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.09 161.21 25.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.64 0.734 . . . . 1.32 111.145 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.8 Cg_endo -69.77 -28.57 25.06 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.704 2.27 . . . . 0.46 112.32 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -85.1 -17.76 36.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.217 -0.447 . . . . 2.49 110.936 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.32 -54.0 4.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 2.82 110.998 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.58 -40.03 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.26 111.095 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -34.72 76.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 1.28 110.86 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -46.77 69.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.29 110.793 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 10.3 p -68.0 -30.03 46.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.21 111.183 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -75.66 -32.25 60.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 2.04 110.923 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -89.43 -20.29 24.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 1.61 110.901 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -94.36 -32.55 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.3 110.828 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.931 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -128.31 -54.05 1.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.33 110.843 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.38 12.12 2.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.807 -0.711 . . . . 0.31 112.49 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -70.9 121.53 18.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.682 0.277 . . . . 0.66 110.853 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -152.18 105.27 3.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.296 -0.411 . . . . 2.27 110.923 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.7 t -160.73 176.52 11.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.61 110.91 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.12 -20.8 13.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.7 110.952 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -92.02 13.13 19.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 1.57 110.938 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.669 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.54 163.89 22.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.33 110.921 179.909 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.6 tm? -173.35 129.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.2 110.851 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.76 ' CZ ' HG22 ' A' ' 72' ' ' THR . 31.3 m-85 -75.39 137.62 41.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 1.71 110.882 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -150.3 146.41 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.23 111.154 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.712 ' HG2' HD13 ' A' ' 130' ' ' LEU . 23.2 tt0 -98.9 132.05 44.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 1.57 110.926 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -126.99 149.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.23 111.144 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.464 ' N ' HD11 ' A' ' 130' ' ' LEU . 7.0 t -137.06 152.64 50.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.37 111.094 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.637 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -144.1 137.48 7.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.73 . . . . 0.17 112.483 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -92.83 140.18 29.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 1.75 110.832 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.57 135.29 49.77 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.622 0.725 . . . . 1.26 110.855 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 127.47 14.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.724 2.283 . . . . 0.32 112.292 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.34 110.908 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.774 0.321 . . . . 3.49 110.875 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.02 -21.94 62.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.45 111.092 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -51.49 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 2.35 110.83 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -122.24 22.55 10.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 1.97 110.842 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.31 40.14 52.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.26 112.529 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.543 HG23 HG21 ' A' ' 12' ' ' VAL . 1.7 mp -78.51 159.26 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.23 111.15 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.725 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -152.43 163.48 39.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 1.36 110.859 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.47 126.1 35.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.32 111.096 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.69 -0.0 20.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.72 -0.752 . . . . 0.3 112.477 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -117.55 170.64 8.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.827 0.346 . . . . 1.12 110.902 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.81 113.79 27.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 1.36 110.856 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 ' HB ' ' A' ' 62' ' ' ILE . 99.1 t -118.5 125.89 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 1.96 111.177 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.781 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -103.16 128.44 50.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.28 111.124 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.843 HG11 HG12 ' A' ' 29' ' ' VAL . 60.7 t -101.32 120.84 51.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.17 111.166 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.5 t -104.31 120.87 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.23 111.128 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.4 p-90 -120.48 168.99 10.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.19 110.898 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.76 -169.93 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 1.75 110.813 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -57.41 -35.56 70.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 3.53 110.886 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.54 -9.9 59.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 1.24 110.837 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.04 94.44 10.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.686 0.755 . . . . 0.13 110.912 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 142.03 46.72 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.683 2.255 . . . . 0.19 112.34 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.0 t -48.99 -32.57 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.17 111.12 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.38 -52.93 41.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 2.67 110.851 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.55 -44.96 10.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.17 111.048 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.467 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.45 -61.25 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.13 110.917 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -35.95 24.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 3.42 110.87 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.41 -47.25 44.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.786 -0.721 . . . . 0.18 112.439 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 mt -61.94 -38.61 89.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.48 110.928 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.843 HG12 HG11 ' A' ' 14' ' ' VAL . 17.5 m -78.09 -31.35 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.62 111.155 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.33 -58.0 9.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 1.59 110.84 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -40.05 74.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 1.73 110.909 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.879 HD23 HD21 ' A' ' 35' ' ' LEU . 88.4 mt -73.12 -25.07 60.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.24 110.891 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.472 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.37 -25.26 46.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.37 110.877 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.49 -30.25 17.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.22 111.153 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.879 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -90.75 -35.18 15.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.2 110.904 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.725 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.4 -46.9 4.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.2 111.135 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.31 -13.74 50.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.73 . . . . 0.26 112.477 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -62.58 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 2.0 110.882 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -96.01 -38.11 10.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 2.03 110.903 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.56 -132.98 6.52 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.759 -0.734 . . . . 0.27 112.461 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -149.22 152.67 36.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 2.18 110.906 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.8 t -137.68 122.81 24.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.23 111.1 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -112.14 157.63 20.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.18 110.844 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.58 135.19 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.17 111.132 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -142.51 151.1 41.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 2.02 110.847 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -103.26 134.59 46.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.4 110.861 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.722 ' CD1' HG21 ' A' ' 73' ' ' THR . 26.7 mt -51.89 -36.48 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.33 111.15 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -32.84 69.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 2.19 110.869 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -103.52 20.92 16.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 3.52 110.93 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.845 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.15 -27.8 3.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 1.06 110.928 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -55.1 -32.7 62.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 1.04 110.888 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -84.86 -15.33 45.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 1.06 110.929 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB2' HD13 ' A' ' 50' ' ' LEU . 47.0 m -63.77 -12.61 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.88 110.892 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -73.83 63.1 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.28 111.083 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.406 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 4.8 m80 -64.46 -70.17 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.38 110.873 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.686 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.12 -168.2 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 1.13 110.914 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -106.35 128.12 53.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 2.01 110.846 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 48.93 77.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 1.34 110.843 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.7 p -130.12 -34.2 1.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.26 110.845 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.2 m-85 -98.99 120.25 39.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 1.42 110.886 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.13 -20.72 62.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 1.5 110.842 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.699 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.2 mt -146.62 144.5 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.23 111.153 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.92 HG21 HG23 ' A' ' 83' ' ' ILE . 17.2 mm -134.69 131.71 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.12 111.118 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -113.94 137.06 52.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.17 110.976 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.47 101.64 6.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.15 110.873 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.63 74.66 0.27 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.804 -0.713 . . . . 0.16 112.428 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.576 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.2 mm? -106.63 56.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 0.58 110.893 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.0 159.79 60.1 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.621 0.724 . . . . 0.23 111.2 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 124.14 10.77 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.24 112.32 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.5 7.11 88.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.21 112.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 68' ' ' VAL . 10.0 p -55.58 151.49 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.972 0.415 . . . . 0.78 110.829 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 29.7 p -140.33 108.96 5.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.18 111.132 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.722 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.79 153.81 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 0.26 111.126 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.96 HD12 HD22 ' A' ' 147' ' ' LEU . 5.3 mt -132.25 105.78 7.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.22 110.916 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -82.35 152.5 26.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.25 110.845 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.0 m -131.94 176.98 7.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.48 110.843 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -37.27 45.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.24 111.079 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.25 -44.41 96.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 2.07 110.883 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.845 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -75.11 -54.85 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.19 111.133 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 119' ' ' LEU . 61.7 mt -51.08 -38.92 54.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.22 110.906 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.84 -55.2 24.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.32 111.101 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -56.09 -44.96 79.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 2.82 110.887 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.92 HG23 HG21 ' A' ' 63' ' ' ILE . 49.9 mm -55.08 -67.76 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.22 111.132 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.07 -40.1 57.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.25 111.067 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -52.95 -49.06 66.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 2.85 110.883 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.686 HG22 ' O ' ' A' ' 56' ' ' LYS . 38.7 pt -87.02 -5.3 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.19 111.162 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -80.92 117.3 21.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.25 110.887 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -56.81 158.69 8.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.598 0.714 . . . . 2.29 110.917 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 54.0 Cg_endo -69.73 114.03 3.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 0.19 112.365 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.03 3.27 54.75 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.15 112.504 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.38 -162.8 17.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.784 -0.722 . . . . 0.14 112.502 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.3 m -137.01 155.5 49.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.347 . . . . 0.27 110.872 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -139.56 115.55 10.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.15 110.893 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.551 ' N ' HD22 ' A' ' 93' ' ' LEU . 58.6 m-85 -110.15 132.1 54.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 1.9 110.873 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.549 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.78 158.76 44.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.15 110.883 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.38 128.29 44.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 1.86 110.905 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.596 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -150.69 146.19 19.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 2.26 110.914 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.608 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.73 138.07 37.04 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.656 2.238 . . . . 0.18 112.365 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 155' ' ' LEU . 14.9 m -120.71 146.55 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.19 111.098 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -110.59 132.58 54.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 1.93 110.851 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.2 p -105.15 25.9 10.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 1.11 111.145 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.63 25.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.7 111.106 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.5 t -143.66 159.79 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.74 111.123 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.53 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -56.66 -178.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 1.79 110.889 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -66.81 -68.27 0.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 2.05 110.873 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -60.0 -75.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 2.19 110.859 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.81 -167.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 1.72 110.863 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -7.48 58.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 1.91 110.886 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.44 141.02 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.53 111.106 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -63.17 115.09 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 2.43 110.895 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.53 HG21 ' O ' ' A' ' 104' ' ' ASP . 33.1 p -83.19 -179.8 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.27 111.113 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.63 55.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.28 111.091 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.19 -48.9 77.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.31 110.887 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -37.92 75.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 2.3 110.888 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.596 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.3 tm? -65.17 -55.05 20.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.34 110.912 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.8 m -57.37 -45.59 84.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.35 110.897 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -42.42 91.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.48 110.852 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.89 97.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.32 111.075 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.56 HD11 HD12 ' A' ' 93' ' ' LEU . 14.8 tp -64.52 -51.44 62.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.25 110.916 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.5 m -62.28 -31.55 72.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.34 111.113 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.04 -10.27 53.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.67 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.5 6.51 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 1.7 110.864 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.82 6.0 32.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.49 112.465 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -106.69 171.63 7.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 0.28 110.942 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 126' ' ' GLU . 27.4 m -150.14 171.15 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.27 111.144 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.516 ' HG3' HG23 ' A' ' 125' ' ' VAL . 22.5 mt-10 51.76 44.29 29.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 1.85 110.903 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.419 HG13 HD23 ' A' ' 119' ' ' LEU . 89.6 t -81.09 143.03 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.25 111.109 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 160.22 8.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 1.57 110.902 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -77.75 146.18 36.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 2.5 110.906 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.475 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.1 mp -105.6 -36.96 6.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.2 110.964 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.85 176.21 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 1.16 110.932 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.698 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.7 tmt_? -132.87 137.98 46.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 4.28 110.845 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -125.74 138.07 31.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.615 0.722 . . . . 1.82 110.888 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.413 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.7 Cg_endo -69.71 165.04 32.27 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.729 2.286 . . . . 0.23 112.35 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.676 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.03 126.48 43.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.28 110.944 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.52 161.27 23.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.619 0.723 . . . . 1.49 111.107 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -24.57 29.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.241 . . . . 0.31 112.353 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -85.49 -22.54 28.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 2.54 110.886 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -87.51 -52.86 5.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 2.5 110.901 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 136' ' ' THR . 7.4 p -49.62 -40.34 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.23 111.169 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -33.49 74.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 1.16 110.921 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -46.19 67.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.23 110.888 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.708 HG23 HD13 ' A' ' 147' ' ' LEU . 9.2 p -68.37 -30.71 48.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.16 111.101 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -76.21 -31.45 58.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 1.87 110.862 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -89.7 -20.44 23.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 1.63 110.841 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -94.66 -32.87 13.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.27 110.849 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.96 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.19 -54.17 1.38 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.3 110.934 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.51 13.75 2.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.28 112.483 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -70.63 122.01 18.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 0.75 110.826 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -151.53 105.32 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 2.4 110.837 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.1 t -160.53 173.82 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.7 110.86 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.71 -17.59 14.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 1.56 110.858 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.76 12.52 29.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 1.53 110.911 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.676 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -81.61 165.18 21.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.25 110.952 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.44 130.24 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.18 110.973 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.2 m-85 -74.34 133.44 42.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 1.8 110.877 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.04 145.19 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.22 111.156 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.576 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.6 tt0 -98.97 129.26 45.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.91 110.957 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.54 151.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.21 111.102 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.456 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.1 t -134.91 161.56 34.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.25 111.141 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.43 139.5 7.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.19 112.476 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -97.56 140.62 31.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.368 . . . . 1.62 110.889 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 5.2 tptt -80.71 134.79 53.28 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.599 0.714 . . . . 2.32 110.877 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 119.19 6.18 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.39 112.301 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -102.3 152.0 21.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.37 110.883 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -71.51 81.44 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 6.84 110.92 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -179.26 34.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 10.14 110.865 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.0 t -149.92 -72.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 6.86 111.105 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 97.41 28.11 8.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 6.09 112.487 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.5 m -55.03 -60.78 2.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.384 . . . . 7.74 110.879 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.4 -74.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 6.38 110.896 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 11.01 110.893 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.418 ' O ' HD12 ' A' ' 6' ' ' ILE . 5.1 ptp . . . . . 0 N--CA 1.458 -0.036 0 CA-C-O 120.784 0.326 . . . . 3.9 110.893 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.6 -21.07 65.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.5 111.098 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.1 -51.42 64.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 1.97 110.802 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' A' ' 6' ' ' ILE . 4.5 m-85 -122.14 21.4 10.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 1.53 110.898 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 54.46 41.82 73.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.768 -0.73 . . . . 0.31 112.451 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.538 HG23 HG21 ' A' ' 12' ' ' VAL . 1.5 mp -83.14 160.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.32 111.137 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.733 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -156.62 168.99 25.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.82 110.831 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.8 132.28 35.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.46 111.034 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.05 1.31 30.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.28 112.482 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -118.18 166.95 11.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.781 0.324 . . . . 1.2 110.933 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.67 113.05 26.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 2.17 110.899 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 62' ' ' ILE . 95.3 t -117.35 132.52 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 1.92 111.136 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.793 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -109.03 125.29 51.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.23 111.057 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.828 HG11 HG12 ' A' ' 29' ' ' VAL . 99.6 t -98.35 120.37 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.16 111.144 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.31 118.45 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.2 111.134 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -118.6 168.85 10.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 0.19 110.912 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -151.48 -169.91 3.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.267 -0.424 . . . . 1.85 110.857 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -57.63 -35.49 70.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 3.02 110.882 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.61 -9.51 58.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 1.21 110.848 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.92 94.62 10.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.748 0.785 . . . . 0.15 110.923 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 142.11 47.33 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.657 2.238 . . . . 0.23 112.34 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.13 -32.57 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.21 111.108 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.28 -52.92 40.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 2.59 110.907 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.9 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.19 111.155 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.6 -61.41 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.15 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -49.6 -36.01 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 2.49 110.901 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.21 -47.22 45.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 0.2 112.47 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.96 -38.57 89.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.755 0.312 . . . . 0.52 110.87 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.828 HG12 HG11 ' A' ' 14' ' ' VAL . 17.0 m -78.21 -31.09 16.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.63 111.079 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -62.54 -57.86 9.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 1.69 110.852 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -40.01 75.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 1.75 110.94 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.886 HD23 HD21 ' A' ' 35' ' ' LEU . 88.1 mt -73.17 -24.77 60.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.24 110.89 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.547 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.5 -25.03 45.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.38 110.825 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.74 -30.36 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.22 111.026 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.886 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.81 -34.93 15.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.21 110.905 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.79 -46.06 4.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.21 111.139 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.83 -12.62 54.42 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.828 -0.701 . . . . 0.25 112.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.61 -62.6 1.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.754 0.311 . . . . 2.18 110.938 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -96.33 -37.85 10.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 2.56 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.13 -129.87 5.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 0.26 112.497 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -152.59 152.03 31.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.88 0.371 . . . . 2.18 110.885 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.547 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.0 t -136.33 124.83 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.22 111.036 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -114.07 155.83 25.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.15 110.9 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.52 134.8 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.14 111.141 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -142.76 151.3 41.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 1.26 110.864 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -103.3 134.99 45.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.4 110.906 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.673 ' CD1' HG21 ' A' ' 73' ' ' THR . 26.4 mt -52.17 -36.12 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.28 111.128 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -71.54 -32.25 67.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 2.01 110.877 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -103.18 20.11 18.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 3.61 110.856 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.833 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.32 -28.08 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 1.07 110.899 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.53 -33.46 63.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 1.05 110.9 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -84.06 -15.15 48.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 1.06 110.969 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.454 ' HB2' HD13 ' A' ' 50' ' ' LEU . 34.5 m -66.55 -10.13 41.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.87 110.859 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.5 63.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.27 111.059 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -64.02 -67.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.36 110.873 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -153.85 -178.22 6.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 1.38 110.849 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -92.63 130.52 38.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 1.83 110.885 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 t 51.79 83.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 2.11 110.879 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.4 p -136.06 -39.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.28 110.773 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.7 m-85 -100.51 122.25 42.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 2.03 110.975 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.5 m-20 -71.73 -21.9 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 1.73 110.853 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.693 ' HB ' HG22 ' A' ' 12' ' ' VAL . 21.4 mt -145.34 144.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.22 111.087 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.93 HG21 HG23 ' A' ' 83' ' ' ILE . 17.2 mm -133.75 132.7 56.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.13 111.104 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -114.58 136.88 52.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.15 110.916 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.44 100.33 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.13 110.854 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.54 74.97 0.24 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.16 112.446 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.556 HD13 ' OE1' ' A' ' 158' ' ' GLN . 3.9 mm? -107.45 58.19 0.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.866 0.365 . . . . 0.57 110.928 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.0 159.65 63.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.611 0.719 . . . . 0.23 111.146 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 116.73 4.7 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.601 2.201 . . . . 0.26 112.355 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.46 7.13 69.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.841 -0.695 . . . . 0.17 112.465 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.55 150.24 12.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.939 0.4 . . . . 0.68 110.87 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.773 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 39.5 p -138.98 108.45 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.21 111.127 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.673 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.14 153.44 18.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.25 111.239 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.879 HD12 HD22 ' A' ' 147' ' ' LEU . 3.3 mt -132.77 104.57 6.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.28 110.856 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -81.16 153.74 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.26 110.885 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.1 m -131.56 -176.29 3.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.43 110.925 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.8 -36.93 70.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.23 111.106 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.59 -46.48 88.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 2.32 110.874 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.833 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -73.04 -54.96 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 0.2 111.079 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 119' ' ' LEU . 65.2 mt -50.72 -40.18 53.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.19 110.96 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.02 -53.94 35.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.053 -0.521 . . . . 0.3 111.15 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.23 -44.8 88.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 3.01 110.868 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.93 HG23 HG21 ' A' ' 63' ' ' ILE . 38.7 mm -55.67 -68.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.2 111.099 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.33 -37.82 49.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.21 111.187 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -55.11 -49.83 70.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 3.35 110.898 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 56' ' ' LYS . 34.3 pt -85.21 -7.02 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.2 111.108 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.95 111.78 14.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.142 -0.481 . . . . 0.38 110.9 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 61' ' ' ASP . 48.8 mtt180 -51.46 159.53 1.17 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.59 0.71 . . . . 2.24 110.852 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 114.44 3.7 Favored 'Trans proline' 0 N--CA 1.466 -0.113 0 C-N-CA 122.786 2.324 . . . . 0.16 112.342 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.77 2.41 56.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.662 -0.78 . . . . 0.15 112.416 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.28 -162.57 13.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.647 -0.787 . . . . 0.13 112.551 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.2 m -138.32 156.03 48.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.832 0.349 . . . . 0.35 110.9 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.704 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -140.01 114.31 9.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.16 110.974 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.554 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.0 m-85 -108.46 132.34 53.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 1.65 110.897 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.576 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.51 162.31 39.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.13 110.845 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.05 129.35 35.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 1.88 110.842 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.72 148.65 20.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.655 0.74 . . . . 3.71 110.854 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.617 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.1 Cg_endo -69.82 140.88 43.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.61 2.206 . . . . 0.18 112.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.9 m -125.86 146.67 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.22 111.099 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' CD ' HG21 ' A' ' 103' ' ' VAL . 46.8 mt-10 -108.89 132.75 53.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 2.06 110.953 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p -90.94 -42.68 10.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 1.29 111.091 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.559 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.5 40.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.59 111.111 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' CD ' ' A' ' 100' ' ' GLU . 26.4 t -148.03 150.05 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.63 111.069 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -52.86 171.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.69 110.854 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -66.37 -54.17 27.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 2.83 110.96 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -70.66 -75.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 1.69 110.837 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t 52.31 -169.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.034 0.445 . . . . 2.2 110.841 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -81.71 -4.69 56.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 1.77 110.877 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.12 150.4 21.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.4 111.043 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.18 119.2 13.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 2.97 110.844 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.647 HG21 ' O ' ' A' ' 104' ' ' ASP . 62.8 p -91.81 178.86 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.29 111.201 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.4 -53.61 55.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.2 111.127 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -61.06 -47.16 87.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.26 110.819 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -42.25 91.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 2.47 110.889 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -61.82 -57.43 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.48 110.886 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 66.6 m -52.05 -44.97 64.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.23 110.888 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -42.06 87.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.29 110.824 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.11 97.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.22 111.095 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.556 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.0 tp -66.2 -50.93 62.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.23 110.987 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.0 m -61.99 -33.31 74.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.31 111.138 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.87 -10.45 53.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.66 110.897 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.72 5.25 29.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 1.7 110.872 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.81 11.23 25.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.647 -0.787 . . . . 0.68 112.38 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.704 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -112.13 171.0 7.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 0.26 110.883 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.2 m -150.9 170.19 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.21 111.168 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 53.01 44.41 30.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 2.32 110.92 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.4 t -81.04 142.94 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.25 111.174 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.93 158.58 7.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 1.59 110.866 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -77.23 145.68 37.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 2.28 110.784 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.502 HD11 ' N ' ' A' ' 160' ' ' THR . 2.1 mp -105.15 -35.55 7.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.23 110.975 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.1 176.42 12.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 1.09 110.879 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.72 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -131.86 137.4 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 4.12 110.907 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -124.02 137.65 29.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 1.83 110.874 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.426 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.9 Cg_endo -69.74 165.02 32.34 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.693 2.262 . . . . 0.22 112.353 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.671 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.15 127.47 44.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.27 110.914 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.434 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.21 161.1 24.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 1.21 111.145 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.434 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.6 Cg_endo -69.76 -28.79 24.83 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.625 2.217 . . . . 0.32 112.307 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -85.24 -17.86 35.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 2.77 110.924 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.23 -53.25 4.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 2.33 110.909 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.22 -40.65 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.25 111.123 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -34.86 76.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 1.18 110.926 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.86 -46.18 72.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.22 110.904 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 8.5 p -68.38 -30.19 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.077 -0.51 . . . . 0.18 111.2 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -75.64 -32.59 60.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.81 110.834 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -89.54 -20.18 24.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 1.72 110.877 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -94.11 -32.81 13.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.32 110.887 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.879 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.98 -54.25 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.36 110.85 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.65 8.02 2.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.32 112.459 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -70.2 121.26 17.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 0.7 110.822 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -152.32 104.72 2.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 3.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 t -161.03 172.13 17.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.61 110.879 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.28 -11.57 15.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 1.57 110.864 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.559 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 4.9 m-80 -99.92 14.29 30.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 1.55 110.923 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.671 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -87.39 165.86 15.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.34 110.866 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.72 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -171.46 130.06 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.19 111.023 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.773 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.4 m-85 -72.7 132.31 43.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 1.7 110.883 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.17 143.89 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.22 111.148 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.556 ' OE1' HD13 ' A' ' 67' ' ' LEU . 3.0 tt0 -98.69 133.08 43.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 1.86 110.848 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.73 148.14 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.48 111.205 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.502 ' N ' HD11 ' A' ' 130' ' ' LEU . 6.1 t -132.62 156.06 47.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.29 111.122 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -145.58 139.11 8.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.19 112.465 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -96.74 132.7 42.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.36 . . . . 3.5 110.926 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 135.3 77.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.597 0.713 . . . . 1.2 110.887 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 128.22 15.6 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.631 2.221 . . . . 0.31 112.32 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -108.83 150.56 27.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.3 110.887 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.3 t80 65.01 151.8 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 5.86 110.869 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -73.61 109.62 7.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 9.8 110.868 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.1 m -116.81 -27.03 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 5.37 111.123 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.82 38.11 63.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 5.26 112.464 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.3 p -130.4 175.94 8.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 5.67 110.883 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.5 m 72.15 -69.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 6.3 110.803 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 6.54 110.863 -179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.624 ' O ' HD12 ' A' ' 6' ' ' ILE . 8.8 ttm . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.765 0.317 . . . . 8.62 110.903 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.94 -13.69 60.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 1.22 111.158 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -51.38 65.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 3.23 110.926 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.514 ' HE1' HD12 ' A' ' 67' ' ' LEU . 2.9 m-85 -93.72 -14.98 25.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 2.07 110.869 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.5 48.59 10.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.725 -0.75 . . . . 0.39 112.45 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.824 HG23 HG21 ' A' ' 12' ' ' VAL . 1.2 mp -88.32 162.01 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.37 . . . . 0.6 111.136 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.64 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -150.34 170.01 20.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.811 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.67 133.36 34.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.4 111.109 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.21 -6.07 30.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.781 -0.723 . . . . 0.31 112.536 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -111.88 168.96 9.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 1.16 110.899 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.04 114.32 28.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 1.28 110.872 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.824 HG21 HG23 ' A' ' 6' ' ' ILE . 88.2 t -119.3 126.97 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 2.01 111.149 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.804 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -104.0 128.22 51.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.33 111.153 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.805 HG11 HG12 ' A' ' 29' ' ' VAL . 97.7 t -100.38 119.23 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.23 111.159 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.84 118.14 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.25 111.171 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -118.19 169.03 10.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.31 110.952 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' HB3' HD12 ' A' ' 47' ' ' ILE . 9.4 p-10 -151.67 -170.47 3.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 1.83 110.875 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -35.56 69.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 6.31 110.901 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.61 -9.36 58.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.34 110.87 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.93 94.43 10.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.613 0.72 . . . . 0.23 110.823 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 142.37 47.55 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.678 2.252 . . . . 0.3 112.45 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -49.07 -32.68 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.32 111.042 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -51.09 -52.93 38.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 2.51 110.878 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.62 -44.93 10.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.27 111.067 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.468 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.76 -61.3 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.23 110.929 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.55 -37.07 25.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 2.55 110.878 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -47.29 50.35 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.736 -0.745 . . . . 0.27 112.437 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.5 mt -61.75 -38.84 89.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.52 110.934 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.805 HG12 HG11 ' A' ' 14' ' ' VAL . 17.8 m -78.13 -30.77 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.64 111.11 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.52 -58.27 8.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 1.58 110.875 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -39.57 74.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 1.8 110.884 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.813 HD23 HD21 ' A' ' 35' ' ' LEU . 97.0 mt -73.36 -25.37 60.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 0.24 110.872 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.561 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -77.63 -24.81 49.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 0.41 110.964 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.66 -29.7 16.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.29 111.179 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.813 HD21 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -91.49 -31.05 16.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.29 110.912 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -106.84 -45.47 4.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.26 111.15 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.44 -12.42 51.47 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.722 -0.751 . . . . 0.31 112.529 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.79 -62.71 1.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.329 . . . . 1.85 110.822 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -99.57 -36.5 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 2.65 110.861 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.22 -129.46 4.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.741 . . . . 0.26 112.448 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -154.9 152.01 29.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.357 . . . . 2.23 110.882 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.561 HG21 ' HA ' ' A' ' 33' ' ' GLN . 92.9 t -136.0 122.97 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.22 111.165 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.6 t -113.09 154.03 27.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.17 110.829 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -117.14 134.28 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.17 111.208 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -142.04 151.24 42.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 1.26 110.882 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -103.25 134.95 45.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.862 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.725 ' CD1' HG21 ' A' ' 73' ' ' THR . 29.5 mt -52.29 -36.54 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.32 111.092 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -70.79 -32.44 69.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 2.03 110.924 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -103.75 20.71 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 3.64 110.855 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.838 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.09 -27.84 3.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 1.07 110.899 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -55.01 -33.09 62.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 1.02 110.937 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -84.81 -15.53 44.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 1.16 110.937 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.508 ' HB2' HD13 ' A' ' 50' ' ' LEU . 48.0 m -63.69 -12.73 36.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.87 110.899 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -74.13 61.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.3 111.082 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.403 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 3.4 m80 -63.03 -69.54 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.37 110.869 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.664 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.02 -168.75 2.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 1.16 110.957 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -107.37 131.02 54.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 1.73 110.923 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.25 73.5 0.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 1.2 110.829 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.2 p -127.76 -34.46 2.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.28 110.836 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.4 m-85 -99.29 118.34 35.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 1.42 110.849 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.78 -20.89 63.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.04 -0.527 . . . . 1.75 110.939 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.701 ' HB ' HG22 ' A' ' 12' ' ' VAL . 25.3 mt -146.98 144.88 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.26 111.116 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.864 HG21 HG23 ' A' ' 83' ' ' ILE . 15.9 mm -135.09 131.58 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.14 111.104 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -112.68 137.34 51.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.16 110.883 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.61 100.55 5.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.14 110.844 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.61 74.28 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 0.18 112.514 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.514 HD12 ' HE1' ' A' ' 4' ' ' PHE . 4.0 mm? -107.03 59.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.348 . . . . 0.6 110.879 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.84 159.77 66.7 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.542 0.687 . . . . 0.25 111.124 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 116.31 4.49 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.657 2.238 . . . . 0.26 112.426 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.58 6.42 68.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.2 112.493 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -56.03 150.55 13.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.66 110.896 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.765 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 37.2 p -140.24 108.59 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.22 111.148 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.725 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.15 147.67 12.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.25 111.049 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.941 HD12 HD22 ' A' ' 147' ' ' LEU . 2.4 mt -126.23 99.9 6.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.34 110.874 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -76.71 149.01 36.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.24 110.948 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.9 m -128.25 177.33 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.55 110.885 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.17 -37.77 48.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.23 111.101 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.82 -44.53 96.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.448 . . . . 2.08 110.882 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.838 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.2 mp -74.94 -55.25 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.21 111.175 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 119' ' ' LEU . 61.0 mt -50.71 -38.64 48.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.24 110.876 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.19 -56.54 15.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.36 111.122 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.443 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -55.03 -42.39 72.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 2.76 110.862 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.864 HG23 HG21 ' A' ' 63' ' ' ILE . 50.2 mm -57.66 -68.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.22 111.097 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.71 -36.21 35.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.23 111.051 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -56.84 -52.3 65.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 2.79 110.881 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 56' ' ' LYS . 46.6 pt -82.29 -6.5 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.26 111.081 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -79.8 127.97 32.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.4 110.93 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -66.82 159.76 73.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.582 0.705 . . . . 2.25 110.835 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 114.33 3.67 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.2 112.328 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.8 2.75 56.2 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.772 -0.728 . . . . 0.24 112.531 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.76 -161.36 10.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.805 -0.712 . . . . 0.16 112.484 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 15.7 m -139.08 153.7 48.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.36 110.954 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.707 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.06 114.47 10.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.2 110.883 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.555 ' N ' HD22 ' A' ' 93' ' ' LEU . 45.7 m-85 -108.79 133.47 52.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 1.64 110.956 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.51 159.12 44.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.15 110.919 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 125.15 38.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 1.81 110.886 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.617 ' OE1' HD23 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -148.97 147.44 24.02 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.649 0.738 . . . . 2.48 110.897 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.619 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.1 Cg_endo -69.81 145.23 56.25 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.654 2.236 . . . . 0.21 112.332 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.8 m -131.41 146.67 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.19 111.154 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -104.88 132.97 50.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 2.09 110.899 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 p -105.71 26.01 10.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 1.56 111.083 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.29 26.51 0.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.67 111.098 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.19 159.48 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.78 111.152 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.57 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -57.24 -179.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 1.97 110.837 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -66.09 -67.93 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 2.67 110.897 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -60.99 -75.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 2.55 110.913 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 54.63 -166.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 1.93 110.855 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -79.9 -7.97 59.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 2.07 110.872 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.645 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.0 m -145.16 150.13 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.6 111.079 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -68.29 113.29 5.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.135 -0.484 . . . . 2.33 110.874 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.57 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.2 p -84.42 179.69 7.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.34 111.108 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.49 -53.34 59.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.2 111.136 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.74 -49.18 78.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.922 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -58.37 -40.91 83.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 2.61 110.909 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -61.97 -54.83 36.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.41 110.84 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 70.8 m -55.45 -47.79 75.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.24 110.89 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.26 110.809 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.99 98.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.23 111.076 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.587 HD11 HD12 ' A' ' 93' ' ' LEU . 14.9 tp -65.8 -50.23 65.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.24 110.922 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.1 m -65.52 -30.73 71.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.108 -0.496 . . . . 0.25 111.204 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.429 HD23 ' HG2' ' A' ' 172' ' ' ARG . 18.5 mt -86.99 -10.47 53.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.58 110.942 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.19 5.52 29.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 1.8 110.847 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.04 5.19 35.47 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.747 -0.74 . . . . 0.56 112.468 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -105.45 172.48 6.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.26 110.88 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.486 HG23 ' HG3' ' A' ' 126' ' ' GLU . 28.2 m -151.14 171.38 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.29 111.078 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HG3' HG23 ' A' ' 125' ' ' VAL . 28.8 mt-10 55.16 43.53 29.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 2.04 110.924 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.506 HG13 HD23 ' A' ' 119' ' ' LEU . 97.9 t -77.7 140.91 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.32 111.124 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.16 159.79 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 1.61 110.899 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.08 147.44 30.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 2.18 110.939 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.754 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.5 mp -107.45 -36.43 6.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.18 110.957 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -157.1 176.24 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 1.15 110.9 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.731 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.9 tmt_? -132.35 137.27 47.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 4.33 110.942 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -124.38 138.72 31.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.635 0.731 . . . . 1.39 110.902 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.418 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.4 Cg_endo -69.86 163.43 38.39 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.653 2.235 . . . . 0.27 112.299 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.661 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -95.65 127.09 41.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 0.35 110.95 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.53 160.53 27.2 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.554 0.693 . . . . 1.28 111.105 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.7 Cg_endo -69.7 -29.2 24.53 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.68 2.253 . . . . 0.45 112.316 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -84.97 -19.06 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 2.98 110.876 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -53.58 5.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 2.17 110.905 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.5 -41.93 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.29 111.158 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -33.86 72.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 1.37 110.872 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.94 -44.93 68.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.34 110.796 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.68 HG23 HD13 ' A' ' 147' ' ' LEU . 7.4 p -68.97 -31.59 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.21 111.188 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -76.65 -30.9 57.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.076 -0.511 . . . . 2.52 110.929 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -89.73 -20.62 23.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.221 -0.445 . . . . 1.78 110.919 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -95.01 -32.51 13.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.857 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.941 HD22 HD12 ' A' ' 74' ' ' LEU . 2.7 mp -127.18 -54.06 1.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.42 110.891 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.37 10.51 2.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.71 -0.757 . . . . 0.48 112.472 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.645 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.8 t-160 -70.08 120.42 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.711 0.291 . . . . 1.2 110.869 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.44 112.3 4.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 3.02 110.897 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.66 172.17 17.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 1.06 110.865 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.56 -9.35 16.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 2.18 110.86 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.63 13.35 22.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 1.85 110.925 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.661 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -75.57 164.86 25.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.27 110.912 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -173.92 130.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.21 110.901 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.765 ' CZ ' HG22 ' A' ' 72' ' ' THR . 32.3 m-85 -74.29 131.77 41.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 1.79 110.879 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.94 140.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.2 111.114 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.754 ' HG2' HD13 ' A' ' 130' ' ' LEU . 39.1 tt0 -93.65 128.5 39.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 2.3 110.895 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.01 151.73 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.24 111.239 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.46 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.6 t -131.4 159.32 38.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.252 -0.431 . . . . 0.28 111.168 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.478 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -149.33 129.9 3.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.774 -0.727 . . . . 0.25 112.527 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -89.52 139.28 30.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 1.55 110.925 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.24 135.27 50.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.587 0.708 . . . . 1.62 110.906 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 129.65 18.03 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.731 2.287 . . . . 0.41 112.361 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -109.8 149.32 29.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.298 -0.41 . . . . 0.49 110.922 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 30.1 t80 64.97 151.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 5.67 110.876 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.86 173.83 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 10.21 110.856 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.6 m -151.98 -41.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.525 . . . . 6.03 111.121 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 129.04 -45.98 1.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.803 -0.713 . . . . 7.46 112.518 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.15 -73.81 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.376 . . . . 8.15 110.81 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.7 m 56.54 -176.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 5.78 110.843 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.429 ' HG2' HD23 ' A' ' 121' ' ' LEU . 7.9 tmm_? . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 6.78 110.889 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.759 0.314 . . . . 3.59 110.87 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.97 -20.79 65.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.44 111.095 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -54.04 -51.2 64.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 2.2 110.953 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -122.33 21.64 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 1.52 110.89 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.82 39.98 56.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.78 -0.724 . . . . 0.23 112.507 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.52 HG23 HG21 ' A' ' 12' ' ' VAL . 1.7 mp -77.97 159.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.857 0.36 . . . . 0.22 111.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -151.55 162.21 41.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 1.44 110.934 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.4 126.34 35.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.28 111.135 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.06 -2.59 19.24 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.735 -0.745 . . . . 0.27 112.433 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -115.49 170.49 8.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.842 0.353 . . . . 1.1 110.9 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.87 114.14 28.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 2.23 110.929 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 62' ' ' ILE . 92.4 t -119.28 125.38 74.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.117 -0.492 . . . . 1.98 111.154 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.766 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -102.79 129.96 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.32 111.125 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.831 HG11 HG12 ' A' ' 29' ' ' VAL . 60.3 t -101.3 119.92 50.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.18 111.146 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.24 118.35 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.21 111.074 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -118.5 169.24 9.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.498 . . . . 0.19 110.898 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -151.49 -170.72 3.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.483 . . . . 1.78 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -57.06 -35.67 69.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 3.09 110.9 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -73.28 -9.59 58.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 1.27 110.848 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.02 94.44 10.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.647 0.737 . . . . 0.15 110.855 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 142.23 47.11 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.662 2.242 . . . . 0.21 112.359 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -48.83 -32.75 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.2 111.122 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.13 -53.04 37.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 2.69 110.893 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -44.89 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.17 111.055 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.476 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.6 -61.46 2.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.14 110.976 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -36.96 24.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 2.8 110.867 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.72 -47.14 50.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 0.19 112.523 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.83 -39.29 91.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.768 0.318 . . . . 0.46 110.872 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.831 HG12 HG11 ' A' ' 14' ' ' VAL . 17.5 m -77.69 -31.19 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.63 111.075 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.29 -58.56 7.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 1.55 110.845 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -39.94 74.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 1.73 110.945 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.892 HD23 HD21 ' A' ' 35' ' ' LEU . 85.1 mt -73.07 -24.67 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.23 110.996 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.486 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.55 -25.18 45.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.37 110.947 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 -29.9 17.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.22 111.163 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.892 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.42 -35.21 14.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.18 110.853 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.738 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.9 -45.86 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.21 111.091 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.47 -12.87 53.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.27 112.456 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.17 -62.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 2.5 110.897 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -90.08 -40.85 12.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.96 110.921 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.43 -130.04 6.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.741 -0.742 . . . . 0.25 112.553 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -150.23 152.87 35.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.887 0.375 . . . . 2.2 110.928 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 33' ' ' GLN . 96.6 t -136.4 125.44 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.22 111.146 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -114.53 156.89 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 0.16 110.814 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -118.53 135.04 60.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.15 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -143.14 151.31 40.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 2.01 110.868 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -103.22 134.9 45.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.193 -0.458 . . . . 0.4 110.854 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.729 ' CD1' HG21 ' A' ' 73' ' ' THR . 29.1 mt -52.4 -36.51 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.27 111.108 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -70.87 -32.13 69.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 2.0 110.868 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -103.87 20.62 17.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 3.54 110.92 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.83 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.09 -27.94 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 1.07 110.918 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.26 -33.37 63.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 1.07 110.938 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -84.62 -15.14 46.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 1.18 110.935 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.459 ' HB2' HD13 ' A' ' 50' ' ' LEU . 45.5 m -64.64 -11.61 37.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.87 110.796 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.33 61.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.28 111.023 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.401 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 3.2 m80 -62.8 -69.74 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.4 110.865 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.661 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.97 -168.64 2.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 1.12 111.045 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.13 130.55 54.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.335 -0.393 . . . . 1.81 110.944 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.38 73.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 1.21 110.853 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.8 p -127.93 -34.59 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.26 110.832 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.2 m-85 -98.85 117.9 34.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 1.43 110.921 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.41 -20.36 63.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 1.48 110.887 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.693 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.1 mt -148.05 144.91 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.25 111.142 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.915 HG21 HG23 ' A' ' 83' ' ' ILE . 20.6 mm -135.28 130.1 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.18 111.113 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -110.46 137.29 48.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.16 110.897 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.56 100.63 5.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.13 110.84 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.74 76.0 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.15 112.458 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.35 58.21 0.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.59 110.902 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.54 160.11 62.25 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 121.618 0.723 . . . . 0.22 111.18 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 116.64 4.66 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.672 2.248 . . . . 0.24 112.361 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.1 7.39 70.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.16 112.537 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.49 149.75 13.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.408 . . . . 0.68 110.839 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.768 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 31.1 p -138.73 108.58 6.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.17 111.117 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.729 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.96 146.52 10.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.24 111.102 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.92 HD12 HD22 ' A' ' 147' ' ' LEU . 4.1 mt -125.36 103.37 7.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.21 110.843 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -79.75 151.49 30.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.24 110.809 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -130.59 177.14 7.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.48 110.885 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.99 51.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.32 111.166 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -61.48 -45.68 93.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 1.75 110.885 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.83 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -73.63 -55.41 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.23 111.07 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.0 mt -50.63 -38.68 47.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.26 110.875 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.8 -55.13 29.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.29 111.056 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -42.34 77.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 2.76 110.935 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.915 HG23 HG21 ' A' ' 63' ' ' ILE . 44.9 mm -58.62 -68.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.26 111.054 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.74 -36.06 24.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.21 111.028 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -54.58 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 2.19 110.861 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 56' ' ' LYS . 47.5 pt -79.39 -5.89 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.28 111.192 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -81.73 127.99 33.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.45 110.847 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -65.7 158.77 72.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.669 0.747 . . . . 2.28 110.867 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 114.1 3.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.246 . . . . 0.2 112.34 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.28 2.72 54.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.737 . . . . 0.16 112.476 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.63 -163.48 16.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.15 112.505 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 67.6 m -135.75 153.48 51.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 0.3 110.833 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.662 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.56 114.36 10.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.16 110.88 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.541 ' N ' HD22 ' A' ' 93' ' ' LEU . 50.2 m-85 -108.82 133.34 53.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 1.9 110.949 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.563 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.86 164.11 35.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.14 110.959 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.74 130.46 36.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 1.85 110.915 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.598 ' OE1' HD23 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -153.95 147.75 18.68 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.588 0.709 . . . . 2.34 110.896 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.639 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.0 Cg_endo -69.81 141.58 45.39 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.594 2.196 . . . . 0.17 112.361 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.78 146.66 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.18 111.135 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' CD ' HG21 ' A' ' 103' ' ' VAL . 51.9 mt-10 -109.7 132.64 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 2.07 110.827 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.4 p -91.62 -42.23 10.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 1.18 111.061 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.77 39.94 1.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.259 -0.428 . . . . 0.59 111.096 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' CD ' ' A' ' 100' ' ' GLU . 22.7 t -147.59 150.4 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.187 -0.461 . . . . 0.63 111.099 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.573 ' O ' HG21 ' A' ' 111' ' ' THR . 0.4 OUTLIER -52.94 170.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 1.77 110.836 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -64.35 -57.39 9.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 2.57 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.99 -75.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 1.63 110.87 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t 52.38 -168.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 2.14 110.906 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.37 -6.8 58.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 1.98 110.865 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.437 HG11 ' CG ' ' A' ' 149' ' ' HIS . 2.9 m -140.09 142.63 31.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.4 111.248 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -65.35 111.05 2.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.21 -0.45 . . . . 2.46 110.907 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 104' ' ' ASP . 47.5 p -82.13 -177.72 6.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.23 111.161 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.13 -52.32 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.17 111.132 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.32 -49.77 75.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.21 110.877 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -56.87 -38.86 73.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 1.66 110.838 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -64.89 -54.56 28.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.31 110.927 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.2 m -58.13 -46.24 85.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.24 110.925 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -43.0 94.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.498 . . . . 0.29 110.919 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.51 98.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.21 111.107 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 93' ' ' LEU . 15.5 tp -65.13 -51.65 59.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.216 -0.447 . . . . 0.32 110.909 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.1 m -63.92 -31.16 72.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.25 111.084 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.3 mt -86.79 -10.48 53.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.74 110.893 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.12 5.69 28.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 1.71 110.88 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.13 5.12 35.33 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.806 -0.712 . . . . 0.48 112.523 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.662 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.1 tp -105.57 173.11 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.32 110.956 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.7 m -151.51 173.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.28 111.205 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 51.6 45.15 28.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 1.99 110.874 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.523 HG13 HD23 ' A' ' 119' ' ' LEU . 94.3 t -80.75 143.06 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.2 111.142 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.92 160.49 8.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 2.52 110.915 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -80.26 146.43 31.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 2.25 110.916 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.784 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -104.23 -37.1 7.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.23 110.936 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.0 pm0 -159.07 176.25 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 2.95 110.888 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.732 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.4 tmt_? -130.44 137.21 49.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 4.37 110.82 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -123.77 135.02 25.74 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.726 0.774 . . . . 1.8 110.9 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.425 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.2 Cg_endo -69.82 159.14 54.45 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.721 2.281 . . . . 0.26 112.351 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.668 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -91.97 151.65 20.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.57 110.948 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.531 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -133.65 162.91 54.78 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.498 0.666 . . . . 1.63 111.186 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -23.72 30.17 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.669 2.246 . . . . 0.57 112.293 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -86.26 -23.82 26.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 2.47 110.809 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -87.82 -52.72 5.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 3.95 110.927 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 136' ' ' THR . 7.3 p -50.4 -39.52 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.29 111.128 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -32.64 73.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 1.11 110.97 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.49 -46.74 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.29 110.856 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.706 HG23 HD13 ' A' ' 147' ' ' LEU . 9.7 p -68.19 -29.75 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 0.21 111.091 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -76.45 -33.3 58.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 3.12 110.885 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -88.88 -19.98 25.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 1.84 110.822 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -94.69 -32.26 13.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.34 110.924 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.92 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.31 -54.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.35 110.869 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.77 8.1 2.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.658 -0.782 . . . . 0.32 112.518 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.437 ' CG ' HG11 ' A' ' 109' ' ' VAL . 15.0 t-160 -69.94 121.62 17.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.709 0.29 . . . . 0.64 110.87 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -151.93 104.99 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 3.37 110.906 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.6 t -160.8 171.02 19.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.61 110.868 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.22 -11.85 15.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 1.94 110.877 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.527 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 5.7 m-80 -99.57 14.39 30.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 1.6 110.894 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -87.51 168.92 12.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.34 110.824 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.732 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -172.16 130.36 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.18 110.894 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.768 ' CZ ' HG22 ' A' ' 72' ' ' THR . 19.4 m-85 -74.31 132.81 42.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 1.82 110.897 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.26 147.96 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.22 111.077 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.784 ' HG2' HD13 ' A' ' 130' ' ' LEU . 33.3 tt0 -101.67 135.6 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 2.06 110.938 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.41 149.18 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.22 111.148 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.477 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.2 t -129.55 159.47 36.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.25 111.196 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.49 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -149.93 134.3 4.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.731 -0.747 . . . . 0.15 112.483 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -94.44 140.77 29.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 1.55 110.942 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -81.49 134.79 50.68 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.606 0.717 . . . . 1.94 110.886 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 119.76 6.65 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.714 2.276 . . . . 0.35 112.319 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -103.34 151.91 22.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.32 110.866 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.4 t80 64.63 112.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 6.04 110.887 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 62.08 89.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 9.17 110.926 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 25.0 m -59.9 140.85 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 9.61 111.116 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -141.78 38.22 1.52 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.789 -0.719 . . . . 8.0 112.554 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.8 p -85.74 82.81 8.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 11.79 110.862 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.8 m -56.71 -68.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 8.87 110.833 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 11.78 110.905 -179.895 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.677 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.6 mmm . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.747 0.308 . . . . 8.15 110.933 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.37 -16.09 55.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 1.01 111.044 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -55.05 -51.92 64.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 2.55 110.804 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.461 ' CE1' HD12 ' A' ' 67' ' ' LEU . 5.5 m-85 -109.48 23.26 14.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 1.66 110.94 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.04 41.96 53.72 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 0.45 112.485 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.677 HD12 ' O ' ' A' ' 1' ' ' MET . 1.7 mp -81.31 158.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.31 111.129 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 36' ' ' THR . 37.2 m -146.18 156.35 43.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 1.12 110.863 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.32 127.41 34.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.42 111.143 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.81 -7.48 21.94 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.74 -0.743 . . . . 0.27 112.513 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.17 170.39 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 1.57 110.942 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.92 110.7 22.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 1.34 110.836 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.697 HG12 HG21 ' A' ' 36' ' ' THR . 2.3 p -117.2 129.6 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 2.01 111.168 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.757 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -104.59 130.35 52.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.3 111.101 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.847 HG11 HG12 ' A' ' 29' ' ' VAL . 97.6 t -99.79 117.78 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.16 111.158 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.482 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.3 t -101.54 113.63 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.21 111.21 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -114.51 167.64 10.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 0.19 110.919 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.452 ' HB3' HD12 ' A' ' 47' ' ' ILE . 9.9 p-10 -151.53 -169.59 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 1.79 110.812 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -35.87 69.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 6.79 110.876 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -11.26 60.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 1.13 110.889 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.67 92.87 9.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.609 0.718 . . . . 0.22 110.871 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.72 143.53 51.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.26 112.336 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -48.76 -32.55 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.2 111.125 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.02 -53.57 32.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 2.48 110.895 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.79 -44.75 10.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.17 111.116 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.482 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.2 -61.32 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.14 110.916 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -49.79 -38.35 34.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 2.69 110.813 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.61 -47.58 55.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.8 -0.714 . . . . 0.23 112.428 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.46 -40.26 93.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.366 . . . . 0.59 110.897 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.847 HG12 HG11 ' A' ' 14' ' ' VAL . 18.1 m -76.72 -31.04 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.63 111.209 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.03 -60.07 4.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.183 -0.462 . . . . 1.57 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -40.79 71.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 1.87 110.958 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 HD21 ' A' ' 35' ' ' LEU . 92.8 mt -72.27 -25.2 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.38 110.887 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.426 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.09 -24.18 47.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.39 110.885 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.72 -30.03 17.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.28 111.115 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.821 HD21 HD23 ' A' ' 32' ' ' LEU . 1.6 pp -91.59 -35.34 14.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.27 110.882 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.697 HG21 HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -101.88 -45.28 5.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.25 111.178 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.78 -12.72 49.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.679 -0.772 . . . . 0.29 112.537 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -67.04 -62.74 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.786 0.327 . . . . 1.98 110.883 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -94.66 -39.32 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 2.07 110.958 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.51 -135.2 7.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.801 . . . . 0.38 112.504 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -147.74 151.44 36.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 2.22 110.794 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 33' ' ' GLN . 91.9 t -135.94 117.82 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.33 111.114 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 t -106.93 157.19 17.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.26 110.85 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.22 133.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 0.21 111.142 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -143.69 151.79 40.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 1.27 110.892 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.6 135.21 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.41 110.825 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 50' ' ' LEU . 45.3 mt -52.37 -35.87 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 0.36 111.103 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -31.81 66.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 2.22 110.853 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -105.22 20.32 19.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 3.6 110.896 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.983 HD13 HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -51.78 -26.14 9.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 2.72 110.94 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 mp -53.68 -32.91 53.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 1.14 110.945 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -84.97 -15.76 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 1.09 110.906 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.4 m -64.46 -12.21 41.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 0.88 110.888 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.47 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -73.93 61.34 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.494 . . . . 0.4 111.184 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -59.48 -71.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.58 110.796 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.27 -168.23 2.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 1.35 110.956 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -102.27 116.58 32.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 2.22 110.869 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 t 60.16 84.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 1.97 110.839 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.0 p -134.84 -37.24 0.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.28 110.836 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.1 m-85 -96.84 121.98 39.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.059 -0.519 . . . . 2.01 110.78 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.21 -19.7 60.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 1.51 110.845 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.26 143.95 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.22 111.112 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.941 HG21 HG23 ' A' ' 83' ' ' ILE . 22.1 mm -136.51 127.69 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.17 111.036 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.3 mm? -109.77 137.87 46.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.18 110.95 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.8 100.04 5.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.16 110.866 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.87 74.63 0.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.18 112.518 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.619 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.1 mm? -105.29 58.18 0.68 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 0.61 110.902 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.92 160.01 61.44 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.659 0.742 . . . . 0.23 111.108 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.74 123.88 10.54 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.726 2.284 . . . . 0.31 112.33 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.46 7.11 88.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.667 -0.778 . . . . 0.2 112.535 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 68' ' ' VAL . 8.2 p -55.9 151.58 11.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.958 0.409 . . . . 0.74 110.843 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.74 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.3 p -140.58 109.04 5.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.23 111.101 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.574 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.12 143.19 12.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.32 111.183 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.972 HD12 HD22 ' A' ' 147' ' ' LEU . 4.8 mt -119.98 102.37 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.25 110.93 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -79.1 144.22 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.29 110.844 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 m -124.38 174.92 7.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.42 110.908 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.94 -40.34 57.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.3 111.128 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.99 -45.78 91.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 1.96 110.898 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.983 HG23 HD13 ' A' ' 50' ' ' LEU . 4.3 mp -72.07 -55.38 13.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.31 111.132 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.541 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.9 mt -50.67 -38.54 47.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.52 . . . . 0.28 110.946 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.9 -56.13 13.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.39 111.021 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -54.56 -44.94 73.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.39 . . . . 2.84 110.855 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.941 HG23 HG21 ' A' ' 63' ' ' ILE . 37.9 mm -56.08 -68.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.24 111.098 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.54 -39.65 49.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.28 111.134 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -52.56 -49.63 64.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 3.2 110.829 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 56' ' ' LYS . 41.0 pt -88.18 -4.05 9.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.27 111.102 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -82.04 112.44 19.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.32 110.941 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -52.45 157.68 2.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.645 0.736 . . . . 3.05 110.816 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 113.98 3.55 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.725 2.283 . . . . 0.38 112.326 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.41 2.72 50.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.811 -0.709 . . . . 0.23 112.563 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.78 -165.13 21.61 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.664 -0.779 . . . . 0.18 112.418 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 90.9 m -133.22 151.91 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.46 110.893 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.703 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -136.58 115.22 12.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.15 110.934 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.549 ' N ' HD22 ' A' ' 93' ' ' LEU . 54.7 m-85 -110.33 132.05 54.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 1.91 110.877 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.551 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.66 163.17 38.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.12 110.891 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.91 126.89 29.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 1.85 110.784 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -148.65 149.27 30.57 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.65 0.738 . . . . 2.55 110.892 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.614 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.8 Cg_endo -69.71 139.38 40.28 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.66 2.24 . . . . 0.24 112.329 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.8 m -121.62 146.7 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.31 111.143 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.476 ' CD ' HG21 ' A' ' 103' ' ' VAL . 51.4 mt-10 -117.82 132.0 56.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 1.86 110.887 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.0 p -91.93 -37.43 12.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 1.41 111.099 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.59 37.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.6 111.191 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.476 HG21 ' CD ' ' A' ' 100' ' ' GLU . 31.8 t -147.79 149.55 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.7 111.141 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.575 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -55.86 178.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.85 110.929 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -66.55 -70.44 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 2.64 110.896 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -75.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 2.14 110.922 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.47 -169.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 1.6 110.78 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.0 -2.97 50.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 2.03 110.893 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 m -145.26 144.49 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.44 111.102 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.684 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -67.32 113.15 4.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 2.21 110.877 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 104' ' ' ASP . 60.3 p -84.33 177.45 8.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.21 111.204 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.33 -54.7 36.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.17 111.102 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -59.97 -50.24 74.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.21 110.85 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -38.8 71.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.148 -0.478 . . . . 2.12 110.893 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.533 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -64.51 -54.27 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.37 110.963 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.7 m -59.24 -46.78 87.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.21 110.851 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -44.03 95.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.29 110.874 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.27 98.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.21 111.195 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.541 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.9 tp -65.38 -50.76 64.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.26 110.913 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.2 m -63.51 -31.5 72.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.26 111.16 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.6 mt -87.0 -10.48 53.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.56 110.913 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.58 4.66 31.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.306 -0.406 . . . . 1.73 110.835 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.1 6.7 33.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.49 112.496 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -106.92 172.21 6.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.79 0.328 . . . . 0.27 110.985 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.5 m -151.71 174.27 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.35 111.103 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 52.68 43.9 30.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 2.15 110.88 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.0 143.29 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.26 111.097 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.06 160.19 8.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 1.62 110.85 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -82.34 139.55 34.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 2.98 110.87 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.548 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.5 mp -96.6 -37.92 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.24 110.899 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.05 176.3 12.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 1.11 110.941 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.694 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -129.44 141.27 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 4.01 110.89 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -129.18 136.82 29.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.599 0.714 . . . . 1.41 110.828 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.423 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.9 Cg_endo -69.69 165.16 31.82 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.667 2.245 . . . . 0.25 112.357 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.712 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -97.7 126.13 42.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.29 110.936 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -103.62 160.88 24.72 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.615 0.721 . . . . 1.54 111.08 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -24.63 29.31 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.34 112.36 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -85.52 -22.09 28.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 2.49 110.893 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -87.53 -53.58 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 2.43 110.916 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 136' ' ' THR . 7.4 p -49.8 -40.36 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.29 111.142 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -33.42 74.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 1.19 110.904 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.42 -46.44 66.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.26 110.845 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.0 p -68.51 -30.02 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.3 111.207 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -76.77 -31.57 57.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 2.36 110.9 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -89.57 -20.83 23.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.73 110.799 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.97 -32.0 13.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.44 110.927 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.972 HD22 HD12 ' A' ' 74' ' ' LEU . 2.1 mp -127.29 -54.68 1.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.48 110.845 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.53 13.55 2.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.749 -0.739 . . . . 0.43 112.527 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -70.65 121.51 18.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.85 110.807 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -151.74 105.87 3.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 2.85 110.872 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.9 t -160.51 170.47 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.82 110.852 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.61 -11.34 16.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 1.86 110.87 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -103.59 20.6 17.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 1.93 110.908 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.712 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -90.45 162.98 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.31 110.841 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.6 tm? -169.88 130.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.22 110.965 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.74 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.0 m-85 -75.85 135.57 40.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 1.78 110.956 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.0 144.27 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.29 111.128 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.619 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.7 tt0 -97.67 128.81 44.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 1.98 110.949 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.39 148.95 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.22 111.144 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.471 ' HB ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -127.35 159.62 33.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.3 111.097 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.447 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -150.43 132.13 3.83 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.701 -0.761 . . . . 0.16 112.454 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -94.65 140.35 29.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.814 0.34 . . . . 1.55 110.938 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -80.32 135.41 53.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.638 0.732 . . . . 1.65 110.929 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 120.01 6.87 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.724 2.283 . . . . 0.4 112.361 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -106.15 151.6 24.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.47 110.869 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 17.9 t80 59.92 20.28 9.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 6.24 110.97 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.87 -177.19 0.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 9.89 110.83 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.77 -26.48 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 9.11 111.111 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.7 -49.5 0.84 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.698 -0.763 . . . . 6.8 112.439 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.98 -49.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 8.08 110.909 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.72 -63.9 0.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 9.72 110.864 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 9.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.479 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.822 0.344 . . . . 3.5 110.902 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.37 -19.61 56.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.69 111.177 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.41 -50.1 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 2.0 110.78 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -122.27 18.44 10.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 1.52 110.884 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.38 39.5 73.07 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.751 -0.738 . . . . 0.34 112.519 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 1' ' ' MET . 1.7 mp -76.85 157.53 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 0.33 111.126 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 36' ' ' THR . 26.8 m -149.34 155.75 40.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 1.06 110.83 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.93 123.3 29.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.31 111.096 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.18 -12.06 14.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.41 112.52 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.61 168.66 9.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 1.54 110.914 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -101.21 133.39 45.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.3 110.924 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.566 HG12 HG21 ' A' ' 36' ' ' THR . 1.8 p -138.38 134.59 43.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 2.13 111.16 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.755 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -110.35 127.4 55.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.21 111.114 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.824 HG11 HG12 ' A' ' 29' ' ' VAL . 59.2 t -97.63 117.95 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.22 111.131 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.481 HG12 ' CG1' ' A' ' 47' ' ' ILE . 13.6 t -102.35 110.25 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.26 111.116 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -111.56 167.24 10.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.17 110.97 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.454 ' HB3' HD12 ' A' ' 47' ' ' ILE . 11.3 p-10 -151.0 -169.71 3.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.423 . . . . 1.84 110.874 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -56.68 -35.81 68.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.459 . . . . 2.92 110.903 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.62 -11.4 60.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 1.16 110.894 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.34 93.79 10.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.624 0.726 . . . . 0.14 110.845 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.4 Cg_endo -69.71 142.81 49.15 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.677 2.252 . . . . 0.19 112.341 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.1 t -48.82 -32.59 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 0.17 111.134 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -51.24 -53.35 36.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 2.56 110.8 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.55 -44.79 11.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.16 111.131 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.482 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.36 -61.04 2.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.13 111.017 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.76 -37.91 31.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 2.31 110.871 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.8 -47.67 54.0 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.838 -0.696 . . . . 0.19 112.45 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.51 -40.05 93.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.55 110.873 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.824 HG12 HG11 ' A' ' 14' ' ' VAL . 18.2 m -76.88 -31.45 19.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.63 111.132 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -61.72 -59.95 4.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 1.72 110.947 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -40.41 71.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 1.71 110.882 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.874 HD23 HD21 ' A' ' 35' ' ' LEU . 80.4 mt -72.68 -24.56 61.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.23 110.895 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.7 -24.78 44.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.38 110.911 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 -29.82 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.22 111.163 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.874 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.75 -35.02 14.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.2 110.872 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.566 HG21 HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -102.87 -44.81 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.22 111.12 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.66 -11.2 52.97 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 0.25 112.433 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.99 -62.58 1.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 2.25 110.931 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -90.96 -40.68 11.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 1.97 110.857 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.49 -126.44 4.93 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.759 -0.734 . . . . 0.26 112.438 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -155.58 152.49 28.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 2.2 110.902 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.48 HG21 ' HA ' ' A' ' 33' ' ' GLN . 87.7 t -137.0 127.72 40.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.24 111.12 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 t -116.53 154.12 30.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.16 110.83 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.73 134.65 58.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 0.24 111.054 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -146.33 152.32 38.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.077 -0.511 . . . . 2.1 110.913 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -102.43 137.78 40.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.39 110.809 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.688 ' HA ' HD12 ' A' ' 50' ' ' LEU . 35.5 mt -52.26 -37.04 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.29 111.139 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -26.18 58.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 2.47 110.902 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -104.97 18.12 22.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 3.44 110.899 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.027 HD13 HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -53.84 -26.07 22.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.201 -0.454 . . . . 2.73 110.872 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.96 -34.9 57.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -85.97 -16.0 39.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.1 111.008 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.5 m -63.64 -12.72 36.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.92 110.798 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -74.55 59.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.32 111.134 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -59.17 -70.55 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.47 110.915 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.682 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.39 -169.59 2.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 1.3 111.0 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -105.47 122.11 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 2.19 110.827 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t 59.52 78.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 1.99 110.888 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.5 p -132.7 -37.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.25 110.834 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CD2' HD12 ' A' ' 86' ' ' ILE . 92.8 m-85 -98.13 122.37 41.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 2.06 110.85 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.28 -20.46 60.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 1.51 110.901 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 6' ' ' ILE . 12.4 mt -143.06 144.81 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.28 111.115 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.967 HG21 HG23 ' A' ' 83' ' ' ILE . 20.3 mm -137.56 124.45 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.21 111.072 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.6 mm? -107.61 137.16 46.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 0.24 111.034 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.48 100.91 5.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.17 110.908 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.67 76.04 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.826 -0.702 . . . . 0.17 112.417 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.521 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.4 mm? -107.52 57.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.855 0.359 . . . . 0.59 110.908 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.32 159.64 61.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.708 0.766 . . . . 0.24 111.11 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 124.42 11.05 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.666 2.244 . . . . 0.26 112.359 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.33 7.33 88.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.797 -0.716 . . . . 0.21 112.533 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB3' HG23 ' A' ' 68' ' ' VAL . 10.2 p -55.54 150.88 11.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.429 . . . . 0.78 110.772 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.766 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 30.8 p -138.84 108.86 6.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.16 111.107 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.624 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.36 152.43 16.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.25 111.199 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.993 HD12 HD22 ' A' ' 147' ' ' LEU . 4.4 mt -130.6 101.11 5.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.21 110.894 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -78.06 141.35 38.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.36 110.863 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.82 178.46 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.84 110.909 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.15 62.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.29 111.103 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -56.61 -48.21 77.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 1.96 110.885 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.027 HG23 HD13 ' A' ' 50' ' ' LEU . 4.2 mp -69.1 -56.59 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.29 111.129 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.586 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.8 mt -50.15 -39.09 42.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.29 110.964 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.97 -56.74 10.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.46 111.1 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -54.16 -43.25 70.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 3.03 110.918 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.967 HG23 HG21 ' A' ' 63' ' ' ILE . 41.9 mm -57.94 -69.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.26 111.189 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.12 -36.21 28.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.28 111.075 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -51.5 67.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 2.31 110.983 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 56' ' ' LYS . 43.6 pt -86.81 -2.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.33 111.171 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -83.0 115.28 21.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.27 110.952 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -55.52 157.95 6.49 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.532 0.682 . . . . 3.2 110.889 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 114.02 3.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.735 2.29 . . . . 0.34 112.33 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.16 2.33 51.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 0.22 112.512 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.07 -165.51 19.4 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.781 -0.723 . . . . 0.18 112.456 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 69.1 m -134.55 148.79 50.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.33 . . . . 0.36 110.901 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.725 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.6 tm? -132.72 114.98 14.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.15 110.911 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.501 ' N ' HD22 ' A' ' 93' ' ' LEU . 70.4 m-85 -110.19 132.13 54.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 1.85 110.952 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.561 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.74 164.03 35.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.21 110.939 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.91 129.33 36.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 1.94 110.9 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.461 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -153.63 148.44 19.68 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.677 0.751 . . . . 2.52 110.865 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.651 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.7 145.53 57.75 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.656 2.237 . . . . 0.25 112.367 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 155' ' ' LEU . 14.4 m -129.0 146.49 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.18 111.088 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CD ' HG21 ' A' ' 103' ' ' VAL . 47.7 mt-10 -107.32 132.75 52.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 2.19 110.803 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.8 p -90.69 -42.73 10.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 1.15 111.125 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.633 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -94.83 42.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.64 111.053 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.403 HG21 ' CD ' ' A' ' 100' ' ' GLU . 24.7 t -148.98 150.0 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.26 -0.427 . . . . 0.72 111.12 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.628 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -56.45 169.75 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 2.17 110.844 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.4 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 1.9 p30 -62.37 -54.72 36.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 2.56 110.845 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -66.8 -78.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 2.11 110.869 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p 53.65 -173.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 1.91 110.791 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.52 -3.37 49.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 2.5 110.848 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.86 153.82 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.148 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.01 110.48 6.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 2.85 110.933 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.628 HG21 ' O ' ' A' ' 104' ' ' ASP . 32.7 p -84.97 179.52 7.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.21 111.191 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.43 -53.74 53.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.18 111.001 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.84 -50.09 74.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.99 0.424 . . . . 0.22 110.884 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -56.69 -39.91 74.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 1.7 110.985 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.49 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -63.52 -54.55 34.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.32 110.905 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.1 m -58.6 -46.94 85.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.228 -0.442 . . . . 0.21 110.827 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -43.58 97.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.27 110.834 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.16 -43.52 98.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.21 111.117 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.586 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.1 tp -64.81 -50.46 66.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.23 110.94 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.4 m -63.89 -31.2 72.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.26 111.129 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.5 mt -87.07 -10.5 52.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.56 110.917 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.53 6.21 28.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 1.74 110.845 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.61 7.68 31.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.67 -0.776 . . . . 0.55 112.452 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.725 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -107.57 171.03 7.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.26 110.847 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.05 170.42 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.25 111.131 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 52.89 44.21 30.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 2.27 110.857 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.71 142.77 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.27 111.158 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.97 157.92 6.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 1.61 110.901 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.29 145.7 39.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 2.23 110.858 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.486 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -105.5 -36.19 7.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.2 110.944 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.16 176.0 13.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 1.19 110.981 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -130.93 145.17 51.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 4.25 110.885 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -135.1 136.15 24.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.67 0.748 . . . . 1.87 110.852 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 165.22 31.66 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.693 2.262 . . . . 0.32 112.384 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.683 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -97.96 128.21 44.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.32 110.949 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.425 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.44 160.88 25.3 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.53 0.681 . . . . 1.21 111.163 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.5 Cg_endo -69.83 -28.69 24.61 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.701 2.267 . . . . 0.43 112.294 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -85.37 -17.74 35.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 3.63 110.936 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.59 -53.06 4.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 2.83 110.963 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.32 -40.37 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.33 111.147 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.1 -35.22 77.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.19 110.908 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.85 -46.61 71.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.26 110.831 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.706 HG23 HD13 ' A' ' 147' ' ' LEU . 9.6 p -67.99 -29.97 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.18 111.118 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -75.0 -33.67 61.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 2.32 110.95 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -89.0 -19.97 25.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.056 -0.52 . . . . 1.93 110.842 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -94.01 -32.73 13.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.88 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.993 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.58 -54.24 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.4 110.901 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.97 6.11 2.6 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.806 -0.712 . . . . 0.37 112.479 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -69.9 120.1 15.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.723 0.297 . . . . 0.71 110.903 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.25 104.82 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 2.38 110.913 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.45 174.95 12.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.79 110.864 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.76 -10.54 16.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.55 110.869 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.633 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -99.15 6.6 46.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 1.79 110.935 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.683 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -78.81 166.67 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.3 111.004 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.592 ' HA ' HD23 ' A' ' 135' ' ' LEU . 2.7 tm? -172.94 130.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.25 110.925 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.766 ' CZ ' HG22 ' A' ' 72' ' ' THR . 27.3 m-85 -75.62 134.87 40.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 1.83 110.879 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.83 141.53 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.24 111.183 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.521 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.3 tt0 -93.66 131.26 39.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.88 110.937 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.92 151.73 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.25 111.106 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.472 HG21 HD21 ' A' ' 130' ' ' LEU . 5.3 t -135.9 161.85 34.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.27 111.048 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.26 137.92 6.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.715 -0.755 . . . . 0.15 112.487 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.65 137.5 35.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.308 . . . . 3.5 110.935 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -77.33 135.45 65.7 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.609 0.719 . . . . 1.74 110.905 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 120.09 6.94 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.652 2.235 . . . . 0.39 112.39 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -105.57 151.57 24.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.45 110.94 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 22.4 t80 60.43 19.98 9.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 6.17 110.816 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 62.3 166.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 9.57 110.906 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 33.7 m -150.08 -179.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 5.8 111.194 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -149.85 46.75 0.64 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.717 -0.754 . . . . 6.21 112.517 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.47 -66.76 1.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.36 . . . . 7.34 110.861 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.13 -170.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 7.13 110.865 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . 0.277 4.0 tmm_? . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 6.13 110.855 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.853 0.358 . . . . 4.12 110.908 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.28 -22.19 63.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.53 111.132 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.11 -51.47 64.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.225 -0.443 . . . . 2.4 110.831 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.26 21.18 10.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 1.56 110.848 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.93 37.96 54.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.656 -0.783 . . . . 0.23 112.552 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.455 HG21 HD22 ' A' ' 32' ' ' LEU . 1.9 mp -74.27 156.93 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.343 . . . . 0.27 111.146 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 36' ' ' THR . 28.2 m -146.13 158.5 43.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 1.08 110.891 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.56 129.75 35.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.33 111.131 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.11 -8.52 33.33 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.687 -0.768 . . . . 0.55 112.522 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.61 169.37 8.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 1.49 110.919 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.87 113.21 26.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 1.28 110.824 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.712 HG12 HG21 ' A' ' 36' ' ' THR . 2.4 p -120.57 129.56 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 2.04 111.105 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.753 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -104.65 128.06 52.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.23 111.048 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.778 HG11 HG12 ' A' ' 29' ' ' VAL . 94.9 t -99.93 120.34 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.19 111.13 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 65' ' ' SER . 61.1 t -103.25 123.05 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.086 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -122.6 169.68 10.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.17 110.908 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.75 -171.0 3.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 1.76 110.862 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -56.97 -35.66 69.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 3.36 110.904 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.32 -9.1 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 1.19 110.917 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.05 94.29 10.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.665 0.745 . . . . 0.14 110.799 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.35 47.7 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.659 2.239 . . . . 0.21 112.416 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.01 -32.59 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.22 111.182 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.16 -53.09 37.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.148 -0.478 . . . . 3.2 110.827 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.87 10.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.19 111.151 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.405 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -51.66 -61.49 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.15 110.995 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -36.96 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 2.4 110.934 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.36 -48.31 52.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.729 -0.748 . . . . 0.21 112.495 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.1 mt -60.84 -41.39 95.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.45 110.927 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.778 HG12 HG11 ' A' ' 14' ' ' VAL . 17.1 m -75.45 -31.11 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.64 111.11 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.74 -61.89 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 1.77 110.887 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -40.73 67.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 1.79 110.87 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.843 HD23 HD21 ' A' ' 35' ' ' LEU . 83.5 mt -71.83 -25.5 62.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.3 110.96 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.543 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.05 -24.33 47.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.41 110.984 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.52 -30.52 17.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.26 111.113 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.843 HD21 HD23 ' A' ' 32' ' ' LEU . 1.7 pp -90.91 -35.41 14.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.23 110.896 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.712 HG21 HG12 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -101.65 -46.83 4.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.26 111.083 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.57 -14.33 49.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.742 . . . . 0.28 112.467 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 2.16 110.817 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.34 -35.48 8.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 2.38 110.867 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.17 -133.48 5.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.32 112.499 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -151.39 152.24 32.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 3.45 110.745 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' A' ' 33' ' ' GLN . 84.6 t -136.7 116.51 16.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.38 111.095 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.4 t -106.43 155.98 19.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.27 110.892 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.84 135.69 59.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 0.23 111.174 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -142.69 151.05 40.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 1.3 110.926 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.54 134.65 46.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.4 110.872 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 73' ' ' THR . 19.7 mt -52.3 -36.82 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.35 111.155 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -70.23 -32.6 70.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 2.01 110.899 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -103.54 20.72 17.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 3.52 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.788 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -48.96 -28.54 3.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 1.11 110.902 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -55.82 -32.93 64.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.269 -0.423 . . . . 1.13 110.882 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -84.35 -14.5 49.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 1.09 110.878 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.7 m -64.94 -10.87 32.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.9 110.817 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.17 63.99 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.31 111.122 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.404 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 3.1 m80 -66.07 -70.51 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.43 110.813 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.641 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -142.57 -167.82 2.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.11 110.923 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -111.12 124.07 51.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 1.58 110.906 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t 58.96 75.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 2.04 110.779 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 p -134.07 -35.15 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.28 110.911 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 97.6 m-85 -99.06 117.47 33.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.107 -0.497 . . . . 1.49 110.846 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.02 -19.82 62.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 1.51 110.874 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.2 mt -146.27 144.12 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.22 111.101 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.966 HG21 HG23 ' A' ' 83' ' ' ILE . 20.0 mm -136.3 129.2 46.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.14 111.126 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.1 mm? -113.29 137.75 51.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.26 110.938 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.405 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -129.24 101.7 6.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.16 110.861 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.3 78.09 0.11 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.778 -0.725 . . . . 0.17 112.434 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.8 58.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.57 110.894 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -127.1 158.83 67.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.573 0.702 . . . . 0.22 111.175 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.63 115.88 4.28 Favored 'Trans proline' 0 C--O 1.231 0.125 0 C-N-CA 122.702 2.268 . . . . 0.26 112.394 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.15 6.61 66.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.17 112.456 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.3 152.08 8.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.39 . . . . 0.79 110.924 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.696 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 24.0 p -140.14 108.55 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.21 111.159 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.753 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.3 150.08 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.24 111.153 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.018 HD12 HD22 ' A' ' 147' ' ' LEU . 4.2 mt -129.63 99.61 5.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.31 110.876 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -75.44 153.72 37.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.31 110.82 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 m -130.02 174.99 9.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.47 110.889 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -35.92 37.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.54 111.142 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.0 -42.87 99.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 1.94 110.864 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.788 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -77.21 -54.27 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.38 111.148 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 119' ' ' LEU . 86.5 mt -49.73 -48.37 50.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.4 110.939 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.63 -50.11 55.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.8 111.17 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -43.84 83.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 4.79 110.824 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.966 HG23 HG21 ' A' ' 63' ' ' ILE . 36.6 mm -57.13 -65.18 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.31 111.142 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.99 -38.09 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.31 111.111 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -54.39 -58.03 9.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 2.18 110.875 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 56' ' ' LYS . 50.1 pt -75.5 -8.33 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 0.3 111.128 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -79.48 132.67 36.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.52 110.883 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -70.0 159.56 83.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.568 0.699 . . . . 2.37 110.876 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 113.79 3.49 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.638 2.225 . . . . 0.17 112.345 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.22 3.46 54.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.688 -0.768 . . . . 0.18 112.52 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.41 -160.12 12.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.18 112.473 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.3 m -140.11 154.96 47.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.928 0.394 . . . . 0.26 110.912 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.698 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.5 tm? -139.44 115.38 10.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.17 111.008 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.531 ' N ' HD22 ' A' ' 93' ' ' LEU . 53.9 m-85 -110.96 133.1 53.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 1.61 110.868 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.77 156.9 42.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.19 110.936 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.36 128.32 46.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 1.61 110.816 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.633 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -151.43 144.6 17.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.64 0.734 . . . . 2.29 110.868 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.633 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.87 140.19 41.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.653 2.235 . . . . 0.24 112.329 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.408 HG13 HG23 ' A' ' 157' ' ' VAL . 15.2 m -122.86 146.59 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.19 111.156 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -110.4 132.86 53.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 1.98 110.887 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.0 p -104.38 25.7 9.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 1.15 111.203 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.07 24.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.71 111.182 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.4 t -143.46 159.97 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.72 111.13 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.572 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -55.68 178.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 1.84 110.846 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -66.13 -62.65 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 2.66 110.9 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -65.98 -75.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 1.82 110.894 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.11 -168.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 1.54 110.868 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 -4.22 52.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 2.12 110.897 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.8 m -145.38 141.11 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.48 111.132 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.476 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -63.57 117.8 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 2.45 110.914 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.572 HG21 ' O ' ' A' ' 104' ' ' ASP . 39.2 p -89.68 177.72 6.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.24 111.07 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.02 -54.26 48.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.17 111.054 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.28 -49.75 76.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.042 0.448 . . . . 0.29 110.859 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -57.9 -40.69 80.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 2.21 110.928 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.633 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -61.77 -54.79 37.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.36 110.925 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 54.6 m -58.34 -48.85 79.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.21 110.893 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -45.62 92.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.472 . . . . 0.29 110.812 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.64 -48.15 83.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.23 111.154 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.616 HD11 HD12 ' A' ' 93' ' ' LEU . 15.0 tp -60.39 -52.98 62.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.37 110.921 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.0 m -63.12 -27.1 69.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.34 111.129 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.4 mt -86.97 -12.41 47.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.56 110.968 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.8 p -82.87 3.96 27.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 2.45 110.85 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.67 -4.88 34.68 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.781 -0.723 . . . . 0.71 112.528 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.2 tp -88.95 170.33 10.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.946 0.403 . . . . 0.39 110.923 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.9 m -148.13 172.75 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.31 111.169 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 51.47 45.03 28.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 2.18 110.924 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.465 HG13 HD23 ' A' ' 119' ' ' LEU . 91.0 t -81.57 142.02 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.3 111.093 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.65 8.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 1.66 110.895 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -79.57 145.92 32.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 2.27 110.862 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.678 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.5 mp -105.77 -37.31 6.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.21 110.922 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -162.1 176.67 10.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 1.28 110.983 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -126.72 165.31 19.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 5.53 110.808 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -148.39 136.43 11.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.669 0.747 . . . . 1.38 110.926 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 158.05 58.37 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.746 2.298 . . . . 0.34 112.375 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -93.35 127.01 38.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.36 110.999 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.498 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.12 161.45 22.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.492 0.663 . . . . 1.58 111.254 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -24.67 29.72 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.707 2.271 . . . . 0.5 112.386 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -85.46 -22.93 28.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 2.59 110.799 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -87.72 -53.03 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 2.44 110.911 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.73 -40.01 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.36 111.162 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -33.93 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 1.19 110.932 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -46.57 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.3 110.871 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.741 HG23 HD13 ' A' ' 147' ' ' LEU . 9.0 p -67.94 -30.96 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.17 111.128 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -76.72 -30.31 56.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 2.17 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -89.7 -21.08 22.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 1.67 110.891 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -94.8 -32.64 13.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 0.37 110.851 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.018 HD22 HD12 ' A' ' 74' ' ' LEU . 2.9 mp -127.35 -54.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.38 110.865 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.65 20.5 1.52 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.33 112.517 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -75.37 121.56 22.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.84 110.864 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -151.83 106.44 3.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 2.64 110.911 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.71 173.21 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.61 110.872 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.47 -19.59 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 1.82 110.835 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -96.19 19.9 11.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 1.59 110.925 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.516 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -89.54 163.57 15.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.31 110.823 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -173.48 130.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.28 110.948 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.696 ' CZ ' HG22 ' A' ' 72' ' ' THR . 20.6 m-85 -70.22 135.16 48.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 1.85 110.824 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.408 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.73 147.23 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.29 111.146 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.678 ' HG2' HD13 ' A' ' 130' ' ' LEU . 25.8 tt0 -104.69 125.56 50.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 1.65 110.829 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.24 153.21 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.21 111.152 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.427 ' HB ' HD11 ' A' ' 130' ' ' LEU . 6.6 t -136.92 162.92 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.28 111.136 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.449 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -153.23 136.31 5.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.772 -0.727 . . . . 0.16 112.464 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.64 139.48 30.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.362 . . . . 1.66 110.817 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 135.6 51.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.693 0.759 . . . . 1.34 110.821 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 135.77 31.2 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.622 2.215 . . . . 0.53 112.387 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -116.46 150.17 38.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.43 110.756 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.533 ' O ' HG13 ' A' ' 168' ' ' VAL . 37.5 t80 64.39 112.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 5.8 110.893 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -53.87 111.88 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 10.08 110.886 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 166' ' ' PHE . 31.2 m -107.28 -26.56 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 5.71 111.125 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.05 -47.93 2.7 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.78 -0.724 . . . . 5.86 112.475 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 35.2 m -84.71 83.86 7.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.924 0.392 . . . . 6.83 110.95 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.3 m -161.23 -176.0 5.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 6.12 110.856 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.456 . . . . 7.13 110.867 -179.945 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.702 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.795 0.331 . . . . 8.12 110.896 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.96 -13.5 59.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 1.04 111.078 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.07 -39.31 74.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 2.88 110.898 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' HB2' HD11 ' A' ' 6' ' ' ILE . 9.4 m-85 -122.33 15.27 10.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 2.01 110.842 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.96 41.06 99.24 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.843 -0.694 . . . . 0.24 112.469 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.702 HD12 ' O ' ' A' ' 1' ' ' MET . 1.6 mp -83.36 158.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.33 111.081 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 36' ' ' THR . 0.8 OUTLIER -148.58 164.83 33.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.35 110.864 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.49 129.13 36.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.27 111.023 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.84 -6.51 23.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.773 . . . . 0.25 112.519 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -113.14 167.91 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 1.16 110.846 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.67 137.3 37.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.178 -0.465 . . . . 1.35 110.908 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.614 HG22 ' HB ' ' A' ' 62' ' ' ILE . 47.0 t -140.75 133.21 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 1.86 111.111 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.787 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -110.3 121.98 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.26 111.085 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.817 HG11 HG12 ' A' ' 29' ' ' VAL . 94.9 t -94.59 118.06 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.17 111.068 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.599 HG12 HG13 ' A' ' 47' ' ' ILE . 21.3 t -102.66 113.59 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.2 111.12 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -113.39 167.19 10.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.2 111.013 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.578 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.9 p-10 -148.57 -169.71 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.279 -0.419 . . . . 1.78 110.926 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -58.3 -35.58 72.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 3.64 110.953 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.1 m -73.98 -8.03 54.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 1.45 110.931 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.35 93.33 9.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.716 . . . . 0.17 110.833 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 143.09 50.16 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.729 2.286 . . . . 0.22 112.326 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.81 -32.9 4.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.22 111.101 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -50.99 -53.09 36.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 2.42 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.46 -44.85 11.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.21 111.048 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -52.16 -62.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.15 110.9 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.61 -37.42 27.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 3.34 110.848 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.44 -47.08 53.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.2 112.53 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.47 HD23 ' HZ3' ' A' ' 31' ' ' LYS . 44.5 mt -61.94 -39.35 91.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.47 110.943 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.817 HG12 HG11 ' A' ' 14' ' ' VAL . 18.2 m -77.68 -31.75 17.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.231 -0.44 . . . . 0.62 111.134 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.01 -58.82 6.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 1.82 110.812 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HZ3' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -56.22 -41.1 75.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 3.13 110.88 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.867 HD23 HD21 ' A' ' 35' ' ' LEU . 91.2 mt -72.35 -24.4 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.23 110.952 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.429 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.0 mt-30 -78.16 -24.67 47.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.38 110.897 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.35 -30.29 16.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.31 111.068 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.867 HD21 HD23 ' A' ' 32' ' ' LEU . 1.6 pp -91.55 -35.65 14.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.27 110.96 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.62 -44.2 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.36 111.17 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.33 -11.0 55.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.42 112.424 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.29 -61.97 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.782 0.325 . . . . 2.92 110.918 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 3.7 mm-40 -86.49 -43.0 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 2.06 110.866 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.25 -122.03 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.852 -0.69 . . . . 0.34 112.523 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -157.49 153.35 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 2.25 110.877 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.0 t -138.27 128.72 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.28 111.182 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t -118.11 154.48 32.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.16 110.84 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -115.52 133.31 62.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.17 111.089 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -144.53 152.98 41.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 1.97 110.92 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -101.91 139.62 37.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.46 110.982 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.87 HD13 HG21 ' A' ' 73' ' ' THR . 14.5 mt -51.87 -44.24 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.34 111.169 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -20.11 60.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 3.68 110.833 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -107.12 18.5 21.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 3.52 110.86 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.005 HD13 HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -55.51 -24.56 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 2.7 110.911 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -52.19 -34.7 46.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 1.03 110.95 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -86.25 -16.34 37.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 1.2 110.907 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 m -63.47 -12.84 34.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.88 110.897 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.71 59.46 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.498 . . . . 0.35 111.068 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -61.81 -70.29 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.4 110.829 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.28 -168.78 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 1.23 110.844 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -105.82 131.05 53.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 1.96 110.825 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 49.01 71.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 1.16 110.82 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.8 p -125.61 -34.42 2.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.25 110.884 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 86' ' ' ILE . 99.1 m-85 -99.85 119.18 37.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.495 . . . . 1.48 110.88 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.42 -19.4 62.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 1.54 110.904 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.614 ' HB ' HG22 ' A' ' 12' ' ' VAL . 27.3 mt -146.03 145.44 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.25 111.117 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.976 HG21 HG23 ' A' ' 83' ' ' ILE . 13.3 mm -136.83 127.85 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.16 111.147 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -109.55 137.59 47.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.224 -0.444 . . . . 0.18 110.926 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -130.13 96.42 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.17 110.933 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.03 75.0 0.25 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 0.16 112.436 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.49 62.5 0.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.847 0.356 . . . . 0.59 110.9 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.99 160.12 66.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.533 0.682 . . . . 0.26 111.172 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 116.62 4.65 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.231 . . . . 0.29 112.35 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.14 7.27 70.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.647 -0.787 . . . . 0.22 112.5 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.33 150.23 11.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.075 0.464 . . . . 0.71 110.789 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.757 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 31.7 p -140.05 108.57 5.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.046 -0.525 . . . . 0.26 111.094 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.87 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.8 152.72 15.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.29 111.132 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.973 HD12 HD22 ' A' ' 147' ' ' LEU . 2.3 mt -130.36 101.76 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.36 110.891 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -77.56 149.05 34.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.28 110.84 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.1 m -125.57 178.43 5.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.55 110.857 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.14 -45.21 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.35 111.079 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.92 -48.53 75.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 2.32 110.906 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.005 HG23 HD13 ' A' ' 50' ' ' LEU . 4.3 mp -68.23 -56.55 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.24 111.07 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.602 HD13 ' HA ' ' A' ' 119' ' ' LEU . 62.0 mt -50.67 -39.56 51.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.26 110.966 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.85 -57.1 12.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.31 111.062 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB3' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -53.0 -41.97 65.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 2.93 110.833 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 63' ' ' ILE . 33.7 mm -58.94 -68.58 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.437 . . . . 0.21 111.056 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.79 29.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.23 111.125 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -57.55 -56.0 27.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 3.06 110.934 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.665 HG22 ' O ' ' A' ' 56' ' ' LYS . 50.2 pt -80.01 -5.69 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.22 111.17 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -76.72 129.4 36.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.4 110.904 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -70.4 160.41 81.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.623 0.725 . . . . 2.26 110.908 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 114.17 3.59 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.726 2.284 . . . . 0.27 112.393 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.43 4.79 57.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.22 112.501 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.4 -164.61 14.38 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.73 . . . . 0.2 112.435 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 67.6 m -137.71 146.28 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.4 110.815 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 124' ' ' LEU . 2.0 tm? -129.49 125.39 36.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.4 110.867 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.584 ' N ' HD22 ' A' ' 93' ' ' LEU . 69.9 m-85 -121.34 131.4 54.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 1.91 110.935 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.76 157.18 43.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.18 110.86 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.85 127.28 44.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 2.04 110.907 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -151.3 146.93 19.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.635 0.731 . . . . 2.33 110.832 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.602 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.92 142.44 47.25 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.68 2.253 . . . . 0.2 112.336 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.18 146.69 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.17 111.112 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -105.22 132.63 51.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 2.04 110.946 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.0 p -103.64 26.04 9.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 1.37 111.108 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.99 24.82 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.67 111.105 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -143.73 158.85 16.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.7 111.134 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.598 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -58.39 -177.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 2.07 110.808 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -68.69 -68.81 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 2.09 110.904 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -56.94 -75.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.082 -0.508 . . . . 1.99 110.939 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.7 -169.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 1.81 110.9 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -4.45 54.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 2.16 110.915 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.61 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.4 m -144.5 153.36 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.51 111.126 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.492 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.4 tptt -71.25 108.87 4.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 2.08 110.912 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.598 HG21 ' O ' ' A' ' 104' ' ' ASP . 32.2 p -85.88 177.7 7.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.27 111.13 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.49 -54.31 42.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.27 111.119 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -49.97 75.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.48 110.814 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.46 -41.58 76.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 1.81 110.924 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -61.64 -54.63 40.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 0.38 110.932 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.7 m -58.47 -48.84 79.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.34 110.886 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -46.53 89.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.55 110.879 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.36 -43.47 98.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.36 111.051 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.602 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.1 tp -63.37 -52.37 61.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.29 110.91 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -65.64 -24.65 67.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.33 111.114 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.34 -15.71 42.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.87 110.853 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 40.2 p -83.42 4.69 26.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 2.34 110.873 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.8 -4.77 34.4 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.632 -0.794 . . . . 0.59 112.469 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -86.45 169.37 12.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.904 0.383 . . . . 0.3 110.894 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.56 170.15 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.23 111.118 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 51.99 44.9 29.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 2.43 110.897 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.488 HG13 HD23 ' A' ' 119' ' ' LEU . 91.1 t -80.33 141.75 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.32 111.049 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 158.87 7.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 1.62 110.92 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -77.31 145.92 37.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 2.35 110.86 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.674 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.6 mp -105.26 -36.51 7.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.25 110.949 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.83 176.2 13.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 1.11 110.944 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.697 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -132.2 137.04 47.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 4.12 110.83 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.78 138.26 30.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.699 0.762 . . . . 1.84 110.853 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.413 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.5 Cg_endo -69.77 164.05 35.98 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.664 2.242 . . . . 0.2 112.357 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -95.74 128.47 42.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.29 110.941 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.455 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.46 160.91 25.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.576 0.703 . . . . 1.26 111.117 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.455 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.0 Cg_endo -69.69 -29.83 23.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.261 . . . . 0.4 112.288 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.08 -17.96 35.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 2.79 110.856 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -53.47 4.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 2.48 110.92 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -49.14 -41.09 13.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.26 111.142 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -34.67 73.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 1.27 110.976 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.18 -44.89 71.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.33 110.802 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.675 HG23 HD13 ' A' ' 147' ' ' LEU . 7.2 p -69.0 -32.54 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.19 111.153 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -76.06 -29.9 58.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 2.33 110.858 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -90.14 -20.68 22.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 1.77 110.911 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -94.58 -32.63 13.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.33 110.858 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.973 HD22 HD12 ' A' ' 74' ' ' LEU . 2.6 mp -127.88 -53.87 1.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.45 110.99 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.96 12.3 2.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 0.39 112.501 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.61 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.5 t-160 -70.24 120.38 15.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 1.12 110.818 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -151.9 111.22 3.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 3.27 110.928 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.62 175.09 13.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 1.05 110.869 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.34 -14.19 14.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 2.24 110.876 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -104.82 11.4 33.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 1.83 110.868 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.603 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -74.01 163.18 28.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.32 110.939 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.697 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.88 129.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.18 110.88 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.757 ' CZ ' HG22 ' A' ' 72' ' ' THR . 33.2 m-85 -73.54 132.89 43.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 1.88 110.869 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.01 140.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.22 111.116 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.674 ' HG2' HD13 ' A' ' 130' ' ' LEU . 22.3 tt0 -94.42 126.38 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 1.65 110.922 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.446 HD13 ' HG ' ' A' ' 115' ' ' LEU . 2.8 mp -123.15 153.65 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.34 111.174 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.443 ' HB ' HD11 ' A' ' 130' ' ' LEU . 7.5 t -139.2 164.46 29.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.35 111.141 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -154.7 135.84 4.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.17 112.488 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -91.36 140.02 30.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.866 0.365 . . . . 1.64 110.899 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 135.47 49.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.604 0.716 . . . . 1.26 110.969 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.85 127.87 15.14 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.695 2.263 . . . . 0.36 112.348 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -108.56 149.56 28.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.3 110.869 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.5 t80 65.04 151.81 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 5.82 110.829 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.42 99.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 9.58 110.841 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.8 m -112.03 -30.19 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 5.28 111.129 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 108.91 -28.17 11.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 6.32 112.5 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.5 t -77.98 82.11 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 7.0 110.855 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.77 -170.35 3.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 8.0 110.945 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 9.48 110.845 -179.9 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' O ' HD12 ' A' ' 6' ' ' ILE . 13.3 ptt? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.752 0.31 . . . . 3.97 110.881 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.49 60.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.299 -0.409 . . . . 0.61 111.094 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.96 -50.31 66.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 2.67 110.897 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 6' ' ' ILE . 7.2 m-85 -122.12 11.71 10.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 2.06 110.933 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.37 40.65 99.14 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.726 -0.75 . . . . 0.29 112.502 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.485 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.5 mp -83.53 160.42 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 0.26 111.019 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -158.3 168.63 26.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.08 -0.509 . . . . 1.84 110.773 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.73 132.81 35.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 0.36 111.092 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.88 -8.12 29.55 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.757 -0.735 . . . . 0.25 112.546 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -111.96 165.33 12.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 1.26 110.924 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.56 140.09 33.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 2.16 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 62' ' ' ILE . 47.2 t -142.68 140.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 1.85 111.178 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.767 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -118.02 122.1 42.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.23 111.085 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.799 HG11 HG12 ' A' ' 29' ' ' VAL . 59.6 t -94.64 118.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.18 111.086 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.516 HG12 ' CG1' ' A' ' 47' ' ' ILE . 9.4 t -102.95 110.07 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.26 111.188 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -111.54 167.55 10.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.15 -0.477 . . . . 0.15 110.939 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 7.7 p-10 -151.34 -169.63 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 1.69 110.876 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -56.97 -35.72 69.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 2.91 110.846 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.4 m -73.11 -10.61 59.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 1.57 110.832 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.63 94.9 10.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.729 . . . . 0.13 110.881 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 141.46 45.2 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.717 2.278 . . . . 0.21 112.285 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -48.89 -32.7 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.18 111.154 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.55 -52.66 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 2.54 110.963 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.34 -45.06 10.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.17 111.097 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.488 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.48 -61.34 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.14 110.877 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -49.87 -36.1 25.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 3.31 110.857 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.52 -47.2 43.54 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.486 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.4 mt -62.13 -38.62 89.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.48 110.922 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.799 HG12 HG11 ' A' ' 14' ' ' VAL . 18.2 m -77.96 -31.55 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.62 111.099 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -62.2 -58.01 9.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 1.6 110.872 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -40.24 75.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 2.43 110.929 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.887 HD23 HD21 ' A' ' 35' ' ' LEU . 87.3 mt -73.03 -24.49 60.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.23 110.986 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.465 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.64 -25.25 44.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.37 110.942 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.83 -29.6 17.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.24 111.095 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.887 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.66 -35.0 14.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.19 110.981 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.73 -44.98 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.23 111.06 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.07 -10.94 53.75 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.674 -0.774 . . . . 0.26 112.478 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.5 -62.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.728 0.299 . . . . 3.06 110.852 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.637 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 2.9 mm-40 -90.22 -40.97 11.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 2.18 110.872 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.38 -123.03 4.01 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.661 -0.78 . . . . 0.32 112.572 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -158.28 153.54 25.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.863 0.363 . . . . 2.28 110.827 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 33' ' ' GLN . 96.6 t -138.5 130.86 38.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.187 -0.46 . . . . 0.33 111.137 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 t -119.67 156.02 31.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.17 110.916 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -117.07 135.3 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.18 111.125 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -145.74 151.95 38.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 2.17 110.965 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.73 135.43 44.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.4 110.936 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.66 ' CD1' HG21 ' A' ' 73' ' ' THR . 32.8 mt -51.68 -35.15 17.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.26 111.058 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -75.09 -31.22 61.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 2.1 110.838 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -95.82 18.44 13.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 3.32 110.948 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.791 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.83 -31.13 4.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.11 110.937 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -53.39 -38.84 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 1.11 110.899 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -85.09 -15.85 42.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 1.27 110.899 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -65.94 -11.64 48.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 1.01 110.787 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 63.36 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.32 111.144 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -60.93 -71.66 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.36 110.826 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -150.12 -168.99 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 1.82 110.951 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -102.36 137.47 40.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.74 110.926 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 p 46.57 85.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 1.23 110.833 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.6 p -141.05 -40.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.25 110.87 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.492 ' O ' HD23 ' A' ' 87' ' ' LEU . 94.5 m-85 -99.85 119.52 38.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.51 . . . . 2.06 110.931 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.2 -21.23 62.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 1.51 110.814 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 12' ' ' VAL . 35.8 mt -142.63 144.25 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.34 111.091 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.958 HG21 HG23 ' A' ' 83' ' ' ILE . 19.7 mm -134.9 126.58 47.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.12 111.13 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.1 mm? -109.04 136.82 47.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.19 110.925 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.3 98.39 4.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.12 110.857 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.61 75.52 0.21 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.735 -0.745 . . . . 0.15 112.577 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.24 56.17 0.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.801 0.334 . . . . 0.57 110.938 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -124.44 160.32 53.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.707 0.765 . . . . 0.22 111.12 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 120.35 7.15 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 0.24 112.283 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.22 6.91 83.83 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.828 -0.701 . . . . 0.18 112.54 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.413 ' HB3' HG23 ' A' ' 68' ' ' VAL . 4.7 p -55.97 151.56 11.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.951 0.405 . . . . 0.71 110.825 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.704 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 19.5 p -141.5 109.12 5.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.2 111.187 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.66 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.4 145.48 11.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.3 111.194 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.959 HD12 HD22 ' A' ' 147' ' ' LEU . 4.1 mt -124.18 105.17 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.22 110.894 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -80.1 153.8 28.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.28 110.822 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m -131.34 -176.62 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.39 110.902 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.33 69.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.526 . . . . 0.33 111.139 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -62.56 -45.04 94.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 1.64 110.841 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.791 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -74.97 -55.31 12.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.171 -0.468 . . . . 0.24 111.092 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.544 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.5 mt -50.28 -43.88 53.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.22 110.831 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.45 -52.06 49.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.111 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -44.43 92.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 2.96 110.877 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.958 HG23 HG21 ' A' ' 63' ' ' ILE . 42.3 mm -54.94 -68.18 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.2 111.085 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.65 57.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.27 111.126 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -53.14 -52.61 58.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 2.19 110.874 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 56' ' ' LYS . 36.5 pt -81.63 -8.63 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.18 111.21 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -77.24 124.2 27.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.34 110.876 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -63.1 160.25 40.85 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.703 . . . . 2.24 110.887 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 114.22 3.65 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.265 . . . . 0.28 112.3 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.56 5.52 56.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.587 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.71 -160.95 14.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.16 112.462 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.9 m -139.19 154.26 48.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.28 110.936 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.729 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.56 115.67 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.15 110.796 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.566 ' N ' HD22 ' A' ' 93' ' ' LEU . 47.9 m-85 -110.19 132.4 54.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 1.84 110.903 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.558 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.87 158.71 44.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.21 110.928 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.08 131.38 44.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 2.12 110.899 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.7 150.25 22.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.62 0.724 . . . . 3.59 110.844 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.638 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.72 144.71 55.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 0.24 112.412 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.7 146.59 32.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.28 111.125 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.478 ' HB2' HG22 ' A' ' 111' ' ' THR . 41.9 mt-10 -107.19 133.28 52.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 2.02 110.876 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.8 p -92.42 -42.76 9.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 1.07 111.209 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.677 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.67 40.45 1.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.91 111.037 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.421 HG21 ' CD ' ' A' ' 100' ' ' GLU . 20.7 t -147.65 151.9 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.85 111.113 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.64 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -56.34 178.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 2.31 110.825 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.15 -63.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 2.29 110.895 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -63.65 -75.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 1.82 110.895 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.86 -167.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.479 . . . . 1.73 110.849 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -8.29 59.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 2.31 110.919 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 149' ' ' HIS . 1.5 m -142.58 150.96 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.77 111.119 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HZ3' HD23 ' A' ' 74' ' ' LEU . 2.5 ttpm? -65.99 126.21 27.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 5.11 110.885 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.64 HG21 ' O ' ' A' ' 104' ' ' ASP . 71.7 p -97.83 177.7 5.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.38 111.147 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.87 -54.53 45.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.26 111.056 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -55.16 -48.04 74.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.23 110.908 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -36.41 75.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 2.41 110.838 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.537 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -63.94 -56.57 14.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.51 110.904 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 48.6 m -57.44 -47.62 81.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.28 110.861 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -45.57 92.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.27 110.854 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.31 99.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.479 . . . . 0.23 111.082 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.544 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.0 tp -65.39 -52.57 52.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.22 110.906 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.2 m -61.28 -31.75 71.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.27 111.114 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.9 mt -87.09 -10.67 52.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.6 110.912 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.63 4.95 29.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 1.71 110.869 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.27 7.66 32.29 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.54 112.485 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -106.3 168.44 9.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.849 0.357 . . . . 0.27 110.898 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 171' ' ' SER . 23.0 m -148.41 172.53 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.23 111.133 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 51.63 44.67 29.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.471 . . . . 2.12 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.408 HG13 HD23 ' A' ' 119' ' ' LEU . 45.5 t -79.3 144.66 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.26 111.163 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.3 158.48 5.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 2.85 110.976 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -78.83 147.09 33.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.39 . . . . 2.44 110.837 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.724 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -106.09 -36.51 6.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.21 110.967 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -160.13 176.39 11.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.11 110.916 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.72 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -131.9 137.31 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 4.12 110.848 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -123.53 136.2 26.95 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.592 0.71 . . . . 1.81 110.875 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.416 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.3 Cg_endo -69.75 162.46 41.98 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.642 2.228 . . . . 0.27 112.427 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.681 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -96.63 136.13 37.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.28 110.909 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.577 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -117.67 162.46 28.74 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.519 0.676 . . . . 1.44 111.11 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -22.65 31.53 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.574 2.183 . . . . 0.45 112.323 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -85.15 -26.37 26.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 2.43 110.826 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -88.53 -51.01 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 2.47 110.829 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -49.82 -38.92 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.24 111.188 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.85 -32.95 73.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.16 110.924 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -45.65 68.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.29 110.862 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.712 HG23 HD13 ' A' ' 147' ' ' LEU . 7.4 p -68.75 -30.96 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.18 111.081 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -76.44 -31.1 57.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 2.47 110.876 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -90.26 -20.41 23.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.164 -0.471 . . . . 1.67 110.903 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -94.75 -33.0 13.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.31 110.914 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.959 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -126.2 -54.18 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.32 110.938 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.45 10.67 2.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 0.32 112.45 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.483 ' CD2' HG11 ' A' ' 109' ' ' VAL . 13.0 t-160 -70.18 121.98 18.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.64 110.89 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.48 105.07 3.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 3.22 110.928 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.25 170.7 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.79 110.907 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.49 -6.33 18.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 1.56 110.893 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.677 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 1.8 m120 -105.14 10.56 33.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 3.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.681 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.62 166.93 19.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.31 110.934 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.72 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -172.49 130.71 0.57 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.27 110.906 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.704 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.1 m-85 -75.67 132.13 40.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 1.73 110.88 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.04 146.91 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.22 111.142 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.724 ' HG2' HD13 ' A' ' 130' ' ' LEU . 9.4 tt0 -102.07 131.52 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 2.11 110.899 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.48 149.96 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.25 111.116 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.507 ' N ' HD11 ' A' ' 130' ' ' LEU . 3.3 t -132.05 159.87 37.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.22 111.149 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.19 135.2 5.13 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.821 -0.704 . . . . 0.13 112.506 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -91.54 139.47 30.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.348 . . . . 1.66 110.973 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.23 134.77 51.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 1.29 110.933 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.67 121.66 8.37 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.743 2.296 . . . . 0.37 112.353 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.561 ' O ' HG13 ' A' ' 168' ' ' VAL . 6.9 t-20 -96.16 153.03 18.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.921 0.391 . . . . 0.62 110.89 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -49.2 113.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 7.45 110.883 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 65.51 96.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 7.95 110.977 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 165' ' ' ASN . 3.8 m -122.65 -34.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 8.58 111.131 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 127.2 -47.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 8.02 112.57 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.91 116.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.982 0.42 . . . . 8.74 110.89 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.405 ' HB3' HG11 ' A' ' 125' ' ' VAL . 16.3 m -165.49 -75.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 9.08 110.877 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 6.81 110.926 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.542 ' HG2' HD22 ' A' ' 35' ' ' LEU . 5.2 mtt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.766 0.317 . . . . 3.92 110.903 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.88 -21.41 66.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.44 111.119 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -51.51 63.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 2.11 110.835 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.419 ' HB2' HD11 ' A' ' 6' ' ' ILE . 4.7 m-85 -122.3 20.72 10.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 1.53 110.935 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.33 41.68 80.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.26 112.531 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.515 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.5 mp -83.44 160.52 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.27 111.145 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -157.5 168.61 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 1.81 110.929 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.62 131.81 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.35 111.1 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.88 2.62 30.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.757 -0.735 . . . . 0.4 112.472 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -122.38 165.51 16.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 1.29 110.92 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.73 139.65 34.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 1.29 110.869 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.636 HG22 ' HB ' ' A' ' 62' ' ' ILE . 48.6 t -142.42 142.48 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 1.85 111.197 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.79 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -119.2 118.28 30.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.29 111.194 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.835 HG11 HG12 ' A' ' 29' ' ' VAL . 63.9 t -92.91 118.5 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.16 111.091 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.422 HG12 ' CG1' ' A' ' 47' ' ' ILE . 21.3 t -102.58 116.33 46.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.19 111.168 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -116.79 168.08 10.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.2 110.939 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.63 -169.86 3.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.26 -0.427 . . . . 1.86 110.882 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -57.11 -35.61 69.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 3.38 110.88 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 t -73.49 -10.21 59.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 1.3 110.862 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.96 94.24 10.36 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.698 0.761 . . . . 0.16 110.85 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.89 142.48 47.46 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.667 2.245 . . . . 0.23 112.339 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.07 -32.52 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.22 111.136 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -51.26 -52.97 40.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 2.48 110.957 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -44.68 11.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.2 111.128 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.479 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.74 -61.59 2.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.15 110.92 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -36.41 22.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 2.53 110.918 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.37 -46.76 47.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.682 -0.77 . . . . 0.2 112.426 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.9 mt -62.23 -38.64 90.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.45 110.929 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.835 HG12 HG11 ' A' ' 14' ' ' VAL . 17.2 m -77.97 -31.55 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.62 111.119 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.31 -58.16 8.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.191 -0.459 . . . . 1.65 110.883 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -40.11 74.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.71 110.967 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.861 HD23 HD21 ' A' ' 35' ' ' LEU . 90.2 mt -73.06 -25.17 60.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.24 110.862 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.51 -25.38 45.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.37 110.845 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 -29.58 17.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.24 111.092 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.861 HD21 HD23 ' A' ' 32' ' ' LEU . 1.3 pp -91.46 -34.72 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.23 110.935 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.28 -45.84 4.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.23 111.164 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.03 -12.04 53.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.26 112.513 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -62.56 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 2.88 110.912 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -94.45 -38.97 10.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.15 -0.477 . . . . 2.62 110.865 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.55 -126.8 4.43 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.24 112.453 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -155.28 153.46 30.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 2.21 110.836 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 33' ' ' GLN . 97.4 t -138.38 128.41 34.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.25 111.143 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.0 t -116.87 157.87 24.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.15 110.959 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.07 135.52 60.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.14 111.082 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -144.08 151.41 39.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 1.26 110.82 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.4 134.89 46.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.43 110.905 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.693 ' CD1' HG21 ' A' ' 73' ' ' THR . 24.6 mt -52.23 -36.13 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.37 111.188 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -71.55 -32.27 67.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 2.06 110.968 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -102.54 20.25 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 3.61 110.845 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.79 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -49.03 -28.89 4.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 1.12 110.909 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.581 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -55.81 -34.04 64.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 2.67 110.993 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -83.68 -13.89 53.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 1.12 110.926 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.8 m -68.49 -6.97 28.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.93 110.867 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.26 64.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.118 -0.492 . . . . 0.46 111.089 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -65.24 -69.46 0.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.34 110.902 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.667 ' O ' HG22 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -155.66 -175.21 5.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 2.16 110.84 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -94.42 135.15 36.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 2.01 110.845 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 p 46.29 82.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 1.12 110.852 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -133.33 -38.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.32 110.813 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.467 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.1 m-85 -102.46 122.7 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 1.45 110.886 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.33 -20.56 61.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 1.72 110.769 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.636 ' HB ' HG22 ' A' ' 12' ' ' VAL . 33.5 mt -144.21 144.47 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.35 111.165 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.004 HG21 HG23 ' A' ' 83' ' ' ILE . 15.9 mm -135.29 130.23 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.15 111.158 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.7 mm? -113.88 136.92 52.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.18 110.915 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.57 100.88 5.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.14 110.793 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.79 74.06 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.771 -0.728 . . . . 0.19 112.478 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.97 58.68 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.57 110.91 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.53 159.89 63.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.587 0.708 . . . . 0.22 111.129 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 116.43 4.56 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.642 2.228 . . . . 0.25 112.377 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.15 7.01 68.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.822 -0.704 . . . . 0.17 112.471 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -54.92 150.49 10.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.967 0.413 . . . . 0.7 110.881 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.746 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.2 p -140.15 109.0 5.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.15 111.121 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.693 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.68 152.86 16.38 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.25 111.051 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.974 HD12 HD22 ' A' ' 147' ' ' LEU . 6.1 mt -130.94 99.76 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.23 110.913 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -77.57 138.36 39.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.34 110.901 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.531 ' H ' HD13 ' A' ' 79' ' ' ILE . 16.4 m -115.31 175.61 5.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.63 110.803 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.98 -35.41 33.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.27 111.246 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -62.7 -39.69 94.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.126 -0.488 . . . . 2.3 110.909 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.79 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.8 mp -81.86 -55.17 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.24 111.146 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.3 mt -49.27 -46.1 45.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.32 110.826 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.03 -50.54 58.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.57 111.077 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.515 ' OE2' HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -58.09 -47.13 84.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 4.91 110.901 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.004 HG23 HG21 ' A' ' 63' ' ' ILE . 48.8 mm -53.12 -64.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.26 111.115 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.7 -41.36 61.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.26 111.053 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 tpp85 -51.99 -52.99 46.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 2.1 110.854 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 56' ' ' LYS . 32.4 pt -80.85 -8.41 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.27 111.163 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.17 114.11 15.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.33 110.884 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -53.7 160.43 2.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.702 . . . . 3.52 110.864 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 114.76 3.81 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.677 2.252 . . . . 0.28 112.291 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.67 5.77 57.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 0.24 112.486 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.5 -162.25 20.69 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.694 -0.765 . . . . 0.17 112.482 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.6 m -139.0 153.52 48.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.28 110.94 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.2 tm? -138.28 117.07 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.15 110.898 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.604 ' N ' HD22 ' A' ' 93' ' ' LEU . 47.1 m-85 -112.74 133.51 54.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 1.61 110.867 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.64 159.21 44.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.17 110.946 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.96 126.4 41.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 1.97 110.89 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.627 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -150.33 146.77 20.41 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.673 0.749 . . . . 2.34 110.905 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.628 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.8 Cg_endo -69.77 143.3 50.34 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.761 2.307 . . . . 0.2 112.316 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 155' ' ' LEU . 14.2 m -126.97 146.43 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.2 111.121 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.491 ' HB2' HG22 ' A' ' 111' ' ' THR . 54.1 mt-10 -109.25 132.57 54.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 2.13 110.873 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.9 p -91.27 -38.92 12.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 1.22 111.125 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.556 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -97.77 40.75 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.54 111.101 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.438 HG21 ' CD ' ' A' ' 100' ' ' GLU . 26.2 t -148.07 150.19 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.64 111.068 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.601 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -53.38 172.01 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.488 . . . . 1.71 110.872 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -63.95 -62.83 1.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 2.3 110.856 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -65.66 -75.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 2.36 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 t 53.49 -168.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 2.14 110.928 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.45 -5.73 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 1.71 110.921 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.93 146.63 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.39 111.085 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -67.29 115.06 6.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 2.39 110.891 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.601 HG21 ' O ' ' A' ' 104' ' ' ASP . 72.1 p -88.94 -179.85 6.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.482 . . . . 0.23 111.165 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.18 -53.09 62.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.18 111.08 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -60.19 -49.73 76.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.043 0.449 . . . . 0.27 110.86 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -58.12 -43.11 87.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 2.31 110.902 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.627 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -59.58 -55.2 37.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.3 110.876 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 61.2 m -57.79 -49.26 77.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.24 110.912 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -45.5 88.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.32 110.868 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.65 -46.93 87.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.28 111.111 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.648 HD23 HG13 ' A' ' 127' ' ' VAL . 14.6 tp -60.49 -50.96 71.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.38 110.88 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.5 m -66.31 -26.24 67.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.35 111.214 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.7 mt -86.17 -14.04 45.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.55 110.888 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 p -81.94 2.92 28.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 2.53 110.854 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.8 -4.93 34.43 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.729 . . . . 0.79 112.551 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.2 tp -87.61 170.82 10.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.38 110.896 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.78 170.97 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.4 111.126 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 53.11 44.29 30.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 2.1 110.892 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.648 HG13 HD23 ' A' ' 119' ' ' LEU . 89.9 t -81.69 139.42 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.3 111.009 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.29 162.4 8.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 1.85 110.96 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.57 145.69 32.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 2.54 110.904 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.674 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.8 mp -103.89 -36.79 7.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.472 . . . . 0.22 110.955 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -157.08 176.29 12.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 1.12 110.926 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.742 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.1 tmt_? -131.26 137.24 48.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 4.45 110.881 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -124.53 137.84 30.04 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.607 0.718 . . . . 1.38 110.958 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.414 ' HA ' HD21 ' A' ' 155' ' ' LEU . 52.8 Cg_endo -69.72 165.13 31.96 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.755 2.304 . . . . 0.24 112.329 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.672 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.86 127.21 44.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.27 110.963 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.459 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.74 161.25 23.36 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.555 0.693 . . . . 1.56 111.179 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -24.64 29.31 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.281 . . . . 0.32 112.319 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -85.71 -22.25 27.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 2.58 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -87.71 -52.23 5.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 2.41 110.995 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -49.84 -40.31 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.25 111.136 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -33.03 73.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 1.13 111.011 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -46.34 66.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.26 110.879 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.2 p -68.3 -30.12 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.17 111.113 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -76.34 -32.68 58.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.108 -0.496 . . . . 2.5 110.806 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -89.35 -20.13 24.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.74 110.877 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -94.6 -32.61 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.28 110.894 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.974 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.79 -54.37 1.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.31 110.921 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.18 9.26 2.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.735 -0.745 . . . . 0.29 112.454 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -70.21 120.93 16.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.64 110.858 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -152.63 104.9 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 2.24 110.894 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -161.11 171.26 18.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.67 110.789 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.78 -8.11 17.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 1.87 110.885 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.556 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 2.3 m120 -102.74 12.01 36.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 2.95 110.872 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.672 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -86.07 167.51 14.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.33 110.831 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.742 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -172.61 130.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.2 110.916 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.746 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.3 m-85 -73.61 132.69 43.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.473 . . . . 1.8 110.939 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.39 142.9 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.2 111.09 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.674 ' HG2' HD13 ' A' ' 130' ' ' LEU . 24.0 tt0 -96.86 127.81 43.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 1.62 110.85 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.95 151.39 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.32 111.156 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.452 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.9 t -134.96 162.96 30.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.28 111.217 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.466 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -153.84 134.09 4.21 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 0.13 112.511 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.77 140.37 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 1.67 110.891 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.11 135.48 47.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.54 0.685 . . . . 1.83 110.863 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 125.1 11.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.623 2.215 . . . . 0.38 112.372 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -106.23 150.47 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.933 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.9 t80 65.02 151.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 5.95 111.002 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -66.35 119.69 12.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 9.69 110.849 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.9 m -120.7 178.92 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 5.53 111.105 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -146.78 27.39 1.62 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.797 -0.716 . . . . 5.57 112.521 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.6 m -116.45 75.23 0.95 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.347 . . . . 6.81 110.9 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.25 -170.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 6.85 110.804 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 7.65 110.927 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptm . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.827 0.346 . . . . 4.11 110.853 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.64 -21.42 63.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.47 111.155 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.15 -51.48 64.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 1.98 110.93 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -122.33 22.68 10.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 1.5 110.817 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.15 41.08 53.01 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.772 -0.728 . . . . 0.25 112.454 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.504 HG23 HG21 ' A' ' 12' ' ' VAL . 1.6 mp -80.02 159.68 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 0.23 111.139 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.731 ' O ' HG23 ' A' ' 36' ' ' THR . 0.8 OUTLIER -153.5 164.7 37.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.26 110.952 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.46 126.19 35.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.29 111.051 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.96 0.96 21.05 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.807 -0.711 . . . . 0.29 112.512 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.89 167.15 11.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 1.14 110.974 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.15 112.79 25.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 1.28 110.947 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 62' ' ' ILE . 88.1 t -117.37 130.16 72.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.96 111.013 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.788 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -106.11 124.66 49.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.24 111.105 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.849 HG11 HG12 ' A' ' 29' ' ' VAL . 59.1 t -97.3 117.03 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.2 111.079 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 t -102.56 117.49 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.23 111.085 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -114.88 172.46 7.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 0.37 110.908 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.59 ' HB3' HD12 ' A' ' 47' ' ' ILE . 7.6 p-10 -151.73 -172.98 4.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 2.13 110.879 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -35.49 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 3.61 110.929 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -73.91 -8.03 54.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 1.28 110.831 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.8 m -107.05 93.78 9.73 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.604 0.716 . . . . 0.14 110.833 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.5 Cg_endo -69.74 143.79 52.06 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.634 2.223 . . . . 0.2 112.424 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.0 t -48.88 -32.9 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.2 111.153 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.94 -53.01 36.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 3.25 110.888 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -44.85 10.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.16 111.13 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.466 HD22 HG13 ' A' ' 29' ' ' VAL . 1.8 tm? -52.13 -62.42 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.14 110.938 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.16 -36.25 18.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 2.81 110.911 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.14 -47.16 46.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.714 -0.755 . . . . 0.19 112.5 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.7 mt -61.9 -38.89 90.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.47 110.96 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.849 HG12 HG11 ' A' ' 14' ' ' VAL . 17.6 m -77.6 -31.48 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.63 111.095 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -62.1 -58.52 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 1.58 110.815 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -39.97 75.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 1.68 110.923 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.9 HD23 HD21 ' A' ' 35' ' ' LEU . 84.1 mt -73.06 -24.32 60.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.23 110.972 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.492 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.67 -24.98 44.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.38 110.947 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.98 -29.92 17.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.21 111.087 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.9 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.46 -35.24 14.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.18 110.87 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.14 -45.39 4.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.23 111.059 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.15 -12.24 54.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.25 112.5 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -70.91 -62.55 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.323 . . . . 2.54 110.88 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.505 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 1.1 mm-40 -89.42 -41.11 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 2.38 110.807 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.75 -128.36 5.81 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.788 -0.72 . . . . 0.25 112.541 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -151.82 152.53 32.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 2.2 110.903 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 33' ' ' GLN . 88.2 t -135.46 130.0 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.27 111.121 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 t -120.74 153.14 37.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.18 110.793 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -115.86 138.61 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.23 111.155 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -146.9 151.23 36.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 1.21 110.984 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.09 138.68 39.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.27 110.846 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.814 HD13 HG21 ' A' ' 73' ' ' THR . 27.3 mt -55.04 -42.65 65.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.33 111.147 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -25.56 67.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 4.18 110.904 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -111.24 19.32 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 3.55 110.83 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.789 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -50.27 -27.65 6.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 1.1 110.904 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -55.6 -32.53 63.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 1.14 110.875 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -83.45 -14.31 52.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 1.04 110.951 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.427 ' HB2' HD13 ' A' ' 50' ' ' LEU . 20.7 m -67.56 -8.52 34.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.85 110.884 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.41 64.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.28 111.129 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -65.13 -67.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.38 110.807 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.639 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -154.37 -177.9 6.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 1.39 110.931 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -93.07 130.46 38.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 1.83 110.861 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t 51.63 83.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.14 110.8 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 91.2 p -136.15 -39.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.25 110.792 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 13' ' ' ALA . 99.6 m-85 -100.59 122.01 42.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 1.44 110.8 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.23 -22.04 62.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 1.49 110.854 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.7 ' HB ' HG22 ' A' ' 12' ' ' VAL . 20.4 mt -145.5 143.68 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.26 111.076 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.89 HG21 HG23 ' A' ' 83' ' ' ILE . 18.2 mm -133.03 132.72 58.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.12 111.148 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -115.14 137.21 52.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.19 110.957 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.35 101.33 5.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.16 110.863 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.23 75.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.852 -0.689 . . . . 0.17 112.427 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.48 59.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 0.6 110.85 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.78 159.71 64.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 0.21 111.125 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 116.84 4.76 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.59 2.193 . . . . 0.23 112.406 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.79 7.49 71.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.798 -0.715 . . . . 0.16 112.523 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.47 148.84 14.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.946 0.403 . . . . 0.67 110.882 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.765 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 32.2 p -137.88 108.57 6.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.19 111.127 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.814 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.09 153.47 18.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.26 111.145 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.938 HD12 HD22 ' A' ' 147' ' ' LEU . 4.5 mt -132.12 104.23 6.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 0.23 110.852 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -79.87 153.84 28.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.34 110.829 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.8 m -130.94 175.82 8.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.57 110.824 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.28 -38.22 51.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 0.23 111.07 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.44 -46.03 91.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.193 -0.458 . . . . 2.41 110.819 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.789 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -72.6 -54.6 15.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.22 111.073 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.518 HD13 ' HA ' ' A' ' 119' ' ' LEU . 58.8 mt -51.08 -38.26 50.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 0.19 110.857 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.88 -56.55 15.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.32 111.049 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -44.12 76.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 2.98 110.949 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.89 HG23 HG21 ' A' ' 63' ' ' ILE . 51.1 mm -55.53 -68.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.23 111.172 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.71 -37.4 50.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.18 111.096 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -55.2 -50.07 70.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 3.13 110.873 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 56' ' ' LYS . 32.3 pt -84.99 -7.31 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.2 111.165 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.97 112.04 14.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.17 -0.468 . . . . 0.35 110.834 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -51.35 159.31 1.16 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 2.3 110.878 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 114.61 3.76 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.663 2.242 . . . . 0.16 112.306 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.47 3.32 56.44 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.733 -0.746 . . . . 0.17 112.455 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.98 -159.72 10.31 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.14 112.525 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.7 m -140.91 157.91 44.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.825 0.345 . . . . 0.34 110.942 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.709 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -141.76 115.05 8.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.2 110.896 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.561 ' N ' HD22 ' A' ' 93' ' ' LEU . 44.8 m-85 -109.23 133.9 52.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 1.63 110.914 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.34 162.41 39.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.16 110.874 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.1 123.45 27.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 3.41 110.855 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.627 ' OE1' HD23 ' A' ' 115' ' ' LEU . 1.0 OUTLIER -146.53 147.84 31.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.613 0.72 . . . . 2.58 110.847 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.624 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -69.78 145.61 57.58 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.671 2.247 . . . . 0.2 112.311 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.0 m -131.3 146.45 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.24 111.11 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.73 132.68 53.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 3.6 110.866 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.4 p -100.47 26.07 7.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 1.24 111.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.414 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -151.94 27.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.61 111.129 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 104' ' ' ASP . 5.3 t -143.78 157.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.65 111.162 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.591 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -59.31 -172.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 1.9 110.841 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.41 -74.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 3.45 110.87 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -52.57 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 2.14 110.893 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.69 -169.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 1.8 110.872 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -5.02 56.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 2.09 110.981 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -146.77 145.8 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.46 111.227 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.432 ' H ' HD22 ' A' ' 74' ' ' LEU . 7.0 mmtm -66.07 110.46 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 2.49 110.983 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.591 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.4 p -82.11 177.25 8.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.21 111.103 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.88 -54.67 41.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.18 111.076 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.88 -48.02 83.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.27 110.822 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -57.99 -39.02 77.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 2.04 110.888 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.627 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -64.84 -55.17 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.3 110.873 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -56.76 -45.87 81.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.26 110.804 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -43.13 89.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.35 110.85 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.23 111.124 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.584 HD11 HD12 ' A' ' 93' ' ' LEU . 14.6 tp -65.97 -51.43 58.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.22 110.858 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.0 m -62.76 -32.3 73.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.28 111.125 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.1 mt -86.82 -10.33 53.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.394 . . . . 0.68 110.974 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.02 5.8 27.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 1.75 110.902 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.75 8.36 30.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.755 -0.736 . . . . 0.56 112.445 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -108.92 171.37 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.346 . . . . 0.26 110.953 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.9 m -149.98 170.71 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.21 111.054 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 52.34 44.94 29.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.02 -0.536 . . . . 2.35 110.88 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.422 HG13 HD23 ' A' ' 119' ' ' LEU . 93.1 t -81.78 142.64 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.25 111.121 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 159.75 7.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 1.78 110.894 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.01 139.83 38.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 2.82 110.818 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.665 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -97.63 -37.58 9.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.21 110.831 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.7 176.35 12.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 1.1 110.889 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.706 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -130.14 138.83 50.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 4.2 110.85 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -125.37 136.91 28.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.64 0.733 . . . . 1.42 110.938 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.401 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.1 Cg_endo -69.72 161.49 45.7 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.694 2.263 . . . . 0.21 112.443 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.665 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -94.96 125.4 39.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 0.27 110.963 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.454 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -98.24 160.75 27.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.539 0.685 . . . . 1.26 111.128 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.7 Cg_endo -69.87 -28.92 24.15 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.62 2.214 . . . . 0.39 112.369 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -85.32 -17.82 35.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 3.9 110.88 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.86 -53.52 4.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 2.35 110.899 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 141' ' ' GLN . 5.7 p -50.15 -42.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.25 111.14 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.404 ' N ' HG13 ' A' ' 140' ' ' VAL . 1.0 OUTLIER -65.58 -32.35 73.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 1.31 110.854 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -50.61 28.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.4 110.856 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.658 HG23 HD13 ' A' ' 147' ' ' LEU . 7.2 p -62.21 -28.59 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.2 111.123 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -76.13 -47.34 24.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 1.96 110.842 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -74.45 -19.56 60.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 1.88 110.831 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.48 -33.11 13.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.46 110.786 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.938 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.82 -54.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.45 110.828 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.15 8.2 2.38 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.712 -0.756 . . . . 0.44 112.513 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -70.64 119.94 15.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.76 0.314 . . . . 0.63 110.814 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.53 105.08 2.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 2.19 110.868 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.14 177.52 10.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.76 110.902 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.46 -13.45 15.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 1.84 110.857 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.414 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -95.87 3.5 53.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 3.33 110.881 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.665 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -74.05 163.11 28.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.4 110.974 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.706 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.7 tm? -173.55 129.58 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.256 -0.429 . . . . 0.2 110.902 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.765 ' CZ ' HG22 ' A' ' 72' ' ' THR . 31.6 m-85 -75.73 135.92 40.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 1.83 110.86 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.79 141.99 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.21 111.194 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.665 ' HG2' HD13 ' A' ' 130' ' ' LEU . 17.6 tt0 -94.57 127.66 40.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 1.62 110.938 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.39 149.14 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.22 111.177 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.473 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.2 t -132.5 162.35 31.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.24 111.13 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.56 135.86 5.01 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.666 -0.778 . . . . 0.13 112.436 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -92.91 140.0 29.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 1.61 110.918 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.3 135.02 50.9 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.518 0.675 . . . . 1.21 110.917 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.9 125.2 11.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.612 2.208 . . . . 0.31 112.297 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -105.18 149.26 26.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.855 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -72.85 78.35 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 7.32 110.854 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -178.25 34.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 9.74 110.864 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.7 t -147.09 -63.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 6.62 111.194 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 167.05 -26.83 0.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 5.22 112.489 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.22 172.67 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.889 0.376 . . . . 7.13 110.85 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.18 -42.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 6.04 110.931 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.513 . . . . 6.3 110.885 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' O ' HD12 ' A' ' 6' ' ' ILE . 5.8 ptp . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.844 0.354 . . . . 3.69 110.917 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.06 -18.69 59.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.64 111.149 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -50.01 67.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 2.4 110.876 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 6' ' ' ILE . 6.8 m-85 -122.21 11.92 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 1.61 110.854 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.34 39.5 97.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.812 -0.709 . . . . 0.41 112.445 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.5 mp -81.52 159.82 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.765 0.316 . . . . 0.32 111.181 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.73 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -156.65 168.62 26.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.78 110.865 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.77 130.1 36.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.51 111.106 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.19 2.04 26.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.782 -0.723 . . . . 0.35 112.53 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -118.85 168.0 11.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.816 0.341 . . . . 1.16 110.864 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.02 115.03 29.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.98 0.419 . . . . 2.29 110.851 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.691 HG22 ' HB ' ' A' ' 62' ' ' ILE . 98.3 t -118.42 131.82 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 1.89 111.172 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.792 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -108.18 125.29 51.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.22 111.133 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.826 HG11 HG12 ' A' ' 29' ' ' VAL . 77.6 t -97.47 119.22 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.15 111.11 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.746 HG12 HG13 ' A' ' 47' ' ' ILE . 20.1 t -103.82 112.21 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.19 111.031 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -113.73 170.53 8.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.22 110.928 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 9.0 p-10 -151.96 -169.85 3.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.428 . . . . 1.79 110.909 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -35.69 71.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 6.23 110.865 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.1 m -72.96 -9.55 58.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 1.58 110.835 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.01 94.24 10.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.664 0.745 . . . . 0.23 110.84 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 142.57 48.14 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.726 2.284 . . . . 0.29 112.331 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.9 t -48.47 -33.14 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.27 111.158 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.09 -52.66 41.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 3.1 110.961 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -45.26 10.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.23 111.119 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.457 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.69 -61.54 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.19 110.977 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.46 -35.58 20.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 2.31 110.874 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.47 -47.56 41.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.766 -0.73 . . . . 0.22 112.486 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.7 mt -61.88 -38.1 87.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.5 110.94 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.826 HG12 HG11 ' A' ' 14' ' ' VAL . 17.5 m -78.59 -31.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.63 111.079 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.48 -57.37 11.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 1.67 110.834 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -39.88 76.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.271 -0.422 . . . . 2.35 110.932 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.885 HD23 HD21 ' A' ' 35' ' ' LEU . 89.9 mt -73.26 -24.92 60.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.28 110.932 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.519 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.17 -25.14 47.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.39 110.969 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.7 -30.74 16.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.26 111.099 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.885 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.23 -34.86 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.25 110.97 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.83 -47.02 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.23 111.149 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.5 -13.55 50.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.26 112.451 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.8 -62.62 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 2.66 110.917 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -98.44 -36.87 9.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 2.2 110.935 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.92 -130.91 5.18 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.665 -0.779 . . . . 0.32 112.51 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -152.11 152.24 32.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.323 . . . . 2.22 110.944 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 33' ' ' GLN . 99.3 t -137.0 121.09 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.25 111.174 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -110.13 155.83 21.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.18 110.859 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 p -118.02 133.89 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.15 111.12 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -144.01 151.6 39.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 1.94 110.955 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -103.17 133.28 48.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.49 110.91 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.84 HD13 HG21 ' A' ' 73' ' ' THR . 20.9 mt -49.57 -32.98 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.36 111.091 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -71.32 -39.67 71.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 2.14 110.967 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.3 19.43 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 3.99 110.842 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.736 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -49.24 -27.87 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.431 . . . . 1.08 110.948 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mp -55.65 -32.85 63.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 1.29 110.942 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -83.88 -14.13 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.433 . . . . 1.04 110.906 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB2' HD13 ' A' ' 50' ' ' LEU . 33.4 m -66.47 -9.21 32.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.85 110.875 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.29 63.48 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.31 111.12 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -63.31 -67.75 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.44 110.818 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.562 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -153.28 179.87 8.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 2.19 110.876 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -87.78 133.94 33.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 1.93 110.944 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.7 p 46.3 83.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 1.11 110.807 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.1 p -134.19 -38.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.3 110.858 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 13' ' ' ALA . 99.4 m-85 -100.87 121.74 42.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 1.46 110.839 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.95 -21.44 61.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 1.73 110.844 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.691 ' HB ' HG22 ' A' ' 12' ' ' VAL . 23.0 mt -145.22 144.4 21.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.22 111.104 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.974 HG21 HG23 ' A' ' 83' ' ' ILE . 16.5 mm -134.5 129.17 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.15 111.128 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.1 mm? -111.03 136.31 50.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.17 110.912 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.402 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -129.51 100.65 5.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.16 110.775 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.02 74.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.451 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.551 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.0 mm? -106.31 52.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.57 110.83 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -123.99 159.83 54.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.24 111.141 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.88 10.53 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.633 2.222 . . . . 0.29 112.308 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.67 6.33 88.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.23 112.457 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 68' ' ' VAL . 9.0 p -56.5 151.58 13.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.909 0.385 . . . . 0.76 110.848 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.718 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 26.4 p -141.62 109.17 5.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.15 111.205 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.84 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.63 143.64 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.29 111.104 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.946 HD12 HD22 ' A' ' 147' ' ' LEU . 7.6 mt -122.52 106.01 10.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.27 110.898 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -81.14 153.79 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.31 110.842 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 m -131.97 175.66 9.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.56 110.856 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.71 -38.51 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.28 111.043 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.09 -47.32 86.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.99 110.856 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.736 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.7 mp -71.53 -54.87 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.28 111.077 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 119' ' ' LEU . 66.9 mt -50.3 -39.24 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.2 110.868 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.58 -54.43 27.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.33 111.033 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -56.9 -43.38 81.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 2.7 110.913 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.974 HG23 HG21 ' A' ' 63' ' ' ILE . 44.0 mm -60.02 -68.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.36 111.047 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.25 -31.26 13.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.43 111.167 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -63.83 -49.97 70.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 2.15 110.903 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 56' ' ' LYS . 41.0 pt -84.67 -2.95 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.23 111.077 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -81.6 111.99 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.4 110.934 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -51.9 159.53 1.36 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 2.2 110.827 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 114.75 3.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.723 2.282 . . . . 0.19 112.289 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.14 3.69 56.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.677 -0.773 . . . . 0.17 112.413 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.42 -163.32 15.66 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.747 -0.739 . . . . 0.15 112.494 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 32.5 m -137.02 154.44 50.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.828 0.347 . . . . 0.29 110.855 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.71 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -139.16 115.59 10.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.17 110.902 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.566 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.8 m-85 -110.29 132.16 54.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.64 110.886 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.551 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.68 164.17 35.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.15 110.896 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.87 131.48 31.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.69 110.922 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.81 149.41 22.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 3.61 110.882 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.566 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.4 Cg_endo -69.74 131.92 22.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.266 . . . . 0.41 112.326 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.73 146.8 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.2 111.174 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.467 ' CD ' HG21 ' A' ' 103' ' ' VAL . 45.9 mt-10 -108.48 132.48 53.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 2.09 110.931 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.9 p -91.15 -26.23 19.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.99 111.195 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.73 39.33 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.5 111.129 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.467 HG21 ' CD ' ' A' ' 100' ' ' GLU . 40.5 t -148.24 150.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.69 111.087 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.575 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -54.67 175.58 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 1.88 110.902 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -65.92 -66.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 2.21 110.813 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -62.15 -75.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 2.26 110.944 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t 51.25 -168.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 2.12 110.883 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -80.84 -3.1 50.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 1.66 110.942 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.616 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.0 m -143.53 144.14 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.52 111.12 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.44 117.33 9.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 2.38 110.896 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 104' ' ' ASP . 45.0 p -92.78 -176.02 4.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.36 111.237 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.43 -50.87 69.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.27 111.102 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -52.21 65.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.38 110.832 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -54.88 -41.15 70.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 2.2 110.92 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.505 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -62.43 -54.82 34.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.38 110.888 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 70.3 m -56.0 -48.07 76.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.27 110.843 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -44.97 93.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.36 110.79 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.08 99.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.28 111.063 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.553 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.4 tp -66.29 -53.33 37.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.24 110.875 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.1 m -59.84 -33.01 71.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.28 111.112 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.7 mt -87.15 -10.53 52.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.69 110.936 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.72 4.38 32.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 1.7 110.884 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.87 11.51 26.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 0.7 112.499 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.71 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -110.9 170.41 8.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.356 . . . . 0.3 110.956 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.7 m -151.5 174.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.27 111.063 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 52.07 43.93 30.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 2.17 110.863 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.4 t -75.7 143.04 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.31 111.099 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 159.1 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 1.57 110.849 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.37 146.8 30.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 2.34 110.881 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.508 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.4 mp -106.76 -35.67 6.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.35 110.948 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -160.22 176.24 11.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.23 110.886 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.679 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -132.97 140.4 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.495 . . . . 4.02 110.895 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -126.13 137.46 30.24 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.681 0.753 . . . . 1.53 110.947 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.406 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.6 Cg_endo -69.74 162.51 41.76 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.65 2.233 . . . . 0.28 112.35 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.68 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -98.8 123.13 42.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.51 110.941 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.473 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -100.72 161.04 25.13 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.653 0.74 . . . . 1.51 111.054 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.5 Cg_endo -69.65 -25.78 28.76 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.683 2.255 . . . . 0.67 112.388 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -85.42 -22.06 28.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 2.8 110.916 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -87.85 -52.32 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 2.39 110.995 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.89 -39.98 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.35 111.109 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -33.42 74.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 1.44 110.87 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -46.02 67.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.4 110.949 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.768 HG23 HD13 ' A' ' 147' ' ' LEU . 7.6 p -68.51 -30.25 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.24 111.189 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -31.44 56.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.159 -0.473 . . . . 3.44 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -90.31 -19.83 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 2.04 110.888 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -94.25 -33.62 13.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.59 110.874 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.946 HD22 HD12 ' A' ' 74' ' ' LEU . 3.3 mp -125.19 -54.19 1.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.45 110.936 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.96 10.1 2.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 0.37 112.44 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.616 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.6 t-160 -69.54 120.86 15.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 1.03 110.846 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -149.75 106.38 3.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 3.05 110.936 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.6 174.59 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 1.06 110.906 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -19.14 13.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 2.72 110.818 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -96.6 12.77 30.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 2.3 110.903 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.68 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -77.74 163.7 25.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.29 110.951 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.679 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.49 130.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.22 110.855 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.718 ' CZ ' HG22 ' A' ' 72' ' ' THR . 29.9 m-85 -74.76 132.95 42.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 1.67 110.894 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.82 144.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.19 111.229 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.551 ' OE1' HD13 ' A' ' 67' ' ' LEU . 3.1 tt0 -101.04 128.27 47.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 1.99 110.949 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.0 148.16 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.23 111.103 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.487 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.0 t -125.84 158.99 33.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.31 111.228 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.03 130.77 3.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.79 -0.719 . . . . 0.16 112.521 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.16 139.14 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.924 0.393 . . . . 1.6 110.834 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 135.09 53.29 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.515 0.674 . . . . 1.18 110.964 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 127.15 14.24 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.676 2.251 . . . . 0.32 112.38 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -107.7 150.56 26.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.3 110.885 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -66.32 90.04 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 7.04 110.934 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -179.32 34.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 9.65 110.897 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.7 m -152.07 -41.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 5.93 111.084 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 52.51 33.0 39.68 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 5.77 112.483 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.81 -67.39 0.82 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.837 0.351 . . . . 6.99 110.91 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.67 -74.29 0.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 5.95 110.809 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 7.96 110.885 -179.976 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.3 ptm . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.836 0.35 . . . . 3.93 110.876 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.96 -20.57 66.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.48 111.108 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -51.28 65.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 1.94 110.883 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.29 22.38 10.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 1.5 110.84 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.12 40.74 52.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 0.23 112.529 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.471 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -79.25 159.48 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.725 0.298 . . . . 0.22 111.206 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -152.93 162.69 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 1.33 110.822 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.42 126.53 35.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.28 111.124 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.11 -6.67 17.17 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.73 -0.748 . . . . 0.27 112.487 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -113.69 167.66 10.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 1.22 110.965 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -97.96 140.87 31.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 2.12 110.837 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.647 HG22 ' HB ' ' A' ' 62' ' ' ILE . 54.3 t -142.59 142.69 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 1.84 111.16 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.771 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -119.95 121.74 39.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.24 111.024 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.812 HG11 HG12 ' A' ' 29' ' ' VAL . 57.7 t -94.41 118.57 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.21 111.102 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 47' ' ' ILE . 11.4 t -102.52 110.71 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.28 111.121 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -112.45 167.19 10.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.16 110.925 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 47' ' ' ILE . 6.2 p-10 -149.99 -169.65 3.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 1.98 110.846 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -57.53 -35.62 70.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 2.91 110.894 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.37 -9.54 58.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 1.19 110.866 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.84 94.7 10.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.617 0.722 . . . . 0.13 110.851 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 141.78 46.0 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.7 2.267 . . . . 0.19 112.338 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -48.79 -32.97 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.18 111.114 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.08 -52.92 38.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 3.14 110.834 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.46 -44.96 10.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.16 111.145 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.485 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.74 -61.62 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.13 110.894 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -49.7 -37.41 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 3.08 110.947 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.31 -47.33 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.19 112.475 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.89 -39.84 93.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.45 110.915 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.812 HG12 HG11 ' A' ' 14' ' ' VAL . 17.2 m -76.79 -31.57 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.62 111.231 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.09 -59.56 4.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.115 -0.493 . . . . 1.64 110.786 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -39.82 72.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 1.73 110.874 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.888 HD23 HD21 ' A' ' 35' ' ' LEU . 84.0 mt -73.1 -24.7 60.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.23 110.994 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.417 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.67 -25.21 44.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.4 110.907 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.84 -29.81 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.27 111.141 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.888 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.48 -35.19 14.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.2 110.93 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.08 -45.34 4.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 0.27 111.166 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.44 -11.75 53.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.672 -0.775 . . . . 0.36 112.453 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.43 -62.39 1.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 2.62 110.944 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.536 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 3.2 mm-40 -85.91 -43.18 13.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 2.13 110.841 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.23 -121.03 4.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.727 -0.749 . . . . 0.33 112.533 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -158.33 154.13 26.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 2.3 110.81 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.417 HG21 ' HA ' ' A' ' 33' ' ' GLN . 99.2 t -139.54 131.61 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.33 111.161 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -120.76 157.99 28.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.22 110.831 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.2 134.99 59.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.16 111.138 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -144.76 151.9 39.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.432 . . . . 1.23 110.89 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -101.4 137.39 39.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 1.69 110.9 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.716 ' CD1' HG21 ' A' ' 73' ' ' THR . 17.5 mt -51.03 -49.86 26.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.45 111.107 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -22.55 63.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 3.04 110.927 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -98.52 18.44 16.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 3.46 110.885 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.806 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -49.98 -28.03 6.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 1.11 110.835 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.81 -37.79 60.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 1.19 110.87 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -85.23 -17.21 37.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 1.1 110.972 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.455 ' HB2' HD13 ' A' ' 50' ' ' LEU . 50.1 m -65.37 -12.51 52.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.89 110.908 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.76 64.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.4 111.074 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -65.71 -67.98 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.34 110.86 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.664 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -155.32 -175.48 5.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 1.33 110.856 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -94.06 134.85 36.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 1.83 110.864 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p 46.3 82.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 1.13 110.84 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.8 p -133.53 -38.44 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.31 110.885 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.456 ' O ' HD23 ' A' ' 87' ' ' LEU . 96.3 m-85 -101.97 122.0 43.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 2.04 110.84 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.99 -21.48 61.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 1.49 110.827 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.647 ' HB ' HG22 ' A' ' 12' ' ' VAL . 32.3 mt -142.6 143.88 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.34 111.034 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.875 HG21 HG23 ' A' ' 83' ' ' ILE . 23.0 mm -134.27 128.79 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.17 111.142 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -111.95 136.31 51.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.15 110.913 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.44 101.81 6.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.21 110.826 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.84 75.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.783 -0.722 . . . . 0.17 112.47 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.459 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.4 mm? -108.66 58.26 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.59 110.883 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.02 159.74 65.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.697 0.761 . . . . 0.23 111.196 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 116.73 4.69 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.738 2.292 . . . . 0.25 112.362 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.18 7.14 70.41 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.805 -0.712 . . . . 0.18 112.416 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -55.27 149.7 12.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.859 0.361 . . . . 0.69 110.853 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 27.5 p -140.23 108.86 5.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 0.15 111.212 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.716 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.1 150.27 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.23 111.147 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.971 HD12 HD22 ' A' ' 147' ' ' LEU . 4.5 mt -127.79 102.98 7.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.21 110.918 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -77.63 148.66 34.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.25 110.794 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.0 m -127.17 -178.02 4.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.789 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.75 -41.33 67.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.048 -0.523 . . . . 0.4 111.159 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -57.85 -47.24 83.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 1.85 110.9 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.806 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.2 mp -71.81 -56.75 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.31 111.132 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD13 ' HA ' ' A' ' 119' ' ' LEU . 56.8 mt -50.73 -40.83 55.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.2 110.968 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.56 -56.7 11.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.36 111.114 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -44.49 86.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 2.44 110.855 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.875 HG23 HG21 ' A' ' 63' ' ' ILE . 40.2 mm -53.0 -68.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.24 111.166 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.1 -39.85 60.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.2 111.121 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.6 tpp85 -53.32 -50.25 65.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 2.15 110.893 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 56' ' ' LYS . 34.2 pt -84.11 -8.13 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.18 111.067 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.37 113.42 15.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.31 110.947 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -52.84 159.88 1.65 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.669 0.747 . . . . 2.31 110.867 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.86 114.5 3.74 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.22 112.332 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.26 5.47 57.1 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.17 112.45 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.44 -163.11 18.72 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.844 -0.694 . . . . 0.14 112.407 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 22.8 m -136.55 154.99 50.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.28 110.854 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.703 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -139.69 116.38 10.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.18 110.919 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.578 ' N ' HD22 ' A' ' 93' ' ' LEU . 54.6 m-85 -112.21 131.29 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 1.62 110.927 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.41 160.7 42.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.16 110.97 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.53 127.94 36.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 1.8 110.909 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.78 148.95 29.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.651 0.739 . . . . 2.2 110.842 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.617 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.1 Cg_endo -69.85 140.01 41.3 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.598 2.199 . . . . 0.19 112.376 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.81 146.97 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 0.25 111.091 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.468 ' CD ' HG21 ' A' ' 103' ' ' VAL . 12.8 mt-10 -109.55 132.46 54.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 2.22 110.869 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.4 p -105.61 26.45 9.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 1.29 111.093 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.58 24.41 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.6 111.133 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.468 HG21 ' CD ' ' A' ' 100' ' ' GLU . 4.4 t -144.81 159.24 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.78 111.043 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.564 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -51.02 167.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 1.74 110.819 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -62.78 -50.67 70.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 2.27 110.847 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -74.13 -75.73 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 1.74 110.928 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.443 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.2 t 53.56 -166.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 2.24 110.799 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -8.93 59.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 3.86 110.855 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.436 HG11 ' CG ' ' A' ' 149' ' ' HIS . 2.7 m -140.62 142.78 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.38 111.117 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -63.13 116.15 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 2.24 110.932 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.564 HG21 ' O ' ' A' ' 104' ' ' ASP . 55.7 p -85.03 178.49 7.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.439 . . . . 0.26 111.033 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.97 -54.02 49.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.18 111.144 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -59.9 -48.7 80.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.25 110.851 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -56.8 -39.55 74.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 1.68 110.898 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.499 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -64.53 -54.98 23.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.33 110.857 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.2 m -56.09 -45.34 79.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.21 110.954 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -42.56 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.28 110.82 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.44 98.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.21 111.111 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.0 tp -66.66 -52.98 38.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.421 . . . . 0.23 110.874 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.5 m -59.8 -34.72 73.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.32 111.083 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.7 mt -84.96 -10.21 57.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.63 110.905 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.12 5.45 29.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 1.73 110.8 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.26 7.77 32.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.64 112.495 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -107.31 170.18 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.3 110.992 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -150.86 170.63 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.26 111.162 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 54.77 43.27 30.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 2.1 110.858 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.0 t -75.65 143.51 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.27 111.106 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.1 159.66 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 1.66 110.867 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -81.86 146.05 30.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 2.37 110.924 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.515 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.2 mp -105.92 -35.64 7.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.21 110.885 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -161.3 176.27 11.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 1.09 110.888 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.733 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.4 OUTLIER -132.35 137.84 47.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 4.46 110.823 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.91 137.53 29.01 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.593 0.711 . . . . 1.84 111.002 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.412 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.2 Cg_endo -69.69 165.08 32.09 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.706 2.271 . . . . 0.22 112.389 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.68 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.19 126.56 43.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.27 110.868 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.462 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.34 161.4 23.0 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.606 0.717 . . . . 1.54 111.157 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -24.57 29.81 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.692 2.261 . . . . 0.34 112.366 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.59 -22.52 28.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 2.56 110.898 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -87.79 -52.22 5.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 2.57 110.867 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 136' ' ' THR . 7.3 p -49.69 -40.08 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.27 111.171 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -33.44 74.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 1.13 110.954 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.35 -45.93 68.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.25 110.832 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 8.4 p -68.36 -30.44 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.16 111.103 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -75.98 -32.48 59.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 2.4 110.87 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -89.32 -20.29 24.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 1.65 110.912 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -94.47 -32.78 13.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.29 110.866 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.971 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.55 -54.37 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.31 110.929 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.98 9.11 2.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.768 -0.729 . . . . 0.34 112.537 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.436 ' CG ' HG11 ' A' ' 109' ' ' VAL . 15.3 t-160 -70.3 121.5 17.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.749 0.309 . . . . 0.62 110.879 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -152.08 104.75 3.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 2.15 110.882 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.3 t -161.2 173.12 15.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.72 110.858 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.82 -12.71 15.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 1.7 110.797 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -97.67 10.41 40.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 1.58 110.832 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.68 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -83.59 166.61 18.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.189 -0.46 . . . . 0.27 110.83 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.733 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -172.97 130.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.2 110.978 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 25.9 m-85 -74.79 131.3 40.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 1.74 110.908 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.0 144.18 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.21 111.081 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.515 ' HG2' HD13 ' A' ' 130' ' ' LEU . 3.8 tt0 -99.56 128.41 45.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 1.88 110.919 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.3 149.61 30.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.2 111.118 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.473 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.5 t -127.84 160.88 30.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.109 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.44 132.1 3.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.13 112.503 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -92.94 140.1 29.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 1.65 110.896 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.46 135.13 50.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.603 0.716 . . . . 1.23 110.939 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 123.6 10.26 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.634 2.223 . . . . 0.3 112.346 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -103.55 147.6 26.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.34 110.84 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.2 t80 60.66 19.75 9.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 5.64 110.895 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.54 163.18 24.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.079 -0.509 . . . . 9.33 110.808 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.65 -30.49 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 9.81 111.05 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.47 39.79 60.59 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.743 -0.742 . . . . 9.17 112.451 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.27 -32.75 38.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 11.8 110.881 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.6 m -58.51 -41.93 86.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.5 . . . . 7.86 110.925 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 7.71 110.819 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.812 0.339 . . . . 4.35 110.934 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.17 -21.15 63.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.59 111.142 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.57 -51.53 64.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 3.05 110.917 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.427 ' CE1' HD12 ' A' ' 67' ' ' LEU . 5.6 m-85 -122.32 21.79 10.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 2.01 110.917 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.21 39.77 51.19 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.741 -0.742 . . . . 0.34 112.451 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.458 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.8 mp -77.03 159.19 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.38 111.145 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 36' ' ' THR . 38.1 m -147.33 157.03 43.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 1.15 110.85 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.11 123.71 33.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.513 . . . . 0.47 111.112 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.68 -3.51 21.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.758 -0.734 . . . . 0.29 112.5 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -108.89 169.63 8.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.376 . . . . 1.52 110.898 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -104.62 109.68 21.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 1.38 110.873 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.668 HG12 HG21 ' A' ' 36' ' ' THR . 2.3 p -115.7 135.49 55.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 2.05 111.092 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.754 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -109.7 125.85 53.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.22 111.083 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.842 HG11 HG12 ' A' ' 29' ' ' VAL . 58.5 t -97.72 120.53 47.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.19 111.129 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.408 HG12 HG13 ' A' ' 47' ' ' ILE . 41.0 t -104.31 121.86 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.25 111.13 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -121.38 170.24 9.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.25 110.905 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.408 ' HB3' HD12 ' A' ' 47' ' ' ILE . 9.8 p-10 -151.25 -171.02 3.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 1.84 110.919 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -57.05 -36.11 70.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 3.62 110.881 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -72.08 -10.21 59.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 1.77 110.807 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -107.68 92.86 9.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.618 0.723 . . . . 0.25 110.884 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.79 143.07 49.52 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.678 2.252 . . . . 0.42 112.306 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.6 t -48.29 -32.61 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.3 111.144 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.54 -53.44 37.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 2.59 110.9 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.9 -45.01 10.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.33 111.064 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.684 ' HA ' HD12 ' A' ' 28' ' ' LEU . 2.1 tm? -50.19 -60.26 3.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.22 110.91 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -49.44 -35.76 20.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 2.83 110.952 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.89 -48.31 49.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.698 -0.763 . . . . 0.27 112.478 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 1.045 HD11 HG13 ' A' ' 68' ' ' VAL . 2.1 mt -60.43 -40.55 91.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.865 0.364 . . . . 1.5 110.937 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.842 HG12 HG11 ' A' ' 14' ' ' VAL . 17.3 m -76.79 -30.81 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.63 111.081 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.94 -60.87 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 1.91 110.929 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -40.58 68.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 2.59 110.821 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.806 HD23 HD21 ' A' ' 35' ' ' LEU . 91.8 mt -72.36 -25.57 61.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.33 110.991 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.558 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.36 -24.94 46.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.46 110.844 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.23 -30.1 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.5 111.112 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.806 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.34 -34.88 14.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.4 110.887 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.668 HG21 HG12 ' A' ' 12' ' ' VAL . 1.2 m -103.2 -47.0 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.36 111.186 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.24 -14.64 48.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.763 -0.732 . . . . 0.44 112.478 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -60.78 -62.55 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 2.01 110.858 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.23 -36.35 9.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 2.03 110.873 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.72 -137.48 7.61 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.67 -0.776 . . . . 0.47 112.467 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -146.4 150.33 35.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 3.71 110.925 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 33' ' ' GLN . 85.8 t -133.66 119.31 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.3 111.102 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -108.12 158.04 17.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.22 110.796 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.48 138.14 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.22 111.109 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -145.82 151.31 37.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 1.23 110.891 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.4 134.62 46.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.43 110.958 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.73 ' CD1' HG21 ' A' ' 73' ' ' THR . 37.2 mt -52.77 -35.86 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.32 111.119 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -71.51 -31.64 67.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 2.1 110.896 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -103.91 20.18 18.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 3.61 110.896 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.825 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.19 -28.37 4.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 1.11 110.893 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mp -55.27 -34.01 63.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 1.06 110.892 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -84.04 -14.94 49.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 1.06 110.898 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB2' HD13 ' A' ' 50' ' ' LEU . 32.8 m -67.14 -9.38 39.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.89 110.863 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.87 63.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.31 111.02 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -63.22 -68.13 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.43 110.849 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.602 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -153.85 -176.95 6.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 1.38 110.896 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -92.72 128.95 38.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 1.82 110.91 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 t 51.67 84.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 1.98 110.806 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.1 p -136.23 -38.87 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.31 110.863 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.44 ' O ' HD23 ' A' ' 87' ' ' LEU . 98.6 m-85 -100.21 123.76 44.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 2.01 110.804 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.38 -21.48 60.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 1.72 110.785 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 6' ' ' ILE . 13.4 mt -144.05 143.3 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.22 111.06 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.916 HG21 HG23 ' A' ' 83' ' ' ILE . 22.6 mm -135.62 128.75 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.16 111.187 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.2 mm? -112.61 136.31 52.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.22 110.845 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.97 105.0 8.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.22 110.834 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.26 71.44 0.63 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.768 -0.73 . . . . 0.23 112.488 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.427 HD12 ' CE1' ' A' ' 4' ' ' PHE . 4.2 mm? -104.52 57.09 0.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.818 0.342 . . . . 0.68 110.948 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.045 HG13 HD11 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -124.57 153.01 69.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.637 0.732 . . . . 0.46 111.149 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.688 ' HD2' HG12 ' A' ' 68' ' ' VAL . 54.3 Cg_endo -69.71 116.87 4.75 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.674 2.249 . . . . 0.38 112.336 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.99 6.94 71.15 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.708 -0.758 . . . . 0.47 112.453 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.505 ' HB2' HG23 ' A' ' 68' ' ' VAL . 4.7 t -66.2 152.97 43.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 2.73 110.832 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.706 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 20.0 p -136.68 112.42 9.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.521 . . . . 0.28 111.142 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.73 HG21 ' CD1' ' A' ' 47' ' ' ILE . 1.2 m -162.81 144.82 10.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.42 111.1 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.867 HD12 HD22 ' A' ' 147' ' ' LEU . 9.3 mt -125.28 116.28 21.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.56 110.833 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -89.97 154.06 20.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.28 110.806 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 m -129.51 -177.7 4.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.57 110.923 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.5 -37.06 69.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.472 . . . . 0.25 111.025 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -61.77 -46.28 90.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 2.05 110.85 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.825 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -73.31 -54.64 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.22 111.119 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.8 mt -50.31 -40.8 49.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.22 110.924 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.49 -55.48 18.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.35 111.12 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -45.26 82.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 3.12 110.869 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.916 HG23 HG21 ' A' ' 63' ' ' ILE . 40.4 mm -54.65 -68.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.21 111.088 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.84 -39.3 53.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.21 111.181 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -53.18 -51.47 61.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 2.85 110.912 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 56' ' ' LYS . 29.8 pt -83.96 -6.98 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.19 111.134 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -79.02 111.25 15.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.37 110.854 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -51.79 158.93 1.46 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 3.67 110.923 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.419 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.3 Cg_endo -69.82 114.15 3.62 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.738 2.292 . . . . 0.27 112.243 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.84 2.8 55.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.18 112.453 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.83 -165.78 23.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.544 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 65.5 m -133.51 152.81 51.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.86 0.362 . . . . 0.35 110.924 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.694 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.29 114.79 11.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.15 110.922 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.539 ' N ' HD22 ' A' ' 93' ' ' LEU . 48.4 m-85 -110.54 132.54 54.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 1.88 110.897 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -148.25 157.91 43.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.15 110.81 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.1 126.51 43.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.012 -0.54 . . . . 2.58 110.817 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.607 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -150.53 145.96 19.13 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.689 0.757 . . . . 2.27 110.83 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.45 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.9 Cg_endo -69.75 139.76 41.06 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.721 2.281 . . . . 0.19 112.434 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.52 146.73 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.22 111.144 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.458 ' OE2' HG21 ' A' ' 103' ' ' VAL . 16.8 mt-10 -110.29 132.59 54.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 1.88 110.892 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.9 p -104.18 26.1 9.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 1.21 111.145 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.99 23.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.63 111.131 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.458 HG21 ' OE2' ' A' ' 100' ' ' GLU . 4.6 t -144.49 159.01 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.67 111.145 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.602 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -57.44 -178.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 2.16 110.848 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -68.54 -63.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 2.08 110.84 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.4 -76.03 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 2.27 110.938 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.435 ' HB2' HG11 ' A' ' 103' ' ' VAL . 1.5 p 51.44 -169.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 2.06 110.809 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.54 -3.84 51.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 1.86 110.846 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.41 153.61 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.426 . . . . 0.46 111.112 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.545 ' HB2' HD22 ' A' ' 74' ' ' LEU . 10.0 mmtm -72.28 109.7 6.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 1.89 110.833 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.602 HG21 ' O ' ' A' ' 104' ' ' ASP . 30.2 p -82.4 177.99 8.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.26 111.156 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.85 -54.88 39.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.2 111.101 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.16 -49.28 77.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.27 110.836 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -56.75 -38.63 72.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.191 -0.459 . . . . 1.69 110.96 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.607 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -65.15 -54.89 22.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.32 110.929 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.7 m -57.74 -45.8 85.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.21 110.834 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -42.95 91.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.27 110.87 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.59 93.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.23 111.043 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.654 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.9 tp -65.63 -50.35 65.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.32 110.925 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 96.8 m -61.97 -34.6 76.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.28 111.082 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.13 -10.22 57.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.57 110.87 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.6 6.52 27.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 1.77 110.884 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.41 4.77 34.86 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.51 112.406 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -104.63 170.61 7.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.37 110.895 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.2 m -151.7 173.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.31 111.068 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 51.55 44.1 29.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 2.04 110.878 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 95.3 t -77.73 143.1 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.25 111.186 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.15 159.25 7.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.244 -0.435 . . . . 1.56 110.95 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.99 143.33 32.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 3.29 110.923 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.755 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.3 mp -103.19 -37.0 7.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.28 110.931 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -155.81 176.08 13.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 1.21 110.948 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.689 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.4 tmt_? -132.35 137.49 47.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 4.32 110.893 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -123.87 136.81 27.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.632 0.73 . . . . 1.83 110.941 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HA ' HD21 ' A' ' 155' ' ' LEU . 52.9 Cg_endo -69.77 163.03 39.81 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.759 2.306 . . . . 0.28 112.293 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.679 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -96.45 124.15 40.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.27 110.915 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.445 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -98.77 161.38 25.19 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 121.567 0.699 . . . . 1.22 111.088 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.8 Cg_endo -69.82 -28.41 25.0 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.678 2.252 . . . . 0.37 112.4 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -85.41 -17.71 35.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 3.66 110.824 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.13 -53.66 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 2.33 110.974 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.9 p -49.43 -40.56 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.26 111.127 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -34.61 75.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 1.23 110.831 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.19 -46.38 70.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.28 110.791 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.847 HG23 HD13 ' A' ' 147' ' ' LEU . 9.7 p -68.37 -30.37 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.2 111.14 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -75.49 -32.29 60.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 1.89 110.953 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -89.62 -20.22 23.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 1.95 110.875 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.42 -32.55 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.3 110.809 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.867 HD22 HD12 ' A' ' 74' ' ' LEU . 3.5 mp -128.04 -53.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.41 110.946 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.22 12.4 2.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.814 -0.707 . . . . 0.31 112.491 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -70.6 122.07 19.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.324 . . . . 0.76 110.894 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -151.6 105.44 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 2.73 110.893 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.57 175.21 12.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.62 110.836 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.09 -20.31 13.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 1.75 110.881 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -93.57 13.27 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 1.72 110.984 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.679 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -80.91 163.23 23.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.31 110.938 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.689 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.53 129.99 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.23 110.948 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.706 ' CZ ' HG22 ' A' ' 72' ' ' THR . 33.6 m-85 -73.81 133.49 43.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 1.82 110.842 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.0 139.74 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.26 111.101 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.755 ' HG2' HD13 ' A' ' 130' ' ' LEU . 39.8 tt0 -93.74 129.62 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 2.29 110.938 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.86 150.93 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.424 . . . . 0.23 111.174 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.471 ' N ' HD11 ' A' ' 130' ' ' LEU . 3.1 t -130.04 160.5 33.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.23 111.061 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.76 131.38 3.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.719 -0.753 . . . . 0.16 112.441 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -93.83 140.42 29.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 1.55 110.905 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 9.4 tptt -81.78 134.75 49.8 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.609 0.719 . . . . 2.32 110.818 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 119.39 6.34 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.753 2.302 . . . . 0.42 112.291 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -102.48 151.9 21.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.37 110.904 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -64.44 96.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 6.74 110.934 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -178.41 37.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 10.27 110.91 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.406 HG11 ' OG ' ' A' ' 171' ' ' SER . 41.0 t -146.27 -69.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 6.37 111.154 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.0 -46.8 1.05 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.788 -0.72 . . . . 5.55 112.502 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 86.3 p -153.77 90.45 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 7.0 110.815 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.406 ' OG ' HG11 ' A' ' 168' ' ' VAL . 2.5 m -137.21 -64.37 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 7.65 110.819 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 8.36 110.932 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.534 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.837 0.351 . . . . 3.88 110.942 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.9 -19.04 59.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.64 111.166 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.96 -49.27 69.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 2.1 110.877 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -122.3 18.26 10.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 1.55 110.867 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.17 40.04 73.22 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.788 -0.72 . . . . 0.28 112.417 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 1' ' ' MET . 1.8 mp -77.0 157.5 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.3 111.184 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 36' ' ' THR . 46.2 m -148.3 156.61 42.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 1.11 110.846 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.77 125.31 33.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.44 111.093 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.09 -6.23 23.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 0.28 112.51 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -109.72 167.57 10.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 1.47 110.975 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.51 137.03 38.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 2.21 110.929 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG1' HG21 ' A' ' 36' ' ' THR . 2.1 p -141.86 140.71 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 2.11 111.147 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.745 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -115.64 124.16 50.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.21 111.17 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.851 HG11 HG12 ' A' ' 29' ' ' VAL . 95.3 t -95.88 118.52 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.16 111.086 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.441 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.1 t -102.7 115.28 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 0.18 111.153 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -115.91 167.2 11.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 0.19 110.967 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.421 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.7 p-10 -151.3 -169.54 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 1.75 110.892 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -56.8 -35.74 69.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 3.37 110.937 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -73.06 -10.9 60.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 1.51 110.863 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.25 93.57 9.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.604 0.716 . . . . 0.16 110.891 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.5 Cg_endo -69.77 142.76 48.76 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.719 2.279 . . . . 0.2 112.336 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -48.92 -32.52 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.19 111.144 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.28 -53.2 38.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 2.4 110.913 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -44.95 10.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.19 111.091 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.474 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.27 -61.51 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.16 110.922 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -36.8 31.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 2.38 110.843 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.68 49.91 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.801 -0.714 . . . . 0.23 112.47 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.6 mt -61.7 -40.36 94.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 0.52 110.918 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.851 HG12 HG11 ' A' ' 14' ' ' VAL . 17.3 m -76.16 -31.46 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.63 111.177 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.02 -60.29 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 1.55 110.821 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -40.15 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 1.73 110.938 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.913 HD23 HD21 ' A' ' 35' ' ' LEU . 77.4 mt -72.69 -24.68 61.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.26 110.841 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.4 -24.86 46.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.38 110.926 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.82 -30.02 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.23 111.132 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.913 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.43 -35.3 14.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.22 110.879 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.499 HG21 ' CG1' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -102.33 -44.77 5.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.24 111.057 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.49 -10.94 55.46 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.729 -0.748 . . . . 0.25 112.498 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.32 -62.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 2.26 110.966 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -91.47 -39.94 11.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 2.24 110.875 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.21 -125.73 4.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.34 112.538 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -156.25 152.68 28.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 3.47 110.965 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 33' ' ' GLN . 95.7 t -135.84 130.21 48.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.31 111.203 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -118.61 156.9 28.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.2 110.869 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 p -119.39 136.71 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.19 111.118 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -147.26 152.17 37.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 1.3 110.894 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.66 135.72 43.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.41 110.944 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.645 ' CD1' HG21 ' A' ' 73' ' ' THR . 28.6 mt -51.61 -35.43 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.35 111.19 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -29.99 59.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 2.63 110.905 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -97.89 18.44 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 3.34 110.942 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.827 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.74 -30.23 5.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 1.09 110.999 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -54.51 -37.36 65.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 1.04 110.923 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -84.6 -15.66 44.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 1.08 110.946 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 m -66.95 -10.17 46.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.99 110.872 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.07 63.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.34 111.116 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -61.75 -69.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.35 110.889 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.658 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -153.76 -175.5 5.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 2.12 110.865 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.47 134.84 35.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.59 110.929 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p 46.24 82.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 1.17 110.848 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.3 p -133.4 -38.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.32 110.87 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.442 ' O ' HD23 ' A' ' 87' ' ' LEU . 97.6 m-85 -101.65 122.44 43.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 1.99 110.906 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.55 -21.09 61.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.155 -0.475 . . . . 1.49 110.861 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 6' ' ' ILE . 11.3 mt -143.38 143.52 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.26 111.089 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.865 HG21 HG23 ' A' ' 83' ' ' ILE . 21.3 mm -134.99 129.04 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.13 111.062 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.4 mm? -113.19 136.77 52.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.2 110.888 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.15 101.92 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.18 110.859 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.4 77.43 0.13 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.81 -0.709 . . . . 0.18 112.423 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.45 58.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.61 110.894 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.18 160.12 61.44 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.654 0.74 . . . . 0.25 111.163 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 115.95 4.32 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.709 2.273 . . . . 0.29 112.365 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.84 6.43 67.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.711 -0.756 . . . . 0.2 112.496 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.49 150.37 12.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.991 0.424 . . . . 0.68 110.877 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 26.6 p -140.8 108.96 5.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.16 111.16 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.645 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.2 148.35 11.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 0.25 111.142 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.848 HD12 HD22 ' A' ' 147' ' ' LEU . 1.7 mt -126.23 101.2 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.34 110.935 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.16 138.17 38.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.41 110.848 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.414 ' H ' HD13 ' A' ' 79' ' ' ILE . 58.2 m -115.83 -175.67 2.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.843 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.68 70.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.3 111.167 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -62.31 -42.95 99.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 1.81 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.827 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -77.79 -55.2 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.27 111.165 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 119' ' ' LEU . 64.4 mt -50.36 -41.57 51.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.23 110.895 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.61 -56.51 13.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.34 111.105 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -41.44 74.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.433 . . . . 2.47 110.815 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.865 HG23 HG21 ' A' ' 63' ' ' ILE . 42.9 mm -58.55 -68.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.18 111.107 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.416 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -49.82 -35.0 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.28 111.168 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -59.31 -51.42 70.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 2.43 110.891 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 56' ' ' LYS . 33.2 pt -83.46 -4.04 8.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.22 111.083 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -82.1 112.06 18.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.35 110.917 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -51.65 159.58 1.24 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.61 0.719 . . . . 2.1 110.873 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.8 Cg_endo -69.88 114.26 3.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.685 2.257 . . . . 0.19 112.306 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.63 3.73 56.13 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 0.17 112.466 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.05 -166.94 26.63 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.782 -0.723 . . . . 0.21 112.491 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.5 m -133.1 153.36 51.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.873 0.368 . . . . 0.33 110.95 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.653 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.93 116.37 12.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.16 110.914 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.567 ' N ' HD22 ' A' ' 93' ' ' LEU . 52.6 m-85 -112.33 131.89 55.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 1.84 110.836 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -148.2 156.92 43.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.18 110.866 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.03 126.76 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 2.08 110.917 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.88 146.9 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.65 0.738 . . . . 2.31 110.852 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.59 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.5 Cg_endo -69.68 143.72 52.11 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.586 2.19 . . . . 0.25 112.368 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.38 146.75 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 0.2 111.135 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.459 ' HB2' HG22 ' A' ' 111' ' ' THR . 59.6 mt-10 -106.8 132.85 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 2.18 110.832 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -93.01 -42.11 9.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 1.11 111.129 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.72 39.91 1.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.83 111.182 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.25 150.6 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.85 111.128 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.641 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -56.66 167.92 0.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 1.96 110.912 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.425 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 1.7 p30 -60.54 -55.0 38.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 2.4 110.822 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.59 -77.3 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 2.28 110.853 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p 54.0 -173.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 1.71 110.814 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.63 -2.1 45.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 2.6 110.927 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.581 HG21 ' CE1' ' A' ' 149' ' ' HIS . 1.1 m -143.39 154.52 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.177 -0.465 . . . . 0.86 111.09 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -69.88 121.03 16.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 2.14 110.958 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.641 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.7 p -97.05 -177.96 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.23 111.109 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -52.9 63.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.22 111.103 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.92 -50.5 73.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.26 110.853 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -58.93 -40.59 85.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 2.23 110.956 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -60.52 -54.64 43.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.41 110.926 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 67.2 m -55.54 -50.99 68.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.34 110.863 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -48.22 82.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.32 110.826 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.27 -51.52 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.064 -0.516 . . . . 0.27 111.092 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.742 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.0 tp -57.38 -47.12 82.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.38 110.839 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.2 m -67.34 -22.24 65.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.54 111.162 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.48 -15.37 40.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 1.18 110.884 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.9 5.0 30.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 1.68 110.892 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.45 -4.86 35.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 0.48 112.573 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -87.06 168.96 12.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.49 110.899 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.5 m -151.39 171.86 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.42 111.135 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 53.58 43.72 30.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 2.11 110.836 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.22 142.51 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.34 111.14 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.07 160.65 8.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 1.74 110.844 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 21.2 tt0 -82.36 146.69 29.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 2.39 110.932 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.666 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.4 mp -107.39 -35.76 6.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.22 110.919 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -157.47 176.24 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 1.18 110.883 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.712 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.2 tmt_? -133.19 137.82 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 4.39 110.877 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -125.49 138.8 32.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.636 0.731 . . . . 1.44 110.91 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.438 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.3 Cg_endo -69.84 164.49 34.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.615 2.21 . . . . 0.25 112.329 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.654 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -97.07 135.76 38.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.4 110.886 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.24 160.98 25.59 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 1.18 111.194 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -29.3 24.02 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.684 2.256 . . . . 0.44 112.27 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -85.31 -19.26 31.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 2.76 110.864 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -53.24 5.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 2.21 110.968 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.7 p -49.21 -41.94 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.36 111.033 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -33.69 72.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 1.23 110.866 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.28 -45.05 70.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.31 110.898 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.716 HG23 HD13 ' A' ' 147' ' ' LEU . 7.2 p -68.89 -32.39 54.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.492 . . . . 0.47 111.172 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -76.3 -30.0 57.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 3.23 110.85 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -90.43 -20.49 22.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 1.63 110.836 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -94.72 -32.96 13.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.59 110.8 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.848 HD22 HD12 ' A' ' 74' ' ' LEU . 3.0 mp -126.75 -53.98 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.86 110.925 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.78 12.07 2.01 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.635 -0.793 . . . . 0.9 112.435 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.581 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.4 t-160 -70.12 121.25 17.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.687 0.279 . . . . 1.36 110.896 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -149.41 111.65 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 3.21 110.847 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.55 165.18 31.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 1.59 110.86 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.76 -7.48 19.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 2.47 110.814 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -115.56 22.8 12.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 1.9 110.862 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.654 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -85.16 169.48 13.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.42 110.92 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.712 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -173.51 130.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.21 110.961 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.2 m-85 -72.94 131.84 42.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 1.81 110.943 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.95 140.38 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.2 111.16 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.666 ' HG2' HD13 ' A' ' 130' ' ' LEU . 23.3 tt0 -93.95 126.84 39.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 1.62 110.864 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 3.3 mp -122.35 151.4 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.26 111.147 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.483 ' HB ' HD21 ' A' ' 130' ' ' LEU . 3.2 t -129.72 161.45 30.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.33 111.145 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.5 130.48 3.07 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.23 112.485 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -94.86 140.56 29.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 1.59 110.838 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 7.5 tptt -82.31 134.54 48.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.535 0.684 . . . . 2.25 110.955 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 118.88 5.94 Favored 'Trans proline' 0 C--O 1.23 0.1 0 C-N-CA 122.723 2.282 . . . . 0.36 112.29 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -100.29 151.97 20.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.32 110.851 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -171.27 -174.62 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 7.37 110.819 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -107.77 30.22 6.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 8.9 110.908 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.0 t -145.21 149.77 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 10.55 111.083 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -52.3 -41.17 54.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 12.0 112.57 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.33 -75.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.396 . . . . 10.99 110.849 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.7 -174.07 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 14.22 110.955 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 10.5 110.882 -179.886 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.426 ' O ' HD12 ' A' ' 6' ' ' ILE . 31.5 mtt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.831 0.348 . . . . 4.26 110.874 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.5 -21.32 66.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.66 111.094 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -54.1 -51.61 63.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 2.32 110.874 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 6' ' ' ILE . 3.9 m-85 -122.22 20.81 10.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 1.57 110.966 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 56.24 40.79 85.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.752 -0.737 . . . . 0.39 112.472 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.518 HG21 HD22 ' A' ' 32' ' ' LEU . 1.4 mp -83.46 160.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.826 0.346 . . . . 0.36 111.067 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.743 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -156.36 168.01 28.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 1.62 110.899 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.51 134.41 34.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.43 111.135 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.51 2.5 37.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.41 112.458 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -121.04 171.88 8.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.793 0.33 . . . . 1.13 110.96 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.54 137.39 40.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 1.36 110.833 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.69 HG22 ' HB ' ' A' ' 62' ' ' ILE . 66.3 t -141.92 123.96 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 1.88 111.098 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.764 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -102.41 125.9 49.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.33 111.216 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.551 HG21 ' CB ' ' A' ' 29' ' ' VAL . 61.3 t -98.12 112.41 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.43 111.113 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.8 t -98.09 129.87 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.46 111.132 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -128.68 170.68 12.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.22 110.915 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 47' ' ' ILE . 11.4 p-10 -151.65 -172.76 4.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 1.77 110.924 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -23.41 62.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 3.14 110.857 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.83 -16.31 48.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.09 110.924 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 m -101.67 102.79 24.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.66 0.743 . . . . 0.31 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 136.85 34.08 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.66 2.24 . . . . 0.45 112.428 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.19 -31.66 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.56 111.121 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.02 -52.46 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 2.48 110.922 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.94 -43.81 12.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.26 111.099 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.548 HD13 ' N ' ' A' ' 26' ' ' LYS . 1.3 tm? -51.48 -60.28 3.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.34 110.915 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.548 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -47.45 -46.83 27.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 2.2 110.963 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.68 -37.02 93.1 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.771 -0.728 . . . . 0.49 112.462 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.719 HD11 HG13 ' A' ' 68' ' ' VAL . 33.8 mt -60.25 -50.75 72.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.78 110.928 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.594 HG22 ' HG3' ' A' ' 33' ' ' GLN . 7.7 p -77.66 -25.28 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 3.33 111.099 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -60.91 -62.43 1.86 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 1.94 110.873 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -40.34 62.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 1.7 110.891 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.808 HD23 HD21 ' A' ' 35' ' ' LEU . 84.7 mt -72.22 -24.48 61.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.46 110.934 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.619 ' HA ' HG21 ' A' ' 42' ' ' VAL . 2.1 mm-40 -77.49 -25.58 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 1.89 110.938 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.15 -31.34 17.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 0.36 111.056 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.808 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.06 -34.76 15.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.37 110.874 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 7' ' ' SER . 1.2 m -103.08 -47.54 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.5 111.174 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.03 -15.6 50.27 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.764 . . . . 0.51 112.467 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.23 -61.06 2.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 1.83 110.793 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -102.88 -34.27 9.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 2.2 110.957 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.34 -120.55 1.9 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 0.61 112.464 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -166.44 156.45 11.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 2.29 110.846 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.619 HG21 ' HA ' ' A' ' 33' ' ' GLN . 21.5 t -145.4 137.55 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.54 111.128 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -129.43 158.37 39.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.45 110.804 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -117.25 141.0 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.488 . . . . 0.35 111.135 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -145.92 151.53 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 2.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -103.58 134.79 46.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.44 110.894 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.742 ' CD1' HG21 ' A' ' 73' ' ' THR . 37.8 mt -52.94 -36.14 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.41 111.061 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -31.41 67.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 2.54 110.816 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -104.0 20.1 18.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 3.54 110.969 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.831 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -49.32 -27.93 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 1.09 110.914 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -54.96 -34.34 63.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.05 110.853 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -84.47 -15.55 45.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 1.06 110.877 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.517 ' HB2' HD13 ' A' ' 50' ' ' LEU . 40.9 m -65.83 -11.05 43.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.95 110.838 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.97 63.0 0.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.32 111.172 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -62.95 -70.82 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.38 110.832 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.598 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -149.7 -169.02 3.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 1.88 110.909 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -102.46 136.37 42.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 1.78 110.87 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.8 p 47.21 85.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 1.37 110.84 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.1 p -140.52 -40.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.26 110.798 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.491 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.4 m-85 -99.42 119.18 37.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 2.13 110.889 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.87 -20.09 62.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 1.69 110.864 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.69 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.4 mt -146.46 143.7 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.27 111.13 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.958 HG21 HG23 ' A' ' 83' ' ' ILE . 16.0 mm -134.09 130.67 55.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.23 111.145 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -112.78 134.14 54.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.213 -0.448 . . . . 0.25 110.931 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.46 95.68 4.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.188 -0.46 . . . . 0.29 110.87 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 53.68 72.17 0.58 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 0.32 112.515 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.97 56.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.792 0.33 . . . . 0.57 110.898 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.719 HG13 HD11 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -123.42 159.9 52.95 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.613 0.72 . . . . 0.27 111.12 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.413 ' HD2' HG12 ' A' ' 68' ' ' VAL . 54.4 Cg_endo -69.72 123.18 9.86 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.669 2.246 . . . . 0.27 112.381 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.27 6.97 87.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.757 -0.735 . . . . 0.2 112.507 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.8 p -55.48 148.57 15.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.77 110.874 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.747 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 29.5 p -137.83 109.1 6.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.18 111.14 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.742 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.37 152.28 16.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.24 111.195 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.947 HD12 HD22 ' A' ' 147' ' ' LEU . 4.6 mt -131.15 103.45 6.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.21 110.959 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -79.52 152.94 29.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.28 110.874 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 m -129.23 176.28 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.57 110.823 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.27 53.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.25 111.11 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.37 -46.1 91.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 1.73 110.853 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.831 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -72.9 -54.54 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.23 111.129 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.63 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.0 mt -50.68 -38.68 48.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.19 110.997 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.83 -52.96 61.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 0.31 111.108 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 -43.18 79.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 2.84 110.922 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.958 HG23 HG21 ' A' ' 63' ' ' ILE . 43.4 mm -59.31 -68.44 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.33 111.194 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.52 -33.8 15.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.2 111.106 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -61.06 -52.51 64.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 2.18 110.94 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 56' ' ' LYS . 29.9 pt -81.43 -4.41 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.28 111.134 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -82.03 122.4 27.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.887 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -61.08 159.67 26.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.525 0.679 . . . . 3.49 110.885 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 114.24 3.64 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.598 2.199 . . . . 0.29 112.39 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.47 5.1 55.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 0.25 112.496 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.11 -159.61 13.19 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 0.25 112.428 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.4 m -140.9 155.04 46.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.332 . . . . 0.39 110.835 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.631 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -139.31 115.57 10.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.184 -0.462 . . . . 0.22 110.917 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.562 ' N ' HD22 ' A' ' 93' ' ' LEU . 49.9 m-85 -109.98 133.71 52.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.88 110.846 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -148.69 158.0 43.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.22 110.954 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.3 123.68 36.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 1.83 110.945 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.66 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -147.55 147.92 29.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.576 0.703 . . . . 2.27 110.947 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.607 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.0 Cg_endo -69.78 144.77 54.97 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.665 2.244 . . . . 0.22 112.293 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 155' ' ' LEU . 5.4 m -125.41 147.1 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.37 111.227 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -115.1 132.36 56.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 1.96 110.893 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.5 p -105.99 25.92 10.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 1.06 111.171 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.19 25.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.77 111.079 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.5 t -143.4 159.96 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.78 111.114 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.509 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -55.91 179.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.071 -0.513 . . . . 2.08 110.865 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -65.32 -66.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 2.48 110.901 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -63.32 -75.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 1.91 110.898 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.23 -168.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 1.67 110.802 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -5.72 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.046 -0.525 . . . . 2.35 110.955 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 m -146.19 145.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.165 -0.47 . . . . 0.51 111.066 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.639 ' H ' HD22 ' A' ' 74' ' ' LEU . 3.4 ttmt -67.68 116.31 8.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 2.32 110.884 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 104' ' ' ASP . 27.7 p -85.35 -179.87 7.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.36 111.077 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.94 -54.56 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.43 111.052 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -48.81 78.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.41 110.829 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -58.95 -38.24 78.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 2.14 110.871 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.66 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -63.59 -54.6 33.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.427 . . . . 0.62 110.933 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.4 m -58.7 -49.56 77.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 0.45 110.965 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -47.47 86.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.59 110.852 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.01 -54.64 42.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.49 111.058 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.63 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.2 tp -53.8 -48.14 70.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.3 110.926 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.8 m -67.63 -22.43 65.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.39 111.125 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.4 mt -86.98 -15.08 39.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.72 110.881 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.46 5.37 27.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 1.88 110.847 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.87 -5.03 34.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.664 -0.779 . . . . 0.68 112.48 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -86.5 166.71 15.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 0.33 110.912 -179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.0 m -147.02 170.43 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.29 111.103 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 52.24 44.72 29.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 2.28 110.895 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.6 t -82.77 141.38 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.34 111.133 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.93 158.84 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 1.69 110.846 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -75.87 146.01 40.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 2.23 110.925 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.684 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.0 mp -104.47 -37.36 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.23 110.975 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -155.43 176.18 12.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 1.17 110.906 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.668 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.9 OUTLIER -128.85 145.3 51.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 4.39 110.786 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -134.32 136.16 25.36 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.624 0.726 . . . . 1.44 110.889 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 164.91 32.75 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.665 2.243 . . . . 0.32 112.344 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.644 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -98.03 126.05 43.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.37 110.948 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.01 161.48 22.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.574 0.702 . . . . 1.49 111.153 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -24.64 29.74 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.711 2.274 . . . . 0.35 112.31 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -85.46 -22.03 28.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.437 . . . . 2.76 110.882 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -87.81 -53.59 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 2.51 110.945 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 136' ' ' THR . 7.5 p -49.58 -40.08 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.23 111.093 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -34.53 76.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 1.19 110.921 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.5 -47.15 67.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.24 110.853 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.697 HG23 HD13 ' A' ' 147' ' ' LEU . 10.3 p -67.59 -30.92 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.17 111.033 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -76.57 -29.58 56.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 1.69 110.936 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -89.91 -21.39 22.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 1.89 110.9 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -94.63 -32.41 13.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.29 110.923 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.947 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.6 -54.37 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.33 110.874 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.11 18.4 1.69 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.767 -0.73 . . . . 0.32 112.512 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -72.69 122.08 20.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.88 110.845 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -151.64 107.62 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 2.74 110.863 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.5 t -160.47 173.8 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.8 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.32 -19.75 13.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.64 110.865 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -96.83 17.05 17.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 1.58 110.959 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -82.78 165.38 19.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.39 110.918 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.668 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.5 tm? -173.73 130.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.25 110.876 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.747 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.8 m-85 -75.84 138.46 41.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 1.71 110.871 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -151.93 148.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.4 111.14 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.684 ' HG2' HD13 ' A' ' 130' ' ' LEU . 19.1 tt0 -100.2 130.29 46.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 1.68 110.902 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.91 150.77 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.36 111.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.466 ' N ' HD11 ' A' ' 130' ' ' LEU . 6.1 t -135.25 161.43 35.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.4 111.125 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.59 135.61 5.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.707 -0.758 . . . . 0.21 112.442 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -91.86 140.31 29.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 1.69 110.898 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 135.26 49.28 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.612 0.72 . . . . 1.29 110.853 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 127.68 14.9 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.688 2.258 . . . . 0.45 112.306 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -108.33 150.03 27.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.34 110.904 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 36.0 t80 64.97 151.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 5.74 110.836 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -80.03 132.91 36.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 8.7 110.908 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.3 m -122.83 -35.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 5.66 111.14 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.15 -36.35 4.27 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.761 -0.733 . . . . 6.08 112.478 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.24 149.28 24.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 6.1 110.786 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.69 144.85 27.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.514 . . . . 8.34 110.898 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 10.35 110.886 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.562 ' O ' HD12 ' A' ' 6' ' ' ILE . 3.5 ptm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.813 0.339 . . . . 4.55 110.872 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.54 -19.43 57.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.46 111.127 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -49.73 68.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 1.83 110.893 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.22 19.97 10.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 1.53 110.854 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.26 41.51 54.46 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.722 -0.752 . . . . 0.21 112.461 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 1' ' ' MET . 1.7 mp -78.0 158.61 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.25 111.089 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 36' ' ' THR . 25.8 m -148.38 157.13 43.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 1.05 110.916 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.33 128.32 34.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.29 111.095 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.36 28.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.738 -0.744 . . . . 0.26 112.487 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.99 167.41 10.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 1.46 110.873 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.21 136.68 38.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 1.29 110.843 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.548 ' CG1' HG21 ' A' ' 36' ' ' THR . 2.0 p -142.43 138.72 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.481 . . . . 2.09 111.183 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.775 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -115.59 129.5 56.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.22 111.154 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.663 HG11 HG12 ' A' ' 29' ' ' VAL . 48.6 t -101.1 123.79 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.3 111.12 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.729 HG12 HG13 ' A' ' 47' ' ' ILE . 4.6 t -105.15 116.45 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.34 111.11 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -119.33 164.63 15.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.21 110.846 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -148.73 -169.52 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 4.66 110.792 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -35.68 67.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 3.19 110.913 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.5 -11.55 60.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 1.13 110.896 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.47 95.52 11.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.673 0.749 . . . . 0.18 110.89 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 141.19 44.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.627 2.218 . . . . 0.2 112.36 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.19 -32.7 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.25 111.106 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.36 -52.5 45.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 2.48 110.922 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.4 -45.07 10.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.16 111.085 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.46 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.9 -61.12 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.17 110.902 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.81 -35.66 23.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 2.47 110.904 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.44 -48.21 45.95 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.731 . . . . 0.2 112.485 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 mt -61.63 -41.22 97.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.746 0.308 . . . . 0.46 110.846 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.663 HG12 HG11 ' A' ' 14' ' ' VAL . 16.2 m -74.91 -31.6 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.63 111.197 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.08 -62.18 1.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 1.8 110.871 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -40.16 65.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 1.78 110.888 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.892 HD23 HD21 ' A' ' 35' ' ' LEU . 76.7 mt -72.77 -25.05 61.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.195 -0.457 . . . . 0.23 110.853 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.51 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.43 -24.75 46.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.42 110.912 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.9 -29.85 17.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.32 111.088 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.892 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.63 -35.05 14.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.26 110.946 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.548 HG21 ' CG1' ' A' ' 12' ' ' VAL . 0.4 OUTLIER -102.45 -44.72 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.28 111.126 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.23 -10.98 54.56 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.661 -0.781 . . . . 0.32 112.446 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -71.38 -62.38 1.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.754 0.311 . . . . 2.21 110.961 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -91.58 -40.18 11.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 1.94 110.881 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.95 -126.49 5.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.68 -0.772 . . . . 0.27 112.488 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -155.27 152.83 29.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 2.21 110.992 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 33' ' ' GLN . 87.7 t -136.72 130.36 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.35 111.132 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 t -118.56 156.14 29.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.22 110.799 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -117.62 132.02 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.19 111.099 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -142.07 152.24 43.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 1.21 110.896 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -101.77 135.61 43.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.42 110.851 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.002 HD13 HG21 ' A' ' 73' ' ' THR . 3.0 mt -50.07 -44.09 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.47 111.15 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -72.24 -27.6 62.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 3.47 110.874 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -95.22 19.24 10.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 3.49 110.942 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.777 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.93 -29.65 3.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 1.09 110.91 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mp -51.91 -36.99 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 1.15 110.959 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -86.01 -19.45 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 1.14 110.926 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.513 ' HB2' HD13 ' A' ' 50' ' ' LEU . 69.2 m -60.21 -16.85 36.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.93 110.889 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -74.44 63.27 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.34 111.053 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.407 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 5.3 m80 -65.27 -70.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.44 110.89 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.666 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.65 -167.92 2.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 1.1 110.829 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -108.79 131.81 54.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 1.86 110.845 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 p 47.16 72.44 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 1.17 110.851 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -127.22 -33.69 2.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.23 110.842 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.2 m-85 -99.81 118.34 36.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 1.46 110.893 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.1 -19.21 62.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 1.72 110.803 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 6' ' ' ILE . 15.9 mt -145.46 144.61 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.25 111.076 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.857 HG21 HG23 ' A' ' 83' ' ' ILE . 19.3 mm -136.7 129.13 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.19 111.144 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -112.7 136.57 52.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.22 110.945 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.13 102.16 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.22 110.914 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.31 77.37 0.13 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.762 -0.732 . . . . 0.24 112.481 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.49 53.75 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.58 110.921 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.56 160.34 53.74 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.611 0.72 . . . . 0.22 111.071 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 116.35 4.51 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.671 2.248 . . . . 0.24 112.433 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.83 6.73 69.46 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.681 -0.771 . . . . 0.21 112.486 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.92 132.08 48.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 0.68 110.907 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.706 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 26.9 p -122.54 108.5 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.25 111.171 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 1.002 HG21 HD13 ' A' ' 47' ' ' ILE . 1.5 m -162.73 154.8 18.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.4 111.147 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.994 HD12 HD22 ' A' ' 147' ' ' LEU . 4.7 mt -133.17 104.58 6.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.31 110.853 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -76.18 153.72 35.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.074 -0.512 . . . . 0.38 110.886 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.1 m -131.56 177.42 7.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.41 110.836 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.7 -42.03 56.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.36 111.002 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.14 -46.07 86.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 1.91 110.954 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.777 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.2 mp -71.9 -56.68 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.3 111.104 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 119' ' ' LEU . 59.1 mt -50.84 -43.45 59.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.2 110.909 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.34 -54.24 34.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.29 111.057 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.417 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -57.63 -43.32 84.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 2.71 110.836 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.857 HG23 HG21 ' A' ' 63' ' ' ILE . 38.6 mm -54.98 -67.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.27 111.088 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.13 -39.77 56.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.23 111.106 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -52.87 -53.9 42.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 2.3 110.889 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 56' ' ' LYS . 36.3 pt -80.15 -8.5 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.21 111.129 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -78.3 127.56 32.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.39 110.916 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -67.41 160.28 72.84 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.657 0.742 . . . . 2.16 110.763 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 113.91 3.53 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.736 2.291 . . . . 0.16 112.336 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.74 56.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.747 -0.739 . . . . 0.14 112.496 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.51 -164.58 19.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.661 -0.78 . . . . 0.13 112.48 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 45.0 m -134.72 154.21 51.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.876 0.369 . . . . 0.34 110.887 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.645 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -139.61 113.99 9.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.18 110.944 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.536 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.3 m-85 -109.39 131.73 54.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 1.94 110.927 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.556 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.79 158.09 43.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.21 110.815 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.74 130.59 45.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 1.81 110.918 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.4 145.67 17.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.637 0.732 . . . . 2.23 110.886 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.615 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.0 Cg_endo -69.92 137.54 35.23 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.678 2.252 . . . . 0.3 112.282 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.491 HG13 HG23 ' A' ' 157' ' ' VAL . 12.2 m -120.33 146.41 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.21 111.091 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.467 ' OE1' HG21 ' A' ' 103' ' ' VAL . 52.1 mt-10 -111.4 132.79 54.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 1.98 110.856 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.2 p -106.39 26.09 10.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 1.11 111.169 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.85 24.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.74 111.145 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.467 HG21 ' OE1' ' A' ' 100' ' ' GLU . 3.1 t -144.22 161.0 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.8 111.137 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.574 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -54.77 177.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.91 110.895 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -67.87 -53.48 26.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 3.48 110.912 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -70.77 -75.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 2.13 110.825 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.03 -168.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 1.49 110.799 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -4.02 53.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 1.63 110.921 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.42 140.25 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.111 -0.495 . . . . 0.66 111.114 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.9 mmpp? -63.66 112.94 3.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 2.93 111.016 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.574 HG21 ' O ' ' A' ' 104' ' ' ASP . 29.3 p -80.28 176.66 9.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.26 111.13 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.98 -54.9 32.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.17 111.075 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.33 -48.85 80.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.23 110.752 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -39.11 72.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 2.3 110.9 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -65.39 -55.15 19.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.31 110.994 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.4 m -56.7 -44.92 82.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.243 -0.435 . . . . 0.24 110.963 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.83 -42.34 85.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 0.26 110.867 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.2 97.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.2 111.161 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.5 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.2 tp -65.17 -53.98 36.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.23 110.894 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 96.1 m -58.28 -36.88 73.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.31 111.173 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.6 mt -83.42 -10.39 58.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.65 110.969 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m -84.65 4.89 30.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 1.71 110.886 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.01 8.68 31.3 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.662 -0.78 . . . . 0.62 112.446 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.645 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -107.46 168.66 9.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.789 0.328 . . . . 0.31 110.892 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.4 HG23 ' HG3' ' A' ' 126' ' ' GLU . 34.2 m -150.57 169.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.25 111.144 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HG3' HG23 ' A' ' 125' ' ' VAL . 1.9 mt-10 56.2 42.64 27.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 2.02 110.927 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.81 144.33 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.46 111.136 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.82 157.13 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 1.48 110.923 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -81.48 147.3 29.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 2.1 110.902 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.764 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.2 mp -108.21 -36.01 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.27 110.927 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -164.86 176.57 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 1.34 110.981 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -126.56 166.25 17.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 8.3 110.84 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -147.96 135.71 10.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.572 0.701 . . . . 1.44 110.897 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 155.83 65.04 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.618 2.212 . . . . 0.31 112.434 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.646 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -92.34 122.83 35.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.26 -0.427 . . . . 0.31 110.973 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.442 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.46 162.0 22.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.539 0.685 . . . . 1.27 111.2 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.6 Cg_endo -69.82 -26.12 27.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.651 2.234 . . . . 0.32 112.334 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -85.33 -19.79 30.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 2.91 110.888 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.22 -54.41 4.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 2.65 110.934 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.95 -38.85 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.22 111.125 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -39.04 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 2.54 110.916 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -45.59 79.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.3 110.864 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.7 p -67.71 -31.25 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.18 111.158 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -75.74 -30.65 59.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.122 -0.49 . . . . 2.11 110.875 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -90.02 -20.48 23.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 1.76 110.876 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -94.43 -32.8 13.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.28 110.941 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.994 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.65 -54.15 1.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.32 110.92 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.8 18.4 1.57 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.36 112.473 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -73.72 122.03 21.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.778 0.323 . . . . 1.06 110.923 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -151.58 105.57 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 2.79 110.966 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.9 t -160.55 170.72 20.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.91 110.873 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.34 -18.34 14.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 1.6 110.902 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -98.5 20.25 13.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 1.55 110.83 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.646 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -88.67 164.26 15.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 0.29 111.025 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.6 tm? -173.26 130.35 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.214 -0.448 . . . . 0.31 110.936 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.706 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.5 m-85 -69.79 134.76 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 1.9 110.848 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.491 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.6 144.94 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 0.32 111.176 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.764 ' HG2' HD13 ' A' ' 130' ' ' LEU . 38.0 tt0 -103.29 130.65 50.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 2.29 110.921 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.05 152.58 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.35 111.118 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.443 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.2 t -131.98 159.19 39.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.31 111.128 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -148.3 133.61 4.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 0.18 112.514 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -94.26 131.82 39.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.925 0.393 . . . . 3.85 110.862 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 135.45 81.19 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.549 0.69 . . . . 1.25 110.898 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 128.79 16.53 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.695 2.263 . . . . 0.36 112.35 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -109.67 150.44 28.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.31 110.903 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.8 t80 64.59 112.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 5.82 110.867 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.46 107.77 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 10.17 110.864 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 170' ' ' SER . 7.0 m -115.46 -30.3 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 5.53 111.114 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.1 24.6 65.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.745 -0.741 . . . . 5.39 112.5 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.513 ' H ' HG23 ' A' ' 168' ' ' VAL . 19.4 m -90.67 137.91 31.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.377 . . . . 5.78 110.817 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.26 -75.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 6.7 110.892 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 6.55 110.923 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.747 0.308 . . . . 3.55 110.868 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.55 63.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.51 111.08 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.35 -51.58 64.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 2.46 110.901 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' A' ' 6' ' ' ILE . 5.2 m-85 -122.26 22.45 10.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 1.62 110.883 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.14 41.65 53.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.718 -0.753 . . . . 0.23 112.488 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.482 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.6 mp -81.02 160.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.904 0.383 . . . . 0.26 111.101 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.737 ' O ' HG23 ' A' ' 36' ' ' THR . 0.5 OUTLIER -156.0 167.84 29.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 1.61 110.858 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.6 128.81 36.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.29 111.098 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.07 2.92 26.52 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.754 -0.736 . . . . 0.36 112.505 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.446 ' NE2' ' HB2' ' A' ' 7' ' ' SER . 2.8 pt20 -116.63 166.95 11.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.86 0.362 . . . . 1.02 110.864 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -106.13 112.89 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 1.37 110.906 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.601 HG13 HG21 ' A' ' 36' ' ' THR . 3.1 m -115.23 141.47 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 2.31 111.165 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.797 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -116.59 112.19 20.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 0.38 111.066 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.843 HG11 HG12 ' A' ' 29' ' ' VAL . 92.2 t -86.53 121.13 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.18 111.074 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG12 ' CG1' ' A' ' 47' ' ' ILE . 18.3 t -106.53 115.76 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.17 111.067 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -115.49 168.73 9.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 0.2 110.977 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -151.42 -170.22 3.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.83 110.896 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -57.1 -35.73 69.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 3.59 110.863 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.8 m -73.34 -9.66 58.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 1.7 110.786 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.29 93.75 10.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.621 0.724 . . . . 0.13 110.848 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.7 Cg_endo -69.76 142.8 48.92 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.723 2.282 . . . . 0.21 112.333 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.05 -32.43 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.23 111.08 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -51.29 -53.24 37.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 2.43 110.903 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.73 -44.86 10.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.21 111.054 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.446 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.2 -61.22 2.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.17 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -49.83 -35.63 23.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 2.53 110.888 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.02 -47.72 44.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 0.28 112.53 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.67 -39.44 91.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.38 . . . . 0.48 110.911 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.843 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -77.14 -31.32 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.66 111.026 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.31 -59.25 5.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 1.75 110.826 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -40.43 73.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 1.66 110.885 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.871 HD23 HD21 ' A' ' 35' ' ' LEU . 87.4 mt -72.59 -25.07 61.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.28 110.953 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.496 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.02 -25.02 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 0.47 110.848 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.47 -30.84 17.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.38 111.114 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.871 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.47 -34.89 15.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.31 110.907 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.32 -47.13 4.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.29 111.132 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.1 -14.5 53.48 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.699 -0.762 . . . . 0.36 112.481 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.43 -62.68 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.756 0.313 . . . . 2.09 110.816 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.95 -33.7 8.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 1.97 110.982 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.61 -131.04 4.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.28 112.54 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -153.28 152.74 31.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.791 0.329 . . . . 3.65 110.872 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 12' ' ' VAL . 98.3 t -139.27 113.69 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.46 111.125 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -103.93 153.18 21.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.15 110.895 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.92 133.46 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.11 -0.495 . . . . 0.17 111.148 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -142.16 151.97 42.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 1.32 110.921 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -102.66 135.11 44.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.39 110.921 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.668 ' CD1' HG21 ' A' ' 73' ' ' THR . 23.9 mt -51.76 -35.15 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.29 111.181 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -29.75 60.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 2.15 110.925 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -98.21 18.59 15.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 3.36 110.926 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.816 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.31 -30.77 5.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 1.11 110.912 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -53.93 -37.91 64.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 1.06 111.062 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -84.9 -15.64 43.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 1.22 110.948 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.6 m -66.31 -10.82 46.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.98 110.9 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.68 63.43 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.473 . . . . 0.32 111.11 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -61.55 -69.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.35 110.801 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.664 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -153.16 -175.88 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 1.29 110.837 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -93.73 135.22 35.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 1.8 110.896 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p 46.64 81.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 1.18 110.819 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.9 p -132.07 -39.17 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.32 110.795 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.458 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.7 m-85 -102.16 123.89 46.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 2.06 110.89 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.28 -21.64 62.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 1.71 110.805 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.0 mt -146.6 142.7 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 0.45 111.166 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 83' ' ' ILE . 17.6 mm -129.2 136.76 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.18 111.147 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.5 mm? -116.12 135.77 53.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.37 110.966 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.72 98.02 4.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.13 110.851 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.11 79.58 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.752 . . . . 0.18 112.502 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.85 55.42 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.56 110.959 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -123.77 158.72 58.78 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.636 0.731 . . . . 0.23 111.141 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 115.91 4.31 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.635 2.223 . . . . 0.25 112.393 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.3 6.6 66.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 0.2 112.474 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.32 151.86 9.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.952 0.406 . . . . 0.83 110.841 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.708 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 21.1 p -140.11 108.77 5.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.27 111.135 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.668 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.92 148.57 12.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.26 111.08 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.042 HD12 HD22 ' A' ' 147' ' ' LEU . 10.1 mt -126.75 99.79 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.34 110.904 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -76.78 143.77 39.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.28 110.848 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.83 -175.52 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 1.08 110.746 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.54 -36.17 71.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.26 111.016 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.58 -44.31 96.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 1.78 110.804 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.816 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -76.03 -55.18 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.19 111.187 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.564 HD22 ' CD1' ' A' ' 119' ' ' LEU . 62.8 mt -50.14 -41.86 49.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.19 110.933 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.56 -55.77 17.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.29 111.12 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -43.25 77.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 2.78 110.903 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 63' ' ' ILE . 42.9 mm -56.74 -68.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.18 111.116 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.14 -35.89 38.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.21 111.018 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -57.25 -51.05 70.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 3.31 110.867 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 56' ' ' LYS . 26.3 pt -83.79 -6.37 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.19 111.072 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -79.29 112.66 16.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.254 -0.43 . . . . 0.3 110.851 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -51.77 159.53 1.31 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.651 0.738 . . . . 2.08 110.87 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 115.82 4.27 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.77 2.313 . . . . 0.23 112.307 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.5 3.06 57.53 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.23 112.43 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.87 -157.51 9.59 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.691 -0.766 . . . . 0.21 112.483 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.5 m -145.29 158.87 43.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.35 . . . . 0.6 110.911 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.628 HD22 ' N ' ' A' ' 94' ' ' PHE . 1.0 OUTLIER -141.25 116.28 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.24 110.921 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.628 ' N ' HD22 ' A' ' 93' ' ' LEU . 57.0 m-85 -108.07 132.57 53.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 1.62 110.896 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.34 158.01 43.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.16 110.902 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.84 129.08 46.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 1.75 110.871 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.78 146.56 18.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.659 0.743 . . . . 2.23 110.849 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.516 ' HG2' HD21 ' A' ' 74' ' ' LEU . 52.7 Cg_endo -69.8 142.74 48.59 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.707 2.272 . . . . 0.23 112.321 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.99 146.76 31.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.19 111.195 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.449 ' CD ' HG21 ' A' ' 103' ' ' VAL . 56.0 mt-10 -109.2 132.88 53.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 1.98 110.892 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.2 p -92.47 -41.83 10.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.12 111.185 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.54 39.18 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.67 111.124 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.449 HG21 ' CD ' ' A' ' 100' ' ' GLU . 22.6 t -147.11 149.08 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.74 111.174 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.594 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -51.76 163.1 0.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.167 -0.469 . . . . 1.98 110.767 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -59.86 -47.56 85.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 3.51 110.849 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -75.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 1.91 110.901 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p 52.26 -170.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 1.98 110.89 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -80.51 -3.7 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 1.71 110.87 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.417 HG11 ' CG ' ' A' ' 149' ' ' HIS . 2.7 m -140.57 145.03 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.407 . . . . 0.38 111.183 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.7 mmtm -65.3 114.52 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 2.1 110.87 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.594 HG21 ' O ' ' A' ' 104' ' ' ASP . 45.5 p -85.91 179.33 7.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.21 111.107 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.4 -53.42 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.19 111.14 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -49.29 78.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.24 110.873 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -58.36 -37.95 76.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.028 -0.533 . . . . 1.76 110.918 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -64.74 -54.68 27.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.32 110.94 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.2 m -58.3 -46.6 85.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.23 110.88 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -43.71 93.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.32 110.918 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.78 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.21 111.081 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.564 ' CD1' HD22 ' A' ' 80' ' ' LEU . 11.6 tp -64.45 -57.87 8.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.39 110.914 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.3 m -55.57 -36.38 66.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.33 111.134 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.9 mt -83.11 -10.71 58.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.88 110.909 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.43 6.42 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 1.75 110.852 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.51 8.04 31.24 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.778 -0.725 . . . . 0.58 112.482 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.643 HD23 ' HA3' ' A' ' 161' ' ' GLY . 1.5 tp -107.5 171.29 7.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.82 0.343 . . . . 0.54 111.005 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.61 169.56 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.28 111.091 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 51.47 43.89 29.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 2.41 110.917 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.27 143.19 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.34 111.136 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 160.06 8.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 1.67 110.883 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.47 140.83 37.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 3.15 110.893 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.705 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.6 mp -98.94 -39.2 8.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.41 110.902 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -160.18 177.09 11.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 1.41 110.811 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 -123.99 168.71 12.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 8.04 110.785 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -151.56 136.67 10.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.743 0.782 . . . . 1.38 110.826 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.91 154.76 66.79 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.711 2.274 . . . . 0.38 112.303 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.646 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -91.55 128.44 37.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.38 110.851 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -106.02 161.45 22.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.618 0.723 . . . . 1.65 111.104 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -24.33 29.59 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.68 2.253 . . . . 0.54 112.351 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -85.3 -22.49 28.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 3.87 110.877 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -87.58 -53.77 4.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.117 -0.492 . . . . 2.73 110.903 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.44 -39.25 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.34 111.061 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -36.12 77.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 2.9 110.965 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -45.76 73.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.4 110.831 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.708 HG23 HD13 ' A' ' 147' ' ' LEU . 9.2 p -68.26 -30.81 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 0.26 111.161 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -75.82 -31.94 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 2.13 110.905 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -89.88 -20.16 23.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 1.74 110.84 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -94.45 -32.92 13.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.848 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.042 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.64 -54.2 1.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.36 110.864 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.1 11.39 2.28 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.787 -0.721 . . . . 0.28 112.51 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.417 ' CG ' HG11 ' A' ' 109' ' ' VAL . 14.8 t-160 -70.34 121.81 18.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.75 0.309 . . . . 0.6 110.798 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -151.76 105.55 3.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 2.24 110.922 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.2 t -160.5 168.38 25.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.6 110.828 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.66 -13.49 15.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.66 110.817 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -100.28 19.97 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.63 110.814 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.646 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -92.8 169.55 10.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.34 110.919 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.662 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.1 tm? -173.57 130.24 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.35 110.931 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.708 ' CZ ' HG22 ' A' ' 72' ' ' THR . 20.1 m-85 -69.98 139.9 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 1.72 110.891 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.13 151.86 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.3 111.216 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.705 ' HG2' HD13 ' A' ' 130' ' ' LEU . 26.1 tt0 -107.8 129.29 55.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 1.56 110.925 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.18 151.17 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.24 111.137 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.512 HG21 HD21 ' A' ' 130' ' ' LEU . 8.9 t -140.54 151.15 44.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.44 111.083 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.643 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -143.35 144.62 13.97 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 0.21 112.496 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -97.66 137.37 36.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 1.81 110.851 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 134.76 65.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.662 0.744 . . . . 1.23 110.856 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 122.05 8.75 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.702 2.268 . . . . 0.37 112.384 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -96.94 153.62 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.66 110.894 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -48.99 113.32 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 5.3 110.865 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 65.63 109.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 8.6 110.853 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.2 m -154.19 -41.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 8.33 111.112 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 137.19 -33.2 2.33 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.733 -0.746 . . . . 7.47 112.437 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.98 97.91 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.936 0.398 . . . . 7.53 110.844 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.9 m -108.08 -175.64 2.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 8.08 110.899 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 7.52 110.898 -179.986 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.749 0.309 . . . . 3.52 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.98 -22.2 64.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.44 111.046 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.11 -51.61 63.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 2.37 110.808 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.23 22.08 10.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.44 . . . . 1.5 110.89 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.34 40.39 60.8 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.731 -0.747 . . . . 0.25 112.479 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.512 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -79.75 159.4 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.22 111.069 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.629 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -154.52 164.56 38.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.29 110.883 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.33 129.87 35.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.31 111.073 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.18 -5.27 25.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.71 -0.757 . . . . 0.26 112.488 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -114.7 167.96 10.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 1.21 110.835 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.37 140.16 33.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 1.33 110.866 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' HB ' ' A' ' 62' ' ' ILE . 48.2 t -142.3 140.13 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 1.85 111.102 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.776 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -117.16 121.89 42.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.26 111.107 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.817 HG11 HG12 ' A' ' 29' ' ' VAL . 64.1 t -95.1 119.6 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.21 111.154 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.487 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.1 t -103.35 112.88 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.23 111.228 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -114.38 167.66 10.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.17 111.012 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.4 -169.79 3.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.354 -0.384 . . . . 1.91 110.82 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -35.52 69.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 3.44 110.861 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -10.25 59.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 1.24 110.863 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.93 94.26 10.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.668 0.747 . . . . 0.15 110.861 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 142.36 47.25 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.713 2.275 . . . . 0.21 112.381 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -49.07 -32.48 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.18 111.105 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -51.32 -53.15 38.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 2.7 110.81 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.48 -44.65 11.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.17 111.163 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.85 -61.4 2.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.13 110.923 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -49.88 -36.8 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 4.93 110.854 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -47.38 49.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.815 -0.707 . . . . 0.19 112.471 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.6 mt -61.82 -39.7 92.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.45 110.959 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.817 HG12 HG11 ' A' ' 14' ' ' VAL . 17.6 m -76.98 -31.71 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.62 111.047 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -61.96 -59.76 4.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 1.77 110.893 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -40.15 70.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 1.76 110.935 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.852 HD23 HD21 ' A' ' 35' ' ' LEU . 87.1 mt -72.76 -25.25 61.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.23 110.966 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.478 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.4 mt-30 -78.59 -25.19 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.39 110.924 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 -29.15 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.26 111.093 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.852 HD21 HD23 ' A' ' 32' ' ' LEU . 1.3 pp -91.72 -34.88 14.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.22 110.933 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -102.52 -45.11 5.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.168 -0.469 . . . . 0.24 111.149 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.87 -12.09 52.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.28 112.51 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -65.74 -62.6 1.42 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 1.86 110.858 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -97.16 -37.4 10.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 2.35 110.959 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.27 -128.91 5.04 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.27 112.499 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -154.93 153.57 31.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.947 0.403 . . . . 2.28 110.847 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 33' ' ' GLN . 86.0 t -138.56 128.44 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.28 111.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -117.42 157.65 25.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.17 110.821 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -118.51 135.72 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.17 111.137 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -145.34 151.96 39.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 1.94 110.892 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.56 135.97 43.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.905 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.747 HD13 HG21 ' A' ' 73' ' ' THR . 30.4 mt -51.25 -35.33 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.28 111.156 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -31.57 61.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 2.49 110.871 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -96.76 19.27 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 3.4 110.911 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.829 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.86 -30.81 4.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 1.06 111.005 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -53.13 -35.84 60.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 1.02 110.924 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -85.75 -18.76 32.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 1.08 110.913 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.475 ' HB2' HD13 ' A' ' 50' ' ' LEU . 65.3 m -60.47 -16.6 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.92 110.822 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.8 63.59 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.34 111.118 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -61.65 -71.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.37 110.832 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.683 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.4 -167.59 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 1.68 110.85 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -104.29 125.78 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 2.03 110.868 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.6 80.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 1.4 110.816 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.2 p -130.61 -36.47 1.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.22 110.812 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.468 ' CD2' HD12 ' A' ' 86' ' ' ILE . 95.7 m-85 -97.23 121.04 38.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 1.48 110.92 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.28 -20.88 61.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 1.7 110.85 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.646 ' HB ' HG22 ' A' ' 12' ' ' VAL . 30.5 mt -143.32 144.51 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.33 111.19 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.894 HG21 HG23 ' A' ' 83' ' ' ILE . 19.7 mm -135.17 128.86 49.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.17 111.207 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -112.46 136.35 52.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.257 -0.429 . . . . 0.17 110.907 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.33 101.74 6.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.18 110.895 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.59 75.95 0.19 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.704 -0.76 . . . . 0.18 112.557 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.23 57.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.58 110.93 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.08 159.62 63.92 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.62 0.724 . . . . 0.25 111.152 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 116.56 4.61 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.27 112.404 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.56 7.14 69.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.671 -0.776 . . . . 0.18 112.539 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.41 150.02 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.88 0.371 . . . . 0.69 110.857 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.763 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 33.7 p -138.48 108.71 6.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.18 111.167 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.747 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.86 149.98 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.26 111.122 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.897 HD12 HD22 ' A' ' 147' ' ' LEU . 2.4 mt -128.04 99.84 5.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.3 110.892 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -76.9 143.05 39.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.37 110.836 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.6 m -121.81 -175.3 3.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.52 110.829 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.82 -35.91 71.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.27 111.1 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.16 -43.54 97.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 2.12 110.851 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.829 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -76.18 -54.9 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.27 111.141 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.685 HD13 ' HA ' ' A' ' 119' ' ' LEU . 64.5 mt -51.11 -42.51 60.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.26 110.945 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.5 -56.83 11.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.35 111.082 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -54.36 -43.25 71.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.443 . . . . 3.07 110.922 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.894 HG23 HG21 ' A' ' 63' ' ' ILE . 41.4 mm -55.8 -67.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.27 111.087 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.15 -39.55 56.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.19 111.086 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -52.86 -50.83 63.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 2.45 110.861 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.683 HG22 ' O ' ' A' ' 56' ' ' LYS . 48.5 pt -85.37 -5.97 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.17 111.09 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -79.53 115.24 19.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.29 110.882 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -55.05 158.79 4.48 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.69 0.757 . . . . 3.06 110.828 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.9 Cg_endo -69.74 114.25 3.64 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.717 2.278 . . . . 0.17 112.306 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.39 55.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.787 -0.72 . . . . 0.17 112.52 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.92 -164.67 24.34 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.754 -0.736 . . . . 0.13 112.467 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.6 m -135.55 152.18 51.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.31 110.857 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.603 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -136.18 115.97 13.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.19 110.917 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.571 ' N ' HD22 ' A' ' 93' ' ' LEU . 55.3 m-85 -112.02 131.37 55.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 1.65 110.925 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.54 159.86 43.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.14 110.855 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.4 128.66 41.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 1.85 110.933 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.33 148.31 22.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.591 0.71 . . . . 2.28 110.902 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.595 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -69.82 142.86 48.77 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.67 2.247 . . . . 0.18 112.307 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.0 m -128.88 146.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.18 111.067 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.503 ' CD ' HG21 ' A' ' 103' ' ' VAL . 19.6 mt-10 -106.99 132.48 52.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 1.89 110.885 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.6 p -103.78 26.11 9.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 1.27 111.192 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.56 26.14 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.61 111.097 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.503 HG21 ' CD ' ' A' ' 100' ' ' GLU . 5.9 t -144.13 157.77 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.6 111.067 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.583 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -54.56 174.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.501 . . . . 1.9 110.887 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -65.67 -64.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 2.56 110.855 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -61.54 -75.84 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.231 -0.441 . . . . 2.18 110.888 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.401 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.7 t 51.64 -168.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 2.09 110.857 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -3.55 50.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 3.67 110.817 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -144.38 148.66 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.457 . . . . 0.44 111.113 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.521 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -69.64 112.72 6.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 2.17 110.947 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.583 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.7 p -87.31 178.6 6.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.22 111.093 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.68 -54.09 50.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.2 111.037 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.74 -49.07 79.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.28 110.909 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -57.72 -41.96 82.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 1.76 110.946 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -61.05 -54.76 40.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.3 110.881 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -57.81 -48.9 78.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.3 111.006 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -45.68 92.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.475 . . . . 0.36 110.931 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.25 -45.79 93.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.25 111.093 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.685 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.2 tp -61.87 -54.07 47.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.314 -0.403 . . . . 0.26 110.83 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.9 m -62.38 -27.53 69.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.25 111.118 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.05 -14.38 50.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.66 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.0 p -84.43 5.58 26.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 2.33 110.863 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.53 -4.7 34.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.663 -0.779 . . . . 0.6 112.5 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -87.16 168.92 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 0.35 111.04 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.9 m -151.0 171.32 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.22 111.089 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 52.39 45.02 29.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 2.22 110.853 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.4 t -79.68 143.56 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.21 111.132 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.9 160.23 8.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 2.49 110.889 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.88 147.16 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 2.4 110.862 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.783 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.5 mp -106.68 -36.0 6.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.21 110.905 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -159.7 176.29 12.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 1.1 110.89 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.707 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.0 OUTLIER -131.96 137.18 47.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 4.61 110.847 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -123.58 137.65 28.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.735 0.779 . . . . 1.4 110.815 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.411 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.8 Cg_endo -69.84 163.92 36.54 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.593 2.195 . . . . 0.22 112.308 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.671 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -96.99 127.03 42.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.28 110.805 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.44 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -100.15 160.91 25.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.584 0.707 . . . . 1.2 111.166 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.44 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.2 Cg_endo -69.72 -28.88 24.89 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.636 2.224 . . . . 0.34 112.378 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.33 -17.9 35.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 2.67 110.822 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.22 -52.83 5.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 2.33 110.892 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 p -49.27 -41.05 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.26 111.125 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -34.82 76.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 1.22 110.986 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -46.19 71.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.167 -0.47 . . . . 0.24 110.89 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.713 HG23 HD13 ' A' ' 147' ' ' LEU . 8.8 p -68.23 -30.15 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.18 111.055 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -75.29 -33.34 61.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 1.8 110.878 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -89.09 -19.93 24.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 1.86 110.838 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -94.1 -32.82 13.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.34 110.881 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.897 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -128.44 -54.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.41 110.936 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.59 7.05 2.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.701 -0.761 . . . . 0.36 112.465 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -70.21 120.44 15.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.78 0.324 . . . . 0.76 110.866 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -152.78 105.03 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 3.3 110.851 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.3 t -161.03 175.98 11.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.61 110.793 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.58 -14.43 14.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 1.55 110.872 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -96.44 6.86 47.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 1.41 110.867 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.671 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -77.98 165.59 23.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.29 110.919 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.707 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.51 130.14 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.21 110.898 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.763 ' CZ ' HG22 ' A' ' 72' ' ' THR . 29.8 m-85 -74.23 133.11 42.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.68 110.84 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.71 144.47 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.18 111.139 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.783 ' HG2' HD13 ' A' ' 130' ' ' LEU . 34.9 tt0 -98.75 130.69 45.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 2.23 110.89 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.83 150.46 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.21 111.084 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.486 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -130.22 160.16 34.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.32 111.089 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.56 132.12 3.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.13 112.474 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -94.15 142.79 27.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 1.71 110.963 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.408 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 2.0 tptt -84.23 135.33 41.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.583 0.706 . . . . 2.27 110.859 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 118.73 5.85 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.703 2.269 . . . . 0.38 112.281 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -102.4 152.16 21.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.47 110.853 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -61.23 99.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 6.65 110.882 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.554 ' O ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -176.38 -173.76 0.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 10.36 110.869 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 167' ' ' GLU . 12.2 m 43.46 -164.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 7.5 111.106 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -93.68 -42.1 4.26 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.738 -0.744 . . . . 7.26 112.466 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.94 157.31 3.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.91 0.386 . . . . 8.04 110.872 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.48 -60.32 0.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 9.04 110.848 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 9.12 110.867 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.743 0.306 . . . . 3.5 110.852 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.99 -19.18 65.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.52 111.088 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.03 -50.93 65.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 2.07 110.798 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 6' ' ' ILE . 7.0 m-85 -122.28 13.72 10.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 1.55 110.82 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.76 40.67 96.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.659 -0.781 . . . . 0.32 112.482 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.485 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.6 mp -80.99 159.96 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.35 111.179 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.727 ' O ' HG23 ' A' ' 36' ' ' THR . 0.4 OUTLIER -155.89 168.48 27.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 1.73 110.934 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.75 130.39 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.37 111.042 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.35 2.63 29.45 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.764 -0.732 . . . . 0.31 112.53 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.443 ' NE2' ' HB2' ' A' ' 7' ' ' SER . 3.3 pt20 -116.73 166.7 11.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 1.06 110.896 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -105.39 114.94 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 2.15 110.794 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.608 HG13 HG21 ' A' ' 36' ' ' THR . 3.4 m -117.85 139.27 45.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.473 . . . . 2.33 111.151 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.763 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -114.01 115.69 28.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.31 111.077 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.808 HG11 HG12 ' A' ' 29' ' ' VAL . 64.8 t -88.95 120.5 37.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.19 111.175 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.628 HG12 HG13 ' A' ' 47' ' ' ILE . 18.5 t -106.17 113.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.48 . . . . 0.18 111.173 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -112.67 167.39 10.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.24 110.871 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.576 ' HB3' HD12 ' A' ' 47' ' ' ILE . 7.2 p-10 -148.34 -169.25 3.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 1.72 110.974 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -58.67 -35.58 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 3.04 110.935 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -7.82 53.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 1.17 110.809 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.58 92.71 8.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.636 0.732 . . . . 0.18 110.907 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 143.27 50.56 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.707 2.271 . . . . 0.29 112.314 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.5 t -48.35 -33.06 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.25 111.145 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.33 -52.92 41.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 2.64 110.846 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.45 -45.3 10.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.25 111.219 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.452 HD22 HG13 ' A' ' 29' ' ' VAL . 1.9 tm? -51.2 -61.68 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.21 111.039 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.59 -35.83 22.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 2.69 110.928 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.16 -47.49 44.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.737 . . . . 0.25 112.573 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.422 HD11 HG13 ' A' ' 68' ' ' VAL . 46.5 mt -61.59 -38.84 89.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.63 110.973 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.808 HG12 HG11 ' A' ' 14' ' ' VAL . 17.3 m -77.66 -31.43 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.65 111.13 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.25 -58.24 8.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 1.59 110.835 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -40.43 76.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 2.59 110.818 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.902 HD23 HD21 ' A' ' 35' ' ' LEU . 87.6 mt -72.73 -24.78 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 0.25 110.948 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.496 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -77.92 -24.87 48.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.436 . . . . 0.41 110.839 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.8 -31.47 16.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.22 111.08 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.902 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -89.74 -35.21 15.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.22 110.931 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.64 -46.9 4.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.21 111.194 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.24 -13.37 53.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.668 -0.777 . . . . 0.26 112.53 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -62.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 2.8 110.897 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -99.85 -35.82 9.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 2.12 110.834 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.32 -129.64 4.53 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.24 112.471 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -153.67 152.28 30.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.854 0.359 . . . . 2.19 110.853 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 12' ' ' VAL . 92.2 t -137.8 117.19 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 0.29 111.069 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.2 t -106.93 153.75 22.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 0.18 110.875 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.53 134.36 58.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.19 111.073 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -144.46 152.52 40.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 1.25 110.921 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -102.49 137.41 40.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.48 110.824 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.945 HD13 HG21 ' A' ' 73' ' ' THR . 9.8 mt -51.38 -44.49 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.39 111.105 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -24.54 61.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 3.6 110.883 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -99.3 18.76 16.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 3.45 110.961 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.803 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.36 -29.31 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 1.11 110.9 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.82 -36.5 48.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 1.13 110.929 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.1 mm-40 -85.77 -20.4 29.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 1.25 110.897 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB2' HD13 ' A' ' 50' ' ' LEU . 66.5 m -59.53 -17.73 34.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.88 110.836 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.76 63.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.29 111.07 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -63.82 -71.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.36 110.79 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.693 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.73 -167.65 2.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 1.62 110.921 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -104.76 125.99 51.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 1.88 110.87 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.27 79.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 1.32 110.887 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.6 p -129.61 -35.42 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.26 110.89 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.454 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.7 m-85 -98.15 121.5 40.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 1.43 110.926 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.29 -21.5 62.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 1.69 110.888 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.1 mt -146.49 143.45 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.38 111.085 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.792 HG21 HD12 ' A' ' 83' ' ' ILE . 22.1 mm -131.22 132.44 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.25 111.045 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -112.15 134.96 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.21 110.959 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.34 101.18 5.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.17 110.846 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.68 78.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.711 -0.756 . . . . 0.2 112.505 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.474 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.5 mm? -110.95 53.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.57 110.91 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -122.78 160.34 49.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.683 0.754 . . . . 0.25 111.028 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.4 ' HD2' HG12 ' A' ' 68' ' ' VAL . 53.2 Cg_endo -69.81 123.34 9.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.765 2.31 . . . . 0.27 112.27 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.78 7.2 88.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.777 -0.725 . . . . 0.2 112.445 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.433 ' HB3' HG23 ' A' ' 68' ' ' VAL . 9.5 p -55.56 151.67 10.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.78 110.819 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.688 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 13.1 p -141.36 111.92 7.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.25 111.136 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.945 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.55 152.35 14.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.23 111.112 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.017 HD12 HD22 ' A' ' 147' ' ' LEU . 5.1 mt -129.68 100.1 5.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.22 110.907 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -75.67 144.79 41.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.25 110.76 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.9 m -122.67 178.96 4.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.38 110.856 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.6 -42.77 62.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.29 111.115 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.96 -46.78 81.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 2.04 110.954 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.803 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.1 mp -71.55 -56.81 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.28 111.157 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.2 mt -50.2 -43.01 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.18 110.874 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.78 -56.68 12.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.29 111.083 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.433 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -54.85 -43.43 73.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 2.91 110.849 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.792 HD12 HG21 ' A' ' 63' ' ' ILE . 40.3 mm -55.35 -67.72 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.28 111.14 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -51.49 -39.54 57.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.22 111.069 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.9 tpp85 -52.82 -50.15 64.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 2.78 110.856 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 56' ' ' LYS . 46.8 pt -86.13 -5.8 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.24 111.119 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -80.15 113.98 18.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.33 110.866 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -52.95 159.03 2.0 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.599 0.714 . . . . 2.24 110.899 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 54.7 Cg_endo -69.77 114.1 3.59 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.698 2.265 . . . . 0.17 112.401 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.29 2.9 55.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.81 -0.71 . . . . 0.18 112.521 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.53 -163.66 16.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.657 -0.783 . . . . 0.16 112.483 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.3 m -137.55 154.52 49.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.35 110.856 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.6 HD22 ' N ' ' A' ' 94' ' ' PHE . 1.2 tm? -137.49 116.31 12.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.15 110.943 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.6 ' N ' HD22 ' A' ' 93' ' ' LEU . 61.1 m-85 -109.74 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 1.62 110.868 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.573 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.73 163.15 38.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.15 110.926 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.03 129.71 34.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 1.82 110.913 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -152.26 149.5 23.2 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.673 0.749 . . . . 2.49 110.875 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.618 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.4 Cg_endo -69.74 143.22 50.27 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.246 . . . . 0.19 112.39 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.0 m -129.74 146.36 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.24 111.111 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.421 ' CD ' HG21 ' A' ' 103' ' ' VAL . 46.6 mt-10 -107.92 132.79 53.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 2.04 110.824 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.7 p -91.63 -42.72 10.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 1.14 111.154 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.666 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.56 40.28 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.73 111.093 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.421 HG21 ' CD ' ' A' ' 100' ' ' GLU . 21.4 t -147.96 151.85 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.71 111.146 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.65 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -53.55 173.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 1.89 110.874 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -66.95 -53.96 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 2.73 110.914 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -72.94 -76.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 2.65 110.871 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t 54.01 -167.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 2.31 110.933 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -6.16 57.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 2.31 110.884 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.1 m -141.48 146.42 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.54 111.16 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 123.26 19.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 2.46 110.902 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.65 HG21 ' O ' ' A' ' 104' ' ' ASP . 70.0 p -96.1 -179.54 4.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.22 111.166 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.78 -53.89 49.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.24 111.099 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.13 -48.41 81.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.42 110.889 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.28 -49.61 76.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 2.96 110.9 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.539 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -52.45 -55.52 21.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.81 110.96 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 74.8 m -51.2 -49.1 61.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.45 110.909 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -43.85 92.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.52 110.815 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.44 -48.79 80.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.488 . . . . 0.35 111.057 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.703 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.1 tp -57.78 -52.4 65.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.35 110.917 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.2 m -63.13 -29.46 70.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.57 111.154 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.0 mt -79.5 -17.17 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 1.09 110.932 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.3 p -82.64 3.57 28.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 2.36 110.953 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.48 -4.85 35.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.6 112.472 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -85.5 168.4 14.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.45 110.88 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.16 171.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.31 111.084 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 54.29 43.64 30.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.16 -0.473 . . . . 2.19 110.907 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.8 t -75.36 142.87 13.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.34 111.176 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.09 159.18 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 1.76 110.922 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -81.87 146.69 29.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 2.25 110.854 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.547 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.0 mp -106.44 -35.83 6.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 0.19 110.948 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -159.55 176.22 12.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 1.15 110.886 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.724 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.8 tmt_? -133.79 138.11 45.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 4.29 110.809 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -125.07 137.87 30.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.633 0.73 . . . . 1.43 110.868 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.41 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.6 Cg_endo -69.78 163.93 36.47 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.69 2.26 . . . . 0.27 112.346 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.693 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -98.7 125.53 44.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.34 110.999 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.491 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.1 161.58 22.48 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.603 0.716 . . . . 1.39 111.129 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.481 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.8 Cg_endo -69.78 -23.77 30.35 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.75 2.3 . . . . 0.37 112.344 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -85.08 -24.21 28.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 2.34 110.826 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -88.46 -51.03 5.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 2.62 110.948 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.32 -39.33 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.26 111.157 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -34.68 76.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 2.74 110.857 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -46.2 71.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.27 110.869 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.706 HG23 HD13 ' A' ' 147' ' ' LEU . 8.6 p -67.91 -30.47 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.19 111.169 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -75.51 -32.74 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 2.3 110.958 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -89.47 -20.0 24.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 1.74 110.882 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -94.17 -33.13 13.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.35 110.846 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.017 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.77 -54.15 1.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.33 110.863 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.2 6.71 2.69 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.717 -0.754 . . . . 0.35 112.451 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.543 ' CE1' HG21 ' A' ' 109' ' ' VAL . 6.8 t-160 -70.1 119.99 15.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.83 110.827 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -153.45 104.8 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 2.29 110.961 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -161.29 174.38 13.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.74 110.897 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.88 -8.17 17.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 1.88 110.848 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.666 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 m-80 -101.92 8.04 41.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 1.76 110.872 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.693 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -82.16 165.28 20.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.33 110.997 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.724 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -171.33 130.59 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.28 110.921 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.688 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.4 m-85 -75.24 131.38 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 1.72 110.916 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.13 144.84 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.22 111.173 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.547 ' HG2' HD13 ' A' ' 130' ' ' LEU . 4.3 tt0 -100.09 128.38 46.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 1.84 110.924 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.14 150.98 28.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.26 111.11 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.448 ' N ' HD11 ' A' ' 130' ' ' LEU . 1.9 t -129.29 158.74 38.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.39 111.127 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.51 130.74 3.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 0.19 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -94.27 140.86 29.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 1.6 110.97 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 6.3 tptm -82.25 134.41 48.92 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.568 0.699 . . . . 1.41 110.884 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 118.79 5.89 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 0.41 112.354 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -100.45 152.16 20.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.35 110.871 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 29.0 t80 60.83 19.4 9.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 6.03 110.926 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 62.79 164.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.499 . . . . 9.74 110.878 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.7 m -145.55 -178.36 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 5.82 111.166 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -156.72 33.21 0.57 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.69 -0.767 . . . . 5.92 112.463 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.43 -71.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 7.11 110.817 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.7 m -95.5 -67.15 0.87 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.084 -0.507 . . . . 7.63 110.809 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 5.99 110.902 -179.917 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.548 ' O ' HD12 ' A' ' 6' ' ' ILE . 6.9 ptm . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.765 0.317 . . . . 4.46 110.901 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.36 -19.67 56.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.45 111.094 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.03 -49.55 68.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 2.07 110.826 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -122.29 20.6 10.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 1.52 110.891 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.08 39.49 49.69 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.718 -0.753 . . . . 0.22 112.39 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 1' ' ' MET . 1.8 mp -74.92 157.68 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.25 111.136 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.619 ' O ' HG23 ' A' ' 36' ' ' THR . 37.9 m -146.21 157.53 43.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 1.07 110.836 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.2 129.22 35.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.29 111.159 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.09 -9.02 31.42 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.742 . . . . 0.54 112.495 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -103.41 168.0 9.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.869 0.366 . . . . 1.52 110.832 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.79 112.05 24.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 1.3 110.907 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.721 HG12 HG21 ' A' ' 36' ' ' THR . 2.6 p -119.36 133.67 65.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 1.99 111.08 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -107.89 133.44 52.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.34 111.08 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.764 HG11 HG12 ' A' ' 29' ' ' VAL . 99.9 t -104.43 120.51 54.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.17 111.087 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 47' ' ' ILE . 12.1 t -103.88 115.41 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.18 111.16 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -114.68 168.0 10.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.913 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.595 ' HB3' HD12 ' A' ' 47' ' ' ILE . 5.2 p-10 -150.95 -169.45 3.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 1.94 110.92 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -57.8 -35.56 70.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 3.35 110.9 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.69 -9.29 58.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 1.35 110.82 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.95 92.16 8.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.606 0.717 . . . . 0.17 110.902 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 143.98 52.59 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.703 2.269 . . . . 0.23 112.227 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.3 t -48.39 -32.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.19 111.161 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.23 -53.0 39.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 3.27 110.924 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.8 -45.02 10.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.19 111.067 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.475 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.5 -61.89 1.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.16 110.881 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -49.69 -37.86 30.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 4.88 110.894 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.39 -48.15 53.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.765 -0.731 . . . . 0.21 112.427 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.15 -41.04 96.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.49 110.991 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.764 HG12 HG11 ' A' ' 14' ' ' VAL . 18.1 m -75.84 -31.13 21.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.63 111.166 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -61.75 -61.38 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 1.6 110.92 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -40.78 68.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 1.77 110.854 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.833 HD23 HD21 ' A' ' 35' ' ' LEU . 83.7 mt -72.01 -25.31 61.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.465 . . . . 0.3 110.9 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.538 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.17 -24.62 47.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.39 110.922 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.62 -30.11 17.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.27 111.114 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.833 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.54 -35.05 14.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.24 110.872 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.721 HG21 HG12 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -102.87 -45.4 4.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.27 111.058 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.74 -12.13 52.13 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.791 -0.719 . . . . 0.3 112.447 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -67.96 -62.72 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.33 . . . . 2.55 110.879 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -95.09 -38.9 10.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 2.79 110.896 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.58 -130.6 5.68 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.717 -0.754 . . . . 0.25 112.473 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -152.59 151.28 30.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.841 0.353 . . . . 2.21 110.853 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' A' ' 33' ' ' GLN . 84.0 t -134.54 121.42 35.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.22 111.123 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 t -110.66 152.94 25.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.23 110.881 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -115.65 136.67 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.2 111.17 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -146.47 152.69 39.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.38 110.911 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -102.35 138.61 39.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.5 110.878 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.978 HD13 HG21 ' A' ' 73' ' ' THR . 14.0 mt -53.87 -43.26 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.179 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.58 -21.69 61.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 3.61 110.914 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -100.73 16.39 25.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 3.42 110.903 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.785 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.59 -29.79 4.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 1.14 110.905 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.89 -41.07 61.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 1.12 110.884 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -84.98 -15.96 42.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 1.08 110.908 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.459 ' HB2' HD13 ' A' ' 50' ' ' LEU . 51.0 m -66.67 -11.46 54.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.911 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.14 61.0 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.48 111.092 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -58.52 -71.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.57 110.839 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -150.79 -168.51 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 1.91 110.813 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.58 136.05 43.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 1.99 110.903 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.2 p 47.45 86.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 1.21 110.885 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 p -142.3 -39.02 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.47 110.91 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.471 ' O ' HD23 ' A' ' 87' ' ' LEU . 97.9 m-85 -99.66 120.08 39.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.051 -0.522 . . . . 1.47 110.85 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.44 -21.76 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 1.72 110.93 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mt -144.53 144.11 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.28 111.157 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 83' ' ' ILE . 18.9 mm -136.54 130.15 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.15 111.195 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.7 mm? -113.57 137.54 51.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.21 110.956 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.58 100.81 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.14 110.902 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.7 77.97 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.18 112.493 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.77 56.71 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.57 110.853 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.65 159.91 55.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.661 0.743 . . . . 0.21 111.09 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 116.82 4.74 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.672 2.248 . . . . 0.24 112.369 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.96 7.21 70.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.2 112.431 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -54.93 150.56 9.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.69 110.821 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.718 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 19.3 p -140.68 109.45 6.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.22 111.195 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.978 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.09 151.29 15.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.24 111.161 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.037 HD12 HD22 ' A' ' 147' ' ' LEU . 5.2 mt -127.01 99.82 5.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.33 110.905 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -76.9 130.21 37.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.52 110.876 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.489 ' H ' HD13 ' A' ' 79' ' ' ILE . 29.7 m -107.11 177.0 4.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.47 110.924 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.19 -40.07 57.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.142 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.63 -43.41 89.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 1.73 110.879 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.785 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.1 mp -76.04 -56.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.26 111.16 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 mt -49.59 -47.29 49.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.917 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.75 -52.76 37.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.53 111.068 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -43.9 80.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 2.84 110.893 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 63' ' ' ILE . 38.6 mm -55.86 -67.15 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.29 111.102 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.22 -36.65 42.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.29 111.09 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 tpp85 -56.33 -54.98 39.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 2.4 110.926 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 56' ' ' LYS . 24.2 pt -78.44 -8.42 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.33 111.093 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -77.54 124.7 28.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 0.28 110.942 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -64.25 160.67 47.63 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.578 0.704 . . . . 2.15 110.857 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 114.02 3.56 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.656 2.237 . . . . 0.23 112.408 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.43 3.38 56.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.688 -0.768 . . . . 0.2 112.426 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.01 -161.6 13.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.758 . . . . 0.18 112.479 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.7 m -139.59 154.16 47.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.83 0.347 . . . . 0.27 110.883 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 119' ' ' LEU . 1.3 tm? -138.87 113.5 9.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.16 110.945 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.536 ' N ' HD22 ' A' ' 93' ' ' LEU . 46.2 m-85 -108.45 133.44 52.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 1.64 110.85 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.526 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.98 164.15 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.18 110.901 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -135.25 126.99 29.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 1.87 110.998 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.616 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -148.97 148.4 27.12 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.675 0.75 . . . . 2.35 110.863 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.507 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.4 Cg_endo -69.85 139.89 40.99 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.605 2.203 . . . . 0.21 112.355 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 155' ' ' LEU . 5.4 m -120.96 147.4 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.26 111.143 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' OE1' HG21 ' A' ' 103' ' ' VAL . 38.2 mt-10 -116.1 132.63 56.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 1.97 110.904 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.4 p -106.45 26.04 10.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 1.08 111.077 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.17 25.93 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.96 111.046 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.6 t -143.75 159.92 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.97 111.084 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.485 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -56.02 179.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 2.09 110.772 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -64.61 -68.84 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 2.09 110.897 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -62.47 -75.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 2.01 110.87 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.37 -167.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 1.58 110.811 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -6.83 58.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 2.07 110.954 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.29 140.24 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.67 111.114 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.667 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -64.23 115.49 5.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 2.11 110.869 179.973 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.485 HG21 ' O ' ' A' ' 104' ' ' ASP . 28.4 p -83.3 177.77 8.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.27 111.126 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.52 -55.05 28.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.32 111.137 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.8 -51.73 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.3 110.805 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 -38.13 67.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 2.5 110.886 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.616 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.1 tm? -64.74 -54.61 28.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.6 110.874 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 36.4 m -60.07 -46.41 89.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.463 . . . . 0.3 110.922 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -43.98 96.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.33 110.801 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.73 -53.33 59.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.37 111.105 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 93' ' ' LEU . 16.5 tp -57.66 -53.16 61.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.53 110.876 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.8 m -61.57 -26.25 67.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.44 111.177 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.8 mt -87.01 -13.6 44.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 0.67 110.939 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.0 p -82.0 3.5 26.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 2.57 110.877 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.06 -4.35 33.77 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.802 -0.713 . . . . 0.85 112.564 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.662 HD23 ' HA3' ' A' ' 161' ' ' GLY . 1.6 tp -87.9 171.2 10.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.67 110.797 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.44 169.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.38 111.105 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 54.6 44.2 29.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 2.28 110.886 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 86.1 t -81.85 142.68 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 0.33 111.105 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 160.62 8.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 1.63 110.959 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -78.91 142.91 36.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 3.12 110.913 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.725 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.2 mp -100.2 -39.08 8.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.19 110.907 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -154.35 176.34 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 1.12 110.932 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.703 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.0 tmt_? -130.19 138.18 50.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 4.16 110.919 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -125.06 135.8 27.28 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.605 0.717 . . . . 1.89 110.946 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.42 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.7 Cg_endo -69.72 162.52 41.75 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.764 2.309 . . . . 0.3 112.405 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.668 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -97.93 118.54 34.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.53 110.92 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.49 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.0 OUTLIER -96.71 161.07 27.83 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.595 0.712 . . . . 1.47 111.077 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.49 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.9 Cg_endo -69.67 -25.53 28.91 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.6 2.2 . . . . 0.62 112.344 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -85.46 -20.75 29.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 4.23 110.821 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -88.25 -53.29 4.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 2.38 110.85 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 136' ' ' THR . 7.0 p -49.64 -39.46 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.37 111.111 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.01 75.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 1.29 110.874 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.67 -46.69 68.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.4 110.817 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.8 p -68.29 -30.24 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.157 -0.474 . . . . 0.29 111.21 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -76.13 -31.5 58.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.481 . . . . 1.81 110.886 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -89.73 -20.41 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.432 . . . . 2.02 110.905 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -94.54 -32.91 13.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.47 110.805 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.037 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.26 -54.28 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.44 110.896 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.1 17.21 1.66 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.696 -0.764 . . . . 0.36 112.496 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -72.37 122.36 21.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 1.01 110.869 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.38 107.95 3.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 2.87 110.95 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.9 t -160.55 172.23 17.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.84 110.872 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.01 -18.06 14.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 1.69 110.818 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -100.01 18.73 17.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 1.57 110.844 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -83.21 165.35 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.36 110.977 179.952 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.703 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.4 tm? -173.94 130.3 0.4 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.26 110.917 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.718 ' CZ ' HG22 ' A' ' 72' ' ' THR . 23.1 m-85 -75.87 138.63 41.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 1.84 110.924 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -151.88 148.41 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.25 111.079 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.725 ' HG2' HD13 ' A' ' 130' ' ' LEU . 9.9 tt0 -102.36 132.55 48.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 2.16 110.866 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.59 148.85 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.22 111.129 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.512 ' N ' HD11 ' A' ' 130' ' ' LEU . 9.6 t -134.49 157.3 46.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.38 111.109 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.662 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -146.53 141.77 9.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.759 -0.734 . . . . 0.37 112.483 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -98.54 131.97 44.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 3.66 110.91 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.53 135.58 78.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.541 0.686 . . . . 1.79 110.882 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 129.32 17.4 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.667 2.245 . . . . 0.41 112.394 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -110.67 149.92 29.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.39 110.906 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 19.6 t80 64.82 151.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 6.03 110.941 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.67 112.82 3.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 8.13 110.963 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 33.7 m -134.81 169.25 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 5.53 111.132 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -154.61 56.74 0.41 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 5.62 112.505 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.7 t -107.26 -53.67 2.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 7.32 110.943 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.62 -170.06 1.63 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 7.04 110.862 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 6.12 110.878 -179.935 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptm . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.802 0.334 . . . . 4.21 110.849 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.69 -21.74 63.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 0.46 111.189 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.15 -51.52 64.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 1.95 110.85 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.37 22.41 10.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 2.04 110.909 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.28 40.95 53.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 0.26 112.531 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.482 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -80.01 159.91 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.793 0.33 . . . . 0.3 111.118 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -154.44 165.37 36.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 1.17 110.873 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.58 123.71 33.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.32 111.09 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.44 2.87 21.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.646 -0.788 . . . . 0.33 112.467 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.401 HE22 HD12 ' A' ' 62' ' ' ILE . 2.8 pt20 -115.15 168.7 9.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.36 . . . . 1.05 110.898 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -106.93 112.87 26.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 1.37 110.857 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG13 HG21 ' A' ' 36' ' ' THR . 3.0 m -116.05 140.2 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 2.3 111.135 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.803 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -115.92 113.02 22.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.3 111.059 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.785 HG11 HG12 ' A' ' 29' ' ' VAL . 62.4 t -86.97 120.28 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.21 111.082 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.418 HG12 ' CG1' ' A' ' 47' ' ' ILE . 21.7 t -105.29 116.64 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.19 111.09 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -116.2 169.22 9.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.152 -0.476 . . . . 0.2 110.934 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.402 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 9.7 p-10 -151.4 -169.74 3.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 1.78 110.832 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.86 -35.59 71.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 3.13 110.876 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.6 m -73.5 -9.18 58.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 1.58 110.896 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.08 94.47 10.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.655 0.74 . . . . 0.16 110.847 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 142.03 46.69 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.664 2.242 . . . . 0.21 112.345 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.2 t -48.69 -32.94 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.2 111.141 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.34 -52.62 43.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 3.17 110.878 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -45.03 10.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.17 111.097 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.457 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.8 -61.61 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.18 110.846 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -35.42 24.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 2.61 110.784 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.25 -47.54 43.71 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.722 -0.752 . . . . 0.23 112.487 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.05 -39.19 91.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.55 110.968 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.785 HG12 HG11 ' A' ' 14' ' ' VAL . 16.8 m -77.07 -31.46 18.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.65 111.116 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.5 -58.83 6.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 1.66 110.874 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -40.4 74.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 3.01 110.883 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.853 HD23 HD21 ' A' ' 35' ' ' LEU . 89.5 mt -72.65 -25.19 61.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.228 -0.442 . . . . 0.32 110.929 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.468 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -77.89 -24.74 48.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.904 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.66 -31.09 16.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.28 111.083 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.853 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -90.08 -35.14 15.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.26 110.964 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.25 -47.2 4.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.486 . . . . 0.29 111.218 179.893 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.83 -14.68 52.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.749 . . . . 0.29 112.53 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.11 -62.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 1.98 110.869 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -103.86 -33.86 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 2.22 110.854 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.42 -133.34 4.9 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.672 -0.775 . . . . 0.29 112.526 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -150.8 151.53 32.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 2.19 110.869 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 12' ' ' VAL . 99.0 t -139.11 113.35 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.43 111.172 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 t -103.91 154.56 19.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.16 110.811 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.73 130.03 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.21 111.134 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -137.73 150.92 47.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 1.45 110.92 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -103.64 135.32 45.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.45 110.888 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.648 ' CD1' HG21 ' A' ' 73' ' ' THR . 32.0 mt -54.22 -34.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.31 111.185 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -73.27 -30.77 63.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 2.07 110.862 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -102.28 19.4 18.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 3.75 110.924 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.823 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.59 -27.37 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 1.08 110.929 -179.977 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -52.73 -38.65 61.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 1.06 110.907 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -84.48 -14.35 49.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 1.09 110.896 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.652 ' HB3' HD13 ' A' ' 50' ' ' LEU . 24.4 t -63.96 -11.51 29.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 2.05 110.838 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 53.97 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.39 111.153 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -52.1 -71.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.41 110.81 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.676 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -147.83 -168.6 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 1.94 110.878 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -103.73 129.75 51.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 1.68 110.957 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t 51.55 88.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 1.96 110.803 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.4 p -140.59 -39.54 0.42 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.057 -0.519 . . . . 0.26 110.818 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.472 ' O ' HD23 ' A' ' 87' ' ' LEU . 92.6 m-85 -99.9 123.61 44.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 1.47 110.868 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.23 -22.04 62.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 1.52 110.958 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.401 HD12 HE22 ' A' ' 10' ' ' GLN . 14.4 mt -146.14 143.25 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.45 111.164 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.976 HG21 HG23 ' A' ' 83' ' ' ILE . 16.7 mm -130.21 133.68 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.15 111.093 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.7 mm? -112.48 135.64 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.3 110.938 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.32 98.97 5.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.18 110.921 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.7 80.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.695 -0.764 . . . . 0.22 112.591 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.4 mm? -111.94 55.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.58 110.985 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.11 159.52 56.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.696 0.76 . . . . 0.22 111.173 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 116.56 4.6 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.644 2.23 . . . . 0.24 112.437 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.32 7.29 69.88 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.722 -0.751 . . . . 0.16 112.461 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.8 148.41 16.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.384 . . . . 0.67 110.797 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.761 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 32.9 p -136.84 108.66 7.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.494 . . . . 0.19 111.089 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.648 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.95 152.54 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.24 111.174 179.983 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.868 HD12 HD22 ' A' ' 147' ' ' LEU . 3.4 mt -132.05 103.68 6.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.28 110.915 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -80.03 146.85 31.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.27 110.817 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.3 m -124.56 -176.2 3.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.38 110.867 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.71 70.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.22 111.129 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.72 -45.14 94.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 1.83 110.974 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.823 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -74.28 -55.37 12.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.19 111.091 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 119' ' ' LEU . 61.4 mt -49.68 -43.77 47.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.2 110.911 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.41 -50.82 58.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.29 111.136 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -44.53 90.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 3.08 110.86 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 63' ' ' ILE . 41.9 mm -58.08 -68.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.21 111.127 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.37 -37.3 24.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.2 111.135 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -56.9 -52.84 63.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 2.26 110.813 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 56' ' ' LYS . 23.9 pt -81.69 -4.91 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.2 111.135 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -81.34 115.76 20.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.27 110.904 179.91 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -53.42 158.77 2.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.63 0.729 . . . . 3.03 110.846 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.8 Cg_endo -69.72 113.59 3.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.624 2.216 . . . . 0.23 112.426 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.71 3.0 55.27 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.731 -0.747 . . . . 0.26 112.42 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.24 -162.1 15.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.22 112.485 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 98.9 m -138.4 157.17 46.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.38 110.831 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.669 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.2 tm? -139.86 115.94 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.15 110.88 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.599 ' N ' HD22 ' A' ' 93' ' ' LEU . 67.5 m-85 -109.18 131.86 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 1.88 110.847 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.572 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.28 164.34 34.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.18 110.91 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.76 129.3 32.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 1.87 110.907 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.663 ' OE1' HD23 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -152.52 149.61 23.02 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.674 0.749 . . . . 2.53 110.864 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.629 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.2 Cg_endo -69.81 144.19 52.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.667 2.245 . . . . 0.21 112.308 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.82 146.61 33.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.25 111.167 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' CD ' HG21 ' A' ' 103' ' ' VAL . 42.8 mt-10 -106.79 132.91 52.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 2.09 110.94 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p -93.27 -42.5 9.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 1.1 111.161 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.677 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.36 39.89 1.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.8 111.162 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' CD ' ' A' ' 100' ' ' GLU . 20.1 t -147.29 150.97 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.76 111.147 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.616 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -54.05 164.32 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 2.27 110.866 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -59.99 -48.32 82.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 2.49 110.941 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.12 -75.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 1.99 110.846 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p 53.02 -171.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 1.82 110.862 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -4.42 53.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 2.29 110.961 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.505 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.5 m -140.81 151.26 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.286 -0.415 . . . . 0.52 111.228 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -68.26 111.66 4.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 2.41 110.9 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.616 HG21 ' O ' ' A' ' 104' ' ' ASP . 46.9 p -83.14 179.65 7.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.28 111.198 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.65 -53.59 55.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.19 111.102 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.88 -47.95 84.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.24 110.843 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -39.11 80.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 2.72 110.91 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -64.7 -55.25 21.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.449 . . . . 0.39 110.904 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 60.6 m -55.93 -44.83 78.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 0.21 110.842 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.4 -40.78 96.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.27 110.852 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.82 92.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.22 111.125 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.599 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.1 tp -64.82 -50.77 65.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.26 110.978 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.3 m -63.63 -35.22 79.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.29 111.145 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -83.48 -10.28 58.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.54 110.884 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 m -84.87 5.78 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 1.73 110.881 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.22 3.98 35.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 0.5 112.507 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -104.81 172.42 6.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.932 0.396 . . . . 0.3 110.865 -179.869 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 m -151.58 174.08 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.33 111.23 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 51.22 45.09 28.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 2.02 110.938 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.42 HG13 HD23 ' A' ' 119' ' ' LEU . 89.4 t -79.7 143.81 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.22 111.107 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.49 8.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 2.47 110.92 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -81.15 145.77 30.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 2.27 110.969 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.62 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.8 mp -105.23 -35.65 7.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.18 110.949 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -159.57 176.33 12.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.172 -0.467 . . . . 1.13 111.02 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.731 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.0 tmt_? -132.4 138.16 47.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 4.29 110.785 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -125.18 137.97 30.76 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.625 0.726 . . . . 1.86 110.967 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.422 ' HA ' HD21 ' A' ' 155' ' ' LEU . 55.2 Cg_endo -69.6 164.05 35.86 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.76 2.307 . . . . 0.26 112.403 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.678 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -97.61 128.58 44.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.31 110.913 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.48 160.95 25.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.608 0.718 . . . . 1.21 111.108 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.86 -28.81 24.31 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.649 2.233 . . . . 0.33 112.333 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -85.35 -17.78 35.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 3.74 110.844 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 -52.9 5.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 2.27 110.936 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.8 p -49.19 -40.66 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.29 111.134 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -34.78 76.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 1.18 110.884 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.98 -46.31 71.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.27 110.882 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.708 HG23 HD13 ' A' ' 147' ' ' LEU . 8.9 p -68.12 -30.08 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.24 111.167 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -75.27 -33.33 61.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 1.82 110.855 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -89.12 -19.91 24.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 1.7 110.818 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -94.16 -32.77 13.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.83 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.868 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -128.4 -54.26 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.45 110.871 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.31 4.95 2.76 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.705 -0.76 . . . . 0.41 112.484 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.505 ' CE1' HG21 ' A' ' 109' ' ' VAL . 8.1 t-160 -70.08 120.17 15.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.87 110.805 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -153.26 104.76 2.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 2.21 110.967 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.34 173.42 15.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.77 110.911 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.98 -10.06 16.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 1.95 110.895 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.677 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 1.6 m120 -99.9 9.08 43.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 3.13 110.904 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.678 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -83.2 167.14 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.44 110.938 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -172.33 130.13 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.24 110.898 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.761 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.9 m-85 -73.76 132.23 42.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 1.72 110.853 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.07 142.26 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.21 111.171 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.62 ' HG2' HD13 ' A' ' 130' ' ' LEU . 7.5 tt0 -96.46 129.44 43.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 1.69 110.874 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.97 151.63 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.22 111.198 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.448 ' N ' HD11 ' A' ' 130' ' ' LEU . 3.0 t -131.91 160.85 34.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.28 111.156 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.409 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -152.39 134.51 4.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.757 -0.735 . . . . 0.17 112.509 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -95.19 141.1 29.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 1.67 110.914 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 4.7 tptm -81.95 134.09 50.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.559 0.695 . . . . 1.38 110.871 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 119.26 6.23 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.645 2.23 . . . . 0.44 112.376 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -99.39 151.62 20.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.38 110.929 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 42.5 t80 65.1 151.95 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 5.81 110.823 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.8 111.56 2.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 8.4 110.947 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.18 171.33 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 5.89 111.08 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -141.73 47.9 0.82 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.741 -0.742 . . . . 5.61 112.469 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.4 t -139.1 161.87 36.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 6.83 110.85 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.47 -75.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 7.58 110.743 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 7.01 110.887 -179.864 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.817 0.341 . . . . 4.17 110.952 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.93 -21.37 63.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.47 111.063 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -54.33 -51.21 65.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 2.83 110.874 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.31 22.0 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 1.52 110.876 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.15 40.63 52.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.788 -0.72 . . . . 0.28 112.469 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.49 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -79.05 159.8 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.821 0.343 . . . . 0.25 111.121 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 36' ' ' THR . 1.3 m -154.32 166.52 32.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 1.13 110.842 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.6 125.41 35.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 0.3 111.159 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.91 2.9 23.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.814 -0.707 . . . . 0.32 112.514 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.422 HE22 HD12 ' A' ' 62' ' ' ILE . 2.3 pt20 -115.54 166.99 11.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 1.04 110.882 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -105.61 114.96 29.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 1.35 110.796 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 42' ' ' VAL . 3.3 m -118.06 139.13 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 2.29 111.08 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.788 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -114.64 114.44 25.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.34 111.146 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.828 HG11 HG12 ' A' ' 29' ' ' VAL . 97.2 t -87.66 121.84 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.2 111.182 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.548 HG12 HG13 ' A' ' 47' ' ' ILE . 18.1 t -107.36 116.72 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.17 111.139 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -115.76 167.18 11.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.881 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.63 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.2 p-10 -146.29 -169.52 3.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 1.74 110.89 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -59.42 -35.21 73.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 2.96 110.972 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.76 -6.83 51.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.492 . . . . 1.23 110.891 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.6 m -107.17 93.87 10.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.706 0.765 . . . . 0.16 110.881 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 54.8 Cg_endo -69.63 142.47 48.58 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.727 2.284 . . . . 0.21 112.456 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -49.2 -32.42 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.19 111.125 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.49 -52.82 43.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 3.21 110.946 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.53 -44.88 10.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.18 111.178 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.419 HD22 HG13 ' A' ' 29' ' ' VAL . 1.9 tm? -51.66 -61.72 2.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.14 110.935 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -34.61 22.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 2.31 110.9 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.11 -48.24 40.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.2 112.437 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.6 mt -61.33 -39.98 92.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.368 . . . . 0.47 110.92 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.828 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -76.23 -31.69 21.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.63 111.186 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.89 -60.03 4.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 1.66 110.851 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -40.22 72.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 1.71 110.926 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.904 HD23 HD21 ' A' ' 35' ' ' LEU . 81.2 mt -72.52 -24.65 61.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.25 110.927 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.41 -24.95 45.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.38 110.914 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.78 -30.07 17.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.23 111.104 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.904 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.42 -35.05 14.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.22 110.877 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.11 -45.47 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.25 111.137 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.26 -12.61 56.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.822 -0.704 . . . . 0.27 112.449 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -65.78 -62.72 1.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 2.6 110.858 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -96.52 -37.43 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 2.23 110.88 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.55 -129.43 4.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.784 -0.722 . . . . 0.24 112.489 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -153.4 153.04 31.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 3.79 110.835 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 12' ' ' VAL . 95.0 t -138.98 119.81 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.26 111.188 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -109.76 154.69 22.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.16 110.899 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -115.83 134.53 58.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.14 111.097 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -144.3 152.38 40.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 1.27 110.986 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -102.56 137.64 40.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.47 110.852 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.925 HD13 HG21 ' A' ' 73' ' ' THR . 11.2 mt -50.91 -46.77 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 0.4 111.208 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -24.73 63.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 3.71 110.905 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -98.22 18.52 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 3.42 110.812 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.809 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.75 -29.13 4.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 1.07 110.943 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.594 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -52.52 -36.31 55.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 2.55 110.975 179.844 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -85.86 -19.47 30.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 1.25 110.905 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.413 ' HB2' HD13 ' A' ' 50' ' ' LEU . 63.6 m -60.69 -16.69 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 0.88 110.877 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.94 63.49 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.4 111.174 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.403 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 12.5 m-70 -64.9 -70.24 0.24 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 0.39 110.846 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.706 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.13 -168.08 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 1.15 110.924 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -105.88 126.68 52.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 2.22 110.905 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.14 79.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 1.34 110.846 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.7 p -130.11 -35.33 1.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.33 110.856 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.446 ' O ' HD23 ' A' ' 87' ' ' LEU . 93.5 m-85 -98.52 122.02 41.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.094 -0.503 . . . . 2.05 110.873 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.61 -21.69 61.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 1.52 110.949 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.422 HD12 HE22 ' A' ' 10' ' ' GLN . 13.7 mt -145.67 143.46 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.42 111.155 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.832 HG21 HG23 ' A' ' 83' ' ' ILE . 18.8 mm -130.52 132.85 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.444 . . . . 0.16 111.155 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -111.7 135.2 52.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.836 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.52 98.52 4.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.766 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.64 78.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.22 112.475 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.71 54.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.358 . . . . 0.58 110.939 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.4 159.77 53.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.569 0.699 . . . . 0.21 111.128 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 116.34 4.52 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.702 2.268 . . . . 0.22 112.373 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.61 7.02 69.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.739 -0.743 . . . . 0.22 112.495 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.26 136.59 48.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.68 110.906 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.729 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.2 p -126.03 108.41 11.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.19 111.122 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.925 HG21 HD13 ' A' ' 47' ' ' ILE . 1.1 m -163.3 155.8 18.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.33 111.202 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.979 HD12 HD22 ' A' ' 147' ' ' LEU . 3.9 mt -133.55 105.8 7.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.251 -0.431 . . . . 0.22 110.983 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -79.44 150.98 31.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.24 110.903 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m -130.64 -177.46 4.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.49 110.884 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.98 68.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.38 111.078 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -47.12 86.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 2.14 110.929 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.809 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -71.9 -56.48 10.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.3 111.185 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.6 mt -50.78 -39.54 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.22 110.949 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.14 -56.88 12.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.41 111.099 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.422 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -55.97 -43.53 77.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 2.93 110.968 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.832 HG23 HG21 ' A' ' 63' ' ' ILE . 43.4 mm -55.15 -68.33 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.24 111.047 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.17 -39.75 57.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.28 111.194 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -52.84 -49.54 65.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 2.48 110.946 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 56' ' ' LYS . 40.0 pt -86.66 -5.62 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.26 111.23 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -80.13 113.36 18.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.27 110.851 179.966 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -52.8 158.49 2.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 2.45 110.863 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.404 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.3 Cg_endo -69.75 114.22 3.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.669 2.246 . . . . 0.24 112.299 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.99 3.09 54.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.829 -0.701 . . . . 0.26 112.522 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.77 -159.7 12.46 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 0.22 112.453 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.3 m -141.98 157.28 45.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.55 110.918 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.688 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.2 tm? -139.37 114.61 9.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.21 110.927 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.587 ' N ' HD22 ' A' ' 93' ' ' LEU . 73.5 m-85 -106.33 132.55 52.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.84 110.848 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.616 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.81 163.84 36.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.17 110.895 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.46 130.8 35.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 1.85 110.837 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.8 147.28 18.3 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.64 0.733 . . . . 2.16 110.915 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.464 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.4 Cg_endo -69.75 141.38 45.13 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.776 2.317 . . . . 0.22 112.329 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.39 146.95 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 0.2 111.11 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.438 ' CD ' HG21 ' A' ' 103' ' ' VAL . 52.2 mt-10 -108.97 133.04 53.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 1.97 110.844 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.0 p -92.0 -41.91 10.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 1.11 111.179 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.74 40.34 1.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.68 111.094 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.438 HG21 ' CD ' ' A' ' 100' ' ' GLU . 25.8 t -147.93 149.82 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.69 111.02 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -54.11 175.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 2.11 110.945 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.7 -63.51 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 2.32 110.89 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.41 -75.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 1.64 110.894 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.77 -168.23 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 1.67 110.826 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.467 ' HG3' HG13 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -79.9 -7.9 59.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 1.75 110.928 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.467 HG13 ' HG3' ' A' ' 108' ' ' LYS . 2.4 m -141.14 145.73 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.4 111.15 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -64.93 115.35 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 2.21 110.947 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 104' ' ' ASP . 80.8 p -86.82 178.88 6.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.29 111.145 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.76 -51.75 66.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.17 111.153 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.66 -49.41 77.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.23 110.838 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -37.56 76.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 1.88 110.931 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -64.61 -55.39 20.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.31 110.844 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.9 m -57.64 -46.2 84.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.21 110.894 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -42.85 95.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.26 110.828 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.46 -44.31 96.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.496 . . . . 0.21 111.175 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 93' ' ' LEU . 14.9 tp -64.45 -52.11 59.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.24 110.893 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.7 m -61.55 -31.62 71.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.24 111.085 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.91 -10.32 53.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 0.53 110.897 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.01 5.6 28.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 1.71 110.866 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.74 5.92 33.22 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.755 . . . . 0.48 112.436 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -105.87 170.38 7.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.28 110.985 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -150.19 170.59 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.432 . . . . 0.31 111.162 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 53.77 44.15 30.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 2.47 110.858 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.14 144.43 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.21 111.216 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 156.99 6.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 1.64 110.915 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.45 141.34 38.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 3.04 110.907 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.766 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.4 mp -99.74 -36.4 9.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.25 110.869 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -163.15 176.9 9.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 1.33 110.886 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -125.53 166.05 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 7.25 110.927 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -149.21 136.17 10.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.695 0.76 . . . . 1.38 110.895 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 154.78 67.43 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.726 2.284 . . . . 0.32 112.372 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.648 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -91.14 125.96 36.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.43 . . . . 0.31 110.932 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.417 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.36 161.37 24.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.598 0.713 . . . . 1.21 111.107 -179.991 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.417 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.2 Cg_endo -69.78 -28.49 25.09 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.661 2.241 . . . . 0.38 112.388 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.36 -17.97 35.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 2.81 110.839 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 -53.01 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 2.59 110.899 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 p -49.66 -40.61 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.24 111.095 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -34.67 76.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 1.15 110.905 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -46.12 71.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.22 110.86 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 9.0 p -68.45 -30.34 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.17 111.059 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -75.56 -32.52 60.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 2.57 110.935 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -89.56 -20.01 24.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 1.79 110.903 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -94.3 -32.74 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.3 110.884 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.979 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -128.03 -54.29 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.34 110.878 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.36 9.1 2.43 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.818 -0.706 . . . . 0.31 112.478 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.402 ' CG ' HG11 ' A' ' 109' ' ' VAL . 11.0 t-160 -70.31 121.68 18.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.64 110.901 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -151.8 105.42 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 2.62 110.864 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.6 t -160.44 169.55 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.72 110.888 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.65 -14.87 15.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 1.62 110.858 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -99.33 19.94 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 1.6 110.896 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.648 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -92.2 167.96 11.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.31 110.969 179.887 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -172.49 129.81 0.56 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.26 110.926 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.729 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.2 m-85 -70.16 135.98 49.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 1.86 110.861 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.32 148.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.25 111.183 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.766 ' HG2' HD13 ' A' ' 130' ' ' LEU . 37.7 tt0 -105.03 132.03 51.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 2.3 110.839 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.23 153.04 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.21 111.139 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.415 ' N ' HD11 ' A' ' 130' ' ' LEU . 7.8 t -139.25 152.46 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.34 111.123 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.84 140.74 10.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.19 112.49 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -97.28 139.54 33.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.732 0.301 . . . . 1.64 110.962 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 1.4 tptt -78.99 134.37 60.07 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.508 0.67 . . . . 2.37 110.899 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 118.61 5.78 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.694 2.263 . . . . 0.44 112.304 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -100.4 152.23 20.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.33 110.923 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.0 t80 61.06 19.31 9.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.421 . . . . 5.9 110.959 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 63.53 160.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.506 . . . . 10.07 110.86 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.32 178.29 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 5.82 111.167 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.49 28.82 1.33 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 5.86 112.479 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.3 p -147.09 59.16 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 6.37 110.876 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.1 -176.14 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 7.62 110.85 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 6.73 110.843 -179.936 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.721 0.296 . . . . 3.56 110.878 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.45 -22.62 66.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.53 111.163 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -54.13 -51.57 63.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 2.41 110.839 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -122.3 24.35 9.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 2.09 110.908 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.94 38.33 46.38 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.861 -0.685 . . . . 0.44 112.471 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 7' ' ' SER . 1.7 mp -76.82 158.73 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.869 0.366 . . . . 0.45 111.129 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 36' ' ' THR . 33.7 m -147.14 158.55 43.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.506 . . . . 1.16 110.839 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.18 130.6 35.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.62 111.153 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.86 -6.12 32.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.751 -0.737 . . . . 0.49 112.479 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.56 168.91 8.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.778 0.323 . . . . 1.54 110.904 -179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.66 110.98 23.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 1.42 110.886 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.775 HG12 HG21 ' A' ' 36' ' ' THR . 2.5 p -118.99 130.52 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.129 -0.487 . . . . 2.06 111.043 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.758 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -105.97 132.72 51.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.51 . . . . 0.32 111.081 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.732 HG11 HG12 ' A' ' 29' ' ' VAL . 96.3 t -101.6 120.13 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.19 111.088 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.711 HG12 HG13 ' A' ' 47' ' ' ILE . 15.8 t -103.24 116.66 47.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.22 111.154 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -117.04 166.36 12.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.36 110.863 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.585 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.1 p-10 -144.24 -169.79 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 1.91 110.885 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.58 -35.52 74.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 3.37 110.939 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 t -73.41 -7.84 53.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 1.23 110.926 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.2 93.21 9.03 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.682 0.753 . . . . 0.31 110.886 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 143.12 50.11 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.671 2.247 . . . . 0.46 112.372 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.09 -32.47 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.35 111.096 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.19 -53.36 35.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 2.55 110.89 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.81 -44.92 10.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.4 111.046 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.12 -61.01 2.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.24 -0.436 . . . . 0.31 110.897 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -33.59 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 3.26 110.881 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.77 -49.05 38.33 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.748 -0.739 . . . . 0.37 112.473 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.701 HD12 HG13 ' A' ' 68' ' ' VAL . 21.8 mt -60.68 -40.61 92.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.867 0.365 . . . . 0.77 110.939 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.732 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -75.7 -31.36 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.64 111.132 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -61.91 -61.75 2.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 1.73 110.863 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -40.48 66.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 1.56 110.87 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.706 HD23 HD21 ' A' ' 35' ' ' LEU . 58.7 mt -72.23 -25.86 61.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.37 110.899 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.445 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.33 -23.85 46.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.41 110.898 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.97 -29.64 17.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.208 -0.451 . . . . 0.46 111.124 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.706 HD21 HD23 ' A' ' 32' ' ' LEU . 1.9 pp -91.38 -36.09 14.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.35 110.84 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.775 HG21 HG12 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -98.06 -45.92 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.42 111.176 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.74 -15.8 42.9 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.58 112.532 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.36 -62.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 2.27 110.945 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -107.02 -33.8 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 2.33 110.99 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.08 -134.54 5.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.689 -0.767 . . . . 0.34 112.481 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -154.15 152.3 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 3.63 110.937 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.9 t -136.32 123.71 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.25 111.12 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.4 t -113.22 153.85 27.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 0.16 110.834 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.97 132.41 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.16 111.22 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -142.25 152.46 43.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 1.31 110.925 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -102.7 137.49 40.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.53 110.887 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.04 HD13 HG21 ' A' ' 73' ' ' THR . 12.5 mt -52.46 -43.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.51 111.214 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -24.16 61.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 3.69 110.867 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -98.02 16.54 20.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 3.37 110.963 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.852 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -49.42 -28.15 4.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.465 . . . . 1.12 110.899 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -49.89 -44.11 49.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.18 110.995 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -85.82 -14.77 44.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 1.34 110.865 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.482 ' HB3' HD13 ' A' ' 50' ' ' LEU . 23.8 t -60.44 -15.39 26.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 2.04 110.844 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.628 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -75.17 52.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.46 111.126 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -50.85 -71.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.5 110.893 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.644 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.38 -168.32 2.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 1.89 110.813 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -108.46 130.17 55.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.123 -0.489 . . . . 1.73 110.967 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.8 72.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 1.17 110.895 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.5 p -126.76 -33.72 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 0.29 110.784 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 96.7 m-85 -99.3 118.4 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 1.45 110.868 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.37 -20.2 62.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.497 . . . . 1.52 110.879 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 mt -145.88 144.41 20.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.22 111.126 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.784 HG21 HG23 ' A' ' 83' ' ' ILE . 21.3 mm -137.29 130.22 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.2 111.134 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -111.47 137.63 49.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.2 110.894 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -129.52 97.56 4.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.3 110.889 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.65 73.68 0.35 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.745 -0.74 . . . . 0.4 112.465 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.694 HD13 ' OE1' ' A' ' 158' ' ' GLN . 3.9 mm? -95.54 -19.35 19.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 2.12 110.884 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.701 HG13 HD12 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -48.34 152.59 1.52 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 0.74 111.125 179.792 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.9 123.52 10.13 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.638 2.225 . . . . 0.66 112.33 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.72 0.21 75.78 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.58 112.454 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.565 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -54.61 146.66 16.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.984 0.421 . . . . 1.32 110.866 -179.749 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.711 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 18.3 p -137.02 109.07 7.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.39 111.114 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' THR . . . . . 1.04 HG21 HD13 ' A' ' 47' ' ' ILE . 2.3 m -162.28 140.06 8.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 0.66 111.164 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.092 HD12 HD22 ' A' ' 147' ' ' LEU . 15.8 mt -113.65 105.96 13.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.59 110.912 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -79.63 151.06 30.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.34 110.806 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.8 m -130.94 -177.15 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.41 110.831 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.01 69.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.44 111.096 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -47.78 84.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 2.46 110.933 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.852 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -70.82 -56.59 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.23 111.15 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.0 mt -50.95 -39.18 54.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.29 110.907 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.95 -56.87 13.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.4 111.089 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.628 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -57.02 -41.87 79.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 2.48 110.897 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.784 HG23 HG21 ' A' ' 63' ' ' ILE . 37.2 mm -56.6 -68.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.22 111.134 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.45 -38.23 42.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.26 111.117 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.59 -56.07 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 2.31 110.893 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 56' ' ' LYS . 34.2 pt -77.42 -8.22 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.25 111.062 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -79.24 127.27 31.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.45 110.971 179.886 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -66.54 159.99 69.99 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 2.34 110.916 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 114.15 3.62 Favored 'Trans proline' 0 C--N 1.34 0.082 0 C-N-CA 122.632 2.221 . . . . 0.16 112.356 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.05 1.98 55.98 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.17 112.51 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.78 -164.03 11.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.636 -0.792 . . . . 0.14 112.519 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 60.0 m -135.47 152.3 51.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.31 110.863 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.714 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.0 112.24 9.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.19 110.903 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.515 ' N ' HD22 ' A' ' 93' ' ' LEU . 48.0 m-85 -106.44 133.62 50.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 1.65 110.828 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -148.58 158.78 44.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.23 110.955 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.79 125.62 34.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 2.35 110.97 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.569 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -148.43 146.05 21.79 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 2.24 110.864 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.61 140.04 42.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.718 2.279 . . . . 0.22 112.392 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.417 HG13 HG23 ' A' ' 157' ' ' VAL . 9.1 m -126.71 146.76 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.28 111.103 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' OE2' HG21 ' A' ' 103' ' ' VAL . 0.9 OUTLIER -113.79 132.38 55.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 3.62 110.875 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.0 p -104.29 26.15 9.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 1.2 111.134 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -146.68 23.11 1.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.53 111.119 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.462 HG11 ' OG ' ' A' ' 107' ' ' SER . 3.8 t -145.02 159.45 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.74 111.127 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.571 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -52.04 169.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 1.91 110.809 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -64.25 -49.73 70.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 2.21 110.987 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -72.62 -75.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 2.41 110.93 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.462 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.5 t 52.0 -169.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 2.32 110.8 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.41 -3.23 48.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 1.65 110.948 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.2 141.14 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.47 111.116 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 114.17 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 2.22 110.846 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.571 HG21 ' O ' ' A' ' 104' ' ' ASP . 44.0 p -83.55 177.61 8.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.2 111.125 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.95 -53.93 49.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.17 111.041 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -49.68 76.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.441 . . . . 0.22 110.903 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -56.29 -40.22 73.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 1.69 110.806 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -63.75 -55.04 26.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.31 110.954 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -57.58 -46.27 84.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.26 110.865 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.425 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -64.42 -42.96 95.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.3 110.883 -179.764 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.74 92.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.26 111.137 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.617 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.7 tp -62.7 -52.83 61.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.26 110.901 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.8 m -61.8 -35.52 78.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.27 111.147 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 117' ' ' SER . 17.3 mt -81.59 -10.4 59.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.56 110.919 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.83 5.19 29.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 1.75 110.842 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.21 -2.47 35.07 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.772 -0.728 . . . . 0.51 112.465 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -96.13 169.87 9.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.815 0.341 . . . . 0.28 110.98 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.429 HG23 ' HG3' ' A' ' 126' ' ' GLU . 29.0 m -151.05 171.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.32 111.128 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 125' ' ' VAL . 2.9 mt-10 56.93 43.61 24.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 2.03 110.905 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.4 t -75.19 142.83 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.39 111.128 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.63 156.38 6.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 1.73 110.938 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -82.17 145.36 30.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 2.13 110.874 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.431 HD11 ' N ' ' A' ' 160' ' ' THR . 1.5 mp -105.76 -35.22 7.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.28 110.95 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -166.17 176.64 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 1.31 110.906 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -125.41 166.12 17.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 8.3 110.875 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -146.91 134.22 10.22 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.684 0.754 . . . . 1.52 110.876 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 157.56 60.07 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.629 2.219 . . . . 0.44 112.369 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.679 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -94.46 129.59 41.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.38 110.95 179.928 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.592 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -112.68 162.74 20.21 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.52 0.676 . . . . 1.39 111.151 179.996 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 -22.66 32.24 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.642 2.228 . . . . 0.63 112.397 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -85.03 -25.76 27.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 2.64 110.964 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -88.58 -52.73 5.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.111 -0.495 . . . . 2.63 110.794 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -49.77 -39.05 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.48 111.101 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -33.86 75.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 1.2 110.941 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -46.6 67.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.951 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.683 HG23 HD13 ' A' ' 147' ' ' LEU . 8.8 p -68.11 -30.86 49.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.21 111.11 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -76.87 -29.99 56.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 2.06 110.92 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -89.64 -21.6 22.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 1.97 110.884 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -95.03 -32.17 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.39 110.804 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.092 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -127.04 -54.49 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.52 110.857 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.58 14.17 2.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.52 112.543 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -70.76 121.29 17.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.793 0.33 . . . . 0.85 110.812 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -152.17 105.36 3.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 2.54 110.863 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.74 172.16 17.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.63 110.816 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.71 -17.27 14.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 1.88 110.917 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -96.89 20.32 11.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 1.61 110.859 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.679 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -93.53 162.67 13.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.37 110.923 179.957 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.632 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -171.2 130.65 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.36 110.933 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.711 ' CZ ' HG22 ' A' ' 72' ' ' THR . 25.3 m-85 -70.33 135.28 48.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 1.7 110.885 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.417 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.19 142.47 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.36 111.155 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.694 ' OE1' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -101.09 127.37 47.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 2.09 110.894 -179.981 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.33 151.48 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.426 . . . . 0.27 111.188 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.431 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -130.43 154.59 47.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.222 -0.445 . . . . 0.3 111.107 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.431 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -142.89 131.39 4.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.755 -0.736 . . . . 0.19 112.467 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -91.63 131.63 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 3.59 110.918 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.81 135.44 77.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 1.65 110.963 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 131.47 21.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.731 2.288 . . . . 0.47 112.365 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -111.85 150.2 30.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.44 110.824 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.01 72.35 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.463 . . . . 7.32 110.888 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.39 32.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 10.07 110.903 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.3 m -151.3 -178.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 6.6 111.13 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -132.07 25.12 3.94 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.666 -0.778 . . . . 7.15 112.5 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.17 -74.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.891 0.377 . . . . 8.48 110.848 -179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.98 -73.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 6.18 110.942 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 8.18 110.821 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.715 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.821 0.343 . . . . 5.82 110.849 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.94 60.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 1.11 111.129 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.93 -40.91 70.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 1.96 110.901 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 6' ' ' ILE . 9.8 m-85 -122.34 16.95 10.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 1.54 110.767 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.74 39.14 96.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.36 112.439 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.814 HD13 HD21 ' A' ' 32' ' ' LEU . 1.6 mp -80.89 156.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.884 0.373 . . . . 0.37 111.128 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.73 161.38 38.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 1.66 110.879 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.54 134.9 33.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.38 111.088 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.64 -1.66 30.61 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.719 -0.753 . . . . 0.26 112.501 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -117.14 173.26 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 1.13 110.868 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.4 116.3 31.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.34 110.919 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG22 ' HB ' ' A' ' 62' ' ' ILE . 97.3 t -119.58 129.38 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 1.94 111.124 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.778 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -107.33 126.41 52.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.24 111.122 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.74 HG11 HG12 ' A' ' 29' ' ' VAL . 98.1 t -98.9 119.41 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.2 111.094 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -102.31 117.58 47.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.18 111.108 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -118.02 169.91 9.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.438 . . . . 0.23 110.9 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.408 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 9.6 p-10 -151.65 -169.87 3.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 1.74 110.837 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -58.21 -35.55 71.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 3.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.9 -8.15 55.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 1.24 110.873 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.71 95.25 11.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.651 0.739 . . . . 0.19 110.873 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 141.57 45.27 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.628 2.219 . . . . 0.33 112.326 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.02 -32.84 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.31 111.154 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -50.98 -52.8 38.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 2.4 110.903 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.6 11.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.29 111.085 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.447 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -52.6 -61.69 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.21 110.99 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -36.57 27.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 2.25 110.962 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.75 49.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.21 112.534 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.6 mt -61.55 -39.97 93.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.64 110.918 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 HG11 ' A' ' 14' ' ' VAL . 17.1 m -76.9 -30.71 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.64 111.18 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.82 -59.84 4.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 1.63 110.909 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -40.08 70.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 1.91 110.881 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.919 HD23 HD21 ' A' ' 35' ' ' LEU . 85.8 mt -73.27 -25.7 60.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.27 110.825 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.624 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.0 mt-30 -77.1 -24.06 51.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.309 -0.405 . . . . 0.42 110.935 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.13 -32.22 15.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.27 111.133 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.919 HD21 HD23 ' A' ' 32' ' ' LEU . 1.7 pp -88.31 -36.51 16.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.3 110.87 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -96.64 -47.09 6.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.47 111.11 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.34 -15.58 45.91 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.753 -0.737 . . . . 0.48 112.523 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -56.07 -62.59 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 1.93 110.898 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -107.19 -33.26 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 2.71 110.88 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.22 -131.52 4.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.3 112.522 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -156.35 153.08 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 3.92 110.798 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 33' ' ' GLN . 97.7 t -134.93 126.51 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.25 111.169 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.8 t -116.5 152.62 33.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.28 110.827 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.03 131.77 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.19 111.069 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -139.23 150.97 46.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 1.38 110.87 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -103.44 135.18 45.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.4 110.876 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.681 ' CD1' HG21 ' A' ' 73' ' ' THR . 36.4 mt -53.69 -34.18 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.09 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -31.7 63.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 2.23 110.937 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -100.84 19.7 16.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 3.7 110.893 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.821 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.26 -26.94 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 1.08 110.885 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.26 -38.49 58.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.226 -0.443 . . . . 1.06 110.911 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -84.5 -14.36 49.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.169 -0.469 . . . . 1.08 110.906 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.654 ' HB3' HD13 ' A' ' 50' ' ' LEU . 19.6 t -60.08 -15.19 21.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 2.2 110.805 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.405 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -75.17 53.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.44 111.111 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -53.56 -70.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.65 110.922 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.673 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.68 -168.26 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 1.08 110.888 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -107.74 129.87 55.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 1.73 110.901 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.19 75.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 1.25 110.88 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.0 p -129.65 -34.15 1.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.22 110.843 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.6 m-85 -99.73 118.06 35.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 1.44 110.842 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.07 -20.08 64.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 1.48 110.857 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.685 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.8 mt -147.8 143.6 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.23 111.134 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.861 HG21 HG23 ' A' ' 83' ' ' ILE . 18.5 mm -133.92 132.69 56.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.14 111.162 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.6 mm? -113.8 137.64 51.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.19 110.847 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.23 98.35 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.16 110.814 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.59 74.41 0.29 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.818 -0.706 . . . . 0.18 112.469 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.45 61.41 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.352 . . . . 0.58 110.883 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.444 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -129.34 159.93 66.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 0.34 111.204 179.799 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 115.82 4.26 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.66 2.24 . . . . 0.32 112.409 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.71 7.65 68.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 0.22 112.51 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.4 150.93 10.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.73 110.858 -179.729 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.764 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 36.1 p -139.72 108.18 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.23 111.196 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.681 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.51 156.18 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.29 111.126 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.002 HD12 HD22 ' A' ' 147' ' ' LEU . 5.7 mt -133.85 109.6 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.24 110.844 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -86.51 153.92 21.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.28 110.869 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 m -131.78 -175.75 3.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.39 110.766 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.16 -36.54 70.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.27 111.031 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.39 -45.94 88.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 2.08 110.899 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.821 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -73.02 -55.27 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.23 111.146 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 119' ' ' LEU . 65.7 mt -50.33 -44.8 54.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.28 110.874 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.59 -53.8 34.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.39 111.012 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -55.32 -43.37 74.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 2.88 110.904 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.861 HG23 HG21 ' A' ' 63' ' ' ILE . 41.9 mm -57.12 -67.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.25 111.168 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.05 -36.58 40.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.24 111.132 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.2 tpp85 -56.74 -50.67 71.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 2.5 110.846 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 56' ' ' LYS . 37.2 pt -84.29 -6.02 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.19 111.12 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -81.14 123.34 28.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.29 110.926 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -61.85 159.08 38.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 3.19 110.869 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.407 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.7 Cg_endo -69.76 114.2 3.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.688 2.259 . . . . 0.2 112.326 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.74 4.28 54.64 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.71 -0.757 . . . . 0.23 112.496 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.72 -164.31 22.79 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.787 -0.72 . . . . 0.18 112.485 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 53.8 m -136.25 151.06 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.808 0.337 . . . . 0.37 110.86 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 94' ' ' PHE . 2.1 tm? -134.02 127.45 32.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.175 -0.466 . . . . 0.48 110.94 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.602 ' N ' HD22 ' A' ' 93' ' ' LEU . 59.2 m-85 -122.72 133.54 54.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 1.85 110.872 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -148.65 163.69 36.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.47 . . . . 0.23 110.913 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.02 129.87 30.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 2.79 110.972 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.88 148.59 19.63 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.742 0.782 . . . . 3.63 110.873 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 136.51 33.23 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.645 2.23 . . . . 0.31 112.382 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 157' ' ' VAL . 11.9 m -120.66 146.83 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.2 111.202 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.44 ' CD ' HG21 ' A' ' 103' ' ' VAL . 62.2 mt-10 -110.48 132.97 53.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.92 110.901 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.0 p -91.41 -40.7 11.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 1.25 111.135 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.52 38.28 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.56 111.166 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.44 HG21 ' CD ' ' A' ' 100' ' ' GLU . 22.0 t -147.53 149.92 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.64 111.121 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.634 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -53.31 173.05 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 1.82 110.793 179.888 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -67.15 -53.37 31.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.167 -0.47 . . . . 2.92 110.94 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -75.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 1.91 110.862 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.67 -169.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 1.52 110.894 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.691 ' HG3' HG13 ' A' ' 109' ' ' VAL . 17.0 pttt -80.51 -4.86 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 3.15 110.922 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.691 HG13 ' HG3' ' A' ' 108' ' ' LYS . 2.7 m -139.92 148.21 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.4 111.16 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.443 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.5 tppt? -69.14 115.06 7.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 2.2 110.875 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.634 HG21 ' O ' ' A' ' 104' ' ' ASP . 48.7 p -87.83 -178.33 6.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.33 111.153 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.78 64.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.32 111.151 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.27 -49.46 77.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.46 110.854 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.56 -43.21 71.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 1.87 110.883 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.499 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -61.8 -55.74 26.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.54 110.975 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.9 m -55.3 -46.81 76.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.27 110.894 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -44.23 94.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.46 110.892 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 80' ' ' LEU . . . -62.21 -49.81 74.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.42 111.106 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.603 ' HA ' HD13 ' A' ' 80' ' ' LEU . 12.8 tp -57.55 -52.46 65.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.3 110.923 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 92.0 m -64.21 -29.04 70.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.3 111.198 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.1 mt -81.11 -16.27 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.8 110.835 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 p -82.32 3.2 28.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 2.62 110.859 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.46 -4.94 35.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.804 -0.712 . . . . 0.86 112.502 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -83.97 169.02 15.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.31 110.927 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.52 170.25 2.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.37 111.126 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 53.4 44.48 29.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 2.23 110.956 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.8 142.54 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.29 111.109 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.15 160.04 7.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 1.79 110.868 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.86 140.73 36.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 2.87 110.956 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.746 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.4 mp -98.6 -37.28 9.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.31 110.926 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -163.16 176.78 9.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 1.38 110.917 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.1 mtt-85 -125.63 167.01 15.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 8.44 110.875 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -149.7 134.22 9.23 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.662 0.744 . . . . 1.81 110.898 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 156.54 63.08 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.269 . . . . 0.35 112.38 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.67 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -89.6 154.1 20.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.71 110.92 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.601 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -138.07 163.28 48.87 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.56 0.695 . . . . 1.6 111.111 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 136' ' ' THR . 53.2 Cg_endo -69.78 -23.75 30.37 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.706 2.271 . . . . 0.47 112.32 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -85.66 -24.66 26.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 3.99 110.954 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -88.13 -53.85 4.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 4.08 110.931 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 136' ' ' THR . 7.1 p -50.59 -39.15 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.23 111.112 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -34.03 75.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 1.24 110.916 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -46.48 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.29 110.854 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.696 HG23 HD13 ' A' ' 147' ' ' LEU . 8.6 p -67.73 -30.95 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.19 111.131 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -77.22 -29.97 54.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 2.16 110.866 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -89.37 -21.85 22.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 1.82 110.813 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -95.04 -31.97 13.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.814 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.002 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -127.25 -54.67 1.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.36 110.87 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.93 13.09 2.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.771 . . . . 0.37 112.437 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.404 ' CG ' HG11 ' A' ' 109' ' ' VAL . 15.5 t-160 -70.55 122.23 19.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.61 110.803 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -151.38 105.57 3.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 2.92 110.924 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t -158.35 171.28 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.58 110.86 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.09 -17.12 14.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 2.01 110.786 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -99.28 21.29 12.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.299 -0.41 . . . . 1.65 110.866 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -90.4 166.14 13.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.45 . . . . 0.27 111.016 179.928 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.67 ' HA ' HD23 ' A' ' 135' ' ' LEU . 2.7 tm? -172.03 130.31 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.2 110.841 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.764 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.1 m-85 -72.6 133.74 44.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 1.74 110.87 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.407 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.07 157.19 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.37 111.068 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.746 ' HG2' HD13 ' A' ' 130' ' ' LEU . 37.7 tt0 -113.57 133.56 55.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 2.2 110.905 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.94 152.32 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.24 111.132 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.431 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.7 t -136.29 163.62 29.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.26 111.172 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.98 136.76 5.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.753 -0.737 . . . . 0.21 112.491 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -94.92 142.67 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 1.78 110.925 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 13.4 tptm -82.8 135.55 45.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.574 0.702 . . . . 1.82 110.935 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 118.89 5.95 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.727 2.285 . . . . 0.46 112.41 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -104.05 152.81 21.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.62 110.878 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -69.35 85.01 0.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 6.53 110.9 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -179.39 34.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 10.69 110.968 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 89.6 t -131.73 -74.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 7.27 111.157 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 178.9 31.19 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.788 -0.72 . . . . 6.1 112.488 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.41 -169.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.371 . . . . 8.25 110.816 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.66 -178.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.493 . . . . 7.38 110.87 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 6.13 110.88 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' HD12 ' A' ' 6' ' ' ILE . 6.6 ptt? . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.836 0.35 . . . . 3.6 110.956 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.09 -18.3 62.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.67 111.055 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.99 -51.22 70.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 2.37 110.857 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.472 ' HB2' HD11 ' A' ' 6' ' ' ILE . 12.4 m-85 -122.14 24.31 9.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 2.08 110.899 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.45 44.54 53.25 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.81 -0.709 . . . . 0.51 112.426 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -88.53 163.55 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.784 0.326 . . . . 0.5 111.17 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.628 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -151.22 163.6 38.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 1.47 110.811 -179.947 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.33 134.31 34.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.34 111.086 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.52 2.41 32.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.28 112.439 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.43 172.42 7.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.806 0.336 . . . . 1.04 110.955 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.18 114.29 28.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 2.14 110.891 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.632 HG22 ' HB ' ' A' ' 62' ' ' ILE . 92.6 t -117.06 133.9 62.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 1.87 111.101 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.758 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -111.45 125.91 54.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.21 111.092 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.691 HG11 HG12 ' A' ' 29' ' ' VAL . 95.2 t -98.04 122.22 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.2 111.223 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.422 HG12 ' CG1' ' A' ' 47' ' ' ILE . 18.7 t -105.93 114.83 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.21 111.169 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -115.58 168.93 9.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.17 110.956 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -151.08 -170.34 3.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 1.9 110.82 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -57.0 -35.89 69.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 3.63 110.912 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -73.14 -10.38 59.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 1.71 110.839 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.61 93.41 10.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.683 0.754 . . . . 0.24 110.851 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.7 143.11 50.06 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.615 2.21 . . . . 0.36 112.38 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.0 t -48.96 -32.08 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.25 111.061 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.62 -53.69 35.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 2.33 110.888 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB1' HG12 ' A' ' 68' ' ' VAL . . . -87.69 -44.7 10.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.33 111.114 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -50.18 -59.58 3.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.28 110.904 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -48.26 -32.84 7.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 4.79 110.868 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.37 -46.41 33.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 0.54 112.48 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.642 HD12 HG13 ' A' ' 68' ' ' VAL . 14.0 mt -61.96 -35.63 79.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 1.37 110.903 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.691 HG12 HG11 ' A' ' 14' ' ' VAL . 22.0 m -80.93 -32.94 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.64 111.109 179.837 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -61.6 -54.61 40.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 1.68 110.904 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.499 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -57.19 -36.89 71.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 2.52 110.836 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.706 HD23 HD21 ' A' ' 35' ' ' LEU . 60.1 mt -76.9 -25.01 52.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.91 110.96 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.579 ' HA ' HG21 ' A' ' 42' ' ' VAL . 4.8 mt-30 -78.18 -26.13 47.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.49 110.927 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.52 -31.67 15.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.52 111.105 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.706 HD21 HD23 ' A' ' 32' ' ' LEU . 1.3 pp -89.36 -35.86 15.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.59 110.985 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.7 -47.16 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.28 111.101 179.97 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.91 -15.36 42.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.769 -0.729 . . . . 0.36 112.495 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.06 -62.85 1.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.331 . . . . 1.84 110.846 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -105.82 -34.77 7.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 2.76 110.817 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.5 -127.3 2.14 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.822 -0.704 . . . . 0.29 112.493 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -157.52 151.27 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 3.84 110.782 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 33' ' ' GLN . 88.3 t -136.24 120.13 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.31 111.167 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.7 t -110.34 155.44 22.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.15 110.879 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.47 134.7 61.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.15 111.139 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -143.46 151.83 40.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 1.3 110.932 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -103.01 135.98 43.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.44 110.812 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.665 ' CD1' HG21 ' A' ' 73' ' ' THR . 25.3 mt -52.17 -35.31 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.25 111.102 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -74.96 -29.24 60.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 1.97 110.905 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -99.5 18.49 17.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 3.4 110.908 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.83 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.56 -30.47 5.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 1.13 110.901 -179.981 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mp -54.32 -37.35 64.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 1.07 110.882 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -84.82 -15.52 44.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 1.08 110.864 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.9 m -66.63 -10.37 45.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.95 110.894 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.02 63.47 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.28 111.091 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -62.03 -69.34 0.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.35 110.795 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.66 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -153.38 -175.76 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 2.17 110.903 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -93.84 135.12 35.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 1.94 110.917 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p 46.42 82.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.423 . . . . 1.12 110.87 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.3 p -133.57 -38.35 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.3 110.893 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.479 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.0 m-85 -102.0 122.72 44.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 1.44 110.821 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.87 -23.19 62.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 1.5 110.841 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 12' ' ' VAL . 19.4 mt -145.04 143.02 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.27 111.108 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.773 HG21 HG23 ' A' ' 83' ' ' ILE . 20.3 mm -132.75 133.74 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.16 111.097 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -114.21 135.94 53.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.21 110.943 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.32 97.47 4.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.29 110.894 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.15 73.28 0.38 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.719 -0.753 . . . . 0.39 112.554 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.417 HD11 ' HB3' ' A' ' 94' ' ' PHE . 4.1 mm? -93.97 -19.14 21.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 2.16 110.971 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.768 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.2 OUTLIER -47.54 151.12 1.51 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.659 0.742 . . . . 0.69 111.113 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 135.38 30.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.657 2.238 . . . . 0.71 112.298 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.92 1.4 78.78 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.702 -0.761 . . . . 0.38 112.437 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.768 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -54.62 154.63 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.991 0.424 . . . . 1.37 110.815 -179.739 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.733 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.4 p -140.86 109.4 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.16 111.106 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.665 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -160.72 154.19 22.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.23 111.241 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.996 HD12 HD22 ' A' ' 147' ' ' LEU . 6.3 mt -130.93 107.35 9.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 0.23 110.896 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -84.2 153.88 23.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.893 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.3 m -131.8 -176.15 3.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.39 110.845 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.68 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.28 111.171 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -62.52 -45.99 90.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 2.08 110.884 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.83 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -73.7 -54.96 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.23 111.109 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 119' ' ' LEU . 59.9 mt -50.66 -41.12 55.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.23 110.898 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.0 -54.86 24.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.3 111.139 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.45 -43.33 83.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 2.38 110.936 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.773 HG23 HG21 ' A' ' 63' ' ' ILE . 43.2 mm -56.24 -68.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.19 111.202 179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.91 -36.66 39.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 0.21 111.152 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -56.24 -51.76 66.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 2.06 110.871 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 56' ' ' LYS . 25.8 pt -83.13 -6.62 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.2 111.093 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -79.13 112.88 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.34 110.932 179.879 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -51.82 159.51 1.33 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.662 0.744 . . . . 2.24 110.791 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.61 114.59 3.73 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.666 2.244 . . . . 0.2 112.413 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.35 3.65 56.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.68 -0.772 . . . . 0.14 112.479 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.16 -157.97 8.9 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.767 -0.73 . . . . 0.13 112.545 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.5 m -144.2 156.07 44.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.365 . . . . 0.45 110.874 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.681 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.5 112.74 8.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.25 110.949 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.549 ' N ' HD22 ' A' ' 93' ' ' LEU . 45.5 m-85 -105.42 133.01 50.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 1.7 110.842 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.615 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.5 164.15 35.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.17 110.904 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.23 123.94 19.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 2.53 110.82 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.61 150.93 45.26 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 3.64 110.946 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.603 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.5 Cg_endo -69.83 138.21 37.06 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.641 2.227 . . . . 0.22 112.365 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.2 m -122.31 147.28 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.29 111.061 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.423 ' OE2' HG21 ' A' ' 103' ' ' VAL . 13.2 mt-10 -114.76 132.59 56.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 1.98 110.859 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.7 p -104.4 25.98 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 1.1 111.093 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.68 23.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.71 111.053 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.423 HG21 ' OE2' ' A' ' 100' ' ' GLU . 3.4 t -144.4 160.47 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.72 111.19 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.587 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -55.94 179.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 1.93 110.854 -179.989 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.07 -60.42 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 1.94 110.808 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -64.61 -75.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 2.28 110.886 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.93 -168.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 1.58 110.878 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -5.0 55.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 1.92 110.972 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.06 140.43 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.6 111.17 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.584 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -61.54 119.15 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 2.22 110.944 179.841 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.587 HG21 ' O ' ' A' ' 104' ' ' ASP . 49.0 p -89.07 175.31 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.26 111.195 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.55 -55.13 38.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.25 111.123 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -61.05 -47.96 83.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.43 110.865 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -58.1 -40.96 82.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 1.69 110.864 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.5 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -62.96 -57.37 10.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 0.42 110.863 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 61.9 m -51.72 -44.71 63.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.3 110.945 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -42.12 85.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.35 110.914 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.74 97.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.24 111.073 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 93' ' ' LEU . 14.7 tp -66.36 -51.74 54.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.27 110.92 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -62.39 -32.23 73.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.31 111.146 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.09 -10.73 52.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.72 110.889 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.34 4.62 30.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 1.7 110.855 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.47 10.0 28.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.784 -0.722 . . . . 0.53 112.45 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -110.3 171.63 7.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.3 110.946 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 m -150.01 173.04 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.27 111.088 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 51.73 44.92 28.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 2.06 110.927 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.417 HG13 HD23 ' A' ' 119' ' ' LEU . 96.5 t -81.6 141.73 14.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.22 111.131 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 159.07 7.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.116 -0.493 . . . . 1.87 110.983 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.22 139.72 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 3.38 110.959 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.752 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.2 mp -95.84 -38.17 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.23 110.945 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.7 pm0 -157.68 176.37 12.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.452 . . . . 2.99 110.926 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.726 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.7 tmt_? -128.1 138.08 52.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 4.33 110.829 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -124.3 136.38 27.61 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.683 0.754 . . . . 1.38 110.853 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 164.75 33.4 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.743 2.295 . . . . 0.25 112.291 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -97.61 125.71 42.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.3 110.9 179.993 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.0 161.34 23.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.528 0.68 . . . . 1.56 111.108 -179.976 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -24.08 29.94 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.628 2.219 . . . . 0.46 112.382 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -85.08 -22.26 29.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 2.6 110.944 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -87.76 -54.6 4.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 2.38 110.832 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 136' ' ' THR . 7.7 p -49.03 -39.12 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.34 111.116 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -37.86 80.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 2.78 110.865 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -46.91 75.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.32 110.888 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.682 HG23 HD13 ' A' ' 147' ' ' LEU . 10.8 p -67.37 -30.67 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 0.27 111.131 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -75.95 -30.63 58.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 3.55 110.864 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -90.06 -20.51 23.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 1.89 110.887 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -94.5 -32.69 13.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.34 110.871 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.996 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.9 -53.86 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.49 110.982 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.79 15.21 1.97 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.776 -0.726 . . . . 0.47 112.541 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -70.92 121.69 18.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.768 0.318 . . . . 0.98 110.891 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -152.11 105.53 3.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 2.34 110.833 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -160.66 175.79 12.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.76 110.777 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.24 -21.89 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 1.72 110.842 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -91.4 13.29 17.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 1.54 110.965 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.664 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.54 164.63 21.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.42 110.89 179.923 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.5 tm? -173.72 130.09 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.2 110.902 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.733 ' CZ ' HG22 ' A' ' 72' ' ' THR . 27.1 m-85 -76.08 137.99 40.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 1.72 110.925 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -150.45 150.06 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.26 111.128 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.752 ' HG2' HD13 ' A' ' 130' ' ' LEU . 11.3 tt0 -103.49 133.91 47.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 2.16 110.896 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.43 147.35 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.28 111.126 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.513 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.4 t -132.63 148.97 52.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.48 111.024 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.99 135.4 7.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.71 -0.757 . . . . 0.14 112.519 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -90.89 140.09 30.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 1.74 110.836 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 135.04 51.38 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 1.24 110.872 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 124.03 10.67 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.644 2.229 . . . . 0.29 112.38 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -104.1 150.78 24.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.33 110.942 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -76.45 66.76 2.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 7.27 110.894 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -109.74 30.27 6.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 10.12 110.843 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.5 t -149.66 -72.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.202 -0.454 . . . . 7.67 111.117 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 167.7 -26.85 0.15 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.731 . . . . 8.31 112.483 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.28 126.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.957 0.408 . . . . 9.42 110.758 -179.75 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.81 -74.34 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 7.19 110.776 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 8.7 tpm_? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 8.04 110.867 -179.895 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.741 0.305 . . . . 3.58 110.899 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.94 -21.95 65.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.55 111.127 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.06 -51.58 63.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 2.15 110.865 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.27 21.55 10.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 2.02 110.912 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.67 38.91 59.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.721 . . . . 0.29 112.502 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.8 mp -76.97 158.12 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.28 111.126 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 36' ' ' THR . 18.5 m -149.62 157.02 42.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.177 -0.465 . . . . 1.05 110.8 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.53 125.59 33.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.35 111.063 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.95 -6.2 23.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 0.31 112.53 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -110.05 167.57 10.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.758 0.313 . . . . 1.5 110.917 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.66 136.33 39.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 1.3 110.841 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.536 HG12 HG21 ' A' ' 36' ' ' THR . 1.8 p -141.03 136.89 34.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 2.14 111.087 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.745 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -112.3 124.14 51.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.23 111.159 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.85 HG11 HG12 ' A' ' 29' ' ' VAL . 65.7 t -94.69 116.97 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.2 111.121 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.531 HG12 ' CG1' ' A' ' 47' ' ' ILE . 14.5 t -101.31 112.05 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.22 111.15 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -114.52 165.85 12.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.23 110.967 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HB3' HD12 ' A' ' 47' ' ' ILE . 10.3 p-10 -147.36 -170.54 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.305 -0.407 . . . . 1.87 110.916 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -56.95 -35.94 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 4.09 110.815 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -72.61 -9.31 58.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.3 110.804 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.16 94.04 10.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.703 0.763 . . . . 0.15 110.838 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.3 47.64 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.691 2.261 . . . . 0.21 112.335 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.9 t -48.74 -32.94 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.21 111.149 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.84 -53.06 35.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 2.52 110.874 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.57 -44.88 10.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.18 111.095 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -51.96 -61.7 2.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.15 110.81 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.72 -36.76 26.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 2.59 110.89 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.38 -47.75 49.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.74 . . . . 0.21 112.478 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 mt -61.72 -40.44 95.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 0.49 110.921 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.85 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -75.92 -31.68 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.65 111.087 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.92 -60.46 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 1.7 110.916 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -40.16 71.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 1.73 110.802 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.909 HD23 HD21 ' A' ' 35' ' ' LEU . 77.2 mt -72.7 -24.69 61.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.25 110.935 179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.475 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.47 -24.96 45.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.39 110.927 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.72 -29.93 17.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.22 111.093 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.909 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.61 -35.23 14.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.22 110.873 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.536 HG21 HG12 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -102.46 -44.9 5.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 0.23 111.053 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.97 -11.18 54.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.793 -0.718 . . . . 0.25 112.512 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.3 -62.44 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.685 0.278 . . . . 2.96 110.775 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -91.41 -40.08 11.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 2.25 110.915 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.92 -125.86 4.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.756 -0.735 . . . . 0.27 112.49 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -156.37 152.88 28.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.885 0.374 . . . . 2.16 110.846 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 33' ' ' GLN . 92.3 t -136.91 127.96 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.23 111.104 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.4 t -116.93 152.91 33.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.19 110.823 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.69 132.28 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.23 111.197 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -143.54 152.0 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 1.28 110.905 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -102.38 137.78 40.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.44 110.886 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.784 HD13 HG21 ' A' ' 73' ' ' THR . 36.8 mt -52.65 -36.74 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.27 111.095 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -75.7 -25.18 56.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 2.03 110.862 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -103.89 16.15 27.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 3.37 110.981 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.885 HD13 HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -52.49 -24.72 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 2.74 110.91 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -51.16 -38.96 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.902 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -84.91 -14.2 48.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 1.37 110.907 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.463 ' O ' HG21 ' A' ' 86' ' ' ILE . 19.4 t -58.97 -15.46 13.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 2.4 110.795 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -74.63 53.18 0.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.56 111.168 179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -51.14 -72.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.35 110.865 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.505 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.83 -168.24 2.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 1.62 110.926 179.984 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -100.5 121.09 41.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 2.14 110.944 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.05 84.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.41 110.842 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 p -132.59 -36.84 1.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.28 110.854 -179.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.465 ' CD2' HD12 ' A' ' 86' ' ' ILE . 98.1 m-85 -96.03 120.4 36.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 1.46 110.878 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.39 -20.48 61.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 1.77 110.9 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 6' ' ' ILE . 11.1 mt -143.51 144.28 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.3 111.071 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.014 HG21 HG23 ' A' ' 83' ' ' ILE . 20.9 mm -136.13 126.11 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.14 111.189 179.794 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.5 mm? -108.85 137.41 46.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.25 111.001 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.62 99.75 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.14 110.869 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.48 78.93 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.655 -0.783 . . . . 0.18 112.478 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.04 58.07 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 0.58 110.867 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -128.09 159.75 65.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.676 0.751 . . . . 0.24 111.124 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.74 115.63 4.18 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.738 2.292 . . . . 0.27 112.294 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.69 6.32 65.83 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.679 -0.772 . . . . 0.2 112.515 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.43 150.21 12.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.79 110.804 -179.69 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.727 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 22.0 p -140.3 108.86 5.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.22 111.062 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.784 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.16 144.18 9.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.29 111.162 179.989 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.009 HD12 HD22 ' A' ' 147' ' ' LEU . 10.4 mt -120.68 99.63 6.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 0.38 111.032 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -75.69 137.55 40.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.4 110.785 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.437 ' H ' HD13 ' A' ' 79' ' ' ILE . 68.0 m -116.99 178.45 4.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.42 110.884 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.57 -44.12 62.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.31 111.059 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.28 -47.75 77.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 1.87 110.912 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.885 HG23 HD13 ' A' ' 50' ' ' LEU . 4.2 mp -69.79 -56.53 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.23 111.17 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.716 HD13 ' HA ' ' A' ' 119' ' ' LEU . 69.4 mt -50.23 -40.45 47.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.21 110.953 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.93 -57.04 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.29 111.177 179.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -53.69 -43.09 68.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 2.83 110.903 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.014 HG23 HG21 ' A' ' 63' ' ' ILE . 41.7 mm -57.47 -68.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.118 -0.492 . . . . 0.19 111.051 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -50.3 -37.69 37.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.19 111.117 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -53.95 -55.23 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 2.85 110.756 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 56' ' ' LYS . 49.5 pt -81.29 -5.6 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.22 111.066 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -78.64 117.86 20.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.25 110.874 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.7 mtt-85 -57.56 158.87 10.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.598 0.713 . . . . 3.01 110.891 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 54.4 Cg_endo -69.65 114.14 3.59 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.26 . . . . 0.19 112.32 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.33 3.58 55.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.19 112.46 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.02 -165.62 23.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.83 -0.7 . . . . 0.17 112.542 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.3 m -134.84 150.48 50.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.866 0.365 . . . . 0.31 110.896 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.62 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -134.7 115.0 13.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.15 110.963 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.535 ' N ' HD22 ' A' ' 93' ' ' LEU . 54.4 m-85 -110.37 132.47 54.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 1.63 110.792 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.53 159.02 44.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.14 110.871 -179.964 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 130.12 44.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 2.5 110.958 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.66 146.89 18.0 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.653 0.74 . . . . 2.33 110.885 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.515 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.9 Cg_endo -69.69 142.23 47.68 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.674 2.25 . . . . 0.23 112.361 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 157' ' ' VAL . 12.4 m -127.05 146.83 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.19 111.114 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.453 ' CD ' HG21 ' A' ' 103' ' ' VAL . 50.2 mt-10 -107.84 132.92 52.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 1.95 110.926 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.4 p -92.85 -41.4 10.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 1.09 111.15 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.57 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.51 38.53 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.75 110.973 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.453 HG21 ' CD ' ' A' ' 100' ' ' GLU . 21.2 t -146.89 150.63 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.76 111.13 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.641 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -53.51 173.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.82 110.834 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -66.97 -53.7 29.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 2.74 110.91 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -75.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 1.7 110.916 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 52.37 -169.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 1.63 110.836 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -80.3 -5.34 56.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 2.05 110.966 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.81 147.91 22.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.48 111.05 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.2 116.08 8.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 2.11 110.908 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.641 HG21 ' O ' ' A' ' 104' ' ' ASP . 51.4 p -88.21 -178.98 6.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.24 111.102 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.6 64.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.23 111.111 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.66 -49.63 76.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.26 110.939 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -57.1 -44.62 83.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 1.88 110.888 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -59.03 -55.45 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.954 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 71.5 m -53.71 -49.12 68.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.37 110.949 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -45.64 93.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.48 110.862 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.82 -44.84 93.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.34 111.116 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.716 ' HA ' HD13 ' A' ' 80' ' ' LEU . 12.5 tp -61.54 -54.12 47.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.35 110.912 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 100.0 m -61.85 -27.7 68.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.53 111.149 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.01 -17.45 50.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 1.01 110.854 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 p -82.37 3.03 29.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 2.4 110.823 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.38 -4.87 35.28 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.789 -0.72 . . . . 0.56 112.523 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.62 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -84.56 168.13 15.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 0.44 110.916 -179.931 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.501 HG23 ' HG3' ' A' ' 126' ' ' GLU . 27.2 m -150.79 172.97 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.34 111.142 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.501 ' HG3' HG23 ' A' ' 125' ' ' VAL . 36.9 mt-10 53.14 43.05 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 2.21 110.912 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.89 142.27 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.29 111.132 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.78 158.33 7.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 1.65 110.891 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -82.26 147.22 29.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 2.39 110.829 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.775 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.2 mp -107.78 -36.03 6.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.18 111.017 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -164.6 176.49 8.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.471 . . . . 1.29 110.853 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -126.12 165.76 18.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 8.32 110.867 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -148.62 136.34 11.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.671 0.748 . . . . 1.39 110.83 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 157.13 61.51 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.588 2.192 . . . . 0.36 112.448 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.645 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -93.98 127.58 39.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.31 -0.405 . . . . 0.36 110.933 179.976 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.471 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.56 161.37 23.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.544 0.687 . . . . 1.58 111.121 179.983 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -24.85 29.22 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.688 2.259 . . . . 0.46 112.325 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -85.75 -21.99 27.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 3.64 110.922 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -87.5 -53.07 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 2.5 110.93 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -50.13 -41.36 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.34 111.069 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.4 ' N ' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -65.06 -32.39 74.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.13 110.772 -179.929 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -51.32 24.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.58 110.841 -179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.638 HG23 HD13 ' A' ' 147' ' ' LEU . 9.4 p -61.54 -28.39 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.34 111.125 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -75.99 -48.58 20.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 1.93 110.915 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -73.26 -19.73 61.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 1.84 110.929 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -94.19 -33.36 13.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.51 110.835 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.009 HD22 HD12 ' A' ' 74' ' ' LEU . 2.2 mp -129.44 -54.09 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.45 110.916 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.57 14.59 1.9 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.688 -0.768 . . . . 0.31 112.513 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -74.62 120.34 20.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.853 0.359 . . . . 0.62 110.84 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -152.09 105.08 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 4.31 110.865 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.04 167.89 25.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.468 . . . . 0.63 110.816 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.77 -6.72 20.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 1.97 110.945 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 153' ' ' ASN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 2.2 m120 -104.08 14.02 31.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 2.78 110.844 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.645 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -90.26 168.95 11.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.42 110.919 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.629 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -173.51 130.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.28 111.013 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.727 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.7 m-85 -69.38 134.66 49.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 1.88 110.825 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.409 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.73 143.28 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.085 -0.507 . . . . 0.31 111.139 179.976 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.775 ' HG2' HD13 ' A' ' 130' ' ' LEU . 37.5 tt0 -100.79 127.88 47.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 2.28 110.967 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.84 152.18 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.21 111.069 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.449 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -131.54 159.13 39.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.27 111.154 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.4 130.19 3.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.21 112.433 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -93.0 140.27 29.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 1.59 110.919 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 5.3 tptm -81.24 134.27 52.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.507 0.67 . . . . 1.38 110.92 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 119.78 6.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.625 2.217 . . . . 0.32 112.413 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -101.54 151.82 21.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.36 110.868 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -63.94 96.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 6.84 110.876 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -174.89 32.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 9.73 110.965 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.04 -65.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 6.33 111.103 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 174.52 -50.59 0.14 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.624 -0.798 . . . . 6.81 112.42 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.75 -46.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 8.17 110.842 -179.767 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.18 -169.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 7.19 110.897 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.9 tpt85 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 6.25 110.902 -179.844 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.702 0.287 . . . . 3.79 110.782 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.78 63.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.5 111.148 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.35 -51.51 64.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.28 110.858 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.535 ' CE1' HD12 ' A' ' 67' ' ' LEU . 4.6 m-85 -122.16 22.27 10.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.235 -0.439 . . . . 2.03 110.894 -179.878 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.16 37.82 47.24 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.26 112.527 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.454 HG21 HD22 ' A' ' 32' ' ' LEU . 1.9 mp -73.95 156.42 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.791 0.329 . . . . 0.3 111.175 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.579 ' O ' HG23 ' A' ' 36' ' ' THR . 57.7 m -147.7 154.73 40.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 1.11 110.897 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.17 125.31 33.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.36 111.177 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.27 -6.56 19.05 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.744 -0.741 . . . . 0.26 112.498 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.8 170.62 7.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 1.54 110.972 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.13 112.44 25.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 1.33 110.926 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.695 HG12 HG21 ' A' ' 36' ' ' THR . 2.2 p -118.31 131.75 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 2.02 111.153 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.753 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -107.26 125.63 51.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.23 111.097 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.815 HG11 HG12 ' A' ' 29' ' ' VAL . 91.4 t -96.18 117.4 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.19 111.24 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 65' ' ' SER . 21.0 t -100.86 119.9 49.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.24 111.102 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -120.0 168.95 10.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 0.19 110.946 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.437 ' HB3' HD12 ' A' ' 47' ' ' ILE . 10.3 p-10 -151.83 -170.28 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 1.91 110.842 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -57.03 -35.6 69.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 2.93 110.975 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 m -73.62 -9.24 58.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.497 . . . . 1.61 110.842 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -106.97 94.2 10.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.634 0.731 . . . . 0.17 110.888 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 54.0 Cg_endo -69.75 142.29 47.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.681 2.254 . . . . 0.21 112.386 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.2 t -48.99 -32.61 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.18 111.096 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.13 -53.06 37.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 2.42 110.903 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.66 -44.56 11.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.17 111.078 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.454 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -52.07 -61.42 2.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.15 110.908 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.14 -37.6 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 2.81 110.914 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.8 -47.54 54.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 0.24 112.409 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 mt -61.49 -40.98 96.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.915 0.388 . . . . 0.46 110.937 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.815 HG12 HG11 ' A' ' 14' ' ' VAL . 17.2 m -75.81 -31.42 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.63 111.065 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.75 -61.15 2.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 1.57 110.843 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.8 -40.59 69.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 1.74 110.85 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.867 HD23 HD21 ' A' ' 35' ' ' LEU . 80.6 mt -71.99 -25.07 61.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.35 110.944 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.519 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.33 -24.54 46.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.38 111.0 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.76 -29.79 17.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.29 111.156 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.867 HD21 HD23 ' A' ' 32' ' ' LEU . 1.6 pp -91.58 -35.46 14.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.29 110.945 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.695 HG21 HG12 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -102.16 -44.89 5.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.23 111.13 -179.978 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.22 -12.16 49.12 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.704 -0.76 . . . . 0.27 112.555 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -67.67 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 1.93 110.871 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -95.56 -38.99 10.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.093 -0.503 . . . . 2.61 110.94 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.1 -131.32 5.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 0.24 112.492 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -152.88 151.73 30.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.932 0.396 . . . . 3.51 110.832 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 33' ' ' GLN . 89.6 t -135.01 125.06 44.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.22 111.107 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -115.87 152.49 33.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.22 110.833 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.32 133.66 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.5 . . . . 0.18 111.089 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -140.93 150.83 43.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 1.59 110.874 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -103.44 134.64 46.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.45 110.833 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.788 HD13 HG21 ' A' ' 73' ' ' THR . 35.2 mt -51.56 -34.56 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.31 111.151 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -71.46 -34.76 70.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.507 . . . . 2.0 110.896 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -101.1 16.15 26.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.262 -0.427 . . . . 3.67 110.874 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.686 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -48.87 -42.8 37.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.17 110.89 -179.971 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -55.5 -39.48 70.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 3.33 110.908 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.16 -13.14 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 5.15 110.924 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.7 m -77.19 -0.47 25.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 1.68 110.874 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.706 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -69.1 70.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.65 111.135 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -51.06 -73.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.439 . . . . 1.49 110.78 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.666 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -142.58 -165.18 1.98 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 1.21 110.915 -179.954 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -106.36 128.71 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 2.15 110.866 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.44 71.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.32 110.826 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.7 p -126.39 -32.13 2.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.28 110.802 -179.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.441 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.1 m-85 -100.24 119.31 38.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 1.43 110.897 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.39 -20.04 62.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 1.52 110.88 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 mt -143.99 144.46 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.25 111.161 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.934 HG21 HG23 ' A' ' 83' ' ' ILE . 22.3 mm -137.66 127.85 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.14 111.185 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.3 mm? -111.3 137.98 48.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.22 110.885 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.408 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -129.63 100.96 5.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.13 110.879 -179.981 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.37 72.2 0.56 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.687 -0.768 . . . . 0.18 112.512 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.578 HD13 ' OE1' ' A' ' 158' ' ' GLN . 3.9 mm? -103.86 58.85 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.339 . . . . 0.62 110.939 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.2 159.73 65.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.546 0.688 . . . . 0.22 111.172 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.89 117.42 5.08 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.233 . . . . 0.22 112.302 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.51 7.24 72.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.818 -0.706 . . . . 0.2 112.53 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.72 146.83 20.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.997 0.427 . . . . 0.69 110.845 -179.761 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.742 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 34.8 p -136.11 108.58 7.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.18 111.127 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.788 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -160.87 147.51 15.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.25 111.143 179.971 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.964 HD12 HD22 ' A' ' 147' ' ' LEU . 5.4 mt -123.63 103.54 8.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.25 110.911 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -81.26 141.95 33.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.34 110.893 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.3 m -123.57 174.73 7.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.46 110.804 -179.725 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.08 55.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.36 111.144 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.38 -46.05 91.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.144 -0.48 . . . . 2.14 110.889 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.686 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -73.15 -55.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.4 111.062 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 119' ' ' LEU . 57.1 mt -49.75 -37.68 30.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.26 110.933 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.75 -57.0 9.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.41 111.096 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.706 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -57.05 -40.58 77.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.189 -0.459 . . . . 2.7 110.905 -179.912 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.934 HG23 HG21 ' A' ' 63' ' ' ILE . 51.9 mm -59.33 -67.58 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.33 111.095 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.43 -33.69 31.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.27 111.106 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -57.23 13.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 2.21 110.824 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 56' ' ' LYS . 26.7 pt -75.15 -8.88 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.26 111.172 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -77.07 125.84 29.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.143 -0.481 . . . . 0.39 110.924 179.875 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -67.05 160.52 69.95 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.651 0.738 . . . . 3.67 110.966 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 114.06 3.57 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.631 2.221 . . . . 0.19 112.366 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.83 3.99 56.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.17 112.468 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.12 -164.48 17.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 0.13 112.435 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 61.2 m -135.32 150.6 50.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.35 110.892 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.694 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -135.44 114.4 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.15 110.867 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.538 ' N ' HD22 ' A' ' 93' ' ' LEU . 59.1 m-85 -109.59 132.35 54.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 1.68 110.88 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.545 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.48 164.16 35.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.19 110.905 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -136.26 124.56 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 1.92 110.959 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.451 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -146.31 150.52 41.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 2.3 110.945 179.935 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.599 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.9 Cg_endo -69.7 139.87 41.49 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.697 2.265 . . . . 0.22 112.382 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.7 m -121.37 147.27 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.37 111.119 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.47 ' CD ' HG21 ' A' ' 103' ' ' VAL . 50.7 mt-10 -119.31 131.92 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 1.96 110.925 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 p -92.73 -36.24 13.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 1.48 111.123 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.51 37.33 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.71 111.137 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.47 HG21 ' CD ' ' A' ' 100' ' ' GLU . 30.7 t -147.68 149.35 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.79 111.123 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.54 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -56.59 179.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 1.71 110.81 179.98 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.41 -74.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 2.71 110.857 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -54.74 -77.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 1.85 110.945 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.25 -169.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 1.64 110.955 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -4.08 52.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 2.35 110.945 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -145.85 141.18 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.55 111.143 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.599 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.1 mmtm -65.66 111.54 3.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 2.88 110.878 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.54 HG21 ' O ' ' A' ' 104' ' ' ASP . 44.8 p -81.0 177.39 9.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.2 111.165 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.56 -55.29 26.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 0.22 111.191 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 m -60.49 -49.68 76.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.27 110.877 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -38.51 70.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 2.83 110.943 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.492 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -65.4 -54.89 22.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.32 110.874 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 48.2 m -57.67 -45.33 85.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.26 110.856 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -42.95 88.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.34 110.858 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.84 97.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.24 111.088 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.574 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.5 tp -65.52 -50.46 65.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.22 110.878 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 95.5 m -64.13 -31.72 73.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.24 111.131 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.2 mt -86.75 -10.39 53.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.402 . . . . 0.63 110.894 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.07 5.17 30.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.416 . . . . 1.77 110.859 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.27 6.42 33.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.672 -0.775 . . . . 0.54 112.405 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -106.67 172.44 6.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.777 0.322 . . . . 0.27 110.985 -179.949 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' A' ' 126' ' ' GLU . 24.4 m -151.18 173.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.26 111.101 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HG3' HG23 ' A' ' 125' ' ' VAL . 36.6 mt-10 53.37 43.93 30.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 2.22 110.862 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 95.5 t -77.5 141.35 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.27 111.03 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 161.43 8.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 1.7 110.841 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 20.4 tt0 -82.26 145.9 29.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 2.09 110.855 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.0 mp -105.59 -35.97 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.33 110.927 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -157.41 175.82 13.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.19 110.981 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -128.62 147.95 50.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 4.12 110.834 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -137.32 134.4 18.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.695 0.759 . . . . 1.4 110.955 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.412 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.1 Cg_endo -69.77 165.21 31.73 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.737 2.292 . . . . 0.24 112.352 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.753 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -97.77 125.53 42.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.29 110.894 179.998 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.448 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.97 161.95 21.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.603 0.716 . . . . 1.27 111.089 -179.977 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.448 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.9 Cg_endo -69.75 -27.85 26.01 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.822 2.348 . . . . 0.33 112.253 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.54 -18.13 34.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 2.66 110.888 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.59 -54.27 4.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 2.78 110.931 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -49.89 -39.96 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.24 111.086 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -34.11 76.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 1.17 110.912 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -47.16 67.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.26 110.811 -179.772 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.69 HG23 HD13 ' A' ' 147' ' ' LEU . 11.1 p -68.08 -30.02 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.16 111.197 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -75.76 -32.25 59.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 1.94 110.908 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -89.4 -20.16 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 1.74 110.916 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -94.34 -32.84 13.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.3 110.848 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.964 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.11 -54.1 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.3 110.88 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.6 16.25 1.68 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.709 -0.758 . . . . 0.29 112.433 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -72.84 122.0 20.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.733 0.302 . . . . 0.88 110.887 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -151.51 105.45 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 2.1 110.848 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -160.54 170.03 21.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.69 110.882 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.14 -14.07 15.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 1.97 110.891 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -101.74 23.39 11.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 1.72 110.855 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.753 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -92.25 163.49 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.23 -0.441 . . . . 0.3 110.891 -179.962 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.587 ' HA ' HD23 ' A' ' 135' ' ' LEU . 2.6 tm? -169.72 130.69 1.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.22 110.939 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.742 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.3 m-85 -76.42 136.86 39.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 1.79 110.874 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.54 145.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.37 111.128 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.578 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.9 tt0 -97.83 129.62 44.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 1.9 110.898 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 3.8 mp -124.44 149.18 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.21 111.071 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.475 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.5 t -126.8 160.73 30.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.31 111.087 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -151.7 128.88 2.67 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.68 -0.772 . . . . 0.19 112.495 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -90.02 139.67 30.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 1.55 110.84 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.81 135.22 49.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.567 0.699 . . . . 1.24 110.873 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 128.41 16.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.647 2.231 . . . . 0.38 112.298 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -108.43 149.48 28.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.854 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -65.05 92.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 7.28 110.897 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.33 34.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 9.0 110.857 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.87 -69.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 6.04 111.054 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.77 -19.82 4.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.835 -0.698 . . . . 5.63 112.525 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.8 m -59.42 -175.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 6.57 110.851 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -68.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 6.96 110.798 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 7.77 110.974 180.0 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.817 0.342 . . . . 3.69 110.886 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.16 -18.78 64.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.59 111.1 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.99 -50.91 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 1.86 110.839 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 6' ' ' ILE . 8.3 m-85 -122.31 13.82 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 1.98 110.797 -179.839 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.76 38.98 96.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.23 112.504 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.7 mp -78.9 158.78 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.22 111.071 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -152.65 162.07 41.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 1.35 110.915 -179.921 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.23 126.32 35.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.26 111.058 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.08 -5.85 17.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.674 -0.774 . . . . 0.25 112.46 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -114.13 168.96 9.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.319 . . . . 1.19 110.857 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.58 140.64 32.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 1.32 110.808 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.654 HG22 ' HB ' ' A' ' 62' ' ' ILE . 61.9 t -142.63 138.46 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 1.84 111.135 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.764 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -115.4 123.94 49.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.23 111.136 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.805 HG11 HG12 ' A' ' 29' ' ' VAL . 59.1 t -97.43 118.19 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.24 111.1 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.503 HG12 ' CG1' ' A' ' 47' ' ' ILE . 13.4 t -102.47 110.98 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.29 111.092 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -112.4 167.38 10.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.19 110.928 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 10.1 p-10 -151.18 -169.46 3.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.69 110.858 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.98 -35.95 69.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 5.75 110.857 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.8 m -72.95 -10.34 59.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 1.52 110.869 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.91 94.48 10.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 0.16 110.879 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 141.42 45.29 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.718 2.279 . . . . 0.21 112.396 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.0 t -48.64 -32.9 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.24 111.128 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.28 -52.64 43.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 3.15 110.891 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.53 -44.94 10.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.22 111.036 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.486 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.87 -61.55 2.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.275 -0.421 . . . . 0.19 110.939 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -37.41 28.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 2.82 110.874 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.21 -47.37 53.04 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.27 112.457 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.93 -39.97 93.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.53 110.92 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.805 HG12 HG11 ' A' ' 14' ' ' VAL . 18.1 m -76.82 -31.56 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.63 111.12 179.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -61.98 -59.8 4.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 1.85 110.868 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -40.2 71.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.425 . . . . 2.4 110.876 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.887 HD23 HD21 ' A' ' 35' ' ' LEU . 82.6 mt -72.94 -24.57 60.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.24 110.957 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.402 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.59 -25.36 45.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.43 110.917 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.88 -30.0 17.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.474 . . . . 0.37 111.076 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.887 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.48 -35.08 14.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.27 110.894 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.59 -45.49 4.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.31 111.128 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.07 -12.29 54.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.747 -0.74 . . . . 0.45 112.445 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.39 -62.54 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 2.86 110.951 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 3.6 mm-40 -84.81 -43.6 14.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 2.04 110.923 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.52 -121.86 4.31 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.33 112.471 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -157.03 153.84 28.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 3.32 110.853 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 33' ' ' GLN . 95.0 t -139.24 129.91 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 0.35 111.084 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -118.2 157.95 26.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.18 110.816 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.87 135.07 60.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.18 111.19 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -145.45 151.76 38.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 1.29 110.811 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.85 135.94 43.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.41 110.913 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.724 ' CD1' HG21 ' A' ' 73' ' ' THR . 23.1 mt -51.34 -35.03 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.24 111.087 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -32.05 62.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 2.67 110.863 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.7 19.48 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 3.36 110.882 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.736 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.67 -31.05 4.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.424 . . . . 1.13 110.91 -179.929 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -54.31 -36.3 63.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 1.09 110.947 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -85.46 -15.91 41.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 1.07 110.991 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 m -64.01 -13.32 45.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.93 110.874 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.64 65.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.37 111.118 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -63.84 -72.46 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.4 110.888 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.77 -166.28 2.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 1.61 110.967 179.954 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -106.69 127.13 53.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.957 0.408 . . . . 1.69 110.885 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 49.15 75.88 0.14 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.5 . . . . 1.25 110.886 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.2 p -127.48 -34.4 2.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.25 110.808 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.472 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.4 m-85 -98.54 120.82 39.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 1.48 110.885 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.5 -20.61 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 1.69 110.862 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.654 ' HB ' HG22 ' A' ' 12' ' ' VAL . 30.6 mt -143.87 144.23 23.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.226 -0.443 . . . . 0.32 111.101 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.933 HG21 HG23 ' A' ' 83' ' ' ILE . 23.1 mm -134.65 126.52 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.16 111.137 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.2 mm? -111.16 131.96 54.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.19 110.841 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.7 100.01 6.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.14 110.852 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.59 75.37 0.22 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.792 -0.718 . . . . 0.17 112.479 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.42 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.6 mm? -106.27 55.71 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.891 0.377 . . . . 0.59 110.88 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -123.96 160.07 53.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.579 0.705 . . . . 0.22 111.081 179.925 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 123.29 9.93 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.653 2.236 . . . . 0.27 112.427 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.93 7.52 87.82 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.712 -0.756 . . . . 0.17 112.54 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 68' ' ' VAL . 9.7 p -55.58 149.1 14.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.052 0.453 . . . . 0.75 110.828 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 30.5 p -138.79 109.12 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.044 -0.526 . . . . 0.18 111.2 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.724 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -160.43 156.77 26.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.31 111.106 -179.856 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.849 HD12 HD22 ' A' ' 147' ' ' LEU . 4.7 mt -135.04 106.55 6.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.29 110.915 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -82.11 153.83 25.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.37 110.901 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.7 m -131.0 176.32 8.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.63 110.884 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.47 -36.28 43.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.486 . . . . 0.23 111.094 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -62.5 -42.79 99.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 1.62 110.868 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.736 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -77.53 -55.58 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.3 111.138 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 119' ' ' LEU . 56.0 mt -48.87 -49.69 38.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.27 110.998 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.89 -48.28 51.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.59 111.062 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -46.76 88.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 4.92 110.903 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.933 HG23 HG21 ' A' ' 63' ' ' ILE . 49.9 mm -53.63 -64.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.25 111.122 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.78 -41.38 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.27 111.134 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -51.63 -51.31 56.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 2.55 110.867 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 56' ' ' LYS . 47.4 pt -84.3 -6.29 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.2 111.175 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -80.45 116.64 20.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.29 110.883 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -55.91 159.19 5.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.665 0.745 . . . . 2.3 110.811 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.6 Cg_endo -69.74 113.93 3.53 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.721 2.281 . . . . 0.23 112.395 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.23 4.46 55.18 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.788 -0.72 . . . . 0.21 112.436 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.53 -163.46 19.97 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.776 -0.726 . . . . 0.16 112.407 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.9 m -136.18 154.61 50.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.31 110.9 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.715 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.94 116.36 11.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.2 110.904 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.581 ' N ' HD22 ' A' ' 93' ' ' LEU . 47.6 m-85 -111.68 131.26 55.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 1.7 110.831 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.486 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.67 163.44 37.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.19 110.851 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -137.11 134.43 36.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 3.58 110.894 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.72 148.94 20.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.699 0.761 . . . . 3.48 110.876 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.607 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.6 Cg_endo -69.71 131.91 22.31 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.706 2.271 . . . . 0.46 112.383 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.2 m -120.15 146.59 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.29 111.197 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.28 132.87 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 3.43 110.875 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.1 p -102.56 26.61 7.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 1.06 111.152 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.77 24.72 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.64 111.114 179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.3 t -145.22 160.39 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.21 -0.45 . . . . 0.73 111.11 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.601 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -55.02 177.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 1.95 110.925 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -67.9 -53.03 29.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 3.43 110.875 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -70.88 -76.43 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.97 110.877 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.65 -168.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 1.54 110.851 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -5.28 56.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 1.74 110.872 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -146.02 140.92 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.52 111.149 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -60.6 121.51 12.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 2.37 110.856 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.601 HG21 ' O ' ' A' ' 104' ' ' ASP . 47.3 p -90.02 177.2 6.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.3 111.13 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.07 -54.73 43.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.22 111.097 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -59.51 -48.51 81.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.25 110.872 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -56.73 -40.83 76.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 2.9 110.874 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.514 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -62.91 -54.11 43.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.429 . . . . 0.41 110.894 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.3 m -55.83 -47.93 76.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.27 110.923 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -45.57 88.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.34 110.868 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.32 97.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.32 111.083 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.5 tp -65.94 -53.77 34.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.416 . . . . 0.26 110.957 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.2 m -59.12 -33.48 70.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.38 111.155 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.4 mt -86.99 -10.27 53.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.87 110.953 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.2 m -85.06 4.85 32.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 1.68 110.814 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.14 11.25 26.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.71 112.492 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -111.32 170.77 7.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 0.28 110.839 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.423 HG23 ' HG3' ' A' ' 126' ' ' GLU . 25.6 m -151.38 173.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.28 111.112 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 125' ' ' VAL . 29.8 mt-10 51.72 43.88 29.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 2.2 110.81 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.8 t -75.54 143.63 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.36 111.15 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.16 158.42 6.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 1.56 110.949 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 32.2 tt0 -80.5 145.35 31.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 2.14 110.915 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.3 mp -104.34 -36.71 7.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.29 110.867 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -159.59 176.16 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.16 110.937 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.719 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.3 tmt_? -133.17 138.0 46.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 4.41 110.92 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -123.84 136.11 27.02 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.672 0.749 . . . . 1.5 110.868 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.425 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.3 Cg_endo -69.89 158.82 55.51 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.597 2.198 . . . . 0.31 112.342 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -94.44 124.53 38.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.54 110.91 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.477 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.07 162.7 18.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 1.56 111.135 179.918 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 136' ' ' THR . 53.4 Cg_endo -69.79 -23.15 30.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.661 2.241 . . . . 0.66 112.31 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.79 -22.53 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 2.34 110.965 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -87.65 -53.91 4.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 3.98 110.911 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 136' ' ' THR . 7.7 p -50.66 -40.21 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.35 111.149 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -31.98 73.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 1.31 110.987 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -51.38 19.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.46 110.89 -179.849 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.641 HG23 HD13 ' A' ' 147' ' ' LEU . 7.3 p -61.72 -28.29 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.29 111.098 179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -76.28 -48.24 20.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 2.46 110.86 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -73.63 -19.32 60.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 2.17 110.959 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.5 -33.56 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.65 110.82 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.849 HD22 HD12 ' A' ' 74' ' ' LEU . 2.2 mp -128.32 -54.43 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.72 110.925 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.81 12.66 1.91 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.736 -0.745 . . . . 0.63 112.556 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.405 ' HB3' HG22 ' A' ' 143' ' ' VAL . 21.9 t-160 -70.77 121.37 17.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.93 110.834 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -152.04 105.48 3.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 2.73 110.946 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.48 175.02 13.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.66 110.826 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.82 -17.82 13.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.072 -0.513 . . . . 1.71 110.793 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -94.66 12.17 28.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 1.53 110.839 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.707 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.31 164.02 22.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.41 110.92 179.949 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.719 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.35 132.08 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.2 110.876 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 17.7 m-85 -77.09 131.86 38.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 1.73 110.845 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.69 144.37 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.21 111.139 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.527 ' HG2' HD13 ' A' ' 130' ' ' LEU . 3.4 tt0 -102.01 130.6 48.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 2.06 110.898 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 4.3 mp -126.03 149.72 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.31 111.183 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.45 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.5 t -127.88 160.48 31.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.29 111.062 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.52 132.22 3.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.83 -0.7 . . . . 0.15 112.606 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -94.71 140.84 29.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 1.77 110.925 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 6.2 tptm -81.46 134.52 51.23 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.621 0.724 . . . . 1.4 110.851 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 118.75 5.87 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.775 2.316 . . . . 0.42 112.328 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -100.48 152.02 20.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.5 110.895 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.4 t80 61.13 19.53 10.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 6.1 110.902 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -179.2 -172.65 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 9.73 110.908 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -75.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 9.31 111.16 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 52.27 70.29 0.94 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.772 -0.728 . . . . 8.11 112.525 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 46.6 p -175.38 32.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.851 0.358 . . . . 10.07 110.854 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.26 -75.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 10.67 110.814 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 30.2 ttp85 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 9.27 110.951 -179.885 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptp . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.75 0.31 . . . . 3.71 110.866 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.42 -21.73 63.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.49 111.04 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -54.14 -51.59 63.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.328 -0.396 . . . . 2.72 110.851 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.401 ' HB2' HD11 ' A' ' 6' ' ' ILE . 5.2 m-85 -122.4 22.13 10.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 1.53 110.758 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.51 41.92 56.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.814 -0.708 . . . . 0.31 112.445 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.483 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.6 mp -81.51 160.22 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.817 0.342 . . . . 0.34 111.099 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 36' ' ' THR . 0.4 OUTLIER -156.48 168.21 28.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 1.72 110.818 -179.927 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.64 130.62 35.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.4 111.099 179.881 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.15 2.79 29.79 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.719 -0.753 . . . . 0.3 112.448 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.446 ' NE2' ' HB2' ' A' ' 7' ' ' SER . 3.6 pt20 -116.96 166.88 11.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 1.05 110.958 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.02 115.19 29.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 1.3 110.848 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.591 HG13 HG21 ' A' ' 36' ' ' THR . 3.4 m -117.95 139.78 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 2.31 111.151 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.761 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -114.04 112.12 22.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.39 111.089 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.892 HG11 HG12 ' A' ' 29' ' ' VAL . 95.9 t -87.65 121.87 38.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.21 111.163 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.592 HG12 HG13 ' A' ' 47' ' ' ILE . 17.6 t -108.29 119.84 58.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.2 111.219 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -117.8 166.15 12.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.19 110.972 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.646 ' HB3' HD12 ' A' ' 47' ' ' ILE . 6.2 p-10 -145.65 -169.06 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.309 -0.405 . . . . 1.69 110.872 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -59.59 -35.28 73.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 3.44 110.937 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.4 m -74.68 -6.92 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 1.53 110.86 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.62 92.7 8.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.682 0.753 . . . . 0.13 110.906 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 54.9 Cg_endo -69.71 143.08 49.94 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 0.2 112.413 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t -48.8 -32.77 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.18 111.193 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -51.0 -53.26 34.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 3.13 110.872 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.57 -44.95 10.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 0.16 111.12 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.45 -61.95 1.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.13 110.968 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.52 -35.77 21.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 2.6 110.921 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.87 -47.67 45.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.677 -0.773 . . . . 0.19 112.548 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.4 mt -61.73 -39.86 93.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.92 0.391 . . . . 0.48 110.987 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.892 HG12 HG11 ' A' ' 14' ' ' VAL . 17.0 m -76.65 -31.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.63 111.199 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.38 -59.68 4.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 1.66 110.807 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -40.29 72.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 1.7 110.945 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.862 HD23 HD21 ' A' ' 35' ' ' LEU . 86.4 mt -72.78 -24.93 61.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.24 110.883 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.478 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.49 -25.01 45.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.38 110.82 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.59 -29.95 17.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.22 111.094 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.862 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.6 -34.82 14.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.19 110.892 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.17 -45.6 4.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.22 111.134 179.918 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.47 -12.27 55.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.3 112.505 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -65.33 -62.66 1.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 2.62 110.989 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.09 -36.49 10.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 1.88 110.925 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.32 -128.74 4.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.25 112.452 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -154.32 153.19 31.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 2.21 110.799 -179.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 12' ' ' VAL . 94.8 t -138.88 117.05 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.31 111.116 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.3 t -107.01 151.35 25.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.22 110.794 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -114.24 136.29 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.14 111.02 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -144.99 152.2 39.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.142 -0.481 . . . . 1.27 110.842 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -102.8 134.34 46.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.48 110.952 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.926 HD13 HG21 ' A' ' 73' ' ' THR . 10.2 mt -50.29 -33.56 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.34 111.101 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -76.48 -34.3 58.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 2.64 110.878 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -93.37 18.57 9.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 3.16 110.821 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.793 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.49 -30.25 4.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 1.12 110.961 179.891 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mp -53.45 -37.95 63.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 1.08 110.844 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -85.23 -16.18 41.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 1.18 110.834 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.467 ' HB2' HD13 ' A' ' 50' ' ' LEU . 48.8 m -65.41 -12.38 51.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 0.95 110.873 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.84 61.2 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.41 111.099 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -58.62 -71.82 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.117 -0.492 . . . . 0.47 110.806 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -150.2 -168.68 3.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 1.75 110.866 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -102.18 137.71 40.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 1.94 110.899 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 p 46.55 85.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 1.19 110.873 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 p -139.97 -40.49 0.44 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.46 110.865 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.494 ' O ' HD23 ' A' ' 87' ' ' LEU . 96.4 m-85 -99.64 120.42 39.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 1.48 110.889 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.62 -21.6 63.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 1.5 110.819 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 14.5 mt -147.16 142.64 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.38 111.165 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.921 HG21 HG23 ' A' ' 83' ' ' ILE . 22.5 mm -129.43 134.42 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.27 111.109 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -114.54 135.24 54.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.29 110.924 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.76 97.73 4.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.15 110.801 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.48 79.54 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.22 112.47 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.88 56.69 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.59 110.959 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.31 159.35 57.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.617 0.723 . . . . 0.21 111.16 179.809 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 116.46 4.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.683 2.255 . . . . 0.25 112.375 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.31 7.37 69.82 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.2 112.533 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -54.79 144.25 23.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.974 0.416 . . . . 0.68 110.87 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.76 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 31.5 p -133.49 108.5 8.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.19 111.166 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.926 HG21 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -162.7 149.53 13.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.25 111.095 -180.0 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.931 HD12 HD22 ' A' ' 147' ' ' LEU . 3.4 mt -127.52 99.99 5.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.13 -0.486 . . . . 0.26 110.967 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -73.23 145.95 45.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.32 110.881 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.513 ' H ' HD13 ' A' ' 79' ' ' ILE . 1.5 m -120.28 172.8 7.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.55 110.742 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.34 -39.7 47.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.33 111.125 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.6 -38.31 84.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 2.38 110.909 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.793 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -79.81 -54.84 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.23 111.201 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' A' ' 119' ' ' LEU . 50.0 mt -49.84 -45.87 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.33 110.906 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.75 -51.65 54.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.174 -0.467 . . . . 0.46 111.014 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -42.48 77.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 2.61 110.886 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.921 HG23 HG21 ' A' ' 63' ' ' ILE . 36.9 mm -59.93 -68.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.28 111.093 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.57 -32.68 19.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.45 111.127 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -61.02 -56.15 24.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 2.35 110.906 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 56' ' ' LYS . 29.8 pt -76.95 -6.72 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.3 111.165 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -78.36 124.31 27.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.27 110.891 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -62.67 160.23 37.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.572 0.701 . . . . 2.13 110.869 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 114.04 3.56 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.73 2.286 . . . . 0.23 112.318 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.71 3.5 56.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.819 -0.705 . . . . 0.21 112.44 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.11 -156.9 9.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.716 -0.754 . . . . 0.22 112.423 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.3 m -146.0 158.18 43.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.888 0.375 . . . . 0.5 110.833 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.631 HD22 ' N ' ' A' ' 94' ' ' PHE . 1.0 OUTLIER -140.38 116.14 10.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.18 110.954 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.631 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.0 m-85 -108.76 132.73 53.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.63 110.84 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.533 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.56 160.59 42.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.16 110.878 179.944 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 126.37 36.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 1.81 110.862 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.522 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -149.9 148.13 24.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.659 0.742 . . . . 2.3 110.875 179.982 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.6 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.5 Cg_endo -69.65 143.95 53.05 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.718 2.279 . . . . 0.23 112.386 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.6 m -127.12 147.0 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.25 111.1 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.01 132.42 56.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 3.15 110.811 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.7 p -104.75 25.99 9.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 1.04 111.247 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.65 26.31 0.83 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.74 111.104 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 104' ' ' ASP . 4.8 t -144.09 158.64 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.75 111.114 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.543 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -57.11 -177.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.86 110.886 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -66.5 -73.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 2.4 110.874 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.34 -75.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 2.34 110.834 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.75 -168.56 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 1.68 110.747 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -6.28 57.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 1.74 110.886 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.3 m -146.61 143.44 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.48 111.079 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.491 ' H ' HD22 ' A' ' 74' ' ' LEU . 7.6 ttmt -65.61 113.18 4.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.4 110.963 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.543 HG21 ' O ' ' A' ' 104' ' ' ASP . 30.3 p -83.19 179.83 7.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.25 111.187 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.65 -54.27 47.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.28 111.042 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -49.54 76.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.26 110.865 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -39.74 76.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 2.14 110.865 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.522 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.3 tm? -62.97 -55.1 28.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.4 110.965 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.7 m -57.84 -47.43 82.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.25 110.853 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -44.33 96.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.28 110.912 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.11 -50.96 71.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.3 111.182 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.634 ' CD1' HD22 ' A' ' 80' ' ' LEU . 7.1 tp -59.68 -57.31 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.54 110.865 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -57.52 -26.56 61.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.38 111.14 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.9 mt -84.3 -16.0 44.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.75 110.93 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.0 p -82.2 3.09 28.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 2.52 110.809 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.81 -4.85 34.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.92 112.49 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.637 HD23 ' HA3' ' A' ' 161' ' ' GLY . 1.4 tp -83.32 171.3 13.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.54 110.92 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.07 169.66 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.42 111.146 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 51.64 44.93 28.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 2.24 110.881 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.16 139.44 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.28 111.149 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.18 159.98 7.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 1.84 110.879 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -77.54 145.29 37.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 2.61 110.913 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.712 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.1 mp -102.16 -37.53 8.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.25 110.917 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -156.04 176.27 12.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 3.0 110.957 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ARG . . . . . 0.726 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.0 tmt_? -129.39 136.87 50.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.328 -0.397 . . . . 4.23 110.929 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -123.55 136.56 27.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.62 0.724 . . . . 1.39 110.999 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.403 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.7 Cg_endo -69.71 163.2 39.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.649 2.233 . . . . 0.26 112.388 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.669 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -96.79 124.35 40.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.174 -0.466 . . . . 0.29 110.909 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.456 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.09 161.21 25.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.64 0.734 . . . . 1.32 111.145 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.8 Cg_endo -69.77 -28.57 25.06 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.704 2.27 . . . . 0.46 112.32 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -85.1 -17.76 36.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.217 -0.447 . . . . 2.49 110.936 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.32 -54.0 4.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 2.82 110.998 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.58 -40.03 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.26 111.095 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -34.72 76.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 1.28 110.86 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -46.77 69.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.29 110.793 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 10.3 p -68.0 -30.03 46.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.21 111.183 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -75.66 -32.25 60.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 2.04 110.923 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -89.43 -20.29 24.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 1.61 110.901 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -94.36 -32.55 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.3 110.828 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.931 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -128.31 -54.05 1.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.33 110.843 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.38 12.12 2.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.807 -0.711 . . . . 0.31 112.49 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -70.9 121.53 18.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.682 0.277 . . . . 0.66 110.853 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -152.18 105.27 3.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.296 -0.411 . . . . 2.27 110.923 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.7 t -160.73 176.52 11.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.61 110.91 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.12 -20.8 13.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.7 110.952 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -92.02 13.13 19.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 1.57 110.938 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.669 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.54 163.89 22.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.33 110.921 179.909 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.6 tm? -173.35 129.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.2 110.851 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.76 ' CZ ' HG22 ' A' ' 72' ' ' THR . 31.3 m-85 -75.39 137.62 41.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 1.71 110.882 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -150.3 146.41 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.23 111.154 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.712 ' HG2' HD13 ' A' ' 130' ' ' LEU . 23.2 tt0 -98.9 132.05 44.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 1.57 110.926 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -126.99 149.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.23 111.144 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.464 ' N ' HD11 ' A' ' 130' ' ' LEU . 7.0 t -137.06 152.64 50.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.37 111.094 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.637 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -144.1 137.48 7.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.73 . . . . 0.17 112.483 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -92.83 140.18 29.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 1.75 110.832 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.57 135.29 49.77 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.622 0.725 . . . . 1.26 110.855 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 127.47 14.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.724 2.283 . . . . 0.32 112.292 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -107.67 149.24 28.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.34 110.908 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -69.31 85.31 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 7.01 110.953 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.46 34.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 9.25 110.851 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 26.6 m -150.06 166.35 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 6.07 111.121 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -112.41 -19.61 6.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.685 -0.769 . . . . 6.35 112.531 179.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 87.1 p -53.51 170.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.341 . . . . 7.17 110.869 -179.727 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 -170.97 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 7.28 110.89 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 10.81 110.864 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.832 0.349 . . . . 2.35 110.83 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -122.24 22.55 10.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 1.97 110.842 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.31 40.14 52.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.26 112.529 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.543 HG23 HG21 ' A' ' 12' ' ' VAL . 1.7 mp -78.51 159.26 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.23 111.15 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.725 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -152.43 163.48 39.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 1.36 110.859 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.47 126.1 35.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.32 111.096 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.69 -0.0 20.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.72 -0.752 . . . . 0.3 112.477 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -117.55 170.64 8.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.827 0.346 . . . . 1.12 110.902 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.81 113.79 27.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 1.36 110.856 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 ' HB ' ' A' ' 62' ' ' ILE . 99.1 t -118.5 125.89 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 1.96 111.177 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.781 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -103.16 128.44 50.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.28 111.124 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.843 HG11 HG12 ' A' ' 29' ' ' VAL . 60.7 t -101.32 120.84 51.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.17 111.166 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.5 t -104.31 120.87 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.23 111.128 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.4 p-90 -120.48 168.99 10.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.19 110.898 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.76 -169.93 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 1.75 110.813 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -57.41 -35.56 70.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 3.53 110.886 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.54 -9.9 59.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 1.24 110.837 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.04 94.44 10.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.686 0.755 . . . . 0.13 110.912 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 142.03 46.72 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.683 2.255 . . . . 0.19 112.34 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.0 t -48.99 -32.57 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.17 111.12 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.38 -52.93 41.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 2.67 110.851 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.55 -44.96 10.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.17 111.048 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.467 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.45 -61.25 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.13 110.917 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -35.95 24.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 3.42 110.87 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.41 -47.25 44.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.786 -0.721 . . . . 0.18 112.439 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 mt -61.94 -38.61 89.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.48 110.928 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.843 HG12 HG11 ' A' ' 14' ' ' VAL . 17.5 m -78.09 -31.35 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.62 111.155 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.33 -58.0 9.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 1.59 110.84 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -40.05 74.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 1.73 110.909 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.879 HD23 HD21 ' A' ' 35' ' ' LEU . 88.4 mt -73.12 -25.07 60.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.24 110.891 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.472 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.37 -25.26 46.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.37 110.877 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.49 -30.25 17.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.22 111.153 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.879 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -90.75 -35.18 15.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.2 110.904 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.725 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.4 -46.9 4.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.2 111.135 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.31 -13.74 50.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.73 . . . . 0.26 112.477 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -62.58 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 2.0 110.882 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -96.01 -38.11 10.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 2.03 110.903 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.56 -132.98 6.52 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.759 -0.734 . . . . 0.27 112.461 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -149.22 152.67 36.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 2.18 110.906 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.8 t -137.68 122.81 24.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.23 111.1 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -112.14 157.63 20.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.18 110.844 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.58 135.19 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.17 111.132 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -142.51 151.1 41.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 2.02 110.847 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -103.26 134.59 46.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.4 110.861 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.722 ' CD1' HG21 ' A' ' 73' ' ' THR . 26.7 mt -51.89 -36.48 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.33 111.15 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -32.84 69.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 2.19 110.869 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.52 20.92 16.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 3.52 110.93 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.845 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.15 -27.8 3.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 1.06 110.928 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -55.1 -32.7 62.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 1.04 110.888 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -84.86 -15.33 45.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 1.06 110.929 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB2' HD13 ' A' ' 50' ' ' LEU . 47.0 m -63.77 -12.61 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.88 110.892 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -73.83 63.1 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.28 111.083 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.406 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 12.1 m-70 -64.46 -70.17 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.38 110.873 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.686 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.12 -168.2 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 1.13 110.914 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -106.35 128.12 53.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 2.01 110.846 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 48.93 77.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 1.34 110.843 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.7 p -130.12 -34.2 1.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.26 110.845 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.2 m-85 -98.99 120.25 39.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 1.42 110.886 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.13 -20.72 62.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 1.5 110.842 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.699 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.2 mt -146.62 144.5 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.23 111.153 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.92 HG21 HG23 ' A' ' 83' ' ' ILE . 17.2 mm -134.69 131.71 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.12 111.118 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -113.94 137.06 52.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.17 110.976 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.47 101.64 6.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.15 110.873 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.63 74.66 0.27 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.804 -0.713 . . . . 0.16 112.428 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.576 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.2 mm? -106.63 56.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 0.58 110.893 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.0 159.79 60.1 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.621 0.724 . . . . 0.23 111.2 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 124.14 10.77 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.24 112.32 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.5 7.11 88.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.21 112.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 68' ' ' VAL . 10.0 p -55.58 151.49 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.972 0.415 . . . . 0.78 110.829 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 29.7 p -140.33 108.96 5.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.18 111.132 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.722 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.79 153.81 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 0.26 111.126 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.96 HD12 HD22 ' A' ' 147' ' ' LEU . 5.3 mt -132.25 105.78 7.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.22 110.916 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -82.35 152.5 26.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.25 110.845 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.0 m -131.94 176.98 7.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.48 110.843 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -37.27 45.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.24 111.079 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.25 -44.41 96.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 2.07 110.883 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.845 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -75.11 -54.85 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.19 111.133 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 119' ' ' LEU . 61.7 mt -51.08 -38.92 54.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.22 110.906 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.84 -55.2 24.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.32 111.101 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -56.09 -44.96 79.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 2.82 110.887 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.92 HG23 HG21 ' A' ' 63' ' ' ILE . 49.9 mm -55.08 -67.76 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.22 111.132 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.07 -40.1 57.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.25 111.067 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -52.95 -49.06 66.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 2.85 110.883 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.686 HG22 ' O ' ' A' ' 56' ' ' LYS . 38.7 pt -87.02 -5.3 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.19 111.162 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -80.92 117.3 21.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.25 110.887 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -56.81 158.69 8.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.598 0.714 . . . . 2.29 110.917 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 54.0 Cg_endo -69.73 114.03 3.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 0.19 112.365 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.03 3.27 54.75 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.15 112.504 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.38 -162.8 17.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.784 -0.722 . . . . 0.14 112.502 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.3 m -137.01 155.5 49.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.347 . . . . 0.27 110.872 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -139.56 115.55 10.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.15 110.893 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.551 ' N ' HD22 ' A' ' 93' ' ' LEU . 58.6 m-85 -110.15 132.1 54.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 1.9 110.873 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.549 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.78 158.76 44.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.15 110.883 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.38 128.29 44.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 1.86 110.905 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.596 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -150.69 146.19 19.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 2.26 110.914 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.608 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.73 138.07 37.04 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.656 2.238 . . . . 0.18 112.365 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 155' ' ' LEU . 14.9 m -120.71 146.55 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.19 111.098 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -110.59 132.58 54.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 1.93 110.851 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.2 p -105.15 25.9 10.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 1.11 111.145 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.63 25.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.7 111.106 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.5 t -143.66 159.79 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.74 111.123 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.53 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -56.66 -178.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 1.79 110.889 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -66.81 -68.27 0.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 2.05 110.873 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -60.0 -75.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 2.19 110.859 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.81 -167.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 1.72 110.863 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -7.48 58.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 1.91 110.886 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.44 141.02 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.53 111.106 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -63.17 115.09 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 2.43 110.895 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.53 HG21 ' O ' ' A' ' 104' ' ' ASP . 33.1 p -83.19 -179.8 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.27 111.113 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.63 55.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.28 111.091 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.19 -48.9 77.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.31 110.887 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -37.92 75.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 2.3 110.888 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.596 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.3 tm? -65.17 -55.05 20.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.34 110.912 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.8 m -57.37 -45.59 84.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.35 110.897 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -42.42 91.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.48 110.852 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.89 97.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.32 111.075 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.56 HD11 HD12 ' A' ' 93' ' ' LEU . 14.8 tp -64.52 -51.44 62.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.25 110.916 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.5 m -62.28 -31.55 72.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.34 111.113 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.04 -10.27 53.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.67 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.5 6.51 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 1.7 110.864 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.82 6.0 32.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.49 112.465 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -106.69 171.63 7.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 0.28 110.942 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 126' ' ' GLU . 27.4 m -150.14 171.15 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.27 111.144 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.516 ' HG3' HG23 ' A' ' 125' ' ' VAL . 22.5 mt-10 51.76 44.29 29.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 1.85 110.903 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.419 HG13 HD23 ' A' ' 119' ' ' LEU . 89.6 t -81.09 143.03 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.25 111.109 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 160.22 8.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 1.57 110.902 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -77.75 146.18 36.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 2.5 110.906 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.475 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.1 mp -105.6 -36.96 6.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.2 110.964 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.85 176.21 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 1.16 110.932 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.698 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.7 tmt_? -132.87 137.98 46.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 4.28 110.845 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -125.74 138.07 31.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.615 0.722 . . . . 1.82 110.888 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.413 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.7 Cg_endo -69.71 165.04 32.27 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.729 2.286 . . . . 0.23 112.35 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.676 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.03 126.48 43.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.28 110.944 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.52 161.27 23.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.619 0.723 . . . . 1.49 111.107 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -24.57 29.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.241 . . . . 0.31 112.353 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -85.49 -22.54 28.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 2.54 110.886 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -87.51 -52.86 5.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 2.5 110.901 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 136' ' ' THR . 7.4 p -49.62 -40.34 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.23 111.169 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -33.49 74.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 1.16 110.921 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -46.19 67.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.23 110.888 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.708 HG23 HD13 ' A' ' 147' ' ' LEU . 9.2 p -68.37 -30.71 48.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.16 111.101 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -76.21 -31.45 58.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 1.87 110.862 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -89.7 -20.44 23.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 1.63 110.841 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.66 -32.87 13.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.27 110.849 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.96 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.19 -54.17 1.38 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.3 110.934 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.51 13.75 2.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.28 112.483 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -70.63 122.01 18.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 0.75 110.826 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -151.53 105.32 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 2.4 110.837 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.1 t -160.53 173.82 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.7 110.86 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.71 -17.59 14.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 1.56 110.858 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.76 12.52 29.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 1.53 110.911 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.676 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -81.61 165.18 21.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.25 110.952 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.44 130.24 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.18 110.973 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.2 m-85 -74.34 133.44 42.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 1.8 110.877 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.04 145.19 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.22 111.156 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.576 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.6 tt0 -98.97 129.26 45.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.91 110.957 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.54 151.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.21 111.102 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.456 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.1 t -134.91 161.56 34.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.25 111.141 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.43 139.5 7.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.19 112.476 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -97.56 140.62 31.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.368 . . . . 1.62 110.889 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 5.2 tptt -80.71 134.79 53.28 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.599 0.714 . . . . 2.32 110.877 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 119.19 6.18 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.39 112.301 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.37 110.883 179.985 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.77 0.319 . . . . 1.97 110.802 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' A' ' 6' ' ' ILE . 4.5 m-85 -122.14 21.4 10.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 1.53 110.898 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 54.46 41.82 73.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.768 -0.73 . . . . 0.31 112.451 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.538 HG23 HG21 ' A' ' 12' ' ' VAL . 1.5 mp -83.14 160.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.32 111.137 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.733 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -156.62 168.99 25.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.82 110.831 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.8 132.28 35.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.46 111.034 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.05 1.31 30.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.28 112.482 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -118.18 166.95 11.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.781 0.324 . . . . 1.2 110.933 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.67 113.05 26.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 2.17 110.899 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 62' ' ' ILE . 95.3 t -117.35 132.52 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 1.92 111.136 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.793 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -109.03 125.29 51.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.23 111.057 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.828 HG11 HG12 ' A' ' 29' ' ' VAL . 99.6 t -98.35 120.37 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.16 111.144 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.31 118.45 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.2 111.134 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -118.6 168.85 10.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 0.19 110.912 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -151.48 -169.91 3.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.267 -0.424 . . . . 1.85 110.857 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -57.63 -35.49 70.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 3.02 110.882 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.61 -9.51 58.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 1.21 110.848 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.92 94.62 10.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.748 0.785 . . . . 0.15 110.923 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 142.11 47.33 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.657 2.238 . . . . 0.23 112.34 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.13 -32.57 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.21 111.108 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.28 -52.92 40.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 2.59 110.907 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.9 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.19 111.155 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.6 -61.41 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.15 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -49.6 -36.01 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 2.49 110.901 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.21 -47.22 45.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 0.2 112.47 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.96 -38.57 89.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.755 0.312 . . . . 0.52 110.87 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.828 HG12 HG11 ' A' ' 14' ' ' VAL . 17.0 m -78.21 -31.09 16.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.63 111.079 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -62.54 -57.86 9.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 1.69 110.852 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -40.01 75.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 1.75 110.94 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.886 HD23 HD21 ' A' ' 35' ' ' LEU . 88.1 mt -73.17 -24.77 60.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.24 110.89 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.547 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.5 -25.03 45.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.38 110.825 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.74 -30.36 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.22 111.026 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.886 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.81 -34.93 15.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.21 110.905 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.79 -46.06 4.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.21 111.139 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.83 -12.62 54.42 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.828 -0.701 . . . . 0.25 112.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.61 -62.6 1.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.754 0.311 . . . . 2.18 110.938 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -96.33 -37.85 10.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 2.56 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.13 -129.87 5.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 0.26 112.497 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -152.59 152.03 31.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.88 0.371 . . . . 2.18 110.885 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.547 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.0 t -136.33 124.83 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.22 111.036 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -114.07 155.83 25.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.15 110.9 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.52 134.8 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.14 111.141 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -142.76 151.3 41.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 1.26 110.864 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -103.3 134.99 45.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.4 110.906 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.673 ' CD1' HG21 ' A' ' 73' ' ' THR . 26.4 mt -52.17 -36.12 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.28 111.128 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -71.54 -32.25 67.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 2.01 110.877 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -103.18 20.11 18.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 3.61 110.856 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.833 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.32 -28.08 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 1.07 110.899 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.53 -33.46 63.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 1.05 110.9 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -84.06 -15.15 48.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 1.06 110.969 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.454 ' HB2' HD13 ' A' ' 50' ' ' LEU . 34.5 m -66.55 -10.13 41.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.87 110.859 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.5 63.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.27 111.059 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -64.02 -67.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.36 110.873 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -153.85 -178.22 6.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 1.38 110.849 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -92.63 130.52 38.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 1.83 110.885 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 t 51.79 83.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 2.11 110.879 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.4 p -136.06 -39.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.28 110.773 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.7 m-85 -100.51 122.25 42.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 2.03 110.975 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.5 m-20 -71.73 -21.9 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 1.73 110.853 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.693 ' HB ' HG22 ' A' ' 12' ' ' VAL . 21.4 mt -145.34 144.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.22 111.087 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.93 HG21 HG23 ' A' ' 83' ' ' ILE . 17.2 mm -133.75 132.7 56.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.13 111.104 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -114.58 136.88 52.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.15 110.916 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.44 100.33 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.13 110.854 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.54 74.97 0.24 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.16 112.446 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.556 HD13 ' OE1' ' A' ' 158' ' ' GLN . 3.9 mm? -107.45 58.19 0.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.866 0.365 . . . . 0.57 110.928 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.0 159.65 63.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.611 0.719 . . . . 0.23 111.146 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 116.73 4.7 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.601 2.201 . . . . 0.26 112.355 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.46 7.13 69.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.841 -0.695 . . . . 0.17 112.465 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.55 150.24 12.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.939 0.4 . . . . 0.68 110.87 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.773 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 39.5 p -138.98 108.45 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.21 111.127 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.673 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.14 153.44 18.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.25 111.239 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.879 HD12 HD22 ' A' ' 147' ' ' LEU . 3.3 mt -132.77 104.57 6.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.28 110.856 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -81.16 153.74 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.26 110.885 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.1 m -131.56 -176.29 3.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.43 110.925 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.8 -36.93 70.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.23 111.106 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.59 -46.48 88.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 2.32 110.874 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.833 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -73.04 -54.96 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 0.2 111.079 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 119' ' ' LEU . 65.2 mt -50.72 -40.18 53.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.19 110.96 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.02 -53.94 35.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.053 -0.521 . . . . 0.3 111.15 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.23 -44.8 88.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 3.01 110.868 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.93 HG23 HG21 ' A' ' 63' ' ' ILE . 38.7 mm -55.67 -68.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.2 111.099 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.33 -37.82 49.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.21 111.187 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -55.11 -49.83 70.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 3.35 110.898 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 56' ' ' LYS . 34.3 pt -85.21 -7.02 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.2 111.108 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.95 111.78 14.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.142 -0.481 . . . . 0.38 110.9 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 61' ' ' ASP . 48.8 mtt180 -51.46 159.53 1.17 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.59 0.71 . . . . 2.24 110.852 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 114.44 3.7 Favored 'Trans proline' 0 N--CA 1.466 -0.113 0 C-N-CA 122.786 2.324 . . . . 0.16 112.342 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.77 2.41 56.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.662 -0.78 . . . . 0.15 112.416 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.28 -162.57 13.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.647 -0.787 . . . . 0.13 112.551 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.2 m -138.32 156.03 48.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.832 0.349 . . . . 0.35 110.9 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.704 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -140.01 114.31 9.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.16 110.974 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.554 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.0 m-85 -108.46 132.34 53.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 1.65 110.897 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.576 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.51 162.31 39.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.13 110.845 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.05 129.35 35.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 1.88 110.842 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.72 148.65 20.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.655 0.74 . . . . 3.71 110.854 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.617 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.1 Cg_endo -69.82 140.88 43.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.61 2.206 . . . . 0.18 112.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.9 m -125.86 146.67 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.22 111.099 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' CD ' HG21 ' A' ' 103' ' ' VAL . 46.8 mt-10 -108.89 132.75 53.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 2.06 110.953 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p -90.94 -42.68 10.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 1.29 111.091 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.559 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.5 40.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.59 111.111 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' CD ' ' A' ' 100' ' ' GLU . 26.4 t -148.03 150.05 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.63 111.069 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -52.86 171.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.69 110.854 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -66.37 -54.17 27.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 2.83 110.96 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -70.66 -75.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 1.69 110.837 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t 52.31 -169.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.034 0.445 . . . . 2.2 110.841 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -81.71 -4.69 56.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 1.77 110.877 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.12 150.4 21.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.4 111.043 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.18 119.2 13.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 2.97 110.844 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.647 HG21 ' O ' ' A' ' 104' ' ' ASP . 62.8 p -91.81 178.86 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.29 111.201 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.4 -53.61 55.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.2 111.127 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -61.06 -47.16 87.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.26 110.819 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -42.25 91.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 2.47 110.889 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -61.82 -57.43 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.48 110.886 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 66.6 m -52.05 -44.97 64.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.23 110.888 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -42.06 87.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.29 110.824 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.11 97.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.22 111.095 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.556 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.0 tp -66.2 -50.93 62.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.23 110.987 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.0 m -61.99 -33.31 74.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.31 111.138 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.87 -10.45 53.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.66 110.897 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.72 5.25 29.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 1.7 110.872 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.81 11.23 25.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.647 -0.787 . . . . 0.68 112.38 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.704 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -112.13 171.0 7.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 0.26 110.883 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.2 m -150.9 170.19 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.21 111.168 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 53.01 44.41 30.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 2.32 110.92 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.4 t -81.04 142.94 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.25 111.174 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.93 158.58 7.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 1.59 110.866 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -77.23 145.68 37.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 2.28 110.784 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.502 HD11 ' N ' ' A' ' 160' ' ' THR . 2.1 mp -105.15 -35.55 7.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.23 110.975 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.1 176.42 12.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 1.09 110.879 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.72 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -131.86 137.4 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 4.12 110.907 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -124.02 137.65 29.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 1.83 110.874 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.426 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.9 Cg_endo -69.74 165.02 32.34 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.693 2.262 . . . . 0.22 112.353 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.671 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.15 127.47 44.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.27 110.914 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.434 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.21 161.1 24.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 1.21 111.145 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.434 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.6 Cg_endo -69.76 -28.79 24.83 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.625 2.217 . . . . 0.32 112.307 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -85.24 -17.86 35.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 2.77 110.924 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.23 -53.25 4.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 2.33 110.909 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.22 -40.65 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.25 111.123 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.402 HE21 ' N ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -68.77 -34.86 76.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 1.18 110.926 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.402 ' N ' HE21 ' A' ' 141' ' ' GLN . 0.3 OUTLIER -67.86 -46.18 72.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.22 110.904 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 8.5 p -68.38 -30.19 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.077 -0.51 . . . . 0.18 111.2 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -75.64 -32.59 60.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.81 110.834 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -89.54 -20.18 24.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 1.72 110.877 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -94.11 -32.81 13.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.32 110.887 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.879 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.98 -54.25 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.36 110.85 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.65 8.02 2.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.32 112.459 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -70.2 121.26 17.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 0.7 110.822 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -152.32 104.72 2.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 3.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 t -161.03 172.13 17.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.61 110.879 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.28 -11.57 15.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 1.57 110.864 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.559 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 4.9 m-80 -99.92 14.29 30.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 1.55 110.923 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.671 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -87.39 165.86 15.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.34 110.866 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.72 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -171.46 130.06 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.19 111.023 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.773 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.4 m-85 -72.7 132.31 43.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 1.7 110.883 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.17 143.89 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.22 111.148 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.556 ' OE1' HD13 ' A' ' 67' ' ' LEU . 3.0 tt0 -98.69 133.08 43.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 1.86 110.848 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.73 148.14 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.48 111.205 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.502 ' N ' HD11 ' A' ' 130' ' ' LEU . 6.1 t -132.62 156.06 47.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.29 111.122 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -145.58 139.11 8.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.19 112.465 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -96.74 132.7 42.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.36 . . . . 3.5 110.926 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 135.3 77.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.597 0.713 . . . . 1.2 110.887 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 128.22 15.6 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.631 2.221 . . . . 0.31 112.32 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.3 110.887 -179.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.804 0.335 . . . . 3.23 110.926 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.514 ' HE1' HD12 ' A' ' 67' ' ' LEU . 2.9 m-85 -93.72 -14.98 25.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 2.07 110.869 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.5 48.59 10.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.725 -0.75 . . . . 0.39 112.45 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.824 HG23 HG21 ' A' ' 12' ' ' VAL . 1.2 mp -88.32 162.01 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.37 . . . . 0.6 111.136 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.64 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -150.34 170.01 20.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.811 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.67 133.36 34.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.4 111.109 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.21 -6.07 30.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.781 -0.723 . . . . 0.31 112.536 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -111.88 168.96 9.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 1.16 110.899 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.04 114.32 28.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 1.28 110.872 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.824 HG21 HG23 ' A' ' 6' ' ' ILE . 88.2 t -119.3 126.97 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 2.01 111.149 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.804 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -104.0 128.22 51.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.33 111.153 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.805 HG11 HG12 ' A' ' 29' ' ' VAL . 97.7 t -100.38 119.23 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.23 111.159 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.84 118.14 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.25 111.171 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -118.19 169.03 10.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.31 110.952 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.414 ' HB3' HD12 ' A' ' 47' ' ' ILE . 9.4 p-10 -151.67 -170.47 3.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 1.83 110.875 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -35.56 69.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 6.31 110.901 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.61 -9.36 58.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.34 110.87 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.93 94.43 10.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.613 0.72 . . . . 0.23 110.823 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 142.37 47.55 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.678 2.252 . . . . 0.3 112.45 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -49.07 -32.68 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.32 111.042 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -51.09 -52.93 38.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 2.51 110.878 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.62 -44.93 10.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.27 111.067 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.468 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.76 -61.3 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.23 110.929 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.55 -37.07 25.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 2.55 110.878 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -47.29 50.35 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.736 -0.745 . . . . 0.27 112.437 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.5 mt -61.75 -38.84 89.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.52 110.934 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.805 HG12 HG11 ' A' ' 14' ' ' VAL . 17.8 m -78.13 -30.77 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.64 111.11 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.52 -58.27 8.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 1.58 110.875 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -39.57 74.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 1.8 110.884 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.813 HD23 HD21 ' A' ' 35' ' ' LEU . 97.0 mt -73.36 -25.37 60.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 0.24 110.872 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.561 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -77.63 -24.81 49.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 0.41 110.964 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.66 -29.7 16.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.29 111.179 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.813 HD21 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -91.49 -31.05 16.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.29 110.912 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -106.84 -45.47 4.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.26 111.15 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.44 -12.42 51.47 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.722 -0.751 . . . . 0.31 112.529 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.79 -62.71 1.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.329 . . . . 1.85 110.822 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -99.57 -36.5 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 2.65 110.861 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.22 -129.46 4.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.741 . . . . 0.26 112.448 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -154.9 152.01 29.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.357 . . . . 2.23 110.882 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.561 HG21 ' HA ' ' A' ' 33' ' ' GLN . 92.9 t -136.0 122.97 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.22 111.165 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.6 t -113.09 154.03 27.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.17 110.829 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -117.14 134.28 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.17 111.208 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -142.04 151.24 42.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 1.26 110.882 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -103.25 134.95 45.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.862 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.725 ' CD1' HG21 ' A' ' 73' ' ' THR . 29.5 mt -52.29 -36.54 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.32 111.092 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -70.79 -32.44 69.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 2.03 110.924 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.75 20.71 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 3.64 110.855 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.838 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.09 -27.84 3.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 1.07 110.899 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -55.01 -33.09 62.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 1.02 110.937 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -84.81 -15.53 44.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 1.16 110.937 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.508 ' HB2' HD13 ' A' ' 50' ' ' LEU . 48.0 m -63.69 -12.73 36.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.87 110.899 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -74.13 61.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.3 111.082 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.403 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 11.9 m170 -63.03 -69.54 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.37 110.869 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.664 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.02 -168.75 2.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 1.16 110.957 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -107.37 131.02 54.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 1.73 110.923 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.25 73.5 0.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 1.2 110.829 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.2 p -127.76 -34.46 2.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.28 110.836 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.4 m-85 -99.29 118.34 35.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 1.42 110.849 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.78 -20.89 63.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.04 -0.527 . . . . 1.75 110.939 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.701 ' HB ' HG22 ' A' ' 12' ' ' VAL . 25.3 mt -146.98 144.88 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.26 111.116 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.864 HG21 HG23 ' A' ' 83' ' ' ILE . 15.9 mm -135.09 131.58 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.14 111.104 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -112.68 137.34 51.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.16 110.883 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.61 100.55 5.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.14 110.844 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.61 74.28 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 0.18 112.514 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.514 HD12 ' HE1' ' A' ' 4' ' ' PHE . 4.0 mm? -107.03 59.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.348 . . . . 0.6 110.879 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.84 159.77 66.7 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.542 0.687 . . . . 0.25 111.124 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 116.31 4.49 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.657 2.238 . . . . 0.26 112.426 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.58 6.42 68.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.2 112.493 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -56.03 150.55 13.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.66 110.896 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.765 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 37.2 p -140.24 108.59 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.22 111.148 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.725 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.15 147.67 12.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.25 111.049 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.941 HD12 HD22 ' A' ' 147' ' ' LEU . 2.4 mt -126.23 99.9 6.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.34 110.874 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -76.71 149.01 36.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.24 110.948 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.9 m -128.25 177.33 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.55 110.885 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.17 -37.77 48.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.23 111.101 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.82 -44.53 96.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.448 . . . . 2.08 110.882 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.838 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.2 mp -74.94 -55.25 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.21 111.175 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 119' ' ' LEU . 61.0 mt -50.71 -38.64 48.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.24 110.876 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.19 -56.54 15.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.36 111.122 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.443 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -55.03 -42.39 72.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 2.76 110.862 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.864 HG23 HG21 ' A' ' 63' ' ' ILE . 50.2 mm -57.66 -68.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.22 111.097 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.71 -36.21 35.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.23 111.051 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -56.84 -52.3 65.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 2.79 110.881 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 56' ' ' LYS . 46.6 pt -82.29 -6.5 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.26 111.081 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -79.8 127.97 32.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.4 110.93 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -66.82 159.76 73.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.582 0.705 . . . . 2.25 110.835 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 114.33 3.67 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.2 112.328 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.8 2.75 56.2 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.772 -0.728 . . . . 0.24 112.531 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.76 -161.36 10.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.805 -0.712 . . . . 0.16 112.484 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 15.7 m -139.08 153.7 48.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.36 110.954 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.707 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.06 114.47 10.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.2 110.883 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.555 ' N ' HD22 ' A' ' 93' ' ' LEU . 45.7 m-85 -108.79 133.47 52.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 1.64 110.956 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.51 159.12 44.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.15 110.919 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 125.15 38.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 1.81 110.886 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.617 ' OE1' HD23 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -148.97 147.44 24.02 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.649 0.738 . . . . 2.48 110.897 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.619 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.1 Cg_endo -69.81 145.23 56.25 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.654 2.236 . . . . 0.21 112.332 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.8 m -131.41 146.67 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.19 111.154 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -104.88 132.97 50.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 2.09 110.899 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 p -105.71 26.01 10.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 1.56 111.083 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.29 26.51 0.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.67 111.098 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.19 159.48 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.78 111.152 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.57 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -57.24 -179.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 1.97 110.837 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -66.09 -67.93 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 2.67 110.897 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -60.99 -75.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 2.55 110.913 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 54.63 -166.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 1.93 110.855 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -79.9 -7.97 59.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 2.07 110.872 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.645 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.0 m -145.16 150.13 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.6 111.079 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -68.29 113.29 5.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.135 -0.484 . . . . 2.33 110.874 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.57 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.2 p -84.42 179.69 7.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.34 111.108 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.49 -53.34 59.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.2 111.136 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.74 -49.18 78.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.922 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -58.37 -40.91 83.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 2.61 110.909 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -61.97 -54.83 36.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.41 110.84 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 70.8 m -55.45 -47.79 75.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.24 110.89 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.26 110.809 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.99 98.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.23 111.076 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.587 HD11 HD12 ' A' ' 93' ' ' LEU . 14.9 tp -65.8 -50.23 65.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.24 110.922 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.1 m -65.52 -30.73 71.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.108 -0.496 . . . . 0.25 111.204 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.5 mt -86.99 -10.47 53.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.58 110.942 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.19 5.52 29.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 1.8 110.847 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.04 5.19 35.47 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.747 -0.74 . . . . 0.56 112.468 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -105.45 172.48 6.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.26 110.88 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.486 HG23 ' HG3' ' A' ' 126' ' ' GLU . 28.2 m -151.14 171.38 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.29 111.078 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HG3' HG23 ' A' ' 125' ' ' VAL . 28.8 mt-10 55.16 43.53 29.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 2.04 110.924 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.506 HG13 HD23 ' A' ' 119' ' ' LEU . 97.9 t -77.7 140.91 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.32 111.124 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.16 159.79 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 1.61 110.899 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.08 147.44 30.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 2.18 110.939 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.754 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.5 mp -107.45 -36.43 6.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.18 110.957 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 176.24 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 1.15 110.9 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.731 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.9 tmt_? -132.35 137.27 47.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 4.33 110.942 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -124.38 138.72 31.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.635 0.731 . . . . 1.39 110.902 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.418 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.4 Cg_endo -69.86 163.43 38.39 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.653 2.235 . . . . 0.27 112.299 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.661 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -95.65 127.09 41.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 0.35 110.95 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.53 160.53 27.2 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.554 0.693 . . . . 1.28 111.105 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.7 Cg_endo -69.7 -29.2 24.53 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.68 2.253 . . . . 0.45 112.316 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -84.97 -19.06 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 2.98 110.876 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -53.58 5.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 2.17 110.905 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.5 -41.93 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.29 111.158 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -33.86 72.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 1.37 110.872 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.94 -44.93 68.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.34 110.796 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.68 HG23 HD13 ' A' ' 147' ' ' LEU . 7.4 p -68.97 -31.59 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.21 111.188 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -76.65 -30.9 57.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.076 -0.511 . . . . 2.52 110.929 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -89.73 -20.62 23.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.221 -0.445 . . . . 1.78 110.919 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -95.01 -32.51 13.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.857 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.941 HD22 HD12 ' A' ' 74' ' ' LEU . 2.7 mp -127.18 -54.06 1.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.42 110.891 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.37 10.51 2.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.71 -0.757 . . . . 0.48 112.472 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.645 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.8 t-160 -70.08 120.42 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.711 0.291 . . . . 1.2 110.869 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.44 112.3 4.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 3.02 110.897 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.66 172.17 17.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 1.06 110.865 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.56 -9.35 16.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 2.18 110.86 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -110.63 13.35 22.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 1.85 110.925 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.661 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -75.57 164.86 25.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.27 110.912 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -173.92 130.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.21 110.901 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.765 ' CZ ' HG22 ' A' ' 72' ' ' THR . 32.3 m-85 -74.29 131.77 41.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 1.79 110.879 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.94 140.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.2 111.114 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.754 ' HG2' HD13 ' A' ' 130' ' ' LEU . 11.0 tt0 -93.65 128.5 39.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 2.3 110.895 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.01 151.73 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.24 111.239 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.46 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.6 t -131.4 159.32 38.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.252 -0.431 . . . . 0.28 111.168 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.478 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -149.33 129.9 3.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.774 -0.727 . . . . 0.25 112.527 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -89.52 139.28 30.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 1.55 110.925 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.24 135.27 50.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.587 0.708 . . . . 1.62 110.906 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 129.65 18.03 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.731 2.287 . . . . 0.41 112.361 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.298 -0.41 . . . . 0.49 110.922 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.864 0.364 . . . . 2.2 110.953 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -122.33 21.64 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 1.52 110.89 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.82 39.98 56.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.78 -0.724 . . . . 0.23 112.507 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.52 HG23 HG21 ' A' ' 12' ' ' VAL . 1.7 mp -77.97 159.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.857 0.36 . . . . 0.22 111.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -151.55 162.21 41.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 1.44 110.934 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.4 126.34 35.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.28 111.135 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.06 -2.59 19.24 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.735 -0.745 . . . . 0.27 112.433 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -115.49 170.49 8.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.842 0.353 . . . . 1.1 110.9 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.87 114.14 28.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 2.23 110.929 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 62' ' ' ILE . 92.4 t -119.28 125.38 74.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.117 -0.492 . . . . 1.98 111.154 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.766 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -102.79 129.96 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.32 111.125 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.831 HG11 HG12 ' A' ' 29' ' ' VAL . 60.3 t -101.3 119.92 50.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.18 111.146 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.24 118.35 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.21 111.074 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -118.5 169.24 9.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.498 . . . . 0.19 110.898 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -151.49 -170.72 3.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.483 . . . . 1.78 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -57.06 -35.67 69.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 3.09 110.9 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -73.28 -9.59 58.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 1.27 110.848 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.02 94.44 10.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.647 0.737 . . . . 0.15 110.855 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 142.23 47.11 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.662 2.242 . . . . 0.21 112.359 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -48.83 -32.75 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.2 111.122 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.13 -53.04 37.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 2.69 110.893 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -44.89 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.17 111.055 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.476 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.6 -61.46 2.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.14 110.976 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -36.96 24.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 2.8 110.867 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.72 -47.14 50.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 0.19 112.523 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.83 -39.29 91.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.768 0.318 . . . . 0.46 110.872 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.831 HG12 HG11 ' A' ' 14' ' ' VAL . 17.5 m -77.69 -31.19 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.63 111.075 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.29 -58.56 7.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 1.55 110.845 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -39.94 74.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 1.73 110.945 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.892 HD23 HD21 ' A' ' 35' ' ' LEU . 85.1 mt -73.07 -24.67 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.23 110.996 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.486 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.55 -25.18 45.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.37 110.947 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 -29.9 17.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.22 111.163 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.892 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.42 -35.21 14.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.18 110.853 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.738 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.9 -45.86 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.21 111.091 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.47 -12.87 53.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.27 112.456 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.17 -62.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 2.5 110.897 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -90.08 -40.85 12.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.96 110.921 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.43 -130.04 6.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.741 -0.742 . . . . 0.25 112.553 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -150.23 152.87 35.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.887 0.375 . . . . 2.2 110.928 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 33' ' ' GLN . 96.6 t -136.4 125.44 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.22 111.146 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -114.53 156.89 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 0.16 110.814 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -118.53 135.04 60.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.15 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -143.14 151.31 40.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 2.01 110.868 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -103.22 134.9 45.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.193 -0.458 . . . . 0.4 110.854 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.729 ' CD1' HG21 ' A' ' 73' ' ' THR . 29.1 mt -52.4 -36.51 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.27 111.108 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -70.87 -32.13 69.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 2.0 110.868 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.87 20.62 17.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 3.54 110.92 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.83 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.09 -27.94 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 1.07 110.918 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.26 -33.37 63.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 1.07 110.938 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -84.62 -15.14 46.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 1.18 110.935 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.459 ' HB2' HD13 ' A' ' 50' ' ' LEU . 45.5 m -64.64 -11.61 37.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.87 110.796 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.33 61.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.28 111.023 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.401 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 11.9 m170 -62.8 -69.74 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.4 110.865 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.661 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.97 -168.64 2.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 1.12 111.045 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.13 130.55 54.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.335 -0.393 . . . . 1.81 110.944 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.38 73.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 1.21 110.853 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.8 p -127.93 -34.59 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.26 110.832 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.2 m-85 -98.85 117.9 34.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 1.43 110.921 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.41 -20.36 63.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 1.48 110.887 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.693 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.1 mt -148.05 144.91 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.25 111.142 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.915 HG21 HG23 ' A' ' 83' ' ' ILE . 20.6 mm -135.28 130.1 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.18 111.113 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -110.46 137.29 48.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.16 110.897 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.56 100.63 5.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.13 110.84 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.74 76.0 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.15 112.458 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.35 58.21 0.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.59 110.902 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.54 160.11 62.25 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 121.618 0.723 . . . . 0.22 111.18 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 116.64 4.66 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.672 2.248 . . . . 0.24 112.361 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.1 7.39 70.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.16 112.537 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.49 149.75 13.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.408 . . . . 0.68 110.839 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.768 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 31.1 p -138.73 108.58 6.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.17 111.117 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.729 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.96 146.52 10.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.24 111.102 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.92 HD12 HD22 ' A' ' 147' ' ' LEU . 4.1 mt -125.36 103.37 7.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.21 110.843 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -79.75 151.49 30.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.24 110.809 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -130.59 177.14 7.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.48 110.885 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.99 51.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.32 111.166 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -61.48 -45.68 93.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 1.75 110.885 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.83 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -73.63 -55.41 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.23 111.07 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.0 mt -50.63 -38.68 47.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.26 110.875 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.8 -55.13 29.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.29 111.056 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -42.34 77.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 2.76 110.935 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.915 HG23 HG21 ' A' ' 63' ' ' ILE . 44.9 mm -58.62 -68.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.26 111.054 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.74 -36.06 24.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.21 111.028 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -54.58 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 2.19 110.861 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 56' ' ' LYS . 47.5 pt -79.39 -5.89 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.28 111.192 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -81.73 127.99 33.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.45 110.847 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -65.7 158.77 72.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.669 0.747 . . . . 2.28 110.867 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 114.1 3.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.246 . . . . 0.2 112.34 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.28 2.72 54.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.737 . . . . 0.16 112.476 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.63 -163.48 16.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.15 112.505 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 67.6 m -135.75 153.48 51.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 0.3 110.833 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.662 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.56 114.36 10.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.16 110.88 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.541 ' N ' HD22 ' A' ' 93' ' ' LEU . 50.2 m-85 -108.82 133.34 53.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 1.9 110.949 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.563 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.86 164.11 35.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.14 110.959 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.74 130.46 36.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 1.85 110.915 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.598 ' OE1' HD23 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -153.95 147.75 18.68 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.588 0.709 . . . . 2.34 110.896 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.639 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.0 Cg_endo -69.81 141.58 45.39 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.594 2.196 . . . . 0.17 112.361 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.78 146.66 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.18 111.135 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' CD ' HG21 ' A' ' 103' ' ' VAL . 51.9 mt-10 -109.7 132.64 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 2.07 110.827 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.4 p -91.62 -42.23 10.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 1.18 111.061 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.77 39.94 1.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.259 -0.428 . . . . 0.59 111.096 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' CD ' ' A' ' 100' ' ' GLU . 22.7 t -147.59 150.4 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.187 -0.461 . . . . 0.63 111.099 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.573 ' O ' HG21 ' A' ' 111' ' ' THR . 0.4 OUTLIER -52.94 170.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 1.77 110.836 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -64.35 -57.39 9.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 2.57 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.99 -75.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 1.63 110.87 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t 52.38 -168.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 2.14 110.906 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.37 -6.8 58.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 1.98 110.865 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.437 HG11 ' CG ' ' A' ' 149' ' ' HIS . 2.9 m -140.09 142.63 31.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.4 111.248 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -65.35 111.05 2.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.21 -0.45 . . . . 2.46 110.907 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 104' ' ' ASP . 47.5 p -82.13 -177.72 6.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.23 111.161 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.13 -52.32 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.17 111.132 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.32 -49.77 75.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.21 110.877 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -56.87 -38.86 73.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 1.66 110.838 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -64.89 -54.56 28.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.31 110.927 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.2 m -58.13 -46.24 85.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.24 110.925 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -43.0 94.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.498 . . . . 0.29 110.919 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.51 98.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.21 111.107 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 93' ' ' LEU . 15.5 tp -65.13 -51.65 59.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.216 -0.447 . . . . 0.32 110.909 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.1 m -63.92 -31.16 72.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.25 111.084 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.3 mt -86.79 -10.48 53.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.74 110.893 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.12 5.69 28.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 1.71 110.88 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.13 5.12 35.33 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.806 -0.712 . . . . 0.48 112.523 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.662 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.1 tp -105.57 173.11 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.32 110.956 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.7 m -151.51 173.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.28 111.205 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 51.6 45.15 28.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 1.99 110.874 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.523 HG13 HD23 ' A' ' 119' ' ' LEU . 94.3 t -80.75 143.06 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.2 111.142 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.92 160.49 8.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 2.52 110.915 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -80.26 146.43 31.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 2.25 110.916 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.784 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -104.23 -37.1 7.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.23 110.936 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.0 pm0 -159.07 176.25 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 2.95 110.888 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.732 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.4 tmt_? -130.44 137.21 49.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 4.37 110.82 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -123.77 135.02 25.74 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.726 0.774 . . . . 1.8 110.9 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.425 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.2 Cg_endo -69.82 159.14 54.45 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.721 2.281 . . . . 0.26 112.351 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.668 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -91.97 151.65 20.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.57 110.948 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.531 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -133.65 162.91 54.78 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.498 0.666 . . . . 1.63 111.186 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -23.72 30.17 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.669 2.246 . . . . 0.57 112.293 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -86.26 -23.82 26.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 2.47 110.809 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -87.82 -52.72 5.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 3.95 110.927 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 136' ' ' THR . 7.3 p -50.4 -39.52 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.29 111.128 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -32.64 73.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 1.11 110.97 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.49 -46.74 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.29 110.856 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.706 HG23 HD13 ' A' ' 147' ' ' LEU . 9.7 p -68.19 -29.75 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 0.21 111.091 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -76.45 -33.3 58.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 3.12 110.885 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -88.88 -19.98 25.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 1.84 110.822 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -94.69 -32.26 13.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.34 110.924 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.92 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.31 -54.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.35 110.869 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.77 8.1 2.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.658 -0.782 . . . . 0.32 112.518 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.437 ' CG ' HG11 ' A' ' 109' ' ' VAL . 15.0 t-160 -69.94 121.62 17.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.709 0.29 . . . . 0.64 110.87 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -151.93 104.99 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 3.37 110.906 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.6 t -160.8 171.02 19.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.61 110.868 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.22 -11.85 15.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 1.94 110.877 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.527 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 5.7 m-80 -99.57 14.39 30.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 1.6 110.894 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -87.51 168.92 12.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.34 110.824 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.732 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -172.16 130.36 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.18 110.894 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.768 ' CZ ' HG22 ' A' ' 72' ' ' THR . 19.4 m-85 -74.31 132.81 42.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 1.82 110.897 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.26 147.96 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.22 111.077 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.784 ' HG2' HD13 ' A' ' 130' ' ' LEU . 8.7 tt0 -101.67 135.6 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 2.06 110.938 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.41 149.18 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.22 111.148 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.477 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.2 t -129.55 159.47 36.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.25 111.196 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.49 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -149.93 134.3 4.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.731 -0.747 . . . . 0.15 112.483 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -94.44 140.77 29.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 1.55 110.942 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -81.49 134.79 50.68 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.606 0.717 . . . . 1.94 110.886 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 119.76 6.65 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.714 2.276 . . . . 0.35 112.319 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.32 110.866 179.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 t0 . . . . . 0 C--O 1.233 0.193 0 CA-C-O 120.823 0.344 . . . . 2.55 110.804 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.461 ' CE1' HD12 ' A' ' 67' ' ' LEU . 5.5 m-85 -109.48 23.26 14.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 1.66 110.94 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.04 41.96 53.72 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 0.45 112.485 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.488 HD13 HD21 ' A' ' 32' ' ' LEU . 1.7 mp -81.31 158.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.31 111.129 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 36' ' ' THR . 37.2 m -146.18 156.35 43.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 1.12 110.863 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.32 127.41 34.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.42 111.143 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.81 -7.48 21.94 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.74 -0.743 . . . . 0.27 112.513 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.17 170.39 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 1.57 110.942 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.92 110.7 22.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 1.34 110.836 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.697 HG12 HG21 ' A' ' 36' ' ' THR . 2.3 p -117.2 129.6 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 2.01 111.168 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.757 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -104.59 130.35 52.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.3 111.101 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.847 HG11 HG12 ' A' ' 29' ' ' VAL . 97.6 t -99.79 117.78 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.16 111.158 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.482 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.3 t -101.54 113.63 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.21 111.21 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -114.51 167.64 10.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 0.19 110.919 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.452 ' HB3' HD12 ' A' ' 47' ' ' ILE . 9.9 p-10 -151.53 -169.59 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 1.79 110.812 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -35.87 69.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 6.79 110.876 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -11.26 60.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 1.13 110.889 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.67 92.87 9.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.609 0.718 . . . . 0.22 110.871 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.72 143.53 51.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.26 112.336 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -48.76 -32.55 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.2 111.125 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.02 -53.57 32.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 2.48 110.895 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.79 -44.75 10.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.17 111.116 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.482 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.2 -61.32 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.14 110.916 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -49.79 -38.35 34.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 2.69 110.813 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.61 -47.58 55.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.8 -0.714 . . . . 0.23 112.428 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.46 -40.26 93.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.366 . . . . 0.59 110.897 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.847 HG12 HG11 ' A' ' 14' ' ' VAL . 18.1 m -76.72 -31.04 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.63 111.209 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.03 -60.07 4.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.183 -0.462 . . . . 1.57 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -40.79 71.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 1.87 110.958 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 HD21 ' A' ' 35' ' ' LEU . 92.8 mt -72.27 -25.2 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.38 110.887 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.426 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.09 -24.18 47.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.39 110.885 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.72 -30.03 17.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.28 111.115 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.821 HD21 HD23 ' A' ' 32' ' ' LEU . 1.6 pp -91.59 -35.34 14.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.27 110.882 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.697 HG21 HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -101.88 -45.28 5.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.25 111.178 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.78 -12.72 49.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.679 -0.772 . . . . 0.29 112.537 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -67.04 -62.74 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.786 0.327 . . . . 1.98 110.883 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -94.66 -39.32 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 2.07 110.958 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.51 -135.2 7.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.801 . . . . 0.38 112.504 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -147.74 151.44 36.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 2.22 110.794 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 33' ' ' GLN . 91.9 t -135.94 117.82 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.33 111.114 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 t -106.93 157.19 17.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.26 110.85 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.22 133.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 0.21 111.142 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -143.69 151.79 40.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 1.27 110.892 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.6 135.21 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.41 110.825 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 50' ' ' LEU . 45.3 mt -52.37 -35.87 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 0.36 111.103 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -31.81 66.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 2.22 110.853 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -105.22 20.32 19.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 3.6 110.896 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.983 HD13 HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -51.78 -26.14 9.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 2.72 110.94 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 mp -53.68 -32.91 53.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 1.14 110.945 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -84.97 -15.76 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 1.09 110.906 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.4 m -64.46 -12.21 41.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 0.88 110.888 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.47 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -73.93 61.34 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.494 . . . . 0.4 111.184 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -59.48 -71.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.58 110.796 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.495 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.27 -168.23 2.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 1.35 110.956 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -102.27 116.58 32.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 2.22 110.869 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 t 60.16 84.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 1.97 110.839 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.0 p -134.84 -37.24 0.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.28 110.836 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.1 m-85 -96.84 121.98 39.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.059 -0.519 . . . . 2.01 110.78 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.21 -19.7 60.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 1.51 110.845 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.26 143.95 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.22 111.112 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.941 HG21 HG23 ' A' ' 83' ' ' ILE . 22.1 mm -136.51 127.69 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.17 111.036 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.3 mm? -109.77 137.87 46.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.18 110.95 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.8 100.04 5.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.16 110.866 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.87 74.63 0.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.18 112.518 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.619 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.1 mm? -105.29 58.18 0.68 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 0.61 110.902 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.92 160.01 61.44 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.659 0.742 . . . . 0.23 111.108 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.74 123.88 10.54 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.726 2.284 . . . . 0.31 112.33 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.46 7.11 88.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.667 -0.778 . . . . 0.2 112.535 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 68' ' ' VAL . 8.2 p -55.9 151.58 11.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.958 0.409 . . . . 0.74 110.843 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.74 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.3 p -140.58 109.04 5.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.23 111.101 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.574 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.12 143.19 12.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.32 111.183 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.972 HD12 HD22 ' A' ' 147' ' ' LEU . 4.8 mt -119.98 102.37 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.25 110.93 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -79.1 144.22 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.29 110.844 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 m -124.38 174.92 7.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.42 110.908 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.94 -40.34 57.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.3 111.128 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.99 -45.78 91.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 1.96 110.898 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.983 HG23 HD13 ' A' ' 50' ' ' LEU . 4.3 mp -72.07 -55.38 13.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.31 111.132 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.541 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.9 mt -50.67 -38.54 47.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.52 . . . . 0.28 110.946 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.9 -56.13 13.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.39 111.021 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -54.56 -44.94 73.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.39 . . . . 2.84 110.855 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.941 HG23 HG21 ' A' ' 63' ' ' ILE . 37.9 mm -56.08 -68.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.24 111.098 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.54 -39.65 49.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.28 111.134 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -52.56 -49.63 64.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 3.2 110.829 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 56' ' ' LYS . 41.0 pt -88.18 -4.05 9.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.27 111.102 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -82.04 112.44 19.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.32 110.941 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -52.45 157.68 2.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.645 0.736 . . . . 3.05 110.816 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 113.98 3.55 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.725 2.283 . . . . 0.38 112.326 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.41 2.72 50.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.811 -0.709 . . . . 0.23 112.563 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.78 -165.13 21.61 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.664 -0.779 . . . . 0.18 112.418 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 90.9 m -133.22 151.91 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.46 110.893 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.703 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -136.58 115.22 12.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.15 110.934 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.549 ' N ' HD22 ' A' ' 93' ' ' LEU . 54.7 m-85 -110.33 132.05 54.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 1.91 110.877 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.551 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.66 163.17 38.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.12 110.891 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.91 126.89 29.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 1.85 110.784 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.533 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -148.65 149.27 30.57 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.65 0.738 . . . . 2.55 110.892 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.614 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.8 Cg_endo -69.71 139.38 40.28 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.66 2.24 . . . . 0.24 112.329 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.8 m -121.62 146.7 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.31 111.143 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.476 ' CD ' HG21 ' A' ' 103' ' ' VAL . 51.4 mt-10 -117.82 132.0 56.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 1.86 110.887 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.0 p -91.93 -37.43 12.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 1.41 111.099 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.59 37.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.6 111.191 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.476 HG21 ' CD ' ' A' ' 100' ' ' GLU . 31.8 t -147.79 149.55 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.7 111.141 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.575 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -55.86 178.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.85 110.929 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -66.55 -70.44 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 2.64 110.896 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -75.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 2.14 110.922 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.47 -169.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 1.6 110.78 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.0 -2.97 50.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 2.03 110.893 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 m -145.26 144.49 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.44 111.102 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.684 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -67.32 113.15 4.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 2.21 110.877 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 104' ' ' ASP . 60.3 p -84.33 177.45 8.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.21 111.204 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.33 -54.7 36.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.17 111.102 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -59.97 -50.24 74.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.21 110.85 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -38.8 71.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.148 -0.478 . . . . 2.12 110.893 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.533 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -64.51 -54.27 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.37 110.963 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.7 m -59.24 -46.78 87.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.21 110.851 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -44.03 95.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.29 110.874 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.27 98.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.21 111.195 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.541 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.9 tp -65.38 -50.76 64.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.26 110.913 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.2 m -63.51 -31.5 72.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.26 111.16 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.6 mt -87.0 -10.48 53.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.56 110.913 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.58 4.66 31.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.306 -0.406 . . . . 1.73 110.835 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.1 6.7 33.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.49 112.496 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -106.92 172.21 6.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.79 0.328 . . . . 0.27 110.985 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.5 m -151.71 174.27 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.35 111.103 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 52.68 43.9 30.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 2.15 110.88 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.0 143.29 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.26 111.097 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.06 160.19 8.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 1.62 110.85 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -82.34 139.55 34.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 2.98 110.87 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.548 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.5 mp -96.6 -37.92 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.24 110.899 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.05 176.3 12.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 1.11 110.941 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.694 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -129.44 141.27 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 4.01 110.89 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -129.18 136.82 29.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.599 0.714 . . . . 1.41 110.828 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.423 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.9 Cg_endo -69.69 165.16 31.82 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.667 2.245 . . . . 0.25 112.357 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.712 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -97.7 126.13 42.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.29 110.936 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -103.62 160.88 24.72 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.615 0.721 . . . . 1.54 111.08 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -24.63 29.31 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.34 112.36 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -85.52 -22.09 28.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 2.49 110.893 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -87.53 -53.58 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 2.43 110.916 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 136' ' ' THR . 7.4 p -49.8 -40.36 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.29 111.142 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.05 -33.42 74.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 1.19 110.904 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.42 -46.44 66.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.26 110.845 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.0 p -68.51 -30.02 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.3 111.207 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -76.77 -31.57 57.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 2.36 110.9 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -89.57 -20.83 23.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.73 110.799 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.97 -32.0 13.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.44 110.927 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.972 HD22 HD12 ' A' ' 74' ' ' LEU . 2.1 mp -127.29 -54.68 1.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.48 110.845 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.53 13.55 2.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.749 -0.739 . . . . 0.43 112.527 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -70.65 121.51 18.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.85 110.807 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -151.74 105.87 3.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 2.85 110.872 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.9 t -160.51 170.47 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.82 110.852 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.61 -11.34 16.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 1.86 110.87 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -103.59 20.6 17.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 1.93 110.908 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.712 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -90.45 162.98 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.31 110.841 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.6 tm? -169.88 130.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.22 110.965 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.74 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.0 m-85 -75.85 135.57 40.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 1.78 110.956 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.0 144.27 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.29 111.128 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.619 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.7 tt0 -97.67 128.81 44.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 1.98 110.949 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.39 148.95 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.22 111.144 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.471 ' HB ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -127.35 159.62 33.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.3 111.097 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.447 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -150.43 132.13 3.83 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.701 -0.761 . . . . 0.16 112.454 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -94.65 140.35 29.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.814 0.34 . . . . 1.55 110.938 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -80.32 135.41 53.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.638 0.732 . . . . 1.65 110.929 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 120.01 6.87 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.724 2.283 . . . . 0.4 112.361 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.47 110.869 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.841 0.353 . . . . 2.0 110.78 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -122.27 18.44 10.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 1.52 110.884 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.38 39.5 73.07 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.751 -0.738 . . . . 0.34 112.519 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.473 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -76.85 157.53 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 0.33 111.126 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 36' ' ' THR . 26.8 m -149.34 155.75 40.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 1.06 110.83 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.93 123.3 29.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.31 111.096 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.18 -12.06 14.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.41 112.52 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -103.61 168.66 9.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 1.54 110.914 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -101.21 133.39 45.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.3 110.924 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.566 HG12 HG21 ' A' ' 36' ' ' THR . 1.8 p -138.38 134.59 43.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 2.13 111.16 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.755 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -110.35 127.4 55.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.21 111.114 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.824 HG11 HG12 ' A' ' 29' ' ' VAL . 59.2 t -97.63 117.95 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.22 111.131 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.481 HG12 ' CG1' ' A' ' 47' ' ' ILE . 13.6 t -102.35 110.25 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.26 111.116 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -111.56 167.24 10.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.17 110.97 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.454 ' HB3' HD12 ' A' ' 47' ' ' ILE . 11.3 p-10 -151.0 -169.71 3.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.423 . . . . 1.84 110.874 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -56.68 -35.81 68.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.459 . . . . 2.92 110.903 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.62 -11.4 60.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 1.16 110.894 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.34 93.79 10.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.624 0.726 . . . . 0.14 110.845 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.4 Cg_endo -69.71 142.81 49.15 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.677 2.252 . . . . 0.19 112.341 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.1 t -48.82 -32.59 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 0.17 111.134 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -51.24 -53.35 36.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 2.56 110.8 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.55 -44.79 11.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.16 111.131 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.482 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.36 -61.04 2.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.13 111.017 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.76 -37.91 31.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 2.31 110.871 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.8 -47.67 54.0 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.838 -0.696 . . . . 0.19 112.45 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.51 -40.05 93.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.55 110.873 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.824 HG12 HG11 ' A' ' 14' ' ' VAL . 18.2 m -76.88 -31.45 19.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.63 111.132 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -61.72 -59.95 4.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 1.72 110.947 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -40.41 71.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 1.71 110.882 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.874 HD23 HD21 ' A' ' 35' ' ' LEU . 80.4 mt -72.68 -24.56 61.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.23 110.895 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.48 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.7 -24.78 44.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.38 110.911 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 -29.82 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.22 111.163 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.874 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.75 -35.02 14.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.2 110.872 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.566 HG21 HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -102.87 -44.81 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.22 111.12 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.66 -11.2 52.97 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 0.25 112.433 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.99 -62.58 1.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 2.25 110.931 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -90.96 -40.68 11.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 1.97 110.857 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.49 -126.44 4.93 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.759 -0.734 . . . . 0.26 112.438 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -155.58 152.49 28.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 2.2 110.902 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.48 HG21 ' HA ' ' A' ' 33' ' ' GLN . 87.7 t -137.0 127.72 40.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.24 111.12 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 t -116.53 154.12 30.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.16 110.83 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.73 134.65 58.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 0.24 111.054 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -146.33 152.32 38.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.077 -0.511 . . . . 2.1 110.913 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -102.43 137.78 40.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.39 110.809 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.688 ' HA ' HD12 ' A' ' 50' ' ' LEU . 35.5 mt -52.26 -37.04 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.29 111.139 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -26.18 58.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 2.47 110.902 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -104.97 18.12 22.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 3.44 110.899 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.027 HD13 HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -53.84 -26.07 22.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.201 -0.454 . . . . 2.73 110.872 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.96 -34.9 57.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -85.97 -16.0 39.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.1 111.008 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.5 m -63.64 -12.72 36.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.92 110.798 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -74.55 59.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.32 111.134 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -59.17 -70.55 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.47 110.915 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.682 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.39 -169.59 2.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 1.3 111.0 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -105.47 122.11 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 2.19 110.827 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t 59.52 78.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 1.99 110.888 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.5 p -132.7 -37.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.25 110.834 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CD2' HD12 ' A' ' 86' ' ' ILE . 92.8 m-85 -98.13 122.37 41.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 2.06 110.85 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.28 -20.46 60.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 1.51 110.901 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 6' ' ' ILE . 12.4 mt -143.06 144.81 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.28 111.115 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.967 HG21 HG23 ' A' ' 83' ' ' ILE . 20.3 mm -137.56 124.45 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.21 111.072 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.6 mm? -107.61 137.16 46.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 0.24 111.034 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.48 100.91 5.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.17 110.908 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.67 76.04 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.826 -0.702 . . . . 0.17 112.417 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.521 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.4 mm? -107.52 57.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.855 0.359 . . . . 0.59 110.908 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.32 159.64 61.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.708 0.766 . . . . 0.24 111.11 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 124.42 11.05 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.666 2.244 . . . . 0.26 112.359 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.33 7.33 88.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.797 -0.716 . . . . 0.21 112.533 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB3' HG23 ' A' ' 68' ' ' VAL . 10.2 p -55.54 150.88 11.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.429 . . . . 0.78 110.772 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.766 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 30.8 p -138.84 108.86 6.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.16 111.107 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.624 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.36 152.43 16.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.25 111.199 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.993 HD12 HD22 ' A' ' 147' ' ' LEU . 4.4 mt -130.6 101.11 5.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.21 110.894 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -78.06 141.35 38.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.36 110.863 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.82 178.46 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.84 110.909 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.15 62.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.29 111.103 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -56.61 -48.21 77.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 1.96 110.885 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.027 HG23 HD13 ' A' ' 50' ' ' LEU . 4.2 mp -69.1 -56.59 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.29 111.129 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.586 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.8 mt -50.15 -39.09 42.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.29 110.964 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.97 -56.74 10.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.46 111.1 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.426 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -54.16 -43.25 70.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 3.03 110.918 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.967 HG23 HG21 ' A' ' 63' ' ' ILE . 41.9 mm -57.94 -69.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.26 111.189 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.12 -36.21 28.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.28 111.075 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -51.5 67.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 2.31 110.983 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 56' ' ' LYS . 43.6 pt -86.81 -2.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.33 111.171 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -83.0 115.28 21.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.27 110.952 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -55.52 157.95 6.49 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.532 0.682 . . . . 3.2 110.889 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 114.02 3.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.735 2.29 . . . . 0.34 112.33 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.16 2.33 51.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 0.22 112.512 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.07 -165.51 19.4 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.781 -0.723 . . . . 0.18 112.456 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 69.1 m -134.55 148.79 50.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.33 . . . . 0.36 110.901 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.725 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.6 tm? -132.72 114.98 14.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.15 110.911 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.501 ' N ' HD22 ' A' ' 93' ' ' LEU . 70.4 m-85 -110.19 132.13 54.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 1.85 110.952 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.561 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.74 164.03 35.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.21 110.939 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.91 129.33 36.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 1.94 110.9 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.461 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -153.63 148.44 19.68 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.677 0.751 . . . . 2.52 110.865 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.651 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.7 145.53 57.75 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.656 2.237 . . . . 0.25 112.367 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 155' ' ' LEU . 14.4 m -129.0 146.49 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.18 111.088 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CD ' HG21 ' A' ' 103' ' ' VAL . 47.7 mt-10 -107.32 132.75 52.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 2.19 110.803 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.8 p -90.69 -42.73 10.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 1.15 111.125 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.633 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -94.83 42.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.64 111.053 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.403 HG21 ' CD ' ' A' ' 100' ' ' GLU . 24.7 t -148.98 150.0 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.26 -0.427 . . . . 0.72 111.12 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.628 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -56.45 169.75 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 2.17 110.844 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.4 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 1.9 p30 -62.37 -54.72 36.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 2.56 110.845 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -66.8 -78.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 2.11 110.869 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p 53.65 -173.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 1.91 110.791 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.52 -3.37 49.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 2.5 110.848 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.86 153.82 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.148 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.01 110.48 6.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 2.85 110.933 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.628 HG21 ' O ' ' A' ' 104' ' ' ASP . 32.7 p -84.97 179.52 7.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.21 111.191 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.43 -53.74 53.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.18 111.001 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.84 -50.09 74.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.99 0.424 . . . . 0.22 110.884 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -56.69 -39.91 74.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 1.7 110.985 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.49 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -63.52 -54.55 34.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.32 110.905 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.1 m -58.6 -46.94 85.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.228 -0.442 . . . . 0.21 110.827 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -43.58 97.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.27 110.834 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.16 -43.52 98.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.21 111.117 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.586 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.1 tp -64.81 -50.46 66.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.23 110.94 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.4 m -63.89 -31.2 72.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.26 111.129 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.5 mt -87.07 -10.5 52.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.56 110.917 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.53 6.21 28.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 1.74 110.845 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.61 7.68 31.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.67 -0.776 . . . . 0.55 112.452 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.725 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -107.57 171.03 7.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.26 110.847 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.05 170.42 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.25 111.131 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 52.89 44.21 30.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 2.27 110.857 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.71 142.77 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.27 111.158 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.97 157.92 6.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 1.61 110.901 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.29 145.7 39.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 2.23 110.858 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.486 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -105.5 -36.19 7.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.2 110.944 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.16 176.0 13.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 1.19 110.981 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -130.93 145.17 51.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 4.25 110.885 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -135.1 136.15 24.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.67 0.748 . . . . 1.87 110.852 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 165.22 31.66 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.693 2.262 . . . . 0.32 112.384 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.683 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -97.96 128.21 44.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.32 110.949 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.425 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.44 160.88 25.3 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.53 0.681 . . . . 1.21 111.163 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.5 Cg_endo -69.83 -28.69 24.61 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.701 2.267 . . . . 0.43 112.294 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -85.37 -17.74 35.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 3.63 110.936 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.59 -53.06 4.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 2.83 110.963 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.32 -40.37 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.33 111.147 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.414 HE21 ' N ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -68.1 -35.22 77.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.19 110.908 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.414 ' N ' HE21 ' A' ' 141' ' ' GLN . 0.3 OUTLIER -67.85 -46.61 71.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.26 110.831 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.706 HG23 HD13 ' A' ' 147' ' ' LEU . 9.6 p -67.99 -29.97 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.18 111.118 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -75.0 -33.67 61.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 2.32 110.95 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -89.0 -19.97 25.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.056 -0.52 . . . . 1.93 110.842 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -94.01 -32.73 13.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.88 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.993 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.58 -54.24 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.4 110.901 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.97 6.11 2.6 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.806 -0.712 . . . . 0.37 112.479 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -69.9 120.1 15.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.723 0.297 . . . . 0.71 110.903 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.25 104.82 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 2.38 110.913 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.45 174.95 12.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.79 110.864 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.76 -10.54 16.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.55 110.869 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.633 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -99.15 6.6 46.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 1.79 110.935 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.683 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -78.81 166.67 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.3 111.004 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.592 ' HA ' HD23 ' A' ' 135' ' ' LEU . 2.7 tm? -172.94 130.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.25 110.925 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.766 ' CZ ' HG22 ' A' ' 72' ' ' THR . 27.3 m-85 -75.62 134.87 40.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 1.83 110.879 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.83 141.53 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.24 111.183 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.521 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.3 tt0 -93.66 131.26 39.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.88 110.937 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.92 151.73 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.25 111.106 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.472 HG21 HD21 ' A' ' 130' ' ' LEU . 5.3 t -135.9 161.85 34.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.27 111.048 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.26 137.92 6.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.715 -0.755 . . . . 0.15 112.487 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.65 137.5 35.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.308 . . . . 3.5 110.935 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -77.33 135.45 65.7 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.609 0.719 . . . . 1.74 110.905 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 120.09 6.94 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.652 2.235 . . . . 0.39 112.39 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.45 110.94 179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.826 0.346 . . . . 2.4 110.831 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.26 21.18 10.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 1.56 110.848 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.93 37.96 54.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.656 -0.783 . . . . 0.23 112.552 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.455 HG21 HD22 ' A' ' 32' ' ' LEU . 1.9 mp -74.27 156.93 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.343 . . . . 0.27 111.146 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 36' ' ' THR . 28.2 m -146.13 158.5 43.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 1.08 110.891 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.56 129.75 35.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.33 111.131 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.11 -8.52 33.33 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.687 -0.768 . . . . 0.55 112.522 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -103.61 169.37 8.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 1.49 110.919 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.87 113.21 26.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 1.28 110.824 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.712 HG12 HG21 ' A' ' 36' ' ' THR . 2.4 p -120.57 129.56 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 2.04 111.105 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.753 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -104.65 128.06 52.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.23 111.048 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.778 HG11 HG12 ' A' ' 29' ' ' VAL . 94.9 t -99.93 120.34 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.19 111.13 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 65' ' ' SER . 61.1 t -103.25 123.05 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.086 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -122.6 169.68 10.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.17 110.908 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.75 -171.0 3.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 1.76 110.862 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -56.97 -35.66 69.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 3.36 110.904 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.32 -9.1 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 1.19 110.917 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.05 94.29 10.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.665 0.745 . . . . 0.14 110.799 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.35 47.7 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.659 2.239 . . . . 0.21 112.416 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.01 -32.59 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.22 111.182 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.16 -53.09 37.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.148 -0.478 . . . . 3.2 110.827 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.87 10.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.19 111.151 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.405 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -51.66 -61.49 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.15 110.995 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -36.96 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 2.4 110.934 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.36 -48.31 52.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.729 -0.748 . . . . 0.21 112.495 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.1 mt -60.84 -41.39 95.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.45 110.927 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.778 HG12 HG11 ' A' ' 14' ' ' VAL . 17.1 m -75.45 -31.11 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.64 111.11 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.74 -61.89 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 1.77 110.887 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -40.73 67.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 1.79 110.87 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.843 HD23 HD21 ' A' ' 35' ' ' LEU . 83.5 mt -71.83 -25.5 62.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.3 110.96 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.543 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.05 -24.33 47.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.41 110.984 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.52 -30.52 17.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.26 111.113 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.843 HD21 HD23 ' A' ' 32' ' ' LEU . 1.7 pp -90.91 -35.41 14.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.23 110.896 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.712 HG21 HG12 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -101.65 -46.83 4.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.26 111.083 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.57 -14.33 49.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.742 . . . . 0.28 112.467 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 2.16 110.817 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.34 -35.48 8.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 2.38 110.867 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.17 -133.48 5.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.32 112.499 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -151.39 152.24 32.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 3.45 110.745 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' A' ' 33' ' ' GLN . 84.6 t -136.7 116.51 16.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.38 111.095 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.4 t -106.43 155.98 19.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.27 110.892 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.84 135.69 59.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 0.23 111.174 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -142.69 151.05 40.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 1.3 110.926 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.54 134.65 46.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.4 110.872 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 73' ' ' THR . 19.7 mt -52.3 -36.82 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.35 111.155 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -70.23 -32.6 70.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 2.01 110.899 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.54 20.72 17.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 3.52 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.788 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -48.96 -28.54 3.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 1.11 110.902 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -55.82 -32.93 64.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.269 -0.423 . . . . 1.13 110.882 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -84.35 -14.5 49.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 1.09 110.878 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.7 m -64.94 -10.87 32.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.9 110.817 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.17 63.99 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.31 111.122 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.404 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 11.9 m170 -66.07 -70.51 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.43 110.813 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.641 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -142.57 -167.82 2.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.11 110.923 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -111.12 124.07 51.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 1.58 110.906 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t 58.96 75.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 2.04 110.779 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 p -134.07 -35.15 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.28 110.911 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 97.6 m-85 -99.06 117.47 33.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.107 -0.497 . . . . 1.49 110.846 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.02 -19.82 62.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 1.51 110.874 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.2 mt -146.27 144.12 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.22 111.101 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.966 HG21 HG23 ' A' ' 83' ' ' ILE . 20.0 mm -136.3 129.2 46.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.14 111.126 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.1 mm? -113.29 137.75 51.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.26 110.938 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.405 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -129.24 101.7 6.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.16 110.861 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.3 78.09 0.11 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.778 -0.725 . . . . 0.17 112.434 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.8 58.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.57 110.894 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -127.1 158.83 67.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.573 0.702 . . . . 0.22 111.175 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.63 115.88 4.28 Favored 'Trans proline' 0 C--O 1.231 0.125 0 C-N-CA 122.702 2.268 . . . . 0.26 112.394 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.15 6.61 66.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.17 112.456 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.3 152.08 8.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.39 . . . . 0.79 110.924 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.696 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 24.0 p -140.14 108.55 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.21 111.159 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.753 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.3 150.08 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.24 111.153 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.018 HD12 HD22 ' A' ' 147' ' ' LEU . 4.2 mt -129.63 99.61 5.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.31 110.876 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -75.44 153.72 37.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.31 110.82 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 m -130.02 174.99 9.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.47 110.889 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -35.92 37.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.54 111.142 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.0 -42.87 99.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 1.94 110.864 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.788 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -77.21 -54.27 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.38 111.148 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 119' ' ' LEU . 86.5 mt -49.73 -48.37 50.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.4 110.939 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.63 -50.11 55.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.8 111.17 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -43.84 83.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 4.79 110.824 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.966 HG23 HG21 ' A' ' 63' ' ' ILE . 36.6 mm -57.13 -65.18 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.31 111.142 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.99 -38.09 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.31 111.111 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -54.39 -58.03 9.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 2.18 110.875 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 56' ' ' LYS . 50.1 pt -75.5 -8.33 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 0.3 111.128 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -79.48 132.67 36.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.52 110.883 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -70.0 159.56 83.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.568 0.699 . . . . 2.37 110.876 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 113.79 3.49 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.638 2.225 . . . . 0.17 112.345 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.22 3.46 54.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.688 -0.768 . . . . 0.18 112.52 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.41 -160.12 12.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.18 112.473 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.3 m -140.11 154.96 47.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.928 0.394 . . . . 0.26 110.912 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.698 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.5 tm? -139.44 115.38 10.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.17 111.008 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.531 ' N ' HD22 ' A' ' 93' ' ' LEU . 53.9 m-85 -110.96 133.1 53.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 1.61 110.868 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.77 156.9 42.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.19 110.936 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.36 128.32 46.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 1.61 110.816 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.633 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -151.43 144.6 17.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.64 0.734 . . . . 2.29 110.868 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.633 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.87 140.19 41.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.653 2.235 . . . . 0.24 112.329 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.408 HG13 HG23 ' A' ' 157' ' ' VAL . 15.2 m -122.86 146.59 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.19 111.156 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -110.4 132.86 53.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 1.98 110.887 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.0 p -104.38 25.7 9.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 1.15 111.203 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.07 24.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.71 111.182 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.4 t -143.46 159.97 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.72 111.13 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.572 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -55.68 178.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 1.84 110.846 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -66.13 -62.65 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 2.66 110.9 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -65.98 -75.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 1.82 110.894 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.11 -168.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 1.54 110.868 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 -4.22 52.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 2.12 110.897 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.8 m -145.38 141.11 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.48 111.132 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.476 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -63.57 117.8 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 2.45 110.914 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.572 HG21 ' O ' ' A' ' 104' ' ' ASP . 39.2 p -89.68 177.72 6.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.24 111.07 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.02 -54.26 48.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.17 111.054 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.28 -49.75 76.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.042 0.448 . . . . 0.29 110.859 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -57.9 -40.69 80.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 2.21 110.928 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.633 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -61.77 -54.79 37.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.36 110.925 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 54.6 m -58.34 -48.85 79.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.21 110.893 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -45.62 92.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.472 . . . . 0.29 110.812 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.64 -48.15 83.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.23 111.154 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.616 HD11 HD12 ' A' ' 93' ' ' LEU . 15.0 tp -60.39 -52.98 62.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.37 110.921 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.0 m -63.12 -27.1 69.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.34 111.129 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.4 mt -86.97 -12.41 47.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.56 110.968 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.8 p -82.87 3.96 27.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 2.45 110.85 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.67 -4.88 34.68 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.781 -0.723 . . . . 0.71 112.528 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.2 tp -88.95 170.33 10.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.946 0.403 . . . . 0.39 110.923 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.9 m -148.13 172.75 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.31 111.169 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 51.47 45.03 28.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 2.18 110.924 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.465 HG13 HD23 ' A' ' 119' ' ' LEU . 91.0 t -81.57 142.02 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.3 111.093 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.65 8.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 1.66 110.895 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -79.57 145.92 32.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 2.27 110.862 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.678 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.5 mp -105.77 -37.31 6.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.21 110.922 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -162.1 176.67 10.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 1.28 110.983 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -126.72 165.31 19.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 5.53 110.808 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -148.39 136.43 11.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.669 0.747 . . . . 1.38 110.926 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 158.05 58.37 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.746 2.298 . . . . 0.34 112.375 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -93.35 127.01 38.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.36 110.999 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.498 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.12 161.45 22.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.492 0.663 . . . . 1.58 111.254 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -24.67 29.72 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.707 2.271 . . . . 0.5 112.386 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -85.46 -22.93 28.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 2.59 110.799 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -87.72 -53.03 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 2.44 110.911 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.73 -40.01 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.36 111.162 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -33.93 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 1.19 110.932 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -46.57 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.3 110.871 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.741 HG23 HD13 ' A' ' 147' ' ' LEU . 9.0 p -67.94 -30.96 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.17 111.128 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -76.72 -30.31 56.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 2.17 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -89.7 -21.08 22.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 1.67 110.891 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -94.8 -32.64 13.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 0.37 110.851 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.018 HD22 HD12 ' A' ' 74' ' ' LEU . 2.9 mp -127.35 -54.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.38 110.865 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.65 20.5 1.52 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.33 112.517 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -75.37 121.56 22.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.84 110.864 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -151.83 106.44 3.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 2.64 110.911 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.71 173.21 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.61 110.872 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.47 -19.59 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 1.82 110.835 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -96.19 19.9 11.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 1.59 110.925 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.516 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -89.54 163.57 15.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.31 110.823 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -173.48 130.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.28 110.948 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.696 ' CZ ' HG22 ' A' ' 72' ' ' THR . 20.6 m-85 -70.22 135.16 48.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 1.85 110.824 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.408 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.73 147.23 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.29 111.146 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.678 ' HG2' HD13 ' A' ' 130' ' ' LEU . 25.8 tt0 -104.69 125.56 50.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 1.65 110.829 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.24 153.21 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.21 111.152 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.427 ' HB ' HD11 ' A' ' 130' ' ' LEU . 6.6 t -136.92 162.92 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.28 111.136 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.449 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -153.23 136.31 5.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.772 -0.727 . . . . 0.16 112.464 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.64 139.48 30.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.362 . . . . 1.66 110.817 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 135.6 51.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.693 0.759 . . . . 1.34 110.821 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 135.77 31.2 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.622 2.215 . . . . 0.53 112.387 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.43 110.756 -179.863 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.4 t0 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.871 0.367 . . . . 2.88 110.898 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.453 ' HB2' HD11 ' A' ' 6' ' ' ILE . 9.4 m-85 -122.33 15.27 10.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 2.01 110.842 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.96 41.06 99.24 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.843 -0.694 . . . . 0.24 112.469 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.653 HD13 HD21 ' A' ' 32' ' ' LEU . 1.6 mp -83.36 158.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.33 111.081 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 36' ' ' THR . 0.8 OUTLIER -148.58 164.83 33.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.35 110.864 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.49 129.13 36.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.27 111.023 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.84 -6.51 23.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.773 . . . . 0.25 112.519 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -113.14 167.91 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 1.16 110.846 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.67 137.3 37.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.178 -0.465 . . . . 1.35 110.908 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.614 HG22 ' HB ' ' A' ' 62' ' ' ILE . 47.0 t -140.75 133.21 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 1.86 111.111 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.787 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -110.3 121.98 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.26 111.085 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.817 HG11 HG12 ' A' ' 29' ' ' VAL . 94.9 t -94.59 118.06 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.17 111.068 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.599 HG12 HG13 ' A' ' 47' ' ' ILE . 21.3 t -102.66 113.59 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.2 111.12 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -113.39 167.19 10.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.2 111.013 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.578 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.9 p-10 -148.57 -169.71 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.279 -0.419 . . . . 1.78 110.926 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -58.3 -35.58 72.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 3.64 110.953 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.1 m -73.98 -8.03 54.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 1.45 110.931 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.35 93.33 9.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.716 . . . . 0.17 110.833 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 143.09 50.16 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.729 2.286 . . . . 0.22 112.326 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.81 -32.9 4.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.22 111.101 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -50.99 -53.09 36.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 2.42 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.46 -44.85 11.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.21 111.048 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -52.16 -62.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.15 110.9 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.61 -37.42 27.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 3.34 110.848 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.44 -47.08 53.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.2 112.53 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.47 HD23 ' HZ3' ' A' ' 31' ' ' LYS . 44.5 mt -61.94 -39.35 91.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.47 110.943 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.817 HG12 HG11 ' A' ' 14' ' ' VAL . 18.2 m -77.68 -31.75 17.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.231 -0.44 . . . . 0.62 111.134 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.01 -58.82 6.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 1.82 110.812 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HZ3' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -56.22 -41.1 75.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 3.13 110.88 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.867 HD23 HD21 ' A' ' 35' ' ' LEU . 91.2 mt -72.35 -24.4 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.23 110.952 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.429 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.0 mt-30 -78.16 -24.67 47.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.38 110.897 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.35 -30.29 16.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.31 111.068 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.867 HD21 HD23 ' A' ' 32' ' ' LEU . 1.6 pp -91.55 -35.65 14.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.27 110.96 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.62 -44.2 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.36 111.17 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.33 -11.0 55.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.42 112.424 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.29 -61.97 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.782 0.325 . . . . 2.92 110.918 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 3.7 mm-40 -86.49 -43.0 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 2.06 110.866 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.25 -122.03 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.852 -0.69 . . . . 0.34 112.523 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -157.49 153.35 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 2.25 110.877 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.0 t -138.27 128.72 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.28 111.182 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t -118.11 154.48 32.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.16 110.84 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -115.52 133.31 62.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.17 111.089 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -144.53 152.98 41.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 1.97 110.92 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -101.91 139.62 37.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.46 110.982 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.87 HD13 HG21 ' A' ' 73' ' ' THR . 14.5 mt -51.87 -44.24 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.34 111.169 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -20.11 60.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 3.68 110.833 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -107.12 18.5 21.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 3.52 110.86 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.005 HD13 HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -55.51 -24.56 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 2.7 110.911 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -52.19 -34.7 46.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 1.03 110.95 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -86.25 -16.34 37.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 1.2 110.907 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 m -63.47 -12.84 34.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.88 110.897 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.71 59.46 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.498 . . . . 0.35 111.068 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -61.81 -70.29 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.4 110.829 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.28 -168.78 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 1.23 110.844 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -105.82 131.05 53.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 1.96 110.825 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 49.01 71.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 1.16 110.82 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.8 p -125.61 -34.42 2.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.25 110.884 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 86' ' ' ILE . 99.1 m-85 -99.85 119.18 37.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.495 . . . . 1.48 110.88 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.42 -19.4 62.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 1.54 110.904 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.614 ' HB ' HG22 ' A' ' 12' ' ' VAL . 27.3 mt -146.03 145.44 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.25 111.117 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.976 HG21 HG23 ' A' ' 83' ' ' ILE . 13.3 mm -136.83 127.85 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.16 111.147 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -109.55 137.59 47.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.224 -0.444 . . . . 0.18 110.926 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -130.13 96.42 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.17 110.933 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.03 75.0 0.25 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 0.16 112.436 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.49 62.5 0.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.847 0.356 . . . . 0.59 110.9 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.99 160.12 66.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.533 0.682 . . . . 0.26 111.172 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 116.62 4.65 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.231 . . . . 0.29 112.35 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.14 7.27 70.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.647 -0.787 . . . . 0.22 112.5 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.33 150.23 11.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.075 0.464 . . . . 0.71 110.789 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.757 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 31.7 p -140.05 108.57 5.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.046 -0.525 . . . . 0.26 111.094 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.87 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.8 152.72 15.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.29 111.132 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.973 HD12 HD22 ' A' ' 147' ' ' LEU . 2.3 mt -130.36 101.76 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.36 110.891 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -77.56 149.05 34.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.28 110.84 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.1 m -125.57 178.43 5.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.55 110.857 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.14 -45.21 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.35 111.079 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.92 -48.53 75.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 2.32 110.906 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.005 HG23 HD13 ' A' ' 50' ' ' LEU . 4.3 mp -68.23 -56.55 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.24 111.07 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.602 HD13 ' HA ' ' A' ' 119' ' ' LEU . 62.0 mt -50.67 -39.56 51.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.26 110.966 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.85 -57.1 12.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.31 111.062 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB3' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -53.0 -41.97 65.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 2.93 110.833 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 63' ' ' ILE . 33.7 mm -58.94 -68.58 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.437 . . . . 0.21 111.056 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.79 29.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.23 111.125 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -57.55 -56.0 27.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 3.06 110.934 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.665 HG22 ' O ' ' A' ' 56' ' ' LYS . 50.2 pt -80.01 -5.69 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.22 111.17 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -76.72 129.4 36.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.4 110.904 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -70.4 160.41 81.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.623 0.725 . . . . 2.26 110.908 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 114.17 3.59 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.726 2.284 . . . . 0.27 112.393 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.43 4.79 57.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.22 112.501 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.4 -164.61 14.38 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.73 . . . . 0.2 112.435 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 67.6 m -137.71 146.28 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.4 110.815 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 124' ' ' LEU . 2.0 tm? -129.49 125.39 36.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.4 110.867 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.584 ' N ' HD22 ' A' ' 93' ' ' LEU . 69.9 m-85 -121.34 131.4 54.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 1.91 110.935 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.76 157.18 43.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.18 110.86 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.85 127.28 44.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 2.04 110.907 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -151.3 146.93 19.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.635 0.731 . . . . 2.33 110.832 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.602 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.92 142.44 47.25 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.68 2.253 . . . . 0.2 112.336 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.18 146.69 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.17 111.112 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -105.22 132.63 51.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 2.04 110.946 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.0 p -103.64 26.04 9.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 1.37 111.108 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.99 24.82 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.67 111.105 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -143.73 158.85 16.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.7 111.134 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.598 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -58.39 -177.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 2.07 110.808 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -68.69 -68.81 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 2.09 110.904 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -56.94 -75.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.082 -0.508 . . . . 1.99 110.939 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.7 -169.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 1.81 110.9 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -4.45 54.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 2.16 110.915 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.61 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.4 m -144.5 153.36 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.51 111.126 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.492 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.4 tptt -71.25 108.87 4.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 2.08 110.912 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.598 HG21 ' O ' ' A' ' 104' ' ' ASP . 32.2 p -85.88 177.7 7.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.27 111.13 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.49 -54.31 42.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.27 111.119 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -49.97 75.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.48 110.814 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.46 -41.58 76.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 1.81 110.924 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -61.64 -54.63 40.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 0.38 110.932 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.7 m -58.47 -48.84 79.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.34 110.886 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -46.53 89.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.55 110.879 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.36 -43.47 98.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.36 111.051 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.602 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.1 tp -63.37 -52.37 61.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.29 110.91 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -65.64 -24.65 67.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.33 111.114 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.34 -15.71 42.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.87 110.853 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 40.2 p -83.42 4.69 26.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 2.34 110.873 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.8 -4.77 34.4 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.632 -0.794 . . . . 0.59 112.469 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -86.45 169.37 12.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.904 0.383 . . . . 0.3 110.894 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.56 170.15 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.23 111.118 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 51.99 44.9 29.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 2.43 110.897 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.488 HG13 HD23 ' A' ' 119' ' ' LEU . 91.1 t -80.33 141.75 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.32 111.049 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 158.87 7.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 1.62 110.92 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -77.31 145.92 37.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 2.35 110.86 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.674 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.6 mp -105.26 -36.51 7.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.25 110.949 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.83 176.2 13.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 1.11 110.944 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.697 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -132.2 137.04 47.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 4.12 110.83 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.78 138.26 30.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.699 0.762 . . . . 1.84 110.853 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.413 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.5 Cg_endo -69.77 164.05 35.98 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.664 2.242 . . . . 0.2 112.357 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -95.74 128.47 42.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.29 110.941 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.455 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.46 160.91 25.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.576 0.703 . . . . 1.26 111.117 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.455 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.0 Cg_endo -69.69 -29.83 23.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.261 . . . . 0.4 112.288 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.08 -17.96 35.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 2.79 110.856 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -53.47 4.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 2.48 110.92 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -49.14 -41.09 13.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.26 111.142 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -34.67 73.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 1.27 110.976 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.18 -44.89 71.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.33 110.802 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.675 HG23 HD13 ' A' ' 147' ' ' LEU . 7.2 p -69.0 -32.54 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.19 111.153 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -76.06 -29.9 58.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 2.33 110.858 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -90.14 -20.68 22.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 1.77 110.911 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -94.58 -32.63 13.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.33 110.858 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.973 HD22 HD12 ' A' ' 74' ' ' LEU . 2.6 mp -127.88 -53.87 1.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.45 110.99 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.96 12.3 2.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 0.39 112.501 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.61 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.5 t-160 -70.24 120.38 15.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 1.12 110.818 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -151.9 111.22 3.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 3.27 110.928 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.62 175.09 13.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 1.05 110.869 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.34 -14.19 14.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 2.24 110.876 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -104.82 11.4 33.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 1.83 110.868 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.603 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -74.01 163.18 28.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.32 110.939 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.697 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.88 129.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.18 110.88 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.757 ' CZ ' HG22 ' A' ' 72' ' ' THR . 33.2 m-85 -73.54 132.89 43.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 1.88 110.869 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.01 140.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.22 111.116 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.674 ' HG2' HD13 ' A' ' 130' ' ' LEU . 22.3 tt0 -94.42 126.38 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 1.65 110.922 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.446 HD13 ' HG ' ' A' ' 115' ' ' LEU . 2.8 mp -123.15 153.65 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.34 111.174 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.443 ' HB ' HD11 ' A' ' 130' ' ' LEU . 7.5 t -139.2 164.46 29.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.35 111.141 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -154.7 135.84 4.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.17 112.488 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -91.36 140.02 30.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.866 0.365 . . . . 1.64 110.899 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 135.47 49.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.604 0.716 . . . . 1.26 110.969 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.85 127.87 15.14 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.695 2.263 . . . . 0.36 112.348 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.3 110.869 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.875 0.369 . . . . 2.67 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 6' ' ' ILE . 7.2 m-85 -122.12 11.71 10.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 2.06 110.933 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.37 40.65 99.14 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.726 -0.75 . . . . 0.29 112.502 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.485 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.5 mp -83.53 160.42 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 0.26 111.019 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -158.3 168.63 26.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.08 -0.509 . . . . 1.84 110.773 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.73 132.81 35.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 0.36 111.092 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.88 -8.12 29.55 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.757 -0.735 . . . . 0.25 112.546 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -111.96 165.33 12.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 1.26 110.924 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.56 140.09 33.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 2.16 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 62' ' ' ILE . 47.2 t -142.68 140.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 1.85 111.178 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.767 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -118.02 122.1 42.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.23 111.085 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.799 HG11 HG12 ' A' ' 29' ' ' VAL . 59.6 t -94.64 118.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.18 111.086 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.516 HG12 ' CG1' ' A' ' 47' ' ' ILE . 9.4 t -102.95 110.07 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.26 111.188 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -111.54 167.55 10.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.15 -0.477 . . . . 0.15 110.939 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 7.7 p-10 -151.34 -169.63 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 1.69 110.876 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -56.97 -35.72 69.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 2.91 110.846 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.4 m -73.11 -10.61 59.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 1.57 110.832 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.63 94.9 10.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.729 . . . . 0.13 110.881 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 141.46 45.2 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.717 2.278 . . . . 0.21 112.285 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -48.89 -32.7 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.18 111.154 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.55 -52.66 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 2.54 110.963 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.34 -45.06 10.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.17 111.097 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.488 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.48 -61.34 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.14 110.877 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -49.87 -36.1 25.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 3.31 110.857 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.52 -47.2 43.54 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.486 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.4 mt -62.13 -38.62 89.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.48 110.922 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.799 HG12 HG11 ' A' ' 14' ' ' VAL . 18.2 m -77.96 -31.55 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.62 111.099 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -62.2 -58.01 9.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 1.6 110.872 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -40.24 75.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 2.43 110.929 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.887 HD23 HD21 ' A' ' 35' ' ' LEU . 87.3 mt -73.03 -24.49 60.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.23 110.986 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.465 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.64 -25.25 44.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.37 110.942 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.83 -29.6 17.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.24 111.095 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.887 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.66 -35.0 14.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.19 110.981 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.73 -44.98 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.23 111.06 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.07 -10.94 53.75 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.674 -0.774 . . . . 0.26 112.478 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.5 -62.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.728 0.299 . . . . 3.06 110.852 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.637 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 2.9 mm-40 -90.22 -40.97 11.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 2.18 110.872 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.38 -123.03 4.01 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.661 -0.78 . . . . 0.32 112.572 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -158.28 153.54 25.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.863 0.363 . . . . 2.28 110.827 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 33' ' ' GLN . 96.6 t -138.5 130.86 38.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.187 -0.46 . . . . 0.33 111.137 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 t -119.67 156.02 31.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.17 110.916 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -117.07 135.3 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.18 111.125 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -145.74 151.95 38.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 2.17 110.965 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.73 135.43 44.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.4 110.936 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.66 ' CD1' HG21 ' A' ' 73' ' ' THR . 32.8 mt -51.68 -35.15 17.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.26 111.058 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -75.09 -31.22 61.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 2.1 110.838 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -95.82 18.44 13.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 3.32 110.948 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.791 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.83 -31.13 4.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.11 110.937 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -53.39 -38.84 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 1.11 110.899 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -85.09 -15.85 42.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 1.27 110.899 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -65.94 -11.64 48.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 1.01 110.787 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 63.36 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.32 111.144 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -60.93 -71.66 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.36 110.826 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -150.12 -168.99 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 1.82 110.951 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -102.36 137.47 40.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.74 110.926 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 p 46.57 85.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 1.23 110.833 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.6 p -141.05 -40.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.25 110.87 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.492 ' O ' HD23 ' A' ' 87' ' ' LEU . 94.5 m-85 -99.85 119.52 38.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.51 . . . . 2.06 110.931 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.2 -21.23 62.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 1.51 110.814 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 12' ' ' VAL . 35.8 mt -142.63 144.25 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.34 111.091 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.958 HG21 HG23 ' A' ' 83' ' ' ILE . 19.7 mm -134.9 126.58 47.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.12 111.13 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.1 mm? -109.04 136.82 47.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.19 110.925 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.3 98.39 4.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.12 110.857 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.61 75.52 0.21 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.735 -0.745 . . . . 0.15 112.577 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.24 56.17 0.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.801 0.334 . . . . 0.57 110.938 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -124.44 160.32 53.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.707 0.765 . . . . 0.22 111.12 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 120.35 7.15 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 0.24 112.283 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.22 6.91 83.83 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.828 -0.701 . . . . 0.18 112.54 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.413 ' HB3' HG23 ' A' ' 68' ' ' VAL . 4.7 p -55.97 151.56 11.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.951 0.405 . . . . 0.71 110.825 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.704 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 19.5 p -141.5 109.12 5.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.2 111.187 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.66 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.4 145.48 11.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.3 111.194 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.959 HD12 HD22 ' A' ' 147' ' ' LEU . 4.1 mt -124.18 105.17 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.22 110.894 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -80.1 153.8 28.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.28 110.822 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m -131.34 -176.62 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.39 110.902 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.33 69.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.526 . . . . 0.33 111.139 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -62.56 -45.04 94.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 1.64 110.841 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.791 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -74.97 -55.31 12.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.171 -0.468 . . . . 0.24 111.092 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.544 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.5 mt -50.28 -43.88 53.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.22 110.831 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.45 -52.06 49.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.111 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -44.43 92.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 2.96 110.877 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.958 HG23 HG21 ' A' ' 63' ' ' ILE . 42.3 mm -54.94 -68.18 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.2 111.085 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.65 57.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.27 111.126 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -53.14 -52.61 58.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 2.19 110.874 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 56' ' ' LYS . 36.5 pt -81.63 -8.63 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.18 111.21 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -77.24 124.2 27.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.34 110.876 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -63.1 160.25 40.85 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.703 . . . . 2.24 110.887 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 114.22 3.65 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.265 . . . . 0.28 112.3 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.56 5.52 56.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.587 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.71 -160.95 14.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.16 112.462 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.9 m -139.19 154.26 48.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.28 110.936 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.729 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.56 115.67 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.15 110.796 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.566 ' N ' HD22 ' A' ' 93' ' ' LEU . 47.9 m-85 -110.19 132.4 54.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 1.84 110.903 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.558 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.87 158.71 44.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.21 110.928 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.08 131.38 44.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 2.12 110.899 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.7 150.25 22.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.62 0.724 . . . . 3.59 110.844 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.638 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.72 144.71 55.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 0.24 112.412 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.7 146.59 32.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.28 111.125 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.478 ' HB2' HG22 ' A' ' 111' ' ' THR . 41.9 mt-10 -107.19 133.28 52.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 2.02 110.876 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.8 p -92.42 -42.76 9.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 1.07 111.209 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.677 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.67 40.45 1.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.91 111.037 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.421 HG21 ' CD ' ' A' ' 100' ' ' GLU . 20.7 t -147.65 151.9 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.85 111.113 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.64 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -56.34 178.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 2.31 110.825 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.15 -63.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 2.29 110.895 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -63.65 -75.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 1.82 110.895 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.86 -167.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.479 . . . . 1.73 110.849 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -8.29 59.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 2.31 110.919 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 149' ' ' HIS . 1.5 m -142.58 150.96 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.77 111.119 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HZ3' HD23 ' A' ' 74' ' ' LEU . 2.5 ttpm? -65.99 126.21 27.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 5.11 110.885 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.64 HG21 ' O ' ' A' ' 104' ' ' ASP . 71.7 p -97.83 177.7 5.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.38 111.147 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.87 -54.53 45.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.26 111.056 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -55.16 -48.04 74.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.23 110.908 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -36.41 75.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 2.41 110.838 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.537 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -63.94 -56.57 14.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.51 110.904 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 48.6 m -57.44 -47.62 81.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.28 110.861 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -45.57 92.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.27 110.854 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.31 99.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.479 . . . . 0.23 111.082 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.544 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.0 tp -65.39 -52.57 52.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.22 110.906 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.2 m -61.28 -31.75 71.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.27 111.114 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.9 mt -87.09 -10.67 52.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.6 110.912 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.63 4.95 29.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 1.71 110.869 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.27 7.66 32.29 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.54 112.485 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -106.3 168.44 9.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.849 0.357 . . . . 0.27 110.898 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 23.0 m -148.41 172.53 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.23 111.133 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 51.63 44.67 29.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.471 . . . . 2.12 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.408 HG13 HD23 ' A' ' 119' ' ' LEU . 45.5 t -79.3 144.66 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.26 111.163 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.3 158.48 5.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 2.85 110.976 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -78.83 147.09 33.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.39 . . . . 2.44 110.837 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.724 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -106.09 -36.51 6.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.21 110.967 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 176.39 11.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.11 110.916 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.72 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -131.9 137.31 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 4.12 110.848 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -123.53 136.2 26.95 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.592 0.71 . . . . 1.81 110.875 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.416 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.3 Cg_endo -69.75 162.46 41.98 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.642 2.228 . . . . 0.27 112.427 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.681 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -96.63 136.13 37.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.28 110.909 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.577 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -117.67 162.46 28.74 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.519 0.676 . . . . 1.44 111.11 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -22.65 31.53 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.574 2.183 . . . . 0.45 112.323 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -85.15 -26.37 26.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 2.43 110.826 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -88.53 -51.01 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 2.47 110.829 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -49.82 -38.92 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.24 111.188 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.85 -32.95 73.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.16 110.924 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -45.65 68.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.29 110.862 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.712 HG23 HD13 ' A' ' 147' ' ' LEU . 7.4 p -68.75 -30.96 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.18 111.081 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -76.44 -31.1 57.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 2.47 110.876 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -90.26 -20.41 23.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.164 -0.471 . . . . 1.67 110.903 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -94.75 -33.0 13.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.31 110.914 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.959 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -126.2 -54.18 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.32 110.938 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.45 10.67 2.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 0.32 112.45 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.483 ' CD2' HG11 ' A' ' 109' ' ' VAL . 13.0 t-160 -70.18 121.98 18.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.64 110.89 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.48 105.07 3.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 3.22 110.928 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.25 170.7 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.79 110.907 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.49 -6.33 18.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 1.56 110.893 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.677 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 1.8 m120 -105.14 10.56 33.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 3.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.681 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.62 166.93 19.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.31 110.934 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.72 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -172.49 130.71 0.57 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.27 110.906 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.704 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.1 m-85 -75.67 132.13 40.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 1.73 110.88 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.04 146.91 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.22 111.142 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.724 ' HG2' HD13 ' A' ' 130' ' ' LEU . 9.4 tt0 -102.07 131.52 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 2.11 110.899 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.48 149.96 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.25 111.116 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.507 ' N ' HD11 ' A' ' 130' ' ' LEU . 3.3 t -132.05 159.87 37.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.22 111.149 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.19 135.2 5.13 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.821 -0.704 . . . . 0.13 112.506 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -91.54 139.47 30.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.348 . . . . 1.66 110.973 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.23 134.77 51.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 1.29 110.933 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.67 121.66 8.37 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.743 2.296 . . . . 0.37 112.353 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 C--N 1.328 -0.369 0 CA-C-O 120.921 0.391 . . . . 0.62 110.89 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.858 0.361 . . . . 2.11 110.835 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.419 ' HB2' HD11 ' A' ' 6' ' ' ILE . 4.7 m-85 -122.3 20.72 10.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 1.53 110.935 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.33 41.68 80.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.26 112.531 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.515 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.5 mp -83.44 160.52 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.27 111.145 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -157.5 168.61 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 1.81 110.929 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.62 131.81 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.35 111.1 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.88 2.62 30.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.757 -0.735 . . . . 0.4 112.472 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -122.38 165.51 16.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 1.29 110.92 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.73 139.65 34.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 1.29 110.869 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.636 HG22 ' HB ' ' A' ' 62' ' ' ILE . 48.6 t -142.42 142.48 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 1.85 111.197 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.79 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -119.2 118.28 30.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.29 111.194 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.835 HG11 HG12 ' A' ' 29' ' ' VAL . 63.9 t -92.91 118.5 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.16 111.091 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.422 HG12 ' CG1' ' A' ' 47' ' ' ILE . 21.3 t -102.58 116.33 46.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.19 111.168 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -116.79 168.08 10.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.2 110.939 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.63 -169.86 3.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.26 -0.427 . . . . 1.86 110.882 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -57.11 -35.61 69.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 3.38 110.88 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 t -73.49 -10.21 59.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 1.3 110.862 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.96 94.24 10.36 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.698 0.761 . . . . 0.16 110.85 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.89 142.48 47.46 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.667 2.245 . . . . 0.23 112.339 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.07 -32.52 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.22 111.136 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -51.26 -52.97 40.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 2.48 110.957 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -44.68 11.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.2 111.128 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.479 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.74 -61.59 2.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.15 110.92 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -36.41 22.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 2.53 110.918 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.37 -46.76 47.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.682 -0.77 . . . . 0.2 112.426 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.9 mt -62.23 -38.64 90.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.45 110.929 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.835 HG12 HG11 ' A' ' 14' ' ' VAL . 17.2 m -77.97 -31.55 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.62 111.119 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.31 -58.16 8.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.191 -0.459 . . . . 1.65 110.883 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -40.11 74.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.71 110.967 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.861 HD23 HD21 ' A' ' 35' ' ' LEU . 90.2 mt -73.06 -25.17 60.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.24 110.862 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.51 -25.38 45.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.37 110.845 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 -29.58 17.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.24 111.092 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.861 HD21 HD23 ' A' ' 32' ' ' LEU . 1.3 pp -91.46 -34.72 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.23 110.935 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.28 -45.84 4.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.23 111.164 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.03 -12.04 53.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.26 112.513 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -62.56 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 2.88 110.912 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -94.45 -38.97 10.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.15 -0.477 . . . . 2.62 110.865 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.55 -126.8 4.43 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.24 112.453 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -155.28 153.46 30.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 2.21 110.836 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 33' ' ' GLN . 97.4 t -138.38 128.41 34.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.25 111.143 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.0 t -116.87 157.87 24.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.15 110.959 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.07 135.52 60.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.14 111.082 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -144.08 151.41 39.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 1.26 110.82 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.4 134.89 46.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.43 110.905 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.693 ' CD1' HG21 ' A' ' 73' ' ' THR . 24.6 mt -52.23 -36.13 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.37 111.188 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -71.55 -32.27 67.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 2.06 110.968 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -102.54 20.25 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 3.61 110.845 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.79 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -49.03 -28.89 4.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 1.12 110.909 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.581 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -55.81 -34.04 64.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 2.67 110.993 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -83.68 -13.89 53.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 1.12 110.926 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.8 m -68.49 -6.97 28.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.93 110.867 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.26 64.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.118 -0.492 . . . . 0.46 111.089 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -65.24 -69.46 0.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.34 110.902 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.667 ' O ' HG22 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -155.66 -175.21 5.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 2.16 110.84 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -94.42 135.15 36.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 2.01 110.845 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 p 46.29 82.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 1.12 110.852 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -133.33 -38.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.32 110.813 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.467 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.1 m-85 -102.46 122.7 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 1.45 110.886 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.33 -20.56 61.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 1.72 110.769 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.636 ' HB ' HG22 ' A' ' 12' ' ' VAL . 33.5 mt -144.21 144.47 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.35 111.165 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.004 HG21 HG23 ' A' ' 83' ' ' ILE . 15.9 mm -135.29 130.23 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.15 111.158 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.7 mm? -113.88 136.92 52.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.18 110.915 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.57 100.88 5.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.14 110.793 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.79 74.06 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.771 -0.728 . . . . 0.19 112.478 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.97 58.68 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.57 110.91 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.53 159.89 63.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.587 0.708 . . . . 0.22 111.129 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 116.43 4.56 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.642 2.228 . . . . 0.25 112.377 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.15 7.01 68.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.822 -0.704 . . . . 0.17 112.471 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -54.92 150.49 10.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.967 0.413 . . . . 0.7 110.881 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.746 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.2 p -140.15 109.0 5.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.15 111.121 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.693 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.68 152.86 16.38 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.25 111.051 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.974 HD12 HD22 ' A' ' 147' ' ' LEU . 6.1 mt -130.94 99.76 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.23 110.913 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -77.57 138.36 39.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.34 110.901 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.531 ' H ' HD13 ' A' ' 79' ' ' ILE . 16.4 m -115.31 175.61 5.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.63 110.803 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.98 -35.41 33.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.27 111.246 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -62.7 -39.69 94.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.126 -0.488 . . . . 2.3 110.909 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.79 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.8 mp -81.86 -55.17 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.24 111.146 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.3 mt -49.27 -46.1 45.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.32 110.826 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.03 -50.54 58.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.57 111.077 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.515 ' OE2' HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -58.09 -47.13 84.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 4.91 110.901 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.004 HG23 HG21 ' A' ' 63' ' ' ILE . 48.8 mm -53.12 -64.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.26 111.115 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.7 -41.36 61.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.26 111.053 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 tpp85 -51.99 -52.99 46.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 2.1 110.854 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 56' ' ' LYS . 32.4 pt -80.85 -8.41 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.27 111.163 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.17 114.11 15.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.33 110.884 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -53.7 160.43 2.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.702 . . . . 3.52 110.864 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 114.76 3.81 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.677 2.252 . . . . 0.28 112.291 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.67 5.77 57.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 0.24 112.486 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.5 -162.25 20.69 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.694 -0.765 . . . . 0.17 112.482 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.6 m -139.0 153.52 48.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.28 110.94 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.2 tm? -138.28 117.07 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.15 110.898 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.604 ' N ' HD22 ' A' ' 93' ' ' LEU . 47.1 m-85 -112.74 133.51 54.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 1.61 110.867 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.64 159.21 44.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.17 110.946 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.96 126.4 41.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 1.97 110.89 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.627 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -150.33 146.77 20.41 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.673 0.749 . . . . 2.34 110.905 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.628 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.8 Cg_endo -69.77 143.3 50.34 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.761 2.307 . . . . 0.2 112.316 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 155' ' ' LEU . 14.2 m -126.97 146.43 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.2 111.121 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.491 ' HB2' HG22 ' A' ' 111' ' ' THR . 54.1 mt-10 -109.25 132.57 54.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 2.13 110.873 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.9 p -91.27 -38.92 12.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 1.22 111.125 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.556 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -97.77 40.75 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.54 111.101 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.438 HG21 ' CD ' ' A' ' 100' ' ' GLU . 26.2 t -148.07 150.19 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.64 111.068 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.601 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -53.38 172.01 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.488 . . . . 1.71 110.872 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -63.95 -62.83 1.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 2.3 110.856 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -65.66 -75.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 2.36 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 t 53.49 -168.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 2.14 110.928 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.45 -5.73 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 1.71 110.921 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.93 146.63 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.39 111.085 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -67.29 115.06 6.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 2.39 110.891 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.601 HG21 ' O ' ' A' ' 104' ' ' ASP . 72.1 p -88.94 -179.85 6.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.482 . . . . 0.23 111.165 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.18 -53.09 62.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.18 111.08 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -60.19 -49.73 76.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.043 0.449 . . . . 0.27 110.86 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -58.12 -43.11 87.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 2.31 110.902 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.627 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -59.58 -55.2 37.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.3 110.876 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 61.2 m -57.79 -49.26 77.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.24 110.912 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -45.5 88.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.32 110.868 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.65 -46.93 87.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.28 111.111 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.648 HD23 HG13 ' A' ' 127' ' ' VAL . 14.6 tp -60.49 -50.96 71.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.38 110.88 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.5 m -66.31 -26.24 67.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.35 111.214 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.7 mt -86.17 -14.04 45.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.55 110.888 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 p -81.94 2.92 28.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 2.53 110.854 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.8 -4.93 34.43 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.729 . . . . 0.79 112.551 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.2 tp -87.61 170.82 10.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.38 110.896 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.78 170.97 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.4 111.126 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 53.11 44.29 30.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 2.1 110.892 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.648 HG13 HD23 ' A' ' 119' ' ' LEU . 89.9 t -81.69 139.42 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.3 111.009 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.29 162.4 8.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 1.85 110.96 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.57 145.69 32.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 2.54 110.904 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.674 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.8 mp -103.89 -36.79 7.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.472 . . . . 0.22 110.955 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.08 176.29 12.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 1.12 110.926 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.742 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.1 tmt_? -131.26 137.24 48.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 4.45 110.881 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -124.53 137.84 30.04 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.607 0.718 . . . . 1.38 110.958 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.414 ' HA ' HD21 ' A' ' 155' ' ' LEU . 52.8 Cg_endo -69.72 165.13 31.96 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.755 2.304 . . . . 0.24 112.329 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.672 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.86 127.21 44.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.27 110.963 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.459 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.74 161.25 23.36 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.555 0.693 . . . . 1.56 111.179 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -24.64 29.31 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.281 . . . . 0.32 112.319 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -85.71 -22.25 27.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 2.58 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -87.71 -52.23 5.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 2.41 110.995 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -49.84 -40.31 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.25 111.136 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -33.03 73.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 1.13 111.011 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -46.34 66.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.26 110.879 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.2 p -68.3 -30.12 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.17 111.113 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -76.34 -32.68 58.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.108 -0.496 . . . . 2.5 110.806 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -89.35 -20.13 24.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.74 110.877 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -94.6 -32.61 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.28 110.894 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.974 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.79 -54.37 1.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.31 110.921 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.18 9.26 2.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.735 -0.745 . . . . 0.29 112.454 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -70.21 120.93 16.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.64 110.858 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -152.63 104.9 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 2.24 110.894 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -161.11 171.26 18.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.67 110.789 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.78 -8.11 17.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 1.87 110.885 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.556 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 2.3 m120 -102.74 12.01 36.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 2.95 110.872 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.672 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -86.07 167.51 14.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.33 110.831 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.742 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -172.61 130.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.2 110.916 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.746 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.3 m-85 -73.61 132.69 43.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.473 . . . . 1.8 110.939 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.39 142.9 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.2 111.09 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.674 ' HG2' HD13 ' A' ' 130' ' ' LEU . 24.0 tt0 -96.86 127.81 43.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 1.62 110.85 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.95 151.39 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.32 111.156 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.452 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.9 t -134.96 162.96 30.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.28 111.217 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.466 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -153.84 134.09 4.21 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 0.13 112.511 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.77 140.37 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 1.67 110.891 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.11 135.48 47.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.54 0.685 . . . . 1.83 110.863 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 125.1 11.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.623 2.215 . . . . 0.38 112.372 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.933 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.919 0.39 . . . . 1.98 110.93 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -122.33 22.68 10.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 1.5 110.817 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.15 41.08 53.01 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.772 -0.728 . . . . 0.25 112.454 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.504 HG23 HG21 ' A' ' 12' ' ' VAL . 1.6 mp -80.02 159.68 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 0.23 111.139 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.731 ' O ' HG23 ' A' ' 36' ' ' THR . 0.8 OUTLIER -153.5 164.7 37.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.26 110.952 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.46 126.19 35.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.29 111.051 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.96 0.96 21.05 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.807 -0.711 . . . . 0.29 112.512 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.89 167.15 11.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 1.14 110.974 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.15 112.79 25.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 1.28 110.947 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 62' ' ' ILE . 88.1 t -117.37 130.16 72.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.96 111.013 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.788 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -106.11 124.66 49.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.24 111.105 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.849 HG11 HG12 ' A' ' 29' ' ' VAL . 59.1 t -97.3 117.03 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.2 111.079 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 t -102.56 117.49 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.23 111.085 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -114.88 172.46 7.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 0.37 110.908 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.59 ' HB3' HD12 ' A' ' 47' ' ' ILE . 7.6 p-10 -151.73 -172.98 4.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 2.13 110.879 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -35.49 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 3.61 110.929 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -73.91 -8.03 54.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 1.28 110.831 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.8 m -107.05 93.78 9.73 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.604 0.716 . . . . 0.14 110.833 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.5 Cg_endo -69.74 143.79 52.06 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.634 2.223 . . . . 0.2 112.424 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.0 t -48.88 -32.9 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.2 111.153 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.94 -53.01 36.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 3.25 110.888 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -44.85 10.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.16 111.13 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.466 HD22 HG13 ' A' ' 29' ' ' VAL . 1.8 tm? -52.13 -62.42 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.14 110.938 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.16 -36.25 18.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 2.81 110.911 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.14 -47.16 46.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.714 -0.755 . . . . 0.19 112.5 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.7 mt -61.9 -38.89 90.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.47 110.96 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.849 HG12 HG11 ' A' ' 14' ' ' VAL . 17.6 m -77.6 -31.48 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.63 111.095 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -62.1 -58.52 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 1.58 110.815 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -39.97 75.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 1.68 110.923 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.9 HD23 HD21 ' A' ' 35' ' ' LEU . 84.1 mt -73.06 -24.32 60.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.23 110.972 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.492 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.67 -24.98 44.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.38 110.947 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.98 -29.92 17.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.21 111.087 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.9 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.46 -35.24 14.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.18 110.87 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.14 -45.39 4.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.23 111.059 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.15 -12.24 54.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.25 112.5 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -70.91 -62.55 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.323 . . . . 2.54 110.88 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.505 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 1.1 mm-40 -89.42 -41.11 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 2.38 110.807 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.75 -128.36 5.81 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.788 -0.72 . . . . 0.25 112.541 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -151.82 152.53 32.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 2.2 110.903 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 33' ' ' GLN . 88.2 t -135.46 130.0 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.27 111.121 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 t -120.74 153.14 37.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.18 110.793 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -115.86 138.61 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.23 111.155 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -146.9 151.23 36.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 1.21 110.984 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.09 138.68 39.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.27 110.846 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.814 HD13 HG21 ' A' ' 73' ' ' THR . 27.3 mt -55.04 -42.65 65.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.33 111.147 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -25.56 67.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 4.18 110.904 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -111.24 19.32 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 3.55 110.83 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.789 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -50.27 -27.65 6.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 1.1 110.904 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -55.6 -32.53 63.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 1.14 110.875 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -83.45 -14.31 52.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 1.04 110.951 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.427 ' HB2' HD13 ' A' ' 50' ' ' LEU . 20.7 m -67.56 -8.52 34.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.85 110.884 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.41 64.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.28 111.129 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -65.13 -67.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.38 110.807 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.639 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -154.37 -177.9 6.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 1.39 110.931 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -93.07 130.46 38.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 1.83 110.861 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t 51.63 83.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.14 110.8 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 91.2 p -136.15 -39.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.25 110.792 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 13' ' ' ALA . 99.6 m-85 -100.59 122.01 42.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 1.44 110.8 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.23 -22.04 62.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 1.49 110.854 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.7 ' HB ' HG22 ' A' ' 12' ' ' VAL . 20.4 mt -145.5 143.68 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.26 111.076 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.89 HG21 HG23 ' A' ' 83' ' ' ILE . 18.2 mm -133.03 132.72 58.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.12 111.148 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -115.14 137.21 52.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.19 110.957 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.35 101.33 5.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.16 110.863 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.23 75.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.852 -0.689 . . . . 0.17 112.427 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.48 59.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 0.6 110.85 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.78 159.71 64.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 0.21 111.125 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 116.84 4.76 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.59 2.193 . . . . 0.23 112.406 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.79 7.49 71.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.798 -0.715 . . . . 0.16 112.523 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.47 148.84 14.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.946 0.403 . . . . 0.67 110.882 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.765 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 32.2 p -137.88 108.57 6.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.19 111.127 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.814 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.09 153.47 18.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.26 111.145 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.938 HD12 HD22 ' A' ' 147' ' ' LEU . 4.5 mt -132.12 104.23 6.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 0.23 110.852 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -79.87 153.84 28.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.34 110.829 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.8 m -130.94 175.82 8.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.57 110.824 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.28 -38.22 51.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 0.23 111.07 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.44 -46.03 91.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.193 -0.458 . . . . 2.41 110.819 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.789 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -72.6 -54.6 15.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.22 111.073 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.518 HD13 ' HA ' ' A' ' 119' ' ' LEU . 58.8 mt -51.08 -38.26 50.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 0.19 110.857 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.88 -56.55 15.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.32 111.049 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -44.12 76.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 2.98 110.949 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.89 HG23 HG21 ' A' ' 63' ' ' ILE . 51.1 mm -55.53 -68.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.23 111.172 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.71 -37.4 50.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.18 111.096 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -55.2 -50.07 70.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 3.13 110.873 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 56' ' ' LYS . 32.3 pt -84.99 -7.31 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.2 111.165 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.97 112.04 14.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.17 -0.468 . . . . 0.35 110.834 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -51.35 159.31 1.16 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 2.3 110.878 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 114.61 3.76 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.663 2.242 . . . . 0.16 112.306 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.47 3.32 56.44 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.733 -0.746 . . . . 0.17 112.455 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.98 -159.72 10.31 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.14 112.525 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.7 m -140.91 157.91 44.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.825 0.345 . . . . 0.34 110.942 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.709 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -141.76 115.05 8.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.2 110.896 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.561 ' N ' HD22 ' A' ' 93' ' ' LEU . 44.8 m-85 -109.23 133.9 52.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 1.63 110.914 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.34 162.41 39.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.16 110.874 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.1 123.45 27.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 3.41 110.855 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.627 ' OE1' HD23 ' A' ' 115' ' ' LEU . 1.0 OUTLIER -146.53 147.84 31.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.613 0.72 . . . . 2.58 110.847 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.624 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -69.78 145.61 57.58 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.671 2.247 . . . . 0.2 112.311 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.0 m -131.3 146.45 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.24 111.11 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.73 132.68 53.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 3.6 110.866 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.4 p -100.47 26.07 7.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 1.24 111.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.414 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -151.94 27.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.61 111.129 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 104' ' ' ASP . 5.3 t -143.78 157.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.65 111.162 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.591 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -59.31 -172.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 1.9 110.841 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.41 -74.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 3.45 110.87 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -52.57 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 2.14 110.893 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.69 -169.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 1.8 110.872 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -5.02 56.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 2.09 110.981 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -146.77 145.8 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.46 111.227 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.432 ' H ' HD22 ' A' ' 74' ' ' LEU . 7.0 mmtm -66.07 110.46 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 2.49 110.983 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.591 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.4 p -82.11 177.25 8.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.21 111.103 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.88 -54.67 41.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.18 111.076 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.88 -48.02 83.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.27 110.822 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -57.99 -39.02 77.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 2.04 110.888 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.627 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -64.84 -55.17 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.3 110.873 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -56.76 -45.87 81.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.26 110.804 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -43.13 89.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.35 110.85 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.23 111.124 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.584 HD11 HD12 ' A' ' 93' ' ' LEU . 14.6 tp -65.97 -51.43 58.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.22 110.858 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.0 m -62.76 -32.3 73.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.28 111.125 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.1 mt -86.82 -10.33 53.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.394 . . . . 0.68 110.974 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.02 5.8 27.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 1.75 110.902 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.75 8.36 30.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.755 -0.736 . . . . 0.56 112.445 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -108.92 171.37 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.346 . . . . 0.26 110.953 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.9 m -149.98 170.71 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.21 111.054 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 52.34 44.94 29.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.02 -0.536 . . . . 2.35 110.88 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.422 HG13 HD23 ' A' ' 119' ' ' LEU . 93.1 t -81.78 142.64 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.25 111.121 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 159.75 7.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 1.78 110.894 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.01 139.83 38.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 2.82 110.818 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.665 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -97.63 -37.58 9.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.21 110.831 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.7 176.35 12.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 1.1 110.889 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.706 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -130.14 138.83 50.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 4.2 110.85 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -125.37 136.91 28.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.64 0.733 . . . . 1.42 110.938 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.401 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.1 Cg_endo -69.72 161.49 45.7 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.694 2.263 . . . . 0.21 112.443 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.665 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -94.96 125.4 39.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 0.27 110.963 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.454 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -98.24 160.75 27.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.539 0.685 . . . . 1.26 111.128 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.7 Cg_endo -69.87 -28.92 24.15 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.62 2.214 . . . . 0.39 112.369 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -85.32 -17.82 35.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 3.9 110.88 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.86 -53.52 4.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 2.35 110.899 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 141' ' ' GLN . 5.7 p -50.15 -42.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.25 111.14 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.404 ' N ' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -65.58 -32.35 73.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 1.31 110.854 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -50.61 28.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.4 110.856 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.658 HG23 HD13 ' A' ' 147' ' ' LEU . 7.2 p -62.21 -28.59 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.2 111.123 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -76.13 -47.34 24.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 1.96 110.842 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -74.45 -19.56 60.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 1.88 110.831 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.48 -33.11 13.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.46 110.786 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.938 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.82 -54.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.45 110.828 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.15 8.2 2.38 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.712 -0.756 . . . . 0.44 112.513 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -70.64 119.94 15.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.76 0.314 . . . . 0.63 110.814 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.53 105.08 2.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 2.19 110.868 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.14 177.52 10.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.76 110.902 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.46 -13.45 15.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 1.84 110.857 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.414 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -95.87 3.5 53.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 3.33 110.881 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.665 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -74.05 163.11 28.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.4 110.974 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.706 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.7 tm? -173.55 129.58 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.256 -0.429 . . . . 0.2 110.902 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.765 ' CZ ' HG22 ' A' ' 72' ' ' THR . 31.6 m-85 -75.73 135.92 40.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 1.83 110.86 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.79 141.99 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.21 111.194 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.665 ' HG2' HD13 ' A' ' 130' ' ' LEU . 17.6 tt0 -94.57 127.66 40.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 1.62 110.938 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.39 149.14 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.22 111.177 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.473 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.2 t -132.5 162.35 31.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.24 111.13 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.56 135.86 5.01 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.666 -0.778 . . . . 0.13 112.436 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -92.91 140.0 29.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 1.61 110.918 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.3 135.02 50.9 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.518 0.675 . . . . 1.21 110.917 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.9 125.2 11.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.612 2.208 . . . . 0.31 112.297 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.855 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.767 0.318 . . . . 2.4 110.876 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 6' ' ' ILE . 6.8 m-85 -122.21 11.92 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 1.61 110.854 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.34 39.5 97.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.812 -0.709 . . . . 0.41 112.445 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.5 mp -81.52 159.82 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.765 0.316 . . . . 0.32 111.181 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.73 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -156.65 168.62 26.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.78 110.865 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.77 130.1 36.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.51 111.106 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.19 2.04 26.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.782 -0.723 . . . . 0.35 112.53 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -118.85 168.0 11.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.816 0.341 . . . . 1.16 110.864 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.02 115.03 29.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.98 0.419 . . . . 2.29 110.851 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.691 HG22 ' HB ' ' A' ' 62' ' ' ILE . 98.3 t -118.42 131.82 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 1.89 111.172 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.792 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -108.18 125.29 51.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.22 111.133 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.826 HG11 HG12 ' A' ' 29' ' ' VAL . 77.6 t -97.47 119.22 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.15 111.11 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.746 HG12 HG13 ' A' ' 47' ' ' ILE . 20.1 t -103.82 112.21 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.19 111.031 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -113.73 170.53 8.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.22 110.928 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 9.0 p-10 -151.96 -169.85 3.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.428 . . . . 1.79 110.909 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -35.69 71.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 6.23 110.865 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.1 m -72.96 -9.55 58.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 1.58 110.835 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.01 94.24 10.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.664 0.745 . . . . 0.23 110.84 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 142.57 48.14 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.726 2.284 . . . . 0.29 112.331 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.9 t -48.47 -33.14 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.27 111.158 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.09 -52.66 41.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 3.1 110.961 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -45.26 10.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.23 111.119 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.457 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.69 -61.54 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.19 110.977 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.46 -35.58 20.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 2.31 110.874 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.47 -47.56 41.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.766 -0.73 . . . . 0.22 112.486 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.7 mt -61.88 -38.1 87.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.5 110.94 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.826 HG12 HG11 ' A' ' 14' ' ' VAL . 17.5 m -78.59 -31.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.63 111.079 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.48 -57.37 11.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 1.67 110.834 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -39.88 76.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.271 -0.422 . . . . 2.35 110.932 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.885 HD23 HD21 ' A' ' 35' ' ' LEU . 89.9 mt -73.26 -24.92 60.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.28 110.932 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.519 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.17 -25.14 47.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.39 110.969 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.7 -30.74 16.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.26 111.099 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.885 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.23 -34.86 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.25 110.97 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.83 -47.02 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.23 111.149 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.5 -13.55 50.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.26 112.451 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.8 -62.62 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 2.66 110.917 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -98.44 -36.87 9.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 2.2 110.935 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.92 -130.91 5.18 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.665 -0.779 . . . . 0.32 112.51 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -152.11 152.24 32.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.323 . . . . 2.22 110.944 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 33' ' ' GLN . 99.3 t -137.0 121.09 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.25 111.174 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -110.13 155.83 21.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.18 110.859 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 p -118.02 133.89 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.15 111.12 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -144.01 151.6 39.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 1.94 110.955 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -103.17 133.28 48.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.49 110.91 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.84 HD13 HG21 ' A' ' 73' ' ' THR . 20.9 mt -49.57 -32.98 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.36 111.091 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -71.32 -39.67 71.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 2.14 110.967 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.3 19.43 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 3.99 110.842 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.736 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -49.24 -27.87 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.431 . . . . 1.08 110.948 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mp -55.65 -32.85 63.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 1.29 110.942 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -83.88 -14.13 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.433 . . . . 1.04 110.906 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB2' HD13 ' A' ' 50' ' ' LEU . 33.4 m -66.47 -9.21 32.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.85 110.875 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.29 63.48 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.31 111.12 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -63.31 -67.75 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.44 110.818 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.562 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -153.28 179.87 8.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 2.19 110.876 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -87.78 133.94 33.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 1.93 110.944 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.7 p 46.3 83.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 1.11 110.807 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.1 p -134.19 -38.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.3 110.858 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 13' ' ' ALA . 99.4 m-85 -100.87 121.74 42.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 1.46 110.839 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.95 -21.44 61.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 1.73 110.844 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.691 ' HB ' HG22 ' A' ' 12' ' ' VAL . 23.0 mt -145.22 144.4 21.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.22 111.104 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.974 HG21 HG23 ' A' ' 83' ' ' ILE . 16.5 mm -134.5 129.17 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.15 111.128 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.1 mm? -111.03 136.31 50.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.17 110.912 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.402 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -129.51 100.65 5.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.16 110.775 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.02 74.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.451 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.551 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.0 mm? -106.31 52.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.57 110.83 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -123.99 159.83 54.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.24 111.141 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.88 10.53 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.633 2.222 . . . . 0.29 112.308 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.67 6.33 88.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.23 112.457 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 68' ' ' VAL . 9.0 p -56.5 151.58 13.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.909 0.385 . . . . 0.76 110.848 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.718 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 26.4 p -141.62 109.17 5.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.15 111.205 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.84 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.63 143.64 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.29 111.104 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.946 HD12 HD22 ' A' ' 147' ' ' LEU . 7.6 mt -122.52 106.01 10.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.27 110.898 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -81.14 153.79 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.31 110.842 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 m -131.97 175.66 9.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.56 110.856 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.71 -38.51 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.28 111.043 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.09 -47.32 86.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.99 110.856 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.736 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.7 mp -71.53 -54.87 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.28 111.077 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 119' ' ' LEU . 66.9 mt -50.3 -39.24 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.2 110.868 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.58 -54.43 27.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.33 111.033 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -56.9 -43.38 81.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 2.7 110.913 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.974 HG23 HG21 ' A' ' 63' ' ' ILE . 44.0 mm -60.02 -68.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.36 111.047 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.25 -31.26 13.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.43 111.167 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -63.83 -49.97 70.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 2.15 110.903 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 56' ' ' LYS . 41.0 pt -84.67 -2.95 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.23 111.077 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -81.6 111.99 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.4 110.934 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -51.9 159.53 1.36 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 2.2 110.827 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 114.75 3.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.723 2.282 . . . . 0.19 112.289 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.14 3.69 56.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.677 -0.773 . . . . 0.17 112.413 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.42 -163.32 15.66 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.747 -0.739 . . . . 0.15 112.494 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 32.5 m -137.02 154.44 50.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.828 0.347 . . . . 0.29 110.855 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.71 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -139.16 115.59 10.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.17 110.902 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.566 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.8 m-85 -110.29 132.16 54.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.64 110.886 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.551 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.68 164.17 35.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.15 110.896 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.87 131.48 31.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.69 110.922 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.81 149.41 22.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 3.61 110.882 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.566 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.4 Cg_endo -69.74 131.92 22.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.266 . . . . 0.41 112.326 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.73 146.8 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.2 111.174 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.467 ' CD ' HG21 ' A' ' 103' ' ' VAL . 45.9 mt-10 -108.48 132.48 53.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 2.09 110.931 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.9 p -91.15 -26.23 19.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.99 111.195 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.73 39.33 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.5 111.129 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.467 HG21 ' CD ' ' A' ' 100' ' ' GLU . 40.5 t -148.24 150.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.69 111.087 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.575 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -54.67 175.58 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 1.88 110.902 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -65.92 -66.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 2.21 110.813 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -62.15 -75.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 2.26 110.944 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t 51.25 -168.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 2.12 110.883 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -80.84 -3.1 50.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 1.66 110.942 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.616 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.0 m -143.53 144.14 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.52 111.12 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.44 117.33 9.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 2.38 110.896 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 104' ' ' ASP . 45.0 p -92.78 -176.02 4.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.36 111.237 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.43 -50.87 69.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.27 111.102 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -52.21 65.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.38 110.832 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -54.88 -41.15 70.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 2.2 110.92 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.505 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -62.43 -54.82 34.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.38 110.888 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 70.3 m -56.0 -48.07 76.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.27 110.843 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -44.97 93.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.36 110.79 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.08 99.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.28 111.063 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.553 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.4 tp -66.29 -53.33 37.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.24 110.875 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.1 m -59.84 -33.01 71.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.28 111.112 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.7 mt -87.15 -10.53 52.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.69 110.936 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.72 4.38 32.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 1.7 110.884 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.87 11.51 26.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 0.7 112.499 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.71 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -110.9 170.41 8.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.356 . . . . 0.3 110.956 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.7 m -151.5 174.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.27 111.063 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 52.07 43.93 30.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 2.17 110.863 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.4 t -75.7 143.04 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.31 111.099 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 159.1 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 1.57 110.849 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.37 146.8 30.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 2.34 110.881 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.508 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.4 mp -106.76 -35.67 6.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.35 110.948 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.22 176.24 11.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.23 110.886 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.679 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -132.97 140.4 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.495 . . . . 4.02 110.895 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -126.13 137.46 30.24 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.681 0.753 . . . . 1.53 110.947 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.406 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.6 Cg_endo -69.74 162.51 41.76 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.65 2.233 . . . . 0.28 112.35 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.68 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -98.8 123.13 42.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.51 110.941 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.473 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -100.72 161.04 25.13 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.653 0.74 . . . . 1.51 111.054 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.5 Cg_endo -69.65 -25.78 28.76 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.683 2.255 . . . . 0.67 112.388 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -85.42 -22.06 28.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 2.8 110.916 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -87.85 -52.32 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 2.39 110.995 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.89 -39.98 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.35 111.109 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -33.42 74.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 1.44 110.87 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -46.02 67.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.4 110.949 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.768 HG23 HD13 ' A' ' 147' ' ' LEU . 7.6 p -68.51 -30.25 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.24 111.189 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -31.44 56.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.159 -0.473 . . . . 3.44 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -90.31 -19.83 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 2.04 110.888 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -94.25 -33.62 13.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.59 110.874 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.946 HD22 HD12 ' A' ' 74' ' ' LEU . 3.3 mp -125.19 -54.19 1.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.45 110.936 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.96 10.1 2.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 0.37 112.44 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.616 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.6 t-160 -69.54 120.86 15.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 1.03 110.846 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -149.75 106.38 3.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 3.05 110.936 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.6 174.59 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 1.06 110.906 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -19.14 13.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 2.72 110.818 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -96.6 12.77 30.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 2.3 110.903 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.68 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -77.74 163.7 25.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.29 110.951 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.679 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.49 130.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.22 110.855 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.718 ' CZ ' HG22 ' A' ' 72' ' ' THR . 29.9 m-85 -74.76 132.95 42.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 1.67 110.894 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.82 144.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.19 111.229 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.551 ' OE1' HD13 ' A' ' 67' ' ' LEU . 3.1 tt0 -101.04 128.27 47.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 1.99 110.949 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.0 148.16 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.23 111.103 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.487 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.0 t -125.84 158.99 33.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.31 111.228 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.03 130.77 3.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.79 -0.719 . . . . 0.16 112.521 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.16 139.14 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.924 0.393 . . . . 1.6 110.834 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 135.09 53.29 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.515 0.674 . . . . 1.18 110.964 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 127.15 14.24 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.676 2.251 . . . . 0.32 112.38 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.3 110.885 -179.981 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.808 0.337 . . . . 1.94 110.883 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.29 22.38 10.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 1.5 110.84 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.12 40.74 52.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 0.23 112.529 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.471 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -79.25 159.48 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.725 0.298 . . . . 0.22 111.206 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -152.93 162.69 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 1.33 110.822 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.42 126.53 35.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.28 111.124 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.11 -6.67 17.17 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.73 -0.748 . . . . 0.27 112.487 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -113.69 167.66 10.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 1.22 110.965 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -97.96 140.87 31.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 2.12 110.837 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.647 HG22 ' HB ' ' A' ' 62' ' ' ILE . 54.3 t -142.59 142.69 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 1.84 111.16 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.771 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -119.95 121.74 39.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.24 111.024 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.812 HG11 HG12 ' A' ' 29' ' ' VAL . 57.7 t -94.41 118.57 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.21 111.102 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 47' ' ' ILE . 11.4 t -102.52 110.71 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.28 111.121 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -112.45 167.19 10.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.16 110.925 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 47' ' ' ILE . 6.2 p-10 -149.99 -169.65 3.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 1.98 110.846 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -57.53 -35.62 70.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 2.91 110.894 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.37 -9.54 58.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 1.19 110.866 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.84 94.7 10.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.617 0.722 . . . . 0.13 110.851 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 141.78 46.0 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.7 2.267 . . . . 0.19 112.338 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -48.79 -32.97 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.18 111.114 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.08 -52.92 38.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 3.14 110.834 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.46 -44.96 10.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.16 111.145 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.485 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.74 -61.62 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.13 110.894 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -49.7 -37.41 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 3.08 110.947 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.31 -47.33 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.19 112.475 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.89 -39.84 93.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.45 110.915 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.812 HG12 HG11 ' A' ' 14' ' ' VAL . 17.2 m -76.79 -31.57 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.62 111.231 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.09 -59.56 4.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.115 -0.493 . . . . 1.64 110.786 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -39.82 72.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 1.73 110.874 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.888 HD23 HD21 ' A' ' 35' ' ' LEU . 84.0 mt -73.1 -24.7 60.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.23 110.994 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.417 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.67 -25.21 44.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.4 110.907 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.84 -29.81 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.27 111.141 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.888 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.48 -35.19 14.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.2 110.93 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.08 -45.34 4.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 0.27 111.166 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.44 -11.75 53.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.672 -0.775 . . . . 0.36 112.453 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.43 -62.39 1.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 2.62 110.944 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.536 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 3.2 mm-40 -85.91 -43.18 13.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 2.13 110.841 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.23 -121.03 4.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.727 -0.749 . . . . 0.33 112.533 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -158.33 154.13 26.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 2.3 110.81 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.417 HG21 ' HA ' ' A' ' 33' ' ' GLN . 99.2 t -139.54 131.61 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.33 111.161 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -120.76 157.99 28.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.22 110.831 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.2 134.99 59.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.16 111.138 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -144.76 151.9 39.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.432 . . . . 1.23 110.89 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -101.4 137.39 39.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 1.69 110.9 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.716 ' CD1' HG21 ' A' ' 73' ' ' THR . 17.5 mt -51.03 -49.86 26.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.45 111.107 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -22.55 63.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 3.04 110.927 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -98.52 18.44 16.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 3.46 110.885 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.806 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -49.98 -28.03 6.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 1.11 110.835 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.81 -37.79 60.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 1.19 110.87 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -85.23 -17.21 37.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 1.1 110.972 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.455 ' HB2' HD13 ' A' ' 50' ' ' LEU . 50.1 m -65.37 -12.51 52.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.89 110.908 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.76 64.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.4 111.074 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -65.71 -67.98 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.34 110.86 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.664 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -155.32 -175.48 5.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 1.33 110.856 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -94.06 134.85 36.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 1.83 110.864 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p 46.3 82.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 1.13 110.84 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.8 p -133.53 -38.44 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.31 110.885 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.456 ' O ' HD23 ' A' ' 87' ' ' LEU . 96.3 m-85 -101.97 122.0 43.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 2.04 110.84 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.99 -21.48 61.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 1.49 110.827 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.647 ' HB ' HG22 ' A' ' 12' ' ' VAL . 32.3 mt -142.6 143.88 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.34 111.034 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.875 HG21 HG23 ' A' ' 83' ' ' ILE . 23.0 mm -134.27 128.79 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.17 111.142 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -111.95 136.31 51.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.15 110.913 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.44 101.81 6.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.21 110.826 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.84 75.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.783 -0.722 . . . . 0.17 112.47 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.459 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.4 mm? -108.66 58.26 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.59 110.883 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.02 159.74 65.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.697 0.761 . . . . 0.23 111.196 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 116.73 4.69 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.738 2.292 . . . . 0.25 112.362 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.18 7.14 70.41 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.805 -0.712 . . . . 0.18 112.416 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -55.27 149.7 12.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.859 0.361 . . . . 0.69 110.853 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 27.5 p -140.23 108.86 5.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 0.15 111.212 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.716 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.1 150.27 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.23 111.147 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.971 HD12 HD22 ' A' ' 147' ' ' LEU . 4.5 mt -127.79 102.98 7.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.21 110.918 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -77.63 148.66 34.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.25 110.794 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.0 m -127.17 -178.02 4.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.789 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.75 -41.33 67.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.048 -0.523 . . . . 0.4 111.159 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -57.85 -47.24 83.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 1.85 110.9 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.806 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.2 mp -71.81 -56.75 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.31 111.132 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.513 HD13 ' HA ' ' A' ' 119' ' ' LEU . 56.8 mt -50.73 -40.83 55.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.2 110.968 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.56 -56.7 11.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.36 111.114 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -44.49 86.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 2.44 110.855 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.875 HG23 HG21 ' A' ' 63' ' ' ILE . 40.2 mm -53.0 -68.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.24 111.166 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.1 -39.85 60.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.2 111.121 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.6 tpp85 -53.32 -50.25 65.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 2.15 110.893 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 56' ' ' LYS . 34.2 pt -84.11 -8.13 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.18 111.067 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.37 113.42 15.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.31 110.947 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -52.84 159.88 1.65 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.669 0.747 . . . . 2.31 110.867 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.86 114.5 3.74 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.22 112.332 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.26 5.47 57.1 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.17 112.45 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.44 -163.11 18.72 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.844 -0.694 . . . . 0.14 112.407 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 22.8 m -136.55 154.99 50.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.28 110.854 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.703 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -139.69 116.38 10.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.18 110.919 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.578 ' N ' HD22 ' A' ' 93' ' ' LEU . 54.6 m-85 -112.21 131.29 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 1.62 110.927 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.41 160.7 42.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.16 110.97 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.53 127.94 36.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 1.8 110.909 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.78 148.95 29.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.651 0.739 . . . . 2.2 110.842 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.617 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.1 Cg_endo -69.85 140.01 41.3 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.598 2.199 . . . . 0.19 112.376 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.81 146.97 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 0.25 111.091 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.468 ' CD ' HG21 ' A' ' 103' ' ' VAL . 12.8 mt-10 -109.55 132.46 54.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 2.22 110.869 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.4 p -105.61 26.45 9.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 1.29 111.093 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.58 24.41 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.6 111.133 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.468 HG21 ' CD ' ' A' ' 100' ' ' GLU . 4.4 t -144.81 159.24 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.78 111.043 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.564 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -51.02 167.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 1.74 110.819 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -62.78 -50.67 70.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 2.27 110.847 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -74.13 -75.73 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 1.74 110.928 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.443 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.2 t 53.56 -166.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 2.24 110.799 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -8.93 59.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 3.86 110.855 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.436 HG11 ' CG ' ' A' ' 149' ' ' HIS . 2.7 m -140.62 142.78 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.38 111.117 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -63.13 116.15 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 2.24 110.932 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.564 HG21 ' O ' ' A' ' 104' ' ' ASP . 55.7 p -85.03 178.49 7.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.439 . . . . 0.26 111.033 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.97 -54.02 49.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.18 111.144 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -59.9 -48.7 80.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.25 110.851 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -56.8 -39.55 74.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 1.68 110.898 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.499 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -64.53 -54.98 23.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.33 110.857 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.2 m -56.09 -45.34 79.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.21 110.954 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -42.56 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.28 110.82 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.44 98.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.21 111.111 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.0 tp -66.66 -52.98 38.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.421 . . . . 0.23 110.874 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.5 m -59.8 -34.72 73.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.32 111.083 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.7 mt -84.96 -10.21 57.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.63 110.905 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.12 5.45 29.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 1.73 110.8 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.26 7.77 32.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.64 112.495 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -107.31 170.18 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.3 110.992 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -150.86 170.63 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.26 111.162 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 54.77 43.27 30.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 2.1 110.858 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.0 t -75.65 143.51 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.27 111.106 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.1 159.66 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 1.66 110.867 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -81.86 146.05 30.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 2.37 110.924 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.515 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.2 mp -105.92 -35.64 7.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.21 110.885 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.3 176.27 11.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 1.09 110.888 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.733 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.4 OUTLIER -132.35 137.84 47.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 4.46 110.823 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.91 137.53 29.01 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.593 0.711 . . . . 1.84 111.002 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.412 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.2 Cg_endo -69.69 165.08 32.09 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.706 2.271 . . . . 0.22 112.389 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.68 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.19 126.56 43.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.27 110.868 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.462 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.34 161.4 23.0 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.606 0.717 . . . . 1.54 111.157 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -24.57 29.81 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.692 2.261 . . . . 0.34 112.366 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.59 -22.52 28.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 2.56 110.898 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -87.79 -52.22 5.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 2.57 110.867 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 136' ' ' THR . 7.3 p -49.69 -40.08 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.27 111.171 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -33.44 74.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 1.13 110.954 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.35 -45.93 68.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.25 110.832 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 8.4 p -68.36 -30.44 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.16 111.103 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -75.98 -32.48 59.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 2.4 110.87 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -89.32 -20.29 24.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 1.65 110.912 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -94.47 -32.78 13.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.29 110.866 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.971 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.55 -54.37 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.31 110.929 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.98 9.11 2.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.768 -0.729 . . . . 0.34 112.537 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.436 ' CG ' HG11 ' A' ' 109' ' ' VAL . 15.3 t-160 -70.3 121.5 17.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.749 0.309 . . . . 0.62 110.879 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -152.08 104.75 3.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 2.15 110.882 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.3 t -161.2 173.12 15.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.72 110.858 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.82 -12.71 15.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 1.7 110.797 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -97.67 10.41 40.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 1.58 110.832 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.68 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -83.59 166.61 18.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.189 -0.46 . . . . 0.27 110.83 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.733 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -172.97 130.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.2 110.978 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 25.9 m-85 -74.79 131.3 40.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 1.74 110.908 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.0 144.18 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.21 111.081 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.515 ' HG2' HD13 ' A' ' 130' ' ' LEU . 3.8 tt0 -99.56 128.41 45.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 1.88 110.919 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.3 149.61 30.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.2 111.118 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.473 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.5 t -127.84 160.88 30.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.109 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.44 132.1 3.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.13 112.503 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -92.94 140.1 29.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 1.65 110.896 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.46 135.13 50.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.603 0.716 . . . . 1.23 110.939 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 123.6 10.26 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.634 2.223 . . . . 0.3 112.346 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.34 110.84 -179.986 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.871 0.367 . . . . 3.05 110.917 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.427 ' CE1' HD12 ' A' ' 67' ' ' LEU . 5.6 m-85 -122.32 21.79 10.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 2.01 110.917 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.21 39.77 51.19 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.741 -0.742 . . . . 0.34 112.451 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.458 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.8 mp -77.03 159.19 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.38 111.145 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 36' ' ' THR . 38.1 m -147.33 157.03 43.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 1.15 110.85 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.11 123.71 33.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.513 . . . . 0.47 111.112 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.68 -3.51 21.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.758 -0.734 . . . . 0.29 112.5 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -108.89 169.63 8.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.376 . . . . 1.52 110.898 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -104.62 109.68 21.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 1.38 110.873 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.668 HG12 HG21 ' A' ' 36' ' ' THR . 2.3 p -115.7 135.49 55.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 2.05 111.092 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.754 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -109.7 125.85 53.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.22 111.083 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.842 HG11 HG12 ' A' ' 29' ' ' VAL . 58.5 t -97.72 120.53 47.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.19 111.129 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.408 HG12 HG13 ' A' ' 47' ' ' ILE . 41.0 t -104.31 121.86 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.25 111.13 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -121.38 170.24 9.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.25 110.905 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.408 ' HB3' HD12 ' A' ' 47' ' ' ILE . 9.8 p-10 -151.25 -171.02 3.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 1.84 110.919 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -57.05 -36.11 70.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 3.62 110.881 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -72.08 -10.21 59.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 1.77 110.807 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -107.68 92.86 9.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.618 0.723 . . . . 0.25 110.884 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.79 143.07 49.52 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.678 2.252 . . . . 0.42 112.306 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.6 t -48.29 -32.61 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.3 111.144 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.54 -53.44 37.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 2.59 110.9 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.9 -45.01 10.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.33 111.064 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.684 ' HA ' HD12 ' A' ' 28' ' ' LEU . 2.1 tm? -50.19 -60.26 3.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.22 110.91 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -49.44 -35.76 20.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 2.83 110.952 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.89 -48.31 49.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.698 -0.763 . . . . 0.27 112.478 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 1.045 HD11 HG13 ' A' ' 68' ' ' VAL . 2.1 mt -60.43 -40.55 91.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.865 0.364 . . . . 1.5 110.937 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.842 HG12 HG11 ' A' ' 14' ' ' VAL . 17.3 m -76.79 -30.81 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.63 111.081 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.94 -60.87 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 1.91 110.929 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -40.58 68.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 2.59 110.821 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.806 HD23 HD21 ' A' ' 35' ' ' LEU . 91.8 mt -72.36 -25.57 61.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.33 110.991 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.558 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.36 -24.94 46.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.46 110.844 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.23 -30.1 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.5 111.112 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.806 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.34 -34.88 14.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.4 110.887 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.668 HG21 HG12 ' A' ' 12' ' ' VAL . 1.2 m -103.2 -47.0 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.36 111.186 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.24 -14.64 48.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.763 -0.732 . . . . 0.44 112.478 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -60.78 -62.55 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 2.01 110.858 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.23 -36.35 9.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 2.03 110.873 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.72 -137.48 7.61 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.67 -0.776 . . . . 0.47 112.467 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -146.4 150.33 35.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 3.71 110.925 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 33' ' ' GLN . 85.8 t -133.66 119.31 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.3 111.102 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -108.12 158.04 17.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.22 110.796 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.48 138.14 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.22 111.109 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -145.82 151.31 37.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 1.23 110.891 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.4 134.62 46.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.43 110.958 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.73 ' CD1' HG21 ' A' ' 73' ' ' THR . 37.2 mt -52.77 -35.86 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.32 111.119 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -71.51 -31.64 67.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 2.1 110.896 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.91 20.18 18.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 3.61 110.896 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.825 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.19 -28.37 4.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 1.11 110.893 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mp -55.27 -34.01 63.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 1.06 110.892 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -84.04 -14.94 49.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 1.06 110.898 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB2' HD13 ' A' ' 50' ' ' LEU . 32.8 m -67.14 -9.38 39.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.89 110.863 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.87 63.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.31 111.02 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -63.22 -68.13 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.43 110.849 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.602 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -153.85 -176.95 6.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 1.38 110.896 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -92.72 128.95 38.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 1.82 110.91 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 t 51.67 84.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 1.98 110.806 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.1 p -136.23 -38.87 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.31 110.863 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.44 ' O ' HD23 ' A' ' 87' ' ' LEU . 98.6 m-85 -100.21 123.76 44.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 2.01 110.804 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.38 -21.48 60.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 1.72 110.785 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 6' ' ' ILE . 13.4 mt -144.05 143.3 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.22 111.06 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.916 HG21 HG23 ' A' ' 83' ' ' ILE . 22.6 mm -135.62 128.75 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.16 111.187 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.2 mm? -112.61 136.31 52.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.22 110.845 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.97 105.0 8.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.22 110.834 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.26 71.44 0.63 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.768 -0.73 . . . . 0.23 112.488 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.427 HD12 ' CE1' ' A' ' 4' ' ' PHE . 4.2 mm? -104.52 57.09 0.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.818 0.342 . . . . 0.68 110.948 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.045 HG13 HD11 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -124.57 153.01 69.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.637 0.732 . . . . 0.46 111.149 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.688 ' HD2' HG12 ' A' ' 68' ' ' VAL . 54.3 Cg_endo -69.71 116.87 4.75 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.674 2.249 . . . . 0.38 112.336 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.99 6.94 71.15 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.708 -0.758 . . . . 0.47 112.453 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.505 ' HB2' HG23 ' A' ' 68' ' ' VAL . 4.7 t -66.2 152.97 43.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 2.73 110.832 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.706 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 20.0 p -136.68 112.42 9.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.521 . . . . 0.28 111.142 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.73 HG21 ' CD1' ' A' ' 47' ' ' ILE . 1.2 m -162.81 144.82 10.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.42 111.1 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.867 HD12 HD22 ' A' ' 147' ' ' LEU . 9.3 mt -125.28 116.28 21.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.56 110.833 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -89.97 154.06 20.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.28 110.806 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 m -129.51 -177.7 4.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.57 110.923 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.5 -37.06 69.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.472 . . . . 0.25 111.025 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -61.77 -46.28 90.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 2.05 110.85 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.825 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -73.31 -54.64 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.22 111.119 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.8 mt -50.31 -40.8 49.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.22 110.924 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.49 -55.48 18.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.35 111.12 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -45.26 82.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 3.12 110.869 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.916 HG23 HG21 ' A' ' 63' ' ' ILE . 40.4 mm -54.65 -68.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.21 111.088 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.84 -39.3 53.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.21 111.181 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -53.18 -51.47 61.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 2.85 110.912 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 56' ' ' LYS . 29.8 pt -83.96 -6.98 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.19 111.134 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -79.02 111.25 15.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.37 110.854 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -51.79 158.93 1.46 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 3.67 110.923 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.419 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.3 Cg_endo -69.82 114.15 3.62 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.738 2.292 . . . . 0.27 112.243 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.84 2.8 55.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.18 112.453 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.83 -165.78 23.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.544 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 65.5 m -133.51 152.81 51.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.86 0.362 . . . . 0.35 110.924 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.694 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.29 114.79 11.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.15 110.922 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.539 ' N ' HD22 ' A' ' 93' ' ' LEU . 48.4 m-85 -110.54 132.54 54.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 1.88 110.897 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -148.25 157.91 43.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.15 110.81 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.1 126.51 43.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.012 -0.54 . . . . 2.58 110.817 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.607 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -150.53 145.96 19.13 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.689 0.757 . . . . 2.27 110.83 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.45 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.9 Cg_endo -69.75 139.76 41.06 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.721 2.281 . . . . 0.19 112.434 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.52 146.73 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.22 111.144 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.458 ' OE2' HG21 ' A' ' 103' ' ' VAL . 16.8 mt-10 -110.29 132.59 54.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 1.88 110.892 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.9 p -104.18 26.1 9.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 1.21 111.145 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.99 23.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.63 111.131 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.458 HG21 ' OE2' ' A' ' 100' ' ' GLU . 4.6 t -144.49 159.01 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.67 111.145 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.602 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -57.44 -178.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 2.16 110.848 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -68.54 -63.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 2.08 110.84 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.4 -76.03 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 2.27 110.938 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.435 ' HB2' HG11 ' A' ' 103' ' ' VAL . 1.5 p 51.44 -169.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 2.06 110.809 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.54 -3.84 51.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 1.86 110.846 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.41 153.61 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.426 . . . . 0.46 111.112 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.545 ' HB2' HD22 ' A' ' 74' ' ' LEU . 10.0 mmtm -72.28 109.7 6.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 1.89 110.833 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.602 HG21 ' O ' ' A' ' 104' ' ' ASP . 30.2 p -82.4 177.99 8.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.26 111.156 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.85 -54.88 39.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.2 111.101 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.16 -49.28 77.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.27 110.836 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -56.75 -38.63 72.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.191 -0.459 . . . . 1.69 110.96 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.607 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -65.15 -54.89 22.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.32 110.929 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.7 m -57.74 -45.8 85.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.21 110.834 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -42.95 91.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.27 110.87 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.59 93.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.23 111.043 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.654 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.9 tp -65.63 -50.35 65.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.32 110.925 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 96.8 m -61.97 -34.6 76.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.28 111.082 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.13 -10.22 57.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.57 110.87 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.6 6.52 27.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 1.77 110.884 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.41 4.77 34.86 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.51 112.406 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -104.63 170.61 7.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.37 110.895 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.2 m -151.7 173.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.31 111.068 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 51.55 44.1 29.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 2.04 110.878 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 95.3 t -77.73 143.1 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.25 111.186 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.15 159.25 7.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.244 -0.435 . . . . 1.56 110.95 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.99 143.33 32.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 3.29 110.923 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.755 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.3 mp -103.19 -37.0 7.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.28 110.931 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.81 176.08 13.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 1.21 110.948 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.689 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.4 tmt_? -132.35 137.49 47.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 4.32 110.893 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -123.87 136.81 27.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.632 0.73 . . . . 1.83 110.941 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HA ' HD21 ' A' ' 155' ' ' LEU . 52.9 Cg_endo -69.77 163.03 39.81 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.759 2.306 . . . . 0.28 112.293 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.679 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -96.45 124.15 40.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.27 110.915 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.445 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -98.77 161.38 25.19 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 121.567 0.699 . . . . 1.22 111.088 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.8 Cg_endo -69.82 -28.41 25.0 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.678 2.252 . . . . 0.37 112.4 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -85.41 -17.71 35.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 3.66 110.824 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.13 -53.66 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 2.33 110.974 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.9 p -49.43 -40.56 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.26 111.127 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -34.61 75.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 1.23 110.831 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.19 -46.38 70.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.28 110.791 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.847 HG23 HD13 ' A' ' 147' ' ' LEU . 9.7 p -68.37 -30.37 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.2 111.14 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -75.49 -32.29 60.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 1.89 110.953 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -89.62 -20.22 23.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 1.95 110.875 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.42 -32.55 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.3 110.809 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.867 HD22 HD12 ' A' ' 74' ' ' LEU . 3.5 mp -128.04 -53.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.41 110.946 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.22 12.4 2.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.814 -0.707 . . . . 0.31 112.491 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -70.6 122.07 19.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.324 . . . . 0.76 110.894 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -151.6 105.44 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 2.73 110.893 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.57 175.21 12.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.62 110.836 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.09 -20.31 13.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 1.75 110.881 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -93.57 13.27 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 1.72 110.984 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.679 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -80.91 163.23 23.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.31 110.938 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.689 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.53 129.99 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.23 110.948 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.706 ' CZ ' HG22 ' A' ' 72' ' ' THR . 33.6 m-85 -73.81 133.49 43.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 1.82 110.842 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.0 139.74 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.26 111.101 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.755 ' HG2' HD13 ' A' ' 130' ' ' LEU . 11.3 tt0 -93.74 129.62 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 2.29 110.938 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.86 150.93 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.424 . . . . 0.23 111.174 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.471 ' N ' HD11 ' A' ' 130' ' ' LEU . 3.1 t -130.04 160.5 33.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.23 111.061 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.76 131.38 3.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.719 -0.753 . . . . 0.16 112.441 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -93.83 140.42 29.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 1.55 110.905 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 9.4 tptt -81.78 134.75 49.8 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.609 0.719 . . . . 2.32 110.818 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 119.39 6.34 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.753 2.302 . . . . 0.42 112.291 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.37 110.904 179.945 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.91 0.386 . . . . 2.1 110.877 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -122.3 18.26 10.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 1.55 110.867 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.17 40.04 73.22 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.788 -0.72 . . . . 0.28 112.417 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.464 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.8 mp -77.0 157.5 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.3 111.184 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 36' ' ' THR . 46.2 m -148.3 156.61 42.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 1.11 110.846 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.77 125.31 33.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.44 111.093 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.09 -6.23 23.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 0.28 112.51 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.72 167.57 10.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 1.47 110.975 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.51 137.03 38.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 2.21 110.929 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG1' HG21 ' A' ' 36' ' ' THR . 2.1 p -141.86 140.71 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 2.11 111.147 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.745 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -115.64 124.16 50.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.21 111.17 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.851 HG11 HG12 ' A' ' 29' ' ' VAL . 95.3 t -95.88 118.52 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.16 111.086 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.441 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.1 t -102.7 115.28 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 0.18 111.153 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -115.91 167.2 11.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 0.19 110.967 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.421 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.7 p-10 -151.3 -169.54 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 1.75 110.892 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -56.8 -35.74 69.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 3.37 110.937 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -73.06 -10.9 60.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 1.51 110.863 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.25 93.57 9.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.604 0.716 . . . . 0.16 110.891 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.5 Cg_endo -69.77 142.76 48.76 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.719 2.279 . . . . 0.2 112.336 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -48.92 -32.52 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.19 111.144 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.28 -53.2 38.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 2.4 110.913 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -44.95 10.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.19 111.091 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.474 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.27 -61.51 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.16 110.922 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -36.8 31.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 2.38 110.843 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.68 49.91 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.801 -0.714 . . . . 0.23 112.47 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.6 mt -61.7 -40.36 94.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 0.52 110.918 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.851 HG12 HG11 ' A' ' 14' ' ' VAL . 17.3 m -76.16 -31.46 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.63 111.177 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.02 -60.29 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 1.55 110.821 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -40.15 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 1.73 110.938 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.913 HD23 HD21 ' A' ' 35' ' ' LEU . 77.4 mt -72.69 -24.68 61.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.26 110.841 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.4 -24.86 46.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.38 110.926 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.82 -30.02 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.23 111.132 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.913 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.43 -35.3 14.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.22 110.879 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.499 HG21 ' CG1' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -102.33 -44.77 5.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.24 111.057 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.49 -10.94 55.46 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.729 -0.748 . . . . 0.25 112.498 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.32 -62.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 2.26 110.966 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -91.47 -39.94 11.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 2.24 110.875 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.21 -125.73 4.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.34 112.538 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -156.25 152.68 28.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 3.47 110.965 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 33' ' ' GLN . 95.7 t -135.84 130.21 48.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.31 111.203 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -118.61 156.9 28.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.2 110.869 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 p -119.39 136.71 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.19 111.118 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -147.26 152.17 37.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 1.3 110.894 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.66 135.72 43.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.41 110.944 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.645 ' CD1' HG21 ' A' ' 73' ' ' THR . 28.6 mt -51.61 -35.43 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.35 111.19 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -29.99 59.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 2.63 110.905 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -97.89 18.44 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 3.34 110.942 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.827 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.74 -30.23 5.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 1.09 110.999 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -54.51 -37.36 65.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 1.04 110.923 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -84.6 -15.66 44.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 1.08 110.946 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 m -66.95 -10.17 46.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.99 110.872 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.07 63.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.34 111.116 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -61.75 -69.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.35 110.889 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.658 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -153.76 -175.5 5.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 2.12 110.865 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.47 134.84 35.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.59 110.929 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p 46.24 82.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 1.17 110.848 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.3 p -133.4 -38.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.32 110.87 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.442 ' O ' HD23 ' A' ' 87' ' ' LEU . 97.6 m-85 -101.65 122.44 43.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 1.99 110.906 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.55 -21.09 61.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.155 -0.475 . . . . 1.49 110.861 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 6' ' ' ILE . 11.3 mt -143.38 143.52 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.26 111.089 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.865 HG21 HG23 ' A' ' 83' ' ' ILE . 21.3 mm -134.99 129.04 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.13 111.062 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.4 mm? -113.19 136.77 52.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.2 110.888 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.15 101.92 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.18 110.859 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.4 77.43 0.13 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.81 -0.709 . . . . 0.18 112.423 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.45 58.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.61 110.894 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.18 160.12 61.44 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.654 0.74 . . . . 0.25 111.163 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 115.95 4.32 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.709 2.273 . . . . 0.29 112.365 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.84 6.43 67.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.711 -0.756 . . . . 0.2 112.496 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.49 150.37 12.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.991 0.424 . . . . 0.68 110.877 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 26.6 p -140.8 108.96 5.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.16 111.16 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.645 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.2 148.35 11.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 0.25 111.142 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.848 HD12 HD22 ' A' ' 147' ' ' LEU . 1.7 mt -126.23 101.2 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.34 110.935 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.16 138.17 38.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.41 110.848 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.414 ' H ' HD13 ' A' ' 79' ' ' ILE . 58.2 m -115.83 -175.67 2.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.843 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.68 70.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.3 111.167 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -62.31 -42.95 99.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 1.81 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.827 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -77.79 -55.2 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.27 111.165 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 119' ' ' LEU . 64.4 mt -50.36 -41.57 51.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.23 110.895 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.61 -56.51 13.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.34 111.105 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -41.44 74.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.433 . . . . 2.47 110.815 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.865 HG23 HG21 ' A' ' 63' ' ' ILE . 42.9 mm -58.55 -68.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.18 111.107 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.416 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -49.82 -35.0 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.28 111.168 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -59.31 -51.42 70.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 2.43 110.891 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 56' ' ' LYS . 33.2 pt -83.46 -4.04 8.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.22 111.083 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -82.1 112.06 18.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.35 110.917 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -51.65 159.58 1.24 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.61 0.719 . . . . 2.1 110.873 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.8 Cg_endo -69.88 114.26 3.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.685 2.257 . . . . 0.19 112.306 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.63 3.73 56.13 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 0.17 112.466 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.05 -166.94 26.63 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.782 -0.723 . . . . 0.21 112.491 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.5 m -133.1 153.36 51.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.873 0.368 . . . . 0.33 110.95 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.653 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.93 116.37 12.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.16 110.914 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.567 ' N ' HD22 ' A' ' 93' ' ' LEU . 52.6 m-85 -112.33 131.89 55.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 1.84 110.836 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -148.2 156.92 43.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.18 110.866 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.03 126.76 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 2.08 110.917 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.88 146.9 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.65 0.738 . . . . 2.31 110.852 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.59 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.5 Cg_endo -69.68 143.72 52.11 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.586 2.19 . . . . 0.25 112.368 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.38 146.75 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 0.2 111.135 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.459 ' HB2' HG22 ' A' ' 111' ' ' THR . 59.6 mt-10 -106.8 132.85 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 2.18 110.832 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -93.01 -42.11 9.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 1.11 111.129 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.72 39.91 1.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.83 111.182 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.25 150.6 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.85 111.128 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.641 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -56.66 167.92 0.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 1.96 110.912 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.425 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 1.7 p30 -60.54 -55.0 38.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 2.4 110.822 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.59 -77.3 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 2.28 110.853 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p 54.0 -173.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 1.71 110.814 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.63 -2.1 45.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 2.6 110.927 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.581 HG21 ' CE1' ' A' ' 149' ' ' HIS . 1.1 m -143.39 154.52 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.177 -0.465 . . . . 0.86 111.09 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -69.88 121.03 16.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 2.14 110.958 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.641 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.7 p -97.05 -177.96 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.23 111.109 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -52.9 63.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.22 111.103 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.92 -50.5 73.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.26 110.853 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -58.93 -40.59 85.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 2.23 110.956 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -60.52 -54.64 43.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.41 110.926 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 67.2 m -55.54 -50.99 68.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.34 110.863 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -48.22 82.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.32 110.826 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.27 -51.52 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.064 -0.516 . . . . 0.27 111.092 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.742 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.0 tp -57.38 -47.12 82.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.38 110.839 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.2 m -67.34 -22.24 65.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.54 111.162 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.48 -15.37 40.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 1.18 110.884 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.9 5.0 30.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 1.68 110.892 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.45 -4.86 35.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 0.48 112.573 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -87.06 168.96 12.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.49 110.899 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.5 m -151.39 171.86 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.42 111.135 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 53.58 43.72 30.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 2.11 110.836 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.22 142.51 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.34 111.14 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.07 160.65 8.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 1.74 110.844 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 21.2 tt0 -82.36 146.69 29.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 2.39 110.932 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.666 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.4 mp -107.39 -35.76 6.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.22 110.919 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.47 176.24 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 1.18 110.883 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.712 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.2 tmt_? -133.19 137.82 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 4.39 110.877 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -125.49 138.8 32.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.636 0.731 . . . . 1.44 110.91 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.438 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.3 Cg_endo -69.84 164.49 34.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.615 2.21 . . . . 0.25 112.329 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.654 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -97.07 135.76 38.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.4 110.886 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.24 160.98 25.59 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 1.18 111.194 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -29.3 24.02 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.684 2.256 . . . . 0.44 112.27 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -85.31 -19.26 31.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 2.76 110.864 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -53.24 5.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 2.21 110.968 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.7 p -49.21 -41.94 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.36 111.033 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -33.69 72.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 1.23 110.866 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.28 -45.05 70.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.31 110.898 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.716 HG23 HD13 ' A' ' 147' ' ' LEU . 7.2 p -68.89 -32.39 54.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.492 . . . . 0.47 111.172 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -76.3 -30.0 57.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 3.23 110.85 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -90.43 -20.49 22.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 1.63 110.836 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -94.72 -32.96 13.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.59 110.8 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.848 HD22 HD12 ' A' ' 74' ' ' LEU . 3.0 mp -126.75 -53.98 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.86 110.925 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.78 12.07 2.01 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.635 -0.793 . . . . 0.9 112.435 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.581 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.4 t-160 -70.12 121.25 17.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.687 0.279 . . . . 1.36 110.896 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -149.41 111.65 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 3.21 110.847 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.55 165.18 31.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 1.59 110.86 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.76 -7.48 19.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 2.47 110.814 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -115.56 22.8 12.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 1.9 110.862 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.654 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -85.16 169.48 13.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.42 110.92 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.712 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -173.51 130.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.21 110.961 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.2 m-85 -72.94 131.84 42.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 1.81 110.943 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.95 140.38 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.2 111.16 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.666 ' HG2' HD13 ' A' ' 130' ' ' LEU . 23.3 tt0 -93.95 126.84 39.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 1.62 110.864 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 3.3 mp -122.35 151.4 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.26 111.147 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.483 ' HB ' HD21 ' A' ' 130' ' ' LEU . 3.2 t -129.72 161.45 30.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.33 111.145 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.5 130.48 3.07 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.23 112.485 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -94.86 140.56 29.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 1.59 110.838 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 7.5 tptt -82.31 134.54 48.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.535 0.684 . . . . 2.25 110.955 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 118.88 5.94 Favored 'Trans proline' 0 C--O 1.23 0.1 0 C-N-CA 122.723 2.282 . . . . 0.36 112.29 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.32 110.851 179.996 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t0 . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.863 0.363 . . . . 2.32 110.874 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 6' ' ' ILE . 3.9 m-85 -122.22 20.81 10.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 1.57 110.966 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 56.24 40.79 85.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.752 -0.737 . . . . 0.39 112.472 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.518 HG21 HD22 ' A' ' 32' ' ' LEU . 1.4 mp -83.46 160.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.826 0.346 . . . . 0.36 111.067 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.743 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -156.36 168.01 28.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 1.62 110.899 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.51 134.41 34.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.43 111.135 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.51 2.5 37.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.41 112.458 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -121.04 171.88 8.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.793 0.33 . . . . 1.13 110.96 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.54 137.39 40.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 1.36 110.833 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.69 HG22 ' HB ' ' A' ' 62' ' ' ILE . 66.3 t -141.92 123.96 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 1.88 111.098 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.764 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -102.41 125.9 49.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.33 111.216 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.551 HG21 ' CB ' ' A' ' 29' ' ' VAL . 61.3 t -98.12 112.41 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.43 111.113 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.8 t -98.09 129.87 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.46 111.132 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -128.68 170.68 12.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.22 110.915 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 47' ' ' ILE . 11.4 p-10 -151.65 -172.76 4.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 1.77 110.924 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -23.41 62.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 3.14 110.857 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.83 -16.31 48.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.09 110.924 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 m -101.67 102.79 24.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.66 0.743 . . . . 0.31 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 136.85 34.08 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.66 2.24 . . . . 0.45 112.428 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.19 -31.66 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.56 111.121 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.02 -52.46 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 2.48 110.922 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.94 -43.81 12.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.26 111.099 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.548 HD13 ' N ' ' A' ' 26' ' ' LYS . 1.3 tm? -51.48 -60.28 3.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.34 110.915 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.548 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -47.45 -46.83 27.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 2.2 110.963 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.68 -37.02 93.1 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.771 -0.728 . . . . 0.49 112.462 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.719 HD11 HG13 ' A' ' 68' ' ' VAL . 33.8 mt -60.25 -50.75 72.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.78 110.928 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.594 HG22 ' HG3' ' A' ' 33' ' ' GLN . 7.7 p -77.66 -25.28 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 3.33 111.099 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -60.91 -62.43 1.86 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 1.94 110.873 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -40.34 62.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 1.7 110.891 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.808 HD23 HD21 ' A' ' 35' ' ' LEU . 84.7 mt -72.22 -24.48 61.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.46 110.934 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.619 ' HA ' HG21 ' A' ' 42' ' ' VAL . 2.1 mm-40 -77.49 -25.58 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 1.89 110.938 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.15 -31.34 17.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 0.36 111.056 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.808 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.06 -34.76 15.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.37 110.874 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 7' ' ' SER . 1.2 m -103.08 -47.54 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.5 111.174 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.03 -15.6 50.27 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.764 . . . . 0.51 112.467 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.23 -61.06 2.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 1.83 110.793 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -102.88 -34.27 9.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 2.2 110.957 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.34 -120.55 1.9 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 0.61 112.464 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -166.44 156.45 11.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 2.29 110.846 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.619 HG21 ' HA ' ' A' ' 33' ' ' GLN . 21.5 t -145.4 137.55 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.54 111.128 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -129.43 158.37 39.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.45 110.804 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -117.25 141.0 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.488 . . . . 0.35 111.135 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -145.92 151.53 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 2.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -103.58 134.79 46.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.44 110.894 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.742 ' CD1' HG21 ' A' ' 73' ' ' THR . 37.8 mt -52.94 -36.14 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.41 111.061 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -31.41 67.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 2.54 110.816 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -104.0 20.1 18.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 3.54 110.969 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.831 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -49.32 -27.93 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 1.09 110.914 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -54.96 -34.34 63.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.05 110.853 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -84.47 -15.55 45.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 1.06 110.877 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.517 ' HB2' HD13 ' A' ' 50' ' ' LEU . 40.9 m -65.83 -11.05 43.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.95 110.838 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.97 63.0 0.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.32 111.172 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -62.95 -70.82 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.38 110.832 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.598 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -149.7 -169.02 3.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 1.88 110.909 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -102.46 136.37 42.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 1.78 110.87 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.8 p 47.21 85.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 1.37 110.84 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.1 p -140.52 -40.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.26 110.798 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.491 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.4 m-85 -99.42 119.18 37.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 2.13 110.889 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.87 -20.09 62.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 1.69 110.864 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.69 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.4 mt -146.46 143.7 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.27 111.13 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.958 HG21 HG23 ' A' ' 83' ' ' ILE . 16.0 mm -134.09 130.67 55.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.23 111.145 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -112.78 134.14 54.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.213 -0.448 . . . . 0.25 110.931 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.46 95.68 4.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.188 -0.46 . . . . 0.29 110.87 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 53.68 72.17 0.58 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 0.32 112.515 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.97 56.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.792 0.33 . . . . 0.57 110.898 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.719 HG13 HD11 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -123.42 159.9 52.95 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.613 0.72 . . . . 0.27 111.12 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.413 ' HD2' HG12 ' A' ' 68' ' ' VAL . 54.4 Cg_endo -69.72 123.18 9.86 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.669 2.246 . . . . 0.27 112.381 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.27 6.97 87.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.757 -0.735 . . . . 0.2 112.507 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.8 p -55.48 148.57 15.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.77 110.874 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.747 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 29.5 p -137.83 109.1 6.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.18 111.14 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.742 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.37 152.28 16.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.24 111.195 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.947 HD12 HD22 ' A' ' 147' ' ' LEU . 4.6 mt -131.15 103.45 6.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.21 110.959 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -79.52 152.94 29.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.28 110.874 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 m -129.23 176.28 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.57 110.823 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.27 53.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.25 111.11 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.37 -46.1 91.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 1.73 110.853 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.831 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -72.9 -54.54 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.23 111.129 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.63 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.0 mt -50.68 -38.68 48.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.19 110.997 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.83 -52.96 61.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 0.31 111.108 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 -43.18 79.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 2.84 110.922 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.958 HG23 HG21 ' A' ' 63' ' ' ILE . 43.4 mm -59.31 -68.44 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.33 111.194 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.52 -33.8 15.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.2 111.106 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -61.06 -52.51 64.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 2.18 110.94 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 56' ' ' LYS . 29.9 pt -81.43 -4.41 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.28 111.134 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -82.03 122.4 27.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.887 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -61.08 159.67 26.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.525 0.679 . . . . 3.49 110.885 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 114.24 3.64 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.598 2.199 . . . . 0.29 112.39 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.47 5.1 55.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 0.25 112.496 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.11 -159.61 13.19 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 0.25 112.428 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.4 m -140.9 155.04 46.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.332 . . . . 0.39 110.835 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.631 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -139.31 115.57 10.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.184 -0.462 . . . . 0.22 110.917 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.562 ' N ' HD22 ' A' ' 93' ' ' LEU . 49.9 m-85 -109.98 133.71 52.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.88 110.846 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -148.69 158.0 43.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.22 110.954 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.3 123.68 36.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 1.83 110.945 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.66 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -147.55 147.92 29.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.576 0.703 . . . . 2.27 110.947 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.607 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.0 Cg_endo -69.78 144.77 54.97 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.665 2.244 . . . . 0.22 112.293 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 155' ' ' LEU . 5.4 m -125.41 147.1 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.37 111.227 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -115.1 132.36 56.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 1.96 110.893 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.5 p -105.99 25.92 10.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 1.06 111.171 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.19 25.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.77 111.079 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.5 t -143.4 159.96 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.78 111.114 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.509 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -55.91 179.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.071 -0.513 . . . . 2.08 110.865 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -65.32 -66.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 2.48 110.901 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -63.32 -75.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 1.91 110.898 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.23 -168.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 1.67 110.802 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -5.72 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.046 -0.525 . . . . 2.35 110.955 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 m -146.19 145.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.165 -0.47 . . . . 0.51 111.066 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.639 ' H ' HD22 ' A' ' 74' ' ' LEU . 3.4 ttmt -67.68 116.31 8.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 2.32 110.884 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 104' ' ' ASP . 27.7 p -85.35 -179.87 7.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.36 111.077 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.94 -54.56 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.43 111.052 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -48.81 78.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.41 110.829 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -58.95 -38.24 78.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 2.14 110.871 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.66 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -63.59 -54.6 33.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.427 . . . . 0.62 110.933 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.4 m -58.7 -49.56 77.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 0.45 110.965 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -47.47 86.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.59 110.852 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.01 -54.64 42.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.49 111.058 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.63 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.2 tp -53.8 -48.14 70.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.3 110.926 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.8 m -67.63 -22.43 65.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.39 111.125 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.4 mt -86.98 -15.08 39.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.72 110.881 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.46 5.37 27.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 1.88 110.847 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.87 -5.03 34.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.664 -0.779 . . . . 0.68 112.48 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -86.5 166.71 15.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 0.33 110.912 -179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.0 m -147.02 170.43 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.29 111.103 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 52.24 44.72 29.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 2.28 110.895 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.6 t -82.77 141.38 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.34 111.133 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.93 158.84 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 1.69 110.846 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -75.87 146.01 40.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 2.23 110.925 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.684 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.0 mp -104.47 -37.36 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.23 110.975 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.43 176.18 12.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 1.17 110.906 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.668 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.9 OUTLIER -128.85 145.3 51.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 4.39 110.786 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -134.32 136.16 25.36 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.624 0.726 . . . . 1.44 110.889 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 164.91 32.75 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.665 2.243 . . . . 0.32 112.344 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.644 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -98.03 126.05 43.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.37 110.948 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.01 161.48 22.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.574 0.702 . . . . 1.49 111.153 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -24.64 29.74 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.711 2.274 . . . . 0.35 112.31 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -85.46 -22.03 28.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.437 . . . . 2.76 110.882 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -87.81 -53.59 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 2.51 110.945 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 136' ' ' THR . 7.5 p -49.58 -40.08 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.23 111.093 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -34.53 76.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 1.19 110.921 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.5 -47.15 67.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.24 110.853 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.697 HG23 HD13 ' A' ' 147' ' ' LEU . 10.3 p -67.59 -30.92 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.17 111.033 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -76.57 -29.58 56.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 1.69 110.936 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -89.91 -21.39 22.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 1.89 110.9 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.63 -32.41 13.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.29 110.923 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.947 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.6 -54.37 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.33 110.874 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.11 18.4 1.69 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.767 -0.73 . . . . 0.32 112.512 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -72.69 122.08 20.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.88 110.845 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -151.64 107.62 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 2.74 110.863 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.5 t -160.47 173.8 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.8 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.32 -19.75 13.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.64 110.865 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -96.83 17.05 17.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 1.58 110.959 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -82.78 165.38 19.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.39 110.918 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.668 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.5 tm? -173.73 130.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.25 110.876 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.747 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.8 m-85 -75.84 138.46 41.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 1.71 110.871 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -151.93 148.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.4 111.14 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.684 ' HG2' HD13 ' A' ' 130' ' ' LEU . 19.1 tt0 -100.2 130.29 46.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 1.68 110.902 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.91 150.77 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.36 111.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.466 ' N ' HD11 ' A' ' 130' ' ' LEU . 6.1 t -135.25 161.43 35.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.4 111.125 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.59 135.61 5.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.707 -0.758 . . . . 0.21 112.442 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -91.86 140.31 29.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 1.69 110.898 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 135.26 49.28 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.612 0.72 . . . . 1.29 110.853 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 127.68 14.9 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.688 2.258 . . . . 0.45 112.306 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.34 110.904 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.848 0.356 . . . . 1.83 110.893 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.22 19.97 10.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 1.53 110.854 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.26 41.51 54.46 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.722 -0.752 . . . . 0.21 112.461 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.488 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -78.0 158.61 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.25 111.089 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 36' ' ' THR . 25.8 m -148.38 157.13 43.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 1.05 110.916 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.33 128.32 34.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.29 111.095 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.36 28.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.738 -0.744 . . . . 0.26 112.487 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.99 167.41 10.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 1.46 110.873 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.21 136.68 38.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 1.29 110.843 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.548 ' CG1' HG21 ' A' ' 36' ' ' THR . 2.0 p -142.43 138.72 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.481 . . . . 2.09 111.183 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.775 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -115.59 129.5 56.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.22 111.154 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.663 HG11 HG12 ' A' ' 29' ' ' VAL . 48.6 t -101.1 123.79 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.3 111.12 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.729 HG12 HG13 ' A' ' 47' ' ' ILE . 4.6 t -105.15 116.45 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.34 111.11 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -119.33 164.63 15.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.21 110.846 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -148.73 -169.52 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 4.66 110.792 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -35.68 67.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 3.19 110.913 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.5 -11.55 60.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 1.13 110.896 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.47 95.52 11.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.673 0.749 . . . . 0.18 110.89 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 141.19 44.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.627 2.218 . . . . 0.2 112.36 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.19 -32.7 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.25 111.106 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.36 -52.5 45.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 2.48 110.922 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.4 -45.07 10.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.16 111.085 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.46 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.9 -61.12 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.17 110.902 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.81 -35.66 23.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 2.47 110.904 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.44 -48.21 45.95 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.731 . . . . 0.2 112.485 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 mt -61.63 -41.22 97.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.746 0.308 . . . . 0.46 110.846 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.663 HG12 HG11 ' A' ' 14' ' ' VAL . 16.2 m -74.91 -31.6 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.63 111.197 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.08 -62.18 1.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 1.8 110.871 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -40.16 65.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 1.78 110.888 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.892 HD23 HD21 ' A' ' 35' ' ' LEU . 76.7 mt -72.77 -25.05 61.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.195 -0.457 . . . . 0.23 110.853 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.51 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.43 -24.75 46.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.42 110.912 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.9 -29.85 17.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.32 111.088 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.892 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.63 -35.05 14.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.26 110.946 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.548 HG21 ' CG1' ' A' ' 12' ' ' VAL . 0.4 OUTLIER -102.45 -44.72 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.28 111.126 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.23 -10.98 54.56 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.661 -0.781 . . . . 0.32 112.446 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -71.38 -62.38 1.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.754 0.311 . . . . 2.21 110.961 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -91.58 -40.18 11.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 1.94 110.881 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.95 -126.49 5.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.68 -0.772 . . . . 0.27 112.488 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -155.27 152.83 29.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 2.21 110.992 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 33' ' ' GLN . 87.7 t -136.72 130.36 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.35 111.132 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 t -118.56 156.14 29.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.22 110.799 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -117.62 132.02 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.19 111.099 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -142.07 152.24 43.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 1.21 110.896 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -101.77 135.61 43.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.42 110.851 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.002 HD13 HG21 ' A' ' 73' ' ' THR . 3.0 mt -50.07 -44.09 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.47 111.15 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -72.24 -27.6 62.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 3.47 110.874 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -95.22 19.24 10.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 3.49 110.942 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.777 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.93 -29.65 3.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 1.09 110.91 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mp -51.91 -36.99 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 1.15 110.959 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -86.01 -19.45 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 1.14 110.926 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.513 ' HB2' HD13 ' A' ' 50' ' ' LEU . 69.2 m -60.21 -16.85 36.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.93 110.889 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -74.44 63.27 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.34 111.053 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.407 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 12.3 m-70 -65.27 -70.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.44 110.89 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.666 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.65 -167.92 2.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 1.1 110.829 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -108.79 131.81 54.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 1.86 110.845 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 p 47.16 72.44 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 1.17 110.851 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -127.22 -33.69 2.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.23 110.842 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.2 m-85 -99.81 118.34 36.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 1.46 110.893 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.1 -19.21 62.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 1.72 110.803 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 6' ' ' ILE . 15.9 mt -145.46 144.61 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.25 111.076 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.857 HG21 HG23 ' A' ' 83' ' ' ILE . 19.3 mm -136.7 129.13 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.19 111.144 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -112.7 136.57 52.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.22 110.945 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.13 102.16 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.22 110.914 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.31 77.37 0.13 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.762 -0.732 . . . . 0.24 112.481 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.49 53.75 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.58 110.921 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.56 160.34 53.74 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.611 0.72 . . . . 0.22 111.071 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 116.35 4.51 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.671 2.248 . . . . 0.24 112.433 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.83 6.73 69.46 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.681 -0.771 . . . . 0.21 112.486 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.92 132.08 48.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 0.68 110.907 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.706 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 26.9 p -122.54 108.5 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.25 111.171 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 1.002 HG21 HD13 ' A' ' 47' ' ' ILE . 1.5 m -162.73 154.8 18.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.4 111.147 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.994 HD12 HD22 ' A' ' 147' ' ' LEU . 4.7 mt -133.17 104.58 6.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.31 110.853 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -76.18 153.72 35.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.074 -0.512 . . . . 0.38 110.886 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.1 m -131.56 177.42 7.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.41 110.836 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.7 -42.03 56.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.36 111.002 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.14 -46.07 86.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 1.91 110.954 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.777 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.2 mp -71.9 -56.68 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.3 111.104 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 119' ' ' LEU . 59.1 mt -50.84 -43.45 59.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.2 110.909 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.34 -54.24 34.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.29 111.057 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.417 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -57.63 -43.32 84.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 2.71 110.836 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.857 HG23 HG21 ' A' ' 63' ' ' ILE . 38.6 mm -54.98 -67.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.27 111.088 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.13 -39.77 56.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.23 111.106 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -52.87 -53.9 42.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 2.3 110.889 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 56' ' ' LYS . 36.3 pt -80.15 -8.5 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.21 111.129 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -78.3 127.56 32.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.39 110.916 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -67.41 160.28 72.84 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.657 0.742 . . . . 2.16 110.763 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 113.91 3.53 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.736 2.291 . . . . 0.16 112.336 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.74 56.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.747 -0.739 . . . . 0.14 112.496 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.51 -164.58 19.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.661 -0.78 . . . . 0.13 112.48 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 45.0 m -134.72 154.21 51.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.876 0.369 . . . . 0.34 110.887 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.645 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -139.61 113.99 9.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.18 110.944 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.536 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.3 m-85 -109.39 131.73 54.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 1.94 110.927 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.556 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.79 158.09 43.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.21 110.815 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.74 130.59 45.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 1.81 110.918 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.4 145.67 17.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.637 0.732 . . . . 2.23 110.886 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.615 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.0 Cg_endo -69.92 137.54 35.23 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.678 2.252 . . . . 0.3 112.282 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.491 HG13 HG23 ' A' ' 157' ' ' VAL . 12.2 m -120.33 146.41 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.21 111.091 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.467 ' OE1' HG21 ' A' ' 103' ' ' VAL . 52.1 mt-10 -111.4 132.79 54.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 1.98 110.856 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.2 p -106.39 26.09 10.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 1.11 111.169 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.85 24.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.74 111.145 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.467 HG21 ' OE1' ' A' ' 100' ' ' GLU . 3.1 t -144.22 161.0 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.8 111.137 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.574 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -54.77 177.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.91 110.895 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -67.87 -53.48 26.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 3.48 110.912 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -70.77 -75.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 2.13 110.825 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.03 -168.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 1.49 110.799 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -4.02 53.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 1.63 110.921 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.42 140.25 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.111 -0.495 . . . . 0.66 111.114 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.9 mmpp? -63.66 112.94 3.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 2.93 111.016 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.574 HG21 ' O ' ' A' ' 104' ' ' ASP . 29.3 p -80.28 176.66 9.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.26 111.13 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.98 -54.9 32.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.17 111.075 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.33 -48.85 80.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.23 110.752 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -39.11 72.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 2.3 110.9 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -65.39 -55.15 19.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.31 110.994 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.4 m -56.7 -44.92 82.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.243 -0.435 . . . . 0.24 110.963 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.83 -42.34 85.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 0.26 110.867 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.2 97.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.2 111.161 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.5 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.2 tp -65.17 -53.98 36.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.23 110.894 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 96.1 m -58.28 -36.88 73.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.31 111.173 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.6 mt -83.42 -10.39 58.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.65 110.969 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m -84.65 4.89 30.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 1.71 110.886 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.01 8.68 31.3 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.662 -0.78 . . . . 0.62 112.446 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.645 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -107.46 168.66 9.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.789 0.328 . . . . 0.31 110.892 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.4 HG23 ' HG3' ' A' ' 126' ' ' GLU . 34.2 m -150.57 169.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.25 111.144 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HG3' HG23 ' A' ' 125' ' ' VAL . 1.9 mt-10 56.2 42.64 27.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 2.02 110.927 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.81 144.33 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.46 111.136 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.82 157.13 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 1.48 110.923 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -81.48 147.3 29.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 2.1 110.902 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.764 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.2 mp -108.21 -36.01 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.27 110.927 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -164.86 176.57 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 1.34 110.981 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -126.56 166.25 17.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 8.3 110.84 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -147.96 135.71 10.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.572 0.701 . . . . 1.44 110.897 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 155.83 65.04 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.618 2.212 . . . . 0.31 112.434 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.646 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -92.34 122.83 35.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.26 -0.427 . . . . 0.31 110.973 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.442 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.46 162.0 22.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.539 0.685 . . . . 1.27 111.2 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.6 Cg_endo -69.82 -26.12 27.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.651 2.234 . . . . 0.32 112.334 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -85.33 -19.79 30.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 2.91 110.888 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.22 -54.41 4.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 2.65 110.934 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.95 -38.85 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.22 111.125 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -39.04 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 2.54 110.916 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -45.59 79.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.3 110.864 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.7 p -67.71 -31.25 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.18 111.158 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -75.74 -30.65 59.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.122 -0.49 . . . . 2.11 110.875 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -90.02 -20.48 23.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 1.76 110.876 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.43 -32.8 13.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.28 110.941 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.994 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.65 -54.15 1.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.32 110.92 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.8 18.4 1.57 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.36 112.473 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -73.72 122.03 21.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.778 0.323 . . . . 1.06 110.923 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -151.58 105.57 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 2.79 110.966 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.9 t -160.55 170.72 20.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.91 110.873 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.34 -18.34 14.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 1.6 110.902 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -98.5 20.25 13.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 1.55 110.83 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.646 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -88.67 164.26 15.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 0.29 111.025 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.6 tm? -173.26 130.35 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.214 -0.448 . . . . 0.31 110.936 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.706 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.5 m-85 -69.79 134.76 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 1.9 110.848 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.491 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.6 144.94 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 0.32 111.176 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.764 ' HG2' HD13 ' A' ' 130' ' ' LEU . 10.7 tt0 -103.29 130.65 50.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 2.29 110.921 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.05 152.58 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.35 111.118 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.443 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.2 t -131.98 159.19 39.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.31 111.128 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -148.3 133.61 4.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 0.18 112.514 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -94.26 131.82 39.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.925 0.393 . . . . 3.85 110.862 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 135.45 81.19 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.549 0.69 . . . . 1.25 110.898 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 128.79 16.53 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.695 2.263 . . . . 0.36 112.35 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.31 110.903 179.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.88 0.372 . . . . 2.46 110.901 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' A' ' 6' ' ' ILE . 5.2 m-85 -122.26 22.45 10.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 1.62 110.883 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.14 41.65 53.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.718 -0.753 . . . . 0.23 112.488 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.482 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.6 mp -81.02 160.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.904 0.383 . . . . 0.26 111.101 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.737 ' O ' HG23 ' A' ' 36' ' ' THR . 0.5 OUTLIER -156.0 167.84 29.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 1.61 110.858 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.6 128.81 36.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.29 111.098 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.07 2.92 26.52 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.754 -0.736 . . . . 0.36 112.505 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.437 HE22 HD12 ' A' ' 62' ' ' ILE . 2.2 pt20 -116.63 166.95 11.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.86 0.362 . . . . 1.02 110.864 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -106.13 112.89 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 1.37 110.906 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.601 HG13 HG21 ' A' ' 36' ' ' THR . 3.1 m -115.23 141.47 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 2.31 111.165 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.797 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -116.59 112.19 20.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 0.38 111.066 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.843 HG11 HG12 ' A' ' 29' ' ' VAL . 92.2 t -86.53 121.13 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.18 111.074 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG12 ' CG1' ' A' ' 47' ' ' ILE . 18.3 t -106.53 115.76 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.17 111.067 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -115.49 168.73 9.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 0.2 110.977 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -151.42 -170.22 3.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.83 110.896 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -57.1 -35.73 69.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 3.59 110.863 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.8 m -73.34 -9.66 58.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 1.7 110.786 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.29 93.75 10.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.621 0.724 . . . . 0.13 110.848 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.7 Cg_endo -69.76 142.8 48.92 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.723 2.282 . . . . 0.21 112.333 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.05 -32.43 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.23 111.08 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -51.29 -53.24 37.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 2.43 110.903 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.73 -44.86 10.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.21 111.054 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.446 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.2 -61.22 2.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.17 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -49.83 -35.63 23.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 2.53 110.888 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.02 -47.72 44.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 0.28 112.53 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.67 -39.44 91.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.38 . . . . 0.48 110.911 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.843 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -77.14 -31.32 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.66 111.026 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.31 -59.25 5.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 1.75 110.826 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -40.43 73.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 1.66 110.885 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.871 HD23 HD21 ' A' ' 35' ' ' LEU . 87.4 mt -72.59 -25.07 61.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.28 110.953 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.496 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.02 -25.02 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 0.47 110.848 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.47 -30.84 17.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.38 111.114 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.871 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.47 -34.89 15.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.31 110.907 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.32 -47.13 4.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.29 111.132 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.1 -14.5 53.48 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.699 -0.762 . . . . 0.36 112.481 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.43 -62.68 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.756 0.313 . . . . 2.09 110.816 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.95 -33.7 8.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 1.97 110.982 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.61 -131.04 4.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.28 112.54 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -153.28 152.74 31.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.791 0.329 . . . . 3.65 110.872 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 12' ' ' VAL . 98.3 t -139.27 113.69 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.46 111.125 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -103.93 153.18 21.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.15 110.895 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.92 133.46 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.11 -0.495 . . . . 0.17 111.148 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -142.16 151.97 42.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 1.32 110.921 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -102.66 135.11 44.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.39 110.921 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.668 ' CD1' HG21 ' A' ' 73' ' ' THR . 23.9 mt -51.76 -35.15 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.29 111.181 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -29.75 60.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 2.15 110.925 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -98.21 18.59 15.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 3.36 110.926 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.816 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.31 -30.77 5.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 1.11 110.912 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -53.93 -37.91 64.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 1.06 111.062 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -84.9 -15.64 43.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 1.22 110.948 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.6 m -66.31 -10.82 46.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.98 110.9 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.68 63.43 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.473 . . . . 0.32 111.11 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -61.55 -69.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.35 110.801 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.664 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -153.16 -175.88 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 1.29 110.837 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -93.73 135.22 35.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 1.8 110.896 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p 46.64 81.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 1.18 110.819 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.9 p -132.07 -39.17 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.32 110.795 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.458 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.7 m-85 -102.16 123.89 46.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 2.06 110.89 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.28 -21.64 62.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 1.71 110.805 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.437 HD12 HE22 ' A' ' 10' ' ' GLN . 13.0 mt -146.6 142.7 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 0.45 111.166 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 83' ' ' ILE . 17.6 mm -129.2 136.76 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.18 111.147 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.5 mm? -116.12 135.77 53.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.37 110.966 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.72 98.02 4.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.13 110.851 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.11 79.58 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.752 . . . . 0.18 112.502 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.85 55.42 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.56 110.959 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -123.77 158.72 58.78 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.636 0.731 . . . . 0.23 111.141 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 115.91 4.31 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.635 2.223 . . . . 0.25 112.393 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.3 6.6 66.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 0.2 112.474 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.32 151.86 9.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.952 0.406 . . . . 0.83 110.841 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.708 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 21.1 p -140.11 108.77 5.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.27 111.135 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.668 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.92 148.57 12.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.26 111.08 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.042 HD12 HD22 ' A' ' 147' ' ' LEU . 10.1 mt -126.75 99.79 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.34 110.904 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -76.78 143.77 39.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.28 110.848 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.83 -175.52 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 1.08 110.746 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.54 -36.17 71.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.26 111.016 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.58 -44.31 96.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 1.78 110.804 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.816 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -76.03 -55.18 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.19 111.187 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.564 HD22 ' CD1' ' A' ' 119' ' ' LEU . 62.8 mt -50.14 -41.86 49.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.19 110.933 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.56 -55.77 17.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.29 111.12 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -43.25 77.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 2.78 110.903 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 63' ' ' ILE . 42.9 mm -56.74 -68.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.18 111.116 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.14 -35.89 38.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.21 111.018 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -57.25 -51.05 70.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 3.31 110.867 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 56' ' ' LYS . 26.3 pt -83.79 -6.37 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.19 111.072 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -79.29 112.66 16.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.254 -0.43 . . . . 0.3 110.851 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -51.77 159.53 1.31 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.651 0.738 . . . . 2.08 110.87 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 115.82 4.27 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.77 2.313 . . . . 0.23 112.307 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.5 3.06 57.53 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.23 112.43 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.87 -157.51 9.59 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.691 -0.766 . . . . 0.21 112.483 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.5 m -145.29 158.87 43.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.35 . . . . 0.6 110.911 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.628 HD22 ' N ' ' A' ' 94' ' ' PHE . 1.0 OUTLIER -141.25 116.28 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.24 110.921 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.628 ' N ' HD22 ' A' ' 93' ' ' LEU . 57.0 m-85 -108.07 132.57 53.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 1.62 110.896 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.34 158.01 43.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.16 110.902 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.84 129.08 46.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 1.75 110.871 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.78 146.56 18.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.659 0.743 . . . . 2.23 110.849 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.516 ' HG2' HD21 ' A' ' 74' ' ' LEU . 52.7 Cg_endo -69.8 142.74 48.59 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.707 2.272 . . . . 0.23 112.321 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.99 146.76 31.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.19 111.195 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.449 ' CD ' HG21 ' A' ' 103' ' ' VAL . 56.0 mt-10 -109.2 132.88 53.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 1.98 110.892 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.2 p -92.47 -41.83 10.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.12 111.185 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.54 39.18 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.67 111.124 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.449 HG21 ' CD ' ' A' ' 100' ' ' GLU . 22.6 t -147.11 149.08 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.74 111.174 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.594 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -51.76 163.1 0.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.167 -0.469 . . . . 1.98 110.767 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -59.86 -47.56 85.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 3.51 110.849 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -75.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 1.91 110.901 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p 52.26 -170.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 1.98 110.89 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -80.51 -3.7 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 1.71 110.87 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.417 HG11 ' CG ' ' A' ' 149' ' ' HIS . 2.7 m -140.57 145.03 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.407 . . . . 0.38 111.183 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.7 mmtm -65.3 114.52 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 2.1 110.87 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.594 HG21 ' O ' ' A' ' 104' ' ' ASP . 45.5 p -85.91 179.33 7.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.21 111.107 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.4 -53.42 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.19 111.14 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -49.29 78.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.24 110.873 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -58.36 -37.95 76.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.028 -0.533 . . . . 1.76 110.918 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -64.74 -54.68 27.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.32 110.94 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.2 m -58.3 -46.6 85.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.23 110.88 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -43.71 93.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.32 110.918 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.78 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.21 111.081 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.564 ' CD1' HD22 ' A' ' 80' ' ' LEU . 11.6 tp -64.45 -57.87 8.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.39 110.914 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.3 m -55.57 -36.38 66.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.33 111.134 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.9 mt -83.11 -10.71 58.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.88 110.909 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.43 6.42 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 1.75 110.852 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.51 8.04 31.24 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.778 -0.725 . . . . 0.58 112.482 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.643 HD23 ' HA3' ' A' ' 161' ' ' GLY . 1.5 tp -107.5 171.29 7.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.82 0.343 . . . . 0.54 111.005 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.61 169.56 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.28 111.091 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 51.47 43.89 29.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 2.41 110.917 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.27 143.19 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.34 111.136 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 160.06 8.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 1.67 110.883 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.47 140.83 37.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 3.15 110.893 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.705 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.6 mp -98.94 -39.2 8.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.41 110.902 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -160.18 177.09 11.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 1.41 110.811 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 -123.99 168.71 12.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 8.04 110.785 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -151.56 136.67 10.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.743 0.782 . . . . 1.38 110.826 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.91 154.76 66.79 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.711 2.274 . . . . 0.38 112.303 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.646 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -91.55 128.44 37.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.38 110.851 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -106.02 161.45 22.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.618 0.723 . . . . 1.65 111.104 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -24.33 29.59 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.68 2.253 . . . . 0.54 112.351 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -85.3 -22.49 28.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 3.87 110.877 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -87.58 -53.77 4.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.117 -0.492 . . . . 2.73 110.903 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.44 -39.25 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.34 111.061 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -36.12 77.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 2.9 110.965 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -45.76 73.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.4 110.831 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.708 HG23 HD13 ' A' ' 147' ' ' LEU . 9.2 p -68.26 -30.81 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 0.26 111.161 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -75.82 -31.94 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 2.13 110.905 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -89.88 -20.16 23.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 1.74 110.84 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.45 -32.92 13.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.848 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.042 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.64 -54.2 1.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.36 110.864 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.1 11.39 2.28 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.787 -0.721 . . . . 0.28 112.51 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.417 ' CG ' HG11 ' A' ' 109' ' ' VAL . 14.8 t-160 -70.34 121.81 18.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.75 0.309 . . . . 0.6 110.798 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -151.76 105.55 3.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 2.24 110.922 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.2 t -160.5 168.38 25.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.6 110.828 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.66 -13.49 15.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.66 110.817 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -100.28 19.97 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.63 110.814 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.646 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -92.8 169.55 10.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.34 110.919 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.662 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.1 tm? -173.57 130.24 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.35 110.931 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.708 ' CZ ' HG22 ' A' ' 72' ' ' THR . 20.1 m-85 -69.98 139.9 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 1.72 110.891 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.13 151.86 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.3 111.216 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.705 ' HG2' HD13 ' A' ' 130' ' ' LEU . 26.1 tt0 -107.8 129.29 55.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 1.56 110.925 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.18 151.17 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.24 111.137 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.512 HG21 HD21 ' A' ' 130' ' ' LEU . 8.9 t -140.54 151.15 44.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.44 111.083 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.643 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -143.35 144.62 13.97 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 0.21 112.496 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -97.66 137.37 36.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 1.81 110.851 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 134.76 65.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.662 0.744 . . . . 1.23 110.856 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 122.05 8.75 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.702 2.268 . . . . 0.37 112.384 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.66 110.894 -179.983 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.737 0.303 . . . . 2.37 110.808 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.23 22.08 10.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.44 . . . . 1.5 110.89 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.34 40.39 60.8 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.731 -0.747 . . . . 0.25 112.479 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.512 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -79.75 159.4 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.22 111.069 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.629 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -154.52 164.56 38.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.29 110.883 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.33 129.87 35.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.31 111.073 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.18 -5.27 25.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.71 -0.757 . . . . 0.26 112.488 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -114.7 167.96 10.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 1.21 110.835 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.37 140.16 33.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 1.33 110.866 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' HB ' ' A' ' 62' ' ' ILE . 48.2 t -142.3 140.13 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 1.85 111.102 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.776 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -117.16 121.89 42.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.26 111.107 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.817 HG11 HG12 ' A' ' 29' ' ' VAL . 64.1 t -95.1 119.6 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.21 111.154 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.487 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.1 t -103.35 112.88 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.23 111.228 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -114.38 167.66 10.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.17 111.012 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.4 -169.79 3.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.354 -0.384 . . . . 1.91 110.82 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -35.52 69.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 3.44 110.861 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -10.25 59.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 1.24 110.863 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.93 94.26 10.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.668 0.747 . . . . 0.15 110.861 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 142.36 47.25 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.713 2.275 . . . . 0.21 112.381 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -49.07 -32.48 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.18 111.105 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -51.32 -53.15 38.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 2.7 110.81 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.48 -44.65 11.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.17 111.163 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.478 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.85 -61.4 2.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.13 110.923 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -49.88 -36.8 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 4.93 110.854 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -47.38 49.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.815 -0.707 . . . . 0.19 112.471 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.6 mt -61.82 -39.7 92.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.45 110.959 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.817 HG12 HG11 ' A' ' 14' ' ' VAL . 17.6 m -76.98 -31.71 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.62 111.047 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -61.96 -59.76 4.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 1.77 110.893 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -40.15 70.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 1.76 110.935 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.852 HD23 HD21 ' A' ' 35' ' ' LEU . 87.1 mt -72.76 -25.25 61.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.23 110.966 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.478 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.4 mt-30 -78.59 -25.19 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.39 110.924 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 -29.15 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.26 111.093 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.852 HD21 HD23 ' A' ' 32' ' ' LEU . 1.3 pp -91.72 -34.88 14.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.22 110.933 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -102.52 -45.11 5.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.168 -0.469 . . . . 0.24 111.149 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.87 -12.09 52.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.28 112.51 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -65.74 -62.6 1.42 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 1.86 110.858 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -97.16 -37.4 10.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 2.35 110.959 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.27 -128.91 5.04 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.27 112.499 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -154.93 153.57 31.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.947 0.403 . . . . 2.28 110.847 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 33' ' ' GLN . 86.0 t -138.56 128.44 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.28 111.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -117.42 157.65 25.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.17 110.821 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -118.51 135.72 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.17 111.137 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -145.34 151.96 39.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 1.94 110.892 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.56 135.97 43.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.905 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.747 HD13 HG21 ' A' ' 73' ' ' THR . 30.4 mt -51.25 -35.33 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.28 111.156 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -31.57 61.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 2.49 110.871 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -96.76 19.27 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 3.4 110.911 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.829 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.86 -30.81 4.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 1.06 111.005 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -53.13 -35.84 60.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 1.02 110.924 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -85.75 -18.76 32.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 1.08 110.913 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.475 ' HB2' HD13 ' A' ' 50' ' ' LEU . 65.3 m -60.47 -16.6 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.92 110.822 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.8 63.59 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.34 111.118 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -61.65 -71.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.37 110.832 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.683 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.4 -167.59 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 1.68 110.85 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -104.29 125.78 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 2.03 110.868 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.6 80.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 1.4 110.816 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.2 p -130.61 -36.47 1.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.22 110.812 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.468 ' CD2' HD12 ' A' ' 86' ' ' ILE . 95.7 m-85 -97.23 121.04 38.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 1.48 110.92 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.28 -20.88 61.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 1.7 110.85 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.646 ' HB ' HG22 ' A' ' 12' ' ' VAL . 30.5 mt -143.32 144.51 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.33 111.19 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.894 HG21 HG23 ' A' ' 83' ' ' ILE . 19.7 mm -135.17 128.86 49.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.17 111.207 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -112.46 136.35 52.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.257 -0.429 . . . . 0.17 110.907 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.33 101.74 6.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.18 110.895 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.59 75.95 0.19 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.704 -0.76 . . . . 0.18 112.557 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.23 57.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.58 110.93 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.08 159.62 63.92 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.62 0.724 . . . . 0.25 111.152 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 116.56 4.61 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.27 112.404 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.56 7.14 69.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.671 -0.776 . . . . 0.18 112.539 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.41 150.02 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.88 0.371 . . . . 0.69 110.857 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.763 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 33.7 p -138.48 108.71 6.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.18 111.167 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.747 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.86 149.98 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.26 111.122 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.897 HD12 HD22 ' A' ' 147' ' ' LEU . 2.4 mt -128.04 99.84 5.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.3 110.892 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -76.9 143.05 39.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.37 110.836 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.6 m -121.81 -175.3 3.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.52 110.829 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.82 -35.91 71.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.27 111.1 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.16 -43.54 97.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 2.12 110.851 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.829 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -76.18 -54.9 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.27 111.141 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.685 HD13 ' HA ' ' A' ' 119' ' ' LEU . 64.5 mt -51.11 -42.51 60.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.26 110.945 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.5 -56.83 11.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.35 111.082 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.426 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -54.36 -43.25 71.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.443 . . . . 3.07 110.922 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.894 HG23 HG21 ' A' ' 63' ' ' ILE . 41.4 mm -55.8 -67.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.27 111.087 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.15 -39.55 56.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.19 111.086 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -52.86 -50.83 63.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 2.45 110.861 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.683 HG22 ' O ' ' A' ' 56' ' ' LYS . 48.5 pt -85.37 -5.97 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.17 111.09 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -79.53 115.24 19.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.29 110.882 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -55.05 158.79 4.48 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.69 0.757 . . . . 3.06 110.828 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.9 Cg_endo -69.74 114.25 3.64 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.717 2.278 . . . . 0.17 112.306 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.39 55.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.787 -0.72 . . . . 0.17 112.52 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.92 -164.67 24.34 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.754 -0.736 . . . . 0.13 112.467 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.6 m -135.55 152.18 51.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.31 110.857 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.603 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -136.18 115.97 13.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.19 110.917 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.571 ' N ' HD22 ' A' ' 93' ' ' LEU . 55.3 m-85 -112.02 131.37 55.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 1.65 110.925 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.54 159.86 43.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.14 110.855 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.4 128.66 41.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 1.85 110.933 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.33 148.31 22.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.591 0.71 . . . . 2.28 110.902 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.595 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -69.82 142.86 48.77 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.67 2.247 . . . . 0.18 112.307 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.0 m -128.88 146.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.18 111.067 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.503 ' CD ' HG21 ' A' ' 103' ' ' VAL . 19.6 mt-10 -106.99 132.48 52.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 1.89 110.885 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.6 p -103.78 26.11 9.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 1.27 111.192 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.56 26.14 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.61 111.097 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.503 HG21 ' CD ' ' A' ' 100' ' ' GLU . 5.9 t -144.13 157.77 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.6 111.067 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.583 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -54.56 174.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.501 . . . . 1.9 110.887 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -65.67 -64.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 2.56 110.855 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -61.54 -75.84 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.231 -0.441 . . . . 2.18 110.888 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.401 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.7 t 51.64 -168.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 2.09 110.857 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -3.55 50.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 3.67 110.817 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -144.38 148.66 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.457 . . . . 0.44 111.113 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.521 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -69.64 112.72 6.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 2.17 110.947 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.583 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.7 p -87.31 178.6 6.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.22 111.093 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.68 -54.09 50.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.2 111.037 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.74 -49.07 79.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.28 110.909 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -57.72 -41.96 82.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 1.76 110.946 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -61.05 -54.76 40.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.3 110.881 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -57.81 -48.9 78.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.3 111.006 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -45.68 92.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.475 . . . . 0.36 110.931 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.25 -45.79 93.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.25 111.093 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.685 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.2 tp -61.87 -54.07 47.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.314 -0.403 . . . . 0.26 110.83 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.9 m -62.38 -27.53 69.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.25 111.118 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.05 -14.38 50.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.66 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.0 p -84.43 5.58 26.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 2.33 110.863 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.53 -4.7 34.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.663 -0.779 . . . . 0.6 112.5 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -87.16 168.92 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 0.35 111.04 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.9 m -151.0 171.32 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.22 111.089 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 52.39 45.02 29.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 2.22 110.853 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.4 t -79.68 143.56 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.21 111.132 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.9 160.23 8.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 2.49 110.889 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.88 147.16 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 2.4 110.862 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.783 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.5 mp -106.68 -36.0 6.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.21 110.905 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.7 176.29 12.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 1.1 110.89 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.707 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.0 OUTLIER -131.96 137.18 47.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 4.61 110.847 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -123.58 137.65 28.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.735 0.779 . . . . 1.4 110.815 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.411 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.8 Cg_endo -69.84 163.92 36.54 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.593 2.195 . . . . 0.22 112.308 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.671 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -96.99 127.03 42.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.28 110.805 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.44 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -100.15 160.91 25.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.584 0.707 . . . . 1.2 111.166 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.44 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.2 Cg_endo -69.72 -28.88 24.89 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.636 2.224 . . . . 0.34 112.378 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.33 -17.9 35.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 2.67 110.822 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.22 -52.83 5.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 2.33 110.892 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 p -49.27 -41.05 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.26 111.125 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -34.82 76.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 1.22 110.986 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -46.19 71.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.167 -0.47 . . . . 0.24 110.89 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.713 HG23 HD13 ' A' ' 147' ' ' LEU . 8.8 p -68.23 -30.15 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.18 111.055 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -75.29 -33.34 61.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 1.8 110.878 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -89.09 -19.93 24.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 1.86 110.838 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -94.1 -32.82 13.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.34 110.881 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.897 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -128.44 -54.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.41 110.936 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.59 7.05 2.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.701 -0.761 . . . . 0.36 112.465 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -70.21 120.44 15.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.78 0.324 . . . . 0.76 110.866 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -152.78 105.03 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 3.3 110.851 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.3 t -161.03 175.98 11.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.61 110.793 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.58 -14.43 14.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 1.55 110.872 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -96.44 6.86 47.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 1.41 110.867 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.671 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -77.98 165.59 23.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.29 110.919 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.707 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.51 130.14 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.21 110.898 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.763 ' CZ ' HG22 ' A' ' 72' ' ' THR . 29.8 m-85 -74.23 133.11 42.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.68 110.84 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.71 144.47 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.18 111.139 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.783 ' HG2' HD13 ' A' ' 130' ' ' LEU . 9.2 tt0 -98.75 130.69 45.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 2.23 110.89 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.83 150.46 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.21 111.084 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.486 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -130.22 160.16 34.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.32 111.089 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.56 132.12 3.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.13 112.474 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -94.15 142.79 27.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 1.71 110.963 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.408 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 2.0 tptt -84.23 135.33 41.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.583 0.706 . . . . 2.27 110.859 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 118.73 5.85 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.703 2.269 . . . . 0.38 112.281 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.47 110.853 -179.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.798 0.332 . . . . 2.07 110.798 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 6' ' ' ILE . 7.0 m-85 -122.28 13.72 10.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 1.55 110.82 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.76 40.67 96.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.659 -0.781 . . . . 0.32 112.482 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.485 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.6 mp -80.99 159.96 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.35 111.179 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.727 ' O ' HG23 ' A' ' 36' ' ' THR . 0.4 OUTLIER -155.89 168.48 27.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 1.73 110.934 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.75 130.39 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.37 111.042 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.35 2.63 29.45 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.764 -0.732 . . . . 0.31 112.53 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.417 HE22 HD12 ' A' ' 62' ' ' ILE . 2.7 pt20 -116.73 166.7 11.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 1.06 110.896 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -105.39 114.94 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 2.15 110.794 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.608 HG13 HG21 ' A' ' 36' ' ' THR . 3.4 m -117.85 139.27 45.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.473 . . . . 2.33 111.151 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.763 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -114.01 115.69 28.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.31 111.077 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.808 HG11 HG12 ' A' ' 29' ' ' VAL . 64.8 t -88.95 120.5 37.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.19 111.175 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.628 HG12 HG13 ' A' ' 47' ' ' ILE . 18.5 t -106.17 113.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.48 . . . . 0.18 111.173 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -112.67 167.39 10.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.24 110.871 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.576 ' HB3' HD12 ' A' ' 47' ' ' ILE . 7.2 p-10 -148.34 -169.25 3.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 1.72 110.974 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -58.67 -35.58 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 3.04 110.935 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -7.82 53.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 1.17 110.809 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.58 92.71 8.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.636 0.732 . . . . 0.18 110.907 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 143.27 50.56 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.707 2.271 . . . . 0.29 112.314 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.5 t -48.35 -33.06 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.25 111.145 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.33 -52.92 41.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 2.64 110.846 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.45 -45.3 10.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.25 111.219 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.452 HD22 HG13 ' A' ' 29' ' ' VAL . 1.9 tm? -51.2 -61.68 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.21 111.039 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.59 -35.83 22.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 2.69 110.928 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.16 -47.49 44.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.737 . . . . 0.25 112.573 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.422 HD11 HG13 ' A' ' 68' ' ' VAL . 46.5 mt -61.59 -38.84 89.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.63 110.973 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.808 HG12 HG11 ' A' ' 14' ' ' VAL . 17.3 m -77.66 -31.43 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.65 111.13 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.25 -58.24 8.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 1.59 110.835 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -40.43 76.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 2.59 110.818 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.902 HD23 HD21 ' A' ' 35' ' ' LEU . 87.6 mt -72.73 -24.78 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 0.25 110.948 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.496 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -77.92 -24.87 48.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.436 . . . . 0.41 110.839 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.8 -31.47 16.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.22 111.08 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.902 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -89.74 -35.21 15.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.22 110.931 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.64 -46.9 4.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.21 111.194 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.24 -13.37 53.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.668 -0.777 . . . . 0.26 112.53 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -62.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 2.8 110.897 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -99.85 -35.82 9.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 2.12 110.834 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.32 -129.64 4.53 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.24 112.471 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -153.67 152.28 30.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.854 0.359 . . . . 2.19 110.853 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 12' ' ' VAL . 92.2 t -137.8 117.19 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 0.29 111.069 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.2 t -106.93 153.75 22.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 0.18 110.875 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.53 134.36 58.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.19 111.073 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -144.46 152.52 40.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 1.25 110.921 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -102.49 137.41 40.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.48 110.824 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.945 HD13 HG21 ' A' ' 73' ' ' THR . 9.8 mt -51.38 -44.49 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.39 111.105 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -24.54 61.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 3.6 110.883 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -99.3 18.76 16.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 3.45 110.961 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.803 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.36 -29.31 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 1.11 110.9 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.82 -36.5 48.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 1.13 110.929 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.1 mm-40 -85.77 -20.4 29.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 1.25 110.897 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB2' HD13 ' A' ' 50' ' ' LEU . 66.5 m -59.53 -17.73 34.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.88 110.836 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.76 63.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.29 111.07 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -63.82 -71.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.36 110.79 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.693 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.73 -167.65 2.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 1.62 110.921 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -104.76 125.99 51.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 1.88 110.87 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.27 79.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 1.32 110.887 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.6 p -129.61 -35.42 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.26 110.89 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.454 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.7 m-85 -98.15 121.5 40.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 1.43 110.926 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.29 -21.5 62.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 1.69 110.888 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.417 HD12 HE22 ' A' ' 10' ' ' GLN . 14.1 mt -146.49 143.45 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.38 111.085 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.792 HG21 HD12 ' A' ' 83' ' ' ILE . 22.1 mm -131.22 132.44 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.25 111.045 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -112.15 134.96 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.21 110.959 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.34 101.18 5.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.17 110.846 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.68 78.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.711 -0.756 . . . . 0.2 112.505 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.474 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.5 mm? -110.95 53.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.57 110.91 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -122.78 160.34 49.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.683 0.754 . . . . 0.25 111.028 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.4 ' HD2' HG12 ' A' ' 68' ' ' VAL . 53.2 Cg_endo -69.81 123.34 9.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.765 2.31 . . . . 0.27 112.27 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.78 7.2 88.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.777 -0.725 . . . . 0.2 112.445 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.433 ' HB3' HG23 ' A' ' 68' ' ' VAL . 9.5 p -55.56 151.67 10.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.78 110.819 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.688 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 13.1 p -141.36 111.92 7.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.25 111.136 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.945 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.55 152.35 14.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.23 111.112 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.017 HD12 HD22 ' A' ' 147' ' ' LEU . 5.1 mt -129.68 100.1 5.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.22 110.907 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -75.67 144.79 41.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.25 110.76 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.9 m -122.67 178.96 4.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.38 110.856 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.6 -42.77 62.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.29 111.115 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.96 -46.78 81.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 2.04 110.954 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.803 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.1 mp -71.55 -56.81 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.28 111.157 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.2 mt -50.2 -43.01 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.18 110.874 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.78 -56.68 12.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.29 111.083 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.433 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -54.85 -43.43 73.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 2.91 110.849 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.792 HD12 HG21 ' A' ' 63' ' ' ILE . 40.3 mm -55.35 -67.72 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.28 111.14 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -51.49 -39.54 57.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.22 111.069 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.9 tpp85 -52.82 -50.15 64.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 2.78 110.856 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 56' ' ' LYS . 46.8 pt -86.13 -5.8 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.24 111.119 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -80.15 113.98 18.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.33 110.866 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -52.95 159.03 2.0 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.599 0.714 . . . . 2.24 110.899 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 54.7 Cg_endo -69.77 114.1 3.59 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.698 2.265 . . . . 0.17 112.401 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.29 2.9 55.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.81 -0.71 . . . . 0.18 112.521 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.53 -163.66 16.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.657 -0.783 . . . . 0.16 112.483 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.3 m -137.55 154.52 49.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.35 110.856 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.6 HD22 ' N ' ' A' ' 94' ' ' PHE . 1.2 tm? -137.49 116.31 12.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.15 110.943 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.6 ' N ' HD22 ' A' ' 93' ' ' LEU . 61.1 m-85 -109.74 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 1.62 110.868 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.573 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.73 163.15 38.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.15 110.926 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.03 129.71 34.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 1.82 110.913 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.539 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -152.26 149.5 23.2 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.673 0.749 . . . . 2.49 110.875 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.618 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.4 Cg_endo -69.74 143.22 50.27 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.246 . . . . 0.19 112.39 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.0 m -129.74 146.36 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.24 111.111 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.421 ' CD ' HG21 ' A' ' 103' ' ' VAL . 46.6 mt-10 -107.92 132.79 53.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 2.04 110.824 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.7 p -91.63 -42.72 10.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 1.14 111.154 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.666 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.56 40.28 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.73 111.093 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.421 HG21 ' CD ' ' A' ' 100' ' ' GLU . 21.4 t -147.96 151.85 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.71 111.146 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.65 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -53.55 173.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 1.89 110.874 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -66.95 -53.96 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 2.73 110.914 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -72.94 -76.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 2.65 110.871 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t 54.01 -167.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 2.31 110.933 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -6.16 57.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 2.31 110.884 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.1 m -141.48 146.42 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.54 111.16 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 123.26 19.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 2.46 110.902 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.65 HG21 ' O ' ' A' ' 104' ' ' ASP . 70.0 p -96.1 -179.54 4.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.22 111.166 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.78 -53.89 49.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.24 111.099 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.13 -48.41 81.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.42 110.889 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.28 -49.61 76.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 2.96 110.9 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.539 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -52.45 -55.52 21.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.81 110.96 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 74.8 m -51.2 -49.1 61.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.45 110.909 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -43.85 92.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.52 110.815 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.44 -48.79 80.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.488 . . . . 0.35 111.057 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.703 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.1 tp -57.78 -52.4 65.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.35 110.917 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.2 m -63.13 -29.46 70.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.57 111.154 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.0 mt -79.5 -17.17 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 1.09 110.932 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.3 p -82.64 3.57 28.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 2.36 110.953 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.48 -4.85 35.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.6 112.472 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -85.5 168.4 14.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.45 110.88 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.16 171.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.31 111.084 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 54.29 43.64 30.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.16 -0.473 . . . . 2.19 110.907 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.8 t -75.36 142.87 13.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.34 111.176 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.09 159.18 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 1.76 110.922 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -81.87 146.69 29.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 2.25 110.854 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.547 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.0 mp -106.44 -35.83 6.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 0.19 110.948 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.55 176.22 12.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 1.15 110.886 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.724 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.8 tmt_? -133.79 138.11 45.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 4.29 110.809 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -125.07 137.87 30.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.633 0.73 . . . . 1.43 110.868 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.41 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.6 Cg_endo -69.78 163.93 36.47 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.69 2.26 . . . . 0.27 112.346 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.693 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -98.7 125.53 44.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.34 110.999 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.491 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.1 161.58 22.48 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.603 0.716 . . . . 1.39 111.129 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.481 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.8 Cg_endo -69.78 -23.77 30.35 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.75 2.3 . . . . 0.37 112.344 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -85.08 -24.21 28.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 2.34 110.826 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -88.46 -51.03 5.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 2.62 110.948 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.32 -39.33 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.26 111.157 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -34.68 76.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 2.74 110.857 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -46.2 71.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.27 110.869 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.706 HG23 HD13 ' A' ' 147' ' ' LEU . 8.6 p -67.91 -30.47 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.19 111.169 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -75.51 -32.74 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 2.3 110.958 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -89.47 -20.0 24.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 1.74 110.882 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -94.17 -33.13 13.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.35 110.846 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.017 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.77 -54.15 1.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.33 110.863 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.2 6.71 2.69 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.717 -0.754 . . . . 0.35 112.451 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.543 ' CE1' HG21 ' A' ' 109' ' ' VAL . 6.8 t-160 -70.1 119.99 15.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.83 110.827 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -153.45 104.8 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 2.29 110.961 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -161.29 174.38 13.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.74 110.897 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.88 -8.17 17.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 1.88 110.848 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.666 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 m-80 -101.92 8.04 41.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 1.76 110.872 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.693 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -82.16 165.28 20.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.33 110.997 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.724 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -171.33 130.59 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.28 110.921 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.688 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.4 m-85 -75.24 131.38 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 1.72 110.916 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.13 144.84 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.22 111.173 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.547 ' HG2' HD13 ' A' ' 130' ' ' LEU . 4.3 tt0 -100.09 128.38 46.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 1.84 110.924 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.14 150.98 28.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.26 111.11 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.448 ' N ' HD11 ' A' ' 130' ' ' LEU . 1.9 t -129.29 158.74 38.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.39 111.127 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.51 130.74 3.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 0.19 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -94.27 140.86 29.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 1.6 110.97 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 6.3 tptm -82.25 134.41 48.92 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.568 0.699 . . . . 1.41 110.884 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 118.79 5.89 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 0.41 112.354 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.35 110.871 -179.961 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.83 0.348 . . . . 2.07 110.826 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -122.29 20.6 10.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 1.52 110.891 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.08 39.49 49.69 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.718 -0.753 . . . . 0.22 112.39 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.418 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.8 mp -74.92 157.68 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.25 111.136 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.619 ' O ' HG23 ' A' ' 36' ' ' THR . 37.9 m -146.21 157.53 43.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 1.07 110.836 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.2 129.22 35.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.29 111.159 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.09 -9.02 31.42 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.742 . . . . 0.54 112.495 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -103.41 168.0 9.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.869 0.366 . . . . 1.52 110.832 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.79 112.05 24.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 1.3 110.907 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.721 HG12 HG21 ' A' ' 36' ' ' THR . 2.6 p -119.36 133.67 65.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 1.99 111.08 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -107.89 133.44 52.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.34 111.08 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.764 HG11 HG12 ' A' ' 29' ' ' VAL . 99.9 t -104.43 120.51 54.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.17 111.087 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 47' ' ' ILE . 12.1 t -103.88 115.41 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.18 111.16 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -114.68 168.0 10.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.913 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.595 ' HB3' HD12 ' A' ' 47' ' ' ILE . 5.2 p-10 -150.95 -169.45 3.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 1.94 110.92 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -57.8 -35.56 70.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 3.35 110.9 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.69 -9.29 58.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 1.35 110.82 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.95 92.16 8.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.606 0.717 . . . . 0.17 110.902 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 143.98 52.59 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.703 2.269 . . . . 0.23 112.227 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.3 t -48.39 -32.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.19 111.161 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.23 -53.0 39.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 3.27 110.924 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.8 -45.02 10.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.19 111.067 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.475 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.5 -61.89 1.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.16 110.881 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -49.69 -37.86 30.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 4.88 110.894 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.39 -48.15 53.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.765 -0.731 . . . . 0.21 112.427 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.15 -41.04 96.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.49 110.991 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.764 HG12 HG11 ' A' ' 14' ' ' VAL . 18.1 m -75.84 -31.13 21.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.63 111.166 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -61.75 -61.38 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 1.6 110.92 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -40.78 68.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 1.77 110.854 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.833 HD23 HD21 ' A' ' 35' ' ' LEU . 83.7 mt -72.01 -25.31 61.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.465 . . . . 0.3 110.9 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.538 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.17 -24.62 47.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.39 110.922 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.62 -30.11 17.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.27 111.114 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.833 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.54 -35.05 14.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.24 110.872 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.721 HG21 HG12 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -102.87 -45.4 4.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.27 111.058 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.74 -12.13 52.13 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.791 -0.719 . . . . 0.3 112.447 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -67.96 -62.72 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.33 . . . . 2.55 110.879 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -95.09 -38.9 10.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 2.79 110.896 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.58 -130.6 5.68 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.717 -0.754 . . . . 0.25 112.473 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -152.59 151.28 30.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.841 0.353 . . . . 2.21 110.853 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' A' ' 33' ' ' GLN . 84.0 t -134.54 121.42 35.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.22 111.123 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 t -110.66 152.94 25.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.23 110.881 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -115.65 136.67 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.2 111.17 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -146.47 152.69 39.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.38 110.911 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -102.35 138.61 39.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.5 110.878 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.978 HD13 HG21 ' A' ' 73' ' ' THR . 14.0 mt -53.87 -43.26 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.179 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.58 -21.69 61.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 3.61 110.914 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -100.73 16.39 25.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 3.42 110.903 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.785 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.59 -29.79 4.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 1.14 110.905 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.89 -41.07 61.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 1.12 110.884 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -84.98 -15.96 42.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 1.08 110.908 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.459 ' HB2' HD13 ' A' ' 50' ' ' LEU . 51.0 m -66.67 -11.46 54.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.911 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.14 61.0 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.48 111.092 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -58.52 -71.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.57 110.839 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -150.79 -168.51 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 1.91 110.813 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.58 136.05 43.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 1.99 110.903 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.2 p 47.45 86.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 1.21 110.885 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 p -142.3 -39.02 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.47 110.91 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.471 ' O ' HD23 ' A' ' 87' ' ' LEU . 97.9 m-85 -99.66 120.08 39.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.051 -0.522 . . . . 1.47 110.85 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.44 -21.76 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 1.72 110.93 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mt -144.53 144.11 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.28 111.157 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 83' ' ' ILE . 18.9 mm -136.54 130.15 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.15 111.195 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.7 mm? -113.57 137.54 51.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.21 110.956 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.58 100.81 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.14 110.902 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.7 77.97 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.18 112.493 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.77 56.71 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.57 110.853 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.65 159.91 55.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.661 0.743 . . . . 0.21 111.09 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 116.82 4.74 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.672 2.248 . . . . 0.24 112.369 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.96 7.21 70.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.2 112.431 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -54.93 150.56 9.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.69 110.821 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.718 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 19.3 p -140.68 109.45 6.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.22 111.195 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.978 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.09 151.29 15.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.24 111.161 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.037 HD12 HD22 ' A' ' 147' ' ' LEU . 5.2 mt -127.01 99.82 5.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.33 110.905 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -76.9 130.21 37.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.52 110.876 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.489 ' H ' HD13 ' A' ' 79' ' ' ILE . 29.7 m -107.11 177.0 4.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.47 110.924 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.19 -40.07 57.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.142 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.63 -43.41 89.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 1.73 110.879 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.785 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.1 mp -76.04 -56.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.26 111.16 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 mt -49.59 -47.29 49.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.917 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.75 -52.76 37.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.53 111.068 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -43.9 80.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 2.84 110.893 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 63' ' ' ILE . 38.6 mm -55.86 -67.15 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.29 111.102 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.22 -36.65 42.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.29 111.09 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 tpp85 -56.33 -54.98 39.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 2.4 110.926 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 56' ' ' LYS . 24.2 pt -78.44 -8.42 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.33 111.093 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -77.54 124.7 28.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 0.28 110.942 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -64.25 160.67 47.63 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.578 0.704 . . . . 2.15 110.857 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 114.02 3.56 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.656 2.237 . . . . 0.23 112.408 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.43 3.38 56.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.688 -0.768 . . . . 0.2 112.426 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.01 -161.6 13.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.758 . . . . 0.18 112.479 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.7 m -139.59 154.16 47.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.83 0.347 . . . . 0.27 110.883 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 119' ' ' LEU . 1.3 tm? -138.87 113.5 9.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.16 110.945 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.536 ' N ' HD22 ' A' ' 93' ' ' LEU . 46.2 m-85 -108.45 133.44 52.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 1.64 110.85 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.526 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.98 164.15 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.18 110.901 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -135.25 126.99 29.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 1.87 110.998 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.616 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -148.97 148.4 27.12 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.675 0.75 . . . . 2.35 110.863 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.507 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.4 Cg_endo -69.85 139.89 40.99 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.605 2.203 . . . . 0.21 112.355 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 155' ' ' LEU . 5.4 m -120.96 147.4 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.26 111.143 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.409 ' OE1' HG21 ' A' ' 103' ' ' VAL . 38.2 mt-10 -116.1 132.63 56.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 1.97 110.904 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.4 p -106.45 26.04 10.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 1.08 111.077 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.17 25.93 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.96 111.046 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.6 t -143.75 159.92 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.97 111.084 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.485 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -56.02 179.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 2.09 110.772 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -64.61 -68.84 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 2.09 110.897 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -62.47 -75.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 2.01 110.87 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.37 -167.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 1.58 110.811 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -6.83 58.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 2.07 110.954 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.29 140.24 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.67 111.114 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.667 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -64.23 115.49 5.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 2.11 110.869 179.973 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.485 HG21 ' O ' ' A' ' 104' ' ' ASP . 28.4 p -83.3 177.77 8.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.27 111.126 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.52 -55.05 28.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.32 111.137 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.8 -51.73 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.3 110.805 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 -38.13 67.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 2.5 110.886 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.616 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.1 tm? -64.74 -54.61 28.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.6 110.874 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 36.4 m -60.07 -46.41 89.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.463 . . . . 0.3 110.922 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -43.98 96.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.33 110.801 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.73 -53.33 59.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.37 111.105 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 93' ' ' LEU . 16.5 tp -57.66 -53.16 61.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.53 110.876 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.8 m -61.57 -26.25 67.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.44 111.177 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.8 mt -87.01 -13.6 44.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 0.67 110.939 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.0 p -82.0 3.5 26.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 2.57 110.877 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.06 -4.35 33.77 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.802 -0.713 . . . . 0.85 112.564 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.662 HD23 ' HA3' ' A' ' 161' ' ' GLY . 1.6 tp -87.9 171.2 10.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.67 110.797 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.44 169.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.38 111.105 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 54.6 44.2 29.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 2.28 110.886 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 86.1 t -81.85 142.68 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 0.33 111.105 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 160.62 8.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 1.63 110.959 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -78.91 142.91 36.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 3.12 110.913 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.725 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.2 mp -100.2 -39.08 8.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.19 110.907 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.35 176.34 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 1.12 110.932 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.703 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.0 tmt_? -130.19 138.18 50.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 4.16 110.919 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -125.06 135.8 27.28 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.605 0.717 . . . . 1.89 110.946 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.42 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.7 Cg_endo -69.72 162.52 41.75 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.764 2.309 . . . . 0.3 112.405 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.668 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -97.93 118.54 34.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.53 110.92 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.49 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.0 OUTLIER -96.71 161.07 27.83 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.595 0.712 . . . . 1.47 111.077 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.49 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.9 Cg_endo -69.67 -25.53 28.91 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.6 2.2 . . . . 0.62 112.344 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -85.46 -20.75 29.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 4.23 110.821 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -88.25 -53.29 4.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 2.38 110.85 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 136' ' ' THR . 7.0 p -49.64 -39.46 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.37 111.111 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.01 75.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 1.29 110.874 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.67 -46.69 68.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.4 110.817 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.8 p -68.29 -30.24 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.157 -0.474 . . . . 0.29 111.21 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -76.13 -31.5 58.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.481 . . . . 1.81 110.886 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -89.73 -20.41 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.432 . . . . 2.02 110.905 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -94.54 -32.91 13.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.47 110.805 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.037 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.26 -54.28 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.44 110.896 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.1 17.21 1.66 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.696 -0.764 . . . . 0.36 112.496 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -72.37 122.36 21.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 1.01 110.869 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.38 107.95 3.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 2.87 110.95 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.9 t -160.55 172.23 17.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.84 110.872 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.01 -18.06 14.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 1.69 110.818 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -100.01 18.73 17.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 1.57 110.844 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -83.21 165.35 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.36 110.977 179.952 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.703 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.4 tm? -173.94 130.3 0.4 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.26 110.917 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.718 ' CZ ' HG22 ' A' ' 72' ' ' THR . 23.1 m-85 -75.87 138.63 41.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 1.84 110.924 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -151.88 148.41 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.25 111.079 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.725 ' HG2' HD13 ' A' ' 130' ' ' LEU . 9.9 tt0 -102.36 132.55 48.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 2.16 110.866 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.59 148.85 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.22 111.129 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.512 ' N ' HD11 ' A' ' 130' ' ' LEU . 9.6 t -134.49 157.3 46.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.38 111.109 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.662 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -146.53 141.77 9.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.759 -0.734 . . . . 0.37 112.483 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -98.54 131.97 44.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 3.66 110.91 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.53 135.58 78.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.541 0.686 . . . . 1.79 110.882 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 129.32 17.4 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.667 2.245 . . . . 0.41 112.394 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.39 110.906 -179.99 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.872 0.368 . . . . 1.95 110.85 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.37 22.41 10.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 2.04 110.909 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.28 40.95 53.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 0.26 112.531 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.482 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -80.01 159.91 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.793 0.33 . . . . 0.3 111.118 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -154.44 165.37 36.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 1.17 110.873 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.58 123.71 33.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.32 111.09 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.44 2.87 21.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.646 -0.788 . . . . 0.33 112.467 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.401 HE22 HD12 ' A' ' 62' ' ' ILE . 2.8 pt20 -115.15 168.7 9.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.36 . . . . 1.05 110.898 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -106.93 112.87 26.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 1.37 110.857 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG13 HG21 ' A' ' 36' ' ' THR . 3.0 m -116.05 140.2 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 2.3 111.135 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.803 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -115.92 113.02 22.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.3 111.059 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.785 HG11 HG12 ' A' ' 29' ' ' VAL . 62.4 t -86.97 120.28 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.21 111.082 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.418 HG12 ' CG1' ' A' ' 47' ' ' ILE . 21.7 t -105.29 116.64 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.19 111.09 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -116.2 169.22 9.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.152 -0.476 . . . . 0.2 110.934 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.402 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 9.7 p-10 -151.4 -169.74 3.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 1.78 110.832 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.86 -35.59 71.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 3.13 110.876 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.6 m -73.5 -9.18 58.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 1.58 110.896 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.08 94.47 10.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.655 0.74 . . . . 0.16 110.847 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 142.03 46.69 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.664 2.242 . . . . 0.21 112.345 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.2 t -48.69 -32.94 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.2 111.141 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.34 -52.62 43.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 3.17 110.878 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -45.03 10.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.17 111.097 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.457 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.8 -61.61 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.18 110.846 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -35.42 24.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 2.61 110.784 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.25 -47.54 43.71 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.722 -0.752 . . . . 0.23 112.487 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.05 -39.19 91.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.55 110.968 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.785 HG12 HG11 ' A' ' 14' ' ' VAL . 16.8 m -77.07 -31.46 18.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.65 111.116 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.5 -58.83 6.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 1.66 110.874 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -40.4 74.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 3.01 110.883 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.853 HD23 HD21 ' A' ' 35' ' ' LEU . 89.5 mt -72.65 -25.19 61.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.228 -0.442 . . . . 0.32 110.929 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.468 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -77.89 -24.74 48.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.904 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.66 -31.09 16.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.28 111.083 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.853 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -90.08 -35.14 15.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.26 110.964 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.25 -47.2 4.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.486 . . . . 0.29 111.218 179.893 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.83 -14.68 52.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.749 . . . . 0.29 112.53 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.11 -62.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 1.98 110.869 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -103.86 -33.86 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 2.22 110.854 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.42 -133.34 4.9 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.672 -0.775 . . . . 0.29 112.526 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -150.8 151.53 32.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 2.19 110.869 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 12' ' ' VAL . 99.0 t -139.11 113.35 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.43 111.172 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 t -103.91 154.56 19.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.16 110.811 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.73 130.03 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.21 111.134 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -137.73 150.92 47.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 1.45 110.92 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -103.64 135.32 45.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.45 110.888 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.648 ' CD1' HG21 ' A' ' 73' ' ' THR . 32.0 mt -54.22 -34.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.31 111.185 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -73.27 -30.77 63.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 2.07 110.862 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -102.28 19.4 18.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 3.75 110.924 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.823 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.59 -27.37 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 1.08 110.929 -179.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -52.73 -38.65 61.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 1.06 110.907 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -84.48 -14.35 49.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 1.09 110.896 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.652 ' HB3' HD13 ' A' ' 50' ' ' LEU . 24.4 t -63.96 -11.51 29.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 2.05 110.838 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 53.97 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.39 111.153 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -52.1 -71.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.41 110.81 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.676 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -147.83 -168.6 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 1.94 110.878 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -103.73 129.75 51.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 1.68 110.957 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t 51.55 88.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 1.96 110.803 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.4 p -140.59 -39.54 0.42 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.057 -0.519 . . . . 0.26 110.818 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.472 ' O ' HD23 ' A' ' 87' ' ' LEU . 92.6 m-85 -99.9 123.61 44.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 1.47 110.868 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.23 -22.04 62.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 1.52 110.958 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.401 HD12 HE22 ' A' ' 10' ' ' GLN . 14.4 mt -146.14 143.25 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.45 111.164 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.976 HG21 HG23 ' A' ' 83' ' ' ILE . 16.7 mm -130.21 133.68 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.15 111.093 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.7 mm? -112.48 135.64 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.3 110.938 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.32 98.97 5.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.18 110.921 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.7 80.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.695 -0.764 . . . . 0.22 112.591 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.4 mm? -111.94 55.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.58 110.985 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.11 159.52 56.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.696 0.76 . . . . 0.22 111.173 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 116.56 4.6 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.644 2.23 . . . . 0.24 112.437 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.32 7.29 69.88 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.722 -0.751 . . . . 0.16 112.461 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.8 148.41 16.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.384 . . . . 0.67 110.797 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.761 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 32.9 p -136.84 108.66 7.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.494 . . . . 0.19 111.089 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.648 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.95 152.54 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.24 111.174 179.983 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.868 HD12 HD22 ' A' ' 147' ' ' LEU . 3.4 mt -132.05 103.68 6.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.28 110.915 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -80.03 146.85 31.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.27 110.817 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.3 m -124.56 -176.2 3.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.38 110.867 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.71 70.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.22 111.129 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.72 -45.14 94.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 1.83 110.974 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.823 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -74.28 -55.37 12.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.19 111.091 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 119' ' ' LEU . 61.4 mt -49.68 -43.77 47.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.2 110.911 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.41 -50.82 58.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.29 111.136 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -44.53 90.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 3.08 110.86 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 63' ' ' ILE . 41.9 mm -58.08 -68.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.21 111.127 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.37 -37.3 24.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.2 111.135 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -56.9 -52.84 63.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 2.26 110.813 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 56' ' ' LYS . 23.9 pt -81.69 -4.91 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.2 111.135 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -81.34 115.76 20.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.27 110.904 179.91 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -53.42 158.77 2.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.63 0.729 . . . . 3.03 110.846 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.8 Cg_endo -69.72 113.59 3.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.624 2.216 . . . . 0.23 112.426 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.71 3.0 55.27 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.731 -0.747 . . . . 0.26 112.42 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.24 -162.1 15.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.22 112.485 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 98.9 m -138.4 157.17 46.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.38 110.831 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.669 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.2 tm? -139.86 115.94 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.15 110.88 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.599 ' N ' HD22 ' A' ' 93' ' ' LEU . 67.5 m-85 -109.18 131.86 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 1.88 110.847 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.572 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.28 164.34 34.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.18 110.91 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.76 129.3 32.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 1.87 110.907 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.663 ' OE1' HD23 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -152.52 149.61 23.02 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.674 0.749 . . . . 2.53 110.864 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.629 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.2 Cg_endo -69.81 144.19 52.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.667 2.245 . . . . 0.21 112.308 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.82 146.61 33.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.25 111.167 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.434 ' CD ' HG21 ' A' ' 103' ' ' VAL . 42.8 mt-10 -106.79 132.91 52.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 2.09 110.94 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p -93.27 -42.5 9.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 1.1 111.161 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.677 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.36 39.89 1.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.8 111.162 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' CD ' ' A' ' 100' ' ' GLU . 20.1 t -147.29 150.97 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.76 111.147 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.616 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -54.05 164.32 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 2.27 110.866 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -59.99 -48.32 82.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 2.49 110.941 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.12 -75.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 1.99 110.846 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p 53.02 -171.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 1.82 110.862 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -4.42 53.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 2.29 110.961 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.505 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.5 m -140.81 151.26 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.286 -0.415 . . . . 0.52 111.228 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -68.26 111.66 4.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 2.41 110.9 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.616 HG21 ' O ' ' A' ' 104' ' ' ASP . 46.9 p -83.14 179.65 7.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.28 111.198 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.65 -53.59 55.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.19 111.102 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.88 -47.95 84.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.24 110.843 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -39.11 80.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 2.72 110.91 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -64.7 -55.25 21.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.449 . . . . 0.39 110.904 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 60.6 m -55.93 -44.83 78.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 0.21 110.842 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.4 -40.78 96.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.27 110.852 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.82 92.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.22 111.125 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.599 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.1 tp -64.82 -50.77 65.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.26 110.978 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.3 m -63.63 -35.22 79.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.29 111.145 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -83.48 -10.28 58.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.54 110.884 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 m -84.87 5.78 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 1.73 110.881 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.22 3.98 35.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 0.5 112.507 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -104.81 172.42 6.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.932 0.396 . . . . 0.3 110.865 -179.869 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 m -151.58 174.08 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.33 111.23 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 51.22 45.09 28.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 2.02 110.938 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.42 HG13 HD23 ' A' ' 119' ' ' LEU . 89.4 t -79.7 143.81 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.22 111.107 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.49 8.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 2.47 110.92 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -81.15 145.77 30.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 2.27 110.969 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.62 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.8 mp -105.23 -35.65 7.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.18 110.949 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.57 176.33 12.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.172 -0.467 . . . . 1.13 111.02 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.731 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.0 tmt_? -132.4 138.16 47.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 4.29 110.785 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -125.18 137.97 30.76 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.625 0.726 . . . . 1.86 110.967 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.422 ' HA ' HD21 ' A' ' 155' ' ' LEU . 55.2 Cg_endo -69.6 164.05 35.86 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.76 2.307 . . . . 0.26 112.403 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.678 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -97.61 128.58 44.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.31 110.913 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.48 160.95 25.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.608 0.718 . . . . 1.21 111.108 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.86 -28.81 24.31 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.649 2.233 . . . . 0.33 112.333 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -85.35 -17.78 35.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 3.74 110.844 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 -52.9 5.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 2.27 110.936 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.8 p -49.19 -40.66 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.29 111.134 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -34.78 76.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 1.18 110.884 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.98 -46.31 71.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.27 110.882 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.708 HG23 HD13 ' A' ' 147' ' ' LEU . 8.9 p -68.12 -30.08 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.24 111.167 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -75.27 -33.33 61.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 1.82 110.855 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -89.12 -19.91 24.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 1.7 110.818 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -94.16 -32.77 13.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.83 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.868 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -128.4 -54.26 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.45 110.871 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.31 4.95 2.76 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.705 -0.76 . . . . 0.41 112.484 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.505 ' CE1' HG21 ' A' ' 109' ' ' VAL . 8.1 t-160 -70.08 120.17 15.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.87 110.805 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -153.26 104.76 2.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 2.21 110.967 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.34 173.42 15.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.77 110.911 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.98 -10.06 16.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 1.95 110.895 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.677 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 1.6 m120 -99.9 9.08 43.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 3.13 110.904 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.678 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -83.2 167.14 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.44 110.938 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -172.33 130.13 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.24 110.898 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.761 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.9 m-85 -73.76 132.23 42.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 1.72 110.853 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.07 142.26 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.21 111.171 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.62 ' HG2' HD13 ' A' ' 130' ' ' LEU . 7.5 tt0 -96.46 129.44 43.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 1.69 110.874 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.97 151.63 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.22 111.198 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.448 ' N ' HD11 ' A' ' 130' ' ' LEU . 3.0 t -131.91 160.85 34.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.28 111.156 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.409 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -152.39 134.51 4.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.757 -0.735 . . . . 0.17 112.509 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -95.19 141.1 29.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 1.67 110.914 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 4.7 tptm -81.95 134.09 50.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.559 0.695 . . . . 1.38 110.871 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 119.26 6.23 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.645 2.23 . . . . 0.44 112.376 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.38 110.929 -179.961 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.749 0.309 . . . . 2.83 110.874 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.31 22.0 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 1.52 110.876 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.15 40.63 52.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.788 -0.72 . . . . 0.28 112.469 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.49 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -79.05 159.8 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.821 0.343 . . . . 0.25 111.121 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 36' ' ' THR . 1.3 m -154.32 166.52 32.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 1.13 110.842 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.6 125.41 35.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 0.3 111.159 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.91 2.9 23.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.814 -0.707 . . . . 0.32 112.514 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.422 HE22 HD12 ' A' ' 62' ' ' ILE . 2.3 pt20 -115.54 166.99 11.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 1.04 110.882 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -105.61 114.96 29.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 1.35 110.796 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 42' ' ' VAL . 3.3 m -118.06 139.13 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 2.29 111.08 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.788 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -114.64 114.44 25.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.34 111.146 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.828 HG11 HG12 ' A' ' 29' ' ' VAL . 97.2 t -87.66 121.84 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.2 111.182 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.548 HG12 HG13 ' A' ' 47' ' ' ILE . 18.1 t -107.36 116.72 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.17 111.139 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -115.76 167.18 11.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.881 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.63 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.2 p-10 -146.29 -169.52 3.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 1.74 110.89 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -59.42 -35.21 73.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 2.96 110.972 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.76 -6.83 51.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.492 . . . . 1.23 110.891 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.6 m -107.17 93.87 10.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.706 0.765 . . . . 0.16 110.881 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 54.8 Cg_endo -69.63 142.47 48.58 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.727 2.284 . . . . 0.21 112.456 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -49.2 -32.42 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.19 111.125 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.49 -52.82 43.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 3.21 110.946 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.53 -44.88 10.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.18 111.178 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.419 HD22 HG13 ' A' ' 29' ' ' VAL . 1.9 tm? -51.66 -61.72 2.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.14 110.935 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -34.61 22.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 2.31 110.9 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.11 -48.24 40.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.2 112.437 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.6 mt -61.33 -39.98 92.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.368 . . . . 0.47 110.92 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.828 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -76.23 -31.69 21.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.63 111.186 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.89 -60.03 4.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 1.66 110.851 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -40.22 72.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 1.71 110.926 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.904 HD23 HD21 ' A' ' 35' ' ' LEU . 81.2 mt -72.52 -24.65 61.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.25 110.927 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.41 -24.95 45.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.38 110.914 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.78 -30.07 17.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.23 111.104 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.904 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.42 -35.05 14.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.22 110.877 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.11 -45.47 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.25 111.137 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.26 -12.61 56.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.822 -0.704 . . . . 0.27 112.449 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -65.78 -62.72 1.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 2.6 110.858 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -96.52 -37.43 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 2.23 110.88 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.55 -129.43 4.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.784 -0.722 . . . . 0.24 112.489 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -153.4 153.04 31.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 3.79 110.835 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 12' ' ' VAL . 95.0 t -138.98 119.81 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.26 111.188 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -109.76 154.69 22.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.16 110.899 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -115.83 134.53 58.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.14 111.097 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -144.3 152.38 40.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 1.27 110.986 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -102.56 137.64 40.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.47 110.852 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.925 HD13 HG21 ' A' ' 73' ' ' THR . 11.2 mt -50.91 -46.77 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 0.4 111.208 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -24.73 63.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 3.71 110.905 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -98.22 18.52 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 3.42 110.812 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.809 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.75 -29.13 4.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 1.07 110.943 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.594 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -52.52 -36.31 55.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 2.55 110.975 179.844 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -85.86 -19.47 30.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 1.25 110.905 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.413 ' HB2' HD13 ' A' ' 50' ' ' LEU . 63.6 m -60.69 -16.69 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 0.88 110.877 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.94 63.49 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.4 111.174 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.403 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 12.5 m-70 -64.9 -70.24 0.24 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 0.39 110.846 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.706 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.13 -168.08 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 1.15 110.924 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -105.88 126.68 52.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 2.22 110.905 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.14 79.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 1.34 110.846 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.7 p -130.11 -35.33 1.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.33 110.856 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.446 ' O ' HD23 ' A' ' 87' ' ' LEU . 93.5 m-85 -98.52 122.02 41.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.094 -0.503 . . . . 2.05 110.873 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.61 -21.69 61.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 1.52 110.949 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.422 HD12 HE22 ' A' ' 10' ' ' GLN . 13.7 mt -145.67 143.46 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.42 111.155 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.832 HG21 HG23 ' A' ' 83' ' ' ILE . 18.8 mm -130.52 132.85 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.444 . . . . 0.16 111.155 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -111.7 135.2 52.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.836 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.52 98.52 4.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.766 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.64 78.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.22 112.475 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.71 54.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.358 . . . . 0.58 110.939 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.4 159.77 53.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.569 0.699 . . . . 0.21 111.128 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 116.34 4.52 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.702 2.268 . . . . 0.22 112.373 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.61 7.02 69.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.739 -0.743 . . . . 0.22 112.495 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.26 136.59 48.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.68 110.906 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.729 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.2 p -126.03 108.41 11.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.19 111.122 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.925 HG21 HD13 ' A' ' 47' ' ' ILE . 1.1 m -163.3 155.8 18.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.33 111.202 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.979 HD12 HD22 ' A' ' 147' ' ' LEU . 3.9 mt -133.55 105.8 7.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.251 -0.431 . . . . 0.22 110.983 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -79.44 150.98 31.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.24 110.903 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m -130.64 -177.46 4.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.49 110.884 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.98 68.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.38 111.078 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -47.12 86.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 2.14 110.929 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.809 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -71.9 -56.48 10.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.3 111.185 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.6 mt -50.78 -39.54 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.22 110.949 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.14 -56.88 12.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.41 111.099 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.422 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -55.97 -43.53 77.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 2.93 110.968 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.832 HG23 HG21 ' A' ' 63' ' ' ILE . 43.4 mm -55.15 -68.33 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.24 111.047 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.17 -39.75 57.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.28 111.194 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -52.84 -49.54 65.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 2.48 110.946 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 56' ' ' LYS . 40.0 pt -86.66 -5.62 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.26 111.23 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -80.13 113.36 18.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.27 110.851 179.966 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -52.8 158.49 2.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 2.45 110.863 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.404 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.3 Cg_endo -69.75 114.22 3.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.669 2.246 . . . . 0.24 112.299 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.99 3.09 54.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.829 -0.701 . . . . 0.26 112.522 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.77 -159.7 12.46 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 0.22 112.453 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.3 m -141.98 157.28 45.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.55 110.918 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.688 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.2 tm? -139.37 114.61 9.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.21 110.927 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.587 ' N ' HD22 ' A' ' 93' ' ' LEU . 73.5 m-85 -106.33 132.55 52.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.84 110.848 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.616 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.81 163.84 36.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.17 110.895 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.46 130.8 35.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 1.85 110.837 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.8 147.28 18.3 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.64 0.733 . . . . 2.16 110.915 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.464 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.4 Cg_endo -69.75 141.38 45.13 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.776 2.317 . . . . 0.22 112.329 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.39 146.95 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 0.2 111.11 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.438 ' CD ' HG21 ' A' ' 103' ' ' VAL . 52.2 mt-10 -108.97 133.04 53.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 1.97 110.844 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.0 p -92.0 -41.91 10.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 1.11 111.179 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.74 40.34 1.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.68 111.094 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.438 HG21 ' CD ' ' A' ' 100' ' ' GLU . 25.8 t -147.93 149.82 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.69 111.02 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -54.11 175.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 2.11 110.945 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.7 -63.51 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 2.32 110.89 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.41 -75.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 1.64 110.894 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.77 -168.23 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 1.67 110.826 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.467 ' HG3' HG13 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -79.9 -7.9 59.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 1.75 110.928 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.467 HG13 ' HG3' ' A' ' 108' ' ' LYS . 2.4 m -141.14 145.73 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.4 111.15 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -64.93 115.35 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 2.21 110.947 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 104' ' ' ASP . 80.8 p -86.82 178.88 6.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.29 111.145 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.76 -51.75 66.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.17 111.153 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.66 -49.41 77.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.23 110.838 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -37.56 76.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 1.88 110.931 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -64.61 -55.39 20.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.31 110.844 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.9 m -57.64 -46.2 84.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.21 110.894 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -42.85 95.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.26 110.828 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.46 -44.31 96.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.496 . . . . 0.21 111.175 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 93' ' ' LEU . 14.9 tp -64.45 -52.11 59.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.24 110.893 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.7 m -61.55 -31.62 71.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.24 111.085 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.91 -10.32 53.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 0.53 110.897 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.01 5.6 28.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 1.71 110.866 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.74 5.92 33.22 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.755 . . . . 0.48 112.436 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -105.87 170.38 7.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.28 110.985 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -150.19 170.59 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.432 . . . . 0.31 111.162 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 53.77 44.15 30.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 2.47 110.858 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.14 144.43 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.21 111.216 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 156.99 6.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 1.64 110.915 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.45 141.34 38.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 3.04 110.907 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.766 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.4 mp -99.74 -36.4 9.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.25 110.869 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -163.15 176.9 9.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 1.33 110.886 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -125.53 166.05 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 7.25 110.927 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -149.21 136.17 10.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.695 0.76 . . . . 1.38 110.895 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 154.78 67.43 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.726 2.284 . . . . 0.32 112.372 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.648 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -91.14 125.96 36.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.43 . . . . 0.31 110.932 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.417 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.36 161.37 24.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.598 0.713 . . . . 1.21 111.107 -179.991 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.417 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.2 Cg_endo -69.78 -28.49 25.09 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.661 2.241 . . . . 0.38 112.388 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.36 -17.97 35.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 2.81 110.839 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 -53.01 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 2.59 110.899 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 p -49.66 -40.61 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.24 111.095 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -34.67 76.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 1.15 110.905 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -46.12 71.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.22 110.86 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 9.0 p -68.45 -30.34 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.17 111.059 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -75.56 -32.52 60.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 2.57 110.935 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -89.56 -20.01 24.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 1.79 110.903 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -94.3 -32.74 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.3 110.884 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.979 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -128.03 -54.29 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.34 110.878 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.36 9.1 2.43 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.818 -0.706 . . . . 0.31 112.478 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.402 ' CG ' HG11 ' A' ' 109' ' ' VAL . 11.0 t-160 -70.31 121.68 18.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.64 110.901 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -151.8 105.42 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 2.62 110.864 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.6 t -160.44 169.55 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.72 110.888 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.65 -14.87 15.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 1.62 110.858 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -99.33 19.94 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 1.6 110.896 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.648 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -92.2 167.96 11.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.31 110.969 179.887 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -172.49 129.81 0.56 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.26 110.926 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.729 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.2 m-85 -70.16 135.98 49.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 1.86 110.861 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.32 148.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.25 111.183 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.766 ' HG2' HD13 ' A' ' 130' ' ' LEU . 10.5 tt0 -105.03 132.03 51.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 2.3 110.839 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.23 153.04 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.21 111.139 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.415 ' N ' HD11 ' A' ' 130' ' ' LEU . 7.8 t -139.25 152.46 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.34 111.123 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.84 140.74 10.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.19 112.49 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -97.28 139.54 33.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.732 0.301 . . . . 1.64 110.962 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 1.4 tptt -78.99 134.37 60.07 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.508 0.67 . . . . 2.37 110.899 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 118.61 5.78 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.694 2.263 . . . . 0.44 112.304 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.33 110.923 179.954 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.8 0.333 . . . . 2.41 110.839 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -122.3 24.35 9.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 2.09 110.908 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.94 38.33 46.38 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.861 -0.685 . . . . 0.44 112.471 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 7' ' ' SER . 1.7 mp -76.82 158.73 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.869 0.366 . . . . 0.45 111.129 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 36' ' ' THR . 33.7 m -147.14 158.55 43.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.506 . . . . 1.16 110.839 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.18 130.6 35.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.62 111.153 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.86 -6.12 32.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.751 -0.737 . . . . 0.49 112.479 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -106.56 168.91 8.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.778 0.323 . . . . 1.54 110.904 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.66 110.98 23.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 1.42 110.886 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.775 HG12 HG21 ' A' ' 36' ' ' THR . 2.5 p -118.99 130.52 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.129 -0.487 . . . . 2.06 111.043 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.758 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -105.97 132.72 51.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.51 . . . . 0.32 111.081 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.732 HG11 HG12 ' A' ' 29' ' ' VAL . 96.3 t -101.6 120.13 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.19 111.088 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.711 HG12 HG13 ' A' ' 47' ' ' ILE . 15.8 t -103.24 116.66 47.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.22 111.154 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -117.04 166.36 12.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.36 110.863 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.585 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.1 p-10 -144.24 -169.79 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 1.91 110.885 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.58 -35.52 74.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 3.37 110.939 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 t -73.41 -7.84 53.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 1.23 110.926 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.2 93.21 9.03 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.682 0.753 . . . . 0.31 110.886 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 143.12 50.11 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.671 2.247 . . . . 0.46 112.372 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.09 -32.47 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.35 111.096 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.19 -53.36 35.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 2.55 110.89 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.81 -44.92 10.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.4 111.046 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.12 -61.01 2.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.24 -0.436 . . . . 0.31 110.897 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -33.59 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 3.26 110.881 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.77 -49.05 38.33 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.748 -0.739 . . . . 0.37 112.473 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.701 HD12 HG13 ' A' ' 68' ' ' VAL . 21.8 mt -60.68 -40.61 92.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.867 0.365 . . . . 0.77 110.939 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.732 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -75.7 -31.36 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.64 111.132 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -61.91 -61.75 2.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 1.73 110.863 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -40.48 66.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 1.56 110.87 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.706 HD23 HD21 ' A' ' 35' ' ' LEU . 58.7 mt -72.23 -25.86 61.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.37 110.899 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.445 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.33 -23.85 46.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.41 110.898 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.97 -29.64 17.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.208 -0.451 . . . . 0.46 111.124 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.706 HD21 HD23 ' A' ' 32' ' ' LEU . 1.9 pp -91.38 -36.09 14.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.35 110.84 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.775 HG21 HG12 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -98.06 -45.92 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.42 111.176 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.74 -15.8 42.9 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.58 112.532 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.36 -62.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 2.27 110.945 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -107.02 -33.8 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 2.33 110.99 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.08 -134.54 5.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.689 -0.767 . . . . 0.34 112.481 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -154.15 152.3 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 3.63 110.937 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.9 t -136.32 123.71 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.25 111.12 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.4 t -113.22 153.85 27.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 0.16 110.834 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.97 132.41 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.16 111.22 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -142.25 152.46 43.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 1.31 110.925 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -102.7 137.49 40.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.53 110.887 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.04 HD13 HG21 ' A' ' 73' ' ' THR . 12.5 mt -52.46 -43.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.51 111.214 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -24.16 61.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 3.69 110.867 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -98.02 16.54 20.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 3.37 110.963 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.852 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -49.42 -28.15 4.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.465 . . . . 1.12 110.899 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -49.89 -44.11 49.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.18 110.995 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -85.82 -14.77 44.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 1.34 110.865 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.482 ' HB3' HD13 ' A' ' 50' ' ' LEU . 23.8 t -60.44 -15.39 26.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 2.04 110.844 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.628 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -75.17 52.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.46 111.126 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -50.85 -71.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.5 110.893 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.644 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.38 -168.32 2.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 1.89 110.813 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -108.46 130.17 55.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.123 -0.489 . . . . 1.73 110.967 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.8 72.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 1.17 110.895 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.5 p -126.76 -33.72 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 0.29 110.784 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 96.7 m-85 -99.3 118.4 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 1.45 110.868 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.37 -20.2 62.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.497 . . . . 1.52 110.879 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 mt -145.88 144.41 20.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.22 111.126 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.784 HG21 HG23 ' A' ' 83' ' ' ILE . 21.3 mm -137.29 130.22 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.2 111.134 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -111.47 137.63 49.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.2 110.894 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -129.52 97.56 4.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.3 110.889 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.65 73.68 0.35 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.745 -0.74 . . . . 0.4 112.465 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.694 HD13 ' OE1' ' A' ' 158' ' ' GLN . 3.9 mm? -95.54 -19.35 19.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 2.12 110.884 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.701 HG13 HD12 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -48.34 152.59 1.52 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 0.74 111.125 179.792 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.9 123.52 10.13 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.638 2.225 . . . . 0.66 112.33 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.72 0.21 75.78 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.58 112.454 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.565 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -54.61 146.66 16.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.984 0.421 . . . . 1.32 110.866 -179.749 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.711 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 18.3 p -137.02 109.07 7.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.39 111.114 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 1.04 HG21 HD13 ' A' ' 47' ' ' ILE . 2.3 m -162.28 140.06 8.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 0.66 111.164 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.092 HD12 HD22 ' A' ' 147' ' ' LEU . 15.8 mt -113.65 105.96 13.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.59 110.912 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -79.63 151.06 30.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.34 110.806 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.8 m -130.94 -177.15 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.41 110.831 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.01 69.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.44 111.096 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -47.78 84.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 2.46 110.933 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.852 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -70.82 -56.59 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.23 111.15 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.0 mt -50.95 -39.18 54.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.29 110.907 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.95 -56.87 13.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.4 111.089 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.628 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -57.02 -41.87 79.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 2.48 110.897 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.784 HG23 HG21 ' A' ' 63' ' ' ILE . 37.2 mm -56.6 -68.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.22 111.134 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.45 -38.23 42.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.26 111.117 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.59 -56.07 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 2.31 110.893 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 56' ' ' LYS . 34.2 pt -77.42 -8.22 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.25 111.062 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -79.24 127.27 31.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.45 110.971 179.886 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -66.54 159.99 69.99 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 2.34 110.916 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 114.15 3.62 Favored 'Trans proline' 0 C--N 1.34 0.082 0 C-N-CA 122.632 2.221 . . . . 0.16 112.356 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.05 1.98 55.98 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.17 112.51 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.78 -164.03 11.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.636 -0.792 . . . . 0.14 112.519 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 60.0 m -135.47 152.3 51.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.31 110.863 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.714 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.0 112.24 9.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.19 110.903 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.515 ' N ' HD22 ' A' ' 93' ' ' LEU . 48.0 m-85 -106.44 133.62 50.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 1.65 110.828 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -148.58 158.78 44.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.23 110.955 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.79 125.62 34.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 2.35 110.97 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.569 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -148.43 146.05 21.79 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 2.24 110.864 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.61 140.04 42.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.718 2.279 . . . . 0.22 112.392 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.417 HG13 HG23 ' A' ' 157' ' ' VAL . 9.1 m -126.71 146.76 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.28 111.103 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.405 ' OE2' HG21 ' A' ' 103' ' ' VAL . 0.9 OUTLIER -113.79 132.38 55.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 3.62 110.875 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.0 p -104.29 26.15 9.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 1.2 111.134 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -146.68 23.11 1.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.53 111.119 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.462 HG11 ' OG ' ' A' ' 107' ' ' SER . 3.8 t -145.02 159.45 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.74 111.127 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.571 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -52.04 169.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 1.91 110.809 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -64.25 -49.73 70.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 2.21 110.987 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -72.62 -75.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 2.41 110.93 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.462 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.5 t 52.0 -169.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 2.32 110.8 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.41 -3.23 48.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 1.65 110.948 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.2 141.14 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.47 111.116 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 114.17 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 2.22 110.846 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.571 HG21 ' O ' ' A' ' 104' ' ' ASP . 44.0 p -83.55 177.61 8.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.2 111.125 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.95 -53.93 49.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.17 111.041 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -49.68 76.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.441 . . . . 0.22 110.903 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -56.29 -40.22 73.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 1.69 110.806 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -63.75 -55.04 26.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.31 110.954 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -57.58 -46.27 84.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.26 110.865 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.425 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -64.42 -42.96 95.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.3 110.883 -179.764 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.74 92.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.26 111.137 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.617 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.7 tp -62.7 -52.83 61.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.26 110.901 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.8 m -61.8 -35.52 78.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.27 111.147 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 117' ' ' SER . 17.3 mt -81.59 -10.4 59.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.56 110.919 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.83 5.19 29.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 1.75 110.842 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.21 -2.47 35.07 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.772 -0.728 . . . . 0.51 112.465 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -96.13 169.87 9.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.815 0.341 . . . . 0.28 110.98 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.429 HG23 ' HG3' ' A' ' 126' ' ' GLU . 29.0 m -151.05 171.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.32 111.128 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 125' ' ' VAL . 2.9 mt-10 56.93 43.61 24.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 2.03 110.905 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.4 t -75.19 142.83 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.39 111.128 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.63 156.38 6.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 1.73 110.938 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -82.17 145.36 30.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 2.13 110.874 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.431 HD11 ' N ' ' A' ' 160' ' ' THR . 1.5 mp -105.76 -35.22 7.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.28 110.95 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.601 ' NE2' HE21 ' A' ' 158' ' ' GLN . 0.7 OUTLIER -166.17 176.64 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 1.31 110.906 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -125.41 166.12 17.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 8.3 110.875 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -146.91 134.22 10.22 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.684 0.754 . . . . 1.52 110.876 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 157.56 60.07 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.629 2.219 . . . . 0.44 112.369 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.679 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -94.46 129.59 41.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.38 110.95 179.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.592 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -112.68 162.74 20.21 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.52 0.676 . . . . 1.39 111.151 179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 -22.66 32.24 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.642 2.228 . . . . 0.63 112.397 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -85.03 -25.76 27.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 2.64 110.964 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -88.58 -52.73 5.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.111 -0.495 . . . . 2.63 110.794 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -49.77 -39.05 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.48 111.101 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.08 -33.86 75.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 1.2 110.941 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -46.6 67.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.951 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.683 HG23 HD13 ' A' ' 147' ' ' LEU . 8.8 p -68.11 -30.86 49.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.21 111.11 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -76.87 -29.99 56.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 2.06 110.92 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -89.64 -21.6 22.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 1.97 110.884 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -95.03 -32.17 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.39 110.804 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.092 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -127.04 -54.49 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.52 110.857 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.58 14.17 2.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.52 112.543 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -70.76 121.29 17.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.793 0.33 . . . . 0.85 110.812 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -152.17 105.36 3.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 2.54 110.863 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.74 172.16 17.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.63 110.816 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.71 -17.27 14.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 1.88 110.917 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -96.89 20.32 11.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 1.61 110.859 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.679 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -93.53 162.67 13.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.37 110.923 179.957 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.632 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -171.2 130.65 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.36 110.933 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.711 ' CZ ' HG22 ' A' ' 72' ' ' THR . 25.3 m-85 -70.33 135.28 48.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 1.7 110.885 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.417 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.19 142.47 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.36 111.155 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.694 ' OE1' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -101.09 127.37 47.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 2.09 110.894 -179.981 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.33 151.48 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.426 . . . . 0.27 111.188 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.431 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -130.43 154.59 47.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.222 -0.445 . . . . 0.3 111.107 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.431 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -142.89 131.39 4.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.755 -0.736 . . . . 0.19 112.467 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -91.63 131.63 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 3.59 110.918 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.81 135.44 77.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 1.65 110.963 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 131.47 21.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.731 2.288 . . . . 0.47 112.365 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.44 110.824 -179.946 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.845 0.355 . . . . 1.96 110.901 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 6' ' ' ILE . 9.8 m-85 -122.34 16.95 10.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 1.54 110.767 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.74 39.14 96.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.36 112.439 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.814 HD13 HD21 ' A' ' 32' ' ' LEU . 1.6 mp -80.89 156.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.884 0.373 . . . . 0.37 111.128 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.73 161.38 38.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 1.66 110.879 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.54 134.9 33.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.38 111.088 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.64 -1.66 30.61 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.719 -0.753 . . . . 0.26 112.501 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -117.14 173.26 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 1.13 110.868 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.4 116.3 31.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.34 110.919 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG22 ' HB ' ' A' ' 62' ' ' ILE . 97.3 t -119.58 129.38 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 1.94 111.124 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.778 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -107.33 126.41 52.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.24 111.122 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.74 HG11 HG12 ' A' ' 29' ' ' VAL . 98.1 t -98.9 119.41 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.2 111.094 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -102.31 117.58 47.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.18 111.108 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -118.02 169.91 9.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.438 . . . . 0.23 110.9 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.408 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 9.6 p-10 -151.65 -169.87 3.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 1.74 110.837 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -58.21 -35.55 71.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 3.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.9 -8.15 55.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 1.24 110.873 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.71 95.25 11.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.651 0.739 . . . . 0.19 110.873 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 141.57 45.27 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.628 2.219 . . . . 0.33 112.326 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.02 -32.84 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.31 111.154 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -50.98 -52.8 38.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 2.4 110.903 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.6 11.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.29 111.085 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.447 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -52.6 -61.69 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.21 110.99 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -36.57 27.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 2.25 110.962 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.75 49.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.21 112.534 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.6 mt -61.55 -39.97 93.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.64 110.918 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 HG11 ' A' ' 14' ' ' VAL . 17.1 m -76.9 -30.71 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.64 111.18 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.82 -59.84 4.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 1.63 110.909 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -40.08 70.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 1.91 110.881 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.919 HD23 HD21 ' A' ' 35' ' ' LEU . 85.8 mt -73.27 -25.7 60.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.27 110.825 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.624 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.0 mt-30 -77.1 -24.06 51.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.309 -0.405 . . . . 0.42 110.935 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.13 -32.22 15.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.27 111.133 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.919 HD21 HD23 ' A' ' 32' ' ' LEU . 1.7 pp -88.31 -36.51 16.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.3 110.87 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -96.64 -47.09 6.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.47 111.11 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.34 -15.58 45.91 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.753 -0.737 . . . . 0.48 112.523 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -56.07 -62.59 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 1.93 110.898 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -107.19 -33.26 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 2.71 110.88 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.22 -131.52 4.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.3 112.522 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -156.35 153.08 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 3.92 110.798 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 33' ' ' GLN . 97.7 t -134.93 126.51 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.25 111.169 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.8 t -116.5 152.62 33.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.28 110.827 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.03 131.77 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.19 111.069 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -139.23 150.97 46.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 1.38 110.87 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -103.44 135.18 45.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.4 110.876 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.681 ' CD1' HG21 ' A' ' 73' ' ' THR . 36.4 mt -53.69 -34.18 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.09 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -31.7 63.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 2.23 110.937 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -100.84 19.7 16.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 3.7 110.893 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.821 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.26 -26.94 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 1.08 110.885 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.26 -38.49 58.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.226 -0.443 . . . . 1.06 110.911 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -84.5 -14.36 49.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.169 -0.469 . . . . 1.08 110.906 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.654 ' HB3' HD13 ' A' ' 50' ' ' LEU . 19.6 t -60.08 -15.19 21.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 2.2 110.805 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.405 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -75.17 53.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.44 111.111 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -53.56 -70.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.65 110.922 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.673 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.68 -168.26 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 1.08 110.888 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -107.74 129.87 55.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 1.73 110.901 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.19 75.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 1.25 110.88 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.0 p -129.65 -34.15 1.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.22 110.843 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.6 m-85 -99.73 118.06 35.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 1.44 110.842 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.07 -20.08 64.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 1.48 110.857 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.685 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.8 mt -147.8 143.6 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.23 111.134 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.861 HG21 HG23 ' A' ' 83' ' ' ILE . 18.5 mm -133.92 132.69 56.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.14 111.162 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.6 mm? -113.8 137.64 51.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.19 110.847 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.23 98.35 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.16 110.814 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.59 74.41 0.29 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.818 -0.706 . . . . 0.18 112.469 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.45 61.41 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.352 . . . . 0.58 110.883 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.444 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -129.34 159.93 66.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 0.34 111.204 179.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 115.82 4.26 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.66 2.24 . . . . 0.32 112.409 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.71 7.65 68.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 0.22 112.51 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.4 150.93 10.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.73 110.858 -179.729 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.764 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 36.1 p -139.72 108.18 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.23 111.196 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.681 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.51 156.18 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.29 111.126 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.002 HD12 HD22 ' A' ' 147' ' ' LEU . 5.7 mt -133.85 109.6 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.24 110.844 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -86.51 153.92 21.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.28 110.869 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 m -131.78 -175.75 3.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.39 110.766 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.16 -36.54 70.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.27 111.031 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.39 -45.94 88.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 2.08 110.899 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.821 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -73.02 -55.27 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.23 111.146 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 119' ' ' LEU . 65.7 mt -50.33 -44.8 54.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.28 110.874 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.59 -53.8 34.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.39 111.012 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -55.32 -43.37 74.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 2.88 110.904 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.861 HG23 HG21 ' A' ' 63' ' ' ILE . 41.9 mm -57.12 -67.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.25 111.168 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.05 -36.58 40.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.24 111.132 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.2 tpp85 -56.74 -50.67 71.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 2.5 110.846 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 56' ' ' LYS . 37.2 pt -84.29 -6.02 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.19 111.12 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -81.14 123.34 28.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.29 110.926 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -61.85 159.08 38.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 3.19 110.869 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.407 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.7 Cg_endo -69.76 114.2 3.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.688 2.259 . . . . 0.2 112.326 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.74 4.28 54.64 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.71 -0.757 . . . . 0.23 112.496 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.72 -164.31 22.79 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.787 -0.72 . . . . 0.18 112.485 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 53.8 m -136.25 151.06 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.808 0.337 . . . . 0.37 110.86 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 94' ' ' PHE . 2.1 tm? -134.02 127.45 32.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.175 -0.466 . . . . 0.48 110.94 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.602 ' N ' HD22 ' A' ' 93' ' ' LEU . 59.2 m-85 -122.72 133.54 54.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 1.85 110.872 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -148.65 163.69 36.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.47 . . . . 0.23 110.913 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.02 129.87 30.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 2.79 110.972 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.88 148.59 19.63 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.742 0.782 . . . . 3.63 110.873 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 136.51 33.23 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.645 2.23 . . . . 0.31 112.382 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 157' ' ' VAL . 11.9 m -120.66 146.83 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.2 111.202 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.44 ' CD ' HG21 ' A' ' 103' ' ' VAL . 62.2 mt-10 -110.48 132.97 53.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.92 110.901 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.0 p -91.41 -40.7 11.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 1.25 111.135 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.52 38.28 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.56 111.166 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.44 HG21 ' CD ' ' A' ' 100' ' ' GLU . 22.0 t -147.53 149.92 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.64 111.121 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.634 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -53.31 173.05 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 1.82 110.793 179.888 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -67.15 -53.37 31.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.167 -0.47 . . . . 2.92 110.94 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -75.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 1.91 110.862 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.67 -169.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 1.52 110.894 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.691 ' HG3' HG13 ' A' ' 109' ' ' VAL . 17.0 pttt -80.51 -4.86 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 3.15 110.922 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.691 HG13 ' HG3' ' A' ' 108' ' ' LYS . 2.7 m -139.92 148.21 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.4 111.16 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.443 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.5 tppt? -69.14 115.06 7.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 2.2 110.875 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.634 HG21 ' O ' ' A' ' 104' ' ' ASP . 48.7 p -87.83 -178.33 6.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.33 111.153 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.78 64.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.32 111.151 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.27 -49.46 77.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.46 110.854 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.56 -43.21 71.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 1.87 110.883 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.499 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -61.8 -55.74 26.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.54 110.975 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.9 m -55.3 -46.81 76.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.27 110.894 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -44.23 94.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.46 110.892 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 80' ' ' LEU . . . -62.21 -49.81 74.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.42 111.106 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.603 ' HA ' HD13 ' A' ' 80' ' ' LEU . 12.8 tp -57.55 -52.46 65.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.3 110.923 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 92.0 m -64.21 -29.04 70.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.3 111.198 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.1 mt -81.11 -16.27 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.8 110.835 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 p -82.32 3.2 28.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 2.62 110.859 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.46 -4.94 35.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.804 -0.712 . . . . 0.86 112.502 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -83.97 169.02 15.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.31 110.927 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.52 170.25 2.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.37 111.126 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 53.4 44.48 29.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 2.23 110.956 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.8 142.54 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.29 111.109 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.15 160.04 7.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 1.79 110.868 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.86 140.73 36.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 2.87 110.956 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.746 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.4 mp -98.6 -37.28 9.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.31 110.926 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -163.16 176.78 9.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 1.38 110.917 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.1 mtt-85 -125.63 167.01 15.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 8.44 110.875 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -149.7 134.22 9.23 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.662 0.744 . . . . 1.81 110.898 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 156.54 63.08 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.269 . . . . 0.35 112.38 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.67 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -89.6 154.1 20.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.71 110.92 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.601 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -138.07 163.28 48.87 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.56 0.695 . . . . 1.6 111.111 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 136' ' ' THR . 53.2 Cg_endo -69.78 -23.75 30.37 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.706 2.271 . . . . 0.47 112.32 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -85.66 -24.66 26.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 3.99 110.954 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -88.13 -53.85 4.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 4.08 110.931 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 136' ' ' THR . 7.1 p -50.59 -39.15 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.23 111.112 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.02 -34.03 75.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 1.24 110.916 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -46.48 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.29 110.854 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.696 HG23 HD13 ' A' ' 147' ' ' LEU . 8.6 p -67.73 -30.95 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.19 111.131 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -77.22 -29.97 54.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 2.16 110.866 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -89.37 -21.85 22.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 1.82 110.813 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -95.04 -31.97 13.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.814 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.002 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -127.25 -54.67 1.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.36 110.87 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.93 13.09 2.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.771 . . . . 0.37 112.437 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.404 ' CG ' HG11 ' A' ' 109' ' ' VAL . 15.5 t-160 -70.55 122.23 19.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.61 110.803 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -151.38 105.57 3.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 2.92 110.924 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t -158.35 171.28 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.58 110.86 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.09 -17.12 14.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 2.01 110.786 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -99.28 21.29 12.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.299 -0.41 . . . . 1.65 110.866 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -90.4 166.14 13.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.45 . . . . 0.27 111.016 179.928 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.67 ' HA ' HD23 ' A' ' 135' ' ' LEU . 2.7 tm? -172.03 130.31 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.2 110.841 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.764 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.1 m-85 -72.6 133.74 44.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 1.74 110.87 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.407 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.07 157.19 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.37 111.068 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.746 ' HG2' HD13 ' A' ' 130' ' ' LEU . 10.5 tt0 -113.57 133.56 55.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 2.2 110.905 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.94 152.32 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.24 111.132 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.431 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.7 t -136.29 163.62 29.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.26 111.172 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.98 136.76 5.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.753 -0.737 . . . . 0.21 112.491 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -94.92 142.67 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 1.78 110.925 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 13.4 tptm -82.8 135.55 45.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.574 0.702 . . . . 1.82 110.935 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 118.89 5.95 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.727 2.285 . . . . 0.46 112.41 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.62 110.878 -179.923 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.761 0.315 . . . . 2.37 110.857 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.472 ' HB2' HD11 ' A' ' 6' ' ' ILE . 12.4 m-85 -122.14 24.31 9.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 2.08 110.899 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.45 44.54 53.25 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.81 -0.709 . . . . 0.51 112.426 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -88.53 163.55 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.784 0.326 . . . . 0.5 111.17 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.628 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -151.22 163.6 38.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 1.47 110.811 -179.947 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.33 134.31 34.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.34 111.086 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.52 2.41 32.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.28 112.439 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.43 172.42 7.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.806 0.336 . . . . 1.04 110.955 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.18 114.29 28.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 2.14 110.891 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.632 HG22 ' HB ' ' A' ' 62' ' ' ILE . 92.6 t -117.06 133.9 62.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 1.87 111.101 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.758 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -111.45 125.91 54.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.21 111.092 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.691 HG11 HG12 ' A' ' 29' ' ' VAL . 95.2 t -98.04 122.22 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.2 111.223 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.422 HG12 ' CG1' ' A' ' 47' ' ' ILE . 18.7 t -105.93 114.83 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.21 111.169 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -115.58 168.93 9.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.17 110.956 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -151.08 -170.34 3.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 1.9 110.82 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -57.0 -35.89 69.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 3.63 110.912 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -73.14 -10.38 59.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 1.71 110.839 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.61 93.41 10.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.683 0.754 . . . . 0.24 110.851 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.7 143.11 50.06 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.615 2.21 . . . . 0.36 112.38 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.0 t -48.96 -32.08 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.25 111.061 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.62 -53.69 35.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 2.33 110.888 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB1' HG12 ' A' ' 68' ' ' VAL . . . -87.69 -44.7 10.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.33 111.114 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -50.18 -59.58 3.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.28 110.904 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -48.26 -32.84 7.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 4.79 110.868 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.37 -46.41 33.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 0.54 112.48 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.642 HD12 HG13 ' A' ' 68' ' ' VAL . 14.0 mt -61.96 -35.63 79.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 1.37 110.903 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.691 HG12 HG11 ' A' ' 14' ' ' VAL . 22.0 m -80.93 -32.94 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.64 111.109 179.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -61.6 -54.61 40.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 1.68 110.904 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.499 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -57.19 -36.89 71.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 2.52 110.836 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.706 HD23 HD21 ' A' ' 35' ' ' LEU . 60.1 mt -76.9 -25.01 52.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.91 110.96 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.579 ' HA ' HG21 ' A' ' 42' ' ' VAL . 4.8 mt-30 -78.18 -26.13 47.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.49 110.927 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.52 -31.67 15.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.52 111.105 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.706 HD21 HD23 ' A' ' 32' ' ' LEU . 1.3 pp -89.36 -35.86 15.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.59 110.985 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.7 -47.16 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.28 111.101 179.97 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.91 -15.36 42.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.769 -0.729 . . . . 0.36 112.495 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.06 -62.85 1.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.331 . . . . 1.84 110.846 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -105.82 -34.77 7.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 2.76 110.817 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.5 -127.3 2.14 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.822 -0.704 . . . . 0.29 112.493 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -157.52 151.27 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 3.84 110.782 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 33' ' ' GLN . 88.3 t -136.24 120.13 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.31 111.167 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.7 t -110.34 155.44 22.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.15 110.879 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.47 134.7 61.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.15 111.139 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -143.46 151.83 40.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 1.3 110.932 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -103.01 135.98 43.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.44 110.812 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.665 ' CD1' HG21 ' A' ' 73' ' ' THR . 25.3 mt -52.17 -35.31 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.25 111.102 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -74.96 -29.24 60.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 1.97 110.905 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -99.5 18.49 17.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 3.4 110.908 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.83 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.56 -30.47 5.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 1.13 110.901 -179.981 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mp -54.32 -37.35 64.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 1.07 110.882 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -84.82 -15.52 44.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 1.08 110.864 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.9 m -66.63 -10.37 45.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.95 110.894 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.02 63.47 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.28 111.091 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -62.03 -69.34 0.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.35 110.795 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.66 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -153.38 -175.76 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 2.17 110.903 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -93.84 135.12 35.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 1.94 110.917 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p 46.42 82.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.423 . . . . 1.12 110.87 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.3 p -133.57 -38.35 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.3 110.893 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.479 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.0 m-85 -102.0 122.72 44.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 1.44 110.821 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.87 -23.19 62.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 1.5 110.841 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 12' ' ' VAL . 19.4 mt -145.04 143.02 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.27 111.108 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.773 HG21 HG23 ' A' ' 83' ' ' ILE . 20.3 mm -132.75 133.74 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.16 111.097 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -114.21 135.94 53.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.21 110.943 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.32 97.47 4.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.29 110.894 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.15 73.28 0.38 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.719 -0.753 . . . . 0.39 112.554 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.417 HD11 ' HB3' ' A' ' 94' ' ' PHE . 4.1 mm? -93.97 -19.14 21.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 2.16 110.971 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.768 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.2 OUTLIER -47.54 151.12 1.51 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.659 0.742 . . . . 0.69 111.113 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 135.38 30.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.657 2.238 . . . . 0.71 112.298 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.92 1.4 78.78 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.702 -0.761 . . . . 0.38 112.437 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.768 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -54.62 154.63 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.991 0.424 . . . . 1.37 110.815 -179.739 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.733 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.4 p -140.86 109.4 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.16 111.106 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.665 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -160.72 154.19 22.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.23 111.241 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.996 HD12 HD22 ' A' ' 147' ' ' LEU . 6.3 mt -130.93 107.35 9.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 0.23 110.896 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -84.2 153.88 23.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.893 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.3 m -131.8 -176.15 3.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.39 110.845 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.68 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.28 111.171 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -62.52 -45.99 90.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 2.08 110.884 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.83 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -73.7 -54.96 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.23 111.109 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 119' ' ' LEU . 59.9 mt -50.66 -41.12 55.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.23 110.898 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.0 -54.86 24.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.3 111.139 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.45 -43.33 83.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 2.38 110.936 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.773 HG23 HG21 ' A' ' 63' ' ' ILE . 43.2 mm -56.24 -68.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.19 111.202 179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.91 -36.66 39.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 0.21 111.152 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -56.24 -51.76 66.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 2.06 110.871 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 56' ' ' LYS . 25.8 pt -83.13 -6.62 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.2 111.093 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -79.13 112.88 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.34 110.932 179.879 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -51.82 159.51 1.33 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.662 0.744 . . . . 2.24 110.791 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.61 114.59 3.73 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.666 2.244 . . . . 0.2 112.413 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.35 3.65 56.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.68 -0.772 . . . . 0.14 112.479 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.16 -157.97 8.9 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.767 -0.73 . . . . 0.13 112.545 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.5 m -144.2 156.07 44.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.365 . . . . 0.45 110.874 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.681 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.5 112.74 8.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.25 110.949 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.549 ' N ' HD22 ' A' ' 93' ' ' LEU . 45.5 m-85 -105.42 133.01 50.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 1.7 110.842 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.615 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.5 164.15 35.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.17 110.904 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.23 123.94 19.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 2.53 110.82 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.61 150.93 45.26 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 3.64 110.946 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.603 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.5 Cg_endo -69.83 138.21 37.06 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.641 2.227 . . . . 0.22 112.365 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.2 m -122.31 147.28 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.29 111.061 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.423 ' OE2' HG21 ' A' ' 103' ' ' VAL . 13.2 mt-10 -114.76 132.59 56.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 1.98 110.859 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.7 p -104.4 25.98 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 1.1 111.093 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.68 23.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.71 111.053 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.423 HG21 ' OE2' ' A' ' 100' ' ' GLU . 3.4 t -144.4 160.47 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.72 111.19 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.587 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -55.94 179.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 1.93 110.854 -179.989 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.07 -60.42 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 1.94 110.808 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -64.61 -75.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 2.28 110.886 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.93 -168.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 1.58 110.878 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -5.0 55.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 1.92 110.972 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.06 140.43 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.6 111.17 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.584 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -61.54 119.15 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 2.22 110.944 179.841 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.587 HG21 ' O ' ' A' ' 104' ' ' ASP . 49.0 p -89.07 175.31 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.26 111.195 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.55 -55.13 38.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.25 111.123 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -61.05 -47.96 83.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.43 110.865 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -58.1 -40.96 82.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 1.69 110.864 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.5 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -62.96 -57.37 10.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 0.42 110.863 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 61.9 m -51.72 -44.71 63.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.3 110.945 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -42.12 85.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.35 110.914 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.74 97.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.24 111.073 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 93' ' ' LEU . 14.7 tp -66.36 -51.74 54.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.27 110.92 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -62.39 -32.23 73.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.31 111.146 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.09 -10.73 52.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.72 110.889 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.34 4.62 30.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 1.7 110.855 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.47 10.0 28.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.784 -0.722 . . . . 0.53 112.45 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -110.3 171.63 7.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.3 110.946 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 m -150.01 173.04 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.27 111.088 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 51.73 44.92 28.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 2.06 110.927 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.417 HG13 HD23 ' A' ' 119' ' ' LEU . 96.5 t -81.6 141.73 14.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.22 111.131 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 159.07 7.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.116 -0.493 . . . . 1.87 110.983 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.22 139.72 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 3.38 110.959 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.752 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.2 mp -95.84 -38.17 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.23 110.945 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.7 pm0 -157.68 176.37 12.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.452 . . . . 2.99 110.926 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.726 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.7 tmt_? -128.1 138.08 52.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 4.33 110.829 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -124.3 136.38 27.61 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.683 0.754 . . . . 1.38 110.853 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 164.75 33.4 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.743 2.295 . . . . 0.25 112.291 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -97.61 125.71 42.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.3 110.9 179.993 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.0 161.34 23.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.528 0.68 . . . . 1.56 111.108 -179.976 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -24.08 29.94 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.628 2.219 . . . . 0.46 112.382 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -85.08 -22.26 29.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 2.6 110.944 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -87.76 -54.6 4.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 2.38 110.832 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 136' ' ' THR . 7.7 p -49.03 -39.12 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.34 111.116 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -37.86 80.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 2.78 110.865 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -46.91 75.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.32 110.888 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.682 HG23 HD13 ' A' ' 147' ' ' LEU . 10.8 p -67.37 -30.67 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 0.27 111.131 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -75.95 -30.63 58.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 3.55 110.864 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -90.06 -20.51 23.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 1.89 110.887 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.5 -32.69 13.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.34 110.871 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.996 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.9 -53.86 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.49 110.982 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.79 15.21 1.97 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.776 -0.726 . . . . 0.47 112.541 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -70.92 121.69 18.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.768 0.318 . . . . 0.98 110.891 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -152.11 105.53 3.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 2.34 110.833 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -160.66 175.79 12.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.76 110.777 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.24 -21.89 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 1.72 110.842 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -91.4 13.29 17.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 1.54 110.965 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.664 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.54 164.63 21.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.42 110.89 179.923 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.5 tm? -173.72 130.09 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.2 110.902 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.733 ' CZ ' HG22 ' A' ' 72' ' ' THR . 27.1 m-85 -76.08 137.99 40.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 1.72 110.925 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -150.45 150.06 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.26 111.128 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.752 ' HG2' HD13 ' A' ' 130' ' ' LEU . 11.3 tt0 -103.49 133.91 47.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 2.16 110.896 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.43 147.35 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.28 111.126 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.513 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.4 t -132.63 148.97 52.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.48 111.024 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.99 135.4 7.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.71 -0.757 . . . . 0.14 112.519 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -90.89 140.09 30.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 1.74 110.836 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 135.04 51.38 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 1.24 110.872 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 124.03 10.67 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.644 2.229 . . . . 0.29 112.38 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.33 110.942 179.995 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.915 0.388 . . . . 2.15 110.865 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.27 21.55 10.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 2.02 110.912 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.67 38.91 59.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.721 . . . . 0.29 112.502 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.467 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.8 mp -76.97 158.12 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.28 111.126 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 36' ' ' THR . 18.5 m -149.62 157.02 42.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.177 -0.465 . . . . 1.05 110.8 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.53 125.59 33.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.35 111.063 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.95 -6.2 23.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 0.31 112.53 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.05 167.57 10.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.758 0.313 . . . . 1.5 110.917 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.66 136.33 39.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 1.3 110.841 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.536 HG12 HG21 ' A' ' 36' ' ' THR . 1.8 p -141.03 136.89 34.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 2.14 111.087 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.745 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -112.3 124.14 51.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.23 111.159 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.85 HG11 HG12 ' A' ' 29' ' ' VAL . 65.7 t -94.69 116.97 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.2 111.121 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.531 HG12 ' CG1' ' A' ' 47' ' ' ILE . 14.5 t -101.31 112.05 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.22 111.15 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -114.52 165.85 12.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.23 110.967 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HB3' HD12 ' A' ' 47' ' ' ILE . 10.3 p-10 -147.36 -170.54 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.305 -0.407 . . . . 1.87 110.916 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -56.95 -35.94 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 4.09 110.815 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -72.61 -9.31 58.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.3 110.804 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.16 94.04 10.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.703 0.763 . . . . 0.15 110.838 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.3 47.64 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.691 2.261 . . . . 0.21 112.335 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.9 t -48.74 -32.94 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.21 111.149 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.84 -53.06 35.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 2.52 110.874 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.57 -44.88 10.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.18 111.095 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.464 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -51.96 -61.7 2.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.15 110.81 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.72 -36.76 26.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 2.59 110.89 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.38 -47.75 49.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.74 . . . . 0.21 112.478 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 mt -61.72 -40.44 95.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 0.49 110.921 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.85 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -75.92 -31.68 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.65 111.087 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.92 -60.46 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 1.7 110.916 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -40.16 71.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 1.73 110.802 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.909 HD23 HD21 ' A' ' 35' ' ' LEU . 77.2 mt -72.7 -24.69 61.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.25 110.935 179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.475 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.47 -24.96 45.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.39 110.927 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.72 -29.93 17.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.22 111.093 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.909 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.61 -35.23 14.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.22 110.873 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.536 HG21 HG12 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -102.46 -44.9 5.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 0.23 111.053 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.97 -11.18 54.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.793 -0.718 . . . . 0.25 112.512 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.3 -62.44 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.685 0.278 . . . . 2.96 110.775 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -91.41 -40.08 11.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 2.25 110.915 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.92 -125.86 4.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.756 -0.735 . . . . 0.27 112.49 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -156.37 152.88 28.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.885 0.374 . . . . 2.16 110.846 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 33' ' ' GLN . 92.3 t -136.91 127.96 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.23 111.104 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.4 t -116.93 152.91 33.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.19 110.823 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.69 132.28 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.23 111.197 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -143.54 152.0 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 1.28 110.905 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -102.38 137.78 40.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.44 110.886 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.784 HD13 HG21 ' A' ' 73' ' ' THR . 36.8 mt -52.65 -36.74 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.27 111.095 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -75.7 -25.18 56.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 2.03 110.862 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -103.89 16.15 27.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 3.37 110.981 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.885 HD13 HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -52.49 -24.72 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 2.74 110.91 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -51.16 -38.96 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.902 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -84.91 -14.2 48.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 1.37 110.907 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.463 ' O ' HG21 ' A' ' 86' ' ' ILE . 19.4 t -58.97 -15.46 13.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 2.4 110.795 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -74.63 53.18 0.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.56 111.168 179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -51.14 -72.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.35 110.865 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.505 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.83 -168.24 2.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 1.62 110.926 179.984 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -100.5 121.09 41.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 2.14 110.944 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.05 84.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.41 110.842 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 p -132.59 -36.84 1.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.28 110.854 -179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.465 ' CD2' HD12 ' A' ' 86' ' ' ILE . 98.1 m-85 -96.03 120.4 36.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 1.46 110.878 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.39 -20.48 61.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 1.77 110.9 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 6' ' ' ILE . 11.1 mt -143.51 144.28 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.3 111.071 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.014 HG21 HG23 ' A' ' 83' ' ' ILE . 20.9 mm -136.13 126.11 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.14 111.189 179.794 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.5 mm? -108.85 137.41 46.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.25 111.001 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.62 99.75 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.14 110.869 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.48 78.93 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.655 -0.783 . . . . 0.18 112.478 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.04 58.07 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 0.58 110.867 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -128.09 159.75 65.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.676 0.751 . . . . 0.24 111.124 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.74 115.63 4.18 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.738 2.292 . . . . 0.27 112.294 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.69 6.32 65.83 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.679 -0.772 . . . . 0.2 112.515 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.43 150.21 12.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.79 110.804 -179.69 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.727 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 22.0 p -140.3 108.86 5.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.22 111.062 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.784 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.16 144.18 9.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.29 111.162 179.989 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.009 HD12 HD22 ' A' ' 147' ' ' LEU . 10.4 mt -120.68 99.63 6.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 0.38 111.032 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -75.69 137.55 40.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.4 110.785 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.437 ' H ' HD13 ' A' ' 79' ' ' ILE . 68.0 m -116.99 178.45 4.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.42 110.884 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.57 -44.12 62.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.31 111.059 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.28 -47.75 77.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 1.87 110.912 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.885 HG23 HD13 ' A' ' 50' ' ' LEU . 4.2 mp -69.79 -56.53 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.23 111.17 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.716 HD13 ' HA ' ' A' ' 119' ' ' LEU . 69.4 mt -50.23 -40.45 47.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.21 110.953 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.93 -57.04 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.29 111.177 179.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -53.69 -43.09 68.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 2.83 110.903 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.014 HG23 HG21 ' A' ' 63' ' ' ILE . 41.7 mm -57.47 -68.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.118 -0.492 . . . . 0.19 111.051 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -50.3 -37.69 37.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.19 111.117 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -53.95 -55.23 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 2.85 110.756 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 56' ' ' LYS . 49.5 pt -81.29 -5.6 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.22 111.066 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -78.64 117.86 20.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.25 110.874 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.7 mtt-85 -57.56 158.87 10.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.598 0.713 . . . . 3.01 110.891 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 54.4 Cg_endo -69.65 114.14 3.59 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.26 . . . . 0.19 112.32 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.33 3.58 55.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.19 112.46 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.02 -165.62 23.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.83 -0.7 . . . . 0.17 112.542 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.3 m -134.84 150.48 50.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.866 0.365 . . . . 0.31 110.896 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.62 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -134.7 115.0 13.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.15 110.963 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.535 ' N ' HD22 ' A' ' 93' ' ' LEU . 54.4 m-85 -110.37 132.47 54.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 1.63 110.792 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.53 159.02 44.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.14 110.871 -179.964 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 130.12 44.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 2.5 110.958 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.66 146.89 18.0 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.653 0.74 . . . . 2.33 110.885 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.515 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.9 Cg_endo -69.69 142.23 47.68 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.674 2.25 . . . . 0.23 112.361 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 157' ' ' VAL . 12.4 m -127.05 146.83 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.19 111.114 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.453 ' CD ' HG21 ' A' ' 103' ' ' VAL . 50.2 mt-10 -107.84 132.92 52.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 1.95 110.926 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.4 p -92.85 -41.4 10.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 1.09 111.15 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.57 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.51 38.53 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.75 110.973 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.453 HG21 ' CD ' ' A' ' 100' ' ' GLU . 21.2 t -146.89 150.63 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.76 111.13 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.641 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -53.51 173.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.82 110.834 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -66.97 -53.7 29.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 2.74 110.91 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -75.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 1.7 110.916 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 52.37 -169.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 1.63 110.836 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -80.3 -5.34 56.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 2.05 110.966 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.81 147.91 22.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.48 111.05 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.2 116.08 8.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 2.11 110.908 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.641 HG21 ' O ' ' A' ' 104' ' ' ASP . 51.4 p -88.21 -178.98 6.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.24 111.102 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.6 64.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.23 111.111 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.66 -49.63 76.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.26 110.939 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -57.1 -44.62 83.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 1.88 110.888 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -59.03 -55.45 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.954 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 71.5 m -53.71 -49.12 68.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.37 110.949 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -45.64 93.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.48 110.862 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.82 -44.84 93.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.34 111.116 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.716 ' HA ' HD13 ' A' ' 80' ' ' LEU . 12.5 tp -61.54 -54.12 47.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.35 110.912 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 100.0 m -61.85 -27.7 68.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.53 111.149 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.01 -17.45 50.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 1.01 110.854 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 p -82.37 3.03 29.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 2.4 110.823 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.38 -4.87 35.28 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.789 -0.72 . . . . 0.56 112.523 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.62 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -84.56 168.13 15.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 0.44 110.916 -179.931 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.501 HG23 ' HG3' ' A' ' 126' ' ' GLU . 27.2 m -150.79 172.97 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.34 111.142 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.501 ' HG3' HG23 ' A' ' 125' ' ' VAL . 36.9 mt-10 53.14 43.05 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 2.21 110.912 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.89 142.27 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.29 111.132 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.78 158.33 7.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 1.65 110.891 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -82.26 147.22 29.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 2.39 110.829 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.775 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.2 mp -107.78 -36.03 6.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.18 111.017 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -164.6 176.49 8.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.471 . . . . 1.29 110.853 179.872 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -126.12 165.76 18.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 8.32 110.867 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -148.62 136.34 11.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.671 0.748 . . . . 1.39 110.83 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 157.13 61.51 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.588 2.192 . . . . 0.36 112.448 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.645 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -93.98 127.58 39.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.31 -0.405 . . . . 0.36 110.933 179.976 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.471 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.56 161.37 23.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.544 0.687 . . . . 1.58 111.121 179.983 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -24.85 29.22 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.688 2.259 . . . . 0.46 112.325 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -85.75 -21.99 27.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 3.64 110.922 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -87.5 -53.07 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 2.5 110.93 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -50.13 -41.36 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.34 111.069 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.4 ' N ' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -65.06 -32.39 74.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.13 110.772 -179.929 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -51.32 24.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.58 110.841 -179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.638 HG23 HD13 ' A' ' 147' ' ' LEU . 9.4 p -61.54 -28.39 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.34 111.125 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -75.99 -48.58 20.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 1.93 110.915 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -73.26 -19.73 61.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 1.84 110.929 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.19 -33.36 13.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.51 110.835 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.009 HD22 HD12 ' A' ' 74' ' ' LEU . 2.2 mp -129.44 -54.09 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.45 110.916 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.57 14.59 1.9 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.688 -0.768 . . . . 0.31 112.513 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -74.62 120.34 20.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.853 0.359 . . . . 0.62 110.84 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -152.09 105.08 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 4.31 110.865 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.04 167.89 25.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.468 . . . . 0.63 110.816 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.77 -6.72 20.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 1.97 110.945 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 2.2 m120 -104.08 14.02 31.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 2.78 110.844 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.645 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -90.26 168.95 11.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.42 110.919 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.629 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -173.51 130.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.28 111.013 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.727 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.7 m-85 -69.38 134.66 49.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 1.88 110.825 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.409 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.73 143.28 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.085 -0.507 . . . . 0.31 111.139 179.976 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.775 ' HG2' HD13 ' A' ' 130' ' ' LEU . 10.4 tt0 -100.79 127.88 47.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 2.28 110.967 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.84 152.18 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.21 111.069 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.449 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -131.54 159.13 39.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.27 111.154 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.4 130.19 3.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.21 112.433 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -93.0 140.27 29.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 1.59 110.919 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 5.3 tptm -81.24 134.27 52.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.507 0.67 . . . . 1.38 110.92 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 119.78 6.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.625 2.217 . . . . 0.32 112.413 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.36 110.868 -179.973 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.789 0.328 . . . . 2.28 110.858 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.535 ' CE1' HD12 ' A' ' 67' ' ' LEU . 4.6 m-85 -122.16 22.27 10.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.235 -0.439 . . . . 2.03 110.894 -179.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.16 37.82 47.24 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.26 112.527 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.454 HG21 HD22 ' A' ' 32' ' ' LEU . 1.9 mp -73.95 156.42 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.791 0.329 . . . . 0.3 111.175 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.579 ' O ' HG23 ' A' ' 36' ' ' THR . 57.7 m -147.7 154.73 40.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 1.11 110.897 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.17 125.31 33.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.36 111.177 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.27 -6.56 19.05 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.744 -0.741 . . . . 0.26 112.498 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.8 170.62 7.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 1.54 110.972 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.13 112.44 25.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 1.33 110.926 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.695 HG12 HG21 ' A' ' 36' ' ' THR . 2.2 p -118.31 131.75 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 2.02 111.153 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.753 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -107.26 125.63 51.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.23 111.097 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.815 HG11 HG12 ' A' ' 29' ' ' VAL . 91.4 t -96.18 117.4 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.19 111.24 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 65' ' ' SER . 21.0 t -100.86 119.9 49.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.24 111.102 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -120.0 168.95 10.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 0.19 110.946 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.437 ' HB3' HD12 ' A' ' 47' ' ' ILE . 10.3 p-10 -151.83 -170.28 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 1.91 110.842 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -57.03 -35.6 69.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 2.93 110.975 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 m -73.62 -9.24 58.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.497 . . . . 1.61 110.842 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -106.97 94.2 10.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.634 0.731 . . . . 0.17 110.888 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 54.0 Cg_endo -69.75 142.29 47.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.681 2.254 . . . . 0.21 112.386 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.2 t -48.99 -32.61 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.18 111.096 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.13 -53.06 37.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 2.42 110.903 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.66 -44.56 11.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.17 111.078 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.454 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -52.07 -61.42 2.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.15 110.908 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.14 -37.6 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 2.81 110.914 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.8 -47.54 54.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 0.24 112.409 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 mt -61.49 -40.98 96.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.915 0.388 . . . . 0.46 110.937 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.815 HG12 HG11 ' A' ' 14' ' ' VAL . 17.2 m -75.81 -31.42 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.63 111.065 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.75 -61.15 2.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 1.57 110.843 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.8 -40.59 69.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 1.74 110.85 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.867 HD23 HD21 ' A' ' 35' ' ' LEU . 80.6 mt -71.99 -25.07 61.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.35 110.944 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.519 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.33 -24.54 46.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.38 111.0 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.76 -29.79 17.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.29 111.156 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.867 HD21 HD23 ' A' ' 32' ' ' LEU . 1.6 pp -91.58 -35.46 14.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.29 110.945 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.695 HG21 HG12 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -102.16 -44.89 5.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.23 111.13 -179.978 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.22 -12.16 49.12 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.704 -0.76 . . . . 0.27 112.555 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -67.67 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 1.93 110.871 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -95.56 -38.99 10.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.093 -0.503 . . . . 2.61 110.94 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.1 -131.32 5.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 0.24 112.492 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -152.88 151.73 30.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.932 0.396 . . . . 3.51 110.832 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 33' ' ' GLN . 89.6 t -135.01 125.06 44.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.22 111.107 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -115.87 152.49 33.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.22 110.833 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.32 133.66 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.5 . . . . 0.18 111.089 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -140.93 150.83 43.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 1.59 110.874 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -103.44 134.64 46.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.45 110.833 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.788 HD13 HG21 ' A' ' 73' ' ' THR . 35.2 mt -51.56 -34.56 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.31 111.151 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -71.46 -34.76 70.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.507 . . . . 2.0 110.896 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -101.1 16.15 26.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.262 -0.427 . . . . 3.67 110.874 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.686 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -48.87 -42.8 37.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.17 110.89 -179.971 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -55.5 -39.48 70.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 3.33 110.908 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.16 -13.14 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 5.15 110.924 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.7 m -77.19 -0.47 25.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 1.68 110.874 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.706 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -69.1 70.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.65 111.135 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -51.06 -73.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.439 . . . . 1.49 110.78 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.666 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -142.58 -165.18 1.98 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 1.21 110.915 -179.954 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -106.36 128.71 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 2.15 110.866 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.44 71.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.32 110.826 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.7 p -126.39 -32.13 2.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.28 110.802 -179.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.441 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.1 m-85 -100.24 119.31 38.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 1.43 110.897 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.39 -20.04 62.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 1.52 110.88 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 mt -143.99 144.46 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.25 111.161 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.934 HG21 HG23 ' A' ' 83' ' ' ILE . 22.3 mm -137.66 127.85 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.14 111.185 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.3 mm? -111.3 137.98 48.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.22 110.885 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.408 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -129.63 100.96 5.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.13 110.879 -179.981 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.37 72.2 0.56 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.687 -0.768 . . . . 0.18 112.512 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.578 HD13 ' OE1' ' A' ' 158' ' ' GLN . 3.9 mm? -103.86 58.85 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.339 . . . . 0.62 110.939 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.2 159.73 65.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.546 0.688 . . . . 0.22 111.172 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.89 117.42 5.08 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.233 . . . . 0.22 112.302 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.51 7.24 72.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.818 -0.706 . . . . 0.2 112.53 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.72 146.83 20.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.997 0.427 . . . . 0.69 110.845 -179.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.742 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 34.8 p -136.11 108.58 7.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.18 111.127 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.788 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -160.87 147.51 15.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.25 111.143 179.971 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.964 HD12 HD22 ' A' ' 147' ' ' LEU . 5.4 mt -123.63 103.54 8.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.25 110.911 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -81.26 141.95 33.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.34 110.893 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.3 m -123.57 174.73 7.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.46 110.804 -179.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.08 55.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.36 111.144 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.38 -46.05 91.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.144 -0.48 . . . . 2.14 110.889 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.686 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -73.15 -55.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.4 111.062 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 119' ' ' LEU . 57.1 mt -49.75 -37.68 30.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.26 110.933 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.75 -57.0 9.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.41 111.096 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.706 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -57.05 -40.58 77.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.189 -0.459 . . . . 2.7 110.905 -179.912 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.934 HG23 HG21 ' A' ' 63' ' ' ILE . 51.9 mm -59.33 -67.58 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.33 111.095 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.43 -33.69 31.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.27 111.106 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -57.23 13.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 2.21 110.824 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 56' ' ' LYS . 26.7 pt -75.15 -8.88 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.26 111.172 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -77.07 125.84 29.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.143 -0.481 . . . . 0.39 110.924 179.875 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -67.05 160.52 69.95 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.651 0.738 . . . . 3.67 110.966 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 114.06 3.57 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.631 2.221 . . . . 0.19 112.366 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.83 3.99 56.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.17 112.468 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.12 -164.48 17.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 0.13 112.435 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 61.2 m -135.32 150.6 50.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.35 110.892 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.694 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -135.44 114.4 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.15 110.867 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.538 ' N ' HD22 ' A' ' 93' ' ' LEU . 59.1 m-85 -109.59 132.35 54.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 1.68 110.88 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.545 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.48 164.16 35.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.19 110.905 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -136.26 124.56 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 1.92 110.959 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.451 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -146.31 150.52 41.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 2.3 110.945 179.935 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.599 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.9 Cg_endo -69.7 139.87 41.49 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.697 2.265 . . . . 0.22 112.382 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.7 m -121.37 147.27 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.37 111.119 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.47 ' CD ' HG21 ' A' ' 103' ' ' VAL . 50.7 mt-10 -119.31 131.92 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 1.96 110.925 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 p -92.73 -36.24 13.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 1.48 111.123 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.51 37.33 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.71 111.137 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.47 HG21 ' CD ' ' A' ' 100' ' ' GLU . 30.7 t -147.68 149.35 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.79 111.123 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.54 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -56.59 179.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 1.71 110.81 179.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.41 -74.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 2.71 110.857 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -54.74 -77.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 1.85 110.945 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.25 -169.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 1.64 110.955 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -4.08 52.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 2.35 110.945 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -145.85 141.18 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.55 111.143 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.599 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.1 mmtm -65.66 111.54 3.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 2.88 110.878 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.54 HG21 ' O ' ' A' ' 104' ' ' ASP . 44.8 p -81.0 177.39 9.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.2 111.165 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.56 -55.29 26.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 0.22 111.191 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 m -60.49 -49.68 76.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.27 110.877 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -38.51 70.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 2.83 110.943 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.492 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -65.4 -54.89 22.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.32 110.874 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 48.2 m -57.67 -45.33 85.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.26 110.856 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -42.95 88.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.34 110.858 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.84 97.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.24 111.088 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.574 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.5 tp -65.52 -50.46 65.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.22 110.878 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 95.5 m -64.13 -31.72 73.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.24 111.131 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.2 mt -86.75 -10.39 53.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.402 . . . . 0.63 110.894 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.07 5.17 30.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.416 . . . . 1.77 110.859 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.27 6.42 33.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.672 -0.775 . . . . 0.54 112.405 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -106.67 172.44 6.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.777 0.322 . . . . 0.27 110.985 -179.949 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' A' ' 126' ' ' GLU . 24.4 m -151.18 173.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.26 111.101 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HG3' HG23 ' A' ' 125' ' ' VAL . 36.6 mt-10 53.37 43.93 30.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 2.22 110.862 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 95.5 t -77.5 141.35 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.27 111.03 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 161.43 8.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 1.7 110.841 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 20.4 tt0 -82.26 145.9 29.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 2.09 110.855 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.0 mp -105.59 -35.97 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.33 110.927 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.41 175.82 13.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.19 110.981 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -128.62 147.95 50.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 4.12 110.834 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -137.32 134.4 18.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.695 0.759 . . . . 1.4 110.955 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.412 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.1 Cg_endo -69.77 165.21 31.73 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.737 2.292 . . . . 0.24 112.352 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.753 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -97.77 125.53 42.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.29 110.894 179.998 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.448 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.97 161.95 21.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.603 0.716 . . . . 1.27 111.089 -179.977 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.448 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.9 Cg_endo -69.75 -27.85 26.01 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.822 2.348 . . . . 0.33 112.253 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.54 -18.13 34.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 2.66 110.888 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.59 -54.27 4.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 2.78 110.931 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -49.89 -39.96 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.24 111.086 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -34.11 76.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 1.17 110.912 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -47.16 67.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.26 110.811 -179.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.69 HG23 HD13 ' A' ' 147' ' ' LEU . 11.1 p -68.08 -30.02 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.16 111.197 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -75.76 -32.25 59.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 1.94 110.908 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -89.4 -20.16 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 1.74 110.916 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -94.34 -32.84 13.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.3 110.848 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.964 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.11 -54.1 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.3 110.88 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.6 16.25 1.68 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.709 -0.758 . . . . 0.29 112.433 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -72.84 122.0 20.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.733 0.302 . . . . 0.88 110.887 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -151.51 105.45 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 2.1 110.848 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -160.54 170.03 21.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.69 110.882 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.14 -14.07 15.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 1.97 110.891 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -101.74 23.39 11.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 1.72 110.855 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.753 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -92.25 163.49 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.23 -0.441 . . . . 0.3 110.891 -179.962 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.587 ' HA ' HD23 ' A' ' 135' ' ' LEU . 2.6 tm? -169.72 130.69 1.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.22 110.939 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.742 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.3 m-85 -76.42 136.86 39.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 1.79 110.874 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.54 145.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.37 111.128 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.578 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.9 tt0 -97.83 129.62 44.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 1.9 110.898 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 3.8 mp -124.44 149.18 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.21 111.071 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.475 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.5 t -126.8 160.73 30.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.31 111.087 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -151.7 128.88 2.67 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.68 -0.772 . . . . 0.19 112.495 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -90.02 139.67 30.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 1.55 110.84 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.81 135.22 49.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.567 0.699 . . . . 1.24 110.873 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 128.41 16.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.647 2.231 . . . . 0.38 112.298 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.854 -179.989 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.798 0.332 . . . . 1.86 110.839 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 6' ' ' ILE . 8.3 m-85 -122.31 13.82 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 1.98 110.797 -179.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.76 38.98 96.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.23 112.504 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.7 mp -78.9 158.78 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.22 111.071 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -152.65 162.07 41.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 1.35 110.915 -179.921 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.23 126.32 35.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.26 111.058 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.08 -5.85 17.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.674 -0.774 . . . . 0.25 112.46 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -114.13 168.96 9.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.319 . . . . 1.19 110.857 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.58 140.64 32.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 1.32 110.808 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.654 HG22 ' HB ' ' A' ' 62' ' ' ILE . 61.9 t -142.63 138.46 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 1.84 111.135 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.764 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -115.4 123.94 49.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.23 111.136 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.805 HG11 HG12 ' A' ' 29' ' ' VAL . 59.1 t -97.43 118.19 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.24 111.1 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.503 HG12 ' CG1' ' A' ' 47' ' ' ILE . 13.4 t -102.47 110.98 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.29 111.092 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -112.4 167.38 10.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.19 110.928 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 10.1 p-10 -151.18 -169.46 3.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.69 110.858 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.98 -35.95 69.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 5.75 110.857 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.8 m -72.95 -10.34 59.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 1.52 110.869 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.91 94.48 10.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 0.16 110.879 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 141.42 45.29 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.718 2.279 . . . . 0.21 112.396 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.0 t -48.64 -32.9 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.24 111.128 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.28 -52.64 43.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 3.15 110.891 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.53 -44.94 10.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.22 111.036 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.486 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.87 -61.55 2.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.275 -0.421 . . . . 0.19 110.939 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -37.41 28.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 2.82 110.874 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.21 -47.37 53.04 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.27 112.457 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.93 -39.97 93.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.53 110.92 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.805 HG12 HG11 ' A' ' 14' ' ' VAL . 18.1 m -76.82 -31.56 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.63 111.12 179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -61.98 -59.8 4.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 1.85 110.868 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -40.2 71.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.425 . . . . 2.4 110.876 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.887 HD23 HD21 ' A' ' 35' ' ' LEU . 82.6 mt -72.94 -24.57 60.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.24 110.957 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.402 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.59 -25.36 45.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.43 110.917 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.88 -30.0 17.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.474 . . . . 0.37 111.076 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.887 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.48 -35.08 14.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.27 110.894 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.59 -45.49 4.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.31 111.128 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.07 -12.29 54.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.747 -0.74 . . . . 0.45 112.445 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.39 -62.54 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 2.86 110.951 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 3.6 mm-40 -84.81 -43.6 14.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 2.04 110.923 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.52 -121.86 4.31 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.33 112.471 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -157.03 153.84 28.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 3.32 110.853 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 33' ' ' GLN . 95.0 t -139.24 129.91 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 0.35 111.084 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -118.2 157.95 26.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.18 110.816 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.87 135.07 60.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.18 111.19 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -145.45 151.76 38.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 1.29 110.811 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.85 135.94 43.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.41 110.913 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.724 ' CD1' HG21 ' A' ' 73' ' ' THR . 23.1 mt -51.34 -35.03 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.24 111.087 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -32.05 62.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 2.67 110.863 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.7 19.48 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 3.36 110.882 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.736 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.67 -31.05 4.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.424 . . . . 1.13 110.91 -179.929 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -54.31 -36.3 63.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 1.09 110.947 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -85.46 -15.91 41.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 1.07 110.991 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 m -64.01 -13.32 45.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.93 110.874 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.64 65.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.37 111.118 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -63.84 -72.46 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.4 110.888 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.77 -166.28 2.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 1.61 110.967 179.954 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -106.69 127.13 53.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.957 0.408 . . . . 1.69 110.885 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 49.15 75.88 0.14 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.5 . . . . 1.25 110.886 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.2 p -127.48 -34.4 2.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.25 110.808 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.472 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.4 m-85 -98.54 120.82 39.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 1.48 110.885 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.5 -20.61 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 1.69 110.862 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.654 ' HB ' HG22 ' A' ' 12' ' ' VAL . 30.6 mt -143.87 144.23 23.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.226 -0.443 . . . . 0.32 111.101 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.933 HG21 HG23 ' A' ' 83' ' ' ILE . 23.1 mm -134.65 126.52 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.16 111.137 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.2 mm? -111.16 131.96 54.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.19 110.841 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.7 100.01 6.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.14 110.852 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.59 75.37 0.22 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.792 -0.718 . . . . 0.17 112.479 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.42 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.6 mm? -106.27 55.71 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.891 0.377 . . . . 0.59 110.88 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -123.96 160.07 53.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.579 0.705 . . . . 0.22 111.081 179.925 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 123.29 9.93 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.653 2.236 . . . . 0.27 112.427 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.93 7.52 87.82 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.712 -0.756 . . . . 0.17 112.54 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 68' ' ' VAL . 9.7 p -55.58 149.1 14.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.052 0.453 . . . . 0.75 110.828 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 30.5 p -138.79 109.12 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.044 -0.526 . . . . 0.18 111.2 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.724 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -160.43 156.77 26.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.31 111.106 -179.856 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.849 HD12 HD22 ' A' ' 147' ' ' LEU . 4.7 mt -135.04 106.55 6.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.29 110.915 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -82.11 153.83 25.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.37 110.901 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.7 m -131.0 176.32 8.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.63 110.884 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.47 -36.28 43.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.486 . . . . 0.23 111.094 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -62.5 -42.79 99.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 1.62 110.868 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.736 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -77.53 -55.58 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.3 111.138 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 119' ' ' LEU . 56.0 mt -48.87 -49.69 38.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.27 110.998 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.89 -48.28 51.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.59 111.062 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -46.76 88.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 4.92 110.903 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.933 HG23 HG21 ' A' ' 63' ' ' ILE . 49.9 mm -53.63 -64.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.25 111.122 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.78 -41.38 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.27 111.134 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -51.63 -51.31 56.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 2.55 110.867 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 56' ' ' LYS . 47.4 pt -84.3 -6.29 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.2 111.175 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -80.45 116.64 20.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.29 110.883 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -55.91 159.19 5.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.665 0.745 . . . . 2.3 110.811 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.6 Cg_endo -69.74 113.93 3.53 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.721 2.281 . . . . 0.23 112.395 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.23 4.46 55.18 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.788 -0.72 . . . . 0.21 112.436 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.53 -163.46 19.97 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.776 -0.726 . . . . 0.16 112.407 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.9 m -136.18 154.61 50.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.31 110.9 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.715 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.94 116.36 11.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.2 110.904 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.581 ' N ' HD22 ' A' ' 93' ' ' LEU . 47.6 m-85 -111.68 131.26 55.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 1.7 110.831 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.486 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.67 163.44 37.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.19 110.851 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -137.11 134.43 36.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 3.58 110.894 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.72 148.94 20.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.699 0.761 . . . . 3.48 110.876 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.607 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.6 Cg_endo -69.71 131.91 22.31 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.706 2.271 . . . . 0.46 112.383 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.2 m -120.15 146.59 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.29 111.197 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.28 132.87 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 3.43 110.875 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.1 p -102.56 26.61 7.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 1.06 111.152 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.77 24.72 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.64 111.114 179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.3 t -145.22 160.39 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.21 -0.45 . . . . 0.73 111.11 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.601 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -55.02 177.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 1.95 110.925 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -67.9 -53.03 29.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 3.43 110.875 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -70.88 -76.43 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.97 110.877 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.65 -168.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 1.54 110.851 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -5.28 56.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 1.74 110.872 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -146.02 140.92 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.52 111.149 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -60.6 121.51 12.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 2.37 110.856 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.601 HG21 ' O ' ' A' ' 104' ' ' ASP . 47.3 p -90.02 177.2 6.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.3 111.13 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.07 -54.73 43.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.22 111.097 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -59.51 -48.51 81.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.25 110.872 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -56.73 -40.83 76.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 2.9 110.874 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.514 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -62.91 -54.11 43.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.429 . . . . 0.41 110.894 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.3 m -55.83 -47.93 76.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.27 110.923 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -45.57 88.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.34 110.868 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.32 97.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.32 111.083 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.5 tp -65.94 -53.77 34.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.416 . . . . 0.26 110.957 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.2 m -59.12 -33.48 70.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.38 111.155 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.4 mt -86.99 -10.27 53.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.87 110.953 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.2 m -85.06 4.85 32.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 1.68 110.814 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.14 11.25 26.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.71 112.492 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -111.32 170.77 7.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 0.28 110.839 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.423 HG23 ' HG3' ' A' ' 126' ' ' GLU . 25.6 m -151.38 173.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.28 111.112 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 125' ' ' VAL . 29.8 mt-10 51.72 43.88 29.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 2.2 110.81 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.8 t -75.54 143.63 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.36 111.15 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.16 158.42 6.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 1.56 110.949 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 32.2 tt0 -80.5 145.35 31.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 2.14 110.915 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.3 mp -104.34 -36.71 7.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.29 110.867 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.59 176.16 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.16 110.937 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.719 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.3 tmt_? -133.17 138.0 46.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 4.41 110.92 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -123.84 136.11 27.02 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.672 0.749 . . . . 1.5 110.868 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.425 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.3 Cg_endo -69.89 158.82 55.51 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.597 2.198 . . . . 0.31 112.342 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -94.44 124.53 38.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.54 110.91 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.477 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.07 162.7 18.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 1.56 111.135 179.918 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 136' ' ' THR . 53.4 Cg_endo -69.79 -23.15 30.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.661 2.241 . . . . 0.66 112.31 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.79 -22.53 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 2.34 110.965 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -87.65 -53.91 4.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 3.98 110.911 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 136' ' ' THR . 7.7 p -50.66 -40.21 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.35 111.149 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -31.98 73.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 1.31 110.987 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -51.38 19.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.46 110.89 -179.849 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.641 HG23 HD13 ' A' ' 147' ' ' LEU . 7.3 p -61.72 -28.29 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.29 111.098 179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -76.28 -48.24 20.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 2.46 110.86 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -73.63 -19.32 60.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 2.17 110.959 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.5 -33.56 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.65 110.82 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.849 HD22 HD12 ' A' ' 74' ' ' LEU . 2.2 mp -128.32 -54.43 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.72 110.925 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.81 12.66 1.91 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.736 -0.745 . . . . 0.63 112.556 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.405 ' HB3' HG22 ' A' ' 143' ' ' VAL . 21.9 t-160 -70.77 121.37 17.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.93 110.834 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -152.04 105.48 3.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 2.73 110.946 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.48 175.02 13.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.66 110.826 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.82 -17.82 13.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.072 -0.513 . . . . 1.71 110.793 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -94.66 12.17 28.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 1.53 110.839 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.707 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.31 164.02 22.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.41 110.92 179.949 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.719 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.35 132.08 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.2 110.876 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 17.7 m-85 -77.09 131.86 38.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 1.73 110.845 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.69 144.37 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.21 111.139 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.527 ' HG2' HD13 ' A' ' 130' ' ' LEU . 3.4 tt0 -102.01 130.6 48.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 2.06 110.898 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 4.3 mp -126.03 149.72 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.31 111.183 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.45 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.5 t -127.88 160.48 31.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.29 111.062 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.52 132.22 3.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.83 -0.7 . . . . 0.15 112.606 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -94.71 140.84 29.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 1.77 110.925 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 6.2 tptm -81.46 134.52 51.23 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.621 0.724 . . . . 1.4 110.851 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 118.75 5.87 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.775 2.316 . . . . 0.42 112.328 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.5 110.895 179.961 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.898 0.38 . . . . 2.72 110.851 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.401 ' HB2' HD11 ' A' ' 6' ' ' ILE . 5.2 m-85 -122.4 22.13 10.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 1.53 110.758 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.51 41.92 56.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.814 -0.708 . . . . 0.31 112.445 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.483 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.6 mp -81.51 160.22 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.817 0.342 . . . . 0.34 111.099 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 36' ' ' THR . 0.4 OUTLIER -156.48 168.21 28.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 1.72 110.818 -179.927 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.64 130.62 35.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.4 111.099 179.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.15 2.79 29.79 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.719 -0.753 . . . . 0.3 112.448 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.414 HE22 HD12 ' A' ' 62' ' ' ILE . 3.0 pt20 -116.96 166.88 11.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 1.05 110.958 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.02 115.19 29.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 1.3 110.848 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.591 HG13 HG21 ' A' ' 36' ' ' THR . 3.4 m -117.95 139.78 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 2.31 111.151 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.761 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -114.04 112.12 22.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.39 111.089 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.892 HG11 HG12 ' A' ' 29' ' ' VAL . 95.9 t -87.65 121.87 38.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.21 111.163 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.592 HG12 HG13 ' A' ' 47' ' ' ILE . 17.6 t -108.29 119.84 58.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.2 111.219 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -117.8 166.15 12.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.19 110.972 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.646 ' HB3' HD12 ' A' ' 47' ' ' ILE . 6.2 p-10 -145.65 -169.06 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.309 -0.405 . . . . 1.69 110.872 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -59.59 -35.28 73.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 3.44 110.937 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.4 m -74.68 -6.92 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 1.53 110.86 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.62 92.7 8.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.682 0.753 . . . . 0.13 110.906 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 54.9 Cg_endo -69.71 143.08 49.94 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 0.2 112.413 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t -48.8 -32.77 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.18 111.193 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -51.0 -53.26 34.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 3.13 110.872 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.57 -44.95 10.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 0.16 111.12 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.45 -61.95 1.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.13 110.968 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.52 -35.77 21.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 2.6 110.921 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.87 -47.67 45.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.677 -0.773 . . . . 0.19 112.548 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.4 mt -61.73 -39.86 93.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.92 0.391 . . . . 0.48 110.987 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.892 HG12 HG11 ' A' ' 14' ' ' VAL . 17.0 m -76.65 -31.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.63 111.199 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.38 -59.68 4.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 1.66 110.807 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -40.29 72.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 1.7 110.945 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.862 HD23 HD21 ' A' ' 35' ' ' LEU . 86.4 mt -72.78 -24.93 61.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.24 110.883 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.478 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.49 -25.01 45.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.38 110.82 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.59 -29.95 17.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.22 111.094 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.862 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.6 -34.82 14.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.19 110.892 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.17 -45.6 4.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.22 111.134 179.918 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.47 -12.27 55.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.3 112.505 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -65.33 -62.66 1.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 2.62 110.989 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.09 -36.49 10.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 1.88 110.925 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.32 -128.74 4.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.25 112.452 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -154.32 153.19 31.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 2.21 110.799 -179.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 12' ' ' VAL . 94.8 t -138.88 117.05 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.31 111.116 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.3 t -107.01 151.35 25.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.22 110.794 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -114.24 136.29 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.14 111.02 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -144.99 152.2 39.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.142 -0.481 . . . . 1.27 110.842 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -102.8 134.34 46.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.48 110.952 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.926 HD13 HG21 ' A' ' 73' ' ' THR . 10.2 mt -50.29 -33.56 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.34 111.101 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -76.48 -34.3 58.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 2.64 110.878 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -93.37 18.57 9.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 3.16 110.821 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.793 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.49 -30.25 4.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 1.12 110.961 179.891 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mp -53.45 -37.95 63.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 1.08 110.844 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -85.23 -16.18 41.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 1.18 110.834 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.467 ' HB2' HD13 ' A' ' 50' ' ' LEU . 48.8 m -65.41 -12.38 51.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 0.95 110.873 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.84 61.2 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.41 111.099 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -58.62 -71.82 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.117 -0.492 . . . . 0.47 110.806 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -150.2 -168.68 3.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 1.75 110.866 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -102.18 137.71 40.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 1.94 110.899 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 p 46.55 85.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 1.19 110.873 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 p -139.97 -40.49 0.44 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.46 110.865 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.494 ' O ' HD23 ' A' ' 87' ' ' LEU . 96.4 m-85 -99.64 120.42 39.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 1.48 110.889 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.62 -21.6 63.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 1.5 110.819 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.414 HD12 HE22 ' A' ' 10' ' ' GLN . 14.5 mt -147.16 142.64 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.38 111.165 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.921 HG21 HG23 ' A' ' 83' ' ' ILE . 22.5 mm -129.43 134.42 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.27 111.109 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -114.54 135.24 54.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.29 110.924 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.76 97.73 4.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.15 110.801 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.48 79.54 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.22 112.47 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.88 56.69 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.59 110.959 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.31 159.35 57.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.617 0.723 . . . . 0.21 111.16 179.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 116.46 4.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.683 2.255 . . . . 0.25 112.375 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.31 7.37 69.82 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.2 112.533 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -54.79 144.25 23.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.974 0.416 . . . . 0.68 110.87 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.76 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 31.5 p -133.49 108.5 8.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.19 111.166 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.926 HG21 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -162.7 149.53 13.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.25 111.095 -180.0 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.931 HD12 HD22 ' A' ' 147' ' ' LEU . 3.4 mt -127.52 99.99 5.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.13 -0.486 . . . . 0.26 110.967 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -73.23 145.95 45.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.32 110.881 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.513 ' H ' HD13 ' A' ' 79' ' ' ILE . 1.5 m -120.28 172.8 7.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.55 110.742 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.34 -39.7 47.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.33 111.125 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.6 -38.31 84.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 2.38 110.909 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.793 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -79.81 -54.84 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.23 111.201 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' A' ' 119' ' ' LEU . 50.0 mt -49.84 -45.87 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.33 110.906 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.75 -51.65 54.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.174 -0.467 . . . . 0.46 111.014 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -42.48 77.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 2.61 110.886 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.921 HG23 HG21 ' A' ' 63' ' ' ILE . 36.9 mm -59.93 -68.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.28 111.093 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.57 -32.68 19.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.45 111.127 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -61.02 -56.15 24.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 2.35 110.906 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 56' ' ' LYS . 29.8 pt -76.95 -6.72 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.3 111.165 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -78.36 124.31 27.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.27 110.891 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -62.67 160.23 37.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.572 0.701 . . . . 2.13 110.869 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 114.04 3.56 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.73 2.286 . . . . 0.23 112.318 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.71 3.5 56.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.819 -0.705 . . . . 0.21 112.44 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.11 -156.9 9.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.716 -0.754 . . . . 0.22 112.423 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.3 m -146.0 158.18 43.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.888 0.375 . . . . 0.5 110.833 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.631 HD22 ' N ' ' A' ' 94' ' ' PHE . 1.0 OUTLIER -140.38 116.14 10.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.18 110.954 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.631 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.0 m-85 -108.76 132.73 53.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.63 110.84 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.533 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.56 160.59 42.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.16 110.878 179.944 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 126.37 36.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 1.81 110.862 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.522 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -149.9 148.13 24.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.659 0.742 . . . . 2.3 110.875 179.982 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.6 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.5 Cg_endo -69.65 143.95 53.05 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.718 2.279 . . . . 0.23 112.386 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.6 m -127.12 147.0 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.25 111.1 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.01 132.42 56.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 3.15 110.811 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.7 p -104.75 25.99 9.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 1.04 111.247 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.65 26.31 0.83 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.74 111.104 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 104' ' ' ASP . 4.8 t -144.09 158.64 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.75 111.114 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.543 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -57.11 -177.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.86 110.886 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -66.5 -73.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 2.4 110.874 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.34 -75.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 2.34 110.834 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.75 -168.56 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 1.68 110.747 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -6.28 57.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 1.74 110.886 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.3 m -146.61 143.44 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.48 111.079 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.491 ' H ' HD22 ' A' ' 74' ' ' LEU . 7.6 ttmt -65.61 113.18 4.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.4 110.963 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.543 HG21 ' O ' ' A' ' 104' ' ' ASP . 30.3 p -83.19 179.83 7.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.25 111.187 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.65 -54.27 47.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.28 111.042 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -49.54 76.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.26 110.865 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -39.74 76.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 2.14 110.865 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.522 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.3 tm? -62.97 -55.1 28.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.4 110.965 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.7 m -57.84 -47.43 82.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.25 110.853 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -44.33 96.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.28 110.912 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.11 -50.96 71.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.3 111.182 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.634 ' CD1' HD22 ' A' ' 80' ' ' LEU . 7.1 tp -59.68 -57.31 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.54 110.865 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -57.52 -26.56 61.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.38 111.14 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.9 mt -84.3 -16.0 44.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.75 110.93 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.0 p -82.2 3.09 28.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 2.52 110.809 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.81 -4.85 34.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.92 112.49 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.637 HD23 ' HA3' ' A' ' 161' ' ' GLY . 1.4 tp -83.32 171.3 13.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.54 110.92 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.07 169.66 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.42 111.146 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 51.64 44.93 28.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 2.24 110.881 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.16 139.44 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.28 111.149 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.18 159.98 7.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 1.84 110.879 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -77.54 145.29 37.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 2.61 110.913 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.712 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.1 mp -102.16 -37.53 8.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.25 110.917 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -156.04 176.27 12.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 3.0 110.957 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . 0.726 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.0 tmt_? -129.39 136.87 50.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.328 -0.397 . . . . 4.23 110.929 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -123.55 136.56 27.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.62 0.724 . . . . 1.39 110.999 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.403 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.7 Cg_endo -69.71 163.2 39.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.649 2.233 . . . . 0.26 112.388 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.669 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -96.79 124.35 40.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.174 -0.466 . . . . 0.29 110.909 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.456 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.09 161.21 25.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.64 0.734 . . . . 1.32 111.145 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.8 Cg_endo -69.77 -28.57 25.06 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.704 2.27 . . . . 0.46 112.32 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -85.1 -17.76 36.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.217 -0.447 . . . . 2.49 110.936 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.32 -54.0 4.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 2.82 110.998 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.58 -40.03 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.26 111.095 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -34.72 76.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 1.28 110.86 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -46.77 69.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.29 110.793 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 10.3 p -68.0 -30.03 46.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.21 111.183 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -75.66 -32.25 60.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 2.04 110.923 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -89.43 -20.29 24.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 1.61 110.901 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -94.36 -32.55 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.3 110.828 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.931 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -128.31 -54.05 1.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.33 110.843 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.38 12.12 2.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.807 -0.711 . . . . 0.31 112.49 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -70.9 121.53 18.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.682 0.277 . . . . 0.66 110.853 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -152.18 105.27 3.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.296 -0.411 . . . . 2.27 110.923 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.7 t -160.73 176.52 11.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.61 110.91 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.12 -20.8 13.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.7 110.952 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -92.02 13.13 19.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 1.57 110.938 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.669 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.54 163.89 22.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.33 110.921 179.909 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.6 tm? -173.35 129.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.2 110.851 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.76 ' CZ ' HG22 ' A' ' 72' ' ' THR . 31.3 m-85 -75.39 137.62 41.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 1.71 110.882 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -150.3 146.41 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.23 111.154 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.712 ' HG2' HD13 ' A' ' 130' ' ' LEU . 23.2 tt0 -98.9 132.05 44.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 1.57 110.926 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -126.99 149.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.23 111.144 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.464 ' N ' HD11 ' A' ' 130' ' ' LEU . 7.0 t -137.06 152.64 50.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.37 111.094 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.637 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -144.1 137.48 7.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.73 . . . . 0.17 112.483 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -92.83 140.18 29.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 1.75 110.832 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.57 135.29 49.77 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.622 0.725 . . . . 1.26 110.855 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 127.47 14.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.724 2.283 . . . . 0.32 112.292 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.34 110.908 179.965 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.774 0.321 . . . . 3.49 110.875 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.02 -21.94 62.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.267 -0.424 . . . . 0.45 111.092 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -51.49 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 2.35 110.83 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -122.24 22.55 10.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 1.97 110.842 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.31 40.14 52.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.733 -0.746 . . . . 0.26 112.529 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.543 HG23 HG21 ' A' ' 12' ' ' VAL . 1.7 mp -78.51 159.26 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.23 111.15 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.725 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -152.43 163.48 39.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.463 . . . . 1.36 110.859 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.47 126.1 35.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.32 111.096 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.69 -0.0 20.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.72 -0.752 . . . . 0.3 112.477 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -117.55 170.64 8.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.827 0.346 . . . . 1.12 110.902 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.81 113.79 27.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 1.36 110.856 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 ' HB ' ' A' ' 62' ' ' ILE . 99.1 t -118.5 125.89 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 1.96 111.177 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.781 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -103.16 128.44 50.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.28 111.124 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.843 HG11 HG12 ' A' ' 29' ' ' VAL . 60.7 t -101.32 120.84 51.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.17 111.166 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.5 t -104.31 120.87 55.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.23 111.128 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.4 p-90 -120.48 168.99 10.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.19 110.898 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -151.76 -169.93 3.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 1.75 110.813 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -57.41 -35.56 70.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 3.53 110.886 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.54 -9.9 59.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 1.24 110.837 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.04 94.44 10.83 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.686 0.755 . . . . 0.13 110.912 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 142.03 46.72 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.683 2.255 . . . . 0.19 112.34 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.0 t -48.99 -32.57 4.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.17 111.12 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.38 -52.93 41.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 2.67 110.851 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.55 -44.96 10.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.17 111.048 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.467 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.45 -61.25 2.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.13 110.917 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -35.95 24.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 3.42 110.87 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.41 -47.25 44.09 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.786 -0.721 . . . . 0.18 112.439 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.5 mt -61.94 -38.61 89.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.826 0.346 . . . . 0.48 110.928 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.843 HG12 HG11 ' A' ' 14' ' ' VAL . 17.5 m -78.09 -31.35 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.62 111.155 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -62.33 -58.0 9.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 1.59 110.84 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.71 -40.05 74.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 1.73 110.909 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.879 HD23 HD21 ' A' ' 35' ' ' LEU . 88.4 mt -73.12 -25.07 60.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.24 110.891 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.472 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.37 -25.26 46.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.37 110.877 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.49 -30.25 17.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.22 111.153 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.879 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -90.75 -35.18 15.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.2 110.904 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.725 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.4 -46.9 4.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.2 111.135 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.31 -13.74 50.93 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.768 -0.73 . . . . 0.26 112.477 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.89 -62.58 1.55 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.794 0.331 . . . . 2.0 110.882 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -96.01 -38.11 10.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 2.03 110.903 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.56 -132.98 6.52 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.759 -0.734 . . . . 0.27 112.461 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -149.22 152.67 36.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.871 0.367 . . . . 2.18 110.906 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.8 t -137.68 122.81 24.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.23 111.1 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -112.14 157.63 20.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.18 110.844 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.58 135.19 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.17 111.132 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -142.51 151.1 41.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 2.02 110.847 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -103.26 134.59 46.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.4 110.861 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.722 ' CD1' HG21 ' A' ' 73' ' ' THR . 26.7 mt -51.89 -36.48 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.33 111.15 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.95 -32.84 69.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 2.19 110.869 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.52 20.92 16.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 3.52 110.93 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.845 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.15 -27.8 3.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 1.06 110.928 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -55.1 -32.7 62.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 1.04 110.888 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -84.86 -15.33 45.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 1.06 110.929 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB2' HD13 ' A' ' 50' ' ' LEU . 47.0 m -63.77 -12.61 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.88 110.892 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -73.83 63.1 0.87 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.28 111.083 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.406 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 12.1 m-70 -64.46 -70.17 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.38 110.873 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.686 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.12 -168.2 2.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 1.13 110.914 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -106.35 128.12 53.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 2.01 110.846 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 48.93 77.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.104 -0.498 . . . . 1.34 110.843 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.7 p -130.12 -34.2 1.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.26 110.845 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.516 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.2 m-85 -98.99 120.25 39.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 1.42 110.886 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.13 -20.72 62.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 1.5 110.842 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.699 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.2 mt -146.62 144.5 20.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.23 111.153 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.92 HG21 HG23 ' A' ' 83' ' ' ILE . 17.2 mm -134.69 131.71 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.12 111.118 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -113.94 137.06 52.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.2 -0.455 . . . . 0.17 110.976 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.47 101.64 6.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.15 110.873 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.63 74.66 0.27 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.804 -0.713 . . . . 0.16 112.428 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.576 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.2 mm? -106.63 56.8 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.839 0.352 . . . . 0.58 110.893 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.0 159.79 60.1 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.621 0.724 . . . . 0.23 111.2 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 124.14 10.77 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.737 2.291 . . . . 0.24 112.32 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.5 7.11 88.62 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.21 112.489 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 68' ' ' VAL . 10.0 p -55.58 151.49 10.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.972 0.415 . . . . 0.78 110.829 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 29.7 p -140.33 108.96 5.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.111 -0.495 . . . . 0.18 111.132 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.722 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.79 153.81 19.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 0.26 111.126 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.96 HD12 HD22 ' A' ' 147' ' ' LEU . 5.3 mt -132.25 105.78 7.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.22 110.916 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -82.35 152.5 26.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.25 110.845 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.0 m -131.94 176.98 7.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.48 110.843 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -37.27 45.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.24 111.079 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.25 -44.41 96.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 2.07 110.883 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.845 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -75.11 -54.85 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.19 111.133 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 119' ' ' LEU . 61.7 mt -51.08 -38.92 54.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.22 110.906 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.84 -55.2 24.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.32 111.101 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -56.09 -44.96 79.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 2.82 110.887 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.92 HG23 HG21 ' A' ' 63' ' ' ILE . 49.9 mm -55.08 -67.76 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.22 111.132 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.07 -40.1 57.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.464 . . . . 0.25 111.067 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -52.95 -49.06 66.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 2.85 110.883 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.686 HG22 ' O ' ' A' ' 56' ' ' LYS . 38.7 pt -87.02 -5.3 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.19 111.162 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -80.92 117.3 21.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.25 110.887 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -56.81 158.69 8.33 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.598 0.714 . . . . 2.29 110.917 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 54.0 Cg_endo -69.73 114.03 3.57 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.651 2.234 . . . . 0.19 112.365 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.03 3.27 54.75 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.15 112.504 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.38 -162.8 17.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.784 -0.722 . . . . 0.14 112.502 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 27.3 m -137.01 155.5 49.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.347 . . . . 0.27 110.872 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.702 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -139.56 115.55 10.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.15 110.893 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.551 ' N ' HD22 ' A' ' 93' ' ' LEU . 58.6 m-85 -110.15 132.1 54.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 1.9 110.873 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.549 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.78 158.76 44.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.15 110.883 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.38 128.29 44.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 1.86 110.905 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.596 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -150.69 146.19 19.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.646 0.736 . . . . 2.26 110.914 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.608 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.73 138.07 37.04 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.656 2.238 . . . . 0.18 112.365 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 155' ' ' LEU . 14.9 m -120.71 146.55 25.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.25 -0.432 . . . . 0.19 111.098 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -110.59 132.58 54.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.465 . . . . 1.93 110.851 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.2 p -105.15 25.9 10.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.139 -0.482 . . . . 1.11 111.145 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.63 25.39 0.76 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.7 111.106 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.5 t -143.66 159.79 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.74 111.123 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.53 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -56.66 -178.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 1.79 110.889 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -66.81 -68.27 0.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.465 . . . . 2.05 110.873 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -60.0 -75.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 2.19 110.859 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.81 -167.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 1.72 110.863 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -7.48 58.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 1.91 110.886 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.6 m -146.44 141.02 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.53 111.106 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -63.17 115.09 4.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 2.43 110.895 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.53 HG21 ' O ' ' A' ' 104' ' ' ASP . 33.1 p -83.19 -179.8 7.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.27 111.113 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.56 -53.63 55.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.28 111.091 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.19 -48.9 77.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.31 110.887 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -37.92 75.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 2.3 110.888 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.596 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.3 tm? -65.17 -55.05 20.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.34 110.912 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.8 m -57.37 -45.59 84.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.35 110.897 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -42.42 91.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.48 110.852 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.56 -43.89 97.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.32 111.075 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.56 HD11 HD12 ' A' ' 93' ' ' LEU . 14.8 tp -64.52 -51.44 62.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.25 110.916 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.5 m -62.28 -31.55 72.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.34 111.113 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 32.0 mt -87.04 -10.27 53.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.67 110.912 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.5 6.51 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 1.7 110.864 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.82 6.0 32.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.49 112.465 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.702 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -106.69 171.63 7.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.862 0.363 . . . . 0.28 110.942 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 126' ' ' GLU . 27.4 m -150.14 171.15 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 0.27 111.144 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.516 ' HG3' HG23 ' A' ' 125' ' ' VAL . 22.5 mt-10 51.76 44.29 29.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 1.85 110.903 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.419 HG13 HD23 ' A' ' 119' ' ' LEU . 89.6 t -81.09 143.03 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.25 111.109 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 160.22 8.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 1.57 110.902 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -77.75 146.18 36.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 2.5 110.906 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.475 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.1 mp -105.6 -36.96 6.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.2 110.964 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.85 176.21 12.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 1.16 110.932 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.698 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.7 tmt_? -132.87 137.98 46.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 4.28 110.845 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -125.74 138.07 31.24 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.615 0.722 . . . . 1.82 110.888 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.413 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.7 Cg_endo -69.71 165.04 32.27 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.729 2.286 . . . . 0.23 112.35 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.676 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.03 126.48 43.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.28 110.944 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.52 161.27 23.34 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.619 0.723 . . . . 1.49 111.107 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -24.57 29.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.661 2.241 . . . . 0.31 112.353 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -85.49 -22.54 28.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 2.54 110.886 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -87.51 -52.86 5.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 2.5 110.901 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 136' ' ' THR . 7.4 p -49.62 -40.34 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.23 111.169 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -33.49 74.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 1.16 110.921 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.39 -46.19 67.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.23 110.888 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.708 HG23 HD13 ' A' ' 147' ' ' LEU . 9.2 p -68.37 -30.71 48.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.102 -0.499 . . . . 0.16 111.101 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -76.21 -31.45 58.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 1.87 110.862 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -89.7 -20.44 23.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 1.63 110.841 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.66 -32.87 13.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.27 110.849 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.96 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.19 -54.17 1.38 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.3 110.934 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.51 13.75 2.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 0.28 112.483 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -70.63 122.01 18.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.309 . . . . 0.75 110.826 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -151.53 105.32 3.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 2.4 110.837 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.1 t -160.53 173.82 14.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.7 110.86 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.71 -17.59 14.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 1.56 110.858 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -95.76 12.52 29.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 1.53 110.911 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.676 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -81.61 165.18 21.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.25 110.952 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.698 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.44 130.24 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.18 110.973 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.2 m-85 -74.34 133.44 42.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 1.8 110.877 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.04 145.19 20.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.22 111.156 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.576 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.6 tt0 -98.97 129.26 45.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.91 110.957 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.54 151.2 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.21 111.102 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.456 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.1 t -134.91 161.56 34.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.25 111.141 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.43 139.5 7.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.712 -0.756 . . . . 0.19 112.476 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -97.56 140.62 31.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.874 0.368 . . . . 1.62 110.889 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 5.2 tptt -80.71 134.79 53.28 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.599 0.714 . . . . 2.32 110.877 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 119.19 6.18 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.681 2.254 . . . . 0.39 112.301 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -102.3 152.0 21.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.37 110.883 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -71.51 81.44 0.8 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 6.84 110.92 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -179.26 34.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 10.14 110.865 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.0 t -149.92 -72.77 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 6.86 111.105 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 97.41 28.11 8.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 6.09 112.487 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.5 m -55.03 -60.78 2.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.384 . . . . 7.74 110.879 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.4 -74.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 6.38 110.896 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 11.01 110.893 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.418 ' O ' HD12 ' A' ' 6' ' ' ILE . 5.1 ptp . . . . . 0 N--CA 1.458 -0.036 0 CA-C-O 120.784 0.326 . . . . 3.9 110.893 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.6 -21.07 65.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.5 111.098 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.1 -51.42 64.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 1.97 110.802 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' A' ' 6' ' ' ILE . 4.5 m-85 -122.14 21.4 10.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 1.53 110.898 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 54.46 41.82 73.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.768 -0.73 . . . . 0.31 112.451 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.538 HG23 HG21 ' A' ' 12' ' ' VAL . 1.5 mp -83.14 160.4 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.32 111.137 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.733 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -156.62 168.99 25.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.82 110.831 -179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.8 132.28 35.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.46 111.034 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.05 1.31 30.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.28 112.482 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -118.18 166.95 11.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.781 0.324 . . . . 1.2 110.933 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.67 113.05 26.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 2.17 110.899 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 62' ' ' ILE . 95.3 t -117.35 132.52 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 1.92 111.136 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.793 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -109.03 125.29 51.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 0.23 111.057 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.828 HG11 HG12 ' A' ' 29' ' ' VAL . 99.6 t -98.35 120.37 47.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.16 111.144 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.31 118.45 51.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.2 111.134 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -118.6 168.85 10.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 0.19 110.912 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -151.48 -169.91 3.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.267 -0.424 . . . . 1.85 110.857 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -57.63 -35.49 70.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 3.02 110.882 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.61 -9.51 58.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 1.21 110.848 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.92 94.62 10.92 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.748 0.785 . . . . 0.15 110.923 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 142.11 47.33 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.657 2.238 . . . . 0.23 112.34 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.13 -32.57 5.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.284 -0.416 . . . . 0.21 111.108 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.28 -52.92 40.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 2.59 110.907 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.9 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.19 111.155 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.6 -61.41 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.15 110.918 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -49.6 -36.01 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 2.49 110.901 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.21 -47.22 45.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 0.2 112.47 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 mt -61.96 -38.57 89.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.755 0.312 . . . . 0.52 110.87 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.828 HG12 HG11 ' A' ' 14' ' ' VAL . 17.0 m -78.21 -31.09 16.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.63 111.079 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -62.54 -57.86 9.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 1.69 110.852 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -40.01 75.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 1.75 110.94 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.886 HD23 HD21 ' A' ' 35' ' ' LEU . 88.1 mt -73.17 -24.77 60.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.24 110.89 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.547 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.5 -25.03 45.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.38 110.825 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.74 -30.36 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 0.22 111.026 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.886 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.81 -34.93 15.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.21 110.905 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.79 -46.06 4.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.21 111.139 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.83 -12.62 54.42 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.828 -0.701 . . . . 0.25 112.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -65.61 -62.6 1.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.754 0.311 . . . . 2.18 110.938 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -96.33 -37.85 10.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 2.56 110.931 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.13 -129.87 5.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 0.26 112.497 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -152.59 152.03 31.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.88 0.371 . . . . 2.18 110.885 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.547 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.0 t -136.33 124.83 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.22 111.036 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -114.07 155.83 25.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.15 110.9 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.2 p -118.52 134.8 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.14 111.141 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -142.76 151.3 41.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 1.26 110.864 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -103.3 134.99 45.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 0.4 110.906 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.673 ' CD1' HG21 ' A' ' 73' ' ' THR . 26.4 mt -52.17 -36.12 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.28 111.128 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -71.54 -32.25 67.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 2.01 110.877 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -103.18 20.11 18.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.225 -0.443 . . . . 3.61 110.856 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.833 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.32 -28.08 4.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 1.07 110.899 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.53 -33.46 63.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 1.05 110.9 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -84.06 -15.15 48.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.438 . . . . 1.06 110.969 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.454 ' HB2' HD13 ' A' ' 50' ' ' LEU . 34.5 m -66.55 -10.13 41.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.137 -0.483 . . . . 0.87 110.859 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.5 63.87 0.83 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.27 111.059 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -64.02 -67.64 0.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.36 110.873 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -153.85 -178.22 6.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 1.38 110.849 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -92.63 130.52 38.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.437 . . . . 1.83 110.885 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 t 51.79 83.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 2.11 110.879 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.4 p -136.06 -39.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.28 110.773 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.7 m-85 -100.51 122.25 42.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 2.03 110.975 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.404 ' HA ' ' HB2' ' A' ' 88' ' ' ARG . 1.5 m-20 -71.73 -21.9 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 1.73 110.853 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.693 ' HB ' HG22 ' A' ' 12' ' ' VAL . 21.4 mt -145.34 144.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.22 111.087 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.93 HG21 HG23 ' A' ' 83' ' ' ILE . 17.2 mm -133.75 132.7 56.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 0.13 111.104 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -114.58 136.88 52.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.15 110.916 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.44 100.33 5.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.13 110.854 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.54 74.97 0.24 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.739 . . . . 0.16 112.446 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.556 HD13 ' OE1' ' A' ' 158' ' ' GLN . 3.9 mm? -107.45 58.19 0.62 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.866 0.365 . . . . 0.57 110.928 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.0 159.65 63.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.611 0.719 . . . . 0.23 111.146 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.86 116.73 4.7 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.601 2.201 . . . . 0.26 112.355 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.46 7.13 69.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.841 -0.695 . . . . 0.17 112.465 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.55 150.24 12.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.939 0.4 . . . . 0.68 110.87 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.773 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 39.5 p -138.98 108.45 6.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.21 111.127 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.673 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.14 153.44 18.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.25 111.239 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.879 HD12 HD22 ' A' ' 147' ' ' LEU . 3.3 mt -132.77 104.57 6.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.28 110.856 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -81.16 153.74 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.26 110.885 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.1 m -131.56 -176.29 3.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.43 110.925 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.8 -36.93 70.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.23 111.106 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.59 -46.48 88.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 2.32 110.874 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.833 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -73.04 -54.96 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.198 -0.455 . . . . 0.2 111.079 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.556 HD13 ' HA ' ' A' ' 119' ' ' LEU . 65.2 mt -50.72 -40.18 53.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.19 110.96 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.02 -53.94 35.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.053 -0.521 . . . . 0.3 111.15 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.23 -44.8 88.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 3.01 110.868 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.93 HG23 HG21 ' A' ' 63' ' ' ILE . 38.7 mm -55.67 -68.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 0.2 111.099 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.33 -37.82 49.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.21 111.187 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.9 tpp180 -55.11 -49.83 70.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 3.35 110.898 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 56' ' ' LYS . 34.3 pt -85.21 -7.02 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.2 111.108 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.95 111.78 14.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.142 -0.481 . . . . 0.38 110.9 179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.404 ' HB2' ' HA ' ' A' ' 61' ' ' ASP . 48.8 mtt180 -51.46 159.53 1.17 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.59 0.71 . . . . 2.24 110.852 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 114.44 3.7 Favored 'Trans proline' 0 N--CA 1.466 -0.113 0 C-N-CA 122.786 2.324 . . . . 0.16 112.342 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.77 2.41 56.25 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.662 -0.78 . . . . 0.15 112.416 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.28 -162.57 13.62 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.647 -0.787 . . . . 0.13 112.551 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.2 m -138.32 156.03 48.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.832 0.349 . . . . 0.35 110.9 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.704 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -140.01 114.31 9.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 0.16 110.974 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.554 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.0 m-85 -108.46 132.34 53.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 1.65 110.897 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.576 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.51 162.31 39.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.459 . . . . 0.13 110.845 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.05 129.35 35.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 1.88 110.842 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.72 148.65 20.85 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.655 0.74 . . . . 3.71 110.854 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.617 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.1 Cg_endo -69.82 140.88 43.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.61 2.206 . . . . 0.18 112.309 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.9 m -125.86 146.67 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.155 -0.475 . . . . 0.22 111.099 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' CD ' HG21 ' A' ' 103' ' ' VAL . 46.8 mt-10 -108.89 132.75 53.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 2.06 110.953 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p -90.94 -42.68 10.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 1.29 111.091 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.559 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.5 40.73 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.59 111.111 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' CD ' ' A' ' 100' ' ' GLU . 26.4 t -148.03 150.05 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.63 111.069 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.647 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -52.86 171.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 1.69 110.854 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -66.37 -54.17 27.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.148 -0.478 . . . . 2.83 110.96 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -70.66 -75.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 1.69 110.837 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t 52.31 -169.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.034 0.445 . . . . 2.2 110.841 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.7 pttt -81.71 -4.69 56.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 1.77 110.877 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.12 150.4 21.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.4 111.043 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.18 119.2 13.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 2.97 110.844 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.647 HG21 ' O ' ' A' ' 104' ' ' ASP . 62.8 p -91.81 178.86 5.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.29 111.201 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.4 -53.61 55.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.2 111.127 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -61.06 -47.16 87.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.26 110.819 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.36 -42.25 91.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 2.47 110.889 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -61.82 -57.43 11.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.48 110.886 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 66.6 m -52.05 -44.97 64.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.23 110.888 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -42.06 87.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.29 110.824 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.11 97.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.22 111.095 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.556 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.0 tp -66.2 -50.93 62.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.23 110.987 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.0 m -61.99 -33.31 74.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.31 111.138 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.87 -10.45 53.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.66 110.897 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.72 5.25 29.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 1.7 110.872 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.81 11.23 25.09 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.647 -0.787 . . . . 0.68 112.38 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.704 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -112.13 171.0 7.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 0.26 110.883 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.2 m -150.9 170.19 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.21 111.168 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 53.01 44.41 30.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.192 -0.458 . . . . 2.32 110.92 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.4 t -81.04 142.94 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.25 111.174 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.93 158.58 7.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 1.59 110.866 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -77.23 145.68 37.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 2.28 110.784 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.502 HD11 ' N ' ' A' ' 160' ' ' THR . 2.1 mp -105.15 -35.55 7.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 0.23 110.975 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.1 176.42 12.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 1.09 110.879 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.72 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -131.86 137.4 48.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 4.12 110.907 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -124.02 137.65 29.29 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.604 0.716 . . . . 1.83 110.874 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.426 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.9 Cg_endo -69.74 165.02 32.34 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.693 2.262 . . . . 0.22 112.353 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.671 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.15 127.47 44.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.27 110.914 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.434 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.21 161.1 24.71 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.599 0.714 . . . . 1.21 111.145 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.434 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.6 Cg_endo -69.76 -28.79 24.83 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.625 2.217 . . . . 0.32 112.307 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -85.24 -17.86 35.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 2.77 110.924 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.23 -53.25 4.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 2.33 110.909 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.22 -40.65 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 0.25 111.123 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.402 HE21 ' N ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -68.77 -34.86 76.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.493 . . . . 1.18 110.926 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.402 ' N ' HE21 ' A' ' 141' ' ' GLN . 0.3 OUTLIER -67.86 -46.18 72.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.22 110.904 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 8.5 p -68.38 -30.19 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.077 -0.51 . . . . 0.18 111.2 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -75.64 -32.59 60.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.81 110.834 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -89.54 -20.18 24.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 1.72 110.877 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -94.11 -32.81 13.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.32 110.887 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.879 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.98 -54.25 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.36 110.85 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.65 8.02 2.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.712 -0.756 . . . . 0.32 112.459 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -70.2 121.26 17.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.784 0.326 . . . . 0.7 110.822 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -152.32 104.72 2.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 3.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.5 t -161.03 172.13 17.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.61 110.879 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.28 -11.57 15.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 1.57 110.864 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.559 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 4.9 m-80 -99.92 14.29 30.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 1.55 110.923 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.671 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -87.39 165.86 15.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.34 110.866 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.72 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -171.46 130.06 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.19 111.023 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.773 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.4 m-85 -72.7 132.31 43.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 1.7 110.883 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.17 143.89 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.22 111.148 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.556 ' OE1' HD13 ' A' ' 67' ' ' LEU . 3.0 tt0 -98.69 133.08 43.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 1.86 110.848 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.73 148.14 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.48 111.205 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.502 ' N ' HD11 ' A' ' 130' ' ' LEU . 6.1 t -132.62 156.06 47.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.29 111.122 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -145.58 139.11 8.04 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.19 112.465 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -96.74 132.7 42.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.857 0.36 . . . . 3.5 110.926 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.02 135.3 77.08 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.597 0.713 . . . . 1.2 110.887 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 128.22 15.6 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.631 2.221 . . . . 0.31 112.32 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -108.83 150.56 27.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.091 -0.504 . . . . 0.3 110.887 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.3 t80 65.01 151.8 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 5.86 110.869 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -73.61 109.62 7.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 9.8 110.868 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.1 m -116.81 -27.03 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 5.37 111.123 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.82 38.11 63.74 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 5.26 112.464 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.3 p -130.4 175.94 8.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.874 0.369 . . . . 5.67 110.883 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.5 m 72.15 -69.44 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 6.3 110.803 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 6.54 110.863 -179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.624 ' O ' HD12 ' A' ' 6' ' ' ILE . 8.8 ttm . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.765 0.317 . . . . 8.62 110.903 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.94 -13.69 60.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 1.22 111.158 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.58 -51.38 65.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.157 -0.474 . . . . 3.23 110.926 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.514 ' HE1' HD12 ' A' ' 67' ' ' LEU . 2.9 m-85 -93.72 -14.98 25.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 2.07 110.869 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 75.5 48.59 10.37 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.725 -0.75 . . . . 0.39 112.45 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.824 HG23 HG21 ' A' ' 12' ' ' VAL . 1.2 mp -88.32 162.01 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.878 0.37 . . . . 0.6 111.136 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.64 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -150.34 170.01 20.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 1.74 110.811 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.67 133.36 34.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.4 111.109 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.21 -6.07 30.39 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.781 -0.723 . . . . 0.31 112.536 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -111.88 168.96 9.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 1.16 110.899 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.04 114.32 28.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 1.28 110.872 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.824 HG21 HG23 ' A' ' 6' ' ' ILE . 88.2 t -119.3 126.97 75.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 2.01 111.149 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.804 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -104.0 128.22 51.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.298 -0.41 . . . . 0.33 111.153 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.805 HG11 HG12 ' A' ' 29' ' ' VAL . 97.7 t -100.38 119.23 48.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.23 111.159 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.84 118.14 49.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 0.25 111.171 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -118.19 169.03 10.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.31 110.952 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' HB3' HD12 ' A' ' 47' ' ' ILE . 9.4 p-10 -151.67 -170.47 3.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 1.83 110.875 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -35.56 69.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 6.31 110.901 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.61 -9.36 58.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.34 110.87 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.93 94.43 10.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.613 0.72 . . . . 0.23 110.823 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 142.37 47.55 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.678 2.252 . . . . 0.3 112.45 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -49.07 -32.68 5.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.32 111.042 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -51.09 -52.93 38.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 2.51 110.878 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.62 -44.93 10.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 0.27 111.067 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.468 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.76 -61.3 2.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.23 110.929 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.55 -37.07 25.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 2.55 110.878 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -47.29 50.35 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.736 -0.745 . . . . 0.27 112.437 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 48.5 mt -61.75 -38.84 89.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.52 110.934 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.805 HG12 HG11 ' A' ' 14' ' ' VAL . 17.8 m -78.13 -30.77 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.64 111.11 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -62.52 -58.27 8.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 1.58 110.875 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -39.57 74.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 1.8 110.884 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.813 HD23 HD21 ' A' ' 35' ' ' LEU . 97.0 mt -73.36 -25.37 60.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.285 -0.416 . . . . 0.24 110.872 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.561 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -77.63 -24.81 49.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.477 . . . . 0.41 110.964 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.66 -29.7 16.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.29 111.179 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.813 HD21 HD23 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -91.49 -31.05 16.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.29 110.912 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -106.84 -45.47 4.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.254 -0.43 . . . . 0.26 111.15 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.44 -12.42 51.47 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.722 -0.751 . . . . 0.31 112.529 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.79 -62.71 1.41 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.79 0.329 . . . . 1.85 110.822 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -99.57 -36.5 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 2.65 110.861 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.22 -129.46 4.82 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.741 . . . . 0.26 112.448 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -154.9 152.01 29.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.357 . . . . 2.23 110.882 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.561 HG21 ' HA ' ' A' ' 33' ' ' GLN . 92.9 t -136.0 122.97 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.22 111.165 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.6 t -113.09 154.03 27.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.17 110.829 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 p -117.14 134.28 61.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.17 111.208 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -142.04 151.24 42.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 1.26 110.882 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -103.25 134.95 45.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.862 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.725 ' CD1' HG21 ' A' ' 73' ' ' THR . 29.5 mt -52.29 -36.54 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.32 111.092 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -70.79 -32.44 69.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 2.03 110.924 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.75 20.71 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 3.64 110.855 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.838 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.09 -27.84 3.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 1.07 110.899 -179.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -55.01 -33.09 62.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.259 -0.428 . . . . 1.02 110.937 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -84.81 -15.53 44.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 1.16 110.937 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.508 ' HB2' HD13 ' A' ' 50' ' ' LEU . 48.0 m -63.69 -12.73 36.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.113 -0.494 . . . . 0.87 110.899 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.443 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -74.13 61.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.3 111.082 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.403 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 11.9 m170 -63.03 -69.54 0.26 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 0.37 110.869 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.664 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.02 -168.75 2.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 1.16 110.957 179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -107.37 131.02 54.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.428 . . . . 1.73 110.923 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.25 73.5 0.21 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 1.2 110.829 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.2 p -127.76 -34.46 2.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.28 110.836 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.4 m-85 -99.29 118.34 35.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.158 -0.474 . . . . 1.42 110.849 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.78 -20.89 63.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.04 -0.527 . . . . 1.75 110.939 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.701 ' HB ' HG22 ' A' ' 12' ' ' VAL . 25.3 mt -146.98 144.88 19.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.26 111.116 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.864 HG21 HG23 ' A' ' 83' ' ' ILE . 15.9 mm -135.09 131.58 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.14 111.104 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -112.68 137.34 51.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.16 110.883 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.61 100.55 5.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.14 110.844 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.61 74.28 0.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 0.18 112.514 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.514 HD12 ' HE1' ' A' ' 4' ' ' PHE . 4.0 mm? -107.03 59.6 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.832 0.348 . . . . 0.6 110.879 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.84 159.77 66.7 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.542 0.687 . . . . 0.25 111.124 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.71 116.31 4.49 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.657 2.238 . . . . 0.26 112.426 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.58 6.42 68.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.763 -0.732 . . . . 0.2 112.493 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -56.03 150.55 13.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.66 110.896 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.765 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 37.2 p -140.24 108.59 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.22 111.148 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.725 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.15 147.67 12.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.25 111.049 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.941 HD12 HD22 ' A' ' 147' ' ' LEU . 2.4 mt -126.23 99.9 6.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.34 110.874 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -76.71 149.01 36.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.24 110.948 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.9 m -128.25 177.33 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 0.55 110.885 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.17 -37.77 48.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.23 111.101 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.82 -44.53 96.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.213 -0.448 . . . . 2.08 110.882 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.838 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.2 mp -74.94 -55.25 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.21 111.175 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 119' ' ' LEU . 61.0 mt -50.71 -38.64 48.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.24 110.876 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.19 -56.54 15.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.36 111.122 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.443 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -55.03 -42.39 72.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 2.76 110.862 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.864 HG23 HG21 ' A' ' 63' ' ' ILE . 50.2 mm -57.66 -68.3 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.22 111.097 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.71 -36.21 35.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 0.23 111.051 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -56.84 -52.3 65.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 2.79 110.881 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 56' ' ' LYS . 46.6 pt -82.29 -6.5 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.26 111.081 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -79.8 127.97 32.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.4 110.93 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -66.82 159.76 73.21 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.582 0.705 . . . . 2.25 110.835 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 114.33 3.67 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.2 112.328 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.8 2.75 56.2 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.772 -0.728 . . . . 0.24 112.531 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.76 -161.36 10.24 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.805 -0.712 . . . . 0.16 112.484 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 15.7 m -139.08 153.7 48.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.811 0.339 . . . . 0.36 110.954 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.707 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.06 114.47 10.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.2 110.883 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.555 ' N ' HD22 ' A' ' 93' ' ' LEU . 45.7 m-85 -108.79 133.47 52.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 1.64 110.956 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.51 159.12 44.37 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.445 . . . . 0.15 110.919 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.17 125.15 38.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 1.81 110.886 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.617 ' OE1' HD23 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -148.97 147.44 24.02 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.649 0.738 . . . . 2.48 110.897 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.619 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.1 Cg_endo -69.81 145.23 56.25 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.654 2.236 . . . . 0.21 112.332 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.8 m -131.41 146.67 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.19 111.154 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -104.88 132.97 50.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.204 -0.453 . . . . 2.09 110.899 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 p -105.71 26.01 10.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 1.56 111.083 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -153.29 26.51 0.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.67 111.098 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.19 159.48 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.78 111.152 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.57 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -57.24 -179.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 1.97 110.837 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -66.09 -67.93 0.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 2.67 110.897 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -60.99 -75.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 2.55 110.913 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 54.63 -166.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 1.93 110.855 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -79.9 -7.97 59.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 2.07 110.872 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.645 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.0 m -145.16 150.13 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.981 0.42 . . . . 0.6 111.079 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -68.29 113.29 5.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.135 -0.484 . . . . 2.33 110.874 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.57 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.2 p -84.42 179.69 7.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.34 111.108 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.49 -53.34 59.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.249 -0.432 . . . . 0.2 111.136 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.74 -49.18 78.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.922 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -58.37 -40.91 83.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 2.61 110.909 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.488 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -61.97 -54.83 36.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.177 -0.465 . . . . 0.41 110.84 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 70.8 m -55.45 -47.79 75.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 0.24 110.89 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.61 -43.26 99.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.26 110.809 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.99 98.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.23 111.076 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.587 HD11 HD12 ' A' ' 93' ' ' LEU . 14.9 tp -65.8 -50.23 65.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.24 110.922 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 89.1 m -65.52 -30.73 71.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.108 -0.496 . . . . 0.25 111.204 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.429 HD23 ' HG2' ' A' ' 172' ' ' ARG . 18.5 mt -86.99 -10.47 53.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.58 110.942 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.19 5.52 29.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 1.8 110.847 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.04 5.19 35.47 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.747 -0.74 . . . . 0.56 112.468 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.707 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -105.45 172.48 6.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.26 110.88 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.486 HG23 ' HG3' ' A' ' 126' ' ' GLU . 28.2 m -151.14 171.38 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.29 111.078 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HG3' HG23 ' A' ' 125' ' ' VAL . 28.8 mt-10 55.16 43.53 29.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 2.04 110.924 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.506 HG13 HD23 ' A' ' 119' ' ' LEU . 97.9 t -77.7 140.91 16.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 0.32 111.124 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.16 159.79 7.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 1.61 110.899 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.08 147.44 30.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 2.18 110.939 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.754 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.5 mp -107.45 -36.43 6.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 0.18 110.957 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.1 176.24 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 1.15 110.9 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.731 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.9 tmt_? -132.35 137.27 47.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 4.33 110.942 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -124.38 138.72 31.47 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.635 0.731 . . . . 1.39 110.902 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.418 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.4 Cg_endo -69.86 163.43 38.39 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.653 2.235 . . . . 0.27 112.299 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.661 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -95.65 127.09 41.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.215 -0.448 . . . . 0.35 110.95 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.53 160.53 27.2 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.554 0.693 . . . . 1.28 111.105 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.7 Cg_endo -69.7 -29.2 24.53 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.68 2.253 . . . . 0.45 112.316 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -84.97 -19.06 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 2.98 110.876 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.81 -53.58 5.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 2.17 110.905 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -49.5 -41.93 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.29 111.158 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -33.86 72.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 1.37 110.872 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.94 -44.93 68.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.34 110.796 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.68 HG23 HD13 ' A' ' 147' ' ' LEU . 7.4 p -68.97 -31.59 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.21 111.188 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -76.65 -30.9 57.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.076 -0.511 . . . . 2.52 110.929 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -89.73 -20.62 23.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.221 -0.445 . . . . 1.78 110.919 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -95.01 -32.51 13.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.857 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.941 HD22 HD12 ' A' ' 74' ' ' LEU . 2.7 mp -127.18 -54.06 1.38 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.42 110.891 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.37 10.51 2.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.71 -0.757 . . . . 0.48 112.472 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.645 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.8 t-160 -70.08 120.42 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.711 0.291 . . . . 1.2 110.869 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.44 112.3 4.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 3.02 110.897 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.66 172.17 17.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.21 -0.45 . . . . 1.06 110.865 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.56 -9.35 16.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.136 -0.484 . . . . 2.18 110.86 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -110.63 13.35 22.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.174 -0.466 . . . . 1.85 110.925 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.661 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -75.57 164.86 25.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.15 -0.477 . . . . 0.27 110.912 179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -173.92 130.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.21 110.901 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.765 ' CZ ' HG22 ' A' ' 72' ' ' THR . 32.3 m-85 -74.29 131.77 41.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 1.79 110.879 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.94 140.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.2 111.114 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.754 ' HG2' HD13 ' A' ' 130' ' ' LEU . 11.0 tt0 -93.65 128.5 39.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 2.3 110.895 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.01 151.73 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.24 111.239 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.46 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.6 t -131.4 159.32 38.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.252 -0.431 . . . . 0.28 111.168 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.478 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -149.33 129.9 3.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.774 -0.727 . . . . 0.25 112.527 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -89.52 139.28 30.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 1.55 110.925 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.24 135.27 50.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.587 0.708 . . . . 1.62 110.906 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 129.65 18.03 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.731 2.287 . . . . 0.41 112.361 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -109.8 149.32 29.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.298 -0.41 . . . . 0.49 110.922 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 30.1 t80 64.97 151.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.267 -0.424 . . . . 5.67 110.876 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.86 173.83 0.96 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 10.21 110.856 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.6 m -151.98 -41.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.046 -0.525 . . . . 6.03 111.121 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 129.04 -45.98 1.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.803 -0.713 . . . . 7.46 112.518 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.15 -73.81 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.376 . . . . 8.15 110.81 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.7 m 56.54 -176.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 5.78 110.843 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.429 ' HG2' HD23 ' A' ' 121' ' ' LEU . 7.9 tmm_? . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.472 . . . . 6.78 110.889 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.759 0.314 . . . . 3.59 110.87 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.97 -20.79 65.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.44 111.095 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -54.04 -51.2 64.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 2.2 110.953 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -122.33 21.64 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 1.52 110.89 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.82 39.98 56.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.78 -0.724 . . . . 0.23 112.507 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.52 HG23 HG21 ' A' ' 12' ' ' VAL . 1.7 mp -77.97 159.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.857 0.36 . . . . 0.22 111.164 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.738 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -151.55 162.21 41.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 1.44 110.934 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.4 126.34 35.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.28 111.135 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.06 -2.59 19.24 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.735 -0.745 . . . . 0.27 112.433 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -115.49 170.49 8.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.842 0.353 . . . . 1.1 110.9 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.87 114.14 28.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 2.23 110.929 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.693 HG22 ' HB ' ' A' ' 62' ' ' ILE . 92.4 t -119.28 125.38 74.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.117 -0.492 . . . . 1.98 111.154 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.766 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -102.79 129.96 49.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.182 -0.463 . . . . 0.32 111.125 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.831 HG11 HG12 ' A' ' 29' ' ' VAL . 60.3 t -101.3 119.92 50.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.18 111.146 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.24 118.35 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.21 111.074 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -118.5 169.24 9.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.498 . . . . 0.19 110.898 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -151.49 -170.72 3.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.136 -0.483 . . . . 1.78 110.899 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -57.06 -35.67 69.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 3.09 110.9 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -73.28 -9.59 58.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 1.27 110.848 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.02 94.44 10.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.647 0.737 . . . . 0.15 110.855 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 142.23 47.11 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.662 2.242 . . . . 0.21 112.359 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -48.83 -32.75 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.2 111.122 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.13 -53.04 37.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 2.69 110.893 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -44.89 10.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.17 111.055 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.476 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.6 -61.46 2.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 0.14 110.976 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.48 -36.96 24.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 2.8 110.867 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.72 -47.14 50.4 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.689 -0.767 . . . . 0.19 112.523 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 mt -61.83 -39.29 91.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.768 0.318 . . . . 0.46 110.872 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.831 HG12 HG11 ' A' ' 14' ' ' VAL . 17.5 m -77.69 -31.19 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.63 111.075 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.29 -58.56 7.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 1.55 110.845 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -39.94 74.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 1.73 110.945 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.892 HD23 HD21 ' A' ' 35' ' ' LEU . 85.1 mt -73.07 -24.67 60.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.23 110.996 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.486 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.55 -25.18 45.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.127 -0.488 . . . . 0.37 110.947 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 -29.9 17.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.22 111.163 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.892 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.42 -35.21 14.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.18 110.853 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.738 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.9 -45.86 4.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.21 111.091 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.47 -12.87 53.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 0.27 112.456 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -69.17 -62.58 1.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.81 0.338 . . . . 2.5 110.897 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -90.08 -40.85 12.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.96 110.921 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.43 -130.04 6.3 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.741 -0.742 . . . . 0.25 112.553 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -150.23 152.87 35.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.887 0.375 . . . . 2.2 110.928 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 33' ' ' GLN . 96.6 t -136.4 125.44 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.22 111.146 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -114.53 156.89 23.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.24 -0.436 . . . . 0.16 110.814 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.0 p -118.53 135.04 60.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 0.15 111.108 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -143.14 151.31 40.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 2.01 110.868 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -103.22 134.9 45.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.193 -0.458 . . . . 0.4 110.854 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.729 ' CD1' HG21 ' A' ' 73' ' ' THR . 29.1 mt -52.4 -36.51 21.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.27 111.108 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -70.87 -32.13 69.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 2.0 110.868 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.87 20.62 17.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 3.54 110.92 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.83 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.09 -27.94 3.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 1.07 110.918 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -55.26 -33.37 63.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 1.07 110.938 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -84.62 -15.14 46.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 1.18 110.935 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.459 ' HB2' HD13 ' A' ' 50' ' ' LEU . 45.5 m -64.64 -11.61 37.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.87 110.796 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.33 61.42 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.28 111.023 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.401 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 11.9 m170 -62.8 -69.74 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.4 110.865 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.661 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.97 -168.64 2.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.313 -0.403 . . . . 1.12 111.045 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.13 130.55 54.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.335 -0.393 . . . . 1.81 110.944 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.38 73.82 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 1.21 110.853 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.8 p -127.93 -34.59 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.26 110.832 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.545 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.2 m-85 -98.85 117.9 34.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 1.43 110.921 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.41 -20.36 63.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 1.48 110.887 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.693 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.1 mt -148.05 144.91 18.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.25 111.142 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.915 HG21 HG23 ' A' ' 83' ' ' ILE . 20.6 mm -135.28 130.1 50.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.18 111.113 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -110.46 137.29 48.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.16 110.897 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.56 100.63 5.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 0.13 110.84 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.74 76.0 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.15 112.458 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -108.35 58.21 0.61 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.59 110.902 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.54 160.11 62.25 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 121.618 0.723 . . . . 0.22 111.18 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 116.64 4.66 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.672 2.248 . . . . 0.24 112.361 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.1 7.39 70.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.741 -0.742 . . . . 0.16 112.537 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.49 149.75 13.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.408 . . . . 0.68 110.839 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.768 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 31.1 p -138.73 108.58 6.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.085 -0.507 . . . . 0.17 111.117 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.729 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.96 146.52 10.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.24 111.102 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.92 HD12 HD22 ' A' ' 147' ' ' LEU . 4.1 mt -125.36 103.37 7.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.167 -0.469 . . . . 0.21 110.843 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -79.75 151.49 30.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.24 110.809 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -130.59 177.14 7.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.48 110.885 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.49 -37.99 51.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.32 111.166 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -61.48 -45.68 93.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 1.75 110.885 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.83 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -73.63 -55.41 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.23 111.07 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.0 mt -50.63 -38.68 47.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.26 110.875 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.8 -55.13 29.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 0.29 111.056 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.32 -42.34 77.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 2.76 110.935 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.915 HG23 HG21 ' A' ' 63' ' ' ILE . 44.9 mm -58.62 -68.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.128 -0.487 . . . . 0.26 111.054 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.74 -36.06 24.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.21 111.028 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -54.58 45.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.257 -0.429 . . . . 2.19 110.861 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 56' ' ' LYS . 47.5 pt -79.39 -5.89 8.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.28 111.192 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -81.73 127.99 33.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.45 110.847 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -65.7 158.77 72.96 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.669 0.747 . . . . 2.28 110.867 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 114.1 3.59 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.67 2.246 . . . . 0.2 112.34 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.28 2.72 54.11 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.753 -0.737 . . . . 0.16 112.476 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.63 -163.48 16.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.759 -0.734 . . . . 0.15 112.505 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 67.6 m -135.75 153.48 51.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.849 0.357 . . . . 0.3 110.833 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.662 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.56 114.36 10.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 0.16 110.88 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.541 ' N ' HD22 ' A' ' 93' ' ' LEU . 50.2 m-85 -108.82 133.34 53.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 1.9 110.949 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.563 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.86 164.11 35.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 0.14 110.959 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.74 130.46 36.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 1.85 110.915 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.598 ' OE1' HD23 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -153.95 147.75 18.68 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.588 0.709 . . . . 2.34 110.896 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.639 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.0 Cg_endo -69.81 141.58 45.39 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.594 2.196 . . . . 0.17 112.361 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.78 146.66 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.18 111.135 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' CD ' HG21 ' A' ' 103' ' ' VAL . 51.9 mt-10 -109.7 132.64 53.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 2.07 110.827 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.4 p -91.62 -42.23 10.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 1.18 111.061 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.77 39.94 1.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.259 -0.428 . . . . 0.59 111.096 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' CD ' ' A' ' 100' ' ' GLU . 22.7 t -147.59 150.4 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.187 -0.461 . . . . 0.63 111.099 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.573 ' O ' HG21 ' A' ' 111' ' ' THR . 0.4 OUTLIER -52.94 170.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 1.77 110.836 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -64.35 -57.39 9.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 2.57 110.864 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.99 -75.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 1.63 110.87 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.5 t 52.38 -168.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 2.14 110.906 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.37 -6.8 58.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 1.98 110.865 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.437 HG11 ' CG ' ' A' ' 149' ' ' HIS . 2.9 m -140.09 142.63 31.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.4 111.248 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -65.35 111.05 2.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.21 -0.45 . . . . 2.46 110.907 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 104' ' ' ASP . 47.5 p -82.13 -177.72 6.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.23 111.161 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.13 -52.32 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.17 111.132 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.32 -49.77 75.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.21 110.877 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -56.87 -38.86 73.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.092 -0.504 . . . . 1.66 110.838 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -64.89 -54.56 28.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.31 110.927 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.2 m -58.13 -46.24 85.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.24 110.925 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -43.0 94.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.498 . . . . 0.29 110.919 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.51 98.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.21 111.107 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 93' ' ' LEU . 15.5 tp -65.13 -51.65 59.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.216 -0.447 . . . . 0.32 110.909 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.1 m -63.92 -31.16 72.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.25 111.084 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.3 mt -86.79 -10.48 53.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.74 110.893 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.12 5.69 28.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 1.71 110.88 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.13 5.12 35.33 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.806 -0.712 . . . . 0.48 112.523 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.662 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.1 tp -105.57 173.11 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.32 110.956 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.7 m -151.51 173.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.28 111.205 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 51.6 45.15 28.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 1.99 110.874 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.523 HG13 HD23 ' A' ' 119' ' ' LEU . 94.3 t -80.75 143.06 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.2 111.142 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.92 160.49 8.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 2.52 110.915 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -80.26 146.43 31.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 2.25 110.916 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.784 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -104.23 -37.1 7.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.166 -0.47 . . . . 0.23 110.936 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.0 pm0 -159.07 176.25 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 2.95 110.888 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.732 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.4 tmt_? -130.44 137.21 49.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 4.37 110.82 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -123.77 135.02 25.74 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.726 0.774 . . . . 1.8 110.9 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.425 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.2 Cg_endo -69.82 159.14 54.45 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.721 2.281 . . . . 0.26 112.351 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.668 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -91.97 151.65 20.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.57 110.948 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.531 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -133.65 162.91 54.78 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.498 0.666 . . . . 1.63 111.186 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.83 -23.72 30.17 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.669 2.246 . . . . 0.57 112.293 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -86.26 -23.82 26.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 2.47 110.809 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -87.82 -52.72 5.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 3.95 110.927 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 136' ' ' THR . 7.3 p -50.4 -39.52 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.116 -0.493 . . . . 0.29 111.128 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -32.64 73.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.477 . . . . 1.11 110.97 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.49 -46.74 63.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.29 110.856 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.706 HG23 HD13 ' A' ' 147' ' ' LEU . 9.7 p -68.19 -29.75 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 0.21 111.091 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -76.45 -33.3 58.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 3.12 110.885 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -88.88 -19.98 25.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 1.84 110.822 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -94.69 -32.26 13.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.34 110.924 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.92 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.31 -54.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 0.35 110.869 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.77 8.1 2.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.658 -0.782 . . . . 0.32 112.518 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.437 ' CG ' HG11 ' A' ' 109' ' ' VAL . 15.0 t-160 -69.94 121.62 17.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.709 0.29 . . . . 0.64 110.87 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -151.93 104.99 3.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 3.37 110.906 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 6.6 t -160.8 171.02 19.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.61 110.868 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.22 -11.85 15.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 1.94 110.877 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.527 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 5.7 m-80 -99.57 14.39 30.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 1.6 110.894 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -87.51 168.92 12.65 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.34 110.824 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.732 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -172.16 130.36 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.18 110.894 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.768 ' CZ ' HG22 ' A' ' 72' ' ' THR . 19.4 m-85 -74.31 132.81 42.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 1.82 110.897 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.26 147.96 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.22 111.077 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.784 ' HG2' HD13 ' A' ' 130' ' ' LEU . 8.7 tt0 -101.67 135.6 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 2.06 110.938 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.41 149.18 32.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.233 -0.44 . . . . 0.22 111.148 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.477 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.2 t -129.55 159.47 36.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.25 111.196 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.49 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -149.93 134.3 4.78 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.731 -0.747 . . . . 0.15 112.483 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -94.44 140.77 29.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 1.55 110.942 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -81.49 134.79 50.68 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.606 0.717 . . . . 1.94 110.886 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 119.76 6.65 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.714 2.276 . . . . 0.35 112.319 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -103.34 151.91 22.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 0.32 110.866 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 32.4 t80 64.63 112.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 6.04 110.887 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 62.08 89.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 9.17 110.926 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 25.0 m -59.9 140.85 17.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 9.61 111.116 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -141.78 38.22 1.52 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.789 -0.719 . . . . 8.0 112.554 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 11.8 p -85.74 82.81 8.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.878 0.37 . . . . 11.79 110.862 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 1.8 m -56.71 -68.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 8.87 110.833 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 10.1 ttt-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 11.78 110.905 -179.895 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.677 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.6 mmm . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.747 0.308 . . . . 8.15 110.933 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.37 -16.09 55.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 1.01 111.044 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -55.05 -51.92 64.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 2.55 110.804 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.461 ' CE1' HD12 ' A' ' 67' ' ' LEU . 5.5 m-85 -109.48 23.26 14.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 1.66 110.94 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.04 41.96 53.72 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.78 -0.724 . . . . 0.45 112.485 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.677 HD12 ' O ' ' A' ' 1' ' ' MET . 1.7 mp -81.31 158.99 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.811 0.339 . . . . 0.31 111.129 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.601 ' O ' HG23 ' A' ' 36' ' ' THR . 37.2 m -146.18 156.35 43.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 1.12 110.863 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.32 127.41 34.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.42 111.143 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.81 -7.48 21.94 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.74 -0.743 . . . . 0.27 112.513 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -108.17 170.39 8.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 1.57 110.942 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.92 110.7 22.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 1.34 110.836 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.697 HG12 HG21 ' A' ' 36' ' ' THR . 2.3 p -117.2 129.6 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 2.01 111.168 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.757 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -104.59 130.35 52.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.3 111.101 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.847 HG11 HG12 ' A' ' 29' ' ' VAL . 97.6 t -99.79 117.78 45.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.16 111.158 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.482 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.3 t -101.54 113.63 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.21 111.21 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -114.51 167.64 10.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 0.19 110.919 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.452 ' HB3' HD12 ' A' ' 47' ' ' ILE . 9.9 p-10 -151.53 -169.59 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 1.79 110.812 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -35.87 69.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 6.79 110.876 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 -11.26 60.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 1.13 110.889 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.67 92.87 9.3 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.609 0.718 . . . . 0.22 110.871 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.72 143.53 51.32 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.26 112.336 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -48.76 -32.55 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.2 111.125 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.02 -53.57 32.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 2.48 110.895 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.79 -44.75 10.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.17 111.116 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.482 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.2 -61.32 2.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.14 110.916 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -49.79 -38.35 34.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 2.69 110.813 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.61 -47.58 55.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.8 -0.714 . . . . 0.23 112.428 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.46 -40.26 93.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.366 . . . . 0.59 110.897 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.847 HG12 HG11 ' A' ' 14' ' ' VAL . 18.1 m -76.72 -31.04 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.63 111.209 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -62.03 -60.07 4.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.183 -0.462 . . . . 1.57 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -40.79 71.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 1.87 110.958 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.821 HD23 HD21 ' A' ' 35' ' ' LEU . 92.8 mt -72.27 -25.2 61.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.38 110.887 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.426 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.09 -24.18 47.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.39 110.885 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.72 -30.03 17.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.28 111.115 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.821 HD21 HD23 ' A' ' 32' ' ' LEU . 1.6 pp -91.59 -35.34 14.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.27 110.882 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.697 HG21 HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -101.88 -45.28 5.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.25 111.178 179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.78 -12.72 49.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.679 -0.772 . . . . 0.29 112.537 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -67.04 -62.74 1.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.786 0.327 . . . . 1.98 110.883 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -94.66 -39.32 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 2.07 110.958 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.51 -135.2 7.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.801 . . . . 0.38 112.504 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -147.74 151.44 36.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.898 0.38 . . . . 2.22 110.794 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.426 HG21 ' HA ' ' A' ' 33' ' ' GLN . 91.9 t -135.94 117.82 20.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 0.33 111.114 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.4 t -106.93 157.19 17.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.26 110.85 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.22 133.81 64.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.064 -0.517 . . . . 0.21 111.142 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -143.69 151.79 40.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 1.27 110.892 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.6 135.21 44.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.41 110.825 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.771 ' HA ' HD12 ' A' ' 50' ' ' LEU . 45.3 mt -52.37 -35.87 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 0.36 111.103 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.21 -31.81 66.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 2.22 110.853 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -105.22 20.32 19.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 3.6 110.896 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.983 HD13 HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -51.78 -26.14 9.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 2.72 110.94 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.7 mp -53.68 -32.91 53.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 1.14 110.945 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -84.97 -15.76 43.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 1.09 110.906 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.4 m -64.46 -12.21 41.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 0.88 110.888 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.47 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -73.93 61.34 0.79 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.112 -0.494 . . . . 0.4 111.184 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -59.48 -71.76 0.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.58 110.796 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.27 -168.23 2.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 1.35 110.956 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -102.27 116.58 32.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 2.22 110.869 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.1 t 60.16 84.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 1.97 110.839 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.0 p -134.84 -37.24 0.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.492 . . . . 0.28 110.836 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.1 m-85 -96.84 121.98 39.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.059 -0.519 . . . . 2.01 110.78 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.21 -19.7 60.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 1.51 110.845 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.7 mt -145.26 143.95 21.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.22 111.112 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.941 HG21 HG23 ' A' ' 83' ' ' ILE . 22.1 mm -136.51 127.69 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.17 111.036 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.3 mm? -109.77 137.87 46.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.18 110.95 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.8 100.04 5.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.16 110.866 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.87 74.63 0.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 0.18 112.518 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.619 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.1 mm? -105.29 58.18 0.68 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.82 0.343 . . . . 0.61 110.902 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.92 160.01 61.44 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.659 0.742 . . . . 0.23 111.108 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.74 123.88 10.54 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.726 2.284 . . . . 0.31 112.33 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.46 7.11 88.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.667 -0.778 . . . . 0.2 112.535 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 68' ' ' VAL . 8.2 p -55.9 151.58 11.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.958 0.409 . . . . 0.74 110.843 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.74 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.3 p -140.58 109.04 5.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 0.23 111.101 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.574 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.12 143.19 12.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.32 111.183 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.972 HD12 HD22 ' A' ' 147' ' ' LEU . 4.8 mt -119.98 102.37 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 0.25 110.93 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -79.1 144.22 34.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.29 110.844 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.6 m -124.38 174.92 7.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.42 110.908 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.94 -40.34 57.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.3 111.128 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.99 -45.78 91.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 1.96 110.898 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.983 HG23 HD13 ' A' ' 50' ' ' LEU . 4.3 mp -72.07 -55.38 13.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.138 -0.483 . . . . 0.31 111.132 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.541 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.9 mt -50.67 -38.54 47.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.057 -0.52 . . . . 0.28 110.946 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.9 -56.13 13.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.39 111.021 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -54.56 -44.94 73.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.343 -0.39 . . . . 2.84 110.855 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.941 HG23 HG21 ' A' ' 63' ' ' ILE . 37.9 mm -56.08 -68.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.24 111.098 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.54 -39.65 49.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.28 111.134 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 -52.56 -49.63 64.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 3.2 110.829 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 56' ' ' LYS . 41.0 pt -88.18 -4.05 9.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.282 -0.417 . . . . 0.27 111.102 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -82.04 112.44 19.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.32 110.941 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -52.45 157.68 2.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.645 0.736 . . . . 3.05 110.816 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 113.98 3.55 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.725 2.283 . . . . 0.38 112.326 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.41 2.72 50.67 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.811 -0.709 . . . . 0.23 112.563 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.78 -165.13 21.61 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.664 -0.779 . . . . 0.18 112.418 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 90.9 m -133.22 151.91 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.349 . . . . 0.46 110.893 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.703 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -136.58 115.22 12.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.15 110.934 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.549 ' N ' HD22 ' A' ' 93' ' ' LEU . 54.7 m-85 -110.33 132.05 54.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.116 -0.493 . . . . 1.91 110.877 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.551 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.66 163.17 38.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.12 110.891 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.91 126.89 29.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 1.85 110.784 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.533 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -148.65 149.27 30.57 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 121.65 0.738 . . . . 2.55 110.892 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.614 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.8 Cg_endo -69.71 139.38 40.28 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.66 2.24 . . . . 0.24 112.329 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.8 m -121.62 146.7 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.31 111.143 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.476 ' CD ' HG21 ' A' ' 103' ' ' VAL . 51.4 mt-10 -117.82 132.0 56.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.445 . . . . 1.86 110.887 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.0 p -91.93 -37.43 12.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 1.41 111.099 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.59 37.78 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.243 -0.435 . . . . 0.6 111.191 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.476 HG21 ' CD ' ' A' ' 100' ' ' GLU . 31.8 t -147.79 149.55 15.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.148 -0.478 . . . . 0.7 111.141 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.575 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -55.86 178.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.85 110.929 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -66.55 -70.44 0.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 2.64 110.896 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -57.57 -75.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 2.14 110.922 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.47 -169.55 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 1.6 110.78 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.0 -2.97 50.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.046 -0.524 . . . . 2.03 110.893 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.2 m -145.26 144.49 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.44 111.102 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.684 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -67.32 113.15 4.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 2.21 110.877 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 104' ' ' ASP . 60.3 p -84.33 177.45 8.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.21 111.204 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.33 -54.7 36.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 0.17 111.102 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -59.97 -50.24 74.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 0.21 110.85 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -38.8 71.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.148 -0.478 . . . . 2.12 110.893 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.533 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -64.51 -54.27 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.37 110.963 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.7 m -59.24 -46.78 87.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.21 110.851 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -44.03 95.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 0.29 110.874 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.27 98.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.086 -0.506 . . . . 0.21 111.195 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.541 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.9 tp -65.38 -50.76 64.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.26 110.913 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.2 m -63.51 -31.5 72.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.26 111.16 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 39.6 mt -87.0 -10.48 53.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.56 110.913 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.58 4.66 31.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.306 -0.406 . . . . 1.73 110.835 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.1 6.7 33.9 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.704 -0.76 . . . . 0.49 112.496 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -106.92 172.21 6.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.79 0.328 . . . . 0.27 110.985 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.5 m -151.71 174.27 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.269 -0.423 . . . . 0.35 111.103 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 52.68 43.9 30.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.096 -0.502 . . . . 2.15 110.88 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.0 143.29 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.26 111.097 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.06 160.19 8.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 1.62 110.85 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -82.34 139.55 34.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 2.98 110.87 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.548 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.5 mp -96.6 -37.92 10.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.24 110.899 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.05 176.3 12.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 1.11 110.941 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.694 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -129.44 141.27 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 4.01 110.89 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -129.18 136.82 29.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.599 0.714 . . . . 1.41 110.828 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.423 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.9 Cg_endo -69.69 165.16 31.82 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.667 2.245 . . . . 0.25 112.357 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.712 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -97.7 126.13 42.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.465 . . . . 0.29 110.936 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -103.62 160.88 24.72 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.615 0.721 . . . . 1.54 111.08 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -24.63 29.31 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.34 112.36 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -85.52 -22.09 28.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 2.49 110.893 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -87.53 -53.58 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 2.43 110.916 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 136' ' ' THR . 7.4 p -49.8 -40.36 15.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.29 111.142 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.05 -33.42 74.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 1.19 110.904 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.42 -46.44 66.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.266 -0.425 . . . . 0.26 110.845 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.0 p -68.51 -30.02 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.3 111.207 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -76.77 -31.57 57.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.075 -0.511 . . . . 2.36 110.9 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -89.57 -20.83 23.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.73 110.799 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.97 -32.0 13.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.44 110.927 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.972 HD22 HD12 ' A' ' 74' ' ' LEU . 2.1 mp -127.29 -54.68 1.36 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.48 110.845 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.53 13.55 2.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.749 -0.739 . . . . 0.43 112.527 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -70.65 121.51 18.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.85 110.807 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -151.74 105.87 3.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.232 -0.44 . . . . 2.85 110.872 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.9 t -160.51 170.47 20.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.82 110.852 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.61 -11.34 16.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 1.86 110.87 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -103.59 20.6 17.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 1.93 110.908 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.712 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -90.45 162.98 14.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.31 110.841 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.6 tm? -169.88 130.75 1.02 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.22 110.965 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.74 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.0 m-85 -75.85 135.57 40.19 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 1.78 110.956 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.0 144.27 18.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.29 111.128 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.619 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.7 tt0 -97.67 128.81 44.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 1.98 110.949 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.39 148.95 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.22 111.144 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.471 ' HB ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -127.35 159.62 33.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.3 111.097 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.447 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -150.43 132.13 3.83 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.701 -0.761 . . . . 0.16 112.454 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -94.65 140.35 29.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.814 0.34 . . . . 1.55 110.938 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -80.32 135.41 53.95 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.638 0.732 . . . . 1.65 110.929 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 120.01 6.87 Favored 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.724 2.283 . . . . 0.4 112.361 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -106.15 151.6 24.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.47 110.869 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 17.9 t80 59.92 20.28 9.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 6.24 110.97 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.87 -177.19 0.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.118 -0.492 . . . . 9.89 110.83 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 6.6 m -115.77 -26.48 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 9.11 111.111 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.7 -49.5 0.84 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.698 -0.763 . . . . 6.8 112.439 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.98 -49.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.906 0.384 . . . . 8.08 110.909 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.72 -63.9 0.56 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 9.72 110.864 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 9.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.479 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.822 0.344 . . . . 3.5 110.902 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.37 -19.61 56.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.69 111.177 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -54.41 -50.1 68.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 2.0 110.78 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -122.27 18.44 10.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 1.52 110.884 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.38 39.5 73.07 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.751 -0.738 . . . . 0.34 112.519 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 1' ' ' MET . 1.7 mp -76.85 157.53 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.842 0.353 . . . . 0.33 111.126 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 36' ' ' THR . 26.8 m -149.34 155.75 40.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.14 -0.482 . . . . 1.06 110.83 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.93 123.3 29.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.31 111.096 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.18 -12.06 14.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.796 -0.716 . . . . 0.41 112.52 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -103.61 168.66 9.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.812 0.339 . . . . 1.54 110.914 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -101.21 133.39 45.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 1.3 110.924 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.566 HG12 HG21 ' A' ' 36' ' ' THR . 1.8 p -138.38 134.59 43.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 2.13 111.16 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.755 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -110.35 127.4 55.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.21 111.114 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.824 HG11 HG12 ' A' ' 29' ' ' VAL . 59.2 t -97.63 117.95 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.22 111.131 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.481 HG12 ' CG1' ' A' ' 47' ' ' ILE . 13.6 t -102.35 110.25 28.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.26 111.116 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.4 p-90 -111.56 167.24 10.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.151 -0.477 . . . . 0.17 110.97 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.454 ' HB3' HD12 ' A' ' 47' ' ' ILE . 11.3 p-10 -151.0 -169.71 3.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.423 . . . . 1.84 110.874 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -56.68 -35.81 68.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.459 . . . . 2.92 110.903 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.62 -11.4 60.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 1.16 110.894 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.34 93.79 10.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.624 0.726 . . . . 0.14 110.845 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.4 Cg_endo -69.71 142.81 49.15 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.677 2.252 . . . . 0.19 112.341 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.1 t -48.82 -32.59 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 0.17 111.134 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -51.24 -53.35 36.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 2.56 110.8 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.55 -44.79 11.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.449 . . . . 0.16 111.131 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.482 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.36 -61.04 2.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.13 111.017 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.76 -37.91 31.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 2.31 110.871 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.8 -47.67 54.0 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.838 -0.696 . . . . 0.19 112.45 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.5 mt -61.51 -40.05 93.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.85 0.357 . . . . 0.55 110.873 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.824 HG12 HG11 ' A' ' 14' ' ' VAL . 18.2 m -76.88 -31.45 19.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.63 111.132 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -61.72 -59.95 4.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 1.72 110.947 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -40.41 71.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 1.71 110.882 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.874 HD23 HD21 ' A' ' 35' ' ' LEU . 80.4 mt -72.68 -24.56 61.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.23 110.895 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.48 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.7 -24.78 44.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.38 110.911 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.79 -29.82 17.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.22 111.163 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.874 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.75 -35.02 14.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.211 -0.45 . . . . 0.2 110.872 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.566 HG21 HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER -102.87 -44.81 5.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.22 111.12 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.66 -11.2 52.97 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 0.25 112.433 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.99 -62.58 1.38 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.834 0.349 . . . . 2.25 110.931 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -90.96 -40.68 11.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 1.97 110.857 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.49 -126.44 4.93 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.759 -0.734 . . . . 0.26 112.438 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -155.58 152.49 28.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.748 0.308 . . . . 2.2 110.902 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.48 HG21 ' HA ' ' A' ' 33' ' ' GLN . 87.7 t -137.0 127.72 40.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.24 111.12 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 t -116.53 154.12 30.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.16 110.83 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.73 134.65 58.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 0.24 111.054 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -146.33 152.32 38.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.077 -0.511 . . . . 2.1 110.913 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -102.43 137.78 40.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.474 . . . . 0.39 110.809 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.688 ' HA ' HD12 ' A' ' 50' ' ' LEU . 35.5 mt -52.26 -37.04 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.29 111.139 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -26.18 58.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 2.47 110.902 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -104.97 18.12 22.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 3.44 110.899 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.027 HD13 HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -53.84 -26.07 22.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.201 -0.454 . . . . 2.73 110.872 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.96 -34.9 57.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.871 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.7 mm-40 -85.97 -16.0 39.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.1 111.008 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.5 m -63.64 -12.72 36.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.92 110.798 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -74.55 59.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.32 111.134 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -59.17 -70.55 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.47 110.915 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.682 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.39 -169.59 2.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 1.3 111.0 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -105.47 122.11 45.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 2.19 110.827 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.1 t 59.52 78.66 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 1.99 110.888 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.5 p -132.7 -37.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.25 110.834 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.447 ' CD2' HD12 ' A' ' 86' ' ' ILE . 92.8 m-85 -98.13 122.37 41.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 2.06 110.85 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.28 -20.46 60.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 1.51 110.901 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 6' ' ' ILE . 12.4 mt -143.06 144.81 23.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.28 111.115 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.967 HG21 HG23 ' A' ' 83' ' ' ILE . 20.3 mm -137.56 124.45 28.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.21 111.072 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.6 mm? -107.61 137.16 46.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.114 -0.494 . . . . 0.24 111.034 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.48 100.91 5.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.17 110.908 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.67 76.04 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.826 -0.702 . . . . 0.17 112.417 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.521 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.4 mm? -107.52 57.53 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.855 0.359 . . . . 0.59 110.908 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -126.32 159.64 61.73 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.708 0.766 . . . . 0.24 111.11 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 124.42 11.05 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.666 2.244 . . . . 0.26 112.359 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.33 7.33 88.47 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.797 -0.716 . . . . 0.21 112.533 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB3' HG23 ' A' ' 68' ' ' VAL . 10.2 p -55.54 150.88 11.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.429 . . . . 0.78 110.772 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.766 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 30.8 p -138.84 108.86 6.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.16 111.107 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.624 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.36 152.43 16.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.25 111.199 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.993 HD12 HD22 ' A' ' 147' ' ' LEU . 4.4 mt -130.6 101.11 5.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.21 110.894 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.2 m80 -78.06 141.35 38.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.36 110.863 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.82 178.46 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.84 110.909 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.51 -44.15 62.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.29 111.103 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -56.61 -48.21 77.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 1.96 110.885 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.027 HG23 HD13 ' A' ' 50' ' ' LEU . 4.2 mp -69.1 -56.59 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.29 111.129 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.586 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.8 mt -50.15 -39.09 42.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.29 110.964 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.97 -56.74 10.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.46 111.1 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -54.16 -43.25 70.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.185 -0.461 . . . . 3.03 110.918 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.967 HG23 HG21 ' A' ' 63' ' ' ILE . 41.9 mm -57.94 -69.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 0.26 111.189 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.12 -36.21 28.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.28 111.075 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -51.5 67.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 2.31 110.983 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 56' ' ' LYS . 43.6 pt -86.81 -2.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.33 111.171 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -83.0 115.28 21.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.27 110.952 179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.1 mtt-85 -55.52 157.95 6.49 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.532 0.682 . . . . 3.2 110.889 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 114.02 3.56 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.735 2.29 . . . . 0.34 112.33 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.16 2.33 51.38 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.717 -0.754 . . . . 0.22 112.512 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.07 -165.51 19.4 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.781 -0.723 . . . . 0.18 112.456 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 69.1 m -134.55 148.79 50.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.33 . . . . 0.36 110.901 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.725 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.6 tm? -132.72 114.98 14.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.168 -0.469 . . . . 0.15 110.911 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.501 ' N ' HD22 ' A' ' 93' ' ' LEU . 70.4 m-85 -110.19 132.13 54.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 1.85 110.952 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.561 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.74 164.03 35.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.21 110.939 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.91 129.33 36.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 1.94 110.9 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.461 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -153.63 148.44 19.68 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.677 0.751 . . . . 2.52 110.865 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.651 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.7 145.53 57.75 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.656 2.237 . . . . 0.25 112.367 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 155' ' ' LEU . 14.4 m -129.0 146.49 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.18 111.088 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' CD ' HG21 ' A' ' 103' ' ' VAL . 47.7 mt-10 -107.32 132.75 52.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.276 -0.42 . . . . 2.19 110.803 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.8 p -90.69 -42.73 10.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 1.15 111.125 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.633 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -94.83 42.49 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.64 111.053 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.403 HG21 ' CD ' ' A' ' 100' ' ' GLU . 24.7 t -148.98 150.0 14.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.26 -0.427 . . . . 0.72 111.12 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.628 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -56.45 169.75 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 2.17 110.844 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.4 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 1.9 p30 -62.37 -54.72 36.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 2.56 110.845 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -66.8 -78.15 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 2.11 110.869 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p 53.65 -173.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 1.91 110.791 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.52 -3.37 49.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.041 -0.527 . . . . 2.5 110.848 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.86 153.82 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.148 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.01 110.48 6.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 2.85 110.933 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.628 HG21 ' O ' ' A' ' 104' ' ' ASP . 32.7 p -84.97 179.52 7.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.21 111.191 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.43 -53.74 53.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.28 -0.418 . . . . 0.18 111.001 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.84 -50.09 74.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.99 0.424 . . . . 0.22 110.884 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -56.69 -39.91 74.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.502 . . . . 1.7 110.985 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.49 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -63.52 -54.55 34.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.32 110.905 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 59.1 m -58.6 -46.94 85.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.228 -0.442 . . . . 0.21 110.827 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -43.58 97.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.27 110.834 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.16 -43.52 98.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.21 111.117 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.586 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.1 tp -64.81 -50.46 66.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.162 -0.472 . . . . 0.23 110.94 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.4 m -63.89 -31.2 72.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.26 111.129 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 43.5 mt -87.07 -10.5 52.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.56 110.917 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.53 6.21 28.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 1.74 110.845 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.61 7.68 31.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.67 -0.776 . . . . 0.55 112.452 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.725 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -107.57 171.03 7.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.911 0.386 . . . . 0.26 110.847 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.05 170.42 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.25 111.131 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 52.89 44.21 30.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 2.27 110.857 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.71 142.77 13.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.27 111.158 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.97 157.92 6.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 1.61 110.901 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -76.29 145.7 39.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 2.23 110.858 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.486 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -105.5 -36.19 7.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.151 -0.477 . . . . 0.2 110.944 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.16 176.0 13.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 1.19 110.981 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -130.93 145.17 51.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 4.25 110.885 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -135.1 136.15 24.26 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.67 0.748 . . . . 1.87 110.852 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 165.22 31.66 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.693 2.262 . . . . 0.32 112.384 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.683 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -97.96 128.21 44.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.32 110.949 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.425 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.44 160.88 25.3 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.53 0.681 . . . . 1.21 111.163 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.425 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.5 Cg_endo -69.83 -28.69 24.61 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.701 2.267 . . . . 0.43 112.294 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -85.37 -17.74 35.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.303 -0.408 . . . . 3.63 110.936 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.59 -53.06 4.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.159 -0.473 . . . . 2.83 110.963 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.7 p -49.32 -40.37 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.33 111.147 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.414 HE21 ' N ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -68.1 -35.22 77.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 1.19 110.908 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.414 ' N ' HE21 ' A' ' 141' ' ' GLN . 0.3 OUTLIER -67.85 -46.61 71.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.26 110.831 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.706 HG23 HD13 ' A' ' 147' ' ' LEU . 9.6 p -67.99 -29.97 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.18 111.118 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -75.0 -33.67 61.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 2.32 110.95 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -89.0 -19.97 25.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.056 -0.52 . . . . 1.93 110.842 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -94.01 -32.73 13.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.88 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.993 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.58 -54.24 1.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.4 110.901 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.97 6.11 2.6 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.806 -0.712 . . . . 0.37 112.479 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -69.9 120.1 15.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.723 0.297 . . . . 0.71 110.903 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.25 104.82 2.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 2.38 110.913 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.45 174.95 12.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 0.79 110.864 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.76 -10.54 16.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.55 110.869 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.633 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -99.15 6.6 46.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 1.79 110.935 -179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.683 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -78.81 166.67 22.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.3 111.004 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.592 ' HA ' HD23 ' A' ' 135' ' ' LEU . 2.7 tm? -172.94 130.38 0.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.25 110.925 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.766 ' CZ ' HG22 ' A' ' 72' ' ' THR . 27.3 m-85 -75.62 134.87 40.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 1.83 110.879 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.83 141.53 18.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.24 111.183 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.521 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.3 tt0 -93.66 131.26 39.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 1.88 110.937 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -127.92 151.73 35.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.25 111.106 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.472 HG21 HD21 ' A' ' 130' ' ' LEU . 5.3 t -135.9 161.85 34.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.27 111.048 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.26 137.92 6.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.715 -0.755 . . . . 0.15 112.487 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.65 137.5 35.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.748 0.308 . . . . 3.5 110.935 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 14.3 tptp -77.33 135.45 65.7 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.609 0.719 . . . . 1.74 110.905 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 120.09 6.94 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.652 2.235 . . . . 0.39 112.39 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -105.57 151.57 24.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.45 110.94 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 22.4 t80 60.43 19.98 9.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 6.17 110.816 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 62.3 166.13 0.11 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 9.57 110.906 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 33.7 m -150.08 -179.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 5.8 111.194 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -149.85 46.75 0.64 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.717 -0.754 . . . . 6.21 112.517 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.47 -66.76 1.05 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.857 0.36 . . . . 7.34 110.861 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.13 -170.16 1.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 7.13 110.865 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . 0.277 4.0 tmm_? . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 6.13 110.855 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.853 0.358 . . . . 4.12 110.908 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.28 -22.19 63.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.53 111.132 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.11 -51.47 64.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.225 -0.443 . . . . 2.4 110.831 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.26 21.18 10.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 1.56 110.848 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.93 37.96 54.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.656 -0.783 . . . . 0.23 112.552 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.455 HG21 HD22 ' A' ' 32' ' ' LEU . 1.9 mp -74.27 156.93 6.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.819 0.343 . . . . 0.27 111.146 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.655 ' O ' HG23 ' A' ' 36' ' ' THR . 28.2 m -146.13 158.5 43.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 1.08 110.891 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.56 129.75 35.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.33 111.131 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.11 -8.52 33.33 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.687 -0.768 . . . . 0.55 112.522 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -103.61 169.37 8.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.846 0.355 . . . . 1.49 110.919 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -103.87 113.21 26.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.256 -0.429 . . . . 1.28 110.824 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.712 HG12 HG21 ' A' ' 36' ' ' THR . 2.4 p -120.57 129.56 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.125 -0.489 . . . . 2.04 111.105 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.753 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -104.65 128.06 52.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.23 111.048 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.778 HG11 HG12 ' A' ' 29' ' ' VAL . 94.9 t -99.93 120.34 49.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.19 111.13 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 65' ' ' SER . 61.1 t -103.25 123.05 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.086 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -122.6 169.68 10.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.17 110.908 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -151.75 -171.0 3.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 1.76 110.862 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -56.97 -35.66 69.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.277 -0.419 . . . . 3.36 110.904 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.32 -9.1 58.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 1.19 110.917 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.05 94.29 10.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.665 0.745 . . . . 0.14 110.799 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.35 47.7 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.659 2.239 . . . . 0.21 112.416 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.01 -32.59 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.22 111.182 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.16 -53.09 37.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.148 -0.478 . . . . 3.2 110.827 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.87 10.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.19 111.151 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.405 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -51.66 -61.49 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.15 110.995 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -36.96 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.042 -0.526 . . . . 2.4 110.934 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.36 -48.31 52.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.729 -0.748 . . . . 0.21 112.495 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.1 mt -60.84 -41.39 95.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.883 0.373 . . . . 0.45 110.927 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.778 HG12 HG11 ' A' ' 14' ' ' VAL . 17.1 m -75.45 -31.11 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.64 111.11 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -61.74 -61.89 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 1.77 110.887 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.04 -40.73 67.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 1.79 110.87 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.843 HD23 HD21 ' A' ' 35' ' ' LEU . 83.5 mt -71.83 -25.5 62.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.3 110.96 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.543 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.05 -24.33 47.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.41 110.984 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.52 -30.52 17.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 0.26 111.113 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.843 HD21 HD23 ' A' ' 32' ' ' LEU . 1.7 pp -90.91 -35.41 14.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.23 110.896 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.712 HG21 HG12 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -101.65 -46.83 4.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.243 -0.435 . . . . 0.26 111.083 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.57 -14.33 49.36 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.742 . . . . 0.28 112.467 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -62.88 1.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 2.16 110.817 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -102.34 -35.48 8.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 2.38 110.867 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.17 -133.48 5.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.724 -0.751 . . . . 0.32 112.499 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -151.39 152.24 32.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 3.45 110.745 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' A' ' 33' ' ' GLN . 84.6 t -136.7 116.51 16.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.38 111.095 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.4 t -106.43 155.98 19.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.27 110.892 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -119.84 135.69 59.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.21 -0.45 . . . . 0.23 111.174 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -142.69 151.05 40.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 1.3 110.926 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.54 134.65 46.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.4 110.872 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 73' ' ' THR . 19.7 mt -52.3 -36.82 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.35 111.155 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -70.23 -32.6 70.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.474 . . . . 2.01 110.899 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.54 20.72 17.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 3.52 110.916 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.788 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -48.96 -28.54 3.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 1.11 110.902 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -55.82 -32.93 64.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.269 -0.423 . . . . 1.13 110.882 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -84.35 -14.5 49.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 1.09 110.878 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.7 m -64.94 -10.87 32.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.9 110.817 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.17 63.99 1.03 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.31 111.122 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.404 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 11.9 m170 -66.07 -70.51 0.24 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 0.43 110.813 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.641 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -142.57 -167.82 2.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.11 110.923 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -111.12 124.07 51.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 1.58 110.906 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.9 t 58.96 75.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 2.04 110.779 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 p -134.07 -35.15 0.95 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.16 -0.473 . . . . 0.28 110.911 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.44 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 97.6 m-85 -99.06 117.47 33.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.107 -0.497 . . . . 1.49 110.846 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.02 -19.82 62.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.176 -0.465 . . . . 1.51 110.874 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.2 mt -146.27 144.12 20.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.22 111.101 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.966 HG21 HG23 ' A' ' 83' ' ' ILE . 20.0 mm -136.3 129.2 46.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.074 -0.512 . . . . 0.14 111.126 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.1 mm? -113.29 137.75 51.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.212 -0.449 . . . . 0.26 110.938 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.405 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -129.24 101.7 6.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.16 110.861 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.3 78.09 0.11 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.778 -0.725 . . . . 0.17 112.434 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.8 58.51 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.57 110.894 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -127.1 158.83 67.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.573 0.702 . . . . 0.22 111.175 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.63 115.88 4.28 Favored 'Trans proline' 0 C--O 1.231 0.125 0 C-N-CA 122.702 2.268 . . . . 0.26 112.394 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.15 6.61 66.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.737 -0.744 . . . . 0.17 112.456 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.3 152.08 8.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.918 0.39 . . . . 0.79 110.924 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.696 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 24.0 p -140.14 108.55 5.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.21 111.159 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.753 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.3 150.08 12.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.24 111.153 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.018 HD12 HD22 ' A' ' 147' ' ' LEU . 4.2 mt -129.63 99.61 5.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.31 110.876 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -75.44 153.72 37.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.31 110.82 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.2 m -130.02 174.99 9.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 0.47 110.889 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -35.92 37.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.54 111.142 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.0 -42.87 99.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.224 -0.443 . . . . 1.94 110.864 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.788 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -77.21 -54.27 13.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 0.38 111.148 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.572 HD13 ' HA ' ' A' ' 119' ' ' LEU . 86.5 mt -49.73 -48.37 50.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.4 110.939 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.63 -50.11 55.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.8 111.17 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -43.84 83.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 4.79 110.824 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.966 HG23 HG21 ' A' ' 63' ' ' ILE . 36.6 mm -57.13 -65.18 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.31 111.142 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.99 -38.09 49.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.141 -0.481 . . . . 0.31 111.111 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -54.39 -58.03 9.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 2.18 110.875 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 56' ' ' LYS . 50.1 pt -75.5 -8.33 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 0.3 111.128 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -79.48 132.67 36.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.52 110.883 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -70.0 159.56 83.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.568 0.699 . . . . 2.37 110.876 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 113.79 3.49 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.638 2.225 . . . . 0.17 112.345 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.22 3.46 54.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.688 -0.768 . . . . 0.18 112.52 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.41 -160.12 12.12 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.692 -0.766 . . . . 0.18 112.473 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.3 m -140.11 154.96 47.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.928 0.394 . . . . 0.26 110.912 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.698 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.5 tm? -139.44 115.38 10.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.17 111.008 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.531 ' N ' HD22 ' A' ' 93' ' ' LEU . 53.9 m-85 -110.96 133.1 53.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 1.61 110.868 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.563 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.77 156.9 42.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.19 110.936 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.36 128.32 46.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 1.61 110.816 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.633 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -151.43 144.6 17.13 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.64 0.734 . . . . 2.29 110.868 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.633 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.87 140.19 41.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.653 2.235 . . . . 0.24 112.329 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.408 HG13 HG23 ' A' ' 157' ' ' VAL . 15.2 m -122.86 146.59 27.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.19 111.156 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -110.4 132.86 53.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 1.98 110.887 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.0 p -104.38 25.7 9.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.162 -0.472 . . . . 1.15 111.203 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.07 24.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.71 111.182 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.406 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.4 t -143.46 159.97 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.72 111.13 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.572 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -55.68 178.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 1.84 110.846 179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -66.13 -62.65 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 2.66 110.9 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -65.98 -75.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 1.82 110.894 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.11 -168.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 1.54 110.868 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 -4.22 52.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 2.12 110.897 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.8 m -145.38 141.11 22.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.48 111.132 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.476 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -63.57 117.8 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 2.45 110.914 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.572 HG21 ' O ' ' A' ' 104' ' ' ASP . 39.2 p -89.68 177.72 6.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.24 111.07 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.02 -54.26 48.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 0.17 111.054 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.28 -49.75 76.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.042 0.448 . . . . 0.29 110.859 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -57.9 -40.69 80.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 2.21 110.928 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.633 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -61.77 -54.79 37.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.36 110.925 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 54.6 m -58.34 -48.85 79.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.21 110.893 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -45.62 92.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.472 . . . . 0.29 110.812 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.64 -48.15 83.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 0.23 111.154 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.616 HD11 HD12 ' A' ' 93' ' ' LEU . 15.0 tp -60.39 -52.98 62.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.37 110.921 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.0 m -63.12 -27.1 69.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.34 111.129 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.4 mt -86.97 -12.41 47.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.56 110.968 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.8 p -82.87 3.96 27.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.106 -0.497 . . . . 2.45 110.85 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.67 -4.88 34.68 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.781 -0.723 . . . . 0.71 112.528 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.2 tp -88.95 170.33 10.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.946 0.403 . . . . 0.39 110.923 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.9 m -148.13 172.75 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.31 111.169 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 51.47 45.03 28.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 2.18 110.924 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.465 HG13 HD23 ' A' ' 119' ' ' LEU . 91.0 t -81.57 142.02 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.104 -0.498 . . . . 0.3 111.093 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.65 8.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 1.66 110.895 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -79.57 145.92 32.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.248 -0.433 . . . . 2.27 110.862 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.678 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.5 mp -105.77 -37.31 6.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.21 110.922 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -162.1 176.67 10.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 1.28 110.983 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 -126.72 165.31 19.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 5.53 110.808 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -148.39 136.43 11.21 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.669 0.747 . . . . 1.38 110.926 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 158.05 58.37 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.746 2.298 . . . . 0.34 112.375 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -93.35 127.01 38.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.237 -0.438 . . . . 0.36 110.999 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.498 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.12 161.45 22.72 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.492 0.663 . . . . 1.58 111.254 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -24.67 29.72 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.707 2.271 . . . . 0.5 112.386 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -85.46 -22.93 28.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 2.59 110.799 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -87.72 -53.03 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 2.44 110.911 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.73 -40.01 15.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.084 -0.507 . . . . 0.36 111.162 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.4 -33.93 75.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 1.19 110.932 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -46.57 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.3 110.871 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.741 HG23 HD13 ' A' ' 147' ' ' LEU . 9.0 p -67.94 -30.96 50.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.17 111.128 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -76.72 -30.31 56.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.105 -0.498 . . . . 2.17 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -89.7 -21.08 22.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 1.67 110.891 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -94.8 -32.64 13.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.14 -0.482 . . . . 0.37 110.851 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.018 HD22 HD12 ' A' ' 74' ' ' LEU . 2.9 mp -127.35 -54.49 1.36 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.38 110.865 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.65 20.5 1.52 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.729 -0.748 . . . . 0.33 112.517 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -75.37 121.56 22.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.725 0.298 . . . . 0.84 110.864 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -151.83 106.44 3.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 2.64 110.911 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.71 173.21 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.61 110.872 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.47 -19.59 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 1.82 110.835 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -96.19 19.9 11.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.423 . . . . 1.59 110.925 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.516 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -89.54 163.57 15.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.074 -0.512 . . . . 0.31 110.823 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -173.48 130.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.28 110.948 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.696 ' CZ ' HG22 ' A' ' 72' ' ' THR . 20.6 m-85 -70.22 135.16 48.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 1.85 110.824 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.408 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.73 147.23 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.29 111.146 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.678 ' HG2' HD13 ' A' ' 130' ' ' LEU . 25.8 tt0 -104.69 125.56 50.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 1.65 110.829 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -123.24 153.21 28.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.21 111.152 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.427 ' HB ' HD11 ' A' ' 130' ' ' LEU . 6.6 t -136.92 162.92 31.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.28 111.136 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.449 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -153.23 136.31 5.26 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.772 -0.727 . . . . 0.16 112.464 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.64 139.48 30.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.861 0.362 . . . . 1.66 110.817 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 135.6 51.36 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.693 0.759 . . . . 1.34 110.821 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 135.77 31.2 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.622 2.215 . . . . 0.53 112.387 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -116.46 150.17 38.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 0.43 110.756 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.533 ' O ' HG13 ' A' ' 168' ' ' VAL . 37.5 t80 64.39 112.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 5.8 110.893 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -53.87 111.88 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 10.08 110.886 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 166' ' ' PHE . 31.2 m -107.28 -26.56 3.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 5.71 111.125 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.05 -47.93 2.7 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.78 -0.724 . . . . 5.86 112.475 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 35.2 m -84.71 83.86 7.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.924 0.392 . . . . 6.83 110.95 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 17.3 m -161.23 -176.0 5.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 6.12 110.856 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 52.8 ttt180 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.198 -0.456 . . . . 7.13 110.867 -179.945 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.702 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.795 0.331 . . . . 8.12 110.896 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.96 -13.5 59.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 1.04 111.078 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.07 -39.31 74.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 2.88 110.898 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' HB2' HD11 ' A' ' 6' ' ' ILE . 9.4 m-85 -122.33 15.27 10.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 2.01 110.842 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.96 41.06 99.24 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.843 -0.694 . . . . 0.24 112.469 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.702 HD12 ' O ' ' A' ' 1' ' ' MET . 1.6 mp -83.36 158.34 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.33 111.081 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 36' ' ' THR . 0.8 OUTLIER -148.58 164.83 33.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.108 -0.496 . . . . 1.35 110.864 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.49 129.13 36.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.27 111.023 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.84 -6.51 23.97 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.773 . . . . 0.25 112.519 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -113.14 167.91 10.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 1.16 110.846 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.67 137.3 37.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.178 -0.465 . . . . 1.35 110.908 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.614 HG22 ' HB ' ' A' ' 62' ' ' ILE . 47.0 t -140.75 133.21 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 1.86 111.111 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.787 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -110.3 121.98 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.26 111.085 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.817 HG11 HG12 ' A' ' 29' ' ' VAL . 94.9 t -94.59 118.06 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.17 111.068 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.599 HG12 HG13 ' A' ' 47' ' ' ILE . 21.3 t -102.66 113.59 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 0.2 111.12 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -113.39 167.19 10.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.2 111.013 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.578 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.9 p-10 -148.57 -169.71 3.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.279 -0.419 . . . . 1.78 110.926 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -58.3 -35.58 72.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 3.64 110.953 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.1 m -73.98 -8.03 54.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.224 -0.444 . . . . 1.45 110.931 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.35 93.33 9.51 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.603 0.716 . . . . 0.17 110.833 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 143.09 50.16 Favored 'Trans proline' 0 C--O 1.231 0.128 0 C-N-CA 122.729 2.286 . . . . 0.22 112.326 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.81 -32.9 4.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.22 111.101 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -50.99 -53.09 36.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 2.42 110.886 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.46 -44.85 11.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.21 111.048 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -52.16 -62.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.15 110.9 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.61 -37.42 27.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 3.34 110.848 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.44 -47.08 53.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.2 112.53 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.47 HD23 ' HZ3' ' A' ' 31' ' ' LYS . 44.5 mt -61.94 -39.35 91.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.47 110.943 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.817 HG12 HG11 ' A' ' 14' ' ' VAL . 18.2 m -77.68 -31.75 17.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.231 -0.44 . . . . 0.62 111.134 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.01 -58.82 6.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 1.82 110.812 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HZ3' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -56.22 -41.1 75.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.25 -0.432 . . . . 3.13 110.88 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.867 HD23 HD21 ' A' ' 35' ' ' LEU . 91.2 mt -72.35 -24.4 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.23 110.952 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.429 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.0 mt-30 -78.16 -24.67 47.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.38 110.897 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.35 -30.29 16.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.31 111.068 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.867 HD21 HD23 ' A' ' 32' ' ' LEU . 1.6 pp -91.55 -35.65 14.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.27 110.96 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.62 -44.2 5.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.44 . . . . 0.36 111.17 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.33 -11.0 55.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.761 -0.733 . . . . 0.42 112.424 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -76.29 -61.97 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.782 0.325 . . . . 2.92 110.918 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 3.7 mm-40 -86.49 -43.0 13.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 2.06 110.866 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.25 -122.03 4.29 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.852 -0.69 . . . . 0.34 112.523 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -157.49 153.35 26.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.91 0.386 . . . . 2.25 110.877 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.0 t -138.27 128.72 35.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 0.28 111.182 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.5 t -118.11 154.48 32.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.15 -0.477 . . . . 0.16 110.84 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -115.52 133.31 62.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.17 111.089 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -144.53 152.98 41.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 1.97 110.92 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -101.91 139.62 37.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.46 110.982 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.87 HD13 HG21 ' A' ' 73' ' ' THR . 14.5 mt -51.87 -44.24 37.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.34 111.169 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.1 -20.11 60.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 3.68 110.833 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -107.12 18.5 21.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 3.52 110.86 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.005 HD13 HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -55.51 -24.56 32.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 2.7 110.911 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.1 mp -52.19 -34.7 46.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 1.03 110.95 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -86.25 -16.34 37.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 1.2 110.907 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 m -63.47 -12.84 34.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.88 110.897 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.71 59.46 0.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.498 . . . . 0.35 111.068 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -61.81 -70.29 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.4 110.829 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.665 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.28 -168.78 2.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 1.23 110.844 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -105.82 131.05 53.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 1.96 110.825 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 49.01 71.95 0.33 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 1.16 110.82 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 80.8 p -125.61 -34.42 2.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.25 110.884 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' CD2' HD12 ' A' ' 86' ' ' ILE . 99.1 m-85 -99.85 119.18 37.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.112 -0.495 . . . . 1.48 110.88 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.42 -19.4 62.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.186 -0.461 . . . . 1.54 110.904 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.614 ' HB ' HG22 ' A' ' 12' ' ' VAL . 27.3 mt -146.03 145.44 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.25 111.117 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.976 HG21 HG23 ' A' ' 83' ' ' ILE . 13.3 mm -136.83 127.85 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.16 111.147 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -109.55 137.59 47.16 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.224 -0.444 . . . . 0.18 110.926 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.41 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.7 OUTLIER -130.13 96.42 4.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.17 110.933 -179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 54.03 75.0 0.25 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.801 -0.714 . . . . 0.16 112.436 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.49 62.5 0.61 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.847 0.356 . . . . 0.59 110.9 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.99 160.12 66.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.533 0.682 . . . . 0.26 111.172 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 116.62 4.65 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.231 . . . . 0.29 112.35 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.14 7.27 70.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.647 -0.787 . . . . 0.22 112.5 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.33 150.23 11.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.075 0.464 . . . . 0.71 110.789 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.757 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 31.7 p -140.05 108.57 5.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.046 -0.525 . . . . 0.26 111.094 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.87 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.8 152.72 15.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.29 111.132 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.973 HD12 HD22 ' A' ' 147' ' ' LEU . 2.3 mt -130.36 101.76 5.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.36 110.891 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -77.56 149.05 34.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.28 110.84 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.1 m -125.57 178.43 5.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.55 110.857 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.14 -45.21 61.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.35 111.079 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.92 -48.53 75.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 2.32 110.906 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.005 HG23 HD13 ' A' ' 50' ' ' LEU . 4.3 mp -68.23 -56.55 12.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.24 111.07 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.602 HD13 ' HA ' ' A' ' 119' ' ' LEU . 62.0 mt -50.67 -39.56 51.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.26 110.966 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.85 -57.1 12.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.31 111.062 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.473 ' HB3' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -53.0 -41.97 65.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 2.93 110.833 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 63' ' ' ILE . 33.7 mm -58.94 -68.58 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.437 . . . . 0.21 111.056 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.79 29.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.23 111.125 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.2 tpp85 -57.55 -56.0 27.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 3.06 110.934 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.665 HG22 ' O ' ' A' ' 56' ' ' LYS . 50.2 pt -80.01 -5.69 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.22 111.17 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -76.72 129.4 36.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.4 110.904 179.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -70.4 160.41 81.34 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.623 0.725 . . . . 2.26 110.908 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 114.17 3.59 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.726 2.284 . . . . 0.27 112.393 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.43 4.79 57.17 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.743 -0.741 . . . . 0.22 112.501 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.4 -164.61 14.38 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.73 . . . . 0.2 112.435 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 67.6 m -137.71 146.28 43.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.926 0.393 . . . . 0.4 110.815 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 124' ' ' LEU . 2.0 tm? -129.49 125.39 36.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.4 110.867 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.584 ' N ' HD22 ' A' ' 93' ' ' LEU . 69.9 m-85 -121.34 131.4 54.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 1.91 110.935 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.76 157.18 43.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.18 110.86 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -126.85 127.28 44.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 2.04 110.907 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -151.3 146.93 19.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.635 0.731 . . . . 2.33 110.832 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.602 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.92 142.44 47.25 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.68 2.253 . . . . 0.2 112.336 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.18 146.69 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.17 111.112 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -105.22 132.63 51.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 2.04 110.946 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.0 p -103.64 26.04 9.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 1.37 111.108 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -152.99 24.82 0.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.67 111.105 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 3.6 t -143.73 158.85 16.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.25 -0.432 . . . . 0.7 111.134 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.598 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -58.39 -177.09 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 2.07 110.808 179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -68.69 -68.81 0.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.162 -0.472 . . . . 2.09 110.904 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -56.94 -75.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.082 -0.508 . . . . 1.99 110.939 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.7 -169.14 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 1.81 110.9 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -4.45 54.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 2.16 110.915 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.61 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.4 m -144.5 153.36 15.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.51 111.126 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.492 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.4 tptt -71.25 108.87 4.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 2.08 110.912 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.598 HG21 ' O ' ' A' ' 104' ' ' ASP . 32.2 p -85.88 177.7 7.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.338 -0.392 . . . . 0.27 111.13 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.49 -54.31 42.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.27 111.119 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.67 -49.97 75.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.48 110.814 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.46 -41.58 76.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.095 -0.502 . . . . 1.81 110.924 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -61.64 -54.63 40.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.22 -0.446 . . . . 0.38 110.932 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 43.7 m -58.47 -48.84 79.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.34 110.886 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.38 -46.53 89.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.55 110.879 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.36 -43.47 98.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.36 111.051 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.602 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.1 tp -63.37 -52.37 61.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.29 110.91 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -65.64 -24.65 67.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.33 111.114 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.9 mt -85.34 -15.71 42.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.87 110.853 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 40.2 p -83.42 4.69 26.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 2.34 110.873 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.8 -4.77 34.4 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.632 -0.794 . . . . 0.59 112.469 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -86.45 169.37 12.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.904 0.383 . . . . 0.3 110.894 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.56 170.15 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.23 111.118 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 51.99 44.9 29.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 2.43 110.897 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.488 HG13 HD23 ' A' ' 119' ' ' LEU . 91.1 t -80.33 141.75 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.32 111.049 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 158.87 7.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.087 -0.506 . . . . 1.62 110.92 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -77.31 145.92 37.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 2.35 110.86 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.674 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.6 mp -105.26 -36.51 7.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.25 110.949 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.83 176.2 13.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 1.11 110.944 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.697 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.2 OUTLIER -132.2 137.04 47.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 4.12 110.83 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.78 138.26 30.13 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.699 0.762 . . . . 1.84 110.853 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.413 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.5 Cg_endo -69.77 164.05 35.98 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.664 2.242 . . . . 0.2 112.357 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -95.74 128.47 42.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.29 110.941 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.455 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.46 160.91 25.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.576 0.703 . . . . 1.26 111.117 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.455 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.0 Cg_endo -69.69 -29.83 23.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.691 2.261 . . . . 0.4 112.288 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.08 -17.96 35.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 2.79 110.856 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -53.47 4.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.208 -0.451 . . . . 2.48 110.92 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.2 p -49.14 -41.09 13.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.26 111.142 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.2 -34.67 73.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 1.27 110.976 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.18 -44.89 71.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.33 110.802 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.675 HG23 HD13 ' A' ' 147' ' ' LEU . 7.2 p -69.0 -32.54 54.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.19 111.153 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -76.06 -29.9 58.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 2.33 110.858 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -90.14 -20.68 22.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 1.77 110.911 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -94.58 -32.63 13.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.33 110.858 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.973 HD22 HD12 ' A' ' 74' ' ' LEU . 2.6 mp -127.88 -53.87 1.32 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.45 110.99 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.96 12.3 2.16 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.729 -0.748 . . . . 0.39 112.501 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.61 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.5 t-160 -70.24 120.38 15.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.737 0.303 . . . . 1.12 110.818 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -151.9 111.22 3.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 3.27 110.928 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.62 175.09 13.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 1.05 110.869 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.34 -14.19 14.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 2.24 110.876 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -104.82 11.4 33.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 1.83 110.868 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.603 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -74.01 163.18 28.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 0.32 110.939 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.697 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.88 129.83 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 0.18 110.88 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.757 ' CZ ' HG22 ' A' ' 72' ' ' THR . 33.2 m-85 -73.54 132.89 43.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.142 -0.481 . . . . 1.88 110.869 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.01 140.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.22 111.116 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.674 ' HG2' HD13 ' A' ' 130' ' ' LEU . 22.3 tt0 -94.42 126.38 39.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 1.65 110.922 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.446 HD13 ' HG ' ' A' ' 115' ' ' LEU . 2.8 mp -123.15 153.65 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.34 111.174 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.443 ' HB ' HD11 ' A' ' 130' ' ' LEU . 7.5 t -139.2 164.46 29.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.35 111.141 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -154.7 135.84 4.89 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.17 112.488 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -91.36 140.02 30.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.866 0.365 . . . . 1.64 110.899 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 135.47 49.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.604 0.716 . . . . 1.26 110.969 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.85 127.87 15.14 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.695 2.263 . . . . 0.36 112.348 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -108.56 149.56 28.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.3 110.869 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 13.5 t80 65.04 151.81 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 5.82 110.829 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.42 99.76 0.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 9.58 110.841 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.8 m -112.03 -30.19 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 5.28 111.129 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 108.91 -28.17 11.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.732 -0.747 . . . . 6.32 112.5 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 4.5 t -77.98 82.11 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.877 0.37 . . . . 7.0 110.855 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.77 -170.35 3.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 8.0 110.945 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 9.48 110.845 -179.9 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' O ' HD12 ' A' ' 6' ' ' ILE . 13.3 ptt? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.752 0.31 . . . . 3.97 110.881 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.79 -18.49 60.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.299 -0.409 . . . . 0.61 111.094 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.96 -50.31 66.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 2.67 110.897 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 6' ' ' ILE . 7.2 m-85 -122.12 11.71 10.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.454 . . . . 2.06 110.933 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.37 40.65 99.14 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.726 -0.75 . . . . 0.29 112.502 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.485 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.5 mp -83.53 160.42 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.857 0.36 . . . . 0.26 111.019 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -158.3 168.63 26.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.08 -0.509 . . . . 1.84 110.773 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.73 132.81 35.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.141 -0.481 . . . . 0.36 111.092 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.88 -8.12 29.55 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.757 -0.735 . . . . 0.25 112.546 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -111.96 165.33 12.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 1.26 110.924 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.56 140.09 33.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 2.16 110.913 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.615 HG22 ' HB ' ' A' ' 62' ' ' ILE . 47.2 t -142.68 140.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 1.85 111.178 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.767 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -118.02 122.1 42.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.23 111.085 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.799 HG11 HG12 ' A' ' 29' ' ' VAL . 59.6 t -94.64 118.77 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.18 111.086 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.516 HG12 ' CG1' ' A' ' 47' ' ' ILE . 9.4 t -102.95 110.07 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.26 111.188 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -111.54 167.55 10.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.15 -0.477 . . . . 0.15 110.939 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 7.7 p-10 -151.34 -169.63 3.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 1.69 110.876 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -56.97 -35.72 69.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 2.91 110.846 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 40.4 m -73.11 -10.61 59.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.439 . . . . 1.57 110.832 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.63 94.9 10.92 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.632 0.729 . . . . 0.13 110.881 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 141.46 45.2 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.717 2.278 . . . . 0.21 112.285 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 99.3 t -48.89 -32.7 4.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.18 111.154 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.55 -52.66 45.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 2.54 110.963 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.34 -45.06 10.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.17 111.097 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.488 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.48 -61.34 2.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.14 110.877 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -49.87 -36.1 25.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 3.31 110.857 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.52 -47.2 43.54 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.486 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.4 mt -62.13 -38.62 89.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.904 0.383 . . . . 0.48 110.922 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.799 HG12 HG11 ' A' ' 14' ' ' VAL . 18.2 m -77.96 -31.55 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 0.62 111.099 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -62.2 -58.01 9.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 1.6 110.872 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.8 -40.24 75.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 2.43 110.929 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.887 HD23 HD21 ' A' ' 35' ' ' LEU . 87.3 mt -73.03 -24.49 60.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.23 110.986 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.465 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.64 -25.25 44.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.37 110.942 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.83 -29.6 17.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.24 111.095 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.887 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.66 -35.0 14.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.19 110.981 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.73 -44.98 4.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.23 111.06 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.07 -10.94 53.75 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.674 -0.774 . . . . 0.26 112.478 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.5 -62.68 1.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.728 0.299 . . . . 3.06 110.852 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.637 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 2.9 mm-40 -90.22 -40.97 11.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 2.18 110.872 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.38 -123.03 4.01 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.661 -0.78 . . . . 0.32 112.572 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -158.28 153.54 25.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.863 0.363 . . . . 2.28 110.827 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 33' ' ' GLN . 96.6 t -138.5 130.86 38.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.187 -0.46 . . . . 0.33 111.137 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 t -119.67 156.02 31.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.17 110.916 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -117.07 135.3 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.18 111.125 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -145.74 151.95 38.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 2.17 110.965 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.73 135.43 44.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.4 110.936 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.66 ' CD1' HG21 ' A' ' 73' ' ' THR . 32.8 mt -51.68 -35.15 17.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.26 111.058 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -75.09 -31.22 61.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 2.1 110.838 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -95.82 18.44 13.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 3.32 110.948 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.791 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.83 -31.13 4.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 1.11 110.937 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -53.39 -38.84 63.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 1.11 110.899 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.9 mm-40 -85.09 -15.85 42.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 1.27 110.899 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.1 m -65.94 -11.64 48.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 1.01 110.787 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.46 63.36 1.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.32 111.144 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -60.93 -71.66 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.36 110.826 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -150.12 -168.99 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.188 -0.46 . . . . 1.82 110.951 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.2 tt0 -102.36 137.47 40.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.74 110.926 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.3 p 46.57 85.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 1.23 110.833 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.6 p -141.05 -40.35 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.081 -0.508 . . . . 0.25 110.87 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.492 ' O ' HD23 ' A' ' 87' ' ' LEU . 94.5 m-85 -99.85 119.52 38.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.079 -0.51 . . . . 2.06 110.931 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.2 -21.23 62.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 1.51 110.814 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 12' ' ' VAL . 35.8 mt -142.63 144.25 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.34 111.091 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.958 HG21 HG23 ' A' ' 83' ' ' ILE . 19.7 mm -134.9 126.58 47.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.127 -0.488 . . . . 0.12 111.13 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.1 mm? -109.04 136.82 47.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.114 -0.494 . . . . 0.19 110.925 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.3 98.39 4.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.181 -0.463 . . . . 0.12 110.857 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.61 75.52 0.21 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.735 -0.745 . . . . 0.15 112.577 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -107.24 56.17 0.64 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.801 0.334 . . . . 0.57 110.938 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.413 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -124.44 160.32 53.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.707 0.765 . . . . 0.22 111.12 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 120.35 7.15 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 0.24 112.283 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.22 6.91 83.83 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.828 -0.701 . . . . 0.18 112.54 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.413 ' HB3' HG23 ' A' ' 68' ' ' VAL . 4.7 p -55.97 151.56 11.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.951 0.405 . . . . 0.71 110.825 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.704 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 19.5 p -141.5 109.12 5.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.2 111.187 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.66 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.4 145.48 11.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.3 111.194 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.959 HD12 HD22 ' A' ' 147' ' ' LEU . 4.1 mt -124.18 105.17 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.22 110.894 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -80.1 153.8 28.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.28 110.822 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.4 m -131.34 -176.62 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 0.39 110.902 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.33 69.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.526 . . . . 0.33 111.139 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -62.56 -45.04 94.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.11 -0.495 . . . . 1.64 110.841 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.791 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -74.97 -55.31 12.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.171 -0.468 . . . . 0.24 111.092 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.544 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.5 mt -50.28 -43.88 53.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.211 -0.45 . . . . 0.22 110.831 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.45 -52.06 49.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.111 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -44.43 92.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 2.96 110.877 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.958 HG23 HG21 ' A' ' 63' ' ' ILE . 42.3 mm -54.94 -68.18 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.2 111.085 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.65 57.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.27 111.126 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.4 tpp85 -53.14 -52.61 58.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 2.19 110.874 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 56' ' ' LYS . 36.5 pt -81.63 -8.63 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.18 111.21 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -77.24 124.2 27.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.34 110.876 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -63.1 160.25 40.85 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.703 . . . . 2.24 110.887 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 114.22 3.65 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.698 2.265 . . . . 0.28 112.3 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.56 5.52 56.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.803 -0.713 . . . . 0.19 112.587 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.71 -160.95 14.59 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.761 -0.733 . . . . 0.16 112.462 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 13.9 m -139.19 154.26 48.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.28 110.936 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.729 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.56 115.67 10.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.15 110.796 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.566 ' N ' HD22 ' A' ' 93' ' ' LEU . 47.9 m-85 -110.19 132.4 54.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 1.84 110.903 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.558 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.87 158.71 44.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.21 110.928 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.08 131.38 44.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 2.12 110.899 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.7 150.25 22.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.62 0.724 . . . . 3.59 110.844 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.638 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.7 Cg_endo -69.72 144.71 55.1 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.657 2.238 . . . . 0.24 112.412 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.4 m -132.7 146.59 32.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.28 111.125 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.478 ' HB2' HG22 ' A' ' 111' ' ' THR . 41.9 mt-10 -107.19 133.28 52.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 2.02 110.876 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.8 p -92.42 -42.76 9.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 1.07 111.209 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.677 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.67 40.45 1.07 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.47 . . . . 0.91 111.037 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.421 HG21 ' CD ' ' A' ' 100' ' ' GLU . 20.7 t -147.65 151.9 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.85 111.113 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.64 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -56.34 178.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 2.31 110.825 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -68.15 -63.57 1.03 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 2.29 110.895 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -63.65 -75.47 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 1.82 110.895 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 53.86 -167.65 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.145 -0.479 . . . . 1.73 110.849 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -8.29 59.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 2.31 110.919 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 149' ' ' HIS . 1.5 m -142.58 150.96 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.77 111.119 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HZ3' HD23 ' A' ' 74' ' ' LEU . 2.5 ttpm? -65.99 126.21 27.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.45 . . . . 5.11 110.885 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.64 HG21 ' O ' ' A' ' 104' ' ' ASP . 71.7 p -97.83 177.7 5.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 0.38 111.147 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.87 -54.53 45.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.26 111.056 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -55.16 -48.04 74.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.23 110.908 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -36.41 75.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 2.41 110.838 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.537 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -63.94 -56.57 14.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 0.51 110.904 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 48.6 m -57.44 -47.62 81.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.119 -0.491 . . . . 0.28 110.861 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -45.57 92.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.27 110.854 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.04 -43.31 99.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.479 . . . . 0.23 111.082 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.544 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.0 tp -65.39 -52.57 52.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.22 110.906 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.2 m -61.28 -31.75 71.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.469 . . . . 0.27 111.114 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.9 mt -87.09 -10.67 52.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.26 -0.427 . . . . 0.6 110.912 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.63 4.95 29.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 1.71 110.869 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.27 7.66 32.29 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.739 -0.744 . . . . 0.54 112.485 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -106.3 168.44 9.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.849 0.357 . . . . 0.27 110.898 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 171' ' ' SER . 23.0 m -148.41 172.53 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.23 111.133 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 51.63 44.67 29.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.471 . . . . 2.12 110.836 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.408 HG13 HD23 ' A' ' 119' ' ' LEU . 45.5 t -79.3 144.66 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.26 111.163 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.3 158.48 5.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 2.85 110.976 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -78.83 147.09 33.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.918 0.39 . . . . 2.44 110.837 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.724 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -106.09 -36.51 6.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 0.21 110.967 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.13 176.39 11.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.11 110.916 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.72 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -131.9 137.31 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 4.12 110.848 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -123.53 136.2 26.95 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.592 0.71 . . . . 1.81 110.875 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.416 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.3 Cg_endo -69.75 162.46 41.98 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.642 2.228 . . . . 0.27 112.427 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.681 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -96.63 136.13 37.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.273 -0.421 . . . . 0.28 110.909 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.577 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -117.67 162.46 28.74 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.519 0.676 . . . . 1.44 111.11 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -22.65 31.53 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.574 2.183 . . . . 0.45 112.323 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -85.15 -26.37 26.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 2.43 110.826 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -88.53 -51.01 5.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 2.47 110.829 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -49.82 -38.92 14.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.24 111.188 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.85 -32.95 73.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.16 110.924 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -45.65 68.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 0.29 110.862 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.712 HG23 HD13 ' A' ' 147' ' ' LEU . 7.4 p -68.75 -30.96 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.18 111.081 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -76.44 -31.1 57.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.486 . . . . 2.47 110.876 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -90.26 -20.41 23.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.164 -0.471 . . . . 1.67 110.903 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -94.75 -33.0 13.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.31 110.914 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.959 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -126.2 -54.18 1.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.32 110.938 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.45 10.67 2.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.741 -0.742 . . . . 0.32 112.45 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.483 ' CD2' HG11 ' A' ' 109' ' ' VAL . 13.0 t-160 -70.18 121.98 18.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.64 110.89 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.48 105.07 3.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 3.22 110.928 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.25 170.7 19.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.79 110.907 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.49 -6.33 18.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 1.56 110.893 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.677 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 1.8 m120 -105.14 10.56 33.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 3.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.681 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.62 166.93 19.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.31 110.934 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.72 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -172.49 130.71 0.57 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.27 110.906 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.704 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.1 m-85 -75.67 132.13 40.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 1.73 110.88 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.04 146.91 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.22 111.142 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.724 ' HG2' HD13 ' A' ' 130' ' ' LEU . 9.4 tt0 -102.07 131.52 48.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 2.11 110.899 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.48 149.96 34.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 0.25 111.116 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.507 ' N ' HD11 ' A' ' 130' ' ' LEU . 3.3 t -132.05 159.87 37.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.22 111.149 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.19 135.2 5.13 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.821 -0.704 . . . . 0.13 112.506 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -91.54 139.47 30.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.348 . . . . 1.66 110.973 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.23 134.77 51.53 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 1.29 110.933 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.67 121.66 8.37 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.743 2.296 . . . . 0.37 112.353 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.561 ' O ' HG13 ' A' ' 168' ' ' VAL . 6.9 t-20 -96.16 153.03 18.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.921 0.391 . . . . 0.62 110.89 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -49.2 113.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 7.45 110.883 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 65.51 96.43 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 7.95 110.977 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 165' ' ' ASN . 3.8 m -122.65 -34.49 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 8.58 111.131 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 127.2 -47.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 8.02 112.57 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.91 116.2 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.982 0.42 . . . . 8.74 110.89 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.405 ' HB3' HG11 ' A' ' 125' ' ' VAL . 16.3 m -165.49 -75.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.114 -0.494 . . . . 9.08 110.877 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 67.6 ttp85 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 6.81 110.926 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.542 ' HG2' HD22 ' A' ' 35' ' ' LEU . 5.2 mtt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.766 0.317 . . . . 3.92 110.903 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.88 -21.41 66.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.44 111.119 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -51.51 63.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 2.11 110.835 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.419 ' HB2' HD11 ' A' ' 6' ' ' ILE . 4.7 m-85 -122.3 20.72 10.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 1.53 110.935 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.33 41.68 80.57 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.26 112.531 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.515 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.5 mp -83.44 160.52 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.27 111.145 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -157.5 168.61 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 1.81 110.929 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.62 131.81 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.35 111.1 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.88 2.62 30.27 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.757 -0.735 . . . . 0.4 112.472 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -122.38 165.51 16.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.816 0.341 . . . . 1.29 110.92 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.73 139.65 34.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 1.29 110.869 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.636 HG22 ' HB ' ' A' ' 62' ' ' ILE . 48.6 t -142.42 142.48 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.065 -0.516 . . . . 1.85 111.197 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.79 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -119.2 118.28 30.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.23 -0.441 . . . . 0.29 111.194 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.835 HG11 HG12 ' A' ' 29' ' ' VAL . 63.9 t -92.91 118.5 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.16 111.091 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.422 HG12 ' CG1' ' A' ' 47' ' ' ILE . 21.3 t -102.58 116.33 46.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.485 . . . . 0.19 111.168 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.7 p-90 -116.79 168.08 10.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 0.2 110.939 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.63 -169.86 3.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.26 -0.427 . . . . 1.86 110.882 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -57.11 -35.61 69.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.304 -0.407 . . . . 3.38 110.88 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.8 t -73.49 -10.21 59.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 1.3 110.862 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.96 94.24 10.36 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.698 0.761 . . . . 0.16 110.85 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.89 142.48 47.46 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.667 2.245 . . . . 0.23 112.339 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.07 -32.52 5.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.2 -0.454 . . . . 0.22 111.136 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -51.26 -52.97 40.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 2.48 110.957 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.63 -44.68 11.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 0.2 111.128 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.479 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.74 -61.59 2.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 0.15 110.92 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.49 -36.41 22.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 2.53 110.918 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.37 -46.76 47.25 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.682 -0.77 . . . . 0.2 112.426 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 52.9 mt -62.23 -38.64 90.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.45 110.929 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.835 HG12 HG11 ' A' ' 14' ' ' VAL . 17.2 m -77.97 -31.55 16.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.62 111.119 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.31 -58.16 8.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.191 -0.459 . . . . 1.65 110.883 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -40.11 74.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 1.71 110.967 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.861 HD23 HD21 ' A' ' 35' ' ' LEU . 90.2 mt -73.06 -25.17 60.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.24 110.862 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.3 mt-30 -78.51 -25.38 45.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.37 110.845 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 -29.58 17.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.24 111.092 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.861 HD21 HD23 ' A' ' 32' ' ' LEU . 1.3 pp -91.46 -34.72 14.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.23 110.935 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.28 -45.84 4.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.23 111.164 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.03 -12.04 53.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 0.26 112.513 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.67 -62.56 1.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 2.88 110.912 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -94.45 -38.97 10.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.15 -0.477 . . . . 2.62 110.865 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.55 -126.8 4.43 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.24 112.453 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -155.28 153.46 30.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 2.21 110.836 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 33' ' ' GLN . 97.4 t -138.38 128.41 34.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.138 -0.483 . . . . 0.25 111.143 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.0 t -116.87 157.87 24.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.15 110.959 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 p -120.07 135.52 60.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.14 111.082 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -144.08 151.41 39.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.14 -0.482 . . . . 1.26 110.82 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.4 134.89 46.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.083 -0.508 . . . . 0.43 110.905 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.693 ' CD1' HG21 ' A' ' 73' ' ' THR . 24.6 mt -52.23 -36.13 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.37 111.188 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -71.55 -32.27 67.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 2.06 110.968 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -102.54 20.25 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 3.61 110.845 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.79 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -49.03 -28.89 4.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.247 -0.433 . . . . 1.12 110.909 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.581 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -55.81 -34.04 64.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 2.67 110.993 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -83.68 -13.89 53.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.09 -0.505 . . . . 1.12 110.926 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.8 m -68.49 -6.97 28.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.93 110.867 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.26 64.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.118 -0.492 . . . . 0.46 111.089 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -65.24 -69.46 0.29 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.34 110.902 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.667 ' O ' HG22 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -155.66 -175.21 5.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.131 -0.486 . . . . 2.16 110.84 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -94.42 135.15 36.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 2.01 110.845 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 p 46.29 82.07 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 1.12 110.852 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.5 p -133.33 -38.07 0.95 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.32 110.813 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.467 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.1 m-85 -102.46 122.7 44.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 1.45 110.886 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.33 -20.56 61.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 1.72 110.769 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.636 ' HB ' HG22 ' A' ' 12' ' ' VAL . 33.5 mt -144.21 144.47 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.35 111.165 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.004 HG21 HG23 ' A' ' 83' ' ' ILE . 15.9 mm -135.29 130.23 50.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.15 111.158 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.7 mm? -113.88 136.92 52.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.18 110.915 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.57 100.88 5.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.152 -0.476 . . . . 0.14 110.793 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.79 74.06 0.32 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.771 -0.728 . . . . 0.19 112.478 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.97 58.68 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.57 110.91 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.53 159.89 63.42 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.587 0.708 . . . . 0.22 111.129 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 116.43 4.56 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.642 2.228 . . . . 0.25 112.377 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.15 7.01 68.35 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.822 -0.704 . . . . 0.17 112.471 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -54.92 150.49 10.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.967 0.413 . . . . 0.7 110.881 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.746 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.2 p -140.15 109.0 5.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.15 111.121 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.693 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.68 152.86 16.38 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.25 111.051 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.974 HD12 HD22 ' A' ' 147' ' ' LEU . 6.1 mt -130.94 99.76 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.23 110.913 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -77.57 138.36 39.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.34 110.901 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.531 ' H ' HD13 ' A' ' 79' ' ' ILE . 16.4 m -115.31 175.61 5.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.63 110.803 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.98 -35.41 33.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.27 111.246 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -62.7 -39.69 94.82 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.126 -0.488 . . . . 2.3 110.909 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.79 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.8 mp -81.86 -55.17 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.24 111.146 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.3 mt -49.27 -46.1 45.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.32 110.826 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.03 -50.54 58.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.57 111.077 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.515 ' OE2' HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -58.09 -47.13 84.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 4.91 110.901 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.004 HG23 HG21 ' A' ' 63' ' ' ILE . 48.8 mm -53.12 -64.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.26 111.115 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.7 -41.36 61.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 0.26 111.053 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 tpp85 -51.99 -52.99 46.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 2.1 110.854 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 56' ' ' LYS . 32.4 pt -80.85 -8.41 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.27 111.163 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.17 114.11 15.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.102 -0.499 . . . . 0.33 110.884 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 -53.7 160.43 2.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.573 0.702 . . . . 3.52 110.864 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 114.76 3.81 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.677 2.252 . . . . 0.28 112.291 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.67 5.77 57.57 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.737 . . . . 0.24 112.486 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.5 -162.25 20.69 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.694 -0.765 . . . . 0.17 112.482 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.6 m -139.0 153.52 48.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.819 0.342 . . . . 0.28 110.94 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.628 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.2 tm? -138.28 117.07 12.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.15 110.898 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.604 ' N ' HD22 ' A' ' 93' ' ' LEU . 47.1 m-85 -112.74 133.51 54.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.13 -0.486 . . . . 1.61 110.867 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.504 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.64 159.21 44.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.17 110.946 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.96 126.4 41.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 1.97 110.89 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.627 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -150.33 146.77 20.41 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.673 0.749 . . . . 2.34 110.905 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.628 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.8 Cg_endo -69.77 143.3 50.34 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.761 2.307 . . . . 0.2 112.316 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 155' ' ' LEU . 14.2 m -126.97 146.43 32.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.2 111.121 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.491 ' HB2' HG22 ' A' ' 111' ' ' THR . 54.1 mt-10 -109.25 132.57 54.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 2.13 110.873 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.9 p -91.27 -38.92 12.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 1.22 111.125 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.556 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -97.77 40.75 1.15 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.54 111.101 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.438 HG21 ' CD ' ' A' ' 100' ' ' GLU . 26.2 t -148.07 150.19 14.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.64 111.068 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.601 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -53.38 172.01 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.488 . . . . 1.71 110.872 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -63.95 -62.83 1.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 2.3 110.856 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -65.66 -75.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 2.36 110.892 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.6 t 53.49 -168.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 2.14 110.928 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.45 -5.73 57.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.475 . . . . 1.71 110.921 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.93 146.63 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.39 111.085 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -67.29 115.06 6.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 2.39 110.891 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.601 HG21 ' O ' ' A' ' 104' ' ' ASP . 72.1 p -88.94 -179.85 6.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.141 -0.482 . . . . 0.23 111.165 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.18 -53.09 62.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.18 111.08 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -60.19 -49.73 76.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.043 0.449 . . . . 0.27 110.86 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -58.12 -43.11 87.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 2.31 110.902 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.627 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -59.58 -55.2 37.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.236 -0.438 . . . . 0.3 110.876 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 61.2 m -57.79 -49.26 77.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.24 110.912 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.52 -45.5 88.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.32 110.868 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.65 -46.93 87.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 0.28 111.111 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.648 HD23 HG13 ' A' ' 127' ' ' VAL . 14.6 tp -60.49 -50.96 71.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.38 110.88 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.5 m -66.31 -26.24 67.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.35 111.214 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 37.7 mt -86.17 -14.04 45.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.55 110.888 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 p -81.94 2.92 28.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 2.53 110.854 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.8 -4.93 34.43 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.729 . . . . 0.79 112.551 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.628 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.2 tp -87.61 170.82 10.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.919 0.39 . . . . 0.38 110.896 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.78 170.97 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.4 111.126 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 53.11 44.29 30.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 2.1 110.892 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.648 HG13 HD23 ' A' ' 119' ' ' LEU . 89.9 t -81.69 139.42 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.3 111.009 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.29 162.4 8.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 1.85 110.96 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.57 145.69 32.99 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.288 -0.414 . . . . 2.54 110.904 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.674 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.8 mp -103.89 -36.79 7.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.472 . . . . 0.22 110.955 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.08 176.29 12.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 1.12 110.926 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.742 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.1 tmt_? -131.26 137.24 48.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 4.45 110.881 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -124.53 137.84 30.04 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.607 0.718 . . . . 1.38 110.958 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.414 ' HA ' HD21 ' A' ' 155' ' ' LEU . 52.8 Cg_endo -69.72 165.13 31.96 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.755 2.304 . . . . 0.24 112.329 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.672 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.86 127.21 44.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.258 -0.428 . . . . 0.27 110.963 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.459 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.74 161.25 23.36 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.555 0.693 . . . . 1.56 111.179 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 -24.64 29.31 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.721 2.281 . . . . 0.32 112.319 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -85.71 -22.25 27.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.243 -0.435 . . . . 2.58 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -87.71 -52.23 5.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 2.41 110.995 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -49.84 -40.31 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.25 111.136 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -33.03 73.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 1.13 111.011 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.74 -46.34 66.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.26 110.879 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.2 p -68.3 -30.12 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.17 111.113 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -76.34 -32.68 58.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.108 -0.496 . . . . 2.5 110.806 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -89.35 -20.13 24.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.296 -0.411 . . . . 1.74 110.877 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -94.6 -32.61 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.28 110.894 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.974 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.79 -54.37 1.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.31 110.921 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.18 9.26 2.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.735 -0.745 . . . . 0.29 112.454 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -70.21 120.93 16.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.81 0.338 . . . . 0.64 110.858 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -152.63 104.9 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 2.24 110.894 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -161.11 171.26 18.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.67 110.789 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.78 -8.11 17.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 1.87 110.885 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.556 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 2.3 m120 -102.74 12.01 36.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 2.95 110.872 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.672 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -86.07 167.51 14.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.33 110.831 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.742 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -172.61 130.3 0.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.2 110.916 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.746 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.3 m-85 -73.61 132.69 43.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.473 . . . . 1.8 110.939 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.39 142.9 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.2 111.09 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.674 ' HG2' HD13 ' A' ' 130' ' ' LEU . 24.0 tt0 -96.86 127.81 43.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.463 . . . . 1.62 110.85 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -123.95 151.39 28.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.32 111.156 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.452 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.9 t -134.96 162.96 30.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.129 -0.487 . . . . 0.28 111.217 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.466 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -153.84 134.09 4.21 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.754 -0.736 . . . . 0.13 112.511 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.77 140.37 29.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.902 0.382 . . . . 1.67 110.891 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.11 135.48 47.84 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.54 0.685 . . . . 1.83 110.863 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 125.1 11.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.623 2.215 . . . . 0.38 112.372 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -106.23 150.47 25.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.44 110.933 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 41.9 t80 65.02 151.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.432 . . . . 5.95 111.002 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -66.35 119.69 12.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 9.69 110.849 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.9 m -120.7 178.92 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.097 -0.501 . . . . 5.53 111.105 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -146.78 27.39 1.62 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.797 -0.716 . . . . 5.57 112.521 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 3.6 m -116.45 75.23 0.95 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.347 . . . . 6.81 110.9 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 55.25 -170.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 6.85 110.804 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 7.65 110.927 -179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptm . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.827 0.346 . . . . 4.11 110.853 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.64 -21.42 63.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.47 111.155 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.15 -51.48 64.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 1.98 110.93 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -122.33 22.68 10.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 1.5 110.817 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.15 41.08 53.01 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.772 -0.728 . . . . 0.25 112.454 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.504 HG23 HG21 ' A' ' 12' ' ' VAL . 1.6 mp -80.02 159.68 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.894 0.378 . . . . 0.23 111.139 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.731 ' O ' HG23 ' A' ' 36' ' ' THR . 0.8 OUTLIER -153.5 164.7 37.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 1.26 110.952 -179.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.46 126.19 35.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.29 111.051 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.96 0.96 21.05 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.807 -0.711 . . . . 0.29 112.512 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -117.89 167.15 11.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 1.14 110.974 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -102.15 112.79 25.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 1.28 110.947 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.7 HG22 ' HB ' ' A' ' 62' ' ' ILE . 88.1 t -117.37 130.16 72.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.96 111.013 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.788 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -106.11 124.66 49.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.464 . . . . 0.24 111.105 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.849 HG11 HG12 ' A' ' 29' ' ' VAL . 59.1 t -97.3 117.03 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.2 111.079 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 t -102.56 117.49 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.23 111.085 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -114.88 172.46 7.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 0.37 110.908 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.59 ' HB3' HD12 ' A' ' 47' ' ' ILE . 7.6 p-10 -151.73 -172.98 4.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 2.13 110.879 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -35.49 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 3.61 110.929 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 t -73.91 -8.03 54.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.294 -0.412 . . . . 1.28 110.831 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.8 m -107.05 93.78 9.73 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.604 0.716 . . . . 0.14 110.833 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.5 Cg_endo -69.74 143.79 52.06 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.634 2.223 . . . . 0.2 112.424 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.0 t -48.88 -32.9 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.322 -0.399 . . . . 0.2 111.153 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.94 -53.01 36.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.174 -0.466 . . . . 3.25 110.888 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -44.85 10.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.16 111.13 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.466 HD22 HG13 ' A' ' 29' ' ' VAL . 1.8 tm? -52.13 -62.42 1.65 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 0.14 110.938 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.16 -36.25 18.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 2.81 110.911 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.14 -47.16 46.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.714 -0.755 . . . . 0.19 112.5 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.7 mt -61.9 -38.89 90.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.47 110.96 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.849 HG12 HG11 ' A' ' 14' ' ' VAL . 17.6 m -77.6 -31.48 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.63 111.095 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -62.1 -58.52 7.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 1.58 110.815 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -39.97 75.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 1.68 110.923 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.9 HD23 HD21 ' A' ' 35' ' ' LEU . 84.1 mt -73.06 -24.32 60.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.23 110.972 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.492 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.67 -24.98 44.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.38 110.947 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.98 -29.92 17.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.21 111.087 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.9 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.46 -35.24 14.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.18 110.87 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.14 -45.39 4.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.23 111.059 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.15 -12.24 54.5 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.755 -0.736 . . . . 0.25 112.5 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -70.91 -62.55 1.35 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.323 . . . . 2.54 110.88 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.505 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 1.1 mm-40 -89.42 -41.11 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 2.38 110.807 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.75 -128.36 5.81 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.788 -0.72 . . . . 0.25 112.541 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -151.82 152.53 32.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.825 0.345 . . . . 2.2 110.903 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.492 HG21 ' HA ' ' A' ' 33' ' ' GLN . 88.2 t -135.46 130.0 49.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.27 111.121 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 t -120.74 153.14 37.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.469 . . . . 0.18 110.793 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.4 p -115.86 138.61 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.23 111.155 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -146.9 151.23 36.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 1.21 110.984 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -103.09 138.68 39.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.27 110.846 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.814 HD13 HG21 ' A' ' 73' ' ' THR . 27.3 mt -55.04 -42.65 65.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 0.33 111.147 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -25.56 67.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 4.18 110.904 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -111.24 19.32 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 3.55 110.83 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.789 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -50.27 -27.65 6.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 1.1 110.904 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -55.6 -32.53 63.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 1.14 110.875 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -83.45 -14.31 52.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 1.04 110.951 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.427 ' HB2' HD13 ' A' ' 50' ' ' LEU . 20.7 m -67.56 -8.52 34.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.85 110.884 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.41 64.14 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.28 111.129 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -65.13 -67.04 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.38 110.807 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.639 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -154.37 -177.9 6.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 1.39 110.931 -179.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -93.07 130.46 38.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 1.83 110.861 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.2 t 51.63 83.95 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.431 . . . . 2.14 110.8 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 91.2 p -136.15 -39.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.25 110.792 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 13' ' ' ALA . 99.6 m-85 -100.59 122.01 42.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 1.44 110.8 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.23 -22.04 62.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.11 -0.495 . . . . 1.49 110.854 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.7 ' HB ' HG22 ' A' ' 12' ' ' VAL . 20.4 mt -145.5 143.68 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.26 111.076 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.89 HG21 HG23 ' A' ' 83' ' ' ILE . 18.2 mm -133.03 132.72 58.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.12 111.148 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -115.14 137.21 52.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.19 110.957 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.35 101.33 5.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.223 -0.444 . . . . 0.16 110.863 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.23 75.36 0.22 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.852 -0.689 . . . . 0.17 112.427 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.48 59.71 0.62 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.801 0.334 . . . . 0.6 110.85 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.78 159.71 64.87 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.612 0.72 . . . . 0.21 111.125 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 116.84 4.76 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.59 2.193 . . . . 0.23 112.406 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.79 7.49 71.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.798 -0.715 . . . . 0.16 112.523 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.47 148.84 14.56 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.946 0.403 . . . . 0.67 110.882 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.765 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 32.2 p -137.88 108.57 6.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.19 111.127 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.814 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.09 153.47 18.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.26 111.145 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.938 HD12 HD22 ' A' ' 147' ' ' LEU . 4.5 mt -132.12 104.23 6.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.51 . . . . 0.23 110.852 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -79.87 153.84 28.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.34 110.829 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.8 m -130.94 175.82 8.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.57 110.824 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.28 -38.22 51.62 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.501 . . . . 0.23 111.07 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.44 -46.03 91.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.193 -0.458 . . . . 2.41 110.819 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.789 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -72.6 -54.6 15.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.22 111.073 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.518 HD13 ' HA ' ' A' ' 119' ' ' LEU . 58.8 mt -51.08 -38.26 50.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.222 -0.444 . . . . 0.19 110.857 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.88 -56.55 15.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.226 -0.443 . . . . 0.32 111.049 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.44 -44.12 76.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 2.98 110.949 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.89 HG23 HG21 ' A' ' 63' ' ' ILE . 51.1 mm -55.53 -68.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.23 111.172 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.71 -37.4 50.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.18 111.096 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 -55.2 -50.07 70.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 3.13 110.873 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 56' ' ' LYS . 32.3 pt -84.99 -7.31 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.2 111.165 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.97 112.04 14.46 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.17 -0.468 . . . . 0.35 110.834 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -51.35 159.31 1.16 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.608 0.718 . . . . 2.3 110.878 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 114.61 3.76 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.663 2.242 . . . . 0.16 112.306 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.47 3.32 56.44 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.733 -0.746 . . . . 0.17 112.455 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.98 -159.72 10.31 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.14 112.525 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 23.7 m -140.91 157.91 44.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.825 0.345 . . . . 0.34 110.942 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.709 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -141.76 115.05 8.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.199 -0.455 . . . . 0.2 110.896 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.561 ' N ' HD22 ' A' ' 93' ' ' LEU . 44.8 m-85 -109.23 133.9 52.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 1.63 110.914 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.505 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.34 162.41 39.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.16 110.874 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.1 123.45 27.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 3.41 110.855 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.627 ' OE1' HD23 ' A' ' 115' ' ' LEU . 1.0 OUTLIER -146.53 147.84 31.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 121.613 0.72 . . . . 2.58 110.847 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.624 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -69.78 145.61 57.58 Favored 'Trans proline' 0 N--CA 1.465 -0.178 0 C-N-CA 122.671 2.247 . . . . 0.2 112.311 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.0 m -131.3 146.45 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.24 111.11 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.73 132.68 53.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 3.6 110.866 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.4 p -100.47 26.07 7.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 1.24 111.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.414 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -151.94 27.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.61 111.129 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.407 HG12 ' N ' ' A' ' 104' ' ' ASP . 5.3 t -143.78 157.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.65 111.162 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.591 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -59.31 -172.59 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 1.9 110.841 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.41 -74.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 3.45 110.87 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -52.57 -75.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.166 -0.47 . . . . 2.14 110.893 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.69 -169.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 1.8 110.872 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 -5.02 56.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 2.09 110.981 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -146.77 145.8 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.46 111.227 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.432 ' H ' HD22 ' A' ' 74' ' ' LEU . 7.0 mmtm -66.07 110.46 2.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 2.49 110.983 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.591 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.4 p -82.11 177.25 8.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.21 111.103 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.88 -54.67 41.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.18 111.076 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.88 -48.02 83.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.27 110.822 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.6 tmtm? -57.99 -39.02 77.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 2.04 110.888 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.627 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -64.84 -55.17 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.3 110.873 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -56.76 -45.87 81.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.26 110.804 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.87 -43.13 89.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.35 110.85 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.72 98.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.23 111.124 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.584 HD11 HD12 ' A' ' 93' ' ' LEU . 14.6 tp -65.97 -51.43 58.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.22 110.858 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.0 m -62.76 -32.3 73.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.328 -0.396 . . . . 0.28 111.125 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.1 mt -86.82 -10.33 53.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.332 -0.394 . . . . 0.68 110.974 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.02 5.8 27.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 1.75 110.902 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.75 8.36 30.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.755 -0.736 . . . . 0.56 112.445 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -108.92 171.37 7.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.346 . . . . 0.26 110.953 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.9 m -149.98 170.71 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.21 111.054 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 52.34 44.94 29.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.02 -0.536 . . . . 2.35 110.88 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.422 HG13 HD23 ' A' ' 119' ' ' LEU . 93.1 t -81.78 142.64 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.25 111.121 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 159.75 7.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.226 -0.443 . . . . 1.78 110.894 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.01 139.83 38.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 2.82 110.818 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.665 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.9 mp -97.63 -37.58 9.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.21 110.831 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.7 176.35 12.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 1.1 110.889 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.706 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -130.14 138.83 50.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.475 . . . . 4.2 110.85 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -125.37 136.91 28.87 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.64 0.733 . . . . 1.42 110.938 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.401 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.1 Cg_endo -69.72 161.49 45.7 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.694 2.263 . . . . 0.21 112.443 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.665 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -94.96 125.4 39.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.302 -0.408 . . . . 0.27 110.963 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.454 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -98.24 160.75 27.47 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.539 0.685 . . . . 1.26 111.128 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.454 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.7 Cg_endo -69.87 -28.92 24.15 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.62 2.214 . . . . 0.39 112.369 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -85.32 -17.82 35.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 3.9 110.88 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.86 -53.52 4.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 2.35 110.899 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 141' ' ' GLN . 5.7 p -50.15 -42.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.25 111.14 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.404 ' N ' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -65.58 -32.35 73.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 1.31 110.854 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -50.61 28.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.4 110.856 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.658 HG23 HD13 ' A' ' 147' ' ' LEU . 7.2 p -62.21 -28.59 44.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.2 111.123 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -76.13 -47.34 24.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 1.96 110.842 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -74.45 -19.56 60.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 1.88 110.831 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.48 -33.11 13.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.46 110.786 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.938 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.82 -54.1 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.45 110.828 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.15 8.2 2.38 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.712 -0.756 . . . . 0.44 112.513 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -70.64 119.94 15.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.76 0.314 . . . . 0.63 110.814 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.53 105.08 2.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.153 -0.476 . . . . 2.19 110.868 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.14 177.52 10.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.76 110.902 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.46 -13.45 15.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 1.84 110.857 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.414 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -95.87 3.5 53.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 3.33 110.881 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.665 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -74.05 163.11 28.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.4 110.974 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.706 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.7 tm? -173.55 129.58 0.43 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.256 -0.429 . . . . 0.2 110.902 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.765 ' CZ ' HG22 ' A' ' 72' ' ' THR . 31.6 m-85 -75.73 135.92 40.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 1.83 110.86 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.79 141.99 19.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.082 -0.508 . . . . 0.21 111.194 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.665 ' HG2' HD13 ' A' ' 130' ' ' LEU . 17.6 tt0 -94.57 127.66 40.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 1.62 110.938 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -124.39 149.14 28.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.22 111.177 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.473 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.2 t -132.5 162.35 31.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.24 111.13 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.56 135.86 5.01 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.666 -0.778 . . . . 0.13 112.436 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -92.91 140.0 29.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.867 0.365 . . . . 1.61 110.918 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.3 135.02 50.9 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.518 0.675 . . . . 1.21 110.917 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.9 125.2 11.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.612 2.208 . . . . 0.31 112.297 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -105.18 149.26 26.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.855 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -72.85 78.35 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 7.32 110.854 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -178.25 34.09 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 9.74 110.864 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.7 t -147.09 -63.49 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 6.62 111.194 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 167.05 -26.83 0.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.778 -0.725 . . . . 5.22 112.489 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.22 172.67 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.889 0.376 . . . . 7.13 110.85 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.18 -42.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 6.04 110.931 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.513 . . . . 6.3 110.885 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' O ' HD12 ' A' ' 6' ' ' ILE . 5.8 ptp . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.844 0.354 . . . . 3.69 110.917 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.06 -18.69 59.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 0.64 111.149 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -50.01 67.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 2.4 110.876 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.493 ' CD2' HD11 ' A' ' 6' ' ' ILE . 6.8 m-85 -122.21 11.92 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 1.61 110.854 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.34 39.5 97.87 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.812 -0.709 . . . . 0.41 112.445 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.493 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.5 mp -81.52 159.82 3.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.765 0.316 . . . . 0.32 111.181 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.73 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -156.65 168.62 26.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.78 110.865 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.77 130.1 36.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.51 111.106 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.19 2.04 26.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.782 -0.723 . . . . 0.35 112.53 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -118.85 168.0 11.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.816 0.341 . . . . 1.16 110.864 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.02 115.03 29.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.98 0.419 . . . . 2.29 110.851 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.691 HG22 ' HB ' ' A' ' 62' ' ' ILE . 98.3 t -118.42 131.82 70.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 1.89 111.172 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.792 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -108.18 125.29 51.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.22 111.133 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.826 HG11 HG12 ' A' ' 29' ' ' VAL . 77.6 t -97.47 119.22 45.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.15 111.11 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.746 HG12 HG13 ' A' ' 47' ' ' ILE . 20.1 t -103.82 112.21 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.19 111.031 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -113.73 170.53 8.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.22 110.928 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 9.0 p-10 -151.96 -169.85 3.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.428 . . . . 1.79 110.909 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -35.69 71.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 6.23 110.865 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.1 m -72.96 -9.55 58.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 1.58 110.835 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.01 94.24 10.43 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.664 0.745 . . . . 0.23 110.84 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 142.57 48.14 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.726 2.284 . . . . 0.29 112.331 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.9 t -48.47 -33.14 4.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.27 111.158 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.09 -52.66 41.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.154 -0.475 . . . . 3.1 110.961 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -45.26 10.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.23 111.119 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.457 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.69 -61.54 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.19 110.977 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.46 -35.58 20.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 2.31 110.874 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.47 -47.56 41.85 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.766 -0.73 . . . . 0.22 112.486 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.7 mt -61.88 -38.1 87.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.931 0.396 . . . . 0.5 110.94 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.826 HG12 HG11 ' A' ' 14' ' ' VAL . 17.5 m -78.59 -31.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.63 111.079 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.48 -57.37 11.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 1.67 110.834 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -39.88 76.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.271 -0.422 . . . . 2.35 110.932 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.885 HD23 HD21 ' A' ' 35' ' ' LEU . 89.9 mt -73.26 -24.92 60.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.28 110.932 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.519 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.17 -25.14 47.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.39 110.969 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.7 -30.74 16.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.26 111.099 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.885 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.23 -34.86 15.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 0.25 110.97 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.73 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.83 -47.02 4.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.23 111.149 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.5 -13.55 50.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.26 112.451 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.8 -62.62 1.6 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 2.66 110.917 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -98.44 -36.87 9.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.113 -0.494 . . . . 2.2 110.935 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.92 -130.91 5.18 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.665 -0.779 . . . . 0.32 112.51 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -152.11 152.24 32.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.323 . . . . 2.22 110.944 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 33' ' ' GLN . 99.3 t -137.0 121.09 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.25 111.174 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -110.13 155.83 21.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.18 110.859 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 p -118.02 133.89 63.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.087 -0.506 . . . . 0.15 111.12 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -144.01 151.6 39.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 1.94 110.955 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -103.17 133.28 48.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.49 110.91 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.84 HD13 HG21 ' A' ' 73' ' ' THR . 20.9 mt -49.57 -32.98 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.27 -0.423 . . . . 0.36 111.091 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -71.32 -39.67 71.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 2.14 110.967 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.3 19.43 14.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 3.99 110.842 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.736 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -49.24 -27.87 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.431 . . . . 1.08 110.948 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mp -55.65 -32.85 63.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 1.29 110.942 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -83.88 -14.13 51.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.433 . . . . 1.04 110.906 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB2' HD13 ' A' ' 50' ' ' LEU . 33.4 m -66.47 -9.21 32.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.85 110.875 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.29 63.48 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.31 111.12 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -63.31 -67.75 0.4 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 0.44 110.818 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.562 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -153.28 179.87 8.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 2.19 110.876 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -87.78 133.94 33.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 1.93 110.944 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.7 p 46.3 83.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 1.11 110.807 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.1 p -134.19 -38.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.3 110.858 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 13' ' ' ALA . 99.4 m-85 -100.87 121.74 42.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 1.46 110.839 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.95 -21.44 61.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.122 -0.49 . . . . 1.73 110.844 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.691 ' HB ' HG22 ' A' ' 12' ' ' VAL . 23.0 mt -145.22 144.4 21.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.247 -0.433 . . . . 0.22 111.104 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.974 HG21 HG23 ' A' ' 83' ' ' ILE . 16.5 mm -134.5 129.17 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.15 111.128 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.1 mm? -111.03 136.31 50.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.17 110.912 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.402 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -129.51 100.65 5.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.16 110.775 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.02 74.2 0.32 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.451 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.551 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.0 mm? -106.31 52.9 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.839 0.352 . . . . 0.57 110.83 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.437 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -123.99 159.83 54.66 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.628 0.728 . . . . 0.24 111.141 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 123.88 10.53 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.633 2.222 . . . . 0.29 112.308 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.67 6.33 88.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.716 -0.754 . . . . 0.23 112.457 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.437 ' HB3' HG23 ' A' ' 68' ' ' VAL . 9.0 p -56.5 151.58 13.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.909 0.385 . . . . 0.76 110.848 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.718 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 26.4 p -141.62 109.17 5.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.15 111.205 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.84 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.63 143.64 11.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.29 111.104 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.946 HD12 HD22 ' A' ' 147' ' ' LEU . 7.6 mt -122.52 106.01 10.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.27 110.898 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -81.14 153.79 27.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.31 110.842 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 m -131.97 175.66 9.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.56 110.856 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.71 -38.51 55.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.28 111.043 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.09 -47.32 86.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 1.99 110.856 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.736 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.7 mp -71.53 -54.87 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.138 -0.483 . . . . 0.28 111.077 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.553 HD13 ' HA ' ' A' ' 119' ' ' LEU . 66.9 mt -50.3 -39.24 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.2 110.868 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.58 -54.43 27.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.33 111.033 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -56.9 -43.38 81.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.297 -0.41 . . . . 2.7 110.913 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.974 HG23 HG21 ' A' ' 63' ' ' ILE . 44.0 mm -60.02 -68.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.106 -0.497 . . . . 0.36 111.047 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.25 -31.26 13.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.43 111.167 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -63.83 -49.97 70.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 2.15 110.903 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.562 HG22 ' O ' ' A' ' 56' ' ' LYS . 41.0 pt -84.67 -2.95 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.23 111.077 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -81.6 111.99 18.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 0.4 110.934 179.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -51.9 159.53 1.36 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 2.2 110.827 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 114.75 3.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.723 2.282 . . . . 0.19 112.289 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.14 3.69 56.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.677 -0.773 . . . . 0.17 112.413 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.42 -163.32 15.66 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.747 -0.739 . . . . 0.15 112.494 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 32.5 m -137.02 154.44 50.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.828 0.347 . . . . 0.29 110.855 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.71 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -139.16 115.59 10.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.17 110.902 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.566 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.8 m-85 -110.29 132.16 54.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 1.64 110.886 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.551 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.68 164.17 35.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.15 110.896 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.87 131.48 31.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 1.69 110.922 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.81 149.41 22.11 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 3.61 110.882 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.566 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.4 Cg_endo -69.74 131.92 22.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.7 2.266 . . . . 0.41 112.326 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.73 146.8 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.2 111.174 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.467 ' CD ' HG21 ' A' ' 103' ' ' VAL . 45.9 mt-10 -108.48 132.48 53.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 2.09 110.931 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 17.9 p -91.15 -26.23 19.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.99 111.195 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -109.73 39.33 2.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.5 111.129 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.467 HG21 ' CD ' ' A' ' 100' ' ' GLU . 40.5 t -148.24 150.11 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.69 111.087 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.575 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -54.67 175.58 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 1.88 110.902 179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -65.92 -66.81 0.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 2.21 110.813 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -62.15 -75.96 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 2.26 110.944 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.7 t 51.25 -168.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 2.12 110.883 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -80.84 -3.1 50.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 1.66 110.942 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.616 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.0 m -143.53 144.14 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.52 111.12 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.44 117.33 9.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 2.38 110.896 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.575 HG21 ' O ' ' A' ' 104' ' ' ASP . 45.0 p -92.78 -176.02 4.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.227 -0.442 . . . . 0.36 111.237 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -62.43 -50.87 69.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.297 -0.41 . . . . 0.27 111.102 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.29 -52.21 65.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.38 110.832 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -54.88 -41.15 70.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 2.2 110.92 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.505 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -62.43 -54.82 34.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.38 110.888 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 70.3 m -56.0 -48.07 76.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.27 110.843 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -44.97 93.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.36 110.79 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.92 -42.08 99.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.135 -0.484 . . . . 0.28 111.063 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.553 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.4 tp -66.29 -53.33 37.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.24 110.875 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.1 m -59.84 -33.01 71.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 0.28 111.112 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.7 mt -87.15 -10.53 52.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.69 110.936 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.72 4.38 32.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 1.7 110.884 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.87 11.51 26.22 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 0.7 112.499 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.71 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -110.9 170.41 8.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.847 0.356 . . . . 0.3 110.956 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.7 m -151.5 174.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.185 -0.461 . . . . 0.27 111.063 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 52.07 43.93 30.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 2.17 110.863 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.4 t -75.7 143.04 13.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.31 111.099 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 159.1 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 1.57 110.849 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -81.37 146.8 30.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 2.34 110.881 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.508 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.4 mp -106.76 -35.67 6.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.35 110.948 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.22 176.24 11.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 1.23 110.886 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.679 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.0 OUTLIER -132.97 140.4 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.495 . . . . 4.02 110.895 -179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -126.13 137.46 30.24 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.681 0.753 . . . . 1.53 110.947 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.406 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.6 Cg_endo -69.74 162.51 41.76 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.65 2.233 . . . . 0.28 112.35 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.68 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -98.8 123.13 42.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.195 -0.457 . . . . 0.51 110.941 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.473 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -100.72 161.04 25.13 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.653 0.74 . . . . 1.51 111.054 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.46 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.5 Cg_endo -69.65 -25.78 28.76 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.683 2.255 . . . . 0.67 112.388 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -85.42 -22.06 28.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 2.8 110.916 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -87.85 -52.32 5.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 2.39 110.995 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.89 -39.98 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.35 111.109 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -33.42 74.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 1.44 110.87 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -46.02 67.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.4 110.949 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.768 HG23 HD13 ' A' ' 147' ' ' LEU . 7.6 p -68.51 -30.25 46.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 0.24 111.189 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.03 -31.44 56.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.159 -0.473 . . . . 3.44 110.915 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -90.31 -19.83 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 2.04 110.888 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -94.25 -33.62 13.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.459 . . . . 0.59 110.874 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.946 HD22 HD12 ' A' ' 74' ' ' LEU . 3.3 mp -125.19 -54.19 1.6 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.45 110.936 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.96 10.1 2.06 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 0.37 112.44 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.616 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.6 t-160 -69.54 120.86 15.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 1.03 110.846 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -149.75 106.38 3.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.25 -0.432 . . . . 3.05 110.936 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.6 174.59 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.09 -0.504 . . . . 1.06 110.906 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.06 -19.14 13.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 2.72 110.818 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -96.6 12.77 30.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 2.3 110.903 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.68 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -77.74 163.7 25.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.29 110.951 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.679 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.49 130.44 0.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.22 110.855 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.718 ' CZ ' HG22 ' A' ' 72' ' ' THR . 29.9 m-85 -74.76 132.95 42.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 1.67 110.894 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.82 144.95 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.19 111.229 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.551 ' OE1' HD13 ' A' ' 67' ' ' LEU . 3.1 tt0 -101.04 128.27 47.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 1.99 110.949 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.0 148.16 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.23 111.103 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.487 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.0 t -125.84 158.99 33.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.31 111.228 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.03 130.77 3.38 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.79 -0.719 . . . . 0.16 112.521 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -92.16 139.14 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.924 0.393 . . . . 1.6 110.834 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.59 135.09 53.29 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.515 0.674 . . . . 1.18 110.964 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 127.15 14.24 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.676 2.251 . . . . 0.32 112.38 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -107.7 150.56 26.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.3 110.885 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -66.32 90.04 0.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 7.04 110.934 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -179.32 34.81 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 9.65 110.897 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.7 m -152.07 -41.57 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.181 -0.463 . . . . 5.93 111.084 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 52.51 33.0 39.68 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.723 -0.751 . . . . 5.77 112.483 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.81 -67.39 0.82 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.837 0.351 . . . . 6.99 110.91 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.67 -74.29 0.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 5.95 110.809 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 7.96 110.885 -179.976 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.3 ptm . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.836 0.35 . . . . 3.93 110.876 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.96 -20.57 66.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.48 111.108 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -51.28 65.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 1.94 110.883 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.29 22.38 10.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 1.5 110.84 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.12 40.74 52.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 0.23 112.529 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.471 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -79.25 159.48 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.725 0.298 . . . . 0.22 111.206 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -152.93 162.69 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 1.33 110.822 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.42 126.53 35.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.076 -0.511 . . . . 0.28 111.124 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.11 -6.67 17.17 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.73 -0.748 . . . . 0.27 112.487 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -113.69 167.66 10.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 1.22 110.965 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -97.96 140.87 31.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 2.12 110.837 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.647 HG22 ' HB ' ' A' ' 62' ' ' ILE . 54.3 t -142.59 142.69 26.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 1.84 111.16 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.771 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -119.95 121.74 39.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.161 -0.472 . . . . 0.24 111.024 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.812 HG11 HG12 ' A' ' 29' ' ' VAL . 57.7 t -94.41 118.57 40.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.21 111.102 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 47' ' ' ILE . 11.4 t -102.52 110.71 29.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.28 111.121 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -112.45 167.19 10.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.16 110.925 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.481 ' HB3' HD12 ' A' ' 47' ' ' ILE . 6.2 p-10 -149.99 -169.65 3.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 1.98 110.846 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -57.53 -35.62 70.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 2.91 110.894 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.37 -9.54 58.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 1.19 110.866 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.84 94.7 10.94 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.617 0.722 . . . . 0.13 110.851 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 141.78 46.0 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.7 2.267 . . . . 0.19 112.338 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.1 t -48.79 -32.97 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.415 . . . . 0.18 111.114 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.08 -52.92 38.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 3.14 110.834 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.46 -44.96 10.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.119 -0.491 . . . . 0.16 111.145 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.485 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.74 -61.62 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.245 -0.434 . . . . 0.13 110.894 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -49.7 -37.41 28.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 3.08 110.947 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.31 -47.33 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.19 112.475 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.89 -39.84 93.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.895 0.379 . . . . 0.45 110.915 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.812 HG12 HG11 ' A' ' 14' ' ' VAL . 17.2 m -76.79 -31.57 19.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.62 111.231 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.09 -59.56 4.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.115 -0.493 . . . . 1.64 110.786 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -39.82 72.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 1.73 110.874 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.888 HD23 HD21 ' A' ' 35' ' ' LEU . 84.0 mt -73.1 -24.7 60.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.23 110.994 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.417 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.67 -25.21 44.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.4 110.907 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.84 -29.81 17.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.27 111.141 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.888 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.48 -35.19 14.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.2 110.93 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.08 -45.34 4.75 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 0.27 111.166 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.44 -11.75 53.83 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.672 -0.775 . . . . 0.36 112.453 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -74.43 -62.39 1.54 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.747 0.308 . . . . 2.62 110.944 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.536 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 3.2 mm-40 -85.91 -43.18 13.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 2.13 110.841 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.23 -121.03 4.1 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.727 -0.749 . . . . 0.33 112.533 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -158.33 154.13 26.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 2.3 110.81 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.417 HG21 ' HA ' ' A' ' 33' ' ' GLN . 99.2 t -139.54 131.61 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.33 111.161 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -120.76 157.99 28.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.22 110.831 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.2 134.99 59.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.078 -0.51 . . . . 0.16 111.138 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -144.76 151.9 39.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.432 . . . . 1.23 110.89 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -101.4 137.39 39.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 1.69 110.9 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.716 ' CD1' HG21 ' A' ' 73' ' ' THR . 17.5 mt -51.03 -49.86 26.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.156 -0.475 . . . . 0.45 111.107 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -22.55 63.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 3.04 110.927 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -98.52 18.44 16.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 3.46 110.885 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.806 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -49.98 -28.03 6.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.457 . . . . 1.11 110.835 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.81 -37.79 60.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 1.19 110.87 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -85.23 -17.21 37.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 1.1 110.972 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.455 ' HB2' HD13 ' A' ' 50' ' ' LEU . 50.1 m -65.37 -12.51 52.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.89 110.908 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.76 64.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.12 -0.491 . . . . 0.4 111.074 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -65.71 -67.98 0.4 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.34 110.86 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.664 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -155.32 -175.48 5.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 1.33 110.856 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -94.06 134.85 36.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 1.83 110.864 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p 46.3 82.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 1.13 110.84 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.8 p -133.53 -38.44 0.92 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.31 110.885 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.456 ' O ' HD23 ' A' ' 87' ' ' LEU . 96.3 m-85 -101.97 122.0 43.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 2.04 110.84 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.99 -21.48 61.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 1.49 110.827 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.647 ' HB ' HG22 ' A' ' 12' ' ' VAL . 32.3 mt -142.6 143.88 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.34 111.034 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.875 HG21 HG23 ' A' ' 83' ' ' ILE . 23.0 mm -134.27 128.79 52.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.17 111.142 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.432 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -111.95 136.31 51.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.15 110.913 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.44 101.81 6.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 0.21 110.826 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.84 75.95 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.783 -0.722 . . . . 0.17 112.47 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.459 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.4 mm? -108.66 58.26 0.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.849 0.357 . . . . 0.59 110.883 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.02 159.74 65.18 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.697 0.761 . . . . 0.23 111.196 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 116.73 4.69 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.738 2.292 . . . . 0.25 112.362 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.18 7.14 70.41 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.805 -0.712 . . . . 0.18 112.416 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -55.27 149.7 12.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.859 0.361 . . . . 0.69 110.853 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 27.5 p -140.23 108.86 5.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 0.15 111.212 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.716 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.1 150.27 12.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.23 111.147 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.971 HD12 HD22 ' A' ' 147' ' ' LEU . 4.5 mt -127.79 102.98 7.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.21 110.918 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -77.63 148.66 34.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.454 . . . . 0.25 110.794 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 64.0 m -127.17 -178.02 4.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.789 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.75 -41.33 67.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.048 -0.523 . . . . 0.4 111.159 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -57.85 -47.24 83.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 1.85 110.9 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.806 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.2 mp -71.81 -56.75 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.31 111.132 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD13 ' HA ' ' A' ' 119' ' ' LEU . 56.8 mt -50.73 -40.83 55.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.2 110.968 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.56 -56.7 11.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.141 -0.481 . . . . 0.36 111.114 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -44.49 86.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 2.44 110.855 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.875 HG23 HG21 ' A' ' 63' ' ' ILE . 40.2 mm -53.0 -68.88 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.24 111.166 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.1 -39.85 60.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.2 111.121 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.6 tpp85 -53.32 -50.25 65.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 2.15 110.893 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 56' ' ' LYS . 34.2 pt -84.11 -8.13 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.18 111.067 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -77.37 113.42 15.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.188 -0.46 . . . . 0.31 110.947 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -52.84 159.88 1.65 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.669 0.747 . . . . 2.31 110.867 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.86 114.5 3.74 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.685 2.257 . . . . 0.22 112.332 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.26 5.47 57.1 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.17 112.45 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.44 -163.11 18.72 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.844 -0.694 . . . . 0.14 112.407 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 22.8 m -136.55 154.99 50.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.28 110.854 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.703 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -139.69 116.38 10.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.18 110.919 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.578 ' N ' HD22 ' A' ' 93' ' ' LEU . 54.6 m-85 -112.21 131.29 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 1.62 110.927 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.514 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.41 160.7 42.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.247 -0.433 . . . . 0.16 110.97 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.53 127.94 36.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 1.8 110.909 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.78 148.95 29.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.651 0.739 . . . . 2.2 110.842 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.617 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.1 Cg_endo -69.85 140.01 41.3 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.598 2.199 . . . . 0.19 112.376 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.7 m -127.81 146.97 32.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.426 . . . . 0.25 111.091 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.468 ' CD ' HG21 ' A' ' 103' ' ' VAL . 12.8 mt-10 -109.55 132.46 54.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 2.22 110.869 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 37.4 p -105.61 26.45 9.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 1.29 111.093 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.58 24.41 0.69 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.6 111.133 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.468 HG21 ' CD ' ' A' ' 100' ' ' GLU . 4.4 t -144.81 159.24 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.78 111.043 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.564 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -51.02 167.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 1.74 110.819 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -62.78 -50.67 70.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 2.27 110.847 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -74.13 -75.73 0.15 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 1.74 110.928 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.443 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.2 t 53.56 -166.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 2.24 110.799 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -8.93 59.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 3.86 110.855 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.436 HG11 ' CG ' ' A' ' 149' ' ' HIS . 2.7 m -140.62 142.78 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.38 111.117 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -63.13 116.15 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 2.24 110.932 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.564 HG21 ' O ' ' A' ' 104' ' ' ASP . 55.7 p -85.03 178.49 7.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.233 -0.439 . . . . 0.26 111.033 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.97 -54.02 49.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.18 111.144 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -59.9 -48.7 80.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.25 110.851 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -56.8 -39.55 74.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 1.68 110.898 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.499 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -64.53 -54.98 23.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 0.33 110.857 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.2 m -56.09 -45.34 79.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.21 110.954 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.46 -42.56 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.28 110.82 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.46 -41.44 98.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.21 111.111 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.513 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.0 tp -66.66 -52.98 38.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.275 -0.421 . . . . 0.23 110.874 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 87.5 m -59.8 -34.72 73.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.32 111.083 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 22.7 mt -84.96 -10.21 57.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.63 110.905 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.12 5.45 29.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 1.73 110.8 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.26 7.77 32.15 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.759 . . . . 0.64 112.495 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -107.31 170.18 8.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.3 110.992 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -150.86 170.63 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.26 111.162 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 54.77 43.27 30.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 2.1 110.858 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 99.0 t -75.65 143.51 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.27 111.106 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.1 159.66 7.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 1.66 110.867 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -81.86 146.05 30.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 2.37 110.924 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.515 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.2 mp -105.92 -35.64 7.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.21 110.885 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.3 176.27 11.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 1.09 110.888 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.733 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.4 OUTLIER -132.35 137.84 47.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 4.46 110.823 -179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -123.91 137.53 29.01 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.593 0.711 . . . . 1.84 111.002 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.412 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.2 Cg_endo -69.69 165.08 32.09 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.706 2.271 . . . . 0.22 112.389 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.68 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -98.19 126.56 43.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.27 110.868 179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.462 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.34 161.4 23.0 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.606 0.717 . . . . 1.54 111.157 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 -24.57 29.81 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.692 2.261 . . . . 0.34 112.366 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -85.59 -22.52 28.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 2.56 110.898 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -87.79 -52.22 5.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 2.57 110.867 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 136' ' ' THR . 7.3 p -49.69 -40.08 15.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.146 -0.479 . . . . 0.27 111.171 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -33.44 74.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 1.13 110.954 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.35 -45.93 68.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 0.25 110.832 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 8.4 p -68.36 -30.44 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.16 111.103 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -75.98 -32.48 59.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 2.4 110.87 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -89.32 -20.29 24.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.222 -0.445 . . . . 1.65 110.912 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -94.47 -32.78 13.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.29 110.866 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.971 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.55 -54.37 1.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.31 110.929 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.98 9.11 2.53 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.768 -0.729 . . . . 0.34 112.537 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.436 ' CG ' HG11 ' A' ' 109' ' ' VAL . 15.3 t-160 -70.3 121.5 17.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.749 0.309 . . . . 0.62 110.879 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -152.08 104.75 3.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 2.15 110.882 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.3 t -161.2 173.12 15.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.72 110.858 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.82 -12.71 15.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.233 -0.439 . . . . 1.7 110.797 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -97.67 10.41 40.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 1.58 110.832 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.68 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -83.59 166.61 18.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.189 -0.46 . . . . 0.27 110.83 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.733 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -172.97 130.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.2 110.978 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 25.9 m-85 -74.79 131.3 40.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 1.74 110.908 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.0 144.18 25.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.21 111.081 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.515 ' HG2' HD13 ' A' ' 130' ' ' LEU . 3.8 tt0 -99.56 128.41 45.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 1.88 110.919 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.3 149.61 30.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.2 111.118 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.473 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.5 t -127.84 160.88 30.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.109 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.44 132.1 3.61 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.13 112.503 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -92.94 140.1 29.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 1.65 110.896 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.46 135.13 50.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.603 0.716 . . . . 1.23 110.939 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 123.6 10.26 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.634 2.223 . . . . 0.3 112.346 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -103.55 147.6 26.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.34 110.84 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.2 t80 60.66 19.75 9.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 5.64 110.895 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.54 163.18 24.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.079 -0.509 . . . . 9.33 110.808 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.0 m -117.65 -30.49 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 9.81 111.05 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.47 39.79 60.59 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.743 -0.742 . . . . 9.17 112.451 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.27 -32.75 38.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 11.8 110.881 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.6 m -58.51 -41.93 86.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.5 . . . . 7.86 110.925 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 7.71 110.819 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.812 0.339 . . . . 4.35 110.934 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.17 -21.15 63.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.59 111.142 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -54.57 -51.53 64.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 3.05 110.917 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.427 ' CE1' HD12 ' A' ' 67' ' ' LEU . 5.6 m-85 -122.32 21.79 10.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 2.01 110.917 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.21 39.77 51.19 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.741 -0.742 . . . . 0.34 112.451 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.458 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.8 mp -77.03 159.19 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.38 111.145 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 36' ' ' THR . 38.1 m -147.33 157.03 43.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 1.15 110.85 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.11 123.71 33.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.513 . . . . 0.47 111.112 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.68 -3.51 21.42 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.758 -0.734 . . . . 0.29 112.5 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -108.89 169.63 8.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.376 . . . . 1.52 110.898 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -104.62 109.68 21.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 1.38 110.873 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.668 HG12 HG21 ' A' ' 36' ' ' THR . 2.3 p -115.7 135.49 55.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 2.05 111.092 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.754 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -109.7 125.85 53.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.22 111.083 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.842 HG11 HG12 ' A' ' 29' ' ' VAL . 58.5 t -97.72 120.53 47.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.19 111.129 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.408 HG12 HG13 ' A' ' 47' ' ' ILE . 41.0 t -104.31 121.86 56.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.25 111.13 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -121.38 170.24 9.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.25 110.905 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.408 ' HB3' HD12 ' A' ' 47' ' ' ILE . 9.8 p-10 -151.25 -171.02 3.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 1.84 110.919 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 tttp -57.05 -36.11 70.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 3.62 110.881 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.5 m -72.08 -10.21 59.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 1.77 110.807 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m -107.68 92.86 9.31 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.618 0.723 . . . . 0.25 110.884 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.79 143.07 49.52 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.678 2.252 . . . . 0.42 112.306 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 98.6 t -48.29 -32.61 3.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.3 111.144 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.54 -53.44 37.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 2.59 110.9 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.9 -45.01 10.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.143 -0.48 . . . . 0.33 111.064 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.684 ' HA ' HD12 ' A' ' 28' ' ' LEU . 2.1 tm? -50.19 -60.26 3.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.22 110.91 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -49.44 -35.76 20.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 2.83 110.952 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.89 -48.31 49.31 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.698 -0.763 . . . . 0.27 112.478 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 1.045 HD11 HG13 ' A' ' 68' ' ' VAL . 2.1 mt -60.43 -40.55 91.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.865 0.364 . . . . 1.5 110.937 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.842 HG12 HG11 ' A' ' 14' ' ' VAL . 17.3 m -76.79 -30.81 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.63 111.081 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.94 -60.87 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.152 -0.476 . . . . 1.91 110.929 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -40.58 68.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.506 . . . . 2.59 110.821 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.806 HD23 HD21 ' A' ' 35' ' ' LEU . 91.8 mt -72.36 -25.57 61.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.33 110.991 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.558 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.36 -24.94 46.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.46 110.844 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.23 -30.1 17.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.5 111.112 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.806 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.34 -34.88 14.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.4 110.887 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.668 HG21 HG12 ' A' ' 12' ' ' VAL . 1.2 m -103.2 -47.0 4.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.36 111.186 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.24 -14.64 48.36 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.763 -0.732 . . . . 0.44 112.478 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -60.78 -62.55 1.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.758 0.313 . . . . 2.01 110.858 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.23 -36.35 9.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 2.03 110.873 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.72 -137.48 7.61 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.67 -0.776 . . . . 0.47 112.467 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.3 ttt-85 -146.4 150.33 35.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 3.71 110.925 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 33' ' ' GLN . 85.8 t -133.66 119.31 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.161 -0.472 . . . . 0.3 111.102 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.1 t -108.12 158.04 17.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.22 110.796 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -121.48 138.14 52.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.22 111.109 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -145.82 151.31 37.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 1.23 110.891 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -103.4 134.62 46.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.22 -0.445 . . . . 0.43 110.958 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.73 ' CD1' HG21 ' A' ' 73' ' ' THR . 37.2 mt -52.77 -35.86 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.32 111.119 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -71.51 -31.64 67.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 2.1 110.896 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -103.91 20.18 18.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 3.61 110.896 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.825 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -49.19 -28.37 4.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 1.11 110.893 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.3 mp -55.27 -34.01 63.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 1.06 110.892 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 64.7 mm-40 -84.04 -14.94 49.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.294 -0.412 . . . . 1.06 110.898 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB2' HD13 ' A' ' 50' ' ' LEU . 32.8 m -67.14 -9.38 39.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.314 -0.403 . . . . 0.89 110.863 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.87 63.93 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.31 111.02 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -63.22 -68.13 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.229 -0.441 . . . . 0.43 110.849 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.602 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -153.85 -176.95 6.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 1.38 110.896 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -92.72 128.95 38.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 1.82 110.91 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.8 t 51.67 84.87 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 1.98 110.806 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 90.1 p -136.23 -38.87 0.68 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.31 110.863 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.44 ' O ' HD23 ' A' ' 87' ' ' LEU . 98.6 m-85 -100.21 123.76 44.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 2.01 110.804 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.38 -21.48 60.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 1.72 110.785 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 6' ' ' ILE . 13.4 mt -144.05 143.3 23.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.22 111.06 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.916 HG21 HG23 ' A' ' 83' ' ' ILE . 22.6 mm -135.62 128.75 47.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.16 111.187 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.2 mm? -112.61 136.31 52.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.22 110.845 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.97 105.0 8.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 0.22 110.834 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.26 71.44 0.63 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.768 -0.73 . . . . 0.23 112.488 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.427 HD12 ' CE1' ' A' ' 4' ' ' PHE . 4.2 mm? -104.52 57.09 0.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.818 0.342 . . . . 0.68 110.948 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.045 HG13 HD11 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -124.57 153.01 69.67 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.637 0.732 . . . . 0.46 111.149 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.688 ' HD2' HG12 ' A' ' 68' ' ' VAL . 54.3 Cg_endo -69.71 116.87 4.75 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.674 2.249 . . . . 0.38 112.336 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.99 6.94 71.15 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.708 -0.758 . . . . 0.47 112.453 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.505 ' HB2' HG23 ' A' ' 68' ' ' VAL . 4.7 t -66.2 152.97 43.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 2.73 110.832 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.706 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 20.0 p -136.68 112.42 9.48 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.521 . . . . 0.28 111.142 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.73 HG21 ' CD1' ' A' ' 47' ' ' ILE . 1.2 m -162.81 144.82 10.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.42 111.1 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.867 HD12 HD22 ' A' ' 147' ' ' LEU . 9.3 mt -125.28 116.28 21.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.56 110.833 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -89.97 154.06 20.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.236 -0.438 . . . . 0.28 110.806 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.6 m -129.51 -177.7 4.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.57 110.923 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.5 -37.06 69.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.163 -0.472 . . . . 0.25 111.025 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -61.77 -46.28 90.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 2.05 110.85 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.825 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -73.31 -54.64 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.468 . . . . 0.22 111.119 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.654 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.8 mt -50.31 -40.8 49.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.22 110.924 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.49 -55.48 18.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.35 111.12 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -45.26 82.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 3.12 110.869 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.916 HG23 HG21 ' A' ' 63' ' ' ILE . 40.4 mm -54.65 -68.85 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.21 111.088 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.84 -39.3 53.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.21 111.181 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -53.18 -51.47 61.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 2.85 110.912 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.602 HG22 ' O ' ' A' ' 56' ' ' LYS . 29.8 pt -83.96 -6.98 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.19 111.134 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.3 OUTLIER -79.02 111.25 15.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.37 110.854 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.3 mtt-85 -51.79 158.93 1.46 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 3.67 110.923 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.419 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.3 Cg_endo -69.82 114.15 3.62 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.738 2.292 . . . . 0.27 112.243 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.84 2.8 55.14 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.18 112.453 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.83 -165.78 23.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.19 112.544 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 65.5 m -133.51 152.81 51.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.86 0.362 . . . . 0.35 110.924 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.694 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.29 114.79 11.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.15 110.922 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.539 ' N ' HD22 ' A' ' 93' ' ' LEU . 48.4 m-85 -110.54 132.54 54.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 1.88 110.897 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.561 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -148.25 157.91 43.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.15 110.81 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.1 126.51 43.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.012 -0.54 . . . . 2.58 110.817 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.607 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -150.53 145.96 19.13 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.689 0.757 . . . . 2.27 110.83 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.45 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.9 Cg_endo -69.75 139.76 41.06 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.721 2.281 . . . . 0.19 112.434 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.52 146.73 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.31 -0.405 . . . . 0.22 111.144 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.458 ' OE2' HG21 ' A' ' 103' ' ' VAL . 16.8 mt-10 -110.29 132.59 54.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 1.88 110.892 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.9 p -104.18 26.1 9.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 1.21 111.145 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.99 23.42 0.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.63 111.131 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.458 HG21 ' OE2' ' A' ' 100' ' ' GLU . 4.6 t -144.49 159.01 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.67 111.145 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.602 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -57.44 -178.02 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 2.16 110.848 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -68.54 -63.37 1.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 2.08 110.84 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -59.4 -76.03 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 2.27 110.938 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.435 ' HB2' HG11 ' A' ' 103' ' ' VAL . 1.5 p 51.44 -169.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 2.06 110.809 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.54 -3.84 51.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 1.86 110.846 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -146.41 153.61 12.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.426 . . . . 0.46 111.112 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.545 ' HB2' HD22 ' A' ' 74' ' ' LEU . 10.0 mmtm -72.28 109.7 6.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 1.89 110.833 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.602 HG21 ' O ' ' A' ' 104' ' ' ASP . 30.2 p -82.4 177.99 8.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.26 111.156 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.85 -54.88 39.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.3 -0.409 . . . . 0.2 111.101 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.16 -49.28 77.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.27 110.836 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -56.75 -38.63 72.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.191 -0.459 . . . . 1.69 110.96 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.607 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -65.15 -54.89 22.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.32 110.929 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.7 m -57.74 -45.8 85.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.206 -0.452 . . . . 0.21 110.834 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -42.95 91.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.27 110.87 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.45 -43.59 93.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.23 111.043 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.654 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.9 tp -65.63 -50.35 65.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.32 110.925 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 96.8 m -61.97 -34.6 76.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.477 . . . . 0.28 111.082 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 30.0 mt -84.13 -10.22 57.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.57 110.87 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.6 6.52 27.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 1.77 110.884 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.41 4.77 34.86 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.51 112.406 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -104.63 170.61 7.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.37 110.895 -179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.2 m -151.7 173.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.31 111.068 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 51.55 44.1 29.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.077 -0.511 . . . . 2.04 110.878 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 95.3 t -77.73 143.1 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.25 111.186 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.15 159.25 7.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.244 -0.435 . . . . 1.56 110.95 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.99 143.33 32.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.308 -0.405 . . . . 3.29 110.923 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.755 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.3 mp -103.19 -37.0 7.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.134 -0.485 . . . . 0.28 110.931 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.81 176.08 13.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 1.21 110.948 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.689 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.4 tmt_? -132.35 137.49 47.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 4.32 110.893 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -123.87 136.81 27.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.632 0.73 . . . . 1.83 110.941 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HA ' HD21 ' A' ' 155' ' ' LEU . 52.9 Cg_endo -69.77 163.03 39.81 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.759 2.306 . . . . 0.28 112.293 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.679 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -96.45 124.15 40.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.27 110.915 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.445 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -98.77 161.38 25.19 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 121.567 0.699 . . . . 1.22 111.088 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.445 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.8 Cg_endo -69.82 -28.41 25.0 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.678 2.252 . . . . 0.37 112.4 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -85.41 -17.71 35.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 3.66 110.824 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.13 -53.66 4.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 2.33 110.974 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.9 p -49.43 -40.56 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.26 111.127 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.79 -34.61 75.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 1.23 110.831 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.19 -46.38 70.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.28 110.791 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.847 HG23 HD13 ' A' ' 147' ' ' LEU . 9.7 p -68.37 -30.37 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.086 -0.506 . . . . 0.2 111.14 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -75.49 -32.29 60.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 1.89 110.953 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -89.62 -20.22 23.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 1.95 110.875 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.42 -32.55 13.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.3 110.809 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.867 HD22 HD12 ' A' ' 74' ' ' LEU . 3.5 mp -128.04 -53.98 1.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.41 110.946 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.22 12.4 2.08 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.814 -0.707 . . . . 0.31 112.491 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -70.6 122.07 19.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.324 . . . . 0.76 110.894 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 75.6 tt0 -151.6 105.44 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 2.73 110.893 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.57 175.21 12.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.62 110.836 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.09 -20.31 13.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 1.75 110.881 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -93.57 13.27 22.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 1.72 110.984 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.679 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -80.91 163.23 23.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.31 110.938 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.689 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.53 129.99 0.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.23 110.948 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.706 ' CZ ' HG22 ' A' ' 72' ' ' THR . 33.6 m-85 -73.81 133.49 43.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 1.82 110.842 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.0 139.74 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 0.26 111.101 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.755 ' HG2' HD13 ' A' ' 130' ' ' LEU . 11.3 tt0 -93.74 129.62 40.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 2.29 110.938 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.86 150.93 31.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.424 . . . . 0.23 111.174 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.471 ' N ' HD11 ' A' ' 130' ' ' LEU . 3.1 t -130.04 160.5 33.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.23 111.061 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -150.76 131.38 3.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.719 -0.753 . . . . 0.16 112.441 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -93.83 140.42 29.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.837 0.351 . . . . 1.55 110.905 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 9.4 tptt -81.78 134.75 49.8 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.609 0.719 . . . . 2.32 110.818 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 119.39 6.34 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.753 2.302 . . . . 0.42 112.291 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -102.48 151.9 21.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 0.37 110.904 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -64.44 96.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 6.74 110.934 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -178.41 37.94 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 10.27 110.91 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.406 HG11 ' OG ' ' A' ' 171' ' ' SER . 41.0 t -146.27 -69.19 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.139 -0.482 . . . . 6.37 111.154 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.0 -46.8 1.05 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.788 -0.72 . . . . 5.55 112.502 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 86.3 p -153.77 90.45 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 7.0 110.815 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.406 ' OG ' HG11 ' A' ' 168' ' ' VAL . 2.5 m -137.21 -64.37 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 7.65 110.819 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.089 -0.505 . . . . 8.36 110.932 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.534 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.837 0.351 . . . . 3.88 110.942 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.9 -19.04 59.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.64 111.166 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -53.96 -49.27 69.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 2.1 110.877 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -122.3 18.26 10.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 1.55 110.867 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.17 40.04 73.22 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.788 -0.72 . . . . 0.28 112.417 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 1' ' ' MET . 1.8 mp -77.0 157.5 5.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.763 0.316 . . . . 0.3 111.184 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.472 ' O ' HG23 ' A' ' 36' ' ' THR . 46.2 m -148.3 156.61 42.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 1.11 110.846 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.77 125.31 33.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.44 111.093 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.09 -6.23 23.56 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 0.28 112.51 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -109.72 167.57 10.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.801 0.334 . . . . 1.47 110.975 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.51 137.03 38.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 2.21 110.929 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' CG1' HG21 ' A' ' 36' ' ' THR . 2.1 p -141.86 140.71 30.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 2.11 111.147 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.745 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -115.64 124.16 50.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.21 111.17 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.851 HG11 HG12 ' A' ' 29' ' ' VAL . 95.3 t -95.88 118.52 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.278 -0.419 . . . . 0.16 111.086 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.441 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.1 t -102.7 115.28 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.462 . . . . 0.18 111.153 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.8 p-90 -115.91 167.2 11.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 0.19 110.967 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.421 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.7 p-10 -151.3 -169.54 3.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.266 -0.425 . . . . 1.75 110.892 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.6 ttmm -56.8 -35.74 69.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 3.37 110.937 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -73.06 -10.9 60.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.256 -0.429 . . . . 1.51 110.863 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.25 93.57 9.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.604 0.716 . . . . 0.16 110.891 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.5 Cg_endo -69.77 142.76 48.76 Favored 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.719 2.279 . . . . 0.2 112.336 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.5 t -48.92 -32.52 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.19 111.144 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.28 -53.2 38.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.496 . . . . 2.4 110.913 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.56 -44.95 10.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.19 111.091 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.474 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.27 -61.51 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.16 110.922 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -36.8 31.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 2.38 110.843 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.68 49.91 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.801 -0.714 . . . . 0.23 112.47 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.6 mt -61.7 -40.36 94.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.83 0.348 . . . . 0.52 110.918 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.851 HG12 HG11 ' A' ' 14' ' ' VAL . 17.3 m -76.16 -31.46 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.209 -0.45 . . . . 0.63 111.177 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -62.02 -60.29 3.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 1.55 110.821 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.65 -40.15 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 1.73 110.938 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.913 HD23 HD21 ' A' ' 35' ' ' LEU . 77.4 mt -72.69 -24.68 61.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.26 110.841 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.505 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.4 -24.86 46.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.38 110.926 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.82 -30.02 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.23 111.132 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.913 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.43 -35.3 14.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.22 110.879 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.499 HG21 ' CG1' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -102.33 -44.77 5.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.24 111.057 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.49 -10.94 55.46 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.729 -0.748 . . . . 0.25 112.498 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.32 -62.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 2.26 110.966 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -91.47 -39.94 11.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 2.24 110.875 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.21 -125.73 4.91 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.34 112.538 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -156.25 152.68 28.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.817 0.341 . . . . 3.47 110.965 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 33' ' ' GLN . 95.7 t -135.84 130.21 48.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.31 111.203 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -118.61 156.9 28.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.2 110.869 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 p -119.39 136.71 55.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.19 111.118 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -147.26 152.17 37.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.203 -0.453 . . . . 1.3 110.894 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -102.66 135.72 43.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.41 110.944 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.645 ' CD1' HG21 ' A' ' 73' ' ' THR . 28.6 mt -51.61 -35.43 17.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.35 111.19 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -29.99 59.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.495 . . . . 2.63 110.905 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -97.89 18.44 15.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 3.34 110.942 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.827 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.74 -30.23 5.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.486 . . . . 1.09 110.999 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -54.51 -37.36 65.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 1.04 110.923 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.6 mm-40 -84.6 -15.66 44.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 1.08 110.946 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.1 m -66.95 -10.17 46.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 0.99 110.872 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.07 63.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.34 111.116 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -61.75 -69.75 0.23 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.35 110.889 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.658 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -153.76 -175.5 5.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 2.12 110.865 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.47 134.84 35.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.59 110.929 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 p 46.24 82.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.162 -0.472 . . . . 1.17 110.848 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.3 p -133.4 -38.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 0.32 110.87 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.442 ' O ' HD23 ' A' ' 87' ' ' LEU . 97.6 m-85 -101.65 122.44 43.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 1.99 110.906 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.55 -21.09 61.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.155 -0.475 . . . . 1.49 110.861 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 6' ' ' ILE . 11.3 mt -143.38 143.52 24.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.127 -0.488 . . . . 0.26 111.089 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.865 HG21 HG23 ' A' ' 83' ' ' ILE . 21.3 mm -134.99 129.04 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.13 111.062 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.4 mm? -113.19 136.77 52.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.2 110.888 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.15 101.92 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.18 110.859 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.4 77.43 0.13 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.81 -0.709 . . . . 0.18 112.423 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.45 58.44 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.9 0.381 . . . . 0.61 110.894 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.18 160.12 61.44 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.654 0.74 . . . . 0.25 111.163 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 115.95 4.32 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.709 2.273 . . . . 0.29 112.365 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.84 6.43 67.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.711 -0.756 . . . . 0.2 112.496 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.49 150.37 12.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.991 0.424 . . . . 0.68 110.877 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 26.6 p -140.8 108.96 5.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.16 111.16 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.645 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.2 148.35 11.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.275 -0.421 . . . . 0.25 111.142 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.848 HD12 HD22 ' A' ' 147' ' ' LEU . 1.7 mt -126.23 101.2 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.34 110.935 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -78.16 138.17 38.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.41 110.848 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.414 ' H ' HD13 ' A' ' 79' ' ' ILE . 58.2 m -115.83 -175.67 2.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.843 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.59 -35.68 70.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.474 . . . . 0.3 111.167 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -62.31 -42.95 99.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 1.81 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.827 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -77.79 -55.2 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.27 111.165 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.742 HD13 ' HA ' ' A' ' 119' ' ' LEU . 64.4 mt -50.36 -41.57 51.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.23 110.895 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.61 -56.51 13.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.34 111.105 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.83 -41.44 74.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.433 . . . . 2.47 110.815 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.865 HG23 HG21 ' A' ' 63' ' ' ILE . 42.9 mm -58.55 -68.87 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.18 111.107 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.416 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -49.82 -35.0 21.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.28 111.168 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -59.31 -51.42 70.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 2.43 110.891 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.658 HG22 ' O ' ' A' ' 56' ' ' LYS . 33.2 pt -83.46 -4.04 8.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.22 111.083 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -82.1 112.06 18.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.35 110.917 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -51.65 159.58 1.24 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.61 0.719 . . . . 2.1 110.873 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.8 Cg_endo -69.88 114.26 3.66 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.685 2.257 . . . . 0.19 112.306 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.63 3.73 56.13 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.78 -0.724 . . . . 0.17 112.466 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.05 -166.94 26.63 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.782 -0.723 . . . . 0.21 112.491 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 62.5 m -133.1 153.36 51.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.873 0.368 . . . . 0.33 110.95 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.653 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.93 116.37 12.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 0.16 110.914 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.567 ' N ' HD22 ' A' ' 93' ' ' LEU . 52.6 m-85 -112.33 131.89 55.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 1.84 110.836 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -148.2 156.92 43.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.18 110.866 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -125.03 126.76 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 2.08 110.917 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.88 146.9 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.65 0.738 . . . . 2.31 110.852 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.59 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.5 Cg_endo -69.68 143.72 52.11 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.586 2.19 . . . . 0.25 112.368 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 m -128.38 146.75 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 0.2 111.135 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.459 ' HB2' HG22 ' A' ' 111' ' ' THR . 59.6 mt-10 -106.8 132.85 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 2.18 110.832 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 41.8 p -93.01 -42.11 9.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.098 -0.501 . . . . 1.11 111.129 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.72 39.91 1.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.83 111.182 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.25 150.6 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.85 111.128 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.641 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -56.66 167.92 0.67 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.186 -0.461 . . . . 1.96 110.912 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.425 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 1.7 p30 -60.54 -55.0 38.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 2.4 110.822 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.59 -77.3 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 2.28 110.853 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.1 p 54.0 -173.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.462 . . . . 1.71 110.814 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.63 -2.1 45.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 2.6 110.927 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.581 HG21 ' CE1' ' A' ' 149' ' ' HIS . 1.1 m -143.39 154.52 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.177 -0.465 . . . . 0.86 111.09 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -69.88 121.03 16.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 2.14 110.958 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.641 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.7 p -97.05 -177.96 4.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.23 111.109 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.53 -52.9 63.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.22 111.103 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.92 -50.5 73.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.26 110.853 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -58.93 -40.59 85.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 2.23 110.956 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -60.52 -54.64 43.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.41 110.926 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 67.2 m -55.54 -50.99 68.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.34 110.863 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.64 -48.22 82.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.32 110.826 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.27 -51.52 64.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.064 -0.516 . . . . 0.27 111.092 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.742 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.0 tp -57.38 -47.12 82.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 0.38 110.839 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.2 m -67.34 -22.24 65.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.54 111.162 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.9 mt -86.48 -15.37 40.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 1.18 110.884 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.9 5.0 30.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.442 . . . . 1.68 110.892 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.45 -4.86 35.12 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.728 -0.749 . . . . 0.48 112.573 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -87.06 168.96 12.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.844 0.354 . . . . 0.49 110.899 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.5 m -151.39 171.86 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.481 . . . . 0.42 111.135 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 53.58 43.72 30.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 2.11 110.836 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.22 142.51 14.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.34 111.14 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.07 160.65 8.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 1.74 110.844 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 21.2 tt0 -82.36 146.69 29.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 2.39 110.932 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.666 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.4 mp -107.39 -35.76 6.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.22 110.919 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.47 176.24 12.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 1.18 110.883 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.712 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.2 tmt_? -133.19 137.82 46.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 4.39 110.877 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -125.49 138.8 32.52 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.636 0.731 . . . . 1.44 110.91 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.438 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.3 Cg_endo -69.84 164.49 34.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.615 2.21 . . . . 0.25 112.329 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.654 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -97.07 135.76 38.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.4 110.886 179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.24 160.98 25.59 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.579 0.704 . . . . 1.18 111.194 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -29.3 24.02 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.684 2.256 . . . . 0.44 112.27 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -85.31 -19.26 31.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 2.76 110.864 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -53.24 5.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 2.21 110.968 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.7 p -49.21 -41.94 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.36 111.033 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -33.69 72.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.145 -0.48 . . . . 1.23 110.866 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.28 -45.05 70.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.31 110.898 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.716 HG23 HD13 ' A' ' 147' ' ' LEU . 7.2 p -68.89 -32.39 54.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.119 -0.492 . . . . 0.47 111.172 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -76.3 -30.0 57.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 3.23 110.85 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -90.43 -20.49 22.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 1.63 110.836 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -94.72 -32.96 13.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.59 110.8 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.848 HD22 HD12 ' A' ' 74' ' ' LEU . 3.0 mp -126.75 -53.98 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.86 110.925 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.78 12.07 2.01 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.635 -0.793 . . . . 0.9 112.435 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.581 ' CE1' HG21 ' A' ' 109' ' ' VAL . 3.4 t-160 -70.12 121.25 17.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.687 0.279 . . . . 1.36 110.896 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -149.41 111.65 4.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 3.21 110.847 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -160.55 165.18 31.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 1.59 110.86 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.76 -7.48 19.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 2.47 110.814 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -115.56 22.8 12.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 1.9 110.862 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.654 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -85.16 169.48 13.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.42 110.92 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.712 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -173.51 130.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.21 110.961 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.2 m-85 -72.94 131.84 42.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 1.81 110.943 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.95 140.38 25.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.2 111.16 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.666 ' HG2' HD13 ' A' ' 130' ' ' LEU . 23.3 tt0 -93.95 126.84 39.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.071 -0.513 . . . . 1.62 110.864 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 3.3 mp -122.35 151.4 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.26 111.147 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.483 ' HB ' HD21 ' A' ' 130' ' ' LEU . 3.2 t -129.72 161.45 30.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.33 111.145 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -152.5 130.48 3.07 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.748 -0.739 . . . . 0.23 112.485 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -94.86 140.56 29.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.843 0.354 . . . . 1.59 110.838 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 7.5 tptt -82.31 134.54 48.49 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.535 0.684 . . . . 2.25 110.955 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 118.88 5.94 Favored 'Trans proline' 0 C--O 1.23 0.1 0 C-N-CA 122.723 2.282 . . . . 0.36 112.29 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -100.29 151.97 20.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.32 110.851 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -171.27 -174.62 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 7.37 110.819 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -107.77 30.22 6.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 8.9 110.908 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.0 t -145.21 149.77 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 10.55 111.083 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -52.3 -41.17 54.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 12.0 112.57 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.33 -75.81 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.396 . . . . 10.99 110.849 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.7 -174.07 0.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 14.22 110.955 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 10.5 110.882 -179.886 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.426 ' O ' HD12 ' A' ' 6' ' ' ILE . 31.5 mtt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.831 0.348 . . . . 4.26 110.874 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.5 -21.32 66.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.66 111.094 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -54.1 -51.61 63.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 2.32 110.874 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 6' ' ' ILE . 3.9 m-85 -122.22 20.81 10.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 1.57 110.966 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 56.24 40.79 85.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.752 -0.737 . . . . 0.39 112.472 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.518 HG21 HD22 ' A' ' 32' ' ' LEU . 1.4 mp -83.46 160.7 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.826 0.346 . . . . 0.36 111.067 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.743 ' O ' HG23 ' A' ' 36' ' ' THR . 0.3 OUTLIER -156.36 168.01 28.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 1.62 110.899 -179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.51 134.41 34.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.43 111.135 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.51 2.5 37.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.745 -0.74 . . . . 0.41 112.458 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -121.04 171.88 8.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.793 0.33 . . . . 1.13 110.96 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.54 137.39 40.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 1.36 110.833 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.69 HG22 ' HB ' ' A' ' 62' ' ' ILE . 66.3 t -141.92 123.96 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 1.88 111.098 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.764 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -102.41 125.9 49.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.33 111.216 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.551 HG21 ' CB ' ' A' ' 29' ' ' VAL . 61.3 t -98.12 112.41 30.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 0.43 111.113 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.8 t -98.09 129.87 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.46 111.132 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -128.68 170.68 12.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.22 110.915 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 47' ' ' ILE . 11.4 p-10 -151.65 -172.76 4.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 1.77 110.924 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -23.41 62.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 3.14 110.857 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.83 -16.31 48.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 1.09 110.924 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 m -101.67 102.79 24.23 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.66 0.743 . . . . 0.31 110.908 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 136.85 34.08 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.66 2.24 . . . . 0.45 112.428 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.19 -31.66 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.56 111.121 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -53.02 -52.46 58.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 2.48 110.922 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.94 -43.81 12.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.146 -0.479 . . . . 0.26 111.099 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.548 HD13 ' N ' ' A' ' 26' ' ' LYS . 1.3 tm? -51.48 -60.28 3.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.34 110.915 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.548 ' N ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -47.45 -46.83 27.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 2.2 110.963 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.68 -37.02 93.1 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.771 -0.728 . . . . 0.49 112.462 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.719 HD11 HG13 ' A' ' 68' ' ' VAL . 33.8 mt -60.25 -50.75 72.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.78 110.928 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.594 HG22 ' HG3' ' A' ' 33' ' ' GLN . 7.7 p -77.66 -25.28 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 3.33 111.099 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -60.91 -62.43 1.86 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.142 -0.481 . . . . 1.94 110.873 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.7 -40.34 62.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 1.7 110.891 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.808 HD23 HD21 ' A' ' 35' ' ' LEU . 84.7 mt -72.22 -24.48 61.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.46 110.934 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.619 ' HA ' HG21 ' A' ' 42' ' ' VAL . 2.1 mm-40 -77.49 -25.58 50.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 1.89 110.938 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.15 -31.34 17.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 0.36 111.056 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.808 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.06 -34.76 15.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.21 -0.45 . . . . 0.37 110.874 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 7' ' ' SER . 1.2 m -103.08 -47.54 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.296 -0.411 . . . . 0.5 111.174 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.03 -15.6 50.27 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.697 -0.764 . . . . 0.51 112.467 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.23 -61.06 2.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.867 0.365 . . . . 1.83 110.793 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -102.88 -34.27 9.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 2.2 110.957 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.34 -120.55 1.9 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.739 -0.743 . . . . 0.61 112.464 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -166.44 156.45 11.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.867 0.365 . . . . 2.29 110.846 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.619 HG21 ' HA ' ' A' ' 33' ' ' GLN . 21.5 t -145.4 137.55 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.54 111.128 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.2 t -129.43 158.37 39.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.45 110.804 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -117.25 141.0 37.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.488 . . . . 0.35 111.135 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -145.92 151.53 38.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 2.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -103.58 134.79 46.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.44 110.894 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.742 ' CD1' HG21 ' A' ' 73' ' ' THR . 37.8 mt -52.94 -36.14 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.49 . . . . 0.41 111.061 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -31.41 67.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.253 -0.43 . . . . 2.54 110.816 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -104.0 20.1 18.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 3.54 110.969 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.831 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -49.32 -27.93 4.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 1.09 110.914 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -54.96 -34.34 63.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.05 110.853 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 55.0 mm-40 -84.47 -15.55 45.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 1.06 110.877 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.517 ' HB2' HD13 ' A' ' 50' ' ' LEU . 40.9 m -65.83 -11.05 43.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.95 110.838 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.97 63.0 0.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.32 111.172 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -62.95 -70.82 0.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.223 -0.444 . . . . 0.38 110.832 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.598 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -149.7 -169.02 3.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.276 -0.42 . . . . 1.88 110.909 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -102.46 136.37 42.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 1.78 110.87 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 91.8 p 47.21 85.79 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 1.37 110.84 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.1 p -140.52 -40.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.26 110.798 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.491 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.4 m-85 -99.42 119.18 37.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 2.13 110.889 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -70.87 -20.09 62.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 1.69 110.864 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.69 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.4 mt -146.46 143.7 20.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.27 111.13 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.958 HG21 HG23 ' A' ' 83' ' ' ILE . 16.0 mm -134.09 130.67 55.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.23 111.145 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -112.78 134.14 54.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.213 -0.448 . . . . 0.25 110.931 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.46 95.68 4.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.188 -0.46 . . . . 0.29 110.87 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 53.68 72.17 0.58 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 0.32 112.515 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.97 56.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.792 0.33 . . . . 0.57 110.898 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.719 HG13 HD11 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -123.42 159.9 52.95 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 121.613 0.72 . . . . 0.27 111.12 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.413 ' HD2' HG12 ' A' ' 68' ' ' VAL . 54.4 Cg_endo -69.72 123.18 9.86 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.669 2.246 . . . . 0.27 112.381 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.27 6.97 87.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.757 -0.735 . . . . 0.2 112.507 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.8 p -55.48 148.57 15.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.77 110.874 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.747 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 29.5 p -137.83 109.1 6.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.18 111.14 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.742 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.37 152.28 16.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.24 111.195 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.947 HD12 HD22 ' A' ' 147' ' ' LEU . 4.6 mt -131.15 103.45 6.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.21 110.959 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 23.1 m80 -79.52 152.94 29.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.28 110.874 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 m -129.23 176.28 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.57 110.823 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.55 -38.27 53.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.25 111.11 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -61.37 -46.1 91.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.198 -0.456 . . . . 1.73 110.853 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.831 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -72.9 -54.54 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.23 111.129 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.63 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.0 mt -50.68 -38.68 48.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.19 110.997 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.83 -52.96 61.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 0.31 111.108 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 -43.18 79.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 2.84 110.922 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.958 HG23 HG21 ' A' ' 63' ' ' ILE . 43.4 mm -59.31 -68.44 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.33 111.194 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.52 -33.8 15.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.2 111.106 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -61.06 -52.51 64.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 2.18 110.94 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 56' ' ' LYS . 29.9 pt -81.43 -4.41 7.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.28 111.134 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.491 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -82.03 122.4 27.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.887 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtt-85 -61.08 159.67 26.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.525 0.679 . . . . 3.49 110.885 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 114.24 3.64 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.598 2.199 . . . . 0.29 112.39 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.47 5.1 55.89 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.682 -0.771 . . . . 0.25 112.496 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.11 -159.61 13.19 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.736 -0.745 . . . . 0.25 112.428 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 8.4 m -140.9 155.04 46.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.796 0.332 . . . . 0.39 110.835 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.631 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -139.31 115.57 10.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.184 -0.462 . . . . 0.22 110.917 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.562 ' N ' HD22 ' A' ' 93' ' ' LEU . 49.9 m-85 -109.98 133.71 52.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.88 110.846 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.543 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -148.69 158.0 43.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.22 110.954 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.3 123.68 36.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 1.83 110.945 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.66 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -147.55 147.92 29.35 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.576 0.703 . . . . 2.27 110.947 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.607 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.0 Cg_endo -69.78 144.77 54.97 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.665 2.244 . . . . 0.22 112.293 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 155' ' ' LEU . 5.4 m -125.41 147.1 30.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.37 111.227 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -115.1 132.36 56.63 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 1.96 110.893 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.5 p -105.99 25.92 10.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.15 -0.477 . . . . 1.06 111.171 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.19 25.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.77 111.079 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.5 t -143.4 159.96 17.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.25 -0.432 . . . . 0.78 111.114 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.509 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -55.91 179.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.071 -0.513 . . . . 2.08 110.865 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -65.32 -66.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 2.48 110.901 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -63.32 -75.65 0.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 1.91 110.898 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.23 -168.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 1.67 110.802 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.34 -5.72 56.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.046 -0.525 . . . . 2.35 110.955 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.0 m -146.19 145.31 20.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.165 -0.47 . . . . 0.51 111.066 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.639 ' H ' HD22 ' A' ' 74' ' ' LEU . 3.4 ttmt -67.68 116.31 8.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 2.32 110.884 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 104' ' ' ASP . 27.7 p -85.35 -179.87 7.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.233 -0.439 . . . . 0.36 111.077 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.94 -54.56 45.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.43 111.052 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -48.81 78.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.41 110.829 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.0 tmtm? -58.95 -38.24 78.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 2.14 110.871 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.66 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.2 tm? -63.59 -54.6 33.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.427 . . . . 0.62 110.933 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.4 m -58.7 -49.56 77.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.107 -0.497 . . . . 0.45 110.965 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -47.47 86.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.59 110.852 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.01 -54.64 42.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.49 111.058 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.63 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.2 tp -53.8 -48.14 70.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.3 110.926 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.8 m -67.63 -22.43 65.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.39 111.125 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 19.4 mt -86.98 -15.08 39.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.72 110.881 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.46 5.37 27.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 1.88 110.847 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.87 -5.03 34.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.664 -0.779 . . . . 0.68 112.48 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -86.5 166.71 15.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 0.33 110.912 -179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.0 m -147.02 170.43 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.29 111.103 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 52.24 44.72 29.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 2.28 110.895 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.6 t -82.77 141.38 15.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.34 111.133 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.93 158.84 7.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 1.69 110.846 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -75.87 146.01 40.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 2.23 110.925 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.684 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.0 mp -104.47 -37.36 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.23 110.975 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.43 176.18 12.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.483 . . . . 1.17 110.906 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.668 ' HG2' HD11 ' A' ' 155' ' ' LEU . 0.9 OUTLIER -128.85 145.3 51.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 4.39 110.786 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -134.32 136.16 25.36 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.624 0.726 . . . . 1.44 110.889 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 164.91 32.75 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.665 2.243 . . . . 0.32 112.344 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.644 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -98.03 126.05 43.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.149 -0.478 . . . . 0.37 110.948 179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.463 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.01 161.48 22.63 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.574 0.702 . . . . 1.49 111.153 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -24.64 29.74 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.711 2.274 . . . . 0.35 112.31 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -85.46 -22.03 28.45 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.437 . . . . 2.76 110.882 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -87.81 -53.59 4.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 2.51 110.945 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 136' ' ' THR . 7.5 p -49.58 -40.08 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.23 111.093 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -34.53 76.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 1.19 110.921 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.5 -47.15 67.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.24 110.853 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.697 HG23 HD13 ' A' ' 147' ' ' LEU . 10.3 p -67.59 -30.92 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.17 111.033 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -76.57 -29.58 56.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 1.69 110.936 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -89.91 -21.39 22.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 1.89 110.9 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.63 -32.41 13.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.29 110.923 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.947 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.6 -54.37 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.33 110.874 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.11 18.4 1.69 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.767 -0.73 . . . . 0.32 112.512 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -72.69 122.08 20.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.819 0.342 . . . . 0.88 110.845 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -151.64 107.62 3.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 2.74 110.863 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.5 t -160.47 173.8 15.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.8 110.884 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.32 -19.75 13.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.64 110.865 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -96.83 17.05 17.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 1.58 110.959 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.643 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -82.78 165.38 19.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.39 110.918 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.668 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.5 tm? -173.73 130.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.25 110.876 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.747 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.8 m-85 -75.84 138.46 41.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 1.71 110.871 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -151.93 148.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.491 . . . . 0.4 111.14 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.684 ' HG2' HD13 ' A' ' 130' ' ' LEU . 19.1 tt0 -100.2 130.29 46.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 1.68 110.902 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.91 150.77 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.36 111.114 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.466 ' N ' HD11 ' A' ' 130' ' ' LEU . 6.1 t -135.25 161.43 35.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.4 111.125 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.59 135.61 5.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.707 -0.758 . . . . 0.21 112.442 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -91.86 140.31 29.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.837 0.351 . . . . 1.69 110.898 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 135.26 49.28 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.612 0.72 . . . . 1.29 110.853 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 127.68 14.9 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.688 2.258 . . . . 0.45 112.306 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -108.33 150.03 27.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.455 . . . . 0.34 110.904 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 36.0 t80 64.97 151.59 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 5.74 110.836 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -80.03 132.91 36.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.094 -0.503 . . . . 8.7 110.908 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 7.3 m -122.83 -35.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.465 . . . . 5.66 111.14 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.15 -36.35 4.27 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.761 -0.733 . . . . 6.08 112.478 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.24 149.28 24.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.898 0.38 . . . . 6.1 110.786 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.69 144.85 27.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.07 -0.514 . . . . 8.34 110.898 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 10.35 110.886 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.562 ' O ' HD12 ' A' ' 6' ' ' ILE . 3.5 ptm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.813 0.339 . . . . 4.55 110.872 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.54 -19.43 57.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.26 -0.427 . . . . 0.46 111.127 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.04 -49.73 68.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 1.83 110.893 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -122.22 19.97 10.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 1.53 110.854 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.26 41.51 54.46 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.722 -0.752 . . . . 0.21 112.461 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 1' ' ' MET . 1.7 mp -78.0 158.61 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.25 111.089 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.465 ' O ' HG23 ' A' ' 36' ' ' THR . 25.8 m -148.38 157.13 43.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 1.05 110.916 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.33 128.32 34.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.29 111.095 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 111.03 -3.36 28.58 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.738 -0.744 . . . . 0.26 112.487 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.99 167.41 10.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 1.46 110.873 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.21 136.68 38.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 1.29 110.843 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.548 ' CG1' HG21 ' A' ' 36' ' ' THR . 2.0 p -142.43 138.72 29.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.481 . . . . 2.09 111.183 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.775 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -115.59 129.5 56.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 0.22 111.154 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.663 HG11 HG12 ' A' ' 29' ' ' VAL . 48.6 t -101.1 123.79 54.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.244 -0.434 . . . . 0.3 111.12 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.729 HG12 HG13 ' A' ' 47' ' ' ILE . 4.6 t -105.15 116.45 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.34 111.11 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -119.33 164.63 15.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 0.21 110.846 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -148.73 -169.52 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 4.66 110.792 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.35 -35.68 67.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 3.19 110.913 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.5 -11.55 60.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.211 -0.45 . . . . 1.13 110.896 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -106.47 95.52 11.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.673 0.749 . . . . 0.18 110.89 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 141.19 44.84 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.627 2.218 . . . . 0.2 112.36 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.19 -32.7 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.25 111.106 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.36 -52.5 45.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 2.48 110.922 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.4 -45.07 10.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.16 111.085 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.46 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.9 -61.12 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.17 110.902 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.81 -35.66 23.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 2.47 110.904 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.44 -48.21 45.95 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.731 . . . . 0.2 112.485 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 mt -61.63 -41.22 97.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.746 0.308 . . . . 0.46 110.846 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.663 HG12 HG11 ' A' ' 14' ' ' VAL . 16.2 m -74.91 -31.6 25.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.63 111.197 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -62.08 -62.18 1.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.131 -0.486 . . . . 1.8 110.871 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.6 -40.16 65.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.134 -0.484 . . . . 1.78 110.888 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.892 HD23 HD21 ' A' ' 35' ' ' LEU . 76.7 mt -72.77 -25.05 61.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.195 -0.457 . . . . 0.23 110.853 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.51 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.43 -24.75 46.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.256 -0.429 . . . . 0.42 110.912 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.9 -29.85 17.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 0.32 111.088 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.892 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.63 -35.05 14.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.26 110.946 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.548 HG21 ' CG1' ' A' ' 12' ' ' VAL . 0.4 OUTLIER -102.45 -44.72 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 0.28 111.126 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.23 -10.98 54.56 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.661 -0.781 . . . . 0.32 112.446 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -71.38 -62.38 1.43 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.754 0.311 . . . . 2.21 110.961 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -91.58 -40.18 11.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.457 . . . . 1.94 110.881 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.95 -126.49 5.06 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.68 -0.772 . . . . 0.27 112.488 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -155.27 152.83 29.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 2.21 110.992 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.51 HG21 ' HA ' ' A' ' 33' ' ' GLN . 87.7 t -136.72 130.36 46.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.261 -0.427 . . . . 0.35 111.132 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 t -118.56 156.14 29.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.22 110.799 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -117.62 132.02 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.19 111.099 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -142.07 152.24 43.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 1.21 110.896 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -101.77 135.61 43.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.42 110.851 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.002 HD13 HG21 ' A' ' 73' ' ' THR . 3.0 mt -50.07 -44.09 21.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 0.47 111.15 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -72.24 -27.6 62.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 3.47 110.874 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -95.22 19.24 10.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 3.49 110.942 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.777 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.93 -29.65 3.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 1.09 110.91 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mp -51.91 -36.99 50.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 1.15 110.959 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -86.01 -19.45 30.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 1.14 110.926 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.513 ' HB2' HD13 ' A' ' 50' ' ' LEU . 69.2 m -60.21 -16.85 36.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.93 110.889 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -74.44 63.27 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.093 -0.503 . . . . 0.34 111.053 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.407 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 12.3 m-70 -65.27 -70.09 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.44 110.89 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.666 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.65 -167.92 2.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.302 -0.408 . . . . 1.1 110.829 179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -108.79 131.81 54.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 1.86 110.845 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 p 47.16 72.44 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 1.17 110.851 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 p -127.22 -33.69 2.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 0.23 110.842 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.2 m-85 -99.81 118.34 36.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 1.46 110.893 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.1 -19.21 62.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 1.72 110.803 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 6' ' ' ILE . 15.9 mt -145.46 144.61 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.25 111.076 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.857 HG21 HG23 ' A' ' 83' ' ' ILE . 19.3 mm -136.7 129.13 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.19 111.144 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.407 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -112.7 136.57 52.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.22 110.945 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.13 102.16 6.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.22 110.914 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.31 77.37 0.13 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.762 -0.732 . . . . 0.24 112.481 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.49 53.75 0.68 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.58 110.921 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.56 160.34 53.74 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 121.611 0.72 . . . . 0.22 111.071 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 116.35 4.51 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.671 2.248 . . . . 0.24 112.433 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.83 6.73 69.46 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.681 -0.771 . . . . 0.21 112.486 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.92 132.08 48.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 0.68 110.907 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.706 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 26.9 p -122.54 108.5 13.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.25 111.171 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 1.002 HG21 HD13 ' A' ' 47' ' ' ILE . 1.5 m -162.73 154.8 18.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.4 111.147 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.994 HD12 HD22 ' A' ' 147' ' ' LEU . 4.7 mt -133.17 104.58 6.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.31 110.853 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -76.18 153.72 35.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.074 -0.512 . . . . 0.38 110.886 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.1 m -131.56 177.42 7.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.41 110.836 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.7 -42.03 56.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.36 111.002 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -58.14 -46.07 86.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 1.91 110.954 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.777 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.2 mp -71.9 -56.68 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.3 111.104 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.5 HD13 ' HA ' ' A' ' 119' ' ' LEU . 59.1 mt -50.84 -43.45 59.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.2 110.909 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.34 -54.24 34.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 0.29 111.057 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.417 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -57.63 -43.32 84.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 2.71 110.836 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.857 HG23 HG21 ' A' ' 63' ' ' ILE . 38.6 mm -54.98 -67.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.16 -0.473 . . . . 0.27 111.088 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.13 -39.77 56.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.23 111.106 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.1 tpp85 -52.87 -53.9 42.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 2.3 110.889 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 56' ' ' LYS . 36.3 pt -80.15 -8.5 11.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.21 111.129 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -78.3 127.56 32.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.439 . . . . 0.39 110.916 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -67.41 160.28 72.84 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.657 0.742 . . . . 2.16 110.763 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 113.91 3.53 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.736 2.291 . . . . 0.16 112.336 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.74 56.38 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.747 -0.739 . . . . 0.14 112.496 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.51 -164.58 19.07 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.661 -0.78 . . . . 0.13 112.48 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 45.0 m -134.72 154.21 51.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.876 0.369 . . . . 0.34 110.887 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.645 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -139.61 113.99 9.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.18 110.944 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.536 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.3 m-85 -109.39 131.73 54.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 1.94 110.927 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.556 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.79 158.09 43.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.21 110.815 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.74 130.59 45.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 1.81 110.918 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.4 145.67 17.66 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.637 0.732 . . . . 2.23 110.886 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.615 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.0 Cg_endo -69.92 137.54 35.23 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.678 2.252 . . . . 0.3 112.282 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.491 HG13 HG23 ' A' ' 157' ' ' VAL . 12.2 m -120.33 146.41 25.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.21 111.091 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.467 ' OE1' HG21 ' A' ' 103' ' ' VAL . 52.1 mt-10 -111.4 132.79 54.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 1.98 110.856 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.2 p -106.39 26.09 10.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 1.11 111.169 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.85 24.01 1.08 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.74 111.145 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.467 HG21 ' OE1' ' A' ' 100' ' ' GLU . 3.1 t -144.22 161.0 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.279 -0.419 . . . . 0.8 111.137 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.574 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -54.77 177.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.91 110.895 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -67.87 -53.48 26.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 3.48 110.912 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -70.77 -75.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 2.13 110.825 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.03 -168.92 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 1.49 110.799 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -4.02 53.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 1.63 110.921 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 m -145.42 140.25 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.111 -0.495 . . . . 0.66 111.114 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.9 mmpp? -63.66 112.94 3.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 2.93 111.016 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.574 HG21 ' O ' ' A' ' 104' ' ' ASP . 29.3 p -80.28 176.66 9.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.26 111.13 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.98 -54.9 32.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.17 111.075 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.33 -48.85 80.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.23 110.752 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.42 -39.11 72.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 2.3 110.9 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.496 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -65.39 -55.15 19.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.31 110.994 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.4 m -56.7 -44.92 82.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.243 -0.435 . . . . 0.24 110.963 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.83 -42.34 85.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 0.26 110.867 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.63 -43.2 97.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.2 111.161 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.5 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.2 tp -65.17 -53.98 36.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.23 110.894 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 96.1 m -58.28 -36.88 73.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.31 111.173 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 45.6 mt -83.42 -10.39 58.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.65 110.969 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 m -84.65 4.89 30.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 1.71 110.886 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.01 8.68 31.3 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.662 -0.78 . . . . 0.62 112.446 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.645 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.7 OUTLIER -107.46 168.66 9.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.789 0.328 . . . . 0.31 110.892 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.4 HG23 ' HG3' ' A' ' 126' ' ' GLU . 34.2 m -150.57 169.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.25 111.144 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.4 ' HG3' HG23 ' A' ' 125' ' ' VAL . 1.9 mt-10 56.2 42.64 27.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 2.02 110.927 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.81 144.33 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.46 111.136 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.82 157.13 6.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 1.48 110.923 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -81.48 147.3 29.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 2.1 110.902 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.764 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.2 mp -108.21 -36.01 6.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.27 110.927 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -164.86 176.57 8.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 1.34 110.981 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -126.56 166.25 17.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 8.3 110.84 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -147.96 135.71 10.81 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.572 0.701 . . . . 1.44 110.897 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 155.83 65.04 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.618 2.212 . . . . 0.31 112.434 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.646 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -92.34 122.83 35.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.26 -0.427 . . . . 0.31 110.973 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.442 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.46 162.0 22.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.539 0.685 . . . . 1.27 111.2 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.6 Cg_endo -69.82 -26.12 27.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.651 2.234 . . . . 0.32 112.334 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -85.33 -19.79 30.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 2.91 110.888 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.22 -54.41 4.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 2.65 110.934 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.6 p -49.95 -38.85 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.22 111.125 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -39.04 78.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 2.54 110.916 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -45.59 79.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.3 110.864 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.7 p -67.71 -31.25 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.083 -0.508 . . . . 0.18 111.158 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -75.74 -30.65 59.3 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.122 -0.49 . . . . 2.11 110.875 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -90.02 -20.48 23.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 1.76 110.876 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.43 -32.8 13.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.28 110.941 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.994 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.65 -54.15 1.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.32 110.92 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.8 18.4 1.57 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.36 112.473 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -73.72 122.03 21.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.778 0.323 . . . . 1.06 110.923 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -151.58 105.57 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 2.79 110.966 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.9 t -160.55 170.72 20.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.91 110.873 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.34 -18.34 14.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 1.6 110.902 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -98.5 20.25 13.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.239 -0.437 . . . . 1.55 110.83 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.646 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -88.67 164.26 15.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.185 -0.461 . . . . 0.29 111.025 179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.6 tm? -173.26 130.35 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.214 -0.448 . . . . 0.31 110.936 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.706 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.5 m-85 -69.79 134.76 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 1.9 110.848 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.491 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.6 144.94 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.039 -0.528 . . . . 0.32 111.176 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.764 ' HG2' HD13 ' A' ' 130' ' ' LEU . 10.7 tt0 -103.29 130.65 50.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 2.29 110.921 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.4 mp -129.05 152.58 37.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.35 111.118 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.443 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.2 t -131.98 159.19 39.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.31 111.128 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -148.3 133.61 4.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.766 -0.73 . . . . 0.18 112.514 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -94.26 131.82 39.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.925 0.393 . . . . 3.85 110.862 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.63 135.45 81.19 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.549 0.69 . . . . 1.25 110.898 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 128.79 16.53 Favored 'Trans proline' 0 C--O 1.23 0.121 0 C-N-CA 122.695 2.263 . . . . 0.36 112.35 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -109.67 150.44 28.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.31 110.903 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 44.8 t80 64.59 112.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 5.82 110.867 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.46 107.77 0.24 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 10.17 110.864 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 170' ' ' SER . 7.0 m -115.46 -30.3 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 5.53 111.114 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.1 24.6 65.97 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.745 -0.741 . . . . 5.39 112.5 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.513 ' H ' HG23 ' A' ' 168' ' ' VAL . 19.4 m -90.67 137.91 31.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.377 . . . . 5.78 110.817 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.26 -75.8 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.096 -0.502 . . . . 6.7 110.892 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 6.55 110.923 179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.747 0.308 . . . . 3.55 110.868 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.0 -21.55 63.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.51 111.08 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.35 -51.58 64.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 2.46 110.901 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.402 ' HB2' HD11 ' A' ' 6' ' ' ILE . 5.2 m-85 -122.26 22.45 10.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 1.62 110.883 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.14 41.65 53.91 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.718 -0.753 . . . . 0.23 112.488 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.482 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.6 mp -81.02 160.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.904 0.383 . . . . 0.26 111.101 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.737 ' O ' HG23 ' A' ' 36' ' ' THR . 0.5 OUTLIER -156.0 167.84 29.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 1.61 110.858 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.6 128.81 36.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.29 111.098 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.07 2.92 26.52 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.754 -0.736 . . . . 0.36 112.505 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.437 HE22 HD12 ' A' ' 62' ' ' ILE . 2.2 pt20 -116.63 166.95 11.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.86 0.362 . . . . 1.02 110.864 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -106.13 112.89 26.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 1.37 110.906 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.601 HG13 HG21 ' A' ' 36' ' ' THR . 3.1 m -115.23 141.47 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 2.31 111.165 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.797 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -116.59 112.19 20.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.191 -0.459 . . . . 0.38 111.066 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.843 HG11 HG12 ' A' ' 29' ' ' VAL . 92.2 t -86.53 121.13 37.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.18 111.074 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG12 ' CG1' ' A' ' 47' ' ' ILE . 18.3 t -106.53 115.76 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.17 111.067 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -115.49 168.73 9.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.282 -0.417 . . . . 0.2 110.977 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -151.42 -170.22 3.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 1.83 110.896 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -57.1 -35.73 69.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 3.59 110.863 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.8 m -73.34 -9.66 58.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 1.7 110.786 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.29 93.75 10.14 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.621 0.724 . . . . 0.13 110.848 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 53.7 Cg_endo -69.76 142.8 48.92 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.723 2.282 . . . . 0.21 112.333 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.5 t -49.05 -32.43 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.23 111.08 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -51.29 -53.24 37.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 2.43 110.903 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.73 -44.86 10.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.21 111.054 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.446 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.2 -61.22 2.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.17 110.914 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -49.83 -35.63 23.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 2.53 110.888 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.02 -47.72 44.5 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.728 . . . . 0.28 112.53 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.1 mt -61.67 -39.44 91.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.897 0.38 . . . . 0.48 110.911 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.843 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -77.14 -31.32 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.66 111.026 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -62.31 -59.25 5.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 1.75 110.826 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -40.43 73.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 1.66 110.885 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.871 HD23 HD21 ' A' ' 35' ' ' LEU . 87.4 mt -72.59 -25.07 61.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.28 110.953 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.496 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.02 -25.02 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 0.47 110.848 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.47 -30.84 17.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.286 -0.416 . . . . 0.38 111.114 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.871 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -90.47 -34.89 15.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.31 110.907 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.737 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.32 -47.13 4.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.29 111.132 179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.1 -14.5 53.48 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.699 -0.762 . . . . 0.36 112.481 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.43 -62.68 1.67 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.756 0.313 . . . . 2.09 110.816 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -103.95 -33.7 8.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 1.97 110.982 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.61 -131.04 4.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.28 112.54 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.0 ttt-85 -153.28 152.74 31.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.791 0.329 . . . . 3.65 110.872 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 12' ' ' VAL . 98.3 t -139.27 113.69 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.46 111.125 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -103.93 153.18 21.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.15 110.895 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.5 p -115.92 133.46 62.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.11 -0.495 . . . . 0.17 111.148 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -142.16 151.97 42.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 1.32 110.921 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -102.66 135.11 44.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.102 -0.499 . . . . 0.39 110.921 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.668 ' CD1' HG21 ' A' ' 73' ' ' THR . 23.9 mt -51.76 -35.15 17.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.29 111.181 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.25 -29.75 60.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 2.15 110.925 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -98.21 18.59 15.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 3.36 110.926 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.816 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.31 -30.77 5.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 1.11 110.912 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.8 mp -53.93 -37.91 64.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 1.06 111.062 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -84.9 -15.64 43.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 1.22 110.948 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.6 m -66.31 -10.82 46.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 0.98 110.9 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.68 63.43 0.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.473 . . . . 0.32 111.11 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -61.55 -69.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.35 110.801 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.664 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -153.16 -175.88 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 1.29 110.837 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -93.73 135.22 35.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.454 . . . . 1.8 110.896 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p 46.64 81.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 1.18 110.819 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 87.9 p -132.07 -39.17 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 0.32 110.795 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.458 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.7 m-85 -102.16 123.89 46.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 2.06 110.89 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.28 -21.64 62.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.486 . . . . 1.71 110.805 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.437 HD12 HE22 ' A' ' 10' ' ' GLN . 13.0 mt -146.6 142.7 20.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.233 -0.439 . . . . 0.45 111.166 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 83' ' ' ILE . 17.6 mm -129.2 136.76 58.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.18 111.147 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.5 mm? -116.12 135.77 53.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.37 110.966 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.72 98.02 4.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.13 110.851 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.11 79.58 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.752 . . . . 0.18 112.502 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.85 55.42 0.64 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.935 0.398 . . . . 0.56 110.959 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -123.77 158.72 58.78 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.636 0.731 . . . . 0.23 111.141 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 115.91 4.31 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.635 2.223 . . . . 0.25 112.393 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.3 6.6 66.27 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 0.2 112.474 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.32 151.86 9.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.952 0.406 . . . . 0.83 110.841 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.708 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 21.1 p -140.11 108.77 5.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 0.27 111.135 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.668 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.92 148.57 12.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.26 111.08 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.042 HD12 HD22 ' A' ' 147' ' ' LEU . 10.1 mt -126.75 99.79 5.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.34 110.904 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -76.78 143.77 39.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 0.28 110.848 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.83 -175.52 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 1.08 110.746 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.54 -36.17 71.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.26 111.016 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -62.58 -44.31 96.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.199 -0.455 . . . . 1.78 110.804 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.816 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -76.03 -55.18 11.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.19 111.187 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.564 HD22 ' CD1' ' A' ' 119' ' ' LEU . 62.8 mt -50.14 -41.86 49.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.076 -0.511 . . . . 0.19 110.933 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.56 -55.77 17.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.29 111.12 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.11 -43.25 77.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.21 -0.45 . . . . 2.78 110.903 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 63' ' ' ILE . 42.9 mm -56.74 -68.54 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 0.18 111.116 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.14 -35.89 38.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.21 111.018 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -57.25 -51.05 70.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 3.31 110.867 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 56' ' ' LYS . 26.3 pt -83.79 -6.37 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.19 111.072 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -79.29 112.66 16.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.254 -0.43 . . . . 0.3 110.851 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -51.77 159.53 1.31 Allowed Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.651 0.738 . . . . 2.08 110.87 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 115.82 4.27 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.77 2.313 . . . . 0.23 112.307 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.5 3.06 57.53 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 0.23 112.43 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.87 -157.51 9.59 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.691 -0.766 . . . . 0.21 112.483 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.5 m -145.29 158.87 43.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.834 0.35 . . . . 0.6 110.911 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.628 HD22 ' N ' ' A' ' 94' ' ' PHE . 1.0 OUTLIER -141.25 116.28 9.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.24 110.921 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.628 ' N ' HD22 ' A' ' 93' ' ' LEU . 57.0 m-85 -108.07 132.57 53.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 1.62 110.896 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.34 158.01 43.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.493 . . . . 0.16 110.902 -179.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.84 129.08 46.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 1.75 110.871 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.78 146.56 18.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.659 0.743 . . . . 2.23 110.849 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.516 ' HG2' HD21 ' A' ' 74' ' ' LEU . 52.7 Cg_endo -69.8 142.74 48.59 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.707 2.272 . . . . 0.23 112.321 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.99 146.76 31.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.19 111.195 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.449 ' CD ' HG21 ' A' ' 103' ' ' VAL . 56.0 mt-10 -109.2 132.88 53.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 1.98 110.892 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 22.2 p -92.47 -41.83 10.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.12 111.185 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.54 39.18 1.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.67 111.124 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.449 HG21 ' CD ' ' A' ' 100' ' ' GLU . 22.6 t -147.11 149.08 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.74 111.174 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.594 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -51.76 163.1 0.34 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.167 -0.469 . . . . 1.98 110.767 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -59.86 -47.56 85.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 3.51 110.849 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.73 -75.55 0.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 1.91 110.901 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p 52.26 -170.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 1.98 110.89 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -80.51 -3.7 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 1.71 110.87 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.417 HG11 ' CG ' ' A' ' 149' ' ' HIS . 2.7 m -140.57 145.03 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.407 . . . . 0.38 111.183 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.7 mmtm -65.3 114.52 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 2.1 110.87 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.594 HG21 ' O ' ' A' ' 104' ' ' ASP . 45.5 p -85.91 179.33 7.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.432 . . . . 0.21 111.107 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.4 -53.42 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.19 111.14 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -49.29 78.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.24 110.873 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -58.36 -37.95 76.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.028 -0.533 . . . . 1.76 110.918 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.497 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.2 tm? -64.74 -54.68 27.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.32 110.94 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.2 m -58.3 -46.6 85.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.455 . . . . 0.23 110.88 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -43.71 93.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.32 110.918 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.78 -43.36 99.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.083 -0.508 . . . . 0.21 111.081 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.564 ' CD1' HD22 ' A' ' 80' ' ' LEU . 11.6 tp -64.45 -57.87 8.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.39 110.914 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.3 m -55.57 -36.38 66.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.33 111.134 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.9 mt -83.11 -10.71 58.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 0.88 110.909 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.43 6.42 26.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 1.75 110.852 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.51 8.04 31.24 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.778 -0.725 . . . . 0.58 112.482 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.643 HD23 ' HA3' ' A' ' 161' ' ' GLY . 1.5 tp -107.5 171.29 7.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.82 0.343 . . . . 0.54 111.005 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.61 169.56 2.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.28 111.091 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 51.47 43.89 29.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 2.41 110.917 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.6 t -81.27 143.19 12.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.34 111.136 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 160.06 8.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 1.67 110.883 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.47 140.83 37.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 3.15 110.893 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.705 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.6 mp -98.94 -39.2 8.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.41 110.902 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -160.18 177.09 11.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.474 . . . . 1.41 110.811 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.6 mtm-85 -123.99 168.71 12.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 8.04 110.785 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -151.56 136.67 10.54 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.743 0.782 . . . . 1.38 110.826 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.91 154.76 66.79 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.711 2.274 . . . . 0.38 112.303 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.646 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -91.55 128.44 37.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.38 110.851 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -106.02 161.45 22.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.618 0.723 . . . . 1.65 111.104 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 -24.33 29.59 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.68 2.253 . . . . 0.54 112.351 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.4 mp0 -85.3 -22.49 28.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 3.87 110.877 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -87.58 -53.77 4.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.117 -0.492 . . . . 2.73 110.903 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.44 -39.25 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.34 111.061 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -36.12 77.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 2.9 110.965 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.84 -45.76 73.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.4 110.831 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.708 HG23 HD13 ' A' ' 147' ' ' LEU . 9.2 p -68.26 -30.81 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 0.26 111.161 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -75.82 -31.94 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 2.13 110.905 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -89.88 -20.16 23.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 1.74 110.84 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -94.45 -32.92 13.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.848 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.042 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.64 -54.2 1.34 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.36 110.864 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.1 11.39 2.28 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.787 -0.721 . . . . 0.28 112.51 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.417 ' CG ' HG11 ' A' ' 109' ' ' VAL . 14.8 t-160 -70.34 121.81 18.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.75 0.309 . . . . 0.6 110.798 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -151.76 105.55 3.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 2.24 110.922 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 4.2 t -160.5 168.38 25.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.6 110.828 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.66 -13.49 15.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 1.66 110.817 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -100.28 19.97 15.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 1.63 110.814 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.646 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -92.8 169.55 10.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.34 110.919 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.662 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.1 tm? -173.57 130.24 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.35 110.931 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.708 ' CZ ' HG22 ' A' ' 72' ' ' THR . 20.1 m-85 -69.98 139.9 52.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 1.72 110.891 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.13 151.86 12.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.3 111.216 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.705 ' HG2' HD13 ' A' ' 130' ' ' LEU . 26.1 tt0 -107.8 129.29 55.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 1.56 110.925 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.18 151.17 30.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.24 111.137 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.512 HG21 HD21 ' A' ' 130' ' ' LEU . 8.9 t -140.54 151.15 44.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.44 111.083 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.643 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -143.35 144.62 13.97 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 0.21 112.496 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -97.66 137.37 36.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 1.81 110.851 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 134.76 65.58 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.662 0.744 . . . . 1.23 110.856 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 122.05 8.75 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.702 2.268 . . . . 0.37 112.384 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -96.94 153.62 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.66 110.894 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -48.99 113.32 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 5.3 110.865 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 65.63 109.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 8.6 110.853 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.2 m -154.19 -41.29 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 8.33 111.112 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 137.19 -33.2 2.33 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.733 -0.746 . . . . 7.47 112.437 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.98 97.91 1.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.936 0.398 . . . . 7.53 110.844 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.9 m -108.08 -175.64 2.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 8.08 110.899 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 37.1 ttt85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 7.52 110.898 -179.986 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.749 0.309 . . . . 3.52 110.882 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.98 -22.2 64.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.44 111.046 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.11 -51.61 63.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 2.37 110.808 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.23 22.08 10.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.44 . . . . 1.5 110.89 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.34 40.39 60.8 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.731 -0.747 . . . . 0.25 112.479 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.512 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -79.75 159.4 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.808 0.337 . . . . 0.22 111.069 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.629 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -154.52 164.56 38.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.29 110.883 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.33 129.87 35.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.158 -0.474 . . . . 0.31 111.073 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.18 -5.27 25.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.71 -0.757 . . . . 0.26 112.488 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -114.7 167.96 10.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 1.21 110.835 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.37 140.16 33.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 1.33 110.866 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' HB ' ' A' ' 62' ' ' ILE . 48.2 t -142.3 140.13 29.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 1.85 111.102 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.776 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -117.16 121.89 42.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.26 111.107 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.817 HG11 HG12 ' A' ' 29' ' ' VAL . 64.1 t -95.1 119.6 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.21 111.154 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.487 HG12 ' CG1' ' A' ' 47' ' ' ILE . 16.1 t -103.35 112.88 38.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.23 111.228 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -114.38 167.66 10.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.196 -0.456 . . . . 0.17 111.012 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -151.4 -169.79 3.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.354 -0.384 . . . . 1.91 110.82 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -35.52 69.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 3.44 110.861 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.46 -10.25 59.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 1.24 110.863 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.93 94.26 10.36 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.668 0.747 . . . . 0.15 110.861 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 142.36 47.25 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.713 2.275 . . . . 0.21 112.381 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -49.07 -32.48 5.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.18 111.105 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -51.32 -53.15 38.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 2.7 110.81 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.48 -44.65 11.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.17 111.163 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.478 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.85 -61.4 2.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.13 110.923 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -49.88 -36.8 28.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.296 -0.411 . . . . 4.93 110.854 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.61 -47.38 49.78 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.815 -0.707 . . . . 0.19 112.471 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.6 mt -61.82 -39.7 92.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.893 0.378 . . . . 0.45 110.959 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.817 HG12 HG11 ' A' ' 14' ' ' VAL . 17.6 m -76.98 -31.71 19.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.62 111.047 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -61.96 -59.76 4.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 1.77 110.893 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -40.15 70.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 1.76 110.935 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.852 HD23 HD21 ' A' ' 35' ' ' LEU . 87.1 mt -72.76 -25.25 61.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.23 110.966 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.478 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.4 mt-30 -78.59 -25.19 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.39 110.924 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.77 -29.15 17.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.26 111.093 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.852 HD21 HD23 ' A' ' 32' ' ' LEU . 1.3 pp -91.72 -34.88 14.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.22 110.933 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -102.52 -45.11 5.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.168 -0.469 . . . . 0.24 111.149 179.916 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.87 -12.09 52.75 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.769 -0.729 . . . . 0.28 112.51 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -65.74 -62.6 1.42 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.735 0.302 . . . . 1.86 110.858 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -97.16 -37.4 10.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 2.35 110.959 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.27 -128.91 5.04 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.75 -0.738 . . . . 0.27 112.499 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -154.93 153.57 31.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.947 0.403 . . . . 2.28 110.847 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 33' ' ' GLN . 86.0 t -138.56 128.44 33.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.28 111.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -117.42 157.65 25.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.17 110.821 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -118.51 135.72 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.17 111.137 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -145.34 151.96 39.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 1.94 110.892 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.56 135.97 43.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.44 110.905 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.747 HD13 HG21 ' A' ' 73' ' ' THR . 30.4 mt -51.25 -35.33 15.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.28 111.156 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.14 -31.57 61.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 2.49 110.871 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -96.76 19.27 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 3.4 110.911 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.829 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.86 -30.81 4.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 1.06 111.005 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -53.13 -35.84 60.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 1.02 110.924 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -85.75 -18.76 32.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 1.08 110.913 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.475 ' HB2' HD13 ' A' ' 50' ' ' LEU . 65.3 m -60.47 -16.6 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.92 110.822 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.426 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.8 63.59 0.9 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.34 111.118 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -61.65 -71.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.37 110.832 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.683 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.4 -167.59 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 1.68 110.85 -179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -104.29 125.78 50.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 2.03 110.868 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.6 80.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 1.4 110.816 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 52.2 p -130.61 -36.47 1.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.22 110.812 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.468 ' CD2' HD12 ' A' ' 86' ' ' ILE . 95.7 m-85 -97.23 121.04 38.67 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 1.48 110.92 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.28 -20.88 61.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.174 -0.466 . . . . 1.7 110.85 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.646 ' HB ' HG22 ' A' ' 12' ' ' VAL . 30.5 mt -143.32 144.51 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.33 111.19 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.894 HG21 HG23 ' A' ' 83' ' ' ILE . 19.7 mm -135.17 128.86 49.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.17 111.207 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -112.46 136.35 52.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.257 -0.429 . . . . 0.17 110.907 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.33 101.74 6.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.18 110.895 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.59 75.95 0.19 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.704 -0.76 . . . . 0.18 112.557 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -108.23 57.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.58 110.93 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.08 159.62 63.92 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.62 0.724 . . . . 0.25 111.152 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 116.56 4.61 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.68 2.253 . . . . 0.27 112.404 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.56 7.14 69.54 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.671 -0.776 . . . . 0.18 112.539 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.41 150.02 12.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.88 0.371 . . . . 0.69 110.857 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.763 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 33.7 p -138.48 108.71 6.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.18 111.167 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.747 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.86 149.98 13.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.26 111.122 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.897 HD12 HD22 ' A' ' 147' ' ' LEU . 2.4 mt -128.04 99.84 5.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.3 110.892 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.8 m80 -76.9 143.05 39.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.37 110.836 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.6 m -121.81 -175.3 3.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.52 110.829 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.82 -35.91 71.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.27 111.1 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -63.16 -43.54 97.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.204 -0.453 . . . . 2.12 110.851 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.829 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -76.18 -54.9 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.27 111.141 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.685 HD13 ' HA ' ' A' ' 119' ' ' LEU . 64.5 mt -51.11 -42.51 60.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.26 110.945 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.5 -56.83 11.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.35 111.082 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -54.36 -43.25 71.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.443 . . . . 3.07 110.922 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.894 HG23 HG21 ' A' ' 63' ' ' ILE . 41.4 mm -55.8 -67.6 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.27 111.087 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.15 -39.55 56.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.19 111.086 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -52.86 -50.83 63.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 2.45 110.861 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.683 HG22 ' O ' ' A' ' 56' ' ' LYS . 48.5 pt -85.37 -5.97 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.17 111.09 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -79.53 115.24 19.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 0.29 110.882 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.1 mtt-85 -55.05 158.79 4.48 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.69 0.757 . . . . 3.06 110.828 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.9 Cg_endo -69.74 114.25 3.64 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.717 2.278 . . . . 0.17 112.306 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.95 4.39 55.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.787 -0.72 . . . . 0.17 112.52 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.92 -164.67 24.34 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.754 -0.736 . . . . 0.13 112.467 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.6 m -135.55 152.18 51.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.31 110.857 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.603 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -136.18 115.97 13.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 0.19 110.917 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.571 ' N ' HD22 ' A' ' 93' ' ' LEU . 55.3 m-85 -112.02 131.37 55.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 1.65 110.925 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.533 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.54 159.86 43.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.14 110.855 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.4 128.66 41.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 1.85 110.933 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.33 148.31 22.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.591 0.71 . . . . 2.28 110.902 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.595 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -69.82 142.86 48.77 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.67 2.247 . . . . 0.18 112.307 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.0 m -128.88 146.83 33.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.18 111.067 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.503 ' CD ' HG21 ' A' ' 103' ' ' VAL . 19.6 mt-10 -106.99 132.48 52.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 1.89 110.885 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.6 p -103.78 26.11 9.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 1.27 111.192 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -154.56 26.14 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.61 111.097 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.503 HG21 ' CD ' ' A' ' 100' ' ' GLU . 5.9 t -144.13 157.77 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.6 111.067 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.583 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -54.56 174.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.501 . . . . 1.9 110.887 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -65.67 -64.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 2.56 110.855 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -61.54 -75.84 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.231 -0.441 . . . . 2.18 110.888 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.401 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.7 t 51.64 -168.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 2.09 110.857 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -3.55 50.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 3.67 110.817 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.5 m -144.38 148.66 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.457 . . . . 0.44 111.113 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.521 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -69.64 112.72 6.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 2.17 110.947 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.583 HG21 ' O ' ' A' ' 104' ' ' ASP . 43.7 p -87.31 178.6 6.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.22 111.093 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.68 -54.09 50.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.2 111.037 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.74 -49.07 79.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.28 110.909 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -57.72 -41.96 82.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.505 . . . . 1.76 110.946 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -61.05 -54.76 40.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.3 110.881 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -57.81 -48.9 78.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.3 111.006 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -45.68 92.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.154 -0.475 . . . . 0.36 110.931 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.25 -45.79 93.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.485 . . . . 0.25 111.093 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.685 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.2 tp -61.87 -54.07 47.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.314 -0.403 . . . . 0.26 110.83 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.9 m -62.38 -27.53 69.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.25 111.118 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.05 -14.38 50.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.274 -0.421 . . . . 0.66 110.909 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.0 p -84.43 5.58 26.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 2.33 110.863 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.53 -4.7 34.93 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.663 -0.779 . . . . 0.6 112.5 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -87.16 168.92 12.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.838 0.351 . . . . 0.35 111.04 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.9 m -151.0 171.32 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.22 111.089 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 52.39 45.02 29.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 2.22 110.853 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 89.4 t -79.68 143.56 12.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.21 111.132 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.9 160.23 8.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 2.49 110.889 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -80.88 147.16 30.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 2.4 110.862 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.783 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.5 mp -106.68 -36.0 6.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.21 110.905 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.7 176.29 12.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 1.1 110.89 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.707 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.0 OUTLIER -131.96 137.18 47.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 4.61 110.847 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -123.58 137.65 28.95 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.735 0.779 . . . . 1.4 110.815 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.411 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.8 Cg_endo -69.84 163.92 36.54 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.593 2.195 . . . . 0.22 112.308 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.671 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -96.99 127.03 42.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 0.28 110.805 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.44 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -100.15 160.91 25.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.584 0.707 . . . . 1.2 111.166 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.44 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.2 Cg_endo -69.72 -28.88 24.89 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.636 2.224 . . . . 0.34 112.378 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.33 -17.9 35.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.236 -0.438 . . . . 2.67 110.822 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.22 -52.83 5.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 2.33 110.892 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.3 p -49.27 -41.05 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.26 111.125 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -34.82 76.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 1.22 110.986 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -46.19 71.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.167 -0.47 . . . . 0.24 110.89 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.713 HG23 HD13 ' A' ' 147' ' ' LEU . 8.8 p -68.23 -30.15 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.18 111.055 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -75.29 -33.34 61.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 1.8 110.878 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -89.09 -19.93 24.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 1.86 110.838 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.2 m170 -94.1 -32.82 13.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.34 110.881 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.897 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -128.44 -54.19 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.41 110.936 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.59 7.05 2.49 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.701 -0.761 . . . . 0.36 112.465 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -70.21 120.44 15.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.78 0.324 . . . . 0.76 110.866 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -152.78 105.03 2.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 3.3 110.851 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.3 t -161.03 175.98 11.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.465 . . . . 0.61 110.793 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.58 -14.43 14.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 1.55 110.872 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -96.44 6.86 47.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 1.41 110.867 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.671 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -77.98 165.59 23.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.29 110.919 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.707 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.51 130.14 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.461 . . . . 0.21 110.898 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.763 ' CZ ' HG22 ' A' ' 72' ' ' THR . 29.8 m-85 -74.23 133.11 42.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.68 110.84 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.71 144.47 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.18 111.139 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.783 ' HG2' HD13 ' A' ' 130' ' ' LEU . 9.2 tt0 -98.75 130.69 45.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 2.23 110.89 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.83 150.46 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.463 . . . . 0.21 111.084 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.486 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -130.22 160.16 34.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.32 111.089 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.56 132.12 3.71 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.783 -0.722 . . . . 0.13 112.474 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -94.15 142.79 27.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 1.71 110.963 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.408 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 2.0 tptt -84.23 135.33 41.84 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.583 0.706 . . . . 2.27 110.859 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.84 118.73 5.85 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.703 2.269 . . . . 0.38 112.281 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -102.4 152.16 21.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.155 -0.475 . . . . 0.47 110.853 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -61.23 99.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 6.65 110.882 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.554 ' O ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -176.38 -173.76 0.55 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 10.36 110.869 -179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 167' ' ' GLU . 12.2 m 43.46 -164.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 7.5 111.106 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -93.68 -42.1 4.26 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.738 -0.744 . . . . 7.26 112.466 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.94 157.31 3.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.91 0.386 . . . . 8.04 110.872 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.48 -60.32 0.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 9.04 110.848 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 9.12 110.867 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.743 0.306 . . . . 3.5 110.852 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.99 -19.18 65.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.52 111.088 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.03 -50.93 65.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 2.07 110.798 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.485 ' CD2' HD11 ' A' ' 6' ' ' ILE . 7.0 m-85 -122.28 13.72 10.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.201 -0.454 . . . . 1.55 110.82 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.76 40.67 96.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.659 -0.781 . . . . 0.32 112.482 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.485 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.6 mp -80.99 159.96 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.35 111.179 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.727 ' O ' HG23 ' A' ' 36' ' ' THR . 0.4 OUTLIER -155.89 168.48 27.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 1.73 110.934 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.75 130.39 36.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.37 111.042 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.35 2.63 29.45 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.764 -0.732 . . . . 0.31 112.53 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.417 HE22 HD12 ' A' ' 62' ' ' ILE . 2.7 pt20 -116.73 166.7 11.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 1.06 110.896 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -105.39 114.94 29.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 2.15 110.794 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.608 HG13 HG21 ' A' ' 36' ' ' THR . 3.4 m -117.85 139.27 45.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.473 . . . . 2.33 111.151 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.763 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -114.01 115.69 28.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.31 111.077 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.808 HG11 HG12 ' A' ' 29' ' ' VAL . 64.8 t -88.95 120.5 37.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.19 111.175 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.628 HG12 HG13 ' A' ' 47' ' ' ILE . 18.5 t -106.17 113.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.48 . . . . 0.18 111.173 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.2 p-90 -112.67 167.39 10.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.24 110.871 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.576 ' HB3' HD12 ' A' ' 47' ' ' ILE . 7.2 p-10 -148.34 -169.25 3.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 1.72 110.974 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -58.67 -35.58 72.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 3.04 110.935 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -7.82 53.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 1.17 110.809 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.58 92.71 8.94 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.636 0.732 . . . . 0.18 110.907 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 143.27 50.56 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.707 2.271 . . . . 0.29 112.314 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.5 t -48.35 -33.06 4.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.25 111.145 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.33 -52.92 41.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 2.64 110.846 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.45 -45.3 10.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.25 111.219 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.452 HD22 HG13 ' A' ' 29' ' ' VAL . 1.9 tm? -51.2 -61.68 2.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.21 111.039 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -49.59 -35.83 22.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 2.69 110.928 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.16 -47.49 44.69 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.753 -0.737 . . . . 0.25 112.573 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.422 HD11 HG13 ' A' ' 68' ' ' VAL . 46.5 mt -61.59 -38.84 89.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.371 . . . . 0.63 110.973 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.808 HG12 HG11 ' A' ' 14' ' ' VAL . 17.3 m -77.66 -31.43 17.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.65 111.13 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.25 -58.24 8.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.194 -0.457 . . . . 1.59 110.835 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.93 -40.43 76.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 2.59 110.818 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.902 HD23 HD21 ' A' ' 35' ' ' LEU . 87.6 mt -72.73 -24.78 61.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.267 -0.424 . . . . 0.25 110.948 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.496 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -77.92 -24.87 48.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.24 -0.436 . . . . 0.41 110.839 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.8 -31.47 16.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.22 111.08 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.902 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -89.74 -35.21 15.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.22 110.931 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.64 -46.9 4.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.21 111.194 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.24 -13.37 53.71 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.668 -0.777 . . . . 0.26 112.53 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -62.67 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 2.8 110.897 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -99.85 -35.82 9.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 2.12 110.834 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.32 -129.64 4.53 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 0.24 112.471 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -153.67 152.28 30.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.854 0.359 . . . . 2.19 110.853 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 12' ' ' VAL . 92.2 t -137.8 117.19 14.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 0.29 111.069 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.2 t -106.93 153.75 22.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.065 -0.516 . . . . 0.18 110.875 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.8 p -115.53 134.36 58.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.19 111.073 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -144.46 152.52 40.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.093 -0.503 . . . . 1.25 110.921 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -102.49 137.41 40.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.48 110.824 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.945 HD13 HG21 ' A' ' 73' ' ' THR . 9.8 mt -51.38 -44.49 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.39 111.105 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -24.54 61.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.124 -0.489 . . . . 3.6 110.883 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -99.3 18.76 16.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 3.45 110.961 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.803 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.36 -29.31 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 1.11 110.9 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.82 -36.5 48.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 1.13 110.929 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 61.1 mm-40 -85.77 -20.4 29.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 1.25 110.897 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.518 ' HB2' HD13 ' A' ' 50' ' ' LEU . 66.5 m -59.53 -17.73 34.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.88 110.836 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.76 63.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.29 111.07 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -63.82 -71.52 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 0.36 110.79 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.693 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.73 -167.65 2.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.311 -0.404 . . . . 1.62 110.921 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -104.76 125.99 51.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 1.88 110.87 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.27 79.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 1.32 110.887 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 64.6 p -129.61 -35.42 1.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.26 110.89 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.454 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.7 m-85 -98.15 121.5 40.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 1.43 110.926 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.29 -21.5 62.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 1.69 110.888 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.417 HD12 HE22 ' A' ' 10' ' ' GLN . 14.1 mt -146.49 143.45 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.38 111.085 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.792 HG21 HD12 ' A' ' 83' ' ' ILE . 22.1 mm -131.22 132.44 63.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.25 111.045 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.0 mm? -112.15 134.96 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.21 110.959 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.34 101.18 5.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.226 -0.443 . . . . 0.17 110.846 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.68 78.98 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.711 -0.756 . . . . 0.2 112.505 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.474 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.5 mm? -110.95 53.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.57 110.91 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -122.78 160.34 49.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.683 0.754 . . . . 0.25 111.028 179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.4 ' HD2' HG12 ' A' ' 68' ' ' VAL . 53.2 Cg_endo -69.81 123.34 9.99 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.765 2.31 . . . . 0.27 112.27 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.78 7.2 88.33 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.777 -0.725 . . . . 0.2 112.445 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.433 ' HB3' HG23 ' A' ' 68' ' ' VAL . 9.5 p -55.56 151.67 10.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.78 110.819 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.688 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 13.1 p -141.36 111.92 7.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.25 111.136 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.945 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.55 152.35 14.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.23 111.112 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.017 HD12 HD22 ' A' ' 147' ' ' LEU . 5.1 mt -129.68 100.1 5.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 0.22 110.907 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -75.67 144.79 41.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.281 -0.418 . . . . 0.25 110.76 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.9 m -122.67 178.96 4.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.38 110.856 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.6 -42.77 62.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.29 111.115 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -56.96 -46.78 81.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 2.04 110.954 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.803 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.1 mp -71.55 -56.81 9.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.166 -0.47 . . . . 0.28 111.157 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.703 HD13 ' HA ' ' A' ' 119' ' ' LEU . 63.2 mt -50.2 -43.01 52.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.114 -0.494 . . . . 0.18 110.874 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.78 -56.68 12.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.29 111.083 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.433 ' CG ' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -54.85 -43.43 73.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 2.91 110.849 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.792 HD12 HG21 ' A' ' 63' ' ' ILE . 40.3 mm -55.35 -67.72 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.28 111.14 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -51.49 -39.54 57.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.22 111.069 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 18.9 tpp85 -52.82 -50.15 64.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 2.78 110.856 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.693 HG22 ' O ' ' A' ' 56' ' ' LYS . 46.8 pt -86.13 -5.8 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.24 111.119 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -80.15 113.98 18.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 0.33 110.866 179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -52.95 159.03 2.0 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.599 0.714 . . . . 2.24 110.899 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 54.7 Cg_endo -69.77 114.1 3.59 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.698 2.265 . . . . 0.17 112.401 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.29 2.9 55.7 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.81 -0.71 . . . . 0.18 112.521 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.53 -163.66 16.87 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.657 -0.783 . . . . 0.16 112.483 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 18.3 m -137.55 154.52 49.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.35 110.856 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.6 HD22 ' N ' ' A' ' 94' ' ' PHE . 1.2 tm? -137.49 116.31 12.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.15 110.943 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.6 ' N ' HD22 ' A' ' 93' ' ' LEU . 61.1 m-85 -109.74 131.9 54.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 1.62 110.868 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.573 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.73 163.15 38.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.494 . . . . 0.15 110.926 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.03 129.71 34.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 1.82 110.913 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.539 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -152.26 149.5 23.2 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.673 0.749 . . . . 2.49 110.875 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.618 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.4 Cg_endo -69.74 143.22 50.27 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.246 . . . . 0.19 112.39 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.0 m -129.74 146.36 34.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.24 111.111 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.421 ' CD ' HG21 ' A' ' 103' ' ' VAL . 46.6 mt-10 -107.92 132.79 53.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 2.04 110.824 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.7 p -91.63 -42.72 10.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 1.14 111.154 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.666 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.56 40.28 1.07 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.73 111.093 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.421 HG21 ' CD ' ' A' ' 100' ' ' GLU . 21.4 t -147.96 151.85 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.254 -0.43 . . . . 0.71 111.146 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.65 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -53.55 173.28 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 1.89 110.874 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -66.95 -53.96 26.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 2.73 110.914 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -72.94 -76.3 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 2.65 110.871 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t 54.01 -167.95 0.07 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 2.31 110.933 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.57 -6.16 57.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 2.31 110.884 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.543 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.1 m -141.48 146.42 23.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 0.54 111.16 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.34 123.26 19.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 2.46 110.902 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.65 HG21 ' O ' ' A' ' 104' ' ' ASP . 70.0 p -96.1 -179.54 4.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.3 -0.409 . . . . 0.22 111.166 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.78 -53.89 49.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.24 111.099 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.13 -48.41 81.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.42 110.889 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -60.28 -49.61 76.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 2.96 110.9 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.539 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -52.45 -55.52 21.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.234 -0.439 . . . . 0.81 110.96 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 74.8 m -51.2 -49.1 61.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.45 110.909 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.42 -43.85 92.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.52 110.815 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.44 -48.79 80.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.488 . . . . 0.35 111.057 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.703 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.1 tp -57.78 -52.4 65.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.35 110.917 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 98.2 m -63.13 -29.46 70.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.57 111.154 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.0 mt -79.5 -17.17 54.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 1.09 110.932 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.3 p -82.64 3.57 28.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 2.36 110.953 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.48 -4.85 35.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.754 -0.736 . . . . 0.6 112.472 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.553 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -85.5 168.4 14.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.952 0.406 . . . . 0.45 110.88 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.5 m -151.16 171.11 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.31 111.084 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 54.29 43.64 30.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.16 -0.473 . . . . 2.19 110.907 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.8 t -75.36 142.87 13.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.34 111.176 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.09 159.18 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 1.76 110.922 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -81.87 146.69 29.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.445 . . . . 2.25 110.854 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.547 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.0 mp -106.44 -35.83 6.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 0.19 110.948 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.55 176.22 12.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 1.15 110.886 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.724 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.8 tmt_? -133.79 138.11 45.51 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.226 -0.443 . . . . 4.29 110.809 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -125.07 137.87 30.5 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.633 0.73 . . . . 1.43 110.868 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.41 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.6 Cg_endo -69.78 163.93 36.47 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.69 2.26 . . . . 0.27 112.346 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.693 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -98.7 125.53 44.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.34 110.999 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.491 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -104.1 161.58 22.48 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 121.603 0.716 . . . . 1.39 111.129 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.481 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.8 Cg_endo -69.78 -23.77 30.35 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.75 2.3 . . . . 0.37 112.344 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -85.08 -24.21 28.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 2.34 110.826 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -88.46 -51.03 5.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.458 . . . . 2.62 110.948 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 136' ' ' THR . 7.6 p -49.32 -39.33 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.26 111.157 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -34.68 76.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 2.74 110.857 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -46.2 71.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.207 -0.451 . . . . 0.27 110.869 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.706 HG23 HD13 ' A' ' 147' ' ' LEU . 8.6 p -67.91 -30.47 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.19 111.169 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -75.51 -32.74 60.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 2.3 110.958 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -89.47 -20.0 24.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 1.74 110.882 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -94.17 -33.13 13.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.35 110.846 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.017 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -127.77 -54.15 1.32 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.176 -0.466 . . . . 0.33 110.863 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 133.2 6.71 2.69 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.717 -0.754 . . . . 0.35 112.451 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.543 ' CE1' HG21 ' A' ' 109' ' ' VAL . 6.8 t-160 -70.1 119.99 15.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.747 0.308 . . . . 0.83 110.827 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -153.45 104.8 2.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 2.29 110.961 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.8 t -161.29 174.38 13.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.74 110.897 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.88 -8.17 17.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 1.88 110.848 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.666 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 m-80 -101.92 8.04 41.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 1.76 110.872 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.693 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -82.16 165.28 20.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 0.33 110.997 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.724 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -171.33 130.59 0.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.326 -0.397 . . . . 0.28 110.921 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.688 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.4 m-85 -75.24 131.38 40.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 1.72 110.916 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.13 144.84 23.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.22 111.173 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.547 ' HG2' HD13 ' A' ' 130' ' ' LEU . 4.3 tt0 -100.09 128.38 46.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 1.84 110.924 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.14 150.98 28.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.26 111.11 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.448 ' N ' HD11 ' A' ' 130' ' ' LEU . 1.9 t -129.29 158.74 38.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.39 111.127 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.51 130.74 3.42 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 0.19 112.5 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -94.27 140.86 29.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.862 0.363 . . . . 1.6 110.97 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 6.3 tptm -82.25 134.41 48.92 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.568 0.699 . . . . 1.41 110.884 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 118.79 5.89 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.681 2.254 . . . . 0.41 112.354 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -100.45 152.16 20.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.35 110.871 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 29.0 t80 60.83 19.4 9.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 6.03 110.926 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 62.79 164.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.103 -0.499 . . . . 9.74 110.878 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.7 m -145.55 -178.36 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 5.82 111.166 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -156.72 33.21 0.57 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.69 -0.767 . . . . 5.92 112.463 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.43 -71.02 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 7.11 110.817 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.7 m -95.5 -67.15 0.87 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.084 -0.507 . . . . 7.63 110.809 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 5.99 110.902 -179.917 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.548 ' O ' HD12 ' A' ' 6' ' ' ILE . 6.9 ptm . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.765 0.317 . . . . 4.46 110.901 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.36 -19.67 56.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.45 111.094 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.03 -49.55 68.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 2.07 110.826 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -122.29 20.6 10.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 1.52 110.891 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.08 39.49 49.69 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.718 -0.753 . . . . 0.22 112.39 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 1' ' ' MET . 1.8 mp -74.92 157.68 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.25 111.136 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.619 ' O ' HG23 ' A' ' 36' ' ' THR . 37.9 m -146.21 157.53 43.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 1.07 110.836 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -88.2 129.22 35.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.29 111.159 179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.09 -9.02 31.42 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.741 -0.742 . . . . 0.54 112.495 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -103.41 168.0 9.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.869 0.366 . . . . 1.52 110.832 -179.826 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.79 112.05 24.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.137 -0.483 . . . . 1.3 110.907 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.721 HG12 HG21 ' A' ' 36' ' ' THR . 2.6 p -119.36 133.67 65.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.165 -0.471 . . . . 1.99 111.08 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.735 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -107.89 133.44 52.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 0.34 111.08 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.764 HG11 HG12 ' A' ' 29' ' ' VAL . 99.9 t -104.43 120.51 54.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.117 -0.492 . . . . 0.17 111.087 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 47' ' ' ILE . 12.1 t -103.88 115.41 45.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.18 111.16 179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -114.68 168.0 10.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.913 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.595 ' HB3' HD12 ' A' ' 47' ' ' ILE . 5.2 p-10 -150.95 -169.45 3.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 1.94 110.92 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -57.8 -35.56 70.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 3.35 110.9 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.69 -9.29 58.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.421 . . . . 1.35 110.82 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.95 92.16 8.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.606 0.717 . . . . 0.17 110.902 -179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 143.98 52.59 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.703 2.269 . . . . 0.23 112.227 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.3 t -48.39 -32.9 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 0.19 111.161 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -51.23 -53.0 39.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 3.27 110.924 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.8 -45.02 10.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.19 111.067 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.475 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.5 -61.89 1.96 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.16 110.881 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -49.69 -37.86 30.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 4.88 110.894 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.39 -48.15 53.37 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.765 -0.731 . . . . 0.21 112.427 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.7 mt -61.15 -41.04 96.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.49 110.991 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.764 HG12 HG11 ' A' ' 14' ' ' VAL . 18.1 m -75.84 -31.13 21.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.63 111.166 179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -61.75 -61.38 2.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 1.6 110.92 179.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.27 -40.78 68.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.294 -0.412 . . . . 1.77 110.854 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.833 HD23 HD21 ' A' ' 35' ' ' LEU . 83.7 mt -72.01 -25.31 61.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.178 -0.465 . . . . 0.3 110.9 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.538 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.17 -24.62 47.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.203 -0.453 . . . . 0.39 110.922 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.62 -30.11 17.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.27 111.114 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.833 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.54 -35.05 14.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 0.24 110.872 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.721 HG21 HG12 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -102.87 -45.4 4.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.27 111.058 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.74 -12.13 52.13 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.791 -0.719 . . . . 0.3 112.447 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -67.96 -62.72 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.792 0.33 . . . . 2.55 110.879 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -95.09 -38.9 10.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 2.79 110.896 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.58 -130.6 5.68 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.717 -0.754 . . . . 0.25 112.473 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -152.59 151.28 30.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.841 0.353 . . . . 2.21 110.853 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' A' ' 33' ' ' GLN . 84.0 t -134.54 121.42 35.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.22 111.123 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.3 t -110.66 152.94 25.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.23 110.881 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.7 p -115.65 136.67 51.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.082 -0.508 . . . . 0.2 111.17 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -146.47 152.69 39.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.38 110.911 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -102.35 138.61 39.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.5 110.878 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.978 HD13 HG21 ' A' ' 73' ' ' THR . 14.0 mt -53.87 -43.26 56.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.179 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.58 -21.69 61.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 3.61 110.914 179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -100.73 16.39 25.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 3.42 110.903 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.785 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.59 -29.79 4.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 1.14 110.905 -179.892 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.89 -41.07 61.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 1.12 110.884 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -84.98 -15.96 42.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 1.08 110.908 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.459 ' HB2' HD13 ' A' ' 50' ' ' LEU . 51.0 m -66.67 -11.46 54.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.911 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.14 61.0 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.48 111.092 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -58.52 -71.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.282 -0.417 . . . . 0.57 110.839 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -150.79 -168.51 3.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.237 -0.438 . . . . 1.91 110.813 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.58 136.05 43.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.175 -0.466 . . . . 1.99 110.903 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 92.2 p 47.45 86.87 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 1.21 110.885 -179.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 p -142.3 -39.02 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.495 . . . . 0.47 110.91 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.471 ' O ' HD23 ' A' ' 87' ' ' LEU . 97.9 m-85 -99.66 120.08 39.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.051 -0.522 . . . . 1.47 110.85 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.44 -21.76 62.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 1.72 110.93 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 20.7 mt -144.53 144.11 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.117 -0.492 . . . . 0.28 111.157 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.817 HG21 HG23 ' A' ' 83' ' ' ILE . 18.9 mm -136.54 130.15 46.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.15 111.195 179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.417 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.7 mm? -113.57 137.54 51.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.21 110.956 179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.58 100.81 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.14 110.902 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.7 77.97 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.773 -0.727 . . . . 0.18 112.493 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.77 56.71 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.57 110.853 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.65 159.91 55.97 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.661 0.743 . . . . 0.21 111.09 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 116.82 4.74 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.672 2.248 . . . . 0.24 112.369 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.96 7.21 70.88 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.775 -0.726 . . . . 0.2 112.431 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -54.93 150.56 9.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.007 0.432 . . . . 0.69 110.821 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.718 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 19.3 p -140.68 109.45 6.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.22 111.195 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.978 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.09 151.29 15.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.24 111.161 179.995 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.037 HD12 HD22 ' A' ' 147' ' ' LEU . 5.2 mt -127.01 99.82 5.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 0.33 110.905 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -76.9 130.21 37.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.52 110.876 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.489 ' H ' HD13 ' A' ' 79' ' ' ILE . 29.7 m -107.11 177.0 4.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 0.47 110.924 -179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.19 -40.07 57.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.142 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.63 -43.41 89.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 1.73 110.879 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.785 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.1 mp -76.04 -56.39 8.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.26 111.16 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 mt -49.59 -47.29 49.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.917 179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.75 -52.76 37.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.53 111.068 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.63 -43.9 80.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 2.84 110.893 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.817 HG23 HG21 ' A' ' 63' ' ' ILE . 38.6 mm -55.86 -67.15 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.29 111.102 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.22 -36.65 42.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 0.29 111.09 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 tpp85 -56.33 -54.98 39.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.269 -0.423 . . . . 2.4 110.926 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 56' ' ' LYS . 24.2 pt -78.44 -8.42 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.33 111.093 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -77.54 124.7 28.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 0.28 110.942 179.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -64.25 160.67 47.63 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.578 0.704 . . . . 2.15 110.857 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.72 114.02 3.56 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.656 2.237 . . . . 0.23 112.408 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.43 3.38 56.45 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.688 -0.768 . . . . 0.2 112.426 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.01 -161.6 13.38 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.758 . . . . 0.18 112.479 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 14.7 m -139.59 154.16 47.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.83 0.347 . . . . 0.27 110.883 -179.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.636 HD12 HD11 ' A' ' 119' ' ' LEU . 1.3 tm? -138.87 113.5 9.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.204 -0.453 . . . . 0.16 110.945 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.536 ' N ' HD22 ' A' ' 93' ' ' LEU . 46.2 m-85 -108.45 133.44 52.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 1.64 110.85 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.526 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.98 164.15 35.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.18 110.901 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -135.25 126.99 29.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 1.87 110.998 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.616 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.6 OUTLIER -148.97 148.4 27.12 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.675 0.75 . . . . 2.35 110.863 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.507 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.4 Cg_endo -69.85 139.89 40.99 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.605 2.203 . . . . 0.21 112.355 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 155' ' ' LEU . 5.4 m -120.96 147.4 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.26 111.143 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.409 ' OE1' HG21 ' A' ' 103' ' ' VAL . 38.2 mt-10 -116.1 132.63 56.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.226 -0.443 . . . . 1.97 110.904 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 15.4 p -106.45 26.04 10.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 1.08 111.077 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -150.17 25.93 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.96 111.046 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.6 t -143.75 159.92 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.97 111.084 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.485 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -56.02 179.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 2.09 110.772 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -64.61 -68.84 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 2.09 110.897 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -62.47 -75.88 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 2.01 110.87 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.37 -167.26 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 1.58 110.811 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.03 -6.83 58.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 2.07 110.954 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.29 140.24 20.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.67 111.114 179.824 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.667 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.4 OUTLIER -64.23 115.49 5.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 2.11 110.869 179.973 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.485 HG21 ' O ' ' A' ' 104' ' ' ASP . 28.4 p -83.3 177.77 8.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.27 111.126 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.52 -55.05 28.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.455 . . . . 0.32 111.137 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.8 -51.73 68.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.3 110.805 -179.745 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.98 -38.13 67.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 2.5 110.886 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.616 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.1 tm? -64.74 -54.61 28.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 0.6 110.874 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 36.4 m -60.07 -46.41 89.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.463 . . . . 0.3 110.922 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.38 -43.98 96.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.33 110.801 -179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.73 -53.33 59.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.37 111.105 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.636 HD11 HD12 ' A' ' 93' ' ' LEU . 16.5 tp -57.66 -53.16 61.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.53 110.876 -179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.8 m -61.57 -26.25 67.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.459 . . . . 0.44 111.177 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.8 mt -87.01 -13.6 44.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 0.67 110.939 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.0 p -82.0 3.5 26.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 2.57 110.877 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.06 -4.35 33.77 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.802 -0.713 . . . . 0.85 112.564 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.662 HD23 ' HA3' ' A' ' 161' ' ' GLY . 1.6 tp -87.9 171.2 10.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.926 0.393 . . . . 0.67 110.797 -179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.44 169.24 2.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.162 -0.472 . . . . 0.38 111.105 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 54.6 44.2 29.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 2.28 110.886 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 86.1 t -81.85 142.68 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.033 -0.53 . . . . 0.33 111.105 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.08 160.62 8.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 1.63 110.959 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -78.91 142.91 36.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 3.12 110.913 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.725 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.2 mp -100.2 -39.08 8.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.19 110.907 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.35 176.34 12.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 1.12 110.932 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.703 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.0 tmt_? -130.19 138.18 50.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 4.16 110.919 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -125.06 135.8 27.28 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.605 0.717 . . . . 1.89 110.946 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.42 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.7 Cg_endo -69.72 162.52 41.75 Favored 'Trans proline' 0 N--CA 1.465 -0.19 0 C-N-CA 122.764 2.309 . . . . 0.3 112.405 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.668 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -97.93 118.54 34.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 0.53 110.92 179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.49 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.0 OUTLIER -96.71 161.07 27.83 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.595 0.712 . . . . 1.47 111.077 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.49 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.9 Cg_endo -69.67 -25.53 28.91 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.6 2.2 . . . . 0.62 112.344 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -85.46 -20.75 29.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 4.23 110.821 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -88.25 -53.29 4.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 2.38 110.85 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 136' ' ' THR . 7.0 p -49.64 -39.46 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.37 111.111 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -34.01 75.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 1.29 110.874 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.67 -46.69 68.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.4 110.817 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.703 HG23 HD13 ' A' ' 147' ' ' LEU . 9.8 p -68.29 -30.24 47.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.157 -0.474 . . . . 0.29 111.21 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -76.13 -31.5 58.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.481 . . . . 1.81 110.886 179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -89.73 -20.41 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.432 . . . . 2.02 110.905 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -94.54 -32.91 13.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.47 110.805 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.037 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.26 -54.28 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.248 -0.433 . . . . 0.44 110.896 -179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.1 17.21 1.66 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.696 -0.764 . . . . 0.36 112.496 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 -72.37 122.36 21.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 1.01 110.869 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.38 107.95 3.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 2.87 110.95 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.9 t -160.55 172.23 17.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.84 110.872 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.01 -18.06 14.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 1.69 110.818 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -100.01 18.73 17.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 1.57 110.844 -179.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -83.21 165.35 19.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.36 110.977 179.952 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.703 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.4 tm? -173.94 130.3 0.4 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.219 -0.446 . . . . 0.26 110.917 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.718 ' CZ ' HG22 ' A' ' 72' ' ' THR . 23.1 m-85 -75.87 138.63 41.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 1.84 110.924 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -151.88 148.41 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.25 111.079 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.725 ' HG2' HD13 ' A' ' 130' ' ' LEU . 9.9 tt0 -102.36 132.55 48.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 2.16 110.866 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mp -127.59 148.85 32.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.22 111.129 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.512 ' N ' HD11 ' A' ' 130' ' ' LEU . 9.6 t -134.49 157.3 46.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.38 111.109 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.662 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -146.53 141.77 9.83 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.759 -0.734 . . . . 0.37 112.483 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -98.54 131.97 44.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 3.66 110.91 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.53 135.58 78.48 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.541 0.686 . . . . 1.79 110.882 179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 129.32 17.4 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.667 2.245 . . . . 0.41 112.394 179.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -110.67 149.92 29.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.39 110.906 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 19.6 t80 64.82 151.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 6.03 110.941 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.67 112.82 3.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 8.13 110.963 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 33.7 m -134.81 169.25 21.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 5.53 111.132 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -154.61 56.74 0.41 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.718 -0.753 . . . . 5.62 112.505 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 22.7 t -107.26 -53.67 2.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 7.32 110.943 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.62 -170.06 1.63 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.111 -0.495 . . . . 7.04 110.862 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 6.12 110.878 -179.935 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptm . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.802 0.334 . . . . 4.21 110.849 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.69 -21.74 63.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.314 -0.403 . . . . 0.46 111.189 179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.15 -51.52 64.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 1.95 110.85 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.37 22.41 10.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 2.04 110.909 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.28 40.95 53.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 0.26 112.531 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.482 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -80.01 159.91 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.793 0.33 . . . . 0.3 111.118 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -154.44 165.37 36.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 1.17 110.873 -179.862 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.58 123.71 33.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.32 111.09 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.44 2.87 21.17 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.646 -0.788 . . . . 0.33 112.467 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.401 HE22 HD12 ' A' ' 62' ' ' ILE . 2.8 pt20 -115.15 168.7 9.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.857 0.36 . . . . 1.05 110.898 -179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -106.93 112.87 26.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 1.37 110.857 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG13 HG21 ' A' ' 36' ' ' THR . 3.0 m -116.05 140.2 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 2.3 111.135 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.803 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -115.92 113.02 22.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.3 111.059 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.785 HG11 HG12 ' A' ' 29' ' ' VAL . 62.4 t -86.97 120.28 36.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.21 111.082 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.418 HG12 ' CG1' ' A' ' 47' ' ' ILE . 21.7 t -105.29 116.64 49.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.19 111.09 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -116.2 169.22 9.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.152 -0.476 . . . . 0.2 110.934 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.402 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 9.7 p-10 -151.4 -169.74 3.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 1.78 110.832 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.86 -35.59 71.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 3.13 110.876 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.6 m -73.5 -9.18 58.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 1.58 110.896 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.08 94.47 10.96 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.655 0.74 . . . . 0.16 110.847 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.79 142.03 46.69 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.664 2.242 . . . . 0.21 112.345 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.2 t -48.69 -32.94 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.2 111.141 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.34 -52.62 43.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 3.17 110.878 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.47 -45.03 10.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 0.17 111.097 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.457 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.8 -61.61 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.18 110.846 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.97 -35.42 24.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 2.61 110.784 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.25 -47.54 43.71 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.722 -0.752 . . . . 0.23 112.487 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.05 -39.19 91.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.967 0.413 . . . . 0.55 110.968 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.785 HG12 HG11 ' A' ' 14' ' ' VAL . 16.8 m -77.07 -31.46 18.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.186 -0.461 . . . . 0.65 111.116 179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -62.5 -58.83 6.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 1.66 110.874 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.3 -40.4 74.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 3.01 110.883 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.853 HD23 HD21 ' A' ' 35' ' ' LEU . 89.5 mt -72.65 -25.19 61.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.228 -0.442 . . . . 0.32 110.929 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.468 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -77.89 -24.74 48.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.904 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.66 -31.09 16.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.28 111.083 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.853 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -90.08 -35.14 15.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.26 110.964 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -103.25 -47.2 4.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.132 -0.486 . . . . 0.29 111.218 179.893 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.83 -14.68 52.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.749 . . . . 0.29 112.53 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.11 -62.71 1.62 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.75 0.309 . . . . 1.98 110.869 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -103.86 -33.86 8.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 2.22 110.854 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.42 -133.34 4.9 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.672 -0.775 . . . . 0.29 112.526 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -150.8 151.53 32.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.751 0.31 . . . . 2.19 110.869 -179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.531 HG22 HG22 ' A' ' 12' ' ' VAL . 99.0 t -139.11 113.35 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.43 111.172 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 t -103.91 154.56 19.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.16 110.811 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 p -116.73 130.03 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 0.21 111.134 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -137.73 150.92 47.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 1.45 110.92 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -103.64 135.32 45.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.45 110.888 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.648 ' CD1' HG21 ' A' ' 73' ' ' THR . 32.0 mt -54.22 -34.55 27.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.479 . . . . 0.31 111.185 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptmt -73.27 -30.77 63.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 2.07 110.862 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -102.28 19.4 18.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 3.75 110.924 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.823 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.59 -27.37 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 1.08 110.929 -179.977 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -52.73 -38.65 61.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 1.06 110.907 179.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -84.48 -14.35 49.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.126 -0.488 . . . . 1.09 110.896 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.652 ' HB3' HD13 ' A' ' 50' ' ' LEU . 24.4 t -63.96 -11.51 29.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 2.05 110.838 -179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.97 53.97 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.39 111.153 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -52.1 -71.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.41 110.81 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.676 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -147.83 -168.6 3.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 1.94 110.878 -179.928 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -103.73 129.75 51.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 1.68 110.957 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 t 51.55 88.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 1.96 110.803 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 17.4 p -140.59 -39.54 0.42 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.057 -0.519 . . . . 0.26 110.818 -179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.472 ' O ' HD23 ' A' ' 87' ' ' LEU . 92.6 m-85 -99.9 123.61 44.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 1.47 110.868 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.23 -22.04 62.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 1.52 110.958 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.401 HD12 HE22 ' A' ' 10' ' ' GLN . 14.4 mt -146.14 143.25 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.45 111.164 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.976 HG21 HG23 ' A' ' 83' ' ' ILE . 16.7 mm -130.21 133.68 63.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.15 111.093 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.7 mm? -112.48 135.64 52.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.159 -0.473 . . . . 0.3 110.938 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.32 98.97 5.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.18 110.921 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.7 80.9 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.695 -0.764 . . . . 0.22 112.591 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.4 mm? -111.94 55.62 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.58 110.985 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.11 159.52 56.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.696 0.76 . . . . 0.22 111.173 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 116.56 4.6 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.644 2.23 . . . . 0.24 112.437 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.32 7.29 69.88 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.722 -0.751 . . . . 0.16 112.461 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.8 148.41 16.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.905 0.384 . . . . 0.67 110.797 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.761 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 32.9 p -136.84 108.66 7.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.112 -0.494 . . . . 0.19 111.089 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.648 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -161.95 152.54 17.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.24 111.174 179.983 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.868 HD12 HD22 ' A' ' 147' ' ' LEU . 3.4 mt -132.05 103.68 6.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.28 110.915 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -80.03 146.85 31.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.27 110.817 179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 43.3 m -124.56 -176.2 3.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.38 110.867 -179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.71 70.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.22 111.129 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -62.72 -45.14 94.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 1.83 110.974 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.823 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -74.28 -55.37 12.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.19 111.091 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 119' ' ' LEU . 61.4 mt -49.68 -43.77 47.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.2 110.911 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.41 -50.82 58.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.29 111.136 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.72 -44.53 90.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 3.08 110.86 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.976 HG23 HG21 ' A' ' 63' ' ' ILE . 41.9 mm -58.08 -68.25 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.21 111.127 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.37 -37.3 24.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 0.2 111.135 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -56.9 -52.84 63.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 2.26 110.813 -179.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 56' ' ' LYS . 23.9 pt -81.69 -4.91 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.2 111.135 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -81.34 115.76 20.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.27 110.904 179.91 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 11.0 mtp85 -53.42 158.77 2.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.63 0.729 . . . . 3.03 110.846 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.402 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.8 Cg_endo -69.72 113.59 3.42 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.624 2.216 . . . . 0.23 112.426 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.71 3.0 55.27 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.731 -0.747 . . . . 0.26 112.42 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.24 -162.1 15.5 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.22 112.485 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 98.9 m -138.4 157.17 46.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.857 0.36 . . . . 0.38 110.831 -179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.669 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.2 tm? -139.86 115.94 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.15 110.88 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.599 ' N ' HD22 ' A' ' 93' ' ' LEU . 67.5 m-85 -109.18 131.86 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 1.88 110.847 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.572 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.28 164.34 34.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 0.18 110.91 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.76 129.3 32.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 1.87 110.907 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.663 ' OE1' HD23 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -152.52 149.61 23.02 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.674 0.749 . . . . 2.53 110.864 179.958 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.629 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.2 Cg_endo -69.81 144.19 52.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.667 2.245 . . . . 0.21 112.308 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 m -130.82 146.61 33.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.44 . . . . 0.25 111.167 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.434 ' CD ' HG21 ' A' ' 103' ' ' VAL . 42.8 mt-10 -106.79 132.91 52.22 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.177 -0.465 . . . . 2.09 110.94 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.6 p -93.27 -42.5 9.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 1.1 111.161 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.677 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.36 39.89 1.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.8 111.162 179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' CD ' ' A' ' 100' ' ' GLU . 20.1 t -147.29 150.97 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.246 -0.434 . . . . 0.76 111.147 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.616 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -54.05 164.32 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 2.27 110.866 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -59.99 -48.32 82.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.142 -0.481 . . . . 2.49 110.941 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.12 -75.75 0.14 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 1.99 110.846 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.2 p 53.02 -171.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 1.82 110.862 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -4.42 53.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.097 -0.501 . . . . 2.29 110.961 179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.505 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.5 m -140.81 151.26 20.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.286 -0.415 . . . . 0.52 111.228 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -68.26 111.66 4.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 2.41 110.9 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.616 HG21 ' O ' ' A' ' 104' ' ' ASP . 46.9 p -83.14 179.65 7.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.28 111.198 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.65 -53.59 55.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.19 111.102 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.2 m -60.88 -47.95 84.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.24 110.843 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -39.11 80.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 2.72 110.91 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -64.7 -55.25 21.18 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.213 -0.449 . . . . 0.39 110.904 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 60.6 m -55.93 -44.83 78.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 0.21 110.842 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.4 -40.78 96.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.27 110.852 -179.75 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.61 -41.82 92.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.22 111.125 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.599 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.1 tp -64.82 -50.77 65.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.26 110.978 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.3 m -63.63 -35.22 79.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.29 111.145 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 35.0 mt -83.48 -10.28 58.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.54 110.884 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 m -84.87 5.78 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 1.73 110.881 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.22 3.98 35.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.719 . . . . 0.5 112.507 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -104.81 172.42 6.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.932 0.396 . . . . 0.3 110.865 -179.869 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 m -151.58 174.08 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.33 111.23 179.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 51.22 45.09 28.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 2.02 110.938 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.42 HG13 HD23 ' A' ' 119' ' ' LEU . 89.4 t -79.7 143.81 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.22 111.107 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.98 160.49 8.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 2.47 110.92 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -81.15 145.77 30.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 2.27 110.969 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.62 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.8 mp -105.23 -35.65 7.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.18 110.949 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.57 176.33 12.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.172 -0.467 . . . . 1.13 111.02 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.731 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.0 tmt_? -132.4 138.16 47.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 4.29 110.785 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -125.18 137.97 30.76 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.625 0.726 . . . . 1.86 110.967 -179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.422 ' HA ' HD21 ' A' ' 155' ' ' LEU . 55.2 Cg_endo -69.6 164.05 35.86 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.76 2.307 . . . . 0.26 112.403 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.678 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -97.61 128.58 44.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.31 110.913 -179.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.48 160.95 25.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.608 0.718 . . . . 1.21 111.108 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.86 -28.81 24.31 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.649 2.233 . . . . 0.33 112.333 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -85.35 -17.78 35.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 3.74 110.844 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 -52.9 5.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 2.27 110.936 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.8 p -49.19 -40.66 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.29 111.134 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -34.78 76.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 1.18 110.884 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.98 -46.31 71.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.27 110.882 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.708 HG23 HD13 ' A' ' 147' ' ' LEU . 8.9 p -68.12 -30.08 46.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.24 111.167 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 62.1 ttt180 -75.27 -33.33 61.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 1.82 110.855 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -89.12 -19.91 24.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 1.7 110.818 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -94.16 -32.77 13.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.83 -179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.868 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -128.4 -54.26 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.45 110.871 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.31 4.95 2.76 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.705 -0.76 . . . . 0.41 112.484 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.505 ' CE1' HG21 ' A' ' 109' ' ' VAL . 8.1 t-160 -70.08 120.17 15.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.805 0.336 . . . . 0.87 110.805 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -153.26 104.76 2.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 2.21 110.967 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.34 173.42 15.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.77 110.911 -179.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.98 -10.06 16.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.434 . . . . 1.95 110.895 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.677 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 1.6 m120 -99.9 9.08 43.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 3.13 110.904 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.678 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -83.2 167.14 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.44 110.938 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.731 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.9 tm? -172.33 130.13 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.24 110.898 179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.761 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.9 m-85 -73.76 132.23 42.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 1.72 110.853 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.07 142.26 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.21 111.171 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.62 ' HG2' HD13 ' A' ' 130' ' ' LEU . 7.5 tt0 -96.46 129.44 43.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 1.69 110.874 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.97 151.63 32.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.22 111.198 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.448 ' N ' HD11 ' A' ' 130' ' ' LEU . 3.0 t -131.91 160.85 34.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.28 111.156 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.409 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -152.39 134.51 4.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.757 -0.735 . . . . 0.17 112.509 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -95.19 141.1 29.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.887 0.375 . . . . 1.67 110.914 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.402 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 4.7 tptm -81.95 134.09 50.46 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.559 0.695 . . . . 1.38 110.871 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 119.26 6.23 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.645 2.23 . . . . 0.44 112.376 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -99.39 151.62 20.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.38 110.929 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 42.5 t80 65.1 151.95 0.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 5.81 110.823 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.8 111.56 2.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 8.4 110.947 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.18 171.33 14.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 5.89 111.08 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -141.73 47.9 0.82 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.741 -0.742 . . . . 5.61 112.469 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 31.4 t -139.1 161.87 36.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 6.83 110.85 -179.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.47 -75.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 7.58 110.743 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 7.01 110.887 -179.864 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.817 0.341 . . . . 4.17 110.952 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.93 -21.37 63.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.47 111.063 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -54.33 -51.21 65.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 2.83 110.874 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -122.31 22.0 10.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.259 -0.428 . . . . 1.52 110.876 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.15 40.63 52.24 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.788 -0.72 . . . . 0.28 112.469 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.49 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.7 mp -79.05 159.8 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.821 0.343 . . . . 0.25 111.121 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 36' ' ' THR . 1.3 m -154.32 166.52 32.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 1.13 110.842 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.6 125.41 35.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.452 . . . . 0.3 111.159 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.91 2.9 23.61 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.814 -0.707 . . . . 0.32 112.514 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.422 HE22 HD12 ' A' ' 62' ' ' ILE . 2.3 pt20 -115.54 166.99 11.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 1.04 110.882 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -105.61 114.96 29.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 1.35 110.796 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 42' ' ' VAL . 3.3 m -118.06 139.13 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 2.29 111.08 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.788 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -114.64 114.44 25.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.34 111.146 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.828 HG11 HG12 ' A' ' 29' ' ' VAL . 97.2 t -87.66 121.84 38.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.2 111.182 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.548 HG12 HG13 ' A' ' 47' ' ' ILE . 18.1 t -107.36 116.72 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.17 111.139 179.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.0 p-90 -115.76 167.18 11.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.23 110.881 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.63 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.2 p-10 -146.29 -169.52 3.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 1.74 110.89 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -59.42 -35.21 73.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 2.96 110.972 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.76 -6.83 51.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.119 -0.492 . . . . 1.23 110.891 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.6 m -107.17 93.87 10.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.706 0.765 . . . . 0.16 110.881 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 54.8 Cg_endo -69.63 142.47 48.58 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.727 2.284 . . . . 0.21 112.456 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 92.9 t -49.2 -32.42 5.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.19 111.125 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.49 -52.82 43.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.134 -0.485 . . . . 3.21 110.946 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.53 -44.88 10.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.18 111.178 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.419 HD22 HG13 ' A' ' 29' ' ' VAL . 1.9 tm? -51.66 -61.72 2.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.14 110.935 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 -34.61 22.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 2.31 110.9 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.11 -48.24 40.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.781 -0.723 . . . . 0.2 112.437 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 44.6 mt -61.33 -39.98 92.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.872 0.368 . . . . 0.47 110.92 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.828 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -76.23 -31.69 21.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.63 111.186 179.777 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -61.89 -60.03 4.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 1.66 110.851 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.74 -40.22 72.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 1.71 110.926 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.904 HD23 HD21 ' A' ' 35' ' ' LEU . 81.2 mt -72.52 -24.65 61.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.255 -0.429 . . . . 0.25 110.927 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.45 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.41 -24.95 45.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.118 -0.492 . . . . 0.38 110.914 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.78 -30.07 17.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.195 -0.457 . . . . 0.23 111.104 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.904 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.42 -35.05 14.59 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.22 110.877 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.726 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.11 -45.47 4.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.25 111.137 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.26 -12.61 56.01 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.822 -0.704 . . . . 0.27 112.449 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -65.78 -62.72 1.35 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 2.6 110.858 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -96.52 -37.43 10.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 2.23 110.88 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.55 -129.43 4.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.784 -0.722 . . . . 0.24 112.489 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.3 ttt-85 -153.4 153.04 31.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 3.79 110.835 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 12' ' ' VAL . 95.0 t -138.98 119.81 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.26 111.188 179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.6 t -109.76 154.69 22.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.16 110.899 -179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.3 p -115.83 134.53 58.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.503 . . . . 0.14 111.097 179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -144.3 152.38 40.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 1.27 110.986 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -102.56 137.64 40.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.47 110.852 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.925 HD13 HG21 ' A' ' 73' ' ' THR . 11.2 mt -50.91 -46.77 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.51 . . . . 0.4 111.208 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -24.73 63.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 3.71 110.905 179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -98.22 18.52 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 3.42 110.812 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.809 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.75 -29.13 4.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 1.07 110.943 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.594 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -52.52 -36.31 55.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 2.55 110.975 179.844 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -85.86 -19.47 30.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 1.25 110.905 179.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.413 ' HB2' HD13 ' A' ' 50' ' ' LEU . 63.6 m -60.69 -16.69 42.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 0.88 110.877 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.414 ' HB2' ' CG ' ' A' ' 82' ' ' GLU . . . -73.94 63.49 0.93 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.4 111.174 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.403 ' HB3' ' HD3' ' A' ' 56' ' ' LYS . 12.5 m-70 -64.9 -70.24 0.24 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.148 -0.478 . . . . 0.39 110.846 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.706 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.13 -168.08 2.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 1.15 110.924 -179.983 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -105.88 126.68 52.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.238 -0.437 . . . . 2.22 110.905 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 49.14 79.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 1.34 110.846 -179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 77.7 p -130.11 -35.33 1.6 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.33 110.856 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.446 ' O ' HD23 ' A' ' 87' ' ' LEU . 93.5 m-85 -98.52 122.02 41.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.094 -0.503 . . . . 2.05 110.873 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.61 -21.69 61.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 1.52 110.949 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.422 HD12 HE22 ' A' ' 10' ' ' GLN . 13.7 mt -145.67 143.46 21.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.481 . . . . 0.42 111.155 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.832 HG21 HG23 ' A' ' 83' ' ' ILE . 18.8 mm -130.52 132.85 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.222 -0.444 . . . . 0.16 111.155 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -111.7 135.2 52.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.836 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.52 98.52 4.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.766 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.64 78.93 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.736 -0.745 . . . . 0.22 112.475 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -109.71 54.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.358 . . . . 0.58 110.939 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.4 159.77 53.46 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.569 0.699 . . . . 0.21 111.128 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 116.34 4.52 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.702 2.268 . . . . 0.22 112.373 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.61 7.02 69.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.739 -0.743 . . . . 0.22 112.495 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -55.26 136.59 48.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.68 110.906 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.729 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.2 p -126.03 108.41 11.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.19 111.122 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.925 HG21 HD13 ' A' ' 47' ' ' ILE . 1.1 m -163.3 155.8 18.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.33 111.202 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.979 HD12 HD22 ' A' ' 147' ' ' LEU . 3.9 mt -133.55 105.8 7.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.251 -0.431 . . . . 0.22 110.983 179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -79.44 150.98 31.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.24 110.903 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.1 m -130.64 -177.46 4.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.49 110.884 -179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.65 -39.98 68.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.38 111.078 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.42 -47.12 86.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.268 -0.424 . . . . 2.14 110.929 -179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.809 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -71.9 -56.48 10.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.128 -0.487 . . . . 0.3 111.185 179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.6 mt -50.78 -39.54 52.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.22 110.949 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.14 -56.88 12.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.41 111.099 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.422 ' HB2' HD12 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -55.97 -43.53 77.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 2.93 110.968 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.832 HG23 HG21 ' A' ' 63' ' ' ILE . 43.4 mm -55.15 -68.33 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.24 111.047 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.17 -39.75 57.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.28 111.194 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -52.84 -49.54 65.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 2.48 110.946 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 56' ' ' LYS . 40.0 pt -86.66 -5.62 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.26 111.23 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -80.13 113.36 18.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.149 -0.478 . . . . 0.27 110.851 179.966 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -52.8 158.49 2.19 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.588 0.709 . . . . 2.45 110.863 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.404 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.3 Cg_endo -69.75 114.22 3.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.669 2.246 . . . . 0.24 112.299 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.99 3.09 54.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.829 -0.701 . . . . 0.26 112.522 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.77 -159.7 12.46 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.761 -0.733 . . . . 0.22 112.453 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.3 m -141.98 157.28 45.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.777 0.322 . . . . 0.55 110.918 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.688 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.2 tm? -139.37 114.61 9.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 0.21 110.927 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.587 ' N ' HD22 ' A' ' 93' ' ' LEU . 73.5 m-85 -106.33 132.55 52.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 1.84 110.848 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.616 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.81 163.84 36.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.17 110.895 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.46 130.8 35.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 1.85 110.837 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.8 147.28 18.3 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.64 0.733 . . . . 2.16 110.915 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.464 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.4 Cg_endo -69.75 141.38 45.13 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.776 2.317 . . . . 0.22 112.329 -179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.39 146.95 30.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 0.2 111.11 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.438 ' CD ' HG21 ' A' ' 103' ' ' VAL . 52.2 mt-10 -108.97 133.04 53.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.128 -0.487 . . . . 1.97 110.844 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 30.0 p -92.0 -41.91 10.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 1.11 111.179 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.74 40.34 1.05 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.68 111.094 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.438 HG21 ' CD ' ' A' ' 100' ' ' GLU . 25.8 t -147.93 149.82 14.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.69 111.02 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.614 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -54.11 175.47 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 2.11 110.945 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -65.7 -63.51 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 2.32 110.89 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.41 -75.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 1.64 110.894 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.77 -168.23 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 1.67 110.826 -179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.467 ' HG3' HG13 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -79.9 -7.9 59.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 1.75 110.928 179.937 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.467 HG13 ' HG3' ' A' ' 108' ' ' LYS . 2.4 m -141.14 145.73 24.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.148 -0.478 . . . . 0.4 111.15 179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 2.3 ttmp? -64.93 115.35 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 2.21 110.947 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.614 HG21 ' O ' ' A' ' 104' ' ' ASP . 80.8 p -86.82 178.88 6.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.29 111.145 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.76 -51.75 66.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.17 111.153 179.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.66 -49.41 77.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.23 110.838 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.78 -37.56 76.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 1.88 110.931 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.491 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -64.61 -55.39 20.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.31 110.844 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 55.9 m -57.64 -46.2 84.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.21 110.894 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -42.85 95.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.26 110.828 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.46 -44.31 96.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.11 -0.496 . . . . 0.21 111.175 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.618 HD11 HD12 ' A' ' 93' ' ' LEU . 14.9 tp -64.45 -52.11 59.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 0.24 110.893 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.7 m -61.55 -31.62 71.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.24 111.085 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.91 -10.32 53.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.254 -0.43 . . . . 0.53 110.897 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.01 5.6 28.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 1.71 110.866 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.74 5.92 33.22 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.755 . . . . 0.48 112.436 179.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -105.87 170.38 7.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.822 0.344 . . . . 0.28 110.985 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 28.3 m -150.19 170.59 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.432 . . . . 0.31 111.162 179.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 53.77 44.15 30.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.197 -0.456 . . . . 2.47 110.858 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.6 t -80.14 144.43 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.21 111.216 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 156.99 6.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.247 -0.433 . . . . 1.64 110.915 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.45 141.34 38.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.23 -0.441 . . . . 3.04 110.907 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.766 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.4 mp -99.74 -36.4 9.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.25 110.869 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -163.15 176.9 9.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 1.33 110.886 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -125.53 166.05 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 7.25 110.927 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -149.21 136.17 10.76 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.695 0.76 . . . . 1.38 110.895 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 154.78 67.43 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.726 2.284 . . . . 0.32 112.372 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.648 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.1 OUTLIER -91.14 125.96 36.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.43 . . . . 0.31 110.932 179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.417 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.36 161.37 24.84 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.598 0.713 . . . . 1.21 111.107 -179.991 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.417 ' HD2' HG22 ' A' ' 136' ' ' THR . 54.2 Cg_endo -69.78 -28.49 25.09 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.661 2.241 . . . . 0.38 112.388 179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -85.36 -17.97 35.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 2.81 110.839 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.25 -53.01 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 2.59 110.899 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.5 p -49.66 -40.61 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.172 -0.467 . . . . 0.24 111.095 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -34.67 76.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 1.15 110.905 -179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 -46.12 71.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.22 110.86 -179.806 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 9.0 p -68.45 -30.34 47.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.17 111.059 -179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -75.56 -32.52 60.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 2.57 110.935 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -89.56 -20.01 24.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.165 -0.47 . . . . 1.79 110.903 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -94.3 -32.74 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 0.3 110.884 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.979 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -128.03 -54.29 1.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.34 110.878 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 132.36 9.1 2.43 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.818 -0.706 . . . . 0.31 112.478 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.402 ' CG ' HG11 ' A' ' 109' ' ' VAL . 11.0 t-160 -70.31 121.68 18.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.805 0.336 . . . . 0.64 110.901 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -151.8 105.42 3.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 2.62 110.864 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.6 t -160.44 169.55 22.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.72 110.888 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.65 -14.87 15.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 1.62 110.858 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -99.33 19.94 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 1.6 110.896 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.648 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -92.2 167.96 11.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.31 110.969 179.887 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.628 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -172.49 129.81 0.56 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.43 . . . . 0.26 110.926 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.729 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.2 m-85 -70.16 135.98 49.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 1.86 110.861 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.32 148.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.25 111.183 179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.766 ' HG2' HD13 ' A' ' 130' ' ' LEU . 10.5 tt0 -105.03 132.03 51.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 2.3 110.839 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.23 153.04 38.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.21 111.139 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.415 ' N ' HD11 ' A' ' 130' ' ' LEU . 7.8 t -139.25 152.46 47.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.34 111.123 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -142.84 140.74 10.02 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.19 112.49 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -97.28 139.54 33.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.732 0.301 . . . . 1.64 110.962 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.404 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 1.4 tptt -78.99 134.37 60.07 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.508 0.67 . . . . 2.37 110.899 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 118.61 5.78 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.694 2.263 . . . . 0.44 112.304 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -100.4 152.23 20.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.33 110.923 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.0 t80 61.06 19.31 9.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.421 . . . . 5.9 110.959 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 63.53 160.46 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.506 . . . . 10.07 110.86 -179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 35.8 m -116.32 178.29 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 5.82 111.167 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -148.49 28.82 1.33 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.721 -0.752 . . . . 5.86 112.479 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 2.3 p -147.09 59.16 1.17 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.862 0.363 . . . . 6.37 110.876 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.1 -176.14 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 7.62 110.85 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 6.73 110.843 -179.936 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.8 ptt? . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.721 0.296 . . . . 3.56 110.878 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.45 -22.62 66.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.53 111.163 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -54.13 -51.57 63.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 2.41 110.839 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -122.3 24.35 9.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 2.09 110.908 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.94 38.33 46.38 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.861 -0.685 . . . . 0.44 112.471 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.404 HG22 ' N ' ' A' ' 7' ' ' SER . 1.7 mp -76.82 158.73 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.869 0.366 . . . . 0.45 111.129 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 36' ' ' THR . 33.7 m -147.14 158.55 43.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.506 . . . . 1.16 110.839 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.18 130.6 35.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.62 111.153 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.86 -6.12 32.79 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.751 -0.737 . . . . 0.49 112.479 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -106.56 168.91 8.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.778 0.323 . . . . 1.54 110.904 -179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -102.66 110.98 23.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 1.42 110.886 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.775 HG12 HG21 ' A' ' 36' ' ' THR . 2.5 p -118.99 130.52 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.129 -0.487 . . . . 2.06 111.043 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.758 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -105.97 132.72 51.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.079 -0.51 . . . . 0.32 111.081 179.873 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.732 HG11 HG12 ' A' ' 29' ' ' VAL . 96.3 t -101.6 120.13 50.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.19 111.088 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.711 HG12 HG13 ' A' ' 47' ' ' ILE . 15.8 t -103.24 116.66 47.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.149 -0.478 . . . . 0.22 111.154 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -117.04 166.36 12.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.36 110.863 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.585 ' HB3' HD12 ' A' ' 47' ' ' ILE . 8.1 p-10 -144.24 -169.79 3.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 1.91 110.885 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.58 -35.52 74.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 3.37 110.939 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.7 t -73.41 -7.84 53.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 1.23 110.926 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.2 93.21 9.03 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.682 0.753 . . . . 0.31 110.886 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 143.12 50.11 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.671 2.247 . . . . 0.46 112.372 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.09 -32.47 5.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.35 111.096 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.19 -53.36 35.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 2.55 110.89 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.81 -44.92 10.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.486 . . . . 0.4 111.046 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -51.12 -61.01 2.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.24 -0.436 . . . . 0.31 110.897 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -33.59 16.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 3.26 110.881 179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.77 -49.05 38.33 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.748 -0.739 . . . . 0.37 112.473 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.701 HD12 HG13 ' A' ' 68' ' ' VAL . 21.8 mt -60.68 -40.61 92.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.867 0.365 . . . . 0.77 110.939 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.732 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -75.7 -31.36 22.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.64 111.132 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -61.91 -61.75 2.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 1.73 110.863 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.76 -40.48 66.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 1.56 110.87 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.706 HD23 HD21 ' A' ' 35' ' ' LEU . 58.7 mt -72.23 -25.86 61.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.239 -0.437 . . . . 0.37 110.899 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.445 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.33 -23.85 46.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.41 110.898 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.97 -29.64 17.29 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.208 -0.451 . . . . 0.46 111.124 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.706 HD21 HD23 ' A' ' 32' ' ' LEU . 1.9 pp -91.38 -36.09 14.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.35 110.84 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.775 HG21 HG12 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -98.06 -45.92 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.42 111.176 -179.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.74 -15.8 42.9 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 0.58 112.532 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.36 -62.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 2.27 110.945 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -107.02 -33.8 7.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 2.33 110.99 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.08 -134.54 5.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.689 -0.767 . . . . 0.34 112.481 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 43.8 ttt85 -154.15 152.3 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.871 0.367 . . . . 3.63 110.937 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 33' ' ' GLN . 98.9 t -136.32 123.71 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.25 111.12 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.4 t -113.22 153.85 27.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 0.16 110.834 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.97 132.41 64.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.16 111.22 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -142.25 152.46 43.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.114 -0.494 . . . . 1.31 110.925 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -102.7 137.49 40.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.53 110.887 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.04 HD13 HG21 ' A' ' 73' ' ' THR . 12.5 mt -52.46 -43.62 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.51 111.214 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -24.16 61.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 3.69 110.867 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -98.02 16.54 20.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 3.37 110.963 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.852 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -49.42 -28.15 4.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.176 -0.465 . . . . 1.12 110.899 -179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -49.89 -44.11 49.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 1.18 110.995 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -85.82 -14.77 44.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 1.34 110.865 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.482 ' HB3' HD13 ' A' ' 50' ' ' LEU . 23.8 t -60.44 -15.39 26.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 2.04 110.844 -179.863 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.628 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -75.17 52.97 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.46 111.126 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -50.85 -71.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.5 110.893 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.644 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -139.38 -168.32 2.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 1.89 110.813 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -108.46 130.17 55.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.123 -0.489 . . . . 1.73 110.967 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 47.8 72.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 1.17 110.895 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.5 p -126.76 -33.72 2.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 0.29 110.784 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 96.7 m-85 -99.3 118.4 35.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 1.45 110.868 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.37 -20.2 62.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.108 -0.497 . . . . 1.52 110.879 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.5 mt -145.88 144.41 20.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.22 111.126 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.784 HG21 HG23 ' A' ' 83' ' ' ILE . 21.3 mm -137.29 130.22 43.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.2 111.134 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -111.47 137.63 49.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.2 110.894 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.8 OUTLIER -129.52 97.56 4.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.3 110.889 -179.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.65 73.68 0.35 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.745 -0.74 . . . . 0.4 112.465 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.694 HD13 ' OE1' ' A' ' 158' ' ' GLN . 3.9 mm? -95.54 -19.35 19.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 2.12 110.884 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.701 HG13 HD12 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -48.34 152.59 1.52 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.72 . . . . 0.74 111.125 179.792 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.9 123.52 10.13 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.638 2.225 . . . . 0.66 112.33 179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.72 0.21 75.78 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.58 112.454 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.565 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -54.61 146.66 16.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.984 0.421 . . . . 1.32 110.866 -179.749 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.711 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 18.3 p -137.02 109.07 7.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.124 -0.489 . . . . 0.39 111.114 -179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 1.04 HG21 HD13 ' A' ' 47' ' ' ILE . 2.3 m -162.28 140.06 8.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 0.66 111.164 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.092 HD12 HD22 ' A' ' 147' ' ' LEU . 15.8 mt -113.65 105.96 13.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.256 -0.429 . . . . 0.59 110.912 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -79.63 151.06 30.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.34 110.806 179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.8 m -130.94 -177.15 4.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.41 110.831 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.01 69.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 0.44 111.096 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -47.78 84.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.211 -0.45 . . . . 2.46 110.933 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.852 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -70.82 -56.59 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.23 111.15 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 119' ' ' LEU . 60.0 mt -50.95 -39.18 54.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 0.29 110.907 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.95 -56.87 13.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.4 111.089 179.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.628 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -57.02 -41.87 79.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.327 -0.397 . . . . 2.48 110.897 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.784 HG23 HG21 ' A' ' 63' ' ' ILE . 37.2 mm -56.6 -68.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.22 111.134 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.45 -38.23 42.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.26 111.117 179.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.59 -56.07 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 2.31 110.893 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 56' ' ' LYS . 34.2 pt -77.42 -8.22 11.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.25 111.062 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.417 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.8 OUTLIER -79.24 127.27 31.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.45 110.971 179.886 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -66.54 159.99 69.99 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 2.34 110.916 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 114.15 3.62 Favored 'Trans proline' 0 C--N 1.34 0.082 0 C-N-CA 122.632 2.221 . . . . 0.16 112.356 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.05 1.98 55.98 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.17 112.51 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -74.78 -164.03 11.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.636 -0.792 . . . . 0.14 112.519 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 60.0 m -135.47 152.3 51.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.801 0.334 . . . . 0.31 110.863 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.714 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -137.0 112.24 9.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.19 110.903 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.515 ' N ' HD22 ' A' ' 93' ' ' LEU . 48.0 m-85 -106.44 133.62 50.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 1.65 110.828 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -148.58 158.78 44.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.152 -0.476 . . . . 0.23 110.955 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.79 125.62 34.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 2.35 110.97 179.724 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.569 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -148.43 146.05 21.79 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.621 0.724 . . . . 2.24 110.864 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.61 140.04 42.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.718 2.279 . . . . 0.22 112.392 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.417 HG13 HG23 ' A' ' 157' ' ' VAL . 9.1 m -126.71 146.76 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.28 111.103 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.405 ' OE2' HG21 ' A' ' 103' ' ' VAL . 0.9 OUTLIER -113.79 132.38 55.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 3.62 110.875 -179.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.0 p -104.29 26.15 9.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 1.2 111.134 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -146.68 23.11 1.26 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.302 -0.408 . . . . 0.53 111.119 179.822 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.462 HG11 ' OG ' ' A' ' 107' ' ' SER . 3.8 t -145.02 159.45 13.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.74 111.127 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.571 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -52.04 169.53 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 1.91 110.809 179.926 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -64.25 -49.73 70.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 2.21 110.987 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -72.62 -75.38 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 2.41 110.93 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.462 ' OG ' HG11 ' A' ' 103' ' ' VAL . 8.5 t 52.0 -169.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 2.32 110.8 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.41 -3.23 48.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 1.65 110.948 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.7 m -145.2 141.14 22.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 0.47 111.116 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.37 114.17 3.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 2.22 110.846 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.571 HG21 ' O ' ' A' ' 104' ' ' ASP . 44.0 p -83.55 177.61 8.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.223 -0.444 . . . . 0.2 111.125 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.95 -53.93 49.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.17 111.041 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.29 -49.68 76.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.229 -0.441 . . . . 0.22 110.903 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 tmtt? -56.29 -40.22 73.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 1.69 110.806 179.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.569 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.4 tm? -63.75 -55.04 26.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.31 110.954 179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.4 m -57.58 -46.27 84.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.26 110.865 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.425 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -64.42 -42.96 95.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.3 110.883 -179.764 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.63 -43.74 92.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.26 111.137 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.617 ' HA ' HD13 ' A' ' 80' ' ' LEU . 15.7 tp -62.7 -52.83 61.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.26 110.901 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.8 m -61.8 -35.52 78.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.27 111.147 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 117' ' ' SER . 17.3 mt -81.59 -10.4 59.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.56 110.919 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.83 5.19 29.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 1.75 110.842 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.21 -2.47 35.07 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.772 -0.728 . . . . 0.51 112.465 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -96.13 169.87 9.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.815 0.341 . . . . 0.28 110.98 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.429 HG23 ' HG3' ' A' ' 126' ' ' GLU . 29.0 m -151.05 171.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.32 111.128 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.429 ' HG3' HG23 ' A' ' 125' ' ' VAL . 2.9 mt-10 56.93 43.61 24.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 2.03 110.905 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.4 t -75.19 142.83 14.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.112 -0.495 . . . . 0.39 111.128 179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.63 156.38 6.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 1.73 110.938 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -82.17 145.36 30.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 2.13 110.874 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.431 HD11 ' N ' ' A' ' 160' ' ' THR . 1.5 mp -105.76 -35.22 7.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.28 110.95 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.601 ' NE2' HE21 ' A' ' 158' ' ' GLN . 0.7 OUTLIER -166.17 176.64 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 1.31 110.906 179.883 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 9.7 mtm180 -125.41 166.12 17.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.116 -0.493 . . . . 8.3 110.875 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -146.91 134.22 10.22 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.684 0.754 . . . . 1.52 110.876 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 157.56 60.07 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.629 2.219 . . . . 0.44 112.369 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.679 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -94.46 129.59 41.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.38 110.95 179.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.592 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.2 OUTLIER -112.68 162.74 20.21 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.52 0.676 . . . . 1.39 111.151 179.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.65 -22.66 32.24 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.642 2.228 . . . . 0.63 112.397 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -85.03 -25.76 27.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 2.64 110.964 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -88.58 -52.73 5.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.111 -0.495 . . . . 2.63 110.794 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -49.77 -39.05 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.465 . . . . 0.48 111.101 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.08 -33.86 75.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 1.2 110.941 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.02 -46.6 67.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.951 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.683 HG23 HD13 ' A' ' 147' ' ' LEU . 8.8 p -68.11 -30.86 49.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.21 111.11 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -76.87 -29.99 56.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 2.06 110.92 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -89.64 -21.6 22.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 1.97 110.884 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -95.03 -32.17 13.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.39 110.804 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.092 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -127.04 -54.49 1.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.52 110.857 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.58 14.17 2.17 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.755 -0.736 . . . . 0.52 112.543 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -70.76 121.29 17.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.793 0.33 . . . . 0.85 110.812 -179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -152.17 105.36 3.05 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 2.54 110.863 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.74 172.16 17.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.63 110.816 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.71 -17.27 14.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 1.88 110.917 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -96.89 20.32 11.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 1.61 110.859 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.679 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -93.53 162.67 13.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.37 110.923 179.957 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.632 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -171.2 130.65 0.75 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.445 . . . . 0.36 110.933 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.711 ' CZ ' HG22 ' A' ' 72' ' ' THR . 25.3 m-85 -70.33 135.28 48.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 1.7 110.885 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.417 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.19 142.47 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.36 111.155 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.694 ' OE1' HD13 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -101.09 127.37 47.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 2.09 110.894 -179.981 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -125.33 151.48 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.426 . . . . 0.27 111.188 179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.431 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -130.43 154.59 47.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.222 -0.445 . . . . 0.3 111.107 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.431 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -142.89 131.39 4.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.755 -0.736 . . . . 0.19 112.467 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -91.63 131.63 36.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 3.59 110.918 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.81 135.44 77.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.615 0.721 . . . . 1.65 110.963 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 131.47 21.35 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.731 2.288 . . . . 0.47 112.365 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -111.85 150.2 30.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.44 110.824 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.01 72.35 2.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.463 . . . . 7.32 110.888 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.39 32.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 10.07 110.903 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.3 m -151.3 -178.58 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 6.6 111.13 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -132.07 25.12 3.94 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.666 -0.778 . . . . 7.15 112.5 179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.17 -74.31 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.891 0.377 . . . . 8.48 110.848 -179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.98 -73.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 6.18 110.942 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 8.18 110.821 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.715 ' O ' HD12 ' A' ' 6' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.821 0.343 . . . . 5.82 110.849 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.39 -14.94 60.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 1.11 111.129 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.93 -40.91 70.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 1.96 110.901 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' CD2' HD11 ' A' ' 6' ' ' ILE . 9.8 m-85 -122.34 16.95 10.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 1.54 110.767 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.74 39.14 96.29 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.779 -0.724 . . . . 0.36 112.439 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.814 HD13 HD21 ' A' ' 32' ' ' LEU . 1.6 mp -80.89 156.06 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.884 0.373 . . . . 0.37 111.128 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.73 161.38 38.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.155 -0.475 . . . . 1.66 110.879 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -89.54 134.9 33.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 0.38 111.088 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.64 -1.66 30.61 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.719 -0.753 . . . . 0.26 112.501 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -117.14 173.26 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 1.13 110.868 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.4 116.3 31.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 1.34 110.919 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG22 ' HB ' ' A' ' 62' ' ' ILE . 97.3 t -119.58 129.38 75.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.464 . . . . 1.94 111.124 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.778 ' HB3' HD13 ' A' ' 63' ' ' ILE . . . -107.33 126.41 52.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.24 111.122 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.74 HG11 HG12 ' A' ' 29' ' ' VAL . 98.1 t -98.9 119.41 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.2 111.094 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.3 t -102.31 117.58 47.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.157 -0.474 . . . . 0.18 111.108 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -118.02 169.91 9.28 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.235 -0.438 . . . . 0.23 110.9 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.408 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 9.6 p-10 -151.65 -169.87 3.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 1.74 110.837 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -58.21 -35.55 71.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.159 -0.473 . . . . 3.0 110.883 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -73.9 -8.15 55.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 1.24 110.873 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.71 95.25 11.78 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.651 0.739 . . . . 0.19 110.873 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 141.57 45.27 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.628 2.219 . . . . 0.33 112.326 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.02 -32.84 5.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.479 . . . . 0.31 111.154 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -50.98 -52.8 38.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 2.4 110.903 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.52 -44.6 11.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.29 111.085 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.447 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -52.6 -61.69 2.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.21 110.99 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.82 -36.57 27.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 2.25 110.962 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.36 -47.75 49.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 0.21 112.534 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.6 mt -61.55 -39.97 93.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.832 0.349 . . . . 0.64 110.918 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 HG11 ' A' ' 14' ' ' VAL . 17.1 m -76.9 -30.71 18.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.64 111.18 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.82 -59.84 4.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 1.63 110.909 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -40.08 70.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 1.91 110.881 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.919 HD23 HD21 ' A' ' 35' ' ' LEU . 85.8 mt -73.27 -25.7 60.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.27 110.825 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.624 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.0 mt-30 -77.1 -24.06 51.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.309 -0.405 . . . . 0.42 110.935 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.13 -32.22 15.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.27 111.133 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.919 HD21 HD23 ' A' ' 32' ' ' LEU . 1.7 pp -88.31 -36.51 16.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.3 110.87 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.2 m -96.64 -47.09 6.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.47 111.11 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.34 -15.58 45.91 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.753 -0.737 . . . . 0.48 112.523 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -56.07 -62.59 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.779 0.323 . . . . 1.93 110.898 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -107.19 -33.26 7.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 2.71 110.88 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.22 -131.52 4.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.734 -0.746 . . . . 0.3 112.522 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -156.35 153.08 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.86 0.362 . . . . 3.92 110.798 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 33' ' ' GLN . 97.7 t -134.93 126.51 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.25 111.169 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.8 t -116.5 152.62 33.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.28 110.827 -179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.5 p -116.03 131.77 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.19 111.069 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -139.23 150.97 46.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 1.38 110.87 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -103.44 135.18 45.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.4 110.876 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.681 ' CD1' HG21 ' A' ' 73' ' ' THR . 36.4 mt -53.69 -34.18 24.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.31 111.09 179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -31.7 63.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.46 . . . . 2.23 110.937 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -100.84 19.7 16.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 3.7 110.893 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.821 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.26 -26.94 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 1.08 110.885 -179.937 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.5 mp -52.26 -38.49 58.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.226 -0.443 . . . . 1.06 110.911 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 -84.5 -14.36 49.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.169 -0.469 . . . . 1.08 110.906 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.654 ' HB3' HD13 ' A' ' 50' ' ' LEU . 19.6 t -60.08 -15.19 21.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 2.2 110.805 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.405 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -75.17 53.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.44 111.111 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -53.56 -70.77 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.65 110.922 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.673 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -141.68 -168.26 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 1.08 110.888 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -107.74 129.87 55.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.3 -0.409 . . . . 1.73 110.901 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 48.19 75.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 1.25 110.88 -179.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.0 p -129.65 -34.15 1.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.22 110.843 -179.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 13' ' ' ALA . 99.6 m-85 -99.73 118.06 35.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 1.44 110.842 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -69.07 -20.08 64.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 1.48 110.857 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.685 ' HB ' HG22 ' A' ' 12' ' ' VAL . 22.8 mt -147.8 143.6 19.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.23 111.134 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.861 HG21 HG23 ' A' ' 83' ' ' ILE . 18.5 mm -133.92 132.69 56.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.254 -0.43 . . . . 0.14 111.162 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.6 mm? -113.8 137.64 51.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.19 110.847 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.23 98.35 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 0.16 110.814 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.59 74.41 0.29 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.818 -0.706 . . . . 0.18 112.469 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.45 61.41 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.352 . . . . 0.58 110.883 -179.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.444 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -129.34 159.93 66.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 0.34 111.204 179.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 115.82 4.26 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.66 2.24 . . . . 0.32 112.409 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.71 7.65 68.56 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.73 -0.748 . . . . 0.22 112.51 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.4 150.93 10.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.73 110.858 -179.729 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.764 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 36.1 p -139.72 108.18 5.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.23 111.196 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.681 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -162.51 156.18 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.29 111.126 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.002 HD12 HD22 ' A' ' 147' ' ' LEU . 5.7 mt -133.85 109.6 9.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.24 110.844 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -86.51 153.92 21.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 0.28 110.869 179.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 m -131.78 -175.75 3.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.39 110.766 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.16 -36.54 70.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.27 111.031 -179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.39 -45.94 88.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 2.08 110.899 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.821 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -73.02 -55.27 13.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.23 111.146 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 119' ' ' LEU . 65.7 mt -50.33 -44.8 54.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 0.28 110.874 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.59 -53.8 34.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.475 . . . . 0.39 111.012 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.405 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -55.32 -43.37 74.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 2.88 110.904 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.861 HG23 HG21 ' A' ' 63' ' ' ILE . 41.9 mm -57.12 -67.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.097 -0.501 . . . . 0.25 111.168 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.05 -36.58 40.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.24 111.132 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 21.2 tpp85 -56.74 -50.67 71.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 2.5 110.846 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.673 HG22 ' O ' ' A' ' 56' ' ' LYS . 37.2 pt -84.29 -6.02 9.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.19 111.12 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.7 OUTLIER -81.14 123.34 28.34 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.237 -0.438 . . . . 0.29 110.926 179.819 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.5 mtt-85 -61.85 159.08 38.29 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.555 0.693 . . . . 3.19 110.869 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.407 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.7 Cg_endo -69.76 114.2 3.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.688 2.259 . . . . 0.2 112.326 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.74 4.28 54.64 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.71 -0.757 . . . . 0.23 112.496 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.72 -164.31 22.79 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.787 -0.72 . . . . 0.18 112.485 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 53.8 m -136.25 151.06 49.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.808 0.337 . . . . 0.37 110.86 -179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.602 HD22 ' N ' ' A' ' 94' ' ' PHE . 2.1 tm? -134.02 127.45 32.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.175 -0.466 . . . . 0.48 110.94 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.602 ' N ' HD22 ' A' ' 93' ' ' LEU . 59.2 m-85 -122.72 133.54 54.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 1.85 110.872 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.482 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.1 pp -148.65 163.69 36.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.47 . . . . 0.23 110.913 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.02 129.87 30.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.217 -0.447 . . . . 2.79 110.972 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.88 148.59 19.63 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.742 0.782 . . . . 3.63 110.873 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 136.51 33.23 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.645 2.23 . . . . 0.31 112.382 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 157' ' ' VAL . 11.9 m -120.66 146.83 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.2 111.202 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.44 ' CD ' HG21 ' A' ' 103' ' ' VAL . 62.2 mt-10 -110.48 132.97 53.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 1.92 110.901 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 23.0 p -91.41 -40.7 11.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 1.25 111.135 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.52 38.28 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.56 111.166 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.44 HG21 ' CD ' ' A' ' 100' ' ' GLU . 22.0 t -147.53 149.92 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.64 111.121 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.634 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -53.31 173.05 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 1.82 110.793 179.888 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -67.15 -53.37 31.18 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.167 -0.47 . . . . 2.92 110.94 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -75.56 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 1.91 110.862 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.67 -169.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.164 -0.471 . . . . 1.52 110.894 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.691 ' HG3' HG13 ' A' ' 109' ' ' VAL . 17.0 pttt -80.51 -4.86 55.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 3.15 110.922 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.691 HG13 ' HG3' ' A' ' 108' ' ' LYS . 2.7 m -139.92 148.21 23.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.4 111.16 179.86 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.443 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.5 tppt? -69.14 115.06 7.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 2.2 110.875 179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.634 HG21 ' O ' ' A' ' 104' ' ' ASP . 48.7 p -87.83 -178.33 6.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.33 111.153 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.78 64.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.32 111.151 179.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.27 -49.46 77.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.46 110.854 -179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.56 -43.21 71.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 1.87 110.883 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.499 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.3 tm? -61.8 -55.74 26.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.54 110.975 179.844 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.9 m -55.3 -46.81 76.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.27 110.894 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -44.23 94.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.46 110.892 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 80' ' ' LEU . . . -62.21 -49.81 74.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.071 -0.513 . . . . 0.42 111.106 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.603 ' HA ' HD13 ' A' ' 80' ' ' LEU . 12.8 tp -57.55 -52.46 65.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.245 -0.434 . . . . 0.3 110.923 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 92.0 m -64.21 -29.04 70.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.3 111.198 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.1 mt -81.11 -16.27 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.8 110.835 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.2 p -82.32 3.2 28.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 2.62 110.859 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.46 -4.94 35.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.804 -0.712 . . . . 0.86 112.502 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -83.97 169.02 15.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.31 110.927 -179.911 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.52 170.25 2.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.37 111.126 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 53.4 44.48 29.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 2.23 110.956 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.8 142.54 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.29 111.109 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.15 160.04 7.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.18 -0.464 . . . . 1.79 110.868 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -79.86 140.73 36.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 2.87 110.956 179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.746 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.4 mp -98.6 -37.28 9.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.31 110.926 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -163.16 176.78 9.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.194 -0.457 . . . . 1.38 110.917 179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 20.1 mtt-85 -125.63 167.01 15.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 8.44 110.875 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -149.7 134.22 9.23 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.662 0.744 . . . . 1.81 110.898 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 156.54 63.08 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.703 2.269 . . . . 0.35 112.38 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.67 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -89.6 154.1 20.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.71 110.92 179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.601 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -138.07 163.28 48.87 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 121.56 0.695 . . . . 1.6 111.111 179.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 136' ' ' THR . 53.2 Cg_endo -69.78 -23.75 30.37 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.706 2.271 . . . . 0.47 112.32 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -85.66 -24.66 26.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 3.99 110.954 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -88.13 -53.85 4.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 4.08 110.931 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.601 HG12 ' O ' ' A' ' 136' ' ' THR . 7.1 p -50.59 -39.15 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.23 111.112 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -68.02 -34.03 75.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 1.24 110.916 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -46.48 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.29 110.854 -179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.696 HG23 HD13 ' A' ' 147' ' ' LEU . 8.6 p -67.73 -30.95 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.495 . . . . 0.19 111.131 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -77.22 -29.97 54.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 2.16 110.866 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -89.37 -21.85 22.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.256 -0.429 . . . . 1.82 110.813 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 12.4 m170 -95.04 -31.97 13.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.32 110.814 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.002 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -127.25 -54.67 1.37 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.257 -0.429 . . . . 0.36 110.87 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.93 13.09 2.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.682 -0.771 . . . . 0.37 112.437 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.404 ' CG ' HG11 ' A' ' 109' ' ' VAL . 15.5 t-160 -70.55 122.23 19.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.719 0.295 . . . . 0.61 110.803 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -151.38 105.57 3.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 2.92 110.924 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.5 t -158.35 171.28 20.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.58 110.86 -179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.09 -17.12 14.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 2.01 110.786 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -99.28 21.29 12.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.299 -0.41 . . . . 1.65 110.866 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -90.4 166.14 13.45 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.45 . . . . 0.27 111.016 179.928 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.67 ' HA ' HD23 ' A' ' 135' ' ' LEU . 2.7 tm? -172.03 130.31 0.63 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.285 -0.416 . . . . 0.2 110.841 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.764 ' CZ ' HG22 ' A' ' 72' ' ' THR . 24.1 m-85 -72.6 133.74 44.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 1.74 110.87 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.407 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.07 157.19 17.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.37 111.068 179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.746 ' HG2' HD13 ' A' ' 130' ' ' LEU . 10.5 tt0 -113.57 133.56 55.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 2.2 110.905 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.94 152.32 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.24 111.132 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.431 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.7 t -136.29 163.62 29.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 0.26 111.172 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -153.98 136.76 5.4 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.753 -0.737 . . . . 0.21 112.491 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -94.92 142.67 27.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.804 0.335 . . . . 1.78 110.925 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 13.4 tptm -82.8 135.55 45.57 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.574 0.702 . . . . 1.82 110.935 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 118.89 5.95 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.727 2.285 . . . . 0.46 112.41 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -104.05 152.81 21.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.62 110.878 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -69.35 85.01 0.4 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 6.53 110.9 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -179.39 34.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 10.69 110.968 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 89.6 t -131.73 -74.98 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 7.27 111.157 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 178.9 31.19 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.788 -0.72 . . . . 6.1 112.488 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 63.41 -169.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.88 0.371 . . . . 8.25 110.816 -179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 63.66 -178.1 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.493 . . . . 7.38 110.87 -179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 6.13 110.88 -179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' HD12 ' A' ' 6' ' ' ILE . 6.6 ptt? . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.836 0.35 . . . . 3.6 110.956 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.09 -18.3 62.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.67 111.055 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.99 -51.22 70.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.414 . . . . 2.37 110.857 179.884 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.472 ' HB2' HD11 ' A' ' 6' ' ' ILE . 12.4 m-85 -122.14 24.31 9.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.22 -0.445 . . . . 2.08 110.899 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.45 44.54 53.25 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.81 -0.709 . . . . 0.51 112.426 -179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 4' ' ' PHE . 1.0 OUTLIER -88.53 163.55 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.784 0.326 . . . . 0.5 111.17 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.628 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -151.22 163.6 38.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 1.47 110.811 -179.947 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.33 134.31 34.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.34 111.086 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.52 2.41 32.88 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.723 -0.751 . . . . 0.28 112.439 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -118.43 172.42 7.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.806 0.336 . . . . 1.04 110.955 -179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -106.18 114.29 28.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.305 -0.407 . . . . 2.14 110.891 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.632 HG22 ' HB ' ' A' ' 62' ' ' ILE . 92.6 t -117.06 133.9 62.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 1.87 111.101 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.758 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -111.45 125.91 54.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.21 111.092 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.691 HG11 HG12 ' A' ' 29' ' ' VAL . 95.2 t -98.04 122.22 49.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.231 -0.441 . . . . 0.2 111.223 179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.422 HG12 ' CG1' ' A' ' 47' ' ' ILE . 18.7 t -105.93 114.83 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.21 111.169 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -115.58 168.93 9.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.17 110.956 -179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -151.08 -170.34 3.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 1.9 110.82 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.8 tttt -57.0 -35.89 69.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 3.63 110.912 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -73.14 -10.38 59.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 1.71 110.839 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -107.61 93.41 10.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.683 0.754 . . . . 0.24 110.851 -179.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.7 143.11 50.06 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.615 2.21 . . . . 0.36 112.38 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.0 t -48.96 -32.08 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.25 111.061 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.62 -53.69 35.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 2.33 110.888 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB1' HG12 ' A' ' 68' ' ' VAL . . . -87.69 -44.7 10.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.33 111.114 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -50.18 -59.58 3.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.28 110.904 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.9 tppt? -48.26 -32.84 7.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 4.79 110.868 179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.37 -46.41 33.65 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.749 . . . . 0.54 112.48 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.642 HD12 HG13 ' A' ' 68' ' ' VAL . 14.0 mt -61.96 -35.63 79.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.909 0.385 . . . . 1.37 110.903 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.691 HG12 HG11 ' A' ' 14' ' ' VAL . 22.0 m -80.93 -32.94 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.64 111.109 179.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -61.6 -54.61 40.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 1.68 110.904 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.499 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -57.19 -36.89 71.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 2.52 110.836 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.706 HD23 HD21 ' A' ' 35' ' ' LEU . 60.1 mt -76.9 -25.01 52.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.91 110.96 179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.579 ' HA ' HG21 ' A' ' 42' ' ' VAL . 4.8 mt-30 -78.18 -26.13 47.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.461 . . . . 0.49 110.927 179.949 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.52 -31.67 15.86 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.52 111.105 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.706 HD21 HD23 ' A' ' 32' ' ' LEU . 1.3 pp -89.36 -35.86 15.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.59 110.985 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.7 -47.16 4.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.113 -0.494 . . . . 0.28 111.101 179.97 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.91 -15.36 42.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.769 -0.729 . . . . 0.36 112.495 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.06 -62.85 1.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.796 0.331 . . . . 1.84 110.846 -179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -105.82 -34.77 7.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 2.76 110.817 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.5 -127.3 2.14 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.822 -0.704 . . . . 0.29 112.493 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 62.7 ttt-85 -157.52 151.27 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.886 0.374 . . . . 3.84 110.782 -179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.579 HG21 ' HA ' ' A' ' 33' ' ' GLN . 88.3 t -136.24 120.13 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.31 111.167 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.7 t -110.34 155.44 22.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.15 110.879 -179.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.7 p -118.47 134.7 61.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.15 111.139 179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -143.46 151.83 40.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 1.3 110.932 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -103.01 135.98 43.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.44 110.812 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.665 ' CD1' HG21 ' A' ' 73' ' ' THR . 25.3 mt -52.17 -35.31 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.25 111.102 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -74.96 -29.24 60.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 1.97 110.905 179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -99.5 18.49 17.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 3.4 110.908 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.83 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.56 -30.47 5.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 1.13 110.901 -179.981 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.1 mp -54.32 -37.35 64.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 1.07 110.882 179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -84.82 -15.52 44.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 1.08 110.864 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.9 m -66.63 -10.37 45.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.95 110.894 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.02 63.47 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.28 111.091 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -62.03 -69.34 0.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 0.35 110.795 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.66 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -153.38 -175.76 5.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 2.17 110.903 -179.979 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -93.84 135.12 35.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.421 . . . . 1.94 110.917 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p 46.42 82.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.423 . . . . 1.12 110.87 -179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 88.3 p -133.57 -38.35 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.3 110.893 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.479 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.0 m-85 -102.0 122.72 44.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.125 -0.489 . . . . 1.44 110.821 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.87 -23.19 62.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.059 -0.519 . . . . 1.5 110.841 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.632 ' HB ' HG22 ' A' ' 12' ' ' VAL . 19.4 mt -145.04 143.02 22.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 0.27 111.108 179.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.773 HG21 HG23 ' A' ' 83' ' ' ILE . 20.3 mm -132.75 133.74 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.16 111.097 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.8 mm? -114.21 135.94 53.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.21 110.943 179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.32 97.47 4.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 0.29 110.894 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 50.15 73.28 0.38 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.719 -0.753 . . . . 0.39 112.554 -179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.417 HD11 ' HB3' ' A' ' 94' ' ' PHE . 4.1 mm? -93.97 -19.14 21.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.87 0.367 . . . . 2.16 110.971 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.768 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.2 OUTLIER -47.54 151.12 1.51 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.659 0.742 . . . . 0.69 111.113 179.807 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.85 135.38 30.09 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.657 2.238 . . . . 0.71 112.298 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.92 1.4 78.78 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.702 -0.761 . . . . 0.38 112.437 179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.768 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.3 OUTLIER -54.62 154.63 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.991 0.424 . . . . 1.37 110.815 -179.739 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.733 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 28.4 p -140.86 109.4 5.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.16 111.106 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.665 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -160.72 154.19 22.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.23 111.241 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.996 HD12 HD22 ' A' ' 147' ' ' LEU . 6.3 mt -130.93 107.35 9.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 0.23 110.896 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -84.2 153.88 23.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.28 110.893 179.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.3 m -131.8 -176.15 3.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.39 110.845 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.68 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.28 111.171 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -62.52 -45.99 90.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 2.08 110.884 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.83 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.5 mp -73.7 -54.96 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.097 -0.501 . . . . 0.23 111.109 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 119' ' ' LEU . 59.9 mt -50.66 -41.12 55.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.23 110.898 179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.0 -54.86 24.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.3 111.139 179.835 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.45 -43.33 83.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 2.38 110.936 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.773 HG23 HG21 ' A' ' 63' ' ' ILE . 43.2 mm -56.24 -68.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.19 111.202 179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.91 -36.66 39.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.146 -0.479 . . . . 0.21 111.152 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.3 tpp85 -56.24 -51.76 66.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 2.06 110.871 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 56' ' ' LYS . 25.8 pt -83.13 -6.62 10.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.2 111.093 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.4 OUTLIER -79.13 112.88 16.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.34 110.932 179.879 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -51.82 159.51 1.33 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.662 0.744 . . . . 2.24 110.791 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.61 114.59 3.73 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.666 2.244 . . . . 0.2 112.413 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.35 3.65 56.47 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.68 -0.772 . . . . 0.14 112.479 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.16 -157.97 8.9 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.767 -0.73 . . . . 0.13 112.545 -179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 10.5 m -144.2 156.07 44.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.868 0.365 . . . . 0.45 110.874 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.681 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.5 112.74 8.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.25 110.949 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.549 ' N ' HD22 ' A' ' 93' ' ' LEU . 45.5 m-85 -105.42 133.01 50.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 1.7 110.842 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.615 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.5 164.15 35.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.17 110.904 -179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.23 123.94 19.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 2.53 110.82 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -145.61 150.93 45.26 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 3.64 110.946 179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.603 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.5 Cg_endo -69.83 138.21 37.06 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.641 2.227 . . . . 0.22 112.365 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.2 m -122.31 147.28 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.29 111.061 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.423 ' OE2' HG21 ' A' ' 103' ' ' VAL . 13.2 mt-10 -114.76 132.59 56.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 1.98 110.859 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.7 p -104.4 25.98 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 1.1 111.093 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -148.68 23.56 0.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.71 111.053 179.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.423 HG21 ' OE2' ' A' ' 100' ' ' GLU . 3.4 t -144.4 160.47 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.72 111.19 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.587 ' O ' HG21 ' A' ' 111' ' ' THR . 0.2 OUTLIER -55.94 179.87 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 1.93 110.854 -179.989 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -68.07 -60.42 2.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 1.94 110.808 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -64.61 -75.85 0.08 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 2.28 110.886 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.93 -168.66 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 1.58 110.878 -179.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.37 -5.0 55.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 1.92 110.972 179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.06 140.43 21.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.6 111.17 179.813 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.584 ' H ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -61.54 119.15 8.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.471 . . . . 2.22 110.944 179.841 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.587 HG21 ' O ' ' A' ' 104' ' ' ASP . 49.0 p -89.07 175.31 7.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.26 111.195 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.55 -55.13 38.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.25 111.123 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.3 m -61.05 -47.96 83.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.43 110.865 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -58.1 -40.96 82.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 1.69 110.864 179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.5 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -62.96 -57.37 10.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.252 -0.431 . . . . 0.42 110.863 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 61.9 m -51.72 -44.71 63.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.3 110.945 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.05 -42.12 85.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.35 110.914 -179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.74 97.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 0.24 111.073 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.644 HD11 HD12 ' A' ' 93' ' ' LEU . 14.7 tp -66.36 -51.74 54.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.27 110.92 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -62.39 -32.23 73.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.15 -0.477 . . . . 0.31 111.146 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.09 -10.73 52.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.72 110.889 179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.34 4.62 30.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 1.7 110.855 -179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.47 10.0 28.07 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.784 -0.722 . . . . 0.53 112.45 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.681 HD21 ' HB3' ' A' ' 93' ' ' LEU . 1.0 OUTLIER -110.3 171.63 7.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.3 110.946 -179.95 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 m -150.01 173.04 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.27 111.088 179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 51.73 44.92 28.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 2.06 110.927 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.417 HG13 HD23 ' A' ' 119' ' ' LEU . 96.5 t -81.6 141.73 14.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.22 111.131 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.95 159.07 7.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.116 -0.493 . . . . 1.87 110.983 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.22 139.72 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.286 -0.415 . . . . 3.38 110.959 179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.752 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.2 mp -95.84 -38.17 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.23 110.945 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 10.7 pm0 -157.68 176.37 12.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.452 . . . . 2.99 110.926 179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.726 ' HG2' HD11 ' A' ' 155' ' ' LEU . 1.7 tmt_? -128.1 138.08 52.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.192 -0.458 . . . . 4.33 110.829 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -124.3 136.38 27.61 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.683 0.754 . . . . 1.38 110.853 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 164.75 33.4 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.743 2.295 . . . . 0.25 112.291 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.2 OUTLIER -97.61 125.71 42.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.3 110.9 179.993 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.456 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.0 161.34 23.05 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.528 0.68 . . . . 1.56 111.108 -179.976 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -24.08 29.94 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.628 2.219 . . . . 0.46 112.382 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -85.08 -22.26 29.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.226 -0.443 . . . . 2.6 110.944 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -87.76 -54.6 4.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 2.38 110.832 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 136' ' ' THR . 7.7 p -49.03 -39.12 11.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.34 111.116 -179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -37.86 80.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 2.78 110.865 -179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -46.91 75.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.32 110.888 -179.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.682 HG23 HD13 ' A' ' 147' ' ' LEU . 10.8 p -67.37 -30.67 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 0.27 111.131 179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 41.1 ttt85 -75.95 -30.63 58.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 3.55 110.864 -179.863 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -90.06 -20.51 23.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 1.89 110.887 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.5 -32.69 13.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.34 110.871 179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.996 HD22 HD12 ' A' ' 74' ' ' LEU . 2.4 mp -127.9 -53.86 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.192 -0.458 . . . . 0.49 110.982 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 129.79 15.21 1.97 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.776 -0.726 . . . . 0.47 112.541 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 22.2 t-160 -70.92 121.69 18.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.768 0.318 . . . . 0.98 110.891 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -152.11 105.53 3.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 2.34 110.833 -179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -160.66 175.79 12.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.478 . . . . 0.76 110.777 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.24 -21.89 12.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 1.72 110.842 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -91.4 13.29 17.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 1.54 110.965 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.664 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.54 164.63 21.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 0.42 110.89 179.923 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.5 tm? -173.72 130.09 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.2 110.902 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.733 ' CZ ' HG22 ' A' ' 72' ' ' THR . 27.1 m-85 -76.08 137.99 40.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 1.72 110.925 179.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -150.45 150.06 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.26 111.128 179.959 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.752 ' HG2' HD13 ' A' ' 130' ' ' LEU . 11.3 tt0 -103.49 133.91 47.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 2.16 110.896 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.43 147.35 33.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.28 111.126 179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.513 ' N ' HD11 ' A' ' 130' ' ' LEU . 5.4 t -132.63 148.97 52.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.48 111.024 -179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -139.99 135.4 7.12 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.71 -0.757 . . . . 0.14 112.519 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -90.89 140.09 30.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.884 0.373 . . . . 1.74 110.836 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 135.04 51.38 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.635 0.731 . . . . 1.24 110.872 179.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 124.03 10.67 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.644 2.229 . . . . 0.29 112.38 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -104.1 150.78 24.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.33 110.942 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -76.45 66.76 2.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 7.27 110.894 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -109.74 30.27 6.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.115 -0.493 . . . . 10.12 110.843 -179.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.5 t -149.66 -72.56 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.202 -0.454 . . . . 7.67 111.117 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 167.7 -26.85 0.15 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.731 . . . . 8.31 112.483 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.28 126.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.957 0.408 . . . . 9.42 110.758 -179.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.81 -74.34 0.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.105 -0.498 . . . . 7.19 110.776 -179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 8.7 tpm_? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 8.04 110.867 -179.895 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.741 0.305 . . . . 3.58 110.899 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.94 -21.95 65.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.55 111.127 179.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.06 -51.58 63.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 2.15 110.865 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -122.27 21.55 10.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 2.02 110.912 -179.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.67 38.91 59.85 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.721 . . . . 0.29 112.502 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.467 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.8 mp -76.97 158.12 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.915 0.388 . . . . 0.28 111.126 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 36' ' ' THR . 18.5 m -149.62 157.02 42.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.177 -0.465 . . . . 1.05 110.8 -179.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.53 125.59 33.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.13 -0.486 . . . . 0.35 111.063 179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.95 -6.2 23.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.69 -0.767 . . . . 0.31 112.53 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.05 167.57 10.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.758 0.313 . . . . 1.5 110.917 -179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.66 136.33 39.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 1.3 110.841 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.536 HG12 HG21 ' A' ' 36' ' ' THR . 1.8 p -141.03 136.89 34.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 2.14 111.087 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.745 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -112.3 124.14 51.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.23 111.159 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.85 HG11 HG12 ' A' ' 29' ' ' VAL . 65.7 t -94.69 116.97 37.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.2 111.121 -179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.531 HG12 ' CG1' ' A' ' 47' ' ' ILE . 14.5 t -101.31 112.05 33.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.22 111.15 179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -114.52 165.85 12.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.23 110.967 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HB3' HD12 ' A' ' 47' ' ' ILE . 10.3 p-10 -147.36 -170.54 3.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.305 -0.407 . . . . 1.87 110.916 179.926 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -56.95 -35.94 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 4.09 110.815 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.2 t -72.61 -9.31 58.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 1.3 110.804 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -107.16 94.04 10.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.703 0.763 . . . . 0.15 110.838 -179.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 142.3 47.64 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.691 2.261 . . . . 0.21 112.335 179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.9 t -48.74 -32.94 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 0.21 111.149 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.84 -53.06 35.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 2.52 110.874 -179.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.57 -44.88 10.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.18 111.095 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -51.96 -61.7 2.1 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.15 110.81 -179.947 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.72 -36.76 26.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 2.59 110.89 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.38 -47.75 49.32 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.74 . . . . 0.21 112.478 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 mt -61.72 -40.44 95.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.875 0.369 . . . . 0.49 110.921 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.85 HG12 HG11 ' A' ' 14' ' ' VAL . 16.9 m -75.92 -31.68 22.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.65 111.087 179.892 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -61.92 -60.46 3.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 1.7 110.916 179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -40.16 71.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 1.73 110.802 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.909 HD23 HD21 ' A' ' 35' ' ' LEU . 77.2 mt -72.7 -24.69 61.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.25 110.935 179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.475 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.47 -24.96 45.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.283 -0.417 . . . . 0.39 110.927 179.914 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.72 -29.93 17.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.22 111.093 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.909 HD21 HD23 ' A' ' 32' ' ' LEU . 1.5 pp -91.61 -35.23 14.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.22 110.873 -179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.536 HG21 HG12 ' A' ' 12' ' ' VAL . 0.9 OUTLIER -102.46 -44.9 5.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 0.23 111.053 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.97 -11.18 54.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.793 -0.718 . . . . 0.25 112.512 179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.3 -62.44 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.685 0.278 . . . . 2.96 110.775 -179.776 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -91.41 -40.08 11.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 2.25 110.915 -179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.92 -125.86 4.87 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.756 -0.735 . . . . 0.27 112.49 -179.975 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -156.37 152.88 28.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.885 0.374 . . . . 2.16 110.846 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 33' ' ' GLN . 92.3 t -136.91 127.96 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.23 111.104 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.4 t -116.93 152.91 33.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.19 110.823 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.69 132.28 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.09 -0.505 . . . . 0.23 111.197 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -143.54 152.0 40.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 1.28 110.905 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -102.38 137.78 40.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.44 110.886 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.784 HD13 HG21 ' A' ' 73' ' ' THR . 36.8 mt -52.65 -36.74 23.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.27 111.095 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -75.7 -25.18 56.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.168 -0.469 . . . . 2.03 110.862 179.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -103.89 16.15 27.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 3.37 110.981 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.885 HD13 HG23 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -52.49 -24.72 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 2.74 110.91 -179.923 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -51.16 -38.96 55.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.902 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -84.91 -14.2 48.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 1.37 110.907 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.463 ' O ' HG21 ' A' ' 86' ' ' ILE . 19.4 t -58.97 -15.46 13.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 2.4 110.795 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.499 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -74.63 53.18 0.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.56 111.168 179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -51.14 -72.07 0.06 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.14 -0.482 . . . . 0.35 110.865 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.505 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -138.83 -168.24 2.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 1.62 110.926 179.984 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -100.5 121.09 41.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 2.14 110.944 179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 51.05 84.78 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.41 110.842 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 p -132.59 -36.84 1.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.28 110.854 -179.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.465 ' CD2' HD12 ' A' ' 86' ' ' ILE . 98.1 m-85 -96.03 120.4 36.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 1.46 110.878 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -72.39 -20.48 61.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 1.77 110.9 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 6' ' ' ILE . 11.1 mt -143.51 144.28 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.3 111.071 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.014 HG21 HG23 ' A' ' 83' ' ' ILE . 20.9 mm -136.13 126.11 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.14 111.189 179.794 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.5 mm? -108.85 137.41 46.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.25 111.001 179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.62 99.75 5.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 0.14 110.869 -179.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.48 78.93 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.655 -0.783 . . . . 0.18 112.478 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -111.04 58.07 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.908 0.385 . . . . 0.58 110.867 -179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.434 HG23 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -128.09 159.75 65.25 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.676 0.751 . . . . 0.24 111.124 179.811 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.74 115.63 4.18 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.738 2.292 . . . . 0.27 112.294 -180.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 91.69 6.32 65.83 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.679 -0.772 . . . . 0.2 112.515 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.434 ' HB2' HG23 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -55.43 150.21 12.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.035 0.445 . . . . 0.79 110.804 -179.69 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.727 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 22.0 p -140.3 108.86 5.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.22 111.062 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.784 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -163.16 144.18 9.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.29 111.162 179.989 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.009 HD12 HD22 ' A' ' 147' ' ' LEU . 10.4 mt -120.68 99.63 6.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.429 . . . . 0.38 111.032 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -75.69 137.55 40.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.245 -0.434 . . . . 0.4 110.785 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.437 ' H ' HD13 ' A' ' 79' ' ' ILE . 68.0 m -116.99 178.45 4.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.42 110.884 -179.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.57 -44.12 62.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.31 111.059 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.28 -47.75 77.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 1.87 110.912 -179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.885 HG23 HD13 ' A' ' 50' ' ' LEU . 4.2 mp -69.79 -56.53 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.102 -0.499 . . . . 0.23 111.17 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.716 HD13 ' HA ' ' A' ' 119' ' ' LEU . 69.4 mt -50.23 -40.45 47.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.21 110.953 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -52.93 -57.04 11.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.29 111.177 179.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -53.69 -43.09 68.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 2.83 110.903 -179.943 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.014 HG23 HG21 ' A' ' 63' ' ' ILE . 41.7 mm -57.47 -68.84 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.118 -0.492 . . . . 0.19 111.051 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.454 ' HB2' HD13 ' A' ' 124' ' ' LEU . . . -50.3 -37.69 37.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.19 111.117 179.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -53.95 -55.23 29.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 2.85 110.756 -179.847 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 56' ' ' LYS . 49.5 pt -81.29 -5.6 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.22 111.066 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -78.64 117.86 20.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.25 110.874 179.882 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.7 mtt-85 -57.56 158.87 10.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.598 0.713 . . . . 3.01 110.891 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 54.4 Cg_endo -69.65 114.14 3.59 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.26 . . . . 0.19 112.32 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.33 3.58 55.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.801 -0.714 . . . . 0.19 112.46 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.02 -165.62 23.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.83 -0.7 . . . . 0.17 112.542 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 52.3 m -134.84 150.48 50.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.866 0.365 . . . . 0.31 110.896 -179.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.62 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -134.7 115.0 13.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.15 110.963 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.535 ' N ' HD22 ' A' ' 93' ' ' LEU . 54.4 m-85 -110.37 132.47 54.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.21 -0.45 . . . . 1.63 110.792 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 95' ' ' LEU . 1.0 OUTLIER -148.53 159.02 44.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.14 110.871 -179.964 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 130.12 44.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 2.5 110.958 179.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.66 146.89 18.0 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.653 0.74 . . . . 2.33 110.885 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.515 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.9 Cg_endo -69.69 142.23 47.68 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.674 2.25 . . . . 0.23 112.361 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 157' ' ' VAL . 12.4 m -127.05 146.83 32.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.19 111.114 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.453 ' CD ' HG21 ' A' ' 103' ' ' VAL . 50.2 mt-10 -107.84 132.92 52.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.209 -0.45 . . . . 1.95 110.926 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.4 p -92.85 -41.4 10.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 1.09 111.15 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.57 ' HB3' ' CG ' ' A' ' 153' ' ' ASN . . . -93.51 38.53 1.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.75 110.973 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.453 HG21 ' CD ' ' A' ' 100' ' ' GLU . 21.2 t -146.89 150.63 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.76 111.13 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.641 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -53.51 173.17 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.274 -0.421 . . . . 1.82 110.834 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -66.97 -53.7 29.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 2.74 110.91 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -75.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 1.7 110.916 179.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 52.37 -169.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 1.63 110.836 -179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -80.3 -5.34 56.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 2.05 110.966 179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.81 147.91 22.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.48 111.05 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.2 116.08 8.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 2.11 110.908 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.641 HG21 ' O ' ' A' ' 104' ' ' ASP . 51.4 p -88.21 -178.98 6.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.24 111.102 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.18 -52.6 64.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.23 111.111 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.66 -49.63 76.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.284 -0.416 . . . . 0.26 110.939 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -57.1 -44.62 83.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.519 . . . . 1.88 110.888 179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -59.03 -55.45 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.954 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 71.5 m -53.71 -49.12 68.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.37 110.949 179.848 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -45.64 93.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.476 . . . . 0.48 110.862 -179.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -59.82 -44.84 93.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.34 111.116 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.716 ' HA ' HD13 ' A' ' 80' ' ' LEU . 12.5 tp -61.54 -54.12 47.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.35 110.912 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 100.0 m -61.85 -27.7 68.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.53 111.149 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.2 mt -81.01 -17.45 50.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 1.01 110.854 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 p -82.37 3.03 29.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 2.4 110.823 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.38 -4.87 35.28 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.789 -0.72 . . . . 0.56 112.523 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.62 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -84.56 168.13 15.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 0.44 110.916 -179.931 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.501 HG23 ' HG3' ' A' ' 126' ' ' GLU . 27.2 m -150.79 172.97 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.34 111.142 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.501 ' HG3' HG23 ' A' ' 125' ' ' VAL . 36.9 mt-10 53.14 43.05 32.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 2.21 110.912 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 97.1 t -74.89 142.27 14.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.29 111.132 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.78 158.33 7.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 1.65 110.891 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -82.26 147.22 29.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 2.39 110.829 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.775 HD13 ' HG2' ' A' ' 158' ' ' GLN . 1.2 mp -107.78 -36.03 6.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.11 -0.495 . . . . 0.18 111.017 179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -164.6 176.49 8.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.163 -0.471 . . . . 1.29 110.853 179.872 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -126.12 165.76 18.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 8.32 110.867 -179.883 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -148.62 136.34 11.07 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.671 0.748 . . . . 1.39 110.83 -179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 157.13 61.51 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.588 2.192 . . . . 0.36 112.448 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.645 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -93.98 127.58 39.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.31 -0.405 . . . . 0.36 110.933 179.976 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.471 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.56 161.37 23.0 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.544 0.687 . . . . 1.58 111.121 179.983 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -24.85 29.22 Favored 'Trans proline' 0 C--O 1.23 0.103 0 C-N-CA 122.688 2.259 . . . . 0.46 112.325 179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -85.75 -21.99 27.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 3.64 110.922 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -87.5 -53.07 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 2.5 110.93 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 136' ' ' THR . 7.2 p -50.13 -41.36 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.34 111.069 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.4 ' N ' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -65.06 -32.39 74.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.13 110.772 -179.929 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -51.32 24.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.267 -0.424 . . . . 0.58 110.841 -179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.638 HG23 HD13 ' A' ' 147' ' ' LEU . 9.4 p -61.54 -28.39 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.486 . . . . 0.34 111.125 179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -75.99 -48.58 20.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 1.93 110.915 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -73.26 -19.73 61.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 1.84 110.929 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.19 -33.36 13.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.51 110.835 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.009 HD22 HD12 ' A' ' 74' ' ' LEU . 2.2 mp -129.44 -54.09 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.45 110.916 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.57 14.59 1.9 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.688 -0.768 . . . . 0.31 112.513 179.878 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -74.62 120.34 20.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.853 0.359 . . . . 0.62 110.84 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -152.09 105.08 3.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 4.31 110.865 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.04 167.89 25.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.468 . . . . 0.63 110.816 -179.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.77 -6.72 20.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 1.97 110.945 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.57 ' CG ' ' HB3' ' A' ' 102' ' ' ALA . 2.2 m120 -104.08 14.02 31.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 2.78 110.844 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.645 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -90.26 168.95 11.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.258 -0.428 . . . . 0.42 110.919 179.96 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.629 HD13 ' O ' ' A' ' 156' ' ' PHE . 2.5 tm? -173.51 130.27 0.44 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.28 111.013 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.727 ' CZ ' HG22 ' A' ' 72' ' ' THR . 22.7 m-85 -69.38 134.66 49.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 1.88 110.825 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.409 HG23 HG13 ' A' ' 99' ' ' VAL . 0.0 OUTLIER -143.73 143.28 24.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.085 -0.507 . . . . 0.31 111.139 179.976 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.775 ' HG2' HD13 ' A' ' 130' ' ' LEU . 10.4 tt0 -100.79 127.88 47.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 2.28 110.967 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.84 152.18 32.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.21 111.069 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.449 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.1 t -131.54 159.13 39.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.27 111.154 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -149.4 130.19 3.26 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 0.21 112.433 179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -93.0 140.27 29.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.848 0.356 . . . . 1.59 110.919 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 5.3 tptm -81.24 134.27 52.37 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.507 0.67 . . . . 1.38 110.92 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 119.78 6.67 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.625 2.217 . . . . 0.32 112.413 179.77 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -101.54 151.82 21.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.36 110.868 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -63.94 96.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 6.84 110.876 179.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -174.89 32.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 9.73 110.965 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 39.1 t -141.04 -65.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 6.33 111.103 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 174.52 -50.59 0.14 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.624 -0.798 . . . . 6.81 112.42 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.75 -46.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.841 0.353 . . . . 8.17 110.842 -179.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.18 -169.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.135 -0.484 . . . . 7.19 110.897 -179.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.9 tpt85 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 6.25 110.902 -179.844 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.702 0.287 . . . . 3.79 110.782 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.75 -22.78 63.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.5 111.148 179.95 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.35 -51.51 64.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.28 110.858 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.535 ' CE1' HD12 ' A' ' 67' ' ' LEU . 4.6 m-85 -122.16 22.27 10.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.235 -0.439 . . . . 2.03 110.894 -179.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.16 37.82 47.24 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.26 112.527 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.454 HG21 HD22 ' A' ' 32' ' ' LEU . 1.9 mp -73.95 156.42 6.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.791 0.329 . . . . 0.3 111.175 -179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.579 ' O ' HG23 ' A' ' 36' ' ' THR . 57.7 m -147.7 154.73 40.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 1.11 110.897 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.17 125.31 33.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.36 111.177 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.27 -6.56 19.05 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.744 -0.741 . . . . 0.26 112.498 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.8 170.62 7.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.308 . . . . 1.54 110.972 -179.897 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -104.13 112.44 25.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 1.33 110.926 -179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.695 HG12 HG21 ' A' ' 36' ' ' THR . 2.2 p -118.31 131.75 70.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 2.02 111.153 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.753 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -107.26 125.63 51.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.23 111.097 179.85 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.815 HG11 HG12 ' A' ' 29' ' ' VAL . 91.4 t -96.18 117.4 40.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.19 111.24 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 65' ' ' SER . 21.0 t -100.86 119.9 49.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.24 111.102 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 10.1 p-90 -120.0 168.95 10.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 0.19 110.946 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.437 ' HB3' HD12 ' A' ' 47' ' ' ILE . 10.3 p-10 -151.83 -170.28 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 1.91 110.842 179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -57.03 -35.6 69.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 2.93 110.975 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 m -73.62 -9.24 58.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.108 -0.497 . . . . 1.61 110.842 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -106.97 94.2 10.31 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.634 0.731 . . . . 0.17 110.888 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 54.0 Cg_endo -69.75 142.29 47.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.681 2.254 . . . . 0.21 112.386 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.2 t -48.99 -32.61 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.18 111.096 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.13 -53.06 37.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 2.42 110.903 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.66 -44.56 11.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.109 -0.496 . . . . 0.17 111.078 179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.454 HD22 HG13 ' A' ' 29' ' ' VAL . 2.2 tm? -52.07 -61.42 2.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.15 110.908 -179.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.14 -37.6 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 2.81 110.914 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.8 -47.54 54.81 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.712 -0.756 . . . . 0.24 112.409 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.5 mt -61.49 -40.98 96.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.915 0.388 . . . . 0.46 110.937 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.815 HG12 HG11 ' A' ' 14' ' ' VAL . 17.2 m -75.81 -31.42 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.63 111.065 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -61.75 -61.15 2.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 1.57 110.843 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.8 -40.59 69.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 1.74 110.85 -179.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.867 HD23 HD21 ' A' ' 35' ' ' LEU . 80.6 mt -71.99 -25.07 61.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.35 110.944 179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.519 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.33 -24.54 46.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.38 111.0 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.76 -29.79 17.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.29 111.156 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.867 HD21 HD23 ' A' ' 32' ' ' LEU . 1.6 pp -91.58 -35.46 14.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.221 -0.445 . . . . 0.29 110.945 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.695 HG21 HG12 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -102.16 -44.89 5.31 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 0.23 111.13 -179.978 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.22 -12.16 49.12 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.704 -0.76 . . . . 0.27 112.555 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -67.67 -62.8 1.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 1.93 110.871 -179.85 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -95.56 -38.99 10.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.093 -0.503 . . . . 2.61 110.94 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.1 -131.32 5.77 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 0.24 112.492 179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.8 ttt85 -152.88 151.73 30.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.932 0.396 . . . . 3.51 110.832 -179.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG21 ' HA ' ' A' ' 33' ' ' GLN . 89.6 t -135.01 125.06 44.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.488 . . . . 0.22 111.107 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -115.87 152.49 33.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.22 110.833 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.7 p -113.32 133.66 58.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.099 -0.5 . . . . 0.18 111.089 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -140.93 150.83 43.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 1.59 110.874 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -103.44 134.64 46.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.45 110.833 -179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.788 HD13 HG21 ' A' ' 73' ' ' THR . 35.2 mt -51.56 -34.56 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.31 111.151 179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -71.46 -34.76 70.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.507 . . . . 2.0 110.896 179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -101.1 16.15 26.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.262 -0.427 . . . . 3.67 110.874 -179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.686 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.3 OUTLIER -48.87 -42.8 37.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 1.17 110.89 -179.971 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.587 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -55.5 -39.48 70.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 3.33 110.908 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -85.16 -13.14 51.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 5.15 110.924 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.7 m -77.19 -0.47 25.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 1.68 110.874 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.706 ' HB2' ' HG3' ' A' ' 82' ' ' GLU . . . -69.1 70.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.65 111.135 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -51.06 -73.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.439 . . . . 1.49 110.78 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.666 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -142.58 -165.18 1.98 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.243 -0.435 . . . . 1.21 110.915 -179.954 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -106.36 128.71 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 2.15 110.866 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 48.44 71.54 0.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.32 110.826 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 76.7 p -126.39 -32.13 2.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.28 110.802 -179.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.441 ' O ' HD23 ' A' ' 87' ' ' LEU . 99.1 m-85 -100.24 119.31 38.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 1.43 110.897 -179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.39 -20.04 62.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.076 -0.511 . . . . 1.52 110.88 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.1 mt -143.99 144.46 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.25 111.161 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.934 HG21 HG23 ' A' ' 83' ' ' ILE . 22.3 mm -137.66 127.85 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.14 111.185 179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.3 mm? -111.3 137.98 48.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.22 110.885 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.408 ' HA ' ' HB ' ' A' ' 15' ' ' VAL . 0.9 OUTLIER -129.63 100.96 5.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.13 110.879 -179.981 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.37 72.2 0.56 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.687 -0.768 . . . . 0.18 112.512 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.578 HD13 ' OE1' ' A' ' 158' ' ' GLN . 3.9 mm? -103.86 58.85 0.73 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.813 0.339 . . . . 0.62 110.939 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.2 159.73 65.59 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.546 0.688 . . . . 0.22 111.172 179.796 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.89 117.42 5.08 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.65 2.233 . . . . 0.22 112.302 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.51 7.24 72.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.818 -0.706 . . . . 0.2 112.53 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 p -55.72 146.83 20.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.997 0.427 . . . . 0.69 110.845 -179.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.742 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 34.8 p -136.11 108.58 7.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.151 -0.477 . . . . 0.18 111.127 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.788 HG21 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -160.87 147.51 15.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.25 111.143 179.971 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.964 HD12 HD22 ' A' ' 147' ' ' LEU . 5.4 mt -123.63 103.54 8.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.25 110.911 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -81.26 141.95 33.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.34 110.893 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.3 m -123.57 174.73 7.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.46 110.804 -179.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.23 -39.08 55.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.06 -0.518 . . . . 0.36 111.144 179.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.38 -46.05 91.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.144 -0.48 . . . . 2.14 110.889 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.686 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -73.15 -55.33 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.4 111.062 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.574 HD13 ' HA ' ' A' ' 119' ' ' LEU . 57.1 mt -49.75 -37.68 30.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 0.26 110.933 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -50.75 -57.0 9.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.41 111.096 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.706 ' HG3' ' HB2' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -57.05 -40.58 77.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.189 -0.459 . . . . 2.7 110.905 -179.912 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.934 HG23 HG21 ' A' ' 63' ' ' ILE . 51.9 mm -59.33 -67.58 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.33 111.095 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.43 -33.69 31.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.27 111.106 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.86 -57.23 13.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 2.21 110.824 -179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 56' ' ' LYS . 26.7 pt -75.15 -8.88 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.26 111.172 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.6 OUTLIER -77.07 125.84 29.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.143 -0.481 . . . . 0.39 110.924 179.875 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -67.05 160.52 69.95 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.651 0.738 . . . . 3.67 110.966 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.68 114.06 3.57 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.631 2.221 . . . . 0.19 112.366 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.83 3.99 56.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.17 112.468 179.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.12 -164.48 17.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 0.13 112.435 -179.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 61.2 m -135.32 150.6 50.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.35 110.892 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.694 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.4 tm? -135.44 114.4 12.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.15 110.867 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.538 ' N ' HD22 ' A' ' 93' ' ' LEU . 59.1 m-85 -109.59 132.35 54.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 1.68 110.88 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.545 HD23 HD11 ' A' ' 93' ' ' LEU . 1.1 pp -148.48 164.16 35.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.19 110.905 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -136.26 124.56 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 1.92 110.959 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.451 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -146.31 150.52 41.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.604 0.716 . . . . 2.3 110.945 179.935 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.599 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.9 Cg_endo -69.7 139.87 41.49 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.697 2.265 . . . . 0.22 112.382 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.7 m -121.37 147.27 25.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.37 111.119 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.47 ' CD ' HG21 ' A' ' 103' ' ' VAL . 50.7 mt-10 -119.31 131.92 55.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.469 . . . . 1.96 110.925 -179.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 12.8 p -92.73 -36.24 13.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 1.48 111.123 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.51 37.33 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.71 111.137 179.863 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.47 HG21 ' CD ' ' A' ' 100' ' ' GLU . 30.7 t -147.68 149.35 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.79 111.123 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.54 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -56.59 179.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 1.71 110.81 179.98 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.41 -74.14 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 2.71 110.857 -179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -54.74 -77.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 1.85 110.945 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 53.25 -169.3 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.476 . . . . 1.64 110.955 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.65 -4.08 52.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 2.35 110.945 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.5 m -145.85 141.18 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.253 -0.43 . . . . 0.55 111.143 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.599 ' H ' HD22 ' A' ' 74' ' ' LEU . 2.1 mmtm -65.66 111.54 3.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 2.88 110.878 179.887 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.54 HG21 ' O ' ' A' ' 104' ' ' ASP . 44.8 p -81.0 177.39 9.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.298 -0.41 . . . . 0.2 111.165 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -53.56 -55.29 26.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.121 -0.491 . . . . 0.22 111.191 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.4 m -60.49 -49.68 76.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.27 110.877 -179.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -38.51 70.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 2.83 110.943 179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.492 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -65.4 -54.89 22.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.32 110.874 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 48.2 m -57.67 -45.33 85.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.26 110.856 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -42.95 88.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.138 -0.483 . . . . 0.34 110.858 -179.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.84 -41.84 97.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.24 111.088 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.574 ' HA ' HD13 ' A' ' 80' ' ' LEU . 14.5 tp -65.52 -50.46 65.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.22 110.878 -179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 95.5 m -64.13 -31.72 73.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.24 111.131 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 16.2 mt -86.75 -10.39 53.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.402 . . . . 0.63 110.894 179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.07 5.17 30.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.416 . . . . 1.77 110.859 -179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.27 6.42 33.81 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.672 -0.775 . . . . 0.54 112.405 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -106.67 172.44 6.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.777 0.322 . . . . 0.27 110.985 -179.949 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' A' ' 126' ' ' GLU . 24.4 m -151.18 173.16 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.26 111.101 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HG3' HG23 ' A' ' 125' ' ' VAL . 36.6 mt-10 53.37 43.93 30.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 2.22 110.862 -179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 95.5 t -77.5 141.35 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 0.27 111.03 -179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.05 161.43 8.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 1.7 110.841 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 20.4 tt0 -82.26 145.9 29.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 2.09 110.855 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.0 mp -105.59 -35.97 7.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.071 -0.513 . . . . 0.33 110.927 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.41 175.82 13.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 1.19 110.981 179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -128.62 147.95 50.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 4.12 110.834 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -137.32 134.4 18.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.695 0.759 . . . . 1.4 110.955 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.412 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.1 Cg_endo -69.77 165.21 31.73 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.737 2.292 . . . . 0.24 112.352 -179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.753 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -97.77 125.53 42.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.29 110.894 179.998 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.448 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -101.97 161.95 21.85 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.603 0.716 . . . . 1.27 111.089 -179.977 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.448 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.9 Cg_endo -69.75 -27.85 26.01 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.822 2.348 . . . . 0.33 112.253 179.969 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.54 -18.13 34.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 2.66 110.888 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.59 -54.27 4.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 2.78 110.931 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.0 p -49.89 -39.96 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.24 111.086 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -34.11 76.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 1.17 110.912 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.7 -47.16 67.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 0.26 110.811 -179.772 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.69 HG23 HD13 ' A' ' 147' ' ' LEU . 11.1 p -68.08 -30.02 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.16 111.197 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -75.76 -32.25 59.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 1.94 110.908 179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 48.0 mm-40 -89.4 -20.16 24.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 1.74 110.916 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -94.34 -32.84 13.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.095 -0.502 . . . . 0.3 110.848 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.964 HD22 HD12 ' A' ' 74' ' ' LEU . 2.3 mp -128.11 -54.1 1.29 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.3 110.88 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 130.6 16.25 1.68 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.709 -0.758 . . . . 0.29 112.433 179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.4 t-160 -72.84 122.0 20.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.733 0.302 . . . . 0.88 110.887 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -151.51 105.45 3.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.246 -0.434 . . . . 2.1 110.848 -179.859 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.2 t -160.54 170.03 21.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.69 110.882 -179.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.14 -14.07 15.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.073 -0.512 . . . . 1.97 110.891 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -101.74 23.39 11.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 1.72 110.855 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.753 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -92.25 163.49 13.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.23 -0.441 . . . . 0.3 110.891 -179.962 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.587 ' HA ' HD23 ' A' ' 135' ' ' LEU . 2.6 tm? -169.72 130.69 1.05 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.22 110.939 179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.742 ' CZ ' HG22 ' A' ' 72' ' ' THR . 26.3 m-85 -76.42 136.86 39.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 1.79 110.874 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.54 145.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.37 111.128 179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.578 ' OE1' HD13 ' A' ' 67' ' ' LEU . 2.9 tt0 -97.83 129.62 44.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 1.9 110.898 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 3.8 mp -124.44 149.18 28.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.21 111.071 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.475 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.5 t -126.8 160.73 30.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.31 111.087 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -151.7 128.88 2.67 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.68 -0.772 . . . . 0.19 112.495 179.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -90.02 139.67 30.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.908 0.385 . . . . 1.55 110.84 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.81 135.22 49.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.567 0.699 . . . . 1.24 110.873 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 128.41 16.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.647 2.231 . . . . 0.38 112.298 179.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -108.43 149.48 28.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.854 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -65.05 92.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 7.28 110.897 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -179.33 34.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 9.0 110.857 -179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.87 -69.36 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 6.04 111.054 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.77 -19.82 4.94 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.835 -0.698 . . . . 5.63 112.525 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 15.8 m -59.42 -175.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 6.57 110.851 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -68.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 6.96 110.798 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 82.7 mtm-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.1 -0.5 . . . . 7.77 110.974 180.0 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.817 0.342 . . . . 3.69 110.886 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.16 -18.78 64.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.59 111.1 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.99 -50.91 65.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 1.86 110.839 179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 6' ' ' ILE . 8.3 m-85 -122.31 13.82 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 1.98 110.797 -179.839 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.76 38.98 96.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.742 -0.742 . . . . 0.23 112.504 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 4' ' ' PHE . 1.7 mp -78.9 158.78 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.22 111.071 -179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.662 ' O ' HG23 ' A' ' 36' ' ' THR . 0.9 OUTLIER -152.65 162.07 41.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 1.35 110.915 -179.921 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 39' ' ' GLU . . . -89.23 126.32 35.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.26 111.058 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.08 -5.85 17.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.674 -0.774 . . . . 0.25 112.46 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -114.13 168.96 9.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.769 0.319 . . . . 1.19 110.857 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -98.58 140.64 32.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 1.32 110.808 -179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.654 HG22 ' HB ' ' A' ' 62' ' ' ILE . 61.9 t -142.63 138.46 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 1.84 111.135 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.764 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -115.4 123.94 49.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.23 111.136 179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.805 HG11 HG12 ' A' ' 29' ' ' VAL . 59.1 t -97.43 118.19 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.24 111.1 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.503 HG12 ' CG1' ' A' ' 47' ' ' ILE . 13.4 t -102.47 110.98 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.29 111.092 179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 14.1 p-90 -112.4 167.38 10.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.19 110.928 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' A' ' 47' ' ' ILE . 10.1 p-10 -151.18 -169.46 3.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 1.69 110.858 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.98 -35.95 69.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 5.75 110.857 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.8 m -72.95 -10.34 59.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.274 -0.421 . . . . 1.52 110.869 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -106.91 94.48 10.68 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 0.16 110.879 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 141.42 45.29 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.718 2.279 . . . . 0.21 112.396 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.0 t -48.64 -32.9 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 0.24 111.128 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -51.28 -52.64 43.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 3.15 110.891 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.53 -44.94 10.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.22 111.036 179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.486 HD22 HG13 ' A' ' 29' ' ' VAL . 2.1 tm? -51.87 -61.55 2.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.275 -0.421 . . . . 0.19 110.939 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -37.41 28.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 2.82 110.874 179.84 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.21 -47.37 53.04 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.763 -0.732 . . . . 0.27 112.457 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.2 mt -61.93 -39.97 93.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.53 110.92 -179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.805 HG12 HG11 ' A' ' 14' ' ' VAL . 18.1 m -76.82 -31.56 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.069 -0.514 . . . . 0.63 111.12 179.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -61.98 -59.8 4.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 1.85 110.868 179.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.56 -40.2 71.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.425 . . . . 2.4 110.876 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.887 HD23 HD21 ' A' ' 35' ' ' LEU . 82.6 mt -72.94 -24.57 60.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.24 110.957 179.905 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.402 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.2 mt-30 -78.59 -25.36 45.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.43 110.917 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.88 -30.0 17.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.474 . . . . 0.37 111.076 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.887 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.48 -35.08 14.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.454 . . . . 0.27 110.894 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.59 -45.49 4.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.31 111.128 179.939 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.07 -12.29 54.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.747 -0.74 . . . . 0.45 112.445 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.39 -62.54 1.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.77 0.319 . . . . 2.86 110.951 -179.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 3.6 mm-40 -84.81 -43.6 14.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 2.04 110.923 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.52 -121.86 4.31 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.812 -0.709 . . . . 0.33 112.471 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 42.2 ttt85 -157.03 153.84 28.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 3.32 110.853 -179.822 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 33' ' ' GLN . 95.0 t -139.24 129.91 32.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.242 -0.435 . . . . 0.35 111.084 -179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -118.2 157.95 26.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.18 110.816 -179.801 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.87 135.07 60.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.18 111.19 179.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -145.45 151.76 38.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 1.29 110.811 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -102.85 135.94 43.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.081 -0.509 . . . . 0.41 110.913 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.724 ' CD1' HG21 ' A' ' 73' ' ' THR . 23.1 mt -51.34 -35.03 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.24 -0.436 . . . . 0.24 111.087 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -32.05 62.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.083 -0.508 . . . . 2.67 110.863 179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -96.7 19.48 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.266 -0.425 . . . . 3.36 110.882 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.736 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -47.67 -31.05 4.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.268 -0.424 . . . . 1.13 110.91 -179.929 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -54.31 -36.3 63.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 1.09 110.947 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -85.46 -15.91 41.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 1.07 110.991 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 54.5 m -64.01 -13.32 45.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.93 110.874 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.64 65.2 0.95 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.161 -0.472 . . . . 0.37 111.118 179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -63.84 -72.46 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.4 110.888 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.732 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -140.77 -166.28 2.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 1.61 110.967 179.954 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -106.69 127.13 53.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.957 0.408 . . . . 1.69 110.885 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 49.15 75.88 0.14 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.099 -0.5 . . . . 1.25 110.886 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.2 p -127.48 -34.4 2.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.25 110.808 -179.813 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.472 ' O ' HD23 ' A' ' 87' ' ' LEU . 95.4 m-85 -98.54 120.82 39.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 1.48 110.885 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.5 -20.61 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 1.69 110.862 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.654 ' HB ' HG22 ' A' ' 12' ' ' VAL . 30.6 mt -143.87 144.23 23.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.226 -0.443 . . . . 0.32 111.101 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.933 HG21 HG23 ' A' ' 83' ' ' ILE . 23.1 mm -134.65 126.52 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.098 -0.501 . . . . 0.16 111.137 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 64' ' ' LEU . 2.2 mm? -111.16 131.96 54.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.19 110.841 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.7 100.01 6.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.14 110.852 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 51.59 75.37 0.22 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.792 -0.718 . . . . 0.17 112.479 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.42 HD13 ' OE1' ' A' ' 158' ' ' GLN . 4.6 mm? -106.27 55.71 0.67 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.891 0.377 . . . . 0.59 110.88 -179.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.425 HG23 ' HB3' ' A' ' 71' ' ' SER . 0.0 OUTLIER -123.96 160.07 53.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.579 0.705 . . . . 0.22 111.081 179.925 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 123.29 9.93 Favored 'Trans proline' 0 N--CA 1.465 -0.192 0 C-N-CA 122.653 2.236 . . . . 0.27 112.427 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.93 7.52 87.82 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.712 -0.756 . . . . 0.17 112.54 -179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 68' ' ' VAL . 9.7 p -55.58 149.1 14.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.052 0.453 . . . . 0.75 110.828 -179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.744 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 30.5 p -138.79 109.12 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.044 -0.526 . . . . 0.18 111.2 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.724 HG21 ' CD1' ' A' ' 47' ' ' ILE . 0.2 OUTLIER -160.43 156.77 26.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.31 111.106 -179.856 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.849 HD12 HD22 ' A' ' 147' ' ' LEU . 4.7 mt -135.04 106.55 6.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.29 110.915 179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -82.11 153.83 25.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.37 110.901 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.7 m -131.0 176.32 8.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.286 -0.415 . . . . 0.63 110.884 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.47 -36.28 43.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.486 . . . . 0.23 111.094 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -62.5 -42.79 99.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 1.62 110.868 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.736 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.4 mp -77.53 -55.58 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.3 111.138 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.472 HD13 ' HA ' ' A' ' 119' ' ' LEU . 56.0 mt -48.87 -49.69 38.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 0.27 110.998 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -49.89 -48.28 51.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.59 111.062 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.64 -46.76 88.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 4.92 110.903 -179.963 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.933 HG23 HG21 ' A' ' 63' ' ' ILE . 49.9 mm -53.63 -64.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.25 111.122 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.78 -41.38 61.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.27 111.134 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -51.63 -51.31 56.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.281 -0.418 . . . . 2.55 110.867 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 56' ' ' LYS . 47.4 pt -84.3 -6.29 10.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.2 111.175 179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -80.45 116.64 20.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.29 110.883 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -55.91 159.19 5.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.665 0.745 . . . . 2.3 110.811 179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.401 ' HA ' ' HG2' ' A' ' 163' ' ' LYS . 53.6 Cg_endo -69.74 113.93 3.53 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.721 2.281 . . . . 0.23 112.395 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.23 4.46 55.18 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.788 -0.72 . . . . 0.21 112.436 179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.53 -163.46 19.97 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.776 -0.726 . . . . 0.16 112.407 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 24.9 m -136.18 154.61 50.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.31 110.9 -179.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.715 ' HB3' HD21 ' A' ' 124' ' ' LEU . 1.3 tm? -138.94 116.36 11.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.2 110.904 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.581 ' N ' HD22 ' A' ' 93' ' ' LEU . 47.6 m-85 -111.68 131.26 55.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 1.7 110.831 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.486 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.67 163.44 37.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.067 -0.515 . . . . 0.19 110.851 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -137.11 134.43 36.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 3.58 110.894 179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.72 148.94 20.15 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.699 0.761 . . . . 3.48 110.876 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.607 ' HG2' HD21 ' A' ' 74' ' ' LEU . 53.6 Cg_endo -69.71 131.91 22.31 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.706 2.271 . . . . 0.46 112.383 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.2 m -120.15 146.59 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 0.29 111.197 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.28 132.87 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 3.43 110.875 -179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.1 p -102.56 26.61 7.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 1.06 111.152 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -147.77 24.72 1.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.164 -0.471 . . . . 0.64 111.114 179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 104' ' ' ASP . 3.3 t -145.22 160.39 13.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.21 -0.45 . . . . 0.73 111.11 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.601 ' O ' HG21 ' A' ' 111' ' ' THR . 0.1 OUTLIER -55.02 177.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 1.95 110.925 179.906 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -67.9 -53.03 29.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 3.43 110.875 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -70.88 -76.43 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 1.97 110.877 179.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.65 -168.6 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 1.54 110.851 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.4 -5.28 56.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 1.74 110.872 179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.1 m -146.02 140.92 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.52 111.149 179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -60.6 121.51 12.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 2.37 110.856 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.601 HG21 ' O ' ' A' ' 104' ' ' ASP . 47.3 p -90.02 177.2 6.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.3 111.13 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.07 -54.73 43.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.22 111.097 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -59.51 -48.51 81.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.25 110.872 -179.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.6 tppt? -56.73 -40.83 76.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 2.9 110.874 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.514 HD13 ' C ' ' A' ' 115' ' ' LEU . 3.4 tm? -62.91 -54.11 43.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.257 -0.429 . . . . 0.41 110.894 179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 56.3 m -55.83 -47.93 76.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.27 110.923 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -45.57 88.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.34 110.868 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.32 97.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.32 111.083 179.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.472 ' HA ' HD13 ' A' ' 80' ' ' LEU . 13.5 tp -65.94 -53.77 34.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.286 -0.416 . . . . 0.26 110.957 179.987 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 97.2 m -59.12 -33.48 70.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.38 111.155 179.918 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 27.4 mt -86.99 -10.27 53.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.87 110.953 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.2 m -85.06 4.85 32.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 1.68 110.814 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.14 11.25 26.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.733 -0.746 . . . . 0.71 112.492 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.715 HD21 ' HB3' ' A' ' 93' ' ' LEU . 0.8 OUTLIER -111.32 170.77 7.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 0.28 110.839 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.423 HG23 ' HG3' ' A' ' 126' ' ' GLU . 25.6 m -151.38 173.02 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.28 111.112 179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 125' ' ' VAL . 29.8 mt-10 51.72 43.88 29.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 2.2 110.81 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 96.8 t -75.54 143.63 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.36 111.15 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.16 158.42 6.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 1.56 110.949 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 32.2 tt0 -80.5 145.35 31.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 2.14 110.915 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.3 mp -104.34 -36.71 7.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.29 110.867 -179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.59 176.16 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 1.16 110.937 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.719 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.3 tmt_? -133.17 138.0 46.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 4.41 110.92 -179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -123.84 136.11 27.02 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.672 0.749 . . . . 1.5 110.868 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.425 ' HA ' HD21 ' A' ' 155' ' ' LEU . 53.3 Cg_endo -69.89 158.82 55.51 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.597 2.198 . . . . 0.31 112.342 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 155' ' ' LEU . 0.1 OUTLIER -94.44 124.53 38.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 0.54 110.91 -179.965 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.477 ' O ' HG12 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -105.07 162.7 18.95 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.639 0.733 . . . . 1.56 111.135 179.918 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 136' ' ' THR . 53.4 Cg_endo -69.79 -23.15 30.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.661 2.241 . . . . 0.66 112.31 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.79 -22.53 27.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.307 -0.406 . . . . 2.34 110.965 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -87.65 -53.91 4.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.091 -0.504 . . . . 3.98 110.911 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 136' ' ' THR . 7.7 p -50.66 -40.21 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.35 111.149 179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -31.98 73.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 1.31 110.987 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -51.38 19.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.46 110.89 -179.849 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.641 HG23 HD13 ' A' ' 147' ' ' LEU . 7.3 p -61.72 -28.29 43.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.098 -0.501 . . . . 0.29 111.098 179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -76.28 -48.24 20.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 2.46 110.86 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -73.63 -19.32 60.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 2.17 110.959 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -94.5 -33.56 13.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.65 110.82 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.849 HD22 HD12 ' A' ' 74' ' ' LEU . 2.2 mp -128.32 -54.43 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.72 110.925 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.81 12.66 1.91 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.736 -0.745 . . . . 0.63 112.556 179.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.405 ' HB3' HG22 ' A' ' 143' ' ' VAL . 21.9 t-160 -70.77 121.37 17.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.839 0.352 . . . . 0.93 110.834 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -152.04 105.48 3.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 2.73 110.946 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.48 175.02 13.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.153 -0.476 . . . . 0.66 110.826 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.82 -17.82 13.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.072 -0.513 . . . . 1.71 110.793 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -94.66 12.17 28.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 1.53 110.839 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.707 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.31 164.02 22.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.41 110.92 179.949 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.719 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.8 tm? -173.35 132.08 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.2 110.876 179.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.744 ' CZ ' HG22 ' A' ' 72' ' ' THR . 17.7 m-85 -77.09 131.86 38.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 1.73 110.845 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.69 144.37 23.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.21 111.139 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.527 ' HG2' HD13 ' A' ' 130' ' ' LEU . 3.4 tt0 -102.01 130.6 48.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.126 -0.488 . . . . 2.06 110.898 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 129' ' ' GLU . 4.3 mp -126.03 149.72 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.31 111.183 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.45 ' N ' HD11 ' A' ' 130' ' ' LEU . 2.5 t -127.88 160.48 31.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.29 111.062 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.52 132.22 3.75 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.83 -0.7 . . . . 0.15 112.606 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -94.71 140.84 29.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.925 0.393 . . . . 1.77 110.925 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.401 ' HG2' ' HA ' ' A' ' 89' ' ' PRO . 6.2 tptm -81.46 134.52 51.23 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.621 0.724 . . . . 1.4 110.851 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 118.75 5.87 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.775 2.316 . . . . 0.42 112.328 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -100.48 152.02 20.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.5 110.895 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 12.4 t80 61.13 19.53 10.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 6.1 110.902 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -179.2 -172.65 0.25 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 9.73 110.908 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.68 -75.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 9.31 111.16 179.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 52.27 70.29 0.94 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.772 -0.728 . . . . 8.11 112.525 -179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 46.6 p -175.38 32.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.851 0.358 . . . . 10.07 110.854 -179.714 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 69.26 -75.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 10.67 110.814 -179.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 30.2 ttp85 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.495 . . . . 9.27 110.951 -179.885 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.0 ptp . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.75 0.31 . . . . 3.71 110.866 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.42 -21.73 63.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.25 -0.432 . . . . 0.49 111.04 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -54.14 -51.59 63.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.328 -0.396 . . . . 2.72 110.851 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.401 ' HB2' HD11 ' A' ' 6' ' ' ILE . 5.2 m-85 -122.4 22.13 10.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 1.53 110.758 -179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.51 41.92 56.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.814 -0.708 . . . . 0.31 112.445 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.483 ' CG2' HD11 ' A' ' 35' ' ' LEU . 1.6 mp -81.51 160.22 3.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.817 0.342 . . . . 0.34 111.099 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 36' ' ' THR . 0.4 OUTLIER -156.48 168.21 28.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 1.72 110.818 -179.927 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 35' ' ' LEU . . . -89.64 130.62 35.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.4 111.099 179.881 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.15 2.79 29.79 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.719 -0.753 . . . . 0.3 112.448 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.414 HE22 HD12 ' A' ' 62' ' ' ILE . 3.0 pt20 -116.96 166.88 11.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.779 0.323 . . . . 1.05 110.958 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -106.02 115.19 29.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 1.3 110.848 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.591 HG13 HG21 ' A' ' 36' ' ' THR . 3.4 m -117.95 139.78 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 2.31 111.151 179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.761 ' HB3' ' CD1' ' A' ' 63' ' ' ILE . . . -114.04 112.12 22.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.39 111.089 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.892 HG11 HG12 ' A' ' 29' ' ' VAL . 95.9 t -87.65 121.87 38.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.21 111.163 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.592 HG12 HG13 ' A' ' 47' ' ' ILE . 17.6 t -108.29 119.84 58.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.2 111.219 179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 11.4 p-90 -117.8 166.15 12.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.19 110.972 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.646 ' HB3' HD12 ' A' ' 47' ' ' ILE . 6.2 p-10 -145.65 -169.06 3.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.309 -0.405 . . . . 1.69 110.872 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -59.59 -35.28 73.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 3.44 110.937 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.4 m -74.68 -6.92 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 1.53 110.86 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 1.5 m -107.62 92.7 8.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.682 0.753 . . . . 0.13 110.906 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 20' ' ' SER . 54.9 Cg_endo -69.71 143.08 49.94 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.689 2.259 . . . . 0.2 112.413 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t -48.8 -32.77 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.18 111.193 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -51.0 -53.26 34.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 3.13 110.872 -179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.57 -44.95 10.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.055 -0.521 . . . . 0.16 111.12 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.461 HD22 HG13 ' A' ' 29' ' ' VAL . 2.0 tm? -51.45 -61.95 1.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.13 110.968 179.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -49.52 -35.77 21.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 2.6 110.921 179.818 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.87 -47.67 45.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.677 -0.773 . . . . 0.19 112.548 179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.4 mt -61.73 -39.86 93.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.92 0.391 . . . . 0.48 110.987 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.892 HG12 HG11 ' A' ' 14' ' ' VAL . 17.0 m -76.65 -31.18 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.216 -0.447 . . . . 0.63 111.199 179.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -62.38 -59.68 4.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.1 -0.5 . . . . 1.66 110.807 179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 -40.29 72.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 1.7 110.945 179.943 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.862 HD23 HD21 ' A' ' 35' ' ' LEU . 86.4 mt -72.78 -24.93 61.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.24 110.883 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.478 ' HA ' HG21 ' A' ' 42' ' ' VAL . 3.1 mt-30 -78.49 -25.01 45.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.38 110.82 -180.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.59 -29.95 17.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.22 111.094 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.862 HD21 HD23 ' A' ' 32' ' ' LEU . 1.4 pp -91.6 -34.82 14.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.19 110.892 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.739 HG23 ' O ' ' A' ' 7' ' ' SER . 0.2 OUTLIER -104.17 -45.6 4.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.22 111.134 179.918 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -65.47 -12.27 55.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.76 -0.733 . . . . 0.3 112.505 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -65.33 -62.66 1.4 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 2.62 110.989 -179.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -98.09 -36.49 10.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 1.88 110.925 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.32 -128.74 4.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.8 -0.714 . . . . 0.25 112.452 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -154.32 153.19 31.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 2.21 110.799 -179.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.549 HG22 HG22 ' A' ' 12' ' ' VAL . 94.8 t -138.88 117.05 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.45 . . . . 0.31 111.116 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.3 t -107.01 151.35 25.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.22 110.794 -179.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.4 p -114.24 136.29 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.05 -0.523 . . . . 0.14 111.02 -179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -144.99 152.2 39.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.142 -0.481 . . . . 1.27 110.842 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -102.8 134.34 46.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.48 110.952 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.926 HD13 HG21 ' A' ' 73' ' ' THR . 10.2 mt -50.29 -33.56 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.34 111.101 179.945 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -76.48 -34.3 58.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 2.64 110.878 179.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -93.37 18.57 9.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.249 -0.432 . . . . 3.16 110.821 -179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.793 ' HG ' HG23 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -48.49 -30.25 4.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 1.12 110.961 179.891 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mp -53.45 -37.95 63.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.152 -0.476 . . . . 1.08 110.844 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -85.23 -16.18 41.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 1.18 110.834 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.467 ' HB2' HD13 ' A' ' 50' ' ' LEU . 48.8 m -65.41 -12.38 51.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.276 -0.42 . . . . 0.95 110.873 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.84 61.2 1.0 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.41 111.099 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -58.62 -71.82 0.11 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.117 -0.492 . . . . 0.47 110.806 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.653 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -150.2 -168.68 3.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 1.75 110.866 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -102.18 137.71 40.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 1.94 110.899 179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.4 p 46.55 85.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 1.19 110.873 -179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.4 p -139.97 -40.49 0.44 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.193 -0.458 . . . . 0.46 110.865 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.494 ' O ' HD23 ' A' ' 87' ' ' LEU . 96.4 m-85 -99.64 120.42 39.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 1.48 110.889 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.62 -21.6 63.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 1.5 110.819 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.414 HD12 HE22 ' A' ' 10' ' ' GLN . 14.5 mt -147.16 142.64 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.38 111.165 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.921 HG21 HG23 ' A' ' 83' ' ' ILE . 22.5 mm -129.43 134.42 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.27 111.109 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 64' ' ' LEU . 1.9 mm? -114.54 135.24 54.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.29 110.924 179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.76 97.73 4.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.15 110.801 -179.833 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 52.48 79.54 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.22 112.47 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.88 56.69 0.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.59 110.959 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.31 159.35 57.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.617 0.723 . . . . 0.21 111.16 179.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 116.46 4.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.683 2.255 . . . . 0.25 112.375 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.31 7.37 69.82 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.2 112.533 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -54.79 144.25 23.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.974 0.416 . . . . 0.68 110.87 -179.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.76 HG22 ' CZ ' ' A' ' 156' ' ' PHE . 31.5 p -133.49 108.5 8.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 0.19 111.166 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.926 HG21 HD13 ' A' ' 47' ' ' ILE . 0.6 OUTLIER -162.7 149.53 13.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.25 111.095 -180.0 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.931 HD12 HD22 ' A' ' 147' ' ' LEU . 3.4 mt -127.52 99.99 5.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.13 -0.486 . . . . 0.26 110.967 179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -73.23 145.95 45.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.32 110.881 179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.513 ' H ' HD13 ' A' ' 79' ' ' ILE . 1.5 m -120.28 172.8 7.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.469 . . . . 0.55 110.742 -179.673 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.34 -39.7 47.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.33 111.125 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.6 -38.31 84.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 2.38 110.909 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.793 HG23 ' HG ' ' A' ' 50' ' ' LEU . 4.3 mp -79.81 -54.84 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.178 -0.465 . . . . 0.23 111.201 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' A' ' 119' ' ' LEU . 50.0 mt -49.84 -45.87 50.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.078 -0.51 . . . . 0.33 110.906 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -51.75 -51.65 54.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.174 -0.467 . . . . 0.46 111.014 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.25 -42.48 77.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 2.61 110.886 -179.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.921 HG23 HG21 ' A' ' 63' ' ' ILE . 36.9 mm -59.93 -68.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 0.28 111.093 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.57 -32.68 19.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.45 111.127 179.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -61.02 -56.15 24.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 2.35 110.906 -179.926 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 56' ' ' LYS . 29.8 pt -76.95 -6.72 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.3 111.165 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 60' ' ' PHE . 0.5 OUTLIER -78.36 124.31 27.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.27 110.891 179.923 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -62.67 160.23 37.23 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.572 0.701 . . . . 2.13 110.869 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 114.04 3.56 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.73 2.286 . . . . 0.23 112.318 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.71 3.5 56.12 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.819 -0.705 . . . . 0.21 112.44 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.11 -156.9 9.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.716 -0.754 . . . . 0.22 112.423 -179.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' CYS . . . . . . . . . . . . . 11.3 m -146.0 158.18 43.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.888 0.375 . . . . 0.5 110.833 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.631 HD22 ' N ' ' A' ' 94' ' ' PHE . 1.0 OUTLIER -140.38 116.14 10.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.18 110.954 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.631 ' N ' HD22 ' A' ' 93' ' ' LEU . 51.0 m-85 -108.76 132.73 53.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.63 110.84 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.533 HD23 HD11 ' A' ' 93' ' ' LEU . 1.0 OUTLIER -148.56 160.59 42.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.141 -0.481 . . . . 0.16 110.878 179.944 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.69 126.37 36.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.145 -0.48 . . . . 1.81 110.862 179.807 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.522 ' OE1' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -149.9 148.13 24.36 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.659 0.742 . . . . 2.3 110.875 179.982 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.6 ' HG2' HD21 ' A' ' 74' ' ' LEU . 54.5 Cg_endo -69.65 143.95 53.05 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.718 2.279 . . . . 0.23 112.386 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.485 HG22 ' O ' ' A' ' 155' ' ' LEU . 4.6 m -127.12 147.0 32.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 0.25 111.1 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.01 132.42 56.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 3.15 110.811 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 31.7 p -104.75 25.99 9.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 1.04 111.247 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -149.65 26.31 0.83 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.74 111.104 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 104' ' ' ASP . 4.8 t -144.09 158.64 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.75 111.114 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.543 ' O ' HG21 ' A' ' 111' ' ' THR . 0.3 OUTLIER -57.11 -177.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 1.86 110.886 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -66.5 -73.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 2.4 110.874 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -56.34 -75.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.448 . . . . 2.34 110.834 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.75 -168.56 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 1.68 110.747 -179.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.05 -6.28 57.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 1.74 110.886 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.3 m -146.61 143.44 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.967 0.413 . . . . 0.48 111.079 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.491 ' H ' HD22 ' A' ' 74' ' ' LEU . 7.6 ttmt -65.61 113.18 4.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.4 110.963 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.543 HG21 ' O ' ' A' ' 104' ' ' ASP . 30.3 p -83.19 179.83 7.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.25 111.187 179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.65 -54.27 47.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.28 111.042 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -49.54 76.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.26 110.865 -179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.38 -39.74 76.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 2.14 110.865 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.522 HD23 ' OE1' ' A' ' 97' ' ' GLU . 3.3 tm? -62.97 -55.1 28.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.4 110.965 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.7 m -57.84 -47.43 82.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.27 -0.423 . . . . 0.25 110.853 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.49 -44.33 96.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.28 110.912 -179.736 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -57.11 -50.96 71.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.3 111.182 179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.634 ' CD1' HD22 ' A' ' 80' ' ' LEU . 7.1 tp -59.68 -57.31 13.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.54 110.865 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 99.1 m -57.52 -26.56 61.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.38 111.14 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.9 mt -84.3 -16.0 44.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.75 110.93 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.0 p -82.2 3.09 28.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 2.52 110.809 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.81 -4.85 34.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.776 -0.726 . . . . 0.92 112.49 -179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.637 HD23 ' HA3' ' A' ' 161' ' ' GLY . 1.4 tp -83.32 171.3 13.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.896 0.379 . . . . 0.54 110.92 -179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.07 169.66 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 0.42 111.146 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 51.64 44.93 28.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 2.24 110.881 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.16 139.44 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.28 111.149 -179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.18 159.98 7.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 1.84 110.879 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -77.54 145.29 37.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 2.61 110.913 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.712 HD13 ' HG2' ' A' ' 158' ' ' GLN . 2.1 mp -102.16 -37.53 8.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.25 110.917 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -156.04 176.27 12.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 3.0 110.957 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . 0.726 ' HG2' HD11 ' A' ' 155' ' ' LEU . 2.0 tmt_? -129.39 136.87 50.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.328 -0.397 . . . . 4.23 110.929 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -123.55 136.56 27.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.62 0.724 . . . . 1.39 110.999 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.403 ' HA ' HD21 ' A' ' 155' ' ' LEU . 54.7 Cg_endo -69.71 163.2 39.11 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.649 2.233 . . . . 0.26 112.388 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.669 ' HG ' HD13 ' A' ' 154' ' ' LEU . 0.2 OUTLIER -96.79 124.35 40.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.174 -0.466 . . . . 0.29 110.909 179.97 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.456 HG22 ' HD2' ' A' ' 137' ' ' PRO . 0.1 OUTLIER -99.09 161.21 25.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.64 0.734 . . . . 1.32 111.145 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 136' ' ' THR . 53.8 Cg_endo -69.77 -28.57 25.06 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.704 2.27 . . . . 0.46 112.32 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -85.1 -17.76 36.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.217 -0.447 . . . . 2.49 110.936 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.32 -54.0 4.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 2.82 110.998 -179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -49.58 -40.03 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.26 111.095 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -34.72 76.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 1.28 110.86 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.26 -46.77 69.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.29 110.793 -179.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.71 HG23 HD13 ' A' ' 147' ' ' LEU . 10.3 p -68.0 -30.03 46.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.132 -0.486 . . . . 0.21 111.183 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -75.66 -32.25 60.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 2.04 110.923 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -89.43 -20.29 24.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 1.61 110.901 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -94.36 -32.55 13.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.3 110.828 -179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.931 HD22 HD12 ' A' ' 74' ' ' LEU . 2.5 mp -128.31 -54.05 1.27 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.33 110.843 -179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 131.38 12.12 2.09 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.807 -0.711 . . . . 0.31 112.49 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -70.9 121.53 18.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.682 0.277 . . . . 0.66 110.853 -179.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -152.18 105.27 3.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.296 -0.411 . . . . 2.27 110.923 -179.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 7.7 t -160.73 176.52 11.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.61 110.91 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.12 -20.8 13.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 1.7 110.952 179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -92.02 13.13 19.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.445 . . . . 1.57 110.938 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.669 HD13 ' HG ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -81.54 163.89 22.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.33 110.921 179.909 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' A' ' 132' ' ' ARG . 2.6 tm? -173.35 129.99 0.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.2 110.851 179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.76 ' CZ ' HG22 ' A' ' 72' ' ' THR . 31.3 m-85 -75.39 137.62 41.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 1.71 110.882 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 132' ' ' ARG . 0.0 OUTLIER -150.3 146.41 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.23 111.154 -179.985 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.712 ' HG2' HD13 ' A' ' 130' ' ' LEU . 23.2 tt0 -98.9 132.05 44.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 1.57 110.926 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.7 mp -126.99 149.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.23 111.144 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.464 ' N ' HD11 ' A' ' 130' ' ' LEU . 7.0 t -137.06 152.64 50.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.37 111.094 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.637 ' HA3' HD23 ' A' ' 124' ' ' LEU . . . -144.1 137.48 7.41 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.768 -0.73 . . . . 0.17 112.483 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -92.83 140.18 29.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.373 . . . . 1.75 110.832 -179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.57 135.29 49.77 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.622 0.725 . . . . 1.26 110.855 179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.88 127.47 14.55 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.724 2.283 . . . . 0.32 112.292 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -107.67 149.24 28.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.34 110.908 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -69.31 85.31 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 7.01 110.953 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -179.46 34.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 9.25 110.851 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 26.6 m -150.06 166.35 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 6.07 111.121 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -112.41 -19.61 6.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.685 -0.769 . . . . 6.35 112.531 179.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 87.1 p -53.51 170.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.341 . . . . 7.17 110.869 -179.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.48 -170.97 3.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 7.28 110.89 -179.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 10.81 110.864 -179.917 . . . . . . . . 1 1 . 1 stop_ save_